PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fargier, G; Favard, C; Parmeggiani, A; Sahuquet, A; Merezegue, F; Morel, A; Denis, M; Molinari, N; Mangeat, PH; Coopman, PJ; Montcourrier, P				Fargier, Guillaume; Favard, Cyril; Parmeggiani, Andrea; Sahuquet, Alain; Merezegue, Fabrice; Morel, Anne; Denis, Marie; Molinari, Nicolas; Mangeat, Paul H.; Coopman, Peter J.; Montcourrier, Philippe			Centrosomal targeting of Syk kinase is controlled by its catalytic activity and depends on microtubules and the dynein motor	FASEB JOURNAL			English	Article						tyrosine kinase; breast cancer	PROTEIN-TYROSINE KINASE; BREAST-CANCER CELLS; ANTIGEN RECEPTOR; GAMMA-TUBULIN; LIVING CELLS; PHOSPHORYLATION; GENE; DYNACTIN; ADHESION; CARCINOMA	The nonreceptor Syk kinase is detected in epithelial cells, where it acts as a tumor suppressor, in addition to its well-established role in immunoreceptor-based signal transduction in hematopoietic cells. Thus, several carcinomas and melanomas have subnormal concentrations of Syk. Although Syk is mainly localized at the plasma membrane, it is also present in centrosomes, where it is involved in the control of cell division. The mechanisms responsible for its centrosomal localization and action are unknown. We used wild-type and mutant fluorescent Syk fusion proteins in live-cell imaging (fluorescence recovery after photo-bleaching, total internal reflection fluorescence, and photoactivation) combined with mathematical modeling to demonstrate that Syk is actively transported to the centrosomes via the microtubules and that this transport depends on the dynein/dynactin molecular motor. Syk can only target the centrosomes if its kinase activity is intact and it is catalytically active at the centrosomes. We showed that the autophosphorylated Y130 Syk residue helps to uncouple Syk from the plasma membrane and to promote its translocation to the centrosome, suggesting that the subcellular location of Syk depends on its autophosphorylation on specific tyrosine residues. We have thus established the details of how Syk is trafficked intracellularly and found evidence that its targeting to the centrosomes is controlled by autophosphorylation.-Fargier, G., Favard, C., Parmeggiani, A., Sahuquet, A., Merezegue, F., Morel, A., Denis, M., Molinari, N., Mangeat, P. H., Coopman, P. J., Montcourrier, P. Centrosomal targeting of Syk kinase is controlled by its catalytic activity and depends on microtubules and the dynein motor. FASEB J. 27, 109-122 (2013). www.fasebj.org	[Fargier, Guillaume; Sahuquet, Alain; Merezegue, Fabrice; Morel, Anne; Mangeat, Paul H.; Coopman, Peter J.; Montcourrier, Philippe] Univ Montpellier I, CNRS, CRBM, UMR 5237, F-34298 Montpellier 5, France; [Fargier, Guillaume; Sahuquet, Alain; Merezegue, Fabrice; Morel, Anne; Mangeat, Paul H.; Coopman, Peter J.; Montcourrier, Philippe] Univ Montpellier 2, CNRS, CRBM, UMR 5237, Montpellier, France; [Fargier, Guillaume; Sahuquet, Alain; Merezegue, Fabrice; Morel, Anne; Mangeat, Paul H.; Coopman, Peter J.; Montcourrier, Philippe] Equipe Labellisee 2007 Ligue Natl Canc, Paris, France; [Favard, Cyril] Univ Montpellier I, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, F-34298 Montpellier 5, France; [Favard, Cyril] Univ Montpellier 2, CNRS, UMR 5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Parmeggiani, Andrea] Univ Montpellier 2, CNRS, UMR Biol Phys & Syst Biol 5235, Montpellier, France; [Denis, Marie; Molinari, Nicolas] Univ Montpellier I, Inst Univ Rech Clin, Lab Biostat Epidemiol & Sante Publ, Unite Pedagog Med, F-34298 Montpellier 5, France; [Coopman, Peter J.; Montcourrier, Philippe] Univ Montpellier I, INSERM, U896, IRCM,CRLC Val dAurelle, F-34298 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Montcourrier, P (corresponding author), Univ Montpellier I, INSERM, U896, IRCM,CRLC Val dAurelle, 208 Rue Apothicaires, F-34298 Montpellier 5, France.	philippe.montcourrier@inserm.fr	Andrea, Parmeggiani/ABF-6554-2020; Favard, Cyril/P-6392-2016; Coopman, Peter/G-7416-2019; molinari, nicolas/Y-9681-2019	Favard, Cyril/0000-0002-8304-2980; Coopman, Peter/0000-0003-3720-523X; Parmeggiani, Andrea/0000-0003-3025-4266	Fondation pour la Recherche Medicale [DGE-20101221267]; Institut National de la Recherche Medicale; Centre National de la Recherche Scientifique; Institut National du Cancer [PL06-111]; Ligue Nationale contre le Cancer (Equipe labelisee); Ministere de l'Enseignement Superieur et de la Recherche	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labelisee)(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche	The authors thank the Montpellier RIO Imaging platform, especially Nicole Lautredou and Vicky Diakou, and the Fondation pour la Recherche Medicale (DGE-20101221267) for microscope funding and Lise Roca (Centre Regional de Lutte Contre le Cancer Val d'Aurelle, Montpellier, France) for help with statistical analysis. PA-GFP was a kind gift from J. Lippincott-Schwartz (U. S. National Institute of Child Health and Human Development/National Institutes of Health, Bethesda, MD, USA), and the authors thank Andreas Merdes and Alexander Dammermann (Centre National de la Recherche Scientifique, Pierre Fabre, Toulouse, France) for the GFP-p50-dynamitin plasmid. The English text was edited by Dr. Owen Parkes. This work was supported by the Institut National de la Recherche Medicale and the Centre National de la Recherche Scientifique. Financial support was provided by grants from the Institut National du Cancer (PL06-111 to P. J. C.) and the Ligue Nationale contre le Cancer (Equipe labelisee 2007 to P. J. C.). G. F. was the recipient of a Ph. D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Campbell KS, 1998, J IMMUNOL, V161, P1728; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Dhillon VS, 2004, BRIT J CANCER, V90, P874, DOI 10.1038/sj.bjc.6601567; Faruki S, 2000, J CELL SCI, V113, P2557; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoeller C, 2005, J INVEST DERMATOL, V124, P1293, DOI 10.1111/j.0022-202X.2005.23685.x; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Ishwaran H, 2001, J AM STAT ASSOC, V96, P161, DOI 10.1198/016214501750332758; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Kunze E, 2008, HISTOL HISTOPATHOL, V23, P539, DOI 10.14670/HH-23.539; Larive RM, 2009, ONCOGENE, V28, P2337, DOI 10.1038/onc.2009.99; Layton T, 2009, AM J PATHOL, V175, P2625, DOI 10.2353/ajpath.2009.090543; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mochly-Rosen D, 1998, FASEB J, V12, P35; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; NAGAI K, 1994, J BIOCHEM-TOKYO, V116, P1176, DOI 10.1093/oxfordjournals.jbchem.a124646; Ogane S, 2009, INT J CANCER, V124, P2651, DOI 10.1002/ijc.24237; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Stupack DG, 1999, J CELL BIOL, V144, P777, DOI 10.1083/jcb.144.4.777; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Sung YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007445; TERRELL GR, 1992, ANN STAT, V20, P1236, DOI 10.1214/aos/1176348768; Tohyama Y, 2009, J BIOCHEM, V145, P267, DOI 10.1093/jb/mvp001; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; Uckun FM, 2010, BRIT J HAEMATOL, V148, P714, DOI 10.1111/j.1365-2141.2009.07983.x; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Ushmorov A, 2006, BLOOD, V107, P2493, DOI 10.1182/blood-2005-09-3765; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Wang S, 2004, WORLD J GASTROENTERO, V10, P1815; Xue L, 2012, P NATL ACAD SCI USA, V109, P5615, DOI 10.1073/pnas.1119418109; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; YANAGI S, 1995, CELL SIGNAL, V7, P185, DOI 10.1016/0898-6568(94)00088-S; Yanagi S, 2001, BIOCHEM BIOPH RES CO, V288, P495, DOI 10.1006/bbrc.2001.5788; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Yuan YF, 2006, CLIN CANCER RES, V12, P6687, DOI 10.1158/1078-0432.CCR-06-0921; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhao SP, 2011, ARCH GYNECOL OBSTET, V283, P1113, DOI 10.1007/s00404-010-1546-6; Zyss D, 2005, CANCER RES, V65, P10872, DOI 10.1158/0008-5472.CAN-05-1270	72	7	7	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					109	122		10.1096/fj.11-202465	http://dx.doi.org/10.1096/fj.11-202465			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047900				2022-12-25	WOS:000313103200012
J	Coquille, S; Roux, C; Fitzpatrick, TB; Thore, S				Coquille, Sandrine; Roux, Celine; Fitzpatrick, Teresa B.; Thore, Stephane			The Last Piece in the Vitamin B-1 Biosynthesis Puzzle STRUCTURAL AND FUNCTIONAL INSIGHT INTO YEAST 4-AMINO-5-HYDROXYMETHYL-2-METHYLPYRIMIDINE PHOSPHATE (HMP-P) SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; THIAMIN; ENZYMES; PYRIDOXINE; HISTIDINE; THIAZOLE; PROMOTER; IRON	Vitamin B-1 is essential for all organisms being well recognized as a necessary cofactor for key metabolic pathways such as glycolysis, and was more recently implicated in DNA damage responses. Little is known about the enzyme responsible for the formation of the pyrimidine moiety (4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate (HMP-P) synthase). We report a structure-function study of the HMP-P synthase from yeast, THI5p. Our crystallographic structure shows that THI5p is a mix between periplasmic binding proteins and pyridoxal 5'-phosphate-dependent enzymes. Mutational and yeast complementation studies identify the key residues for HMP-P biosynthesis as well as the use of pyridoxal 5'-phosphate as a substrate rather thanasacofactor. Furthermore, we could show that iron binding to HMP-P synthase is essential for the reaction.	[Roux, Celine; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Coquille, Sandrine; Thore, Stephane] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	Theresa.fitzpatrick@unige.ch; Stephane.thore@unige.ch	Thore, stéphane/M-7759-2014; Thore, Stephane/AAW-6482-2020	Thore, stéphane/0000-0001-7058-3887; Thore, Stephane/0000-0001-7058-3887; Coquille, Sandrine/0000-0001-6168-3659	Swiss National Science Foundation Research [PP00A-119186, 31003A-124909, 31003A-140924]; University of Geneva; E. Boninchi Foundation; E. & L. Schmidheiny Foundation; Swiss National Science Foundation R'equip Grant [316030-128787]	Swiss National Science Foundation Research(Swiss National Science Foundation (SNSF)); University of Geneva; E. Boninchi Foundation; E. & L. Schmidheiny Foundation; Swiss National Science Foundation R'equip Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Research Grants PP00A-119186 (to T. B. F.), 31003A-124909 and 31003A-140924 (to S. T.), and the University of Geneva.; We are indebted to Dr. Peter A. Meacock (University of Leicester) for kindly providing yeast strain RWY16. We thank the Functional Genomics Center Zurich for the mass spectrometry analysis. We are also grateful to Dr. Nicolas Szydlowski and Dr. Michael Moulin (University of Geneva) for assistance and for developing the vitamin B<INF>6</INF> HPLC method (to be published elsewhere) and to Dr. Markus Kaufmann (University of Geneva) for performing the static light scattering analysis. We thank all the members of the Thore laboratory for providing excellent feedback. We are grateful to Vincent Olieric and Wang Meitian at the Swiss Light Source and to Andrew McCarthy at the European Synchrotron Radiation Facility, whose outstanding efforts have made these experiments possible. We further acknowledge the financial contributions from the E. Boninchi Foundation, the E. & L. Schmidheiny Foundation, and the Swiss National Science Foundation R'equip Grant 316030-128787 used to set up the crystallography platform.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bale S, 2010, BIOCHEMISTRY-US, V49, P8929, DOI 10.1021/bi101209t; Beinert H, 1978, Methods Enzymol, V54, P435; Bisht S, 2012, J BIOL CHEM, V287, P20369, DOI 10.1074/jbc.M112.351809; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2011, NATURE, V478, P542, DOI 10.1038/nature10503; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Denesyuk AI, 2003, BBA-PROTEINS PROTEOM, V1647, P234, DOI 10.1016/S1570-9639(03)00057-8; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai RY, 2012, J AM CHEM SOC, V134, P9157, DOI 10.1021/ja302474a; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MAO B, 1982, J BIOL CHEM, V257, P1131; Matsuda N, 2004, J BIOCHEM, V135, P33, DOI 10.1093/jb/mvh004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore PS, 1995, BIOCHIMIE, V77, P724, DOI 10.1016/0300-9084(96)88189-2; Mozzarelli A, 2006, CHEM REC, V6, P275, DOI 10.1002/tcr.20094; Raschke M, 2007, P NATL ACAD SCI USA, V104, P19637, DOI 10.1073/pnas.0709597104; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STOOKEY L, 1970, TALANTA, V17, P644, DOI 10.1016/0039-9140(70)80016-9; TANG CSL, 1994, J BIOL CHEM, V269, P11921; Tazuya K, 1995, BIOCHEM MOL BIOL INT, V36, P883; Uenishi K, 2008, J NUTR SCI VITAMINOL, V54, P25, DOI 10.3177/jnsv.54.7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Zeidler J, 2003, J AM CHEM SOC, V125, P13094, DOI 10.1021/ja030261j; Zurlinden A, 1997, J BACTERIOL, V179, P5956, DOI 10.1128/jb.179.18.5956-5958.1997	39	19	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42333	42343		10.1074/jbc.M112.397240	http://dx.doi.org/10.1074/jbc.M112.397240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048037	Green Published, hybrid			2022-12-25	WOS:000312103000068
J	Purushothaman, A; Babitz, SK; Sanderson, RD				Purushothaman, Anurag; Babitz, Stephen K.; Sanderson, Ralph D.			Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGRESSIVE TUMOR PHENOTYPE; PROTEIN-KINASE; GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SUBSTRATE 1; IN-VIVO; EXPRESSION; METASTASIS; SYNDECAN-1; CANCER	ERK signaling regulates proliferation, survival, drug resistance, and angiogenesis in cancer. Although the mechanisms regulating ERK activation are not fully understood, we previously demonstrated that ERK phosphorylation is elevated by heparanase, an enzyme associated with aggressive behavior of many cancers. In the present study, myeloma cell lines expressing either high or low levels of heparanase were utilized to determine how heparanase stimulates ERK signaling. We discovered that the insulin receptor was abundant on cells expressing either high or low levels of heparanase, but the receptor was highly phosphorylated in heparanase-high cells compared with heparanase-low cells. In addition, protein kinase C activity was elevated in heparanase-high cells, and this enhanced expression of insulin receptor substrate-1 (IRS-1), the principle intracellular substrate for phosphorylation by the insulin receptor. Blocking insulin receptor function with antibody or a small molecule inhibitor or knockdown of IRS-1 expression using shRNA diminished heparanase-mediated ERK activation in the tumor cells. In addition, up-regulation of the insulin signaling pathway by heparanase and the resulting ERK activation were dependent on heparanase retaining its enzyme activity. These results reveal a novel mechanism whereby heparanase enhances activation of the insulin receptor signaling pathway leading to ERK activation and modulation of myeloma behavior.	[Purushothaman, Anurag; Babitz, Stephen K.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1720 2nd Ave S,WTI 602B, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340, P30 AR48311, P30 AR46031]; NATIONAL CANCER INSTITUTE [R01CA135075, R01CA138340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S).; We thank Dr. Israel Vlodavsky (Technion, Haifa, Israel) for providing recombinant heparanase. We acknowledge Enid Keyser at the University of Alabama at Birmingham flow cytometry core facility for assistance with flow analysis (supported by National Institutes of Health Grant P30 AR48311). Histology services were performed by the University of Alabama at Birmingham Center for Metabolic Bone Disease's Histomorphometry and Molecular Analysis Core Laboratory (supported by National Institutes of Health Grant P30 AR46031).	Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Birmann BM, 2009, CANCER EPIDEM BIOMAR, V18, P282, DOI 10.1158/1055-9965.EPI-08-0778; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang Q, 2002, CANCER RES, V62, P6035; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Dalmizrak O, 2007, CANCER RES, V67, P2124, DOI 10.1158/0008-5472.CAN-06-3954; Deangelis T, 2010, J CELL PHYSIOL, V224, P658, DOI 10.1002/jcp.22164; DeVente JE, 1996, J BIOL CHEM, V271, P32276, DOI 10.1074/jbc.271.50.32276; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ito T, 1996, MOL CELL BIOL, V16, P943; Kelly T, 2003, CANCER RES, V63, P8749; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; Levy-Adam F, 2010, SEMIN CANCER BIOL, V20, P153, DOI 10.1016/j.semcancer.2010.06.005; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tanaka S, 1997, HEPATOLOGY, V26, P598; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; WATERS SB, 1993, J BIOL CHEM, V268, P22231; WHITE MF, 1994, J BIOL CHEM, V269, P1; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	43	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41288	41296		10.1074/jbc.M112.391417	http://dx.doi.org/10.1074/jbc.M112.391417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048032	Green Published, hybrid			2022-12-25	WOS:000311887600043
J	Pitroda, SP; Zhou, T; Sweis, RF; Filippo, M; Labay, E; Beckett, MA; Mauceri, HJ; Liang, H; Darga, TE; Perakis, S; Khan, SA; Sutton, HG; Zhang, W; Khodarev, NN; Garcia, JGN; Weichselbaum, RR				Pitroda, Sean P.; Zhou, Tong; Sweis, Randy F.; Filippo, Matthew; Labay, Edwardine; Beckett, Michael A.; Mauceri, Helena J.; Liang, Hua; Darga, Thomas E.; Perakis, Samantha; Khan, Sajid A.; Sutton, Harold G.; Zhang, Wei; Khodarev, Nikolai N.; Garcia, Joe G. N.; Weichselbaum, Ralph R.			Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; BREAST-CANCER; SURVIVAL; LYMPHOMA; DISEASE; REPAIR; CELLS	Background: Vascular endothelial cells contribute to the pathogenesis of numerous human diseases by actively regulating the stromal inflammatory response; however, little is known regarding the role of endothelial inflammation in the growth of human tumors and its influence on the prognosis of human cancers. Methods: Using an experimental model of tumor necrosis factor-alpha (TNF-alpha)-mediated inflammation, we characterized inflammatory gene expression in immunopurified tumor-associated endothelial cells. These genes formed the basis of a multivariate molecular predictor of overall survival that was trained and validated in four types of human cancer. Results: We report that expression of experimentally derived tumor endothelial genes distinguished pathologic tissue specimens from normal controls in several human diseases associated with chronic inflammation. We trained these genes in human cancer datasets and defined a six-gene inflammatory signature that predicted significantly reduced overall survival in breast cancer, colon cancer, lung cancer, and glioma. This endothelial-derived signature predicted outcome independently of, but cooperatively with, standard clinical and pathological prognostic factors. Consistent with these findings, conditioned culture media from human endothelial cells stimulated by pro-inflammatory cytokines accelerated the growth of human colon and breast tumors in immunodeficient mice as compared with conditioned media from untreated endothelial cells. Conclusions: This study provides the first prognostic cancer gene signature derived from an experimental model of tumor-associated endothelial inflammation. These findings support the notion that activation of inflammatory pathways in nonmalignant tumor-infiltrating endothelial cells contributes to tumor growth and progression in multiple human cancers. Importantly, these results identify endothelial-derived factors that could serve as potential targets for therapy in diverse human cancers.	[Pitroda, Sean P.; Sweis, Randy F.; Filippo, Matthew; Labay, Edwardine; Beckett, Michael A.; Mauceri, Helena J.; Liang, Hua; Darga, Thomas E.; Perakis, Samantha; Sutton, Harold G.; Khodarev, Nikolai N.; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Zhou, Tong; Zhang, Wei; Garcia, Joe G. N.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Khan, Sajid A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Weichselbaum, RR (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022	Sweis, Randy/0000-0002-0497-9637; Darga, Thomas/0000-0002-8968-6701; Hasenleithner, Samantha O./0000-0002-9401-5224	Virginia; D. K. Ludwig Fund for Cancer Research; Lung Cancer Research Foundation; Chicago Tumor Institute; Brain Tumor Program Project [PO1 CA 07193312]; United States National Institutes of Health [HL58064, HL98050, HL105371]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050, U01HL105371, P01HL058064] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Lung Cancer Research Foundation; Chicago Tumor Institute; Brain Tumor Program Project; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the Virginia and D. K. Ludwig Fund for Cancer Research (R. R. W.), Lung Cancer Research Foundation (R. R. W.), Chicago Tumor Institute (R. R. W.), and Brain Tumor Program Project (PO1 CA 07193312) (R. R. W.), in addition to, United States National Institutes of Health grants HL58064 (J.G.N.G.), HL98050 (J.G.N.G.), and HL105371 (J.G.N.G.) and a generous gift from the Foglia family (R. R. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; BACON PA, 1994, ANN RHEUM DIS, V53, P621, DOI 10.1136/ard.53.10.621; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cromer WE, 2011, WORLD J GASTROENTERO, V17, P578, DOI 10.3748/wjg.v17.i5.578; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franses JW, 2011, CANCER RES, V71, P7339, DOI 10.1158/0008-5472.CAN-11-1718; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	27	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46104	10.1371/journal.pone.0046104	http://dx.doi.org/10.1371/journal.pone.0046104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056240	gold, Green Submitted, Green Published			2022-12-25	WOS:000309580800009
J	Ahlf, S; Tziridis, K; Korn, S; Strohmeyer, I; Schulze, H				Ahlf, Soenke; Tziridis, Konstantin; Korn, Sabine; Strohmeyer, Ilona; Schulze, Holger			Predisposition for and Prevention of Subjective Tinnitus Development	PLOS ONE			English	Article							GERBIL MERIONES-UNGUICULATUS; SALICYLATE-INDUCED TINNITUS; AUDITORY-CORTEX; FUNCTIONAL-ORGANIZATION; GABAERGIC INHIBITION; INFERIOR COLLICULUS; NEURAL CHANGES; HEARING-LOSS; REORGANIZATION; PLASTICITY	Dysfunction of the inner ear as caused by presbyacusis, injuries or noise traumata may result in subjective tinnitus, but not everyone suffering from one of these diseases develops a tinnitus percept and vice versa. The reasons for these individual differences are still unclear and may explain why different treatments of the disease are beneficial for some patients but not for others. Here we for the first time compare behavioral and neurophysiological data from hearing impaired Mongolian gerbils with (T) and without (NT) a tinnitus percept that may elucidate why some specimen do develop subjective tinnitus after noise trauma while others do not. Although noise trauma induced a similar permanent hearing loss in all animals, tinnitus did develop only in about three quarters of these animals. NT animals showed higher overall cortical and auditory brainstem activity before noise trauma compared to T animals; that is, animals with low overall neuronal activity in the auditory system seem to be prone to develop tinnitus after noise trauma. Furthermore, T animals showed increased activity of cortical neurons representing the tinnitus frequencies after acoustic trauma, whereas NT animals exhibited an activity decrease at moderate sound intensities by that time. Spontaneous activity was generally increased in T but decreased in NT animals. Plastic changes of tonotopic organization were transient, only seen in T animals and vanished by the time the tinnitus percept became chronic. We propose a model for tinnitus prevention that points to a global inhibitory mechanism in auditory cortex that may prevent tinnitus genesis in animals with high overall activity in the auditory system, whereas this mechanism seems not potent enough for tinnitus prevention in animals with low overall activity.	[Ahlf, Soenke; Tziridis, Konstantin; Korn, Sabine; Strohmeyer, Ilona; Schulze, Holger] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Tziridis, K (corresponding author), Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.	konstantin.tziridis@uk-erlangen.de			Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital Erlangen [E7]	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital Erlangen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF, project E7) at the University Hospital Erlangen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Budinger E, 2000, EUR J NEUROSCI, V12, P2452, DOI 10.1046/j.1460-9568.2000.00143.x; CAMPEAU S, 1992, ANIM LEARN BEHAV, V20, P177, DOI 10.3758/BF03200415; Devarajan K, 2012, EFFECT NOISE EXPOSUR; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2003, AURIS NASUS LARYNX, V30, pS7; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Flor H, 2004, APPL PSYCHOPHYS BIOF, V29, P113, DOI 10.1023/B:APBI.0000026637.77671.f4; Foeller E, 2001, JARO, V2, P279; Gerken GM, 1996, HEARING RES, V97, P75, DOI 10.1016/0378-5955(96)00061-5; Guitton MJ, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00012; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Horikawa J, 1996, J PHYSIOL-LONDON, V497, P629, DOI 10.1113/jphysiol.1996.sp021795; Kim DK, 2011, J LARYNGOL OTOL, V125, P246, DOI 10.1017/S0022215110002380; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kurt S, 2008, BRAIN RES, V1220, P58, DOI 10.1016/j.brainres.2007.10.023; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Moeller CK, 2010, EUR J NEUROSCI, V31, P49, DOI 10.1111/j.1460-9568.2009.07039.x; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Norena AJ, 2010, NEUROSCIENCE, V166, P1194, DOI 10.1016/j.neuroscience.2009.12.063; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Stuermer IW, 2000, HEARING RES, V146, P185, DOI 10.1016/S0378-5955(00)00113-1; THOMAS H, 1993, EUR J NEUROSCI, V5, P882, DOI 10.1111/j.1460-9568.1993.tb00940.x; Turner J, 2012, RELATIONSHIP NOISE E; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Walter M., 2012, OPEN J ACOUSTICS, V2, P34, DOI DOI 10.4236/0JA.2012.21004; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; YOUNG JS, 1983, J ACOUST SOC AM, V73, P1686, DOI 10.1121/1.389391	44	36	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44519	10.1371/journal.pone.0044519	http://dx.doi.org/10.1371/journal.pone.0044519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056180	Green Published, Green Submitted, gold			2022-12-25	WOS:000309452600005
J	Spisak, S; Kalmar, A; Galamb, O; Wichmann, B; Sipos, F; Peterfia, B; Csabai, I; Kovalszky, I; Semsey, S; Tulassay, Z; Molnar, B				Spisak, Sandor; Kalmar, Alexandra; Galamb, Orsolya; Wichmann, Barna; Sipos, Ferenc; Peterfia, Balint; Csabai, Istvan; Kovalszky, Ilona; Semsey, Szabolcs; Tulassay, Zsolt; Molnar, Bela			Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; REAL-TIME PCR; TUMOR-SUPPRESSOR GENE; PROMOTER METHYLATION; COLORECTAL-CANCER; MINIMUM INFORMATION; CELL-PROLIFERATION; CARCINOMA; DIFFERENTIATION; MUTATIONS	Tumorigenesis is accompanied by changes in the DNA methylation pattern. Our aim was to test a novel approach for identification of transcripts at whole transcript level which are regulated by DNA methylation. Our approach is based on comparison of data obtained from transcriptome profiling of primary human samples and in vitro cell culture models. Epithelial cells were collected by LCM from normal, adenoma, and tumorous colonic samples. Using gene expression analysis, we identified downregulated genes in the tumors compared to normal tissues. In parallel 3000 upregulated genes were determined in HT-29 colon adenocarcinoma cell culture model after DNA demethylation treatment. Of the 2533 transcripts showing reduced expression in the tumorous samples, 154 had increased expression as a result of DNA demethylation treatment. Approximately 2/3 of these genes had decreased expression already in the adenoma samples. Expression of five genes (GCG, NMES-1, LRMP, FAM161B and PTGDR), was validated using RT-PCR. PTGDR showed ambiguous results, therefore it was further studied to verify the extent of DNA methylation and its effect on the protein level. Results confirmed that our approach is suitable for genome-wide screening of genes which are regulated or inactivated by DNA methylation. Activity of these genes possibly interferes with tumor progression, therefore genes identified can be key factors in the formation and in the progression of the disease.	[Spisak, Sandor; Galamb, Orsolya; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Kalmar, Alexandra; Galamb, Orsolya; Wichmann, Barna; Sipos, Ferenc; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Peterfia, Balint; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Csabai, Istvan] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Semsey, Szabolcs] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark	Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Johns Hopkins University; Eotvos Lorand University; University of Copenhagen; Niels Bohr Institute	Spisak, S (corresponding author), Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary.	spisak@abc.hu	Semsey, Szabolcs/L-6329-2013; Sipos, Ferenc/GYV-6182-2022; Kovalszky, Ilona/ABH-2832-2020; Csabai, Istvan/F-6045-2011	Kovalszky, Ilona/0000-0002-0179-3378; Csabai, Istvan/0000-0001-9232-9898; Semsey, Szabolcs/0000-0002-4522-5495	National Office for Research and Technology, Hungary [TECH_08-A1/2-2008-0114]; Hungarian National Innovation Office; Danish National Research Foundation	National Office for Research and Technology, Hungary(National Office for Research and Technology); Hungarian National Innovation Office; Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was supported by the National Office for Research and Technology, Hungary (TECH_08-A1/2-2008-0114 grant), by the Hungarian National Innovation Office, and by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader S, 1999, ONCOGENE, V18, P8044, DOI 10.1038/sj.onc.1203229; Barrier A, 2005, ONCOGENE, V24, P6155, DOI 10.1038/sj.onc.1208984; Bennett KL, 2011, GENES CHROMOSOMES CA; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carmona FJ, 2010, MUTAT RES-FUND MOL M, V693, P53, DOI 10.1016/j.mrfmmm.2010.07.007; Chen L, 2008, LIVER INT, V28, P997, DOI 10.1111/j.1478-3231.2008.01744.x; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; FEARON ER, 1992, CANCER SURV, V12, P119; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Grady WM, 2005, BIOCHEM SOC T, V33, P684, DOI 10.1042/BST0330684; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Guo Y, 2006, LEUKEMIA, V20, P115, DOI 10.1038/sj.leu.2404019; Heiman E., 2011, ONCOGENE; Herman JG, 1997, CANCER RES, V57, P837; Huang B, 2011, ONCOGENE; Issa JP, 2000, ANN NY ACAD SCI, V910, P140; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Landegren Ulf, 2009, Hum Mutat, V30, pv, DOI 10.1002/humu.21140; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Liu CL, 2008, CSH PROTOCOLS; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Meyer D, 2006, J STAT SOFTW, V17; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prall F, 2006, HUM PATHOL, V37, P578, DOI 10.1016/j.humpath.2006.01.005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sanchez-Aguilera A, 2004, BLOOD, V103, P2351, DOI 10.1182/blood-2003-07-2356; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Siedlecki P, 2006, ACTA BIOCHIM POL, V53, P245; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Spisak S, 2007, ELECTROPHORESIS, V28, P4261, DOI 10.1002/elps.200700539; Spisak Sandor, 2010, Orvosi Hetilap, V151, P805, DOI 10.1556/OH.2010.28867; Spisak Sandor, 2007, Orvosi Hetilap, V148, P1511, DOI 10.1556/OH.2007.28073; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Sung JC, 2004, J AM COLL SURGEONS, V199, pS92; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; SUZUKI H, 1995, HUM MOL GENET, V4, P1883, DOI 10.1093/hmg/4.10.1883; Traicoff JL, 2003, J BIOMED SCI, V10, P792, DOI 10.1159/000073967; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Uemura M, 2011, ONCOGENE; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Wu CC, 2006, EUR J CANCER, V42, P557, DOI 10.1016/j.ejca.2005.11.015; Xiong HH, 2009, J HUAZHONG U SCI-MED, V29, P498, DOI 10.1007/s11596-009-0421-9; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhai RH, 2012, NEOPLASIA, V14, P29, DOI 10.1593/neo.111626; Zhang B, 2007, J HUAZHONG U SCI-MED, V27, P543, DOI 10.1007/s11596-007-0517-z; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang Z, 2006, ONCOGENE, V25, P5436, DOI 10.1038/sj.onc.1209530; Zhou J, 2002, INT J CANCER, V101, P311, DOI 10.1002/ijc.10600	68	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46215	10.1371/journal.pone.0046215	http://dx.doi.org/10.1371/journal.pone.0046215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049694	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388500021
J	Argilaguet, JM; Perez-Martin, E; Nofrarias, M; Gallardo, C; Accensi, F; Lacasta, A; Mora, M; Ballester, M; Galindo-Cardiel, I; Lopez-Soria, S; Escribano, JM; Reche, PA; Rodriguez, F				Argilaguet, Jordi M.; Perez-Martin, Eva; Nofrarias, Miquel; Gallardo, Carmina; Accensi, Francesc; Lacasta, Anna; Mora, Mercedes; Ballester, Maria; Galindo-Cardiel, Ivan; Lopez-Soria, Sergio; Escribano, Jose M.; Reche, Pedro A.; Rodriguez, Fernando			DNA Vaccination Partially Protects against African Swine Fever Virus Lethal Challenge in the Absence of Antibodies	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; VIRULENCE DETERMINANT; IMMUNE-RESPONSE; PEPTIDE BINDING; DOMESTIC SWINE; VIRAL PROTEIN; PIGS; IMMUNIZATION; EXPRESSION; INFECTION	The lack of available vaccines against African swine fever virus (ASFV) means that the evaluation of new immunization strategies is required. Here we show that fusion of the extracellular domain of the ASFV Hemagglutinin (sHA) to p54 and p30, two immunodominant structural viral antigens, exponentially improved both the humoral and the cellular responses induced in pigs after DNA immunization. However, immunization with the resulting plasmid (pCMV-sHAPQ) did not confer protection against lethal challenge with the virulent E75 ASFV-strain. Due to the fact that CD8(+) T-cell responses are emerging as key components for ASFV protection, we designed a new plasmid construct, pCMV-UbsHAPQ, encoding the three viral determinants above mentioned (sHA, p54 and p30) fused to ubiquitin, aiming to improve Class I antigen presentation and to enhance the CTL responses induced. As expected, immunization with pCMV-UbsHAPQ induced specific T-cell responses in the absence of antibodies and, more important, protected a proportion of immunized-pigs from lethal challenge with ASFV. In contrast with control pigs, survivor animals showed a peak of CD8+ T-cells at day 3 post-infection, coinciding with the absence of viremia at this time point. Finally, an in silico prediction of CTL peptides has allowed the identification of two SLA I-restricted 9-mer peptides within the hemagglutinin of the virus, capable of in vitro stimulating the specific secretion of IFN gamma when using PBMCs from survivor pigs. Our results confirm the relevance of T-cell responses in protection against ASF and open new expectations for the future development of more efficient recombinant vaccines against this disease.	[Argilaguet, Jordi M.; Perez-Martin, Eva; Nofrarias, Miquel; Accensi, Francesc; Lacasta, Anna; Mora, Mercedes; Ballester, Maria; Galindo-Cardiel, Ivan; Lopez-Soria, Sergio; Rodriguez, Fernando] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Gallardo, Carmina] CISA INIA, Madrid, Spain; [Escribano, Jose M.] INIA, Dept Biotecnol, Madrid, Spain; [Reche, Pedro A.] Univ Computense Madrid UCM, Dept Microbiol 1, Madrid, Spain; [Accensi, Francesc] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona	Rodriguez, F (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain.	fernando.rodriguez@cresa.uab.es	gallardo, Carmina/AAB-2386-2019; Reche, Pedro A/B-1881-2013; Guilabert, Mercedes/U-6135-2019; Rodriguez, Fernando/GLN-3947-2022; Gallardo+Frontaura, Carmina/ABE-6878-2021; Ballester, Maria/H-7277-2013; Argilaguet, Jordi/E-5109-2016; Perez-MArtin, Eva/AFP-6433-2022; Lopez-Soria, Sergio/F-9858-2012; Ballester, Maria/E-7201-2016; Devis, Maria Ballester/AAV-2467-2020; Lacasta, Anna/P-2278-2017; Accensi, Francesc/C-7051-2008	gallardo, Carmina/0000-0003-3293-306X; Reche, Pedro A/0000-0003-3966-5838; Guilabert, Mercedes/0000-0002-0706-9911; Rodriguez, Fernando/0000-0001-7361-8408; Argilaguet, Jordi/0000-0001-5924-2774; Lopez-Soria, Sergio/0000-0001-7134-2014; Ballester, Maria/0000-0002-5413-4640; Devis, Maria Ballester/0000-0002-5413-4640; Nofrarias Espadamala, Miquel/0000-0002-7983-1389; Lacasta, Anna/0000-0001-8381-9844; Perez-Martin, Eva/0000-0002-4355-4367; Accensi, Francesc/0000-0001-9068-0377	Spanish Ministry of Science and Innovation [CDS2006-00007, AGL2007-66441-C03-344 01/GAN, AGL2010-22229-C03-01]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study has been financed by the CONSOLIDER-"Porcivir'' CDS2006-00007, AGL2007-66441-C03-344 01/GAN and AGL2010-22229-C03-01 research projects from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; ALCARAZ C, 1992, VIRUS RES, V23, P173, DOI 10.1016/0168-1702(92)90076-L; Alonso F, 1997, VIRUS RES, V49, P123, DOI 10.1016/S0168-1702(97)01459-7; Argilaguet JM, 2011, VACCINE, V29, P5379, DOI 10.1016/j.vaccine.2011.05.084; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2228, DOI 10.1002/eji.1830240944; Barderas MG, 2001, ARCH VIROL, V146, P1681, DOI 10.1007/s007050170056; Barry MA, 2004, IMMUNOL REV, V199, P68, DOI 10.1111/j.0105-2896.2004.00143.x; Beltran-Alcrudo D., 2008, AFRICAN SWINE FEVER, P1; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Borca MV, 1998, J VIROL, V72, P2881, DOI 10.1128/JVI.72.4.2881-2889.1998; BORCA MV, 1994, VIROLOGY, V201, P413, DOI 10.1006/viro.1994.1311; BORCA MV, 1994, VIROLOGY, V199, P463, DOI 10.1006/viro.1994.1146; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Brossay A, 2003, BIOCHEM BIOPH RES CO, V309, P992, DOI 10.1016/j.bbrc.2003.08.099; Burrage TG, 2004, J VIROL, V78, P2445, DOI 10.1128/JVI.78.5.2445-2453.2004; Chapman DAG, 2011, EMERG INFECT DIS, V17, P599, DOI 10.3201/eid1704.101283; COGGINS L, 1968, CORNELL VET, V58, P525; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Crosby K, 2004, TRANSPLANTATION, V77, P1288, DOI 10.1097/01.TP.0000120377.57543.D8; Dale C. Jane, 2006, V127, P171; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Diaz I, 2005, VET IMMUNOL IMMUNOP, V106, P107, DOI 10.1016/j.vetimm.2005.01.005; Diez-Rivero CM, 2010, PROTEINS, V78, P63, DOI 10.1002/prot.22535; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; FORMAN AJ, 1982, ARCH VIROL, V74, P91, DOI 10.1007/BF01314703; Gomez-Puertas P, 1998, VIROLOGY, V243, P461, DOI 10.1006/viro.1998.9068; GomezPuertas P, 1996, J VIROL, V70, P5689; Gonzalvo F., 1981, AFRICAN SWINE FEVER, P206; GONZALVO FR, 1986, AM J VET RES, V47, P1858; GONZALVO FR, 1986, AM J VET RES, V47, P1249; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Heegaard PM, ARCH VIROL, V156, P183; Jenson JS, 2000, J IMMUNOL METHODS, V242, P33, DOI 10.1016/S0022-1759(00)00222-2; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Leitao A, 1998, J VIROL METHODS, V75, P113, DOI 10.1016/S0166-0934(98)00105-0; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Littel-van den Hurk SV, 2004, IMMUNOL REV, V199, P113, DOI 10.1111/j.0105-2896.2004.00140.x; Littel-van den Hurk,SV, 2010, VACCINE, V28, P6445, DOI 10.1016/j.vaccine.2010.07.045; MARTINS CLV, 1993, ARCH VIROL, V129, P211, DOI 10.1007/BF01316896; Mebus C. A., 1988, Advances in Virus Research, V35, P251, DOI 10.1016/S0065-3527(08)60714-9; Moore DM, 1998, J VIROL, V72, P10310, DOI 10.1128/JVI.72.12.10310-10315.1998; Neilan JG, 2004, VIROLOGY, V319, P337, DOI 10.1016/j.virol.2003.11.011; Neilan JG, 2002, J VIROL, V76, P3095, DOI 10.1128/JVI.76.7.3095-3104.2002; ONISK DV, 1994, VIROLOGY, V198, P350, DOI 10.1006/viro.1994.1040; Oura CAL, 2005, J GEN VIROL, V86, P2445, DOI 10.1099/vir.0.81038-0; Oviedo JM, 1997, J VIROL METHODS, V64, P27, DOI 10.1016/S0166-0934(96)02140-4; Perez-Filgueira DA, 2006, J CLIN MICROBIOL, V44, P3114, DOI 10.1128/JCM.00406-06; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Rahimi P, 2010, EMERG INFECT DIS, V16, P1946, DOI 10.3201/eid1612.100378; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; RODRIGUEZ F, 1994, J VIROL, V68, P7244, DOI 10.1128/JVI.68.11.7244-7252.1994; Rodriguez F, 2001, J VIROL, V75, P7399, DOI 10.1128/JVI.75.16.7399-7409.2001; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; RuizGonzalvo F, 1996, VIROLOGY, V218, P285, DOI 10.1006/viro.1996.0193; Sanchez Botija C., 1963, ZOOPROFLASSI, V18, P578; SCHLAFER DH, 1984, AM J VET RES, V45, P1367; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; STONE SS, 1967, AM J VET RES, V28, P475; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; WARDLEY RC, 1985, VET IMMUNOL IMMUNOP, V9, P201, DOI 10.1016/0165-2427(85)90071-6; WARDLEY RC, 1983, ARCH VIROL, V76, P73, DOI 10.1007/BF01311692; ZSAK L, 1993, VIROLOGY, V196, P596, DOI 10.1006/viro.1993.1515; Zsak L, 1998, J VIROL, V72, P1028, DOI 10.1128/JVI.72.2.1028-1035.1998	66	82	115	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e40942	10.1371/journal.pone.0040942	http://dx.doi.org/10.1371/journal.pone.0040942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049728	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300003
J	Goo, CK; Lim, HY; Ho, QS; Too, HP; Clement, MV; Wong, KP				Goo, Chong Kiat; Lim, Hwee Ying; Ho, Qin Shi; Too, Heng-Phon; Clement, Marie-Veronique; Wong, Kim Ping			PTEN/Akt Signaling Controls Mitochondrial Respiratory Capacity through 4E-BP1	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; DIRECT INHIBITION; TUMOR-SUPPRESSOR; COMPLEXES I; PROTEIN; CELLS; AKT; CANCER; BIOGENESIS; ACTIVATION	Akt, a serine/threonine kinase has been shown to stimulate glycolysis in cancer cells but its role in mitochondrial respiration is unknown. Using PTEN-knockout mouse embryonic fibroblasts (MEFPTEN-/-) with hyper-activated Akt as a cell model, we observed a higher respiratory capacity in MEFPTEN-/- compared to the wildtype (MEFWT). The respiratory phenotype observed in MEFPTEN-/- was reproduced in MEFWT by gene silencing of PTEN which substantiated its role in regulating mitochondrial function. The increased activities of the respiratory complexes (RCs) I, III and IV were retained in the same relative proportions as those present in MEFWT, alluding to a possible co-ordinated regulation by PTEN/Akt. Using LY294002 (a PI3K inhibitor) and Akt inhibitor IV, we showed that the regulation of enzyme activities and protein expressions of the RCs was dependent on PI3K/Akt. There was insignificant difference in the protein expressions of mitochondrial transcription factor: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and its downstream targets, the nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (mtTFA) between MEFPTEN-/- and MEFWT. Similarly, mRNA levels of the same subunits of the RCs detected in Western blots were not significantly different between MEFPTEN-/- and MEFWT suggesting that the regulation by Akt on mitochondrial function was probably not via gene transcription. On the other hand, a decrease of total 4E-BP1 with a higher expression of its phosphorylated form relative to total 4E-BP1 was found in MEFPTEN-/-, which inferred that the regulation of mitochondrial respiratory activities by Akt was in part through this protein translation pathway. Notably, gene silencing of 4E-BP1 up-regulated the protein expressions of all RCs and the action of 4E-BP1 appeared to be specific to these mitochondrial proteins. In conclusion, PTEN inactivation bestowed a bioenergetic advantage to the cells by up-regulating mitochondrial respiratory capacity through the 4E-BP1-mediated protein translation pathway.	[Goo, Chong Kiat; Lim, Hwee Ying; Ho, Qin Shi; Too, Heng-Phon; Clement, Marie-Veronique; Wong, Kim Ping] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Clement, Marie-Veronique] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore	Wong, KP (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.	bchsitkp@nus.edu.sg			National University of Singapore [R-183-000-261-112]; Biomedical Research Council [09/1/21/19/603]	National University of Singapore(National University of Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by research grants from National University of Singapore (R-183-000-261-112 to KPW) and from the Biomedical Research Council (09/1/21/19/603 to MVC and KPW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; BAGGETTO LG, 1992, CANCER RES, V52, P4935; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cridge AG, 2010, NUCLEIC ACIDS RES, V38, P8039, DOI 10.1093/nar/gkq686; de Groof AJC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-54; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim HW, 2009, BIOCHEM BIOPH RES CO, V389, P187, DOI 10.1016/j.bbrc.2009.08.121; Lim HY, 2011, MITOCHONDRION, V11, P437, DOI 10.1016/j.mito.2010.12.015; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ng LE, 2006, BIOCHEM BIOPH RES CO, V348, P494, DOI 10.1016/j.bbrc.2006.07.089; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stokoe D, 2001, CURR BIOL, V11, pR502, DOI 10.1016/S0960-9822(01)00303-7; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Zhang X, 2004, J BIOL CHEM, V279, P43035, DOI 10.1074/jbc.M402759200; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	51	72	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45806	10.1371/journal.pone.0045806	http://dx.doi.org/10.1371/journal.pone.0045806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049865	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300054
J	Perez-Montarelo, D; Hudson, NJ; Fernandez, AI; Ramayo-Caldas, Y; Dalrymple, BP; Reverter, A				Perez-Montarelo, Dafne; Hudson, Nicholas J.; Fernandez, Ana I.; Ramayo-Caldas, Yuliaxis; Dalrymple, Brian P.; Reverter, Antonio			Porcine Tissue-Specific Regulatory Networks Derived from Meta-Analysis of the Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DIFFERENTIAL EXPRESSION; SKELETAL-MUSCLE; ADIPOSE-TISSUES; PROTEIN; ATLAS; MOUSE; EVOLUTION; REVEALS; PIGS	The processes that drive tissue identity and differentiation remain unclear for most tissue types. So are the gene networks and transcription factors (TF) responsible for the differential structure and function of each particular tissue, and this is particularly true for non model species with incomplete genomic resources. To better understand the regulation of genes responsible for tissue identity in pigs, we have inferred regulatory networks from a meta-analysis of 20 gene expression studies spanning 480 Porcine Affymetrix chips for 134 experimental conditions on 27 distinct tissues. We developed a mixed-model normalization approach with a covariance structure that accommodated the disparity in the origin of the individual studies, and obtained the normalized expression of 12,320 genes across the 27 tissues. Using this resource, we constructed a network, based on the co-expression patterns of 1,072 TF and 1,232 tissue specific genes. The resulting network is consistent with the known biology of tissue development. Within the network, genes clustered by tissue and tissues clustered by site of embryonic origin. These clusters were significantly enriched for genes annotated in key relevant biological processes and confirm gene functions and interactions from the literature. We implemented a Regulatory Impact Factor (RIF) metric to identify the key regulators in skeletal muscle and tissues from the central nervous systems. The normalization of the meta-analysis, the inference of the gene co-expression network and the RIF metric, operated synergistically towards a successful search for tissue-specific regulators. Novel among these findings are evidence suggesting a novel key role of ERCC3 as a muscle regulator. Together, our results recapitulate the known biology behind tissue specificity and provide new valuable insights in a less studied but valuable model species.	[Perez-Montarelo, Dafne; Hudson, Nicholas J.; Dalrymple, Brian P.; Reverter, Antonio] Queensland Biosci Precinct, Commonwealth Sci & Ind Res Org CSIRO Anim Food &, Computat & Syst Biol, Brisbane, Qld, Australia; [Perez-Montarelo, Dafne; Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain; [Ramayo-Caldas, Yuliaxis] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, E-08193 Barcelona, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Autonomous University of Barcelona	Reverter, A (corresponding author), Queensland Biosci Precinct, Commonwealth Sci & Ind Res Org CSIRO Anim Food &, Computat & Syst Biol, Brisbane, Qld, Australia.	Tony.Reverter-Gomez@csiro.au	Caldas, Yuliaxis Ramayo/B-6337-2014; Hudson, Nick/AAF-5644-2020; Hudson, Nicholas J/D-1606-2011; Hudson, Nick/C-1201-2008; Fernández, Ana Isabel/J-3265-2012; Reverter, Antonio/C-9699-2013; Dalrymple, Brian P/F-8721-2010	Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Hudson, Nick/0000-0002-3549-9396; Hudson, Nicholas J/0000-0002-3549-9396; Fernández, Ana Isabel/0000-0002-1509-5191; Reverter, Antonio/0000-0002-4681-9404; Dalrymple, Brian P/0000-0003-3891-5233	Spanish Ministerio de Ciencia e Innovacion [BES-2009-025417]; Spanish Ministerio de Educacion [AP2008-01450]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Educacion(Spanish Government)	The authors acknowledge the assistance of the CSIRO Transformational Biology Capability Platform. D. Perez-Montarelo was funded by an FPI PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2009-025417). Y. Ramayo-Caldas was funded by an FPU PhD grant from the Spanish Ministerio de Educacion (AP2008-01450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Budhram-Mahadeo V, 2001, INT J BIOCHEM CELL B, V33, P1027, DOI 10.1016/S1357-2725(01)00069-3; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Canterini S, 2012, CEREBELLUM, V11, P28, DOI 10.1007/s12311-010-0211-8; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chen B, 2009, DEV BIOL, V326, P75, DOI 10.1016/j.ydbio.2008.10.039; Chen H, 2009, BMC GENOMICS, P10; Chen HH, 2002, DEVELOPMENT, V129, P4879; Depre C, 2010, AM J PHYSIOL-HEART C, V299, pH752, DOI 10.1152/ajpheart.00147.2010; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Ferraz ALJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-173; Fontanesi L, 2011, MEAT SCI, V88, P604, DOI 10.1016/j.meatsci.2011.02.001; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Ilagan RM, 2011, J CELL PHYSIOL, V226, P2702, DOI 10.1002/jcp.22622; Jameel MN, 2010, AM J PHYSIOL-HEART C, V298, pH1348, DOI 10.1152/ajpheart.01100.2009; Jiang CD, 2010, INT J BIOL SCI, V6, P627, DOI 10.7150/ijbs.6.627; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kapushesky M, 2011, NUCL ACIDS RES; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Larder R, 2011, J NEUROSCI, V31, P426, DOI 10.1523/JNEUROSCI.1688-10.2011; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li Y, 2010, INT J BIOL SCI, V6, P350; Lin KM, 2001, LEUKEMIA, V15, P601, DOI 10.1038/sj.leu.2402071; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lkhagvadorj S, 2009, PHYSIOL GENOMICS, V38, P98, DOI 10.1152/physiolgenomics.90372.2008; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahoney MG, 1998, BIOL REPROD, V59, P388, DOI 10.1095/biolreprod59.2.388; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; Mazaud S., 2002, Gene Expression Patterns, V2, P373, DOI 10.1016/S1567-133X(02)00050-9; McKusick V, 2010, ONLINE MENDELIAN INH; Meisel RP, 2012, GENOME RES; Moon JK, 2009, ANIM GENET, V40, P115, DOI 10.1111/j.1365-2052.2008.01798.x; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nagaraj SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S23; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Ostrup E, 2010, BIOL REPROD, V83, P277, DOI 10.1095/biolreprod.109.082321; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Perez-Enciso M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-89; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Pimanda JE, 2010, INT J DEV BIOL, V54, P1201, DOI 10.1387/ijdb.093038jp; Ponsuksili S, 2008, J AGR FOOD CHEM, V56, P10311, DOI 10.1021/jf800881y; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Reverter A, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-8; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swindle MM, 2011, VET PATHOL; Technau U, 2003, INT J DEV BIOL, V47, P531; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tsarovina K, 2010, J NEUROSCI, V30, P10833, DOI 10.1523/JNEUROSCI.0175-10.2010; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang Y, 2008, BMC GENOMICS, P9; Wang YF, 2007, GENOMICS, V90, P72, DOI 10.1016/j.ygeno.2007.03.018; Williamson C, 2012, MOUSE IMPRINTING DAT; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zhang LQ, 2005, MOL BIOL EVOL, V22, P2504, DOI 10.1093/molbev/msi240; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	79	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46159	10.1371/journal.pone.0046159	http://dx.doi.org/10.1371/journal.pone.0046159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049964	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300092
J	Ramsey, JM; Gutierrez-Cabrera, AE; Salgado-Ramirez, L; Peterson, AT; Sanchez-Cordero, V; Ibarra-Cerdena, CN				Ramsey, Janine M.; Gutierrez-Cabrera, Ana E.; Salgado-Ramirez, Liliana; Peterson, A. Townsend; Sanchez-Cordero, Victor; Ibarra-Cerdena, Carlos N.			Ecological Connectivity of Trypanosoma cruzi Reservoirs and Triatoma pallidipennis Hosts in an Anthropogenic Landscape with Endemic Chagas Disease	PLOS ONE			English	Article							INFESTANS HEMIPTERA REDUVIIDAE; SYLVATIC TRIATOMINAE; DOMESTIC POPULATIONS; RISK-FACTORS; MEXICO; TRANSMISSION; VECTORS; INFECTION; CHACO; BATS	Traditional methods for Chagas disease prevention are targeted at domestic vector reduction, as well as control of transfusion and maternal-fetal transmission. Population connectivity of Trypanosoma cruzi-infected vectors and hosts, among sylvatic, ecotone and domestic habitats could jeopardize targeted efforts to reduce human exposure. This connectivity was evaluated in a Mexican community with reports of high vector infestation, human infection, and Chagas disease, surrounded by agricultural and natural areas. We surveyed bats, rodents, and triatomines in dry and rainy seasons in three adjacent habitats (domestic, ecotone, sylvatic), and measured T. cruzi prevalence, and host feeding sources of triatomines. Of 12 bat and 7 rodent species, no bat tested positive for T. cruzi, but all rodent species tested positive in at least one season or habitat. Highest T. cruzi infection prevalence was found in the rodents, Baiomys musculus and Neotoma mexicana. In general, parasite prevalence was not related to habitat or season, although the sylvatic habitat had higher infection prevalence than by chance, during the dry season. Wild and domestic mammals were identified as bloodmeals of T. pallidipennis, with 9% of individuals having mixed human (4.8% single human) and other mammal species in bloodmeals, especially in the dry season; these vectors tested >50% positive for T. cruzi. Overall, ecological connectivity is broad across this matrix, based on high rodent community similarity, vector and T. cruzi presence. Cost-effective T. cruzi, vector control strategies and Chagas disease transmission prevention will need to consider continuous potential for parasite movement over the entire landscape. This study provides clear evidence that these strategies will need to include reservoir/host species in at least ecotones, in addition to domestic habitats.	[Ramsey, Janine M.; Gutierrez-Cabrera, Ana E.; Salgado-Ramirez, Liliana; Ibarra-Cerdena, Carlos N.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Sanchez-Cordero, Victor; Ibarra-Cerdena, Carlos N.] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; University of Kansas; Universidad Nacional Autonoma de Mexico	Ibarra-Cerdena, CN (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.	Ibarra.cerdena@gmail.com	Ramsey, Janine M./AAS-2220-2021; Peterson, A. Townsend/I-5697-2013	Ramsey, Janine M./0000-0002-5950-0830; Peterson, A. Townsend/0000-0003-0243-2379; Ibarra-Cerdena, Carlos N./0000-0003-4980-4344	Secretaria de Salud; Consejo Nacional de Ciencia y Tecnologia (CONACyt) [MOR-2004-CO2-012]; Universidad Nacional Autonoma de Mexico (PAPIIT project) [225408]; Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA]; Tecnologias para la Universidad de la Informacion y la Computacion; CONACyT	Secretaria de Salud; Consejo Nacional de Ciencia y Tecnologia (CONACyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (PAPIIT project); Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA]; Tecnologias para la Universidad de la Informacion y la Computacion; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by the Secretaria de Salud and Consejo Nacional de Ciencia y Tecnologia (CONACyt) project MOR-2004-CO2-012 to JMR, and by the Universidad Nacional Autonoma de Mexico (PAPIIT project 225408 to VS-C, and the Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA], and Tecnologias para la Universidad de la Informacion y la Computacion. AEGC was funded with a scholarship from CONACyT for a M. Sc. degree in vector-borne diseases at the Instituto Nacional de Salud Publica. CNIC is funded with a scholarship from CONACyT for studies at the graduate program in Biomedical Sciences of the Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bello-Gutierrez J, 2010, J WILDLIFE DIS, V46, P1000, DOI 10.7589/0090-3558-46.3.1000; Borges EC, 2005, ACTA TROP, V93, P119, DOI 10.1016/j.actatropica.2004.10.002; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Ceballos G., 2005, MAMIFEROS SILVESTRES, P21; Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Chao A, 2005, ENCY STAT SCI, P7907; Cohen JM, 2006, J MED ENTOMOL, V43, P1252, DOI 10.1603/0022-2585(2006)43[1252:IBTPHR]2.0.CO;2; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Condit R, 2000, J VEG SCI, V11, P649, DOI 10.2307/3236572; DALESSANDRO A, 1985, FACTORES BIOL ECOLOG, V2, P377; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Diosque P, 2004, AM J TROP MED HYG, V71, P590, DOI 10.4269/ajtmh.2004.71.590; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Dumonteil E, 2007, AM J TROP MED HYG, V76, P930, DOI 10.4269/ajtmh.2007.76.930; Enger KS, 2004, J MED ENTOMOL, V41, P760, DOI 10.1603/0022-2585-41.4.760; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Gratz N. G., 1994, P85; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Ibarra-Cerdena CN, 2009, ACTA TROP, V110, P178, DOI 10.1016/j.actatropica.2008.11.012; Kunz TH, 1989, ECOLOGICAL BEHAV MET, P1; Magallon-Gastelum E, 2001, J MED ENTOMOL, V38, P638, DOI 10.1603/0022-2585-38.5.638; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maloney J, 2010, J PARASITOL, V96, P353, DOI 10.1645/GE-2312.1; MARINKELLE CJ, 1982, ANN TROP MED PARASIT, V76, P125, DOI 10.1080/00034983.1982.11687517; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P547, DOI 10.1089/vbz.2010.1503; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Murphy Peter G., 1995, P9, DOI 10.1017/CBO9780511753398.002; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Noireau F, 2009, MEM I OSWALDO CRUZ, V104, P60, DOI 10.1590/S0074-02762009000900010; Pfeiler E, 2006, MOL PHYLOGENET EVOL, V41, P209, DOI 10.1016/j.ympev.2006.07.001; Pinto A. da S., 1986, Revista da Sociedade Brasileira de Medicina Tropical, V19, P31; Ramirez CJ, 2005, ACTA TROP, V93, P23, DOI 10.1016/j.actatropica.2004.09.001; Ramsey JM, 2005, MED VET ENTOMOL, V19, P219, DOI 10.1111/j.0269-283X.2005.00563.x; Ramsey JM, 2000, MED VET ENTOMOL, V14, P19, DOI 10.1046/j.1365-2915.2000.00214.x; Ramsey JM, 2003, J MED ENTOMOL, V40, P912, DOI 10.1603/0022-2585-40.6.912; Rolon M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001026; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Sanchez-Cordero V, 2003, RATS MICE PEOPLE ROD, P526; Schmunis GA, 2007, ISBT SCI SERIES, V2, P6, DOI 10.1111/j.1751-2824.2007.00052.x; SEMARNAT, 2001, DIARIO OFICIAL  0306; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Villegas-Garcia JC, 2004, ANN TROP MED PARASIT, V98, P529, DOI 10.1179/000349804225003497; Zavala-Velazquez J., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P289, DOI 10.1590/S0036-46651996000400009	51	47	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46013	10.1371/journal.pone.0046013	http://dx.doi.org/10.1371/journal.pone.0046013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049923	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300075
J	Vegge, CS; Brondsted, L; Ligowska-Marzeta, M; Ingmer, H				Vegge, Christina S.; Brondsted, Lone; Ligowska-Marzeta, Malgorzata; Ingmer, Hanne			Natural Transformation of Campylobacter jejuni Occurs Beyond Limits of Growth	PLOS ONE			English	Article							COMPETENCE GENE HOMOLOGS; GUILLAIN-BARRE-SYNDROME; NEISSERIA-GONORRHOEAE; STREPTOCOCCUS-PNEUMONIAE; HELICOBACTER-PYLORI; BACILLUS-SUBTILIS; STRESS TOLERANCE; DNA UPTAKE; VIRULENCE; SYSTEM	Campylobacter jejuni is a human bacterial pathogen. While poultry is considered to be a major source of food borne campylobacteriosis, C. jejuni is frequently found in the external environment, and water is another well-known source of human infections. Natural transformation is considered to be one of the main mechanisms for mediating transfer of genetic material and evolution of the organism. Given the diverse habitats of C. jejuni we set out to examine how environmental conditions and physiological processes affect natural transformation of C. jejuni. We show that the efficiency of transformation is correlated to the growth conditions, but more importantly that transformation occurs at growth-restrictive conditions as well as in the late stationary phase; hence revealing that growth per se is not required for C. jejuni to be competent. Yet, natural transformation of C. jejuni is an energy dependent process, that occurs in the absence of transcription but requires an active translational machinery. Moreover, we show the ATP dependent ClpP protease to be important for transformation, which possibly could be associated with reduced protein glycosylation in the ClpP mutant. In contrast, competence of C. jejuni was neither found to be involved in DNA repair following DNA damage nor to provide a growth benefit. Kinetic studies revealed that several transformation events occur per cell cycle indicating that natural transformation of C. jejuni is a highly efficient process. Thus, our findings suggest that horizontal gene transfer by natural transformation takes place in various habitats occupied by C. jejuni.	[Vegge, Christina S.; Brondsted, Lone; Ligowska-Marzeta, Malgorzata; Ingmer, Hanne] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark	University of Copenhagen	Vegge, CS (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	csv@sund.ku.dk		Ingmer, Hanne/0000-0002-8350-5631; Ligowska-Marzeta, Malgorzata/0000-0002-2693-5141; Brondsted, Lone/0000-0002-7930-5725	Danish Research Council for Technology and Production Sciences	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KT, 2011, APPL ENVIRON MICROB, V77, P57, DOI 10.1128/AEM.01603-10; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BOLTON FJ, 1983, J CLIN PATHOL, V36, P829, DOI 10.1136/jcp.36.7.829; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2002, FRONT BIOSCI-LANDMRK, V7, pD1798, DOI 10.2741/claverys; Cohn MT, 2007, APPL ENVIRON MICROB, V73, P7803, DOI 10.1128/AEM.00698-07; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Engberg Jorgen, 1998, Clin Microbiol Infect, V4, P648, DOI 10.1111/j.1469-0691.1998.tb00348.x; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gilbert M, 2004, INFECT IMMUN, V72, P1162, DOI 10.1128/IAI.72.2.1162-1165.2004; Gubbels SM, 2012, SCAND J INFECT DIS; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Jeon B, 2008, ANTIMICROB AGENTS CH, V52, P2699, DOI 10.1128/AAC.01607-07; Jeon B, 2007, J BACTERIOL, V189, P7399, DOI 10.1128/JB.01012-07; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Karagiannis I, 2010, EPIDEMIOL INFECT, V138, P1726, DOI 10.1017/S0950268810002116; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Kim JS, 2008, APPL ENVIRON MICROB, V74, P6121, DOI 10.1128/AEM.01075-08; Knudsen KN, 2006, AVIAN DIS, V50, P10, DOI 10.1637/7376-051005R.1; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Leonard EE, 2003, J INFECT DIS, V187, P691, DOI 10.1086/368268; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Nuijten PJM, 2000, INFECT IMMUN, V68, P7137, DOI 10.1128/IAI.68.12.7137-7140.2000; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Richardson G, 2007, EPIDEMIOL INFECT, V135, P1151, DOI 10.1017/S0950268807007960; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Shane SM, 2003, DIS POULTRY, P615; Shaw FL, 2012, J BACTERIOL; Stingl K, 2010, P NATL ACAD SCI USA, V107, P1184, DOI 10.1073/pnas.0909955107; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Turgay K, 1998, EMBO J, V17, P6730; VanWagoner TM, 2004, J BACTERIOL, V186, P6409, DOI 10.1128/JB.186.19.6409-6421.2004; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wassenaar TM, 1999, MICROBES INFECT, V1, P1023, DOI 10.1016/S1286-4579(99)80520-6; Wiesner RS, 2003, J BACTERIOL, V185, P5408, DOI 10.1128/JB.185.18.5408-5418.2003; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0	60	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45467	10.1371/journal.pone.0045467	http://dx.doi.org/10.1371/journal.pone.0045467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049803	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300026
J	Garwood, R; Ross, A; Sotty, D; Chabard, D; Charbonnier, S; Sutton, M; Withers, PJ				Garwood, Russell; Ross, Andrew; Sotty, Daniel; Chabard, Dominique; Charbonnier, Sylvain; Sutton, Mark; Withers, Philip J.			Tomographic Reconstruction of Neopterous Carboniferous Insect Nymphs	PLOS ONE			English	Article							STEM-GROUP; ORIGIN; PHYLOGENY; EVOLUTION; ODONATOPTERA; SYSTEMATICS; MORPHOLOGY; DIVERSITY; BEHAVIOR; ORDER	Two new polyneopteran insect nymphs from the Montceau-les-Mines Lagerstatte of France are presented. Both are preserved in three dimensions, and are imaged with the aid of X-ray micro-tomography, allowing their morphology to be recovered in unprecedented detail. One-Anebos phrixos gen. et sp. nov.-is of uncertain affinities, and preserves portions of the antennae and eyes, coupled with a heavily spined habitus. The other is a roachoid with long antennae and chewing mouthparts very similar in form to the most generalized mandibulate mouthparts of extant orthopteroid insects. Computer reconstructions reveal limbs in both specimens, allowing identification of the segments and annulation in the tarsus, while poorly developed thoracic wing pads suggest both are young instars. This work describes the morphologically best-known Palaeozoic insect nymphs, allowing a better understanding of the juveniles' palaeobiology and palaeoecology. We also consider the validity of evidence from Palaeozoic juvenile insects in wing origin theories. The study of juvenile Palaeozoic insects is currently a neglected field, yet these fossils provide direct evidence on the evolution of insect development. It is hoped this study will stimulate a renewed interest in such work.	[Garwood, Russell; Withers, Philip J.] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Garwood, Russell] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Ross, Andrew] Natl Museum Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Sotty, Daniel] Museum Hist Nat, Autun, Bourgogne, France; [Chabard, Dominique; Charbonnier, Sylvain] Museum Natl Hist Nat, Dept Hist Terre, F-75231 Paris, France; [Sutton, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England	University of Manchester; University of Manchester; Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN); Imperial College London	Garwood, R (corresponding author), Univ Manchester, Sch Mat, Manchester, Lancs, England.	russell.garwood@manchester.ac.uk	Charbonnier, Sylvain/AAU-9571-2020; Withers, Phil/A-6760-2009; /ABG-2074-2021	Withers, Phil/0000-0002-1946-5647; Garwood, Russell/0000-0002-2803-9471	Natural Environment Research Council; EPSRC [EP/I02249X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work was funded by a Natural Environment Research Council PhD studentship awarded to RG (http://www.nerc.ac.uk). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson T. Prescott, 2005, P169; Beattie R, 2007, AFR INVERTEBR, V48, P41; Bell W. J., 2007, COCKROACHES ECOLOGY; Bethoux O, 2008, SYST ENTOMOL, V33, P529, DOI 10.1111/j.1365-3113.2008.00419.x; Bethoux O, 2009, J PALEONTOL, V83, P931, DOI 10.1666/08-158.1; Bethoux O, 2009, ANN ZOOL, V59, P141, DOI 10.3161/000345409X463949; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bethoux O, 2008, EVOL BIOL, V35, P317, DOI 10.1007/s11692-008-9035-6; Beutel RG, 2008, SYST ENTOMOL, V33, P501, DOI 10.1111/j.1365-3113.2008.00428.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Bitsch J, 2012, J MORPHOL, V273, P919, DOI 10.1002/jmor.20031; Bradley TJ, 2009, INTEGR COMP BIOL, V49, P590, DOI 10.1093/icb/icp043; BRONGNIART C, 1893, RECHERCHES SERVIR HI; Brusca RC, 2003, INVERTEBRATES; Burnham L, 1994, MEMOIRES SECTION SCI, P187; CARPENTER F M, 1968, Psyche (Cambridge), V75, P295; CARPENTER F. M., 1948, PSYCHE, V55, P41, DOI 10.1155/1948/83246; CARPENTER FM, 1992, SUPERCLASS HEXAPOD R, V3; Carpenter Frank M., 1997, P184; Chapman R.F., 2012, INSECTS STRUCTURE FU; Charbonnier S, 2008, PALAIOS, V23, P210, DOI 10.2110/palo.2006.p06-078r; Coram Robert A., 2003, Acta Zoologica Cracoviensia, V46, P311; Courel L., 1994, MEMOIRES SECTION SCI, V12, P33; Demoulin G., 1970, Bull. Inst. r. Sci. nat. Belg., V46, P1; Dudley R, 2011, INTEGR COMP BIOL, V51, P926, DOI 10.1093/icb/icr002; Duncan IJ, 2003, PALAIOS, V18, P256, DOI 10.1669/0883-1351(2003)018<0256:DADOTC>2.0.CO;2; Dworkin IM, 2001, EVOL DEV, V3, P424, DOI 10.1046/j.1525-142X.2001.01047.x; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Fursich FT, 2007, PALAEOGEOGR PALAEOCL, V253, P434, DOI 10.1016/j.palaeo.2007.06.012; Garwood RJ, 2012, PALAEONTOL ELECTRON, V15; Garwood R, 2010, BIOL LETTERS, V6, P699, DOI 10.1098/rsbl.2010.0199; Garwood R, 2009, BIOL LETTERS, V5, P841, DOI 10.1098/rsbl.2009.0464; Garwood RJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1458; Garwood RJ, 2011, PALAEONTOLOGY, V54, P145, DOI 10.1111/j.1475-4983.2010.01000.x; Germain D, 2008, GEODIVERSITAS, V30, P669; Grimaldi David, 2005, pi; Grimaldi DA, 2010, ARTHROPOD STRUCT DEV, V39, P191, DOI 10.1016/j.asd.2009.10.008; Gu JJ, 2011, J PALEONTOL, V85, P303, DOI 10.1666/10-085.1; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Handlirsch A, 1911, AM J SCI, V31, P297; Heming BS., 2003, INSECT DEV EVOLUTION; Heyler D., 1994, QUAND MASSIF CENTRAL, V12, P227; Hubbard M.D., 1980, ADV EPHEMEROPTERA BI, P19, DOI DOI 10.1007/978-1-4613-3066-0_2; JARZEMBOWSKI EA, 1987, J GEOL SOC LONDON, V144, P507, DOI 10.1144/gsjgs.144.3.0507; KUKALOVA J, 1968, Psyche (Cambridge), V75, P310; KUKALOVA-PECK J, 1976, Psyche (Cambridge), V83, P79, DOI 10.1155/1976/36962; Kukalova-Peck Jarmila, 2009, Palaeodiversity, P169; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P2452, DOI 10.1139/z92-330; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; KUKALOVAPECK J, 1987, CAN J ZOOL, V65, P2327, DOI 10.1139/z87-352; KUKALOVAPECK J, 1997, ARTHROPOD RELATIONSH, P249; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Labandeira CC, 1996, P NATL ACAD SCI USA, V93, P8470, DOI 10.1073/pnas.93.16.8470; Legg DA, 2012, PALAEONTOL ELECTRON, V15; Linnaeus C, 1758, SYSTEMA NATURAE PER; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2009, PALAEONTOGR ABT A, V289, P89; Oudard J., 1980, Bulletin Trimestriel de la Societe d'Histoire Naturelle et des Amis du Museum d'Autun, P37; POPLIN C, 1994, MEMOIRES SECTION SCI, V12; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; REILLY SM, 1990, EVOLUTION, V44, P1542, DOI 10.1111/j.1558-5646.1990.tb03845.x; Rolfe W.D.I., 1967, PALAEONTOLOGY, V10, P307; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Sinitshenkova N.D., 2002, P388; Sinitshenkova Nina D., 2003, Acta Zoologica Cracoviensia, V46, P381; Staniczek AH, 2011, INSECT SYST EVOL, V42, P101, DOI 10.1163/187631211X578406; Sutton MD, 2012, PALAEONTOL ELECTRON, V15; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Willmann R., 1998, Systematics Association Special Volume Series, V55, P269; WOOTTON R J, 1972, Palaeontology (Oxford), V15, P662; WOOTTON RJ, 1981, ANNU REV ENTOMOL, V26, P319, DOI 10.1146/annurev.en.26.010181.001535; Wootton RJ, 1972, ESSAYS HYDROBIOLOGY, P69; Zwick P, 2009, AQUAT INSECT, V31, P181, DOI 10.1080/01650420802666827	77	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45779	10.1371/journal.pone.0045779	http://dx.doi.org/10.1371/journal.pone.0045779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049858	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100077
J	Klein, MI; Xiao, J; Lu, BW; Delahunty, CM; Yates, JR; Koo, H				Klein, Marlise I.; Xiao, Jin; Lu, Bingwen; Delahunty, Claire M.; Yates, John R., III; Koo, Hyun			Streptococcus mutans Protein Synthesis during Mixed-Species Biofilm Development by High-Throughput Quantitative Proteomics	PLOS ONE			English	Article							GLUCAN-BINDING PROTEINS; ORAL STREPTOCOCCI; GENE-EXPRESSION; ACID TOLERANCE; INTRACELLULAR POLYSACCHARIDE; SHOTGUN PROTEOMICS; LIPOTEICHOIC ACID; STRESS TOLERANCE; YEAST PROTEOME; DENTAL-CARIES	Biofilms formed on tooth surfaces are comprised of mixed microbiota enmeshed in an extracellular matrix. Oral biofilms are constantly exposed to environmental changes, which influence the microbial composition, matrix formation and expression of virulence. Streptococcus mutans and sucrose are key modulators associated with the evolution of virulent-cariogenic biofilms. In this study, we used a high-throughput quantitative proteomics approach to examine how S. mutans produces relevant proteins that facilitate its establishment and optimal survival during mixed-species biofilms development induced by sucrose. Biofilms of S. mutans, alone or mixed with Actinomyces naeslundii and Streptococcus oralis, were initially formed onto saliva-coated hydroxyapatite surface under carbohydrate-limiting condition. Sucrose (1%, w/v) was then introduced to cause environmental changes, and to induce biofilm accumulation. Multidimensional protein identification technology (MudPIT) approach detected up to 60% of proteins encoded by S. mutans within biofilms. Specific proteins associated with exopolysaccharide matrix assembly, metabolic and stress adaptation processes were highly abundant as the biofilm transit from earlier to later developmental stages following sucrose introduction. Our results indicate that S. mutans within a mixed-species biofilm community increases the expression of specific genes associated with glucan synthesis and remodeling (gtfBC, dexA) and glucan-binding (gbpB) during this transition (P<0.05). Furthermore, S. mutans up-regulates specific adaptation mechanisms to cope with acidic environments (F1F0-ATPase system, fatty acid biosynthesis, branched chain amino acids metabolism), and molecular chaperones (GroEL). Interestingly, the protein levels and gene expression are in general augmented when S. mutans form mixed-species biofilms (vs. single-species biofilms) demonstrating fundamental differences in the matrix assembly, survival and biofilm maintenance in the presence of other organisms. Our data provide insights about how S. mutans optimizes its metabolism and adapts/survives within the mixed-species community in response to a dynamically changing environment. This reflects the intricate physiological processes linked to expression of virulence by this bacterium within complex biofilms.	[Klein, Marlise I.; Xiao, Jin; Koo, Hyun] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Koo, Hyun] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Xiao, Jin] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Lu, Bingwen; Delahunty, Claire M.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA	University of Rochester; University of Rochester; Sichuan University; Scripps Research Institute	Klein, MI (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Marlise_Klein@urmc.rochester.edu; Hyun_Koo@urmc.rochester.edu	Klein, Marlise Inêz/A-2550-2014	Klein, Marlise Inêz/0000-0002-7916-1557	Training Program in Oral Sciences [R90DE022529]; National Institutes of Health [DE16139, P41 RR011823, U01 DE016267]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016139, R90DE022529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Training Program in Oral Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Training Program in Oral Sciences R90DE022529 (M.I.K.) and research grants DE16139 (H.K.), P41 RR011823 and U01 DE016267 (J.R.Y.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; ALLEN PZ, 1990, ARCH ORAL BIOL, V35, P55, DOI 10.1016/0003-9969(90)90115-Q; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bergeron LJ, 2000, J BACTERIOL, V182, P3649, DOI 10.1128/JB.182.13.3649-3654.2000; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Browngardt CM, 2004, FEMS MICROBIOL LETT, V240, P75, DOI 10.1016/j.femsle.2004.09.012; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; CIARDI JE, 1977, SCAND J DENT RES, V85, P387; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Fujiwara T, 2000, INFECT IMMUN, V68, P2475, DOI 10.1128/IAI.68.5.2475-2483.2000; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; GUGGENHEIM B, 1974, HELV ODONTOL ACTA, V18, P101; Hayacibara MF, 2004, CARBOHYD RES, V339, P2127, DOI 10.1016/j.carres.2004.05.031; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Klein MI, MOL ORAL MI IN PRESS; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kuhnert WL, 2004, J BACTERIOL, V186, P8524, DOI 10.1128/JB.186.24.8524-8528.2004; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; LOESCHE WJ, 1967, ARCH ORAL BIOL, V12, P189, DOI 10.1016/0003-9969(67)90037-4; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; MOORE S, 1954, J BIOL CHEM, V211, P907; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Sheng JY, 2007, FEMS MICROBIOL LETT, V272, P196, DOI 10.1111/j.1574-6968.2007.00744.x; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Spatafora GA, 1999, J BACTERIOL, V181, P2363, DOI 10.1128/JB.181.8.2363-2372.1999; Stephen K W, 1971, Caries Res, V5, P28; Svensater G, 2001, FEMS MICROBIOL LETT, V205, P139, DOI 10.1111/j.1574-6968.2001.tb10937.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanzer JM, 1976, P MICR ASP DENT CAR, P596; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; WALKER GJ, 1981, J GEN MICROBIOL, V127, P201; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welin J, 2003, FEMS MICROBIOL LETT, V227, P287, DOI 10.1016/S0378-1097(03)00693-1; Wen ZZT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-111; WILSON RF, 1990, CARIES RES, V24, P203, DOI 10.1159/000261266; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu T, 2006, MOL CELL PROTEOMICS, V5; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005	77	59	62	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45795	10.1371/journal.pone.0045795	http://dx.doi.org/10.1371/journal.pone.0045795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049864	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100082
J	Seppa, P; Queller, DC; Strassmann, JE				Seppa, Perttu; Queller, David C.; Strassmann, Joan E.			Why Wasp Foundresses Change Nests: Relatedness, Dominance, and Nest Quality	PLOS ONE			English	Article							EUSOCIAL HOVER WASPS; SOCIAL WASP; REPRODUCTIVE STRATEGY; GENETICAL EVOLUTION; POLISTES; SKEW; ASSOCIATIONS; DISPERSAL; CONSEQUENCES; DECISIONS	The costs and benefits of different social options are best understood when individuals can be followed as they make different choices, something that can be difficult in social insects. In this detailed study, we follow overwintered females of the social wasp Polistes carolina through different nesting strategies in a stratified habitat where nest site quality varies with proximity to a foraging area, and genetic relatedness among females is known. Females may initiate nests, join nests temporarily or permanently, or abandon nests. Females can become helpers or egglayers, effectively workers or queens. What they actually do can be predicted by a combination of ecological and relatedness factors. Advantages through increased lifetime success of individuals and nests drives foundresses of the social wasp Polistes from solitary to social nest founding. We studied reproductive options of spring foundresses of P. carolina by monitoring individually-marked wasps and assessing reproductive success of each foundress by using DNA microsatellites. We examined what behavioral decisions foundresses make after relaxing a strong ecological constraint, shortage of nesting sites. We also look at the reproductive consequences of different behaviors. As in other Polistes, the most successful strategy for a foundress was to initiate a nest as early as possible and then accept others as subordinates. A common feature for many P. carolina foundresses was, however, that they reassessed their reproductive options by actively monitoring other nests at the field site and sometimes moving permanently to new nests should that offer better (inclusive) fitness prospects compared to their original nests. A clear motivation for moving to new nests was high genetic relatedness; by the end of the foundress period all females were on nests with full sisters.	[Seppa, Perttu; Queller, David C.; Strassmann, Joan E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Seppa, P (corresponding author), Univ Helsinki, Dept Biol Sci, Ctr Excellence Biol Interact, Helsinki, Finland.	perttu.seppa@helsinki.fi	Seppä, Perttu/A-9900-2011	Strassmann, Joan/0000-0003-0638-8440; Seppa, Perttu/0000-0001-5393-6943	Academy of Finland [1713]; National Science Foundation [IBN-9210051, DEB-9510126, DEB 0918931]	Academy of Finland(Academy of Finland); National Science Foundation(National Science Foundation (NSF))	This study was supported by grants from the Academy of Finland (1713) to PS, and from National Science Foundation (IBN-9210051, DEB-9510126, and DEB 0918931) to JES and DCQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crozier R.H., 1996, EVOLUTION SOCIAL INS; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; Field J, 1998, P ROY SOC B-BIOL SCI, V265, P973, DOI 10.1098/rspb.1998.0386; Gadagkar Raghavendra, 1993, P188; Gamboa George J., 1996, P161; GILBERT DA, 1991, J HERED, V82, P378, DOI 10.1093/oxfordjournals.jhered.a111107; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAGEN R H, 1988, Psyche (Cambridge), V95, P191, DOI 10.1155/1988/40461; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinsohn Robert G., 2004, P67, DOI 10.1017/CBO9780511606816.005; HUGHES CR, 1988, BEHAVIOUR, V107, P1, DOI 10.1163/156853988X00151; Hughes CR, 1993, QUEEN NUMBER SOCIALI, P152; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; Koenig Walter D., 2004, P142, DOI 10.1017/CBO9780511606816.010; LORENZI MC, 1995, J INSECT BEHAV, V8, P443, DOI 10.1007/BF01995318; MICHENER C D, 1974, P404; NONACS P, 1995, ECOLOGY, V76, P953, DOI 10.2307/1939359; NONACS P, 1993, BEHAV PROCESS, V30, P47, DOI 10.1016/0376-6357(93)90011-F; Nonacs P, 2006, ANN ZOOL FENN, V43, P443; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; Pardi L, 1942, B ENTOMOL BOLOGNA, V14, P104; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Queller David C., 1996, P218; QUELLER DC, 1989, P NATL ACAD SCI USA, V86, P3224, DOI 10.1073/pnas.86.9.3224; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve H.K., 1991, P99; Reeve Hudson K., 1993, P45; Rissing S.W., 1988, P179; Rosengren Rainer, 1993, P308; Seppa P, 2002, BEHAV ECOL, V13, P531, DOI 10.1093/beheco/13.4.531; Seppa P, 2011, INSECT SOC, V58, P345, DOI 10.1007/s00040-011-0149-y; Starks PT, 1998, P ROY SOC B-BIOL SCI, V265, P1407, DOI 10.1098/rspb.1998.0449; Starks PT, 2001, ANN ZOOL FENN, V38, P189; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Strassmann J.E., 1987, P379; STRASSMANN JE, 1986, MONIT ZOOL ITAL, V20, P87; Strassmann JE, 1997, MOL ECOL, V6, P97, DOI 10.1046/j.1365-294X.1997.00158.x; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Strassmann Joan E.., 1996, P163; Sundstrom L, 2005, ANN ZOOL FENN, V42, P163; Temple HJ, 2009, IBIS, V151, P99, DOI 10.1111/j.1474-919X.2008.00867.x	44	10	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45386	10.1371/journal.pone.0045386	http://dx.doi.org/10.1371/journal.pone.0045386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049791	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100042
J	Vela, A; Fedorova, O; Ding, SC; Pyle, AM				Vela, Adriana; Fedorova, Olga; Ding, Steve C.; Pyle, Anna Marie			The Thermodynamic Basis for Viral RNA Detection by the RIG-I Innate Immune Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION; STRUCTURAL BASIS; TERMINAL DOMAIN; HELICASE; INSIGHTS; ACTIVATION; BINDING; LGP2	RIG-I is a cytoplasmic surveillance protein that contributes to the earliest stages of the vertebrate innate immune response. The protein specifically recognizes 5'-triphosphorylated RNA structures that are released into the cell by viruses, such as influenza and hepatitis C. To understand the energetic basis for viral RNA recognition by RIG-I, we studied the binding of RIG-I domain variants to a family of dsRNA ligands. Thermodynamic analysis revealed that the isolated RIG-I domains each make important contributions to affinity and that they interact using different strategies. Covalent linkage between the domains enhances RNA ligand specificity while reducing overall binding affinity, thereby providing a mechanism for discriminating virus from host RNA.	[Fedorova, Olga; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Vela, Adriana] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Fedorova, Olga; Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ding, Steve C.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Yale University; Yale University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 266 Whitney Ave,Box 208114, New Haven, CT 06520 USA.	anna.pyle@yale.edu						Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Cantor C.R, 1980, BIOPHYSICAL CHEM 3, P874; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Cutler TA, 2009, J MOL BIOL, V386, P854, DOI 10.1016/j.jmb.2008.10.090; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fersht A., 1985, ENZYME STRUCTURE MEC, P129; Fujita T, 2007, BIOCHIMIE, V89, P754, DOI 10.1016/j.biochi.2007.01.013; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hartmann RK, 2005, HANDBOOK OF RNA BIOCHEMISTRY, P1, DOI 10.1002/9783527619504; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qin PZ, 1999, J MOL BIOL, V291, P15, DOI 10.1006/jmbi.1999.2922; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677	28	44	47	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42564	42573		10.1074/jbc.M112.385146	http://dx.doi.org/10.1074/jbc.M112.385146			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23055530	hybrid, Green Published			2022-12-25	WOS:000312501600018
J	Burmeister, BT; Taglieri, DM; Wang, L; Carnegie, GK				Burmeister, Brian T.; Taglieri, Domenico M.; Wang, Li; Carnegie, Graeme K.			Src Homology 2 Domain-containing Phosphatase 2 (Shp2) Is a Component of the A-kinase-anchoring Protein (AKAP)-Lbc Complex and Is Inhibited by Protein Kinase A (PKA) under Pathological Hypertrophic Conditions in the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP SIGNALING COMPLEXES; CARDIAC-HYPERTROPHY; TYROSINE-PHOSPHATASE; DILATED CARDIOMYOPATHY; SCAFFOLDING PROTEINS; LEOPARD-SYNDROME; NOONAN-SYNDROME; NEURAL CREST; LIVING CELLS; PTPN11 SHP2	Pathological cardiac hypertrophy (an increase in cardiac mass resulting from stress-induced cardiac myocyte growth) is a major factor underlying heart failure. Our results identify a novel mechanism of Shp2 inhibition that may promote cardiac hypertrophy. We demonstrate that the tyrosine phosphatase, Shp2, is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex. AKAP-Lbc facilitates PKA phosphorylation of Shp2, which inhibits its protein-tyrosine phosphatase activity. Given the important cardiac roles of both AKAP-Lbc and Shp2, we investigated the AKAP-Lbc-Shp2 interaction in the heart. AKAP-Lbc-tethered PKA is implicated in cardiac hypertrophic signaling; however, mechanism of PKA action is unknown. Mutations resulting in loss of Shp2 catalytic activity are also associated with cardiac hypertrophy and congenital heart defects. Our data indicate that AKAP-Lbc integrates PKA and Shp2 signaling in the heart and that AKAP-Lbc-associated Shp2 activity is reduced in hypertrophic hearts in response to chronic beta-adrenergic stimulation and PKA activation. Thus, while induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through AKAP-Lbc-anchored PKA is a previously unrecognized mechanism that may promote compensatory cardiac hypertrophy.	[Burmeister, Brian T.; Taglieri, Domenico M.; Wang, Li; Carnegie, Graeme K.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Carnegie, GK (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,E403 MSB, Chicago, IL 60612 USA.	carnegie@uic.edu			American Heart Association [11SDG5230003]; National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences [UL1TR000050]; National Institutes of Health through the University of Illinois at Chicago Department of Cardiology [5T32HL072742-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072742] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences; National Institutes of Health through the University of Illinois at Chicago Department of Cardiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 11SDG5230003 (to G.K.C.) and National Center for Advancing Translational Science-University of Illinois at Chicago Center for Clinical and Translational Sciences Grant UL1TR000050.; Supported by National Institutes of Health T32 Training Grant 5T32HL072742-09 through the University of Illinois at Chicago Department of Cardiology.	Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Cariolato L, 2011, J BIOL CHEM, V286, P7925, DOI 10.1074/jbc.M110.185645; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Carnegie GK, 2011, J CARDIOVASC PHARM, V58, P451, DOI 10.1097/FJC.0b013e31821c0220; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2001, J CELL SCI, V114, P1431; Diviani D, 2011, AM J PHYSIOL-HEART C, V301, pH1742, DOI 10.1152/ajpheart.00569.2011; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2008, P NATL ACAD SCI USA, V105, P18930, DOI 10.1073/pnas.0806556105; Marin TM, 2008, CIRC RES, V103, P813, DOI 10.1161/CIRCRESAHA.108.179754; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P11270, DOI 10.1073/pnas.0902230106; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Shi FM, 2011, SCIENCE, V332, P1043, DOI 10.1126/science.1208063; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	35	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40535	40546		10.1074/jbc.M112.385641	http://dx.doi.org/10.1074/jbc.M112.385641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045525	Green Published, hybrid			2022-12-25	WOS:000311448800044
J	Gates, AR; Jones, DOB				Gates, Andrew R.; Jones, Daniel O. B.			Recovery of Benthic Megafauna from Anthropogenic Disturbance at a Hydrocarbon Drilling Well (380 m Depth in the Norwegian Sea)	PLOS ONE			English	Article							REMOTELY OPERATED VEHICLES; FAROE-SHETLAND CHANNEL; IN-SITU OBSERVATIONS; LONG-TERM CHANGE; OFFSHORE OIL; NORTH-SEA; PHYSICAL DISTURBANCE; WEST-COAST; DEEP; COMMUNITIES	Recovery from disturbance in deep water is poorly understood, but as anthropogenic impacts increase in deeper water it is important to quantify the process. Exploratory hydrocarbon drilling causes physical disturbance, smothering the seabed near the well. Video transects obtained by remotely operated vehicles were used to assess the change in invertebrate megafaunal density and diversity caused by drilling a well at 380 m depth in the Norwegian Sea in 2006. Transects were carried out one day before drilling commenced and 27 days, 76 days, and three years later. A background survey, further from the well, was also carried out in 2009. Porifera (45% of observations) and Cnidaria (40%) dominated the megafauna. Porifera accounted for 94% of hard-substratum organisms and cnidarians (Pennatulacea) dominated on the soft sediment (78%). Twenty seven and 76 days after drilling commenced, drill cuttings were visible, extending over 100 m from the well. In this area there were low invertebrate megafaunal densities (0.08 and 0.10 individuals m(-2)) in comparison to pre-drill conditions (0.21 individuals m(-2)). Three years later the visible extent of the cuttings had reduced, reaching 60 m from the well. Within this area the megafaunal density (0.05 individuals m(-2)) was lower than pre-drill and reference transects (0.23 individuals m(-2)). There was a significant increase in total megafaunal invertebrate densities with both distance from drilling and time since drilling although no significant interaction. Beyond the visible disturbance there were similar megafaunal densities (0.14 individuals m(-2)) to pre-drilling and background surveys. Species richness, Shannon-Weiner diversity and multivariate techniques showed similar patterns to density. At this site the effects of exploratory drilling on megafaunal invertebrate density and diversity seem confined to the extent of the visible cuttings pile. However, elevated Barium concentration and reduced sediment grain size suggest persistence of disturbance for three years, with unclear consequences for other components of the benthic fauna.	[Gates, Andrew R.; Jones, Daniel O. B.] Natl Oceanog Ctr, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England	NERC National Oceanography Centre	Gates, AR (corresponding author), Natl Oceanog Ctr, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England.	arg3@noc.ac.uk	Jones, Daniel/A-3412-2009; Gates, Andrew R/I-4321-2012	Jones, Daniel/0000-0001-5218-1649; Gates, Andrew R/0000-0002-2798-5044	Statoil ASA; United Kingdom Natural Environment Research Council; Natural Environment Research Council [noc010004, noc010009] Funding Source: researchfish; NERC [noc010009, noc010004] Funding Source: UKRI	Statoil ASA; United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Statoil ASA funded this work (www.statoil.com). The work was also funded, in part, by the United Kingdom Natural Environment Research Council as part of the Marine Environmental Mapping Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, R LANG ENV STAT COMP; Archambault P, 2001, MAR ECOL PROG SER, V222, P51, DOI 10.3354/meps222051; ATTRILL MJ, 1991, J MAR BIOL ASSOC UK, V71, P311, DOI 10.1017/S0025315400051626; Barlow MJ, 2001, MAR POLLUT BULL, V42, P71, DOI 10.1016/S0025-326X(00)00117-X; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bergmann M, 2011, DEEP-SEA RES PT I, V58, P711, DOI 10.1016/j.dsr.2011.03.007; Bergstad OA, 1999, SARSIA, V84, P67, DOI 10.1080/00364827.1999.10420452; Bett BJ, 2001, PROG OCEANOGR, V50, P349, DOI 10.1016/S0079-6611(01)00066-0; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Black KS, 2002, UNDERWATER TECHNOL, V25, P51, DOI 10.3723/175605402783219208; Bluhm H, 2001, DEEP-SEA RES PT II, V48, P3841, DOI 10.1016/S0967-0645(01)00070-4; Bluhm H, 1995, MAR GEORESOUR GEOTEC, V13, P393, DOI 10.1080/10641199509388295; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Breuer E, 2004, MAR POLLUT BULL, V48, P12, DOI 10.1016/j.marpolbul.2003.08.009; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; CANTELMO FR, 1979, MAR ENVIRON RES, V2, P301, DOI 10.1016/0141-1136(79)90014-X; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Currie DR, 2005, MAR ENVIRON RES, V59, P217, DOI 10.1016/j.marenvres.2004.05.001; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; DAVIES JM, 1981, MAR POLLUT BULL, V12, P412, DOI 10.1016/0025-326X(81)90159-4; Davies JM, 1989, DRILLING WASTES; Dernie KM, 2003, J EXP MAR BIOL ECOL, V285, P415, DOI 10.1016/S0022-0981(02)00541-5; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Edwards DCB, 2008, MAR BIOL, V155, P303, DOI 10.1007/s00227-008-1028-6; Edwards DCB, 2009, ESTUAR COAST SHELF S, V82, P161, DOI 10.1016/j.ecss.2009.01.006; Engel J, 1998, CONSERV BIOL, V12, P1204, DOI 10.1046/j.1523-1739.1998.0120061204.x; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gage JD, 2001, CONT SHELF RES, V21, P957, DOI 10.1016/S0278-4343(00)00120-5; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; GRASSLE JF, 1975, DEEP-SEA RES, V22, P457, DOI 10.1016/0011-7471(75)90020-0; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Hannah RW, 2010, FISH B-NOAA, V108, P30; Hartley JP, 1996, MAR POLLUT BULL, V32, P727, DOI 10.1016/0025-326X(96)00033-1; Holdway DA, 2002, MAR POLLUT BULL, V44, P185, DOI 10.1016/S0025-326X(01)00197-7; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Hovland Martin, 2008, P1; Hudson IR, 2004, J EXP MAR BIOL ECOL, V301, P75, DOI 10.1016/j.jembe.2003.09.015; Hughes SJM, 2010, J EXP MAR BIOL ECOL, V395, P37, DOI 10.1016/j.jembe.2010.08.012; Hylland K, 2008, MAR POLLUT BULL, V56, P414, DOI 10.1016/j.marpolbul.2007.11.004; Hyne NJ, 2001, NONTECHNICAL GUIDE P; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Jones DOB, 2007, DEEP-SEA RES PT I, V54, P1111, DOI 10.1016/j.dsr.2007.04.001; Jones DOB, 2006, MAR ECOL PROG SER, V319, P43, DOI 10.3354/meps319043; Jones DOB, 2012, MAR ECOL PROG SER, V461, P71, DOI 10.3354/meps09827; Jones DOB, 2009, ZOOL SCR, V38, P41, DOI 10.1111/j.1463-6409.2007.00315.x; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kotchen MJ, 2007, ENERG POLICY, V35, P4720, DOI 10.1016/j.enpol.2007.04.007; Kroger K, 2006, MAR ECOL PROG SER, V326, P85, DOI 10.3354/meps326085; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Lepland A, 2008, ENVIRON GEOL, V56, P119, DOI 10.1007/s00254-007-1145-4; Magurran A.E, 2003, MEASURING BIOL DIVER; MAIR JM, 1987, MAR POLLUT BULL, V18, P628; McBride GB, 1999, AUST NZ J STAT, V41, P19, DOI 10.1111/1467-842X.00058; NEFF JM, 1989, MAR ENVIRON RES, V27, P77, DOI 10.1016/0141-1136(89)90002-0; Netto SA, 2009, DEEP-SEA RES PT II, V56, P41, DOI 10.1016/j.dsr2.2008.08.018; Nodder SD, 2003, DEEP-SEA RES PT I, V50, P959, DOI 10.1016/S0967-0637(03)00094-3; Norkko J, 2010, MAR ECOL PROG SER, V413, P253, DOI 10.3354/meps08745; O'Neill Robert V., 1999, Journal of Aquatic Ecosystem Stress and Recovery, V6, P181, DOI 10.1023/A:1009996332614; Oksanen J., 2016, R PACKAG; OLSGARD F, 1995, MAR ECOL PROG SER, V122, P277, DOI 10.3354/meps122277; Pinder D, 2001, OCEAN COAST MANAGE, V44, P579, DOI 10.1016/S0964-5691(01)00070-9; RICE AL, 1982, OCEANOL ACTA, V5, P63; RICE AL, 1992, J MAR BIOL ASSOC UK, V72, P417, DOI 10.1017/S0025315400037796; Sanchez F, 2008, J MARINE SYST, V72, P64, DOI 10.1016/j.jmarsys.2007.04.008; Sanchez F, 2009, CONT SHELF RES, V29, P1174, DOI 10.1016/j.csr.2009.01.004; Santos MFL, 2009, DEEP-SEA RES PT II, V56, P32, DOI 10.1016/j.dsr2.2008.08.017; Schaanning MT, 2008, J EXP MAR BIOL ECOL, V361, P49, DOI 10.1016/j.jembe.2008.04.014; Schratzberger M, 1999, MAR ECOL PROG SER, V181, P227, DOI 10.3354/meps181227; Schulz M, 2010, POLAR BIOL, V33, P1359, DOI 10.1007/s00300-010-0825-9; Smit MGD, 2008, ENVIRON TOXICOL CHEM, V27, P1006, DOI 10.1897/07-339.1; SMITH CR, 1983, DEEP-SEA RES, V30, P907, DOI 10.1016/0198-0149(83)90048-1; TAGATZ ME, 1978, ESTUAR COAST MAR SCI, V7, P401, DOI 10.1016/0302-3524(78)90092-0; Trannum HC, 2011, MAR ECOL PROG SER, V442, P23, DOI 10.3354/meps09340; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; Trannum HC, 2011, MAR POLLUT BULL, V62, P2145, DOI 10.1016/j.marpolbul.2011.07.007; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Vardaro MF, 2009, LIMNOL OCEANOGR, V54, P2081, DOI 10.4319/lo.2009.54.6.2081; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wilson MT, 2002, HYDROBIOLOGIA, V471, P133, DOI 10.1023/A:1016509506094	86	35	35	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44114	10.1371/journal.pone.0044114	http://dx.doi.org/10.1371/journal.pone.0044114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056177	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000309831500005
J	Oh, CJ; Kim, JY; Choi, YK; Kim, HJ; Jeong, JY; Bae, KH; Park, KG; Lee, IK				Oh, Chang Joo; Kim, Joon-Young; Choi, Young-Keun; Kim, Han-Jong; Jeong, Ji-Yun; Bae, Kwi-Hyun; Park, Keun-Gyu; Lee, In-Kyu			Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-beta/Smad Signaling	PLOS ONE			English	Article							FUMARIC-ACID ESTERS; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; ANTIOXIDANT RESPONSE; NRF2; TARGET; SUPPRESSES; DEPOSITION; INDUCTION; PSORIASIS	TGF-beta plays a key role in the development of renal fibrosis. Suppressing the TGF-beta signaling pathway is a possible therapeutic approach for preventing this disease, and reports have suggested that Nrf2 protects against renal fibrosis by inhibiting TGF-beta signaling. This study examines whether dimethylfumarate (DMF), which stimulates Nrf2, prevents renal fibrosis via the Nrf2-mediated suppression of TGF-beta signaling. Results showed that DMF increased nuclear levels of Nrf2, and both DMF and adenovirus-mediated overexpression of Nrf2 (Ad-Nrf2) decreased PAI-1, alpha-smooth muscle actin (alpha-SMA), fibronectin and type 1 collagen expression in TGF-beta-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F). Additionally, DMF and Ad-Nrf2 repressed TGF-beta-stimulated Smad3 activity by inhibiting Smad3 phosphorylation, which was restored by siRNA-mediated knockdown of Nrf2 expression. However, downregulation of the antioxidant response element (ARE)-driven Nrf2 target genes such as NQO1, HO-1 and glutathione S-transferase (GST) did not reverse the inhibitory effect of DMF on TGF-beta-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an ARE-independent anti-fibrotic activity of DMF. Finally, DMF suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and alpha-SMA, fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of Nrf2 and phospho-Smad3, respectively. In summary, DMF attenuated renal fibrosis via the Nrf2-mediated inhibition of TGF-beta/Smad3 signaling in an ARE-independent manner, suggesting that DMF could be used to treat renal fibrosis.	[Oh, Chang Joo; Kim, Joon-Young; Choi, Young-Keun; Kim, Han-Jong; Jeong, Ji-Yun; Bae, Kwi-Hyun; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,WCU Program, Taegu, South Korea; [Kim, Joon-Young] Gwangju Inst Sci & Technol, GIST Coll, Kwangju, South Korea; [Kim, Han-Jong] Chonnam Natl Univ, Hwasun Hosp, Res Inst Clin Med, Hwasun, South Korea	Kyungpook National University; Gwangju Institute of Science & Technology (GIST); Chonnam National University	Lee, IK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,WCU Program, Taegu, South Korea.	leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021		National Research Foundation [2011-0028659, R32-10064, 2011-0019229, 2012-0006798, 2012-0001350]; Korean Ministry of Education, Science and Technology	National Research Foundation; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Research Foundation (2011-0028659; WCU Program, R32-10064; Future-based Technology Development Program Bio Field, 2011-0019229; and Basic Science Research Program, 2012-0006798 to J-YK and 2012-0001350 to H-JK), funded by the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Cross SA, 2011, J IMMUNOL, V187, P5015, DOI 10.4049/jimmunol.1101868; Ellrichmann G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016172; Gagliardini E, 2006, CYTOKINE GROWTH F R, V17, P89, DOI 10.1016/j.cytogfr.2005.09.005; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; Gold R, 2011, CNS DRUGS, V25, P37, DOI 10.2165/11539820-000000000-00000; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Iglesias-de la Cruz MC, 2001, KIDNEY INT, V59, P87, DOI 10.1046/j.1523-1755.2001.00469.x; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; JOHNSON RJ, 1993, J AM SOC NEPHROL, V4, P119; Jung GS, 2012, J AM SOC NEPHROL, V23, P73, DOI 10.1681/ASN.2011010048; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kelly DJ, 2001, J AM SOC NEPHROL, V12, P2098, DOI 10.1681/ASN.V12102098; Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Loewe R, 2006, CANCER RES, V66, P11888, DOI 10.1158/0008-5472.CAN-06-2397; Moharregh-Khiabani D, 2009, CURR NEUROPHARMACOL, V7, P60, DOI 10.2174/157015909787602788; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Ockenfels HM, 1998, BRIT J DERMATOL, V139, P390; Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012; Papadopoulou A, 2010, EXPERT OPIN INV DRUG, V19, P1603, DOI 10.1517/13543784.2010.534778; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Sato S, 2009, BIOCHEM BIOPH RES CO, V379, P411, DOI 10.1016/j.bbrc.2008.12.088; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Seidel P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-145; Shin DH, 2010, FREE RADICAL BIO MED, V48, P1051, DOI 10.1016/j.freeradbiomed.2010.01.021; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Valero T, 2010, J INVEST DERMATOL, V130, P1087, DOI 10.1038/jid.2009.368; Wain EM, 2010, BRIT J DERMATOL, V162, P427, DOI 10.1111/j.1365-2133.2009.09267.x; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yamazoe Y, 2009, CELL BIOL INT, V33, P1087, DOI 10.1016/j.cellbi.2009.06.027; Zhou AH, 2003, KIDNEY INT, V64, P92, DOI 10.1046/j.1523-1755.2003.00045.x	45	74	76	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45870	10.1371/journal.pone.0045870	http://dx.doi.org/10.1371/journal.pone.0045870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056222	Green Submitted, gold, Green Published			2022-12-25	WOS:000309831500022
J	Ghorbani, M; Ardestani, MS; Gigloo, SH; Cohan, RA; Inanlou, DN; Ghorbani, P				Ghorbani, Masoud; Ardestani, Mehdi Shafiee; Gigloo, Sedigheh Hatami; Cohan, Reza Ahangari; Inanlou, Davoud Nouri; Ghorbani, Peyman			Anti Diabetic effect of CL 316,243 (A beta 3-Adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-alpha) Expression	PLOS ONE			English	Article							BROWN ADIPOCYTES; GENE-EXPRESSION; OBESITY; RECEPTORS; GLUCOSE	Objective: Obesity is a risk factor for the development of insulin resistance and is one of the most important contributors to the pathogenesis of type2 diabetes, which acts mainly through the secretion of adipokines such as TNF-alpha that may influence insulin sensitivity. TNF-alpha affects many aspects of adipocyte function, such as adipocyte development and lipid metabolism. Material and Methods: We demonstrated that there is a correlation between the expressions of TNF-a in retroperitoneal WAT and insulin-resistance in 8 genetically obese fa/fa rats. Treatment of animals with CL 316,243, alpha beta 3-adrenergic agonist, showed an improvement of insulin-resistance that was linked with the suppression of TNF-alpha mRNA expression in WAT. Results: These results confirm the association between TNF-alpha expression and the insulin-resistant condition in rats. Our finding indicates that the hyperglycaemia and hyperinsulinemia induced by insulin-resistance correlated positively with the expression of TNF-alpha mRNA in an abdominal WAT depot. Conclusion: We conclude that CL 316,243 possesses both anti-diabetic effects and anti-obesity effects in rodents.	[Ghorbani, Masoud] Pasteur Inst Iran, Dept Microbiol & Immunol, Tehran, Iran; [Ghorbani, Masoud; Gigloo, Sedigheh Hatami; Inanlou, Davoud Nouri] Pasteur Inst Iran, Karaj, Iran; [Ghorbani, Masoud] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ardestani, Mehdi Shafiee; Cohan, Reza Ahangari] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran; [Ghorbani, Peyman] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Ottawa; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Toronto	Ghorbani, M (corresponding author), Pasteur Inst Iran, Dept Microbiol & Immunol, Tehran, Iran.	mghorbani@irimc.org	ahangari cohan, reza/L-9626-2017; Cohan, Reza Ahangari/AAH-3594-2019; Ghorbani, Masoud/U-8549-2019; Ghorbani, Masoud/P-1544-2014	ahangari cohan, reza/0000-0002-0490-4184; Cohan, Reza Ahangari/0000-0002-0490-4184; Ghorbani, Masoud/0000-0002-2367-6690; Ghorbani, Masoud/0000-0002-4299-028X; Ghorbani, Peyman/0000-0002-7398-5141	Medical Council of Canada	Medical Council of Canada	This work was supported by grants from the Medical Council of Canada and performed in part at the University of Ottawa and completed at Pasteur Institute of Iran. No grant number was available at the time. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DALLAIRE F, 1995, BRIT J PHARMACOL, V114, P275, DOI 10.1111/j.1476-5381.1995.tb13223.x; Fu L, 2008, EUR J PHARMACOL, V584, P202, DOI 10.1016/j.ejphar.2008.01.028; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Hyunsook K, 2006, AM J PHYSL ENDO, V290, P6; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; LARGIS EE, 1994, DRUG DEVELOP RES, V32, P69, DOI 10.1002/ddr.430320203; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823	17	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45874	10.1371/journal.pone.0045874	http://dx.doi.org/10.1371/journal.pone.0045874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056223	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800005
J	Li, ZZ; Xu, YW; Warner, D; Volkow, ND				Li, Zizhong; Xu, Youwen; Warner, Don; Volkow, Nora D.			Alcohol ADME in Primates Studied with Positron Emission Tomography	PLOS ONE			English	Article							BRAIN ETHANOL-METABOLISM; RAT-BRAIN; SYSTEM PET; ACETALDEHYDE; DEUTERIUM; OXIDATION; LIVER; KINETICS; CONSUMPTION; POLYMORPHISMS	Background and Purpose: The sensitivity to the intoxicating effects of alcohol as well as its adverse medical consequences differ markedly among individuals, which reflects in part differences in alcohol's absorption, distribution, metabolism, and elimination (ADME) properties. The ADME of alcohol in the body and its relationship with alcohol's brain bioavailability, however, is not well understood. Experimental Approach: The ADME of C-11 labeled alcohol, (CH3CH2OH)-C-11, 1 and C-11 and deuterium dual labeled alcohol, (CH3CD2OH)-C-11, 2 in baboons was compared based on the principle that C-D bond is stronger than C-H bond, thus the reaction is slower if C-D bond breaking occurs in a rate-determining metabolic step. The following ADME parameters in peripheral organs and brain were derived from time activity curve (TAC) of positron emission tomography (PET) scans: peak uptake (C-max); peak uptake time (T-max), half-life of peak uptake (T-1/2), the area under the curve (AUC(60min)), and the residue uptake (C-60min). Key Results: For 1 the highest uptake occurred in the kidney whereas for 2 it occurred in the liver. A deuterium isotope effect was observed in the kidneys in both animals studied and in the liver of one animal but not the other. The highest uptake for 1 and 2 in the brain was in striatum and cerebellum but 2 had higher uptake than 1 in all brain regions most evidently in thalamus and cingulate. Alcohol's brain uptake was significantly higher when given intravenously than when given orally and also when the animal was pretreated with a pharmacological dose of alcohol. Conclusion and Implications: The study shows that alcohol metabolism in peripheral organs had a large effect on alcohol's brain bioavailability. This study sets the stage for clinical investigation on how genetics, gender and alcohol abuse affect alcohol's ADME and its relationship to intoxication and medical consequences.	[Li, Zizhong; Xu, Youwen; Warner, Don] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Volkow, Nora D.] NIAAA, Bethesda, MD USA; [Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Li, ZZ (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	Zizhong_li@eisai.com			Brookhaven National Laboratory (LDRD) [03-103]; National Institute on Alcoholism and Alcohol Abuse [5R21AA014018-03]; United States Department of Energy [DE-AC02-98CH1-886]; National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000551, R21AA014018] Funding Source: NIH RePORTER	Brookhaven National Laboratory (LDRD); National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	ZL was supported by a grant from Brookhaven National Laboratory (LDRD#03-103) and he is the author of a grant from National Institute on Alcoholism and Alcohol Abuse (5R21AA014018-03). This research was also funded by United States Department of Energy (DE-AC02-98CH1-886) and National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2006, NEUROPSYCHOPHARMACOL, V31, P2683, DOI 10.1038/sj.npp.1301023; Amberg R, 2002, BLUTALKOHOL, V39, P11; Beckemeier ME, 1998, J MOL CELL CARDIOL, V30, P2487, DOI 10.1006/jmcc.1998.0812; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; BERNSTEIN J, 1983, RES COMMUN CHEM PATH, V39, P49; BERNSTEIN J, 1990, RES COMMUN CHEM PATH, V68, P219; Chen CH, 2011, ALCOHOL CLIN EXP RES; Chen JC, 2007, J STUD ALCOHOL DRUGS, V68, P649, DOI 10.15288/jsad.2007.68.649; Christie IC, 2008, ALCOHOL, V42, P269, DOI 10.1016/j.alcohol.2008.03.132; CORRALL RJM, 1974, J BIOL CHEM, V249, P3181; Correa M, 2012, NEUROSCI BIOBEHAV R, V36, P404, DOI 10.1016/j.neubiorev.2011.07.009; CRONHOLM T, 1988, ALCOHOL CLIN EXP RES, V12, P683, DOI 10.1111/j.1530-0277.1988.tb00265.x; CRONHOLM T, 1985, BIOCHEM J, V229, P323, DOI 10.1042/bj2290323; DAMGAARD SE, 1980, BIOCHEM J, V191, P613, DOI 10.1042/bj1910613; DAMGAARD SE, 1981, BIOCHEMISTRY-US, V20, P5662, DOI 10.1021/bi00523a004; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; DEGRAZIA JA, 1975, J NUCL MED, V16, P73; FOWLER JS, 1988, J NEUROCHEM, V51, P1524, DOI 10.1111/j.1471-4159.1988.tb01121.x; FRIEL PN, 1995, ALCOHOL CLIN EXP RES, V19, P1055, DOI 10.1111/j.1530-0277.1995.tb00988.x; Friel PN, 1999, J STUD ALCOHOL, V60, P555, DOI 10.15288/jsa.1999.60.555; Gulyas B, 2002, ACTA NEUROL SCAND, V106, P325, DOI 10.1034/j.1600-0404.2002.01302.x; Guo R, 2010, INT J ENV RES PUB HE, V7, P1285, DOI 10.3390/ijerph7041285; Hetherington HP, 1999, MAGNET RESON MED, V42, P1019, DOI 10.1002/(SICI)1522-2594(199912)42:6<1019::AID-MRM5>3.0.CO;2-Y; Hlastala MP, 1998, J APPL PHYSIOL, V84, P401, DOI 10.1152/jappl.1998.84.2.401; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; Howard RJ, 2011, ALCOHOL CLIN EXP RES, V35, P1561, DOI 10.1111/j.1530-0277.2011.01502.x; JACOBSON R, 1986, PSYCHOL MED, V16, P547, DOI 10.1017/S003329170001031X; JULKUNEN RJK, 1985, ALCOHOL, V2, P437, DOI 10.1016/0741-8329(85)90111-9; Karahanian E, 2011, ALCOHOL CLIN EXP RES, V35, P606, DOI 10.1111/j.1530-0277.2011.01439.x; KUIKKA J, 1980, J BIOMED ENG, V2, P87, DOI 10.1016/0141-5425(80)90057-6; Li D, 2011, HUM GENET; Li TK, 2001, ALCOHOL CLIN EXP RES, V25, P136, DOI 10.1111/j.1530-0277.2001.tb02138.x; LIEBER CS, 1988, BIOCHEM SOC T, V16, P232, DOI 10.1042/bst0160232; LUNDQUIST F, 1989, PHARMACOL TOXICOL, V65, P45, DOI 10.1111/j.1600-0773.1989.tb01125.x; LUNDQUIST F, 1990, PHARMACOL TOXICOL, V66, P244, DOI 10.1111/j.1600-0773.1990.tb00742.x; MICHOUDET C, 1987, FEBS LETT, V216, P113, DOI 10.1016/0014-5793(87)80767-6; MICHOUDET C, 1987, BIOCHEM PHARMACOL, V36, P3987, DOI 10.1016/0006-2952(87)90468-0; Peng GS, 2007, PHARMACOGENET GENOM, V17, P845, DOI 10.1097/FPC.0b013e3282609e67; RAICHLE ME, 1976, AM J PHYSIOL, V230, P543, DOI 10.1152/ajplegacy.1976.230.2.543; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Ramchandani VA, 2004, NUTR ALCOHOL LINKING; Salaspuro MP, 2003, BEST PRACT RES CL GA, V17, P679, DOI 10.1016/S1521-6918(03)00035-0; Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x; Upadhya SC, 2002, ALCOHOL CLIN EXP RES, V26, P856, DOI 10.1097/00000374-200206000-00016; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wang GJ, 2000, ALCOHOL CLIN EXP RES, V24, P822, DOI 10.1097/00000374-200006000-00011; WILKINSON PK, 1977, J PHARMACOKINET BIOP, V5, P41, DOI 10.1007/BF01064808; Xiang Y, 2011, NMR BIOMED, V24, P1054, DOI 10.1002/nbm.1653; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115; Zhu W, 2004, ALCOHOL ALCOHOLISM, V39, P53, DOI 10.1093/alcalc/agh023; Zimatkin SM, 2001, ALCOHOL CLIN EXP RES, V25, P982, DOI 10.1097/00000374-200107000-00006; Zimatkin SM, 2001, ALCOHOL CLIN EXP RES, V25, P976, DOI 10.1111/j.1530-0277.2001.tb02305.x	56	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46676	10.1371/journal.pone.0046676	http://dx.doi.org/10.1371/journal.pone.0046676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049712	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388500039
J	Allsop, DJ; Copeland, J; Norberg, MM; Fu, SL; Molnar, A; Lewis, J; Budney, AJ				Allsop, David J.; Copeland, Jan; Norberg, Melissa M.; Fu, Shanlin; Molnar, Anna; Lewis, John; Budney, Alan J.			Quantifying the Clinical Significance of Cannabis Withdrawal	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; DEPENDENCE SCALE SDS; TEST AUDIT; ALCOHOL; SEVERITY; SYMPTOMS; ADOLESCENTS; VALIDITY; TOBACCO; RELIABILITY	Background and Aims: Questions over the clinical significance of cannabis withdrawal have hindered its inclusion as a discrete cannabis induced psychiatric condition in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). This study aims to quantify functional impairment to normal daily activities from cannabis withdrawal, and looks at the factors predicting functional impairment. In addition the study tests the influence of functional impairment from cannabis withdrawal on cannabis use during and after an abstinence attempt. Methods and Results: volunteer sample of 49 non-treatment seeking cannabis users who met DSM-IV criteria for dependence provided daily withdrawal-related functional impairment scores during a one-week baseline phase and two weeks of monitored abstinence from cannabis with a one month follow up. Functional impairment from withdrawal symptoms was strongly associated with symptom severity (p = 0.0001). Participants with more severe cannabis dependence before the abstinence attempt reported greater functional impairment from cannabis withdrawal (p = 0.03). Relapse to cannabis use during the abstinence period was associated with greater functional impairment from a subset of withdrawal symptoms in high dependence users. Higher levels of functional impairment during the abstinence attempt predicted higher levels of cannabis use at one month follow up (p = 0.001). Conclusions: Cannabis withdrawal is clinically significant because it is associated with functional impairment to normal daily activities, as well as relapse to cannabis use. Sample size in the relapse group was small and the use of a non-treatment seeking population requires findings to be replicated in clinical samples. Tailoring treatments to target withdrawal symptoms contributing to functional impairment during a quit attempt may improve treatment outcomes.	[Allsop, David J.; Copeland, Jan; Norberg, Melissa M.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Natl Cannabis Prevent & Informat Ctr, Sydney, NSW, Australia; [Fu, Shanlin; Molnar, Anna; Lewis, John] Univ Technol Sydney, Sch Chem & Forens Sci, Ctr Forens Sci, Sydney, NSW 2007, Australia; [Budney, Alan J.] Geisel Sch Med Dartmouth, Lebanon, NH USA	University of New South Wales Sydney; University of Technology Sydney; Dartmouth College	Allsop, DJ (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Natl Cannabis Prevent & Informat Ctr, Sydney, NSW, Australia.	d.allsop@unsw.edu.au	Norberg, Melissa/H-8365-2014; Fu, Shanlin/D-8286-2013	Norberg, Melissa/0000-0001-7840-9007; Fu, Shanlin/0000-0002-6238-3612	National Health and Medical Research Council, Australia [1006036]; Australian Government Department of Health and Ageing; National Institute on Drug Abuse [DA15186, DA23526]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015186, R01DA023526] Funding Source: NIH RePORTER	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Allsop is supported by a project grant (1006036) from the National Health and Medical Research Council, Australia. Funding for the work was provided by the Australian Government Department of Health and Ageing. Dr. Budney's contribution was funded in part by the National Institute on Drug Abuse, DA15186 and DA23526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, AM J ADDICTION, V17, P199, DOI 10.1080/10550490802019519; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allsop DJ, 2011, DRUG ALCOHOL DEPEN, V119, P123, DOI 10.1016/j.drugalcdep.2011.06.003; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Budney AJ, 2006, CURR OPIN PSYCHIATR, V19, P233, DOI 10.1097/01.yco.0000218592.00689.e5; Budney AJ, 2001, ARCH GEN PSYCHIAT, V58, P917, DOI 10.1001/archpsyc.58.10.917; Budney AJ, 2008, J SUBST ABUSE TREAT, V35, P362, DOI 10.1016/j.jsat.2008.01.002; Cook JM, 2007, GEN HOSP PSYCHIAT, V29, P396, DOI 10.1016/j.genhosppsych.2007.07.001; Copeland J, 2001, J SUBST ABUSE TREAT, V20, P45, DOI 10.1016/S0740-5472(00)00148-3; Copersino ML, 2006, AM J ADDICTION, V15, P8, DOI 10.1080/10550490500418997; Cornelius JR, 2008, ADDICT BEHAV, V33, P1500, DOI 10.1016/j.addbeh.2008.02.001; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V50, P27, DOI 10.1016/S0376-8716(98)00003-9; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; FARRELL M, 1994, ADDICTION, V89, P1471, DOI 10.1111/j.1360-0443.1994.tb03745.x; First MB, 2002, STRUCTURED CLIN INTE; Fu SL, 2008, J ANAL TOXICOL, V32, P292, DOI 10.1093/jat/32.4.292; Gates P, 2012, ADDICTION IN PRESS; Gorelick DA, 2012, DRUG ALCOHOL DEPEN, V123, P141, DOI 10.1016/j.drugalcdep.2011.11.007; GOSSOP M, 1992, BRIT J ADDICT, V87, P1527; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Hall W, 1997, LANCET, V349, P1897, DOI 10.1016/S0140-6736(97)04572-8; Haney M, 2008, PSYCHOPHARMACOLOGY, V197, P157, DOI 10.1007/s00213-007-1020-8; Haney Margaret, 2005, Curr Psychiatry Rep, V7, P360, DOI 10.1007/s11920-005-0036-1; Harrell FE, 2001, REGRESSION MODELING; Hasin DS, 2008, J CLIN PSYCHIAT, V69, P1354, DOI 10.4088/JCP.v69n0902; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Ivis FJ, 2000, DRUG ALCOHOL DEPEN, V60, P97, DOI 10.1016/S0376-8716(99)00145-3; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; LEVIN K, 2010, ART NEWS, V109, P111; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; McBride O, 2010, J STUD ALCOHOL DRUGS, V71, P597, DOI 10.15288/jsad.2010.71.597; Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22; Norberg MM, 2012, DRUG ALCOHOL DEPEN, V121, P247, DOI 10.1016/j.drugalcdep.2011.09.007; Piasecki TM, 2003, J ABNORM PSYCHOL, V112, P14, DOI 10.1037/0021-843X.112.1.14; Piontek D, 2011, ADDICTION, V106, P1137, DOI 10.1111/j.1360-0443.2010.03359.x; Preuss UW, 2010, DRUG ALCOHOL DEPEN, V106, P133, DOI 10.1016/j.drugalcdep.2009.08.008; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rubin A, 2006, J STUD ALCOHOL, V67, P454, DOI 10.15288/jsa.2006.67.454; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; Vandrey R, 2005, DRUG ALCOHOL DEPEN, V78, P205, DOI 10.1016/j.drugalcdep.2004.11.001; Vandrey RG, 2008, DRUG ALCOHOL DEPEN, V92, P48, DOI 10.1016/j.drugalcdep.2007.06.010; ZIMMERMAN DW, 1993, J EXP EDUC, V62, P75, DOI 10.1080/00220973.1993.9943832	48	86	89	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44864	10.1371/journal.pone.0044864	http://dx.doi.org/10.1371/journal.pone.0044864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049760	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300012
J	Fang, P; Zeng, LL; Shen, H; Wang, LB; Li, BJ; Liu, L; Hu, DW				Fang, Peng; Zeng, Ling-Li; Shen, Hui; Wang, Lubin; Li, Baojuan; Liu, Li; Hu, Dewen			Increased Cortical-Limbic Anatomical Network Connectivity in Major Depression Revealed by Diffusion Tensor Imaging	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; BRAIN STRUCTURAL NETWORKS; FRONTAL WHITE-MATTER; ANTERIOR CINGULATE; PATTERN-CLASSIFICATION; SUBGENUAL CINGULATE; HIPPOCAMPAL VOLUMES; GLUCOSE-METABOLISM; PARIETAL CORTEX; PET FINDINGS	Magnetic resonance imaging studies have reported significant functional and structural differences between depressed patients and controls. Little attention has been given, however, to the abnormalities in anatomical connectivity in depressed patients. In the present study, we aim to investigate the alterations in connectivity of whole-brain anatomical networks in those suffering from major depression by using machine learning approaches. Brain anatomical networks were extracted from diffusion magnetic resonance images obtained from both 22 first-episode, treatment-naive adults with major depressive disorder and 26 matched healthy controls. Using machine learning approaches, we differentiated depressed patients from healthy controls based on their whole-brain anatomical connectivity patterns and identified the most discriminating features that represent between-group differences. Classification results showed that 91.7% (patients = 86.4%, controls = 96.2%; permutation test, p<0.0001) of subjects were correctly classified via leave-one-out cross-validation. Moreover, the strengths of all the most discriminating connections were increased in depressed patients relative to the controls, and these connections were primarily located within the cortical-limbic network, especially the frontal-limbic network. These results not only provide initial steps toward the development of neurobiological diagnostic markers for major depressive disorder, but also suggest that abnormal cortical-limbic anatomical networks may contribute to the anatomical basis of emotional dysregulation and cognitive impairments associated with this disease.	[Fang, Peng; Zeng, Ling-Li; Shen, Hui; Wang, Lubin; Li, Baojuan; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Liu, Li] China Med Univ, Dept Psychiat, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China	National University of Defense Technology - China; China Medical University	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Important Basic Research Program of China [2011CB707802]; National High-Tech Program of China [2012AA011601]; Graduate Innovation Fund of National University of Defense Technology [B120303]; National Natural Science Foundation of China [61003202, 60835005]	National Important Basic Research Program of China(National Basic Research Program of China); National High-Tech Program of China(National High Technology Research and Development Program of China); Graduate Innovation Fund of National University of Defense Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Important Basic Research Program of China (2011CB707802), the National High-Tech Program of China (2012AA011601), Graduate Innovation Fund of National University of Defense Technology (B120303) and the National Natural Science Foundation of China (61003202, 60835005).	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Andersson J.L.R, 2007, TR07JA2 FMRIB; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; First M. B., 2002, STRUCTURED CLIN INTE; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Geday J, 2001, NEUROIMAGE, V13, pS406; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Grace AA, 2006, NEUROTOX RES, V10, P93, DOI 10.1007/BF03033238; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Houenou J, 2007, MOL PSYCHIATR, V12, P1001, DOI 10.1038/sj.mp.4002010; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Linden DEJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.049.2009; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu MJ, 2012, NEUROREPORT, V23, P265, DOI 10.1097/WNR.0b013e32834f60a5; Liu TM, 2011, BRAIN IMAGING BEHAV, V5, P189, DOI 10.1007/s11682-011-9123-6; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McLaughlin NCR, 2007, INT J DEV NEUROSCI, V25, P215, DOI 10.1016/j.ijdevneu.2007.03.008; Morita M, 2002, COGNITIVE BRAIN RES, V13, P169, DOI 10.1016/S0926-6410(01)00109-4; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Paulus MP, 2002, BIOL PSYCHIAT, V51, P995, DOI 10.1016/S0006-3223(01)01358-0; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Taylor WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003267; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Videbech P, 2001, PSYCHOL MED, V31, P1147, DOI 10.1017/S0033291701004469; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DG, 2012, BRAIN IMAGING BEHAV, V6, P27, DOI 10.1007/s11682-011-9138-z; Zhu D., 2012, CEREBRAL CO IN PRESS	84	63	67	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45972	10.1371/journal.pone.0045972	http://dx.doi.org/10.1371/journal.pone.0045972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049910	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300069
J	Hall, RI; Wolfe, BB; Wiklund, JA; Edwards, TWD; Farwell, AJ; Dixon, DG				Hall, Roland I.; Wolfe, Brent B.; Wiklund, Johan A.; Edwards, Thomas W. D.; Farwell, Andrea J.; Dixon, D. George			Has Alberta Oil Sands Development Altered Delivery of Polycyclic Aromatic Compounds to the Peace-Athabasca Delta?	PLOS ONE			English	Article							EARLY-LIFE STAGES; LAKE-SEDIMENTS; ORGANIC-MATTER; FOREST-FIRES; RIVER; HYDROCARBONS; CANADA; WATER; BASIN; GEOCHEMISTRY	Background: The extent to which Alberta oil sands mining and upgrading operations have enhanced delivery of bitumen-derived contaminants via the Athabasca River and atmosphere to the Peace-Athabasca Delta (200 km to the north) is a pivotal question that has generated national and international concern. Accounts of rare health disorders in residents of Fort Chipewyan and deformed fish in downstream ecosystems provided impetus for several recent expert-panel assessments regarding the societal and environmental consequences of this multi-billion-dollar industry. Deciphering relative contributions of natural versus industrial processes on downstream supply of polycyclic aromatic compounds (PACs) has been identified as a critical knowledge gap. But, this remains a formidable scientific challenge because loading from natural processes remains unknown. And, industrial activity occurs in the same locations as the natural bitumen deposits, which potentially confounds contemporary upstream-downstream comparisons of contaminant levels. Methods/Principal Findings: Based on analyses of lake sediment cores, we provide evidence that the Athabasca Delta has been a natural repository of PACs carried by the Athabasca River for at least the past two centuries. We detect no measureable increase in the concentration and proportion of river-transported bitumen-associated indicator PACs in sediments deposited in a flood-prone lake since onset of oil sands development. Results also reveal no evidence that industrial activity has contributed measurably to sedimentary concentration of PACs supplied by atmospheric transport. Conclusions/Significance: Findings suggest that natural erosion of exposed bitumen in banks of the Athabasca River and its tributaries is a major process delivering PACs to the Athabasca Delta, and the spring freshet is a key period for contaminant mobilization and transport. This baseline environmental information is essential for informed management of natural resources and human-health concerns by provincial and federal regulatory agencies and industry, and for designing effective long-term monitoring programs for the lower Athabasca River watershed.	[Hall, Roland I.; Wiklund, Johan A.; Farwell, Andrea J.; Dixon, D. George] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Wolfe, Brent B.] Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada; [Edwards, Thomas W. D.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo; Wilfrid Laurier University; University of Waterloo	Hall, RI (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	rihall@uwaterloo.ca	Hall, Roland/AAO-2164-2020; Hall, Roland I/K-3165-2019	Hall, Roland/0000-0002-0314-6449; Wiklund, Johan/0000-0002-2327-5651	Suncor Energy Ltd.	Suncor Energy Ltd.	The research was supported by Suncor Energy Ltd. (http://www.suncor.com), an oil sands mining and production company. Dr. Jon Fennell (WorleyParsons Canada), a respected consultant to industry and government, and a scientific authority on water-related environmental issues in the oil sands industry, helped obtain the funding for the project. During periodic meetings, Dr. Fennell became familiar with the authors' prior hydroecological research in the Peace-Athabasca Delta. And, the authors' discussed with him the concepts and proposals for the project presented in this paper. He was also aware of challenges faced when trying to get the project funded by more traditional research funding routes. Dr. Fennell presented the concept of the research project the authors had developed to a manager at Suncor Energy Ltd., which provided an introduction that led to development of the funding for this project. During the project, Dr. Fennell acted as a liaison for communications between the authors and staff at Suncor Energy Ltd. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The agreement between the University of Waterloo and the funder allowed the funder an opportunity to delay publication by up to 18 months, which they did not execute.	Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; Ballestra SJ, 1994, IAEA300 MAR ENV LAB; Binford M, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Bradley L.J., 1994, J SOIL CONTAM, V3, P349, DOI DOI 10.1080/15320389409383475; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colavecchia MV, 2006, J TOXICOL ENV HEAL A, V69, P967, DOI 10.1080/15287390500362154; Colavecchia MV, 2004, ENVIRON TOXICOL CHEM, V23, P1709, DOI 10.1897/03-412; Conly F. M., 2002, Journal of Environmental Engineering and Science, V1, P187, DOI 10.1139/s02-013; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dowdeswell L., 2010, REPORT SUBMITTED MIN, P1; Environment Canada, 2011, INT MON PROGR OIL SA; Evans MS, 2002, WAT STUD SER, V11, P365; Gabos S, 2001, CHEMOSPHERE, V43, P709, DOI 10.1016/S0045-6535(00)00424-0; Garcia-Aragon J, 2011, J SOIL SEDIMENT, V11, P679, DOI 10.1007/s11368-011-0345-4; Giesy JP, 2010, P NATL ACAD SCI USA, V107, P951, DOI 10.1073/pnas.0912880107; Glew JR, 1989, J PALEOLIMNOL, V2, P241; Gosselin P., 2010, ENV HLTH IMPACTS CAN; Government of Alberta, 2006, ALB OIL SANDS; Grice K, 2007, ORG GEOCHEM, V38, P1795, DOI 10.1016/j.orggeochem.2007.07.001; Hall RI, 2004, MULTICENTURY FLOOD C; Headley JV, 2001, ENVIRON FORENSICS, V2, P335, DOI 10.1006/enfo.2001.0064; Headley JV, 2002, J ENVIRON SCI HEAL A, V37, P1159, DOI 10.1081/ESE-120005979; IRWIN RJ, 1997, ENV CONTAMINANTS ENC; Itoh N, 2010, ORG GEOCHEM, V41, P845, DOI 10.1016/j.orggeochem.2010.04.002; Johnston JW, 2010, HOLOCENE, V20, P801, DOI 10.1177/0959683610362816; Jones R, 2010, MAR POLLUT BULL, V60, P1993, DOI 10.1016/j.marpolbul.2010.07.028; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kersten M, 2002, J ENVIRON MONITOR, V4, P109, DOI 10.1039/b108102k; Mauro D. M., 2006, Land Contamination & Reclamation, V14, P513, DOI 10.2462/09670513.749; McGowan S, 2011, GLOBAL CHANGE BIOL, V17, P1212, DOI 10.1111/j.1365-2486.2010.02304.x; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; OAG, 2010, OIL SPILLS SHIPS; Peters DL, 2006, HYDROL PROCESS, V20, P4073, DOI 10.1002/hyp.6420; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; RAMDAHL T, 1983, NATURE, V306, P580, DOI 10.1038/306580a0; Robbins J.A., 1978, BIOGEOCHEMISTRY LEAD, V1A, P285; Rosenberg, 2004, OIL SANDS REGIONAL A; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Schindler D, 2010, NATURE, V468, P499, DOI 10.1038/468499a; SCRIMGEOUR GJ, 1994, FRESHWATER BIOL, V32, P261, DOI 10.1111/j.1365-2427.1994.tb01125.x; Timoney K, 2002, WETLANDS, V22, P282, DOI 10.1672/0277-5212(2002)022[0282:ADDACS]2.0.CO;2; Timoney K., 2007, STUDY WATER SEDIMENT; Timoney KP, 2011, ENVIRON SCI TECHNOL, V45, P4278, DOI 10.1021/es104375d; Timoney Kevin P., 2009, Open Conservation Biology Journal, V3, P65, DOI 10.2174/1874839200903010065; Tolosa I, 1996, ENVIRON SCI TECHNOL, V30, P2495, DOI 10.1021/es950647x; Vergnoux A, 2011, ENVIRON RES, V111, P193, DOI 10.1016/j.envres.2010.01.008; WAKEHAM SG, 1980, GEOCHIM COSMOCHIM AC, V44, P415, DOI 10.1016/0016-7037(80)90041-1; Wiklund JA, 2012, SCI TOTAL ENVIRON, V433, P379, DOI 10.1016/j.scitotenv.2012.06.074; Wiklund JA, 2012, ECOHYDROLOGY, V5, P351, DOI 10.1002/eco.226; Wolfe BB, 2005, QUATERNARY RES, V64, P147, DOI 10.1016/j.yqres.2005.05.001; Wolfe BB, 2008, ECOHYDROLOGY, V1, P131, DOI 10.1002/eco.13; Wolfe BB, 2007, HYDROL PROCESS, V21, P151, DOI 10.1002/hyp.6229; Wolfe BB, 2006, HYDROL PROCESS, V20, P4131, DOI 10.1002/hyp.6423; Wolfe BB, 2012, ENVIRON REV, V20, P191, DOI [10.1139/A2012-008, 10.1139/a2012-008]; Wolfe BB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047599; Wolfe BB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036125; Yang C, 2011, ENVIRON FORENSICS, V12, P173, DOI 10.1080/15275922.2011.574312; Yi Y, 2008, J HYDROL, V350, P1, DOI 10.1016/j.jhydrol.2007.11.008; YUNKER MB, 1993, GEOCHIM COSMOCHIM AC, V57, P3041, DOI 10.1016/0016-7037(93)90292-5; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0	64	62	62	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46089	10.1371/journal.pone.0046089	http://dx.doi.org/10.1371/journal.pone.0046089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049946	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300083
J	Li, YX; Pal, R; Sung, LY; Feng, HZ; Miao, WM; Cheng, SY; Tian, C; Cheng, T				Li, Yanxin; Pal, Rekha; Sung, Li-Ying; Feng, Haizhong; Miao, Weimin; Cheng, Shi-Yuan; Tian, Cindy; Cheng, Tao			An Opposite Effect of the CDK Inhibitor, p18(INK4c) on Embryonic Stem Cells Compared with Tumor and Adult Stem Cells	PLOS ONE			English	Article							NUCLEAR TRANSFER; CYCLE; OCT4; P21(CIP1/WAF1); TUMORIGENESIS; EXPRESSION; CANCER; MICE; PROLIFERATION; PLURIPOTENCY	Self-renewal is a feature common to both adult and embryonic stem (ES) cells, as well as tumor stem cells (TSCs). The cyclin-dependent kinase inhibitor, p18(INK4c), is a known tumor suppressor that can inhibit self-renewal of tumor cells or adult stem cells. Here, we demonstrate an opposite effect of p18 on ES cells in comparison with teratoma cells. Our results unexpectedly showed that overexpression of p18 accelerated the growth of mouse ES cells and embryonic bodies (EB); on the contrary, inhibited the growth of late stage teratoma. Up-regulation of ES cell markers (i.e., Oct4, Nanog, Sox2, and Rex1) were detected in both ES and EB cells, while concomitant down-regulation of various differentiation markers was observed in EB cells. These results demonstrate that p18 has an opposite effect on ES cells as compared with tumor cells and adult stem cells. Mechanistically, expression of CDK4 was significantly increased with overexpression of p18 in ES cells, likely leading to a release of CDK2 from the inhibition by p21 and p27. As a result, self-renewal of ES cells was enhanced. Our current study suggests that targeting p18 in different cell types may yield different outcomes, thereby having implications for therapeutic manipulations of cell cycle machinery in stem cells.	[Li, Yanxin; Miao, Weimin; Cheng, Tao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Li, Yanxin; Miao, Weimin; Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Ctr Stem Cell Med, Tianjin, Peoples R China; [Li, Yanxin; Miao, Weimin; Cheng, Tao] Peking Union Med Coll, Tianjin, Peoples R China; [Li, Yanxin; Pal, Rekha; Cheng, Tao] Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA USA; [Feng, Haizhong; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Li, Yanxin; Pal, Rekha; Feng, Haizhong; Cheng, Shi-Yuan; Cheng, Tao] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Sung, Li-Ying] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tian, Cindy] Univ Connecticut, Dept Anim Sci, Ctr Regenerat Biol, Storrs, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Taiwan University; University of Connecticut	Cheng, T (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	chengt@pumc.edu.cn	; Feng, Haizhong/E-5795-2017	SUNG, LI-YING/0000-0003-1221-2476; Feng, Haizhong/0000-0003-3552-6865; Cheng, Tao/0000-0002-5925-2769	Ministry of Science and Technology of China [2011ZX09102-010-04, 2011CB964801, 2010DFB30270, 2010CB945204]; Natural Science Foundation of China [81090410, 90913018, 30825017]; National Institutes of Health [R01-HL070561]; Leukemia & Lymphoma Society [1027-08]; NATIONAL CANCER INSTITUTE [R01CA130966, R01CA159811] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070561] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grants from the Ministry of Science and Technology of China (2011ZX09102-010-04, 2011CB964801,2010DFB30270 and 2010CB945204), Natural Science Foundation of China (81090410, 90913018 and 30825017) and National Institutes of Health (R01-HL070561) to TC. TC was a recipient of the Scholar Award from the Leukemia & Lymphoma Society (1027-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Berg JS, 2007, CELL STEM CELL, V1, P359, DOI 10.1016/j.stem.2007.09.007; Boyer MJ, 2008, GENE THER, V15, P117, DOI 10.1038/sj.gt.3303064; Broxmeyer HE, 2011, STEM CELLS DEV; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cheng T, 2008, GENE THER, V15, P67, DOI 10.1038/sj.gt.3303066; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheng T, 2001, BLOOD, V98, P3643, DOI 10.1182/blood.V98.13.3643; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Gilbert DM, 2010, J CELL BIOL, V191, P899, DOI 10.1083/jcb.201007125; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pei XH, 2004, MOL CELL BIOL, V24, P6653, DOI 10.1128/mcb.24.15.6653-6664.2004; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; SAVATIER P, 1994, ONCOGENE, V9, P809; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEBE N, 2010, NAT REV CLIN ONCOL; Tschan MP, 1999, BRIT J HAEMATOL, V106, P644, DOI 10.1046/j.1365-2141.1999.01617.x; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2006, CANCER RES, V66, P343, DOI 10.1158/0008-5472.CAN-05-2945; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zindy F, 2001, MOL CELL BIOL, V21, P3244, DOI 10.1128/MCB.21.9.3244-3255.2001	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45212	10.1371/journal.pone.0045212	http://dx.doi.org/10.1371/journal.pone.0045212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049777	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300018
J	Maresca, G; Natoli, M; Nardella, M; Arisi, I; Trisciuoglio, D; Desideri, M; Brandi, R; D'Aguanno, S; Nicotra, MR; D'Onofrio, M; Urbani, A; Natali, PG; Del Bufalo, D; Felsani, A; D'Agnano, I				Maresca, Giovanna; Natoli, Manuela; Nardella, Marta; Arisi, Ivan; Trisciuoglio, Daniela; Desideri, Marianna; Brandi, Rossella; D'Aguanno, Simona; Nicotra, Maria Rita; D'Onofrio, Mara; Urbani, Andrea; Natali, Pier Giorgio; Del Bufalo, Donatella; Felsani, Armando; D'Agnano, Igea			LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; LAMIN A/C EXPRESSION; A-TYPE LAMINS; NUCLEAR LAMINS; GENE AMPLIFICATION; XENOPUS-LAEVIS; OVARIAN-CANCER; HUMAN TISSUES; PROTEINS; CARCINOMA	Background: Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma. Methodology/Principal Findings: Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases. Conclusions/Significance: We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.	[Maresca, Giovanna; Natoli, Manuela; Nardella, Marta; Felsani, Armando; D'Agnano, Igea] Santa Lucia Fdn IRCCS, CNR Inst Cell Biol & Neurobiol, Rome, Italy; [Arisi, Ivan; Brandi, Rossella; D'Onofrio, Mara] European Brain Res Inst, EBRI Neurogen IIT Unit, Rome, Italy; [Trisciuoglio, Daniela; Desideri, Marianna; Del Bufalo, Donatella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy; [D'Aguanno, Simona; Urbani, Andrea] Univ Roma Tor Vergata, Dept Internal Med, Lab Prote, Santa Lucia Fdn IRCCS, Rome, Italy; [Nicotra, Maria Rita; Natali, Pier Giorgio] Univ G DAnnunzio, Lab CINBO, Chieti, Italy	IRCCS Santa Lucia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Santa Lucia; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara	Felsani, A (corresponding author), Santa Lucia Fdn IRCCS, CNR Inst Cell Biol & Neurobiol, Rome, Italy.	armando.felsani@cnr.it; igea.dagnano@cnr.it	trisciuoglio, Daniela/H-2131-2016; Arisi, Ivan/AAM-1152-2021; Felsani, Armando/D-1784-2010; trisciuoglio, daniela/AAL-4002-2021; desideri, marianna/K-5771-2016; D'Agnano, Igea/AAR-7282-2020; Del Bufalo, Donatella/AAC-1594-2021; Urbani, Andrea/B-2953-2012; D'Aguanno, Simona/H-2179-2016; Del Bufalo, Donatella/K-8673-2016; Urbani, Andrea/AAD-1675-2022	trisciuoglio, Daniela/0000-0002-7007-7914; Arisi, Ivan/0000-0002-0536-2508; Felsani, Armando/0000-0001-8851-6295; desideri, marianna/0000-0002-4311-9656; Del Bufalo, Donatella/0000-0002-3148-6096; D'Aguanno, Simona/0000-0002-1224-4454; Del Bufalo, Donatella/0000-0002-3148-6096; nardella, marta/0000-0002-9949-2169; D'Agnano, Igea/0000-0002-2646-9224	joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity"; Italian Association for Cancer Research [IG 10239]	joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity"; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This study was partially supported by a joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity" (AF) and by IG 10239 from Italian Association for Cancer Research (DDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Ellis DJ, 1997, J CELL SCI, V110, P2507; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fruci D, 2008, J CELL PHYSIOL, V216, P742, DOI 10.1002/jcp.21454; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Handler A, 2000, J NEUROSCI RES, V60, P311, DOI 10.1002/(SICI)1097-4547(20000501)60:3<311::AID-JNR5>3.0.CO;2-X; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lin F, 1997, EXP CELL RES, V236, P378, DOI 10.1006/excr.1997.3735; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Michalik L, 2007, CELL, V129, P649, DOI 10.1016/j.cell.2007.05.001; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; PinolRoma S, 1997, SEMIN CELL DEV BIOL, V8, P57, DOI 10.1006/scdb.1996.0122; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; RIEMER D, 1995, J CELL SCI, V108, P3189; ROBER RA, 1989, DEVELOPMENT, V105, P365; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; Schirmer EC, 2008, MUTAT RES-FUND MOL M, V647, P112, DOI 10.1016/j.mrfmmm.2008.07.012; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; Trisciuoglio D, 2005, J CELL PHYSIOL, V205, P414, DOI 10.1002/jcp.20413; Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Wu ZR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-8; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Zhang Y, 2010, J INT MED RES, V38, P1042, DOI 10.1177/147323001003800331	44	31	31	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45513	10.1371/journal.pone.0045513	http://dx.doi.org/10.1371/journal.pone.0045513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049808	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300029
J	Sato, JR; Hoexter, MQ; Castellanos, XF; Rohde, LA				Sato, Joao Ricardo; Hoexter, Marcelo Queiroz; Castellanos, Xavier Francisco; Rohde, Luis A.			Abnormal Brain Connectivity Patterns in Adults with ADHD: A Coherence Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; SUPPORT; NETWORKS; CLASSIFICATION; ADOLESCENTS; PREVALENCE; CHILDREN	Studies based on functional magnetic resonance imaging (fMRI) during the resting state have shown decreased functional connectivity between the dorsal anterior cingulate cortex (dACC) and regions of the Default Mode Network (DMN) in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD) relative to subjects with typical development (TD). Most studies used Pearson correlation coefficients among the BOLD signals from different brain regions to quantify functional connectivity. Since the Pearson correlation analysis only provides a limited description of functional connectivity, we investigated functional connectivity between the dACC and the posterior cingulate cortex (PCC) in three groups (adult patients with ADHD, n = 21; TD age-matched subjects, n = 21; young TD subjects, n = 21) using a more comprehensive analytical approach - unsupervised machine learning using a one-class support vector machine (OC-SVM) that quantifies an abnormality index for each individual. The median abnormality index for patients with ADHD was greater than for TD age-matched subjects (p = 0.014); the ADHD and young TD indices did not differ significantly (p = 0.480); the median abnormality index of young TD was greater than that of TD age-matched subjects (p = 0.016). Low frequencies below 0.05 Hz and around 0.20 Hz were the most relevant for discriminating between ADHD patients and TD age-matched controls and between the older and younger TD subjects. In addition, we validated our approach using the fMRI data of children publicly released by the ADHD-200 Competition, obtaining similar results. Our findings suggest that the abnormal coherence patterns observed in patients with ADHD in this study resemble the patterns observed in young typically developing subjects, which reinforces the hypothesis that ADHD is associated with brain maturation deficits.	[Sato, Joao Ricardo] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz] Univ Fed Sao Paulo, Lab Interdisciplinar Neurociencias Clin, Sao Paulo, Brazil; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Rohde, Luis A.] Hosp Clin Porto Alegre, Child & Adolescent Psychiat Div, ADHD Outpatient Program, Porto Alegre, RS, Brazil; [Castellanos, Xavier Francisco] NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY USA; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz; Rohde, Luis A.] Inst Nacl Psiquiatria Desenvolvimento, Porto Alegre, RS, Brazil	Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); New York University	Sato, JR (corresponding author), Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil.	jrsatobr@gmail.com	Hoexter, Marcelo Q/D-7620-2013; Rohde, Luis Augusto P/A-6426-2008; Psiquiatria, Inct/I-1060-2013; Castellanos, Francisco Xavier/K-1892-2014	Hoexter, Marcelo Q/0000-0002-9302-4380; Rohde, Luis Augusto P/0000-0002-4552-4188; Castellanos, Francisco Xavier/0000-0001-9192-9437; Sato, Joao Ricardo/0000-0002-7503-9781	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; National Institute of Mental Health [R01MH083246]; Novartis; Janssen-Cilag; Abbott; Eli-Lilly; Shire; Bristol-Myers Squibb; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083246] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Novartis(Novartis); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); Eli-Lilly(Eli Lilly); Shire; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil. JRS and MQH declared no conflict of interest. XFC received support from National Institute of Mental Health (R01MH083246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LAR was on the speakers' bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the last three years (less than U$ 10,000 per year and reflecting less than 5% of his gross income per year). He also received travel awards (air tickets + hotel) for taking part of two child psychiatric meetings from Novartis and Janssen-Cilag in 2010. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Abbott, Eli-Lilly, Janssen-Cilag, Novartis, and Shire.; LAR was on the speakers' bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the last three years (less than U$ 10,000 per year and reflecting less than 5% of his gross income per year). He also received travel awards (air tickets + hotel) for taking part in two child psychiatric meetings from Novartis and Janssen-Cilag. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Abbott, Bristol-Myers Squibb, Eli-Lilly, Janssen-Cilag, Novartis, and Shire. None of this research support was used for this specific study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bloomfield P., 1976, Fourier analysis of time series. An introduction; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Davis R. A, 1987, TIME SERIES THEORY M; Deragotis LR, 1986, SYMPTOM CHECKLIST 90; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; El-Sayed E, 2003, ACTA PAEDIATR, V92, P776, DOI 10.1080/08035250310002777; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Hardoon DR, 2007, NEUROIMAGE, V37, P1250, DOI 10.1016/j.neuroimage.2007.06.017; Harpin V. A., 2005, ARCH DIS CHILD, V90, P2, DOI DOI 10.1136/ADC.2004.059006; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; KINSBOURNE M, 1973, ANN NY ACAD SCI, V205, P268, DOI 10.1111/j.1749-6632.1973.tb43184.x; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mourao-Miranda J, 2011, NEUROIMAGE, V58, P793, DOI 10.1016/j.neuroimage.2011.06.042; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Peters J, 2017, ADAPT COMPUT MACH LE; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024; Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032; Sato JR, 2009, HUM BRAIN MAPP, V30, P1068, DOI 10.1002/hbm.20569; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Song XM, 2009, NEUROIMAGE, V47, P204, DOI 10.1016/j.neuroimage.2009.03.054; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028	49	55	61	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45671	10.1371/journal.pone.0045671	http://dx.doi.org/10.1371/journal.pone.0045671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049834	Green Published, gold			2022-12-25	WOS:000309517300042
J	Sung, JM; Lee, CK; Wu-Hsieh, BA				Sung, Jui-Min; Lee, Chien-Kuo; Wu-Hsieh, Betty A.			Intrahepatic Infiltrating NK and CD8 T Cells Cause Liver Cell Death in Different Phases of Dengue Virus Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; MOUSE MODEL; MEDIATED APOPTOSIS; MICE; HEPATOCYTES; CHILDREN; IMMUNOHISTOCHEMISTRY; REPLICATION; LYMPHOCYTES; DISRUPTION	Elevated liver enzyme level is an outstanding feature in patients with dengue. However, the pathogenic mechanism of liver injury has not been clearly demonstrated. In this study, employing a mouse model we aimed to investigate the immunopathogenic mechanism of dengue liver injury. Immunocompetent C57BL/6 mice were infected intravenously with dengue virus strain 16681. Infected mice had transient viremia, detectable viral capsid gene and cleaved caspase 3 in the liver. In the mean time, NK cell and T cell infiltrations peaked at days 1 and 5, respectively. Neutralizing CXCL10 or depletion of Asialo GM1(+) cells reduced cleaved caspase 3 and TUNEL+ cells in the liver at day 1 after infection. CD8(+) T cells infiltrated into the liver at later time point and at which time intrahepatic leukocytes (IHL) exhibited cytotoxicity against DENV-infected targets. Cleaved caspase 3 and TUNEL+ cells were diminished in mice with TCR beta deficiency and in those depleted of CD8(+) T cells, respectively, at day 5 after infection. Moreover, intrahepatic CD8(+) T cells were like their splenic counterparts recognized DENV NS4B(99-107) peptide. Together, these results show that infiltrating NK and CD8(+) T cells cause liver cell death. While NK cells were responsible for cell death at early time point of infection, CD8(+) T cells were for later. CD8(+) T cells that recognize NS4B(99-107) constitute at least one of the major intrahepatic cytotoxic CD8(+) T cell populations.	[Sung, Jui-Min; Lee, Chien-Kuo; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Taiwan University	Wu-Hsieh, BA (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	bwh@ntu.edu.tw	Lee, Chien-Kuo/AAZ-1039-2020	Lee, Chien-Kuo/0000-0001-8189-6045; WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055	National Research Program for Genomic Medicine grants [98, 99, 100-3112-B-002-042]; National Science Council, Republic of China [98-2745-B-002-003]; Natural Health Research Institute [98A1-PDCO-0107094, 99A1-PDCO-0110114]	National Research Program for Genomic Medicine grants; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Natural Health Research Institute	This work was supported by National Research Program for Genomic Medicine grants (98, 99, 100-3112-B-002-042) and NSC grants (98-2745-B-002-003) from the National Science Council, Republic of China; and Natural Health Research Institute grants (98A1-PDCO-0107094, 99A1-PDCO-0110114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Beaumier CM, 2010, VIRAL IMMUNOL, V23, P477, DOI 10.1089/vim.2010.0034; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; de Macedo FC, 2006, DIAGN MOL PATHOL, V15, P223, DOI 10.1097/01.pdm.0000213462.60645.cd; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; He J, 2009, COMP BIOCHEM PHYS B, V153, P216, DOI 10.1016/j.cbpb.2009.03.003; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee TY, 2009, J HISTOCHEM CYTOCHEM, V57, P469, DOI 10.1369/jhc.2009.952622; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Nagila A, 2011, BIOCHEM BIOPH RES CO, V410, P428, DOI 10.1016/j.bbrc.2011.05.151; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Ozturk B, 2010, J CLIN VIROL, V47, P115, DOI 10.1016/j.jcv.2009.10.015; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Warfield KL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-108; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	45	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46292	10.1371/journal.pone.0046292	http://dx.doi.org/10.1371/journal.pone.0046292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050007	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300105
J	Behrens, JW; Axelsson, M; Neuenfeldt, S; Seth, H				Behrens, Jane W.; Axelsson, Michael; Neuenfeldt, Stefan; Seth, Henrik			Effects of Hypoxic Exposure during Feeding on SDA and Postprandial Cardiovascular Physiology in the Atlantic Cod, Gadus morhua	PLOS ONE			English	Article							GASTROINTESTINAL BLOOD-FLOW; DYNAMIC ACTION; OXYGEN-CONSUMPTION; PROTEIN-SYNTHESIS; BALTIC SEA; TEMPERATURE; RESPONSES; RECOVERY; LEVEL	Some Atlantic cod in the Bornholm Basin undertake vertical foraging migrations into severely hypoxic bottom water. Hypoxic conditions can reduce the postprandial increase in gastrointestinal blood flow (GBF). This could subsequently postpone or reduce the postprandial increase in oxygen consumption (MO2), i.e. the SDA, leading to a disturbed digestion. Additionally, a restricted oxygen uptake could result in an oxygen debt that needs to be compensated for upon return to normoxic waters and this may also affect the ability to process the food. Long-term cardio-respiratory measurements were made on fed G. morhua in order to understand how the cardio-respiratory system of feeding fish respond to a period of hypoxia and a subsequent return to normoxia. These were exposed to 35% water oxygen saturation for 90 minutes, equivalent to the time and oxygen level cod voluntarily endure when searching for food in the Bornholm Basin. We found that i) gastric and intestinal blood flows, cardiac output and MO2 increased after feeding, ii) gastric and intestinal blood flows were spared in hypoxia, and iii) there were no indications of an oxygen debt at the end of the hypoxic period. The magnitude and time course of the measured variables are similar to values obtained from fish not exposed to the hypoxic period. In conclusion, when cod in the field search for and ingest prey under moderate hypoxic conditions they appear to stay within safe limits of oxygen availability as we saw no indications of an oxygen debt, or negative influence on digestive capacity, when simulating field observations.	[Behrens, Jane W.; Neuenfeldt, Stefan] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Axelsson, Michael; Seth, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Seth, Henrik] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden	Technical University of Denmark; University of Gothenburg; University of Gothenburg	Behrens, JW (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	jabeh@aqua.dtu.dk	Axelsson, Michael/D-1412-2009	Axelsson, Michael/0000-0002-7839-3233; Neuenfeldt, Stefan/0000-0001-8574-3257; Behrens, Jane Windfeldt/0000-0002-0136-9681	Carlsberg Foundation [2008_01_0388]	Carlsberg Foundation(Carlsberg Foundation)	The study was financially supported by a post doc stipend [grant number 2008_01_0388] from the Carlsberg Foundation to Jane W. Behrens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NG, 2001, J FISH BIOL, V59, P1198, DOI 10.1006/jfbi.2001.1731; AXELSSON M, 1991, J EXP BIOL, V158, P181; Axelsson M, 2000, J COMP PHYSIOL B, V170, P145, DOI 10.1007/s003600050269; Axelsson M, 2002, J EXP BIOL, V205, P2891; Behrens JW, 2011, LAB ANIM-UK, V45, P240, DOI 10.1258/la.2011.011013; BROWN CR, 1991, PHYSIOL ZOOL, V64, P276, DOI 10.1086/physzool.64.1.30158524; BROWN CR, 1991, PHYSIOL ZOOL, V64, P298, DOI 10.1086/physzool.64.1.30158525; Carter C.G., 2001, Fish Physiology, V20, P31; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Dupont-Prinet A, 2009, COMP BIOCHEM PHYS A, V154, P233, DOI 10.1016/j.cbpa.2009.06.015; Eliason EJ, 2008, COMP BIOCHEM PHYS A, V149, P380, DOI 10.1016/j.cbpa.2008.01.033; Farrell AP, 2001, COMP BIOCHEM PHYS A, V128, P551, DOI 10.1016/S1095-6433(00)00335-4; FRITSCHE R, 1993, RESP PHYSIOL, V94, P173, DOI 10.1016/0034-5687(93)90046-D; Gamperl AK, 2009, FISH PHYSIOL, V27, P301, DOI 10.1016/S1546-5098(08)00007-1; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Grans A, 2009, HYDROBIOLOGIA, V619, P11, DOI 10.1007/s10750-008-9578-7; Grans A, 2010, J EXP BIOL, V213, P3198, DOI 10.1242/jeb.043570; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Lewis JM, 2007, J EXP BIOL, V210, P1935, DOI 10.1242/jeb.005371; McKenzie DJ, 2009, COMP BIOCHEM PHYS A, V153, P332, DOI 10.1016/j.cbpa.2009.03.009; Neuenfeldt S, 2003, J FISH BIOL, V62, P168, DOI 10.1046/j.1095-8649.2003.00013.x; Neuenfeldt S, 2009, J FISH BIOL, V75, P290, DOI 10.1111/j.1095-8649.2009.02281.x; Perez-Casanova JC, 2010, AQUAC RES, V41, P198, DOI 10.1111/j.1365-2109.2009.02318.x; Plante S, 1998, J FISH BIOL, V53, P1342, DOI 10.1006/jfbi.1998.0798; PRIEDE IG, 1977, NATURE, V267, P610, DOI 10.1038/267610a0; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; SCHURMANN H, 1992, J FISH BIOL, V41, P927, DOI 10.1111/j.1095-8649.1992.tb02720.x; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Seth H, 2008, AM J PHYSIOL-REG I, V294, pR1648, DOI 10.1152/ajpregu.00900.2007; Seth H, 2011, FISH PHYSIOL, V30, P351, DOI 10.1016/S1546-5098(10)03009-8; Seth H, 2010, J EXP BIOL, V213, P3118, DOI 10.1242/jeb.043612; Seth H, 2010, AM J PHYSIOL-REG I, V298, pR1240, DOI 10.1152/ajpregu.00781.2009; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Thorarensen H, 1994, THESIS S FRASER U BU; Thuy NH, 2010, J FISH BIOL, V76, P1025, DOI 10.1111/j.1095-8649.2009.02533.x	37	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46227	10.1371/journal.pone.0046227	http://dx.doi.org/10.1371/journal.pone.0046227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049987	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100160
J	Burgess, AP				Burgess, Adrian P.			Towards a Unified Understanding of Event-Related Changes in the EEG: The Firefly Model of Synchronization through Cross-Frequency Phase Modulation	PLOS ONE			English	Article							EVOKED-RESPONSES; RECOGNITION MEMORY; THETA OSCILLATIONS; BRAIN OSCILLATIONS; DYNAMICS; WAVES; GAMMA; DECOMPOSITION; HIPPOCAMPUS; MECHANISM	Although event-related potentials (ERPs) are widely used to study sensory, perceptual and cognitive processes, it remains unknown whether they are phase-locked signals superimposed upon the ongoing electroencephalogram (EEG) or result from phase-alignment of the EEG. Previous attempts to discriminate between these hypotheses have been unsuccessful but here a new test is presented based on the prediction that ERPs generated by phase-alignment will be associated with event-related changes in frequency whereas evoked-ERPs will not. Using empirical mode decomposition (EMD), which allows measurement of narrow-band changes in the EEG without predefining frequency bands, evidence was found for transient frequency slowing in recognition memory ERPs but not in simulated data derived from the evoked model. Furthermore, the timing of phase-alignment was frequency dependent with the earliest alignment occurring at high frequencies. Based on these findings, the Firefly model was developed, which proposes that both evoked and induced power changes derive from frequency-dependent phase-alignment of the ongoing EEG. Simulated data derived from the Firefly model provided a close match with empirical data and the model was able to account for i) the shape and timing of ERPs at different scalp sites, ii) the event-related desynchronization in alpha and synchronization in theta, and iii) changes in the power density spectrum from the pre-stimulus baseline to the post-stimulus period. The Firefly Model, therefore, provides not only a unifying account of event-related changes in the EEG but also a possible mechanism for cross-frequency information processing.	Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	Aston University	Burgess, AP (corresponding author), Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England.	a.p.burgess@aston.ac.uk		Burgess, Adrian P/0000-0002-0977-8105				Basar E, 1980, EEG BRAIN DYNAMICS R, pxxi; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Burgess AP, 2000, PSYCHOPHYSIOLOGY, V37, P596, DOI 10.1017/S0048577200981356; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cong Fengyu, 2009, Nonlinear Biomed Phys, V3, P1, DOI 10.1186/1753-4631-3-1; Fingelkurts Andrew A, 2008, Open Neuroimag J, V2, P73, DOI 10.2174/1874440000802010073; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Haken H, 1983, SYNERGETICS INTRO NO, pxiv; Heckenlively JR, 2006, PRINCIPLES PRACTICE, pxxii; Huang NE, 2005, INTERD MATH SCI, V5, P1; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Luo JW, 2006, PROG NAT SCI-MATER, V16, P942; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nikulin VV, 2007, EUR J NEUROSCI, V25, P3146, DOI 10.1111/j.1460-9568.2007.05553.x; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pletzer B, 2010, BRAIN RES, V1335, P91, DOI 10.1016/j.brainres.2010.03.074; Ritter P, 2009, NEUROIMAGE, V47, P1, DOI 10.1016/j.neuroimage.2009.04.031; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; VAKMAN DE, 1977, USP FIZ NAUK+, V123, P657; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wilding EL, 2006, CLIN EEG NEUROSCI, V37, P315, DOI 10.1177/155005940603700409; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Yeung N, 2004, PSYCHOPHYSIOLOGY, V41, P822, DOI 10.1111/j.1469-8986.2004.00239.x	46	35	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45630	10.1371/journal.pone.0045630	http://dx.doi.org/10.1371/journal.pone.0045630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049827	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100061
J	Garzon-Ospina, D; Lopez, C; Forero-Rodriguez, J; Patarroyo, MA				Garzon-Ospina, Diego; Lopez, Carolina; Forero-Rodriguez, Johanna; Patarroyo, Manuel A.			Genetic Diversity and Selection in Three Plasmodium vivax Merozoite Surface Protein 7 (Pvmsp-7) Genes in a Colombian Population	PLOS ONE			English	Article							MALARIA PARASITE; POSITIVE SELECTION; INTRAGENIC RECOMBINATION; STATISTICAL TESTS; DEATH EVOLUTION; FAMILY; CONVERSION; ANTIGENS; VACCINE; IDENTIFICATION	A completely effective vaccine for malaria (one of the major infectious diseases worldwide) is not yet available; different membrane proteins involved in parasite-host interactions have been proposed as candidates for designing it. It has been found that proteins encoded by the merozoite surface protein (msp)-7 multigene family are antibody targets in natural infection; the nucleotide diversity of three Pvmsp-7 genes was thus analyzed in a Colombian parasite population. By contrast with P. falciparum msp-7 loci and ancestral P. vivax msp-7 genes, specie-specific duplicates of the latter specie display high genetic variability, generated by single nucleotide polymorphisms, repeat regions, and recombination. At least three major allele types are present in Pvmsp-7C, Pvmsp-7H and Pvmsp-7I and positive selection seems to be operating on the central region of these msp-7 genes. Although this region has high genetic polymorphism, the C-terminus (Pfam domain ID: PF12948) is conserved and could be an important candidate when designing a subunit-based antimalarial vaccine.	[Garzon-Ospina, Diego; Lopez, Carolina; Forero-Rodriguez, Johanna; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina] Univ Nacl Colombia, Microbiol Postgrad Program, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia.	mapatarr.fidic@gmail.com	Garzón-Ospina, Diego/L-8585-2016; López-Santana, Carolina/L-8580-2016; Garzón-Ospina, Diego/AFS-7704-2022; Patarroyo, Manuel A/I-8046-2016	Garzón-Ospina, Diego/0000-0003-3829-6719; López-Santana, Carolina/0000-0003-1313-7607; Patarroyo, Manuel A/0000-0002-4751-2500				Andrews TD, 2004, GENETICS, V166, P25, DOI 10.1534/genetics.166.1.25; Anisimova M, 2003, GENETICS, V164, P1229; Betran E, 1997, GENETICS, V146, P89; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Fu YX, 1997, GENETICS, V147, P915; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Garcia Y, 2007, J MED CHEM, V50, P5665, DOI 10.1021/jm070773z; Garzon-Ospina D, 2011, INFECT GENET EVOL, V11, P528, DOI 10.1016/j.meegid.2010.12.002; Garzon-Ospina D, 2010, MOL PHYLOGENET EVOL, V55, P399, DOI 10.1016/j.ympev.2010.02.017; Genton B, 2007, CURR OPIN INFECT DIS, V20, P467, DOI 10.1097/QCO.0b013e3282dd7a29; Gomez A, 2006, PARASITOLOGY, V133, P661, DOI 10.1017/S0031182006001168; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; HUDSON RR, 1985, GENETICS, V111, P147; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Katju V, 2003, GENETICS, V165, P1793; Kelly JK, 1997, GENETICS, V146, P1197; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lysenko AJ, 1968, MED GEOGRAPHY MED GE; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez O, 2004, PARASITOLOGY, V128, P353, DOI 10.1017/S0031182003004773; Martinez Pilar, 2005, Infection Genetics and Evolution, V5, P354, DOI 10.1016/j.meegid.2004.12.001; Mascorro CN, 2005, PARASITOLOGY, V131, P25, DOI 10.1017/S0031182005007547; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; Mello K, 2002, EUKARYOT CELL, V1, P915, DOI 10.1128/EC.1.6.915-925.2002; Mongui A, 2006, BIOCHEM BIOPH RES CO, V351, P639, DOI 10.1016/j.bbrc.2006.10.082; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Peek AS, 2001, J MOL EVOL, V52, P193, DOI 10.1007/s002390010148; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Polley SD, 2001, GENETICS, V158, P1505; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2000, MOL BIOCHEM PARASIT, V109, P111, DOI 10.1016/S0166-6851(00)00238-3; Putaporntip C, 2010, GENE, V456, P24, DOI 10.1016/j.gene.2010.02.007; Putaporntip C, 2009, INFECT GENET EVOL, V9, P821, DOI 10.1016/j.meegid.2009.04.017; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Roy SW, 2009, GENE, V443, P12, DOI 10.1016/j.gene.2009.05.007; Rozas J, 2001, GENETICS, V158, P1147; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Wang L, 2003, PARASITE IMMUNOL, V25, P403, DOI 10.1111/j.1365-3024.2003.00647.x; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	70	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45962	10.1371/journal.pone.0045962	http://dx.doi.org/10.1371/journal.pone.0045962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049905	gold, Green Published, Green Accepted			2022-12-25	WOS:000309556100109
J	Simone, R; Tenca, C; Fais, F; Luciani, M; De Rossi, G; Pesce, G; Bagnasco, M; Saverino, D				Simone, Rita; Tenca, Claudya; Fais, Franco; Luciani, Matteo; De Rossi, Giulio; Pesce, Giampaola; Bagnasco, Marcello; Saverino, Daniele			A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d(+) Expression	PLOS ONE			English	Article							COSTIMULATORY MOLECULES CTLA-4; ACUTE MYELOID-LEUKEMIA; T-CELL-ACTIVATION; CLINICAL-SIGNIFICANCE; NEGATIVE REGULATION; IMMUNE-RESPONSE; ANTIGEN 4; IN-VIVO; CD86; SERUM	CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susceptibility to human cancer. Acute lymphoblastic leukemia is a clonal disorder of lymphoid progenitors representing the most frequent malignancy of childhood. Here, we show the presence at significantly elevated levels of a circulating soluble form of CTLA-4 in 70% of B-ALL pediatric patients with active disease, the positive correlation between the percentage of leukemic B lymphocytes and the amount of serum sCTLA-4, and the expression of sCTLA-4 transcript by B cells in patients. Finally, a correlation between CD1d expression (a negative prognostic marker) and the sCTLA-4 in B-ALL patients was observed. This suggests a possible role of this soluble molecule as a marker of progression or severity of the neoplastic disease.	[Simone, Rita; Tenca, Claudya; Fais, Franco; Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Simone, Rita] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Luciani, Matteo; De Rossi, Giulio] Bambino Gesu Pediat Hosp, Dept Pediat Haematol & Oncol, Rome, Italy; [Pesce, Giampaola; Bagnasco, Marcello] Univ Genoa, Dept Internal Med, Med & Radiometabol Therapy Unit, I-16126 Genoa, Italy	University of Genoa; Northwell Health; IRCCS Bambino Gesu; University of Genoa	Saverino, D (corresponding author), Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy.	daniele.saverino@unige.it	Luciani, Matteo/AAB-3162-2020; Fais, Franco/K-1096-2016; FAIS, FRANCO/AAG-3069-2021; Saverino, Daniele/I-4741-2014	Fais, Franco/0000-0002-6643-7083; FAIS, FRANCO/0000-0002-6643-7083; Pesce, Giampaola/0000-0002-6294-9110	Fondazione CARIGE; Associazione "Davide Ciavattini'' Onlus	Fondazione CARIGE(Fondazione Carige); Associazione "Davide Ciavattini'' Onlus	This work was supported by grants from Fondazione CARIGE and from Associazione "Davide Ciavattini'' Onlus. Fondazione CARIGE as well as Associazione "Davide Ciavattini'' Onlus had no involvement in study design, nor in the collection, analysis and interpretation of data, nor in the writing of the report and in the decision to submit the paper for publication.	Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Caligaris-Cappio F, 2003, ATLAS BLOOD CELLS FU, V2, P567; Carroll William L, 2003, Hematology Am Soc Hematol Educ Program, P102; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Fais F, 2005, LEUKEMIA, V19, P551, DOI 10.1038/sj.leu.2403671; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Gu X, 2010, HUM IMMUNOL, V71, P83, DOI 10.1016/j.humimm.2009.09.353; Hock BD, 2006, BRIT J HAEMATOL, V133, P165, DOI 10.1111/j.1365-2141.2006.05983.x; Hock BD, 2004, LEUKEMIA LYMPHOMA, V45, P2111, DOI 10.1080/10428190410001712199; Hock BD, 2003, CANCER, V98, P1681, DOI 10.1002/cncr.11693; Hock BD, 2002, LEUKEMIA, V16, P865, DOI 10.1038/sj.leu.2402466; Hou RP, 2010, MOL BIOL REP, V37, P515, DOI 10.1007/s11033-009-9705-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Laurent S, 2010, HUM IMMUNOL, V71, P934, DOI 10.1016/j.humimm.2010.07.007; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Pawlak E, 2010, HUM IMMUNOL, V71, P195, DOI 10.1016/j.humimm.2009.11.006; Perez-Garcia A, 2009, LEUKEMIA, V23, P486, DOI 10.1038/leu.2008.339; Pistillo MP, 2003, BLOOD, V101, P202, DOI 10.1182/blood-2002-06-1668; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; PUROHIT S, 2005, J AUTOIMMUNE DIS, V31, P2; Qi P, 2010, INT J COLORECTAL DIS, V25, P39, DOI 10.1007/s00384-009-0806-z; Saito T, 1998, CURR OPIN IMMUNOL, V10, P313, DOI 10.1016/S0952-7915(98)80170-2; Sato S, 2004, RHEUMATOLOGY, V43, P1261, DOI 10.1093/rheumatology/keh303; Saverino D, 2009, J ALLERGY CLIN IMMUN, V123, P258, DOI 10.1016/j.jaci.2008.09.023; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069; Simone Rita, 2009, Current Immunology Reviews, V5, P54; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang XB, 2002, J NEUROIMMUNOL, V130, P224, DOI 10.1016/S0165-5728(02)00228-X; Wong CK, 2005, RHEUMATOLOGY, V44, P989, DOI 10.1093/rheumatology/keh663; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x	41	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44654	10.1371/journal.pone.0044654	http://dx.doi.org/10.1371/journal.pone.0044654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049754	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100019
J	Wu, TC; Chao, CY; Lin, SJ; Chen, JW				Wu, Tao-Cheng; Chao, Chih-Yu; Lin, Shing-Jong; Chen, Jaw-Wen			Low-Dose Dextromethorphan, a NADPH Oxidase Inhibitor, Reduces Blood Pressure and Enhances Vascular Protection in Experimental Hypertension	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; INJURY FOLLOWING TRANSIENT; OXIDATIVE STRESS; FOCAL ISCHEMIA; NITRIC-OXIDE; ACTIVE TREATMENT; AMLODIPINE; DYSFUNCTION; SENSITIVITY; ACTIVATION	Background: Vascular oxidative stress may be increased with age and aggravate endothelial dysfunction and vascular injury in hypertension. This study aimed to investigate the effects of dextromethorphan (DM), a NADPH oxidase inhibitor, either alone or in combination treatment, on blood pressure (BP) and vascular protection in aged spontaneous hypertensive rats (SHRs). Methodology/Principal Findings: Eighteen-week-old WKY rats and SHRs were housed for 2 weeks. SHRs were randomly assigned to one of the 12 groups: untreated; DM monotherapy with 1, 5 or 25 mg/kg/day; amlodipine (AM, a calcium channel blocker) monotherapy with 1 or 5 mg/kg/day; and combination therapy of DM 1, 5 or 25 mg/kg/day with AM 1 or 5 mg/kg/day individually for 4 weeks. The in vitro effects of DM were also examined. In SHRs, AM monotherapy dose-dependently reduced arterial systolic BP. DM in various doses significantly and similarly reduced arterial systolic BP. Combination of DM with AM gave additive effects on BP reduction. DM, either alone or in combination with AM, improved aortic endothelial function indicated by ex vivo acetylcholine-induced relaxation. The combination of low-dose DM with AM gave most significant inhibition on aortic wall thickness in SHRs. Plasma total antioxidant status was significantly increased by all the therapies except for the combination of high-dose DM with high-dose AM. Serum nitrite and nitrate level was significantly reduced by AM but not by DM or the combination of DM with AM. Furthermore, in vitro treatment with DM reduced angiotensin II-induced reactive oxygen species and NADPH oxidase activation in human aortic endothelial cells. Conclusions/Significance: Treatment of DM reduced BP and enhanced vascular protection probably by inhibiting vascular NADPH oxidase in aged hypertensive animals with or without AM treatment. It provides the potential rationale to a novel combination treatment with low-dose DM and AM in clinical hypertension.	[Wu, Tao-Cheng; Chao, Chih-Yu; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Wu, Tao-Cheng; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.	jwchen@vghtpe.gov.tw			Cardiovascular Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan; Taipei Veterans General Hospital, Taiwan, R.O.C. [V99-B2-008]; United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program [NSC-99-2911-I-009-101]	Cardiovascular Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Veterans General Hospital, Taiwan, R.O.C.(Taipei Veterans General Hospital); United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program	This study was partially supported by a grant from Cardiovascular Research Center of National Yang-Ming University, by a grant from Ministry of Education, Aim for the Top University Plan, by a grant from Taipei Veterans General Hospital, Taiwan, R.O.C. (V99-B2-008 to T-CW), and by the United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program under Grant Number: NSC-99-2911-I-009-101. This work was also assisted in part by the Division of Experimental Surgery, the Department of Surgery, Taipei Veterans General Hospital, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, BRIT J PHARMACOL, V153, P926, DOI 10.1038/sj.bjp.0707575; Bhatia K, 2012, AM J PHYSIOL-REG I, V302, pR274, DOI 10.1152/ajpregu.00546.2011; Britton P, 1997, LIFE SCI, V60, P1729, DOI 10.1016/S0024-3205(97)00132-X; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen JW, 2003, ARTERIOSCL THROM VAS, V23, P1559, DOI 10.1161/01.ATV.0000089012.73180.63; Chen YW, 2011, CAN J ANESTH, V58, P55, DOI 10.1007/s12630-010-9408-z; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Delano FA, 2006, MICROCIRCULATION, V13, P551, DOI 10.1080/10739680600885152; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FIESE G, 1969, J PHARM SCI, V58, P599, DOI 10.1002/jps.2600580519; Fujiwara N, 2000, CIRCULATION, V101, P856, DOI 10.1161/01.CIR.101.8.856; GEORGE CP, 1988, BRAIN RES, V440, P375, DOI 10.1016/0006-8993(88)91011-6; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harrison DG, 2007, J AM SOC HYPERTENS, V1, P30, DOI 10.1016/j.jash.2006.11.006; Hung CL, 2009, ACTA CARDIOL SIN, V25, P7; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kitada M, 2003, DIABETES, V52, P2603, DOI 10.2337/diabetes.52.10.2603; Konda T, 2009, AM J NEPHROL, V30, P155, DOI 10.1159/000210396; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Li Fangxiong, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P807, DOI 10.3969/j.issn.1672-7347.2010.08.006; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Liu SL, 2009, CARDIOVASC RES, V82, P161, DOI 10.1093/cvr/cvp043; Lob HE, 2011, HYPERTENSION, V58, P232, DOI 10.1161/HYPERTENSIONAHA.111.172718; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MONYER H, 1988, BRAIN RES, V446, P144, DOI 10.1016/0006-8993(88)91304-2; Mounier-Vehier C, 1998, AM J HYPERTENS, V11, P478, DOI 10.1016/S0895-7061(97)00485-8; Mullan BA, 2002, HYPERTENSION, V40, P804, DOI 10.1161/01.HYP.0000039961.13718.00; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; O'Connor PJ, 2006, ARCH INTERN MED, V166, P1802, DOI 10.1001/archinte.166.17.1802; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; PRINCE DA, 1988, NEUROSCI LETT, V85, P291, DOI 10.1016/0304-3940(88)90581-2; Srivastava P, 1998, PHARMACOL RES, V38, P265, DOI 10.1006/phrs.1998.0357; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STEINBERG GK, 1988, STROKE, V19, P1112, DOI 10.1161/01.STR.19.9.1112; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	44	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46067	10.1371/journal.pone.0046067	http://dx.doi.org/10.1371/journal.pone.0046067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049937	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100130
J	Liu, Z; Li, Q; Li, K; Chen, L; Li, W; Hou, M; Liu, T; Yang, J; Lindvall, C; Bjorkholm, M; Jia, J; Xu, D				Liu, Z.; Li, Q.; Li, K.; Chen, L.; Li, W.; Hou, M.; Liu, T.; Yang, J.; Lindvall, C.; Bjorkholm, M.; Jia, J.; Xu, D.			Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells	ONCOGENE			English	Article						CSCs; EMT; gastric cancer; hTERT	TUMOR-INITIATING CELLS; INDUCED APOPTOSIS; GASTRIC-CANCER; BETA-CATENIN; EXPRESSION; SNAIL; GROWTH; CARCINOMA; SURVIVAL; METASTASIS	Telomerase activation through induction of telomerase reverse transcriptase (hTERT) contributes to malignant transformation by stabilizing telomeres. Clinical studies demonstrate that higher hTERT expression is associated with cancer progression and poor outcomes, but the underlying mechanism is unclear. Because epithelial-mesenchymal transition (EMT) and cancer stem cells (CSCs) are key factors in cancer metastasis and relapse, and hTERT has been shown to exhibit multiple biological activities independently of its telomere-lengthening function, we address a potential role of hTERT in EMT and CSCs using gastric cancer (GC) as a model. hTERT overexpression promotes, whereas its inhibition suppresses, EMT and stemness of GC cells, respectively. Transforming growth factor (TGF)-beta 1 and beta-catenin-mediated EMT was abolished by small interfering RNA depletion of hTERT expression. hTERT interacts with beta-catenin, enhances its nuclear localization and transcriptional activity, and occupies the beta-catenin target vimentin promoter. All these hTERT effects were independent of its telomere-lengthening function or telomerase activity. hTERT and EMT marker expression correlates positively in GC samples. Mouse experiments demonstrate the in vivo stimulation of hTERT on cancer cell colonization. Collectively, hTERT stimulates EMT and induces stemness of cancer cells, thereby promoting cancer metastasis and recurrence. Thus, targeting hTERT may prevent cancer progression by inhibiting EMT and CSCs.	[Liu, Z.; Li, Q.; Chen, L.; Li, W.; Jia, J.] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Peoples R China; [Liu, Z.; Li, Q.; Chen, L.; Li, W.; Jia, J.] Shandong Univ, Hosp 2, Jinan 250012, Peoples R China; [Liu, Z.; Li, Q.; Liu, T.; Yang, J.; Bjorkholm, M.; Xu, D.] Karolinska Univ Hosp, Dept Med, Div Haematol, Stockholm, Sweden; [Liu, Z.; Li, Q.; Liu, T.; Yang, J.; Bjorkholm, M.; Xu, D.] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Liu, Z.; Li, Q.; Li, K.; Hou, M.; Liu, T.; Yang, J.; Bjorkholm, M.; Xu, D.] Karolinska Inst, Stockholm, Sweden; [Li, K.] Karolinska Univ Hosp, Dept Biosci & Nutr, Stockholm, Sweden; [Hou, M.] Karolinska Univ Hosp, Dept Women & Child Hlth, Stockholm, Sweden; [Lindvall, C.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA; [Xu, D.] Shandong Univ, Hosp 2, Cent Res Lab, Jinan 250012, Peoples R China	Shandong University; Shandong University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Van Andel Institute; Shandong University	Jia, J (corresponding author), Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Peoples R China.	jiajihui@sdu.edu.cn; Dawei.Xu@ki.se		Hou, Mi/0000-0002-4573-7028; Xu, Dawei/0000-0003-3141-4524	National Basic Research Program of China [973 Program 2012CB911202]; Swedish Cancer Society; Swedish Research Council; Cancer Society in Stockholm; Swedish Child Cancer Society; Karolinska Institutet Foundations; National Natural Science Foundation of China [30770118, 30800406, 30972775, 81071721, 81000868, 81171536]; National Key Scientific Program of China [2007CB914801]; Science Foundation of Shandong Province [ZR2009CZ001, ZR2009CM002, BS2010YY040]	National Basic Research Program of China(National Basic Research Program of China); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Swedish Child Cancer Society; Karolinska Institutet Foundations(Karolinska Institutet); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Program of China; Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	We thank Drs RA Weinberg (Massachusetts Institute of Technology), CM Counter (Duke University), JM Wong and K Collins (University of California, Berkeley), Y Cong (Beijing Normal University) and W Cui (Imperial College London) for retroviral vectors and plasmids. This study was supported by the National Basic Research Program of China (grant No. 973 Program 2012CB911202), the Swedish Cancer Society, the Swedish Research Council, Cancer Society in Stockholm, Swedish Child Cancer Society, the Karolinska Institutet Foundations, National Natural Science Foundation of China (No.: 30770118, 30800406, 30972775, 81071721, 81000868, 81171536), the National Key Scientific Program of China (2007CB914801) and the Science Foundation of Shandong Province (No.: ZR2009CZ001, ZR2009CM002 and BS2010YY040)	Boukamp P, 2007, EXP DERMATOL, V16, P71, DOI 10.1111/j.1600-0625.2006.00517.x; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen HP, 2009, MOL BIOTECHNOL, V41, P194, DOI 10.1007/s12033-008-9117-9; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Domomt J, 2005, J CLIN ONCOL, V23, P3086, DOI 10.1200/JCO.2005.06.944; Dudognon C, 2004, ONCOGENE, V23, P7469, DOI 10.1038/sj.onc.1208029; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hamad NM, 2002, ONCOGENE, V21, P7121, DOI 10.1038/sj.onc.1205860; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hayry V, 2009, ENDOCR-RELAT CANCER, V16, P1211, DOI 10.1677/ERC-09-0049; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Liu JP, 2010, AGEING RES REV, V9, P245, DOI 10.1016/j.arr.2010.03.002; Liu L, 2011, J PATHOL, V225, P203, DOI 10.1002/path.2914; Luiten RM, 2003, BLOOD, V101, P4512, DOI 10.1182/blood-2002-07-2018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohali A, 2003, J CLIN ONCOL, V21, P3836, DOI 10.1200/JCO.2003.05.059; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Tabori U, 2006, J CLIN ONCOL, V24, P1522, DOI 10.1200/JCO.2005.04.2127; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Terrin L, 2008, CLIN CANCER RES, V14, P7444, DOI 10.1158/1078-0432.CCR-08-0478; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Waldmann J, 2008, BRIT J CANCER, V99, P1900, DOI 10.1038/sj.bjc.6604755; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou LL, 2009, BIOCHEM BIOPH RES CO, V386, P739, DOI 10.1016/j.bbrc.2009.06.116	55	191	199	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 5	2013	32	36					4203	4213		10.1038/onc.2012.441	http://dx.doi.org/10.1038/onc.2012.441			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045275				2022-12-25	WOS:000324168000002
J	King, GJ; Stockli, J; Hu, SH; Winnen, B; Duprez, WGA; Meoli, CC; Junutula, JR; Jarrott, RJ; James, DE; Whitten, AE; Martin, JL				King, Gordon J.; Stoeckli, Jacqueline; Hu, Shu-Hong; Winnen, Brit; Duprez, Wilko G. A.; Meoli, Christopher C.; Junutula, Jagath R.; Jarrott, Russell J.; James, David E.; Whitten, Andrew E.; Martin, Jennifer L.			Membrane Curvature Protein Exhibits Interdomain Flexibility and Binds a Small GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; BAR DOMAINS; PH DOMAIN; IDENTIFICATION; APPL1; ENDOPHILIN; COMPLEX; SYSTEM; RAC	The APPL1 and APPL2 proteins (APPL (adaptor protein, phosphotyrosine interaction, pleckstrin homology (PH) domain, and leucine zipper-containing protein)) are localized to their own endosomal subcompartment and interact with a wide range of proteins and small molecules at the cell surface and in the nucleus. They play important roles in signal transduction through their ability to act as Rab effectors. (Rabs are a family of Ras GTPases involved in membrane trafficking.) Both APPL1 and APPL2 comprise an N-terminal membrane-curving BAR (Bin-amphiphysin-Rvs) domain linked to a PH domain and a C-terminal phosphotyrosine-binding domain. The structure and interactions of APPL1 are well characterized, but little is known about APPL2. Here, we report the crystal structure and low resolution solution structure of the BARPH domains of APPL2. We identify a previously undetected hinge site for rotation between the two domains and speculate that this motion may regulate APPL2 functions. We also identified Rab binding partners of APPL2 and show that these differ from those of APPL1, suggesting that APPL-Rab interaction partners have co-evolved over time. Isothermal titration calorimetry data reveal the interaction between APPL2 and Rab31 has a K-d of 140 nM. Together with other biophysical data, we conclude the stoichiometry of the complex is 2:2.	[King, Gordon J.; Hu, Shu-Hong; Winnen, Brit; Duprez, Wilko G. A.; Jarrott, Russell J.; Whitten, Andrew E.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Stoeckli, Jacqueline; Meoli, Christopher C.; James, David E.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA; [James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Queensland; Garvan Institute of Medical Research; Roche Holding; Genentech; University of New South Wales Sydney	Whitten, AE (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	a.whitten@imb.uq.edu.au; j.martin@imb.uq.edu.au	King, Gordon/J-8718-2014; Stoeckli, Jacqueline/Z-4443-2019; Stoeckli, Jacqueline/D-7053-2016; Junutula, Jagath Reddy/ABD-4753-2020; Martin, Jennifer L./A-6039-2010	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Martin, Jennifer L./0000-0002-9225-8863; Jarrott, Russell/0000-0003-4326-1203; Winnen, Brit/0000-0003-1958-335X; Whitten, Andrew/0000-0001-8856-3120; James, David/0000-0001-5946-5257	Australian National Health and Medical Research Council (NHMRC) [535921]; Australian Synchrotron Grant [AS111/SAXSFI/3171]; ARC [FL0992138]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Synchrotron Grant; ARC(Australian Research Council)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grant 535921. The scattering data were collected with support from Australian Synchrotron Grant AS111/SAXSFI/3171.; An ARC Australian Laureate Fellow (Grant FL0992138) and honorary NHMRC Fellow (ID 455829). To whom correspondence may be addressed: Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia. Tel.: 61-7-3346-2016; Fax: 61-7-3346-2101; E-mail: j.martin@imb.uq.edu.au.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cookson D. J., 2007, SAXS15ID SOFTWARE AC; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Smaczynska-de Rooij II, 2012, TRAFFIC, V13, P317, DOI 10.1111/j.1600-0854.2011.01311.x; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	46	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40996	41006		10.1074/jbc.M112.349803	http://dx.doi.org/10.1074/jbc.M112.349803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055524	Green Published, hybrid			2022-12-25	WOS:000311887600017
J	Adebakin, A; Bradley, J; Gumusgoz, S; Waters, EJ; Lawrence, CB				Adebakin, Adedolapo; Bradley, Jenna; Guemuesgoez, Sarah; Waters, Elizabeth J.; Lawrence, Catherine B.			Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							C-FOS EXPRESSION; CENTRAL-NERVOUS-SYSTEM; OBESE ZUCKER RATS; FOOD-INTAKE; BRAIN-STEM; NUTRITIONAL-STATUS; ARCUATE NUCLEUS; DEMENTIA; CHOLECYSTOKININ; SATIETY	Alzheimer's disease (AD) is associated with non-cognitive symptoms such as changes in feeding behaviour that are often characterised by an increase in appetite. Increased food intake is observed in several mouse models of AD including the triple transgenic (3 x TgAD) mouse, but the mechanisms underlying this hyperphagia are unknown. We therefore examined feeding behaviour in 3 x TgAD mice and tested their sensitivity to exogenous and endogenous satiety factors by assessing food intake and activation of key brain regions. In the behavioural satiety sequence (BSS), 3 x TgAD mice consumed more food after a fast compared to Non-Tg controls. Feeding and drinking behaviours were increased and rest decreased in 3 x TgAD mice, but the overall sequence of behaviours in the BSS was maintained. Exogenous administration of the satiety factor cholecystokinin (CCK; 8-30 mu g/kg, i.p.) dose-dependently reduced food intake in Non-Tg controls and increased inactive behaviour, but had no effect on food intake or behaviour in 3 x TgAD mice. CCK (15 mg/kg, i.p.) increased c-Fos protein expression in the supraoptic nucleus of the hypothalamus, and the nucleus tractus solitarius (NTS) and area postrema of the brainstem to the same extent in Non-Tg and 3 x TgAD mice, but less c-Fos positive cells were detected in the paraventricular hypothalamic nucleus of CCK-treated 3 x TgAD compared to Non-Tg mice. In response to a fast or a period of re-feeding, there was no difference in the number of c-Fox positive cells detected in the arcuate nucleus of the hypothalamus, NTS and area postrema of 3 x TgAD compared to Non-Tg mice. The degree of c-Fos expression in the NTS was positively correlated to food intake in Non-Tg mice, however, this relationship was absent in 3 x TgAD mice. These data demonstrate that 3 x TgAD mice show increased feeding behaviour and insensitivity to satiation, which is possibly due to defective gut-brain signalling in response to endogenous satiety factors released by food ingestion.	[Adebakin, Adedolapo; Bradley, Jenna; Guemuesgoez, Sarah; Waters, Elizabeth J.; Lawrence, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lawrence, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.lawrence@manchester.ac.uk	Dapre, Elizabeth/AAD-5382-2019	Lawrence, Catherine/0000-0002-2372-2968	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Biotechnology and Biological Sciences Research Council (BBSRC) helped to fund a Masters of Research student that performed some of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIN J, 1975, J COMP PHYSIOL PSYCH, V89, P784, DOI 10.1037/h0077040; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Becskei C, 2009, NEUROENDOCRINOLOGY, V90, P371, DOI 10.1159/000251723; Bombois S, 2010, J NUTR HEALTH AGING, V14, P212, DOI 10.1007/s12603-010-0052-7; BURNS A, 1989, PSYCHOL MED, V19, P383, DOI 10.1017/S0033291700012423; Cano V, 2003, NEUROSCI LETT, V343, P13, DOI 10.1016/S0304-3940(03)00277-5; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; CROSS AJ, 1984, J NEUROCHEM, V43, P1574, DOI 10.1111/j.1471-4159.1984.tb06081.x; Dockray GJ, 2012, CURR OPIN ENDOCRINOL, V19, P8, DOI 10.1097/MED.0b013e32834eb77d; Duca FA, 2012, BR J NUTR, P1; ERVIN GN, 1995, J PHARMACOL EXP THER, V273, P1203; Finkel SI, 2003, CLIN GERIATR MED, V19, P799, DOI 10.1016/S0749-0690(03)00046-6; GIBBS J, 1982, PEPTIDES, V3, P553, DOI 10.1016/0196-9781(82)90125-5; Gillette-Guyonnet S, 2007, J NUTR HEALTH AGING, V11, P38; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Greenwood CE, 2005, J GERONTOL A-BIOL, V60, P499, DOI 10.1093/gerona/60.4.499; Guerin O, 2009, CLIN NUTR, V28, P141, DOI 10.1016/j.clnu.2009.01.014; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Gustaw-Rothenberg K, 2009, INT J ENV RES PUB HE, V6, P1335, DOI 10.3390/ijerph6041335; Halford JCG, 1998, PHARMACOL BIOCHEM BE, V61, P159, DOI 10.1016/S0091-3057(98)00032-X; HAMAMURA M, 1991, J PHYSIOL-LONDON, V444, P51, DOI 10.1113/jphysiol.1991.sp018865; Hwang JP, 1997, INT J GERIATR PSYCH, V12, P902, DOI 10.1002/(SICI)1099-1166(199709)12:9<902::AID-GPS660>3.0.CO;2-Q; Keene J, 1998, INT J GERIATR PSYCH, V13, P700, DOI 10.1002/(SICI)1099-1166(1998100)13:10<700::AID-GPS855>3.0.CO;2-D; Keene JM, 1996, INT J GERIATR PSYCH, V11, P1041, DOI 10.1002/(SICI)1099-1166(199612)11:12<1041::AID-GPS541>3.0.CO;2-B; Keene JM, 1997, APPETITE, V28, P151, DOI 10.1006/appe.1996.0061; Keene JM, 1997, APPETITE, V28, P167, DOI 10.1006/appe.1996.0068; Klaffke S, 2006, ACTA NEUROL BELG, V106, P168; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Kyle Gaye, 2011, Br J Community Nurs, V16, P6; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P360, DOI 10.1210/en.143.2.360; Lin S, 1999, BRAIN RES BULL, V49, P215, DOI 10.1016/S0361-9230(99)00049-0; LUCKMAN SM, 1992, J NEUROENDOCRINOL, V4, P149, DOI 10.1111/j.1365-2826.1992.tb00152.x; MAGGIO CA, 1988, PHYSIOL BEHAV, V43, P485, DOI 10.1016/0031-9384(88)90123-0; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; MORRIS CH, 1989, BRIT J PSYCHIAT, V154, P801, DOI 10.1192/bjp.154.6.801; Mosher JT, 1998, PEPTIDES, V19, P849, DOI 10.1016/S0196-9781(98)00025-4; Mosher JT, 1996, PEPTIDES, V17, P483, DOI 10.1016/0196-9781(96)00028-9; MUNGAS D, 1990, J AM GERIATR SOC, V38, P999, DOI 10.1111/j.1532-5415.1990.tb04423.x; Niederau C, 1997, REGUL PEPTIDES, V70, P97, DOI 10.1016/S0167-0115(97)00014-1; NISKANEN L, 1993, AGE AGEING, V22, P132, DOI 10.1093/ageing/22.2.132; OLSON BR, 1993, MOL CELL NEUROSCI, V4, P93, DOI 10.1006/mcne.1993.1011; Owyang C, 2011, J NEUROGASTROENTEROL, V17, P338, DOI 10.5056/jnm.2011.17.4.338; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Renner E, 2010, EUR J NEUROSCI, V31, P302, DOI 10.1111/j.1460-9568.2009.07053.x; Riediger T, 2004, NEUROENDOCRINOLOGY, V79, P317, DOI 10.1159/000079842; Rinaman L, 2010, BRAIN RES, V1350, P18, DOI 10.1016/j.brainres.2010.03.059; Sam AH, 2011, NEUROPHARMACOLOGY; Schwartz GJ, 2010, FORUM NUTR, V63, P141, DOI 10.1159/000264402; Singru PS, 2007, ENDOCRINOLOGY, V148, P638, DOI 10.1210/en.2006-1233; Slaughter SE, 2011, CLIN NUTR, V30, P172, DOI 10.1016/j.clnu.2010.09.001; Smith G, 1998, NEUROPSY NEUROPSY BE, V11, P97; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Smith M A, 1999, J Alzheimers Dis, V1, P203; Spindler AA, 1996, J AM DIET ASSOC, V96, P1013, DOI 10.1016/S0002-8223(96)00270-2; Stoppe G, 1999, DRUG AGING, V14, P41, DOI 10.2165/00002512-199914010-00003; Szelenyi Z, 2004, PHYSIOL BEHAV, V81, P615, DOI 10.1016/j.physbeh.2004.02.025; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Tsang SW, 2010, J NEUROL SCI, V288, P151, DOI 10.1016/j.jns.2009.08.066; Ueyama E, 2004, NEUROSCI LETT, V371, P40, DOI 10.1016/j.neulet.2004.08.035; Vloeberghs E, 2008, BEHAV NEUROSCI, V122, P491, DOI 10.1037/0735-7044.122.3.491; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; Wang PN, 2004, J NEUROL, V251, P314, DOI 10.1007/s00415-004-0316-4; White H, 1998, J AM GERIATR SOC, V46, P1223, DOI 10.1111/j.1532-5415.1998.tb04537.x; White Heidi K, 2004, J Am Med Dir Assoc, V5, P89, DOI 10.1097/01.JAM.0000110646.48753.EF; Zittel TT, 1999, BRAIN RES, V846, P1, DOI 10.1016/S0006-8993(99)01842-9	67	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45179	10.1371/journal.pone.0045179	http://dx.doi.org/10.1371/journal.pone.0045179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056194	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800001
J	Guo, F; Mead, J; Aliya, N; Wang, L; Cuconati, A; Wei, L; Li, K; Block, TM; Guo, JT; Chang, J				Guo, Fang; Mead, Jennifer; Aliya, Nishat; Wang, Lijuan; Cuconati, Andrea; Wei, Lai; Li, Kui; Block, Timothy M.; Guo, Ju-Tao; Chang, Jinhong			RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-3; 1918 INFLUENZA-VIRUS; I-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; INFLAMMATORY RESPONSES; GENE-EXPRESSION; DENDRITIC CELLS	Recognition of virus infection by innate pattern recognition receptors (PRRs), including membrane-associated toll-like receptors (TLR) and cytoplasmic RIG-I-like receptors (RLR), activates cascades of signal transduction pathways leading to production of type I interferons (IFN) and proinflammatory cytokines that orchestrate the elimination of the viruses. Although it has been demonstrated that PRR-mediated innate immunity plays an essential role in defending virus from infection, it also occasionally results in overwhelming production of proinflammatory cytokines that cause severe inflammation, blood vessel leakage and tissue damage. In our efforts to identify small molecules that selectively enhance PRR-mediated antiviral, but not the detrimental inflammatory response, we discovered a compound, RO 90-7501 ('2'-(4-Aminophenyl)-[2,5'-bi-1H-benzimidazol]-5-amine), that significantly promoted both TLR3 and RLR ligand-induced IFN-beta gene expression and antiviral response, most likely via selective activation of p38 mitogen-activated protein kinase (MAPK) pathway. Our results thus imply that pharmacological modulation of PRR signal transduction pathways in favor of the induction of a beneficial antiviral response can be a novel therapeutic strategy.	[Guo, Fang; Mead, Jennifer; Aliya, Nishat; Wang, Lijuan; Block, Timothy M.; Guo, Ju-Tao; Chang, Jinhong] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Cuconati, Andrea; Block, Timothy M.] Inst Hepatitis Virus Res, Hepatitis B Fdn, Doylestown, PA USA; [Wei, Lai] Peking Univ, Inst Hepatol, Beijing 100871, Peoples R China; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Drexel University; Peking University; University of Tennessee System; University of Tennessee Health Science Center	Guo, JT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	ju-tao.guo@drexelmed.edu; jinhong.chang@drexelmed.edu	Cuconati, Andrea/GWV-4662-2022; Cuconati, Andrea/AAI-7533-2020	Cuconati, Andrea/0000-0001-5123-0381	National Institutes of Health [AI061441, AI069285]; Hepatitis B Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069285, U01AI061441, R01AI069285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hepatitis B Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI061441, AI069285) and the Hepatitis B Foundation through an appropriation of the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Bohrmann B, 2000, J STRUCT BIOL, V130, P232, DOI 10.1006/jsbi.2000.4241; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08; Chang YC, 2005, SOUTH MED J, V98, P914, DOI 10.1097/01.SMJ.0000176712.01491.98; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Damm J, 2012, NEUROSCIENCE, V201, P166, DOI 10.1016/j.neuroscience.2011.11.013; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fidock MD, 2011, CLIN PHARMACOL THER, V89, P821, DOI 10.1038/clpt.2011.60; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; Guo H, 2009, J VIROL, V83, P847, DOI 10.1128/JVI.02008-08; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mitchell D, 2010, MOL IMMUNOL, V47, P2065, DOI 10.1016/j.molimm.2010.04.004; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Steer SA, 2006, J IMMUNOL, V177, P3413, DOI 10.4049/jimmunol.177.5.3413; Stewart MJ, 2006, J INTERF CYTOK RES, V26, P521, DOI 10.1089/jir.2006.26.521; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140	43	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e42583	10.1371/journal.pone.0042583	http://dx.doi.org/10.1371/journal.pone.0042583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056170	Green Submitted, Green Published, gold			2022-12-25	WOS:000309454000002
J	Serra-Juhe, C; Rodriguez-Santiago, B; Cusco, I; Vendrell, T; Camats, N; Toran, N; Perez-Jurado, LA				Serra-Juhe, Clara; Rodriguez-Santiago, Benjamin; Cusco, Ivon; Vendrell, Teresa; Camats, Nuria; Toran, Nuria; Perez-Jurado, Luis A.			Contribution of Rare Copy Number Variants to Isolated Human Malformations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL HEART-DEFECTS; ARRAY-CGH; SUBTELOMERIC REARRANGEMENTS; IMBALANCES; MUTATIONS; DELETIONS; IDENTIFICATION; MICRODELETION; ANEUPLOIDIES	Background: Congenital malformations are present in approximately 2-3% of liveborn babies and 20% of stillborn fetuses. The mechanisms underlying the majority of sporadic and isolated congenital malformations are poorly understood, although it is hypothesized that the accumulation of rare genetic, genomic and epigenetic variants converge to deregulate developmental networks. Methodology/Principal Findings: We selected samples from 95 fetuses with congenital malformations not ascribed to a specific syndrome (68 with isolated malformations, 27 with multiple malformations). Karyotyping and Multiplex Ligation-dependent Probe Amplification (MLPA) discarded recurrent genomic and cytogenetic rearrangements. DNA extracted from the affected tissue (46%) or from lung or liver (54%) was analyzed by molecular karyotyping. Validations and inheritance were obtained by MLPA. We identified 22 rare copy number variants (CNV) [>100 kb, either absent (n = 7) or very uncommon (n = 15, <1/2,000) in the control population] in 20/95 fetuses with congenital malformations (21%), including 11 deletions and 11 duplications. One of the 9 tested rearrangements was de novo while the remaining were inherited from a healthy parent. The highest frequency was observed in fetuses with heart hypoplasia (8/17, 62.5%), with two events previously related with the phenotype. Double events hitting candidate genes were detected in two samples with brain malformations. Globally, the burden of deletions was significantly higher in fetuses with malformations compared to controls. Conclusions/Significance: Our data reveal a significant contribution of rare deletion-type CNV, mostly inherited but also de novo, to human congenital malformations, especially heart hypoplasia, and reinforce the hypothesis of a multifactorial etiology in most cases.	[Serra-Juhe, Clara; Cusco, Ivon; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain; [Serra-Juhe, Clara; Cusco, Ivon; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin] Quantitat Genom Med Labs qGenom, Barcelona, Spain; [Vendrell, Teresa] Hosp Univ Vall dHebron, Programa Med Mol & Genet, Barcelona, Spain; [Camats, Nuria; Toran, Nuria] Hosp Univ Vall dHebron, Serv Anat Patol, Barcelona, Spain	Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Perez-Jurado, LA (corresponding author), Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain.	luis.perez@upf.edu	Serra-Juhe, Clara/M-6968-2015; Cusco, I/H-2096-2014; Cusco, Ivon/AAF-4662-2021; Pérez Jurado, Luis Alberto/M-7706-2015; Camats, Nuria/K-8326-2017	Serra-Juhe, Clara/0000-0001-8471-8391; Cusco, I/0000-0003-2104-9332; Cusco, Ivon/0000-0003-2104-9332; Camats, Nuria/0000-0002-4863-8201; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852	Spanish Ministry of Health [PI042063]; CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras) [U735-3]; European Union [LSHG-CT-2006-037627]; Fondo de Investigacion Sanitaria [FIS FI08/00365, FIS CD06/00019]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras); European Union(European Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by grants from the Spanish Ministry of Health (PI042063), the CIBERER (Centro de Investigacion Biomedica en Red de Enfermedades Raras)(U735-3) and the VI Framework Programme of the European Union (LSHG-CT-2006-037627). CS-J and BR-S were supported by predoctoral (FIS FI08/00365) and posdoctoral fellowships (FIS CD06/00019) of the Fondo de Investigacion Sanitaria, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol L, 2012, HUM GENET, V131, P513, DOI 10.1007/s00439-011-1095-5; Ashleigh R, 2012, PEDIAT CARDIOL; Bendavid C, 2007, HUM MUTAT, V28, P1189, DOI 10.1002/humu.20594; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bittel DC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-1; Botto L.D., 2003, PROG PEDIATR CARDIOL, V18, P111, DOI [10.1016/S1058-9813(03)00084-5, DOI 10.1016/S1058-9813(03)00084-5]; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Butler TL, 2010, GENET TEST MOL BIOMA, V14, P797, DOI 10.1089/gtmb.2010.0028; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; De Galan-Roosen AEM, 1998, EUR J OBSTET GYN R B, V80, P55, DOI 10.1016/S0301-2115(98)00085-2; Erdogan F, 2008, J MED GENET, V45, P704, DOI 10.1136/jmg.2008.058776; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hardin J, 2009, AM J MED GENET A, V149A, P877, DOI 10.1002/ajmg.a.32745; Hinton RB, 2007, J AM COLL CARDIOL, V50, P1590, DOI 10.1016/j.jacc.2007.07.021; Iascone M, 2011, CLIN GENET; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Le Caignec C, 2005, J MED GENET, V42, P121, DOI 10.1136/jmg.2004.025478; MITCHELL SC, 1971, AM J CARDIOL, V28, P653, DOI 10.1016/0002-9149(71)90053-1; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NORA JJ, 1976, CIRCULATION, V53, P701, DOI 10.1161/01.CIR.53.4.701; Ogata Tsutomu, 2005, Pediatr Endocrinol Rev, V2, P669; Ohtoshi A, 2004, MOL CELL BIOL, V24, P7548, DOI 10.1128/MCB.24.17.7548-7558.2004; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pietrzyk J J, 1997, Cent Eur J Public Health, V5, P86; Popp S, 2002, HUM GENET, V111, P31, DOI 10.1007/s00439-002-0739-x; Richards AA, 2008, PEDIATR RES, V64, P358, DOI 10.1203/PDR.0b013e31818095d0; Rodriguez-Santiago B, 2010, MOL PSYCHIATR, V15, P1023, DOI 10.1038/mp.2009.53; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Rooms L, 2004, HUM MUTAT, V23, P17, DOI 10.1002/humu.10300; Schaeffer AJ, 2004, AM J HUM GENET, V74, P1168, DOI 10.1086/421250; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Valduga M, 2010, PRENATAL DIAG, V30, P333, DOI 10.1002/pd.2460; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Vialard F, 2009, FETAL DIAGN THER, V25, P277, DOI 10.1159/000224112; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Webber SA, 1996, J PEDIATR-US, V129, P26, DOI 10.1016/S0022-3476(96)70186-5	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45530	10.1371/journal.pone.0045530	http://dx.doi.org/10.1371/journal.pone.0045530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056206	Green Published, gold, Green Submitted			2022-12-25	WOS:000309454000008
J	Iyer, KV; Maharana, S; Gupta, S; Libchaber, A; Tlusty, T; Shivashankar, GV				Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Libchaber, Albert; Tlusty, Tsvi; Shivashankar, G. V.			Modeling and Experimental Methods to Probe the Link between Global Transcription and Spatial Organization of Chromosomes	PLOS ONE			English	Article							HUMAN INTERPHASE CHROMOSOMES; GENE-EXPRESSION; CHROMATIN; NUCLEI; CELLS; TERRITORIES; GENOMES; ASSOCIATION; ORDER	Genomes are spatially assembled into chromosome territories (CT) within the nucleus of living cells. Recent evidences have suggested associations between three-dimensional organization of CTs and the active gene clusters within neighboring CTs. These gene clusters are part of signaling networks sharing similar transcription factor or other downstream transcription machineries. Hence, presence of such gene clusters of active signaling networks in a cell type may regulate the spatial organization of chromosomes in the nucleus. However, given the probabilistic nature of chromosome positions and complex transcription factor networks (TFNs), quantitative methods to establish their correlation is lacking. In this paper, we use chromosome positions and gene expression profiles in interphase fibroblasts and describe methods to capture the correspondence between their spatial position and expression. In addition, numerical simulations designed to incorporate the interacting TFNs, reveal that the chromosome positions are also optimized for the activity of these networks. These methods were validated for specific chromosome pairs mapped in two distinct transcriptional states of T-Cells (naive and activated). Taken together, our methods highlight the functional coupling between topology of chromosomes and their respective gene expression patterns.	[Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Libchaber, Albert] Rockefeller Univ, Lab Expt Condensed Matter Phys, New York, NY 10021 USA; [Tlusty, Tsvi] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Rockefeller University; Weizmann Institute of Science; National University of Singapore; National University of Singapore	Iyer, KV (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	Tsvi.Tlusty@weizmann.ac.il; shiva.gvs@gmail.com	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725; Maharana, Shovamayee/0000-0003-3909-9151	Department of Science and Technology, India [SR/S5/NM-36/2005, DST/SJF/GVS/6223]; Israel Science Foundation [1329/08]; Mechanobiology Institute, Singapore; Council of Scientific and Industrial Research doctoral fellowship	Department of Science and Technology, India(Department of Science & Technology (India)); Israel Science Foundation(Israel Science Foundation); Mechanobiology Institute, Singapore; Council of Scientific and Industrial Research doctoral fellowship	The authors thank the Nanoscience Initiative (SR/S5/NM-36/2005) and Swarnajayanti (DST/SJF/GVS/6223) grants from the Department of Science and Technology, India (http://www.dst.gov.in), Israel Science Foundation grant 1329/08 and Mechanobiology Institute, Singapore. KVI and SM were awarded Council of Scientific and Industrial Research doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chandley AC, 1996, J CELL SCI, V109, P773; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cornforth MN, 2002, J CELL BIOL, V159, P237, DOI 10.1083/jcb.200206009; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fritsche M, 2012, NUCLEIC ACIDS RES, V40, P972, DOI 10.1093/nar/gkr779; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jerabek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037525; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Khrameeva EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033947; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kreth G, 2004, BIOPHYS J, V86, P2803, DOI 10.1016/S0006-3495(04)74333-7; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; Ramirez MJ, 2008, CYTOGENET GENOME RES, V122, P237, DOI 10.1159/000167809; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shu L, 2006, BLOOD CELL MOL DIS, V37, P64, DOI 10.1016/j.bcmd.2006.04.002; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Stine MJ, 2011, CANCER RES, V71, P2433, DOI 10.1158/0008-5472.CAN-10-1875; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053	58	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46628	10.1371/journal.pone.0046628	http://dx.doi.org/10.1371/journal.pone.0046628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049710	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388500037
J	van den Berg, BA; Reinders, MJT; Hulsman, M; Wu, L; Pel, HJ; Roubos, JA; de Ridder, D				van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; Wu, Liang; Pel, Herman J.; Roubos, Johannes A.; de Ridder, Dick			Exploring Sequence Characteristics Related to High-Level Production of Secreted Proteins in Aspergillus niger	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; FILAMENTOUS FUNGI; MOLECULAR-BIOLOGY; ENZYME-PRODUCTION; PREDICTION; STABILITY; SIGNAL; GLYCOSYLATION; EFFICIENCY; EXPRESSION	Protein sequence features are explored in relation to the production of over-expressed extracellular proteins by fungi. Knowledge on features influencing protein production and secretion could be employed to improve enzyme production levels in industrial bioprocesses via protein engineering. A large set, over 600 homologous and nearly 2,000 heterologous fungal genes, were overexpressed in Aspergillus niger using a standardized expression cassette and scored for high versus no production. Subsequently, sequence-based machine learning techniques were applied for identifying relevant DNA and protein sequence features. The amino-acid composition of the protein sequence was found to be most predictive and interpretation revealed that, for both homologous and heterologous gene expression, the same features are important: tyrosine and asparagine composition was found to have a positive correlation with high-level production, whereas for unsuccessful production, contributions were found for methionine and lysine composition. The predictor is available online at http://bioinformatics.tudelft.nl/hipsec. Subsequent work aims at validating these findings by protein engineering as a method for increasing expression levels per gene copy.	[van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Dept Intelligent Syst, Delft Bioinformat Lab, Delft, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Wu, Liang; Pel, Herman J.; Roubos, Johannes A.] DSM Biotechnol Ctr, Delft, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Delft University of Technology; DSM NV	van den Berg, BA (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Dept Intelligent Syst, Delft Bioinformat Lab, Delft, Netherlands.	b.a.vandenberg@tudelft.nl	de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310	BioRange programme of the Netherlands Bioinformatics Centre (NBIC)	BioRange programme of the Netherlands Bioinformatics Centre (NBIC)	This work was supported by the BioRange programme of the Netherlands Bioinformatics Centre (NBIC) and was part of the Kluyver Centre for Genomics of Industrial Fermentation, subsidiaries of the Netherlands Genomics Initiative (NGI). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The used data set was provided by DSM Biotechnology Center. Study design, data collection and analysis, decision to publish, and preparation of the manuscript has been done in cooperation with the DSM employees who are co-authors.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Archer DB, 1997, CRIT REV BIOTECHNOL, V17, P273, DOI 10.3109/07388559709146616; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Carvalho NDSP, 2011, APPL MICROBIOL BIOT, V89, P357, DOI 10.1007/s00253-010-2916-5; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI 10.1006/fgbi.2001.1276; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Eriksen SH, 1998, CURR MICROBIOL, V37, P117, DOI 10.1007/s002849900348; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1, DOI 10.1007/s002530050880; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Jacobs DI, 2009, FUNGAL GENET BIOL, V46, pS141, DOI 10.1016/j.fgb.2008.08.012; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones E., 2001, SCIPY OPEN SOURCE SC; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LESLIE C, 2002, P PSB, V7, P566; Liu Y, 2009, BIOTECHNOL PROGR, V25, P1468, DOI 10.1002/btpr.241; Lubertozzi D, 2009, BIOTECHNOL ADV, V27, P53, DOI 10.1016/j.biotechadv.2008.09.001; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nevalainen KMH, 2005, TRENDS BIOTECHNOL, V23, P468, DOI 10.1016/j.tibtech.2005.06.002; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Toussaint NC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S7; van den Berg BA, 2010, LECT N BIOINFORMAT, V6282, P3, DOI 10.1007/978-3-642-16001-1_1; den Brink HM, 2006, J BIOTECHNOL, V125, P304, DOI 10.1016/j.jbiotec.2006.02.024; van Dijck PWM, 2003, REGUL TOXICOL PHARM, V38, P27, DOI 10.1016/S0273-2300(03)00049-7; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Whyteside G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022692	58	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45869	10.1371/journal.pone.0045869	http://dx.doi.org/10.1371/journal.pone.0045869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049690	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388500017
J	Marschinke, F; Hashemian, S; Matozaki, T; Oldenborg, PA; Stromberg, I				Marschinke, Franziska; Hashemian, Sanaz; Matozaki, Takashi; Oldenborg, Per-Arne; Stromberg, Ingrid			The Absence of CD47 Promotes Nerve Fiber Growth from Cultured Ventral Mesencephalic Dopamine Neurons	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; ORGANOTYPIC TISSUE-CULTURES; CHONDROITIN SULFATE PROTEOGLYCAN; SIGNAL-REGULATORY PROTEIN; NEURITE OUTGROWTH; CORTICAL-NEURONS; CELL-ADHESION; INHIBITION; SHP-2; THROMBOSPONDIN	In ventral mesencephalic organotypic tissue cultures, two timely separated sequences of nerve fiber growth have been observed. The first appearing nerve fiber pattern is a long-distance outgrowth that occurs before astrocytes start to proliferate and migrate to form an astrocytic monolayer that finally surrounds the tissue slice. These long-distance growing nerve fibers are retracted as the astrocytes migrate, and are followed by a secondary outgrowth. The secondary outgrowth is persistent in time but reaches short distances, comparable with outgrowth seen from a dopaminergic graft implanted to the brain. The present study was focused on the interaction between the astrocytes and the long-distance growing non-glial associated nerve fibers. Cross talk between astroglia and neurite formation might occur through the integrin-associated protein CD47. CD47 serves as a ligand for signal regulatory protein (SIRP) alpha and as a receptor for the extracellular matrix protein thrombospondin-1 (TSP-1). Embryonic day 14 ventral mesencephalic tissue from CD47(+/+) and CD47(-/-) mice was used to investigate astrocytic migration and the tyrosine hydroxylase (TH) -positive outgrowth that occurred remote from the astrocytes. TH-immunohistochemistry demonstrated that the non-glial-associated nerve fiber outgrowth in CD47(-/-) cultures reached significantly longer distances and higher density compared to nerve fibers formed in CD47(+/+) cultures at 14 days in vitro. These nerve fibers often had a dotted appearance in CD47(+/+) cultures. No difference in the astrocytic migration was observed. Further investigations revealed that the presence of CD47 in control culture did neither hamper non-glial-associated growth through SIRP alpha nor through TSP-1 since similar outgrowth was found in SIRP alpha mutant cultures and in CD47(+/+) cultures treated with blocking antibodies against the TSP-1, respectively, as in the control cultures. In conclusion, long-distance growing nerve fiber formation is promoted by the absence of CD47, even though the presence of astrocytes is not inhibited.	[Marschinke, Franziska; Hashemian, Sanaz; Oldenborg, Per-Arne; Stromberg, Ingrid] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan	Umea University; Kobe University	Stromberg, I (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	ingrid.stromberg@histocel.umu.se			Swedish Research Council [09917]; Umea University Medical Faculty Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University Medical Faculty Foundations	This study was supported by the Swedish Research Council grant # 09917 and Umea University Medical Faculty Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Bjerken S, 2008, INT J DEV NEUROSCI, V26, P683, DOI 10.1016/j.ijdevneu.2008.07.014; af Bjerken S, 2007, BRAIN RES, V1133, P10, DOI 10.1016/j.brainres.2006.11.052; Araki T, 2000, J NEUROCHEM, V74, P659, DOI 10.1046/j.1471-4159.2000.740659.x; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Berglof E, 2008, J NEUROSCI RES, V86, P84, DOI 10.1002/jnr.21465; Berglof E, 2007, J COMP NEUROL, V501, P431, DOI 10.1002/cne.21251; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Huang AM, 1998, J NEUROSCI, V18, P4305; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Johansson S, 2003, CELL TRANSPLANT, V12, P243, DOI 10.3727/000000003108746803; Johansson S, 2002, J COMP NEUROL, V443, P237, DOI 10.1002/cne.10119; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Marschinke F, 2008, BRAIN RES, V1215, P30, DOI 10.1016/j.brainres.2008.03.070; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mi ZP, 2000, J COMP NEUROL, V416, P335; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Myers SA, 2011, NEUROBIOL DIS, V42, P21, DOI 10.1016/j.nbd.2010.12.010; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ohnishi H, 1999, J NEUROCHEM, V72, P1402, DOI 10.1046/j.1471-4159.1999.721402.x; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Takai S, 2002, J NEUROCHEM, V82, P353, DOI 10.1046/j.1471-4159.2002.00960.x; TAKESHIMA T, 1994, NEUROSCIENCE, V60, P809, DOI 10.1016/0306-4522(94)90506-1; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Wang XXX, 2003, J NEUROCHEM, V86, P55, DOI 10.1046/j.1471-4159.2003.01810.x	42	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45218	10.1371/journal.pone.0045218	http://dx.doi.org/10.1371/journal.pone.0045218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049778	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300019
J	Papi, M; Brunelli, R; Familiari, G; Frassanito, MC; Lamberti, L; Maulucci, G; Monaci, M; Pappalettere, C; Parasassi, T; Relucenti, M; Sylla, L; Ursini, F; De Spirito, M				Papi, Massimiliano; Brunelli, Roberto; Familiari, Giuseppe; Frassanito, Maria Cristina; Lamberti, Luciano; Maulucci, Giuseppe; Monaci, Maurizio; Pappalettere, Carmine; Parasassi, Tiziana; Relucenti, Michela; Sylla, Lakamy; Ursini, Fulvio; De Spirito, Marco			Whole-Depth Change in Bovine Zona Pellucida Biomechanics after Fertilization: How Relevant in Hindering Polyspermy?	PLOS ONE			English	Article							IN-VITRO; RECOGNITION; EGGS	Polyspermy is a common problem in bovine in vitro fertilization (IVF) and has a still unclear etiology. In this specie, after IVF, despite the lack of a biochemical post-fertilization hardening, the stiffness of the outer ZP layer is significantly increased. Therefore, polyspermy might be related to an incomplete or insufficient stiffening of the ZP. We obtained, by using atomic force spectroscopy in physiological conditions, a complete characterization of the biomechanical changes of the inner and outer ZP layers occurring during oocyte maturation/fertilization and correlated them to the ultrastructural changes observed by transmission electron microscopy using ruthenium red and saponin technique. In both the inner and outer ZP layers, stiffness decreased at maturation while, conversely, increased after fertilization. Contextually, at the nanoscale, during maturation both ZP layers displayed a fine filaments network whose length increased while thickness decreased. After fertilization, filaments partially recovered the immature features, appearing again shorter and thicker. Overall, the observed biomechanical modifications were substantiated by ultrastructural findings in the ZP filament mesh. In fertilized ZP, the calculated force necessary to displace ZP filaments resulted quite similar to that previously reported as generated by bovine sperm flagellum. Therefore, in bovine IVF biomechanical modifications of ZP appear ineffective in hindering sperm transit, highlighting the relevance of additional mechanisms operating in vivo.	[Papi, Massimiliano; Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Brunelli, Roberto] Univ Roma La Sapienza, Dipartimento Sci Ginecol Ostetr & Sci Urol, Rome, Italy; [Familiari, Giuseppe; Relucenti, Michela] Univ Roma La Sapienza, Dipartimento Sci Anat Istol Med Legali & Apparato, Rome, Italy; [Frassanito, Maria Cristina; Lamberti, Luciano; Pappalettere, Carmine] Politecn Bari, Dipartimento Ingn Meccan & Gestionale, Bari, Italy; [Monaci, Maurizio; Sylla, Lakamy] Univ Perugia, Dipartimento Patol Diagnost & Clin Vet, I-06100 Perugia, Italy; [Parasassi, Tiziana] CNR, Ist Farmacol Traslazionale, Rome, Italy; [De Spirito, Marco] Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy; [Ursini, Fulvio] Univ Padua, Dipartimento Chim Biol, Padua, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Sapienza University Rome; Politecnico di Bari; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Padua	De Spirito, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	Maulucci, Giuseppe/C-7400-2009; Relucenti, Michela/I-2377-2012; De Spirito, Marco/U-3817-2019; Sylla, Lakamy/AFP-9574-2022; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022	Maulucci, Giuseppe/0000-0002-2154-319X; Relucenti, Michela/0000-0002-3805-9505; De Spirito, Marco/0000-0003-4260-5107; Sylla, Lakamy/0000-0002-7114-4736; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; MONACI, MAURIZIO/0000-0002-6506-6794; Parasassi, Tiziana/0000-0002-9795-0568; LAMBERTI, Luciano/0000-0002-9845-8786; Pappalettere, Carmine/0000-0002-6947-2917	Universita Cattolica del S. Cuore	Universita Cattolica del S. Cuore	The research has been partially funded by Universita Cattolica del S. Cuore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allen MJ, 2010, NANOMED-NANOTECHNOL, V6, P510, DOI 10.1016/j.nano.2009.12.003; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Boccaccio A, 2012, J R SOC INTERFACE, P1742, DOI [10.1098/rsif20120269, DOI 10.1098/RSIF20120269]; Brunelli R, 2007, FASEB J, V21, P3872, DOI 10.1096/fj.07-8189com; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Coy P, 2008, REPRODUCTION, V135, P19, DOI 10.1530/REP-07-0280; De Spirito M, 2006, BIOPHYS J, V90, P4239, DOI 10.1529/biophysj.105.075788; DEGENNES PG, 1985, SCALING CONCEPTS POL; FAMILIARI G, 1992, MOL REPROD DEV, V32, P51, DOI 10.1002/mrd.1080320109; Familiari G, 2008, FRONT BIOSCI-LANDMRK, V13, P6730, DOI 10.2741/3185; Familiari G, 2006, INT REV CYTOL, V249, P53, DOI 10.1016/S0074-7696(06)49002-1; Familiari G, 2006, MICROSC RES TECHNIQ, V69, P415, DOI 10.1002/jemt.20301; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Garg SK, 2006, CLIN IMMUNOL, V121, P23, DOI 10.1016/j.clim.2006.06.003; Green D P, 1997, Rev Reprod, V2, P147, DOI 10.1530/ror.0.0020147; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; HYTTEL P, 1989, ANAT EMBRYOL, V179, P435, DOI 10.1007/BF00319585; Iwamoto K, 1999, J REPROD FERTIL, V117, P395, DOI 10.1530/jrf.0.1170395; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Maulucci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018906; MINHAS BS, 1984, BIOL REPROD, V30, P687, DOI 10.1095/biolreprod30.3.687; NOGUCHI S, 1994, BBA-GEN SUBJECTS, V1201, P7, DOI 10.1016/0304-4165(94)90143-0; Papi M, 2012, APPL PHYS LETT, V88; Papi M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970963; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P987, DOI 10.1007/s00249-009-0468-3; Papi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3107265; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Sun QY, 2003, MICROSC RES TECHNIQ, V61, P342, DOI 10.1002/jemt.10347; Tiribilli B, 2005, ULTRAMICROSCOPY, V102, P227, DOI 10.1016/j.ultramic.2004.10.003	30	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45696	10.1371/journal.pone.0045696	http://dx.doi.org/10.1371/journal.pone.0045696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049839	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300044
J	Perala, MM; Mannisto, S; Kaartinen, NE; Kajantie, E; Osmond, C; Barker, DJP; Valsta, LM; Eriksson, JG				Perala, Mia-Maria; Mannisto, Satu; Kaartinen, Niina E.; Kajantie, Eero; Osmond, Clive; Barker, David J. P.; Valsta, Liisa M.; Eriksson, Johan G.			Body Size at Birth Is Associated with Food and Nutrient Intake in Adulthood	PLOS ONE			English	Article							SWEET TASTE SENSITIVITY; LOW-PROTEIN DIET; PRENATAL EXPOSURE; HEART-DISEASE; FREQUENCY QUESTIONNAIRE; PHYSICAL-ACTIVITY; LEPTIN LEVELS; WEIGHT; RISK; GROWTH	Background: Small body size at birth is associated with an increased risk of cardiovascular disease and type 2 diabetes. Dietary habits are tightly linked with these disorders, but the association between body size at birth and adult diet has been little studied. We examined the association between body size at birth and intake of foods and macronutrients in adulthood. Methodology/Principal Findings: We studied 1797 participants, aged 56 to 70, of the Helsinki Birth Cohort Study, whose birth weight and length were recorded. Preterm births were excluded. During a clinical study, diet was assessed with a validated food-frequency questionnaire. A linear regression model adjusted for potential confounders was used to assess the associations. Intake of fruits and berries was 13.26 g (95% confidence interval [CI]: 0.56, 25.96) higher per 1 kg/m(3) increase in ponderal index (PI) at birth, and 83.16 g (95% CI: 17.76, 148.56) higher per 1 kg higher birth weight. One unit higher PI at birth was associated with 0.14% of energy (E%) lower intake of fat (95% CI: -0.26, -0.03) and 0.18 E% higher intake of carbohydrates (95% CI: 0.04, 0.32) as well as 0.08 E% higher sucrose (95% CI: 0.00, 0.15), 0.05 E% higher fructose (95% CI: 0.01, 0.09), and 0.18 g higher fiber (95% CI: 0.02, 0.34) intake in adulthood. Similar associations were observed between birth weight and macronutrient intake. Conclusions: Prenatal growth may modify later life food and macronutrient intake. Altered dietary habits could potentially explain an increased risk of chronic disease in individuals born with small body size.	[Perala, Mia-Maria; Mannisto, Satu; Kaartinen, Niina E.; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Osmond, Clive; Barker, David J. P.] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Barker, David J. P.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA; [Barker, David J. P.] King Saud Univ, Fetal Programming Res Chair, Riyadh, Saudi Arabia; [Valsta, Liisa M.] Natl Inst Hlth & Welf, Dept Lifestyle & Participat, Helsinki, Finland; [Valsta, Liisa M.] European Food Safety Author, Parma, Italy; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Southampton; Oregon Health & Science University; King Saud University; Finland National Institute for Health & Welfare; European Food Safety Authority; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center	Perala, MM (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	mia.perala@thl.fi	Kaartinen, Niina/AAZ-8585-2020	Eriksson, Johan/0000-0002-2516-2060; Mannisto, Satu/0000-0002-8668-3046; Osmond, Clive/0000-0002-9054-4655; Perala, Mia-Maria/0000-0002-6349-6301	Academy of Finland; Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from Academy of Finland, Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Finska Lakaresallskapet, Samfundet Folkhalsan, Juho Vainio Foundation, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, Yrjo Jahnsson Foundation, The Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, and the Finnish Graduate School on Applied Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Ayres C, 2012, INT J PEDIA IN PRESS; Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Horton ES, 2009, OBESITY, V17, pS43, DOI 10.1038/oby.2009.388; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Ignarro LJ, 2007, CARDIOVASC RES, V73, P326, DOI 10.1016/j.cardiores.2006.06.030; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Kaartinen NE, 2010, EUR J CLIN NUTR, V64, pS68, DOI 10.1038/ejcn.2010.214; Lissner L, 1999, OBES RES, V7, P150, DOI 10.1002/j.1550-8528.1999.tb00696.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Nakamura Y, 2008, DIABETES, V57, P2661, DOI 10.2337/db07-1103; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Phillips DIW, 1999, INT J OBESITY, V23, P1025, DOI 10.1038/sj.ijo.0801050; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Portella AK, 2012, J DEV ORIG HLTH DIS, V3, P140, DOI 10.1017/S2040174412000062; Primeaux SD, 2006, PEPTIDES, V27, P1644, DOI 10.1016/j.peptides.2005.12.009; Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shultis WA, 2005, J EPIDEMIOL COMMUN H, V59, P955, DOI 10.1136/jech.2005.034413; Silveira PP, 2012, PEDIATR RES, V71, P293, DOI 10.1038/pr.2011.39; Stafford M, 1998, BRIT MED J, V316, P1247, DOI 10.1136/bmj.316.7139.1247; Stein AD, 2009, J NUTR, V139, P1555, DOI 10.3945/jn.109.105536; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	37	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46139	10.1371/journal.pone.0046139	http://dx.doi.org/10.1371/journal.pone.0046139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049962	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000309517300090
J	Ruiz-Lopez, MJ; Monello, RJ; Gompper, ME; Eggert, LS				Ruiz-Lopez, Maria Jose; Monello, Ryan J.; Gompper, Matthew E.; Eggert, Lori S.			The Effect and Relative Importance of Neutral Genetic Diversity for Predicting Parasitism Varies across Parasite Taxa	PLOS ONE			English	Article							HETEROZYGOSITY-FITNESS CORRELATIONS; DERMACENTOR-VARIABILIS; SPECIES RICHNESS; RESISTANCE; SELECTION; MHC; POPULATIONS; PREVALENCE; NEMATODES; RESOURCE	Understanding factors that determine heterogeneity in levels of parasitism across individuals is a major challenge in disease ecology. It is known that genetic makeup plays an important role in infection likelihood, but the mechanism remains unclear as does its relative importance when compared to other factors. We analyzed relationships between genetic diversity and macroparasites in outbred, free-ranging populations of raccoons (Procyon lotor). We measured heterozygosity at 14 microsatellite loci and modeled the effects of both multi-locus and single-locus heterozygosity on parasitism using an information theoretic approach and including non-genetic factors that are known to influence the likelihood of parasitism. The association of genetic diversity and parasitism, as well as the relative importance of genetic diversity, differed by parasitic group. Endoparasite species richness was better predicted by a model that included genetic diversity, with the more heterozygous hosts harboring fewer endoparasite species. Genetic diversity was also important in predicting abundance of replete ticks (Dermacentor variabilis). This association fit a curvilinear trend, with hosts that had either high or low levels of heterozygosity harboring fewer parasites than those with intermediate levels. In contrast, genetic diversity was not important in predicting abundance of non-replete ticks and lice (Trichodectes octomaculatus). No strong single-locus effects were observed for either endoparasites or replete ticks. Our results suggest that in outbred populations multi-locus diversity might be important for coping with parasitism. The differences in the relationships between heterozygosity and parasitism for the different parasites suggest that the role of genetic diversity varies with parasite-mediated selective pressures.	[Ruiz-Lopez, Maria Jose; Monello, Ryan J.; Gompper, Matthew E.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Ruiz-Lopez, Maria Jose; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ruiz-Lopez, MJ (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	ruizlopezmj@gmail.com	Ruiz-Lopez, Maria Jose/AAA-8693-2020	Ruiz-Lopez, Maria Jose/0000-0002-6849-644X	National Science Foundation [DEB-0347609, DEB-3170841654]; Division of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); Division of Biological Sciences	This work was supported by National Science Foundation grants DEB-0347609 and DEB-3170841654, and by Division of Biological Sciences new investigator funding to LSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Balloux F, 2004, EVOLUTION, V58, P1891; Berenos C, 2011, P ROY SOC B-BIOL SCI, V278, P218, DOI 10.1098/rspb.2010.1211; Bierne N, 2000, GENETICS, V155, P1981; Blanchet S, 2009, MOL ECOL, V18, P1112, DOI 10.1111/j.1365-294X.2009.04099.x; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cote SD, 2005, MOL ECOL, V14, P4159, DOI 10.1111/j.1365-294X.2005.02733.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DENHOLLANDER N, 1985, EXP PARASITOL, V59, P118, DOI 10.1016/0014-4894(85)90064-5; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Ellison A, 2011, EVOLUTION, V65, P3021, DOI 10.1111/j.1558-5646.2011.01354.x; Elton C., 1958; Excoffier L, 2006, ARLEQUIN VER 3 1 INT; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Gompper ME, 2011, P ROY SOC B-BIOL SCI, V278, P204, DOI 10.1098/rspb.2010.1113; Grau GA, 1970, J WILDLIFE MANAGE, V266, P215; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; King KC, 2012, HEREDITY, V109, P199, DOI 10.1038/hdy.2012.33; LEONARD KJ, 1969, PHYTOPATHOLOGY, V59, P1845; Lieutenant-Gosselin M, 2006, EVOLUTION, V60, P1658; Ljungqvist M, 2010, MOL ECOL, V19, P851, DOI 10.1111/j.1365-294X.2010.04522.x; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Marshall AG, 1982, ECOLOGY ECTOPARASITI; Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x; Meagher S, 1999, EVOLUTION, V53, P1318, DOI [10.2307/2640837, 10.1111/j.1558-5646.1999.tb04547.x]; Moller AP, 2005, OECOLOGIA, V142, P169, DOI 10.1007/s00442-004-1735-8; Monello RJ, 2007, PARASITOLOGY, V134, P2053, DOI 10.1017/S0031182007003423; Monello RJ, 2011, OIKOS, V120, P1427, DOI 10.1111/j.1600-0706.2011.19260.x; Monello RJ, 2010, J ANIM ECOL, V79, P602, DOI 10.1111/j.1365-2656.2010.01663.x; Monello RJ, 2009, J PARASITOL, V95, P56, DOI 10.1645/GE-1643.1; Morand S, 2006, MICROMAMMALS MACROPA; Mueller JC, 2011, EVOL ECOL, V25, P1, DOI 10.1007/s10682-010-9377-2; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Ortego J, 2007, MOL ECOL, V16, P4858, DOI 10.1111/j.1365-294X.2007.03554.x; Ortego J, 2007, MOL ECOL, V16, P3712, DOI 10.1111/j.1365-294X.2007.03406.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; Poulin R, 2000, INT J PARASITOL, V30, P697, DOI 10.1016/S0020-7519(00)00047-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Siripunkaw C, 2008, MOL ECOL RESOUR, V8, P199, DOI 10.1111/j.1471-8286.2007.01922.x; Slate J, 2006, CURR BIOL, V16, pR790, DOI 10.1016/j.cub.2006.08.047; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Thornhill N.W., 1993, NATURAL HIST INBREED; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wehtje M, 2011, WILDLIFE BIOL, V17, P25, DOI 10.2981/10-012; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Whitaker J. O, 1982, ECTOPARASITES MAMMAL; Whiteman NK, 2007, MOL ECOL, V16, P4759, DOI 10.1111/j.1365-294X.2007.03512.x; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Wilson K., 2002, P6	73	15	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45404	10.1371/journal.pone.0045404	http://dx.doi.org/10.1371/journal.pone.0045404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049796	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300025
J	Blechingberg, J; Luo, YL; Bolund, L; Damgaard, CK; Nielsen, AL				Blechingberg, Jenny; Luo, Yonglun; Bolund, Lars; Damgaard, Christian Kroun; Nielsen, Anders Lade			Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEIN; CYTOCHROME-P450 2E1; DENDRITIC SPINES; POLYMERASE-II; TET FAMILY; TLS; MUTATIONS; DISEASE; TRANSFORMATION	The FET family of proteins is composed of FUS/TLS, EWS/EWSR1, and TAF15 and possesses RNA- and DNA-binding capacities. The FET-proteins are involved in transcriptional regulation and RNA processing, and FET-gene deregulation is associated with development of cancer and protein granule formations in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and trinucleotide repeat expansion diseases. We here describe a comparative characterization of FET-protein localization and gene regulatory functions. We show that FUS and TAF15 locate to cellular stress granules to a larger extend than EWS. FET-proteins have no major importance for stress granule formation and cellular stress responses, indicating that FET-protein stress granule association most likely is a downstream response to cellular stress. Gene expression analyses showed that the cellular response towards FUS and TAF15 reduction is relatively similar whereas EWS reduction resulted in a more unique response. The presented data support that FUS and TAF15 are more functionally related to each other, and that the FET-proteins have distinct functions in cellular signaling pathways which could have implications for the neurological disease pathogenesis.	[Blechingberg, Jenny; Luo, Yonglun; Bolund, Lars; Nielsen, Anders Lade] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Damgaard, Christian Kroun] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, AL (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	aln@hum-gen.au.dk	Damgaard, Christian/AAR-4075-2020; Damgaard, Christian/AAP-3147-2021; Luo, Yonglun/C-4708-2013; Damgaard, Christian K/G-7360-2015; Luo, Yonglun/AAG-9253-2020; Nielsen, Anders Lade L/Q-9604-2016	Damgaard, Christian/0000-0003-4940-0868; Luo, Yonglun/0000-0002-0007-7759; Nielsen, Anders Lade L/0000-0003-4372-9961	Faculty of Health, Aarhus University; Fonden til Laegevidenskabens fremme; Danish Research Council (FSS); Lundbeck Foundation	Faculty of Health, Aarhus University; Fonden til Laegevidenskabens fremme; Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Lundbeck Foundation(Lundbeckfonden)	This project was supported by a fellowship to JB by the Faculty of Health, Aarhus University, and supported by Fonden til Laegevidenskabens fremme, the Danish Research Council (FSS), and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; [Anonymous], ALS ONL GEN DAT; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blechingberg J, 2012, GENE, V493, P27, DOI 10.1016/j.gene.2011.11.038; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brooke GN, 2011, CANCER RES, V71, P914, DOI 10.1158/0008-5472.CAN-10-0874; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Doi H, 2010, NEUROSCI RES, V66, P131, DOI 10.1016/j.neures.2009.10.004; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meissner M, 2003, EXP CELL RES, V283, P184, DOI 10.1016/S0014-4827(02)00046-0; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; OHNO T, 1994, ONCOGENE, V9, P3087; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Sanchez-Ramos C, 2011, ANTIOXID REDOX SIGN, V15, P325, DOI 10.1089/ars.2010.3643; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Shahabi HN, 2008, SYNAPSE, V62, P379, DOI 10.1002/syn.20505; Shahabi HN, 2009, J NEURAL TRANSM, V116, P567, DOI 10.1007/s00702-009-0221-1; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Thomsen Rune, 2010, J Bioinform Comput Biol, V8, P885, DOI 10.1142/S0219720010004963; Ticozzi N., 2011, AM J MED GENET B; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Zhou ZL, 2010, BIOCHEM BIOPH RES CO, V398, P565, DOI 10.1016/j.bbrc.2010.06.119; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, J CELL SCI, V110, P1741	60	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46251	10.1371/journal.pone.0046251	http://dx.doi.org/10.1371/journal.pone.0046251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049996	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100167
J	Han, HJ; Kass, PH; Wilsey, BL; Li, CS				Han, Huijun; Kass, Philip H.; Wilsey, Barth L.; Li, Chin-Shang			Individual and County-Level Factors Associated with Use of Multiple Prescribers and Multiple Pharmacies to Obtain Opioid Prescriptions in California	PLOS ONE			English	Article							NEIGHBORHOOD SOCIOECONOMIC-STATUS; CORONARY-HEART-DISEASE; ILLICIT DRUG-USE; INJECTION CESSATION; ADOLESCENT ALCOHOL; MARIJUANA USE; CHRONIC PAIN; RISK; DISADVANTAGE; ENVIRONMENT	Use of multiple prescribers and pharmacies is a means by which some individuals misuse opioids. Community characteristics may be important determinants of the likelihood of this phenomenon independent of individual-level factors. This was a retrospective cohort study with individual-level data derived from California's statewide prescription drug monitoring program (PDMP) and county-level socioeconomic status (SES) data derived from the United States Census. Zero-truncated negative binomial (ZTNB) regression was used to model the association of individual factors (age, gender, drug schedule and drug dose type) and county SES factors (ethnicity, adult educational attainment, median household income, and physician availability) with the number of prescribers and the number of pharmacies that an individual used during a single year (2006). The incidence rates of new prescriber use and new pharmacy use for opioid prescriptions declined across increasing age groups. Males had a lower incidence rate of new prescriber use and new pharmacy use than females. The total number of licensed physicians and surgeons in a county was positively, linearly, and independently associated with the number of prescribers and pharmacies that individuals used for prescription opioids. In summary, younger age, female gender, and living in counties with more licensed physicians and surgeons were associated with use of more prescribers and/or more pharmacies for obtaining prescription opioids.	[Kass, Philip H.; Li, Chin-Shang] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Han, Huijun] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Wilsey, Barth L.] Univ Calif Davis, Med Ctr, Dept Phys Med & Rehabil, Davis, CA 95616 USA; [Wilsey, Barth L.] Univ Calif Davis, Med Ctr, VA No Calif Hlth Care Syst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kass, PH (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	phkass@ucdavis.edu			Robert Wood Johnson Foundation; National Center for Research Resources, a component of the National Institutes of Health (NIH) [UL1 RR024146]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Center for Research Resources, a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this project was provided by the Robert Wood Johnson Foundation. Database architect support was derived through Grant Number UL1 RR024146 from the National Center for Research Resources, a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. This research and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T.L., 2001, ENCY CRIMINOLOGY DEV, V4, P286; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Crum RM, 1996, DRUG ALCOHOL DEPEN, V43, P155, DOI 10.1016/S0376-8716(96)01298-7; Curtis LH, 2006, HEALTH SERV RES, V41, P837, DOI 10.1111/j.1475-6773.2006.00511.x; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; EPA, 1999, FED REG, V74; Food and Drug Administration, 2009, JOINT M DRUG SAF RIS; Franks P, 2010, ANN FAM MED, V8, P447, DOI 10.1370/afm.1167; Furr-Holden CDM, 2011, J STUD ALCOHOL DRUGS, V72, P371, DOI 10.15288/jsad.2011.72.371; Galea S, 2003, J URBAN HEALTH, V80, P50; Genberg BL, 2011, ADDICTION, V106, P1966, DOI 10.1111/j.1360-0443.2011.03501.x; Green TC, 2009, DRUG ALCOHOL DEPEN, V103, P65, DOI 10.1016/j.drugalcdep.2009.03.014; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Kim D, 2010, CANCER-AM CANCER SOC, V116, P4187, DOI 10.1002/cncr.25195; Lineberry TW, 2004, MAYO CLIN PROC, V79, P1031, DOI 10.4065/79.8.1031; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Manchikanti Laxmaiah, 2007, J Opioid Manag, V3, P89; Nandi A, 2010, AM J EPIDEMIOL, V171, P391, DOI 10.1093/aje/kwp416; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB, P68; Pradel V, 2009, PHARMACOEPIDEM DR S, V18, P36, DOI 10.1002/pds.1681; RAND California, 2006, PHYS SURG CAL; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Rustoen T, 2005, CLIN J PAIN, V21, P513, DOI 10.1097/01.ajp.0000146217.31780.ef; Schroeder JR, 2001, ANN EPIDEMIOL, V11, P389, DOI 10.1016/S1047-2797(01)00225-3; Sellstrom E, 2011, HEALTH PLACE, V17, P551, DOI 10.1016/j.healthplace.2010.12.013; Simoni-Wastila L, 2004, AM J PUBLIC HEALTH, V94, P266, DOI 10.2105/AJPH.94.2.266; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Streiner DL, 2002, CAN J PSYCHIAT, V47, P68; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H; Substance Abuse and Mental Health Services Administration, 2007, NSDUH REP ILL DRUG U; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER H A, VH-38A; Substance Abuse and Mental Health Services Administration (Office of Applied Studies), 2009, HHS PUBL; Sunder PK, 2007, AM J COMMUN PSYCHOL, V40, P167, DOI 10.1007/s10464-007-9135-y; Sundquist K, 2004, AM J EPIDEMIOL, V159, P655, DOI 10.1093/aje/kwh096; *US CENS BUR, 2006, AM COMM SURV; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Weisner CM, 2009, PAIN, V145, P287, DOI 10.1016/j.pain.2009.05.006; White Alan G, 2005, J Manag Care Pharm, V11, P469; White AG, 2009, AM J MANAG CARE, V15, P897; Wilsey BL, 2010, DRUG ALCOHOL DEPEN, V112, P99, DOI 10.1016/j.drugalcdep.2010.05.007; Wilson N, 2005, AM J HEALTH PROMOT, V20, P11, DOI 10.4278/0890-1171-20.1.11; Winstanley EL, 2008, DRUG ALCOHOL DEPEN, V92, P173, DOI 10.1016/j.drugalcdep.2007.07.012	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46246	10.1371/journal.pone.0046246	http://dx.doi.org/10.1371/journal.pone.0046246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049992	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100164
J	Pasini, A; Manenti, R; Rothbacher, U; Lemaire, P				Pasini, Andrea; Manenti, Raoul; Rothbaecher, Ute; Lemaire, Patrick			Antagonizing Retinoic Acid and FGF/MAPK Pathways Control Posterior Body Patterning in the Invertebrate Chordate Ciona intestinalis	PLOS ONE			English	Article							EPIDERMAL SENSORY NEURONS; GENE REGULATORY NETWORKS; FGF SIGNALING CONTROLS; CENTRAL-NERVOUS-SYSTEM; EVOLUTIONARY PLASTICITY; TRANSCRIPTION FACTORS; OPPOSING FGF; EXPRESSION; DIFFERENTIATION; SEGMENTATION	Vertebrate embryos exploit the mutual inhibition between the RA and FGF signalling pathways to coordinate the proliferative elongation of the main body axis with the progressive patterning and differentiation of its neuroectodermal and paraxial mesodermal structures. The evolutionary history of this patterning system is still poorly understood. Here, we investigate the role played by the RA and FGF/MAPK signals during the development of the tail structures in the tunicate Ciona intestinalis, an invertebrate chordate belonging to the sister clade of vertebrates, in which the prototypical chordate body plan is established through very derived morphogenetic processes. Ciona embryos are constituted of few cells and develop according to a fixed lineage; elongation of the tail occurs largely by rearrangement of postmitotic cells; mesoderm segmentation and somitogenesis are absent. We show that in the Ciona embryo, the antagonism of the RA and FGF/MAPK signals is required to control the anteroposterior patterning of the tail epidermis. We also demonstrate that the RA, FGF/MAPK and canonical Wnt pathways control the anteroposterior patterning of the tail peripheral nervous system, and reveal the existence of distinct subpopulations of caudal epidermal neurons with different responsiveness to the RA, FGF/MAPK and canonical Wnt signals. Our data provide the first demonstration that the use of the antagonism between the RA and FGF signals to pattern the main body axis predates the emergence of vertebrates and highlight the evolutionary plasticity of this patterning strategy, showing that in different chordates it can be used to pattern different tissues within the same homologous body region.	[Pasini, Andrea; Rothbaecher, Ute; Lemaire, Patrick] Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France; [Manenti, Raoul] Univ Milan, Dipartimento Biol, Milan, Italy; [Lemaire, Patrick] Univ Montpellier, CRBM, UMR5237, CNRS, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pasini, A (corresponding author), Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France.	andrea.pasini@univ-amu.fr	Manenti, Raoul/D-4419-2013; Manenti, Raoul/O-5166-2017; Rothbächer, Ute/G-2688-2013; Rothbächer, Ute/AAB-6901-2022; Lemaire, Patrick/B-5560-2012; Lemaire, Patrick/P-8228-2019	Manenti, Raoul/0000-0001-6071-8194; Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Lemaire, Patrick/0000-0003-4925-2009; Lemaire, Patrick/0000-0003-4925-2009	CNRS; Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net"); Erasmus fellowship	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net")(French National Research Agency (ANR)); Erasmus fellowship	Work was financed by the CNRS and the Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AP, UR and PL are CNRS staff members. RM was supported by an Erasmus fellowship. Thanks to C. Lamy, S. Fujiwara, H. Saiga and T. Kusakabe for the gift of reagents. Thanks to S. Choksi for help with cluster analysis and to C. Sunyach for help with Fig. S3. Thanks to C. Hudson, H. Yasuo, H. Saiga, R. Pennati, M. Schubert for sharing comments, criticisms, unpublished data etc.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032; Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Escriva H, 2002, DEVELOPMENT, V129, P2905; Holland LZ, 2003, BIOESSAYS, V25, P529, DOI 10.1002/bies.10302; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Hudson C, 2007, DEVELOPMENT, V134, P3527, DOI 10.1242/dev.002352; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; Imai K, 2000, DEVELOPMENT, V127, P3009; Imai KS, 2002, MECH DEVELOP, V119, pS275, DOI 10.1016/S0925-4773(03)00128-X; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Kanda M, 2009, DEV BIOL, V335, P454, DOI 10.1016/j.ydbio.2009.09.027; Katsuyama Y, 1999, DEV BIOL, V213, P257, DOI 10.1006/dbio.1999.9403; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Ohtsuka Y, 2001, DEV GENES EVOL, V211, P252; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Passamaneck YJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000714; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Sawada A, 2001, DEVELOPMENT, V128, P4873; Schubert M, 2004, P NATL ACAD SCI USA, V101, P10320, DOI 10.1073/pnas.0403216101; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157; Sobral D, 2009, CURR BIOL, V19, P2014, DOI 10.1016/j.cub.2009.10.036; Terakubo HQ, 2010, DEV DYNAM, V239, P2278, DOI 10.1002/dvdy.22361	51	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46193	10.1371/journal.pone.0046193	http://dx.doi.org/10.1371/journal.pone.0046193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049976	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100151
J	Terahara, N; Sano, M; Ito, M				Terahara, Naoya; Sano, Motohiko; Ito, Masahiro			A Bacillus Flagellar Motor That Can Use Both Na+ and K+ as a Coupling Ion Is Converted by a Single Mutation to Use Only Na+	PLOS ONE			English	Article							ALKALIPHILIC BACILLUS; PH HOMEOSTASIS; FIRMUS OF4; K+/H+ ANTIPORTER; PSEUDOFIRMUS OF4; MOTILITY; TRANSPORT; H+; SUBTILIS; EXPRESSION	In bacteria, the sodium ion (Na+) cycle plays a critical role in negotiating the challenges of an extremely alkaline and sodium-rich environment. Alkaliphilic bacteria that grow optimally at high pH values use Na+ for solute uptake and flagellar rotation because the proton (H+) motive force is insufficient for use at extremely alkaline pH. Only three types of electrically driven rotary motors exist in nature: the F-type ATPase, the V-type ATPase, and the bacterial flagellar motor. Until now, only H+ and Na+ have been reported as coupling ions for these motors. Here, we report that the alkaliphilic bacterium Bacillus alcalophilus Vedder 1934 can grow not only under a Na+-rich and potassium ion (K+)-poor condition but also under the opposite condition in an extremely alkaline environment. In this organism, swimming performance depends on concentrations of Na+, K+ or Rb+. In the absence of Na+, swimming behavior is clearly K+-dependent. This pattern was confirmed in swimming assays of stator-less Bacillus subtilis and Escherichia coli mutants expressing MotPS from B. alcalophilus (BA-MotPS). Furthermore, a single mutation in BA-MotS was identified that converted the naturally bi-functional BA-MotPS to stators that cannot use K+ or Rb+. This is the first report that describes a flagellar motor that can use K+ and Rb+ as coupling ions. The finding will affect the understanding of the operating principles of flagellar motors and the molecular mechanisms of ion selectivity, the field of the evolution of environmental changes and stresses, and areas of nanotechnology.	[Sano, Motohiko; Ito, Masahiro] Toyo Univ, Grad Sch Life Sci, Kawagoe, Saitama, Japan; [Terahara, Naoya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Ito, Masahiro] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University; Osaka University; Toyo University	Ito, M (corresponding author), Toyo Univ, Grad Sch Life Sci, Kawagoe, Saitama, Japan.	masahiro.ito@toyo.jp	ITO, MASAHIRO/H-1960-2013; Terahara, Naoya/AAA-2929-2021	ITO, MASAHIRO/0000-0002-4976-762X; Terahara, Naoya/0000-0002-2849-0756	Ministry of Education, Culture, Sports, Science and Technology of Japan [21370074]; Grants-in-Aid for Scientific Research [10J01439] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Strategic Research Foundation Grant-aided for Private Universities and Grant-in-Aid for Scientific Research (B) No. 21370074 of the Ministry of Education, Culture, Sports, Science and Technology of Japan was awarded to MI. NT is a Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO R, 1992, BIOSCI BIOTECH BIOCH, V56, P48, DOI 10.1271/bbb.56.48; Asai Y, 2000, EMBO J, V19, P3639, DOI 10.1093/emboj/19.14.3639; Atsumi T, 1996, J BACTERIOL, V178, P5024, DOI 10.1128/jb.178.16.5024-5026.1996; BAKKER EP, 1993, ALKALI CATION TRANSP, P00205; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; Castagna M, 1998, P NATL ACAD SCI USA, V95, P5395, DOI 10.1073/pnas.95.9.5395; Che YS, 2008, J BACTERIOL, V190, P6660, DOI 10.1128/JB.00503-08; CLEJAN S, 1989, J BACTERIOL, V171, P1744, DOI 10.1128/jb.171.3.1744-1746.1989; DEMOT R, 1994, MOL MICROBIOL, V12, P333; DOW JAT, 1984, AM J PHYSIOL, V246, pR633, DOI 10.1152/ajpregu.1984.246.4.R633; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Dzioba-Winogrodzki J, 2009, J MOL MICROB BIOTECH, V16, P176, DOI 10.1159/000119547; EPSTEIN W, 1993, BIOCHEM SOC T, V21, P1006, DOI 10.1042/bst0211006; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Fujinami S, 2007, ARCH MICROBIOL, V187, P239, DOI 10.1007/s00203-006-0192-7; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; GRUNDY FJ, 1994, J BACTERIOL, V176, P4527, DOI 10.1128/JB.176.15.4527-4533.1994; GUFFANTI AA, 1979, J BIOL CHEM, V254, P1033; GUFFANTI AA, 1981, P NATL ACAD SCI-BIOL, V78, P1481, DOI 10.1073/pnas.78.3.1481; GUZMAN CA, 1994, GENE, V148, P171, DOI 10.1016/0378-1119(94)90254-2; Harvey WR, 2009, J EXP BIOL, V212, P1620, DOI 10.1242/jeb.031534; HENNIGAN BB, 1993, BIOCHIM BIOPHYS ACTA, V1148, P209, DOI 10.1016/0005-2736(93)90131-I; HIROTA N, 1983, J BIOL CHEM, V258, P577; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Ito M, 2005, J MOL BIOL, V352, P396, DOI 10.1016/j.jmb.2005.07.030; Ito M, 2004, MOL MICROBIOL, V53, P1035, DOI 10.1111/j.1365-2958.2004.04173.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Ito M, 1997, EXTREMOPHILES, V1, P22, DOI 10.1007/s007920050011; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kitada M, 2000, EXTREMOPHILES, V4, P253, DOI 10.1007/s007920070010; KITADA M, 1987, J BACTERIOL, V169, P5761, DOI 10.1128/jb.169.12.5761-5765.1987; Kitada M, 1997, EXTREMOPHILES, V1, P135, DOI 10.1007/s007920050026; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Krulwich T, 2010, ADAPTIVE MECH EXTREM; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; McCarter LL, 2005, J BACTERIOL, V187, P1207, DOI 10.1128/JB.187.4.1207-1209.2005; Ohkuma Moriya, 2003, Microbes and Environments, V18, P145, DOI 10.1264/jsme2.18.145; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x; Radchenko MV, 2006, MOL MICROBIOL, V59, P651, DOI 10.1111/j.1365-2958.2005.04966.x; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Southworth TW, 2001, J BACTERIOL, V183, P5896, DOI 10.1128/JB.183.20.5896-5903.2001; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; SUGIYAMA S, 1985, FEBS LETT, V182, P265, DOI 10.1016/0014-5793(85)80312-4; Swartz TH, 2007, J BACTERIOL, V189, P3081, DOI 10.1128/JB.00021-07; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Vedder A., 1934, ANTON LEEUW INT J G, V1, P143; Wei Y, 2003, J BACTERIOL, V185, P5133, DOI 10.1128/JB.185.17.5133-5147.2003	52	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46248	10.1371/journal.pone.0046248	http://dx.doi.org/10.1371/journal.pone.0046248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049994	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100166
J	Ma, G; Yasunaga, J; Fan, J; Yanagawa, S; Matsuoka, M				Ma, G.; Yasunaga, J.; Fan, J.; Yanagawa, S.; Matsuoka, M.			HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells	ONCOGENE			English	Article						HTLV-1; HBZ; Tax; DAPLE; Wnt signaling pathway; Wnt5a	NF-KAPPA-B; VIRUS TYPE-1; BETA-CATENIN; SIGNALING PATHWAY; TGF-BETA; TRANSCRIPTION FACTOR; VIRAL TRANSCRIPTION; BINDING PROTEIN; ISOMERASE PIN1; IN-VIVO	Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ), the viral gene transcribed from the antisense strand, is consistently expressed in ATL cells and promotes their proliferation. In this study, we found that a Wnt pathway-related protein, disheveled-associating protein with a high frequency of leucine residues (DAPLE), interacts with both HTLV-1 Tax and HBZ. In the presence of DAPLE, Tax activated canonical Wnt signaling. Conversely, HBZ markedly suppressed canonical Wnt activation induced by either Tax/DAPLE or beta-catenin. As a mechanism of HBZ-mediated Wnt suppression, we found that HBZ targets lymphoid enhancer-binding factor 1, one of the key transcription factors of the pathway, and impairs its DNA-binding ability. We also observed that the canonical Wnt pathway was not activated in HTLV-1-infected cells, whereas the representative of noncanonical Wnt ligand, Wnt5a, which antagonizes canonical Wnt signaling, was overexpressed. HBZ was able to induce Wnt5a transcription by enhancing its promoter activity through the TGF-beta pathway. Importantly, knocking down of Wnt5a in ATL cells repressed cellular proliferation and migration. Our results implicate novel roles of HBZ in ATL leukemogenesis through dysregulation of both the canonical and noncanonical Wnt pathways.	[Ma, G.; Yasunaga, J.; Fan, J.; Matsuoka, M.] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 6068507, Japan; [Yanagawa, S.] Kyoto Univ, Inst Virus Res, Lab Gene Anal, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Yasunaga, J (corresponding author), Kyoto Univ, Inst Virus Res, Lab Virus Control, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	jyasunag@virus.kyoto-u.ac.jp		Matsuoka, Masao/0000-0002-0473-754X; Yasunaga, Jun-ichirou/0000-0002-7939-2080	Ministry of Education, Science, Sports, and Culture of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22114003, 221S0001] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H Miyoshi for providing lentiviral packaging vectors and L Kingsbury for proofreading of this manuscript. This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan to MM, and a grant from the Takeda Science Foundation to JY.	Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Clerc I, 2008, J BIOL CHEM, V283, P23903, DOI 10.1074/jbc.M803116200; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Driessens G, 2011, J IMMUNOL, V186, P784, DOI 10.4049/jimmunol.1001562; Fan J, 2005, CANCER RES, V65, P6927, DOI 10.1158/0008-5472.CAN-04-3495; Franchini G, 2003, INT J HEMATOL, V78, P280, DOI 10.1007/BF02983552; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Oshita A, 2003, GENES CELLS, V8, P1005, DOI 10.1111/j.1365-2443.2003.00692.x; Peloponese JM, 2009, J VIROL, V83, P3238, DOI 10.1128/JVI.01824-08; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Saito M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-19; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Shackelford J, 2003, P NATL ACAD SCI USA, V100, P15572, DOI 10.1073/pnas.2636947100; Shibamoto S, 1998, GENES CELLS, V3, P659; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Sukarawan W, 2010, AM J PATHOL, V176, P461, DOI 10.2353/ajpath.2010.090478; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Tezuka N, 2007, BIOCHEM BIOPH RES CO, V356, P648, DOI 10.1016/j.bbrc.2007.03.019; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yanagawa S, 2000, FEBS LETT, V474, P189, DOI 10.1016/S0014-5793(00)01601-X; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	61	51	54	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 5	2013	32	36					4222	4230		10.1038/onc.2012.450	http://dx.doi.org/10.1038/onc.2012.450			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045287	Green Submitted			2022-12-25	WOS:000324168000004
J	Duan, YY; Sun, Y; Zhang, F; Zhang, WK; Wang, D; Wang, Y; Cao, X; Hu, WB; Xie, CY; Cuppoletti, J; Magin, TM; Wang, HX; Wu, ZG; Li, N; Huang, PB				Duan, Yuanyuan; Sun, Ying; Zhang, Fan; Zhang, Wei Kevin; Wang, Dong; Wang, Yan; Cao, Xu; Hu, Wenbao; Xie, Changyan; Cuppoletti, John; Magin, Thomas M.; Wang, Haixia; Wu, Zhenguo; Li, Ning; Huang, Pingbo			Keratin K18 Increases Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Surface Expression by Binding to Its C-terminal Hydrophobic Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; INTERMEDIATE-FILAMENTS; PLASMA-MEMBRANE; MACROMOLECULAR COMPLEXES; APICAL MEMBRANE; PROTEIN-KINASE; MUTATION; MOUSE; LOCALIZATION; CYTOSKELETON	Malfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) leads to cystic fibrosis, but the regulation of CFTR is not fully understood. Here, we identified the intermediate filament protein keratin K18 (K18) as a CFTR-binding protein by various approaches. We mapped a highly conserved "hydrophobic patch" ((FLVI1416)-F-1413) in the CFTR C-terminus, known to determine plasmalemmal CFTR stability, as the K18-binding site. On the other hand, the C-terminal tail of K18 was found to be a critical determinant for binding CFTR. Overexpression of K18 in cells robustly increased the surface expression of wild-type CFTR, whereas depletion of K18 through RNA interference specifically diminished it. K18 binding increased the surface expression of CFTR by accelerating its apical recycling rate without altering CFTR biosynthesis, maturation, or internalization. Importantly, CFTR surface expression was markedly reduced in duodenal and gallbladder epithelia of K18(-/-) mice. Taken together, our results suggest that K18 increases the cell surface expression of CFTR by interacting with the CFTR C-terminal hydrophobic patch. These findings offer novel insights into the regulation of CFTR and suggest that K18 and its dimerization partner, K8, may be modifier genes in cystic fibrosis.	[Duan, Yuanyuan; Sun, Ying; Zhang, Fan; Zhang, Wei Kevin; Wang, Dong; Wang, Yan; Cao, Xu; Hu, Wenbao; Xie, Changyan; Wang, Haixia; Wu, Zhenguo; Li, Ning; Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Wu, Zhenguo; Huang, Pingbo] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Cuppoletti, John] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Magin, Thomas M.] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany; [Magin, Thomas M.] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04103 Leipzig, Germany	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University System of Ohio; University of Cincinnati; Leipzig University; Leipzig University	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	bohuangp@ust.hk	Huang, Pingbo/I-1127-2019; Zhang, Fan/AAB-1175-2020; Zhang, Wei/M-4241-2019; Sun, Ying/F-9124-2019	Huang, Pingbo/0000-0002-4560-8760; Zhang, Wei/0000-0003-4960-6137; Wu, Zhenguo/0000-0003-3049-8324; ZHANG, FAN/0000-0002-7186-6317	Hong Kong Research Grants Council [GRF661008]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grants Council Grant GRF661008 (to P. H.).	Ameen NA, 2001, J CELL SCI, V114, P563; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Davezac N, 2004, PROTEOMICS, V4, P3833, DOI 10.1002/pmic.200400850; Davidson D J, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002551; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dickinson P, 2002, HUM MOL GENET, V11, P243, DOI 10.1093/hmg/11.3.243; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; Gentzsch M, 2002, BIOCHEM J, V366, P541, DOI 10.1042/BJ20020511; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Izawa I, 2000, J BIOL CHEM, V275, P34521, DOI 10.1074/jbc.M003492200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Magin TM, 2004, EXP CELL RES, V301, P91, DOI 10.1016/j.yexcr.2004.08.018; Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729; Milewski MI, 2005, FEBS LETT, V579, P483, DOI 10.1016/j.febslet.2004.11.106; Milewski MI, 2001, J CELL SCI, V114, P719; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140; Salas PJI, 1999, J CELL BIOL, V146, P645, DOI 10.1083/jcb.146.3.645; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Stanke F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-62; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Turvy D N, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1807s36; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Vijayaraj Preethi, 2007, Methods Mol Biol, V360, P203; Vijayaraj P, 2010, EUR J CELL BIOL, V89, P299, DOI 10.1016/j.ejcb.2009.10.016; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Wald FA, 2005, MOL BIOL CELL, V16, P4096, DOI 10.1091/mbc.e05-03-0242; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655	54	22	23	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40547	40559		10.1074/jbc.M112.403584	http://dx.doi.org/10.1074/jbc.M112.403584			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045527	Green Published, hybrid			2022-12-25	WOS:000311448800045
J	Munoz, MC; Laulier, C; Gunn, A; Cheng, A; Robbiani, DF; Nussenzweig, A; Stark, JM				Munoz, Meilen C.; Laulier, Corentin; Gunn, Amanda; Cheng, Anita; Robbiani, Davide F.; Nussenzweig, Andre; Stark, Jeremy M.			Ring Finger Nuclear Factor RNF168 Is Important for Defects in Homologous Recombination Caused by Loss of the Breast Cancer Susceptibility Factor BRCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLASS SWITCH RECOMBINATION; MAMMALIAN-CELLS; DNA-DAMAGE; DIRECTED REPAIR; IONIZING-RADIATION; GENOMIC STABILITY; END RESECTION; GENE BRCA1; 53BP1	The RING finger nuclear factor RNF168 is required for recruitment of several DNA damage response factors to double strand breaks (DSBs), including 53BP1 and BRCA1. Because 53BP1 and BRCA1 function antagonistically during the DSB repair pathway homologous recombination (HR), the influence of RNF168 on HR has been unclear. We report that RNF168 depletion causes an elevated frequency of two distinct HR pathways (homology-directed repair and single strand annealing), suppresses defects in HR caused by BRCA1 silencing, but does not suppress HR defects caused by disruption of CtIP, RAD50, BRCA2, or RAD51. Furthermore, RNF168-depleted cells can form ionizing radiation-induced foci of the recombinase RAD51 without forming BRCA1 ionizing radiation-induced foci, indicating that this loss of BRCA1 recruitment to DSBs does not reflect a loss of function during HR. Additionally, we find that RNF168 and 53BP1 have a similar influence on HR. We suggest that RNF168 is important for HR defects caused by BRCA1 loss.	[Munoz, Meilen C.; Laulier, Corentin; Gunn, Amanda; Cheng, Anita; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, Duarte, CA 91010 USA; [Munoz, Meilen C.; Gunn, Amanda; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Andre] NCI, Lab Genome Integr, Bethesda, MD 20892 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stark, JM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jstark@coh.org		Robbiani, Davide F./0000-0001-7379-3484	National Institutes of Health [RO1CA120954]; Marsha Rivkin Center for Ovarian Cancer Research; University of California [181B-0046]; NATIONAL CANCER INSTITUTE [R01CA120954, ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA120954 (to J. M. S.). This work was also supported by the Marsha Rivkin Center for Ovarian Cancer Research and by Regents of the University of California Breast Cancer Research Program Grant 181B-0046 (to J. M. S.).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Gunn A, 2011, J BIOL CHEM, V286, P42470, DOI 10.1074/jbc.M111.309252; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Laulier C, 2011, NUCLEIC ACIDS RES, V39, P5935, DOI 10.1093/nar/gkr187; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	56	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40618	40628		10.1074/jbc.M112.410951	http://dx.doi.org/10.1074/jbc.M112.410951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055523	hybrid, Green Published			2022-12-25	WOS:000311448800051
J	Xu, XS; Keshwani, M; Meyer, K; Sarikas, A; Taylor, S; Pan, ZQ				Xu, Xinsong; Keshwani, Malik; Meyer, Kathleen; Sarikas, Antonio; Taylor, Susan; Pan, Zhen-Qiang			Identification of the Degradation Determinants of Insulin Receptor Substrate 1 for Signaling Cullin-RING E3 Ubiquitin Ligase 7-mediated Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISITE PHOSPHORYLATION; TUBEROUS SCLEROSIS; MTOR; GROWTH; COMPLEX; CUL7; IRS1; INHIBITION; MECHANISM; MUSCLE	Hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) and its effector kinase S6 kinase 1 (S6K1) is known to trigger multisite seryl phosphorylation of insulin receptor substrate 1 (IRS1), leading to its ubiquitination and degradation. This negative feedback inhibition functions to restrain PI3K activity and plays critical roles in the pathogenesis of cancer and type II diabetes. Recent work has implicated a role for cullin-RING E3 ubiquitin ligase 7 (CRL7) in targeting IRS1 for mTORC1/S6K1-dependent degradation. In the present study we have employed both cell-based degradation and reconstituted ubiquitination approaches to define molecular features associated with IRS1 critical for CRL7-mediated ubiquitination and degradation. We have mapped IRS1 degradation signal sequence to its N-terminal 574 amino acid residues, of which the integrity of Ser-307/Ser-312 and Ser-527, each constituting a S6K1 phosphorylation consensus site, was indispensible for supporting CRL7-forced degradation. In vitro, S6K1 was able to support the ubiquitination of bacterially expressed IRS1 N-terminal fragment by CRL7 but at low levels. In contrast, CRL7 supported efficient ubiquitination of IRS1 N-terminal fragment in hyperphosphorylated form, which was isolated from infected insect cells, suggesting requirement of additional phosphorylation by kinases yet to be identified. Finally, removal of IRS1 amino acids 1-260 led to substantial reduction of ubiquitination efficiency, suggesting a role for this region in mediating productive interactions with CRL7. The requirement of multisite phosphorylation and the N terminus of IRS1 for its turnover may ensure that complete IRS1 degradation occurs only when mTORC1 and S6K1 reach exceedingly high levels.	[Xu, Xinsong; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Keshwani, Malik; Taylor, Susan] Univ Calif San Diego, Dept Pharmacol, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Meyer, Kathleen; Sarikas, Antonio] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany	Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of California System; University of California San Diego; Technical University of Munich	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Meyer, Kathleen/ABA-4397-2020	Meyer, Kathleen/0000-0002-5128-3616	National Institutes of Health [CA095634, GM61051, DK054441]; German Research Foundation [SA 1706/3-1]; Marie Curie International Reintegration Grant [256584]; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Marie Curie International Reintegration Grant(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA095634 and GM61051 (to Z.-Q. P.), as well as DK054441 to S.T.; Supported by Research Grant SA 1706/3-1 from the German Research Foundation and Marie Curie International Reintegration Grant 256584.	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fisher TL, 2004, CURR BIOL, V14, pR1005, DOI 10.1016/j.cub.2004.11.024; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Huber C, 2009, EUR J HUM GENET, V17, P395, DOI 10.1038/ejhg.2008.200; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ponyeam W, 2012, CELL SIGNAL, V24, P290, DOI 10.1016/j.cellsig.2011.08.020; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2005, CELL CYCLE, V4, P46, DOI 10.4161/cc.4.1.1343; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	28	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40758	40766		10.1074/jbc.M112.405209	http://dx.doi.org/10.1074/jbc.M112.405209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045529	hybrid, Green Published			2022-12-25	WOS:000311448800064
J	Hilgen, G; Huebner, AK; Tanimoto, N; Sothilingam, V; Seide, C; Garrido, MG; Schmidt, KF; Seeliger, MW; Lowel, S; Weiler, R; Hubner, CA; Dedek, K				Hilgen, Gerrit; Huebner, Antje K.; Tanimoto, Naoyuki; Sothilingam, Vithiyanjali; Seide, Christina; Garrido, Marina Garcia; Schmidt, Karl-Friedrich; Seeliger, Mathias W.; Loewel, Siegrid; Weiler, Reto; Huebner, Christian A.; Dedek, Karin			Lack of the Sodium-Driven Chloride Bicarbonate Exchanger NCBE Impairs Visual Function in the Mouse Retina	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; SLC4A10 SPLICE VARIANTS; BIPOLAR CELLS; HORIZONTAL CELLS; DEVELOPMENTAL EXPRESSION; COTRANSPORTER KCC2; CL-/HCO3-EXCHANGER; INTRACELLULAR PH; GANGLION-CELLS; RESPONSES	Regulation of ion and pH homeostasis is essential for normal neuronal function. The sodium-driven chloride bicarbonate exchanger NCBE (Slc4a10), a member of the SLC4 family of bicarbonate transporters, uses the transmembrane gradient of sodium to drive cellular net uptake of bicarbonate and to extrude chloride, thereby modulating both intracellular pH (pH(i)) and chloride concentration ([Cl-](i)) in neurons. Here we show that NCBE is strongly expressed in the retina. As GABA(A) receptors conduct both chloride and bicarbonate, we hypothesized that NCBE may be relevant for GABAergic transmission in the retina. Importantly, we found a differential expression of NCBE in bipolar cells: whereas NCBE was expressed on ON and OFF bipolar cell axon terminals, it only localized to dendrites of OFF bipolar cells. On these compartments, NCBE colocalized with the main neuronal chloride extruder KCC2, which renders GABA hyperpolarizing. NCBE was also expressed in starburst amacrine cells, but was absent from neurons known to depolarize in response to GABA, like horizontal cells. Mice lacking NCBE showed decreased visual acuity and contrast sensitivity in behavioral experiments and smaller b-wave amplitudes and longer latencies in electroretinograms. Ganglion cells from NCBE-deficient mice also showed altered temporal response properties. In summary, our data suggest that NCBE may serve to maintain intracellular chloride and bicarbonate concentration in retinal neurons. Consequently, lack of NCBE in the retina may result in changes in pH(i) regulation and chloride-dependent inhibition, leading to altered signal transmission and impaired visual function.	[Huebner, Antje K.; Huebner, Christian A.] Univ Hosp Jena, Inst Human Genet, Jena, Germany; [Hilgen, Gerrit; Weiler, Reto; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Tanimoto, Naoyuki; Sothilingam, Vithiyanjali; Seide, Christina; Garrido, Marina Garcia; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Schmidt, Karl-Friedrich; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	Friedrich Schiller University of Jena; Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Hubner, CA (corresponding author), Univ Hosp Jena, Inst Human Genet, Jena, Germany.	christian.huebner@mti.uni-jena.de; karin.dedek@uni-oldenburg.de	Hübner, Christian/A-2950-2017; Hilgen, Gerrit/AAF-5649-2021; Dedek, Karin/R-6948-2018	Hübner, Christian/0000-0002-1030-4943; Hilgen, Gerrit/0000-0001-5008-5493; Dedek, Karin/0000-0003-1490-0141	Deutsche Forschungsgemeinschaft [We849/16-1/2, Se837/5-2, 6-1/2, Hu800/4-1, 5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de; We849/16-1/2 to KD and RW, Se837/5-2 and 6-1/2 to MWS, and Hu800/4-1 and 5-1 to CAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Blanco R, 1996, VISION RES, V36, P3987, DOI 10.1016/S0042-6989(96)00145-9; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Carcieri SM, 2003, J NEUROPHYSIOL, V90, P1704, DOI 10.1152/jn.00127.2003; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; Dmitriev AV, 2007, VISUAL NEUROSCI, V24, P635, DOI 10.1017/S0952523807070629; Dmitriev AV, 2004, J NEUROPHYSIOL, V91, P2404, DOI 10.1152/jn.00881.2003; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; EXCHANGER SLCJ, 2008, J NEUROSCI, V31, P7300; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; FIVE M, JOURNAL OF BIOLOGICA, V275, P1247; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; HU B, 2001, NEURON, V30, P515; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichinose T, 2005, J PHYSIOL-LONDON, V565, P517, DOI 10.1113/jphysiol.2005.083436; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Lee J, 1996, BRAIN RES, V706, P210, DOI 10.1016/0006-8993(95)01214-1; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Li BQ, 2008, VISUAL NEUROSCI, V25, P109, DOI 10.1017/S0952523808080164; Liu Y, 2010, NEUROSCIENCE, V169, P951, DOI 10.1016/j.neuroscience.2010.06.005; Liu Y, 2011, BRAIN RES, V1390, P33, DOI 10.1016/j.brainres.2011.03.046; Mataruga A, 2007, J COMP NEUROL, V502, P1123, DOI 10.1002/cne.21367; MCALEAR SD, 2004, ADV MOL CEL, V31, P707; MILLER RF, 1983, VISION RES, V23, P399, DOI 10.1016/0042-6989(83)90087-1; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Sinning A, 2011, J NEUROSCI, V31, P7300, DOI 10.1523/JNEUROSCI.0269-11.2011; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; TRU M, 2008, JOURNAL OF NEUROSCIE, V28, P6818, DOI DOI 10.1167/IOVS.09-3724; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Vardi N, 2000, J NEUROSCI, V20, P7657; Vardi Noga, 2002, Keio Journal of Medicine, V51, P154; Vu TQ, 2000, J NEUROSCI, V20, P1414; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wu S M, 1991, Neurosci Res Suppl, V15, pS117; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100; Zhang RW, 2010, J PHYSIOL-LONDON, V588, P2557, DOI 10.1113/jphysiol.2010.187088	60	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46155	10.1371/journal.pone.0046155	http://dx.doi.org/10.1371/journal.pone.0046155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056253	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000309889400010
J	Mori, S; Bernardi, R; Laurent, A; Resnati, M; Crippa, A; Gabrieli, A; Keough, R; Gonda, TJ; Blasi, F				Mori, Silvia; Bernardi, Rosa; Laurent, Audrey; Resnati, Massimo; Crippa, Ambra; Gabrieli, Arianna; Keough, Rebecca; Gonda, Thomas J.; Blasi, Francesco			Myb-Binding Protein 1A (MYBBP1A) Is Essential for Early Embryonic Development, Controls Cell Cycle and Mitosis, and Acts as a Tumor Suppressor	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PREP1; P53; NUCLEOLUS; NORMALIZATION; ACETYLATION; REPRESSOR; SUMMARIES; P38	MYBBP1A is a predominantly nucleolar transcriptional regulator involved in rDNA synthesis and p53 activation via acetylation. However little further information is available as to its function. Here we report that MYBBP1A is developmentally essential in the mouse prior to blastocyst formation. In cell culture, down-regulation of MYBBP1A decreases the growth rate of wild type mouse embryonic stem cells, mouse embryo fibroblasts (MEFs) and of human HeLa cells, where it also promotes apoptosis. HeLa cells either arrest at G2/M or undergo delayed and anomalous mitosis. At mitosis, MYBBP1A is localized to a parachromosomal region and gene-expression profiling shows that its down-regulation affects genes controlling chromosomal segregation and cell cycle. However, MYBBP1A down-regulation increases the growth rate of the immortalized NIH3T3 cells. Such Mybbp1a down-regulated NIH3T3 cells are more susceptible to Ras-induced transformation and cause more potent Ras-driven tumors. We conclude that MYBBP1A is an essential gene with novel roles at the pre-mitotic level and potential tumor suppressor activity.	[Mori, Silvia; Bernardi, Rosa; Blasi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy; [Bernardi, Rosa; Resnati, Massimo; Crippa, Ambra] Ist Sci San Raffaele, I-20132 Milan, Italy; [Laurent, Audrey; Gabrieli, Arianna; Blasi, Francesco] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Keough, Rebecca] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Gonda, Thomas J.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Keough, Rebecca; Gonda, Thomas J.] Inst Med & Vet Sci, Div Human Immunol, Adelaide, SA 5000, Australia; [Keough, Rebecca; Gonda, Thomas J.] Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5000, Australia	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Flinders University South Australia; University of Queensland; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia	Blasi, F (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	francesco.blasi@ifom-ieo-campus.it	Massimo, Resnati/AAN-5854-2020; bernardi, rosa/B-1650-2013; Mori, Silvia/K-1454-2016	Massimo, Resnati/0000-0002-4804-4569; bernardi, rosa/0000-0002-3607-6336; Mori, Silvia/0000-0001-5049-756X; Blasi, Francesco/0000-0001-9406-1784; LAURENT, Audrey/0000-0002-7643-6017; Gonda, Thomas/0000-0002-8792-3021; Gabrieli, Arianna/0000-0002-2657-8025	Associazione Italiana Ricerche sul Cancro (AIRC) [8929]; European Community [201681]; Australian National Health and Medical Research Council [ID000115]	Associazione Italiana Ricerche sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Associazione Italiana Ricerche sul Cancro (AIRC) grant 8929 and European Community FP7 201681 "Prepobedia'' to FB, the Australian National Health and Medical Research Council to RK and TJG (project ID000115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312; Qian HR, 2005, GENOMICS, V86, P495, DOI 10.1016/j.ygeno.2005.06.007; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Shih RSM, 2008, EXP BIOL MED, V233, P317, DOI 10.3181/0708-RM-220; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; Tolstonog GV, 2009, NAT STRUCT MOL BIOL, V16, P900, DOI 10.1038/nsmb0909-900; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x	30	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e39723	10.1371/journal.pone.0039723	http://dx.doi.org/10.1371/journal.pone.0039723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056166	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500002
J	Vallabhaneni, S; Li, X; Vittinghoff, E; Donnell, D; Pilcher, CD; Buchbinder, SP				Vallabhaneni, Snigdha; Li, Xin; Vittinghoff, Eric; Donnell, Deborah; Pilcher, Christopher D.; Buchbinder, Susan P.			Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men	PLOS ONE			English	Article							GAY MEN; INFECTION; BEHAVIORS; VACCINE; INCREASE; SYDNEY	Background: Although efficacy is unknown, many men who have sex with men (MSM) attempt to reduce HIV risk by adapting condom use, partner selection, or sexual position to the partner's HIV serostatus. We assessed the association of seroadaptive practices with HIV acquisition. Methodology/Principal Findings: We pooled data on North American MSM from four longitudinal HIV-prevention studies. Sexual behaviors reported during each six-month interval were assigned sequentially to one of six mutually exclusive risk categories: (1) no unprotected anal intercourse (UAI), (2) having a single negative partner, (3) being an exclusive top (only insertive anal sex), (4) serosorting (multiple partners, all HIV negative), (5) seropositioning (only insertive anal sex with potentially discordant partners), and (6) UAI with no seroadaptive practices. HIV antibody testing was conducted at the end of each interval. We used Cox models to evaluate the independent association of each category with HIV acquisition, controlling for number of partners, age, race, drug use, and intervention assignment. 12,277 participants contributed to 60,162 six-month intervals with 663 HIV seroconversions. No UAI was reported in 47.4% of intervals, UAI with some seroadaptive practices in 31.8%, and UAI with no seroadaptive practices in 20.4%. All seroadaptive practices were associated with a lower risk, compared to UAI with no seroadaptive practices. However, compared to no UAI, serosorting carried twice the risk (HR = 2.03, 95% CI: 1.51-2.73), whereas seropositioning was similar in risk (HR = 0.85, 95% CI: 0.50-1.44), and UAI with a single negative partner and as an exclusive top were both associated with a lower risk (HR = 0.56, 95% CI: 0.32-0.96 and HR = 0.55, 95% CI: 0.36-0.84, respectively). Conclusions/Significance: Seroadaptive practices appear protective when compared with UAI with no seroadaptive practices, but serosorting appears to be twice as risky as no UAI. Condom use and limiting number of partners should be advocated as first-line prevention strategies, but seroadaptive practices may be considered harm-reduction for men at greatest risk.	[Vallabhaneni, Snigdha; Vittinghoff, Eric; Pilcher, Christopher D.; Buchbinder, Susan P.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Li, Xin; Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Buchbinder, Susan P.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; San Francisco Department of Public Health	Vallabhaneni, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	snigdhav@gmail.com		Donnell, Deborah/0000-0002-0587-7480	National Institutes of Health [5R01AI083060-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI083060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by National Institutes of Health 5R01AI083060-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P689; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Elford J, 2007, AIDS, V21, P243, DOI 10.1097/QAD.0b013e3280118fdb; Golden M, 2011, 18 C RETR OPP INF BO; Golden M, 2012, 19 C RETR OPP INF SE; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Jin FY, 2012, SEX TRANSM DIS, V39, P191, DOI 10.1097/OLQ.0b013e3182401a2f; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kennedy CE, 2011, 6 IAS C HIV PATH TRE; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Le Talec J, 2008, 17 INT AIDS C MEX CI; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Pinkerton SD, 2008, AM J PREV MED, V35, P184, DOI 10.1016/j.amepre.2008.04.012; Snowden JM, 2009, SEX TRANSM INFECT, V85, P469, DOI 10.1136/sti.2009.036269; Thiede H, 2009, AM J PUBLIC HEALTH, V99, pS157, DOI 10.2105/AJPH.2006.098582; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003	25	91	92	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45718	10.1371/journal.pone.0045718	http://dx.doi.org/10.1371/journal.pone.0045718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056215	Green Submitted, Green Published, gold			2022-12-25	WOS:000309454000010
J	Schweizer, HP; Choi, KH				Schweizer, Herbert P.; Choi, Kyoung-Hee			Characterization of Molecular Mechanisms Controlling fabAB Transcription in Pseudomonas aeruginosa	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; RNA; FADR; PROTEIN; CLONING; DENITRIFICATION; RECOMBINATION; CONSTRUCTION	Background: The FabAB pathway is one of the unsaturated fatty acid (UFA) synthesis pathways for Pseudomonas aeruginosa. It was previously noted that this operon was upregulated in biofilms and repressed by exogenous UFAs. Deletion of a 30 nt fabA upstream sequence, which is conserved in P. aeruginosa, P. putida, and P. syringae, led to a significant decrease in fabA transcription, suggesting positive regulation by an unknown positive regulatory mechanism. Methods/Principal Findings: Here, genetic and biochemical approaches were employed to identify a potential fabAB activator. Deletion of candidate genes such as PA1611 or PA1627 was performed to determine if any of these gene products act as a fabAB activator. However, none of these genes were involved in the regulation of fabAB transcription. Use of mariner-based random mutagenesis to screen for fabA activator(s) showed that several genes encoding unknown functions, rpoN and DesA may be involved in fabA regulation, but probably via indirect mechanisms. Biochemical attempts performed did fail to isolate an activator of fabAB operon. Conclusion/Significance: The data suggest that fabA expression might not be regulated by protein-binding, but by a distinct mechanism such as a regulatory RNA-based mechanism.	[Choi, Kyoung-Hee] Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, Chonbuk, South Korea; [Schweizer, Herbert P.] Colorado State Univ, Dept Microbiol Immunol & Pathol, IDRC, Ft Collins, CO 80523 USA	Wonkwang University; Colorado State University	Choi, KH (corresponding author), Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, Chonbuk, South Korea.	kheechoi@wku.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0004068]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0004068). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton HA, 1996, MOL MICROBIOL, V21, P1001, DOI 10.1046/j.1365-2958.1996.381426.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CARLSON CA, 1983, APPL ENVIRON MICROB, V45, P1247, DOI 10.1128/AEM.45.4.1247-1253.1983; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; DAVIES KJP, 1989, J GEN MICROBIOL, V135, P2445; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LARSON TJ, 1982, J BACTERIOL, V152, P1008; Lu CD, 1999, J BACTERIOL, V181, P2459, DOI 10.1128/JB.181.8.2459-2464.1999; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Sambrook J., 2001, MOL CLONING; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	37	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45646	10.1371/journal.pone.0045646	http://dx.doi.org/10.1371/journal.pone.0045646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056212	gold, Green Submitted, Green Published			2022-12-25	WOS:000309452600014
J	Gorman, S; Scott, NM; Tan, DHW; Weeden, CE; Tuckey, RC; Bisley, JL; Grimbaldeston, MA; Hart, PH				Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Tuckey, Robert C.; Bisley, Jacqueline L.; Grimbaldeston, Michele A.; Hart, Prue H.			Acute Erythemal Ultraviolet Radiation Causes Systemic Immunosuppression in the Absence of Increased 25-Hydroxyvitamin D-3 Levels in Male Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; VITAMIN-D; UV-RADIATION; CONTACT HYPERSENSITIVITY; MURINE SKIN; IN-VITRO; T-CELLS; IRRADIATION; SUPPRESSION; SUSCEPTIBILITY	Vitamin D is synthesised by ultraviolet (UV) irradiation of skin and is hypothesized to be a direct mediator of the immunosuppression that occurs following UV radiation (UVR) exposure. Both UVR and vitamin D drive immune responses towards tolerance by ultimately increasing the suppressive activities of regulatory T cells. To examine a role for UVR-induced vitamin D, vitamin D-3-deficient mice were established by dietary vitamin D-3 restriction. In comparison to vitamin D-3-replete mice, vitamin D-3-deficient mice had significantly reduced serum levels of 25-hydroxyvitamin D-3 (25(OH)D-3, < 20 nmol.L-1) and 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3, < 20 pmol.L-1). Following either acute erythemal UVR, or chronic sub-erythemal UVR (8 exposures over 4 weeks) treatment, serum 25(OH)D-3 levels significantly increased in vitamin D-3-deficient female but not male mice. To determine if UVR-induced vitamin D was a mediator of UVR-induced systemic immunosuppression, responses were measured in mice that were able (female) or unable (male) to increase systemic levels of 25(OH)D-3 after UVR. Erythemal UVR (>= 4 kJ/m(2)) suppressed contact hypersensitivity responses (T helper type-1 or -17), aspects of allergic airway disease (T helper type-2) and also the in vivo priming capacity of bone marrow-derived dendritic cells to a similar degree in female and male vitamin D-3-deficient mice. Thus, in male mice, UVR-induced 25(OH)D-3 is not essential for mediating the immunosuppressive effects of erythemal UVR.	[Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Bisley, Jacqueline L.; Hart, Prue H.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Bisley, Jacqueline L.; Hart, Prue H.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Tuckey, Robert C.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Grimbaldeston, Michele A.] SA Pathol, Div Human Immunol, Ctr Canc Biol, Adelaide, SA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Centre for Cancer Biology; SA Pathology	Gorman, S (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	shelleyg@ichr.uwa.edu.au	Gorman, Shelley/E-1649-2013; Scott, Naomi/R-9951-2017; Gorman, Shelley/R-9953-2017; Tuckey, Robert/H-5983-2014	Gorman, Shelley/0000-0002-7111-6735; Hart, Prue/0000-0001-7207-6467; Tuckey, Robert/0000-0002-5022-4729; Weeden, Clare/0000-0002-1561-1416	National Health and Medical Research Council of Australia [458612]; Cancer Council of Western Australia [1008985]; Asthma Foundation of Western Australia; Raine Foundation; BrightSpark Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Asthma Foundation of Western Australia; Raine Foundation; BrightSpark Foundation	This study was supported by grants from the National Health and Medical Research Council of Australia (#458612, PHH), the Cancer Council of Western Australia (#1008985, PHH and SG), the Asthma Foundation of Western Australia (SG and PHH), the Raine Foundation (SG and PHH), and the BrightSpark Foundation (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Ellison TI, 2008, J INVEST DERMATOL, V128, P2508, DOI 10.1038/jid.2008.131; Ghoreishi M, 2006, J IMMUNOL, V176, P2635, DOI 10.4049/jimmunol.176.4.2635; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Gorman S, 2007, J INVEST DERMATOL, V127, P915, DOI 10.1038/sj.jid.5700600; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Gorman S, 2010, IMMUNOLOGY, V131, P415, DOI 10.1111/j.1365-2567.2010.03315.x; Gorman S, 2010, J STEROID BIOCHEM, V121, P247, DOI 10.1016/j.jsbmb.2010.02.034; Halliday GM, 2010, J INVEST DERMATOL, V130, P1209, DOI 10.1038/jid.2009.374; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; HAUSER SL, 1984, J IMMUNOL, V132, P1276; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Kelly DA, 2000, J EXP MED, V191, P561, DOI 10.1084/jem.191.3.561; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Lehmann B, 2003, ARCH DERMATOL RES, V295, P24, DOI 10.1007/s00403-003-0387-6; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; McGlade JP, 2007, J IMMUNOL, V178, P2794, DOI 10.4049/jimmunol.178.5.2794; MIYAUCHI H, 1995, J INVEST DERMATOL, V104, P364, DOI 10.1111/1523-1747.ep12665832; Moghaddami M, 2012, IMMUNOL CELL BIOL, V90, P168, DOI 10.1038/icb.2011.22; Ng RLX, 2010, J IMMUNOL, V185, P7207, DOI 10.4049/jimmunol.1001693; Norval M, 2006, PROG BIOPHYS MOL BIO, V92, P108, DOI 10.1016/j.pbiomolbio.2006.02.009; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Paterson CR, 1997, NUTRITION, V13, P771, DOI 10.1016/S0899-9007(97)00186-X; Reeve VE, 2012, PHOTOCH PHOTOBIO SCI, V11, P173, DOI 10.1039/c1pp05224a; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Song YR, 2003, J NUTR, V133, P374, DOI 10.1093/jn/133.2.374; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; TUCKEY RC, 1985, EUR J BIOCHEM, V148, P379, DOI 10.1111/j.1432-1033.1985.tb08849.x; Ullrich SE, 2005, MUTAT RES-FUND MOL M, V571, P185, DOI 10.1016/j.mrfmmm.2004.06.059; Vink AA, 1997, P NATL ACAD SCI USA, V94, P5255, DOI 10.1073/pnas.94.10.5255; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	44	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46006	10.1371/journal.pone.0046006	http://dx.doi.org/10.1371/journal.pone.0046006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049920	Green Accepted, Green Published, gold			2022-12-25	WOS:000309517300074
J	Ratto-Kim, S; Currier, JR; Cox, JH; Excler, JL; Valencia-Micolta, A; Thelian, D; Lo, V; Sayeed, E; Polonis, VR; Earl, PL; Moss, B; Robb, ML; Michael, NL; Kim, JH; Marovich, MA				Ratto-Kim, Silvia; Currier, Jeffrey R.; Cox, Josephine H.; Excler, Jean-Louis; Valencia-Micolta, Anais; Thelian, Doris; Lo, Vicky; Sayeed, Eddy; Polonis, Victoria R.; Earl, Patricia L.; Moss, Bernard; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary A.			Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens	PLOS ONE			English	Article							VACCINE VECTORS; IMMUNOGENICITY; DNA; PROTECTION; ANKARA; SIV	We characterized prime-boost vaccine regimens using heterologous and homologous vector and gene inserts. Heterologous regimens offer a promising approach that focuses the cell-mediated immune response on the insert and away from vector-dominated responses. Ad35-GRIN/ENV (Ad35-GE) vaccine is comprised of two vectors containing sequences from HIV-1 subtype A gag, rt, int, nef (Ad35-GRIN) and env (Ad35-ENV). MVA-CMDR (MVA-C), MVA-KEA (MVA-K) and MVA-TZC (MVA-T) vaccines contain gag, env and pol genes from HIV-1 subtypes CRF01_AE, A and C, respectively. Balb/c mice were immunized with different heterologous and homologous vector and insert prime-boost combinations. HIV and vector-specific immune responses were quantified post-boost vaccination. Gag-specific IFN-gamma ELISPOT, intracellular cytokine staining (ICS) (CD107 alpha, IFN-alpha, TNF-alpha and IL-2), pentamer staining and T-cell phenotyping were used to differentiate responses to inserts and vectors. Ad35-GE prime followed by boost with any of the recombinant MVA constructs (rMVA) induced CD8+ Gag-specific responses superior to Ad35-GE-Ad35-GE or rMVA-rMVA prime-boost combinations. Notably, there was a shift toward insert-focus responses using heterologous vector prime-boost regimens. Gag-specific central and effector memory T cells were generated more rapidly and in greater numbers in the heterologous compared to the homologous prime-boost regimens. These results suggest that heterologous prime-boost vaccination regimens enhance immunity by increasing the magnitude, onset and multifunctionality of the insert-specific cell-mediated immune response compared to homologous vaccination regimens. This study supports the rationale for testing heterologous prime-boost regimens in humans.	[Ratto-Kim, Silvia; Currier, Jeffrey R.; Valencia-Micolta, Anais; Thelian, Doris; Lo, Vicky; Polonis, Victoria R.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA; [Cox, Josephine H.; Excler, Jean-Louis; Sayeed, Eddy] Int AIDS Vaccine Initiat, New York, NY USA; [Earl, Patricia L.; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ratto-Kim, S (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA.	sratto-kim@hivresearch.org		Moss, Bernard/0000-0002-2154-8564; Ratto-Kim, Silvia/0000-0003-2025-6399; Cox, Josephine/0000-0003-1301-7373	United States Army Medical Research and Materiel Command [Y1-AI-2642-12]; National Institute of Allergy and Infectious Diseases; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-6700-P00001]; United States Department of Defense; International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID) [GPO-A-00-06-00006-00]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine; United States Department of Defense(United States Department of Defense); International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by an Interagency Agreement (Y1-AI-2642-12) between the United States Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-6700-P00001) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Defense. This study was also partially funded by the International AIDS Vaccine Initiative and its donors, including the generous support of the American people through the United States Agency for International Development (USAID; USAID Cooperative Agreement number GPO-A-00-06-00006-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bett AJ, 2010, VACCINE, V28, P7881, DOI 10.1016/j.vaccine.2010.09.079; Bot A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-132; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Doe B, 1996, AIDS, V10, P793, DOI 10.1097/00002030-199606001-00015; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Honda M, 2009, J IMMUNOL, V183, P2425, DOI 10.4049/jimmunol.0900581; Keefer M, 2010, AIDS RES HUM RETROV, V26, pA16; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lu Y, 2009, VACCINE, V27, P5411, DOI 10.1016/j.vaccine.2009.06.089; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Pillai VKB, 2011, VACCINE, V29, P5399, DOI 10.1016/j.vaccine.2011.05.083; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Xu JQ, 2006, AIDS, V20, P2293, DOI 10.1097/QAD.0b013e328010ad0c	27	32	35	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45840	10.1371/journal.pone.0045840	http://dx.doi.org/10.1371/journal.pone.0045840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049876	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300058
J	Abouseada, NM; Assafi, MSA; Mahdavi, J; Oldfield, NJ; Wheldon, LM; Wooldridge, KG; Ala'Aldeen, DAA				Abouseada, Noha M.; Assafi, Mahde Saleh A.; Mahdavi, Jafar; Oldfield, Neil J.; Wheldon, Lee M.; Wooldridge, Karl G.; Ala'Aldeen, Dlawer A. A.			Mapping the Laminin Receptor Binding Domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; SYNTHETIC PEPTIDES; PROTEIN P2; VIRUS; IDENTIFICATION; SEQUENCES; ACYLATION; STRAINS; GENE	Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae are major bacterial agents of meningitis. They each bind the 37/67-kDa laminin receptor (LamR) via the surface protein adhesins: meningococcal PilQ and PorA, H. influenzae OmpP2 and pneumococcal CbpA. We have previously reported that a surface-exposed loop of the R2 domain of CbpA mediates LamR-binding. Here we have identified the LamR-binding regions of PorA and OmpP2. Using truncated recombinant proteins we show that binding is dependent on amino acids 171-240 and 91-99 of PorA and OmpP2, respectively, which are predicted to localize to the fourth and second surface-exposed loops, respectively, of these proteins. Synthetic peptides corresponding to the loops bound LamR and could block LamR-binding to bacterial ligands in a dose dependant manner. Meningococci expressing PorA lacking the apex of loop 4 and H. influenzae expressing OmpP2 lacking the apex of loop 2 showed significantly reduced LamR binding. Since both loops are hyper-variable, our data may suggest a molecular basis for the range of LamR-binding capabilities previously reported among different meningococcal and H. influenzae strains.	[Abouseada, Noha M.; Assafi, Mahde Saleh A.; Mahdavi, Jafar; Oldfield, Neil J.; Wheldon, Lee M.; Wooldridge, Karl G.; Ala'Aldeen, Dlawer A. A.] Univ Nottingham, Mol Bacteriol & Immunol Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Ala'Aldeen, DAA (corresponding author), Univ Nottingham, Mol Bacteriol & Immunol Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England.	daa@nottingham.ac.uk	Oldfield, Neil J/C-2599-2009; Abouseada, Noha/H-5017-2016; Assafi, Assist Prof Dr. Mahde Saleh A/AAA-9643-2019	Oldfield, Neil J/0000-0001-7423-8378; Abouseada, Noha/0000-0002-1980-1276; assafi, Mahde/0000-0002-4863-282X; Wooldridge, Karl/0000-0002-7925-9474	Medical Research Council, UK [G0801173]; Medical Research Council [G0801173] Funding Source: researchfish; MRC [G0801173] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK (www.mrc.ac.uk); award number G0801173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; BELL J, 1994, INFECT IMMUN, V62, P2639, DOI 10.1128/IAI.62.6.2639-2643.1994; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; DANNER DB, 1980, GENE, V11, P311, DOI 10.1016/0378-1119(80)90071-2; de Filippis I, 2011, INFECT GENET EVOL, V11, P248, DOI 10.1016/j.meegid.2010.08.011; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Galdiero S, 2006, BIOCHEMISTRY-US, V45, P4491, DOI 10.1021/bi052262p; Galdiero S, 2003, INFECT IMMUN, V71, P2798, DOI 10.1128/IAI.71.5.2798-2809.2003; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Kinoshita K, 1998, BIOCHEM BIOPH RES CO, V253, P277, DOI 10.1006/bbrc.1998.9699; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MAIDEN MCJ, 1991, MOL MICROBIOL, V5, P727, DOI 10.1111/j.1365-2958.1991.tb00743.x; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; MCGUINNESS B, 1990, J EXP MED, V171, P1871, DOI 10.1084/jem.171.6.1871; McNichol BA, 2007, INFECT IMMUN, V75, P5095, DOI 10.1128/IAI.00075-07; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Newcombe J, 1998, MOL MICROBIOL, V30, P453, DOI 10.1046/j.1365-2958.1998.01056.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Protopopova EV, 1999, ZBL BAKT-INT J MED M, V289, P632; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Severino V, 2010, J PROTEOME RES, V9, P1050, DOI 10.1021/pr900931n; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; SRIKUMAR R, 1992, J BACTERIOL, V174, P4007, DOI 10.1128/jb.174.12.4007-4016.1992; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; VANDERLEY P, 1991, INFECT IMMUN, V59, P2963, DOI 10.1128/IAI.59.9.2963-2971.1991; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vitiello M, 2011, MICROBIOL IMMUNOL, V55, P347, DOI 10.1111/j.1348-0421.2011.00318.x; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Yi KC, 1997, INFECT IMMUN, V65, P150, DOI 10.1128/IAI.65.1.150-155.1997	48	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46233	10.1371/journal.pone.0046233	http://dx.doi.org/10.1371/journal.pone.0046233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049988	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100161
J	Chauvel, M; Nesseir, A; Cabral, V; Znaidi, S; Goyard, S; Bachellier-Bassi, S; Firon, A; Legrand, M; Diogo, D; Naulleau, C; Rossignol, T; d'Enfert, C				Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe			A Versatile Overexpression Strategy in the Pathogenic Yeast Candida albicans: Identification of Regulators of Morphogenesis and Fitness	PLOS ONE			English	Article							INDUCED FILAMENTOUS GROWTH; TRANSCRIPTION FACTOR; HYPHAL DEVELOPMENT; LARGE-SCALE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; VIRULENCE FACTORS; TRUE HYPHAL; DELETION; ROLES	Candida albicans is the most frequently encountered human fungal pathogen, causing both superficial infections and life-threatening systemic diseases. Functional genomic studies performed in this organism have mainly used knock-out mutants and extensive collections of overexpression mutants are still lacking. Here, we report the development of a first generation C. albicans ORFeome, the improvement of overexpression systems and the construction of two new libraries of C. albicans strains overexpressing genes for components of signaling networks, in particular protein kinases, protein phosphatases and transcription factors. As a proof of concept, we screened these collections for genes whose overexpression impacts morphogenesis or growth rates in C. albicans. Our screens identified genes previously described for their role in these biological processes, demonstrating the functionality of our strategy, as well as genes that have not been previously associated to these processes. This article emphasizes the potential of systematic overexpression strategies to improve our knowledge of regulatory networks in C. albicans. The C. albicans plasmid and strain collections described here are available at the Fungal Genetics Stock Center. Their extension to a genome-wide scale will represent important resources for the C. albicans community.	[Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe] Inst Pasteur, Dept Genomes & Genet, Unite Biol & Pathogenicite Fong, Paris, France; [Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe] INRA, USC2019, Paris, France; [Nesseir, Audrey; Cabral, Vitor; Diogo, Dorothee] Univ Paris Diderot, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Cite	d'Enfert, C (corresponding author), Inst Pasteur, Dept Genomes & Genet, Unite Biol & Pathogenicite Fong, Paris, France.	christophe.denfert@pasteur.fr	Znaidi, Sadri/W-6952-2019; Bachellier-Bassi, Sophie/AAB-7981-2020; Rossignol, Tristan/B-9398-2008; Cabral, Vitor/G-4460-2015	Znaidi, Sadri/0000-0001-9238-2218; Bachellier-Bassi, Sophie/0000-0003-3970-4825; Rossignol, Tristan/0000-0003-0718-0684; Cabral, Vitor/0000-0002-0367-3521; DIOGO, DOROTHEE/0000-0003-2913-5913; FIRON, Arnaud/0000-0002-5323-5212; Goyard, Sophie/0000-0002-8937-2796; d'Enfert, Christophe/0000-0002-6235-3886	European Commission [LSHM-CT-2005-518199, MRTN-CT-2003-504148, PITN-GA-2008-214004]; Agence Nationale de la Recherche [ANR-08-MIE-033-01]; Wellcome Trust [WT088858MA]; Pasteur-Genopole-Ile-de-France; DIM-Malinf Region Ile-de-France; Institut Pasteur (Bourse Roux); INRA/Institut Pasteur PhD fellowship	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Pasteur-Genopole-Ile-de-France(Region Ile-de-France); DIM-Malinf Region Ile-de-France(Region Ile-de-France); Institut Pasteur (Bourse Roux); INRA/Institut Pasteur PhD fellowship	This work has been supported by the European Commission (EURESFUN, LSHM-CT-2005-518199; Galar Fungail 2, MRTN-CT-2003-504148; FINSysB, PITN-GA-2008-214004), Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01) and the Wellcome Trust (The Candida albicans ORFeome project, WT088858MA). Oligonucleotide synthesis and plasmid sequencing were supported by Pasteur-Genopole-Ile-de-France. AN was the recipient of a PhD fellowship from the DIM-Malinf Region Ile-de-France. VC was the recipient of a PhD fellowship of the European Commission (FINSysB, PITN-GA-2008-214004). SZ was the recipient from post-doctoral fellowships of the European Commission (FINSysB, PITN-GA-2008-214004) and Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01). AF and ML were the recipients of post-doctoral fellowships of Institut Pasteur (Bourse Roux). DD was the recipient of a joined INRA/Institut Pasteur PhD fellowship. TR was the recipient of a post-doctoral fellowship from the European Commission (EURESFUN, LSHM-CT-2005-518199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Benson ES, 2002, EUKARYOT CELL, V1, P787, DOI 10.1128/EC.1.5.787-798.2002; Bharucha N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002058; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Calderone RA, 2002, CANDIDA CANDIDIASIS, P307; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chamilos G, 2009, J INFECT DIS, V200, P152, DOI 10.1086/599363; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Cleary IA, 2010, EUKARYOT CELL, V9, P1363, DOI 10.1128/EC.00088-10; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis DA, 2002, GENETICS, V162, P1573; Delgado ML, 2003, YEAST, V20, P713, DOI 10.1002/yea.993; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029707; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Epp E, 2010, MOL MICROBIOL, V75, P1182, DOI 10.1111/j.1365-2958.2009.07038.x; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Ganguly S, 2011, EUKARYOT CELL, V10, P1448, DOI 10.1128/EC.05196-11; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Hernday AD, 2010, METHOD ENZYMOL, V470, P737, DOI 10.1016/S0076-6879(10)70031-8; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang H, 2008, MICROBIOL RES, V163, P380, DOI 10.1016/j.micres.2008.03.001; Hurtado CAR, 2002, EUKARYOT CELL, V1, P526, DOI 10.1128/EC.1.4.526-537.2002; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Khalaf RA, 2001, GENETICS, V157, P1503; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Legrand M, 2011, CANDIDA CANDIDIASIS, P505; Leuker CE, 1997, GENE, V192, P235, DOI 10.1016/S0378-1119(97)00069-3; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Michel S, 2002, MOL MICROBIOL, V46, P269, DOI 10.1046/j.1365-2958.2002.03167.x; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1988, J MED VET MYCOL, V26, P277; Odds FC, 2008, MICROBIOL-SGM, V154, P3245, DOI 10.1099/mic.0.2008/023671-0; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Rual JF, 2004, CURR OPIN CHEM BIOL, V8, P20, DOI 10.1016/j.cbpa.2003.12.002; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shi QM, 2007, MOL BIOL CELL, V18, P815, DOI 10.1091/mbc.E06-05-0442; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Song WJ, 2011, FEMS YEAST RES, V11, P209, DOI 10.1111/j.1567-1364.2010.00710.x; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spiering MJ, 2010, EUKARYOT CELL, V9, P251, DOI 10.1128/EC.00291-09; Staib P, 2004, INFECT IMMUN, V72, P2386, DOI 10.1128/IAI.72.4.2386-2389.2004; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Vandeputte P, 2012, EUKARYOT CELL, V11, P916, DOI 10.1128/EC.00134-12; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x	102	67	85	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45912	10.1371/journal.pone.0045912	http://dx.doi.org/10.1371/journal.pone.0045912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049891	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100099
J	Jonsson, MT; Thor, G				Jonsson, Mari T.; Thor, Goran			Estimating Coextinction Risks from Epidemic Tree Death: Affiliate Lichen Communities among Diseased Host Tree Populations of Fraxinus excelsior	PLOS ONE			English	Article							CHALARA-FRAXINEA; INFECTIOUS-DISEASE; VIABILITY ANALYSIS; BETA REGRESSION; BIODIVERSITY; PERFORMANCE; PATHOGENS; DYNAMICS; PATTERNS; ECOLOGY	At least 10% of the world's tree species are threatened with extinction and pathogens are increasingly implicated in tree threats. Coextinction and threats to affiliates as a consequence of the loss or decline of their host trees is a poorly understood phenomenon. Ash dieback is an emerging infectious disease causing severe dieback of common ash Fraxinus excelsior throughout Europe. We utilized available empirical data on affiliate epiphytic lichen diversity (174 species and 17,800 observations) among 20 ash dieback infected host tree populations of F. excelsior on the island Gotland in the Baltic Sea, Sweden. From this, we used structured scenario projections scaled with empirical data of ash dieback disease to generate probabilistic models for estimating local and regional lichen coextinction risks. Average coextinction probabilities ((A) over bar) were 0.38 (95% CI +/- 0.09) for lichens occurring on F. excelsior and 0.14 (95% CI +/- 0.03) when considering lichen persistence on all tree species. (A) over bar was strongly linked to local disease incidence levels and generally increasing with lichen host specificity to F. excelsior and decreasing population size. Coextinctions reduced affiliate community viability, with significant local reductions in species richness and shifts in lichen species composition. Affiliates were projected to become locally extirpated before their hosts, illuminating the need to also consider host tree declines. Traditionally managed open wooded meadows had the highest incidence of ash dieback disease and significantly higher proportions of affiliate species projected to go extinct, compared with unmanaged closed forests and semi-open grazed sites. Most cothreatened species were not previously red-listed, which suggest that tree epidemics cause many unforeseen threats to species. Our analysis shows that epidemic tree deaths represent an insidious, mostly overlooked, threat to sessile affiliate communities in forested environments. Current conservation and management strategies must account for secondary extinctions associated with epidemic tree death.	[Jonsson, Mari T.; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Jonsson, MT (corresponding author), Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden.	mari.jonsson@slu.se			WWF; Swedish EPA; Swedish University of Agricultural Sciences; foundation Oscar and Lili Lamms Minne	WWF; Swedish EPA; Swedish University of Agricultural Sciences; foundation Oscar and Lili Lamms Minne	This work was supported by WWF, the Swedish EPA, the Swedish University of Agricultural Sciences and the foundation Oscar and Lili Lamms Minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund J, 2010, J ECOL, V98, P218, DOI 10.1111/j.1365-2745.2009.01584.x; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Bakys R, 2009, EUR J FOREST RES, V128, P51, DOI 10.1007/s10342-008-0238-2; CASTELLO JD, 1995, BIOSCIENCE, V45, P16, DOI 10.2307/1312531; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Ebenman B, 2004, ECOLOGY, V85, P2591, DOI 10.1890/03-8018; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Eskelson BNI, 2011, FOREST SCI, V57, P212; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gardenfors U., 2010, RED LIST SWEDISH SPE; Gelman A., 2007, DATA ANAL USING REGR; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Juodvalkis A., 2002, L U MOKSLO DARBAI BI, V56, P17; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; KROK TOB, 2001, SVENSK FLORA FANEROG; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; La Porta N, 2008, CAN J PLANT PATHOL, V30, P177, DOI 10.1080/07060661.2008.10540534; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Lohmus P., 2003, Folia Cryptogamica Estonica, P19; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; McKinney LV, 2011, HEREDITY, V106, P788, DOI 10.1038/hdy.2010.119; Moir ML, 2010, CONSERV BIOL, V24, P682, DOI 10.1111/j.1523-1739.2009.01398.x; Oldfield S., 1998, WORLD LIST THREATENE; Pliura A, 2011, BALT FOR, V17, P17; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Poykko H, 2003, J ANIM ECOL, V72, P383, DOI 10.1046/j.1365-2656.2003.00709.x; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; ROSE F, 1984, Field Studies, V6, P117; Santesson R., 2004, LICHENFORMING LICHEN; Smith C. W., 2009, LICHENS GREAT BRITAI; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Smith KF, 2005, FRONT ECOL ENVIRON, V3, P29, DOI 10.1890/1540-9295(2005)003[0029:ETTEID]2.0.CO;2; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]	46	49	50	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45701	10.1371/journal.pone.0045701	http://dx.doi.org/10.1371/journal.pone.0045701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049840	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000309556100069
J	Kurdi, M; Cherel, G; Lenting, PJ; Denis, CV; Christophe, OD				Kurdi, Mohamad; Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.			Coagulation Factor X Interaction with Macrophages through Its N-Glycans Protects It from a Rapid Clearance	PLOS ONE			English	Article							IN-VIVO; BLOOD-COAGULATION; ENDOTHELIAL-CELLS; RECEPTOR; LIVER; ADENOVIRUS; HEMOPHILIA; CONTRIBUTE; BINDING; HEXON	Factor X (FX), a plasma glycoprotein playing a central role in coagulation has a long circulatory half-life compared to closely related coagulation factors. The activation peptide of FX has been shown to influence its clearance with two N-glycans as key determinants of FX's relatively long survival. To decipher FX clearance mechanism, organ biodistribution and cellular interactions of human plasma FX (pd-FX), recombinant FX (rFX), N-deglycosylated FX (N-degly-FX) and recombinant FX mutated at both N-glycosylation sites (rFX(N181A-N191A)) were evaluated. Biodistribution analysis of I-125-labelled FX proteins after administration to mice revealed liver as major target organ for all FX variants. Liver tissue sections analysis showed an interaction of pd-FX and N-degly-FX to different cell types. These findings were confirmed in cell binding studies revealing that FX and FX without N-glycans interact with macrophages and hepatocytes, respectively. N-degly-FX appeared to be degraded in hepatocytes while interestingly pd-FX was not by macrophages. Furthermore, the chemical inactivation of macrophages by gadolinium chloride resulted in a significant decrease of circulating pd-FX into mice and not of N-degly-FX. Altogether our data lead to the conclusion that FX interaction with macrophages through its N-glycans protects it from a rapid clearance explaining its relatively long circulatory half-life.	[Kurdi, Mohamad; Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.] Univ Paris Sud, UMR S 770, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Christophe, OD (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	olivier.christophe-kb@inserm.fr	Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013; christophe, olivier/W-4268-2017; Denis, Cecile/A-7649-2011	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; christophe, olivier/0000-0002-9080-6336; Denis, Cecile/0000-0001-5152-9156	Institut National de la Sante et de la Recherche Medicale of France (INSERM); University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi	Institut National de la Sante et de la Recherche Medicale of France (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi	This study was supported in part by Institut National de la Sante et de la Recherche Medicale of France (INSERM), and by University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1999, HEPATOLOGY, V29, P728, DOI 10.1002/hep.510290324; Bae JS, 2010, J BIOL CHEM, V285, P34803, DOI 10.1074/jbc.M110.163642; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Paolo NC, 2009, MOL THER, V17, P675, DOI 10.1038/mt.2008.307; Disse J, 2011, J BIOL CHEM, V286, P5756, DOI 10.1074/jbc.M110.201228; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUCHS HE, 1983, J CLIN INVEST, V72, P2041, DOI 10.1172/JCI111169; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gueguen P, 2010, J THROMB HAEMOST, V8, P1651, DOI 10.1111/j.1538-7836.2010.03905.x; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Harstad EB, 2002, TOXICOL APPL PHARM, V180, P178, DOI 10.1006/taap.2002.9385; HERTZBERG M, 1994, BLOOD REV, V8, P56, DOI 10.1016/0268-960X(94)90007-8; HJORT PF, 1961, SCAND J CLIN LAB INV, V13, P668, DOI 10.3109/00365516109137342; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Johansson L, 2011, BLOOD, V117, P3445, DOI 10.1182/blood-2010-06-290098; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; LIUCHEN LY, 1993, MOL PHARMACOL, V44, P749; Louvain-Quintard VB, 2005, J BIOL CHEM, V280, P41352, DOI 10.1074/jbc.M507846200; MANN KG, 1990, BLOOD, V76, P1; Narita M, 1998, BLOOD, V91, P555, DOI 10.1182/blood.V91.2.555.555_555_560; NAWROTH PP, 1985, THROMB RES, V40, P677, DOI 10.1016/0049-3848(85)90305-6; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; ROBERTS HR, 1965, THROMB DIATH HAEMOST, V13, P305, DOI 10.1055/s-0038-1656232; SAKAI T, 1990, J BIOL CHEM, V265, P9105; Sen P, 2011, BLOOD, V118, P2635, DOI 10.1182/blood-2011-05-354571; THOMAS P, 1977, BIOCHEM SOC T, V5, P312, DOI 10.1042/bst0050312; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45111	10.1371/journal.pone.0045111	http://dx.doi.org/10.1371/journal.pone.0045111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049768	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100027
J	Negro, F; Farina, D				Negro, Francesco; Farina, Dario			Factors Influencing the Estimates of Correlation between Motor Unit Activities in Humans	PLOS ONE			English	Article							SHORT-TERM SYNCHRONIZATION; NEURONAL SPIKE TRAINS; MOTONEURON SYNCHRONIZATION; COMMON MODULATION; SPINAL-CORD; MUSCLES; DISCHARGE; COHERENCE; CONTRACTIONS; INTERCOSTAL	Background: Alpha motoneurons receive common synaptic inputs from spinal and supraspinal pathways. As a result, a certain degree of correlation can be observed between motoneuron spike trains during voluntary contractions. This has been studied by using correlation measures in the time and frequency domains. These measures are interpreted as reflecting different types of connectivity in the spinal networks, although the relation between the degree of correlation of the output motoneuron spike trains and of their synaptic inputs is unclear. Methodology/Principal Findings: In this study, we analyze theoretically this relation and we complete this analysis by simulations and experimental data on the abductor digiti minimi muscle. The results demonstrate that correlation measures between motoneuron output spike trains are inherently influenced by the discharge rate and that this influence cannot be compensated by normalization. Because of the influence of discharge rate, frequency domain measures of correlation (coherence) do not identify the full frequency content of the common input signal when computed from pairs of motoneurons. Rather, an increase in sampling rate is needed by using cumulative spike trains of several motoneurons. Moreover, the application of averaging filters to the spike trains influences the magnitude of the estimated correlation levels calculated in the time, but not in the frequency domain (coherence). Conclusions: It is concluded that the analysis of coherence in different frequency bands between cumulative spike trains of a sufficient number of motoneurons provides information on the spectrum of the common synaptic input. Nonetheless, the absolute values of coherent peaks cannot be compared across conditions with different cumulative discharge rates.	[Negro, Francesco; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Negro, Francesco] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark	University of Gottingen; Aalborg University	Negro, F (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany.	negro.francesco@bccn.uni-goettingen.de	Farina, Dario/AAB-2648-2019; Negro, Francesco/H-4471-2019; Negro, Francesco/K-1345-2013	Negro, Francesco/0000-0002-9094-8932; Negro, Francesco/0000-0002-9094-8932	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen [1GQ0810]; European Research Council Advanced Grant DEMOVE [267888]	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen(Federal Ministry of Education & Research (BMBF)); European Research Council Advanced Grant DEMOVE	The authors acknowledge financial support by the German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen under grant number 1GQ0810 and the European Research Council Advanced Grant DEMOVE (contract #267888) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P381, DOI 10.1113/jphysiol.1991.sp018390; Christou EA, 2007, EXP BRAIN RES, V178, P285, DOI 10.1007/s00221-006-0739-5; Cisi RRL, 2008, J COMPUT NEUROSCI, V25, P520, DOI 10.1007/s10827-008-0092-8; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; DAVEY NJ, 1993, EXP PHYSIOL, V78, P649, DOI 10.1113/expphysiol.1993.sp003713; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; De Luca CJ, 2002, J NEUROPHYSIOL, V87, P2200, DOI 10.1152/jn.00793.2001; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; ELLAWAY PH, 1985, Q J EXP PHYSIOL CMS, V70, P219, DOI 10.1113/expphysiol.1985.sp002905; ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; FARMER SF, 1993, J PHYSIOL-LONDON, V463, P83, DOI 10.1113/jphysiol.1993.sp019585; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gerstein GL, 2000, J NEUROSCI METH, V100, P41, DOI 10.1016/S0165-0270(00)00226-0; Heckman C, 2004, HAND CLIN N, V4, P119; ISHIZUKA N, 1979, J COMP NEUROL, V186, P189, DOI 10.1002/cne.901860206; Johnston JA, 2005, J NEUROPHYSIOL, V94, P206, DOI 10.1152/jn.01134.2004; Kakuda N, 1999, J PHYSIOL-LONDON, V520, P929, DOI 10.1111/j.1469-7793.1999.00929.x; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; KIRKWOOD PA, 1978, J PHYSIOL-LONDON, V275, P103, DOI 10.1113/jphysiol.1978.sp012180; Laine CM, 2011, J NEUROPHYSIOL, V105, P380, DOI 10.1152/jn.00766.2010; LAWRENCE DG, 1985, J COMP NEUROL, V232, P499, DOI 10.1002/cne.902320407; Lazar AA, 2004, IEEE T CIRCUITS-I, V51, P2060, DOI 10.1109/TCSI.2004.835026; Lazar AA, 2008, NEURAL COMPUT, V20, P2715, DOI 10.1162/neco.2008.06-07-559; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lowery MM, 2007, J NEUROSCI METH, V163, P384, DOI 10.1016/j.jneumeth.2007.03.011; Maltenfort MG, 1998, J NEUROPHYSIOL, V80, P309, DOI 10.1152/jn.1998.80.1.309; Marsden JF, 1999, J PHYSIOL-LONDON, V521, P553, DOI 10.1111/j.1469-7793.1999.00553.x; Mattei B, 2003, J PHYSIOL-LONDON, V548, P615, DOI 10.1113/jphysiol.2002.033126; McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015; MILLS KR, 1995, J PHYSIOL-LONDON, V483, P511, DOI 10.1113/jphysiol.1995.sp020602; Mochizuki G, 2007, J NEUROPHYSIOL, V97, P3917, DOI 10.1152/jn.01025.2006; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; MORI S, 1975, J NEUROPHYSIOL, V38, P859, DOI 10.1152/jn.1975.38.4.859; Moritz CT, 2005, J NEUROPHYSIOL, V94, P105, DOI 10.1152/jn.01179.2004; Myers Lance J, 2004, J Neuroeng Rehabil, V1, P2, DOI 10.1186/1743-0003-1-2; Nakao M, 1997, IEEE T BIO-MED ENG, V44, P419, DOI 10.1109/10.568918; Negro F, 2011, J NEUROPHYSIOL, V106, P2688, DOI 10.1152/jn.00336.2011; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Rice A, 2011, J NEUROPHYSIOL, V105, P2330, DOI 10.1152/jn.01078.2010; Rosenbaum R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00058; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Santo Neto H, ARCH ITALIANO ANATOM, V90, P47; SCHMIED A, 1994, J PHYSIOL-LONDON, V480, P369, DOI 10.1113/jphysiol.1994.sp020367; Schmied A, 2010, CLIN NEUROPHYSIOL, V121, P1624, DOI 10.1016/j.clinph.2010.02.165; SEARS TA, 1976, J PHYSIOL-LONDON, V263, P357, DOI 10.1113/jphysiol.1976.sp011635; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Semmler JG, 1997, BRAIN RES, V767, P314, DOI 10.1016/S0006-8993(97)00621-5; Semmler JG, 2004, J NEUROPHYSIOL, V92, P3320, DOI 10.1152/jn.00316.2004; Shampine LF., 1975, COMPUTER SOLUTION OR; Shea-Brown E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108102; Taylor AM, 2004, J NEUROPHYSIOL, V91, P796, DOI 10.1152/jn.00802.2003; Tchumatchenko T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00068; Tchumatchenko T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/neuro.10.001.2010; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; Traub R. D., 1991, NEURONAL NETWORKS HI, V777; Turker KS, 2001, J NEUROPHYSIOL, V86, P2807, DOI 10.1152/jn.2001.86.6.2807; Vaughan CW, 1997, J PHYSIOL-LONDON, V503, P673, DOI 10.1111/j.1469-7793.1997.673bg.x	61	60	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44894	10.1371/journal.pone.0044894	http://dx.doi.org/10.1371/journal.pone.0044894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049762	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100023
J	Rasmussen, JG; Riis, SE; Frobert, O; Yang, SF; Kastrup, J; Zachar, V; Simonsen, U; Fink, T				Rasmussen, Jeppe Grondahl; Riis, Simone Elkjaer; Frobert, Ole; Yang, Sufang; Kastrup, Jens; Zachar, Vladimir; Simonsen, Ulf; Fink, Trine			Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; GROWTH-FACTOR EXPRESSION; EPITHELIAL-CELLS; MOLECULAR-CLONING; STROMAL CELLS; CANCER CELLS; FACTOR-ALPHA; HYPOXIA; PATHWAYS	Background: Human adipose stem cells (hASCs) can promote angiogenesis through secretion of proangiogenic factors such as vascular endothelial growth factor (VEGF). In other cell types, it has been shown that induction of VEGF is mediated by both protease activated receptor 2 (PAR2) and hypoxia inducible factor 1(HIF-1). The present study hypothesized that PAR2 stimulation through activation of kinase signaling cascades lead to induction of HIF-1 and secretion of VEGF. Methodology/Principal Findings: Immunohistochemistry revealed the expression of PAR2 receptors on the surface of hASCs. Blocking the PAR2 receptors with a specific antibody prior to trypsin treatment showed these receptors are involved in trypsin-evoked increase in VEGF secretion from hASCs. Blocking with specific kinase inhibitors suggested that that activation of MEK/ERK and PI3-kinase/Akt pathways are involved in trypsin-eveoked induction of VEGF. The effect of the trypsin treatment on the transcription of VEGF peaked at 6 hours after the treatment and was comparable to the activation observed after keeping hASCs for 24 hours at 1% oxygen. In contrast to hypoxia, trypsin alone failed to induce HIF-1 measured with ELISA, while the combination of trypsin and hypoxia had an additive effect on both VEGF transcription and secretion, results which were confirmed by Western blot. Conclusion: In hASCs trypsin and hypoxia induce VEGF expression through separate pathways.	[Rasmussen, Jeppe Grondahl; Simonsen, Ulf] Aarhus Univ, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark; [Rasmussen, Jeppe Grondahl; Riis, Simone Elkjaer; Yang, Sufang; Zachar, Vladimir; Fink, Trine] Aalborg Univ, Lab Stem Cell Res, Aalborg, Denmark; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Yang, Sufang] Guangxi Univ, Anim Reprod Inst, Nanning 530004, Peoples R China; [Kastrup, Jens] Copenhagen Univ Hosp, Cardiac Stem Cell Lab, Ctr Heart, Rigshosp, Copenhagen, Denmark	Aarhus University; Aalborg University; Orebro University; Guangxi University; Rigshospitalet; University of Copenhagen	Fink, T (corresponding author), Aarhus Univ, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark.	trinef@hst.aau.dk	Fink, Trine/H-4434-2012; Fink, Trine/ABC-4003-2020; Porsborg, Simone Riis/AAI-6397-2021	Fink, Trine/0000-0001-7578-1137; Fink, Trine/0000-0001-7578-1137; Porsborg, Simone Riis/0000-0003-0167-5408; Zachar, Vladimir/0000-0002-5279-2690; Frobert, Ole/0000-0002-5846-345X	Danish Heart Foundation [08-4-R64-A2020-B584-22460, 07-4-B584-A1453-22364, 1004-R78-A2925-22599]; Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; Faculty of Health Science, Aarhus University	Danish Heart Foundation; Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; Faculty of Health Science, Aarhus University	This work was supported by grants from the Danish Heart Foundation (08-4-R64-A2020-B584-22460 to J.G.R., 07-4-B584-A1453-22364 to J.G.R., and 1004-R78-A2925-22599 to J.G.R.); Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; and the Faculty of Health Science, Aarhus University (to J.G.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, BIOCHEM BIOPH RES CO, V401, P321, DOI 10.1016/j.bbrc.2010.09.012; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutra-Oliveira A, 2012, BIOCHEM BIOPH RES CO, V421, P221, DOI 10.1016/j.bbrc.2012.03.140; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fink Trine, 2011, Front Biosci (Elite Ed), V3, P256, DOI 10.2741/e241; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Leung KW, 2011, ANGIOGENESIS, V14, P515, DOI 10.1007/s10456-011-9235-z; Liu Y, 2006, BIOCHEM BIOPH RES CO, V344, P1263, DOI 10.1016/j.bbrc.2006.04.005; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Pilgaard L, 2009, REGEN MED, V4, P539, DOI [10.2217/rme.09.28, 10.2217/RME.09.28]; Pilgaard L, 2008, REGEN MED, V3, P705, DOI 10.2217/17460751.3.5.705; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Yagi Y, 2006, EUR J PHARMACOL, V536, P19, DOI 10.1016/j.ejphar.2006.02.024; Zachar V, 2011, EXPERT OPIN BIOL TH, V11, P775, DOI 10.1517/14712598.2011.570258; Zhong H, 2000, CANCER RES, V60, P1541; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	34	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46087	10.1371/journal.pone.0046087	http://dx.doi.org/10.1371/journal.pone.0046087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049945	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100134
J	Wu, XH; Fu, Y; Yang, DY; Zhang, RH; Zheng, WP; Nie, HM; Xie, Y; Yan, N; Hao, GY; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Wu, Xuhang; Fu, Yan; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Detailed Transcriptome Description of the Neglected Cestode Taenia multiceps	PLOS ONE			English	Article							PARASITIC NEMATODE; HUMAN COENUROSIS; GENE-EXPRESSION; CEREBRALIS CYST; SHEEP; INFECTION; PROTEIN; GENOME; ANNOTATION; SINENSIS	Background: The larval stage of Taenia multiceps, a global cestode, encysts in the central nervous system (CNS) of sheep and other livestock. This frequently leads to their death and huge socioeconomic losses, especially in developing countries. This parasite can also cause zoonotic infections in humans, but has been largely neglected due to a lack of diagnostic techniques and studies. Recent developments in next-generation sequencing provide an opportunity to explore the transcriptome of T. multiceps. Methodology/Principal Findings: We obtained a total of 31,282 unigenes (mean length 920 bp) using Illumina paired-end sequencing technology and a new Trinity de novo assembler without a referenced genome. Individual transcription molecules were determined by sequence-based annotations and/or domain-based annotations against public databases (Nr, UniprotKB/Swiss-Prot, COG, KEGG, UniProtKB/TrEMBL, InterPro and Pfam). We identified 26,110 (83.47%) unigenes and inferred 20,896 (66.8%) coding sequences (CDS). Further comparative transcripts analysis with other cestodes (Taenia pisiformis, Taenia solium, Echincoccus granulosus and Echincoccus multilocularis) and intestinal parasites (Trichinella spiralis, Ancylostoma caninum and Ascaris suum) showed that 5,100 common genes were shared among three Taenia tapeworms, 261 conserved genes were detected among five Taeniidae cestodes, and 109 common genes were found in four zoonotic intestinal parasites. Some of the common genes were genes required for parasite survival, involved in parasite-host interactions. In addition, we amplified two full-length CDS of unigenes from the common genes using RT-PCR. Conclusions/Significance: This study provides an extensive transcriptome of the adult stage of T. multiceps, and demonstrates that comparative transcriptomic investigations deserve to be further studied. This transcriptome dataset forms a substantial public information platform to achieve a fundamental understanding of the biology of T. multiceps, and helps in the identification of drug targets and parasite-host interaction studies.	[Wu, Xuhang; Fu, Yan; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn		Hao, Guiying/0000-0003-0233-4947	Program for Changjiang Scholars and Innovative Research Team in University PCSIRT [IRT0848]	Program for Changjiang Scholars and Innovative Research Team in University PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the "Program for Changjiang Scholars and Innovative Research Team in University" (PCSIRT) (No. IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Shehada MN, 2002, PREV VET MED, V55, P201, DOI 10.1016/S0167-5877(02)00056-9; Achenef M, 1999, TROP ANIM HEALTH PRO, V31, P15, DOI 10.1023/A:1005125316275; Almeida CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-35; Almeida GT, 2011, EXPT PARASI IN PRESS; [Anonymous], 2011, MOL PHYLOGENET EVOL, P638; BENGER A, 1981, AM J TROP MED HYG, V30, P638, DOI 10.4269/ajtmh.1981.30.638; Benifla M, 2007, J NEUROSURG, V107, P511, DOI 10.3171/PED-07/12/511; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Bussell KM, 1997, VET REC, V140, P560, DOI 10.1136/vr.140.21.560; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; DOHERTY ML, 1989, VET REC, V124, P591, DOI 10.1136/vr.124.22.591; EDWARDS GT, 1982, BRIT VET J, V138, P489, DOI 10.1016/S0007-1935(17)30934-X; El-On Joseph, 2008, Vet Ital, V44, P621; Euzeby J, 1966, MALADIES VERMINEUSES; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gauci C, 2008, INT J PARASITOL, V38, P1041, DOI 10.1016/j.ijpara.2007.11.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HERBERT IV, 1984, ANN TROP MED PARASIT, V78, P243, DOI 10.1080/00034983.1984.11811809; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ing MB, 1998, CLIN INFECT DIS, V27, P519, DOI 10.1086/514716; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Li G, 2007, ADV PARASIT, P109; Lundstrom J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000919; Ma X, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-481; Mahadevan A, 2011, CLIN NEUROPATHOL, V30, P28, DOI 10.5414/NPP30028; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olson PD, 2012, PARASITE IMMUNOL, V34, P130, DOI 10.1111/j.1365-3024.2011.01319.x; Pan Q, 2004, MOLECULAR PARASITOLO, P353; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Riddiford N, 2011, DEV GENES EVOL, P1; Scala A, 2007, VET PARASITOL, V143, P294, DOI 10.1016/j.vetpar.2006.08.020; Sharma DK, 2006, SMALL RUMINANT RES, V64, P197, DOI 10.1016/j.smallrumres.2005.05.021; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Skerritt GC, 1991, COENUROSIS DIS SHEEP; Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269; Varcasia A, 2009, VET PARASITOL, V162, P285, DOI 10.1016/j.vetpar.2009.03.008; Verma A. K., 2012, Journal of Pharmacy Research, V5, P1248; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; WILSON VCLC, 1972, T ROY SOC TROP MED H, V66, P611, DOI 10.1016/0035-9203(72)90307-0; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YOSHINO T, 1988, JPN J VET SCI, V50, P433; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	62	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45830	10.1371/journal.pone.0045830	http://dx.doi.org/10.1371/journal.pone.0045830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049872	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100086
J	Hsu, YL; Hou, MF; Kuo, PL; Huang, YF; Tsai, EM				Hsu, Y-L; Hou, M-F; Kuo, P-L; Huang, Y-F; Tsai, E-M			Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway	ONCOGENE			English	Article						breast cancer; osteoblasts; CXCL5; cancer progression	EPITHELIAL-MESENCHYMAL TRANSITIONS; ACTIVATED PROTEIN-KINASE; SNAIL; EXPRESSION; GROWTH; CELLS; MECHANISMS; DISEASE; GENE; MSK	The skeleton is the most common metastatic site for breast cancer, with bone metastasis causing pain as well as risk of pathological fractures. Interaction between tumors and the bone microenvironment creates a vicious cycle that accelerates both bone destruction and cancer progression. This study is the first to analyze the soluble factors secreted by breast tumor-associated osteoblasts (TAOBs), which are responsible for promoting cancer progression. The addition of CXCL5 (chemokine (C-X-C motif) ligand 5), present in large amounts in TAOB-condition medium (TAOB-CM), mimicked the inductive effect of TAOB-CM on breast cancer epithelial-mesenchymal transition, migration and invasion. In contrast, inhibition of CXCL5 in OBs decreased TAOB-mediated cancer progression. Inducement of MCF-7 and MDA-MB-231 cancer progression by TAOB-derived CXCL5 is associated with increased Raf/MEK/ERK activation, and mitogen-and stress-activated protein kinase 1 (MSK1) and Elk-1 phosphorylation, as well as Snail upregulation. Activation of Elk-1 facilitates recruitment of phosphorylated MSK1, which in turn enhances histone H3 acetylation and phosphorylation (serine 10) of Snail promoter, resulting in Snail enhancement and E-cadherin downregulation. Moreover, mice treated with anti-CXCL5 antibodies showed decreased metastasis of 4T1 breast cancer cells. Our study suggests that inhibition of CXCL5-mediated ERK/Snail signaling is an attractive therapeutic target for treating metastases in breast cancer patients.	[Hsu, Y-L; Tsai, E-M] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan; [Hou, M-F; Kuo, P-L; Huang, Y-F] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung 807, Taiwan; [Hou, M-F; Kuo, P-L; Huang, Y-F] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Kuo, P-L] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Tsai, E-M] Kaohsiung Med Univ Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hsu, YL (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	hsuyl326@gmail.com		Huang, Ya-Fang/0000-0002-7790-8071; Hou, Ming-Feng/0000-0001-6030-9702	National Science Council of Taiwan [NSC 99-2320-B-037-017-MY3]; Excellence for Cancer Research Center Grant, the Department of Health, Executive Yuan, Taipei, Taiwan [DOH101-TD-C-111-002]; Kaohsiung Medical University Hospital [KMUH 99-9I04]; Kaohsiung Medical University Research Foundation [KMUER008]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Excellence for Cancer Research Center Grant, the Department of Health, Executive Yuan, Taipei, Taiwan; Kaohsiung Medical University Hospital; Kaohsiung Medical University Research Foundation	This study is supported by grants from the National Science Council of Taiwan (NSC 99-2320-B-037-017-MY3), the Excellence for Cancer Research Center Grant, the Department of Health, Executive Yuan, Taipei, Taiwan (DOH101-TD-C-111-002), the Kaohsiung Medical University Hospital (KMUH 99-9I04) and the Kaohsiung Medical University Research Foundation (KMUER008).	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Besnard A, 2011, J NEUROSCI, V31, P14296, DOI 10.1523/JNEUROSCI.2890-11.2011; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cassinat B, 2011, MOL CELL BIOL, V31, P1409, DOI 10.1128/MCB.00756-10; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chen Y, 2011, J BIOL CHEM, V286, P42575, DOI 10.1074/jbc.M111.294595; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Espino PS, 2006, CANCER RES, V66, P4610, DOI 10.1158/0008-5472.CAN-05-4251; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsu YL, 2011, J BIOL CHEM, V286, P37335, DOI 10.1074/jbc.M111.256156; Jorda M, 2007, EXP CELL RES, V313, P2389, DOI 10.1016/j.yexcr.2007.04.001; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Pacheco-Rodriguez G, 2009, J IMMUNOL, V182, P1270, DOI 10.4049/jimmunol.182.3.1270; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van't Veer LJ, 2003, NAT MED, V9, P999, DOI 10.1038/nm0803-999b; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yuen HF, 2011, J PATHOL, V224, P78, DOI 10.1002/path.2859; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099	38	97	104	1	33	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4436	4447		10.1038/onc.2012.444	http://dx.doi.org/10.1038/onc.2012.444			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23045282				2022-12-25	WOS:000324404200012
J	Shum, CKY; Lau, ST; Tsoi, LLS; Chan, LK; Yam, JWP; Ohira, M; Nakagawara, A; Tam, PKH; Ngan, ESW				Shum, C. K. Y.; Lau, S. T.; Tsoi, L. L. S.; Chan, L. K.; Yam, J. W. P.; Ohira, M.; Nakagawara, A.; Tam, P. K. H.; Ngan, E. S. W.			Kruppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation	ONCOGENE			English	Article						differentiation; regression; neuroblastoma	CREST STEM-CELLS; BREAST-CANCER; CHILDHOOD NEUROBLASTOMA; GENE AMPLIFICATION; PROGNOSTIC-FACTORS; SERUM FERRITIN; EXPRESSION; PROGRESSION; TUMORS; MYCN	Neuroblastoma (NB) is an embryonal tumor and possesses a unique propensity to exhibit either a spontaneous regression or an unrestrained growth. However, the underlying mechanism for this paradoxical clinical outcome remains largely unclear. Quantitative RT-PCR analysis on 102 primary NB tumors revealed that lower Kruppel-like factor 4 (KLF4) expression is frequently found in the unfavorable NB (Mann-Whitney test, P = 0.027). In particular with the high-risk factors such as age of patient 41 year, MYCN amplification and low TRKA expression, the decreased expression of KLF4 was significantly associated with an unfavorable NB outcome. Despite knockdown of KLF4 alone is not sufficient to increase tumorigenicity of NB cells in vivo, stable expression of KLF4 short hairpin RNA in Be(2)-C cells significantly promoted growth of NB cells and inhibited cell differentiation toward fibromuscular lineage. In concordant with these observations, overexpression of KLF4 in SH-SY-5Y cells profoundly suppressed cell proliferation by direct upregulation of cell-cycle inhibitor protein p21(WAF1/CIP1), and knocking down p21(WAF1/CIP1) could partially rescue the suppressive effect of KLF4. Importantly, KLF4 overexpressing cells have lost their neuroblastic phenotypes, they were epithelial-like, strongly substrate-adherent, expressing smooth muscle marker and became non-tumorigenic, suggesting that KLF4 expression is crucial for lineage determination of NB cells, probably, favoring spontaneous tumor regression. Subsequent global gene expression profiling further revealed that transforming growth factor beta (TGF beta) and cell-cycle pathways are highly dysregulated upon KLF4 overexpression, and myogenic modulators, MEF2A and MYOD1 were found significantly upregulated. Taken together, we have demonstrated that KLF4 contributes to the favorable disease outcome by directly mediating the growth and lineage determination of NB cells.	[Shum, C. K. Y.; Lau, S. T.; Tsoi, L. L. S.; Tam, P. K. H.; Ngan, E. S. W.] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Chan, L. K.; Yam, J. W. P.] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Ohira, M.; Nakagawara, A.] Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan; [Tam, P. K. H.; Ngan, E. S. W.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chiba Cancer Center; University of Hong Kong	Ngan, ESW (corresponding author), Univ Hong Kong, Dept Surg, Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	engan@hku.hk	Ngan, Elly/N-1543-2019; Kong, Chan Lo/AAI-9300-2020; /C-4405-2009; Yam, Judy Wai Ping/C-4454-2009	Ngan, Elly/0000-0002-0022-7999; Kong, Chan Lo/0000-0003-3082-1013; /0000-0001-6231-3035; Yam, Judy Wai Ping/0000-0002-5637-121X	University of Hong Kong; Hong Kong Research Grants Council [HKU773909]; Hong Kong Children Cancer Foundation	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Children Cancer Foundation	This study was funded by seed funding grant for basic research from the University of Hong Kong, General Research Grant HKU773909 from the Hong Kong Research Grants Council and research grant from Hong Kong Children Cancer Foundation to ESWN.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Beppu Y, 2005, CANCER RES, V65, P4775, DOI 10.1158/0008-5472.CAN-04-3332; Biagiotti T, 2006, STEM CELLS, V24, P443, DOI 10.1634/stemcells.2004-0264; BIEDLER JL, 1978, CANCER RES, V38, P3751; BRESLOW N, 1971, CANCER RES, V31, P2098; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; HANN HWL, 1985, CANCER RES, V45, P2843; Iehara T, 2006, BRIT J CANCER, V94, P1510, DOI 10.1038/sj.bjc.6603149; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kaneko M, 2002, J PEDIAT HEMATOL ONC, V24, P613, DOI 10.1097/00043426-200211000-00004; Katz JP, 2002, DEVELOPMENT, V129, P2619; Keshelava N, 2001, CANCER RES, V61, P6185; Lastowska M, 2001, J CLIN ONCOL, V19, P3080; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Lutz W, 1998, ONCOGENE, V17, P339, DOI 10.1038/sj.onc.1200201; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Marzi F, 2007, CANCER RES, V67, P2402, DOI 10.1158/0008-5472.CAN-06-3208; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SHUSTER JJ, 1992, AM J CLIN ONCOL-CANC, V15, P295, DOI 10.1097/00000421-199208000-00004; SILBER JH, 1991, CANCER RES, V51, P1426; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Tweddle DA, 2001, CANCER RES, V61, P8; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	57	24	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4086	4099		10.1038/onc.2012.437	http://dx.doi.org/10.1038/onc.2012.437			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23045286				2022-12-25	WOS:000323748500004
J	Takei, Y; Iizuka, R; Ueno, T; Funatsu, T				Takei, Yodai; Iizuka, Ryo; Ueno, Taro; Funatsu, Takashi			Single-molecule Observation of Protein Folding in Symmetric GroEL-(GroES)(2) Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROEL-GROES COMPLEXES; SUBSTRATE PROTEIN; CHAPERONIN GROEL; ATP; POLYPEPTIDE; CAVITY; CYCLE; ENCAPSULATION; CONFORMATION; CATALYSIS	The chaperonin, GroEL, is an essential molecular chaperone that mediates protein folding together with its cofactor, GroES, in Escherichia coli. It is widely believed that the two rings of GroEL alternate between the folding active state coupled to GroES binding during the reaction cycle. In other words, an asymmetric GroEL-GroES complex (the bullet-shaped complex) is formed throughout the cycle, whereas a symmetric GroEL-(GroES)(2) complex (the football-shaped complex) is not formed. We have recently shown that the football-shaped complex coexists with the bullet-shaped complex during the reaction cycle. However, how protein folding proceeds in the football-shaped complex remains poorly understood. Here, we used GFP as a substrate to visualize protein folding in the football-shaped complex by single-molecule fluorescence techniques. We directly showed that GFP folding occurs in both rings of the football-shaped complex. Remarkably, the folding was a sequential two-step reaction, and the kinetics were in excellent agreement with those in the bullet-shaped complex. These results demonstrate that the same reactions take place independently in both rings of the football-shaped complex to facilitate protein folding.	[Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Funatsu, Takashi] Japan Sci & Technol Corp, Core Res Evolutionary Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Ministry of Education, Culture, Sports, Science and Technology of Japan [24370061, 21121004, 22020006]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research (B) 24370061 (to T. F.), Scientific Research on Innovative Areas 21121004 (to T. F.), and Scientific Research on Priority Areas 22020006 (to R. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also supported by the Funding Program for World-Leading Innovative R & D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science.	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17334, DOI 10.1073/pnas.0807429105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; Koike-Takeshita A, 2006, J BIOL CHEM, V281, P962, DOI 10.1074/jbc.M506298200; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Llorca O, 1996, J BIOL CHEM, V271, P68, DOI 10.1074/jbc.271.1.68; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Motojima F, 2010, EMBO J, V29, P4008, DOI 10.1038/emboj.2010.262; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Nojima T, 2012, J MOL BIOL, V422, P291, DOI 10.1016/j.jmb.2012.05.026; Nojima T, 2009, J BIOL CHEM, V284, P22834, DOI 10.1074/jbc.M109.020057; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tanaka S, 2010, BBA-PROTEINS PROTEOM, V1804, P866, DOI 10.1016/j.bbapap.2009.12.016; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Yamasaki R, 1999, J MOL BIOL, V292, P965, DOI 10.1006/jmbi.1999.3129	42	24	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41118	41125		10.1074/jbc.M112.398628	http://dx.doi.org/10.1074/jbc.M112.398628			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048033	hybrid, Green Published			2022-12-25	WOS:000311887600028
J	Nsair, A; Schenke-Layland, K; Van Handel, B; Evseenko, D; Kahn, M; Zhao, P; Mendelis, J; Heydarkhan, S; Awaji, O; Vottler, M; Geist, S; Chyu, J; Gago-Lopez, N; Crooks, GM; Plath, K; Goldhaber, J; Mikkola, HKA; MacLellan, WR				Nsair, Ali; Schenke-Layland, Katja; Van Handel, Ben; Evseenko, Denis; Kahn, Michael; Zhao, Peng; Mendelis, Joseph; Heydarkhan, Sanaz; Awaji, Obina; Vottler, Miriam; Geist, Susanne; Chyu, Jennifer; Gago-Lopez, Nuria; Crooks, Gay M.; Plath, Kathrin; Goldhaber, Josh; Mikkola, Hanna K. A.; MacLellan, W. Robb			Characterization and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE; CARDIAC MYOCYTES; MAMMALIAN HEART; NEURAL CREST; FIBROBLASTS; LINEAGES; MOUSE; CARDIOMYOCYTE; DIFFERENTIATION; POPULATION	Background: Cardiovascular progenitor cells (CPCs) have been identified within the developing mouse heart and differentiating pluripotent stem cells by intracellular transcription factors Nkx2.5 and Islet 1 (Isl1). Study of endogenous and induced pluripotent stem cell (iPSC)-derived CPCs has been limited due to the lack of specific cell surface markers to isolate them and conditions for their in vitro expansion that maintain their multipotency. Methodology/Principal Findings: We sought to identify specific cell surface markers that label endogenous embryonic CPCs and validated these markers in iPSC-derived Isl1(+)/Nkx2.5(+) CPCs. We developed conditions that allow propagation and characterization of endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPCs and protocols for their clonal expansion in vitro and transplantation in vivo. Transcriptome analysis of CPCs from differentiating mouse embryonic stem cells identified a panel of surface markers. Comparison of these markers as well as previously described surface markers revealed the combination of Flt1(+)/Flt4(+) best identified and facilitated enrichment for Isl1(+)/Nkx2.5(+) CPCs from embryonic hearts and differentiating iPSCs. Endogenous mouse and iPSC-derived Flt1(+)/Flt4(+) CPCs differentiated into all three cardiovascular lineages in vitro. Flt1(+)/Flt4(+) CPCs transplanted into left ventricles demonstrated robust engraftment and differentiation into mature cardiomyocytes (CMs). Conclusion/Significance: The cell surface marker combination of Flt1 and Flt4 specifically identify and enrich for an endogenous and iPSC-derived Isl1(+)/Nkx2.5(+) CPC with trilineage cardiovascular potential in vitro and robust ability for engraftment and differentiation into morphologically and electrophysiologically mature adult CMs in vivo post transplantation into adult hearts.	[Nsair, Ali; Schenke-Layland, Katja; Zhao, Peng; Mendelis, Joseph; Heydarkhan, Sanaz; Awaji, Obina; Chyu, Jennifer; Gago-Lopez, Nuria] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol & Med, Los Angeles, CA 90095 USA; [Schenke-Layland, Katja; Vottler, Miriam; Geist, Susanne] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Dept Cell & Tissue Engn, Stuttgart, Germany; [Schenke-Layland, Katja; Vottler, Miriam; Geist, Susanne] Univ Tubingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany; [Evseenko, Denis; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Van Handel, Ben; Mikkola, Hanna K. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Van Handel, Ben; Evseenko, Denis; Crooks, Gay M.; Plath, Kathrin; Mikkola, Hanna K. A.] Univ Calif Los Angeles, David Geffen Sch Med, Edythe & Eli Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Goldhaber, Josh] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Kahn, Michael] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Kahn, Michael] Univ So Calif, Inst Stem Cell & Regenerat Med, Los Angeles, CA USA; [MacLellan, W. Robb] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fraunhofer Gesellschaft; Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Southern California; University of Southern California; University of Washington; University of Washington Seattle	Nsair, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol & Med, Los Angeles, CA 90095 USA.	ansair@mednet.ucla.edu	Schenke-Layland, Katja/E-5940-2013; López, Nuria Gago/M-3300-2014	Schenke-Layland, Katja/0000-0001-8066-5157; López, Nuria Gago/0000-0001-8220-7467; Plath, Kathrin/0000-0001-7796-3372; Goldhaber, Joshua/0000-0001-8413-5719	National Institutes of Health [5T32HL007895-10, P01-HL080111, R0-HL094941]; Laubisch and Cardiovascular Development Funds; Ruth Kirschstein National Research Service Award [GM007185]; Alberta Heritage Foundation for Medical Research Fellowship (AHFMR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070748, R21HL094941, R01HL070828, P01HL080111, T32HL007895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch and Cardiovascular Development Funds; Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation for Medical Research Fellowship (AHFMR)(Alberta Heritage Foundation for Medical Research); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (5T32HL007895-10 to KS-L; P01-HL080111 and R0-HL094941 to WRM), Laubisch and Cardiovascular Development Funds (to WRM), Ruth Kirschstein National Research Service Award (GM007185 to BVH), and the Alberta Heritage Foundation for Medical Research Fellowship (AHFMR to AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2009, NATURE, V460, P18, DOI 10.1038/460018a; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Deuse T, 2011, J CELL SCI, V124, P3029, DOI 10.1242/jcs.087718; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Khattar P, 2011, STEM CELLS DEV, V20, P1043, DOI 10.1089/scd.2010.0374; Kuraitis D, 2010, CURR OPIN CARDIOL, V25, P575, DOI 10.1097/HCO.0b013e32833f0318; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Povsic TJ, 2010, EXPERT REV CARDIOVAS, V8, P1107, DOI 10.1586/ERC.10.99; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamura Y, 2011, ARTERIOSCL THROM VAS, V31, P582, DOI 10.1161/ATVBAHA.110.214726; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weinberger F, 2012, CIRC RES, V110, P1303, DOI 10.1161/CIRCRESAHA.111.259630; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yi BA, 2010, J CLIN INVEST, V120, P20, DOI 10.1172/JCI40820; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	40	25	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45603	10.1371/journal.pone.0045603	http://dx.doi.org/10.1371/journal.pone.0045603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056209	Green Submitted, gold, Green Published			2022-12-25	WOS:000309889400007
J	Huppert, A; Barnea, O; Katriel, G; Yaari, R; Roll, U; Stone, L				Huppert, Amit; Barnea, Oren; Katriel, Guy; Yaari, Rami; Roll, Uri; Stone, Lewi			Modeling and Statistical Analysis of the Spatio-Temporal Patterns of Seasonal Influenza in Israel	PLOS ONE			English	Article							PANDEMIC INFLUENZA; UNITED-STATES; REPRODUCTIVE NUMBER; SCHOOL CLOSURE; TRANSMISSION; DISEASE; EPIDEMICS; DYNAMICS; OUTBREAK; VACCINATION	Background: Seasonal influenza outbreaks are a serious burden for public health worldwide and cause morbidity to millions of people each year. In the temperate zone influenza is predominantly seasonal, with epidemics occurring every winter, but the severity of the outbreaks vary substantially between years. In this study we used a highly detailed database, which gave us both temporal and spatial information of influenza dynamics in Israel in the years 1998-2009. We use a discrete-time stochastic epidemic SIR model to find estimates and credible confidence intervals of key epidemiological parameters. Findings: Despite the biological complexity of the disease we found that a simple SIR-type model can be fitted successfully to the seasonal influenza data. This was true at both the national levels and at the scale of single cities. The effective reproductive number Re varies between the different years both nationally and among Israeli cities. However, we did not find differences in Re between different Israeli cities within a year. Re was positively correlated to the strength of the spatial synchronization in Israel. For those years in which the disease was more "infectious", then outbreaks in different cities tended to occur with smaller time lags. Our spatial analysis demonstrates that both the timing and the strength of the outbreak within a year are highly synchronized between the Israeli cities. We extend the spatial analysis to demonstrate the existence of high synchrony between Israeli and French influenza outbreaks. Conclusions: The data analysis combined with mathematical modeling provided a better understanding of the spatiotemporal and synchronization dynamics of influenza in Israel and between Israel and France. Altogether, we show that despite major differences in demography and weather conditions intra-annual influenza epidemics are tightly synchronized in both their timing and magnitude, while they may vary greatly between years. The predominance of a similar main strain of influenza, combined with population mixing serve to enhance local and global influenza synchronization within an influenza season.	[Barnea, Oren; Katriel, Guy; Yaari, Rami; Roll, Uri; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Huppert, Amit] Chaim Sheba Med Ctr, Gertner Inst, IL-52621 Tel Hashomer, Israel; [Yaari, Rami] Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel; [Katriel, Guy] ORT Braude Coll, Dept Math, Karmiel, Israel	Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	Stone, L (corresponding author), Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il	Roll, Uri/AAE-7137-2019	Roll, Uri/0000-0002-5418-1164; Stone, Lewi/0000-0002-6465-579X; Katriel, Guy/0000-0001-7411-4789	EU-FP7 Epiwork grant; Maccabi Institute for Health Services Research Grant; Israel Science Foundation; Israel Ministry of Health; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Israel National Institute for Health Policy and Health Services Research	EU-FP7 Epiwork grant; Maccabi Institute for Health Services Research Grant; Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Israel National Institute for Health Policy and Health Services Research	This work was supported by the EU-FP7 Epiwork grant, the Maccabi Institute for Health Services Research Grant, the Israel Science Foundation and the Israel Ministry of Health. UR is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. RY is supported by the Israel National Institute for Health Policy and Health Services Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Bailey NTJ, 1975, MATH THEORY INFECT D; Barnea O, 2011, MATH BIOSCI ENG, V8, P561, DOI 10.3934/mbe.2011.8.561; BAROYAN O V, 1971, Advances in Applied Probability, V3, P224, DOI 10.2307/1426167; Baroyan OV, 1977, MODELLING PREDICTION; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Bolker B, 2008, ECOLOGICAL MODELS DA; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Brauer F., 2005, ELECTRON J DIFFER EQ, V2005, P29; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; Cintron-Arias A, 2009, MATH BIOSCI ENG, V6, P261, DOI 10.3934/mbe.2009.6.261; Cliff A D, 1993, Stat Methods Med Res, V2, P43, DOI 10.1177/096228029300200104; Coelho FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019616; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Edlund S, 2011, ELECTRON J HEALTH IN, V6; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, ECOLOGICAL IMMUNOLOG, P422, DOI [10.1038/nature01491.1., DOI 10.1038/NATURE01491.1]; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heymann AD, 2009, EPIDEMIOL INFECT, V137, P1369, DOI 10.1017/S0950268809002556; Hoen AG, 2011, CAN MED ASSOC J, V183, pE1025, DOI 10.1503/cmaj.110241; Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515; Katriel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009565; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lin J, 1999, MATH BIOSCI, V162, P33, DOI 10.1016/S0025-5564(99)00042-5; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Roll U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-92; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SPICER CC, 1979, BRIT MED BULL, V35, P23, DOI 10.1093/oxfordjournals.bmb.a071536; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; STONE L, 1992, P ROY SOC B-BIOL SCI, V250, P77, DOI 10.1098/rspb.1992.0133; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Truscott James, 2009, PLoS Curr, V1, pRRN1125; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	58	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45107	10.1371/journal.pone.0045107	http://dx.doi.org/10.1371/journal.pone.0045107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056192	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500014
J	Watsuji, TO; Nishizawa, M; Morono, Y; Hirayama, H; Kawagucci, S; Takahata, N; Sano, Y; Takai, K				Watsuji, Tomo-o; Nishizawa, Manabu; Morono, Yuki; Hirayama, Hisako; Kawagucci, Shinsuke; Takahata, Naoto; Sano, Yuji; Takai, Ken			Cell-Specific Thioautotrophic Productivity of Epsilon-Proteobacterial Epibionts Associated with Shinkaia crosnieri	PLOS ONE			English	Article							DIVERSITY; CARBON; CRAB	In this study, we report experimental evidence of the thioautotrophic activity of the epibiotic microbial community associated with the setae of Shinkaia crosnieri, a galatheid crab that is endemic to deep-sea hydrothermal systems in the Okinawa Trough in Japan. Microbial consumption of reduced sulfur compounds under in situ hydrostatic and atmospheric pressure provided evidence of sulfur-oxidizing activity by the epibiotic microbial community; the rate of sulfur oxidation was similar under in situ and decompressed conditions. Results of the microbial consumption of reduced sulfur compounds and tracer experiments using C-13-labeled bicarbonate in the presence and absence of thiosulfate (used as a thioautotrophic substrate) convincingly demonstrated that the epibiotic microbial community on S. crosnieri drove primary production via an energy metabolism that was coupled with the oxidation of reductive sulfur compounds. A combination of tracer experiments, fluorescence in situ hybridization (FISH) and nano-scale secondary ion mass spectrometry (Nano-SIMS) indicated that the filamentous cells of the genus Sulfurovum belonging to the class Epsilonproteobacteria were thioautotrophs in the epibiotic community of S. crosnieri. In conclusion, our results strongly suggest that thioautotrophic production by Sulfurovum members present as the epibiotic microbial community play a predominant role in a probable nutritional ectosymbiosis with S. crosnieri.	[Watsuji, Tomo-o; Hirayama, Hisako; Kawagucci, Shinsuke; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Subsurface Geobiol Adv Res Team SUGAR, Extremobiosphere Res Program XBR, Inst Biogeosci, Yokosuka, Kanagawa, Japan; [Nishizawa, Manabu] JAMSTEC, Precambrian Ecosyst Lab, Yokosuka, Kanagawa, Japan; [Morono, Yuki] JAMSTEC, Geomicrobiol Grp, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan; [Takahata, Naoto; Sano, Yuji] Univ Tokyo, Atomosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo	Watsuji, TO (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Subsurface Geobiol Adv Res Team SUGAR, Extremobiosphere Res Program XBR, Inst Biogeosci, Yokosuka, Kanagawa, Japan.	watsuji@jamstec.go.jp	Sano, Yuji/B-8971-2015; Kawagucci, Shinsuke/O-7813-2019; Takahata, Naoto/AAF-5161-2019; kawagucci, shinsuke/H-6047-2013; , 西澤学/M-9598-2016; Kawagucci, Shinsuke/H-4192-2013	Sano, Yuji/0000-0002-3305-5644; kawagucci, shinsuke/0000-0002-7807-024X; , 西澤学/0000-0002-6467-670X; Morono, Yuki/0000-0001-8928-4254	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20109005, 21244077]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Marine-Earth Science and Technology (JAMSTEC)	This work was supported by a Grant-in-Aid for Science Research (Nos. 20109005 and 21244077 to K. Takai) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and by a grant from the Japan Agency for Marine-Earth Science and Technology (JAMSTEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Kawagucci S, 2011, GEOCHEM J, V45, P109; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Takai K, 2009, ENVIRON MICROBIOL, V11, P1983, DOI 10.1111/j.1462-2920.2009.01921.x; Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	20	20	20	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46282	10.1371/journal.pone.0046282	http://dx.doi.org/10.1371/journal.pone.0046282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056274	gold, Green Submitted, Green Published			2022-12-25	WOS:000309452600032
J	Levy, E; Kennington, WJ; Tomkins, JL; Lebas, NR				Levy, Esther; Kennington, W. Jason; Tomkins, Joseph L.; LeBas, Natasha R.			Phylogeography and Population Genetic Structure of the Ornate Dragon Lizard, Ctenophorus ornatus	PLOS ONE			English	Article							DIRECT-DEVELOPING FROG; AUSTRALIAN LIZARD; LACERTA-AGILIS; F-STATISTICS; SAND LIZARD; DISPERSAL; FLOW; BIOGEOGRAPHY; SOFTWARE; PATTERNS	Species inhabiting ancient, geologically stable landscapes that have been impacted by agriculture and urbanisation are expected to have complex patterns of genetic subdivision due to the influence of both historical and contemporary gene flow. Here, we investigate genetic differences among populations of the granite outcrop-dwelling lizard Ctenophorus ornatus, a phenotypically variable species with a wide geographical distribution across the south-west of Western Australia. Phylogenetic analysis of mitochondrial DNA sequence data revealed two distinct evolutionary lineages that have been isolated for more than four million years within the C. ornatus complex. This evolutionary split is associated with a change in dorsal colouration of the lizards from deep brown or black to reddish-pink. In addition, analysis of microsatellite data revealed high levels of genetic structuring within each lineage, as well as strong isolation by distance at multiple spatial scales. Among the 50 outcrop populations' analysed, non-hierarchical Bayesian clustering analysis revealed the presence of 23 distinct genetic groups, with outcrop populations less than 4 km apart usually forming a single genetic group. When a hierarchical analysis was carried out, almost every outcrop was assigned to a different genetic group. Our results show there are multiple levels of genetic structuring in C. ornatus, reflecting the influence of both historical and contemporary evolutionary processes. They also highlight the need to recognise the presence of two evolutionarily distinct lineages when making conservation management decisions on this species.	[Levy, Esther; Kennington, W. Jason; Tomkins, Joseph L.; LeBas, Natasha R.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia	University of Western Australia	Levy, E (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia.	levye01@student.uwa.edu.au	Kennington, Winn J/H-5182-2014; Tomkins, Joseph L/A-8091-2011; LeBas, Natasha R/E-7339-2015	Kennington, Winn J/0000-0001-6100-6543; Tomkins, Joseph L/0000-0003-1259-7898; LeBas, Natasha R/0000-0003-4706-3909	Holsworth Wildlife Research Endowment; School of Animal Biology at the University of Western Australia; Australian Postgraduate Award; Australian Research Council Fellowships	Holsworth Wildlife Research Endowment; School of Animal Biology at the University of Western Australia; Australian Postgraduate Award(Australian Government); Australian Research Council Fellowships(Australian Research Council)	This research was supported by the Holsworth Wildlife Research Endowment and the School of Animal Biology at the University of Western Australia. EL was funded by an Australian Postgraduate Award. NRL and JLT were funded by Australian Research Council Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Beard JS, 2000, J BIOGEOGR, V27, P1257, DOI 10.1046/j.1365-2699.2000.00509.x; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Byrne M, 2000, AUST J BOT, V48, P305, DOI 10.1071/BT99017; Byrne M, 2004, AUST J BOT, V52, P459, DOI 10.1071/BT03117; Byrne M, 2003, THEOR APPL GENET, V107, P1208, DOI 10.1007/s00122-003-1365-2; Byrne M, 2003, HEREDITY, V91, P389, DOI 10.1038/sj.hdy.6800346; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Capula M, 1996, HEREDITY, V77, P518, DOI 10.1038/hdy.1996.179; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clark RW, 2008, MOL ECOL, V17, P719; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coates DJ, 2003, AM J BOT, V90, P997, DOI 10.3732/ajb.90.7.997; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dever JA, 2002, COPEIA, P1078; Edward D.H.D., 1989, Acta Biologica Debrecina Supplementum Oecologica Hungarica, V2, P181; Edwards DL, 2008, J BIOGEOGR, V35, P1803, DOI 10.1111/j.1365-2699.2008.01927.x; Edwards DL, 2007, MOL PHYLOGENET EVOL, V45, P494, DOI 10.1016/j.ympev.2007.05.023; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gardner MG, 2007, J ETHOL, V25, P263, DOI 10.1007/s10164-006-0022-z; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Gullberg A, 1998, BIOL J LINN SOC, V65, P257, DOI 10.1006/bijl.1998.0221; Hart MW, 2011, EVOLUTION, V65, P613, DOI 10.1111/j.1558-5646.2010.01202.x; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Jarvis N., 1986, W AUSTR ATLAS HUMAN; King RB, 2001, COPEIA, P602, DOI 10.1643/0045-8511(2001)001[0602:POPSAG]2.0.CO;2; LAMONT BB, 1995, AUST J BOT, V43, P283, DOI 10.1071/BT9950283; Lebas NR, 2000, MOL ECOL, V9, P365, DOI 10.1046/j.1365-294x.2000.00874.x; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lebas NR, 2001, MOL ECOL, V10, P193, DOI 10.1046/j.1365-294X.2001.01174.x; Levy E, 2010, CONSERV GENET RESOUR, V2, P313, DOI 10.1007/s12686-010-9216-3; Levy E, 2010, MOL ECOL, V19, P4192, DOI 10.1111/j.1365-294X.2010.04810.x; MAIN BY, 1991, J NAT HIST, V25, P383, DOI 10.1080/00222939100770271; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Melville J, 2001, J EXP ZOOL, V291, P339, DOI 10.1002/jez.1133; Melville J, 2008, AUST J ZOOL, V56, P159, DOI 10.1071/ZO07069; Moir ML, 2009, J BIOGEOGR, V36, P1958, DOI 10.1111/j.1365-2699.2009.02137.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oksanen J., 2011, VEGAN COMMUNITY ECOL; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2009, DOCUMENTATION STRUCT; Rix MG, 2010, INVERTEBR SYST, V24, P209, DOI 10.1071/IS09048; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN D E, 1979, Bulletin of the American Museum of Natural History, V162, P267; Rousset F, 1997, GENETICS, V145, P1219; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; STORR GM, 1983, LIZARDS W AUSTR, V0002; Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K., 2011, MOL BIOL EVOLU UNPUB; Twidale CR., 1982, GRANITE LANDFORMS; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Withers P. C., 2000, Journal of the Royal Society of Western Australia, V83, P103; Zofkova M, 2009, HYDROBIOLOGIA, V635, P67, DOI 10.1007/s10750-009-9862-1	68	16	17	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46351	10.1371/journal.pone.0046351	http://dx.doi.org/10.1371/journal.pone.0046351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049697	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388500024
J	Asthagiri, AR; Vasquez, RA; Butman, JA; Wu, TX; Morgan, K; Brewer, CC; King, K; Zalewski, C; Kim, HJ; Lonser, RR				Asthagiri, Ashok R.; Vasquez, Raul A.; Butman, John A.; Wu, Tianxia; Morgan, Keaton; Brewer, Carmen C.; King, Kelly; Zalewski, Chris; Kim, H. Jeffrey; Lonser, Russell R.			Mechanisms of Hearing Loss in Neurofibromatosis Type 2	PLOS ONE			English	Article							VESTIBULAR-SCHWANNOMA; NATURAL-HISTORY; FLUID; DETERIORATION; BEVACIZUMAB; PROTEINS	Introduction: Patients with neurofibromatosis type 2 (NF2) develop bilateral cochleovestibular schwannomas (CVSs) that cause binaural deafness in most individuals. Hearing loss occurs in an unpredictable manner and the underlying mechanisms are not known. To gain insight into the pathophysiologic basis for hearing loss in NF2, we performed a prospective cross-sectional study of untreated ears in NF2 patients. Methods: One hundred consecutive NF2 patients in a prospective natural history study were included. Clinical and audiometric data were analyzed for treatment naive ears. In addition to standard MR-imaging sequences, alterations in intralabyrinthine protein content were determined utilizing high resolution FLAIR, the presence of cochlear aperture obstruction was determined by examining 3D T2 sequences, and endolymphatic hydrops was identified on delayed post-contrast FLAIR sequences. Results: Eighty-nine ears harboring 84 untreated CVSs in 56 consecutive NF2 patients (age 30 +/- 16 years) were analyzed. Thirty-four (38%) ears had varying degrees of hearing loss. Elevated intralabyrinthine protein was identified in 70 (75%) ears by FLAIR MR-imaging and was strongly associated with the presence of hearing loss (32/34 hearing loss ears; 94%)(Fisher's exact test; P = .005). Elevated intralabyrinthine protein was associated with the presence of CVS-associated cochlear aperture obstruction (64 of 67 ears with elevated protein; 96%)(Fisher's exact test; P<0.0001) in both normal and hearing loss ears. Elevated intralabyrinthine protein was not identified in ears without CVS (5 ears). While larger tumor size was associated with hearing loss (P = 0.006), 16 hearing loss ears (47%) harbored CVSs less than 0.5 cm(3), including 14 ears (88%) with block of the cochlear aperture and elevated protein. Discussion: These findings are consistent with a model in which hearing loss develops as a result of cochlear aperture obstruction and accumulation of intralabyrinthine protein. MRI based identification of elevated intralabyrinthine protein may help identify the ear at-risk for developing hearing loss.	[Asthagiri, Ashok R.; Vasquez, Raul A.; Morgan, Keaton; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Vasquez, Raul A.] Univ Florida, Dept Neurol Surg, Gainesville, FL USA; [Butman, John A.] NIH, Ctr Clin, Bethesda, MD USA; [Wu, Tianxia] NINDS, Clin Neurosci Program, NIH, Bethesda, MD 20892 USA; [Brewer, Carmen C.; King, Kelly; Zalewski, Chris] Natl Inst Deafness & Other Commun Disorders, Audiol Unit, Otolaryngol Branch, NIH, Bethesda, MD USA; [Kim, H. Jeffrey] Natl Inst Deafness & Other Commun Disorders, Off Clin Director, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Asthagiri, AR (corresponding author), NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	asthagiria@ninds.nih.gov	Butman, John A/A-2694-2008; Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195; Morgan, Keaton/0000-0001-9140-4454	National Institute of Neurologic Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; Clinical Center at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003132, ZIANS003053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIDDC000075, ZIADC000064] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Clinical Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the Intramural Research Program of the National Institute of Neurologic Disorders and Stroke, National Institute on Deafness and Other Communication Disorders and the Clinical Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MM, 1996, LARYNGOSCOPE, V106, P694, DOI 10.1097/00005537-199606000-00007; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Baser ME, 2002, NEUROLOGY, V59, P1759, DOI 10.1212/01.WNL.0000035638.74084.F4; Butman JA, 2008, JAMA-J AM MED ASSOC, V300, P1334, DOI 10.1001/jama.300.11.1334; Butman JA, 2007, JAMA-J AM MED ASSOC, V298, P41, DOI 10.1001/jama.298.1.41; DIX M R, 1950, J Laryngol Otol, V64, P658; ECKERMEIER L, 1979, ARCH OHREN NASEN KEH, V222, P1, DOI 10.1007/BF00456332; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; EVANS DGR, 1992, Q J MED, V84, P603; Fisher LM, 2009, OTOL NEUROTOL, V30, P835, DOI 10.1097/MAO.0b013e3181b2364c; Froin G, 1903, GAZ HOP, P76; GARDNER WJ, 1954, NEW ENGL J MED, V250, P932, DOI 10.1056/NEJM195406032502202; Graamans K, 2003, ACTA OTO-LARYNGOL, V123, P51, DOI 10.1080/0036554021000028075; King KA, 2007, EAR HEARING, V28, P831, DOI 10.1097/AUD.0b013e318157677f; LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P519, DOI 10.1097/00004728-199207000-00004; Lysaght AC, 2011, J PROTEOME RES, V10, P3845, DOI 10.1021/pr200346q; Masuda A, 2004, OTOL NEUROTOL, V25, P150, DOI 10.1097/00129492-200403000-00012; Melhem ER, 1997, AM J ROENTGENOL, V169, P859, DOI 10.2214/ajr.169.3.9275912; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Pennings RJE, 2011, NEUROSURGERY, V68, P68, DOI 10.1227/NEU.0b013e3181fc60cb; Plotkin SR, 2012, OTOL NEUROTOL, V33, P1046, DOI 10.1097/MAO.0b013e31825e73f5; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Roosli C, 2012, OTOL NEUROTOL, V33, P473, DOI 10.1097/MAO.0b013e318248ee02; Schuknecht H F, 1966, Nihon Jibiinkoka Gakkai Kaiho, V69, P1825; Shepherd RK, 2004, ARCH OTOLARYNGOL, V130, P518, DOI 10.1001/archotol.130.5.518; Silverstein H, 1973, Otolaryngol Clin North Am, V6, P229; SILVERSTEIN H, 1966, ARCHIV OTOLARYNGOL, V84, P395; Slattery WH, 2005, OTOL NEUROTOL, V26, P733, DOI 10.1097/01.mao.0000169048.15889.80; Tagaya M, 2011, ACTA OTO-LARYNGOL, V131, P474, DOI 10.3109/00016489.2010.534114; THOMSEN J, 1982, ORL J OTO-RHINO-LARY, V44, P61, DOI 10.1159/000275574; Trofatter J A, 1993, Cell, V75, P826; WENTHOLD RJ, 1982, BRAIN RES, V253, P263, DOI 10.1016/0006-8993(82)90693-X; Yamazaki M, 2009, NEURORADIOLOGY, V51, P855, DOI 10.1007/s00234-009-0588-6; Yoshida T, 2008, LARYNGOSCOPE, V118, P1433, DOI 10.1097/MLG.0b013e318172ef85	35	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46132	10.1371/journal.pone.0046132	http://dx.doi.org/10.1371/journal.pone.0046132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049959	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300088
J	Breinholt, JW; Porter, ML; Crandall, KA				Breinholt, Jesse W.; Porter, Megan L.; Crandall, Keith A.			Testing Phylogenetic Hypotheses of the Subgenera of the Freshwater Crayfish Genus Cambarus (Decapoda: Cambaridae)	PLOS ONE			English	Article							CONVERGENT EVOLUTION; MOLECULAR SYSTEMATICS; ORCONECTES DECAPODA; LARVAL MORPHOLOGY; SPECIES COMPLEX; TREE SELECTION; CAVE CRAYFISH; RIBOSOMAL DNA; MIXED MODELS; RIVER-BASIN	Background: The genus Cambarus is one of three most species rich crayfish genera in the Northern Hemisphere. The genus has its center of diversity in the Southern Appalachians of the United States and has been divided into 12 subgenera. Using Cambarus we test the correspondence of subgeneric designations based on morphology used in traditional crayfish taxonomy to the underlying evolutionary history for these crayfish. We further test for significant correlation and explanatory power of geographic distance, taxonomic model, and a habitat model to estimated phylogenetic distance with multiple variable regression. Methodology/Principal Findings: We use three mitochondrial and one nuclear gene regions to estimate the phylogenetic relationships for species within the genus Cambarus and test evolutionary hypotheses of relationships and associated morphological and biogeographical hypotheses. Our resulting phylogeny indicates that the genus Cambarus is polyphyletic, however we fail to reject the monophyly of Cambarus with a topology test. The majority of the Cambarus subgenera are rejected as monophyletic, suggesting the morphological characters used to define those taxa are subject to convergent evolution. While we found incongruence between taxonomy and estimated phylogenetic relationships, a multiple model regression analysis indicates that taxonomy had more explanatory power of genetic relationships than either habitat or geographic distance. Conclusions: We find convergent evolution has impacted the morphological features used to delimit Cambarus subgenera. Studies of the crayfish genus Orconectes have shown gonopod morphology used to delimit subgenera is also affected by convergent evolution. This suggests that morphological diagnoses based on traditional crayfish taxonomy might be confounded by convergent evolution across the cambarids and has little utility in diagnosing relationships or defining natural groups. We further suggest that convergent morphological evolution appears to be a common occurrence in invertebrates suggesting the need for careful phylogenetically based interpretations of morphological evolution in invertebrate systematics.	[Breinholt, Jesse W.; Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Porter, Megan L.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Crandall, Keith A.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA	Brigham Young University; University of South Dakota; George Washington University	Breinholt, JW (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	jessebreinholt@gmail.com	Breinholt, Jesse/K-6252-2019; Breinholt, Jesse/F-4330-2014; Crandall, Keith A./H-2789-2019	Breinholt, Jesse/0000-0002-3867-2430; Breinholt, Jesse/0000-0002-3867-2430; Crandall, Keith A./0000-0002-0836-3389	US NSF [EF-0531762]; Brigham Young University	US NSF(National Science Foundation (NSF)); Brigham Young University	This work was partially funded by a grant from the US NSF EF-0531762 awarded to KAC and Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow P-M, 2004, Q REV BIOL IN PRESS; Alejandrino A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-164; Bichain JM, 2007, MOL PHYLOGENET EVOL, V45, P927, DOI 10.1016/j.ympev.2007.07.018; Bone Q, 2005, J MAR BIOL ASSOC UK, V85, P641, DOI 10.1017/S0025315405011574; Bouchard R.W., 1976, Smithsonian Contributions to Zoology, VNo. 224, P1; Bouchard R.W., 1972, ASB Bull, V19, P56; Bouchard Raymond W., 1995, Notulae Naturae (Philadelphia), V471, P1; Breinholt J, 2009, CRUSTACEAN ISS, V18, P305; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P121, DOI 10.1651/08-3089.1; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Byrne M, 2003, BIOL BULL-US, V205, P285, DOI 10.2307/1543292; Cooper JE, 2010, P BIOL SOC WASH, V123, P335, DOI 10.2988/10-20.1; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Crandall KA, 1996, SYST BIOL, V45, P1; Crandall KA, 1998, BIOL CONSERV, V84, P107, DOI 10.1016/S0006-3207(97)00112-2; Crandall KA, 2007, CONSERV GENET, V10, P177; Crandall KA, 1996, COURIER FORSCHUNGSIN; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Daniels SR, 2006, MOL PHYLOGENET EVOL, V40, P227, DOI 10.1016/j.ympev.2006.02.022; De Grave S, 2009, RAFFLES B ZOOL, P1; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Erichson W, 1846, ARCH NATURGESCH, V12, P86; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fetzner Jr JW, 2011, GLOBAL CRAYFISH RESO; Fetzner JW, 1996, J CRUSTACEAN BIOL, V16, P111, DOI 10.2307/1548936; Finlay JB, 2006, ANIM CONSERV, V9, P375, DOI 10.1111/j.1469-1795.2006.00046.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forgie SA, 2006, MOL PHYLOGENET EVOL, V40, P662, DOI 10.1016/j.ympev.2006.04.018; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guiasu RC, 2009, CRUSTACEANA, V82, P721, DOI 10.1163/156854009X407722; Hobbs H.H. Jr., 1974, Smithsonian Contributions to Zoology, VNo. 164, P1; HOBBS HH, 1988, P BIOL SOC WASH, V101, P644; HOBBS HH, 1969, RES DIVISION MONOGRA, V1, P93; Hobbs Jr. H.H., 1989, SMITHS CONTRIB ZOOL, V480, P236, DOI [10.5479/si.00810282.480, DOI 10.5479/SI.00810282.480]; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Husemann M, 2012, ZOOL SCR, V41, P515, DOI 10.1111/j.1463-6409.2012.00548.x; JEZERINAC RF, 1993, P BIOL SOC WASH, V106, P532; Kanzaki N., 2006, Journal of the Japanese Forest Society, V88, P392, DOI 10.4005/jjfs.88.392; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2001, J MOL EVOL, V53, P477, DOI 10.1007/s002390010238; Kohler F, 2008, MALACOLOGIA, V50, P331; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Loughman ZJ, 2011, P BIOL SOC WASH, V124, P99, DOI 10.2988/10-09.1; Maddison, 2019, MESQUITE MODULAR SYS; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Mathews LM, 2008, MOL PHYLOGENET EVOL, V48, P126, DOI 10.1016/j.ympev.2008.02.006; McHenry MJ, 2004, EVOLUTION, V58, P1209; Mokady O, 1999, J MOL EVOL, V49, P367, DOI 10.1007/PL00006560; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Perez-Losada M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-15; Podolsky RD, 2005, BIOL BULL-US, V209, P127, DOI 10.2307/3593130; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Rhoades Rendell, 1944, AMER MIDLAND NAT, V31, P111, DOI 10.2307/2421386; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SINCLAIR E. A., 2004, FRESHWATER CRAYFISH, V14, P1; Song H, 2008, P NATL ACAD SC UNPUB; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor CA, 2002, J CRUSTACEAN BIOL, V22, P874, DOI 10.1651/0278-0372(2002)022[0874:POTCSC]2.0.CO;2; Taylor CA, 2007, FISHERIES, V32, P372, DOI 10.1577/1548-8446(2007)32[372:AROTCS]2.0.CO;2; Taylor CA, 2006, BIOL J LINN SOC, V89, P1, DOI 10.1111/j.1095-8312.2006.00637.x; Taylor PD, 2006, J GEOL SOC LONDON, V163, P225, DOI 10.1144/0016-764905-145; Thoma RF, 2011, P BIOL SOC WASH, V124, P318; Toon A, 2009, CRUSTACEAN ISS, V18, P9; Toon A, 2010, J BIOGEOGR, V37, P2275, DOI 10.1111/j.1365-2699.2010.02374.x; Whiting AS, 2000, ANIM CONSERV, V3, P155; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	79	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46105	10.1371/journal.pone.0046105	http://dx.doi.org/10.1371/journal.pone.0046105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049950	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300085
J	Dama, MS				Dama, Madhukar Shivajirao			Parasite Stress Predicts Offspring Sex Ratio	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; HEPATITIS-B; CYCLE DAY; BIRTH; MORTALITY; SONS; UNDERNUTRITION; POPULATIONS; TRIMESTER; PATTERNS	In this study, I predict that the global variation of offspring sex ratio might be influenced in part by the level of parasite stress. From an energetic standpoint, higher gestational costs of producing a male offspring could decrease male births in a population with limited resources. This implies that, any factor that limits the parental resources could be expected to favor female offspring production. Human sex ratio at birth (SRB) is believed to be influenced by numerous socioeconomic, biological, and environmental factors. Here, I test a prediction that parasite stress, by virtue of its effects on the general health condition, may limit the parental investment ability and therefore could influence the SRB at the population level. The statistical analysis supports this prediction, and show that the level of parasite stress has a significant inverse relation with population SRB across the world. Further, this relation is many-folds stronger than the association of SRB with other factors, like; polygyny, fertility, latitude, and son-preference. Hence, I propose that condition affecting ability of parasites (but not adaptive significance) could be a likely causal basis for the striking variation of SRB across populations.	Karnataka Vet Anim & Fisheries Sci Univ, Inst Wildlife Vet Res, Somavarpet Taluk, Karnataka, India		Dama, MS (corresponding author), Karnataka Vet Anim & Fisheries Sci Univ, Inst Wildlife Vet Res, Somavarpet Taluk, Karnataka, India.	madhukar262@gmail.com	Dama, Madhukar/H-9945-2012	Dama, Madhukar/0000-0002-8361-1530				[Anonymous], 1989, RACIAL ETHNIC DIFFER; [Anonymous], 2004, WORLD HLTH REP; Barber N, 2004, SOC BIOL, V51, P71; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; Betzig L, 2012, EVOL HUM BEHAV, V33, P309, DOI 10.1016/j.evolhumbehav.2011.10.008; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Brown GR, 2009, TRENDS ECOL EVOL, V24, P297, DOI 10.1016/j.tree.2009.02.005; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butts SF, 2010, FERTIL STERIL, V93, P681, DOI 10.1016/j.fertnstert.2009.10.047; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; CHAHNAZARIAN A, 1988, J BIOSOC SCI, V20, P357, DOI 10.1017/S0021932000006696; Chambliss R, 1949, SOC FORCES, V28, P190, DOI 10.2307/2572646; CHARNOV E L, 1982; Cramer JS, 2010, HUM BIOL, V82, P103, DOI 10.3378/027.082.0106; Dama MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023792; Das Gupta M, 2006, POPUL DEV REV, V32, P328; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DREW JS, 1978, SCIENCE, V201, P687, DOI 10.1126/science.566954; Ember C.R., 2001, CROSS CULTURAL RES M; Florey HW, 1970, GEN PATHOLOGY; Fox J., 1991, SAGE U PAPER SERIES; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Grech V, 2000, J EPIDEMIOL COMMUN H, V54, P244, DOI 10.1136/jech.54.4.244; Grech V, 2002, BRIT MED J, V324, P1010, DOI 10.1136/bmj.324.7344.1010; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Helle S, 2009, J ANIM ECOL, V78, P1226, DOI 10.1111/j.1365-2656.2009.01598.x; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hummer RA, 2011, DU BOIS REV, V8, P5, DOI 10.1017/S1742058X11000051; Ian CWH, 2002, HUMAN SEX RATIOS ADA; JAKOBOVITS AA, 1991, EUR J OBSTET GYN R B, V40, P211, DOI 10.1016/0028-2243(91)90119-6; James WH, 2006, ENVIRON RES, V100, P77, DOI 10.1016/j.envres.2005.03.001; JAMES WH, 1971, LANCET, V1, P112; James WH, 2000, HUM REPROD, V15, P1206, DOI 10.1093/humrep/15.5.1206; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Levine RS, 2001, PUBLIC HEALTH REP, V116, P474, DOI 10.1093/phr/116.5.474; Lin MJ, 2012, AM J HUM BIOL, V24, P541, DOI 10.1002/ajhb.22267; Mace R, 2003, COMP BIOCHEM PHYS A, V136, P85, DOI 10.1016/S1095-6433(03)00019-9; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Piazze J, 1999, EARLY HUM DEV, V54, P137, DOI 10.1016/S0378-3782(98)00088-7; Pollet T, 2010, J EVOLUTIONARY PSYCH, V8, P57; PRICE B, 1977, PSYCHOL BULL, V84, P759, DOI 10.1037/0033-2909.84.4.759; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Richardus JH, 2001, AM J PUBLIC HEALTH, V91, P1251, DOI 10.2105/AJPH.91.8.1251; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shields MD, 2002, BRIT MED J, V325, P335; Sparks PJ, 2009, MATERN CHILD HLTH J, V13, P769, DOI 10.1007/s10995-009-0476-z; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS138, DOI 10.1098/rsbl.2003.0123; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS37, DOI 10.1098/rsbl.2003.0086; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; United Nations Development Programme, 2009, HUM DEV REP; US Central Intelligence Agency, 2011, WORLD FACTB; WHITING JWM, 1993, AM ANTHROPOL, V95, P435, DOI 10.1525/aa.1993.95.2.02a00090; WHO, 2004, GLOB BURD DIS 2004; Winkleby MA, 2004, AM J HEALTH PROMOT, V19, P19, DOI 10.4278/0890-1171-19.1.19; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organization, 2011, GLOB HLTH RISKS MORT; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	65	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46169	10.1371/journal.pone.0046169	http://dx.doi.org/10.1371/journal.pone.0046169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049967	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300093
J	Miller-Rushing, AJ; Primack, RB; Phillips, N; Kaufmann, RK				Miller-Rushing, Abraham J.; Primack, Richard B.; Phillips, Nathan; Kaufmann, Robert K.			Effects of Warming Temperatures on Winning Times in the Boston Marathon	PLOS ONE			English	Article							RUNNING PERFORMANCE; DISTANCE RUNNERS; WEATHER; WOMEN; MEN	It is not known whether global warming will affect winning times in endurance events, and counterbalance improvements in race performances that have occurred over the past century. We examined a time series (1933-2004) from the Boston Marathon to test for an effect of warming on winning times by men and women. We found that warmer temperatures and headwinds on the day of the race slow winning times. However, 1.6 degrees C warming in annual temperatures in Boston between 1933 and 2004 did not consistently slow winning times because of high variability in temperatures on race day. Starting times for the race changed to earlier in the day beginning in 2006, making it difficult to anticipate effects of future warming on winning times. However, our models indicate that if race starting times had not changed and average race day temperatures had warmed by 0.058 degrees C/yr, a high-end estimate, we would have had a 95% chance of detecting a consistent slowing of winning marathon times by 2100. If average race day temperatures had warmed by 0.028 degrees C/yr, a mid-range estimate, we would have had a 64% chance of detecting a consistent slowing of winning times by 2100.	[Miller-Rushing, Abraham J.; Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Phillips, Nathan; Kaufmann, Robert K.] Boston Univ, Dept Geog & Environm, Boston, MA 02215 USA	Boston University; Boston University	Primack, RB (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	primack@bu.edu	Kaufmann, Robert K/I-4962-2017; Miller-Rushing, Abraham/D-5102-2009	Kaufmann, Robert K/0000-0002-5670-7027; Miller-Rushing, Abraham/0000-0003-3203-0143	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; CONOVER JH, 1985, B AM METEOROL SOC, V66, P30, DOI 10.1175/1520-0477(1985)066<0030:HOTHOT>2.0.CO;2; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2007, MED SCI SPORT EXER, V39, P2029, DOI 10.1249/mss.0b013e318149f2c3; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; IPCC, 2007, CONTRIBUTION WORKING; Martin DE, 1999, CHANCE, V12, P20, DOI DOI 10.1080/09332480.1999.10542170; McCann DJ, 1997, MED SCI SPORT EXER, V29, P955, DOI 10.1097/00005768-199707000-00016; New England Regional Assessment Group, 2001, PREP CHANG CLIM POT; NIELSEN B, 1988, EUR J APPL PHYSIOL O, V58, P189, DOI 10.1007/BF00636625; Sparling PB, 1998, MED SCI SPORT EXER, V30, P1725, DOI 10.1097/00005768-199812000-00011; TRAPASSO LM, 1989, INT J BIOMETEOROL, V33, P233, DOI 10.1007/BF01051083; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; YAGLOU C P, 1957, AMA Arch Ind Health, V16, P302; ZHANG SP, 1992, INT J BIOMETEOROL, V36, P63; Zhang XY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020137	19	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43579	10.1371/journal.pone.0043579	http://dx.doi.org/10.1371/journal.pone.0043579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049738	Green Published, gold			2022-12-25	WOS:000309517300006
J	Porco, D; Potapov, M; Bedos, A; Busmachiu, G; Weiner, WM; Hamra-Kroua, S; Deharveng, L				Porco, David; Potapov, Mikhail; Bedos, Anne; Busmachiu, Galina; Weiner, Wanda M.; Hamra-Kroua, Salah; Deharveng, Louis			Cryptic Diversity in the Ubiquist Species Parisotoma notabilis (Collembola, Isotomidae): A Long-Used Chimeric Species?	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; SPRINGTAILS HEXAPODA; SOIL; MITOCHONDRIAL; COMMUNITIES; FOREST; POPULATIONS; DIVERGENCE; EARTHWORM; POLLUTION	Parisotoma notabilis is the most common species of Collembola in Europe and is currently designated as ubiquist. This species has been extensively used in numerous studies and is considered as well characterized on a morphological ground. Despite the homogeneity of its morphology, the sequencing of the barcoding fragment (5' end of COI) for several populations throughout Europe and North America revealed four distinct genetic lineages. The divergence found between these lineages was similar to the genetic distance among other species of the genus Parisotoma included in the analysis. All four lineages have been confirmed by the nuclear gene 28S. This congruence between mitochondrial and nuclear signals, as well as the geographical distribution pattern of lineages observed in Europe, supports the potential specific status of these lineages. Based on specimens from the type locality (Hamburg), the species name was successfully assigned to one of these lineages. This finding raises several problems as Parisotoma notabilis has been widely used in many ecological studies. Accumulation of new data for the different lineages detected, especially ecological information and life history traits, is needed to help resolve this situation.	[Porco, David] Univ Rouen, Ecol Lab, EA ECODIV 1293, FED SCALE, Mont St Aignan, France; [Potapov, Mikhail] Moscow State Pedag Univ, Dept Zool & Ecol, Moscow 119435, Russia; [Bedos, Anne; Deharveng, Louis] Museum Natl Hist Nat, Origine Struct & Evolut Biodiversite UMR7205, F-75231 Paris, France; [Busmachiu, Galina] Moldavian Acad Sci, Inst Zool, Kishinev, Moldova; [Weiner, Wanda M.] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Hamra-Kroua, Salah] Univ Mentouri Constantine, Lab Biosystemat & Ecol Arthropodes, Fac SNV, Dept Biol Anim, Constantine, Algeria	Universite de Rouen Normandie; Moscow State University of Education; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Academy of Sciences of Moldova; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Universite Constantine	Porco, D (corresponding author), Univ Rouen, Ecol Lab, EA ECODIV 1293, FED SCALE, Mont St Aignan, France.	david.porco.gm@gmail.com	Weiner, Wanda Maria/AAW-3735-2020; Potapov, Mikhail/AAG-4607-2022; Potapov, Mikhail B./T-7534-2017; Potapov, Mikhail/AFK-6336-2022	Weiner, Wanda Maria/0000-0002-7257-3671; Potapov, Mikhail/0000-0002-6111-3354; Potapov, Mikhail/0000-0002-6111-3354	NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]	NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada; Ontario Genomics Institute	This work was funded by NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez T, 1997, PEDOBIOLOGIA, V41, P110; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Birky Jr CW, 2009, ASEXUAL SPECIFICATIO, P201; CARAPELLI A, 1995, EUR J SOIL BIOL, V31, P87; CARAPELLI A, 1995, B ZOOL, V62, P71, DOI 10.1080/11250009509356053; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Chahartaghi-Abnieh M, 2007, THESIS; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; D'Haese CA, 2002, P ROY SOC B-BIOL SCI, V269, P1143, DOI 10.1098/rspb.2002.1981; Decaens T, 2012, APPL SOIL E IN PRESS; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Deharveng L, 1996, CONSERV BIOL, V10, P74, DOI 10.1046/j.1523-1739.1996.10010074.x; Deharveng L., 1981, CNFRA (Comite National Francais des Recherches Antarctiques), P33; Fanciulli PP, 2009, PEDOBIOLOGIA, V52, P309, DOI 10.1016/j.pedobi.2008.11.004; Fanciulli PP, 2000, BIOL J LINN SOC, V70, P221, DOI 10.1006/bijl.1999.0369; FANCIULLI PP, 1991, REV ECOL BIOL SOL, V28, P165; FJELLBERG A, 1977, ENTOMOL SCAND, V8, P9, DOI 10.1163/187631277X00026; Fjellberg A, 1980, IDENTIFICATION KEYS; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRATI F, 1992, J HERED, V83, P275, DOI 10.1093/oxfordjournals.jhered.a111213; Frati Francesco, 1995, Polskie Pismo Entomologiczne, V64, P41; Fromm H, 1997, 26 TU; Haimi J, 1996, FRESEN J ANAL CHEM, V354, P672; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hausmann A, 2009, ZOOTAXA, P1; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; Kaprus IJ, 1999, P SHEVCHENKO SCI SOC, V3, P235; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kuznetsova NA, 1997, RUSS J ECOL+, V28, P386; Larink O, 1997, SPRINGTAILS MITES IM, P225; LEE BH, 1977, PAC INSECTS, V17, P155; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LOPES CM, 1994, EUR J SOIL BIOL, V30, P133; Martynova EF, 1977, KOMPONENTY BIOCENOZO, P102; Novo M, 2010, MOL PHYLOGENET EVOL, V56, P507, DOI 10.1016/j.ympev.2010.04.010; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; PETERSEN H, 1971, Revue d'Ecologie et de Biologie du Sol, V8, P133; Petersen H, 1987, SOIL FAUNA SOIL FERT, P217; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Porco D, 2012, INVERTEBRAT IN PRESS; Porco D, 2012, BIOL INVASI IN PRESS; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Porco David, 2010, Zootaxa, V2639, P59; POTAPOV M B, 1991, Acta Zoologica Cracoviensia, V34, P267; Potapov Mikhail, 2001, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V73, P1; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; RUSEK J, 1984, ACTA ENTOMOL BOHEMOS, V81, P343; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmon J. T., 1941, Transactions and Proceedings of the Royal Society of New Zealand, V70, P282; Salmon S, 2010, REV ECOL-TERRE VIE, V65, P45; Simonsen V, 2004, PEDOBIOLOGIA, V48, P297, DOI 10.1016/j.pedobi.2004.03.002; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Soto-Adames FN, 2000, SYST ENTOMOL, V25, P485, DOI 10.1046/j.1365-3113.2000.00127.x; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; TRANVIK L, 1993, J APPL ECOL, V30, P43, DOI 10.2307/2404269; Vaglia T, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1923.1.2; Van Straalen NM, 1996, CRITICAL BODY CONCEN, P5; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Zhou X, 2009, FRONTIERS ZOOLOGY, V6, P9	73	48	52	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46056	10.1371/journal.pone.0046056	http://dx.doi.org/10.1371/journal.pone.0046056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049931	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300078
J	Yang, WY; Zhao, WH; Xiao, JZ; Li, R; Zhang, P; Kissimova-Skarbek, K; Schneider, E; Jia, WP; Ji, LN; Guo, XH; Shan, ZY; Liu, J; Tian, HM; Chen, L; Zhou, ZG; Ji, QH; Ge, JP; Chen, G; Brown, J				Yang, Wenying; Zhao, Wenhui; Xiao, Jianzhong; Li, Rui; Zhang, Ping; Kissimova-Skarbek, Katarzyna; Schneider, Erin; Jia, Weiping; Ji, Linong; Guo, Xiaohui; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Chen, Li; Zhou, Zhiguang; Ji, Qiuhe; Ge, Jiapu; Chen, Gang; Brown, Jonathan			Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity	PLOS ONE			English	Article							PRESSURE-LOWERING DRUGS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; COST-EFFECTIVENESS; LOW-INCOME; FOLLOW-UP; PREVENTION; MELLITUS; PREVALENCE; BURDEN	Background: The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care. Methods: In 2009-10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%. Findings: After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all p<0.05). Adjusted expenditures for medical care were 3.38 times higher among people with diabetes than among people with normal glucose tolerance (p<0.01, unadjusted 3.97). Persons who were diagnosed with >= 10 years prior to the survey paid 3.75 times as much for medical care as those with <= 5 years of diagnosed diabetes. Among persons with diabetes, 45.2% took medication to control blood sugar, 21.1% took an antihypertensive medicine, 22.4% took daily aspirin, and 1.8% took a statin. Over the three months before the interview, 46.1% of persons with diabetes recalled seeing a doctor, 48.9% recalled a blood pressure measurement, and 54.5% recalled a blood sugar test. Over the year preceding the interview, 32.1% recalled a retinal screening and 17.9% recalled a foot examination. Conclusions: In China, health care use and costs were dramatically higher for people with diabetes than for people with normal glucose tolerance and, in relative terms, much higher than in industrialized countries. Low-cost generic medicines that would reduce diabetes expenditures were not fully used.	[Kissimova-Skarbek, Katarzyna; Schneider, Erin; Brown, Jonathan] Int Diabet Federat, Brussels, Belgium; [Yang, Wenying; Zhao, Wenhui; Xiao, Jianzhong] Chinese Japanese Friendship Hosp, Beijing, Peoples R China; [Zhao, Wenhui] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhao, Wenhui] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Rui; Zhang, Ping] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kissimova-Skarbek, Katarzyna] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland; [Schneider, Erin] Natl Bur Asian Res, Seattle, WA USA; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Shenyang, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Taiyuan, Shaanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Changsha, Hunan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China	China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Centers for Disease Control & Prevention - USA; Jagiellonian University; Collegium Medicum Jagiellonian University; Shanghai Jiao Tong University; Peking University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Shandong University; Central South University; Air Force Military Medical University; Fujian Provincial Hospital	Brown, J (corresponding author), Int Diabet Federat, Brussels, Belgium.	jonabrown@gmail.com	Linong, Ji/AAB-6543-2020	Kissimova-Skarbek, Katarzyna/0000-0003-4624-0918; Zhou, Zhiguang/0000-0002-0374-1838	Economic Study Fund of the International Diabetes Federation (IDF); Chinese Diabetes Society; Merck and Co.; Novo Nordisk; Eli Lilly and Co.; Takeda Pharmaceuticals North America; GSK, Inc.; GSK; Eli Lilly; Merck; Roche and Co.	Economic Study Fund of the International Diabetes Federation (IDF); Chinese Diabetes Society; Merck and Co.(Merck & Company); Novo Nordisk(Novo Nordisk); Eli Lilly and Co.(Eli Lilly); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); GSK, Inc.; GSK(GlaxoSmithKline); Eli Lilly(Eli Lilly); Merck(Merck & Company); Roche and Co.	This study was funded by allocations from the Economic Study Fund of the International Diabetes Federation (IDF), a not-for-profit NGO headquartered in Brussels, Belgium, and from the Chinese Diabetes Society. The IDF's Economic Studies Fund was created from contributions that IDF solicited from Merck and Co., Novo Nordisk, Eli Lilly and Co., Takeda Pharmaceuticals North America, and GSK, Inc. These funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, or selection of countries in which economic impact studies were conducted. Additional resources, in the form of volunteer time, logistical support, and expertise were provided by the 12 study sites in China, by the Chinese Diabetes Society, by the Chinese-Japanese Friendship Hospital, by the Kaiser Permanente Center for Health Research, by the United States Centers for Disease Control and Prevention, by the International Diabetes Federation, and by the authors.; Before retirement in 11/09 J. Brown led or could have led studies funded by research contracts with Novo Nordisk, GSK, Takeda Pharmaceuticals North America, Eli Lilly, and Merck. J. Brown had no consulting or other paid or unpaid arrangements with these or other actual or potential commercial funders. Starting in 2002 J. Brown led the creation of the IDF Economic Studies Fund with funds from Novo Nordisk, GSK, Takeda, Eli Lilly, and Merck. As per the rules of the Fund established before solicitation, the funders did not participate in decisions regarding countries to be studied or in doing, analyzing or writing up any study. Since election in Oct 2009 as unpaid IDF VP, J. Brown has accepted no grants or contracts or gifts or employment from any drug or device firms and has not accepted any positions on their editorial or advisory groups. In 2010, J. Brown accepted travel reimbursement from Novo Nordisk to speak at the 6th International Symposium on Diabetes and Pregnancy. In 2009, at the request of IDF, J. Brown accepted reimbursement from IDF to speak at a satellite meeting of ADA sponsored by Roche and Co. Drs. Ping Zhang and Rui Li worked on this project on their own time while in the employ of the United States Center for Disease Control. Drs. Zhang and Li declare that no potential competing interests exist. During most of this study Dr. Skarbek was an employee of the IDF. IDF is supported financially by many commercial entities. She declares that no competing interests exist. All other authors have no potentially competing interests. The authors declare that none of the competing interests described above will alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Banister J, 2010, 53 HARV PROGR GLOB D; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; Chen XB, 2003, CHIN J DIABETES, V11, P238; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Harbage B, 1999, AM J PREV MED, V16, P314, DOI 10.1016/S0749-3797(98)00101-9; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hu J-P, 2007, CHIN J PREV CHRONIC, V15, P4; Human Development Unit East Asia and Pacific Region World Bank, 2011, 62318CN WORLD BANK; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, IDF DIAB ATL; Jonsson B, 1998, DIABETES CARE, V21, pC7, DOI 10.2337/diacare.21.3.C7; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Leeder S, 2004, RACE TIME CHALLENGE; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; Nichols G, 2006, INT DIAB FED TRIENN; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Petrou S, 2002, INT J TECHNOL ASSESS, V18, P705, DOI 10.1017/S026646230200051X; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wang J, 2008, CHIL HLTH QUAL MANAG, V15, P65; Wang WB., 2008, CHIN HLTH RESOUR, V11, P127, DOI DOI 10.3969/J.ISSN.1007-953X.2008.03.013; Wang WB, 2009, AM J MANAG CARE, V15, P593; World Health Organization, 2010, GLOBAL RECOMMENDATIO, P18; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhang Z, 2007, CHINESE HLTH RESOURC, V10, P162	41	57	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e39513	10.1371/journal.pone.0039513	http://dx.doi.org/10.1371/journal.pone.0039513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049727	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300002
J	Aomatsu, N; Yashiro, M; Kashiwagi, S; Takashima, T; Ishikawa, T; Ohsawa, M; Wakasa, K; Hirakawa, K				Aomatsu, Naoki; Yashiro, Masakazu; Kashiwagi, Shinichiro; Takashima, Tsutomu; Ishikawa, Tetsuro; Ohsawa, Masahiko; Wakasa, Kenichi; Hirakawa, Kosei			CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; STEM-CELLS; PROSPECTIVE IDENTIFICATION; PREOPERATIVE DOXORUBICIN; PATHOLOGICAL RESPONSE; GENE-EXPRESSION; PHASE-II; DOCETAXEL; CYCLOPHOSPHAMIDE; THERAPY	Background: Neoadjuvant chemotherapy (NAC) is a standard care regimen for patients with breast cancer. However, the pathologic complete response (pCR) rate remains at 30%. We hypothesized that a cancer stem cell marker may identify NAC-resistant patients, and evaluated CD133 and ALDH1 as a potential surrogate marker for breast cancer. The aim of this study was to find a surrogate maker to predict chemosensitivity of NAC for breast cancer. Methodology/Findings: A total of 102 patients with breast cancer were treated with NAC consisting of epirubicin followed by paclitaxel. Core needle biopsy (CNB) specimens and resected tumors were obtained from all patients before and after NAC, respectively. Chemosensitivity and prognostic potential of CD133 or ALDH1 expression was evaluated by immunohistochemistry. Clinical CR (cCR) and pCR rates were 18% (18/102) and 29% (30/102), respectively. Forty-seven (46%) patients had CD133-positive tumors before NAC, and CD133 expression was significantly associated with a low pCR rate (p = 0.035) and clinical non-responders. Multivariate analysis revealed that CD133 expression was significantly (p = 0.03) related to pCR. Recurrence was more frequent in patients with CD133-positive tumors (21/47, 45%) than that in patients with CD133-negative tumors (7/55, 13%). The number of patients with CD133-positive tumors (62%) after NAC was higher than that (46%) before NAC. Furthermore, most patients with CD133-positive tumors before NAC maintained the same status after NAC. Conclusion/Significance: CD133 before NAC might be a useful marker for predicting the effectiveness of NAC and recurrence of breast cancer after NAC.	[Aomatsu, Naoki; Yashiro, Masakazu; Kashiwagi, Shinichiro; Takashima, Tsutomu; Ishikawa, Tetsuro; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 558, Japan; [Ohsawa, Masahiko; Wakasa, Kenichi] Osaka City Univ, Dept Diagnost Pathol, Grad Sch Med, Abeno Ku, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan.	m9312510@med.osaka-cu.ac.jp	Kashiwagi, Shinichiro/AAE-5243-2020; Kashiwagi, Shinichiro/AAC-7070-2019	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599	Ministry of Education, Science, Sports, Culture and Technology of Japan [20591573, 22390262, 23390329]	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in Aid for Scientific Research (KAKENHI, nos. 20591573, 22390262, and 23390329) from the Ministry of Education, Science, Sports, Culture and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Estevez LG, 2003, CLIN CANCER RES, V9, P686; Evans TRJ, 2005, J CLIN ONCOL, V23, P2988, DOI 10.1200/JCO.2005.06.156; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Horiguchi Kazumi, 2010, Journal of Medical and Dental Sciences, V57, P165; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; Kai K, 2010, BREAST CANCER-TOKYO, V17, P80, DOI 10.1007/s12282-009-0176-y; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Q, 2009, CHINESE MED J-PEKING, V122, P2763, DOI 10.3760/cma.j.issn.0366-6999.2009.22.017; Lorico A, 2011, J ONCOL, V2011, DOI 10.1155/2011/135039; Mayer EL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1755; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rody A, 2007, BREAST, V16, P86, DOI 10.1016/j.breast.2006.06.008; Ross JS, 2005, ADV CLIN CHEM, V40, P99, DOI 10.1016/S0065-2423(05)40003-7; Sachelarie I, 2006, ONCOLOGIST, V11, P574, DOI 10.1634/theoncologist.11-6-574; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singletary S Eva, 2003, Semin Surg Oncol, V21, P53, DOI 10.1002/ssu.10021; Smith IC, 2002, J CLIN ONCOL, V20, P1456, DOI 10.1200/JCO.20.6.1456; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Toi M, 2008, BREAST CANCER RES TR, V110, P531, DOI 10.1007/s10549-007-9744-z; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Zhao P, 2011, CANCER SCI, V102, P1107, DOI 10.1111/j.1349-7006.2011.01894.x	52	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45865	10.1371/journal.pone.0045865	http://dx.doi.org/10.1371/journal.pone.0045865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049880	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100093
J	D'Amato, NC; Ostrander, JH; Bowie, ML; Sistrunk, C; Borowsky, A; Cardiff, RD; Bell, K; Young, LJT; Simin, K; Bachelder, RE; Delrow, J; Dawson, A; Yee, LD; Mrozek, K; Clay, TM; Osada, T; Seewaldt, VL				D'Amato, Nicholas C.; Ostrander, Julie H.; Bowie, Michelle L.; Sistrunk, Christopher; Borowsky, Alexander; Cardiff, Robert D.; Bell, Katie; Young, Lawrence J. T.; Simin, Karl; Bachelder, Robin E.; Delrow, Jeff; Dawson, Alyssa; Yee, Lisa D.; Mrozek, Krzysztof; Clay, Timothy M.; Osada, Takuya; Seewaldt, Victoria L.			Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; E-CADHERIN EXPRESSION; TUMOR PROGRESSION; CELL-LINES; STEM-CELLS; TRANSCRIPTIONAL REPRESSOR; INCREASES SENSITIVITY; STEM/PROGENITOR CELLS; ESTROGEN-RECEPTOR	Breast cancers with a basal-like gene signature are primarily triple-negative, frequently metastatic, and carry a poor prognosis. Basal-like breast cancers are enriched for markers of breast cancer stem cells as well as markers of epithelial-mesenchymal transition (EMT). While EMT is generally thought to be important in the process of metastasis, in vivo evidence of EMT in human disease remains rare. Here we report a novel model of human triple-negative breast cancer, the DKAT cell line, which was isolated from an aggressive, treatment-resistant triple-negative breast cancer that demonstrated morphological and biochemical evidence suggestive of phenotypic plasticity in the patient. The DKAT cell line displays a basal-like phenotype in vitro when cultured in serum-free media, and undergoes phenotypic changes consistent with EMT/MET in response to serum-containing media, a unique property among the breast cancer cell lines we tested. This EMT is marked by increased expression of the transcription factor Zeb1,and Zeb1 is required for the enhanced migratory ability of DKAT cells in the mesenchymal state. DKAT cells also express progenitor-cell markers, and single DKAT cells are able to generate tumorspheres containing both epithelial and mesenchymal cell types. In vivo, as few as ten DKAT cells are capable of forming xenograft tumors which display a range of epithelial and mesenchymal phenotypes. The DKAT model provides a novel model to study the molecular mechanisms regulating phenotypic plasticity and the aggressive biology of triple-negative breast cancers.	[Bowie, Michelle L.; Sistrunk, Christopher; Clay, Timothy M.; Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [D'Amato, Nicholas C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Ostrander, Julie H.] Univ Minnesota, Dept Med, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Borowsky, Alexander; Cardiff, Robert D.; Bell, Katie; Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Simin, Karl] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA USA; [Bachelder, Robin E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Delrow, Jeff; Dawson, Alyssa] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Yee, Lisa D.; Mrozek, Krzysztof] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Osada, Takuya] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Fred Hutchinson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Duke University	Seewaldt, VL (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	seewa001@mc.duke.edu	Borowsky, Alexander D/S-5404-2017; Mrózek, Krzysztof/A-3142-2008	Sistrunk, Christopher/0000-0002-5951-1361	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA68438-AV13, 2P30CA14236-26, R01CA88799, R01CA98441, R01CA114068]; Susan G. Komen Breast Cancer Award [BCTR061314]; V-Foundation Award; Department of Defense Breast Cancer Pre-doctoral Traineeship Award [W81XWH-08-1-0364]; NIH/NCI [P50-CA068438, U01-CA084294, U42-RR14905, P30-CA093373-01]; Kislak-Fields Family Fund; Simeon J. Fortin Charitable Foundation; CDMRP Breast Cancer Center of Excellence [W81XWH-05-1-0405]; NATIONAL CANCER INSTITUTE [R01CA155664, R01CA098441, P30CA014236, P30CA093373, U01CA084294, R01CA158668, P30CA015704, R01CA088799, P50CA068438, R01CA114068] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR014905] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Award(Susan G. Komen Breast Cancer Foundation); V-Foundation Award; Department of Defense Breast Cancer Pre-doctoral Traineeship Award(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kislak-Fields Family Fund; Simeon J. Fortin Charitable Foundation; CDMRP Breast Cancer Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by: VLS: National Institutes of Health/National Cancer Institute (NIH/NCI) grants CA68438-AV13 [AVON/NCI Partners in Progress], 2P30CA14236-26, R01CA88799, R01CA98441, and R01CA114068 [http://www.cancer.gov/researchandfunding]; Susan G. Komen Breast Cancer Award BCTR061314 [http://ww5.komen.org/]; and V-Foundation Award [http://www.jimmyv.org/]. NCD: Department of Defense Breast Cancer Pre-doctoral Traineeship Award W81XWH-08-1-0364 [http://cdmrp.army.mil/bcrp/] TMC: NIH/NCI grant P50-CA068438 [http://www.cancer.gov/researchandfunding]; The Kislak-Fields Family Fund [http://www.kislakrealty.com/celebrating.html]. KS: Simeon J. Fortin Charitable Foundation. RDC: NIH/NCI grants U01-CA084294, U42-RR14905, P30-CA093373-01, and CDMRP Breast Cancer Center of Excellence W81XWH-05-1-0405 [http://www.cancer.gov/researchandfunding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mrozek K, 2002, GENE CHROMOSOME CANC, V34, P137, DOI 10.1002/gcc.10027; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Seewaldt VL, 2001, J CELL BIOL, V155, P471, DOI 10.1083/jcb.200011001; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Wang CS, 2000, CANCER GENET CYTOGEN, V120, P58, DOI 10.1016/S0165-4608(99)00253-8; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45684	10.1371/journal.pone.0045684	http://dx.doi.org/10.1371/journal.pone.0045684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049838	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100068
J	Hanggi, D; Perrin, J; Eicker, S; Beseoglu, K; Etminan, N; Kamp, MA; Heiroth, HJ; Bege, N; Macht, S; Frauenknecht, K; Sommer, C; Kissel, T; Steiger, HJ				Haenggi, Daniel; Perrin, Jason; Eicker, Sven; Beseoglu, Kerim; Etminan, Nima; Kamp, Marcel Alexander; Heiroth, Hi-Jae; Bege, Nadia; Macht, Stephan; Frauenknecht, Katrin; Sommer, Clemens; Kissel, Thomas; Steiger, Hans-Jakob			Local Delivery of Nimodipine by Prolonged-Release Microparticles-Feasibility, Effectiveness and Dose-Finding in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							CHRONIC CEREBRAL VASOSPASM; INTRATHECAL NIMODIPINE; IN-VIVO; MODEL; RAT; ANGIOGRAPHY; ARTERIES; THERAPY; NANOPARTICLES; PREVENTION	Background and Purpose: To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiographic vasospasm and secondary brain injury after experimental subarachnoid hemorrhage (SAH). Methods: 70 male Wistar rats were categorized into three groups: 1) sham operated animals (control), 2) animals with SAH only (control) and the 3) treatment group. SAH was induced using the double hemorrhage model. The treatment group received different concentrations (20%, 30% or 40%) of nimodipine microparticles. Angiographic vasospasm was assessed 5 days later using digital subtraction angiography (DSA). Histological analysis of frozen sections was performed using H&E-staining as well as Iba1 and MAP2 immunohistochemistry. Results: DSA images were sufficient for assessment in 42 animals. Severe angiographic vasospasm was present in group 2 (SAH only), as compared to the sham operated group (p<0.001). Only animals within group 3 and the highest nimodipine microparticles concentration (40%) as well as group 1 (sham) demonstrated the largest intracranial artery diameters. Variation in vessel calibers, however, did not result in differences in Iba-1 or MAP2 expression, i.e. in histological findings for secondary brain injury. Conclusions: Local delivery of high-dose nimodipine prolonged-release microparticles at high concentration resulted in significant reduction in angiographic vasospasm after experimental SAH and with no histological signs for matrix toxicity.	[Haenggi, Daniel; Perrin, Jason; Eicker, Sven; Beseoglu, Kerim; Etminan, Nima; Kamp, Marcel Alexander; Heiroth, Hi-Jae; Steiger, Hans-Jakob] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Macht, Stephan] Univ Dusseldorf, Inst Neuroradiol, D-40225 Dusseldorf, Germany; [Bege, Nadia; Kissel, Thomas] Univ Marburg, Dept Pharmaceut & Biopharm, Marburg, Germany; [Frauenknecht, Katrin; Sommer, Clemens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, Mainz, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Johannes Gutenberg University of Mainz	Hanggi, D (corresponding author), Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany.	daniel.haenggi@uni-duesseldorf.de	Frauenknecht, Katrin/AAF-1638-2020; Eicker, Sven/B-3341-2015; Steiger, Hans-Jakob/AAN-8307-2021	Frauenknecht, Katrin/0000-0002-1372-3297; Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944	Kluh Foundation, Dusseldorf, Germany	Kluh Foundation, Dusseldorf, Germany	The study was supported by a grant of the Kluh Foundation, Dusseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2003, ACTA NEUROCHIR, V145, P673, DOI 10.1007/s00701-003-0052-z; AUER LM, 1982, ACTA NEUROCHIR, V63, P297, DOI 10.1007/BF01728885; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BOULLIN DJ, 1981, NEURORADIOLOGY, V21, P245, DOI 10.1007/BF02100154; DELGADO TJ, 1985, STROKE, V16, P595, DOI 10.1161/01.STR.16.4.595; Frauenknecht K, 2010, J NEUROIMMUNOL, V227, P1, DOI 10.1016/j.jneuroim.2010.05.043; GIOIA AE, 1985, J NEUROSURG, V62, P721, DOI 10.3171/jns.1985.62.5.0721; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Hanggi D, 2008, CLIN NEUROL NEUROSUR, V110, P784, DOI 10.1016/j.clineuro.2008.05.001; Hanggi D, 2009, NEUROSURGERY, V64, P1155, DOI 10.1227/01.NEU.0000340685.06407.FD; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Kasuya H, 2005, NEUROSURGERY, V56, P895; Lee SH, 2011, INT J PHARMACEUT, V403, P192, DOI 10.1016/j.ijpharm.2010.10.012; LEWIS PJ, 1988, NEUROSURGERY, V22, P492; Li XA, 2010, J CONTROL RELEASE, V147, P304, DOI 10.1016/j.jconrel.2010.07.113; Longo M, 2002, NEURORADIOLOGY, V44, P689, DOI 10.1007/s00234-002-0781-3; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Marbacher S, 2008, INTENS CARE MED, V34, P932, DOI 10.1007/s00134-008-0995-x; Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035; Ono S, 1997, STROKE, V28, P1631, DOI 10.1161/01.STR.28.8.1631; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Satoh M, 2002, STROKE, V33, P775, DOI 10.1161/hs0302.103734; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Tanay E, 2006, BRAIN RES, V1112, P222, DOI 10.1016/j.brainres.2006.07.004; Turowski B, 2007, NEURORADIOLOGY, V49, P129, DOI 10.1007/s00234-006-0168-y; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; VERLOOY J, 1992, ACTA NEUROCHIR, V117, P48, DOI 10.1007/BF01400635; VOLDBY B, 1984, ACTA NEUROCHIR, V70, P243, DOI 10.1007/BF01406653; ZABRAMSKI JM, 1986, NEUROSURGERY, V18, P1	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42597	10.1371/journal.pone.0042597	http://dx.doi.org/10.1371/journal.pone.0042597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049732	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100004
J	Harkin, B; Miellet, S; Kessler, K				Harkin, Ben; Miellet, Sebastien; Kessler, Klaus			What Checkers Actually Check: An Eye Tracking Study of Inhibitory Control and Working Memory	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE CORTEX; COGNITIVE DEFICITS; PANIC DISORDER; ATTENTION; CONFLICT; UNCERTAINTY; DYSFUNCTION; ACTIVATION; TESTS	Background: Not only is compulsive checking the most common symptom in Obsessive Compulsive Disorder (OCD) with an estimated prevalence of 50-80% in patients, but approximately similar to 15% of the general population reveal subclinical checking tendencies that impact negatively on their performance in daily activities. Therefore, it is critical to understand how checking affects attention and memory in clinical as well as subclinical checkers. Eye fixations are commonly used as indicators for the distribution of attention but research in OCD has revealed mixed results at best. Methodology/Principal Finding: Here we report atypical eye movement patterns in subclinical checkers during an ecologically valid working memory (WM) manipulation. Our key manipulation was to present an intermediate probe during the delay period of the memory task, explicitly asking for the location of a letter, which, however, had not been part of the encoding set (i.e., misleading participants). Using eye movement measures we now provide evidence that high checkers' inhibitory impairments for misleading information results in them checking the contents of WM in an atypical manner. Checkers fixate more often and for longer when misleading information is presented than non-checkers. Specifically, checkers spend more time checking stimulus locations as well as locations that had actually been empty during encoding. Conclusions/Significance: We conclude that these atypical eye movement patterns directly reflect internal checking of memory contents and we discuss the implications of our findings for the interpretation of behavioural and neuropsychological data. In addition our results highlight the importance of ecologically valid methodology for revealing the impact of detrimental attention and memory checking on eye movement patterns.	[Harkin, Ben; Kessler, Klaus] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Miellet, Sebastien] Univ Fribourg, CH-1700 Fribourg, Switzerland	University of Glasgow; University of Fribourg	Kessler, K (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	k.kessler@psy.gla.ac.uk	Miellet, Sebastien/AFL-6215-2022	Miellet, Sebastien/0000-0002-3519-033X; Harkin, Ben/0000-0002-1446-9673; Kessler, Klaus/0000-0001-7307-9539	University of Glasgow PhD scholarship; Medical Research Council [MR/J001953/1]	University of Glasgow PhD scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BH was funded by a University of Glasgow PhD scholarship. The research was further supported by the Medical Research Council in the form of a grant to KK (MR/J001953/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado GM, 2011, BEHAV RES THER, V49, P42, DOI 10.1016/j.brat.2010.10.001; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Antony MM, 1998, OBSESSIVE-COMPULSIVE DISORDER, P3; Ashbaugh AR, 2007, COGNITIVE THER RES, V31, P291, DOI 10.1007/s10608-006-9087-9; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Boldrini M, 2005, ACTA PSYCHIAT SCAND, V111, P150, DOI 10.1111/j.1600-0447.2004.00247.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Ciesielski KT, 2007, HUM BRAIN MAPP, V28, P1401, DOI 10.1002/hbm.20365; Ciesielski KT, 2011, CLIN NEUROPHYSIOL, V122, P107, DOI 10.1016/j.clinph.2010.05.027; Ciesielski KT, 2005, NEUROIMAGE, V24, P1180, DOI 10.1016/j.neuroimage.2004.10.018; Crawford H, 1995, 8 INT S AV PSYCH; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dek ECP, 2010, BEHAV RES THER, V48, P580, DOI 10.1016/j.brat.2010.03.009; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Harkin B, 2011, CLIN PSYCHOL REV, V31, P1004, DOI 10.1016/j.cpr.2011.06.004; Harkin B, 2011, FRONT PSYCHOL, V2, DOI [10.3389/fpsyg.2011.00078, 10.3389/fpsyt.2011.00037]; Harkin B, 2011, APPL COGNITIVE PSYCH, V25, P219, DOI 10.1002/acp.1666; Harkin B, 2009, BEHAV RES THER, V47, P504, DOI 10.1016/j.brat.2009.03.002; Harkin BL, 2008, BEHAV RES THER, V46, P861, DOI 10.1016/j.brat.2008.03.009; HENDERSON JG, 1988, J CLIN PSYCHOL, V44, P747, DOI 10.1002/1097-4679(198809)44:5<747::AID-JCLP2270440513>3.0.CO;2-2; Henseler I, 2008, J PSYCHIATR NEUROSCI, V33, P209; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaafari N, 2011, ACTA PSYCHIAT SCAND, V124, P87, DOI 10.1111/j.1600-0447.2011.01721.x; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1186, DOI 10.1016/S1388-2457(01)00543-0; Koch K, 2012, NEUROPSYCHOLOGIA, V50, P958, DOI 10.1016/j.neuropsychologia.2012.02.002; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Kyrios M, 1999, 33 C ASS ADV BEH THE; Lind C, 2009, J ANXIETY DISORD, V23, P1047, DOI 10.1016/j.janxdis.2009.07.005; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2007, INHIBITION COGNITION; Mataix-Cols D, 1999, BIOL PSYCHIAT, V45, P898, DOI 10.1016/S0006-3223(98)00260-1; MataixCols D, 1997, PSYCHIAT RES, V72, P115, DOI 10.1016/S0165-1781(97)00074-7; Morein-Zamir S, 2010, PSYCHOPHARMACOLOGY, V212, P357, DOI 10.1007/s00213-010-1963-z; Moritz Steffen, 2003, Cogn Neuropsychiatry, V8, P261; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; Najmi S, 2010, J ABNORM PSYCHOL, V119, P136, DOI 10.1037/a0017549; Nakao T, 2009, J PSYCHIATR RES, V43, P784, DOI 10.1016/j.jpsychires.2008.10.013; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1243, DOI 10.1037/0096-1523.32.5.1243; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Omori IM, 2007, J PSYCHIATR RES, V41, P776, DOI 10.1016/j.jpsychires.2006.05.005; Purcell R, 1998, ARCH GEN PSYCHIAT, V55, P415, DOI 10.1001/archpsyc.55.5.415; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; Radomsky AS, 2010, J BEHAV THER EXP PSY, V41, P345, DOI 10.1016/j.jbtep.2010.03.005; RASMUSSEN SA, 1988, PSYCHOPHARMACOL BULL, V24, P466; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rotge JY, 2007, EUR NEUROPSYCHOPHARM, V17, pS300, DOI 10.1016/S0924-977X(07)70424-8; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Stein MB, 1997, AM J PSYCHIAT, V154, P1120; Sweeney JA, 2002, PROG BRAIN RES, V140, P507; Tallis F, 1999, BEHAV RES THER, V37, P161, DOI 10.1016/S0005-7967(98)00075-8; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Thordarson DS, 2004, BEHAV RES THER, V42, P1289, DOI 10.1016/j.brat.2003.08.007; Tolin DF, 2003, J ANXIETY DISORD, V17, P233, DOI 10.1016/S0887-6185(02)00182-2; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; van den Hout M, 2004, J BEHAV THER EXP PSY, V35, P165, DOI 10.1016/j.jbtep.2004.04.007; van den Hout M, 2003, BEHAV RES THER, V41, P301, DOI 10.1016/S00005-7967(02)00012-8; van den Hout M, 2003, BEHAV RES THER, V41, P369, DOI 10.1016/S0005-7967(02)00097-9; van den Hout MA, 2009, BEHAV RES THER, V47, P535, DOI 10.1016/j.brat.2009.03.001; van den Hout MA, 2008, BEHAV RES THER, V46, P1300, DOI 10.1016/j.brat.2008.09.002; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Veale DM, 1996, PSYCHOL MED, V26, P1261, DOI 10.1017/S0033291700035984; WELLS A, 1990, BEHAV THER, V21, P273, DOI 10.1016/S0005-7894(05)80330-2; Wells A., 2000, EMOTIONAL DISORDERS, DOI DOI 10.1017/S0033291702225702; Woods CM, 2002, CLIN PSYCHOL-SCI PR, V9, P353, DOI 10.1093/clipsy/9.4.353; Zielinski CM, 1991, NEUROPSY NEUROPSY BE, V4, P110; Zitterl W, 2001, PSYCHOPATHOLOGY, V34, P113, DOI 10.1159/000049292	73	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44689	10.1371/journal.pone.0044689	http://dx.doi.org/10.1371/journal.pone.0044689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049755	Green Accepted, Green Published, gold			2022-12-25	WOS:000309556100020
J	He, XW; Knepper, M; Ding, C; Li, J; Castro, S; Siddiqui, M; Schachner, M				He, Xiaowen; Knepper, Michael; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta			Promotion of Spinal Cord Regeneration by Neural Stem Cell-Secreted Trimerized Cell Adhesion Molecule L1	PLOS ONE			English	Article							NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; COMPRESSION INJURY; MICE; EXPRESSION; MIGRATION; NEURONS; BINDING	The L1 cell adhesion molecule promotes neurite outgrowth and neuronal survival in homophilic and heterophilic interactions and enhances neurite outgrowth and neuronal survival homophilically, i.e. by self binding. We investigated whether exploitation of homophilic and possibly also heterophilic mechanisms of neural stem cells overexpressing the full-length transmembrane L1 and a secreted trimer engineered to express its extracellular domain would be more beneficial for functional recovery of the compression injured spinal cord of adult mice than stem cells overexpressing only full-length L1 or the parental, non-engineered cells. Here we report that stem cells expressing trimeric and full-length L1 are indeed more efficient in promoting locomotor recovery when compared to stem cells overexpressing only full-length L1 or the parental stem cells. The trimer expressing stem cells were also more efficient in reducing glial scar volume and expression of chondroitin sulfates and the chondroitin sulfate proteoglycan NG2. They were also more efficient in enhancing regrowth/sprouting and/ or preservation of serotonergic axons, and remyelination and/or myelin sparing. Moreover, degeneration/dying back of corticospinal cord axons was prevented more by the trimer expressing stem cells. These results encourage the view that stem cells engineered to drive the beneficial functions of L1 via homophilic and heterophilic interactions are functionally optimized and may thus be of therapeutic value.	[He, Xiaowen; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, New Brunswick, NJ 08903 USA; [He, Xiaowen; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Knepper, Michael] Univ Hamburg, Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, New Brunswick, NJ 08903 USA.	schachner@stu.edu.cn			New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research"	New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research"	A grant from the New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research" (http://www.state.nj.us/health/spinalcord/). The grant covers the cost of the experimental material and animals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1993, J NEUROSCI, V13, P4764; Barbin G, 2004, NEURON GLIA BIOL, V1, P65, DOI 10.1017/s1740925x04000092; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, ADV EXP MED BIOL, V515, P91; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chen J, 2005, EUR J NEUROSCI, V22, P1895, DOI 10.1111/j.1460-9568.2005.04348.x; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Dihne M, 2003, J NEUROSCI, V23, P6638; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Nagaraj K, 2006, TRENDS BIOCHEM SCI, V31, P544, DOI 10.1016/j.tibs.2006.07.010; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; RATHJEN FG, 1984, EMBO J, V3, P1; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; SEILHEIMER B, 1989, J CELL BIOL, V108, P1909, DOI 10.1083/jcb.108.5.1909; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Zhang Y, 2008, RESTOR NEUROL NEUROS, V26, P81	41	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46223	10.1371/journal.pone.0046223	http://dx.doi.org/10.1371/journal.pone.0046223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049984	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100157
J	Laliberte, E; Adair, EC; Hobbie, SE				Laliberte, Etienne; Adair, E. Carol; Hobbie, Sarah E.			Estimating Litter Decomposition Rate in Single-Pool Models Using Nonlinear Beta Regression	PLOS ONE			English	Article							NITROGEN	Litter decomposition rate (k) is typically estimated from proportional litter mass loss data using models that assume constant, normally distributed errors. However, such data often show non-normal errors with reduced variance near bounds (0 or 1), potentially leading to biased k estimates. We compared the performance of nonlinear regression using the beta distribution, which is well-suited to bounded data and this type of heteroscedasticity, to standard nonlinear regression (normal errors) on simulated and real litter decomposition data. Although the beta model often provided better fits to the simulated data (based on the corrected Akaike Information Criterion, AIC(c)), standard nonlinear regression was robust to violation of homoscedasticity and gave equally or more accurate k estimates as nonlinear beta regression. Our simulation results also suggest that k estimates will be most accurate when study length captures mid to late stage decomposition (50-80% mass loss) and the number of measurements through time is >= 5. Regression method and data transformation choices had the smallest impact on k estimates during mid and late stage decomposition. Estimates of k were more variable among methods and generally less accurate during early and end stage decomposition. With real data, neither model was predominately best; in most cases the models were indistinguishable based on AICc, and gave similar k estimates. However, when decomposition rates were high, normal and beta model k estimates often diverged substantially. Therefore, we recommend a pragmatic approach where both models are compared and the best is selected for a given data set. Alternatively, both models may be used via model averaging to develop weighted parameter estimates. We provide code to perform nonlinear beta regression with freely available software.	[Laliberte, Etienne] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Adair, E. Carol] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Western Australia; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Minnesota System; University of Minnesota Twin Cities	Adair, EC (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	Carol.Adair@uvm.edu	Laliberté, Etienne/B-6855-2008	Laliberté, Etienne/0000-0002-3167-2622; Adair, E. Carol/0000-0002-8567-9045; Hobbie, Sarah/0000-0001-5159-031X	NSF [EF-0553768]; University of California, Santa Barbara; State of California; University of Western Australia; Australian Research Council (ARC); Office Of The Director [1101317] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; University of Western Australia; Australian Research Council (ARC)(Australian Research Council); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was conducted while E.C.A. was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California, Santa Barbara, and the State of California. E.L. was supported by fellowships from the University of Western Australia and the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2010, ECOLOGY, V91, P1225, DOI 10.1890/09-0430.1; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B.M., 2010, BBMLE TOOLS GEN MAXI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Hayes JP, 2006, PHYSIOL BIOCHEM ZOOL, V79, P665, DOI 10.1086/502814; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PAOLINO P, 2001, POLIT ANAL, V0009; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scott D, 1999, NEW ZEAL J AGR RES, V42, P365, DOI 10.1080/00288233.1999.9513386; SHAVER GR, 2001, NPP TUNDRA TOOLIK LA; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Zuur Alain F., 2009, P1	19	6	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45140	10.1371/journal.pone.0045140	http://dx.doi.org/10.1371/journal.pone.0045140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049771	Green Published, gold			2022-12-25	WOS:000309556100029
J	Li, C; Zhang, Q; Hu, WJ; Mu, H; Lin, Z; Ma, L; Park, YD; Zhou, HM				Li, Chang; Zhang, Qian; Hu, Wei-Jiang; Mu, Hang; Lin, Zong; Ma, Long; Park, Yong-Doo; Zhou, Hai-Meng			Effect of SNPs on Creatine Kinase Structure and Function: Identifying Potential Molecular Mechanisms for Possible Creatine Kinase Deficiency Diseases	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CARBONIC-ANHYDRASE-II; K+-CL-COTRANSPORTER; NEURODEGENERATIVE DISORDERS; BRAIN; MUSCLE; ALZHEIMERS; ISOENZYMES; STABILITY; TISSUES	Single-nucleotide polymorphisms (SNPs) are common genetic material changes that often occur naturally. SNPs can cause amino acid replacements that may lead to severe diseases, such as the well-known sickle-cell anemia. We constructed eight SNP mutants of human brain-type creatine kinase (CKB) based on bioinformatics predictions. The biochemical and biophysical characteristics of these SNP mutants were determined and compared to those of the wild-type creatine kinase to explore the potential molecular mechanisms of possible creatine kinase SNP-induced diseases. While the reactivation of six SNP mutants after heat shock dropped more than 45%, only three of them showed notable increases in ANS fluorescence intensity and decreases in catalytic efficiency. Among them, H26Y and P36T bind substrates as well as the wildtype form does, but the melting temperatures (T-m) dropped below body temperature, while the T59I mutant exhibited decreased catalytic activity that was most likely due to the much reduced binding affinity of this mutant for substrates. These findings indicate that SNPs such as H26Y, P36T and T59I have the potential to induce genetic diseases by different mechanisms.	[Li, Chang; Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Zhang, Qian; Ma, Long] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China; [Hu, Wei-Jiang; Mu, Hang; Lin, Zong; Park, Yong-Doo; Zhou, Hai-Meng] Tsinghua Univ, Yangtze Delta Reg Inst, Zhejiang Prov Key Lab Appl Enzymol, Jiaxing, Peoples R China; [Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Bejing Key Lab Prot Therapeut, Beijing 100084, Peoples R China	Tsinghua University; Beijing University of Chinese Medicine; Tsinghua University; Tsinghua University	Zhou, HM (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	zhm-dbs@mail.tsinghua.edu.cn	Li, Chang/E-6862-2011; Li, Chang/AAC-6770-2021	Li, Chang/0000-0002-7725-8873; 	National Key Basic Research and Development (973) Program of China [2011CB910800, 2012CB917304]; National Natural Science Foundation of China [31170732]; Zhejiang Natural Science Foundation [LR12C05001]; Zhejiang leading team of Science & Technology innovation [2010R50019]	National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang leading team of Science & Technology innovation	This study was supported by the National Key Basic Research and Development (973) Program of China (No. 2011CB910800 and No. 2012CB917304, http://www. most. gov. cn/), and the National Natural Science Foundation of China (No. 31170732, http://www. nsfc. gov. cn), Zhejiang Natural Science Foundation (No. LR12C05001, http://www. zjnsf. gov. cn/) and Zhejiang leading team of Science & Technology innovation (Team No. 2010R50019, http://www. zjkjt. gov. cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Aksenov MY, 1997, EXP NEUROL, V146, P458, DOI 10.1006/exnr.1997.6550; Aksenova MV, 1999, DEMENT GERIATR COGN, V10, P158, DOI 10.1159/000017098; Almstedt K, 2004, J MOL BIOL, V342, P619, DOI 10.1016/j.jmb.2004.07.024; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; CARNEY DN, 1984, CANCER RES, V44, P5399; Cox JM, 2003, BIOCHEMISTRY-US, V42, P1863, DOI 10.1021/bi027083b; Crowther DC, 2002, HUM MUTAT, V20, P1, DOI 10.1002/humu.10100; EPPENBERGER HM, 1967, J BIOL CHEM, V242, P204; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Galen RS, 1976, CLIN CHEM, V22; Gao YS, 2010, INT J BIOL MACROMOL, V47, P27, DOI 10.1016/j.ijbiomac.2010.03.025; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; KASTE M, 1977, ARCH NEUROL-CHICAGO, V34, P142, DOI 10.1001/archneur.1977.00500150028004; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; NOGUCHI CT, 1985, ANNU REV BIOPHYS BIO, V14, P239, DOI 10.1146/annurev.biophys.14.1.239; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PERMYAKOV EA, 1980, EUR J BIOCHEM, V109, P307, DOI 10.1111/j.1432-1033.1980.tb04796.x; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Ruijs MWG, 2007, EUR J HUM GENET, V15, P110, DOI 10.1038/sj.ejhg.5201715; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16963; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Uversky VN, 2003, J PHARM SCI, V92, P847, DOI 10.1002/jps.10355; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024681; WATTS DC, 1973, ENZYMES, V8, P383; Yamamichi H, 2001, CLIN CHEM, V47, P1967; YAO QZ, 1982, SCI SIN B-CHEM B A M, V25, P1296; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45949	10.1371/journal.pone.0045949	http://dx.doi.org/10.1371/journal.pone.0045949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049898	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100105
J	Martinez-Morillo, E; Diamandis, A; Romaschin, AD; Diamandis, EP				Martinez-Morillo, Eduardo; Diamandis, Anastasia; Romaschin, Alexander D.; Diamandis, Eleftherios P.			Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							PROTEASE M/NEUROSIN; ALZHEIMERS-DISEASE; SPINAL-CORD; INJURY; DEMYELINATION; DIAGNOSIS; BRAIN	Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition that frequently causes death or significant disabilities. Blood tests to predict possible early complications could be very useful aids for therapy. The aim of this study was to analyze serum levels of kallikrein 6 (KLK6) in individuals with aSAH to determine the relevance of this protease with the outcome of these patients. Methodology/Principal Findings: A reference interval for KLK6 was established by using serum samples (n = 136) from an adult population. Additionally, serum samples (n = 326) from patients with aSAH (n = 13) were collected for 5 to 14 days, to study the concentration of KLK6 in this disease. The correlation between KLK6 and S100B, an existing brain damage biomarker, was analyzed in 8 of 13 patients. The reference interval for KLK6 was established to be 1.04 to 3.93 ng/mL. The mean levels in patients with aSAH within the first 56 hours ranged from 0.27 to 1.44 ng/mL, with lowest levels found in patients with worse outcome. There were significant differences between patients with good recovery or moderate disability (n = 8) and patients with severe disability or death (n = 5) (mean values of 1.03 ng/mL versus 0.47 ng/mL, respectively) (p<0.01). There was no significant correlation between KLK6 and S100B. Conclusions/Significance: Decreased serum concentrations of KLK6 are found in patients with aSAH, with the lowest levels in patients who died.	[Martinez-Morillo, Eduardo; Diamandis, Eleftherios P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebovic Hlth Ctr, Toronto, ON M5G 1X5, Canada; [Diamandis, Anastasia; Diamandis, Eleftherios P.] Toronto Gen Hosp, Dept Clin Biochem, Univ Hlth Network, Toronto, ON, Canada; [Romaschin, Alexander D.] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Diamandis, EP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebovic Hlth Ctr, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Bando Y, 2006, NEUROSCI LETT, V405, P175, DOI 10.1016/j.neulet.2006.06.030; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Edlow JA, 2005, NEUROCRIT CARE, V2, P99, DOI 10.1385/NCC:2:2:099; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; Fraser CG, 2001, BIOL VARIATION PRINC; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Martin Coleman O, 2011, Mo Med, V108, P124; Martinez-Morillo E, 2012, CLIN CHEM LAB MED, V50, P931, DOI 10.1515/cclm-2012-0075; Menendez-Gonzalez M, 2008, J ALZHEIMERS DIS, V14, P59; Menendez-Gonzalez Manuel, 2008, Int Arch Med, V1, P11, DOI 10.1186/1755-7682-1-11; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Strojnik T, 2009, ANTICANCER RES, V29, P3269; Terayama R, 2004, GLIA, V48, P91, DOI 10.1002/glia.20058; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Zacharia BE, 2010, NEUROSURG CLIN N AM, V21, P221, DOI 10.1016/j.nec.2009.10.002	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45676	10.1371/journal.pone.0045676	http://dx.doi.org/10.1371/journal.pone.0045676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049835	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100066
J	Orban, JC; Cattet, F; Lefrant, JY; Leone, M; Jaber, S; Constantin, JM; Allaouchiche, B; Ichai, C				Orban, Jean-Christophe; Cattet, Florian; Lefrant, Jean-Yves; Leone, Marc; Jaber, Samir; Constantin, Jean-Michel; Allaouchiche, Bernard; Ichai, Carole		AzuRea Grp	The Practice of Therapeutic Hypothermia after Cardiac Arrest in France: A National Survey	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS; CLINICAL-PRACTICE; GUIDELINES; IMPLEMENTATION; INTERVENTION; PHYSICIANS; IMPROVE	Aims: Cardiac arrest is a major health concern worldwide accounting for 375,000 cases per year in Europe with a survival rate of <10%. Therapeutic hypothermia has been shown to improve patients' neurological outcome and is recommended by scientific societies. Despite these guidelines, different surveys report a heterogeneous application of this treatment. The aim of the present study was to evaluate the clinical practice of therapeutic hypothermia in cardiac arrest patients. Methods: This self-declarative web based survey was proposed to all registered French adult intensive care units (ICUs) (n = 357). Paediatrics and neurosurgery ICUs were excluded. The different questions addressed the structure, the practical modalities of therapeutic hypothermia and the use of prognostic factors in patients admitted after cardiac arrest. Results: One hundred and thirty-two out of 357 ICUs (37%) answered the questionnaire. Adherence to recommendations regarding the targeted temperature and hypothermia duration were 98% and 94% respectively. Both guidelines were followed in 92% ICUs. During therapeutic hypothermia, sedative drugs were given in 99% ICUs, mostly midazolam (77%) and sufentanil (59%). Neuromuscular blocking agents (NMBA) were used in 97% ICUs, mainly cisatracurium (77%). Numerous prognostic factors were used after cardiac arrest such as clinical factors (95%), biomarkers (53%), electroencephalography (78%) and evoked potentials (35%). Conclusions: In France, adherence to recommendations for therapeutic hypothermia after cardiac arrest is higher than those previously reported in other countries. Numerous prognostic factors are widely used even if their reliability remains controversial.	[Orban, Jean-Christophe; Cattet, Florian; Ichai, Carole] Ctr Hosp Univ Nice, Hop St Roch, Nice, France; [Orban, Jean-Christophe; Ichai, Carole] Univ Nice, Fac Med, IRCAN, Nice, France; [Lefrant, Jean-Yves] Ctr Hosp Univ Nimes, Div Anesthesie Reanimat Douleur Urgences, Nimes, France; [Leone, Marc] Hop Nord Marseille, Serv Anesthesie & Reanimat, Marseille, France; [Jaber, Samir] CHU Montpellier, Dept Anesthesie & Reanimat, Montpellier, France; [Constantin, Jean-Michel] Ctr Hosp Univ Clermont Ferrand, Unite Soins Intensifs, Clermont Ferrand, France; [Allaouchiche, Bernard] Hosp Civils Lyon, Hop Edouard Herriot, Dept Anesthesie Reanimat, Lyon, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU Clermont Ferrand; CHU Lyon	Orban, JC (corresponding author), Ctr Hosp Univ Nice, Hop St Roch, Nice, France.	orban.jc@chu-nice.fr	Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X				Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bianchin A, 2009, MINERVA ANESTESIOL, V75, P357; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chamorro C, 2010, ANESTH ANALG, V110, P1328, DOI 10.1213/ANE.0b013e3181d8cacf; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Deye N, 2010, RESUSCITATION, V81, pS3; Dumas F, 2011, CIRCULATION, V123, P877, DOI 10.1161/CIRCULATIONAHA.110.987347; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Fugate JE, 2011, NEUROLOGY, V77, P1346, DOI 10.1212/WNL.0b013e318231527d; Gillies MA, 2010, RESUSCITATION, V81, P1117, DOI 10.1016/j.resuscitation.2010.05.001; Grasner JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10035; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; Kim JJ, 2011, AM J EMERG MED, V29, P148, DOI 10.1016/j.ajem.2009.08.021; Laver SR, 2006, ANAESTHESIA, V61, P873, DOI 10.1111/j.1365-2044.2006.04552.x; Lefrant JY, 2010, ANN FR ANESTH, V29, P621, DOI 10.1016/j.annfar.2010.04.007; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Seguin R, 2004, CAN FAM PHYSICIAN, V50, P414; Tomte O, 2011, CRIT CARE MED, V39, P443, DOI 10.1097/CCM.0b013e318206b80f; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033	31	21	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45284	10.1371/journal.pone.0045284	http://dx.doi.org/10.1371/journal.pone.0045284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049783	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100037
J	Ramey, AM; Ely, CR; Schmutz, JA; Pearce, JM; Heard, DJ				Ramey, Andrew M.; Ely, Craig R.; Schmutz, Joel A.; Pearce, John M.; Heard, Darryl J.			Molecular Detection of Hematozoa Infections in Tundra Swans Relative to Migration Patterns and Ecological Conditions at Breeding Grounds	PLOS ONE			English	Article							CYGNUS-COLUMBIANUS-COLUMBIANUS; YUKON-KUSKOKWIM DELTA; BLOOD PARASITES; LEUCOCYTOZOON-SIMONDI; BEHAVIOR; MALARIA; ALASKA; ADULT; GEESE; BIRDS	Tundra swans (Cygnus columbianus) are broadly distributed in North America, use a wide variety of habitats, and exhibit diverse migration strategies. We investigated patterns of hematozoa infection in three populations of tundra swans that breed in Alaska using satellite tracking to infer host movement and molecular techniques to assess the prevalence and genetic diversity of parasites. We evaluated whether migratory patterns and environmental conditions at breeding areas explain the prevalence of blood parasites in migratory birds by contrasting the fit of competing models formulated in an occupancy modeling framework and calculating the detection probability of the top model using Akaike Information Criterion (AIC). We described genetic diversity of blood parasites in each population of swans by calculating the number of unique parasite haplotypes observed. Blood parasite infection was significantly different between populations of Alaska tundra swans, with the highest estimated prevalence occurring among birds occupying breeding areas with lower mean daily wind speeds and higher daily summer temperatures. Models including covariates of wind speed and temperature during summer months at breeding grounds better predicted hematozoa prevalence than those that included annual migration distance or duration. Genetic diversity of blood parasites in populations of tundra swans appeared to be relative to hematozoa prevalence. Our results suggest ecological conditions at breeding grounds may explain differences of hematozoa infection among populations of tundra swans that breed in Alaska.	[Ramey, Andrew M.; Ely, Craig R.; Schmutz, Joel A.; Pearce, John M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Heard, Darryl J.] Univ Florida, Coll Vet Med, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Ramey, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	aramey@usgs.gov		Ramey, Andrew/0000-0002-3601-8400	U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program; U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program	U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program; U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program	This work was funded by the U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program, and by the U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnard WH, 2010, CONDOR, V112, P849, DOI 10.1525/cond.2010.100143; Bellrose F, 1980, DUCKS GEESE SWANS N; BENNETT GF, 1982, J WILDLIFE DIS, V18, P287, DOI 10.7589/0090-3558-18.3.287; BENNETT GF, 1972, CAN J ZOOLOG, V50, P1, DOI 10.1139/z72-001; BENNETT GF, 1992, CONDOR, V94, P289, DOI 10.2307/1368821; BENNETT GF, 1981, J WILDLIFE DIS, V17, P213, DOI 10.7589/0090-3558-17.2.213; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; CLS (Collecte Localisation Satellites), 2016, ARG US MAN; Cosgrove CL, 2006, J PARASITOL, V92, P1362, DOI 10.1645/GE-879R.1; Dau CP, 2002, WATERBIRDS, V25, P241; Deviche P, 2001, J WILDLIFE DIS, V37, P28, DOI 10.7589/0090-3558-37.1.28; Douglas D., 2006, DOUGLAS ARGOS FILTER; EIDE A, 1972, J PROTOZOOL, V19, P414, DOI 10.1111/j.1550-7408.1972.tb03494.x; Ely CR, 1997, WILSON BULL, V109, P679; Engstrom H, 2000, WATERBIRDS, V23, P486, DOI 10.2307/1522187; Figuerola J, 2000, EVOL ECOL, V14, P143, DOI 10.1023/A:1011009419264; Gjullin CM, 1961, USDA HDB, V182; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hollmen TE, 1998, CONDOR, V100, P402, DOI 10.2307/1370286; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KLEI T R, 1975, Journal of Wildlife Diseases, V11, P130; LAIRD M, 1961, CAN J ZOOLOG, V39, P209, DOI 10.1139/z61-025; Limpert Roland J., 1991, Wildfowl, P78; MacKenzie DI., 2006, OCCUPANCY ESTIMATION; Moermond Jack E., 1997, Wildfowl, V48, P16; MONDA MJ, 1994, J WILDLIFE MANAGE, V58, P757, DOI 10.2307/3809691; National Oceanic and Atmospheric Administration, NNDC CLIM DAT ONL; NICHOLS JD, 1992, J WILDLIFE MANAGE, V56, P485, DOI 10.2307/3808863; NOBLET R, 1975, J MED ENTOMOL, V12, P111, DOI 10.1093/jmedent/12.1.111; Petrie SA, 2003, CAN J ZOOL, V81, P861, DOI 10.1139/Z03-063; Rambaut A, 2007, FIGTREE V1 0; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; SLADEN W J L, 1973, Wildfowl, V24, P8; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Stickney AA, 2002, WATERBIRDS, V25, P227; SUPER PE, 1995, J WILDLIFE DIS, V31, P447, DOI 10.7589/0090-3558-31.4.447; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2001, J PARASITOL, V87, P930, DOI 10.1645/0022-3395(2001)087[0930:ACOTBP]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILK RJ, 1988, ARCTIC, V41, P288; Wilkins Khristi A., 2010, Wildfowl, V60, P20	50	30	32	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45789	10.1371/journal.pone.0045789	http://dx.doi.org/10.1371/journal.pone.0045789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049862	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100080
J	Song, S; Nones, K; Miller, D; Harliwong, I; Kassahn, KS; Pinese, M; Pajic, M; Gill, AJ; Johns, AL; Anderson, M; Holmes, O; Leonard, C; Taylor, D; Wood, S; Xu, QY; Newell, F; Cowley, MJ; Wu, JM; Wilson, P; Fink, L; Biankin, AV; Waddell, N; Grimmond, SM; Pearson, JV				Song, Sarah; Nones, Katia; Miller, David; Harliwong, Ivon; Kassahn, Karin S.; Pinese, Mark; Pajic, Marina; Gill, Anthony J.; Johns, Amber L.; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Newell, Felicity; Cowley, Mark J.; Wu, Jianmin; Wilson, Peter; Fink, Lynn; Biankin, Andrew V.; Waddell, Nic; Grimmond, Sean M.; Pearson, John V.			qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles	PLOS ONE			English	Article							MUTATION DETECTION; SAMPLES	Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; however this method is both subjective and prone to error due to heterogeneity within lesions and cellularity differences between the sample viewed during pathological review and tissue used for research purposes. In this paper we describe a statistical model to estimate tumour cellularity from SNP array profiles of paired tumour and normal samples using shifts in SNP allele frequency at regions of loss of heterozygosity (LOH) in the tumour. We also provide qpure, a software implementation of the method. Our experiments showed that there is a medium correlation 0.42 (p-value = 0.0001) between tumor cellularity estimated by qpure and pathology review. Interestingly there is a high correlation 0.87 (p-value < 2.2e-16) between cellularity estimates by qpure and deep Ion Torrent sequencing of known somatic KRAS mutations; and a weaker correlation 0.32 (p-value = 0.004) between IonTorrent sequencing and pathology review. This suggests that qpure may be a more accurate predictor of tumour cellularity than pathology review. qpure can be downloaded from https://sourceforge.net/projects/qpure/.	[Song, Sarah; Nones, Katia; Miller, David; Harliwong, Ivon; Kassahn, Karin S.; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Newell, Felicity; Wilson, Peter; Fink, Lynn; Waddell, Nic; Grimmond, Sean M.; Pearson, John V.] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia; [Pinese, Mark; Pajic, Marina; Gill, Anthony J.; Johns, Amber L.; Cowley, Mark J.; Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Program, Sydney, NSW, Australia; [Biankin, Andrew V.] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Liverpool, NSW, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW, Australia; [Song, Sarah] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Gill, Anthony J.] Univ Sydney, Sydney, NSW 2006, Australia; [Gill, Anthony J.] Royal N Shore Hosp, Canc Diag Grp, No Canc Translat Res Unit, St Leonards, NSW 2065, Australia	University of Queensland; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Sydney; Royal North Shore Hospital	Song, S (corresponding author), Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia.	s.song@imb.uq.edu.au; s.grimmond@imb.uq.edu.au	Leonard, Conrad/AAD-2587-2020; Gill, Anthony/D-4215-2015; Pearson, John/AAT-4211-2020; xu, qinying/I-4259-2012; Waddell, Nicola/H-4929-2015; Pearson, John V/F-2249-2011; Fink, Lynn/C-2031-2008; Cowley, Mark/K-8731-2019; Gill, Anthony J./M-5015-2019; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Nones, Katia/AAX-6453-2021; Newell, Felicity/AAN-1253-2020	Leonard, Conrad/0000-0002-4131-2065; Gill, Anthony/0000-0002-9447-1967; xu, qinying/0000-0002-6933-9139; Waddell, Nicola/0000-0002-3950-2476; Pearson, John V/0000-0003-0904-4598; Fink, Lynn/0000-0003-2912-6048; Cowley, Mark/0000-0002-9519-5714; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Nones, Katia/0000-0003-1925-5196; Pajic, Marina/0000-0002-3871-3829; Biankin, Andrew/0000-0002-0362-5597; Kassahn, Karin/0000-0002-1662-3355; Pinese, Mark/0000-0001-5078-6687	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601]; Australian Government: Department of Innovation, Industry, Science and Research; Australian Cancer Research Foundation; Queensland Government (National and International Research Alliances Program); University of Queensland; Cancer Council New South Wales (NSW) [SRP06-01]; Cancer Institute NSW [06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians; Royal College of Pathologists of Australasia; Petre Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government: Department of Innovation, Industry, Science and Research(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation; Queensland Government (National and International Research Alliances Program); University of Queensland(University of Queensland); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians(General Electric); Royal College of Pathologists of Australasia; Petre Foundation	This research has been supported by the National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601); the Australian Government: Department of Innovation, Industry, Science and Research; the Australian Cancer Research Foundation; the Queensland Government (National and International Research Alliances Program); the University of Queensland; the Cancer Council New South Wales (NSW): (SRP06-01); the Cancer Institute NSW: (06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); the Garvan Institute of Medical Research; the Avner Nahmani Pancreatic Cancer Research Foundation; the R.T. Hall Trust; the Petre Foundation; the Gastroenterological Society of Australia; the American Association for Cancer Research Landon Foundation INNOVATOR Award; the Royal Australasian College of Surgeons; the Royal Australasian College of Physicians; and the Royal College of Pathologists of Australasia. SG is a recipient of a NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Hartigan JA, 1979, J ROYAL STAT SOC C, V28, P100, DOI DOI 10.2307/2346830; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Steen JA, 2011, NAT METHODS, V8, P548, DOI 10.1038/nmeth.1634; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92	15	97	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45835	10.1371/journal.pone.0045835	http://dx.doi.org/10.1371/journal.pone.0045835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049875	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100089
J	Trott, AR; Donelson, NC; Griffith, LC; Ejima, A				Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.; Ejima, Aki			Song Choice Is Modulated by Female Movement in Drosophila Males	PLOS ONE			English	Article							COURTSHIP SONG; NEURAL CIRCUITRY; MELANOGASTER; BEHAVIOR; STIMULI; NEUROBIOLOGY; EVOLUTION; OLFACTION; NEURONS; CUES	Mate selection is critical to ensuring the survival of a species. In the fruit fly, Drosophila melanogaster, genetic and anatomical studies have focused on mate recognition and courtship initiation for decades. This model system has proven to be highly amenable for the study of neural systems controlling the decision making process. However, much less is known about how courtship quality is regulated in a temporally dynamic manner in males and how a female assesses male performance as she makes her decision of whether to accept copulation. Here, we report that the courting male dynamically adjusts the relative proportions of the song components, pulse song or sine song, by assessing female locomotion. Male flies deficient for olfaction failed to perform the locomotion-dependent song modulation, indicating that olfactory cues provide essential information regarding proximity to the target female. Olfactory mutant males also showed lower copulation success when paired with wild-type females, suggesting that the male's ability to temporally control song significantly affects female mating receptivity. These results depict the consecutive inter-sex behavioral decisions, in which a male smells the close proximity of a female as an indication of her increased receptivity and accordingly coordinates his song choice, which then enhances the probability of his successful copulation.	[Ejima, Aki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02254 USA; [Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA	Kyoto University; Brandeis University; Brandeis University	Ejima, A (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	aki@cp.kyoto-u.ac.jp.jp		Griffith, Leslie/0000-0003-3164-9876	Hayashi Memorial Foundation for Female Natural Scientists; NOVARTIS Foundation for the Promotion of Science;  [T32 NS007292];  [R01 NS44232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); NOVARTIS Foundation for the Promotion of Science; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	T32 NS007292 to NCD (http://grants.nih.gov/training/T_Table.htm), R01 NS44232 to LCG (http://grants.nih.gov/grants/funding/r01.htm), Grant-in-Aid for Young Scientists (A), Grant-in-Aid for Scientific Research on Innovative Areas, Grant-in-Aid for Exploratory Research to AE (http://www.jsps.go.jp/english/egrants/grants01.html), Hayashi Memorial Foundation for Female Natural Scientists to AE (http://www.smth.jp/en/) and NOVARTIS Foundation for the Promotion of Science to AE (http://novartisfound.or.jp/eng/index-e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt S, 1998, ANIM BEHAV, V56, P87, DOI 10.1006/anbe.1998.0743; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Rybak F, 2002, CAN J ZOOL, V80, P987, DOI 10.1139/Z02-082; SCHILCHER FV, 1976, ANIM BEHAV, V24, P18; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; TRIMARCHI JR, 1994, J COMP NEUROL, V340, P427, DOI 10.1002/cne.903400311; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850	38	19	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46025	10.1371/journal.pone.0046025	http://dx.doi.org/10.1371/journal.pone.0046025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049926	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100122
J	Zanetti-Domingues, LC; Martin-Fernandez, ML; Needham, SR; Rolfe, DJ; Clarke, DT				Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.; Needham, Sarah R.; Rolfe, Daniel J.; Clarke, David T.			A Systematic Investigation of Differential Effects of Cell Culture Substrates on the Extent of Artifacts in Single-Molecule Tracking	PLOS ONE			English	Article							BIOMATERIAL SURFACE-CHEMISTRY; BINDING AFFIBODY MOLECULE; LIPID RAFTS; FLUORESCENCE MICROSCOPY; PARTICLE TRACKING; EGF RECEPTOR; PROTEIN; MEMBRANE; ADHESION; DOMAIN	Single-molecule techniques are being increasingly applied to biomedical investigation, notwithstanding the numerous challenges they pose in terms of signal-to-noise ratio issues. Non-specific binding of probes to glass substrates, in particular, can produce experimental artifacts due to spurious molecules on glass, which can be particularly deleterious in live-cell tracking experiments. In order to resolve the issue of non-specific probe binding to substrates, we performed systematic testing of a range of available surface coatings, using three different proteins, and then extended our assessment to the ability of these coatings to foster cell growth and retain non-adhesive properties. Linear PEG, a passivating agent commonly used both in immobilized-molecule single-molecule techniques and in tissue engineering, is able to both successfully repel non-specific adhesion of fluorescent probes and to foster cell growth when functionalized with appropriate adhesive peptides. Linear PEG treatment results in a significant reduction of tracking artifacts in EGFR tracking with Affibody ligands on a cell line expressing EGFR-eGFP. The findings reported herein could be beneficial to a large number of experimental situations where single-molecule or single-particle precision is required.	[Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.; Needham, Sarah R.; Rolfe, Daniel J.; Clarke, David T.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Clarke, DT (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England.	dave.clarke@stfc.ac.uk	Zanetti-Domingues, Laura Carolina/AAJ-1387-2021; Zanetti-Domingues, Laura Carolina/GWB-9443-2022	Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300; Needham, Sarah/0000-0002-3311-1036; Clarke, David/0000-0002-8776-1341	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; UK Biotechnology and Biological Sciences Research Council [BB/G006911/1]; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), Grant number BB/G006911/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge and thank Dr. Sarah Cartmell (Manchester X-Ray Imaging Facility) and Dr. Paul Roach (Institute for Science and Technology in Medicine, Keele University) for useful advice about biomaterials, Dr. Donna Arndt-Jovin (Max Planck Institute for Biophysical Chemistry) for the kind gift of CHO-EGFR-eGFP cells and Dr. Christopher J Tynan for critical reading of the manuscript and helpful suggestions. The authors gratefully acknowledge funding from the UK Biotechnology and Biological Sciences Research Council (BB/G006911/1).	ATTO-TEC GmbH, 2011, PROD INF ATTO 647N; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199; Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Fordyce P. M, SINGLE MOL TECHNIQUE, P431; Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011; Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335; Harris J. M., 1997, ACS S SERIES, V680; Heyes CD, 2004, J PHYS CHEM B, V108, P13387, DOI 10.1021/jp049057o; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Holtzer L, 2009, SINGLE PARTICLE TRAC, P25; Hovius R, 2006, SINGLE MOL DETECTION; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1349, DOI 10.1093/oxfordjournals.jbchem.a133103; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H; Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Nordberg E, 2007, NUCL MED BIOL, V34, P609, DOI 10.1016/j.nucmedbio.2007.05.010; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Qin M, 2007, COLLOID SURFACE B, V60, P243, DOI 10.1016/j.colsurfb.2007.06.018; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006; Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E; Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850; Tessler LA, 2011, J R SOC INTERFACE, V8, P1400, DOI 10.1098/rsif.2010.0669; Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Zhong H, 2010, COLD SPRING HARBBOR, V2010; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	59	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45655	10.1371/journal.pone.0045655	http://dx.doi.org/10.1371/journal.pone.0045655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049831	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100064
J	Zheng, L; Liang, P; Li, J; Huang, XB; Liu, SC; Zhao, HZ; Han, KQ; Wang, Z				Zheng, Lu; Liang, Ping; Li, Jing; Huang, Xiao-bing; Liu, Shi-cheng; Zhao, Hong-zhi; Han, Ke-qiang; Wang, Zheng			ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; EPIDEMIOLOGY; THERAPY; CANCER	Background: COMMD7 is a newly identified gene overexpressed in hepatocellular carcinoma (HCC) and associated with tumor invasion and poor prognosis. We aim to examine the biological function of COMMD7 in HCC by shRNA silencing. Methods: COMMD7 expressions were examined in human HCC cell lines HepG2, Huh7, Hep3B, HLE, HLF, SK-Hep-1 and PLC/PRF/5 cells. Recombinant pGenesil-COMMD7-shRNA was transfected into COMMD7-abundant HepG2 cells to silence COMMD7 expression. The effects of COMMD7 silencing on HepG2 cell proliferation in vitro and xenograft tumor growth in vivo were evaluated. Flow cytometry profiling was used to detect the presence of apoptosis in COMMD7-silenced HepG2 cells and to differentiate cell cycle distribution. Electrophoretic mobility shift assay and luciferase reporter assays to examine the activities of nuclear factor-kappaB (NF-kappa B) signaling pathways in response to tumor necrosis factor (TNF)-alpha in COMMD7-silenced HepG2 cells. Results: COMMD7 expression level was abundance in HepG2 and SK-Hep-1 cells. COMMD7 was aberrantly overexpressed in HepG2 cells, whilst pGenesil-COMMD7-shRNA exhibited a maximal inhibition rate of 75%. COMMD7 silencing significantly reduced HepG2 cell proliferation and colony formation. The knockdown of COMMD7 resulted in an increased apoptosis and cell cycle arrest at S-phase. COMMD7 knockdown also exhibited an antineoplastic effect in vivo, which manifested as tumor xenograft growth retardation. COMMD7 silencing also suppressed the responsiveness of NF-kappa B signaling pathway to the stimulation with TNF-alpha in vitro. Moreover, the similar suppressive effects of COMMD7 silence on SK-Hep-1 cells were also observed. Conclusions: COMMD7 contributes to HCC progression by reducing cell apoptosis and overcoming cell cycle arrest. The proliferative and antiapoptotic effects of COMMD7 may be mediated by NF-kappa B signaling pathway.	[Zheng, Lu; Liang, Ping; Li, Jing; Huang, Xiao-bing; Liu, Shi-cheng; Zhao, Hong-zhi; Han, Ke-qiang; Wang, Zheng] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University	Liang, P (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China.	xqyylp@hotmail.com; xqyylj@hotmail.com	zheng, lu/GXH-7035-2022		Natural Science Foundation of China [81001105, 30570843]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from Natural Science Foundation of China (# 81001105 and # 30570843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Jakobs TF, 2008, RADIOLOGE, V48, P839, DOI 10.1007/s00117-008-1730-x; Kagawa T, 2010, CANCER-AM CANCER SOC, V116, P3638, DOI 10.1002/cncr.25142; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Kudo M, 2010, ONCOLOGY-BASEL, V78, P154, DOI 10.1159/000315245; Li CX, 2010, EUR J CANCER, V46, P2513, DOI 10.1016/j.ejca.2010.06.015; LI J, 2003, CHINESE J MED GENET, V20, P49; [刘世呈 LIU Shicheng], 2007, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V29, P2207; Mo Qin-Guo, 2003, Ai Zheng, V22, P189; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sahara S, 2010, JPN J RADIOL, V28, P362, DOI 10.1007/s11604-010-0436-y; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VAN WC, 2007, CLIN CANCER RES, V13, P1076; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhao HZ, 2004, WORLD CHIN J DIG, V12, P1785; Zheng L, 2010, HEPATO-GASTROENTEROL, V57, P919; [周建波 ZHOU Jianbo], 2006, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V23, P288; Zhou L, 2007, WORLD J SURG, V31, P1782, DOI 10.1007/s00268-007-9029-z	23	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45412	10.1371/journal.pone.0045412	http://dx.doi.org/10.1371/journal.pone.0045412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049798	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100046
J	Zuccala, ES; Gout, AM; Dekiwadia, C; Marapana, DS; Angrisano, F; Turnbull, L; Riglar, DT; Rogers, KL; Whitchurch, CB; Ralph, SA; Speed, TP; Baum, J				Zuccala, Elizabeth S.; Gout, Alexander M.; Dekiwadia, Chaitali; Marapana, Danushka S.; Angrisano, Fiona; Turnbull, Lynne; Riglar, David T.; Rogers, Kelly L.; Whitchurch, Cynthia B.; Ralph, Stuart A.; Speed, Terence P.; Baum, Jake			Subcompartmentalisation of Proteins in the Rhoptries Correlates with Ordered Events of Erythrocyte Invasion by the Blood Stage Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; HOST-CELL INVASION; TOXOPLASMA-GONDII INVASION; MEMBRANE ANTIGEN 1; APICOMPLEXAN PARASITES; MOVING JUNCTION; PARASITOPHOROUS VACUOLE; STRUCTURED ILLUMINATION; PROTEOMIC ANALYSIS; XIV MYOSIN	Host cell infection by apicomplexan parasites plays an essential role in lifecycle progression for these obligate intracellular pathogens. For most species, including the etiological agents of malaria and toxoplasmosis, infection requires active host-cell invasion dependent on formation of a tight junction - the organising interface between parasite and host cell during entry. Formation of this structure is not, however, shared across all Apicomplexa or indeed all parasite lifecycle stages. Here, using an in silico integrative genomic search and endogenous gene-tagging strategy, we sought to characterise proteins that function specifically during junction-dependent invasion, a class of proteins we term invasins to distinguish them from adhesins that function in species specific host-cell recognition. High-definition imaging of tagged Plasmodium falciparum invasins localised proteins to multiple cellular compartments of the blood stage merozoite. This includes several that localise to distinct subcompartments within the rhoptries. While originating from the same organelle, however, each has very different dynamics during invasion. Apical Sushi Protein and Rhoptry Neck protein 2 release early, following the junction, whilst a novel rhoptry protein PFF0645c releases only after invasion is complete. This supports the idea that organisation of proteins within a secretory organelle determines the order and destination of protein secretion and provides a localisation-based classification strategy for predicting invasin function during apicomplexan parasite invasion.	[Gout, Alexander M.; Speed, Terence P.; Baum, Jake] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Rogers, Kelly L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Imaging Facil, Parkville, Vic 3050, Australia; [Zuccala, Elizabeth S.; Gout, Alexander M.; Angrisano, Fiona; Riglar, David T.; Rogers, Kelly L.; Speed, Terence P.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Turnbull, Lynne; Whitchurch, Cynthia B.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Technology Sydney	Baum, J (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia.	jake@wehi.edu.au	Zuccala, Elizabeth/HDM-5025-2022; Ralph, Stuart/C-8590-2014; Whitchurch, Cynthia/A-5954-2008; Turnbull, Lynne/A-2605-2012	Angrisano, Fiona/0000-0002-0457-5982; Ralph, Stuart/0000-0003-0114-7808; Zuccala, Elizabeth/0000-0002-9189-9810; Rogers, Kelly L./0000-0002-6755-0221; Whitchurch, Cynthia/0000-0003-2296-3791; Turnbull, Lynne/0000-0002-9255-9033; Riglar, David/0000-0002-5004-4373; Baum, Jake/0000-0002-0275-352X	National Health and Medical Research Council of Australia (NHMRC Project) [637340]; Human Frontier Science Program (HFSP Young Investigator Program) [RGY0071/2011]; Australian Postgraduate Award (APA); University of Melbourne Postgraduate Research Scholarship (MRS); Walter & Eliza Hall Institute Postgraduate Scholarship; Pratt Foundation PhD scholarship through the University of Melbourne; Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; Senior Research Fellowship from the NHMRC; Australian Research Council (ARC) Future Fellowship [FT0990350]; Australia Fellowship from the NHMRC; ARC Future Fellowship [FT100100112]	National Health and Medical Research Council of Australia (NHMRC Project)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program (HFSP Young Investigator Program); Australian Postgraduate Award (APA)(Australian Government); University of Melbourne Postgraduate Research Scholarship (MRS); Walter & Eliza Hall Institute Postgraduate Scholarship; Pratt Foundation PhD scholarship through the University of Melbourne; Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; Senior Research Fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); Australia Fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council)	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Funding for the research came from the National Health and Medical Research Council of Australia (NHMRC Project Grant 637340 JB and SAR) and the Human Frontier Science Program (HFSP Young Investigator Program Grant RGY0071/2011 JB). ESZ is supported by an Australian Postgraduate Award (APA); AMG was the recipient of a University of Melbourne Postgraduate Research Scholarship (MRS); FA is supported by a Walter & Eliza Hall Institute Postgraduate Scholarship; DTR is supported by a Pratt Foundation PhD scholarship through the University of Melbourne; LT is supported by a Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; CBW is supported by a Senior Research Fellowship from the NHMRC; SAR is supported by an Australian Research Council (ARC) Future Fellowship (FT0990350); TPS is supported by an Australia Fellowship from the NHMRC. JB is supported by an ARC Future Fellowship (FT100100112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; BANNISTER LH, 1975, PARASITOLOGY, V71, P483, DOI 10.1017/S0031182000047247; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Charron AJ, 2004, TRAFFIC, V5, P855, DOI 10.1111/j.1600-0854.2004.00228.x; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crabb BS, 2004, METH MOL B, V270, P263; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dubremetz JF, 2007, CELL MICROBIOL, V9, P841, DOI 10.1111/j.1462-5822.2007.00909.x; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hossain ME, 2012, PARASITOL RES, V110, P1711, DOI 10.1007/s00436-011-2690-z; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Kawase O, 2010, PARASITOL INT, V59, P211, DOI 10.1016/j.parint.2010.02.001; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kono M, 2012, MOL BIOL EVOL; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; O'Keeffe AH, 2005, MOL BIOCHEM PARASIT, V140, P61, DOI 10.1016/j.molbiopara.2004.12.003; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Putignani L, 2010, INTERDISCIP PERSPECT; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; SAFFER LD, 1992, J PROTOZOOL, V39, P526, DOI 10.1111/j.1550-7408.1992.tb04844.x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SCHUPP E, 1978, Z PARASITENKD, V55, P189, DOI 10.1007/BF00390369; Shaw MK, 2003, TRENDS PARASITOL, V19, P2, DOI 10.1016/S1471-4922(02)00015-6; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Srivastava A, 2010, MOL BIOCHEM PARASIT, V174, P66, DOI 10.1016/j.molbiopara.2010.06.003; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989; TORII M, 1992, J PROTOZOOL, V39, P449, DOI 10.1111/j.1550-7408.1992.tb04830.x; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Triglia T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002075; Tufet-Bayona M, 2009, MOL BIOCHEM PARASIT, V166, P22, DOI 10.1016/j.molbiopara.2009.02.009; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; VERNON LP, 1985, ARCH BIOCHEM BIOPHYS, V238, P18, DOI 10.1016/0003-9861(85)90136-5; VETTERLING JM, 1971, J PROTOZOOL, V18, P248, DOI 10.1111/j.1550-7408.1971.tb03316.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	79	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46160	10.1371/journal.pone.0046160	http://dx.doi.org/10.1371/journal.pone.0046160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049965	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100144
J	Jiang, XP; Langille, MGI; Neches, RY; Elliot, M; Levin, SA; Eisen, JA; Weitz, JS; Dushoff, J				Jiang, Xingpeng; Langille, Morgan G. I.; Neches, Russell Y.; Elliot, Marie; Levin, Simon A.; Eisen, Jonathan A.; Weitz, Joshua S.; Dushoff, Jonathan			Functional Biogeography of Ocean Microbes Revealed through Non-Negative Matrix Factorization	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOMIC ANALYSIS; METAGENOMICS; NETWORKS; SEQUENCE; ECOLOGY	The direct "metagenomic'' sequencing of genomic material from complex assemblages of bacteria, archaea, viruses and microeukaryotes has yielded new insights into the structure of microbial communities. For example, analysis of metagenomic data has revealed the existence of previously unknown microbial taxa whose spatial distributions are limited by environmental conditions, ecological competition, and dispersal mechanisms. However, differences in genotypes that might lead biologists to designate two microbes as taxonomically distinct need not necessarily imply differences in ecological function. Hence, there is a growing need for large-scale analysis of the distribution of microbial function across habitats. Here, we present a framework for investigating the biogeography of microbial function by analyzing the distribution of protein families inferred from environmental sequence data across a global collection of sites. We map over 6,000,000 protein sequences from unassembled reads from the Global Ocean Survey dataset to 8214 protein families, generating a protein family relative abundance matrix that describes the distribution of each protein family across sites. We then use non-negative matrix factorization (NMF) to approximate these protein family profiles as linear combinations of a small number of ecological components. Each component has a characteristic functional profile and site profile. Our approach identifies common functional signatures within several of the components. We use our method as a filter to estimate functional distance between sites, and find that an NMF-filtered measure of functional distance is more strongly correlated with environmental distance than a comparable PCA-filtered measure. We also find that functional distance is more strongly correlated with environmental distance than with geographic distance, in agreement with prior studies. We identify similar protein functions in several components and suggest that functional co-occurrence across metagenomic samples could lead to future methods for de-novo functional prediction. We conclude by discussing how NMF, and other dimension reduction methods, can help enable a macroscopic functional description of marine ecosystems.	[Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Jiang, Xingpeng] Drexel Univ, Coll Informat Sci & Technol, Philadelphia, PA 19104 USA; [Langille, Morgan G. I.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Neches, Russell Y.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Neches, Russell Y.; Eisen, Jonathan A.] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Elliot, Marie; Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Elliot, Marie; Dushoff, Jonathan] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Drexel University; Dalhousie University; University of California System; University of California Davis; University of California System; University of California Davis; McMaster University; McMaster University; Princeton University; University of California System; University of California Davis	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu; dushoff@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Levin, Simon A/J-1218-2014; Eisen, Jonathan A./H-2706-2019	Weitz, Jeffrey/0000-0002-1092-7550; Levin, Simon A/0000-0002-8216-5639; Eisen, Jonathan A./0000-0002-0159-2197; Neches, Russell/0000-0002-2055-8381; Langille, Morgan/0000-0002-6604-3009	Defense Advanced Projects Research Agency [HR0011-05-1-0057, HR0011-09-1-0055]; Gordon and Betty Moore Foundation [1660]; National Science Foundation [1046001]; Burroughs Wellcome Fund	Defense Advanced Projects Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Defense Advanced Projects Research Agency under grants HR0011-05-1-0057 and HR0011-09-1-0055. Additional support was received from the Gordon and Betty Moore Foundation, Grant 1660, to JE, and from the National Science Foundation Award 1046001 to SL. JW holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate C, 2010, IEEE T PATTERN ANAL, V32, P335, DOI 10.1109/TPAMI.2008.292; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Borcard D, 2012, ECOLOGY, V93, P1473; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Fanti C, 2004, ADV NEUR IN, V16, P1603; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Jiang XP, 2012, J MATH BIOL, V64, P697, DOI 10.1007/s00285-011-0428-2; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kim PM, 2003, GENOME RES, V13, P1706, DOI 10.1101/gr.903503; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Maetschke SR, 2010, BIOINFORMATICS, V26, P737, DOI 10.1093/bioinformatics/btq042; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; WHITTAKER RH, 1962, BOT REV, V28, P1, DOI 10.1007/BF02860872; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	38	25	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43866	10.1371/journal.pone.0043866	http://dx.doi.org/10.1371/journal.pone.0043866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23049741	gold, Green Published			2022-12-25	WOS:000311313900010
J	Blackford, JA; Guo, CH; Zhu, R; Dougherty, EJ; Chow, CC; Simons, SS				Blackford, John A., Jr.; Guo, Chunhua; Zhu, Rong; Dougherty, Edward J.; Chow, Carson C.; Simons, S. Stoney, Jr.			Identification of Location and Kinetically Defined Mechanism of Cofactors and Reporter Genes in the Cascade of Steroid-regulated Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR BINDING; PARTIAL AGONIST ACTIVITY; PROSTATE-CANCER CELLS; DOSE-RESPONSE CURVES; INDUCTION PROPERTIES; CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; ANTAGONIST COMPLEXES; HORMONE-RECEPTORS; IN-VIVO	A currently obscure area of steroid hormone action is where the component factors, including receptor and reporter gene, act. The DNA binding of factors can be precisely defined, but the location and timing of factor binding and action are usually not equivalent. These questions are addressed for several factors (e. g. glucocorticoid receptor (GR), reporter, TIF2, NCoR, NELF-A, sSMRT, and STAMP) using our recently developed competition assay. This assay reveals both the kinetically defined mechanism of factor action and where the above factors act relative to both each other and the equilibrium equivalent to the rate-limiting step, which we call the concentration limiting step (CLS). The utility of this competition assay would be greatly increased if the position of the CLS is invariant and if the factor acting at the CLS is known. Here we report that the exogenous GREtkLUC reporter acts at the CLS as an accelerator for gene induction by GRs in U2OS cells. This mechanism of reporter function at the CLS persists with different reporters, factors, receptors, and cell types. We, therefore, propose that the reporter gene always acts at the CLS during gene induction and constitutes a landmark around which one can order the actions of all other factors. Current data suggest that how and where GR and the short form of SMRT act is also constant. These results validate a novel and rational methodology for identifying distally acting factors that would be attractive targets for pharmaceutical intervention in the treatment of diseases involving GR-regulated genes.	[Simons, S. Stoney, Jr.] NIDDK, CEB, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol,NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, CEB, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol,NIH, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov	Guo, Chunhua/N-2586-2014	Dougherty, Edward/0000-0001-7664-9779	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047041, ZIADK075066, ZIADK047040, ZIADK057800, ZIADK075069] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK, National Institutes of Health.	AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Fromm HJ, 1975, INITIAL RATE ENZYME; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Giannoukos G, 2001, MOL ENDOCRINOL, V15, P255, DOI 10.1210/me.15.2.255; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; He YZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-128; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kotekar AS, 2008, MOL CELL BIOL, V28, P7323, DOI 10.1128/MCB.00889-08; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; PRIOR JC, 1990, ENDOCR REV, V11, P386, DOI 10.1210/edrv-11-2-386; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sarlis NJ, 1999, J STEROID BIOCHEM, V68, P89, DOI 10.1016/S0960-0760(99)00021-7; Segel I. H., 1993, NUCLEIC ACIDS RES; Simons SS, 2012, MOL CELL ENDOCRINOL, V348, P373, DOI 10.1016/j.mce.2011.05.030; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Szapary D, 1996, J BIOL CHEM, V271, P30576, DOI 10.1074/jbc.271.48.30576; Szapary D, 2008, MOL CELL ENDOCRINOL, V283, P114, DOI 10.1016/j.mce.2007.11.031; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang Q, 2004, J STEROID BIOCHEM, V91, P197, DOI 10.1016/j.jsbmb.2004.04.007; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Ziegler R, 1998, STEROIDS, V63, P344, DOI 10.1016/S0039-128X(98)00022-1	50	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40982	40995		10.1074/jbc.M112.414805	http://dx.doi.org/10.1074/jbc.M112.414805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055525	hybrid, Green Published			2022-12-25	WOS:000311887600016
J	Menotta, M; Biagiotti, S; Bianchi, M; Chessa, L; Magnani, M				Menotta, Michele; Biagiotti, Sara; Bianchi, Marzia; Chessa, Luciana; Magnani, Mauro			Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROLOGICAL SYMPTOMS; FULL ACTIVATION; GENE-EXPRESSION; CELLS; BETAMETHASONE; PHENOTYPE; IMPROVEMENT; SEQUENCES; INSULIN	Ataxia telangiectasia (AT) is a rare genetic disease, still incurable, resulting from biallelic mutations in the ataxia telangiectasia-mutated (ATM) gene. Recently, short term treatment with glucocorticoid analogues improved neurological symptoms characteristic of this syndrome. Nevertheless, the molecular mechanism involved in glucocorticoid action in AT patients is not yet known. Here we describe, for the first time in mammalian cells, a short direct repeat-mediated noncanonical splicing event induced by dexamethasone, which leads to the skipping of mutations upstream of nucleotide residue 8450 of ATM coding sequence. The resulting transcript provides an alternative ORF translated in a new ATM variant with the complete kinase domain. This miniATM variant was also highlighted in lymphoblastoid cell lines from AT patients and was shown to be likely active. In conclusion, dexamethasone treatment may partly restore ATM activity in ataxia telangiectasia cells by a new molecular mechanism that overcomes most of the mutations so far described within this gene.	[Menotta, Michele; Biagiotti, Sara; Bianchi, Marzia; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, I-61029 Urbino, PU, Italy; [Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy	University of Urbino; Sapienza University Rome	Menotta, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Via Saffi 2, I-61029 Urbino, PU, Italy.	michele.menotta@uniurb.it; sara.biagiotti@uniurb.it	Biagiotti, Sara/E-5043-2016; Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Bianchi, Marzia/0000-0001-9352-7319; Biagiotti, Sara/0000-0001-9554-7858	FanoAteneo; Associazione Nazionale AT "Davide De Marini"	FanoAteneo; Associazione Nazionale AT "Davide De Marini"	This work was supported in part by grants from FanoAteneo and Associazione Nazionale AT "Davide De Marini."	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Boehrs JK, 2007, J NEUROCHEM, V100, P337, DOI 10.1111/j.1471-4159.2006.04254.x; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Broccoletti T, 2011, EUR J NEUROL, V18, P564, DOI 10.1111/j.1468-1331.2010.03203.x; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; Fan J, 2007, J EXP BOT, V58, P3811, DOI 10.1093/jxb/erm231; Gatti RA, 2009, EUR J NEUROL, V16, P653, DOI 10.1111/j.1468-1331.2009.02597.x; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li JL, 2011, J NEUROSCI, V31, P7568, DOI 10.1523/JNEUROSCI.0778-11.2011; Nakada D, 2003, NUCLEIC ACIDS RES, V31, P1715, DOI 10.1093/nar/gkg252; Niu XL, 2010, J GENET GENOMICS, V37, P85, DOI 10.1016/S1673-8527(09)60028-X; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Platzer M, 1997, GENOME RES, V7, P592, DOI 10.1101/gr.7.6.592; Russo I, 2009, EUR J NEUROL, V16, P755, DOI 10.1111/j.1468-1331.2009.02600.x; Sarkaria JN, 1998, CANCER RES, V58, P4375; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Shiotani B, 2011, METHODS MOL BIOL, V782, P181, DOI 10.1007/978-1-61779-273-1_13; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Xia F, 1995, Methods Mol Biol, V48, P151; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	35	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41352	41363		10.1074/jbc.M112.344473	http://dx.doi.org/10.1074/jbc.M112.344473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055520	hybrid, Green Published			2022-12-25	WOS:000311887600049
J	Valente, P; Boekhout, T; Landell, MF; Crestani, J; Pagnocca, C; Sette, LD; Passarini, MRZ; Rosa, CA; Brandao, LR; Pimenta, RS; Ribeiro, JR; Garcia, KM; Lee, CF; Suh, SO; Peter, G; Dlauchy, D; Fell, JW; Scorzetti, G; Theelen, B; Vainstein, MH				Valente, Patricia; Boekhout, Teun; Landell, Melissa Fontes; Crestani, Juliana; Pagnocca, Fernando Carlos; Sette, Lara Duraes; Zambrano Passarini, Michel Rodrigo; Rosa, Carlos Augusto; Brandao, Luciana R.; Pimenta, Raphael S.; Ribeiro, Jose Roberto; Garcia, Karina Marques; Lee, Ching-Fu; Suh, Sung-Oui; Peter, Gabor; Dlauchy, Denes; Fell, Jack W.; Scorzetti, Gloria; Theelen, Bart; Vainstein, Marilene H.			Bandoniozyma gen. nov., a Genus of Fermentative and Non-Fermentative Tremellaceous Yeast Species	PLOS ONE			English	Article							CRYPTOCOCCUS-LAURENTII COMPLEX; MULTIGENE SEQUENCE-ANALYSIS; BASIDIOMYCETOUS YEAST; RIBOSOMAL-RNA; PROPOSAL; COMBINATIONS; SYSTEMATICS; PHYLOGENY; DIVERSITY; TAXA	Background: Independent surveys across the globe led to the proposal of a new basidiomycetous yeast genus within the Bulleromyces clade of the Tremellales, Bandoniozyma gen. nov., with seven new species. Methodology/Principal Findings: The species were characterized by multiple methods, including the analysis of D1/D2 and ITS nucleotide sequences, and morphological and physiological/biochemical traits. Most species can ferment glucose, which is an unusual trait among basidiomycetous yeasts. Conclusions/Significance: In this study we propose the new yeast genus Bandoniozyma, with seven species Bandoniozyma noutii sp. nov. (type species of genus; CBS 8364(T) = DBVPG 4489(T)), Bandoniozyma aquatica sp. nov. (UFMG-DH4.20(T) = CBS 12527(T) = ATCC MYA-4876(T)), Bandoniozyma complexa sp. nov. (CBS 11570(T) = ATCC MYA-4603(T) = MA28a(T)), Bandoniozyma fermentans sp. nov. (CBS 12399(T) = NU7M71(T) = BCRC 23267(T)), Bandoniozyma glucofermentans sp. nov. (CBS 10381(T) = NRRL Y-48076(T) = ATCC MYA-4760(T) = BG 02-7-15-015A-1-1(T)), Bandoniozyma tunnelae sp. nov. (CBS 8024(T) = DBVPG 7000(T)), and Bandoniozyma visegradensis sp. nov. (CBS 12505(T) = NRRL Y-48783(T) = NCAIM Y.01952(T)).	[Valente, Patricia] Univ Fed Rio Grande do Sul, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil; [Valente, Patricia; Landell, Melissa Fontes; Crestani, Juliana; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Boekhout, Teun; Theelen, Bart] Cent Bur Schimmelcultures Fungal Biodivers Ctr, Utrecht, Netherlands; [Pagnocca, Fernando Carlos; Sette, Lara Duraes] Sao Paulo State Univ, Dept Bioquim & Microbiol, Rio Claro, SP, Brazil; [Sette, Lara Duraes; Zambrano Passarini, Michel Rodrigo] Univ Estadual Campinas, Ctr Pluridisciplinar Pesquisas Quim Biol & Agr, Div Recursos Microbianos, Campinas, SP, Brazil; [Rosa, Carlos Augusto; Brandao, Luciana R.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil; [Pimenta, Raphael S.] Univ Fed Tocantins, Lab Microbiol Ambiental & Biotecnol, Palmas, TO, Brazil; [Ribeiro, Jose Roberto; Garcia, Karina Marques] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Lee, Ching-Fu] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan; [Suh, Sung-Oui] Amer Type Culture Collect, Mycol & Bot Program, Manassas, VA USA; [Peter, Gabor; Dlauchy, Denes] Corvinus Univ Budapest, Fac Food Sci, Budapest, Hungary; [Fell, Jack W.; Scorzetti, Gloria] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Key Biscayne, FL USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais; Universidade Federal do Tocantins (UFT); Universidade Federal do Rio de Janeiro; National Tsing Hua University; Corvinus University Budapest	Valente, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil.	patricia.valente@ufrgs.br	Theelen, Bart/GPP-7033-2022; Landell, Melissa F/N-9546-2013; Peter, Gabor/E-9228-2010; Boekhout, Teunis/ABF-2538-2020; Pimenta, Raphael Sanzio/ABE-4515-2021; Vainstein, Marilene H/J-5452-2014; Pimenta, Raphael Sanzio/D-9195-2013; Valente, Patricia/H-4773-2018; Passarini, Michel/H-7377-2012; Pagnocca, Fernando Carlos C/H-1688-2012	Landell, Melissa F/0000-0001-6848-0803; Boekhout, Teunis/0000-0002-0476-3609; Vainstein, Marilene H/0000-0002-3914-2300; Pimenta, Raphael Sanzio/0000-0001-7207-4437; Valente, Patricia/0000-0001-5374-0991; Pagnocca, Fernando Carlos C/0000-0002-5026-1933; Dlauchy, Denes/0000-0003-4425-6684; Sette, Lara/0000-0002-5980-3786	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Pesquisa; Brazilian Electricity Regulatory Agency; BANDEIRANTE Energy S. A.; National Science Foundation [DEB-0206521, DEB-0072741, REU, DEB-0417180, TAMOP 4.2.1/B-09/1/KMR-2010-0005]	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa; Brazilian Electricity Regulatory Agency; BANDEIRANTE Energy S. A.; National Science Foundation(National Science Foundation (NSF))	This work was funded by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Conselho Nacional de Pesquisa, Brazilian Electricity Regulatory Agency, BANDEIRANTE Energy S. A., National Science Foundation Grants DEB-0206521, DEB-0072741, REU, DEB-0417180 and TAMOP 4.2.1/B-09/1/KMR-2010-0005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi AO, 2005, BIOMETALS, V18, P269, DOI 10.1007/s10534-005-1539-2; Barnett JA, 2000, YEASTS CHARACTERISTI, V3; Beech IB, 1999, REV MICROBIOL, V30, P177; BOEKHOUT T, 1991, ANTON LEEUW INT J G, V59, P81, DOI 10.1007/BF00445652; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Crestani J, 2009, INT J SYST EVOL MICR, V59, P631, DOI 10.1099/ijs.0.001800-0; Fell JW, 2011, ANTON LEEUW INT J G, V99, P533, DOI 10.1007/s10482-010-9521-6; Fell JW, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1595, DOI 10.1016/B978-0-444-52149-1.00134-8; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELL JW, 1989, TAXON, V38, P151, DOI 10.2307/1220923; Fell JW, 1987, YEASTS TAXONOMIC STU, V3, P1503; Fell JW, 2008, YEASTS TAXONOMIC STU, V3, P1847; Fonseca A, 1901, YEASTS TAXONOMIC STU, V3; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; HAGENAUER A, 1994, WERKST KORROS, V45, P355; Inacio J, 2008, FEMS YEAST RES, V8, P499, DOI 10.1111/j.1567-1364.2008.00377.x; Kirschner R, 2001, ANTON LEEUW INT J G, V80, P149, DOI 10.1023/A:1012275204498; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2010, FEMS YEAST RES, V10, P353, DOI 10.1111/j.1567-1364.2010.00625.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Kwon-Chung KJ, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1457, DOI 10.1016/B978-0-444-52149-1.00115-4; Margesin R, 2008, INT J SYST EVOL MICR, V58, P2977, DOI 10.1099/ijs.0.2008/000836-0; Middelhoven WJ, 2005, ANTON LEEUW INT J G, V87, P101, DOI 10.1007/s10482-004-1728-y; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Peter G, 2009, FEMS YEAST RES, V9, P328, DOI 10.1111/j.1567-1364.2008.00466.x; Reyes-Novelo E, 2007, REV BIOL TROP, V55, P83; Saluja P, 2007, INT J SYST EVOL MICR, V57, P414, DOI 10.1099/ijs.0.64543-0; Sampaio JP, 2004, INT J SYST EVOL MICR, V54, P987, DOI 10.1099/ijs.0.02970-0; Sampaio JP, 2002, MYCOLOGIA, V94, P873, DOI 10.2307/3761703; Sampaio JP, 2001, INT J SYST EVOL MICR, V51, P687, DOI 10.1099/00207713-51-2-687; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Sette LD, 2010, FUNGAL DIVERS, V44, P53, DOI 10.1007/s13225-010-0048-y; Shin KS, 2006, INT J SYST EVOL MICR, V56, P2241, DOI 10.1099/ijs.0.64353-0; Shockley F.W., 2009, Insecta Mundi, V0072, P1; Statzell-Tallman A, 2008, FEMS YEAST RES, V8, P103, DOI 10.1111/j.1567-1364.2007.00314.x; Sugita T, 2000, J CLIN MICROBIOL, V38, P1468, DOI 10.1128/JCM.38.4.1468-1471.2000; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; Takashima M, 2001, J GEN APPL MICROBIOL, V47, P75, DOI 10.2323/jgam.47.75; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Bel AJE, 2008, J EXP BOT, V59, P261, DOI 10.1093/jxb/erm294; Wang QM, 2008, FEMS YEAST RES, V8, P799, DOI 10.1111/j.1567-1364.2008.00403.x; Wang QM, 2011, INT J SYST EVOL MICR, V61, P210, DOI 10.1099/ijs.0.019299-0; Zamora Fernando, 2009, P3, DOI 10.1007/978-0-387-74118-5_1; ZIMMERMANN MH, 1957, PLANT PHYSIOL, V32, P288, DOI 10.1104/pp.32.4.288	45	17	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46060	10.1371/journal.pone.0046060	http://dx.doi.org/10.1371/journal.pone.0046060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056233	Green Published, gold, Green Submitted			2022-12-25	WOS:000309889400009
J	van Polanen, V; Tiest, WMB; Kappers, AML				van Polanen, Vonne; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Haptic Search for Hard and Soft Spheres	PLOS ONE			English	Article							VISUAL-SEARCH; SUBJECTIVE JUDGMENT; PLASTIC PROPERTIES; POP-OUT; PERCEPTION; FEATURES; BODIES	In this study the saliency of hardness and softness were investigated in an active haptic search task. Two experiments were performed to explore these properties in different contexts. In Experiment 1, blindfolded participants had to grasp a bundle of spheres and determine the presence of a hard target among soft distractors or vice versa. If the difference in compliance between target and distractors was small, reaction times increased with the number of items for both features; a serial strategy was found to be used. When the difference in compliance was large, the reaction times were independent of the number of items, indicating a parallel strategy. In Experiment 2, blindfolded participants pressed their hand on a display filled with hard and soft items. In the search for a soft target, increasing reaction times with the number of items were found, but the location of target and distractors appeared to have a large influence on the search difficulty. In the search for a hard target, reaction times did not depend on the number of items. In sum, this showed that both hardness and softness are salient features.	[van Polanen, Vonne; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands	Utrecht University	van Polanen, V (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	v.van.polanen@vu.nl	van Polanen, Vonne/AAW-3793-2020; Tiest, Wouter M Bergmann/N-8535-2013; van Polanen, Vonne/AAP-7874-2020	van Polanen, Vonne/0000-0003-3111-6199	European Commission [248587, FP7-ICT-2009-4-2-1]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied", within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics". http://www.thehandembodied.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair GWS, 1939, PROC R SOC SER B-BIO, V128, P109, DOI 10.1098/rspb.1939.0046; Coppen FMV, 1942, B J PSYCHOL-GEN SECT, V32, P231, DOI 10.1111/j.2044-8295.1942.tb01022.x; Coren S, 1992, LEFT HANDER SYNDROME; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037/0096-1523.23.6.1680; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1988, PERCEPT PSYCHOPHYS, V44, P222, DOI 10.3758/BF03206291; Plaisier MA, 2008, ACTA PSYCHOL, V128, P368, DOI 10.1016/j.actpsy.2008.03.011; Plaisier MA, 2010, LECT NOTES COMPUT SC, V6192, P219, DOI 10.1007/978-3-642-14075-4_31; Plaisier MA, 2009, ACTA PSYCHOL, V131, P163, DOI 10.1016/j.actpsy.2009.04.003; Plaisier MA, 2009, ATTEN PERCEPT PSYCHO, V71, P421, DOI 10.3758/APP.71.2.421; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; Tiest WMB, 2009, IEEE T HAPTICS, V2, P189, DOI [10.1109/TOH.2009.16, 10.1109/ToH.2009.16]; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Polanen V, 2012, ATTEN PERCEPT PSYCHO, V74, P204, DOI 10.3758/s13414-011-0216-5; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, PERCEPTION, V32, P645, DOI 10.1068/p3414; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006	19	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45298	10.1371/journal.pone.0045298	http://dx.doi.org/10.1371/journal.pone.0045298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056197	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500016
J	Hoyer, S; Nguon, S; Kim, S; Habib, N; Khim, N; Sum, S; Christophel, EM; Bjorge, S; Thomson, A; Kheng, S; Chea, N; Yok, S; Top, S; Ros, S; Sophal, U; Thompson, MM; Mellor, S; Ariey, F; Witkowski, B; Yeang, C; Yeung, S; Duong, S; Newman, RD; Menard, D				Hoyer, Stefan; Nguon, Sokomar; Kim, Saorin; Habib, Najibullah; Khim, Nimol; Sum, Sarorn; Christophel, Eva-Maria; Bjorge, Steven; Thomson, Andrew; Kheng, Sim; Chea, Nguon; Yok, Sovann; Top, Samphornarann; Ros, Seyha; Sophal, Uth; Thompson, Michelle M.; Mellor, Steve; Ariey, Frederic; Witkowski, Benoit; Yeang, Chhiang; Yeung, Shunmay; Duong, Socheat; Newman, Robert D.; Menard, Didier			Focused Screening and Treatment (FSAT): A PCR-Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, Cambodia	PLOS ONE			English	Article							MEFLOQUINE COMBINATION; PLASMODIUM; EFFICACY; PYRIMETHAMINE; EPIDEMIOLOGY; SURVEILLANCE; ELIMINATION; ARTESUNATE; THERAPY	Recent studies have shown that Plasmodium falciparum malaria parasites in Pailin province, along the border between Thailand and Cambodia, have become resistant to artemisinin derivatives. To better define the epidemiology of P. falciparum populations and to assess the risk of the possible spread of these parasites outside Pailin, a new epidemiological tool named "Focused Screening and Treatment" (FSAT), based on active molecular detection of asymptomatic parasite carriers was introduced in 2010. Cross-sectional malariometric surveys using PCR were carried out in 20 out of 109 villages in Pailin province. Individuals detected as P. falciparum carriers were treated with atovaquone-proguanil combination plus a single dose of primaquine if the patient was non-G6PD deficient. Interviews were conducted to elicit history of cross-border travel that might contribute to the spread of artemisinin-resistant parasites. After directly observed treatment, patients were followed up and re-examined on day 7 and day 28. Among 6931 individuals screened, prevalence of P. falciparum carriers was less than 1%, of whom 96% were asymptomatic. Only 1.6% of the individuals had a travel history or plans to go outside Cambodia, with none of those tested being positive for P. falciparum. Retrospective analysis, using 2010 routine surveillance data, showed significant differences in the prevalence of asymptomatic carriers discovered by FSAT between villages classified as "high risk" and "low risk" based on malaria incidence data. All positive individuals treated and followed-up until day 28 were cured. No mutant-type allele related to atovaquone resistance was found. FSAT is a potentially useful tool to detect, treat and track clusters of asymptomatic carriers of P. falciparum along with providing valuable epidemiological information regarding cross-border movements of potential malaria parasite carriers and parasite gene flow.	[Hoyer, Stefan; Newman, Robert D.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Nguon, Sokomar; Kheng, Sim; Chea, Nguon; Yok, Sovann; Top, Samphornarann; Ros, Seyha; Yeang, Chhiang; Duong, Socheat] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Kim, Saorin; Khim, Nimol; Sum, Sarorn; Witkowski, Benoit; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Habib, Najibullah; Bjorge, Steven; Thomson, Andrew] WHO, Phnom Penh, Cambodia; [Christophel, Eva-Maria] WHO, Reg Off Western Pacific, Manila, Philippines; [Sophal, Uth; Thompson, Michelle M.; Mellor, Steve] Malaria Consortium, Manila, Philippines; [Ariey, Frederic] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Yeung, Shunmay] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England	World Health Organization; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; London School of Hygiene & Tropical Medicine	Hoyer, S (corresponding author), WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland.	hoyers@who.int; dmenard@pasteur-kh.org	ariey, frederic/P-1185-2017; Menard, Didier/O-3294-2013; Witkowski, Benoit/T-1118-2019	ariey, frederic/0000-0002-0680-1090; Menard, Didier/0000-0003-1357-4495; Yeung, Shunmay/0000-0002-0997-0850	Bill & Melinda Gates Foundation [48821.01]; WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''; French Ministry of Foreign Affairs	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''; French Ministry of Foreign Affairs	The funding of this operational research was provided by the Bill & Melinda Gates Foundation (Grant No 48821.01) and WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''. Didier Menard was supported by the French Ministry of Foreign Affairs during this work. Shunmay Yeung was the ARC programme was operational research coordinator during the early planning stages of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CONT MAL MULT RES CA; [Anonymous], 2007, METHODS TECHNIQUES C; Atkinson JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-101; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; CONTACOS PETER G., 1963, TRANS ROY SOC TROP MED HYG, V57, P417, DOI 10.1016/0035-9203(63)90074-9; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; DENIS MB, 1991, FOLIA PARASIT, V38, P187; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Denis MB, 2006, TROP MED INT HEALTH, V11, P1360, DOI 10.1111/j.1365-3156.2006.01690.x; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Goudet J., 2003, FSTAT VERSION 2 9 4; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HOFLER W, 1980, DEUT MED WOCHENSCHR, V105, P350; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kuwahata M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-223; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; NEI M, 1978, GENETICS, V89, P583; Phyo AP, 2012, LANCET; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; SMITHUIS FM, 1993, ANTIMICROB AGENTS CH, V37, P1977, DOI 10.1128/AAC.37.9.1977; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; VERDRAGER J, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P111; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Verdrager Jacques, 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P23; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; WHO, 2009, METH SURV ANT DRUG E; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	37	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45797	10.1371/journal.pone.0045797	http://dx.doi.org/10.1371/journal.pone.0045797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049687	gold, Green Published, Green Accepted			2022-12-25	WOS:000309388500014
J	Li, Q; Lu, FR; Wang, KF				Li, Qiang; Lu, Furong; Wang, Kaifa			Modeling of HIV-1 Infection: Insights to the Role of Monocytes/Macrophages, Latently Infected T4 Cells, and HAART Regimes	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; ACTIVE ANTIRETROVIRAL THERAPY; IN-VIVO; LYMPHOID ORGANS; IMMUNODEFICIENCY; PATHOGENESIS; MACROPHAGES; LYMPHOCYTES; APOPTOSIS; RESERVOIR	A novel dynamic model covering five types of cells and three connected compartments, peripheral blood (PB), lymph nodes (LNs), and the central nervous system (CNS), is here proposed. It is based on assessment of the biological principles underlying the interactions between the human immunodeficiency virus type I (HIV-1) and the human immune system. The simulated results of this model matched the three well-documented phases of HIV-1 infection very closely and successfully described the three stages of LN destruction that occur during HIV-1 infection. The model also showed that LNs are the major location of viral replication, creating a pool of latently infected T4 cells during the latency period. A detailed discussion of the role of monocytes/macrophages is made, and the results indicated that infected monocytes/macrophages could determine the progression of HIV-1 infection. The effects of typical highly active antiretroviral therapy (HAART) drugs on HIV-1 infection were analyzed and the results showed that efficiency of each drug but not the time of the treatment start contributed to the change of the turnover of the disease greatly. An incremental count of latently infected T4 cells was made under therapeutic simulation, and patients were found to fail to respond to HAART therapy in the presence of certain stimuli, such as opportunistic infections. In general, the dynamics of the model qualitatively matched clinical observations very closely, indicating that the model may have benefits in evaluating the efficacy of different drug therapy regimens and in the discovery of new monitoring markers and therapeutic schemes for the treatment of HIV-1 infection.	[Li, Qiang; Wang, Kaifa] Third Mil Med Univ, Dept Device & Equipment, Sch Biomed Engn & Med Imaging, Chongqing, Peoples R China; [Lu, Furong] Chongqing Univ, Dept Chem, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China	Army Medical University; Chongqing University	Wang, KF (corresponding author), Third Mil Med Univ, Dept Device & Equipment, Sch Biomed Engn & Med Imaging, Chongqing, Peoples R China.	kaifawang@yahoo.com.cn		Wang, Kaifa/0000-0002-6787-5018	National Natural Science Fund of People's Republic of China [11271369, 30770555]; Natural Science Foundation Project of CQ CSTC [2010BB5020]	National Natural Science Fund of People's Republic of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was partially supported by the National Natural Science Fund of People's Republic of China (11271369, 30770555) and the Natural Science Foundation Project of CQ CSTC (2010BB5020). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlkalizeForHealth, LYMPH SYST HLTH DIS; Althaus CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016468; [Anonymous], 1990, Wkly Epidemiol Rec, V65, P221; [Anonymous], 1995, THEORY EPIDEMICS SER; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; ASCHER MS, 1988, CLIN EXP IMMUNOL, V73, P165; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Barsov EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023703; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Burkhead E, 2009, B MATH BIOL, V71, P25, DOI 10.1007/s11538-008-9351-0; Burton GF, 2002, SEMIN IMMUNOL, V14, P275, DOI 10.1016/S1044-5323(02)00060-X; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Cameron PU, 2000, HIV MANAGEMENT AUSTR, P19; Caponetti G, 2008, ENT-EAR NOSE THROAT, V87, P374, DOI 10.1177/014556130808700706; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Deeks SG, 2007, CLIN PHARMACOL THER, V82, P248, DOI 10.1038/sj.clpt.6100205; Del Cacho E, 2008, J IMMUNOL METHODS, V334, P59, DOI 10.1016/j.jim.2008.02.001; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Ernst JD, 2006, ADV M C M, P246, DOI 10.1017/CBO9780511541513.008; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; GROUARD G, 1995, J IMMUNOL, V155, P3345; GUPTA KK, 1993, NEW ENGL J MED, V328, P288, DOI 10.1056/NEJM199301283280419; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; HENDERSON JM, 1981, RADIOLOGY, V141, P525, DOI 10.1148/radiology.141.2.6974875; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124; Ho J, 2007, J IMMUNOL, V178, P6968, DOI 10.4049/jimmunol.178.11.6968; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; JANEWAY CA, 2001, IMMUNOBIOLOGY, V5; Joly M, 2006, AICHE J, V52, P856, DOI 10.1002/aic.10716; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kesmir C, 1999, J IMMUNOL, V163, P2463; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Kirschner D, 2000, J ACQ IMMUN DEF SYND, V24, P352; Kirschner D., 1996, NOTICES AM MATH SOC, V43, P191; Kirschner DE, 1997, B MATH BIOL, V59, P95; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lawn SD, 2000, J VIROL, V74, P139, DOI 10.1128/JVI.74.1.139-145.2000; Lawyer G, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-26; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Loftus WK, 1999, J CLIN ULTRASOUND, V27, P71, DOI 10.1002/(SICI)1097-0096(199902)27:2<71::AID-JCU4>3.3.CO;2-L; Mangino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022982; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Murray JM, 1998, MATH BIOSCI, V154, P57, DOI 10.1016/S0025-5564(98)10046-9; Nelson PW, 2000, MATH BIOSCI, V163, P201, DOI 10.1016/S0025-5564(99)00055-3; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prosperi MCF, 2010, CLIN INFECT DIS, V50, P1316, DOI 10.1086/651688; Roger W, 1973, ANGIOLOGY, P588; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Rosenberg YJ, 1999, SEMIN IMMUNOL, V11, P139, DOI 10.1006/smim.1999.0169; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sloand EM, 1999, BLOOD, V94, P1021, DOI 10.1182/blood.V94.3.1021.415k29_1021_1027; Stefano GB, 2000, MODERN ASPECTS IMMUN, V1, P63; Thacker TC, 2009, J VIROL, V83, P150, DOI 10.1128/JVI.01652-08; Tsai WP, 1996, VIROLOGY, V226, P205, DOI 10.1006/viro.1996.0648; Tuckwell HC, 1998, J THEOR BIOL, V195, P451, DOI 10.1006/jtbi.1998.0806; Ueno T, 2008, J IMMUNOL, V180, P1107, DOI 10.4049/jimmunol.180.2.1107; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; Waki K, 2010, VIRUSES-BASEL, V2, P1603, DOI 10.3390/v2081603; Walport M., 1999, IMMUNOBIOLOGY; Wang LQ, 1999, J IMMUNOL, V162, P268; Wang LQ, 1997, VIROLOGY, V228, P141, DOI 10.1006/viro.1996.8397; Wasserstein-Robbins F, 2010, B MATH BIOL, V72, P1208, DOI 10.1007/s11538-009-9488-5; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Wu Y, 2010, United States Patent Application, Patent No. [US20100292181A1, 20100292181]	106	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46026	10.1371/journal.pone.0046026	http://dx.doi.org/10.1371/journal.pone.0046026			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049927	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300076
J	Taira, Y; Hayashida, N; Yamaguchi, H; Yamashita, S; Endo, Y; Takamura, N				Taira, Yasuyuki; Hayashida, Naomi; Yamaguchi, Hitoshi; Yamashita, Shunichi; Endo, Yuukou; Takamura, Noboru			Evaluation of Environmental Contamination and Estimated Radiation Doses for the Return to Residents' Homes in Kawauchi Village, Fukushima Prefecture	PLOS ONE			English	Article								To evaluate the environmental contamination and radiation exposure dose rates due to artificial radionuclides in Kawauchi Village, Fukushima Prefecture, the restricted area within a 30-km radius from the Fukushima Dai-ichi Nuclear Power Plant (FNPP), the concentrations of artificial radionuclides in soil samples, tree needles, and mushrooms were analyzed by gamma spectrometry. Nine months have passed since samples were collected on December 19 and 20, 2011, 9 months after the FNPP accident, and the prevalent dose-forming artificial radionuclides from all samples were Cs-134 and Cs-137. The estimated external effective doses from soil samples were 0.42-7.2 mu Sv/h (3.7-63.0 mSv/y) within the 20-km radius from FNPP and 0.0011-0.38 mu Sv/h (0.010-3.3 mSv/y) within the 20-30 km radius from FNPP. The present study revealed that current levels are sufficiently decreasing in Kawauchi Village, especially in areas within the 20- to 30-km radius from FNPP. Thus, residents may return their homes with long-term follow-up of the environmental monitoring and countermeasures such as decontamination and restrictions of the intake of foods for reducing unnecessary exposure. The case of Kawauchi Village will be the first model for the return to residents' homes after the FNPP accident.	[Taira, Yasuyuki; Hayashida, Naomi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan; [Yamaguchi, Hitoshi] Nagasaki Univ, Grad Sch Engn, Dept Ecomat Sci, Nagasaki 852, Japan; [Taira, Yasuyuki; Yamaguchi, Hitoshi] Nagasaki Prefectural Inst Environm Res & Publ Hlt, Omura, Japan; [Endo, Yuukou] Kawauchi Municipal Govt, Fukushima, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234				[Anonymous], 2006, HLTH EFF CHERN ACC S, P182; Endo S, 2011, J ENV RADIOACT; ICRU, 1994, 53 ICRU; International Atomic Energy Agency, 2000, IAEATECDOC1162; International Commission on Radiobiological Protection, 2007, ANN ICRP, V37; International Commission on Radiological Protection, 1996, ICRP PUBL 5; International Commission on Radiological Protection, 2007, ICRP PUBL; Kato H, 2011, J ENV RADIOACT; Ministry of Economy Trade and Industry Japan, BAS POL EM RESP DEC; Ministry of Education Culture Sports Science and Technology, ENV RAD RAD JAP; Ministry of Education Culture Sports Science and Technology Japan, 2012, ENV RAD RAD JAP MON; Ministry of Health Labour and Welfare Japan, INF GREAT E JAP EART; Ministry of Health Labour and Welfare of Japan, NAT HLTH NUTR SURV; Ministry of the Environment Japan, DIS WAST MAN; Monzen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027761; Muck K, 2002, HEALTH PHYS, V82, P141, DOI 10.1097/00004032-200202000-00002; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Taira Y, 2012, RAD PROT DOSIM; Taira Y, 2011, J RADIAT RES, V52, P88, DOI 10.1269/jrr.10104; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD 20; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD 20, VII	21	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45816	10.1371/journal.pone.0045816	http://dx.doi.org/10.1371/journal.pone.0045816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049869	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300056
J	Yang, PH; Deng, JJ; Li, CG; Zhang, PR; Xing, L; Li, ZW; Wang, W; Zhao, Y; Yan, YW; Gu, HJ; Liu, X; Zhao, ZP; Zhang, SG; Wang, XL; Jiang, CY				Yang, Penghui; Deng, Jiejie; Li, Chenggang; Zhang, Peirui; Xing, Li; Li, Zhiwei; Wang, Wei; Zhao, Yan; Yan, Yiwu; Gu, Hongjing; Liu, Xin; Zhao, Zhongpeng; Zhang, Shaogeng; Wang, Xiliang; Jiang, Chengyu			Characterization of the 2009 Pandemic A/Beijing/501/2009 H1N1 Influenza Strain in Human Airway Epithelial Cells and Ferrets	PLOS ONE			English	Article							VIRUS; PATHOGENESIS; VACCINE; IMMUNOGENICITY; TRANSMISSION; RESPONSES; CHILDREN; SAFETY; MODEL; MICE	Background: A novel 2009 swine-origin influenza A H1N1 virus (S-OIV H1N1) has been transmitted among humans worldwide. However, the pathogenesis of this virus in human airway epithelial cells and mammals is not well understood. Methodology/Principal Finding: In this study, we showed that a 2009 A (H1N1) influenza virus strain, A/Beijing/501/2009, isolated from a human patient, caused typical influenza-like symptoms including weight loss, fluctuations in body temperature, and pulmonary pathological changes in ferrets. We demonstrated that the human lung adenocarcinoma epithelial cell line A549 was susceptible to infection and that the infected cells underwent apoptosis at 24 h post-infection. In contrast to the seasonal H1N1 influenza virus, the 2009 A (H1N1) influenza virus strain A/Beijing/501/2009 induced more cell death involving caspase-3-dependent apoptosis in A549 cells. Additionally, ferrets infected with the A/Beijing/501/2009 H1N1 virus strain exhibited increased body temperature, greater weight loss, and higher viral titers in the lungs. Therefore, the A/Beijing/501/2009 H1N1 isolate successfully infected the lungs of ferrets and caused more pathological lesions than the seasonal influenza virus. Our findings demonstrate that the difference in virulence of the 2009 pandemic H1N1 influenza virus and the seasonal H1N1 influenza virus in vitro and in vivo may have been mediated by different mechanisms. Conclusion/Significance: Our understanding of the pathogenesis of the 2009 A (H1N1) influenza virus infection in both humans and animals is broadened by our findings that apoptotic cell death is involved in the cytopathic effect observed in vitro and that the pathological alterations in the lungs of S-OIV H1N1-infected ferrets are much more severe.	[Yang, Penghui; Zhang, Peirui; Li, Zhiwei; Zhang, Shaogeng] 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China; [Yang, Penghui; Xing, Li; Gu, Hongjing; Liu, Xin; Zhao, Zhongpeng; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Deng, Jiejie; Li, Chenggang; Wang, Wei; Zhao, Yan; Yan, Yiwu; Jiang, Chengyu] Tsinghua Univ, State Key Lab Med Mol Biol, Inst Basic Med Sci, Peking Union Med Coll,Chinese Acad Med Sci, Beijing 100084, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Zhang, SG (corresponding author), 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China.	Zhsg302@hotmail.com; xiliangw@126.com; chengyujiang@gmail.com	Yan, Yiwu/P-5499-2017; Wang, Wei/N-9423-2019	Yan, Yiwu/0000-0001-8289-7277; Wang, Wei/0000-0001-9243-8672; zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; National Basic Research Program (973) [2009CB522102, 2012CB518905]; National Key Technologies RD Program [2006AA02Z450, SS2012AA020905]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program (973)(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program)	The study was supported by the National Natural Scientific Foundation (30800977 and 30972614), the Beijing Natural Science Foundation (7112105), the National Basic Research Program (973) (2009CB522102 and 2012CB518905), and the National Key Technologies R&D Program (2006AA02Z450 and SS2012AA020905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Ekchariyawat P, 2012, INNATE IMMUN-LONDON, V18, P390, DOI 10.1177/1753425911410998; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Isken B, 2012, VACCINE; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kiseleva I, 2010, INFLUENZA OTHER RESP, V4, P1, DOI 10.1111/j.1750-2659.2009.00118.x; Kwon D, 2010, J MICROBIOL, V48, P657, DOI 10.1007/s12275-010-0120-z; Lednicky JA, 2010, COMPARATIVE MED, V60, P364; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2001, VIROLOGY, V287, P243, DOI 10.1006/viro.2001.1008; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Shinya K, 2011, J VIROL, V85, P5202, DOI 10.1128/JVI.00239-11; Sun SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-52; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Xu CE, 2011, VIRAL IMMUNOL, V24, P369, DOI 10.1089/vim.2011.0003; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116; Zhu HC, 2011, INFLUENZA OTHER RESP, V5, P82	31	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46184	10.1371/journal.pone.0046184	http://dx.doi.org/10.1371/journal.pone.0046184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049974	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300096
J	Bieg, HJ; Bresciani, JP; Bulthoff, HH; Chuang, LL				Bieg, Hans-Joachim; Bresciani, Jean-Pierre; Buelthoff, Heinrich H.; Chuang, Lewis L.			Looking for Discriminating Is Different from Looking for Looking's Sake	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; HAND COORDINATION; REACTION-TIME; MAIN-SEQUENCE; ARM MOVEMENT; REWARD; ATTENTION; FATIGUE; LATENCY; VISION	Recent studies provide evidence for task-specific influences on saccadic eye movements. For instance, saccades exhibit higher peak velocity when the task requires coordinating eye and hand movements. The current study shows that the need to process task-relevant visual information at the saccade endpoint can be, in itself, sufficient to cause such effects. In this study, participants performed a visual discrimination task which required a saccade for successful completion. We compared the characteristics of these task-related saccades to those of classical target-elicited saccades, which required participants to fixate a visual target without performing a discrimination task. The results show that task-related saccades are faster and initiated earlier than target-elicited saccades. Differences between both saccade types are also noted in their saccade reaction time distributions and their main sequences, i.e., the relationship between saccade velocity, duration, and amplitude.	[Bieg, Hans-Joachim; Buelthoff, Heinrich H.; Chuang, Lewis L.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Bresciani, Jean-Pierre] Univ Pierre Mendes France, Lab Psychol & Neurocognit, CNRS, UMR 5105, Grenoble, France; [Bresciani, Jean-Pierre] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Fribourg; Korea University	Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bresciani, Jean-Pierre/H-4340-2012; Chuang, Lewis/U-4430-2017; Bülthoff, Heinrich H/J-6579-2012	Chuang, Lewis/0000-0002-1975-5716; Bülthoff, Heinrich H/0000-0003-2568-0607; Bresciani, Jean-Pierre/0000-0002-7242-5433	Max Planck Society; Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT); Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	Max Planck Society(Max Planck Society); Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT); Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by a PhD stipend from the Max Planck Society (HJB), the Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT) (HJB, LLC), and by the WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008) (HHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Baguley T, 2011, BEHAV RES METHODS; Bahill T., 1975, MATH BIOSCI, V24, P191; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1988, MOVEMENTS EYES; Cattell JM, 1886, BRAIN, V8, P433; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; De Brabander B, 2002, BEHAV NEUROSCI, V116, P397, DOI 10.1037//0735-7044.116.3.397; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Epelboim J, 1997, VISION RES, V37, P2597, DOI 10.1016/S0042-6989(97)00075-8; Findlay J. M., 2003, ACTIVE VISION PSYCHO; FISCHER B, 1993, EXP BRAIN RES, V92, P528; FISCHER B, 1983, BRAIN RES, V260, P21, DOI 10.1016/0006-8993(83)90760-6; FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28; Garbutt S, 2001, BRIT J OPHTHALMOL, V85, P1477, DOI 10.1136/bjo.85.12.1477; Goossens HHLM, 2006, J NEUROPHYSIOL, V95, P2326, DOI 10.1152/jn.00889.2005; Guyader N, 2010, PSYCHOL RES-PSYCH FO, V74, P12, DOI 10.1007/s00426-008-0218-7; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kline RB, 2005, SIGNIFICANCE TESTING; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Lunenburger L, 2003, EUR J NEUROSCI, V17, P2481, DOI 10.1046/j.1460-9568.2003.02653.x; Madelain L, 2011, J NEUROPHYSIOL, V106, P219, DOI 10.1152/jn.01094.2009; Madelain L, 2011, BEHAV PROCESS, V87, P142, DOI 10.1016/j.beproc.2011.02.009; MANSFIELD RJ, 1973, VISION RES, V13, P2219, DOI 10.1016/0042-6989(73)90224-1; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; Montagnini A, 2005, VISION RES, V45, P3391, DOI 10.1016/j.visres.2005.07.013; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prsa M, 2010, J NEUROSCI, V30, P15834, DOI 10.1523/JNEUROSCI.3901-10.2010; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; REULEN JPH, 1984, BIOL CYBERN, V50, P263, DOI 10.1007/BF00337076; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; SANDERS A F, 1970, Ergonomics, V13, P101, DOI 10.1080/00140137008931124; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; Shadmehr R, 2010, J NEUROSCI, V30, P10507, DOI 10.1523/JNEUROSCI.1343-10.2010; Snyder LH, 2002, J NEUROPHYSIOL, V87, P2279, DOI 10.1152/jn.00854.2001; Stark L, 1975, INVEST OPHTHALMOL, V14, P468; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Stritzke M, 2009, J OPT SOC AM A, V26, pB1, DOI 10.1364/JOSAA.26.0000B1; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	59	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45445	10.1371/journal.pone.0045445	http://dx.doi.org/10.1371/journal.pone.0045445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049801	Green Published, gold			2022-12-25	WOS:000309556100049
J	Ejaz, A; Steinmann, E; Banki, Z; Anggakusuma; Khalid, S; Lengauer, S; Wilhelm, C; Zoller, H; Schloegl, A; Steinmann, J; Grabski, E; Kleines, M; Pietschmann, T; Stoiber, H				Ejaz, Asim; Steinmann, Eike; Banki, Zoltan; Anggakusuma; Khalid, Sana; Lengauer, Susanne; Wilhelm, Corinne; Zoller, Heinz; Schloegl, Anna; Steinmann, Joerg; Grabski, Elena; Kleines, Michael; Pietschmann, Thomas; Stoiber, Heribert			Specific Acquisition of Functional CD59 but Not CD46 or CD55 by Hepatitis C Virus	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; COMPLEMENT ACTIVATION; HUMAN HEPATOCYTES; DENDRITIC CELLS; PROTEIN; REGULATORS; INFECTION; STRATEGIES; MIGRATION; CHIMERAS	Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals.	[Ejaz, Asim; Banki, Zoltan; Khalid, Sana; Lengauer, Susanne; Kleines, Michael; Stoiber, Heribert] Innsbruck Med Univ, Inst Virol, Innsbruck, Austria; [Steinmann, Eike; Anggakusuma; Wilhelm, Corinne; Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany; [Zoller, Heinz; Schloegl, Anna] Univ Innsbruck Hosp, Dept Med, Clin Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Steinmann, Joerg] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Grabski, Elena] Ctr Expt & Clin Infect Res, Inst Expt Infect Res, TWINCORE, Hannover, Germany	Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center for Infection Research; Medical University of Innsbruck; University of Duisburg Essen	Stoiber, H (corresponding author), Innsbruck Med Univ, Inst Virol, Innsbruck, Austria.	hygiene@i-med.ac.at	Ejaz, Asim/J-9236-2019; Kleines, Michael/C-8801-2009; Pietschmann, Thomas/E-9241-2015; Zoller, Heinz/AAD-7225-2019	Pietschmann, Thomas/0000-0001-5138-6239; Steinmann, Eike/0000-0002-3654-9965; Banki, Zoltan/0000-0002-3826-5800; Kusuma, Angga/0000-0002-5060-5310	Austrian Research Fund FWF [215080, 17914]; Federal Government of Tyrol (Tiroler Wissenschaftsfonds) [TWF-2008-1-562]; DFG [STE 1954/1-1]; Emmy Noether-fellowship [PI 734/1-1]; Deutsche Forschungsgemeinschaft (DFG) [SFB900]; Initiative and Networking Fund of the Helmholtz association [SO-024]; Austrian Science Fund (FWF) [P 21508] Funding Source: researchfish	Austrian Research Fund FWF(Austrian Science Fund (FWF)); Federal Government of Tyrol (Tiroler Wissenschaftsfonds); DFG(German Research Foundation (DFG)); Emmy Noether-fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz association; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are supported by grants of the Austrian Research Fund FWF (215080 to ZB and 17914 to HS) and the Federal Government of Tyrol (Tiroler Wissenschaftsfonds TWF-2008-1-562 to HS). E.S. was supported by the DFG (STE 1954/1-1). T.P. was supported by an Emmy Noether-fellowship (PI 734/1-1) and by the SFB900 (project A6) both provided by the Deutsche Forschungsgemeinschaft (DFG) and also by a grant from the Initiative and Networking Fund of the Helmholtz association SO-024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2007, INDIAN J BIOCHEM BIO, V44, P331; Amet T, 2011, HEPATOLOGY; Ariumi Y, PLOS ONE, V6; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bitzegeio J, PLOS PATHOG, V6; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Boson B, PLOS PATHOG, V7; Brown KS, 2010, PROTEIN CELL, V1, P664, DOI 10.1007/s13238-010-0088-9; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chang ML, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-51; Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0; Favoreel HW, 2003, J GEN VIROL, V84, P1, DOI 10.1099/vir.0.18709-0; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Halme J, 2009, MOL IMMUNOL, V46, P2284, DOI 10.1016/j.molimm.2009.04.005; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Khan S, BIOCH J; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pitha PM, 2007, CURR TOP MICROBIOL, V316, P41; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Schmidt J, 2011, BIOMARK MED, V5, P155, DOI [10.2217/BMM.11.19, 10.2217/bmm.11.19]; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Soederholm A, 2007, EUR J IMMUNOL, V37, P2156, DOI 10.1002/eji.200636820; Stoiber H, 1996, J EXP MED, V183, P307, DOI 10.1084/jem.183.1.307; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; Vasei M, 2008, HEPATO-GASTROENTEROL, V55, P1066; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wilflingseder D, 2004, J IMMUNOL, V173, P7497, DOI 10.4049/jimmunol.173.12.7497; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889	51	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45770	10.1371/journal.pone.0045770	http://dx.doi.org/10.1371/journal.pone.0045770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049856	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100076
J	Hu, P; Oomen, C; van Dam, AM; Wester, J; Zhou, JN; Joels, M; Lucassen, PJ				Hu, Pu; Oomen, Charlotte; van Dam, Anne-Marie; Wester, Jordi; Zhou, Jiang-Ning; Joels, Marian; Lucassen, Paul J.			A Single-Day Treatment with Mifepristone Is Sufficient to Normalize Chronic Glucocorticoid Induced Suppression of Hippocampal Cell Proliferation	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; COMBINED DEXAMETHASONE/CRH TEST; CHRONIC PSYCHOSOCIAL STRESS; RAT DENTATE GYRUS; ADULT HIPPOCAMPUS; PSYCHOTIC DEPRESSION; SYNAPTIC PLASTICITY; PROGENITOR CELLS; NUCLEAR ANTIGEN; NERVOUS-SYSTEM	Background: Chronic stress or prolonged administration of glucocorticoids suppresses proliferation and/or survival of newborn cells in adult rat dentate gyrus. Earlier we showed that administration of the glucocorticoid receptor antagonist mifepristone during the final 4 days of a 21 days period of corticosterone treatment fully normalized the number of newborn cells. Here we aimed to better understand how mifepristone achieves this effect and questioned whether an even shorter (single day) mifepristone treatment (instead of 4 days) also suffices to normalize neurogenesis. Methods: We investigated various steps of the neurogenic process, using the immunohistochemical markers BrdU, doublecortin, proliferating cell nuclear antigen as well as glial fibrillary acidic protein, after 17 or 21 days of corticosterone (versus vehicle) treatment. Results: Corticosterone primarily attenuates the proliferation of cells which subsequently develop into neurons; this is fully reversed by mifepristone. Surprisingly, the corticosteroid effects on neurogenesis can even be fully re-set by a single-day treatment with mifepristone (on day 18), despite the continued corticosterone exposure on subsequent days. Conclusions: Our results emphasize that studies into the therapeutical efficacy of new antidepressants, especially those targeting HPA-activity or the glucocorticoid receptor, should explore the possibility to reduce treatment duration.	[Hu, Pu; Oomen, Charlotte; Wester, Jordi; Joels, Marian; Lucassen, Paul J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hu, Pu; Zhou, Jiang-Ning] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [van Dam, Anne-Marie] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Joels, Marian] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	University of Amsterdam; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Lucassen, PJ (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	p.j.lucassen@uva.nl	Joëls, Marian/P-6415-2016; Lucassen, Paul/ABA-3113-2020; Oomen, Charlotte/K-5259-2014; Zhou, JiangNing/N-3374-2013	Lucassen, Paul/0000-0001-9708-9133; Zhou, Jiang-Ning/0000-0003-1225-2873; Joels, Marian/0000-0002-4826-6209	Netherlands Brain Foundation; European Union; ISAO; NWO; Human Frontiers Science Program; Corcept Inc.; Natural Science Foundation of China [81100811]; Corcept Therapeutics, USA	Netherlands Brain Foundation; European Union(European Commission); ISAO; NWO(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program(Human Frontier Science Program); Corcept Inc.; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Corcept Therapeutics, USA	PJL is supported by the Netherlands Brain Foundation, the European Union and ISAO. MJ is supported by NWO and the Human Frontiers Science Program. MJ, PJL and PH were in part supported by Corcept Inc. PH is further supported in part by the Natural Science Foundation of China (81100811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and would like to declare that there are no conflicts of interest to report other than that ms Hu, unaware of this source, was in part supported by a student fellowship awarded to Prof. Dr. Joels by Corcept Therapeutics, USA, (http://www.corcept. com/). This does this alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Blasey CM, 2011, J CLIN PSYCHOPHARM, V31, P436, DOI 10.1097/JCP.0b013e3182239191; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Coyle JT, 2000, ARCH GEN PSYCHIAT, V57, P90, DOI 10.1001/archpsyc.57.1.90; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fleseriu M, 2012, J CLIN ENDOCRINOL ME; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Fuchs E, 2006, FRONT BIOSCI-LANDMRK, V11, P2746, DOI 10.2741/2004; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Hanson ND, 2011, PSYCHONEUROENDOCRINO, V36, P1520, DOI 10.1016/j.psyneuen.2011.04.006; HEIKINHEIMO O, 1994, HUM REPROD, V9, P40, DOI 10.1093/humrep/9.suppl_1.40; HEIKINHEIMO O, 1993, ANN MED, V25, P71, DOI 10.3109/07853899309147861; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Ino H, 2000, MOL BRAIN RES, V78, P163, DOI 10.1016/S0169-328X(00)00092-9; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Karst H, 2007, NEUROPSYCHOPHARMACOL, V32, P1830, DOI 10.1038/sj.npp.1301296; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Krugers HJ, 2006, EUR J NEUROSCI, V23, P3051, DOI 10.1111/j.1460-9568.2006.04842.x; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Limke TL, 2003, DEV NEUROSCI-BASEL, V25, P257, DOI 10.1159/000072273; Llorens-Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028376; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025303; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; Nierenberg AA, 2007, J PSYCHIATR RES, V41, P214, DOI 10.1016/j.jpsychires.2006.02.005; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pariante CM, 2009, ANN NY ACAD SCI, V1179, P144, DOI 10.1111/j.1749-6632.2009.04978.x; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; RATKA A, 1988, NEUROENDOCRINOLOGY, V48, P439, DOI 10.1159/000125046; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Sandi C, 1999, BRAIN RES, V828, P127, DOI 10.1016/S0006-8993(99)01346-3; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Schmidt ED, 2003, NEUROSCIENCE, V116, P275, DOI 10.1016/S0306-4522(02)00555-9; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Simpson GM, 2005, J CLIN PSYCHIAT, V66, P598, DOI 10.4088/JCP.v66n0509; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Stohr T, 1999, BEHAV BRAIN RES, V103, P85, DOI 10.1016/S0166-4328(99)00027-3; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; VANDIJKEN HH, 1993, NEUROENDOCRINOLOGY, V58, P57, DOI 10.1159/000126512; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	75	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46224	10.1371/journal.pone.0046224	http://dx.doi.org/10.1371/journal.pone.0046224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049985	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100158
J	Marx, FM; Dunbar, R; Enarson, DA; Beyers, N				Marx, Florian M.; Dunbar, Rory; Enarson, Donald A.; Beyers, Nulda			The Rate of Sputum Smear-Positive Tuberculosis after Treatment Default in a High-Burden Setting: A Retrospective Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; SINGLE NUCLEOTIDE POLYMORPHISMS; COMMON VARIANTS; CHILDHOOD OBESITY; ADULT OBESITY; GENETIC-VARIANTS; CHINESE CHILDREN; FTO GENE; MC4R	Rationale: High rates of recurrent tuberculosis after successful treatment have been reported from different high burden settings in Sub-Saharan Africa. However, little is known about the rate of smear-positive tuberculosis after treatment default. In particular, it is not known whether or not treatment defaulters continue to be or become again smear-positive and thus pose a potential for transmission of infection to others. Objective: To investigate, in a high tuberculosis burden setting, the rate of re-treatment for smear-positive tuberculosis among cases defaulting from standardized treatment compared to successfully treated cases. Methods: Retrospective cohort study among smear-positive tuberculosis cases treated between 1996 and 2008 in two urban communities in Cape Town, South Africa. Episodes of re-treatment for smear-positive tuberculosis were ascertained via probabilistic record linkage. Survival analysis and Poisson regression were used to compare the rate of smear-positive tuberculosis after treatment default to that after successful treatment. Results: A total of 2,136 smear-positive tuberculosis cases were included in the study. After treatment default, the rate of re-treatment for smear-positive tuberculosis was 6.86 (95% confidence interval [CI]: 5.59-8.41) per 100 person-years compared to 2.09 (95% CI: 1.81-2.41) after cure (adjusted Hazard Ratio [aHR]: 3.97; 95% CI: 3.00-5.26). Among defaulters, the rate was inversely associated with treatment duration and sputum conversion prior to defaulting. Smear grade at start of the index treatment episode (Smear3+: aHR 1.61; 95% CI 1.11-2.33) was independently associated with smear-positive tuberculosis re-treatment, regardless of treatment outcome. Conclusions: In this high-burden setting, there is a high rate of subsequent smear-positive tuberculosis after treatment default. Treatment defaulters are therefore likely to contribute to the pool of infectious source cases in the community. Our findings underscore the importance of preventing treatment default, as a means of successful tuberculosis control in high-burden settings.	[Marx, Florian M.] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Marx, Florian M.; Dunbar, Rory; Enarson, Donald A.; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stellenbosch University	Marx, FM (corresponding author), Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany.	florian.marx@charite.de	Marx, Florian/AAD-7148-2019	Marx, Florian/0000-0003-4630-4598	TREAT TB	TREAT TB	This study was supported by a grant from TREAT TB, managed by the International Union Against Tuberculosis and Lung Disease and provided by USAID. The contents of this document are the sole responsibility of the authors and can under no circumstances be regarded as reflecting the positions of the International Union Against Tuberculosis and Lung Disease (The Union) or those of the donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers S, 2011, MOL GENET METAB, V103, P71, DOI 10.1016/j.ymgme.2011.01.007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cheung CYY, 2010, J CLIN ENDOCR METAB, V95, P1395, DOI 10.1210/jc.2009-1465; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Doak CM, 2012, OBES REV, V13, P174, DOI 10.1111/j.1467-789X.2011.00943.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2009, OBESITY, V17, P1461, DOI 10.1038/oby.2009.53; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hong J, 2013, INT J OBESITY, V37, P673, DOI 10.1038/ijo.2012.87; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Huang H, 2012, MOL BIOL REP, V39, P1739, DOI 10.1007/s11033-011-0914-z; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tabara Y, 2009, INT J OBESITY, V33, P1243, DOI 10.1038/ijo.2009.161; Tao LM, 2012, MOL BIOL REP, V39, P6487, DOI 10.1007/s11033-012-1476-4; Thomsen M, 2012, J CLIN ENDOCR METAB, V97, pE1074, DOI 10.1210/jc.2011-3282; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Valladares M, 2010, NUTR NEUROSCI, V13, P71, DOI 10.1179/147683010X12611460763643; Vogel CIG, 2011, OBESITY FACTS, V4, P67, DOI 10.1159/000324557; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	52	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45724	10.1371/journal.pone.0045724	http://dx.doi.org/10.1371/journal.pone.0045724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049846	Green Published, gold			2022-12-25	WOS:000309556100074
J	Roman, EA; Faraj, SE; Gallo, M; Salvay, AG; Ferreiro, DU; Santos, J				Roman, Ernesto A.; Faraj, Santiago E.; Gallo, Mariana; Salvay, Andres G.; Ferreiro, Diego U.; Santos, Javier			Protein Stability and Dynamics Modulation: The Case of Human Frataxin	PLOS ONE			English	Article							FREE-ENERGY CHANGES; LINEAR EXTRAPOLATION METHOD; IRON-BINDING ACTIVITY; FRIEDREICH ATAXIA; TOPOLOGICAL FRUSTRATION; STAPHYLOCOCCAL NUCLEASE; GLOBULAR-PROTEINS; POINT MUTATIONS; YEAST FRATAXIN; ALPHA-HELICES	Frataxin (FXN) is an alpha/beta protein that plays an essential role in iron homeostasis. Apparently, the function of human FXN (hFXN) depends on the cooperative formation of crucial interactions between helix alpha 1, helix alpha 2, and the C-terminal region (CTR) of the protein. In this work we quantitatively explore these relationships using a purified recombinant fragment hFXN90-195. This variant shows the hydrodynamic behavior expected for a monomeric globular domain. Circular dichroism, fluorescence, and NMR spectroscopies show that hFXN90-195 presents native-like secondary and tertiary structure. However, chemical and temperature induced denaturation show that CTR truncation significantly destabilizes the overall hFXN fold. Accordingly, limited proteolysis experiments suggest that the native-state dynamics of hFXN90-195 and hFXN90-210 are indeed different, being the former form much more sensitive to the protease at specific sites. The overall folding dynamics of hFXN fold was further explored with structure-based protein folding simulations. These suggest that the native ensemble of hFXN can be decomposed in at least two substates, one with consolidation of the CTR and the other without consolidation of the CTR. Explicit-solvent all atom simulations identify some of the proteolytic target sites as flexible regions of the protein. We propose that the local unfolding of CTR may be a critical step for the global unfolding of hFXN, and that modulation of the CTR interactions may strongly affect hFXN physiological function.	[Roman, Ernesto A.; Faraj, Santiago E.; Santos, Javier] Univ Buenos Aires, Inst Quim & Fis Quim Biol, Buenos Aires, DF, Argentina; [Gallo, Mariana] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Gallo, Mariana] IIBBA CONICET, Buenos Aires, DF, Argentina; [Salvay, Andres G.] Univ Nacl La Plata, Inst Fis Liquidos & Sistemas Biol, Fac Ciencias Exactas, La Plata, Argentina; [Salvay, Andres G.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Provincia De Bu, Argentina; [Roman, Ernesto A.; Ferreiro, Diego U.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Prot Physiol Lab,Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Santos, J (corresponding author), Univ Buenos Aires, Inst Quim & Fis Quim Biol, Buenos Aires, DF, Argentina.	jsantos@qb.ffyb.uba.ar	Salvay, Andrés Gerardo/AAC-8505-2021; Faraj, Santiago E./P-3148-2016	Faraj, Santiago E./0000-0001-6608-4700; Santos, Javier/0000-0002-1140-8234; Gallo, Mariana/0000-0002-0022-4499; Salvay, Andres/0000-0003-4020-1336; Ferreiro, Diego/0000-0002-7869-4247	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBACyT)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Universidad de Buenos Aires (UBACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Al-Mahdawi S, 2000, Hum Mutat, V16, P95, DOI 10.1002/1098-1004(200007)16:1<95::AID-HUMU29>3.0.CO;2-E; Baralle M, 2008, AM J HUM GENET, V83, P77, DOI 10.1016/j.ajhg.2008.06.018; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Correia AR, 2008, FEBS J, V275, P3680, DOI 10.1111/j.1742-4658.2008.06512.x; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Correia AR, 2010, BIOCHEM J, V426, P197, DOI 10.1042/BJ20091612; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Eftink MR, 1997, PROTEINS, V28, P227; Fisinger S, 2001, PROTEIN SCI, V10, P809, DOI 10.1110/ps.34901; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hills RD, 2008, J MOL BIOL, V382, P485, DOI 10.1016/j.jmb.2008.07.007; Iannuzzi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021992; Jenik M, 2012, NUCL ACIDS RES; King AC, 2011, PROTEIN SCI, V20, P1546, DOI 10.1002/pro.680; Kondapalli KC, 2010, BIOMOL NMR ASSIGN, V4, P61, DOI 10.1007/s12104-010-9209-x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Layton CJ, 2011, PROTEIN SCI; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Marczenko Z., 1976, SPECTROPHOTOMETRIC D; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nishimura C, 2001, BIOCHEMISTRY-US, V40, P2113, DOI 10.1021/bi000861k; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Puccio H, 2007, Handb Exp Pharmacol, P365; Roman EA, 2010, PROTEINS, V78, P2757, DOI 10.1002/prot.22789; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; SWENDSEN RH, 1993, PHYSICA A, V194, P53, DOI 10.1016/0378-4371(93)90339-6; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vertrees J, 2005, BIOINFORMATICS, V21, P3318, DOI 10.1093/bioinformatics/bti520; Wrabl JO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000722; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	68	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45743	10.1371/journal.pone.0045743	http://dx.doi.org/10.1371/journal.pone.0045743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049850	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100075
J	Bakker, ERM; Hoekstra, E; Franken, PF; Helvensteijn, W; van Deurzen, CHM; van Veelen, W; Kuipers, EJ; Smits, R				Bakker, E. R. M.; Hoekstra, E.; Franken, P. F.; Helvensteijn, W.; van Deurzen, C. H. M.; van Veelen, W.; Kuipers, E. J.; Smits, R.			beta-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer	ONCOGENE			English	Article						beta-catenin; APC; intestinal cancer; mammary tumor	FAMILIAL ADENOMATOUS POLYPOSIS; MOUSE MODEL; INTESTINAL TUMORS; SOMATIC MUTATION; ONCOGENIC KRAS; PROGRESSION; GENE; HETEROZYGOSITY; INSTABILITY; ACTIVATION	Apc-driven tumor formation in patients and Apc-mutant mouse models is generally attributed to increased levels of beta-catenin signaling. We and others have proposed that a specific level of b-catenin signaling is required to successfully initiate tumor formation, and that each tissue prefers different dosages of signaling. This is illustrated by APC genotype - tumor phenotype correlations in cancer patients, and by the different tumor phenotypes displayed by different Apc-mutant mouse models. Apc1638N mice, associated with intermediate b-catenin signaling, characteristically develop intestinal tumors (< 10) and extra-intestinal tumors, including cysts and desmoids. Apc1572T mice associated with lower levels of b-catenin signaling are free of intestinal tumors, but instead develop mammary tumors. Although the concept of b-catenin signaling dosage and its impact on tumor growth among tissues is gaining acceptance, it has not been formally proven. Additionally, alternative explanations for Apc-driven tumor formation have been proposed. To obtain direct evidence for the dominant role of b-catenin dosage in tumor formation and tissue-specific tumor predisposition, we crossed Apc1638N mice with heterozygous b-catenin knockout mice, thereby reducing b-catenin levels. Whereas all the Apc1638N; Ctnnb1(+/+) mice developed gastrointestinal tumors, none were present in the Apc1638N; Ctnnb1(-/-) mice. Incidence of other Apc1638N-associated lesions, including desmoids and cysts, was strongly reduced as well. Interestingly, Apc1638N; Ctnnb1(-/-) females showed an increased incidence of mammary tumors, which are normally rarely observed in Apc1638N mice, and the histological composition of the tumors resembled that of Apc1572T-related tumors. Hereby, we provide in vivo genetic evidence confirming the dominant role of b-catenin dosage in tumor formation and in dictating tumor predisposition among tissues in Apc-driven cancer.	[Bakker, E. R. M.; Hoekstra, E.; Helvensteijn, W.; van Veelen, W.; Kuipers, E. J.; Smits, R.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Franken, P. F.; van Deurzen, C. H. M.] Erasmus MC Univ Med Ctr, Dept Pathol, NL-3015 CE Rotterdam, Netherlands; [Kuipers, E. J.] Erasmus MC Univ Med Ctr, Dept Internal Med, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Smits, R (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	m.j.m.smits@erasmusmc.nl	Hoekstra, Elmer/P-5440-2014; Kuipers, Ernst J/H-3293-2019	Hoekstra, Elmer/0000-0001-8840-8294; Kuipers, Ernst J/0000-0002-0633-3098				Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Albuquerque C, 2011, BBA-REV CANCER, V1816, P219, DOI 10.1016/j.bbcan.2011.07.005; Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; Athineos D, 2010, ONCOGENE, V29, P2585, DOI 10.1038/onc.2010.5; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2010, J PATHOL, V221, P239, DOI 10.1002/path.2718; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Leedham SJ, 2012, GUT, DOI [10.1136/gutjnl-2011-301601, DOI 10.1136/GUTJNL-2011-301601)]; Lewis A, 2012, J PATHOL, V226, P73, DOI 10.1002/path.2972; Mahmoud NN, 1999, CANCER RES, V59, P353; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Obrador-Hevia A, 2010, J PATHOL, V221, P57, DOI 10.1002/path.2685; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneikert J, 2011, HUM MOL GENET, V20, P3554, DOI 10.1093/hmg/ddr273; Shoemaker AR, 1997, CANCER RES, V57, P1999; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Smits R, 1997, CARCINOGENESIS, V18, P321, DOI 10.1093/carcin/18.2.321; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460	33	25	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 19	2013	32	38					4579	4585		10.1038/onc.2012.449	http://dx.doi.org/10.1038/onc.2012.449			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23045279	Green Submitted			2022-12-25	WOS:000324831300014
J	Maglic, D; Zhu, S; Fry, EA; Taneja, P; Kai, F; Kendig, RD; Sugiyama, T; Miller, LD; Willingham, MC; Inoue, K				Maglic, D.; Zhu, S.; Fry, E. A.; Taneja, P.; Kai, F.; Kendig, R. D.; Sugiyama, T.; Miller, L. D.; Willingham, M. C.; Inoue, K.			Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer	ONCOGENE			English	Article						Dmp1 (Dmtf1); breast cancer; loss of heterozygosity; relapse-free survival; Ki67; prognostic marker	TRANSCRIPTION FACTOR DMP1; MDM2 PROTEIN EXPRESSION; CELL-CYCLE ARREST; GENE-EXPRESSION; ARF; P53; HETEROZYGOSITY; LOCALIZATION; MUTATIONS; ACTIVATOR	Our recent study showed critical roles of Dmp1 as a sensor of oncogenic Ras, HER2/neu signaling and activation of the Arf-p53 pathway. To elucidate the role of human DMP1 (hDMP1) in breast cancer, one hundred and ten pairs of human breast cancer specimen were studied for the alterations of the hDMP1-ARF-Hdm2-p53 pathway with follow up of clinical outcomes. Loss of heterozygosity (LOH) of the hDMP1 locus was found in 42% of human breast carcinomas, while that of INK4a/ARF and p53 were found in 20 and 34%, respectively. Hdm2 amplification was found in 13% of the same sample, which was found independently of LOH for hDMP1. Conversely, LOH for hDMP1 was found in mutually exclusive fashion with that of INK4a/ARF and p53, and was associated with low Ki67 index and diploid karyotype. Consistently, LOH for hDMP1 was associated with luminal A category and longer relapse-free survival, while that of p53 was associated with non-luminal A and shorter survival. Thus, loss of hDMP1 could define a new disease category associated with prognosis of breast cancer patients. Human breast epithelial cells/cancer cells with wild-type p53 were sensitive to growth inhibition by activated Dmp1: ER while those that delete p14(ARF) or p53, and/or Hdm2 amplification showed partial or nearly complete resistance, indicating that p53 is a critical target for hDMP1 to exhibit its biological activity.	[Maglic, D.; Zhu, S.; Fry, E. A.; Taneja, P.; Kai, F.; Kendig, R. D.; Sugiyama, T.; Willingham, M. C.; Inoue, K.] Wake Forest Univ Hlth Sci, Dept Pathol, Winston Salem, NC 27157 USA; [Maglic, D.; Fry, E. A.; Taneja, P.; Kai, F.; Kendig, R. D.; Sugiyama, T.; Miller, L. D.; Inoue, K.] Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC 27157 USA; [Maglic, D.; Zhu, S.; Inoue, K.] Wake Forest Univ Hlth Sci, Dept Grad Program Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Inoue, K (corresponding author), Wake Forest Univ Hlth Sci, Dept Pathol, Med Ctr Blvd,2102 Gray Bldg, Winston Salem, NC 27157 USA.	kinoue@triad.rr.com		Miller, Lance/0000-0003-3799-2528	ACS [RSG-07-207-01-MGO]; NIH/NCI [5R01CA106314]; WFUHS [20595]; Susan G Komen Foundation [KG080179]; DOD [BC100907]; NATIONAL CANCER INSTITUTE [R01CA106314] Funding Source: NIH RePORTER	ACS(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WFUHS; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to R Weinberg for HMEC cells; C Sherr, and M Roussel for plasmid DNAs. We thank G Hawkins and Abdoulaye Diallo for LOH analyses of breast cancer samples. We also thank G Kucera for providing information on human breast cancer patients' samples, Guangchao Sui, Tim Kute for helpful discussions, Guorui Deng, and Jordan Chapman for technical assistance. K Inoue is supported by ACS RSG-07-207-01-MGO, NIH/NCI 5R01CA106314, and by Director's Challenge Award #20595 from WFUHS. P Taneja was supported by the Susan G Komen Foundation postdoctoral fellowship KG080179. D Maglic has been supported by DOD pre-doctoral fellowship BC100907.	BIECHE I, 1992, LANCET, V339, P139, DOI 10.1016/0140-6736(92)90208-K; Bodner SM, 1999, GENE, V229, P223, DOI 10.1016/S0378-1119(98)00591-5; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Frazier DP, 2012, CANCER RES, V72, P1740, DOI 10.1158/0008-5472.CAN-11-2410; Gasco M, 2003, HUM MUTAT, V21, P301, DOI 10.1002/humu.10173; Hirai H, 1996, MOL CELL BIOL, V16, P6457; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Inoue K, 2007, ONCOGENE, V26, P4329, DOI 10.1038/sj.onc.1210226; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Inoue K, 2000, GENE DEV, V14, P1797; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Inoue K, 2008, CANCER RES, V68, P4487, DOI 10.1158/0008-5472.CAN-07-6791; Kristjansson AK, 1997, ANTICANCER RES, V17, P93; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Mallakin A, 2006, ONCOGENE, V25, P7703, DOI 10.1038/sj.onc.1209750; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Mallakin A, 2010, INT J CANCER, V126, P1403, DOI 10.1002/ijc.24938; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; MARCHETTI A, 1995, J PATHOL, V175, P31, DOI 10.1002/path.1711750106; Masood S, 2005, CLIN LAB MED, V25, P809, DOI 10.1016/j.cll.2005.08.012; Ross JS, 2003, AM J CLIN PATHOL, V120, P822, DOI 10.1309/6CQ7AXQ6WHHBXUWH; Ross JS, 2005, MOL ONCOLOGY BREAST; Shetty A, 2005, BRIT J CANCER, V93, P1295, DOI 10.1038/sj.bjc.6602829; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smeets SJ, 2011, CLIN CANCER RES, V17, P4959, DOI 10.1158/1078-0432.CCR-11-0462; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sugiyama T, 2008, EXPERT REV MOL DIAGN, V8, P435, DOI 10.1586/14737159.8.4.435; Taneja P, 2010, CLIN MED INSIGHTS-ON, V4, P15; Taneja P, 2010, CANCER RES, V70, P9084, DOI 10.1158/0008-5472.CAN-10-0159; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Turbin DA, 2006, MODERN PATHOL, V19, P69, DOI 10.1038/modpathol.3800484; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009	37	21	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4120	4129		10.1038/onc.2012.423	http://dx.doi.org/10.1038/onc.2012.423			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23045280	Green Accepted			2022-12-25	WOS:000323748500007
J	Negredo, E; Bonjoch, A; Gomez-Mateu, M; Estany, C; Puig, J; Perez-Alvarez, N; Rosales, J; di Gregorio, S; del Rio, L; Gomez, G; Clotet, B				Negredo, Eugenia; Bonjoch, Anna; Gomez-Mateu, Moises; Estany, Carla; Puig, Jordi; Perez-Alvarez, Nuria; Rosales, Joaquin; di Gregorio, Silvana; del Rio, Luis; Gomez, Guadalupe; Clotet, Bonaventura			Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; HIGH PREVALENCE; FRACTURE RISK; OSTEOPOROSIS; WOMEN; DISEASE; OSTEOCLASTOGENESIS; OSTEOBLASTS	Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objective was to assess how often a dual-energy x-ray absorptiometry (DXA) scan should be performed by assessing time of progression to osteopenia/osteoporosis. Methods: All DXA scans performed between 2000 and 2009 from HIV-infected patients with at least two DXA were included. Time to an event (osteopenia and osteoporosis) was assessed using the Kaplan-Meier method. Strata (tertiles) were defined using baseline minimum T scores. Differences between strata in time to an event were compared with the log-rank test. Results: Of 391 patients (1,639 DXAs), 49.6% had osteopenia and 21.7% osteoporosis at their first DXA scan. Of the 112 (28.6%) with normal BMD, 35.7% progressed to osteopenia; median progression time was 6.7 years. These patients were stratified: "low-risk" (baseline minimum T score > -0.2 SD), "middle-risk" (between -0.2 and -0.6 SD), and "high-risk" (from -0.6 to -1 SD); median progression time to osteopenia was 8.7, >7.2, and 1.7 years, respectively (p<0.0001). Of patients with osteopenia, 23.7% progressed to osteoporosis; median progression time was >8.5 years. Progression time was >8.2 years in "low-risk" tertile (T score between -1.1 and -1.6 SD), >8.5 years in "middle-risk" (between -1.6 and -2), and 3.2 years in "high-risk" (from -2 to -2.4) (p<0.0001). Conclusions: Our results may help to define the BMD testing interval. The lowest T score tertiles would suggest recommending a subsequent DXA in 1-2 years; in the highest tertiles, >= 6 years. Early intervention in patients with bone demineralization could reduce fracture-related morbidity/mortality.	[Negredo, Eugenia; Bonjoch, Anna; Estany, Carla; Puig, Jordi; Perez-Alvarez, Nuria; Clotet, Bonaventura] Univ Autonoma Barcelona, Lluita SIDA Fdn, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain; [Gomez-Mateu, Moises; Perez-Alvarez, Nuria; Gomez, Guadalupe] Univ Politecn Cataluna, Stat & Operat Res Dept, Barcelona, Spain; [Rosales, Joaquin; di Gregorio, Silvana; del Rio, Luis] CETIR Ctr Med, Barcelona, Spain; [Clotet, Bonaventura] Irsicaixa Fdn, Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Universitat Politecnica de Catalunya; Institut de Recerca de la Sida - IrsiCaixa	Negredo, E (corresponding author), Univ Autonoma Barcelona, Lluita SIDA Fdn, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain.	enegredo@flsida.org	Gomez, Guadalupe/K-5352-2014; Gomez, Guadalupe/AFS-1974-2022; GÓMEZ MATEU, MOISÉS/G-3816-2011; Perez-Alvarez, Nuria/O-9244-2014; Del Rio, Luis M/H-3037-2016	Gomez, Guadalupe/0000-0003-4252-4884; Gomez, Guadalupe/0000-0003-4252-4884; GÓMEZ MATEU, MOISÉS/0000-0003-4787-6432; Perez-Alvarez, Nuria/0000-0001-6582-1553; Del Rio, Luis M/0000-0003-0720-0673; Bonjoch, Anna/0000-0002-5343-2881; Negredo, Eugenia/0000-0001-5298-1734	Spanish Ministry of Education and Science [MTM2008-06747-C02-00]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported in part by a grant from the Spanish Ministry of Education and Science [Grant number MTM2008-06747-C02-00]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015; Bedimo R, 2011, 6 IAS C HIV PATH TRE; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; Cazanave C, 2010, CROI 2010; Cooper C., 1997, AM J MED, V103, p17S; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Cotter EJ, 2007, AIDS RES HUM RETROV, V23, P1521, DOI 10.1089/aid.2007.0112; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gibellini D, 2008, J MED VIROL, V80, P1507, DOI 10.1002/jmv.21266; Gibellini D, 2010, BIOCHEM BIOPH RES CO, V401, P429, DOI 10.1016/j.bbrc.2010.09.071; Gibellini D, 2010, NEW MICROBIOL, V33, P109; Gomez G, 2009, STAT MODEL, V9, P259, DOI 10.1177/1471082X0900900402; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Grijsen ML, 2010, AIDS, V24, P2233, DOI 10.1097/QAD.0b013e32833c93fe; Gutierrez F, 2011, AIDS REV, V13, P109; Hoy J, 2011, CURR OPIN HIV AIDS, V6, P309, DOI 10.1097/COH.0b013e3283478741; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Knobel H, 2001, AIDS, V15, P807, DOI 10.1097/00002030-200104130-00022; Marubini E., 2004, ANAL SURVIVAL DATA C; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Ofotokun I WN, 2011, HAART INDUCED IMMUNE; Ofotokun I, 2011, DISCOV MED, V11, P385; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Sharma, 2010, CROI 2010; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; Watts NB, 2008, J CLIN DENSITOM, V11, P473, DOI 10.1016/j.jocd.2008.04.003; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Yong MK, 2011, JAIDS-J ACQ IMM DEF, V57, P205, DOI 10.1097/QAI.0b013e31821ecf4c; 2001, JAMA, V285, P785	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46031	10.1371/journal.pone.0046031	http://dx.doi.org/10.1371/journal.pone.0046031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056229	Green Published, gold			2022-12-25	WOS:000309831500024
J	Heyes, DJ; Hardman, SJO; Mansell, D; Gardiner, JM; Scrutton, NS				Heyes, Derren J.; Hardman, Samantha J. O.; Mansell, David; Gardiner, John M.; Scrutton, Nigel S.			Mechanistic Reappraisal of Early Stage Photochemistry in the Light-Driven Enzyme Protochlorophyllide Oxidoreductase	PLOS ONE			English	Article							TIME-RESOLVED ABSORPTION; EXCITED-STATE PROCESSES; PRODUCT RELEASE STEPS; ENERGY-TRANSFER; TRANSIENT ABSORPTION; ACTIVATED ENZYME; CATALYTIC CYCLE; CHLOROPHYLL; DYNAMICS; INTERMEDIATE	The light-driven enzyme protochlorophyllide oxidoreductase (POR) catalyzes the reduction of protochlorophyllide (Pchlide) to chlorophyllide (Chlide). This reaction is a key step in the biosynthesis of chlorophyll. Ultrafast photochemical processes within the Pchlide molecule are required for catalysis and previous studies have suggested that a short-lived excited-state species, known as I675*, is the first catalytic intermediate in the reaction and is essential for capturing excitation energy to drive subsequent hydride and proton transfers. The chemical nature of the I675* excited state species and its role in catalysis are not known. Here, we report time-resolved pump-probe spectroscopy measurements to study the involvement of the I675* intermediate in POR photochemistry. We show that I675* is not unique to the POR-catalyzed photoreduction of Pchlide as it is also formed in the absence of the POR enzyme. The I675* species is only produced in samples that contain both Pchlide substrate and Chlide product and its formation is dependent on the pump excitation wavelength. The rate of formation and the quantum yield is maximized in 50: 50 mixtures of the two pigments (Pchlide and Chlide) and is caused by direct energy transfer between Pchlide and neighboring Chlide molecules, which is inhibited in the polar solvent methanol. Consequently, we have re-evaluated the mechanism for early stage photochemistry in the light-driven reduction of Pchlide and propose that I675* represents an excited state species formed in Pchlide-Chlide dimers, possibly an excimer. Contrary to previous reports, we conclude that this excited state species has no direct mechanistic relevance to the POR-catalyzed reduction of Pchlide.	[Heyes, Derren J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; Univ Manchester, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	Gardiner, John M/Q-7268-2017	Gardiner, John M/0000-0003-1827-6817; Hardman, Samantha/0000-0002-8310-4758; Heyes, Derren/0000-0002-7453-1571	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F000537/1]; Engineering and Physical Sciences Research Council [EP/J020192/1]; Royal Society; EPSRC [EP/J020192/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the United Kingdom Biotechnology and Biological Sciences Research Council (BB/F000537/1), the Engineering and Physical Sciences Research Council (EP/J020192/1) and the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 2003, BIOPHYS J, V84, P2508, DOI 10.1016/S0006-3495(03)75056-5; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Dietzek B, 2004, CHEM PHYS LETT, V397, P110, DOI 10.1016/j.cplett.2004.08.075; Dietzek B, 2006, CHEMPHYSCHEM, V7, P1727, DOI 10.1002/cphc.200600172; Dietzek B, 2010, CHEM PHYS LETT, V492, P157, DOI 10.1016/j.cplett.2010.04.027; Dietzek B, 2009, CHEMPHYSCHEM, V10, P144, DOI 10.1002/cphc.200800536; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Hynninen PH, 2002, J ORG CHEM, V67, P4055, DOI 10.1021/jo010673f; Kleima FJ, 1997, BIOCHEMISTRY-US, V36, P15262, DOI 10.1021/bi9716480; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; LINDSEY JS, 1995, INORG CHEM, V34, P1063, DOI 10.1021/ic00109a011; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MATHIS P, 1972, BIOCHIM BIOPHYS ACTA, V267, P498, DOI 10.1016/0005-2728(72)90178-8; Mathis P, 1972, PLANT PHYSIOL, V51, P115; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Scrutton NS, 2012, PHYS CHEM CHEM PHYS, V14, P8818, DOI 10.1039/c2cp23789j; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Sytina OA, 2012, PHYS CHEM CHEM PHYS, V14, P616, DOI 10.1039/c1cp21713e; Sytina OA, 2010, J PHYS CHEM B, V114, P4335, DOI 10.1021/jp9089326; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; VAUGHAN GD, 1974, BIOCHIM BIOPHYS ACTA, V347, P383, DOI 10.1016/0005-2728(74)90077-2; WASIELEWSKI MR, 1976, P NATL ACAD SCI USA, V73, P4282, DOI 10.1073/pnas.73.12.4282; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	34	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45642	10.1371/journal.pone.0045642	http://dx.doi.org/10.1371/journal.pone.0045642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049830	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300040
J	Jeong, WJ; Rho, JH; Yoon, YG; Yoo, SH; Jeong, NY; Ryu, WY; Ahn, HB; Park, WC; Rho, SH; Yoon, HS; Choi, YH; Yoo, YH				Jeong, Woo Jin; Rho, Jee Hyun; Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Ryu, Won Yeol; Ahn, Hee Bae; Park, Woo Chan; Rho, Sae Heun; Yoon, Hee Seong; Choi, Yung Hyun; Yoo, Young Hyun			Cytoplasmic and Nuclear Anti-Apoptotic Roles of alpha B-Crystallin in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MIMICKING PHOSPHORYLATION; CARDIAC MYOCYTES; MESANGIAL CELLS; SC35 SPECKLES; METHYLGLYOXAL; ACTIVATION; CHAPERONE; CASPASE-2; PIDDOSOME; RPE	In addition to its well-characterized role in the lens, alpha B-crystallin performs other functions. Methylglyoxal (MGO) can alter the function of the basement membrane of retinal pigment epithelial (RPE) cells. Thus, if MGO is not efficiently detoxified, it can induce adverse reactions in RPE cells. In this study, we examined the mechanisms underlying the anti-apoptotic activity of alpha B-crystallin in the human retinal pigment epithelial cell line ARPE-19 following MGO treatment using various assays, including nuclear staining, flow cytometry, DNA electrophoresis, pulse field gel electrophoresis, western blot analysis, confocal microscopy and co-immunoprecipitation assays. To directly assess the role of phosphorylation of alpha B-crystallin, we used site-directed mutagenesis to convert relevant serine residues to alanine residues. Using these techniques, we demonstrated that MGO induces apoptosis in ARPE-19 cells. Silencing alpha B-crystallin sensitized ARPE-19 cells to MGO-induced apoptosis, indicating that alpha B-crystallin protects ARPE-19 cells from MGO-induced apoptosis. Furthermore, we found that alpha B-crystallin interacts with the caspase subtypes, caspase-2L, -2S, -3, -4, -7, -8, -9 and -12 in untreated control ARPE-19 cells and that MGO treatment caused the dissociation of these caspase subtypes from alpha B-crystallin; transfection of S19A, S45A or S59A mutants caused the depletion of alpha B-crystallin from the nuclei of untreated control RPE cells leading to the release of caspase subtypes. Additionally, transfection of these mutants enhanced MGO-induced apoptosis in ARPE-19 cells, indicating that phosphorylation of nuclear alpha B-crystallin on serine residues 19, 45 and 59 plays a pivotal role in preventing apoptosis in ARPE-19 cells. Taken together, these results suggest that alpha B-crystallin prevents caspase activation by physically interacting with caspase subtypes in the cytoplasm and nucleus, thereby protecting RPE cells from MGO-induced apoptosis.	[Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea; [Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Yoo, Young Hyun] Mitochondria Hub Regulat Ctr, Pusan, South Korea; [Jeong, Woo Jin; Rho, Jee Hyun; Ryu, Won Yeol; Ahn, Hee Bae; Park, Woo Chan; Rho, Sae Heun] Dong A Univ, Dept Ophthalmol, Coll Med, Pusan, South Korea; [Yoon, Hee Seong] Sungmo Eye Hosp Inc, Pusan, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Res Inst Oriental Med, Pusan, South Korea	Dong A University; Dong A University; Dong-Eui University; Dong-Eui University; Korea Institute of Oriental Medicine (KIOM)	Yoo, YH (corresponding author), Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea.	yhyoo@dau.ac.kr	; Ryu, Won Yeol/A-2227-2013	Yoon, Young Geol/0000-0003-4524-9531; Ryu, Won Yeol/0000-0001-5135-718X	Korean government [2011-0001262]; National Research Foundation of Korea	Korean government(Korean Government); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (2011-0001262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Derham BK, 2002, BIOCHEM J, V364, P711, DOI 10.1042/BJ20011512; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; Glenn JV, 2009, BBA-GEN SUBJECTS, V1790, P1109, DOI 10.1016/j.bbagen.2009.04.016; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee HK, 2009, J NEUROCHEM, V108, P273, DOI 10.1111/j.1471-4159.2008.05764.x; Li SY, 2007, LIFE SCI, V80, P1051, DOI 10.1016/j.lfs.2006.11.035; Liu BF, 2003, KIDNEY INT, V63, P947, DOI 10.1046/j.1523-1755.2003.00829.x; Logette E, 2003, ONCOGENE, V22, P935, DOI 10.1038/sj.onc.1206172; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Noh SJ, 2008, INVEST OPHTH VIS SCI, V49, P4753, DOI 10.1167/iovs.08-2166; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107	40	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45754	10.1371/journal.pone.0045754	http://dx.doi.org/10.1371/journal.pone.0045754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049853	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517300050
J	Reen, FJ; Woods, DF; Mooij, MJ; Adams, C; O'Gara, F				Reen, F. Jerry; Woods, David F.; Mooij, Marlies J.; Adams, Claire; O'Gara, Fergal			Respiratory Pathogens Adopt a Chronic Lifestyle in Response to Bile	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS QUINOLONE SIGNAL; GASTROESOPHAGEAL-REFLUX DISEASE; LUNG TRANSPLANTATION; AIRWAY COLONIZATION; BRONCHIOLITIS OBLITERANS; PULMONARY-FUNCTION; ACID ASPIRATION; AERUGINOSA; EXPRESSION	Chronic respiratory infections are a major cause of morbidity and mortality, most particularly in Cystic Fibrosis (CF) patients. The recent finding that gastro-esophageal reflux (GER) frequently occurs in CF patients led us to investigate the impact of bile on the behaviour of Pseudomonas aeruginosa and other CF-associated respiratory pathogens. Bile increased biofilm formation, Type Six Secretion, and quorum sensing in P. aeruginosa, all of which are associated with the switch from acute to persistent infection. Furthermore, bile negatively influenced Type Three Secretion and swarming motility in P. aeruginosa, phenotypes associated with acute infection. Bile also modulated biofilm formation in a range of other CF-associated respiratory pathogens, including Burkholderia cepacia and Staphylococcus aureus. Therefore, our results suggest that GER-derived bile may be a host determinant contributing to chronic respiratory infection.	[Reen, F. Jerry; Woods, David F.; Mooij, Marlies J.; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	O'Gara, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie	Reen, Jerry/AAG-7155-2019	Woods, David F/0000-0002-5623-6501; O'Gara, Fergal/0000-0002-2659-0673; Reen, F. Jerry/0000-0002-7717-9892	European Commission [MTKD-CT-2006-042062, O36314, 256596]; Science Foundation Ireland [SFI 04/BR/B0597, 07/IN.1/B948, 08/RFP/GEN1295, 08/RFP/GEN1319, 09/RFP/BMT2350]; Department of Agriculture and Food [DAF RSF 06 321, DAF RSF 06 377, FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [05/EDIV/FP107, PD/2011/2414]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI3]; Health Service Executive (HSE) surveillance fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Health Service Executive (HSE) surveillance fund	This work was supported in part by grants awarded by the European Commission (MTKD-CT-2006-042062; O36314; FP7-PEOPLE-2009-RG, EU 256596, 2010-2013), Science Foundation Ireland (SFI 04/BR/B0597; 07/IN.1/B948; 08/RFP/GEN1295; 08/RFP/GEN1319; 09/RFP/BMT2350), the Department of Agriculture and Food (DAF RSF 06 321; DAF RSF 06 377; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (05/EDIV/FP107; PD/2011/2414), the Health Research Board (RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (Beaufort award C2CRA 2007/082), the Higher Education Authority of Ireland (PRTLI3) and the Health Service Executive (HSE) surveillance fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 1998, J INFECTION, V37, P151, DOI 10.1016/S0163-4453(98)80170-9; Aseeri A, 2012, AM J RESP CRIT CARE, V185, P463, DOI 10.1164/ajrccm.185.4.463; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Blondeau K, 2008, GUT, V57, P1049, DOI 10.1136/gut.2007.146134; Blondeau K, 2010, J PEDIATR GASTR NUTR, V50, P161, DOI 10.1097/MPG.0b013e3181acae98; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Button BM, 2005, J HEART LUNG TRANSPL, V24, P1522, DOI 10.1016/j.healun.2004.11.312; Button BM, 2004, ARCH DIS CHILD, V89, P435, DOI 10.1136/adc.2003.033100; Carpagnano GE, 2006, J INTERN MED, V259, P323, DOI 10.1111/j.1365-2796.2005.01611.x; Cummins J, 2009, MICROBIOL-SGM, V155, P2826, DOI 10.1099/mic.0.025643-0; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; D'Ovidio F, 2005, ANN THORAC SURG, V80, P1254, DOI 10.1016/j.athoracsur.2005.03.106; D'Ovidio F, 2005, J THORAC CARDIOV SUR, V129, P1144, DOI 10.1016/j.jtcvs.2004.10.035; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Fletcher MP, 2007, NAT PROTOC, V2, P1254, DOI 10.1038/nprot.2007.158; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; GOTLEY DC, 1988, BRIT J SURG, V75, P587, DOI 10.1002/bjs.1800750632; Haussler S, 2010, INT J MED MICROBIOL, V300, P544, DOI 10.1016/j.ijmm.2010.08.006; Hallberg K, 2004, J PEDIATR GASTR NUTR, V38, P312, DOI 10.1097/00005176-200403000-00016; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; KORVICK JA, 1991, SURGERY, V109, P62; Koskenniemi K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002741; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Ledson MJ, 1998, J ROY SOC MED, V91, P10, DOI 10.1177/014107689809100104; Ledson MJ, 1998, J ROY SOC MED, V91, P7, DOI 10.1177/014107689809100103; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McGlacken GP, 2010, TETRAHEDRON LETT, V51, P5919, DOI 10.1016/j.tetlet.2010.09.013; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; MESHKINPOUR H, 1981, ARCH SURG-CHICAGO, V116, P1148; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mousa Hayat M, 2012, Curr Gastroenterol Rep, V14, P226, DOI 10.1007/s11894-012-0261-9; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Nassr AO, 2011, J GASTROINTEST SURG, V15, P908, DOI 10.1007/s11605-011-1520-z; Navarro J, 2001, EUR RESPIR J, V18, P298, DOI 10.1183/09031936.01.00068901; Nehra D, 2010, J GASTROINTEST SURG, V14, P6, DOI 10.1007/s11605-009-1026-0; O'Callaghan J, 2012, MICROBIOLOGY; O'Callaghan J, 2011, MICROBIOL-SGM, V157, P3417, DOI 10.1099/mic.0.052050-0; Palm K, 2011, PEDIAT PULMONOL; Pauwels A., 2011, CHEST; Perng DW, 2008, RESPIROLOGY, V13, P983, DOI 10.1111/j.1440-1843.2008.01402.x; Perng DW, 2007, CHEST, V132, P1548, DOI 10.1378/chest.07-1373; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Poulter S, 2010, ENV MICROBIOL REP, V2, P322, DOI 10.1111/j.1758-2229.2010.00140.x; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Quillin SJ, 2011, MOL MICROBIOL, V81, P129, DOI 10.1111/j.1365-2958.2011.07683.x; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Scott M, 1999, AM FAM PHYSICIAN, V59, P1161; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; STRINGER DA, 1988, J CAN ASSOC RADIOL, V39, P100; Sweet MP, 2009, THORAX, V64, P167, DOI 10.1136/thx.2007.082719; Sweet MP, 2007, J THORAC CARDIOV SUR, V133, P1078, DOI 10.1016/j.jtcvs.2006.09.085; van der Doef HPJ, 2009, J PEDIATR-US, V155, P629, DOI 10.1016/j.jpeds.2009.06.040; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Vos R, 2008, EUR RESPIR J, V31, P1037, DOI 10.1183/09031936.00128607; Vos R, 2007, AM J TRANSPLANT, V7, P1278, DOI 10.1111/j.1600-6143.2007.01771.x; Vos R, 2008, J HEART LUNG TRANSPL, V27, P843, DOI 10.1016/j.healun.2008.05.022; Wallick Kristin, 2002, J Cyst Fibros, V1, P99, DOI 10.1016/S1569-1993(02)00036-X; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wileman SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003243.pub2; Wu JCY, 2008, J GASTROEN HEPATOL, V23, P1785, DOI 10.1111/j.1440-1746.2008.05684.x; Wu YC, 2009, CHEST, V136, P118, DOI 10.1378/chest.08-2668; Yang L, 2009, MOL MICROBIOL, V74, P1380, DOI 10.1111/j.1365-2958.2009.06934.x	78	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45978	10.1371/journal.pone.0045978	http://dx.doi.org/10.1371/journal.pone.0045978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049911	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300070
J	Bhattacharya, A; Ziebarth, JD; Cui, Y				Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan			Systematic Analysis of microRNA Targeting Impacted by Small Insertions and Deletions in Human Genome	PLOS ONE			English	Article							PROSTATE-CANCER RISK; FUNCTIONAL POLYMORPHISM; LINKING POLYMORPHISMS; WIDE IDENTIFICATION; POLYMIRTS DATABASE; TUMOR-SUPPRESSOR; HUMAN-DISEASES; MIR-146A GENE; CONFERS RISK; BINDING-SITE	MicroRNAs (miRNAs) are small noncoding RNA that play an important role in posttranscriptional regulation of mRNA. Genetic variations in miRNAs or their target sites have been shown to alter miRNA function and have been associated with risk for several diseases. Previous studies have focused on the most abundant type of genetic variations, single nucleotide polymorphisms (SNPs) that affect miRNA-mRNA interactions. Here, we systematically identified small insertions and deletions (indels) in miRNAs and their target sites, and investigated the effects of indels on miRNA targeting. We studied the distribution of indels in miRNAs and their target sites and found that indels in mature miRNAs, experimentally supported miRNA target sites and PAR-CLIP footprints have significantly lower density compared to flanking regions. We identified over 20 indels in the seed regions of miRNAs, which may disrupt the interactions between these miRNAs and their target genes. We also identified hundreds of indels that alter experimentally supported miRNA target sites. We mapped these genes to human disease pathways to identify indels that affect miRNA targeting in these pathways. We also used the results of genome-wide association studies (GWAS) to identify potential links between miRNA-related indels and diseases.	[Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Ctr Hlth Sci, Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cui, Y (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	ycui2@uthsc.edu	Bhattacharya, Anindya/K-3740-2016	Cui, Yan/0000-0002-7577-6845	The University of Tennessee Center for Integrative and Translational Genomics; Department of Defense grant [W81XHW-05-01-0227]	The University of Tennessee Center for Integrative and Translational Genomics; Department of Defense grant(United States Department of Defense)	This work was supported by The University of Tennessee Center for Integrative and Translational Genomics and Department of Defense grant W81XHW-05-01-0227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouizerat BE, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-29; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen H, 2009, BIOCHEM BIOPH RES CO, V385, P596, DOI 10.1016/j.bbrc.2009.05.113; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Feng NH, 2012, MOL BIOL REP, V39, P369, DOI 10.1007/s11033-011-0747-9; Flies Dallas B., 2011, Yale Journal of Biology and Medicine, V84, P409; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Li J, 2012, J CANC RES CLIN ONCO; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Li X, 2011, BIOCHEM PHARMACOL, V81, P783, DOI 10.1016/j.bcp.2010.12.018; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; O'Halloran AM, 2009, J THROMB THROMBOLYS, V27, P175, DOI 10.1007/s11239-008-0196-z; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vermeer PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030447; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yu XF, 2010, TOXICOL SCI, V118, P391, DOI 10.1093/toxsci/kfq296; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	77	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46176	10.1371/journal.pone.0046176	http://dx.doi.org/10.1371/journal.pone.0046176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049969	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100147
J	Dynon, K; Heng, S; Puryer, M; Li, Y; Walton, K; Endo, Y; Nie, GY				Dynon, Kemperly; Heng, Sophea; Puryer, Michelle; Li, Ying; Walton, Kelly; Endo, Yaeta; Nie, Guiying			HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening	PLOS ONE			English	Article							MATERNAL-FETAL INTERFACE; FACTOR A3 HTRA3; SERINE-PROTEASE; ENDOMETRIAL CANCER; EARLY-PREGNANCY; LUNG-CANCER; PLACENTATION; EXPRESSION; MOUSE; INSULIN	Mammalian HtrA3 (high temperature requirement A3) is a serine protease of the HtrA family. It has two isoforms [long (HtrA3-L) and short (HtrA3-S)] and is important for placental development and cancer progression. Recently, HtrA3 was identified as a potential diagnostic marker for early detection of preeclampsia, a life-threatening pregnancy-specific disorder. Currently there are no high-throughput assays available to detect HtrA3 in human serum. In this study we generated and fully tested a panel of five HtrA3 mouse monoclonal antibodies (mAbs). Three mAbs recognised both HtrA3-L and HtrA3-S and the other two detected HtrA3-L only. All five mAbs were highly specific to HtrA3 and applicable in western blotting and immunohistochemical analysis of endogenous HtrA3 proteins in the mouse and human tissues. Amplified luminescent proximity homogeneous assays-linked immunosorbent assays (AlphaLISAs), were developed to detect HtrA3 isoforms in picomolar levels in serum. The HtrA3 AlphaLISA detected significantly higher serum levels of HtrA3 in women at 13-14 weeks of gestation who subsequently developed preeclampsia compared to gestational-age matched controls. These HtrA3 mAbs are valuable for the development of immunoassays and characterisation of HtrA3 isoform-specific biology. The newly developed HtrA3 AlphaLISA assays are suitable for large scale screening of human serum.	[Dynon, Kemperly; Heng, Sophea; Puryer, Michelle; Li, Ying; Walton, Kelly; Nie, Guiying] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Nie, Guiying] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Prince Henry's Institute of Medical Research; Ehime University; Monash University	Nie, GY (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	guiying.nie@princehenrys.org	Walton, Kelly/ABF-7282-2020	Walton, Kelly/0000-0003-0627-2958; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council of Australia [494808, 494802]; Australian Academy of Science exchange program; Japan Society for the Promotion of Science; Bill & Melinda Gates Foundation [OPP1025076]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science exchange program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Victorian Government's Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia [Fellowship #494808 (to GN) and Program grant #494802], Australian Academy of Science exchange program with the Japan Society for the Promotion of Science (to GN), the Bill & Melinda Gates Foundation [OPP1025076 (to GN)] and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prince Henry's Institute data audit number for this work is 12-04.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beleford D, 2010, CLIN CANCER RES, V16, P398, DOI 10.1158/1078-0432.CCR-09-1677; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bowden M, 2009, J EXP ZOOL PART B, V312B, P701, DOI 10.1002/jez.b.21288; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Bowden MA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-22; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; DOLEA C, 2003, GLOBAL BURDEN HYPERT; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Golla R, 2004, J BIOMOL SCREEN, V9, P62, DOI 10.1177/1087057103260515; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hadker Nandini, 2010, J Med Econ, V13, P728, DOI 10.3111/13696998.2010.535285; Huang B, 2009, ARCH TOXICOL, V83, P619, DOI 10.1007/s00204-009-0410-6; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kato MV, 2000, MOL MED, V6, P126, DOI 10.1007/BF03401780; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; McGiven JA, 2008, J IMMUNOL METHODS, V337, P7, DOI 10.1016/j.jim.2008.05.004; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Narklewicz J, 2008, CLIN BIOCHEM, V41, P561, DOI 10.1016/j.clinbiochem.2008.01.004; Nie G, 2006, PLACENTA, V27, P491, DOI 10.1016/j.placenta.2005.03.009; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Nie GY, 2006, BIOL REPROD, V74, P366, DOI 10.1095/biolreprod.105.047324; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; Petersen SB, 2010, J PHARMACEUT BIOMED, V51, P217, DOI 10.1016/j.jpba.2009.08.008; Poulsen F, 2007, J BIOMOL SCREEN, V12, P240, DOI 10.1177/1087057106297566; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2012, BIOTECHNIQUES, V52, P23, DOI 10.2144/000113798; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Theoleyre S, 2010, BIOCHEM BIOPH RES CO, V394, P453, DOI 10.1016/j.bbrc.2009.11.163; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Wang LJ, 2012, MOL CELL BIOL; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060	41	30	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45956	10.1371/journal.pone.0045956	http://dx.doi.org/10.1371/journal.pone.0045956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049902	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100107
J	Greenwood, BN; Strong, PV; Loughridge, AB; Day, HEW; Clark, PJ; Mika, A; Hellwinkel, JE; Spence, KG; Fleshner, M				Greenwood, Benjamin N.; Strong, Paul V.; Loughridge, Alice B.; Day, Heidi E. W.; Clark, Peter J.; Mika, Agnieszka; Hellwinkel, Justin E.; Spence, Katie G.; Fleshner, Monika			5-HT2C Receptors in the Basolateral Amygdala and Dorsal Striatum Are a Novel Target for the Anxiolytic and Antidepressant Effects of Exercise	PLOS ONE			English	Article							CHLOROPHENYLPIPERAZINE M-CPP; ANXIETY-LIKE BEHAVIOR; PRE-MESSENGER-RNA; META-CHLOROPHENYLPIPERAZINE; VOLUNTARY EXERCISE; NEUROENDOCRINE RESPONSES; UNCONTROLLABLE STRESS; LEARNED HELPLESSNESS; ACUTE FLUOXETINE; CENTRAL NUCLEUS	Physical activity reduces the incidence and severity of psychiatric disorders such as anxiety and depression. Similarly, voluntary wheel running produces anxiolytic- and antidepressant-like effects in rodent models. The specific neurobiological mechanisms underlying the beneficial properties of exercise, however, remain unclear. One relevant pharmacological target in the treatment of psychiatric disorders is the 5-HT2C receptor (5-HT2CR). Consistent with data demonstrating the anxiogenic consequences of 5-HT2CR activation in humans and rodents, we have previously reported that site-specific administration of the selective 5-HT2CR agonist CP-809101 in the lateral/basolateral amygdala (BLA) increases shock-elicited fear while administration of CP-809101 in the dorsal striatum (DS) interferes with shuttle box escape learning. These findings suggest that activation of 5-HT2CR in discrete brain regions contributes to specific anxiety-and depression-like behaviors and may indicate potential brain sites involved in the anxiolytic and antidepressant effects of exercise. The current studies tested the hypothesis that voluntary wheel running reduces the behavioral consequences of 5-HT2CR activation in the BLA and DS, specifically enhanced shock-elicited fear and interference with shuttle box escape learning. After 6 weeks of voluntary wheel running or sedentary conditions, the selective 5-HT2CR agonist CP-809101 was microinjected into either the BLA or the DS of adult Fischer 344 rats, and shock-elicited fear and shuttle box escape learning was assessed. Additionally, in-situ hybridization was used to determine if 6 weeks of voluntary exercise changed levels of 5-HT2CR mRNA. We found that voluntary wheel running reduced the behavioral effects of CP-809101 and reduced levels of 5-HT2CR mRNA in both the BLA and the DS. The current data indicate that expression of 5-HT2CR mRNA in discrete brain sites is sensitive to physical activity status of the organism, and implicates the 5-HT2CR as a target for the beneficial effects of physical activity on mental health.	[Greenwood, Benjamin N.; Strong, Paul V.; Loughridge, Alice B.; Clark, Peter J.; Mika, Agnieszka; Hellwinkel, Justin E.; Spence, Katie G.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Day, Heidi E. W.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Greenwood, Benjamin N.; Strong, Paul V.; Day, Heidi E. W.; Clark, Peter J.; Mika, Agnieszka; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Greenwood, BN (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	ben.greenwood@colorado.edu		DAY, HEIDI/0000-0002-5683-3496; Fleshner, Monika/0000-0002-0470-0827	National Institutes of Health [NIMH 068283, NIMH 050479]; American Foundation for Suicide Prevention	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Suicide Prevention	The work in this manuscript was supported by the National Institutes of Health grant: NIMH 068283 (M.F.), NIMH 050479 (B.G.) and the American Foundation for Suicide Prevention (B.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; Anderson IM, 1999, ADV EXP MED BIOL, V467, P43; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bagdy G, 2001, INT J NEUROPSYCHOPH, V4, P399, DOI 10.1017/S1461145701002632; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Barbon A, 2011, NEUROPSYCHOBIOLOGY, V63, P160, DOI 10.1159/000321593; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; Broocks A, 2001, PSYCHOPHARMACOLOGY, V155, P234, DOI 10.1007/s002130100706; Broocks A, 1999, NEUROPSYCHOPHARMACOL, V20, P150, DOI 10.1016/S0893-133X(98)00056-6; Burghardt NS, 2007, BIOL PSYCHIAT, V62, P1111, DOI 10.1016/j.biopsych.2006.11.023; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Campbell BM, 2003, BRAIN RES, V993, P1, DOI 10.1016/S0006-8993(03)03384-5; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CHARNEY DS, 1987, PSYCHOPHARMACOLOGY, V92, P14, DOI 10.1007/BF00215473; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Cornelio AM, 2007, BEHAV BRAIN RES, V178, P82, DOI 10.1016/j.bbr.2006.12.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cruz APM, 2005, PSYCHOPHARMACOLOGY, V182, P345, DOI 10.1007/s00213-005-0108-2; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dishman RK, 1997, BRAIN RES BULL, V42, P399, DOI 10.1016/S0361-9230(96)00329-2; Duman CH, 2008, BRAIN RES; Dwyer D, 2000, ACTA PHYSIOL SCAND, V170, P211, DOI 10.1111/j.1365-201X.2000.00774.x; EberleWang K, 1997, J COMP NEUROL, V384, P233, DOI 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Fanselow M., 1988, EVOLUTION LEARNING, P197; Fox JH, 2008, BEHAV NEUROSCI, V122, P943, DOI 10.1037/0735-7044.122.4.943; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gatch MB, 2003, LIFE SCI, V73, P1347, DOI 10.1016/S0024-3205(03)00422-3; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; Graeff FG, 1997, NEUROSCI BIOBEHAV R, V21, P791, DOI 10.1016/S0149-7634(96)00059-0; Greenwood BN, 2008, PSYCHOPHARMACOLOGY, V199, P209, DOI 10.1007/s00213-008-1167-y; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Gurevich I, 2002, J NEUROSCI, V22, P10529; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P521, DOI 10.1001/archpsyc.65.5.521; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Iwamoto K, 2009, RNA BIOL, V6, P248, DOI 10.4161/rna.6.3.8370; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Li Q, 2003, J NEUROCHEM, V84, P1256, DOI 10.1046/j.1471-4159.2003.01607.x; Li Q, 2012, NEUROPHARMACOLOGY, V62, P474, DOI 10.1016/j.neuropharm.2011.09.002; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V177, P448, DOI 10.1007/s00213-004-1962-z; Millan MJ, 2005, THERAPIE, V60, P441, DOI 10.2515/therapie:2005065; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Moreau JL, 1996, EUR NEUROPSYCHOPHARM, V6, P169, DOI 10.1016/0924-977X(96)00015-6; Moya Pablo R., 2011, BMC Pharmacology, V11, P3, DOI 10.1186/1471-2210-11-3; MURPHY DL, 1989, PSYCHOPHARMACOLOGY, V98, P275, DOI 10.1007/BF00444705; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Ninan PT, 1999, J CLIN PSYCHIAT, V60, P12; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Olie JP, 2007, INT J NEUROPSYCHOPH, V10, P661, DOI 10.1017/S1461145707007766; Ota KT, 2012, NEUROBIOLOGY DIS; Overstreet DH, 2006, PSYCHOPHARMACOLOGY, V187, P1, DOI 10.1007/s00213-006-0389-0; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pjrek E, 2007, PSYCHOPHARMACOLOGY, V190, P575, DOI 10.1007/s00213-006-0645-3; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; Ribases M, 2008, J PSYCHIATR RES, V42, P50, DOI 10.1016/j.jpsychires.2006.09.001; Saeed SA, 2010, AM FAM PHYSICIAN, V81, P981; Salam JN, 2009, BEHAV BRAIN RES, V197, P31, DOI 10.1016/j.bbr.2008.07.036; Serretti A, 2004, EXPERT OPIN THER TAR, V8, P15, DOI 10.1517/eott.8.1.15.26405; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; SHERMAN AD, 1982, PHARMACOL BIOCHEM BE, V16, P449, DOI 10.1016/0091-3057(82)90451-8; Solberg LC, 1999, AM J PHYSIOL-REG I, V276, pR152, DOI 10.1152/ajpregu.1999.276.1.R152; Stein DJ, 2008, J CLIN PSYCHOPHARM, V28, P561, DOI 10.1097/JCP.0b013e318184ff5b; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Strong PV, 2011, NEUROSCIENCE, V197, P132, DOI 10.1016/j.neuroscience.2011.09.041; Strong PV, 2009, PSYCHOPHARMACOLOGY, V203, P665, DOI 10.1007/s00213-008-1413-3; Strong PV, 2011, NEUROSCIENCE; Van Veen JF, 2007, EUR NEUROPSYCHOPHARM, V17, P637, DOI 10.1016/j.euroneuro.2007.03.005; Vollert C, 2011, BEHAV BRAIN RES, V224, P233, DOI 10.1016/j.bbr.2011.05.010; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	86	54	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46118	10.1371/journal.pone.0046118	http://dx.doi.org/10.1371/journal.pone.0046118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049953	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100138
J	Rothe, J; Watkins, NE; Nagy, M				Rothe, Jessica; Watkins, Norman E., Jr.; Nagy, Marion			New Prediction Model for Probe Specificity in an Allele-Specific Extension Reaction for Haplotype-Specific Extraction (HSE) of Y Chromosome Mixtures	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEAREST-NEIGHBOR THERMODYNAMICS; TAQ DNA-POLYMERASE; DISCRIMINATION; IDENTIFICATION; MISMATCHES; PCR	Allele-specific extension reactions (ASERs) use 3' terminus-specific primers for the selective extension of completely annealed matches by polymerase. The ability of the polymerase to extend non-specific 3' terminal mismatches leads to a failure of the reaction, a process that is only partly understood and predictable, and often requires time-consuming assay design. In our studies we investigated haplotype-specific extraction (HSE) for the separation of male DNA mixtures. HSE is an ASER and provides the ability to distinguish between diploid chromosomes from one or more individuals. Here, we show that the success of HSE and allele- specific extension depend strongly on the concentration difference between complete match and 3' terminal mismatch. Using the oligonucleotide-modeling platform Visual Omp, we demonstrated the dependency of the discrimination power of the polymerase on match- and mismatch-target hybridization between different probe lengths. Therefore, the probe specificity in HSE could be predicted by performing a relative comparison of different probe designs with their simulated differences between the duplex concentration of target-probe match and mismatches. We tested this new model for probe design in more than 300 HSE reactions with 137 different probes and obtained an accordance of 88%.	[Rothe, Jessica; Nagy, Marion] Charite Campus Virchow Klinikum, Dept Forens Genet, Inst Legal Med & Forens Sci, Berlin, Germany; [Watkins, Norman E., Jr.] DNA Software Inc, Ann Arbor, MI USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rothe, J (corresponding author), Charite Campus Virchow Klinikum, Dept Forens Genet, Inst Legal Med & Forens Sci, Berlin, Germany.	jessica.rothe@charite.de		Nagy, Marion/0000-0002-7319-8033				Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Cai YN, 2010, ANAL BIOCHEM, V406, P29, DOI 10.1016/j.ab.2010.06.043; Chan KM, 2011, CLIN BIOCHEM, V44, P1253, DOI 10.1016/j.clinbiochem.2011.07.014; Dapprich J, 2007, TISSUE ANTIGENS, V69, P282, DOI 10.1111/j.1399-0039.2006.00752.x; Dapprich J, 2001, U.S. Patent Application, Patent No. 20010031467; Dapprich J, 2001, Australian Patent, Patent No. 785211; Dapprich J, 2007, HUM IMMUNOL, V68, P418, DOI 10.1016/j.humimm.2007.01.015; Dapprich J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn345; Endres RO, 2007, TISSUE ANTIGENS, V70, P259, DOI 10.1111/j.1399-0039.2007.00889.x; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Lim J, 2009, TISSUE ANTIGENS, V73, P78, DOI 10.1111/j.1399-0039.2008.01177.x; Litos IK, 2011, CLIN CHIM ACTA, V412, P1968, DOI 10.1016/j.cca.2011.07.001; Onodera Kenji, 2007, V402, P61; Rothe J, 2011, FORENSIC SCI INT-GEN, V5, P117, DOI 10.1016/j.fsigen.2010.09.011; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; Ulrich S, 2008, TISSUE ANTIGENS, V71, P91, DOI 10.1111/j.1399-0039.2007.00951.x; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918	22	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45955	10.1371/journal.pone.0045955	http://dx.doi.org/10.1371/journal.pone.0045955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049901	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100106
J	Carlier, VA; VanderElst, L; Janssens, W; Jacquemin, MG; Saint-Remy, JMR				Carlier, Vincent A.; VanderElst, Luc; Janssens, Wim; Jacquemin, Marc G.; Saint-Remy, Jean-Marie R.			Increased Synapse Formation Obtained by T Cell Epitopes Containing a CxxC Motif in Flanking Residues Convert CD4+T Cells into Cytolytic Effectors	PLOS ONE			English	Article							ALTERED PEPTIDE LIGAND; SURFACE EXPRESSION; REDOX REGULATION; FAS LIGAND; ACTIVATION; IDENTIFICATION; MECHANISMS; PLASTICITY; INDUCTION; INFLUENZA	The nature of MHC class II-binding epitopes not only determines the specificity of T cell responses, but may also alter effector cell functions. Cytolytic CD4+ T cells have been observed primarily in anti-viral responses, but very little is known about the conditions under which they can be elicited. Their potential as regulators of immune responses, however, deserves investigations. We describe here that inclusion of a thiol-disulfide oxidoreductase motif within flanking residues of class II-restricted epitopes results, both in vitro and in vivo, in elicitation of antigen-specific cytolytic CD4+ T cells through increased synapse formation. We show that both naive and polarized CD4+ T cells, including Th17 cells, can be converted by cognate recognition of such modified epitopes. Cytolytic CD4+ T cells induce apoptosis on APCs by Fas-FasL interaction. These findings potentially open the way towards a novel form of antigen-specific immunosuppression.	[Carlier, Vincent A.; VanderElst, Luc; Janssens, Wim; Jacquemin, Marc G.; Saint-Remy, Jean-Marie R.] Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium		Saint-Remy, JMR (corresponding author), Univ Louvain, Ctr Mol & Vasc Biol, Louvain, Belgium.	jeanmarie.saint-remy@med.kuleuven.ac.be		Janssens, Wim/0000-0003-1830-2982	University of Leuven/Collen Research foundation	University of Leuven/Collen Research foundation	The work was supported by University of Leuven/Collen Research foundation funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2006, J EXP MED, V203, P995, DOI 10.1084/jem.20051287; Ahangarani RR, 2011, MOL THER, V19, P711, DOI 10.1038/mt.2010.275; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Bluestone JA, 2009, NAT REV IMMUNOL; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corse E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000481; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; GROMKOWSKI SH, 1988, EUR J IMMUNOL, V18, P1385, DOI 10.1002/eji.1830180913; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Janssens W, 2003, J IMMUNOL, V171, P4604, DOI 10.4049/jimmunol.171.9.4604; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KANNER SB, 1992, P NATL ACAD SCI USA, V89, P300, DOI 10.1073/pnas.89.1.300; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kawamura K, 2006, BLOOD, V107, P1031, DOI 10.1182/blood-2005-04-1737; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Locksley RM, 2009, J EXP MED, V206, P1643, DOI 10.1084/jem.20091442; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MURPHY DB, 1992, J IMMUNOL, V148, P3483; NAUJOKAS MF, 1995, IMMUNITY, V3, P359, DOI 10.1016/1074-7613(95)90120-5; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sant'Angelo DB, 2002, EUR J IMMUNOL, V32, P2510, DOI 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tomazzolli R, 2006, ANAL BIOCHEM, V350, P105, DOI 10.1016/j.ab.2005.11.037; Varadhachary AS, 1997, P NATL ACAD SCI USA, V94, P5778, DOI 10.1073/pnas.94.11.5778; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Wu B, 2002, J IMMUNOL, V169, P2430, DOI 10.4049/jimmunol.169.5.2430; Wu B, 2000, EUR J IMMUNOL, V30, P291, DOI 10.1002/1521-4141(200001)30:1<291::AID-IMMU291>3.0.CO;2-T; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	55	6	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45366	10.1371/journal.pone.0045366	http://dx.doi.org/10.1371/journal.pone.0045366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056200	Green Published, Green Submitted, gold			2022-12-25	WOS:000309889400006
J	Ropcke, S; Holz, O; Lauer, G; Muller, M; Rittinghausen, S; Ernst, P; Lahu, G; Elmlinger, M; Krug, N; Hohlfeld, JM				Roepcke, Stefan; Holz, Olaf; Lauer, Gereon; Mueller, Meike; Rittinghausen, Susanne; Ernst, Peter; Lahu, Gezim; Elmlinger, Martin; Krug, Norbert; Hohlfeld, Jens M.			Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VON-WILLEBRAND-FACTOR; SYSTEMIC INFLAMMATION; END-POINTS; SURROGATE; MARKERS; SMOKERS; ASTHMA; OZONE; RISK	Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease, primarily affecting the airways. Stable biomarkers characterizing the inflammatory phenotype of the disease, relevant for disease activity and suited to predict disease progression are needed to monitor the efficacy and safety of drug interventions. We therefore analyzed a large panel of markers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum of 23 healthy smokers and 24 smoking COPD patients (GOLD II) matched for age and gender. Sample collection was performed twice within a period of 6 weeks. Assays for over 100 different markers were validated for the respective matrices prior to analysis. In our study, we found 51 markers with a sufficient repeatability (intraclass correlation coefficient > 0.6), most of these in serum. Differences between groups were observed for markers from all compartments, which extends (von-Willebrand-factor) and confirms (e.g. C-reactive-protein, interleukin-6) previous findings. No correlations between lung and serum markers were observed, including A1AT. Airway inflammation defined by sputum neutrophils showed only a moderate repeatability. This could be improved, when a combination of neutrophils and four sputum fluid phase markers was used to define the inflammatory phenotype. In summary, our study provides comprehensive information on the repeatability and interrelationship of pulmonary and systemic COPD-related markers. These results are relevant for ongoing large clinical trials and future COPD research. While serum markers can discriminate between smokers with and without COPD, they do not seem to sufficiently reflect the disease-associated inflammatory processes within the airways.	[Holz, Olaf; Mueller, Meike; Krug, Norbert; Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Clin Airway Res, Hannover, Germany; [Roepcke, Stefan; Lauer, Gereon; Lahu, Gezim; Elmlinger, Martin] Nycomed GmbH, Dept Biomarker Dev, Constance, Germany; [Holz, Olaf; Krug, Norbert; Hohlfeld, Jens M.] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Rittinghausen, Susanne] Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Toxicol & Environm Hyg, Hannover, Germany; [Ernst, Peter] GeneData AG, Basel, Switzerland	Fraunhofer Gesellschaft; Nycomed GmbH; Fraunhofer Gesellschaft	Holz, O (corresponding author), Fraunhofer Inst Toxicol & Expt Med ITEM, Dept Clin Airway Res, Hannover, Germany.	olaf.holz@item.fraunhofer.de		Rittinghausen, Susanne/0000-0001-6468-6994; Ernst, Peter/0000-0001-7777-1813; Hohlfeld, Jens/0000-0003-2646-6186	Nycomed GmbH	Nycomed GmbH	Fraunhofer has received a research grant for conducting the clinical study from Nycomed GmbH. The funders participated in the study design, in data analysis, pre-study assay validation and the preparation of the manuscript.	Aaron SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-41; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Anderson GP, 2006, EUR RESPIR J, V27, P874, DOI 10.1183/09031936.06.00029306; [Anonymous], 2010, GLOBAL STRATEGY DIAG; Barnes PJ, 2006, AM J RESP CRIT CARE, V174, P6, DOI 10.1164/rccm.200510-1659PP; Beirne P, 2009, EUR RESPIR J, V34, P1376, DOI 10.1183/09031936.00028209; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Cazzola M, 2010, PULM PHARMACOL THER, V23, P493, DOI 10.1016/j.pupt.2010.05.001; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Crapo JD, 2010, P NATL ACAD SCI USA, V107, P8503, DOI 10.1073/pnas.1003826107; de Torres JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016021; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Grootendorst DC, 1997, CLIN EXP ALLERGY, V27, P769, DOI 10.1111/j.1365-2222.1997.tb01211.x; Hernandez ML, 2010, INHAL TOXICOL, V22, P648, DOI 10.3109/08958371003610966; Holz O, 2005, J CLIN PHARMACOL, V45, P498, DOI 10.1177/0091270004273527; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Jorres RA, 2010, DEUT MED WOCHENSCHR, V135, P446, DOI 10.1055/s-0030-1249185; Kolsum Umme, 2009, Int J Chron Obstruct Pulmon Dis, V4, P149; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Petty TL, 2002, CHEST, V121, p116S, DOI 10.1378/chest.121.5_suppl.116S; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Polosa R, 2011, INTERN EMERG MED; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Thum T, 2006, ENVIRON HEALTH PERSP, V114, P1655, DOI 10.1289/ehp.8861; Tzortzaki EG, 2007, CURR MED CHEM, V14, P1037, DOI 10.2174/092986707780362943; Ventetuolo Corey E, 2008, Proc Am Thorac Soc, V5, P617, DOI 10.1513/pats.200803-029SK; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Wouters Emiel F M, 2007, Proc Am Thorac Soc, V4, P626, DOI 10.1513/pats.200706-071TH	36	50	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46207	10.1371/journal.pone.0046207	http://dx.doi.org/10.1371/journal.pone.0046207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056262	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800014
J	Gaskins, AJ; Mumford, SL; Chavarro, JE; Zhang, CL; Pollack, AZ; Wactawski-Wende, J; Perkins, NJ; Schisterman, EF				Gaskins, Audrey J.; Mumford, Sunni L.; Chavarro, Jorge E.; Zhang, Cuilin; Pollack, Anna Z.; Wactawski-Wende, Jean; Perkins, Neil J.; Schisterman, Enrique F.			The Impact of Dietary Folate Intake on Reproductive Function in Premenopausal Women: A Prospective Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; MARGINAL STRUCTURAL MODELS; MENSTRUAL-CYCLE; FOLIC-ACID; FOOD FORTIFICATION; PREVENTION; FERTILITY; SUPPLEMENTATION; BIOAVAILABILITY; BIOCYCLE	Background: Folic acid is recommended to reproductive-aged women to prevent birth defects, though little is known about the effects of dietary intake on other reproductive outcomes. Improved pregnancy rates have been documented after folic acid supplement use, suggesting a possible link with ovulation, however research is limited. Our objective was to evaluate the association between dietary folate intake, hormone levels, and sporadic anovulation in healthy, regularly menstruating women. Methodology/Principal Findings: The BioCycle study (2005-2007) prospectively followed 259 healthy women aged 18-44 years from the western New York region for up to 2 menstrual cycles. Total folate and specific sources of folate were assessed up to 4 times per cycle by 24-hour recall. Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone were measured in serum up to 8 times per cycle, timed using fertility monitors. Anovulation was defined as a cycle with peak progesterone concentration <= 5 ng/mL and no LH peak in the mid/late luteal phase. Higher intake of dietary folate (in dietary equivalents) across tertiles had a marginally significant association with greater luteal progesterone levels (P trend 0.08). Higher intake of synthetic folate was significantly associated with higher luteal progesterone levels (P trend 0.05). Specifically, women in the 3rd tertile of synthetic folate intake had, on average, 16.0% (95% CI, 0.5-33.8%) higher luteal progesterone levels compared to women in the 1st tertile. Moreover, consumption of synthetic folate was significantly and inversely associated with anovulation such that women in the 3rd tertile had a 64% (95% CI, 8-86%) decreased odds of anovulation compared to the women in the 1st tertile (P trend 0.03). Conclusions/Significance: These findings suggest that a diet high in synthetic folate may be associated with increased progesterone levels and lower risk of sporadic anovulation. Further study of the effect of dietary folate and folic acid supplement use on reproductive health is warranted.	[Gaskins, Audrey J.; Mumford, Sunni L.; Zhang, Cuilin; Pollack, Anna Z.; Perkins, Neil J.; Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, Rockville, MD USA; [Gaskins, Audrey J.; Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chavarro, Jorge E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Chavarro, Jorge E.] Harvard Univ, Sch Med, Boston, MA USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, Rockville, MD USA.	schistee@mail.nih.gov	Wactawski-Wende, Jean/AGH-5457-2022; Chavarro, Jorge E/AAE-5665-2021; Gaskins, Audrey/K-6246-2019; Pollack, Anna/L-7652-2018	Wactawski-Wende, Jean/0000-0003-3096-9595; Chavarro, Jorge E/0000-0002-4436-9630; Perkins, Neil/0000-0002-6802-4733; Mumford, Sunni/0000-0003-0133-3176; Schisterman, Enrique/0000-0003-3757-641X; Zhang, Cuilin/0000-0002-8014-2708; Pollack, Anna/0000-0002-4313-3298	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; Harvard Nutrition Department NIH [T32DK007703-16]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Nutrition Department NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The BioCycle Study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. Audrey J. Gaskins is funded by the Harvard Nutrition Department NIH Training Grant T32DK007703-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baily LB, 1998, NUTR REV, V56, P294, DOI 10.1111/j.1753-4887.1998.tb01662.x; Browne RW, 2009, CLIN CHEM, V55, P1245, DOI 10.1373/clinchem.2008.122101; Chavarro JE, 2008, FERTIL STERIL, V89, P668, DOI 10.1016/j.fertnstert.2007.03.089; Chen LT, 2004, NUTR REV, V62, pS40, DOI 10.1301/nr.2004.jun.S40-S43; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel AE, 1996, INT J VITAM NUTR RES, V66, P55; Ebisch IMW, 2007, HUM REPROD UPDATE, V13, P163, DOI 10.1093/humupd/dml054; FLEGAL KM, 1991, AM J EPIDEMIOL, V134, P1233, DOI 10.1093/oxfordjournals.aje.a116026; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; Hecht S, 2009, FERTIL STERIL, V91, P56, DOI 10.1016/j.fertnstert.2007.11.011; Hertrampf E, 2004, NUTR REV, V62, pS44, DOI 10.1111/j.1753-4887.2004.tb00074.x; Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287; Lewis CJ, 1999, AM J CLIN NUTR, V70, P198; MATTE JJ, 1984, J ANIM SCI, V59, P1020, DOI 10.2527/jas1984.5941020x; McMahon JM, 2006, COMPUT STAT DATA AN, V50, P3663, DOI 10.1016/j.csda.2005.08.008; McNulty H, 2004, P NUTR SOC, V63, P529, DOI 10.1079/PNS2004383; MOHANTY D, 1982, J NUTR, V112, P1565, DOI 10.1093/jn/112.8.1565; Mohanty D, 1976, 16 INT C HAEM KYOT J, V2, P66; Mumford SL, 2011, PAEDIATR PERINAT EP, V25, P448, DOI 10.1111/j.1365-3016.2011.01204.x; National Research Council, 1998, DIET REF INT THIAM R; Ray JG, 2004, NUTR REV, V62, pS35, DOI 10.1111/j.1753-4887.2004.tb00072.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Szymanski Wieslaw, 2003, Ginekol Pol, V74, P1392; Thaler CJ, 2006, AM J REPROD IMMUNOL, V55, P251, DOI 10.1111/j.1600-0897.2005.00357.x; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x; WALD N, 1991, LANCET, V338, P131; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Westphal L M, 2006, Clin Exp Obstet Gynecol, V33, P205; Westphal LM, 2004, J REPROD MED, V49, P289; WILLMOTT M, 1968, J ENDOCRINOL, V41, P439, DOI 10.1677/joe.0.0410439; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401	37	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46276	10.1371/journal.pone.0046276	http://dx.doi.org/10.1371/journal.pone.0046276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050004	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300103
J	McDonald, JU; Rosas, M; Brown, GD; Jones, SA; Taylor, PR				McDonald, Jacqueline U.; Rosas, Marcela; Brown, Gordon D.; Jones, Simon A.; Taylor, Philip R.			Differential Dependencies of Monocytes and Neutrophils on Dectin-1, Dectin-2 and Complement for the Recognition of Fungal Particles in Inflammation	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; CANDIDA-ALBICANS; HOST-DEFENSE; IN-VIVO; DENDRITIC CELLS; MACROPHAGES; INDUCTION; PATHWAY; HETEROGENEITY	We have re-investigated the role of the complement system and the non-opsonic pattern recognition receptors dectin-1 and dectin-2 in the recognition of fungal particles by inflammatory neutrophils, monocytes and macrophages. We have used in vivo and ex vivo models to study the recognition and response of these cells: i) We confirm previous observations regarding the importance of complement to neutrophil but not monocytic responses; ii) We show that dectin-1 is important for driving inflammatory cell recruitment to fungal stimuli and that it biases the immediate inflammatory response to one that favors neutrophil over monocyte recruitment; iii) We show that dectin-2 contributes to the physical recognition of fungal particles by inflammatory monocytes/macrophages, but is also expressed on neutrophils, where we show it has the potential to contribute to cellular activation; iv) Additionally, we show that serum-opsonization has the potential to interfere with non-opsonic recognition of fungal particles by dectin-1 and dectin-2, presumably through masking of ligands. Collectively these roles are consistent with previously described roles of dectin-1 and dectin-2 in driving inflammatory and adaptive immune responses and complement in containing fungal burdens. This study emphasizes the importance of heterogeneity of receptor expression across myeloid cell subsets in protective immune responses.	[McDonald, Jacqueline U.; Rosas, Marcela; Jones, Simon A.; Taylor, Philip R.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Sect Infect & Immun, Aberdeen, Scotland	Cardiff University; University of Aberdeen	Taylor, PR (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales.	TaylorPR@cf.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; Jones, Simon Arnett/Q-7017-2018	brown, gordon/0000-0002-0287-5383; Taylor, Philip/0000-0003-0163-1421; Jones, Simon Arnett/0000-0001-7297-9711	UK Medical Research Council [G0601617]; Medical Research Council; Medical Research Council funded Doctoral Training Grant PhD studentship; Wellcome Trust; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council funded Doctoral Training Grant PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (G0601617). JUM is the recipient of a Medical Research Council funded Doctoral Training Grant PhD studentship. GDB is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; CZOP JK, 1978, J IMMUNOL, V120, P1132; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Li X, 2011, CELL HOST MICROBE, V10, P603, DOI 10.1016/j.chom.2011.10.009; Liddiard K, 2011, EUR J IMMUNOL, V41, P2503, DOI 10.1002/eji.201141743; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; ROOS D, 1981, J IMMUNOL, V126, P433; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	42	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45781	10.1371/journal.pone.0045781	http://dx.doi.org/10.1371/journal.pone.0045781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049859	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000309517300053
J	Tolfvenstam, T; Norbeck, O; Ohrmalm, L				Tolfvenstam, Thomas; Norbeck, Oscar; Ohrmalm, Lars			No Evidence of Presence of Parvovirus 4 in a Swedish Cohort of Severely Immunocompromised Children and Adults	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-DONORS; TRANSPLANT PATIENTS; DRUG-USERS; PARV4; INFECTION; PERSISTENCE; B19; EPIDEMIOLOGY; TRANSMISSION	The recently discovered human parvovirus 4 (PARV4) has been associated with seropositivity for human immunodeficiency virus, hepatitis B virus and hepatitis C virus. High prevalence is seen especially in intravenous drug users. The virus has been detected in blood products and persons who have been repeatedly transfused have shown to be a risk-group. Furthermore, reports from different parts of the world suggesting a prevalence ranging from zero to one third of the healthy population and the virus is thought to cause a latent or persistent infection. We investigated the presence of PARV4 DNA and parvovirus B19 (B19) DNA in serum from 231 severely immunocompromised cancer patients that have been exposed for blood products. Compared to B19, which was found in 3.9% of the patients, we found no evidence of PARV4. Our results may indicate a very low prevalence of the virus in Sweden, and it would be useful to measure the real PARV4 exposure of the healthy population as well as individuals with known risk factors by serology.	[Tolfvenstam, Thomas; Norbeck, Oscar; Ohrmalm, Lars] Karolinska Inst, Dept Med, Infect Dis Unit, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Ohrmalm, L (corresponding author), Karolinska Inst, Dept Med, Infect Dis Unit, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden.	lars.ohrmalm@ki.se		Tolfvenstam, Thomas/0000-0003-3549-8083	Stockholm County Council; Karolinska Institutet; Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; The Swedish Childhood Cancer Foundation	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; The Swedish Childhood Cancer Foundation	Grants were received from the Stockholm County Council (www.sll.se)/Karolinska Institutet (www.ki.se), the Swedish Society of Medicine (www.sls.se), the Clas Groschinsky foundation (www.groschinsky.org), Karolinska Institutet Infection Network (www.ki.se) and from The Swedish Childhood Cancer Foundation (www.barncancerfonden.se) for method development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2008, EMERG INFECT DIS, V14, P1811, DOI 10.3201/eid1411.080862; Botto S, 2009, NEW MICROBIOL, V32, P189; Chen MY, 2011, EMERG INFECT DIS, V17, P1954, DOI 10.3201/eid1710.101841; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2007, EMERG INFECT DIS, V13, P175; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Lahtinen A, 2011, EMERG INFECT DIS, V17, P79, DOI 10.3201/eid1701.100750; Lavoie M, 2012, EMERG INFECT DIS, V18, P680, DOI 10.3201/eid1804.110628; Lindblom A, 2005, CLIN INFECT DIS, V41, P1201, DOI 10.1086/444503; Longhi E, 2007, AIDS, V21, P1481, DOI 10.1097/QAD.0b013e3281e38558; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Ma YY, 2012, VOX SANG; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Panning M, 2010, EMERG INFECT DIS, V16, P1143, DOI 10.3201/eid1607.100025; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Schneider B, 2008, J MED VIROL, V80, P345, DOI 10.1002/jmv.21069; Servant-Delmas A, 2009, TRANSFUSION, V49, P1771, DOI 10.1111/j.1537-2995.2009.02286.x; Sharp CP, 2010, EMERG INFECT DIS, V16, P1605, DOI 10.3201/eid1610.101001; Sharp CP, 2009, J INFECT DIS, V200, P1119, DOI 10.1086/605646; Sharp CP, 2011, TRANSFUSION; Simmonds P, 2008, J GEN VIROL, V89, P2299, DOI 10.1099/vir.0.2008/001180-0; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2012, J INFECT DIS; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3210/eid1603.090746, 10.3201/eid1603.090746]; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Touinssi M, 2010, EMERG INFECT DIS, V16, P165, DOI 10.3201/eid1601.090517; Vallerini D, 2008, EMERG INFECT DIS, V14, P185, DOI 10.3201/eid1401.070610; Yang SJ, 2011, J CLIN VIROL, V51, P64, DOI 10.1016/j.jcv.2011.01.017; Yu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029474	32	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46430	10.1371/journal.pone.0046430	http://dx.doi.org/10.1371/journal.pone.0046430			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050026	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300116
J	Canuet, L; Tellado, I; Couceiro, V; Fraile, C; Fernandez-Novoa, L; Ishii, R; Takeda, M; Cacabelos, R				Canuet, Leonides; Tellado, Ivan; Couceiro, Veronica; Fraile, Carmen; Fernandez-Novoa, Lucia; Ishii, Ryouhei; Takeda, Masatoshi; Cacabelos, Ramon			Resting-State Network Disruption and APOE Genotype in Alzheimer's Disease: A lagged Functional Connectivity Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; EVENT-RELATED SYNCHRONIZATION; APOLIPOPROTEIN-E; BRAIN ACTIVITY; EEG SYNCHRONIZATION; ALPHA-ACTIVITY; ALLELE; FMRI; MEMORY	Background: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Alzheimer's disease (AD) and with AD-related abnormalities in cortical rhythms. However, it is unclear whether APOE-4 is linked to a specific pattern of intrinsic functional disintegration of the brain after the development of the disease or during its different stages. This study aimed at identifying spatial patterns and effects of APOE genotype on resting-state oscillations and functional connectivity in patients with AD, using a physiological connectivity index called "lagged phase synchronization''. Methodology/Principal Findings: Resting EEG was recorded during awake, eyes-closed state in 125 patients with AD and 60 elderly controls. Source current density and functional connectivity were determined using eLORETA. Patients with AD exhibited reduced parieto-occipital alpha oscillations compared with controls, and those carrying the APOE-4 allele had reduced alpha activity in the left inferior parietal and temporo-occipital cortex relative to noncarriers. There was a decreased alpha2 connectivity pattern in AD, involving the left temporal and bilateral parietal cortex. Several brain regions exhibited increased lagged phase synchronization in low frequencies, specifically in the theta band, across and within hemispheres, where temporal lobe connections were particularly compromised. Areas with abnormal theta connectivity correlated with cognitive scores. In patients with early AD, we found an APOE-4-related decrease in interhemispheric alpha connectivity in frontal and parieto-temporal regions. Conclusions/Significance: In addition to regional cortical dysfunction, as indicated by abnormal alpha oscillations, there are patterns of functional network disruption affecting theta and alpha bands in AD that associate with the level of cognitive disturbance or with the APOE genotype. These functional patterns of nonlinear connectivity may potentially represent neurophysiological or phenotypic markers of AD, and aid in early detection of the disorder.	[Canuet, Leonides; Tellado, Ivan; Couceiro, Veronica; Fraile, Carmen; Cacabelos, Ramon] Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, Corunna, Spain; [Fernandez-Novoa, Lucia; Cacabelos, Ramon] Inst CNS Disorders & Genom Med, EuroEspes Biotechnol Div Ebiotec, Corunna, Spain; [Ishii, Ryouhei; Takeda, Masatoshi] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Canuet, L (corresponding author), Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, Corunna, Spain.	diagnosticodigital2@euroespes.com	Ishii, Ryouhei/A-9929-2008; Canuet, Leonides/B-1655-2008	Ishii, Ryouhei/0000-0002-4245-0953; Canuet, Leonides/0000-0003-1608-4715				Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderer P, 1998, NEUROPSYCHOBIOLOGY, V37, P20, DOI 10.1159/000026472; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Babiloni C, 2006, ANN NEUROL, V59, P323, DOI 10.1002/ana.20724; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Cacabelos R, 2003, PHARMACOGENOMICS, V4, P597, DOI 10.1517/phgs.4.5.597.23795; Cacabelos R, 1996, ACTA NEUROL SCAND, V93, P72; Cacabelos R., 2006, DRUG FUTURE, V3, P5, DOI [10.2217/1745509X.1.2.303, DOI 10.2217/1745509X.1.2.303]; Cacabelos Ramon, 2005, Methods Find Exp Clin Pharmacol, V27 Suppl A, P1; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Canuet L, 2010, EPILEPSY BEHAV, V17, P109, DOI 10.1016/j.yebeh.2009.11.002; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; de Waal H, 2011, J NEUROL NEUROSUR PS, V82, P67, DOI 10.1136/jnnp.2010.216432; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Filippini N, 2009, J MAGN RESON IMAGING, V29, P1021, DOI 10.1002/jmri.21757; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Alonso JF, 2011, ANN BIOMED ENG, V39, P524, DOI 10.1007/s10439-010-0155-7; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ikezawa K, 2011, NEUROSCI RES, V71, P235, DOI 10.1016/j.neures.2011.07.1819; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Ishii R, 2010, PSYCHOGERIATRICS, V10, P138, DOI 10.1111/j.1479-8301.2010.00326.x; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Jelles B, 2008, CLIN NEUROPHYSIOL, V119, P837, DOI 10.1016/j.clinph.2007.12.002; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kleen JK, 2011, J NEUROSCI, V31, P15397, DOI 10.1523/JNEUROSCI.2196-11.2011; Kramer G, 2008, CLIN NEUROPHYSIOL, V119, P2727, DOI 10.1016/j.clinph.2008.08.019; Kurimoto R, 2008, NEUROSCI LETT, V443, P86, DOI 10.1016/j.neulet.2008.07.015; Lee SH, 2010, NEUROSCI RES, V66, P333, DOI 10.1016/j.neures.2009.12.004; Li TQ, 2011, ACTA RADIOL, V52, P211, DOI 10.1258/ar.2010.100053; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Maestu F, 2011, J CLIN NEUROPHYSIOL, V28, P202, DOI 10.1097/WNP.0b013e3182121743; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meltzer CC, 1996, NEUROLOGY, V47, P454, DOI 10.1212/WNL.47.2.454; Mulert C, 2011, INT J PSYCHOPHYSIOL, V79, P55, DOI 10.1016/j.ijpsycho.2010.08.004; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Park YM, 2008, NEUROSCI RES, V62, P112, DOI 10.1016/j.neures.2008.06.009; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD, 2007, ARXIV07111455STATME; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Reisberg B., 2011, PRINCIPLES PRACTICE, V3rd ed., P162, DOI DOI 10.1002/9780470669600; ROSES AD, 1995, JAMA-J AM MED ASSOC, V273, P374, DOI 10.1001/jama.273.5.374; Rytsar R, 2011, NEUROIMAGE, V57, P1131, DOI 10.1016/j.neuroimage.2011.05.029; Sankari Z, 2011, CLIN NEUROPHYSIOL, V122, P897, DOI 10.1016/j.clinph.2010.09.008; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Takeda M, 2010, PSYCHIAT CLIN NEUROS, V64, P592, DOI 10.1111/j.1440-1819.2010.02148.x; Thatcher RW, 2012, HUM BRAIN MAPP, V33, P1062, DOI 10.1002/hbm.21271; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2615, DOI 10.1016/j.clinph.2006.07.319	81	104	108	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46289	10.1371/journal.pone.0046289	http://dx.doi.org/10.1371/journal.pone.0046289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050006	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100173
J	Jorgensen, PB; Livbjerg, AH; Hansen, HJ; Petersen, T; Hollsberg, P				Jorgensen, Pernille B.; Livbjerg, Astrid H.; Hansen, Hans J.; Petersen, Thor; Hollsberg, Per			Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients	PLOS ONE			English	Article							CD8(+) T-CELLS; CLASS IB MOLECULES; MEDIATED RECOGNITION; ANTIBODY-TITERS; INFECTION; ANTIGEN; BRAIN; QA-1; TCR; IMMUNITY	Multiple sclerosis (MS) is associated with Epstein-Barr virus (EBV) infection, but impaired immune suppression may be part of the disease pathogenesis. CD8(+) T cells that are restricted by HLA-E exert an important immunoregulatory mechanism. To explore how EBV might interfere with immune regulation, we examined the expression of HLA-E and the frequency of CD8(+) cells recognizing HLA-E, presenting either an EBV peptide from the BZLF1 protein or a signal sequence peptide from HLA-A2, in relapsing remitting (MS-RR), primary progressive (MS-PP) MS patients, and healthy controls (HC). Treatment with IFN-alpha or EBV increased HLA-E expression on CD4(+) cells. However, only MS-PP had increased expression of HLA-E on resting CD4(+) cells when compared with HC (p<0.005). CD8(+) cells were divided into CD8(bright) and CD8(dim) cells by flow cytometry analyses. MS-RR had significantly fewer CD8(dim) cells than HC (p<0.003). Flow cytometry analyses were performed with HLA-E tetramers folded in the presence of the EBV or HLA-A2 peptide to identify HLA-E-interacting cells. MS-RR had increased frequency of CD8(bright) cells recognizing HLA-E/A2 (p = 0.006) and HLA-E/BZLF1 (p = 0.016). Conversely, MS-RR had fewer CD8(dim) cells that recognized HLA-E/BZLF1 (p = 0.001), but this could be attributed to the overall lower number of CD8(dim) cells in MS-RR. Whereas HLA-E/A2 was predominantly recognized by CD8(dim) cells, HLA-E/BZLF1 was predominantly recognized by CD8(bright) cells in MS-RR and MS-PP, but not in HC. As expected, HLA-E/A2 was also recognized by CD8-negative cells in a CD94-dependent manner, whereas HLA-E/BZLF1 was poorly recognized in all groups by CD8-negative cells. These data demonstrate that MS-RR patients have expanded their CD8(bright) cells recognizing HLA-E/BZLF1. Moreover, HLA-E/BZLF1 appears to be recognized by the immune system in a different manner than HLA-E/A2.	[Jorgensen, Pernille B.; Livbjerg, Astrid H.; Hollsberg, Per] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hansen, Hans J.; Petersen, Thor] Aarhus Univ Hosp, Dept Neurol, MS Clin, DK-8000 Aarhus, Denmark; [Hollsberg, Per] Aarhus Univ, Danish Neurosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Hollsberg, P (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ph@microbiology.au.dk		Petersen, Thor/0000-0001-5633-2600	Danish Multiple Sclerosis Society	Danish Multiple Sclerosis Society	The study was supported by the Danish Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2010, BRAIN, V133, DOI 10.1093/brain/awq223; Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Correale J, 2008, J NEUROIMMUNOL, V195, P121, DOI 10.1016/j.jneuroim.2007.12.004; Davies A, 2003, J IMMUNOL, V170, P5027, DOI 10.4049/jimmunol.170.10.5027; Garcia P, 2002, EUR J IMMUNOL, V32, P936, DOI 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.3.CO;2-D; Haahr S, 1995, Mult Scler, V1, P73; Haahr S, 2006, REV MED VIROL, V16, P297, DOI 10.1002/rmv.503; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; HOLLSBERG P, 1994, J IMMUNOL, V153, P566; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; IMANI F, 1991, P NATL ACAD SCI USA, V88, P10475, DOI 10.1073/pnas.88.23.10475; Jensen PE, 2004, IMMUNOL RES, V29, P81, DOI 10.1385/IR:29:1-3:081; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Jiang H, 2010, J CLIN INVEST, V120, P3641, DOI 10.1172/JCI43522; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; KIKUTA H, 1984, J GEN VIROL, V65, P837, DOI 10.1099/0022-1317-65-4-837; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; LOTZ M, 1986, J IMMUNOL, V136, P3636; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Pender MP, 2009, AUTOIMMUN REV, V8, P563, DOI 10.1016/j.autrev.2009.01.017; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Romagnani C, 2004, HUM IMMUNOL, V65, P437, DOI 10.1016/j.humimm.2004.02.001; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; SUMAYA CV, 1985, ANN NEUROL, V17, P371, DOI 10.1002/ana.410170412; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Ulbrecht M, 1998, J IMMUNOL, V160, P4375; ULBRECHT M, 1992, J IMMUNOL, V149, P2945; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Watanabe N, 1997, BLOOD, V90, P3662, DOI 10.1182/blood.V90.9.3662; Weiss EH, 1998, AM J REPROD IMMUNOL, V40, P177; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200	51	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46120	10.1371/journal.pone.0046120	http://dx.doi.org/10.1371/journal.pone.0046120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049954	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100139
J	Kim, Y; Sun, H				Kim, Yongsoon; Sun, Hong			ASM-3 Acid Sphingomyelinase Functions as a Positive Regulator of the DAF-2/AGE-1 Signaling Pathway and Serves as a Novel Anti-Aging Target	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; NEMATODE CAENORHABDITIS-ELEGANS; NUCLEAR DAF-16/FOXO ACTIVITY; LIFE-SPAN; C-ELEGANS; MULTIDRUG-RESISTANCE; ENDOCRINE REGULATION; FAMILY-MEMBER; FAT-BODY; LONGEVITY	In C. elegans, the highly conserved DAF-2/insulin/insulin-like growth factor 1 receptor signaling (IIS) pathway regulates longevity, metabolism, reproduction and development. In mammals, acid sphingomyelinase (ASM) is an enzyme that hydrolyzes sphingomyelin to produce ceramide. ASM has been implicated in CD95 death receptor signaling under certain stress conditions. However, the involvement of ASM in growth factor receptor signaling under physiological conditions is not known. Here, we report that in vivo ASM functions as a positive regulator of the DAF-2/IIS pathway in C. elegans. We have shown that inactivation of asm-3 extends animal lifespan and promotes dauer arrest, an alternative developmental process. A significant cooperative effect on lifespan is observed between asm-3 deficiency and loss-of-function alleles of the age-1/PI 3-kinase, with the asm-3; age-1 double mutant animals having a mean lifespan 259% greater than that of the wildtype animals. The lifespan extension phenotypes caused by the loss of asm-3 are dependent on the functions of daf-16/FOXO and daf-18/PTEN. We have demonstrated that inactivation of asm-3 causes nuclear translocation of DAF-16::GFP protein, up-regulates endogenous DAF-16 protein levels and activates the downstream targeting genes of DAF-16. Together, our findings reveal a novel role of asm-3 in regulation of lifespan and diapause by modulating IIS pathway. Importantly, we have found that two drugs known to inhibit mammalian ASM activities, desipramine and clomipramine, markedly extend the lifespan of wild-type animals, in a manner similar to that achieved by genetic inactivation of the asm genes. Our studies illustrate a novel strategy of anti-aging by targeting ASM, which may potentially be extended to mammals.	[Kim, Yongsoon; Sun, Hong] Nevada Canc Inst, Lab Canc Genom, Las Vegas, NV USA; [Kim, Yongsoon; Sun, Hong] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Kim, Y (corresponding author), Nevada Canc Inst, Lab Canc Genom, Las Vegas, NV USA.	ykim@nvcancer.org; hong.sun@unlv.edu			American Cancer Society [RSG-03-246-01-MBC]; Nevada System of Higher Education	American Cancer Society(American Cancer Society); Nevada System of Higher Education	This work was supported in part by the American Cancer Society grant RSG-03-246-01-MBC and Inter-Institutional Biomedical Research Activities Fund from the Nevada System of Higher Education awarded to H.S. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; BRENNER S, 1974, GENETICS, V77, P71; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houthoofd K, 2005, AGING CELL, V4, P87, DOI 10.1111/j.1474-9726.2005.00150.x; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; JAFFREZOU JP, 1995, BBA-MOL CELL RES, V1266, P1, DOI 10.1016/0167-4889(94)00219-5; JAFFREZOU JP, 1991, J BIOL CHEM, V266, P19858; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin XH, 1998, J BIOL CHEM, V273, P14374, DOI 10.1074/jbc.273.23.14374; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Ren P, 1996, SCIENCE, V274, P1398; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zhang YM, 2008, DEV BIOL, V315, P290, DOI 10.1016/j.ydbio.2007.12.032	58	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45890	10.1371/journal.pone.0045890	http://dx.doi.org/10.1371/journal.pone.0045890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049887	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100097
J	Kraska, A; Santin, MD; Dorieux, O; Joseph-Mathurin, N; Bourrin, E; Petit, F; Jan, C; Chaigneau, M; Hantraye, P; Lestage, P; Dhenain, M				Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Lestage, Pierre; Dhenain, Marc			In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin	PLOS ONE			English	Article							INDUCED EXPERIMENTAL DEMENTIA; GROWTH-FACTOR EXPRESSION; ALZHEIMER-LIKE CHANGES; ADULT-RAT BRAIN; OXIDATIVE STRESS; INDUCED MODEL; MEMORY IMPAIRMENT; INSULIN; DISEASE; INJECTION	Cerebral aging is often associated with the occurrence of neurodegenerative diseases leading to dementia. Animal models are critical to elucidate mechanisms associated to dementia and to evaluate neuroprotective drugs. Rats that received intracerebroventricular injection of streptozotocin (icv-STZ) have been reported as a model of dementia. In these animals, this drug induces oxidative stress and brain glucose metabolism impairments associated to insulin signal transduction failure. These mechanisms are reported to be involved in the pathogenesis of Alzheimer's disease and other dementia. Icv-STZ rats also display memory impairments. However, little is known about the precise location of the lesions induced by STZ administration. In this context, the present study characterized the cerebral lesions induced by two-doses of icv-STZ by using high-field magnetic resonance imaging to easily and longitudinally detect cerebral abnormalities and by using immunohistochemistry to evaluate neuronal loss and neuroinflammation (astrocytosis and microgliosis). We showed that, at high doses, icv-STZ induces severe and acute neurodegenerative lesions in the septum and corpus callosum. The lesions are associated with an inflammation process. They are less severe and more progressive at low doses. The relevance of high and low doses of icv-STZ to mimic dementia and evaluate new drugs is discussed in the final part of this article.	[Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Dhenain, Marc] Ctr Natl Rech Sci, URA 2210, Fontenay Aux Roses, France; [Kraska, Audrey; Bourrin, Emmanuel; Lestage, Pierre] Inst Rech Servier, Croissy Sur Seine, France; [Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Dhenain, Marc] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Imagerie Biomed, Mol Imaging Res Ctr, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); Servier; Institut de Recherches Internationales Servier; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dhenain, M (corresponding author), Ctr Natl Rech Sci, URA 2210, Fontenay Aux Roses, France.	Marc.Dhenain@cea.fr	Santin, Mathieu/AAJ-2213-2020; Dhenain, Marc/K-5630-2013	Dhenain, Marc/0000-0001-8804-4101; Joseph-Mathurin, Nelly/0000-0002-9735-5152	France-Alzheimer Association; CNRS (National Center for Scientific Research ("French NIH")); National Foundation for Alzheimer's Disease and Related Disorders; Hoffmann-La Roche	France-Alzheimer Association; CNRS (National Center for Scientific Research ("French NIH")); National Foundation for Alzheimer's Disease and Related Disorders; Hoffmann-La Roche(Hoffmann-La Roche)	This work was supported by the by the France-Alzheimer Association, the longevity program from the CNRS (National Center for Scientific Research ("French NIH")) and the National Foundation for Alzheimer's Disease and Related Disorders. OD was financed by Hoffmann-La Roche but on a project that was unrelated to the current article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Olene Dorieux was financed by Hoffmann-La Roche but on a project that was unrelated to the current article. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrawal R, 2011, EUR NEUROPSYCHOPHARM, V21, P261, DOI 10.1016/j.euroneuro.2010.11.009; Arluison M, 2004, J CHEM NEUROANAT, V28, P117, DOI 10.1016/j.jchemneu.2004.05.009; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Correia SC, 2011, AGEING RES REV, V10, P264, DOI 10.1016/j.arr.2011.01.001; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027; Dhull DK, 2012, J MOL NEUROSCI, V46, P223, DOI 10.1007/s12031-011-9583-6; Diguet E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004637; Eriksson SH, 2009, J NEUROSCI METH, V181, P111, DOI 10.1016/j.jneumeth.2009.05.001; Fitz NF, 2006, BRAIN RES BULL, V69, P660, DOI 10.1016/j.brainresbull.2006.03.011; Frederiksen KS, 2011, NEURODEGENER DIS, V8, P476, DOI 10.1159/000327753; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hung CW, 2010, AGEING RES REV, V9, pS36, DOI 10.1016/j.arr.2010.08.006; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Ishrat T, 2009, BRAIN RES, V1281, P117, DOI 10.1016/j.brainres.2009.04.010; Isik AT, 2009, AGE, V31, P39, DOI 10.1007/s11357-008-9078-8; Janowsky JS, 1996, J AM GERIATR SOC, V44, P798, DOI 10.1111/j.1532-5415.1996.tb03736.x; Javed H, 2011, BRAIN RES, V1389, P133, DOI 10.1016/j.brainres.2011.02.072; KESNER RP, 1988, NEUROBIOL AGING, V9, P609, DOI 10.1016/S0197-4580(88)80122-2; Kirby BP, 2003, BEHAV BRAIN RES, V143, P41, DOI 10.1016/S0166-4328(03)00005-6; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; MCGEER PL, 1986, NEUROLOGY, V36, P1569, DOI 10.1212/WNL.36.12.1569; Niewiadomska G, 2009, PROG NEURO-PSYCHOPH, V33, P791, DOI 10.1016/j.pnpbp.2009.03.039; Pathan AR, 2006, LIFE SCI, V79, P2209, DOI 10.1016/j.lfs.2006.07.018; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinton S, 2011, BEHAV BRAIN RES, V223, P1, DOI 10.1016/j.bbr.2011.04.014; PLASCHKE K, 1993, INT J DEV NEUROSCI, V11, P477, DOI 10.1016/0736-5748(93)90021-5; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Prakash AK, 2009, J PHARM PHARMACOL, V61, P1665, DOI 10.1211/jpp/61.12.0012; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Sapcanin A, 2008, NEUROTOX RES, V13, P97, DOI 10.1007/BF03033561; Saxena G, 2008, EUR J PHARMACOL, V581, P283, DOI 10.1016/j.ejphar.2007.12.009; Sharma B, 2008, PHARMACOL BIOCHEM BE, V89, P535, DOI 10.1016/j.pbb.2008.02.012; Sharma B, 2008, J PSYCHOPHARMACOL, V22, P162, DOI 10.1177/0269881107081553; Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5; Sharma N, 2011, PHARM BIOCH BEHAV, V96, P386; Shoham S, 2003, EXP NEUROL, V184, P1043, DOI 10.1016/j.expneurol.2003.08.015; Shoham S, 2007, NEUROPHARMACOLOGY, V52, P836, DOI 10.1016/j.neuropharm.2006.10.005; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sultana R, 2011, J ALZHEIMERS DIS, V24, P77, DOI 10.3233/JAD-2011-101425; Szkudelski T, 2001, PHYSIOL RES, V50, P537; TERWEL D, 1995, EUR J PHARMACOL, V287, P65, DOI 10.1016/0014-2999(95)00475-4; Tramontina AC, 2011, J NEURAL TRANSM, V118, P1641, DOI 10.1007/s00702-011-0680-z; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	56	62	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46196	10.1371/journal.pone.0046196	http://dx.doi.org/10.1371/journal.pone.0046196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049978	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100153
J	Kumasaka, N; Aoki, M; Okada, Y; Takahashi, A; Ozaki, K; Mushiroda, T; Hirota, T; Tamari, M; Tanaka, T; Nakamura, Y; Kamatani, N; Kubo, M				Kumasaka, Natsuhiko; Aoki, Masayuki; Okada, Yukinori; Takahashi, Atsushi; Ozaki, Kouichi; Mushiroda, Taisei; Hirota, Tomomitsu; Tamari, Mayumi; Tanaka, Toshihiro; Nakamura, Yusuke; Kamatani, Naoyuki; Kubo, Michiaki			Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNRELATED INDIVIDUALS; NICOTINE METABOLISM; COMMON DISEASES; SNP GENOTYPES; ADULT TWINS; BEHAVIOR; METAANALYSIS; IMPUTATION; VARIANTS	Smoking is a major public health problem, but the genetic factors associated with smoking behaviors are not fully elucidated. Here, we have conducted an integrated genome-wide association study to identify common copy number polymorphisms (CNPs) and single nucleotide polymorphisms (SNPs) associated with the number of cigarettes smoked per day (CPD) in Japanese smokers (N = 17,158). Our analysis identified a common CNP with a strong effect on CPD (rs8102683; P = 3.8 x 10(-42)) in the 19q13 region, encompassing the CYP2A6 locus. After adjustment for the associated CNP, we found an additional associated SNP (rs11878604; P = 9.7 x 10(-30)) located 30 kb downstream of the CYP2A6 gene. Imputation of the CYP2A6 locus revealed that haplotypes underlying the CNP and the SNP corresponded to classical, functional alleles of CYP2A6 gene that regulate nicotine metabolism and explained 2% of the phenotypic variance of CPD (ANOVA F-test P = 9.5 x 10(-52)). These haplotypes were also associated with smoking-related diseases, including lung cancer, chronic obstructive pulmonary disease and arteriosclerosis obliterans.	[Aoki, Masayuki; Kubo, Michiaki] RIKEN, Ctr Genom Med, Res Grp Genotyping, Yokohama, Kanagawa, Japan; [Kumasaka, Natsuhiko; Okada, Yukinori; Takahashi, Atsushi] RIKEN, Ctr Genom Med, Res Grp Med Informat, Tokyo, Japan; [Ozaki, Kouichi; Hirota, Tomomitsu; Tamari, Mayumi; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Res Grp Dis Causing Mech, Yokohama, Kanagawa, Japan; [Mushiroda, Taisei; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Res Grp Pharmacogen, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; University of Tokyo	Kubo, M (corresponding author), RIKEN, Ctr Genom Med, Res Grp Genotyping, Yokohama, Kanagawa, Japan.	mkubo@src.riken.jp	Tanaka, Toshihiro/J-9310-2014; Mushiroda, Taisei/E-3022-2010; Kubo, Michiaki/N-7947-2015; Tamari, Mayumi/N-5378-2015	Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was conducted as a part of the BioBank Japan Project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all technical staff of BioBank Japan Project and Laboratory for Genotyping Development at RIKEN for SNP genotyping. This work was conducted as a part of the BioBank Japan Project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DEMPSTER ER, 1950, GENETICS, V35, P212; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Ikeda F, 2011, TOB CONTROL; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumasaka N, 2011, GENET EPIDEMIOL, V35, P831, DOI 10.1002/gepi.20633; Kumasaka N, 2010, J HUM GENET, V55, P525, DOI 10.1038/jhg.2010.63; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLachlan GJ, 1997, EM ALGORITHM EXTENSI; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; QUESENBERRY CP, 1980, J STAT COMPUT SIM, V11, P41, DOI 10.1080/00949658008810388; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schoedel KA, 2004, PHARMACOGENETICS, V14, P615, DOI 10.1097/00008571-200409000-00006; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Swan GE, 2005, PHARMACOGENET GENOM, V15, P115, DOI 10.1097/01213011-200502000-00007; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	38	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44507	10.1371/journal.pone.0044507	http://dx.doi.org/10.1371/journal.pone.0044507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049750	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100015
J	Park, HS; Ni, M; Jeong, KC; Kim, YH; Yu, JH				Park, Hee-Soo; Ni, Min; Jeong, Kwang Cheol; Kim, Young Hwan; Yu, Jae-Hyuk			The Role, Interaction and Regulation of the Velvet Regulator VelB in Aspergillus nidulans	PLOS ONE			English	Article							SECONDARY METABOLISM; TRANSCRIPTION FACTOR; ASEXUAL SPORULATION; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; STRESS-RESPONSE; GENE ENCODES; TREHALOSE; FUMIGATUS; ABAA	The multifunctional regulator VelB physically interacts with other velvet regulators and the resulting complexes govern development and secondary metabolism in the filamentous fungus Aspergillus nidulans. Here, we further characterize VelB's role in governing asexual development and conidiogenesis in A. nidulans. In asexual spore formation, velB deletion strains show reduced number of conidia, and decreased and delayed mRNA accumulation of the key asexual regulatory genes brlA, abaA, and vosA. Overexpression of velB induces a two-fold increase of asexual spore production compared to wild type. Furthermore, the velB deletion mutant exhibits increased conidial germination rates in the presence of glucose, and rapid germination of conidia in the absence of external carbon sources. In vivo immuno-pull-down analyses reveal that VelB primarily interacts with VosA in both asexual and sexual spores, and VelB and VosA play an inter-dependent role in spore viability, focal trehalose biogenesis and control of conidial germination. Genetic and in vitro studies reveal that AbaA positively regulates velB and vosA mRNA expression during sporogenesis, and directly binds to the promoters of velB and vosA. In summary, VelB acts as a positive regulator of asexual development and regulates spore maturation, focal trehalose biogenesis and germination by interacting with VosA in A. nidulans.	[Park, Hee-Soo; Ni, Min; Jeong, Kwang Cheol; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol & Genet, Madison, WI 53706 USA; [Park, Hee-Soo; Yu, Jae-Hyuk] Univ Wisconsin, Dept Mol & Environm Toxicol Ctr, Madison, WI USA; [Kim, Young Hwan] Korea Basic Sci Inst, Mass Spectrometry Team, Mass Spectrometry Res Ctr, Taejon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Basic Science Institute (KBSI)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol & Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Young Hwan/AAA-5484-2022; Park, Hee-Soo/AAC-6422-2019; Yu, Jae-Hyuk/A-2343-2008	Kim, Young Hwan/0000-0003-3478-8839; Yu, Jae-Hyuk/0000-0002-6530-8407	National Science Foundation [IOS-0950850]; USDA CSREES Hatch [WIS01195]; UW Food Research Institute; UW FRI Foster Award; Korea Government (MOEHRD) [KRF-2007-612-E00010]; Korea Basic Science Institute [G30123]; Korea Research Foundation; Division Of Integrative Organismal Sys [0950850] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA CSREES Hatch(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); UW Food Research Institute; UW FRI Foster Award; Korea Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea Basic Science Institute; Korea Research Foundation(National Research Foundation of Korea); Division Of Integrative Organismal Sys(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS-0950850), USDA CSREES Hatch (WIS01195) and UW Food Research Institute grants to JHY. HSP was in part supported by the UW FRI Foster Award and Korea Research Foundation Grant funded by the Korea Government (MOEHRD) (KRF-2007-612-E00010). Y. H. Kim was supported by a grant of Korea Basic Science Institute (G30123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1990, MOL CELL BIOL, V10, P4912, DOI 10.1128/MCB.10.9.4912; ADAMS TH, 1990, P NATL ACAD SCI USA, V87, P5405, DOI 10.1073/pnas.87.14.5405; ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; AGUIRRE J, 1993, MOL MICROBIOL, V8, P211, DOI 10.1111/j.1365-2958.1993.tb01565.x; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kim JY, 2008, MOL CELL PROTEOMICS, V7, P431, DOI 10.1074/mcp.M700194-MCP200; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee J, 2012, MICROBIOLOGY; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Park BC, 2003, FEMS MICROBIOL LETT, V220, P241, DOI 10.1016/S0378-1097(03)00120-4; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Seo JA, 2003, GENETICS, V165, P1083; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shin KS, 2009, CURR GENET, V55, P631, DOI 10.1007/s00294-009-0276-4; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2006, J MICROBIOL, V44, P145; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	51	19	28	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45935	10.1371/journal.pone.0045935	http://dx.doi.org/10.1371/journal.pone.0045935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049895	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100102
J	Peris, D; Lopes, CA; Arias, A; Barrio, E				Peris, David; Lopes, Christian A.; Arias, Armando; Barrio, Eladio			Reconstruction of the Evolutionary History of Saccharomyces cerevisiae x S-kudriavzevii Hybrids Based on Multilocus Sequence Analysis	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; NATURAL HYBRIDS; WINE YEAST; MOLECULAR CHARACTERIZATION; WILD; STRAINS; IDENTIFICATION; POPULATIONS; EXPRESSION; NETWORKS	In recent years, interspecific hybridization and introgression are increasingly recognized as significant events in the evolution of Saccharomyces yeasts. These mechanisms have probably been involved in the origin of novel yeast genotypes and phenotypes, which in due course were to colonize and predominate in the new fermentative environments created by human manipulation. The particular conditions in which hybrids arose are still unknown, as well as the number of possible hybridization events that generated the whole set of natural hybrids described in the literature during recent years. In this study, we could infer at least six different hybridization events that originated a set of 26 S. cerevisiae x S. kudriavzevii hybrids isolated from both fermentative and non-fermentative environments. Different wine S. cerevisiae strains and European S. kudriavzevii strains were probably involved in the hybridization events according to gene sequence information, as well as from previous data on their genome composition and ploidy. Finally, we postulate that these hybrids may have originated after the introduction of vine growing and winemaking practices by the Romans to the present Northern vine-growing limits and spread during the expansion of improved viticulture and enology practices that occurred during the Late Middle Ages.	[Lopes, Christian A.; Barrio, Eladio] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain; [Peris, David; Arias, Armando] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Lopes, Christian A.] Univ Nacl Comahue, Fac Ingn & Ciencias Agr, Inst Multidisciplinario Invest & Desarrollo Patag, Grp Biodiversidad & Biotecnol Levaduras, Neuquen, Argentina; [Arias, Armando] Univ Guadalajara, CUCBA, Unidad Bot & Zool, Lab Biotecn, Zapopan, Jalisco, Mexico; [Barrio, Eladio] Univ Valencia, Dept Genet, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia; Universidad Nacional del Comahue; Universidad de Guadalajara; University of Valencia	Barrio, E (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	eladio.barrio@uv.es	David, Peris/K-8393-2018; Garcia, Armando Arias/AAS-4810-2020; Peris, David/GQB-3861-2022; Barrio, Eladio/G-8969-2015; Arias, Armando/ABH-6081-2020	David, Peris/0000-0001-9912-8802; Barrio, Eladio/0000-0003-1024-954X; Arias, Armando/0000-0002-7474-1878	Spanish Government project [AGL2009-12673-CO2-02]; Generalitat Valenciana grant [PROMETEO/2009/019]; Spanish Government FPI fellowship; Spanish Government postdoctoral contract; Mexican Government PROMEP fellowship	Spanish Government project(Spanish Government); Generalitat Valenciana grant(Center for Forestry Research & Experimentation (CIEF)); Spanish Government FPI fellowship; Spanish Government postdoctoral contract; Mexican Government PROMEP fellowship	This work was supported by Spanish Government project AGL2009-12673-CO2-02 to EB, and Generalitat Valenciana grant PROMETEO/2009/019. DP, CL and AA acknowledge a Spanish Government FPI fellowship, a Spanish Government postdoctoral contract, and a Mexican Government PROMEP fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; Arias A, 2008, DIVERSIDAD GENETICA; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Arroyo-Lopez FN, 2010, YEAST, V27, P1005, DOI 10.1002/yea.1809; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Burton Janet, 2011, CISTERCIANS MIDDLE A; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CORRAN H. S., 1975, HIST BREWING; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Erny C, 2012, APPL ENV MICROBIOL; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Felsenstein Joe, 2005, PHYLIP PHYLOGENY INF; Gangl H, 2009, NEW BIOTECHNOL, V25, P244, DOI 10.1016/j.nbt.2008.10.001; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2007, INT J FOOD MICROBIOL, V116, P11, DOI 10.1016/j.ijfoodmicro.2006.10.047; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Huson DH, 2004, IEEE ACM T COMPUT BI, V1, P151, DOI 10.1109/TCBB.2004.44; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; Joly S, 2004, MOL BIOL EVOL, V21, P1409, DOI 10.1093/molbev/msh140; Kodama Y, 2006, TOP CURR GENET, V15, P145, DOI 10.1007/b106370; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopandic K, 2007, FEMS YEAST RES, V7, P953, DOI 10.1111/j.1567-1364.2007.00240.x; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; McGovern, 2010, UNCORKING QUEST WINE; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; MCGOVERN PE, 1997, EXPEDITION, V39, P3; MICHEL RH, 1992, NATURE, V360, P24, DOI 10.1038/360024b0; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Myers CL, 2004, BIOINFORMATICS, V20, P3533, DOI 10.1093/bioinformatics/bth440; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Naumov GI, 2002, APPL MICROBIOL BIOT, V59, P727, DOI 10.1007/s00253-002-1077-6; Naumov GI, 2001, INT J FOOD MICROBIOL, V65, P163, DOI 10.1016/S0168-1605(00)00515-8; Arroyo-Lopez FN, 2009, INT J FOOD MICROBIOL, V131, P120, DOI 10.1016/j.ijfoodmicro.2009.01.035; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Perez-Traves L, 2012, INT J FOOD MICROBIOL, V156, P102, DOI 10.1016/j.ijfoodmicro.2012.03.008; Peris D, 2012, BMC GENOMIC IN PRESS; Peris D, 2012, YEAST, V29, P81, DOI 10.1002/yea.2891; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salvado Z, 2011, APPL ENVIRON MICROB, V77, P2292, DOI 10.1128/AEM.01861-10; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Staden R, 2000, Methods Mol Biol, V132, P115; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Whitfield JB, 2008, SYST BIOL, V57, P939, DOI 10.1080/10635150802552849; Zambonelli C, 1997, J SCI FOOD AGR, V74, P7, DOI 10.1002/(SICI)1097-0010(199705)74:1<7::AID-JSFA753>3.3.CO;2-O	75	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45527	10.1371/journal.pone.0045527	http://dx.doi.org/10.1371/journal.pone.0045527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049811	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100054
J	Wu, F; Guclu, H				Wu, Felicia; Guclu, Hasan			Aflatoxin Regulations in a Network of Global Maize Trade	PLOS ONE			English	Article							PUBLIC-HEALTH; EXPOSURE; GROWTH	Worldwide, food supplies often contain unavoidable contaminants, many of which adversely affect health and hence are subject to regulations of maximum tolerable levels in food. These regulations differ from nation to nation, and may affect patterns of food trade. We soughtto determine whether there is an association between nations' food safety regulations and global food trade patterns, with implications for public health and policymaking. We developed a network model of maize trade around the world. From maize import/export data for 217 nations from 2000-2009, we calculated basic statistics on volumes of trade; then examined how regulations of aflatoxin, a common contaminant of maize, are similar or different between pairs of nations engaging in significant amounts of maize trade. Globally, market segregation appears to occur among clusters of nations. The United States is at the center of one cluster; European countries make up another cluster with hardly any maize trade with the US; and Argentina, Brazil, and China export maize all over the world. Pairs of nations trading large amounts of maize have very similar aflatoxin regulations: nations with strict standards tend to trade maize with each other, while nations with more relaxed standards tend to trade maize with each other. Rarely among the top pairs of maize-trading nations do total aflatoxin standards (standards based on the sum of the levels of aflatoxins B-1, B-2, G(1), and G(2)) differ by more than 5 mu g/kg. These results suggest that, globally, separate maize trading communities emerge; and nations tend to trade with other nations that have very similar food safety standards.	[Wu, Felicia] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Guclu, Hasan] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Guclu, Hasan] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, F (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA.	few8@pitt.edu	Guclu, Hasan/B-7080-2008	Guclu, Hasan/0000-0003-3582-9460	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [5R01CA153073-2.]; NATIONAL CANCER INSTITUTE [R01CA153073] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), Grant No. 5R01CA153073-2. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boddiger D, 2007, LANCET, V370, P923, DOI 10.1016/S0140-6736(07)61427-5; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; De Nooy W., 2005, EXPLORATORY SOCIAL N; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; FAO, 2004, WORLDW REG MYC FOOD; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; Henry SH, 1999, SCIENCE, V286, P2453, DOI 10.1126/science.286.5449.2453; Jaffee S., 2005, FOOD SAFETY AGR HLTH; *JECFA, 1998, WHO FOOD ADD SER, V40; Jolly P. E., 2008, Mycotoxins: detection methods, management, public health and agricultural trade, P41, DOI 10.1079/9781845930820.0041; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kuniholm MH, 2008, ENVIRON HEALTH PERSP, V116, P1553, DOI 10.1289/ehp.11661; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Lyons R, 2011, STAT POLITICS POLICY, V2, pA2; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Otsuki T, 2001, FOOD POLICY, V26, P495, DOI 10.1016/S0306-9192(01)00018-5; Petroczi A, 2011, WORLD MYCOTOXIN J, V4, P329, DOI 10.3920/WMJ2010.1271; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Egmond HP, 2007, ANAL BIOANAL CHEM, V389, P147, DOI 10.1007/s00216-007-1317-9; Wu F, 2008, WORLD MYCOTOXIN J, V1, P95, DOI 10.3920/WMJ2008.x011; Wu F, 2004, ENVIRON SCI TECHNOL, V38, P4049, DOI 10.1021/es035353n	25	76	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45151	10.1371/journal.pone.0045151	http://dx.doi.org/10.1371/journal.pone.0045151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049773	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000309556100030
J	Yagi-Utsumi, M; Yoshikawa, S; Yamaguchi, Y; Nishi, Y; Kurimoto, E; Ishida, Y; Homma, T; Hoseki, J; Nishikawa, Y; Koide, T; Nagata, K; Kato, K				Yagi-Utsumi, Maho; Yoshikawa, Sumi; Yamaguchi, Yoshiki; Nishi, Yohei; Kurimoto, Eiji; Ishida, Yoshihito; Homma, Takayuki; Hoseki, Jun; Nishikawa, Yoshimi; Koide, Takaki; Nagata, Kazuhiro; Kato, Koichi			NMR and Mutational Identification of the Collagen-Binding Site of the Chaperone Hsp47	PLOS ONE			English	Article							SHOCK-PROTEIN 47; MOLECULAR CHAPERONE; TRIPLE-HELIX; EXPRESSION; LIVER; BIOSYNTHESIS; RECOGNITION	Heat shock protein 47 (Hsp47) acts as a client-specific chaperone for collagen and plays a vital role in collagen maturation and the consequent embryonic development. In addition, this protein can be a potential target for the treatment of fibrosis. Despite its physiological and pathological importance, little is currently known about the collagen-binding mode of Hsp47 from a structural aspect. Here, we describe an NMR study that was conducted to identify the collagen-binding site of Hsp47. We used chicken Hsp47, which has higher solubility than its human counterpart, and applied a selective N-15-labeling method targeting its tryptophan and histidine residues. Spectral assignments were made based on site-directed mutagenesis of the individual residues. By inspecting the spectral changes that were observed upon interaction with a trimeric collagen peptide and the mutational data, we successfully mapped the collagen-binding site in the B/C beta-barrel domain and a nearby loop in a 3D-homology model based upon a serpin fold. This conclusion was confirmed by mutational analysis. Our findings provide a molecular basis for the design of compounds that target the interaction between Hsp47 and procollagen as therapeutics for fibrotic diseases.	[Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448585, Japan; [Yagi-Utsumi, Maho; Yoshikawa, Sumi; Yamaguchi, Yoshiki; Nishi, Yohei; Kurimoto, Eiji; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Yamaguchi, Yoshiki] RIKEN, Syst Glycobiol Res Grp, Dept Biol Chem, Adv Sci Inst, Wako, Saitama, Japan; [Kurimoto, Eiji] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Ishida, Yoshihito; Homma, Takayuki] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Hoseki, Jun; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kyoto 603, Japan; [Nishikawa, Yoshimi; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; RIKEN; Meijo University; Kyoto University; Kyoto Sangyo University; Waseda University	Kato, K (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	kkatonmr@ims.ac.jp	Hoseki, Jun/AAE-6704-2020; Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439; Yagi-Utsumi, Maho/0000-0001-8144-740X; Kato, Koichi/0000-0001-7187-9612	Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [20059030];  [21370050]	Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (20059030, 21370050) (http://www.jsps.go.jp/english/e-grants/index.html) and the Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (https://nanonet.nims.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brown KE, 2005, LAB INVEST, V85, P789, DOI 10.1038/labinvest.3700271; Dafforn TR, 2001, J BIOL CHEM, V276, P49310, DOI 10.1074/jbc.M108896200; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nishida N, 2006, J BIOCHEM, V140, P591, DOI 10.1093/jb/mvj188; Ragg H, 2007, CELL MOL LIFE SCI, V64, P2763, DOI 10.1007/s00018-007-7157-0; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sunamoto M, 1998, INT J EXP PATHOL, V79, P133, DOI 10.1046/j.1365-2613.1998.00061.x; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Yagi-Utsumi Maho, 2010, Int J Alzheimers Dis, V2011, P925073, DOI 10.4061/2011/925073	22	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45930	10.1371/journal.pone.0045930	http://dx.doi.org/10.1371/journal.pone.0045930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049894	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100101
J	Ma, L; Dong, FM; Zaid, M; Kumar, A; Zha, XH				Ma, Loretta; Dong, Fumin; Zaid, Maryam; Kumar, Ashok; Zha, Xiaohui			ABCA1 Protein Enhances Toll-like Receptor 4 (TLR4)-stimulated Interleukin-10 (IL-10) Secretion through Protein Kinase A (PKA) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-CHOLESTEROL ACCUMULATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LIPID RAFTS; IN-VIVO; MACROPHAGES; TRANSPORTER; ATHEROSCLEROSIS; HDL; RETENTION	Nonresolving inflammatory response from macrophages is a major characteristic of atherosclerosis. Macrophage ABCA1 has been previously shown to suppress the secretion of proinflammatory cytokine. In the present study, we demonstrate that ABCA1 also promotes the secretion of IL-10, an anti-inflammatory cytokine critical for inflammation resolution. ABCA1(+/+) bone marrow-derived macrophages secrete more IL-10 but less proinflammatory cytokines than ABCA1(-/-) bone marrow-derived macrophages, similar to alternatively activated ( M2) macrophages. We present evidence that ABCA1 activates PKA and that this elevated PKA activity contributes to M2-like inflammatory response from ABCA1(+/+) bone marrow-derived macrophages. Furthermore, cholesterol lowering by statins, methyl-beta-cyclodextrin, or filipin also activates PKA and, consequently, transforms macrophages toward M2-like phenotype. Conversely, cholesterol enrichment suppresses PKA activity and promotes M1-like inflammatory response. As the primary function of ABCA1 is cholesterol removal, our results suggest that ABCA1 activates PKA by regulating cholesterol. Indeed, forced cholesterol enrichment in ABCA1-expressing macrophages suppresses PKA activation and elicits M1-like response. Collectively, these findings reveal a novel protective process by ABCA1-activated PKA in macrophages. They also suggest cholesterol lowering in extra-hepatic tissues by statins as an anti-inflammation strategy.	[Ma, Loretta; Zaid, Maryam; Zha, Xiaohui] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Dong, Fumin; Zha, Xiaohui] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kumar, Ashok] Childrens Hosp E Ontario, Ottawa, ON K1H 8L6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Zha, XH (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	xzha@ohri.ca			Heart and Stroke Foundation of Ontario [T 7054]; Bell Canada Graduate Scholarship	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Bell Canada Graduate Scholarship	This work was supported by a grant from the Heart and Stroke Foundation of Ontario (Grant T 7054).; Supported by a Bell Canada Graduate Scholarship.	Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Attie AD, 2001, J LIPID RES, V42, P1717; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Gao XL, 2012, MOL BIOL CELL, V23, P503, DOI 10.1091/mbc.E11-07-0658; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Ma L, 2011, J BIOL CHEM, V286, P3370, DOI 10.1074/jbc.M110.173666; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Oram JF, 2001, J LIPID RES, V42, P1173; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; PITHA J, 1988, LIFE SCI, V43, P493, DOI 10.1016/0024-3205(88)90150-6; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Pradel LC, 2009, EUR J IMMUNOL, V39, P2270, DOI 10.1002/eji.200838867; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	34	43	52	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40502	40512		10.1074/jbc.M112.413245	http://dx.doi.org/10.1074/jbc.M112.413245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055522	Green Published, hybrid			2022-12-25	WOS:000311448800041
J	Ohto, U; Yamakawa, N; Akashi-Takamura, S; Miyake, K; Shimizu, T				Ohto, Umeharu; Yamakawa, Natsuko; Akashi-Takamura, Sachiko; Miyake, Kensuke; Shimizu, Toshiyuki			Structural Analyses of Human Toll-like Receptor 4 Polymorphisms D299G and T399I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TLR4 POLYMORPHISMS; ENDOTOXIN; MD-2; RESPONSIVENESS; MUTATIONS; BACTERIAL; VARIANT; SEPSIS	Toll-like receptor 4 (TLR4) and its coreceptor MD-2 recognize bacterial lipopolysaccharide (LPS) and signal the innate immune response. Two single nucleotide polymorphisms (SNPs) of human TLR4, D299G and T399I, have been identified and suggested to be associated with LPS hyporesponsiveness. Moreover, the SNPs have been proposed to be associated with a variety of infectious and noninfectious diseases. However, how the SNPs affect the function of TLR4 remains largely unknown. Here, we report the crystal structure of the human TLR4 (D299G/T399I).MD-2.LPS complex at 2.4 angstrom resolution. The ternary complex exhibited an agonistic "m"-shaped 2: 2: 2 architecture that was similar to that of the human wild type TLR4.MD2.LPS complex. Local structural differences that might affect the binding of the ligands were observed around D299G, but not around T399I, SNP site.	[Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamakawa, Natsuko; Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; University of Tokyo; RIKEN	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [3106]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (B) and Grant-in-Aid for Scientific Research on Innovative Areas (3106) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yamakawa N., 2012, INT IMMUNOL IN PRESS	34	100	103	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40611	40617		10.1074/jbc.M112.404608	http://dx.doi.org/10.1074/jbc.M112.404608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055527	Green Published, hybrid			2022-12-25	WOS:000311448800050
J	Wei, CG; Shi, JW; Liu, B; Shi, Y; Zheng, JT; Xu, GY; Ma, JS; Wang, GQ; Li, F				Wei, Chengguo; Shi, Jingwei; Liu, Bin; Shi, Yue; Zheng, Jingtong; Xu, Guangyu; Ma, Jinshu; Wang, Guoqing; Li, Fan			Molecular Characterization of the Measles Virus Genotypes in JiLin Province, China	PLOS ONE			English	Article							POPULATION-DYNAMICS; EPIDEMIOLOGY; INFERENCE; STRAINS	Measles remains a severe global health threat, and nearly 30 million new cases are reported annually. Although many studies have analyzed measles viruses (MV) at the epidemiologic and phylogenetic levels, no study has yet to integrate these two types of data. To this end, we isolated 16 wild-type MV strains China's Jilin province. The MV genotype H1 was the most prevalent strain. After sequencing the nucleoprotein (N) genes of these strains, a maximum clade credibility tree was constructed by the Bayesian Markov Chain Monte Carlo method using 450 MV strains from GenBank with epidemiological information. The MV N gene evolution rate was 1.127E-3. Analysis of the time of the most recent common ancestor (TMRCA) for genotypes A/B/C/G/H revealed that genotypes D and B had the largest and smallest TMRCA (45.86 and 26.63, respectively). The highest level of genetic diversity for the MV N gene occurred around the year 2000. Here in this study, we uncovered the MV genotypes circulating in China's Jilin Province and estimated the epidemiologic and phylogenetic relationship for the six different genotypes of MV.	[Wei, Chengguo; Shi, Jingwei; Shi, Yue; Zheng, Jingtong; Xu, Guangyu; Ma, Jinshu; Wang, Guoqing; Li, Fan] Jilin Univ, Dept Pathogeny Biol, Norman Bethune Med Coll, Changchun 130023, Jilin, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Changchun 130023, Jilin, Peoples R China; [Liu, Bin] Jilin Univ, Bethune Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, GQ (corresponding author), Jilin Univ, Dept Pathogeny Biol, Norman Bethune Med Coll, Changchun 130023, Jilin, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Basic Research Program of China (973 program) [2011CB512003]; Graduate Innovation Fund of Jilin University [20121125]; National Natural Science Foundation of China [81071424]; Ministry of Education Major Science and Technology Innovation Program Seed Foundation [707020]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Graduate Innovation Fund of Jilin University(Jilin University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Major Science and Technology Innovation Program Seed Foundation	This work was supported by National Basic Research Program of China (973 program, 2011CB512003) and Graduate Innovation Fund of Jilin University(Project No. 20121125). It was also supported in part by National Natural Science Foundation of China (81071424) and The Ministry of Education Major Science and Technology Innovation Program Seed Foundation (707020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P125; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Chibo D, 2002, EMERG INFECT DIS, V8, P735, DOI 10.3201/eid0807.010409; Comert Serdar, 2006, Indian Journal of Pediatrics, V73, P1119, DOI 10.1007/BF02763061; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; de Swart RL, 2000, LANCET, V355, P201, DOI 10.1016/S0140-6736(99)04652-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; El Mubarak HS, 2002, J GEN VIROL, V83, P1437, DOI 10.1099/0022-1317-83-6-1437; Hilleman MR, 2001, VACCINE, V20, P651, DOI 10.1016/S0264-410X(01)00384-X; Jin L, 1998, EPIDEMIOL INFECT, V121, P691, DOI 10.1017/S0950268898001666; Jin L, 2002, J NEUROVIROL, V8, P335, DOI 10.1080/13550280290100752; Kubo H, 2003, J MED VIROL, V69, P273, DOI 10.1002/jmv.10278; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Niedermeyer HP, 2007, ADV OTO-RHINO-LARYNG, V65, P86, DOI 10.1159/000098676; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Rota PA, 2002, EMERG INFECT DIS, V8, P902, DOI 10.3201/eid0809.020206; Schneider-Schaulies Sibylle, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004696; Tamura K, MOL BIOL EVOL; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; WHO, 2005, Wkly Epidemiol Rec, V80, P347; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	28	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46011	10.1371/journal.pone.0046011	http://dx.doi.org/10.1371/journal.pone.0046011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056226	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500023
J	Qing, LY; Xia, Y; Zheng, YC; Zeng, XM				Qing, Liyan; Xia, Yun; Zheng, Yuchi; Zeng, Xiaomao			A De Novo Case of Floating Chromosomal Polymorphisms by Translocation in Quasipaa boulengeri (Anura, Dicroglossidae)	PLOS ONE			English	Article							RECIPROCAL TRANSLOCATION; MAXIMUM-LIKELIHOOD; INTERCHANGE; FREQUENCY; PHYLOGENETICS; HYBRIDIZATION; ORIENTATION; HYBRIDITY; SELECTION; BEHAVIOR	Very few natural polymorphisms involving interchromosomal reciprocal translocations are known in amphibians even in vertebrates. In this study, thirty three populations, including 471 individuals of the spiny frog Quasipaa boulengeri, were karyotypically examined using Giemsa stain or FISH. Five different karyomorphs were observed. The observed heteromorphism was autosomal but not sex-related, as the same heteromorphic chromosomes were found both in males and females. Our results indicated that the variant karyotypes resulted from a mutual interchange occurring between chromosomes 1 and 6. The occurrence of a nearly whole-arm translocation between chromosome no. 1 and no. 6 gave rise to a high frequency of alternate segregation and probably resulted in the maintenance of the translocation polymorphisms in a few populations. The translocation polymorphism is explained by different frequencies of segregation modes of the translocation heterozygote during meiosis. Theoretically, nine karyomorphs should be investigated, however, four expected karyotypes were not found. The absent karyomorphs may result from recessive lethal mutations, position effects, duplications and deficiencies. The phylogenetic inference proved that all populations of Q. boulengeri grouped into a monophyletic clade. The mutual translocation likely evolved just once in this species and the dispersal of the one karyomorph (type IV) can explain the chromosomal variations among populations.	[Qing, Liyan; Xia, Yun; Zheng, Yuchi; Zeng, Xiaomao] Chinese Acad Sci, Dept Herpetol, Chengdu Inst Biol, Chengdu, Peoples R China; [Qing, Liyan; Xia, Yun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zeng, XM (corresponding author), Chinese Acad Sci, Dept Herpetol, Chengdu Inst Biol, Chengdu, Peoples R China.	zengxm@cib.ac.cn	Xia, Yun/T-1095-2017	Xia, Yun/0000-0002-3039-0527; Zeng, Xiaomao/0000-0002-1952-2170; Zheng, Yuchi/0000-0002-1155-5293	National Natural Science Foundation of China (NSFC) [31272282]; Chinese Academy of Sciences (CAS) [KSCX2-EW-J-22]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was partly supported by The National Natural Science Foundation of China (NSFC) 31272282 (http://www.nsfc.gov.cn/Portal0/default152.htm) and Chinese Academy of Sciences (CAS) KSCX2-EW-J-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi Ke, 2009, Current Zoology, V55, P145; Blakeslee AF, 1927, Z INDUKT ABSTAMM L S, P117; BLOOM WL, 1974, CHROMOSOMA, V49, P61; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; CARTER T. C, 1955, JOUR GENETICS, V53, P154, DOI 10.1007/BF02981519; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chen Wenyuan, 1983, Zoological Research, V4, P83; CHIARELLI A. B., 1973, CYTOTAXONOMY VERTEBR; Cleland RE, 1926, BOT GAZ, V82, P55, DOI 10.1086/333633; DARLINGTON C. D., 1937; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fodor A., 1985, Journal of Genetics, V64, P143, DOI 10.1007/BF02931143; FUTUYMA DJ, 1997, EVOLUTIONARY BIOL; GOHIL RN, 1978, CYTOLOGIA, V43, P243, DOI 10.1508/cytologia.43.243; GOSALVEZ J, 1982, CHROMOSOMA, V86, P49, DOI 10.1007/BF00330729; Hartl DL, 1998, GENETICS PRINCIPLES; Hu JS, 2004, MOL PHYLOGENETIC STU; JAMES SH, 1970, HEREDITY, V25, P53, DOI 10.1038/hdy.1970.6; JOHN B, 1963, CHROMOSOMA, V14, P638, DOI 10.1007/BF00326516; KAUFMAN TC, 1978, GENETICS, V90, P579; KAUL D, 1981, GENETICA, V54, P241, DOI 10.1007/BF00135041; Kingston HM, 2002, ABC CLIN GENETICS; Koul A, 1966, J CYTOL GENET, V1, P87; LACHANCE LE, 1964, GENETICS, V49, P959; LANDE R, 1979, EVOLUTION, V33, P234, DOI 10.1111/j.1558-5646.1979.tb04678.x; LAWRENCE CW, 1963, GENETICS, V48, P347; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; LEWIS K. R., 1957, HEREDITY, V11, P11, DOI 10.1038/hdy.1957.2; Li Shushen, 1996, Zoological Research, V17, P84; Li SS, 1999, CHINA ZOOLOGICAL SOC, P976; MCKIM KS, 1988, GENETICS, V120, P987; Muller HJ, 1930, GENETICS, V15, P283; Nai WH, 1999, HEREDITAS BEIJING, V21, P1; Pierce BA, 2002, GENETICS CONCEPTUAL; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRICE S, 1955, GENETICS, V40, P651; RICKARDS GK, 1983, ANNU REV GENET, V17, P443, DOI 10.1146/annurev.ge.17.120183.002303; Roberts PA, 1976, GENETICS BIOL DROS A, P68; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 2001, MOL CLONING LAB MANU; Schmid M, 2004, CYTOGENET GENOME RES, V104, P277, DOI 10.1159/000077502; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; SHALEV A, 1976, CHROMOSOMA, V57, P297, DOI 10.1007/BF00295214; Siqueira S, 2004, GENET MOL BIOL, V27, P363, DOI 10.1590/S1415-47572004000300010; Smith L, 1941, J AGRIC RES, V63, P0741; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUN S, 1967, HEREDITY, V22, P249, DOI 10.1038/hdy.1967.30; SYREN RM, 1981, CHROMOSOMA, V82, P65, DOI 10.1007/BF00285750; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang D, 2006, CHROMOSOME RES PAA B; Wang Z., 1983, Acta Herpetologica Sinica, V2, P1; WHITE M J D, 1973, P961; Yosida T. H., 1980, CYTOGENETICS BLACK R; Zhang JY, 1997, J GUIZHOU NORMAL U N, V15, P48; Zhang LL, 2007, GENETICA, V130, P193, DOI 10.1007/s10709-006-9006-8; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009	61	14	18	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46163	10.1371/journal.pone.0046163	http://dx.doi.org/10.1371/journal.pone.0046163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056254	gold, Green Published, Green Submitted			2022-12-25	WOS:000309454000021
J	Rao, M; Song, WQ; Jiang, AX; Shyr, Y; Lev, S; Greenstein, D; Brantley-Sieders, D; Chen, J				Rao, Meghana; Song, Wenqiang; Jiang, Aixiang; Shyr, Yu; Lev, Sima; Greenstein, David; Brantley-Sieders, Dana; Chen, Jin			VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; METASTATIC PROGRESSION; FFAT MOTIF; MEMBRANE; CANCER; EXPRESSION; TRANSPORT; ER; IDENTIFICATION; TRAFFICKING	VAPB (VAMP- associated protein B) is an ER protein that regulates multiple biological functions. Although aberrant expression of VAPB is associated with breast cancer, its function in tumor cells is poorly understood. In this report, we provide evidence that VAPB regulates breast tumor cell proliferation and AKT activation. VAPB protein expression is elevated in primary and metastatic tumor specimens, and VAPB mRNA expression levels correlated negatively with patient survival in two large breast tumor datasets. Overexpression of VAPB in mammary epithelial cells increased cell growth, whereas VAPB knockdown in tumor cells inhibited cell proliferation in vitro and suppressed tumor growth in orthotopic mammary gland allografts. The growth regulation of mammary tumor cells controlled by VAPB appears to be mediated, at least in part, by modulation of AKT activity. Overexpression of VAPB in MCF10A-HER2 cells enhances phosphorylation of AKT. In contrast, knockdown of VAPB in MMTV-Neu tumor cells inhibited pAKT levels. Pharmacological inhibition of AKT significantly reduced three-dimensional spheroid growth induced by VAPB. Collectively, the genetic, functional and mechanistic analyses suggest a role of VAPB in tumor promotion in human breast cancer.	[Rao, Meghana; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Song, Wenqiang; Brantley-Sieders, Dana; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chen, Jin] Vanderbilt Univ, Sch Med, Dept Cellular & Dev Biol, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu; Chen, Jin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Chen, Jin] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Lev, Sima] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Greenstein, David] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities	Chen, J (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	jin.chen@vanderbilt.edu	Lev, Sima/AAP-7880-2020	Lev, Sima/0000-0002-2108-3330; Chen, Jin/0000-0002-5557-2079; Jiang, Aixiang/0000-0002-6153-7595; Greenstein, David/0000-0001-8189-2087	Department of Veterans Affairs (VA) through a VA Merit Award; National Institutes of Health [CA95004, CA114301, CA1179151, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Department of Defense predoctoral fellowship [W81XWH-10-1-0256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, P30CA068485, R01CA114301, R01CA095004] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057173, R01GM065115] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA) through a VA Merit Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense predoctoral fellowship(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Veterans Affairs (VA) through a VA Merit Award (JC), National Institutes of Health RO1 grants CA95004 & CA114301 (JC), a KO1 award CA1179151 (DBS), and a Department of Defense predoctoral fellowship W81XWH-10-1-0256 (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Vanderbilt Mass Spectrometry Research Center and Dr. Hayes McDonald for support on sample analyses and data interpretations and the Vanderbilt Translational Pathology Shared Resource for tumor section immunohistochemistry. Confocal microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). We also thank Mr. Yoonha Hwang for helping in generating some of the constructs. Temperature-sensitive VSVG-GFP construct was generously provided by Dr. Jennifer Lippencott-Swartz (National Institute of Health).	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Arriola E, 2008, LAB INVEST, V88, P491, DOI 10.1038/labinvest.2008.19; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lapierre LA, 1999, J CELL SCI, V112, P3723; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Moumen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026066; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46281	10.1371/journal.pone.0046281	http://dx.doi.org/10.1371/journal.pone.0046281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049696	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388500023
J	Eyupoglu, IY; Hore, N; Savaskan, NE; Grummich, P; Roessler, K; Buchfelder, M; Ganslandt, O				Eyuepoglu, Ilker Y.; Hore, Nirjhar; Savaskan, Nic E.; Grummich, Peter; Roessler, Karl; Buchfelder, Michael; Ganslandt, Oliver			Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach	PLOS ONE			English	Article							FLUORESCENCE-GUIDED RESECTION; ACID-INDUCED FLUORESCENCE; GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; FUNCTIONAL NEURONAVIGATION; ADJUVANT TEMOZOLOMIDE; CLINICAL ARTICLE; GRADE GLIOMAS; BRAIN-TUMORS; PHASE-III	Despite continuing debates around cytoreductive surgery in malignant gliomas, there is broad consensus that increased extent of tumor reduction improves overall survival. However, maximization of the extent of tumor resection is hampered by difficulty in intraoperative discrimination between normal and pathological tissue. In this context, two established methods for tumor visualization, fluorescence guided surgery with 5-ALA and intraoperative MRI (iMRI) with integrated functional neuronavigation were investigated as a dual intraoperative visualization (DIV) approach. Thirty seven patients presumably suffering from malignant gliomas (WHO grade III or IV) according to radiological appearance were included. Twenty-one experimental sequences showing complete resection according to the 5-ALA technique were confirmed by iMRI. Fourteen sequences showing complete resection according to the 5-ALA technique could not be confirmed by iMRI, which detected residual tumor. Further analysis revealed that these sequences could be classified as functional grade II tumors (adjacent to eloquent brain areas). The combination of fluorescence guided resection and intraoperative evaluation by high field MRI significantly increased the extent of tumor resection in this subgroup of malignant gliomas located adjacent to eloquent areas from 61.7% to 100%; 5-ALA alone proved to be insufficient in attaining gross total resection without the danger of incurring postoperative neurological deterioration. Furthermore, in the case of functional grade III gliomas, iMRI in combination with functional neuronavigation was significantly superior to the 5-ALA resection technique. The extent of resection could be increased from 57.1% to 71.2% without incurring postoperative neurological deficits.	[Eyuepoglu, Ilker Y.; Hore, Nirjhar; Savaskan, Nic E.; Grummich, Peter; Roessler, Karl; Buchfelder, Michael; Ganslandt, Oliver] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany	University of Erlangen Nuremberg	Eyupoglu, IY (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany.	ilker.eyupoglu@uk-erlangen.de	Rössler, Karl/AAN-5096-2021; Savaskan, Nicolai/D-2923-2018	Rössler, Karl/0000-0002-9249-8082; Eyupoglu, Ilker/0000-0002-8185-7764; Savaskan, Nicolai/0000-0003-1348-094X				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; De Witt Hamer PC, 2012, J CLIN ONCOL; Valle RD, 2011, J NEURO-ONCOL, V102, P105, DOI 10.1007/s11060-010-0296-4; Feigl GC, 2010, J NEUROSURG, V113, P352, DOI 10.3171/2009.10.JNS09447; Kleihues P., 2000, TUMOURS NERVOUS SYST; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Kreth FW, 1999, CANCER, V86, P2117, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2117::AID-CNCR33>3.3.CO;2-#; Kubben PL, 2011, LANCET ONCOL, V12, P1062, DOI 10.1016/S1470-2045(11)70130-9; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Liao HG, 2008, LECT NOTES COMPUT SC, V5242, P373, DOI 10.1007/978-3-540-85990-1_45; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Nimsky C, 2004, ADV TECH STAND NEUR, V29, P229; Nimsky C, 2006, NEUROL RES, V28, P482, DOI 10.1179/016164106X115125; ROBERTS DW, 2010, J NEUROSURG; Sanai N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09266; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Stepp H, 2007, J ENVIRON PATHOL TOX, V26, P157, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i2.110; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; STUMMER W, 2010, J NEUROSURG; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tsugu A, 2011, WORLD NEUROSURG, V76, P120, DOI 10.1016/j.wneu.2011.02.005; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466; Vuorinen V, 2003, ACTA NEUROCHIR, V145, P5, DOI 10.1007/s00701-002-1030-6; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2004, NEUROLOGY, V62, P2113, DOI 10.1212/01.WNL.0000127617.89363.84; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316	36	86	88	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44885	10.1371/journal.pone.0044885	http://dx.doi.org/10.1371/journal.pone.0044885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049761	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300013
J	Kriechbaumer, V; Nabok, A; Widdowson, R; Smith, DP; Abell, BM				Kriechbaumer, Verena; Nabok, Alexei; Widdowson, Robert; Smith, David P.; Abell, Ben M.			Quantification of Ligand Binding to G-Protein Coupled Receptors on Cell Membranes by Ellipsometry	PLOS ONE			English	Article							INTERNAL-REFLECTION ELLIPSOMETRY; SURFACE-PLASMON RESONANCE; CHEMOKINE RECEPTORS; CXCR4; RECONSTITUTION; GLYCOSYLATION; INHIBITION; CORECEPTOR; EXPRESSION; RESIDUES	G-protein-coupled receptors (GPCRs) are prime drug targets and targeted by approximately 60% of current therapeutic drugs such as beta-blockers, antipsychotics and analgesics. However, no biophysical methods are available to quantify their interactions with ligand binding in a native environment. Here, we use ellipsometry to quantify specific interactions of receptors within native cell membranes. As a model system, the GPCR-ligand CXCL12 alpha and its receptor CXCR4 are used. Human-derived Ishikawa cells were deposited onto gold coated slides via Langmuir-Schaefer film deposition and interactions between the receptor CXCR4 on these cells and its ligand CXCL12 alpha were detected via total internal reflection ellipsometry (TIRE). This interaction could be inhibited by application of the CXCR4-binding drug AMD3100. Advantages of this approach are that it allows measurement of interactions in a lipid environment without the need for labelling, protein purification or reconstitution of membrane proteins. This technique is potentially applicable to a wide variety of cell types and their membrane receptors, providing a novel method to determine ligand or drug interactions targeting GPCRs and other membrane proteins.	[Kriechbaumer, Verena; Widdowson, Robert; Smith, David P.; Abell, Ben M.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Alexei] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England	Sheffield Hallam University; Sheffield Hallam University	Kriechbaumer, V (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England.	vkriechbaumer@brookes.ac.uk	Nabok, Alexei/AAW-5758-2020; Kriechbaumer, Verena/AAW-9148-2020; Kriechbaumer, Verena/ABF-5534-2020	Kriechbaumer, Verena/0000-0003-3782-5834; Abell, Ben/0000-0002-0953-0046; Smith, David/0000-0001-5177-8574	European Plastic Surgery Research Council (EPSRC) [EP/H000275/1, EP/I016473/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E01559X/1]; BBSRC [BB/E01559X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01559X/1] Funding Source: researchfish	European Plastic Surgery Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Plastic Surgery Research Council (EPSRC) Engineering for Life research grant (number EP/H000275/1) and Feasibility Study grant (number EP/I016473/1), and a Biotechnology and Biological Sciences Research Council (BBSRC) research grant (number BB/E01559X/1) awarded to BMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arwin H, 2004, APPL OPTICS, V43, P3028, DOI 10.1364/AO.43.003028; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Davies S, 2000, BRIT J CANCER, V83, P1730, DOI 10.1054/bjoc.2000.1507; Emons G, 1997, TRENDS ENDOCRIN MET, V8, P355, DOI 10.1016/S1043-2760(97)00155-0; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Fuxe K, 2008, PHYSIOLOGY, V23, P322, DOI 10.1152/physiol.00028.2008; Gerlach LO, 2003, BIOCHEMISTRY-US, V42, P710, DOI 10.1021/bi0264770; Gonzalez-Maeso J, 2010, NAT NEUROSCI, V13, P524, DOI 10.1038/nn0510-524; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Jingami H, 2005, J MOL NEUROSCI, V26, P123, DOI 10.1385/JMN:26:2-3:123; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Kriechbaumer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034455; Kubarek L, 2007, FEBS LETT, V581, P1441, DOI 10.1016/j.febslet.2007.02.070; Liu X, 2003, ANAL BIOCHEM, V314, P301, DOI 10.1016/S0003-2697(02)00696-6; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Murdoch C, 2000, BLOOD, V95, P3032; Nabok A, 2011, SENSOR ACTUAT B-CHEM, V154, P232, DOI 10.1016/j.snb.2010.02.005; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Szekacs A, 2009, APPL OPTICS, V48, pB151, DOI 10.1364/AO.48.00B151; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tsutsumi A, 2011, FERTIL STERIL, V95, P444, DOI 10.1016/j.fertnstert.2010.08.037; Velez-Ruiz GA, 2011, METHODS MOL BIOL, V756, P167, DOI 10.1007/978-1-61779-160-4_8; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Woods AS, 2004, J PROTEOME RES, V3, P478, DOI 10.1021/pr034091l; Woollam J. A., 2002, GUIDE USING WVASE32; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	47	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46221	10.1371/journal.pone.0046221	http://dx.doi.org/10.1371/journal.pone.0046221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049983	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300098
J	Broyles, ST; Staiano, AE; Drazba, KT; Gupta, AK; Sothern, M; Katzmarzyk, PT				Broyles, Stephanie T.; Staiano, Amanda E.; Drazba, Kathryn T.; Gupta, Alok K.; Sothern, Melinda; Katzmarzyk, Peter T.			Elevated C-Reactive Protein in Children from Risky Neighborhoods: Evidence for a Stress Pathway Linking Neighborhoods and Inflammation in Children	PLOS ONE			English	Article							ADULT SOCIOECONOMIC-STATUS; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; OLDER-ADULTS; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; NATIONAL-HEALTH	Background: Childhood socioeconomic status is linked to adult cardiovascular disease and disease risk. One proposed pathway involves inflammation due to exposure to a stress-inducing neighborhood environment. Whether CRP, a marker of systemic inflammation, is associated with stressful neighborhood conditions among children is unknown. Methods and Results: The sample included 385 children 5-18 years of age from 255 households and 101 census tracts. Multilevel logistic regression analyses compared children and adolescents with CRP levels >3 mg/L to those with levels <= 3 mg/L across neighborhood environments. Among children living in neighborhoods (census tracts) in the upper tertile of poverty or crime, 18.6% had elevated CRP levels, in contrast to 7.9% of children living in neighborhoods with lower levels of poverty and crime. Children from neighborhoods with the highest levels of either crime or poverty had 2.7 (95% CI: 1.2-6.2) times the odds of having elevated CRP levels when compared to children from other neighborhoods, independent of adiposity, demographic and behavioral differences. Conclusions: Children living in neighborhoods with high levels of poverty or crime had elevated CRP levels compared to children from other neighborhoods. This result is consistent with a psychosocial pathway favoring early development of cardiovascular risk that involves chronic stress from exposure to socially- and physically-disordered neighborhoods characteristic of poverty.	[Broyles, Stephanie T.; Staiano, Amanda E.; Drazba, Kathryn T.; Gupta, Alok K.; Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Sothern, Melinda] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Broyles, ST (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	stephanie.broyles@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017; Broyles, Stephanie/C-8647-2011; Staiano, Amanda E/H-3956-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Broyles, Stephanie/0000-0003-3168-0056; Staiano, Amanda E/0000-0001-7846-046X; Gupta, Alok/0000-0002-0102-7155	National Institutes of Health [RC1 DK086881]; American Heart Association [11GRNT7750027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, RC1DK086881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant RC1 DK086881 (PTK) and American Heart Association grant 11GRNT7750027 (STB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; [Anonymous], 2004, LIFE COURSE APPROACH; [Anonymous], 2010, POV THRESH; ATTAR BK, 1994, J CLIN CHILD PSYCHOL, V23, P391, DOI 10.1207/s15374424jccp2304_5; Augustin T, 2008, AM J PUBLIC HEALTH, V98, P1664, DOI 10.2105/AJPH.2007.125138; Balagopal P, 2011, CIRCULATION, V123, P2749, DOI 10.1161/CIR.0b013e31821c7c64; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Chichlowska KL, 2009, ANN EPIDEMIOL, V19, P875, DOI 10.1016/j.annepidem.2009.07.094; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cook DG, 2000, ATHEROSCLEROSIS, V149, P139, DOI 10.1016/S0021-9150(99)00312-3; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Dowd JB, 2010, AM J PREV MED, V39, P314, DOI 10.1016/j.amepre.2010.05.014; Dulin-Keita A, 2012, J EPIDEMIOL COMMUN H, V66, P24, DOI 10.1136/jech.2009.092676; Federico Bruno, 2011, BMC Res Notes, V4, P301, DOI 10.1186/1756-0500-4-301; Ford ES, 2005, DIABETES CARE, V28, P878, DOI 10.2337/diacare.28.4.878; Ford ES, 2003, CIRCULATION, V108, P1053, DOI 10.1161/01.CIR.0000080913.81393.B8; Ford ES, 2001, J PEDIATR-US, V138, P486, DOI 10.1067/mpd.2001.112898; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Fuligni AJ, 2009, PSYCHOSOM MED, V71, P329, DOI 10.1097/PSY.0b013e3181921b1f; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Glass TA, 2006, AM J PREV MED, V31, P455, DOI 10.1016/j.amepre.2006.07.028; Goldoftas BF, 2008, EPIDEMIOLOGY, V19, pS268; Goodman E, 2005, PSYCHOSOM MED, V67, P9, DOI 10.1097/01.psy.0000149254.36133.1a; Gouin JP, 2011, HLTH PSYCHOL; Gupta AK, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-36; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204; Holmes ME, 2010, OBES REV, V11, P492, DOI 10.1111/j.1467-789X.2009.00680.x; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Jackson RW, 1999, INT J PSYCHOPHYSIOL, V31, P111, DOI 10.1016/S0167-8760(98)00044-0; Jarvisalo MJ, 2002, ARTERIOSCL THROM VAS, V22, P1323, DOI 10.1161/01.ATV.0000024222.06463.21; Jaye DL, 1997, PEDIATR INFECT DIS J, V16, P735, DOI 10.1097/00006454-199708000-00003; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lande MB, 2008, PEDIATRICS, V122, P1252, DOI 10.1542/peds.2007-3162; Lee RE, 2002, AM J PUBLIC HEALTH, V92, P428, DOI 10.2105/AJPH.92.3.428; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Little R. J. A., 1987, STAT ANAL MISSING DA; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Morley R, 2000, ACTA PAEDIATR, V89, P703, DOI 10.1080/080352500750044043; Muennig P, 2007, PREV MED, V45, P35, DOI 10.1016/j.ypmed.2007.04.005; Murasko JE, 2008, SOC SCI MED, V67, P1889, DOI 10.1016/j.socscimed.2008.09.018; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Owen N, 2003, BRAIN BEHAV IMMUN, V17, P286, DOI 10.1016/S0889-1591(03)00058-8; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perel P, 2006, DIABETES CARE, V29, P2694, DOI 10.2337/dc06-0022; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schafer MH, 2011, J GERONTOL A-BIOL, V66, P667, DOI 10.1093/gerona/glr009; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Slopen N, 2011, BRAIN BEHAV IMMUN; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Williams ED, 2012, DIABETES CARE, V35, P1455, DOI 10.2337/dc11-1410	90	56	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45419	10.1371/journal.pone.0045419	http://dx.doi.org/10.1371/journal.pone.0045419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049799	Green Published, gold			2022-12-25	WOS:000309556100047
J	Cui, W; Zhang, ZJ; Li, WM; Mak, SH; Hu, SQ; Zhang, H; Yuan, S; Rong, JH; Choi, TC; Lee, SMY; Han, YF				Cui, Wei; Zhang, Zaijun; Li, Wenming; Mak, Shinghung; Hu, Shengquan; Zhang, Huan; Yuan, Shuai; Rong, Jianhui; Choi, Tony Chunglit; Lee, Simon M. Y.; Han, Yifan			Unexpected Neuronal Protection of SU5416 against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; PHASE-I; EXPRESSION; GROWTH; NEUROPROTECTION; BIS(7)-TACRINE; PARKINSONISM; ZEBRAFISH; SYSTEM; CELLS	SU5416 was originally designed as a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) for cancer therapy. In this study, we have found for the first time that SU5416 unexpectedly prevented 1-methyl-4-phenylpyridinium ion (MPP+)-induced neuronal apoptosis in cerebellar granule neurons, and decreased 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced loss of dopaminergic neurons and impairment of swimming behavior in zebrafish in a concentration-dependent manner. However, VEGFR-2 kinase inhibitor II, another specific VEGFR-2 inhibitor, failed to reverse neurotoxicity at the concentration exhibiting anti-angiogenic activity, strongly suggesting that the neuroprotective effect of SU5416 is independent from its anti-angiogenic action. SU5416 potently reversed MPP+-increased intracellular nitric oxide level with an efficacy similar to 7-nitroindazole, a specific neuronal nitric oxide synthase (nNOS) inhibitor. Western blotting analysis showed that SU5416 reduced the elevation of nNOS protein expression induced by MPP+. Furthermore, SU5416 directly inhibited the enzyme activity of rat cerebellum nNOS with an IC50 value of 22.7 mu M. In addition, knock-down of nNOS expression using short hairpin RNA (shRNA) abolished the neuroprotective effects of SU5416 against MPP+-induced neuronal loss. Our results strongly demonstrate that SU5416 might exert its unexpected neuroprotective effects by concurrently reducing nNOS protein expression and directly inhibiting nNOS enzyme activity. In view of the capability of SU5416 to cross the blood-brain barrier and the safety for human use, our findings further indicate that SU5416 might be a novel drug candidate for neurodegenerative disorders, particularly those associated with NO-mediated neurotoxicity.	[Cui, Wei; Li, Wenming; Mak, Shinghung; Hu, Shengquan; Zhang, Huan; Choi, Tony Chunglit; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Zaijun; Yuan, Shuai; Lee, Simon M. Y.] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhang, Zaijun] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Inst New Drug Res, Guang Zhou, Guangdong, Peoples R China; [Rong, Jianhui] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Macau; Jinan University; University of Hong Kong	Lee, SMY (corresponding author), Hong Kong Polytech Univ, Inst Modern Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China.	SimonLee@umac.mo; bcyfhan@polyu.edu.hk	hu, shengquan/S-8266-2019; Rong, Jianhui/C-4385-2009	Zhang, Huan/0000-0002-2771-5036; Han, Yifan/0000-0002-5833-069X; Rong, Jianhui/0000-0002-3545-2811; MAK, Shinghung/0000-0002-9103-4833	Research Grants Council of Hong Kong [PolyU5609/09M, 5610/11M]; Hong Kong Polytechnic University [G-U952]; Shenzhen Shuangbai Funding Scheme; Science and Technology Development Fund (FDCT) of Macao SAR [045/2007/A3]; Research Committee of the University of Macau [UL017/09-Y1]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); Shenzhen Shuangbai Funding Scheme; Science and Technology Development Fund (FDCT) of Macao SAR; Research Committee of the University of Macau	This work was supported by grants from the Research Grants Council of Hong Kong (PolyU5609/09M and 5610/11M), The Hong Kong Polytechnic University (G-U952) and the Shenzhen Shuangbai Funding Scheme 2008; the Science and Technology Development Fund (FDCT) of Macao SAR (045/2007/A3) and the Research Committee of the University of Macau (UL017/09-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Cui W, 2011, NEUROCHEM INT, V59, P945, DOI 10.1016/j.neuint.2011.07.005; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Fong TAT, 1999, CANCER RES, V59, P99; Gal S, 2010, NEUROTOX RES, V17, P15, DOI 10.1007/s12640-009-9070-9; Gonzalez-Polo RA, 2004, MOL NEUROBIOL, V30, P253, DOI 10.1385/MN:30:3:253; Grayson M, 2010, NATURE, V466, pS1, DOI 10.1038/466S2a; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Kavya R, 2006, NITRIC OXIDE-BIOL CH, V15, P280, DOI 10.1016/j.niox.2006.07.003; Kieran MW, 2009, PEDIATR BLOOD CANCER, V52, P169, DOI 10.1002/pbc.21873; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li WM, 2007, MOL PHARMACOL, V71, P1258, DOI 10.1124/mol.106.029108; Li WM, 2006, NEUROREPORT, V17, P471, DOI 10.1097/01.wnr.0000209014.09094.72; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Mahairaki V, 2009, J NEUROSCI METH, V179, P292, DOI 10.1016/j.jneumeth.2009.02.006; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Nagl F, 2009, AM J PHYSIOL-CELL PH, V297, pC1146, DOI 10.1152/ajpcell.00034.2009; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Schweitzer J, 2011, DEV NEUROBIOL; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sheng JZ, 2005, J PHARMACOL EXP THER, V315, P931, DOI 10.1124/jpet.105.087932; Shin JH, 2009, CELL, V139, DOI 10.1016/j.cell.2009.09.026; Stopeck A, 2002, CLIN CANCER RES, V8, P2798; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Thomas B, 2008, NEUROCHEM INT, V52, P990, DOI 10.1016/j.neuint.2007.10.012; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Ye C, 2006, TOXICOL IN VITRO, V20, P154, DOI 10.1016/j.tiv.2005.06.047; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	31	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46253	10.1371/journal.pone.0046253	http://dx.doi.org/10.1371/journal.pone.0046253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049997	Green Published, gold			2022-12-25	WOS:000309556100168
J	van Gennip, RGP; van de Water, SGP; Maris-Veldhuis, M; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; Maris-Veldhuis, Mieke; van Rijn, Piet A.			Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; CAPSID PROTEIN; EXPRESSION; PARTICLES; INFECTION; EPIDEMIC	Since 1998, Bluetongue virus (BTV)-serotypes 1, 2, 4, 9, and 16 have invaded European countries around the Mediterranean Basin. In 2006, a huge BT outbreak started after incursion of BTV serotype 8 (BTV8) in North-Western Europe. IN 2008, BTV6 and BTV11 were reported in the Netherlands and Germany, and in Belgium, respectively. In addition, Toggenburg orbivirus (TOV) was detected in 2008 in Swiss goats, which was recognized as a new serotype of BTV (BTV25). The (re-)emergency of BTV serotypes needs a rapid response to supply effective vaccines. Reverse genetics has been developed for BTV1 and more recently also for BTV6. This latter strain, BTV6/net08, is closely related to live-attenuated vaccine for serotype 6 as determined by full genome sequencing. Here, we used this strain as backbone and exchanged segment 2 and 6, respectively Seg-2 (VP2) and Seg-6 (VP5), for those of BTV serotype 1 and 8 using reverse genetics. These so-called 'serotyped' vaccine viruses, as mono-serotype and multi-serotype vaccine, were compared for their protective capacity in sheep. In general, all vaccinated animals developed a neutralizing antibody response against their respective serotype. After challenge at three weeks post vaccination with cell-passaged, virulent BTV8/net07 (BTV8/net07/e1/bhkp3) the vaccinated animals showed nearly no clinical reaction. Even more, challenge virus could not be detected, and seroconversion or boostering after challenge was negligible. These data demonstrate that all sheep were protected from a challenge with BTV8/net07, since sheep of the control group showed viremia, seroconversion and clinical signs that are specific for Bluetongue. The high level of cross-protection is discussed.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; Maris-Veldhuis, Mieke; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Ab Lelystad, Netherlands	Wageningen University & Research	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Ab Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs, Agriculture, and Innovation	Dutch Ministry of Economic Affairs, Agriculture, and Innovation	This research was funded by the Dutch Ministry of Economic Affairs, Agriculture, and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; ELLIS JA, 1990, VET IMMUNOL IMMUNOP, V24, P49, DOI 10.1016/0165-2427(90)90077-6; Eschbaumer M, 2010, VET MICROBIOL, V143, P189, DOI 10.1016/j.vetmic.2009.11.040; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Forzan M, 2004, P NATL ACAD SCI USA, V101, P2100, DOI 10.1073/pnas.0306448101; Gonzalez JM, 2010, VET REC, V166, P757, DOI 10.1136/vr.b4849; HAIG D. A., 1956, ONDER STEPOORT JOUR VET RES, V27, P171; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1973, VIROLOGY, V52, P81, DOI 10.1016/0042-6822(73)90400-5; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; JEGGO M H, 1985, P477; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Matsuo E, 2011, J VIROL, V85, P10213, DOI 10.1128/JVI.05412-11; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Noad R, 2009, VACCINE, V27, pD86, DOI 10.1016/j.vaccine.2009.08.037; OIE, 2022, NUMB NEW H5 OUTBR; OSBURN BI, 1994, COMP IMMUNOL MICROB, V17, P189, DOI 10.1016/0147-9571(94)90042-6; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2009, NAT REV MICROBIOL, V7, P120, DOI 10.1038/nrmicro2052; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; van Gennip RGP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-261; van Rijn PA, 2011, EP 5 ANN M ARNH NETH; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; Veldman D., 2012, VET MICROBIOL; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44619	10.1371/journal.pone.0044619	http://dx.doi.org/10.1371/journal.pone.0044619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049753	Green Published, gold			2022-12-25	WOS:000309556100018
J	Zhou, XL; Xu, J				Zhou, Xiaolin; Xu, Jie			Free Cholesterol Induces Higher beta-Sheet Content in A beta Peptide Oligomers by Aromatic Interaction with Phe19	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; AMYLOID-BETA; CONFORMATIONAL TRANSITION; FIBRIL FORMATION; GAMMA-SECRETASE; IN-VITRO; AGGREGATION; PROTEIN; RAFTS	Accumulating experimental evidence support an enhancing effect of free cholesterol on amyloid-beta (Ab) aggregation. To probe the mechanisms of cholesterol-mediated Ab aggregation, we applied all-atom molecular dynamic simulations on A beta 42 peptides in presence of free cholesterol. Several control systems were also designed to examine the specificity of cholesterol-residue interactions, including mutation on aromatic residue, substitution of cholesterol with sphingomyelin (SM) and DPPC bilayer, and a mixing SM and cholesterol. Each system was performed 4 independent simulations, with a total time of 560 ns. It was found that cholesterol increased beta-sheet formation by 4 folds, but the Phe19 -> Ser mutation on Ab42 peptide totally eliminated cholesterol's effect. A stable contact was recognized between the steroid group of cholesterol and the Benzyl group of Phe19. Interestingly, our simulation revealed a regular 1 ns time interval between the establishment of cholesterol-phenylalanine contact and consequent beta-sheet formation, suggesting an important role of steroid-benzyl interaction in cholesterol-mediated aggregation. The presence of SM slightly increased beta-sheet formation, but the mixture of cholesterol and SM had a strong induction effect. Also, the measurement of Phe19-lipid distance indicates that aromatic side chains of peptides prone to bind to cholesterol on the surface of the mixed micelle. In the DPPC system, polar chains were attracted to the surface of membrane, yielding moderate increase of beta-sheet formation. These results shed light on the mechanism of cholesterol-mediated fibrillogenesis, and help to differentiate the effects of cholesterol and other lipids on beta-sheet formation process.	[Zhou, Xiaolin] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Xu, Jie] Shanghai Jiao Tong Univ, GI Div, Sch Med, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	zhou_xiaolin@163.com; xujieletter@gmail.com	Xu, Jie/C-4283-2016	Xu, Jie/0000-0001-9163-3898	National Natural Science Foundation of China [81200976, 81000861, 81272383]; Shanghai Natural Science Foundation [12ZR1417900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This research project is supported by National Natural Science Foundation of China to Xiaolin Zhou (Grant No. 81200976), National Natural Science Foundation of China to Jie Xu (Grant No. 81000861 and 81272383), and Shanghai Natural Science Foundation (12ZR1417900) to Jie Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdulov NA, 1997, J NEUROCHEM, V69, P1746; Baumketner A, 2006, J MOL BIOL, V362, P567, DOI 10.1016/j.jmb.2006.07.032; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Burns M, 2003, J NEUROSCI, V23, P5645; Cecchini M, 2006, J MOL BIOL, V357, P1306, DOI 10.1016/j.jmb.2006.01.009; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; Distl R, 2001, ACTA NEUROPATHOL, V101, P547; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Harris JR, 2008, MICRON, V39, P1192, DOI 10.1016/j.micron.2008.05.001; Harris JR, 2010, SUBCELL BIOCHEM, V51, P47, DOI 10.1007/978-90-481-8622-8_2; Harris JR, 2002, MICRON, V33, P609, DOI 10.1016/S0968-4328(02)00029-X; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Heaton NJ, 1998, J AM CHEM SOC, V120, P9632, DOI 10.1021/ja980528s; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hoyer S, 2006, NEUROCHEM RES; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Marrink SJ, 1998, BIOPHYS J, V74, P931, DOI 10.1016/S0006-3495(98)74016-0; Mishchenko E L, 2001, Bioorg Khim, V27, P408; Muller-Plathe F, 1999, PHYS REV E, V59, P4894, DOI 10.1103/PhysRevE.59.4894; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nieva J, 2011, CHEM BIOL, V18, P920, DOI 10.1016/j.chembiol.2011.02.018; Panchal M, 2010, J LIPID RES, V51, P598, DOI 10.1194/jlr.M001859; Pastorino L, 2006, EUR J PHARMACOL, V545, P29, DOI 10.1016/j.ejphar.2006.06.078; Sathishkumar K, 2007, J ALZHEIMERS DIS, V11, P261; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Umeda T, 2012, LIFE SCI; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102	43	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46245	10.1371/journal.pone.0046245	http://dx.doi.org/10.1371/journal.pone.0046245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049991	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100163
J	Kasiappan, R; Shen, Z; Tse, AKW; Jinwal, U; Tang, JF; Lungchukiet, P; Sun, YF; Kruk, P; Nicosia, SV; Zhang, XH; Bai, WL				Kasiappan, Ravi; Shen, Zheng; Tse, Anfernee K-W; Jinwal, Umesh; Tang, Jinfu; Lungchukiet, Panida; Sun, Yuefeng; Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong			1,25-Dihydroxyvitamin D3 Suppresses Telomerase Expression and Human Cancer Growth through MicroRNA-498	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN OVARIAN-CANCER; DOWN-REGULATION; MAMMALIAN-CELLS; PROSTATE-CANCER; GENE-EXPRESSION; HTERT GENE; MECHANISMS; PROTEIN; D-3	Telomerase is an essential enzyme that counteracts the telomere attrition accompanying DNA replication during cell division. Regulation of the promoter activity of the gene encoding its catalytic subunit, the telomerase reverse transcriptase, is established as the dominant mechanism conferring the high telomerase activity in proliferating cells, such as embryonic stem and cancer cells. This study reveals a new mechanism of telomerase regulation through non-coding small RNA by showing that microRNA-498 (miR-498) induced by 1,25-dihydroxyvitamin D3 (1,25(OH)(2)D-3) decreases the mRNA expression of the human telomerase reverse transcriptase. MiR-498 was first identified in a microarray analysis as the most induced microRNA by 1,25(OH)(2)D-3 in ovarian cancer cells and subsequently validated by quantitative polymerase chain reaction assays in multiple human cancer types. A functional vitamin D response element was defined in the 5-prime regulatory region of the miR-498 genome, which is occupied by the vitamin D receptor and its coactivators. Further studies showed that miR-498 targeted the 3-prime untranslated region of human telomerase reverse transcriptase mRNA and decreased its expression. The levels of miR-498 expression were decreased in malignant human ovarian tumors as well as human ovarian cancer cell lines. The ability of 1,25(OH)(2)D-3 to decrease human telomerase reverse transcriptase mRNA and to suppress ovarian cancer growth was compromised when miR-498 was depleted using the sponges in cell lines and mouse tumor models. Taken together, our studies define a novel mechanism of telomerase regulation by small non-coding RNAs and identify miR-498 as an important mediator for the anti-tumor activity of 1,25(OH)(2)D-3.	[Kasiappan, Ravi; Shen, Zheng; Tse, Anfernee K-W; Jinwal, Umesh; Tang, Jinfu; Lungchukiet, Panida; Sun, Yuefeng; Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Kruk, Patricia; Nicosia, Santo V.; Zhang, Xiaohong; Bai, Wenlong] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Nicosia, Santo V.] H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	wbai@health.usf.edu	Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Kasiappan, Ravi/0000-0002-5351-9098; Tse, Kai Wing/0000-0002-0046-9808; Sun, Yuefeng/0000-0003-4578-856X	National Institutes of Health [CA111334, CA93666]; United States Department of Defense [BC085205]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA093666, P30CA076292, R01CA111334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111334 and CA93666 (Public Health Service). This work was also supported by an idea grant from Breast Cancer Research Program of the United States Department of Defense Grant BC085205 and a program development grant from Ovarian Cancer Research Fund.	AMFO K, 1995, ONCOGENE, V11, P351; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bicher A, 1997, GYNECOL ONCOL, V66, P36, DOI 10.1006/gyno.1997.4709; Bieche I, 2000, CLIN CANCER RES, V6, P452; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 2004, J BIOL CHEM, V279, P53213, DOI 10.1074/jbc.M410395200; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li PF, 2004, J BIOL CHEM, V279, P25260, DOI 10.1074/jbc.M311052200; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Sun PM, 2007, EUR J OBSTET GYN R B, V130, P249, DOI 10.1016/j.ejogrb.2006.01.028; Toell A, 2000, BIOCHEM J, V352, P301, DOI 10.1042/0264-6021:3520301; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Valastyan S, 2009, RNA BIOL, V6, P541, DOI 10.4161/rna.6.5.10081; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zhang XH, 2005, CLIN CANCER RES, V11, P323; Zhang XH, 2006, CURR CANCER DRUG TAR, V6, P229, DOI 10.2174/156800906776842939; Zou AH, 1997, J BIOL CHEM, V272, P19027, DOI 10.1074/jbc.272.30.19027	57	91	92	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41297	41309		10.1074/jbc.M112.407189	http://dx.doi.org/10.1074/jbc.M112.407189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055531	hybrid, Green Published			2022-12-25	WOS:000311887600044
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Impact of Recovery from Desensitization on Acid-sensing Ion Channel-1a (ASIC1a) Current and Response to High Frequency Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1A; CONTRIBUTES; SELECTIVITY; MODULATION; EXPRESSION; PLASTICITY; RESIDUES; KINETICS; NEURONS; CELLS	ASIC1a is a neuronal sodium channel activated by external H+ ions. To date, all the characterization of ASIC1a has been conducted applying long H+ stimuli lasting several seconds. Such experimental protocols weaken and even silence ASIC1a currents to repetitive stimulation. In this work, we examined ASIC1a currents by methods that use rapid application and removal of H+. We found that brief H+ stimuli, < 100 ms, even if applied at high frequency, prevent desensitization thereby generate full and steady peak currents of human ASIC1a. Kinetic analysis of recovery from desensitization of hASIC1a revealed two desensitized states: short- and long-lasting with time constants of tau(Ds) <= 0.5 and tau(Dl) = 229 s, while in chicken ASIC1a the two desensitized states have similar values tau(D) 4.5 s. It is the large difference in stability of the two desensitized states that makes hASIC1a desensitization more pronounced and complex than in cASIC1a. Furthermore, recovery from desensitization was unrelated to cytosolic variations in pH, ATP, PIP2, or redox state but was dependent on the hydrophobicity of key residues in the first transmembrane segment (TM1). In conclusion, brief H+-stimuli maintain steady the magnitude of peak currents thereby the ASIC1a channel is well poised to partake in high frequency signals in the brain.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu						Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Colquhoun D., 1995, G SINGLE CHANNEL REC; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gitterman DP, 2005, J PHYSIOL-LONDON, V562, P759, DOI 10.1113/jphysiol.2004.075069; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kaila K., 1998, PH BRAIN FUNCTION; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Neaga E, 2005, J NEUROSCI METH, V144, P241, DOI 10.1016/j.jneumeth.2004.11.012; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	29	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40680	40689		10.1074/jbc.M112.418400	http://dx.doi.org/10.1074/jbc.M112.418400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048040	Green Published, hybrid			2022-12-25	WOS:000311448800057
J	Xiong, A; Duan, LH; Chen, J; Fan, ZG; Zheng, F; Tan, Z; Gong, FL; Fang, M				Xiong, Ali; Duan, Lihua; Chen, Jie; Fan, Zhigang; Zheng, Fang; Tan, Zheng; Gong, Feili; Fang, Min			Flt3L Combined with Rapamycin Promotes Cardiac Allograft Tolerance by Inducing Regulatory Dendritic Cells and Allograft Autophagy in Mice	PLOS ONE			English	Article							KIDNEY-TRANSPLANT PATIENTS; T-CELLS; IN-VITRO; LIVER-TRANSPLANTATION; ACUTE REJECTION; CD8(+) CD28(-); GRAFT-SURVIVAL; RECIPIENTS; PROLONG; VIVO	The induction of immune tolerance is still a formidable challenge in organ transplantation. Dendritic cells (DCs) play an important role in orchestrating immune responses by either mediating protective immune responses or inducing antigen specific tolerance. Previous studies demonstrated that the fms-like tyrosine kinase 3 receptor (Flt3) and its ligand (Flt3L) play an essential role in the regulation of DC commitment and development. Here, we report a synergic effect between Flt3L and low-dose rapamycin (Rapa) in the protection of allograft rejction. It was found that Flt3L combined with Rapa significantly prolonged murine cardiac allograft survival time as compared with that of untreated recipients or recipients treated with Rapa or Flt3L alone. Mechanistic studies revealed that Flt3L combined with low-dose of Rapa induced the generation of tolerogenic DCs along with the production of CD25(+) Foxp3(+) regulatory T cells and IL-10 secretion. We also observed enhanced autophagy in the cardiac allograft, which could be another asset contributing to the enhanced allograft survival. All together, these data suggest that Flt3L combined with low-dose of Rapa could be an effective therapeutic approach to induce tolerance in clinical setting of transplantation.	[Xiong, Ali; Duan, Lihua; Chen, Jie; Fan, Zhigang; Zheng, Fang; Tan, Zheng; Gong, Feili; Fang, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China; [Gong, Feili; Fang, Min] Minist Educ, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China; [Gong, Feili; Fang, Min] Minist Hlth, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Gong, FL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Hubei, Peoples R China.	flgong@163.com; minfang89@mail.hust.edu.cn			National Natural Science Foundation of China [81072440]; NSFC-Guangdong Union Grant [U0832003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Union Grant	This work was supported by the National Natural Science Foundation of China (Grant No. 81072440), NSFC-Guangdong Union Grant (Grant No. U0832003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Baan CC, 2007, CLIN TRANSPLANT, V21, P63, DOI 10.1111/j.1399-0012.2006.00584.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Coates PTH, 2004, TRANSPLANTATION, V77, P1080, DOI 10.1097/01.TP.0000122183.60680.C9; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Emmanouilidis N, 2006, TRANSPLANTATION, V81, P455, DOI 10.1097/01.tp.0000195779.01491.4e; Fischer RT, 2011, TRANSPL IMMUNOL, V25, P20, DOI 10.1016/j.trim.2011.05.001; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Gotoh K, 2009, AUTOPHAGY, V5, P351, DOI 10.4161/auto.5.3.7650; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Hendrikx TK, 2009, TRANSPLANTATION, V87, P376, DOI 10.1097/TP.0b013e3181901b69; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Kahan BD, 2001, TRANSPLANTATION, V72, P1181, DOI 10.1097/00007890-200110150-00001; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee K, 2004, J IMMUNOL, V172, P6539, DOI 10.4049/jimmunol.172.11.6539; Lin YX, 2009, HEPATOB PANCREAT DIS, V8, P241; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lunemann JD, 2009, CELL DEATH DIFFER, V16, P79, DOI 10.1038/cdd.2008.113; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; O'Connell PJ, 2002, J IMMUNOL, V168, P143, DOI 10.4049/jimmunol.168.1.143; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rastellini C, 1995, TRANSPLANTATION, V60, P1366; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; STARZL TE, 1993, HEPATOLOGY, V17, P1127; Starzl TE, 1996, IMMUNOL TODAY, V17, P577, DOI 10.1016/S0167-5699(96)10070-0; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steptoe RJ, 1997, J IMMUNOL, V159, P5483; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Suciu-Foca N, 2005, INT IMMUNOPHARMACOL, V5, P7, DOI 10.1016/j.intimp.2004.09.003; Tantravahi J, 2007, ANNU REV MED, V58, P369, DOI 10.1146/annurev.med.58.061705.145143; Trandem K, 2011, J IMMUNOL, V186, P3642, DOI 10.4049/jimmunol.1003292; Velthuis JHL, 2007, TRANSPL IMMUNOL, V18, P159, DOI 10.1016/j.trim.2007.05.009; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; Wang Z, 2009, TRANSPL P, V41, P1574, DOI 10.1016/j.transproceed.2009.01.093; Yoshizawa A, 2005, TRANSPLANT P, V37, P37, DOI 10.1016/j.transproceed.2004.12.259; Yu G, 2008, TRANSPL IMMUNOL, V18, P208, DOI 10.1016/j.trim.2007.08.006; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	53	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46230	10.1371/journal.pone.0046230	http://dx.doi.org/10.1371/journal.pone.0046230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056267	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600028
J	Alfonso, V; Maroniche, GA; Reca, SR; Lopez, MG; del Vas, M; Taboga, O				Alfonso, Victoria; Maroniche, Guillermo A.; Reca, Sol R.; Gabriela Lopez, Maria; del Vas, Mariana; Taboga, Oscar			AcMNPV Core Gene ac109 Is Required for Budded Virion Transport to the Nucleus and for Occlusion of Viral Progeny	PLOS ONE			English	Article							CALIFORNICA MULTIPLE NUCLEOPOLYHEDROVIRUS; ESCHERICHIA-COLI; EFFICIENT GENERATION; STRUCTURAL PROTEINS; POLYHEDROSIS-VIRUS; ODV ENVELOPMENT; BV PRODUCTION; CELLS; BACULOVIRUSES; NUCLEOCAPSIDS	The Autographa californica multiple nucleopolyhedrovirus (AcMNPV) ac109 core gene has been previously characterized as an essential late gene. Our results showed that budded virions could be detected in supernatants of infected Sf-9 cells, even when ac109 knockout viruses displayed a single-cell infection phenotype. Moreover, confocal microscopy analysis revealed that budded virions can enter the cytoplasm but are unable to enter the cell nucleus. This defect could be repaired by complementing ac109 in trans. In addition, polyhedra of normal size could be detected in Sf-9 nuclei infected with ac109 knockout viruses. However, electron microscopy demonstrated that these occlusion bodies were empty. Altogether, these results indicate that ac109 is required for infectivity of both phenotypes of virus.	[Alfonso, Victoria; Reca, Sol R.; Gabriela Lopez, Maria; del Vas, Mariana; Taboga, Oscar] Inst Nacl Tecnol Agr IB INTA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Maroniche, Guillermo A.] Inst Nacl Tecnol Agr IMyZA INTA, Inst Microbiol & Zool Agr, CICVyA, Hurlingham, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Taboga, O (corresponding author), Inst Nacl Tecnol Agr IB INTA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina.	otaboga@cnia.inta.gov.ar		del Vas, Mariana/0000-0002-8365-8582; Alfonso, Victoria/0000-0002-9167-6107; , Oscar/0000-0001-9575-3045; Lopez, Maria Gabriela/0000-0002-0560-7472	Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET) [11420100100101]; Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA) [232161]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET); Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET) No11420100100101 and Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA)No232161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GAM holds a doctoral fellowship from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). VA, MdV and OT are career members of CONICET. The authors would like to thank Dr. Julia Sabio y Garcia for English language editing.	Au S, 2012, J STRUCT BIOL, V177, P90, DOI 10.1016/j.jsb.2011.11.006; Bideshi DK, 2000, J GEN VIROL, V81, P1593, DOI 10.1099/0022-1317-81-6-1593; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; CHARLTON CA, 1993, VIROLOGY, V197, P245, DOI 10.1006/viro.1993.1585; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Fang MG, 2009, VIROLOGY, V389, P66, DOI 10.1016/j.virol.2009.04.003; Lopez MG, 2011, ARCH VIROL, V156, P695, DOI 10.1007/s00705-010-0885-8; Lopez MG, 2010, J BIOTECHNOL, V145, P199, DOI 10.1016/j.jbiotec.2009.10.015; Gandhi KM, 2012, J GEN VIROL, V93, P1795, DOI 10.1099/vir.0.041848-0; Giri L, 2010, J GEN VIROL, V91, P3053, DOI 10.1099/vir.0.024430-0; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; HOHMANN AW, 1983, VIROLOGY, V125, P432, DOI 10.1016/0042-6822(83)90214-3; Hu ZY, 2010, J VIROL, V84, P7437, DOI 10.1128/JVI.02103-09; Lin L, 2009, VIRUS RES, V144, P130, DOI 10.1016/j.virusres.2009.04.010; Liu C, 2008, VIROLOGY, V382, P59, DOI 10.1016/j.virol.2008.09.003; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Maroniche GA, 2011, INSECT MOL BIOL, V20, P675, DOI 10.1111/j.1365-2583.2011.01100.x; McCarthy CB, 2008, VIROLOGY, V372, P325, DOI 10.1016/j.virol.2007.10.019; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Peng K, J GEN VIROL, V91, P659; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang Y, 2008, J VIROL, V82, P4554, DOI 10.1128/JVI.02510-07; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Williams GV, 1997, BACULOVIRUSES, P61, DOI DOI 10.1007/978-1-4899-1834-5_4; Wu WB, 2006, J VIROL, V80, P11475, DOI 10.1128/JVI.01155-06; Wu WB, 2010, J VIROL, V84, P12351, DOI 10.1128/JVI.01598-10; Yuan MJ, 2008, VIROLOGY, V379, P87, DOI 10.1016/j.virol.2008.06.015	37	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46146	10.1371/journal.pone.0046146	http://dx.doi.org/10.1371/journal.pone.0046146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049963	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300091
J	Banerjee, D; Bhat, SN; Bhat, SV; Leporini, D				Banerjee, Debamalya; Bhat, Shrivalli N.; Bhat, Subray V.; Leporini, Dino			Molecular Probe Dynamics Reveals Suppression of Ice-Like Regions in Strongly Confined Supercooled Water	PLOS ONE			English	Article							STOKES-EINSTEIN RELATION; LIQUID WATER; STRUCTURAL RELAXATION; AQUEOUS-SOLUTIONS; THERMAL-BEHAVIOR; PHASE-BEHAVIOR; CAGED DYNAMICS; AMORPHOUS ICE; HIGH-DENSITY; VEIN SYSTEM	The structure of the hydrogen bond network is a key element for understanding water's thermodynamic and kinetic anomalies. While ambient water is strongly believed to be a uniform, continuous hydrogen-bonded liquid, there is growing consensus that supercooled water is better described in terms of distinct domains with either a low-density ice-like structure or a high-density disordered one. We evidenced two distinct rotational mobilities of probe molecules in interstitial supercooled water of polycrystalline ice [Banerjee D, et al. (2009) ESR evidence for 2 coexisting liquid phases in deeply supercooled bulk water. Proc Natl Acad Sci USA 106: 11448-11453]. Here we show that, by increasing the confinement of interstitial water, the mobility of probe molecules, surprisingly, increases. We argue that loose confinement allows the presence of ice-like regions in supercooled water, whereas a tighter confinement yields the suppression of this ordered fraction and leads to higher fluidity. Compelling evidence of the presence of ice-like regions is provided by the probe orientational entropy barrier which is set, through hydrogen bonding, by the configuration of the surrounding water molecules and yields a direct measure of the configurational entropy of the same. We find that, under loose confinement of supercooled water, the entropy barrier surmounted by the slower probe fraction exceeds that of equilibrium water by the melting entropy of ice, whereas no increase of the barrier is observed under stronger confinement. The lower limit of metastability of supercooled water is discussed.	[Banerjee, Debamalya; Bhat, Shrivalli N.; Bhat, Subray V.] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Leporini, Dino] Univ Pisa, Dipartimento Fis Enrico Fermi, Pisa, Italy; [Leporini, Dino] UoS Pisa, Consiglio Nazl Ric, Inst Proc Chim Fis, Pisa, Italy	Indian Institute of Science (IISC) - Bangalore; University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Bhat, SV (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.	svbhat@physics.iisc.ernet.in; dino.leporini@df.unipi.it	Bhat, Subray V/S-3636-2018; Bhat, S V/AAY-7394-2021	Bhat, Subray V/0000-0003-3430-4734; Bhat, S V/0000-0003-3430-4734; Leporini, Dino/0000-0002-9429-0509	Indian National Science Academy; University of Pisa	Indian National Science Academy; University of Pisa	The work was financially supported by the Indian National Science Academy and the University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN MK, 1976, J CHEM PHYS, V64, P134, DOI 10.1063/1.431963; Alavi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3124187; Andreozzi L, 1996, J PHYS-CONDENS MAT, V8, P3795, DOI 10.1088/0953-8984/8/21/007; ANDREOZZI L, 1993, APPL MAGN RESON, V4, P279, DOI 10.1007/BF03162503; Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; Banerjee D, 2009, P NATL ACAD SCI USA, V106, P11448, DOI 10.1073/pnas.0900734106; Barbieri A, 2004, J CHEM PHYS, V120, P437, DOI 10.1063/1.1630293; Barnes PRF, 2003, MICROSC RES TECHNIQ, V62, P62, DOI 10.1002/jemt.10385; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Bhat SN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235702; BORICK SS, 1995, J PHYS CHEM-US, V99, P3781, DOI 10.1021/j100011a054; BOSIO L, 1981, PHYS REV LETT, V46, P597, DOI 10.1103/PhysRevLett.46.597; Brice JC., 1973, GROWTH CRYSTALS LIQU; Brovchenko I, 2008, CHEMPHYSCHEM, V9; Capaccioli S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633242; Chen SH, 2006, P NATL ACAD SCI USA, V103, P12974, DOI 10.1073/pnas.0603253103; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Clark GNI, 2010, MOL PHYS, V108, P1415, DOI 10.1080/00268971003762134; de los Santos F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.010602; De Michele C, 2011, SOFT MATTER, V7, P4025, DOI 10.1039/c0sm00941e; De Michele C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.036702; Debenedetti PG, 2003, J PHYS-CONDENS MAT, V15, pR1669, DOI 10.1088/0953-8984/15/45/R01; Douglas JF, 1998, J NON-CRYST SOLIDS, V235, P137, DOI 10.1016/S0022-3093(98)00501-8; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Errington JR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215503; Feistel R, 2006, J PHYS CHEM REF DATA, V35, P1021, DOI 10.1063/1.2183324; FRANK FC, 1968, NATURE, V220, P350, DOI 10.1038/220350a0; FRANK HS, 1957, DISCUSS FARADAY SOC, P133, DOI 10.1039/df9572400133; Gallo P, 2010, J PHYS CHEM LETT, V1, P729, DOI 10.1021/jz9003125; GIORDANO M, 1983, PHYS REV A, V28, P2474, DOI 10.1103/PhysRevA.28.2474; Houriez C, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478999; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; JENNISKENS P, 1994, SCIENCE, V265, P753, DOI 10.1126/science.11539186; Jenniskens P, 1996, ASTROPHYS J, V473, P1104, DOI 10.1086/178220; Jenniskens P, 1997, J CHEM PHYS, V107, P1232, DOI 10.1063/1.474468; Johari GP, 1998, J CHEM PHYS, V109, P1070, DOI 10.1063/1.476649; Johari GP, 1995, THERMOCHIM ACTA, V266, P31, DOI 10.1016/0040-6031(95)02341-0; JOHARI GP, 1994, J CHEM PHYS, V100, P4548, DOI 10.1063/1.466286; Kim CU, 2009, P NATL ACAD SCI USA, V106, P4596, DOI 10.1073/pnas.0812481106; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Larini L, 2008, NAT PHYS, V4, P42, DOI 10.1038/nphys788; LEIGH JS, 1971, J PHYS CHEM-US, V75, P1202, DOI 10.1021/j100679a003; LEPORINI D, 1994, PHYS REV A, V49, P992, DOI 10.1103/PhysRevA.49.992; MADER HM, 1992, J GLACIOL, V38, P333, DOI 10.3189/S0022143000002227; MADER HM, 1992, J GLACIOL, V38, P359, DOI 10.3189/S0022143000002240; Malani A, 2009, J PHYS CHEM B, V113, P13825, DOI 10.1021/jp902562v; Mallamace F, 2008, P NATL ACAD SCI USA, V105, P12725, DOI 10.1073/pnas.0805032105; Mallamace F, 2007, P NATL ACAD SCI USA, V104, P424, DOI 10.1073/pnas.0607138104; Matsumoto M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.017801; Mazza MG, 2011, P NATL ACAD SCI USA, V108, P19873, DOI 10.1073/pnas.1104299108; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Moore EB, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3158470; NEMETHY G, 1962, J CHEM PHYS, V36, P3382, DOI 10.1063/1.1732472; Nemilov SV, 2007, J NON-CRYST SOLIDS, V353, P4613, DOI 10.1016/j.jnoncrysol.2007.08.045; NORDIO PL, 1976, SPIN LABELING THEORY, P5; Nye J. F., 1973, S HYDROLOGY GLACIERS, V95, P157; NYE JF, 1991, J GLACIOL, V37, P401, DOI 10.3189/S0022143000005839; Ottochian A, 2011, PHILOS MAG, V91, P1786, DOI 10.1080/14786435.2010.521530; Ottochian A, 2011, J NON-CRYST SOLIDS, V357, P298, DOI 10.1016/j.jnoncrysol.2010.05.094; Ottochian A, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269041; POOLE PH, 1994, PHYS REV LETT, V73, P1632, DOI 10.1103/PhysRevLett.73.1632; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; POPLE JA, 1951, PROC R SOC LON SER-A, V205, P163, DOI 10.1098/rspa.1951.0024; PRUPPACHER HR, 1967, PURE APPL GEOPHYS, V68, P186, DOI 10.1007/BF00874894; Puosi F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704674; Puosi F, 2011, J PHYS CHEM B, V115, P14046, DOI 10.1021/jp203659r; Raviv U, 2001, NATURE, V413, P51, DOI 10.1038/35092523; Rosenhain W, 1913, J I MET, V10, P119; ROSS RT, 1965, J CHEM PHYS, V42, P3919, DOI 10.1063/1.1695859; SALVETTI G, 1995, J CHEM PHYS, V102, P4987, DOI 10.1063/1.469548; Santangelo MG, 2008, J PHYS CHEM B, V112, P15546, DOI 10.1021/jp805131j; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Shen XS, 2011, ACS NANO, V5, P8426, DOI 10.1021/nn203399z; Smith JD, 2005, P NATL ACAD SCI USA, V102, P14171, DOI 10.1073/pnas.0506899102; Smith RS, 2011, J PHYS CHEM A, V115, P5908, DOI 10.1021/jp110297q; Soper AK, 2008, MOL PHYS, V106, P2053, DOI 10.1080/00268970802116146; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Souda R, 2007, J PHYS CHEM B, V111, P5628, DOI 10.1021/jp0672050; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P3002, DOI 10.1021/j100212a038; STANLEY HE, 1980, J CHEM PHYS, V73, P3404, DOI 10.1063/1.440538; Starr FW, 2003, PHYSICA A, V323, P51, DOI 10.1016/S0378-4371(03)00012-8; STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451; Stillinger FH, 1980, WATER POLYM; Stokely K, 2010, P NATL ACAD SCI USA, V107, P1301, DOI 10.1073/pnas.0912756107; Tanaka H, 2000, PHYS REV E, V62, P6968, DOI 10.1103/PhysRevE.62.6968; Tanaka H, 2000, J CHEM PHYS, V112, P799, DOI 10.1063/1.480609; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Weil J. A., 2006, ELECT PARAMAGNETIC R; Wettlaufer JS, 2006, ANNU REV FLUID MECH, V38, P427, DOI 10.1146/annurev.fluid.37.061903.175758; Whiting H, 1884, THEORY COHESION; Wikfeldt KT, 2011, PHYS CHEM CHEM PHYS, V13, P19918, DOI 10.1039/c1cp22076d; Zhang H, 2009, P NATL ACAD SCI USA, V106, P7735, DOI 10.1073/pnas.0900227106; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P12206, DOI 10.1073/pnas.1100238108	100	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44382	10.1371/journal.pone.0044382	http://dx.doi.org/10.1371/journal.pone.0044382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049747	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300010
J	Wong, YF; Wilson, PD; Unwin, RJ; Norman, JT; Arno, M; Hendry, BM; Xu, QH				Wong, Yuen Fei; Wilson, Patricia D.; Unwin, Robert J.; Norman, Jill T.; Arno, Matthew; Hendry, Bruce M.; Xu, Qihe			Retinoic Acid Receptor-Dependent, Cell-Autonomous, Endogenous Retinoic Acid Signaling and Its Target Genes in Mouse Collecting Duct Cells	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; PRINCIPAL CELLS; TYROSINE KINASE; EXPRESSION; PROTEIN; KIDNEY; DIFFERENTIATION; BIOSYNTHESIS	Background: Vitamin A is necessary for kidney development and has also been linked to regulation of solute and water homeostasis and to protection against kidney stone disease, infection, inflammation, and scarring. Most functions of vitamin A are mediated by its main active form, all-trans retinoic acid (tRA), which binds retinoic acid receptors (RARs) to modulate gene expression. We and others have recently reported that renal tRA/RAR activity is confined to the ureteric bud (UB) and collecting duct (CD) cell lineage, suggesting that endogenous tRA/RARs primarily act through regulating gene expression in these cells in embryonic and adult kidney, respectively. Methodology/Principal Findings: To explore target genes of endogenous tRA/RARs, we employed the mIMCD-3 mouse inner medullary CD cell line, which is a model of CD principal cells and exhibits constitutive tRA/RAR activity as CD principal cells do in vivo. Combining antagonism of RARs, inhibition of tRA synthesis, exposure to exogenous tRA, and gene expression profiling techniques, we have identified 125 genes as candidate targets and validated 20 genes that were highly regulated (Dhrs3, Sprr1a, and Ppbp were the top three). Endogenous tRA/RARs were more important in maintaining, rather than suppressing, constitutive gene expression. Although many identified genes were expressed in UBs and/or CDs, their exact functions in this cell lineage are still poorly defined. Nevertheless, gene ontology analysis suggests that these genes are involved in kidney development, renal functioning, and regulation of tRA signaling. Conclusions/Significance: A rigorous approach to defining target genes for endogenous tRA/RARs has been established. At the pan-genomic level, genes regulated by endogenous tRA/RARs in a CD cell line have been catalogued for the first time. Such a catalogue will guide further studies on molecular mediators of endogenous tRA/RARs during kidney development and in relation to renal defects associated with vitamin A deficiency.	[Wong, Yuen Fei; Hendry, Bruce M.; Xu, Qihe] Kings Coll London, Dept Renal Med, London WC2R 2LS, England; [Wilson, Patricia D.; Unwin, Robert J.; Norman, Jill T.] UCL, Ctr Nephrol, London, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London WC2R 2LS, England	University of London; King's College London; University of London; University College London; University of London; King's College London	Xu, QH (corresponding author), Kings Coll London, Dept Renal Med, London WC2R 2LS, England.	qihe.xu@kcl.ac.uk	Wong, Yuen Fei/AAE-2086-2020; Wong, Yuen Fei/N-2615-2017; Wilson, Patricia/AAW-8481-2021	Wong, Yuen Fei/0000-0002-8761-2848; Wilson, Patricia/0000-0003-0902-188X	Kidney Research UK [IN1/2010]; European Union [223154]	Kidney Research UK(Kidney Research UK (KRUK)); European Union(European Commission)	This work was supported by a Kidney Research UK innovation grant (Grant reference: IN1/2010) awarded to QX, BMH, PDW and RJU and a European Union Framework Programme 7 grant awarded to QX and BMH (Grant agreement No. 223154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann PM, 2011, CURR MED CHEM, V18, P1405; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Behr R, 2004, J BIOL CHEM, V279, P41936, DOI 10.1074/jbc.M403354200; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Butt MJ, 2007, KIDNEY INT, V72, P936, DOI 10.1038/sj.ki.5002457; Cai Q, 2005, P NATL ACAD SCI USA, V102, P503, DOI 10.1073/pnas.0408840102; Cerignoli F, 2002, CANCER RES, V62, P1196; Chassin C, 2011, CELL MICROBIOL, V13, P1107, DOI 10.1111/j.1462-5822.2011.01614.x; Chen XR, 2008, J IMMUNOL, V180, P138, DOI 10.4049/jimmunol.180.1.138; Cohen DM, 1996, J CLIN INVEST, V97, P1884, DOI 10.1172/JCI118619; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; FUJIMOTO W, 1993, J INVEST DERMATOL, V101, P268, DOI 10.1111/1523-1747.ep12365200; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; JOHNSON AT, 1995, J MED CHEM, V38, P4764, DOI 10.1021/jm00024a003; KANCHA RK, 1992, BIOCHEM MED METAB B, V47, P1, DOI 10.1016/0885-4505(92)90002-G; Kavukcu S, 1999, BJU INT, V83, P1055; Kreutz M, 1998, BLOOD, V91, P4796, DOI 10.1182/blood.V91.12.4796.412k39_4796_4802; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Lee DCW, 2002, ONCOGENE, V21, P5582, DOI 10.1038/sj.onc.1205741; Lelievre-Pegorier M, 1998, KIDNEY INT, V54, P1455, DOI 10.1046/j.1523-1755.1998.00151.x; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Liu SG, 1997, EXP NEPHROL, V5, P295; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Nguyen LT, 2011, ANTIMICROB AGENTS CH, V55, P2074, DOI 10.1128/AAC.01351-10; Paralkar VM, 2002, J CELL PHYSIOL, V190, P207, DOI 10.1002/JCP.10048; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; Sproul A, 2011, AM J PHYSIOL-RENAL, V301, pF44, DOI 10.1152/ajprenal.00666.2010; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van Leersum EC, 1927, BRIT MED J, V1927, P873, DOI 10.1136/bmj.2.3488.873; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; Wong YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016770; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2012, SEMIN NEPHROL, V32, P287, DOI 10.1016/j.semnephrol.2012.04.008; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; ZILE M, 1972, J NUTR, V102, P1255, DOI 10.1093/jn/102.10.1255	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45725	10.1371/journal.pone.0045725	http://dx.doi.org/10.1371/journal.pone.0045725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049847	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300046
J	Adu, B; Dodoo, D; Adukpo, S; Hedley, PL; Arthur, FKN; Gerds, TA; Larsen, SO; Christiansen, M; Theisen, M				Adu, Bright; Dodoo, Daniel; Adukpo, Selorme; Hedley, Paula L.; Arthur, Fareed K. N.; Gerds, Thomas A.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael			Fc Gamma Receptor IIIB (Fc gamma RIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; PLASMODIUM-FALCIPARUM; PERIODONTAL-DISEASE; GENE-FREQUENCIES; IMMUNOGLOBULIN-G; PROTECTION; NEUTROPHILS; POPULATION; RESPONSES; ANTIGENS	Plasmodium falciparum malaria kills nearly a million people annually. Over 90% of these deaths occur in children under five years of age in sub- Saharan Africa. A neutrophil mediated mechanism, the antibody dependent respiratory burst (ADRB),was recently shown to correlate with protection from clinical malaria. Human neutrophils constitutively express Fc gamma receptor-Fc gamma RIIA and Fc gamma RIIIB by which they interact with immunoglobulin (Ig) G (IgG)-subclass antibodies. Polymorphisms in exon 4 of FCGR2A and exon 3 of FCGR3B genes encoding Fc gamma RIIA and Fc gamma RIIIB respectively have been described to alter the affinities of both receptors for IgG. Here, associations between specific polymorphisms, encoding Fc gamma RIIA p.H166R and Fc gamma RIIIB-NA1/NA2/SH variants with clinical malaria were investigated in a longitudinal malaria cohort study. Fc gamma RIIA-p.166H/R was genotyped by gene specific polymerase chain reaction followed by allele specific restriction enzyme digestion. FCGR3B-exon 3 was sequenced in 585 children, aged 1 to 12 years living in a malaria endemic region of Ghana. Multivariate logistic regression analysis found no association between Fc gamma RIIA-166H/R polymorphism and clinical malaria. The A-allele of FCGR3B-c.233C>A (rs5030738) was significantly associated with protection from clinical malaria under two out of three genetic models (additive: p = 0.0061; recessive: p = 0.097; dominant: p = 0.0076) of inheritance. The Fc gamma RIIIB-SH allotype (CTGAAA) containing the 233A-allele (in bold) was associated with protection from malaria (p = 0.049). The Fc gamma RIIIB-NA2*03 allotype (CTGCGA), a variant of the classical Fc gamma RIIIB-NA2 (CTGCAA) was associated with susceptibility to clinical malaria (p = 0.0092). The present study is the first to report an association between a variant of Fc gamma RIIIB-NA2 and susceptibility to clinical malaria and provides justification for further functional characterization of variants of the classical Fc gamma RIIIB allotypes. This would be crucial to the improvement of neutrophil mediated functional assays such as the ADRB assay aimed at assessing the functionality of antibodies induced by candidate malaria vaccines.	[Adu, Bright; Adukpo, Selorme; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Adu, Bright; Theisen, Michael] Univ Copenhagen, Rigshosp, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen, Denmark; [Adu, Bright; Theisen, Michael] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Dodoo, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Hedley, Paula L.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Arthur, Fareed K. N.] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Gerds, Thomas A.] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Ghana; Stellenbosch University; Kwame Nkrumah University Science & Technology; University of Copenhagen	Christiansen, M (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	mic@ssi.dk; mth@ssi.dk	Hedley, Paula L/E-6156-2011; Adu, Bright/ABA-8631-2020; Christiansen, Michael/B-4588-2009	Hedley, Paula L/0000-0001-5801-960X; Adu, Bright/0000-0002-3622-2137; Christiansen, Michael/0000-0003-4713-755X; Theisen, Michael/0000-0003-4412-1392; Gerds, Thomas Alexander/0000-0002-5955-816X; Arthur, Fareed Kow Nanse/0000-0001-7897-2166	European and Developing Countries Clinical Trials Partnership [TA.2007.40200.012]; European Vaccine Initiative; African Malaria Network Trust [008/2008AIA]	European and Developing Countries Clinical Trials Partnership; European Vaccine Initiative; African Malaria Network Trust	The study was funded by grants from the European and Developing Countries Clinical Trials Partnership (www.edctp.org) (TA.2007.40200.012), the European Vaccine Initiative (www.euvaccine.eu) (08-2007) and the African Malaria Network Trust (www.amanet-trust.org) (008/2008AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029465; ALLISON AC, 1983, ANNU REV IMMUNOL, V1, P361, DOI 10.1146/annurev.iy.01.040183.002045; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Blum KS, 2009, VOX SANG, V97, P69, DOI 10.1111/j.1423-0410.2009.01178.x; Boross P, 2008, FC RECEPTORS ENCY LI, P1; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Burkett K, 2006, J STAT SOFTW, V16, P1; BUX J, 1995, TRANSFUSION, V35, P54, DOI 10.1046/j.1537-2995.1995.35195090663.x; Bux J, 1997, BLOOD, V89, P1027, DOI 10.1182/blood.V89.3.1027; Bux J, 1999, BLOOD, V93, P357, DOI 10.1182/blood.V93.1.357.401k39_357_362; CLARK IA, 1983, INFECT IMMUN, V39, P1; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Dimou NL, 2010, J CLIN PERIODONTOL, V37, P255, DOI 10.1111/j.1600-051X.2009.01530.x; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; FEIZI T, 1987, BIOCHEM J, V245, P1; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Jiang XM, 1996, J IMMUNOL METHODS, V199, P55, DOI 10.1016/S0022-1759(96)00164-0; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Koene HR, 1998, BLOOD, V91, P673, DOI 10.1182/blood.V91.2.673.673_673_679; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LECONTE I, 1992, J BIOL CHEM, V267, P17415; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Matsuo K, 2000, TRANSFUSION, V40, P645, DOI 10.1046/j.1537-2995.2000.40060645.x; Ministry of Health, 1992, MAL ACT PLAN 1993 19; MITCHELL MA, 1994, BLOOD, V84, P1753; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; NAJERA JA, 1989, B WORLD HEALTH ORGAN, V67, P229; Niu LH, 2000, BLOOD, V95, P3357, DOI 10.1182/blood.V95.11.3357.011k43_3357_3362; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Omi K, 2002, PARASITOL INT, V51, P361, DOI 10.1016/S1383-5769(02)00040-5; ORY PA, 1989, J CLIN INVEST, V84, P1688, DOI 10.1172/JCI114350; Ouma C, 2011, HUM GENET; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994; SALMON JE, 1990, J CLIN INVEST, V85, P1287, DOI 10.1172/JCI114566; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Schuldt K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002066; Schuldt K, 2010, J MED GENET, V47, P471, DOI 10.1136/jmg.2009.073643; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Shub A, 2009, AUST NZ J OBSTET GYN, V49, P130, DOI 10.1111/j.1479-828X.2009.00953.x; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; SZECOWKA J, 1990, ENDOCRINOLOGY, V126, P1834, DOI 10.1210/endo-126-4-1834; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Terzian CC, 2011, TRANSFUSION; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; TIFFT CJ, 1992, J BIOL CHEM, V267, P3268; Tong Y, 2003, ANN HEMATOL, V82, P574, DOI 10.1007/s00277-003-0725-y; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; WARMERDAM PAM, 1990, J EXP MED, V172, P19, DOI 10.1084/jem.172.1.19; WHO, 2010, WORLD MALARIA REPORT 2010, P1	56	40	40	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46197	10.1371/journal.pone.0046197	http://dx.doi.org/10.1371/journal.pone.0046197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049979	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100154
J	Bal, W; Kurowska, E; Maret, W				Bal, Wojciech; Kurowska, Ewa; Maret, Wolfgang			The Final Frontier of pH and the Undiscovered Country Beyond	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; VOLUME; VALUES	The comparison of volumes of cells and subcellular structures with the pH values reported for them leads to a conflict with the definition of the pH scale. The pH scale is based on the ionic product of water, K-w = [H+]x[OH-]. We used K-w [in a reversed way] to calculate the number of undissociated H2O molecules required by this equilibrium constant to yield at least one of its daughter ions, H+ or OH- at a given pH. In this way we obtained a formula that relates pH to the minimal volume V-pH required to provide a physical meaning to K-w, V-pH = 10(vertical bar pH) - (pKw/2 vertical bar) x 10(pKw/2)/N-A (where N-A is Avogadro's number). For example, at pH 7 (neutral at 25 degrees C) V-pH = 16.6 aL. Any deviation from neutral pH results in a larger V-pH value. Our results indicate that many subcellular structures, including coated vesicles and lysosomes, are too small to contain free H+ ions at equilibrium, thus the definition of pH based on K-w is no longer valid. Larger subcellular structures, such as mitochondria, apparently contain only a few free H+ ions. These results indicate that pH fails to describe intracellular conditions, and that water appears to be dissociated too weakly to provide free H+ ions as a general source for biochemical reactions. Consequences of this finding are discussed.	[Bal, Wojciech; Kurowska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Maret, Wolfgang] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of London; King's College London	Bal, W (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wbal@ibb.waw.pl		Bal, Wojciech/0000-0003-3780-083X	Polish National Centre for Science [2011/01/B/ST4/06144]	Polish National Centre for Science	This work was supported by the Polish National Centre for Science grant number 2011/01/B/ST4/06144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Bates R.G., 1973, J ELECTROCHEM SOC, V120, p263C, DOI [10.1149/1.2403829, DOI 10.1149/1.2403829]; BURSZTAJN S, 1981, CELL TISSUE RES, V220, P573, DOI 10.1007/BF00216761; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Coleman J, 2009, MICROSC MICROANAL, V15, P948, DOI 10.1017/S1431927609095713; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; MARKOWSKA A, 1994, HISTOL HISTOPATHOL, V9, P263; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; THURMOND RL, 1991, BIOPHYS J, V59, P108, DOI 10.1016/S0006-3495(91)82203-2; TSUI FC, 1986, BIOPHYS J, V49, P459, DOI 10.1016/S0006-3495(86)83655-4	12	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45832	10.1371/journal.pone.0045832	http://dx.doi.org/10.1371/journal.pone.0045832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049874	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100088
J	Gromova, I; Gromov, P; Kroman, N; Wielenga, VT; Simon, R; Sauter, G; Moreira, JMA				Gromova, Irina; Gromov, Pavel; Kroman, Niels; Wielenga, Vera Timmermans; Simon, Ronald; Sauter, Guido; Moreira, Jose M. A.			Immunoexpression Analysis and Prognostic Value of BLCAP in Breast Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMAS; HUMAN BLADDER-CANCER; PROTEOMIC STRATEGIES; GENE-EXPRESSION; FOLLOW-UP; PROTEIN; BIOMARKER; DISCOVERY; IDENTIFICATION; CHALLENGES	Bladder Cancer Associated Protein (BLCAP, formerly Bc10), was identified by our laboratory as being down-regulated in bladder cancer with progression. BLCAP is ubiquitously expressed in different tissues, and several studies have found differential expression of BLCAP in various cancer types, such as cervical and renal cancer, as well as human tongue carcinoma and osteosarcoma. Here we report the first study of the expression patterns of BLCAP in breast tissue. We analyzed by immunohistochemistry tissue sections of normal and malignant specimens collected from 123 clinical high-risk breast cancer patients within the Danish Center for Translational Breast Cancer Research (DCTB) prospective study dataset. The staining pattern, the distribution of the immunostaining, and its intensity were studied in detail. We observed weak immunoreactivity for BLCAP in mammary epithelial cells, almost exclusively localizing to the cytoplasm and found that levels of expression of BLCAP were generally higher in malignant cells as compared to normal cells. Quantitative IHC analysis of BLCAP expression in breast tissues confirmed this differential BLCAP expression in tumor cells, and we could establish, in a 62-patient sample matched cohort, that immunostaining intensity for BLCAP was increased in tumors relative to normal tissue, in more than 45% of the cases examined, indicating that BLCAP may be of value as a marker for breast cancer. We also analyzed BLCAP expression and prognostic value using a set of tissue microarrays comprising an independent cohort of 2,197 breast cancer patients for which we had follow-up clinical information.	[Gromova, Irina; Gromov, Pavel; Moreira, Jose M. A.] Danish Canc Soc Res Ctr, Genome Integr Unit, Copenhagen, Denmark; [Gromova, Irina; Gromov, Pavel; Wielenga, Vera Timmermans; Moreira, Jose M. A.] Danish Ctr Translat Breast Canc Res DCTB, Copenhagen, Denmark; [Kroman, Niels] Copenhagen Univ Hosp, Dept Breast Surg, Copenhagen, Denmark; [Wielenga, Vera Timmermans] Copenhagen Univ Hosp, Dept Pathol, Ctr Diagnost Invest, Copenhagen, Denmark; [Simon, Ronald; Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Ctr Diagnost, Hamburg, Germany; [Moreira, Jose M. A.] Univ Copenhagen, Sect Pathobiol, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Sino Danish Breast Canc Res Ctr, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark	Danish Cancer Society; University of Copenhagen; University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Copenhagen; University of Copenhagen	Gromova, I (corresponding author), Danish Canc Soc Res Ctr, Genome Integr Unit, Copenhagen, Denmark.	iig@cancer.dk; jom@cancer.dk		Gromova, Irina/0000-0003-4357-5958; Moreira, Jose/0000-0002-9944-1214; Simon, Ronald/0000-0003-0158-4258	Danish Cancer Society; John and Birthe Meyer Foundation; "Race against Breast Cancer'' foundation	Danish Cancer Society(Danish Cancer Society); John and Birthe Meyer Foundation; "Race against Breast Cancer'' foundation	This work was supported by the Danish Cancer Society through the budget of the Research Center, and by grants from the John and Birthe Meyer Foundation, and the "Race against Breast Cancer'' foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Allred DC, 2011, CANCER PREV RES, V4, P1947, DOI 10.1158/1940-6207.CAPR-11-0478; Bichsel VE, 2001, CANCER J, V7, P69; Birkhahn M, 2007, EXPERT REV ANTICANC, V7, P1717, DOI 10.1586/14737140.7.12.1717; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Celis JE, 2003, CANCER CELL, V3, P9, DOI 10.1016/S1535-6108(02)00242-8; Celis JE, 2005, FEBS J, V272, P2, DOI 10.1111/j.1432-1033.2004.04418.x; Celis JE, 2004, PHARMACOGENOMICS, V5, P381, DOI 10.1517/14622416.5.4.381; Celis JE, 2003, MOL CELL PROTEOMICS, V2, P369, DOI 10.1074/mcp.R300007-MCP200; Celis JE, 2002, MOL CELL PROTEOMICS, V1, P269, DOI 10.1074/mcp.M100031-MCP200; Celis JE, 2009, MOL ONCOL, V3, P220, DOI 10.1016/j.molonc.2009.01.005; Celis JE, 2007, MOL ONCOL, V1, P1, DOI 10.1016/j.molonc.2007.02.003; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Cole K, 2011, CANCER BIOMARK, V9, P177, DOI 10.3233/CBM-2011-0187; Daino K, 2009, INT J CANCER, V125, P612, DOI 10.1002/ijc.24392; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gromov P, 2008, PROTEOM CLIN APPL, V2, P974, DOI 10.1002/prca.200780163; Gromov P, 2010, J PROTEOME RES, V9, P3941, DOI 10.1021/pr100160u; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Gromova I, 1998, INT J ONCOL, V13, P379; Jain KK, 2008, MOL ONCOL, V2, P153, DOI 10.1016/j.molonc.2008.05.003; Kashani-Sabet M, 2009, CLIN CANCER RES, V15, P6987, DOI 10.1158/1078-0432.CCR-09-1777; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Misek D. E., 2011, INT J PROTEOMICS, DOI 10.1155/2011/343582; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Moreira JMA, 2010, MOL ONCOL, V4, P539, DOI 10.1016/j.molonc.2010.09.005; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Ohlsson G, 2005, MOL CELL PROTEOMICS, V4, P570, DOI 10.1074/mcp.M500017-MCP200; Ostergaard M, 1999, ELECTROPHORESIS, V20, P349; Ostergaard M, 1997, CANCER RES, V57, P4111; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Su Hai-chuan, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P465; Whiteley GR, 2006, MOL BIOSYST, V2, P358, DOI 10.1039/b607260g; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zuo Ze-Hua, 2006, Ai Zheng, V25, P811; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45967	10.1371/journal.pone.0045967	http://dx.doi.org/10.1371/journal.pone.0045967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049907	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100110
J	Gui, YS; Wang, LM; Tian, XL; Feng, RE; Ma, AP; Cai, BQ; Zhang, HB; Xu, KF				Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Feng, Ruie; Ma, Aiping; Cai, Baiqiang; Zhang, Hongbing; Xu, Kai-Feng			SPC-Cre-ERT2 Transgenic Mouse for Temporal Gene Deletion in Alveolar Epithelial Cells	PLOS ONE			English	Article							CRE RECOMBINASE; MUTAGENESIS; MODEL	Although several Cre-loxP-based gene knockout mouse models have been generated for the study of gene function in alveolar epithelia in the lung, their applications are still limited. In this study, we developed a SPC-Cre-ERT2 mouse model, in which a tamoxifen-inducible Cre recombinase (Cre-ERT2) is under the control of the human surfactant protein C (SPC) promoter. The specificity and efficiency of Cre-ERT2 activity was first evaluated by crossing SPC-Cre-ERT2 mouse with ROSA26R mouse, alpha beta-galactosidase reporter strain. We found that Cre-ERT2 was expressed in 30.7% type II alveolar epithelial cells of SPC-Cre-ERT2/ROSA26R mouse lung tissues in the presence of tamoxifen. We then tested the tamoxifen-inducible recombinase activity of Cre-ERT2 in a mouse strain bearing TSC1 conditional knockout alleles (TSC1(fx/fx)). TSC1 deletion was detected in the lungs of tamoxifen treated SPC-Cre-ERT2/TSC1(fx/fx) mice. Therefore this SPC-Cre-ERT2 mouse model may be a valuable tool to investigate functions of genes in lung development, physiology and disease.	[Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Ma, Aiping; Cai, Baiqiang; Xu, Kai-Feng] Peking Union Med Coll, Dept Resp Med, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Feng, Ruie; Ma, Aiping; Cai, Baiqiang; Zhang, Hongbing; Xu, Kai-Feng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Lianmei; Zhang, Hongbing] Peking Union Med Coll, State Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Feng, Ruie] Peking Union Med Coll, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xu, KF (corresponding author), Peking Union Med Coll, Dept Resp Med, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China.	kaifeng.xu@gmail.com	Xu, Kai-Feng/AAO-2445-2020; Tian, Xinlun/AAF-5444-2019	Tian, Xinlun/0000-0003-4307-6665	973 Program of China [2009CB522106]	973 Program of China(National Basic Research Program of China)	The work was supported by the 973 Program of China (2009CB522106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Mura M, 2010, AM J PATHOL, V176, P1725, DOI 10.2353/ajpath.2010.090209; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; Sun JP, 2008, AM J PATHOL, V172, P571, DOI 10.2353/ajpath.2008.070286; Tafel Oliver, 2008, BMC Pulm Med, V8, P6, DOI 10.1186/1471-2466-8-6; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310	16	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46076	10.1371/journal.pone.0046076	http://dx.doi.org/10.1371/journal.pone.0046076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049940	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100132
J	Jha, A; Chauhan, R; Mehra, M; Singh, HR; Shankar, R				Jha, Ashwani; Chauhan, Rohit; Mehra, Mrigaya; Singh, Heikham Russiachand; Shankar, Ravi			miR-BAG: Bagging Based Identification of MicroRNA Precursors	PLOS ONE			English	Article							DEEP SEQUENCING DATA; HUMAN GENOME; COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; PREDICTION; CLASSIFICATION; TOOL; SOFTWARE; PROTEINS; HUNDREDS	Non-coding elements such as miRNAs play key regulatory roles in living systems. These ultra-short, similar to 21 bp long, RNA molecules are derived from their hairpin precursors and usually participate in negative gene regulation by binding the target mRNAs. Discovering miRNA candidate regions across the genome has been a challenging problem. Most of the existing tools work reliably only for limited datasets. Here, we have presented a novel reliable approach, miR-BAG, developed to identify miRNA candidate regions in genomes by scanning sequences as well as by using next generation sequencing (NGS) data. miR-BAG utilizes a bootstrap aggregation based machine learning approach, successfully creating an ensemble of complementary learners to attain high accuracy while balancing sensitivity and specificity. miR-BAG was developed for wide range of species and tested extensively for performance over a wide range of experimentally validated data. Consideration of position-specific variation of triplet structural profiles and mature miRNA anchored structural profiles had a positive impact on performance. miR-BAG's performance was found consistent and the accuracy level was observed to be >90% for most of the species considered in the present study. In a detailed comparative analysis, miR-BAG performed better than six existing tools. Using miR-BAG NGS module, we identified a total of 22 novel miRNA candidate regions in cow genome in addition to a total of 42 cow specific miRNA regions. In practice, discovery of miRNA regions in a genome demands high-throughput data analysis, requiring large amount of processing. Considering this, miR-BAG has been developed in multi-threaded parallel architecture as a web server as well as a user friendly GUI standalone version.	[Jha, Ashwani; Chauhan, Rohit; Mehra, Mrigaya; Singh, Heikham Russiachand; Shankar, Ravi] CSIR IHBT, Studio Computat Biol & Bioinformat Biotechnol Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Shankar, R (corresponding author), CSIR IHBT, Studio Computat Biol & Bioinformat Biotechnol Div, Palampur, Himachal Prades, India.	ravish9@gmail.com		jha, Ashwani/0000-0001-8752-3477	CSIR-EMPOWER [OLP-37]; Department of Biotechnology(DBT), Govt of India [BTPR/11098/BID/07/261/2008]	CSIR-EMPOWER; Department of Biotechnology(DBT), Govt of India(Department of Biotechnology (DBT) India)	The study has been funded by CSIR-EMPOWER grant OLP-37 and Department of Biotechnology(DBT), Govt of India, grant# BTPR/11098/BID/07/261/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, J MACH LEARN RES, V10, P931; Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gardner PP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-140; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Saetrom P, 2006, OLIGONUCLEOTIDES, V16, P115, DOI 10.1089/oli.2006.16.115; Smalheiser NR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-403; Soler E, 2006, REPROD NUTR DEV, V46, P579, DOI 10.1051/rnd:2006029; Tanzer Andrea, 2006, V342, P335; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	49	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45782	10.1371/journal.pone.0045782	http://dx.doi.org/10.1371/journal.pone.0045782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049860	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100078
J	Nie, ZY; Fryer, AD; Jacoby, DB				Nie, Zhenying; Fryer, Allison D.; Jacoby, David B.			beta(2)-Agonists Inhibit TNF-alpha-Induced ICAM-1 Expression in Human Airway Parasympathetic Neurons	PLOS ONE			English	Article							CHALLENGED GUINEA-PIGS; INTERCELLULAR-ADHESION MOLECULE-1; MUSCARINIC RECEPTOR FUNCTION; BETA-ADRENERGIC AGONISTS; B-MEDIATED TRANSCRIPTION; MAJOR BASIC-PROTEIN; ACETYLCHOLINE-RELEASE; EOSINOPHIL ADHESION; CHOLINERGIC NERVES; RACEMIC ALBUTEROL	Background: Major basic protein released from eosinophils to airway parasympathetic nerves blocks inhibitory M-2 muscarinic receptors on the parasympathetic nerves, increasing acetylcholine release and potentiating reflex bronchoconstriction. Recruitment of eosinophils to airway parasympathetic neurons requires neural expression of both intercellular adhesion molecular-1 (ICAM-1) and eotaxin. We have shown that inflammatory cytokines induce eotaxin and ICAM-1 expression in parasympathetic neurons. Objective: To test whether the beta(2) agonist albuterol, which is used to treat asthma, changes TNF-alpha-induced eotaxin and ICAM-1 expression in human parasympathetic neurons. Methods: Parasympathetic neurons were isolated from human tracheas and grown in serum-free medium for one week. Cells were incubated with either (R)-albuterol (the active isomer), (S)-albuterol (the inactive isomer) or (R, S)-albuterol for 90 minutes before adding 2 ng/ml TNF-alpha for another 4 hours (for mRNA) or 24 hours (for protein). Results and Conclusions: Baseline expression of eotaxin and ICAM-1 were not changed by any isomer of albuterol as measured by real time RT-PCR. TNF-alpha induced ICAM-1 expression was significantly inhibited by (R)-albuterol in a dose dependent manner, but not by (S) or (R, S)-albuterol. Eotaxin expression was not changed by TNF-alpha or by any isomer of albuterol. The beta-receptor antagonist propranolol blocked the inhibitory effect of (R)-albuterol on TNF-alpha-induced ICAM-1 expression. Clinical Implication: The suppressive effect of (R)-albuterol on neural ICAM-1 expression may be an additional mechanism for decreasing bronchoconstriction, since it would decrease eosinophil recruitment to the airway nerves.	[Nie, Zhenying; Fryer, Allison D.; Jacoby, David B.] Oregon Hlth & Sci Univ, Sch Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA	Oregon Health & Science University	Nie, ZY (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	niez@ohsu.edu	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Jacoby, David/0000-0003-2195-9512	National Institutes of Health [HL55543, HL54659, HL071795, ES014601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054659, R01HL055543, R01HL071795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014601, R01ES017592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funders (grants from National Institutes of Health: HL55543 (ADF), HL54659 (DBJ), HL071795 (DBJ), ES014601 (DBJ)) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sepracor Inc provided albuterol and funding to support part of experiment supplies in this study. But Sepracor Inc also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameredes BT, 2005, J ALLERGY CLIN IMMUN, V116, P65, DOI 10.1016/j.jaci.2005.03.007; Baramki D, 2002, J ALLERGY CLIN IMMUN, V109, P449, DOI 10.1067/mai.2002.122159; Belvisi MG, 1996, BRIT J PHARMACOL, V117, P1413, DOI 10.1111/j.1476-5381.1996.tb15300.x; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; ELBON CL, 1995, AM J RESP CELL MOL, V12, P320, DOI 10.1165/ajrcmb.12.3.7873198; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Handley DA, 2000, J ASTHMA, V37, P319, DOI 10.3109/02770900009055455; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Kikuchi I, 2006, AM J RESP CELL MOL, V34, P760, DOI 10.1165/rcmb.2005-0303OC; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; Nie Z, 2007, J ALLERGY CLIN IMMUN; Nie ZY, 2009, BRIT J PHARMACOL, V156, P201, DOI 10.1111/j.1476-5381.2008.00045.x; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; Penn RB, 1996, CLIN REV ALLERG IMMU, V14, P37, DOI 10.1007/BF02772201; Reid DW, 2003, EUR RESPIR J, V21, P994, DOI 10.1183/09031936.03.00109702; Sawatzky DA, 2002, AM J PHYSIOL-LUNG C, V282, pL1279, DOI 10.1152/ajplung.00279.2001; Stanciu LA, 1998, EUR RESPIR J, V11, P949, DOI 10.1183/09031936.98.11040949; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Volcheck GW, 2005, CLIN EXP ALLERGY, V35, P1341, DOI 10.1111/j.1365-2222.2005.02347.x; Walsh MT, 2004, AM J RESP CELL MOL, V30, P333, DOI 10.1165/rcmb.2003-0188OC; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; WEGNER CD, 1991, AGENT ACTION SUPPL, V34, P529; Zhang XY, 1996, RESP PHYSIOL, V106, P81, DOI 10.1016/0034-5687(96)00062-X; ZHANG XY, 1995, AM J PHYSIOL-LUNG C, V268, pL950, DOI 10.1152/ajplung.1995.268.6.L950	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44780	10.1371/journal.pone.0044780	http://dx.doi.org/10.1371/journal.pone.0044780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049757	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100021
J	Manchanda, PK; Jones, GN; Lee, AA; Pringle, DR; Zhang, M; Yu, L; La Perle, KMD; Kirschner, LS				Manchanda, P. K.; Jones, G. N.; Lee, A. A.; Pringle, D. R.; Zhang, M.; Yu, L.; La Perle, K. M. D.; Kirschner, L. S.			Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors	ONCOGENE			English	Article						PKA; PRKAR1A; Schwann cell tumor; Rac1; Merlin	PROTEIN-KINASE-A; NEUROFIBROMATOSIS TYPE-2 GENE; MEDIATES CONTACT INHIBITION; P21-ACTIVATED KINASE; CYCLIC-AMP; NEURAL CREST; MERLIN; GROWTH; PHOSPHORYLATION; PRODUCT	Schwannomas are peripheral nerve sheath tumors that often occur in the setting of an inherited tumor predisposition syndrome, including neurofibromatosis types 1 (NF1) and 2 (NF2), familial schwannomatosis and Carney complex. Loss of the NF2 tumor suppressor (encoding NF2, or Merlin) is associated with upregulation of the Rac1 small GTPase, which is thought to have a key role in mediating tumor formation. In prior studies, we generated a mouse model of schwannomas by performing tissue-specific knockout (KO) of the Carney complex gene Prkar1a, which encodes the type 1A regulatory subunit of protein kinase A. These tumors exhibited down-regulation of Nf2 protein and an increase in activated Rac1. To assess the requirement for Rac1 in schwannoma formation, we generated a double KO (DKO) of Prkar1a and Rac1 in Schwann cells and monitored tumor formation. Loss of Rac1 reduced tumor formation by reducing proliferation and enhancing apoptosis. Surprisingly, the reduction of tumor formation was accompanied by re-expression of the Nf2 protein. Furthermore, activated Rac1 was able to downregulate Nf2 in vitro in a Pak-dependent manner. These in vivo data indicate that activation of Rac1 is responsible for suppression of Nf2 protein production; deficiency of Nf2 in Schwann cells leads to loss of cellular growth control and tumor formation. Further, PKA activation through mutation in Prkar1a is sufficient to initiate Rac1 signaling, with subsequent reduction of Nf2 and schwannomagenesis. Although in vitro evidence has shown that loss of Nf2 activates Rac1, our data indicate that signaling between Nf2 and Rac1 occurs in a bidirectional fashion, and these interactions are modulated by PKA.	[Manchanda, P. K.; Jones, G. N.; Lee, A. A.; Pringle, D. R.; Zhang, M.; Kirschner, L. S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Yu, L.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [La Perle, K. M. D.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Kirschner, L. S.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kirschner, LS (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, 420 West 12th Ave,Tzagournis Res Facil 544, Columbus, OH 43210 USA.	Lawrence.Kirschner@osumc.edu	La Perle, Krista Marie DuBray/B-3099-2015; yu, lianbo/B-3472-2010		Department of Defense (DOD) Neurofibromatosis program; NATIONAL CANCER INSTITUTE [R01CA112268, P01CA124570, P30CA016058] Funding Source: NIH RePORTER	Department of Defense (DOD) Neurofibromatosis program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from the Department of Defense (DOD) Neurofibromatosis program. We thank Dr Matthew D Ringel and Dr Motoyasu Saji for insightful discussions.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Bashour AM, 2002, MOL CELL BIOL, V22, P1150, DOI 10.1128/MCB.22.4.1150-1157.2002; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chan JR, 2007, J CELL BIOL, V177, P953, DOI 10.1083/jcb.200705105; Cotteret S, 2002, GENOME BIOL, V3; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Feltri ML, 2008, GLIA, V56, P1508, DOI 10.1002/glia.20752; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Gautreau A, 2002, J BIOL CHEM, V277, P31279, DOI 10.1074/jbc.C200125200; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; Izawa I, 1996, FEBS LETT, V382, P53, DOI 10.1016/0014-5793(96)00137-8; Jones GN, 2008, NEOPLASIA, V10, P1213, DOI 10.1593/neo.08652; Jones GN, 2010, MOL ENDOCRINOL, V24, P1559, DOI 10.1210/me.2009-0439; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 2001, J NEUROSCI, V21, P1110; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Kissil Joseph L, 2010, Am J Med Genet A, V152A, P269, DOI 10.1002/ajmg.a.33189; Krause S, 2008, J PERIPHER NERV SYST, V13, P188, DOI 10.1111/j.1529-8027.2008.00177.x; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laulajainen M, 2008, ONCOGENE, V27, P3233, DOI 10.1038/sj.onc.1210988; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; SAINZ J, 1994, HUM MOL GENET, V3, P885, DOI 10.1093/hmg/3.6.885; Schulze KMM, 2002, HUM MOL GENET, V11, P69, DOI 10.1093/hmg/11.1.69; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stemmer-Rachamimov AO, 2004, CANCER RES, V64, P3718, DOI 10.1158/0008-5472.CAN-03-4079; Thaxton C, 2008, ONCOGENE, V27, P2705, DOI 10.1038/sj.onc.1210923; Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Tonks ID, 2003, GENESIS, V37, P131, DOI 10.1002/gene.10242; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yin Z, 2008, GENESIS, V46, P37, DOI 10.1002/dvg.20362; Zhang M, 2010, PROSTATE, V70, P807, DOI 10.1002/pros.21114	50	17	20	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3491	3499		10.1038/onc.2012.374	http://dx.doi.org/10.1038/onc.2012.374			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	23045281	Green Accepted			2022-12-25	WOS:000322220800002
J	Du, Y; An, SO; Liu, L; Li, L; Zhou, XJ; Mason, RP; Mohan, C				Du, Yong; An, Shion; Liu, Li; Li, Li; Zhou, Xin J.; Mason, Ralph P.; Mohan, Chandra			Serial Non-Invasive Monitoring of Renal Disease Following Immune-Mediated Injury Using Near-Infrared Optical Imaging	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; IRON-OXIDE; IN-VIVO; ADHESION; ALPHA-V-BETA-3-INTEGRIN; INFLAMMATION; BIOMARKERS; MORTALITY; NEPHRITIS; SURGERY	Background: Non-invasive monitoring of disease progression in kidney disease is still a major challenge in clinical practice. In vivo near-infrared (NIR) imaging provides a new tool for studying disease mechanisms and non-invasive monitoring of disease development, even in deep organs. The LI-COR IRDye (R) 800CW RGD optical probe (RGD probe) is a NIR fluorophore, that can target integrin alpha v beta 3 (alpha(v)beta(3)) in tissues. Objective: This study aims to monitor renal disease progression in an anti-glomerular basement membrane (GBM) nephritis mouse model. Methods: Anti-GBM nephritis was induced in 129x1/svJ mice by anti-GBM serum challenge. The expression of integrin alpha(v)beta(3) in the diseased kidney was examined by immunohistochemistry and quantitative polymerase chain reaction. The RGD probe and control fluorophores, the 800CW dye, and the BSA-conjugated 800CW dye, were administered into anti-GBM nephritic mice. LI-COR Pearl (R) Impulse imaging system was used for in vivo imaging; while ex vivo organ imaging was acquired using the Maestro (TM) imaging system. Results: Kidney tissue from anti-GBM nephritic mice showed higher levels of integrin alpha(v)beta(3) expression at both the protein and the mRNA level compared to normal mice. The RGD probe allowed in vivo renal imaging and the fluorescent signal could be specifically captured in the diseased kidneys up to 14 days, reflecting longitudinal changes in renal function. Conclusion: The infrared RGD molecular probe that tracks integrin expression can be successfully used to monitor renal disease progression following immune-mediated nephritis.	[Du, Yong; An, Shion; Liu, Li; Li, Li; Zhou, Xin J.; Mason, Ralph P.; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Mason, RP (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	Ralph.mason@utsouthwestern.edu; chandra.mohan@utsouthwestern.edu	Mohan, Chandra/GPX-8233-2022; Mason, Ralph/C-8472-2012; Liu, LI/B-6912-2013; DU, YONG/B-9964-2011	Mason, Ralph/0000-0001-7517-3721; Liu, LI/0000-0002-9731-6145; DU, YONG/0000-0003-1687-9024	National Institutes of Health [AR050812, DK 081872]; NATIONAL CANCER INSTITUTE [U24CA126608, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health funding AR050812 and DK 081872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BARALDI A, 1995, NEPHROL DIAL TRANSPL, V10, P1155, DOI 10.1093/ndt/10.7.1155; Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956; Coca SG, 2008, CLIN J AM SOC NEPHRO, V3, P481, DOI 10.2215/CJN.03520807; Crane LM, 2010, JOVE-J VIS EXP, V44, P2225; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Escobedo JO, 2010, CURR OPIN CHEM BIOL, V14, P64, DOI 10.1016/j.cbpa.2009.10.022; Fischer EG, 2004, BIOCHEM CELL BIOL, V82, P597, DOI 10.1139/O04-051; Fu YY, 2007, CLIN IMMUNOL, V124, P109, DOI 10.1016/j.clim.2007.05.007; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hauger O, 2000, RADIOLOGY, V217, P819, DOI 10.1148/radiology.217.3.r00dc04819; Hayashida T, 2010, J BIOL CHEM, V285, P30741, DOI 10.1074/jbc.M110.105700; Herborn CU, 2002, INVEST RADIOL, V37, P464, DOI 10.1097/00004424-200208000-00008; Jin DK, 1996, J AM SOC NEPHROL, V7, P2636; KANAHARA K, 1994, NEPHRON, V66, P29, DOI 10.1159/000187762; Karadeli E, 2010, RHEUMATOL INT, V30, P1177, DOI 10.1007/s00296-009-1124-z; Kossodo S, 2010, MOL IMAGING BIOL, V12, P488, DOI 10.1007/s11307-009-0279-z; Lahita RG, 2010, SYSTEMIC LUPUS ERYTH, P453; Lee DK, 2010, J CLIN NEUROL, V6, P10, DOI 10.3988/jcn.2010.6.1.10; Mankoff DA, 2007, J NUCL MED, V48, p18N; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Nakamura K, 2010, J CONTROL RELEASE, V148, P351, DOI 10.1016/j.jconrel.2010.09.005; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Patey N, 1996, J PATHOL, V179, P414; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; RoyChaudhury P, 1997, KIDNEY INT, V52, P103, DOI 10.1038/ki.1997.309; Sadick M, 2011, NEPHROL DIAL TRANSPL, V26, P3101, DOI 10.1093/ndt/gfr148; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; SHIKATA K, 1995, AM J KIDNEY DIS, V25, P680, DOI 10.1016/0272-6386(95)90542-1; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	38	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43941	10.1371/journal.pone.0043941	http://dx.doi.org/10.1371/journal.pone.0043941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049742	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300008
J	Juyal, RC; Negi, S; Wakhode, P; Bhat, S; Bhat, B; Thelma, BK				Juyal, Ramesh C.; Negi, Sapna; Wakhode, Preeti; Bhat, Sulekha; Bhat, Bheema; Thelma, B. K.			Potential of Ayurgenomics Approach in Complex Trait Research: Leads from a Pilot Study on Rheumatoid Arthritis	PLOS ONE			English	Article							LIPID-PEROXIDATION; DISEASE SEVERITY; REACTIVE OXYGEN; ASSOCIATION; GENE; POLYMORPHISMS; CLASSIFICATION; VARIABILITY; AYURVEDA; REGION	Background: Inconsistent results across association studies including Genome-wide association, have posed a major challenge in complex disease genetics. Of the several factors which contribute to this, phenotypic heterogeneity is a serious limitation encountered in modern medicine. On the other hand, Ayurveda, a holistic Indian traditional system of medicine, enables subgrouping of individuals into three major categories namely Vata, Pitta and Kapha, based on their physical and mental constitution, referred to as Prakriti. We hypothesised that conditioning association studies on prior risk, predictable in Ayurveda, will uncover much more variance and potentially open up more predictive health. Objectives and Methods: Identification of genetic susceptibility markers by combining the prakriti based subgrouping of individuals with genetic analysis tools was attempted in a Rheumatoid arthritis (RA) cohort. Association of 21 markers from commonly implicated inflammatory and oxidative stress pathways was tested using a case-control approach in a total cohort comprising 325 cases and 356 controls and in the three subgroups separately. We also tested few postulates of Ayurveda on the disease characteristics in different prakriti groups using clinico-genetic data. Results: Inflammatory genes like IL1 beta (C-C-C haplotype, p = 0.0005, OR = 3.09) and CD40 (rs4810485 allelic, p = 0.04, OR = 2.27) seem to be the determinants in Vata subgroup whereas oxidative stress pathway genes are observed in Pitta (SOD3 rs699473, p = 0.004, OR = 1.83; rs2536512 p = 0.005; OR = 1.88 and PON1 rs662, p = 0.04, OR = 1.53) and Kapha (SOD3 rs2536512, genotypic, p = 0.02, OR = 2.39) subgroups. Fixed effect analysis of the associated markers from CD40, SOD3 and TNF alpha with genotype X prakriti interaction terms suggests heterogeneity of effects within the subgroups. Further, disease characteristics such as severity was most pronounced in Vata group. Conclusions: This exploratory study suggests discrete causal pathways for RA etiology in prakriti based subgroups, thereby, validating concepts of prakriti and personalized medicine in Ayurveda. Ayurgenomics approach holds promise for biomarker discovery in complex diseases.	[Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Juyal, Ramesh C.; Negi, Sapna] Natl Inst Immunol, Expt Anim Facil, New Delhi 110067, India; [Wakhode, Preeti; Bhat, Sulekha; Bhat, Bheema] Holy Family Hosp, Dept Ayurveda, New Delhi, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Thelma, BK (corresponding author), Univ Delhi, Dept Genet, South Campus, New Delhi, India.	thelmabk@gmail.com	Negi, Sapna/HGA-5265-2022	Thelma, B.K/0000-0002-2154-5443	Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi [Z.31018/18/2006-RP]	Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi	The financial assistance for this work was provided by Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi, vide F.No. Z.31018/18/2006-R&P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002; Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; [Anonymous], 2000, SUSRUTA SAMHITA; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baskol G, 2005, CLIN BIOCHEM, V38, P951, DOI 10.1016/j.clinbiochem.2005.06.010; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; Bhushan P, 2005, J ALTERN COMPLEM MED, V11, P349, DOI 10.1089/acm.2005.11.349; Buchs N, 2001, GENES IMMUN, V2, P222, DOI 10.1038/sj.gene.6363766; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Dasgupta S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-7; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fonseca JE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2173; Grabar PB, 2009, DIS MARKERS, V26, P41, DOI 10.3233/DMA-2009-0603; Harris ML, 2008, ARTHRITIS RHEUM-US, V58, P1958, DOI 10.1002/art.23596; Hee CS, 2007, MOD RHEUMATOL, V5, P429; Ichikawa N, 2009, MOD RHEUMATOL, V19, P134, DOI 10.1007/s10165-008-0134-0; Lee YH, 2012, INFLAMM RES, V61, P665, DOI 10.1007/s00011-012-0459-1; Martinez A, 2003, GENES IMMUN, V4, P117, DOI 10.1038/sj.gene.6363931; Mulcahy B, 1996, AM J HUM GENET, V59, P676; Naganuma T, 2008, HEREDITAS, V145, P283, DOI 10.1111/j.1601-5223.2008.02086.x; Patwardhan B, 2012, CURRENT SCI, V10, P1406; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Prasher B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-48; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; Sethi TP, 2011, ACS CHEM BIOL, V6, P875, DOI 10.1021/cb2003016; Sharma P., 2003, CHARAKA SAMHITA; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Srikanthamurthy KR, 2001, MADHAVA NIDANAM MADH; Srikanthamurthy KR, 2003, ASHTANGA HRIDAYAM; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Thelma B. K., 2008, PHISPC SERIES HIST S; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; Turesson C, 2006, MAYO CLIN PROC, V81, P94, DOI 10.4065/81.1.94; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720	41	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45752	10.1371/journal.pone.0045752	http://dx.doi.org/10.1371/journal.pone.0045752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049851	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300048
J	Wang, CL; Su, YJ; Zhang, LM; Wang, M; You, J; Zhao, XL; Zhang, ZF; Liu, J; Hao, XS				Wang, Changli; Su, Yanjun; Zhang, Lianmin; Wang, Meng; You, Jian; Zhao, Xiaoliang; Zhang, Zhenfa; Liu, Jun; Hao, Xishan			The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; BETA-CATENIN; CANCER PROGRESSION; BREAST-CANCER; EMT; PATIENT; PHOSPHORYLATION; GROWTH; CELLS; ACTIVATION	The SARI (suppressor of AP-1, regulated by IFN) gene, which is also called BATF2, is associated with the risk of several kinds of cancer, and loss of SARI expression is frequently detected in aggressive and metastatic cancer. However, the functional role of SARI in lung adenocarcinoma remains unknown. We have shown that loss of SARI expression initiates epithelial-mesenchymal transition (EMT), which is visualized by repression of E-cadherin and up-regulation of vimentin in lung adenocarcinoma cell lines and in clinical lung adenocarcinoma specimens. Using a human lung xenograft-mouse model, we observed that knocking down endogenous SARI in human carcinoma cells leads to the development of multiple lymph node metastases. Moreover, we showed that SARI functions as a critical protein in regulating EMT by modulating the (GSK)-3 beta-beta-catenin signaling pathway. These results demonstrate the mechanism of SARI function in EMT and suggest that assessment of SARI may serve as a prognostic biomarker and potential therapeutic target for lung adenocarcinoma metastasis.	[Wang, Changli; Su, Yanjun; Zhang, Lianmin; Wang, Meng; You, Jian; Zhao, Xiaoliang; Zhang, Zhenfa; Liu, Jun; Hao, Xishan] Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Tianjin, Peoples R China	Tianjin Medical University	Liu, J (corresponding author), Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Tianjin, Peoples R China.	liujun0129@gmail.com; xishanhao_1@163.com	Rui, Zhenhua/J-8195-2019	Rui, Zhenhua/0000-0001-6088-0845	National Natural Science Foundation of China [81101776]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, 81101776. The funders had role in study design.	Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Dash R, 2010, ONCOGENE, V29, P4412, DOI 10.1038/onc.2010.194; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Hata A, 2011, LUNG CANC; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Kim AN, 2011, BIOCHEM BIOPH RES CO, V407, P181, DOI 10.1016/j.bbrc.2011.02.134; Kook EH, 2010, ONCOL RES, V18, P445, DOI 10.3727/096504010X12671222663674; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kyprianou N, 2010, P NATL ACAD SCI USA, V107, P2731, DOI 10.1073/pnas.0914721107; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Longo F, 2011, ONKOLOGIE, V34, P326, DOI 10.1159/000328788; Maschler S, 2010, EMBO MOL MED, V2, P401, DOI 10.1002/emmm.201000095; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nozawa N, 2006, PATHOL RES PRACT, V202, P639, DOI 10.1016/j.prp.2006.03.007; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Rich AL, 2011, BRIT J CANCER, V105, P746, DOI 10.1038/bjc.2011.310; Strand A, 2000, BIOCHEM SYST ECOL, V28, P443, DOI 10.1016/S0305-1978(99)00078-2; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Weng JH, 2011, CLIN NUCL MED, V36, P731, DOI 10.1097/RLU.0b013e31821a26bf; Zhang HJ, 2011, MOL CELL BIOCHEM, V355, P309, DOI 10.1007/s11010-011-0869-3	33	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e38046	10.1371/journal.pone.0038046	http://dx.doi.org/10.1371/journal.pone.0038046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049725	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300001
J	Edmond, V; Ghali, B; Penna, A; Taupin, JL; Daburon, S; Moreau, JF; Legembre, P				Edmond, Valerie; Ghali, Benoist; Penna, Aubin; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois; Legembre, Patrick			Precise Mapping of the CD95 Pre-Ligand Assembly Domain	PLOS ONE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; LOW-AFFINITY RECEPTOR; FAS GENE-MUTATIONS; APOPTOSIS; ACTIVATION; SIGNAL; DEATH; SIALYLATION; BINDING	Pre-association of CD95 at the plasma membrane is mandatory for efficient death receptor signaling. This homotrimerization occurs through self-association of an extracellular domain called the pre-ligand assembly domain (PLAD). Using novel molecular and cellular tools, we confirmed that CD95-PLAD is necessary to promote CD95 multimerization and plays a pivotal role in the transmission of apoptotic signals. However, while a human CD95 mutant deleted of the previously described PLAD domain (amino acids 1 to 66) fails to interact with its wild-type counterpart and trigger autonomous cell death, deletion of amino acids 1 to 42 does not prevent homo- or hetero (human/mouse)oligomerization of CD95, and thus does not alter transmission of the apoptotic signal. Overall, these findings indicate that the region between amino acids 43 to 66 corresponds to the minimal motif involved in CD95 homotypic interaction and is necessary to convey an efficient apoptotic signal. Interfering with this PLAD may represent a new therapeutic strategy for altering CD95-induced apoptotic and non-apoptotic signals.	[Edmond, Valerie; Penna, Aubin; Legembre, Patrick] Univ Rennes 1, Rennes, France; [Edmond, Valerie; Penna, Aubin; Legembre, Patrick] INSERM, U1085, IRSET, Rennes, France; [Ghali, Benoist; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois] Univ Bordeaux 2, F-33076 Bordeaux, France; [Ghali, Benoist; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois] CNRS, UMR 5164, Bordeaux, France; [Taupin, Jean-Luc; Moreau, Jean-Francois] CHU Bordeaux, Bordeaux, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Legembre, P (corresponding author), Univ Rennes 1, Rennes, France.	patrick.legembre@inserm.fr	Legembre, Patrick/U-1882-2019; legembre, patrick/L-3475-2016; penna, aubin/AAD-2550-2019; PENNA, aubin/E-2208-2018	Legembre, Patrick/0000-0001-6649-8049; legembre, patrick/0000-0001-6649-8049; penna, aubin/0000-0002-1070-5990; PENNA, aubin/0000-0002-1070-5990	Agence Nationale de la Recherche [ANR JC07_183182]; Institut National du Cancer INCa (projets libres recherche biomedicale); Canceropole GO; Fondation pour la Recherche Medicale; Region Bretagne; Rennes Metropole; Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer INCa (projets libres recherche biomedicale); Canceropole GO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Bretagne(Region Bretagne); Rennes Metropole(Region Bretagne); Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine)	This work was supported by Agence Nationale de la Recherche (ANR JC07_183182), Institut National du Cancer INCa (projets libres recherche biomedicale), Canceropole GO, Fondation pour la Recherche Medicale, Region Bretagne, Rennes Metropole, Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Garcia-Fuster MJ, 2004, EUR J PHARMACOL, V496, P63, DOI 10.1016/j.ejphar.2004.06.018; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; KISHIMOTO T, 1994, STEM CELLS, V12, P37; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Legembre P, 2003, J IMMUNOL, V171, P5659, DOI 10.4049/jimmunol.171.11.5659; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Pensati L, 1997, GASTROENTEROLOGY, V113, P1384, DOI 10.1053/gast.1997.v113.pm9322534; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Taupin JL, 1999, J BIOL CHEM, V274, P14482, DOI 10.1074/jbc.274.20.14482; Tauzin S, 2011, CD95 MEDIATED CELL S; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; Voisin MB, 2002, J BIOL CHEM, V277, P13682, DOI 10.1074/jbc.M111624200	28	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46236	10.1371/journal.pone.0046236	http://dx.doi.org/10.1371/journal.pone.0046236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049989	Green Published, gold			2022-12-25	WOS:000309556100162
J	Genini, D; Garcia-Escudero, R; Carbone, GM; Catapano, CV				Genini, Davide; Garcia-Escudero, Ramon; Carbone, Giuseppina M.; Catapano, Carlo V.			Transcriptional and Non-Transcriptional Functions of PPAR beta/delta in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; NUCLEAR RECEPTORS; ADENOMA GROWTH; KAPPA-B; CARCINOGENESIS; EXPRESSION; GAMMA; INHIBITION; COLON	Peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) is a nuclear receptor involved in regulation of lipid and glucose metabolism, wound healing and inflammation. PPAR beta/delta has been associated also with cancer. Here we investigated the expression of PPAR beta/delta and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC). We found increased expression of PPAR beta/delta, Cox-2, cPLA(2), PGES and VEGF in human NSCLC compared to normal lung. In NSCLC cell lines PPAR beta/delta activation increased proliferation and survival, while PPAR beta/delta knock-down reduced viability and increased apoptosis. PPAR beta/delta agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis. These effects were seen only in high PPAR beta/delta expressing cells, while low expressing cells were less or not affected. The effects were also abolished by PPAR beta/delta knock-down or incubation with a PPAR beta/delta antagonist. Induction of VEGF was due to both binding of PPAR beta/delta to the VEGF promoter and PI3K activation through a non-genomic mechanism. We found that PPAR beta/delta interacted with the PI3K regulatory subunit p85a leading to PI3K activation and Akt phosphorylation. Collectively, these data indicate that PPAR beta/delta might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.	[Genini, Davide; Carbone, Giuseppina M.; Catapano, Carlo V.] Inst Oncol Res IOR, Bellinzona, Switzerland; [Genini, Davide; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid, Spain	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Catapano, CV (corresponding author), Inst Oncol Res IOR, Bellinzona, Switzerland.	carlo.catapano@ior.iosi.ch	Garcia-Escudero, Ramon/A-2735-2012	Garcia-Escudero, Ramon/0000-0001-5640-6542; Catapano, Carlo V./0000-0002-7079-557X	Fondazione Ticinese per la ricerca sul cancro	Fondazione Ticinese per la ricerca sul cancro	This was supported by "Fondazione Ticinese per la ricerca sul cancro.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ermert L, 2003, CLIN CANCER RES, V9, P1604; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Genini D, 2007, J BIOL CHEM, V282, P11776, DOI 10.1074/jbc.M609149200; Genini D, 2008, PPAR RES, V2008, DOI 10.1155/2008/195065; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glinghammar B, 2003, BIOCHEM BIOPH RES CO, V308, P361, DOI 10.1016/S0006-291X(03)01384-6; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Keith RL, 2004, CANCER RES, V64, P5897, DOI 10.1158/0008-5472.CAN-04-1070; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Pedchenko TV, 2008, AM J RESP CELL MOL, V39, P689, DOI 10.1165/rcmb.2007-0426OC; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Reed KR, 2004, ONCOGENE, V23, P8992, DOI 10.1038/sj.onc.1208143; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Yoshinaga M, 2011, DIGEST DIS SCI, V56, P1194, DOI 10.1007/s10620-010-1389-9; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	42	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46009	10.1371/journal.pone.0046009	http://dx.doi.org/10.1371/journal.pone.0046009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049921	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100118
J	Li, J; Lau, G; Chen, LL; Yuan, YF; Huang, J; Luk, JM; Xie, D; Guan, XY				Li, Jian; Lau, George; Chen, Leilei; Yuan, Yun-Fei; Huang, Jun; Luk, John M.; Xie, Dan; Guan, Xin-Yuan			Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression	PLOS ONE			English	Article							TUMOR-METASTASIS; IL-23; IL-12; CARCINOGENESIS; INFLAMMATION; DISTINCT; GROWTH; INNATE	Background: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor prognosis, which often develops from chronic liver inflammatory diseases. Interleukin 23 (IL-23) is an inflammatory cytokine which is reported to play an important role in tumor development in animal model. While the function of IL-23 in HCC development remains unknown, so we investigate the role of IL-23 in HCC progression in this study. Methodology and Principal Finding: Transcript level of IL-23, interleukin 17A (IL-17A) and matrix metalloproteinases 9 (MMP9) in clinical HCC samples (n = 81) was determined by qPCR. Protein expression pattern of IL-23 in primary and metastatic HCC tissues pairs (n = 49 pairs) was determined by immunohistochemistry staining. Cell migration, invasion, RNA interfering and immune blotting were used to characterize the functional and signaling mechanisms in IL-23-treated HCC. Compared with paired non-tumor tissue, higher IL-23 expression was detected in HCC tumor tissues with metastasis. Immunohistochemistry staining confirmed the high expression of IL-23 in metastasis HCC. Immune blotting demonstrated that IL-23 was highly expressed in HCC cell lines with metastasis. Functional study found that IL-23 could promote HCC cell migration and invasion. Molecular analysis revealed that IL-23 could upregulate MMP9 expression via NF-kappa B/p65 signaling activation and IL-17A could improve IL-23 expression in tumor cells directly via activating NF-kappa B/p65 signaling pathway. Conclusions: IL-23 could promote HCC metastasis by the upregulation of MMP9 expression via activating NF-kappa B/p65 signaling pathway. At the same time, IL-17A could further promote IL-23 expression in HCC tumor cells.	[Li, Jian; Yuan, Yun-Fei; Huang, Jun; Xie, Dan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jian; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Li, Jian; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lau, George] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Luk, John M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Guan, XY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xyguan@hku.hk	Huang, Jun/J-7002-2015; Luk, John/A-4085-2008; /A-3639-2009	Huang, Jun/0000-0002-1891-8237; Luk, John/0000-0002-6323-7940; /0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878; Yuan, Yunfei/0000-0003-2467-3683	National Basic Research Program of China [2012CB967000]; National Natural Science Foundation of China [30971606, 30772475]; Hong Kong Research Grant Council Collaborative Research Fund [HKBU5/CRG/10]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council Collaborative Research Fund	This work was supported by the National Basic Research Program of China (2012CB967000), grants from National Natural Science Foundation of China (30971606 and 30772475) and Hong Kong Research Grant Council Collaborative Research Fund (HKBU5/CRG/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x	16	30	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46264	10.1371/journal.pone.0046264	http://dx.doi.org/10.1371/journal.pone.0046264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050001	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100172
J	Ying, M; Liu, G; Shimada, H; Ding, W; May, WA; He, Q; Adams, GB; Wu, L				Ying, M.; Liu, G.; Shimada, H.; Ding, W.; May, W. A.; He, Q.; Adams, G. B.; Wu, L.			Human osteosarcoma CD49f(-) CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity	ONCOGENE			English	Article						osteosarcoma-initiating cells; self-renewal; tumorigenicity; lineage differentiation; osteosarcoma-forming cells; osteogenic differentiation	CANCER-STEM-CELLS; PROSPECTIVE IDENTIFICATION; INITIATING CELLS; TUMOR-GROWTH; EXPRESSION; DIFFERENTIATION; MARKERS; METASTASIS; EXPANSION; ANTIGEN	The biological relationships among self-renewal, tumorigenicity and lineage differentiation of human osteosarcoma-initiating cells (OSIC) remain elusive, making it difficult to identify and distinguish OSIC from osteosarcoma-forming cells (OSFC) for developing OSIC-targeted therapies. Using a new inverse-lineage tracking strategy coupled with serial human-to-mouse xenotransplantation, we identified a subpopulation of osteosarcoma cells with OSIC-like properties and sought to distinguish them from their progeny, OSFC. We found that serial transplantation of cells from different osteosarcoma cell lines and primary osteosarcoma tissues progressively increased the CD49f(+) subpopulation composing the bulk of the osteosarcoma mass. These CD49f(+) cells displayed characteristics of OSFC: limited in vivo tumorigenicity, weak lineage differentiation, more differentiated osteogenic feature and greater chemo-sensitivity. By contrast, their parental CD49f(-) CD133(+) cells had an inhibited osteogenic fate, together with OSIC-like properties of self-renewal, strong tumorigenicity and differentiation to CD49f(+) progeny. Hence, the CD49f(-)CD133(+) phenotype appears to identify OSIC-like cells that possess strong tumorigenicity correlated with an impaired osteogenic fate and the ability to initiate tumor growth through the generation of CD49f(+) progeny. These findings advance our understanding of OSIC-like properties and, for the first time, provide a much-needed distinction between OSIC and OSFC in this cancer.	[Ying, M.; Liu, G.; Shimada, H.; Ding, W.; Wu, L.] Childrens Hosp Los Angeles, Dept Pathol, Saban Res Inst, Los Angeles, CA 90027 USA; [Shimada, H.; May, W. A.; Adams, G. B.; Wu, L.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA; [May, W. A.] Childrens Hosp Los Angeles, Dept Pediat, Saban Res Inst, Los Angeles, CA 90027 USA; [He, Q.] Zhejiang Univ, Sch Pharmaceut Sci, Inst Pharmacol & Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Adams, G. B.] Univ So Calif, Keck Sch Med, Ctr Stem Cell & Regenerat Med, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Zhejiang University; University of Southern California	Wu, L (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pathol, MS 103,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	lingtaow@usc.edu	Liu, Gang/B-7635-2012		National Institutes of Health [R01 CA120512, ARRA-R01CA120512]; NATIONAL CANCER INSTITUTE [R21CA137485, R01CA120512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (R01 CA120512 and ARRA-R01CA120512 to LW).	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bakhshi S, 2010, EXPERT REV ANTICANC, V10, P271, DOI [10.1586/era.09.186, 10.1586/ERA.09.186]; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Joo KM, 2009, METHODS MOL BIOL, V568, P57, DOI 10.1007/978-1-59745-280-9_5; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Luo P, 2010, ONCOGENE, V29, P2772, DOI 10.1038/onc.2010.50; Luo PH, 2007, STEM CELLS, V25, P2628, DOI 10.1634/stemcells.2007-0264; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Maxson S, 2008, J TISSUE ENG REGEN M, V2, P147, DOI 10.1002/term.76; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Oda Y, 2006, MODERN PATHOL, V19, P738, DOI 10.1038/modpathol.3800587; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Thomas D, 2006, J CELL BIOCHEM, V98, P757, DOI 10.1002/jcb.20850; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331; Woodward WA, 2008, CANCER METAST REV, V27, P459, DOI 10.1007/s10555-008-9130-2; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917	47	23	25	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4252	4263		10.1038/onc.2012.438	http://dx.doi.org/10.1038/onc.2012.438			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045288	Green Accepted			2022-12-25	WOS:000324168000007
J	Dach, I; Olesen, C; Signor, L; Nissen, P; le Maire, M; Moller, JV; Ebel, C				Dach, Ingrid; Olesen, Claus; Signor, Luca; Nissen, Poul; le Maire, Marc; Moller, Jesper V.; Ebel, Christine			Active Detergent-solubilized H+,K+-ATPase Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; BOVINE ADP/ATP CARRIER; ALPHA-BETA-UNITS; ANALYTICAL ULTRACENTRIFUGATION; GASTRIC H+,K+-ATPASE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; LIGHT-SCATTERING; FUNCTIONAL-CHARACTERIZATION; SEDIMENTATION-VELOCITY	The H+,K+-ATPase pumps protons or hydronium ions and is responsible for the acidification of the gastric fluid. It is made up of an alpha-catalytic and a beta-glycosylated subunit. The relation between cation translocation and the organization of the protein in the membrane are not well understood. We describe here how pure and functionally active pig gastric H+,K+-ATPase with an apparent Stokes radius of 6.3 nm can be obtained after solubilization with the non-ionic detergent C12E8, followed by exchange of C12E8 with Tween 20 on a Superose 6 column. Mass spectroscopy indicates that the beta-subunit bears an excess mass of 9 kDa attributable to glycosylation. From chemical analysis, there are 0.25 g of phospholipids and around 0.024 g of cholesterol bound per g of protein. Analytical ultracentrifugation shows one main complex, sedimenting at s(20,w) = 7.2 +/- 0.1 S, together with minor amounts of irreversibly aggregated material. From these data, a buoyant molecular mass is calculated, corresponding to an H+,K+-ATPase alpha,beta-protomer of 147.3 kDa. Complementary sedimentation velocity with deuterated water gives a picture of an alpha,beta-protomer with 0.9-1.4 g/g of bound detergent and lipids and a reasonable frictional ratio of 1.5, corresponding to a Stokes radius of 7.1 nm. An alpha(2),beta(2) dimer is rejected by the data. Light scattering coupled to gel filtration confirms the monomeric state of solubilized H+,K+-ATPase. Thus, alpha,beta H+,K+-ATPase is active at least in detergent and may plausibly function as a monomer, as has been established for other P-type ATPases, Ca2+-ATPase and Na+,K+-ATPase.	[Dach, Ingrid; Olesen, Claus; Moller, Jesper V.] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark; [Dach, Ingrid; Olesen, Claus; Moller, Jesper V.] Danish Res Fdn, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark; [Dach, Ingrid; Nissen, Poul] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Signor, Luca; Ebel, Christine] Inst Biol Struct Jean Pierre Ebel, Commissariat Energie Atom & Energies Alternat, F-38027 Grenoble 1, France; [Signor, Luca; Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, F-38027 Grenoble 1, France; [Signor, Luca; Ebel, Christine] CNRS, Inst Biol Struct, F-38027 Grenoble 1, France; [le Maire, Marc] Commissariat Energie Atom & Energies Alternat, Inst Biol & Technol iBiTec S, F-91191 Gif Sur Yvette, France; [le Maire, Marc] Univ Paris 11, CEA Saclay, PC 103, CNRS,UMR 8221, Paris, France; [le Maire, Marc] Univ Paris 11, F-91400 Orsay, France	Aarhus University; Aarhus University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Olesen, C (corresponding author), Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark.	co@biophys.au.dk; marc.lemaire@cea.fr; jvm@biophys.au.dk; christine.ebel@ibs.fr	Signor, Luca/O-7489-2014	Signor, Luca/0000-0003-3880-2466; Olesen, Claus/0000-0002-0462-1686; Ebel, Christine/0000-0002-6912-500X; Nissen, Poul/0000-0003-0948-6628	CNRS; Commissariat a l'Energie Atomique; Universite Joseph Fourier-Grenoble 1; Universite Paris-Sud; European Union [226507-NMI3]; Agence Nationale de la Recherche (Programme blanc DHYN-FHAC)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Universite Joseph Fourier-Grenoble 1; Universite Paris-Sud; European Union(European Commission); Agence Nationale de la Recherche (Programme blanc DHYN-FHAC)(French National Research Agency (ANR))	This work was supported by CNRS, by the Commissariat a l'Energie Atomique, by the Universite Joseph Fourier-Grenoble 1, by the Universite Paris-Sud, and by grants from the European Union (FP7 Grant Agreement 226507-NMI3) and the Agence Nationale de la Recherche (Programme blanc DHYN-FHAC).	Abe K, 2005, J BIOCHEM, V138, P293, DOI 10.1093/jb/mvi127; Abe K, 2003, BIOCHEMISTRY-US, V42, P15132, DOI 10.1021/bi035686x; Abe K, 2002, BIOCHEMISTRY-US, V41, P2438, DOI 10.1021/bi015622r; Abe K, 2010, J STRUCT BIOL, V170, P60, DOI 10.1016/j.jsb.2009.12.008; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; Ayorinde FO, 2000, RAPID COMMUN MASS SP, V14, P2116, DOI 10.1002/1097-0231(20001130)14:22<2116::AID-RCM142>3.0.CO;2-1; Bamford M, 2009, PROGR MED CHEM, V47, P75, DOI 10.1016/S0079-6468(08)00203-8; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BERI RG, 1993, CARBOHYD RES, V238, P11, DOI 10.1016/0008-6215(93)87002-A; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; BROTHERUS JR, 1983, BIOCHIM BIOPHYS ACTA, V731, P290, DOI 10.1016/0005-2736(83)90021-4; Brown P, 2011, TLS-TIMES LIT SUPPL, P6; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Dahout-Gonzalez C, 2003, ACTA CRYSTALLOGR D, V59, P2353, DOI 10.1107/S0907444903020699; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; EDELSTEIN SJ, 1967, J BIOL CHEM, V242, P306; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; ESMANN M, 1980, BIOCHIM BIOPHYS ACTA, V603, P1, DOI 10.1016/0005-2736(80)90386-7; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; Fedosova NU, 1998, BIOCHEMISTRY-US, V37, P13634, DOI 10.1021/bi980703h; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033; HARDWICKE PM, 1974, EUR J BIOCHEM, V42, P183; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; HAYASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V983, P217, DOI 10.1016/0005-2736(89)90237-X; HEEGAARD CW, 1990, J BIOL CHEM, V265, P12020; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Kobayashi T, 2007, J BIOCHEM, V142, P157, DOI 10.1093/jb/mvm150; Lacapere JJ, 2000, BIOCHEM J, V345, P239, DOI 10.1042/0264-6021:3450239; Lauger P., 1991, ELECTROGENIC ION PUM, P224; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; le Maire M., 1986, SARCOPLASMIC RETICUL, V1, P101; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEMAIRE M, 1978, J BIOL CHEM, V253, P7051; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND S, 1988, J BIOL CHEM, V263, P1654; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; Manon F., 2010, INSTRUMENTAL ANAL IN, P433; Mimura K, 2008, BIOCHEMISTRY-US, V47, P6039, DOI 10.1021/bi800445f; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morii M, 2008, J BIOL CHEM, V283, P16876, DOI 10.1074/jbc.M800563200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mullin JM, 2009, DRUG DISCOV TODAY, V14, P647, DOI 10.1016/j.drudis.2009.03.014; Musatov A, 2002, BIOCHEMISTRY-US, V41, P4371, DOI 10.1021/bi016080g; Nishizawa T, 2008, J STRUCT BIOL, V162, P219, DOI 10.1016/j.jsb.2007.12.005; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PHILO J, 1994, J BIOL CHEM, V269, P27840; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; RABON EC, 1988, J BIOL CHEM, V263, P16189; RABON EC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P277, DOI 10.1016/0167-4838(90)90260-M; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Riske KA, 1997, CHEM PHYS LIPIDS, V89, P31, DOI 10.1016/S0009-3084(97)00058-3; SACHS G, 1982, CURR TOP MEMBR TRANS, V16, P135; SACHS G, 1989, J BIOENERG BIOMEMBR, V21, P573, DOI 10.1007/BF00808114; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Shin JM, 2005, BIOCHEMISTRY-US, V44, P16321, DOI 10.1021/bi051342q; Shin JM, 1996, J BIOL CHEM, V271, P1904, DOI 10.1074/jbc.271.4.1904; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKRABANJA ATP, 1987, BIOCHIM BIOPHYS ACTA, V903, P434, DOI 10.1016/0005-2736(87)90050-2; SOUMARMON A, 1983, BIOCHIM BIOPHYS ACTA, V732, P579, DOI 10.1016/0005-2736(83)90234-1; SOUMARMON A, 1986, BIOCHIM BIOPHYS ACTA, V860, P109, DOI 10.1016/0005-2736(86)90504-3; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tyagarajan K, 1997, BIOCHEMISTRY-US, V36, P10200, DOI 10.1021/bi9706125; VILSEN B, 1987, J BIOL CHEM, V262, P10511; Xian YJ, 1997, J STRUCT BIOL, V118, P169, DOI 10.1006/jsbi.1997.3847	88	8	8	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41963	41978		10.1074/jbc.M112.398768	http://dx.doi.org/10.1074/jbc.M112.398768			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23055529	Green Published, hybrid			2022-12-25	WOS:000312103000036
J	Fu, YC; Wang, DW; Chuang, JH				Fu, Yang-chih; Wang, Da-Wei; Chuang, Jen-Hsiang			Representative Contact Diaries for Modeling the Spread of Infectious Diseases in Taiwan	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; PANDEMIC INFLUENZA; HEALTH-CARE; PARAMETERS; NETWORKS; LESSONS; SARS	Recent studies of infectious diseases have attempted to construct more realistic parameters of interpersonal contact patterns from diary-approach surveys. To ensure that such diary-based contact patterns provide accurate baseline data for policy implementation in densely populated Taiwan, we collected contact diaries from a national sample, using 3-stage systematic probability sampling and rigorous in-person interviews. A representative sample of 1,943 contact diaries recorded a total of 24,265 wide-range, face-to-face interpersonal contacts during a 24-hour period. Nearly 70% of the contacts occurred outside of respondents' households. The most active age group was schoolchildren (ages 5-14), who averaged around 16-18 daily contacts, about 2-3 times as many as the least active age groups. We show how such parameters of contact patterns help modify a sophisticated national simulation system that has been used for years to model the spread of pandemic diseases in Taiwan. Based on such actual and representative data that enable researchers to infer findings to the whole population, our analyses aim to facilitate implementing more appropriate and effective strategies for controlling an emerging or pandemic disease infection.	[Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chuang, Jen-Hsiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fu, YC (corresponding author), Acad Sinica, Inst Sociol, Taipei 115, Taiwan.	fuyc@sinica.edu.tw	Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Fu, Yang-chih/0000-0002-2207-5623	Department of Health, Taiwan, Republic of China [DOH99-DC-1004]	Department of Health, Taiwan, Republic of China	This study was sponsored by the Department of Health, Taiwan, Republic of China (grant no. DOH99-DC-1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Chang HJ, 2004, AM J PUBLIC HEALTH, V94, P562, DOI 10.2105/AJPH.94.4.562; Chang YH, 2004, JGSS S 2003 BIRTH JG, P149; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fu Y, 2008, SAGE HDB PUBLIC OPIN, P284, DOI [10.4135/9781848607910.n27, DOI 10.4135/9781848607910.N27]; Fu YC, 2007, FIELD METHOD, V19, P194, DOI 10.1177/1525822X06298590; Fu YC, 2005, SOC NETWORKS, V27, P169, DOI 10.1016/j.socnet.2005.01.008; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Ho TS, 2010, PEDIATR NEONATOL, V51, P83, DOI 10.1016/S1875-9572(10)60016-2; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Kanaan MN, 2005, EPIDEMIOL INFECT, V133, P1009, DOI 10.1017/S0950268805004528; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Lonkila M, 1999, SOCIAL NETWORKS POST; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Smith TW, 2006, COMP SOCIOL, V5, P33, DOI 10.1163/156913306776915614; Tsai MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013292; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Watt JR, 2008, KAOHSIUNG J MED SCI, V24, P563, DOI 10.1016/S1607-551X(09)70017-8; Yang MM, 1996, GIFTS FAVORS BANQUET; Yanjie Bian, 2002, SOCIAL CONNECTIONS C; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	31	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45113	10.1371/journal.pone.0045113	http://dx.doi.org/10.1371/journal.pone.0045113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056193	Green Published, gold			2022-12-25	WOS:000309454000006
J	Li, J; Wu, RG; Meng, FY; Wang, Z; Wang, CM; Wang, YY; Zhang, ZJ				Li, Jian; Wu, Run-guo; Meng, Fan-yun; Wang, Zhong; Wang, Chang-ming; Wang, Yong-yan; Zhang, Zhan-jun			Synergism and Rules from Combination of Baicalin, Jasminoidin and Desoxycholic acid in Refined Qing Kai Ling for Treat Ischemic Stroke Mice Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRADITIONAL CHINESE MEDICINE; MIDDLE CEREBRAL-ARTERY; NITRIC-OXIDE SYNTHASE; INJURY IN-VIVO; GENE-EXPRESSION; REPERFUSION INJURY; FOCAL ISCHEMIA; GROWTH-FACTOR; CELL-DEATH	Refined Qing-Kai-Ling (QKL), a modified Chinese medicine, consists of three main ingredients (Baicalin, Jasminoidin and Desoxycholic acid), plays a synergistic effect on the treatment of the acute stage of ischemic stroke. However, the rules of the combination and synergism are still unknown. Based on the ischemic stroke mice model, all different kinds of combination of Baicalin, Jasminoidin, and Desoxycholic acid were investigated by the methods of neurological examination, microarray, and genomics analysis. As a result, it confirmed that the combination of three drugs offered a better therapeutical effect on ischemic stroke than monotherapy of each drug. Additionally, we used Ingenuity pathway Analysis (IPA) and principal component analysis (PCA) to extract the dominant information of expression changes in 373 ischemia-related genes. The results suggested that 5 principal components (PC1-5) could account for more than 95% energy in the gene data. Moreover, 3 clusters (PC1, PC2+PC5, and PC3+PC4) were addressed with cluster analysis. Furthermore, we matched PCs on the drug-target networks, the findings demonstrated that Baicalin related with PC1 that played the leading role in the combination; Jasminoidin related with PC2+PC5 that played a compensatory role; while Desoxycholic acid had the least performance alone which could relate with PC3+PC4 that played a compatible role. These manifestations were accorded with the principle of herbal formulae of Traditional Chinese Medicine (TCM), emperor-minister-adjuvant-courier. In conclusion, we firstly provided scientific evidence to the classic theory of TCM formulae, an initiating holistic viewpoint of combination therapy of TCM. This study also illustrated that PCA might be an applicable method to analyze the complicated data of drug combination.	[Wu, Run-guo; Wang, Chang-ming; Zhang, Zhan-jun] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jian] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China; [Meng, Fan-yun] Beijing Normal Univ, Sch Resources Sci & Technol, Beijing 100875, Peoples R China; [Wang, Zhong; Wang, Yong-yan] China Acad Tradit Chinese Med, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing Normal University; Beijing University of Chinese Medicine; Beijing Normal University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Zhang, ZJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhang_rzs@bnu.edu.cn		Wu, Runguo/0000-0002-6523-5754	program for new century excellent talents in University [NCET-10-0249]; Program for excellent doctoral dissertation foundation [2007B7]; project of institute of basic research in clinical medicine [Z0175]	program for new century excellent talents in University(Program for New Century Excellent Talents in University (NCET)); Program for excellent doctoral dissertation foundation; project of institute of basic research in clinical medicine	This work was funded by the program for new century excellent talents in University (No. NCET-10-0249), the Program for excellent doctoral dissertation foundation (No. 2007B7) and by the project of institute of basic research in clinical medicine (No. Z0175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco Pierre, 2006, Cerebrovasc Dis, V21 Suppl 1, P35, DOI 10.1159/000090360; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Berezovskaya O, 1996, ACTA NEUROPATHOL, V92, P479, DOI 10.1007/s004010050550; Cao Chunyu, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1549; Carey KM, 2012, ANN PHARMACOTHER, V46, P688, DOI 10.1345/aph.1Q621; Carlson NG, 1999, J IMMUNOL, V163, P3963; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Cheng FF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/567872; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; de Lecinana MA, 2006, J NEUROL SCI, V247, P121, DOI 10.1016/j.jns.2006.03.022; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Efferth T, 2007, CURR MED CHEM, V14, P2024; Fisher M, 2008, STROKE, V39, P250, DOI 10.1161/STROKEAHA.107.512244; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; Gao Yong-Hong, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P135, DOI 10.3736/jcim20090208; Gorelick PB, 2002, STROKE, V33, P862, DOI 10.1161/hs0302.103657; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; HSU CY, 1993, STROKE, V24, pI78; Hua Q, 2008, BIOL PHARM BULL, V31, P633, DOI 10.1248/bpb.31.633; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kernan WN, 2010, STROKE, V41, pS35, DOI 10.1161/STROKEAHA.110.592022; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Li C, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P212; Li H, 2003, J CHROMATOGR B, V788, P93, DOI 10.1016/S1570-0232(02)01032-2; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu Qingyun SJ, 2000, CHIN J IINTEGRATED T, V20, P4; Liu R, 2000, Zhonghua Kou Qiang Yi Xue Za Zhi, V35, P327; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Luo CX, 2007, J NEUROCHEM, V103, P1872, DOI 10.1111/j.1471-4159.2007.04915.x; Mao HP, 2004, J BIOL CHEM, V279, P15472, DOI 10.1074/jbc.M313484200; Marini AM, 2004, RESTOR NEUROL NEUROS, V22, P121; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Read SJ, 2001, J CEREBR BLOOD F MET, V21, P755, DOI 10.1097/00004647-200107000-00001; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Shinozaki Y, 2007, NEUROSCIENCE, V147, P153, DOI 10.1016/j.neuroscience.2007.04.032; Simpson JE, 2009, STROKE, V40, P369, DOI 10.1161/STROKEAHA.108.529214; Szewka Aimee Joy, 2009, Comprehensive Therapy, V35, P72; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013; Vikman P, 2006, EUR J NEUROL, V13, P1324, DOI 10.1111/j.1468-1331.2006.01496.x; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Watanabe S, 2009, J ETHNOPHARMACOL, V125, P203, DOI 10.1016/j.jep.2009.07.014; Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu Lirong, 2004, Zhong Yao Cai, V27, P348; Yang Yan, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P908; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang Chun-ying, 2005, Zhongguo Zhongyao Zazhi, V30, P686; Zhang RL, 2007, CURR MOL MED, V7, P459; Zhang Z.J., 2005, ACTA PHARM SIN, V26, P8; Zhang ZJ, 2006, BRAIN RES, V1123, P188, DOI 10.1016/j.brainres.2006.09.063; Zhang ZJ, 2005, ACTA PHARMACOL SIN, V26, P307, DOI 10.1111/j.1745-7254.2005.00051.x; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	63	14	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45811	10.1371/journal.pone.0045811	http://dx.doi.org/10.1371/journal.pone.0045811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049867	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300055
J	Lyu, ZX; Shao, Q; Gao, YQ; Zhao, XS				Lyu, Zhi-Xin; Shao, Qiang; Gao, Yi Qin; Zhao, Xin Sheng			Direct Observation of the Uptake of Outer Membrane Proteins by the Periplasmic Chaperone Skp	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOGENESIS; DYNAMICS; AGGREGATION; COMPLEXES; MOLECULES; MECHANISM; EVOLUTION	The transportation of membrane proteins through the aqueous subcellular space is an important and challenging process. Its molecular mechanism and the associated structural change are poorly understood. Periplasmic chaperones, such as Skp in Escherichia coli, play key roles in the transportation and protection of outer membrane proteins (OMPs) in Gram-negative bacteria. The molecular mechanism through which Skp interacts with and protects OMPs remains mysterious. Here, a combined experimental and molecular dynamics simulation study was performed to gain the structural and dynamical information in the process of OMPs and Skp binding. Stopped-flow experiments on site specific mutated and labeled Skp and several OMPs, namely OmpC, the transmembrane domain of OmpA, and OmpF, allowed us to obtain the mechanism of OMP entering the Skp cavity, and molecular dynamics simulations yielded detailed molecular interactions responsible for this process. Both experiment and simulation show that the entrance of OMP into Skp is a highly directional process, which is initiated by the interaction between the N-terminus of OMP and the bottom "tentacle" domain of Skp. The opening of the more flexible tentacle of Skp, the non-specific electrostatic interactions between OMP and Skp, and the constant formation and breaking of salt bridges between Skp and its substrate together allow OMP to enter Skp and gradually "climb" into the Skp cavity in the absence of an external energy supply.	[Lyu, Zhi-Xin; Shao, Qiang; Gao, Yi Qin; Zhao, Xin Sheng] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Lyu, Zhi-Xin; Zhao, Xin Sheng] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Dept Biol Chem, Biodynam Opt Imaging Ctr,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Shao, Qiang; Gao, Yi Qin] Peking Univ, Inst Theoret & Computat Chem, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Peking University; Peking University	Gao, YQ (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	gaoyq@pku.edu.cn; zhaoxs@pku.edu.cn	Shao, Qiang/O-4528-2019; gao, yi/HCI-8298-2022	Shao, Qiang/0000-0001-6460-3095; 	National Key Basic Research Foundation of China [2010CB912302, 2012CB917304]; National Natural Science Foundation of China [21233002, 20973015, 91027044, 21125311, 21003003]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Key Basic Research Foundation of China (2010CB912302 to XSZ and 2012CB917304 to XSZ and YQG) and the National Natural Science Foundation of China (21233002 to XSZ and YQG, 20973015 to XSZ, 91027044 and 21125311 to YQG, and 21003003 to QS). YQG is a 2008 Changjiang Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200; Case D, 2006, AMBER 9; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chen XD, 2008, J AM CHEM SOC, V130, P16947, DOI 10.1021/ja804628x; Cierpicki T, 2006, J AM CHEM SOC, V128, P6947, DOI 10.1021/ja0608343; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P1; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; MEADOWS DL, 1991, J IMMUNOL METHODS, V143, P263, DOI 10.1016/0022-1759(91)90051-G; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; Packard BZ, 1996, P NATL ACAD SCI USA, V93, P11640, DOI 10.1073/pnas.93.21.11640; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Qu J, 2009, BIOCHEMISTRY-US, V48, P4926, DOI 10.1021/bi9004039; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WEST W, 1965, J PHYS CHEM-US, V69, P1894, DOI 10.1021/j100890a019; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu S, 2011, BIOCHEM J, V438, P505, DOI 10.1042/BJ20110264; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	42	16	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46068	10.1371/journal.pone.0046068	http://dx.doi.org/10.1371/journal.pone.0046068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049938	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300079
J	Takeuchi, F; Isono, M; Katsuya, T; Yokota, M; Yamamoto, K; Nabika, T; Shimokawa, K; Nakashima, E; Sugiyama, T; Rakugi, H; Yamaguchi, S; Ogihara, T; Yamori, Y; Kato, N				Takeuchi, Fumihiko; Isono, Masato; Katsuya, Tomohiro; Yokota, Mitsuhiro; Yamamoto, Ken; Nabika, Toru; Shimokawa, Kazuro; Nakashima, Eitaro; Sugiyama, Takao; Rakugi, Hiromi; Yamaguchi, Shuhei; Ogihara, Toshio; Yamori, Yukio; Kato, Norihiro			Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; METABOLIC TRAITS; BLOOD-LIPIDS; RISK; LOCI; POPULATION; TRIGLYCERIDES; DYSLIPIDEMIA	Background/Objective: In Japanese populations, we performed a replication study of genetic loci previously identified in European-descent populations as being associated with lipid levels and risk of coronary artery disease (CAD). Methods: We genotyped 48 single nucleotide polymorphisms (SNPs) from 22 candidate loci that had previously been identified by genome-wide association (GWA) meta-analyses for low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and/or triglycerides in Europeans. We selected 22 loci with 2 parallel tracks from 95 reported loci: 16 significant loci (p<1x10(-30) in Europeans) and 6 other loci including those with suggestive evidence of lipid associations in 1292 GWA-scanned Japanese samples. Genotyping was done in 4990 general population samples, and 1347 CAD cases and 1337 controls. For 9 SNPs, we further examined CAD associations in an additional panel of 3052 CAD cases and 6335 controls. Principal Findings: Significant lipid associations (one-tailed p<0.05) were replicated for 18 of 22 loci in Japanese samples, with significant inter-ethnic heterogeneity at 4 loci-APOB, APOE-C1, CETP, and APOA5-and allelic heterogeneity. The strongest association was detected at APOE rs7412 for LDL-C (p = 1.3x10(-41)), CETP rs3764261 for HDL-C (p = 5.2x10(-24)), and APOA5 rs662799 for triglycerides (p = 5.8x10(-54)). CAD association was replicated and/or verified for 4 loci: SORT1 rs611917 (p = 1.7x10(-8)), APOA5 rs662799 (p = 0.0014), LDLR rs1433099 (p = 2.1x10(-7)), and APOE rs7412 (p = 6.1x10(-13)). Conclusions: Our results confirm that most of the tested lipid loci are associated with lipid traits in the Japanese, further indicating that in genetic susceptibility to lipid levels and CAD, the related metabolic pathways are largely common across the populations, while causal variants at individual loci can be population-specific.	[Takeuchi, Fumihiko; Isono, Masato; Shimokawa, Kazuro; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Katsuya, Tomohiro; Rakugi, Hiromi; Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan; [Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Sugiyama, Takao] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; [Yamaguchi, Shuhei] Shimane Univ, Sch Med, Dept Internal Med 3, Izumo, Shimane, Japan; [Ogihara, Toshio] Morinomiya Univ Med Sci, Osaka, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan	National Center for Global Health & Medicine - Japan; Osaka University; Osaka University; Aichi Gakuin University; Kyushu University; Shimane University; Nagoya University; Asahi Life Foundation; Shimane University; Mukogawa Women's University	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp		Rakugi, Hiromi/0000-0001-6508-4338	National Center for Global Health and Medicine; Ministry of Health Labour and Welfare	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Grant of National Center for Global Health and Medicine and the Ministry of Health Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2009, CIRC-CARDIOVASC GENE, V2, P16, DOI 10.1161/CIRCGENETICS.108.813709; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khera AV, 2009, TRENDS CARDIOVAS MED, V19, P195, DOI 10.1016/j.tcm.2009.12.003; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Ordovas JM, 2011, CURR OPIN LIPIDOL, V22, P129, DOI 10.1097/MOL.0b013e32834477a9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Soutar AK, 2010, IUBMB LIFE, V62, P125, DOI 10.1002/iub.299; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Takeuchi F, 2011, GENOME RES, V21, P1122, DOI 10.1101/gr.115832.110; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2012, CURR OPIN LIPIDOL, V23, P98, DOI 10.1097/MOL.0b013e328350fad2; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	41	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46385	10.1371/journal.pone.0046385	http://dx.doi.org/10.1371/journal.pone.0046385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050023	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300113
J	Vervoort, J; Baraniak, A; Gazin, M; Sabirova, J; Lammens, C; Kazma, M; Grabowska, A; Izdebski, R; Carmeli, Y; Kumar-Singh, S; Gniadkowski, M; Goossens, H; Malhotra-Kumar, S				Vervoort, Jascha; Baraniak, Anna; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Kazma, Meital; Grabowska, Anna; Izdebski, Radoslaw; Carmeli, Yehuda; Kumar-Singh, Samir; Gniadkowski, Marek; Goossens, Herman; Malhotra-Kumar, Surbhi		MOSAR WP2 Study Grp; SATURN WP1 Study Grp	Characterization of Two New CTX-M-25-Group Extended-Spectrum beta-Lactamase Variants Identified in Escherichia coli Isolates from Israel	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; CLINICAL ISOLATE; PREVALENCE; ENTEROBACTERIACEAE; CTX-M-15; SPREAD; ENZYME; GENES	Objectives: We characterized two new CTX-M-type extended-spectrum beta-lactamase (ESBL) variants in Escherichia coli isolates from stool samples of two elderly patients admitted at the Tel Aviv Sourasky Medical Center, Israel. Both patients underwent treatment with cephalosporins prior to isolation of the E. coli strains. Methods: ESBLs were detected by the double-disk synergy test and PCR-sequencing of beta-lactamase genes. The bla(CTX-M) genes were cloned into the pCR-BluntII-TOPO vector in E. coli TOP10. The role of amino-acid substitutions V77A and D240G was analyzed by site-directed mutagenesis of the bla(CTX-M-94) and bla(CTX-M-100) genes and comparative characterization of the resulting E. coli recombinants. MICs of beta-lactams were determined by Etest. Plasmid profiling, mating experiments, replicon typing and sequencing of bla(CTX-M) flanking regions were performed to identify the genetic background of the new CTX-M variants. Results: The novel CTX-M beta-lactamases, CTX-M-94 and -100, belonged to the CTX-M-25-group. Both variants differed from CTX-M-25 by the substitution V77A, and from CTX-M-39 by D240G. CTX-M-94 differed from all CTX-M-25-group enzymes by the substitution F119L. Glycine-240 was associated with reduced susceptibility to ceftazidime and leucine-119 with increased resistance to ceftriaxone. bla(CTX-M-94) and bla(CTX-M-100) were located within ISEcp1 transposition units inserted into similar to 93 kb non-conjugative IncFI and similar to 130 kb conjugative IncA/C plasmids, respectively. The plasmids carried also different class 1 integrons. Conclusions: This is the first report on CTX-M-94 and -100 ESBLs, novel members of the CTX-M-25-group.	[Vervoort, Jascha; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium; [Vervoort, Jascha; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Kumar-Singh, Samir; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Baraniak, Anna; Grabowska, Anna; Izdebski, Radoslaw; Gniadkowski, Marek] Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland; [Kazma, Meital; Carmeli, Yehuda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Kazma, Meital; Carmeli, Yehuda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Epidemiol & Antibiot Res, IL-69978 Tel Aviv, Israel; [Kumar-Singh, Samir] Univ Antwerp, Mol Pathol Grp, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; National Medicines Institute Lekow (NIL); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Antwerp	Malhotra-Kumar, S (corresponding author), Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium.	surbhi.malhotra@ua.ac.be	Kumar-Singh, Samir/G-6280-2012; Baraniak, Anna/U-9015-2018	Kumar-Singh, Samir/0000-0001-9466-6732; Baraniak, Anna/0000-0001-9996-8553; , Anna D./0000-0003-1633-6345	European Community [LSHP-CT-2007-037941, 241796]; Polish Ministry of Science and Higher Education [934/6. PR UE/2009/7]	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	JV and M. Gazin are supported by funding from the European Community (MOSAR network contract LSHP-CT-2007-037941; SATURN network contract FP7-HEALTH-2009-SINGLE STAGE-No241796). AB, AG, RI and M. Gniadkowski were also financed by the MOSAR-complementary grant No. 934/6. PR UE/2009/7 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow M, 2008, EMERG INFECT DIS, V14, P423, DOI 10.3201/eid1403.070405; BAUERNFEIND A, 1990, INFECTION, V18, P294, DOI 10.1007/BF01647010; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; CLSI, 2012, M02A11 CLSI; Delmas J, 2008, J MOL BIOL, V375, P192, DOI 10.1016/j.jmb.2007.10.026; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Gniadkowski M, 2008, CLIN MICROBIOL INFEC, V14, P11, DOI 10.1111/j.1469-0691.2007.01854.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Malhotra-Kumar S, 2003, J CLIN MICROBIOL, V41, P5282, DOI 10.1128/JCM.41.11.5282-5284.2003; Mammeri H, 2006, ANTIMICROB AGENTS CH, V50, P2573, DOI 10.1128/AAC.01633-05; Rodriguez MM, 2010, ANTIMICROB AGENTS CH, V54, P3070, DOI 10.1128/AAC.01615-09; McGettigan SE, 2009, J CLIN MICROBIOL, V47, P2970, DOI 10.1128/JCM.00319-09; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Munday CJ, 2004, ANTIMICROB AGENTS CH, V48, P4829, DOI 10.1128/AAC.48.12.4829-4834.2004; Navon-Venezia S, 2008, J ANTIMICROB CHEMOTH, V62, P289, DOI 10.1093/jac/dkn182; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Peirano G, 2010, ANTIMICROB AGENTS CH, V54, P1327, DOI 10.1128/AAC.01338-09; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zhang ZJ, 2009, J CLIN LAB ANAL, V23, P404, DOI 10.1002/jcla.20351	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46329	10.1371/journal.pone.0046329	http://dx.doi.org/10.1371/journal.pone.0046329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050014	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000309517300107
J	Ramamoorthy, S; Nuttall, AL				Ramamoorthy, Sripriya; Nuttall, Alfred L.			Half-Octave Shift in Mammalian Hearing Is an Epiphenomenon of the Cochlear Amplifier	PLOS ONE			English	Article							MECHANICAL WAVE-FORM; BASILAR-MEMBRANE; TECTORIAL MEMBRANE; RESPONSES; MODEL; MOTION; EAR	The cochlear amplifier is a hypothesized positive feedback process responsible for our exquisite hearing sensitivity. Experimental evidence for or against the positive feedback hypothesis is still lacking. Here we apply linear control theory to determine the open-loop gain and the closed-loop sensitivity of the cochlear amplifier from available measurements of basilar membrane vibration in sensitive mammalian cochleae. We show that the frequency of peak closed-loop sensitivity is independent of the stimulus level and close to the characteristic frequency. This implies that the half-octave shift in mammalian hearing is an epiphenomenon of the cochlear amplifier. The open-loop gain is consistent with positive feedback and suggests that the high-frequency cut-off of the outer hair cell transmembrane potential in vivo may be necessary for cochlear amplification.	[Ramamoorthy, Sripriya; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; University of Michigan System; University of Michigan	Ramamoorthy, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA.	ramamoor@ohsu.edu		Ramamoorthy, Sripriya/0000-0002-0782-1229	National Institute on Deafness and Other Communication Disorder [R01 DC 000141]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000141, P30DC005983] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorder(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by National Institute on Deafness and Other Communication Disorder grants R01 DC 000141 (ALN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1971, J ACOUST SOC AM, V49, P1131, DOI 10.1121/1.1912474; Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Astrom K.J., 2009, FEEDBACK SYSTEMS INT; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; CODY AR, 1992, HEARING RES, V62, P166, DOI 10.1016/0378-5955(92)90182-M; CODY AR, 1981, J ACOUST SOC AM, V70, P707, DOI 10.1121/1.386906; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; deBoer E, 1997, J ACOUST SOC AM, V101, P3583, DOI 10.1121/1.418319; Elliott SJ, 2007, J ACOUST SOC AM, V122, P2759, DOI 10.1121/1.2783125; Grosh K, 2004, J ACOUST SOC AM, V115, P2178, DOI 10.1121/1.1695431; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Lu TK, 2006, HEARING RES, V214, P45, DOI 10.1016/j.heares.2006.01.018; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1993, J ACOUST SOC AM, V93, P3320, DOI 10.1121/1.405716; Mountain D. C., 1983, MECH HEARING, P119; MOUNTAIN DC, 1989, HEARING RES, V42, P195, DOI 10.1016/0378-5955(89)90144-5; Nakajima HH, 2000, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON RECENT DEVELOPMENTS IN AUDITORY MECHANICS, P202; Narayan SS, 2000, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON RECENT DEVELOPMENTS IN AUDITORY MECHANICS, P95; NEELY ST, 1993, J ACOUST SOC AM, V94, P137, DOI 10.1121/1.407091; Nuttall AL, 1996, J ACOUST SOC AM, V99, P1556, DOI 10.1121/1.414732; Ogata K., 2010, MODERN CONTROL ENG; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Ramamoorthy S, 2004, THESIS U MICHIGAN AN; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; Ramamoorthy S, 2012, BIOPHYS J, V102, P388, DOI 10.1016/j.bpj.2011.12.040; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45640	10.1371/journal.pone.0045640	http://dx.doi.org/10.1371/journal.pone.0045640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049829	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100063
J	Stranzl, T; Larsen, MV; Lund, O; Nielsen, M; Brunak, S				Stranzl, Thomas; Larsen, Mette V.; Lund, Ole; Nielsen, Morten; Brunak, Soren			The Cancer Exome Generated by Alternative mRNA Splicing Dilutes Predicted HLA Class I Epitope Density	PLOS ONE			English	Article							MHC CLASS-I; MISSENSE MUTATIONS; PANCREATIC-CANCER; GENE-EXPRESSION; DOWN-REGULATION; AMINO-ACIDS; PROTEIN; SEQUENCE; BINDING; LYMPHOCYTES	Several studies have shown that cancers actively regulate alternative splicing. Altered splicing mechanisms in cancer lead to cancer-specific transcripts different from the pool of transcripts occurring only in healthy tissue. At the same time, altered presentation of HLA class I epitopes is frequently observed in various types of cancer. Down-regulation of genes related to HLA class I antigen processing has been observed in several cancer types, leading to fewer HLA class I antigens on the cell surface. Here, we use a peptidome wide analysis of predicted alternative splice forms, based on a publicly available database, to show that peptides over-represented in cancer splice variants comprise significantly fewer predicted HLA class I epitopes compared to peptides from normal transcripts. Peptides over-represented in cancer transcripts are in the case of the three most common HLA class I supertype representatives consistently found to contain fewer predicted epitopes compared to normal tissue. We observed a significant difference in amino acid composition between protein sequences associated with normal versus cancer tissue, as transcripts found in cancer are enriched with hydrophilic amino acids. This variation contributes to the observed significant lower likelihood of cancer-specific peptides to be predicted epitopes compared to peptides found in normal	[Stranzl, Thomas; Larsen, Mette V.; Lund, Ole; Nielsen, Morten; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Brunak, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	brunak@cbs.dtu.dk	Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011; Brunak, Soren/O-6621-2016	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Brunak, Soren/0000-0003-0316-5866	Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"); National Institutes of Health [HHSN26620040006C]	Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"; principal funding recipient, Soren Brunak) and was supported by the National Institutes of Health (contract HHSN26620040006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMANN G, 1989, PROTEIN ENG, V2, P329, DOI 10.1093/protein/2.5.329; Darby N.J., 1993, PROTEIN STRUCTURE; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Fang F, 2007, CANCER SCI, V98, P1678, DOI 10.1111/j.1349-7006.2007.00589.x; Ferris RL, 2006, CLIN CANCER RES, V12, P3890, DOI 10.1158/1078-0432.CCR-05-2750; Figge MA, 2004, CANCER EPIDEM BIOMAR, V13, P1037; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Miranda NFCCD, 2009, J PATHOL, P69, DOI [10.1002/path, DOI 10.1002/PATH]; NA F TA C, 2003, GENE DEV, V17, P419; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029; Ohnuma S, 2009, SURGERY, V145, P57, DOI 10.1016/j.surg.2008.08.010; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870; SIMPSON RJ, 2002, PROTEINS PROTEOMICS; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trinquier G, 1998, PROTEIN ENG, V11, P153, DOI 10.1093/protein/11.3.153; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; WIEDENFELD EA, 1994, CANCER RES, V54, P1175; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579	44	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e38670	10.1371/journal.pone.0038670	http://dx.doi.org/10.1371/journal.pone.0038670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049726	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100001
J	Valli, A; Busnadiego, I; Maliogka, V; Ferrero, D; Caston, JR; Rodriguez, JF; Garcia, JA				Valli, Adrian; Busnadiego, Idoia; Maliogka, Varvara; Ferrero, Diego; Caston, Jose R.; Francisco Rodriguez, Jose; Antonio Garcia, Juan			The VP3 Factor from Viruses of Birnaviridae Family Suppresses RNA Silencing by Binding Both Long and Small RNA Duplexes	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; SMALL INTERFERING RNA; BURSAL-DISEASE-VIRUS; HEPATITIS-C VIRUS; VEIN-YELLOWING-IPOMOVIRUS; INFLUENZA-A VIRUS; ANTIVIRAL IMMUNITY; VIRAL SUPPRESSORS; CELLULAR MICRORNAS; STRUCTURAL POLYMORPHISM	RNA silencing is directly involved in antiviral defense in a wide variety of eukaryotic organisms, including plants, fungi, invertebrates, and presumably vertebrate animals. The study of RNA silencing-mediated antiviral defences in vertebrates is hampered by the overlap with other antiviral mechanisms; thus, heterologous systems are often used to study the interplay between RNA silencing and vertebrate-infecting viruses. In this report we show that the VP3 protein of the avian birnavirus Infectious bursal disease virus (IBDV) displays, in addition to its capacity to bind long double-stranded RNA, the ability to interact with double-stranded small RNA molecules. We also demonstrate that IBDV VP3 prevents the silencing mediated degradation of a reporter mRNA, and that this silencing suppression activity depends on its RNA binding ability. Furthermore, we find that the anti-silencing activity of IBDV VP3 is shared with the homologous proteins expressed by both insect- and fish-infecting birnaviruses. Finally, we show that IBDV VP3 can functionally replace the well-characterized HCPro silencing suppressor of Plum pox virus, a potyvirus that is unable to infect plants in the absence of an active silencing suppressor. Altogether, our results support the idea that VP3 protects the viral genome from host sentinels, including those of the RNA silencing machinery.	[Valli, Adrian; Busnadiego, Idoia; Maliogka, Varvara; Ferrero, Diego; Caston, Jose R.; Francisco Rodriguez, Jose; Antonio Garcia, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	jfrodrig@cnb.csic.es; jagarcia@cnb.uam.es	Ferrero, Diego Sebastian/ABI-6041-2020; Caston, Jose/AAB-8825-2021; Valli, Adrian/H-6738-2012; Busnadiego, Idoia/O-8641-2016; Maliogka, Varvara/ABC-6161-2020; Garcia, Juan Antonio/N-3723-2014; Rodríguez, José F/T-8500-2017; Caston, Jose R/L-5896-2014	Ferrero, Diego Sebastian/0000-0001-6848-9939; Caston, Jose/0000-0003-2350-9048; Valli, Adrian/0000-0002-3266-7200; Busnadiego, Idoia/0000-0002-8781-9099; Maliogka, Varvara/0000-0001-5714-2710; Garcia, Juan Antonio/0000-0002-4861-9609; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose R/0000-0003-2350-9048	Spanish MICINN [BIO2010-18541, BIO2009-12443, BFU2011-25902]; European Union [KBBE-204429]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission)	This work was supported by grants BIO2010-18541, BIO2009-12443 and BFU2011-25902 from the Spanish MICINN and KBBE-204429 from European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2010, FEBS LETT, V584, P4313, DOI 10.1016/j.febslet.2010.09.031; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carbonell A, 2012, MOL PLANT MICROBE IN, V25, P151, DOI 10.1094/MPMI-08-11-0216; CARRINGTON JC, 1989, EMBO J, V8, P365, DOI 10.1002/j.1460-2075.1989.tb03386.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Delgadillo MO, 2004, J GEN VIROL, V85, P993, DOI 10.1099/vir.0.19735-0; Delmas B, 2004, VIRUS TAXONOMY, P561; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Fenner BJ, 2006, J VIROL, V80, P6822, DOI 10.1128/JVI.00079-06; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; FernandezArias A, 1997, J VIROL, V71, P8014; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Harrison SC, 2007, FIELDS VIROLOGY, P59; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; Jing XL, 2011, J VIROL, V85, P12792, DOI 10.1128/JVI.05565-11; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maliogka VI, 2012, J GEN VIROL, V93, P1601, DOI 10.1099/vir.0.042168-0; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pedersen T, 2007, J VIROL, V81, P6652, DOI 10.1128/JVI.02831-06; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Reinisch KM, 2002, NAT STRUCT BIOL, V9, P714, DOI 10.1038/nsb1002-714; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Saugar I, 2010, J BIOL CHEM, V285, P3643, DOI 10.1074/jbc.M109.075994; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shimura H, 2011, BBA-GENE REGUL MECH, V1809, P601, DOI 10.1016/j.bbagrm.2011.04.005; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Valli A, 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a9780470021261, DOI 10.1002/9780470015902.A9780470021261]; Valli A, 2008, J VIROL, V82, P974, DOI 10.1128/JVI.01664-07; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Valli A, 2011, RNA, V17, P1148, DOI 10.1261/rna.2510611; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Van Stry M, 2012, J VIROL; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Xie Z, 2008, BIOCH BIOPHYS ACTA; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhu YL, 2012, J VIROL, V86, P3038, DOI 10.1128/JVI.05741-11; Ziebell H, 2007, J GEN VIROL, V88, P2862, DOI 10.1099/vir.0.83138-0	104	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45957	10.1371/journal.pone.0045957	http://dx.doi.org/10.1371/journal.pone.0045957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049903	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100108
J	Diniz, LP; Almeida, JC; Tortelli, V; Lopes, CV; Setti-Perdigao, P; Stipursky, J; Kahn, SA; Romao, LF; de Miranda, J; Alves-Leon, SV; de Souza, JM; Castro, NG; Panizzutti, R; Gomes, FCA				Diniz, Luan Pereira; Almeida, Juliana Carvalho; Tortelli, Vanessa; Lopes, Charles Vargas; Setti-Perdigao, Pedro; Stipursky, Joice; Kahn, Suzana Assad; Romao, Luciana Ferreira; de Miranda, Joari; Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes; Castro, Newton G.; Panizzutti, Rogerio; Alcantara Gomes, Flavia Carvalho			Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor beta Signaling through Modulation of D-Serine Levels in Cerebral Cortex Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR-ACTIVITY; GFAP GENE PROMOTER; TGF-BETA; NEUROMUSCULAR-JUNCTION; CULTURED ASTROCYTES; CNS SYNAPTOGENESIS; SECRETED PROTEINS; SYNAPTIC ACTIVITY; NERVOUS-SYSTEM	Assembly of synapses requires proper coordination between pre- and postsynaptic elements. Identification of cellular and molecular events in synapse formation and maintenance is a key step to understand human perception, learning, memory, and cognition. A key role for astrocytes in synapse formation and function has been proposed. Here, we show that transforming growth factor beta (TGF-beta) signaling is a novel synaptogenic pathway for cortical neurons induced by murine and human astrocytes. By combining gain and loss of function approaches, we show that TGF-beta 1 induces the formation of functional synapses in mice. Further, TGF-beta 1-induced synaptogenesis involves neuronal activity and secretion of the co-agonist of the NMDA receptor, D-serine. Manipulation of D-serine signaling, by either genetic or pharmacological inhibition, prevented the TGF-beta 1 synaptogenic effect. Our data show a novel molecular mechanism that might impact synaptic function and emphasize the evolutionary aspect of the synaptogenic property of astrocytes, thus shedding light on new potential therapeutic targets for synaptic deficit diseases.	[Diniz, Luan Pereira; Almeida, Juliana Carvalho; Tortelli, Vanessa; Lopes, Charles Vargas; Setti-Perdigao, Pedro; Stipursky, Joice; Kahn, Suzana Assad; Romao, Luciana Ferreira; de Miranda, Joari; Castro, Newton G.; Panizzutti, Rogerio; Alcantara Gomes, Flavia Carvalho] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941590 Rio De Janeiro, RJ, Brazil; [Alves-Leon, Soniza Vieira; de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gomes, FCA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21949590 Rio De Janeiro, RJ, Brazil.	fgomes@icb.ufrj.br	Leon, Soniza V Alves/J-7786-2012; Setti-Perdigão, Pedro/I-8191-2012; Castro, Newton G/C-3263-2009; Romao, Luciana/I-4291-2015; Neurociencia, Inct/I-1011-2013; Castro, Newton/AGX-7014-2022; Gomes, Flavia/AAX-6354-2021; Stipursky, Joice/Y-1961-2019; Gomes, Flavia/C-5383-2013	Setti-Perdigão, Pedro/0000-0002-2105-1451; Castro, Newton G/0000-0001-9570-7428; Castro, Newton/0000-0001-9570-7428; Gomes, Flavia/0000-0003-2966-0638	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute of Glia (iGLIA/CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Institute of Glia (iGLIA/CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Ashwood P, 2008, J NEUROIMMUNOL, V204, P149, DOI 10.1016/j.jneuroim.2008.07.006; Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4; Bae J.J., 2011, INT J PHYSL PATHOPHY, V3, P9; Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Chin J, 2002, J NEUROSCI, V22; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2012, CURR OPIN NEUROBIOL, V22, P438, DOI 10.1016/j.conb.2011.10.003; De Sampaio E., 2002, EUR J NEUROSCI, V16, P2059, DOI [10.1046/j.1460-9568.2002.02283.x, DOI 10.1046/J.1460-9568.2002.02283.X]; DeGroot CJA, 1997, J NEUROSCI RES, V49, P342, DOI 10.1002/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Fester L, 2009, HIPPOCAMPUS, V19, P692, DOI 10.1002/hipo.20548; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Fong SW, 2010, P NATL ACAD SCI USA, V107, P13515, DOI 10.1073/pnas.1001695107; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukushima T, 2007, HIPPOCAMPUS, V17, P5, DOI 10.1002/hipo.20243; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Garcia O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014200; Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Hughes EG, 2010, MOL CELL NEUROSCI, V43, P136, DOI 10.1016/j.mcn.2009.10.004; Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lacmann A, 2007, NEUROSCIENCE, V150, P647, DOI 10.1016/j.neuroscience.2007.09.046; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6; Pyka M, 2011, EUR J NEUROSCI, V33, P2187, DOI 10.1111/j.1460-9568.2011.07690.x; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Schell MJ, 1997, J NEUROSCI, V17, P1604; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Sun M, 2010, J NEUROSCI, V30, P6025, DOI 10.1523/JNEUROSCI.0789-10.2010; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vargas-Lopes C, 2011, J NEUROCHEM, V116, P281, DOI 10.1111/j.1471-4159.2010.07102.x; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vincze C, 2010, J COMP NEUROL, V518, P3752, DOI 10.1002/cne.22422; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhao B, 2012, CELL RES, V22, P1467, DOI 10.1038/cr.2012.92; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	73	145	153	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41432	41445		10.1074/jbc.M112.380824	http://dx.doi.org/10.1074/jbc.M112.380824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055518	Green Published, hybrid			2022-12-25	WOS:000311887600055
J	Alshatwi, AA; Hasan, TN; Syed, NA; Shafi, G; Grace, BL				Alshatwi, Ali A.; Hasan, Tarique N.; Syed, Naveed A.; Shafi, Gowhat; Grace, B. Leena			Identification of Functional SNPs in BARD1 Gene and In Silico Analysis of Damaging SNPs: Based on Data Procured from dbSNP Database	PLOS ONE			English	Article							BREAST-CANCER RISK; CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; ANKYRIN REPEAT; BRCA1; RING; SUSCEPTIBILITY; MUTATIONS; DOMAIN; POLYMORPHISM	Background: The BARD1 gene encodes for the BRCA1-associated RING domain (BARD1) protein. Germ line and somatic mutations in BARD1 are found in sporadic breast, ovarian and uterine cancers. There is a plethora of single nucleotide polymorphisms (SNPs) which may or may not be involved in the onset of female cancers. Hence, before planning a larger population study, it is advisable to sort out the possible functional SNPs. To accomplish this goal, data available in the dbSNP database and different computer programs can be used. To the best of our knowledge, until now there has been no such study on record for the BARD1 gene. Therefore, this study was undertaken to find the functional nsSNPs in BARD1. Result: 2.85% of all SNPs in the dbSNP database were present in the coding regions. SIFT predicted 11 out of 50 nsSNPs as not tolerable and PolyPhen assessed 27 out of 50 nsSNPs as damaging. FastSNP revealed that the rs58253676 SNP in the 3' UTR may have splicing regulator and enhancer functions. In the 5' UTR, rs17489363 and rs17426219 may alter the transcriptional binding site. The intronic region SNP rs67822872 may have a medium-high risk level. The protein structures 1JM7, 3C5R and 2NTE were predicted by PDBSum and shared 100% similarity with the BARD1 amino acid sequence. Among the predicted nsSNPs, rs4986841, rs111367604, rs13389423 and rs139785364 were identified as deleterious and damaging by the SIFT and PolyPhen programs. Additionally, I-Mutant showed a decrease in stability for these nsSNPs upon mutation. Finally, the ExPASy-PROSIT program revealed that the predicted deleterious mutations are contained in the ankyrin ring and BRCT domains. Conclusion: Using the available bioinformatics tools and the data present in the dbSNP database, the four nsSNPs, rs4986841, rs111367604, rs13389423 and rs139785364, were identified as deleterious, reducing the protein stability of BARD1. Hence, these SNPs can be used for the larger population-based studies of female cancers.	[Alshatwi, Ali A.; Hasan, Tarique N.; Syed, Naveed A.; Shafi, Gowhat] King Saud Univ, Dept Food Sci & Nutr, Mol Canc Biol Res Lab, Riyadh, Saudi Arabia; [Hasan, Tarique N.] Bharathiar Univ, Ctr Res & Dev, Coimbatore, Tamil Nadu, India; [Grace, B. Leena] Vinayaka Missions Univ, Dept Biotechnol, Salem, Tami Nadu, India	King Saud University; Bharathiar University; Vinayaka Mission's Research Foundation	Alshatwi, AA (corresponding author), King Saud Univ, Dept Food Sci & Nutr, Mol Canc Biol Res Lab, Riyadh, Saudi Arabia.	alialshatwi@gmail.com	BESLIN, LEENA GRACE/J-4439-2014; Syed, Naveed/K-2318-2012; Alshatwi, Ali/E-5271-2014	BESLIN, LEENA GRACE/0000-0002-7987-0572; Alshatwi, Ali/0000-0002-2441-553X; Noorul Hasan, Tarique/0000-0002-7744-9637	Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia	Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia	This study was financially supported by the Research Centre, Deanship of Research, College of Food and Agricultural Sciences, King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alshatwi AA, 2011, BIOINFORMATION, V7, P334; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bhagwat M., 2010, CURR PROTOC BIOINFOR, P19, DOI DOI 10.1002/0471250953.BI0119S32; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; Dutta Shuchismita, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0109s20; Ellsworth RE, 2010, CURR GENOMICS, V11, P146, DOI 10.2174/138920210791110951; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fox D, 2008, J BIOL CHEM, V283, P21179, DOI 10.1074/jbc.M802333200; George Priya Doss C, 2008, Genomic Med, V2, P23, DOI 10.1007/s11568-008-9019-8; Ghimenti C, 2002, GENE CHROMOSOME CANC, V33, P235, DOI 10.1002/gcc.1223; Gorringe KL, 2008, BREAST CANCER RES TR, V111, P505, DOI 10.1007/s10549-007-9799-x; Hasan Tarique N, 2011, Adv Appl Bioinform Chem, V4, P29, DOI 10.2147/AABC.S17371; Hou WK, 2007, CHINESE MED J-PEKING, V120, P1592, DOI 10.1097/00029330-200709020-00009; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Irminger-Finger I, 2002, INT J BIOCHEM CELL B, V34, P582, DOI 10.1016/S1357-2725(01)00161-3; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Johnatty SE, 2009, BREAST CANCER RES TR, V115, P145, DOI 10.1007/s10549-008-0045-y; Karppinen SM, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020669; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Luu TD, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas018; Morris JR, 2002, J BIOL CHEM, V277, P9382, DOI 10.1074/jbc.M109249200; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Prokunina Ludmila, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007690; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sauer MK, 2005, J MED GENET, V42, P633, DOI 10.1136/jmg.2004.030049; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith C, 2005, NATURE, V435, P991, DOI 10.1038/435991a; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Spurdle AB, 2011, CANCER EPIDEM BIOMAR, V20, P1032, DOI 10.1158/1055-9965.EPI-10-0909; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhou XY, 2009, GYNECOL ONCOL, V114, P327, DOI 10.1016/j.ygyno.2009.05.011; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800	57	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43939	10.1371/journal.pone.0043939	http://dx.doi.org/10.1371/journal.pone.0043939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056176	gold, Green Submitted, Green Published			2022-12-25	WOS:000309889400004
J	Dematheis, F; Kurtz, B; Vidal, S; Smalla, K				Dematheis, Flavia; Kurtz, Benedikt; Vidal, Stefan; Smalla, Kornelia			Microbial Communities Associated with the Larval Gut and Eggs of the Western Corn Rootworm	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; VERTICAL TRANSMISSION; PLATASPID STINKBUG; RIBOSOMAL-RNA; BACTERIA; RHIZOSPHERE; POPULATIONS; COLEOPTERA; WOLBACHIA; MAIZE	Background: The western corn rootworm (WCR) is one of the economically most important pests of maize. A better understanding of microbial communities associated with guts and eggs of the WCR is required in order to develop new pest control strategies, and to assess the potential role of the WCR in the dissemination of microorganisms, e. g., mycotoxin-producing fungi. Methodology/Principal Findings: Total community (TC) DNA was extracted from maize rhizosphere, WCR eggs, and guts of larvae feeding on maize roots grown in three different soil types. Denaturing gradient gel electrophoresis (DGGE) and sequencing of 16S rRNA gene and ITS fragments, PCR-amplified from TC DNA, were used to investigate the fungal and bacterial communities, respectively. Microorganisms in the WCR gut were not influenced by the soil type. Dominant fungal populations in the gut were affiliated to Fusarium spp., while Wolbachia was the most abundant bacterial genus. Identical ribosomal sequences from gut and egg samples confirmed a transovarial transmission of Wolbachia sp. Betaproteobacterial DGGE indicated a stable association of Herbaspirillum sp. with the WCR gut. Dominant egg-associated microorganisms were the bacterium Wolbachia sp. and the fungus Mortierella gamsii. Conclusion/Significance: The soil type-independent composition of the microbial communities in the WCR gut and the dominance of only a few microbial populations suggested either a highly selective environment in the gut lumen or a high abundance of intracellular microorganisms in the gut epithelium. The dominance of Fusarium species in the guts indicated WCR larvae as vectors of mycotoxin-producing fungi. The stable association of Herbaspirillum sp. with WCR gut systems and the absence of corresponding sequences in WCR eggs suggested that this bacterium was postnatally acquired from the environment. The present study provided new insights into the microbial communities associated with larval guts and eggs of the WCR. However, their biological role remains to be explored.	[Kurtz, Benedikt; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Dematheis, Flavia; Smalla, Kornelia] Julius Kuhn Inst Fed Res Ctr Cultivated Plants JK, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany	University of Gottingen; Julius Kuhn-Institut	Vidal, S (corresponding author), Univ Gottingen, Dept Crop Sci, Gottingen, Germany.	svidal@gwdg.de	Vidal, Stefan/AAC-3130-2020; Dematheis, Flavia/GRS-2490-2022; Smalla, Kornelia/H-4002-2011	Vidal, Stefan/0000-0002-1673-4055; 	Deutsche Forschungsgemeinschaft DFG [SM59/7-1, Vi117/17-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG project SM59/7-1 and Vi117/17-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Balsanelli E, 2010, ENVIRON MICROBIOL, V12, P2233, DOI 10.1111/j.1462-2920.2010.02187.x; Barr KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011339; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Belda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021751; BRAND JM, 1975, NATURE, V254, P136, DOI 10.1038/254136a0; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Brune A., 2003, ENCY INSECTS, P1102; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL, P909; Clark TL, 2001, ANN ENTOMOL SOC AM, V94, P877, DOI 10.1603/0013-8746(2001)094[0877:OOWISD]2.0.CO;2; Costa R, 2006, ENVIRON MICROBIOL, V8, P2136, DOI 10.1111/j.1462-2920.2006.01096.x; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; Dematheis F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037288; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; EUTICK ML, 1978, APPL ENVIRON MICROB, V35, P823, DOI 10.1128/AEM.35.5.823-828.1978; FISCHER K, 1995, CAN J MICROBIOL, V41, P666, DOI 10.1139/m95-092; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; GILLIKIN JW, 1992, ARCH INSECT BIOCHEM, V19, P285, DOI 10.1002/arch.940190407; Giordano R, 1997, P NATL ACAD SCI USA, V94, P11439, DOI 10.1073/pnas.94.21.11439; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Kato A, 1998, J ANTIBIOT, V51, P929, DOI 10.7164/antibiotics.51.929; Kato A, 1997, J AM CHEM SOC, V119, P6680, DOI 10.1021/ja970895o; Kempson D., 1968, PEDOBIOLOGIA, V3, P1; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Kurtz B, 2010, ENVIRON ENTOMOL, V39, P1532, DOI 10.1603/EN10025; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Meyer JM, 2008, FLA ENTOMOL, V91, P294, DOI 10.1653/0015-4040(2008)91[294:MSOEIF]2.0.CO;2; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Molnar O, 2008, MYCOL PROG, V7, P111, DOI 10.1007/s11557-008-0558-0; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Oros-Sichler M, 2006, J MICROBIOL METH, V65, P63, DOI 10.1016/j.mimet.2005.06.014; PALMER LT, 1969, PHYTOPATHOLOGY, V59, P1613; PASTI MB, 1990, APPL ENVIRON MICROB, V56, P2213, DOI 10.1128/AEM.56.7.2213-2218.1990; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Rademaker JLW, 1999, MOL MICROBIAL ECOLOG; Ramirez-Puebla ST, 2010, ENVIRON ENTOMOL, V39, P1178, DOI 10.1603/EN10037; Rice M. E., 2004, Plant Health Progress, P1; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Roehrdanz RL, 2007, ANN ENTOMOL SOC AM, V100, P522, DOI 10.1603/0013-8746(2007)100[522:WBILTM]2.0.CO;2; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; Toyota K, 2000, BIOL FERT SOILS, V31, P187, DOI 10.1007/s003740050644; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Wolfson J.L., 1991, P223; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; You M, 2005, APPL ENVIRON MICROB, V71, P8183, DOI 10.1128/AEM.71.12.8183-8190.2005; Yu FG, 2007, ANTIMICROB AGENTS CH, V51, P64, DOI 10.1128/AAC.00931-06; Zhang ZG, 2000, PHYTOPATHOLOGY, V90, P384, DOI 10.1094/PHYTO.2000.90.4.384; Zouache K, 2009, APPL ENVIRON MICROB, V75, P3755, DOI 10.1128/AEM.02964-08	60	22	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44685	10.1371/journal.pone.0044685	http://dx.doi.org/10.1371/journal.pone.0044685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056182	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600007
J	Maughan, H; Wang, PW; Caballero, JD; Fung, P; Gong, YC; Donaldson, SL; Yuan, LJ; Keshavjee, S; Zhang, Y; Yau, YCW; Waters, VJ; Tullis, DE; Hwang, DM; Guttman, DS				Maughan, Heather; Wang, Pauline W.; Caballero, Julio Diaz; Fung, Pauline; Gong, Yunchen; Donaldson, Sylva L.; Yuan, Lijie; Keshavjee, Shaf; Zhang, Yu; Yau, Yvonne C. W.; Waters, Valerie J.; Tullis, D. Elizabeth; Hwang, David M.; Guttman, David S.			Analysis of the Cystic Fibrosis Lung Microbiota via Serial Illumina Sequencing of Bacterial 16S rRNA Hypervariable Regions	PLOS ONE			English	Article							COMMUNITIES; GENERATION; DIVERSITY; INFECTIONS	The characterization of bacterial communities using DNA sequencing has revolutionized our ability to study microbes in nature and discover the ways in which microbial communities affect ecosystem functioning and human health. Here we describe Serial Illumina Sequencing (SI-Seq): a method for deep sequencing of the bacterial 16S rRNA gene using next-generation sequencing technology. SI-Seq serially sequences portions of the V5, V6 and V7 hypervariable regions from barcoded 16S rRNA amplicons using an Illumina short-read genome analyzer. SI-Seq obtains taxonomic resolution similar to 454 pyrosequencing for a fraction of the cost, and can produce hundreds of thousands of reads per sample even with very high multiplexing. We validated SI-Seq using single species and mock community controls, and via a comparison to cystic fibrosis lung microbiota sequenced using 454 FLX Titanium. Our control runs show that SI-Seq has a dynamic range of at least five orders of magnitude, can classify >96% of sequences to the genus level, and performs just as well as 454 and paired-end Illumina methods in estimation of standard microbial ecology diversity measurements. We illustrate the utility of SI-Seq in a pilot sample of central airway secretion samples from cystic fibrosis patients.	[Maughan, Heather; Caballero, Julio Diaz; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Wang, Pauline W.; Fung, Pauline; Gong, Yunchen; Donaldson, Sylva L.; Yuan, Lijie; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Keshavjee, Shaf; Zhang, Yu; Hwang, David M.] Univ Toronto, Latner Thorac Surg Labs, Univ Hlth Network, Toronto, ON, Canada; [Zhang, Yu; Hwang, David M.] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Yau, Yvonne C. W.; Waters, Valerie J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Tullis, D. Elizabeth] St Michaels Hosp, Adult Cyst Fibrosis Clin, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Maughan, H (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	heather.maughan@utoronto.ca; david.guttman@utoronto.ca	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869; Diaz Caballero, Julio/0000-0003-4664-8577; Keshavjee, Shaf/0000-0003-4547-8094	Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant [CMF108027]; National Sanitarium Association; Cystic Fibrosis Canada	Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant(Canadian Institutes of Health Research (CIHR)); National Sanitarium Association; Cystic Fibrosis Canada	This work was supported by: the Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant (CMF108027) (http://www.cihr-irsc.gc.ca/e/193.html); the National Sanitarium Association (http://nationalsanitarium.ca/); and Cystic Fibrosis Canada (www.cysticfibrosis.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Moustafa A, 2010, JALIGNER OPEN SOURCE; Oksanen J., 2016, R PACKAG; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON BA, 2011, MET HUM BOD, P91; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	34	46	57	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45791	10.1371/journal.pone.0045791	http://dx.doi.org/10.1371/journal.pone.0045791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056217	Green Published, Green Submitted, gold			2022-12-25	WOS:000309452600017
J	Blasic, JR; Brown, RL; Robinson, PR				Blasic, Joseph R., Jr.; Brown, R. Lane; Robinson, Phyllis R.			Phosphorylation of Mouse Melanopsin by Protein Kinase A	PLOS ONE			English	Article							GANGLION-CELL PHOTORECEPTORS; DOPAMINE; LIGHT; EXPRESSION; INDUCTION; SLEEP	The visual pigment melanopsin is expressed in intrinsically photosensitive retinal ganglion cells (ipRGCs) in the mammalian retina, where it is involved in non-image forming light responses including circadian photoentrainment, pupil constriction, suppression of pineal melatonin synthesis, and direct photic regulation of sleep. It has recently been shown that the melanopsin-based light response in ipRGCs is attenuated by the neurotransmitter dopamine. Here, we use a heterologous expression system to demonstrate that mouse melanopsin can be phosphorylated by protein kinase A, and that phosphorylation can inhibit melanopsin signaling in HEK cells. Site-directed mutagenesis experiments revealed that this inhibitory effect is primarily mediated by phosphorylation of sites T186 and S287 located in the second and third intracellular loops of melanopsin, respectively. Furthermore, we show that this phosphorylation can occur in vivo using an in situ proximity-dependent ligation assay (PLA). Based on these data, we suggest that the attenuation of the melanopsin-based light response by dopamine is mediated by direct PKA phosphorylation of melanopsin, rather than phosphorylation of a downstream component of the signaling cascade.	[Blasic, Joseph R., Jr.; Robinson, Phyllis R.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Brown, R. Lane] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA	University System of Maryland; University of Maryland Baltimore County; Washington State University	Robinson, PR (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	probinso@umbc.edu			National Science Foundation [IOS0721608]; National Eye Institute [R01EY019053]; National Institutes of Health [T32 GM066706]; NATIONAL EYE INSTITUTE [R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Science Foundation to P. R. R (IOS0721608) and from the National Eye Institute to P. R. R. (R01EY019053). J.B. was supported by a National Institutes of Health training grant (T32 GM066706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Doyle SE, 2002, J NEUROCHEM, V83, P211, DOI 10.1046/j.1471-4159.2002.01149.x; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Van Hook MJ, 2012, EUR J NEUROSCI, V35, P507, DOI 10.1111/j.1460-9568.2011.07975.x; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	29	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45387	10.1371/journal.pone.0045387	http://dx.doi.org/10.1371/journal.pone.0045387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049792	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300023
J	Salnikov, AV; Liu, L; Platen, M; Gladkich, J; Salnikova, O; Ryschich, E; Mattern, J; Moldenhauer, G; Werner, J; Schemmer, P; Buchler, MW; Herr, I				Salnikov, Alexei V.; Liu, Li; Platen, Mitja; Gladkich, Jury; Salnikova, Olga; Ryschich, Eduard; Mattern, Juergen; Moldenhauer, Gerhard; Werner, Jens; Schemmer, Peter; Buechler, Markus W.; Herr, Ingrid			Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INITIATING CELLS; DRUG-RESISTANCE; SOLID TUMORS; PROGRESSION; EXPRESSION; IDENTIFICATION; CONTRIBUTES; METASTASIS; INVASION	Tumor hypoxia induces epithelial-mesenchymal transition (EMT), which induces invasion and metastasis, and is linked to cancer stem cells (CSCs). Whether EMT generates CSCs de novo, enhances migration of existing CSCs or both is unclear. We examined patient tissue of pancreatic ductal adenocarcinoma (PDA) along with carcinomas of breast, lung, kidney, prostate and ovary. For in vitro studies, five established PDA cell lines classified as less (CSClow) and highly aggressive CSC-like cells (CSChigh) were examined by single and double immunofluorescence microscopy, wound-, transwell-, and time-lapse microscopy. HIF-1 alpha and Slug, as well as HIF-2 alpha and CD133 were co-expressed pointing to a putative co-existence of hypoxia, EMT and CSCs in vivo. CSChigh cells exhibited high basal expression of the mesenchymal Vimentin protein but low or absent expression of the epithelial marker E-cadherin, with the opposite result in CSClow cells. Hypoxia triggered altering of cell morphology from an epithelial to a mesenchymal phenotype, which was more pronounced in CSChigh cells. Concomitantly, E-cadherin expression was reduced and expression of Vimentin, Slug, Twist2 and Zeb1 enhanced. While hypoxia caused migration in all cell lines, velocity along with the percentage of migrating, polarized and pseudopodia-forming cells was significantly higher in CSChigh cells. These data indicate that hypoxia-induced EMT occurs in PDA and several other tumor entities. However although hypoxia-induced EMT signaling occurs in all tumor cell populations, only the stem-like cells acquire high migratory potential and thus may be responsible for invasion and metastasis.	[Salnikov, Alexei V.; Liu, Li; Platen, Mitja; Gladkich, Jury; Herr, Ingrid] Heidelberg Univ, Dept Gen Surg, Mol OncoSurg Grp, Heidelberg, Germany; [Salnikov, Alexei V.; Moldenhauer, Gerhard] German Canc Res Ctr, Dept Translat Immunol, D-6900 Heidelberg, Germany; [Salnikov, Alexei V.; Moldenhauer, Gerhard] Natl Ctr Tumor Dis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Herr, I (corresponding author), Heidelberg Univ, Dept Gen Surg, Mol OncoSurg Grp, Heidelberg, Germany.	i.herr@dkfz.de	Liu, Li/AEU-6051-2022; Herr, Ingrid/AAA-2276-2022		German Cancer Aid (Deutsche Krebshilfe) [109362]; German Research Community [DFG HE 3186/11-1]; German-Israeli Foundation for Scientific Research and Development [GIF 1058-7.11/2008]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Research Community(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This study was supported by grants from the German Cancer Aid (Deutsche Krebshilfe 109362), German Research Community (DFG HE 3186/11-1) and German-Israeli Foundation for Scientific Research and Development (GIF 1058-7.11/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bhaskara VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030905; Brown JM, 1998, CANCER RES, V58, P1408; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Cheng JC, 2011, ONCOGENE, V30, P3930, DOI 10.1038/onc.2011.117; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Durand RE, 2001, CANCER METAST REV, V20, P57, DOI 10.1023/A:1013181107707; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Salnikov AV, 2010, INT J CANCER, V126, P950, DOI 10.1002/ijc.24822; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Zhang Y, 2012, ONCOL REP, V27, P1599, DOI 10.3892/or.2012.1681; Zhou W, 2010, INT J ONCOL, V37, P551, DOI 10.3892/ijo_00000704	45	106	115	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46391	10.1371/journal.pone.0046391	http://dx.doi.org/10.1371/journal.pone.0046391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050024	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300114
J	Sancho, P; Mainez, J; Crosas-Molist, E; Roncero, C; Fernandez-Rodriguez, CM; Pinedo, F; Huber, H; Eferl, R; Mikulits, W; Fabregat, I				Sancho, Patricia; Mainez, Jessica; Crosas-Molist, Eva; Roncero, Cesar; Fernandez-Rodriguez, Conrado M.; Pinedo, Fernando; Huber, Heidemarie; Eferl, Robert; Mikulits, Wolfgang; Fabregat, Isabel			NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development	PLOS ONE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; GROWTH-FACTOR-BETA; TGF-BETA; MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; OXIDATIVE STRESS; UP-REGULATION; DIFFERENTIATION; FIBROGENESIS	A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19ARF(-/-), Stat3(Delta hc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl4) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-beta pathway activation. In vitro TGF-beta-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-beta is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-beta-induced epithelial-mesenchymal transition (EMT), but was required for TGF-beta-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-beta-induced death of hepatocytes.	[Sancho, Patricia; Mainez, Jessica; Crosas-Molist, Eva; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona, Spain; [Roncero, Cesar] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Roncero, Cesar] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Fernandez-Rodriguez, Conrado M.] Hosp Univ Fdn Alcorcon, Serv Gastroenterol, Madrid, Spain; [Fernandez-Rodriguez, Conrado M.] Univ Rey Juan Carlos, Madrid, Spain; [Pinedo, Fernando] Hosp Univ Fdn Alcorcon, Unit Pathol, Madrid, Spain; [Huber, Heidemarie; Eferl, Robert; Mikulits, Wolfgang] Med Univ Vienna, Div Inst Canc Res, Dept Med 1, Vienna, Austria; [Eferl, Robert] Ludwig Boltzmann Inst Canc Res LBI CR, Vienna, Austria; [Fabregat, Isabel] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Complutense University of Madrid; Hospital Clinico San Carlos; Alcorcon Foundation University Hospital; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Medical University of Vienna; Ludwig Boltzmann Institute; University of Barcelona	Fabregat, I (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona, Spain.	ifabregat@idibell.cat	Roncero, Cesáreo/H-9039-2015; Sancho, Patricia/ABH-5258-2020; Mikulits, Wolfgang/AAH-4043-2021; Fabregat, Isabel/H-7038-2015	Roncero, Cesáreo/0000-0001-7608-8553; Sancho, Patricia/0000-0002-1092-5395; Pinedo Moraleda, Fernando/0000-0001-7470-093X; Fabregat, Isabel/0000-0003-0136-8440; Mikulits, Wolfgang/0000-0003-4612-7106; Eferl, Robert/0000-0002-6074-7144; Crosas Molist, Eva/0000-0002-2408-0071; Fernandez Rodriguez, Conrado M/0000-0002-1915-2157	Ministerio de Ciencia e Innovacion (MICINN), Spain [BFU2009-07219, ISCIII-RTICC RD06/0020]; AGAUR-Generalitat de Catalunya [2009SGR-312]; European Union [HEALTH-F4-2008-202047]; FPI; FPU; MICINN, Spain	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); European Union(European Commission); FPI(Spanish Government); FPU(Spanish Government); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants to IF from the Ministerio de Ciencia e Innovacion (MICINN), Spain (BFU2009-07219 and ISCIII-RTICC RD06/0020) and AGAUR-Generalitat de Catalunya (2009SGR-312). The work of WM was supported by the European Union, FP7 Health Research project number HEALTH-F4-2008-202047. JM and EC-M were recipients of pre-doctoral fellowships from the FPI and FPU programs, respectively, MICINN, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PA, 2012, FREE RADICAL RES, V46, P204, DOI 10.3109/10715762.2011.647691; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Aram G, 2009, HEPATOLOGY, V49, P911, DOI 10.1002/hep.22708; Baghdasaryan A, 2010, GUT, V59, P521, DOI 10.1136/gut.2009.186528; Barikbin R, 2012, HEPATOLOGY, V55, P553, DOI 10.1002/hep.24711; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2011, J CELL PHYSIOL, V226, P1214, DOI 10.1002/jcp.22439; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; de Andrade JA, 2009, CURR OPIN RHEUMATOL, V21, P649, DOI 10.1097/BOR.0b013e328330da9b; De Minicis S, 2010, HEPATOLOGY, V52, P1420, DOI 10.1002/hep.23804; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Ikeda R, 2011, INFLAMM RES, V60, P597, DOI 10.1007/s00011-011-0309-6; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Jiang JX, 2010, GASTROENTEROLOGY, V139, P1375, DOI 10.1053/j.gastro.2010.05.074; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Martin-Garrido A, FREE RADIC BIOL MED, V50, P354; Matsuzaki K, 2009, FRONT BIOSCI-LANDMRK, V14, P2923, DOI 10.2741/3423; Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009; Proell Verena, 2007, Comp Hepatol, V6, P1, DOI 10.1186/1476-5926-6-1; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2011, FREE RADICAL BIO MED, V51, P1789, DOI 10.1016/j.freeradbiomed.2011.08.011; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Valdes F, 2002, MOL CANCER RES, V1, P68; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Wells RG, 2010, HEPATOLOGY, V51, P737, DOI 10.1002/hep.23529	45	110	117	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45285	10.1371/journal.pone.0045285	http://dx.doi.org/10.1371/journal.pone.0045285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049784	Green Published, gold			2022-12-25	WOS:000309517300020
J	Dechavanne, C; Guillonneau, F; Chiappetta, G; Sago, L; Levy, P; Salnot, V; Guitard, E; Ehrenmann, F; Broussard, C; Chafey, P; Le Port, A; Vinh, J; Mayeux, P; Dugoujon, JM; Lefranc, MP; Migot-Nabias, F				Dechavanne, Celia; Guillonneau, Francois; Chiappetta, Giovanni; Sago, Laila; Levy, Prisca; Salnot, Virginie; Guitard, Evelyne; Ehrenmann, Francois; Broussard, Cedric; Chafey, Philippe; Le Port, Agnes; Vinh, Joelle; Mayeux, Patrick; Dugoujon, Jean-Michel; Lefranc, Marie-Paule; Migot-Nabias, Florence			Mass Spectrometry Detection of G3m and IGHG3 Alleles and Follow-Up of Differential Mother and Neonate IgG3	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IMMUNOGLOBULIN; SEQUENCE; ANTIBODIES; GM; TRANSMISSION; RECEPTORS; ALLOTYPES; NEWBORNS; MALARIA	Mass spectrometry (MS) analysis for detection of immunoglobulins (IG) of the human IgG3 subclass is described that relies on polymorphic amino acids of the heavy gamma3 chains. IgG3 is the most polymorphic human IgG subclass with thirteen G3m allotypes located on the constant CH2 and CH3 domains of the gamma3 chain, the combination of which leads to six major G3m alleles. Amino acid changes resulting of extensive sequencing previously led to the definition of 19 IGHG3 alleles that have been correlated to the G3m alleles. As a proof of concept, MS proteotypic peptides were defined which encompass discriminatory amino acids for the identification of the G3m and IGHG3 alleles. Plasma samples originating from ten individuals either homozygous or heterozygous for different G3m alleles, and including one mother and her baby (drawn sequentially from birth to 9 months of age), were analyzed. Total IgG3 were purified using affinity chromatography and then digested by a combination of AspN and trypsin proteases, and peptides of interest were detected by mass spectrometry. The sensitivity of the method was assessed by mixing variable amounts of two plasma samples bearing distinct G3m allotypes. A label-free approach using the high-performance liquid chromatography (HPLC) retention time of peptides and their MS mass analyzer peak intensity gave semi-quantitative information. Quantification was realized by selected reaction monitoring (SRM) using synthetic peptides as internal standards. The possibility offered by this new methodology to detect and quantify neo-synthesized IgG in newborns will improve knowledge on the first acquisition of antibodies in infants and constitutes a promising diagnostic tool for vertically-transmitted diseases.	[Dechavanne, Celia; Levy, Prisca; Le Port, Agnes; Migot-Nabias, Florence] IRD, Unite Mixte Rech UMR Mere & Enfant Face Infect Tr, Paris, France; [Dechavanne, Celia; Levy, Prisca; Le Port, Agnes; Migot-Nabias, Florence] Univ Paris 05, Fac Pharm, Paris, France; [Chiappetta, Giovanni; Vinh, Joelle] ESPCI ParisTech, Unite Spectrometrie Masse Biol & Proteom SMBP, Unite Serv & Rech USR CNRS 3149, Paris, France; [Guitard, Evelyne; Dugoujon, Jean-Michel] Univ Toulouse 3, Lab Anthropol Mol & Imagerie Synth, Unite Mixte Rech UMR 5288, CNRS, F-31062 Toulouse, France; [Ehrenmann, Francois; Lefranc, Marie-Paule] Univ Montpellier 2, Int ImMunoGeneT Informat Syst IMGT, Lab ImmunoGenet Mol LIGM, Unite Propre Rech UPR CNRS 1142,IGH, Montpellier, France; [Chafey, Philippe] INSERM, Plate Forme Electophorese Bidimens Inst Cochin Pe, U1016, Paris, France; [Mayeux, Patrick] Univ Paris 05, INSERM, U1016, Dept Hematol,Inst Cochin,CNRS, Paris, France; [Lefranc, Marie-Paule] Inst Univ France, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Dechavanne, C (corresponding author), IRD, Unite Mixte Rech UMR Mere & Enfant Face Infect Tr, Paris, France.	celia.dechavanne@gmail.com	Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Guillonneau, Francois/0000-0003-1484-4696; Broussard, Cedric/0000-0001-9508-2341; Ehrenmann, Francois/0000-0003-2727-0070; Dechavanne, Celia/0000-0001-8439-9976; Le Port, Agnes/0000-0002-8337-6569; Salnot, Virginie/0000-0002-7530-4493; Migot-Nabias, Florence/0000-0001-9982-594X				BRUSCO A, 1995, IMMUNOGENETICS, V42, P414, DOI 10.1007/BF00179404; Chippaux JP, 2010, TROP MED INT HEALTH, V15, P87, DOI 10.1111/j.1365-3156.2009.02431.x; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Dugoujon JM, 2004, AM J PHYS ANTHROPOL, V125, P175, DOI 10.1002/ajpa.10405; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; FIELD LL, 1989, GENET EPIDEMIOL, V6, P31, DOI 10.1002/gepi.1370060108; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Goetze AM, 2011, MOL IMMUNOL, V49, P338, DOI 10.1016/j.molimm.2011.09.002; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; HUCK S, 1989, IMMUNOGENETICS, V30, P250, DOI 10.1007/BF02421328; JEFFERIS R, 1992, IMMUNOL LETT, V31, P143, DOI 10.1016/0165-2478(92)90141-A; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Lefranc G., 1976, ACTA ANTHR, V1, P34; Lefranc M.P., 1990, HUMAN IGG SUBCLASSES, P43; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Lindner AK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000783; Migot-Nabias F, 2008, J INFECT DIS, V198, P1892, DOI 10.1086/593210; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinon JM, 2001, J CLIN MICROBIOL, V39, P2267, DOI 10.1128/JCM.39.6.2267-2271.2001; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; VANLOGHEM E, 1982, VOX SANG, V43, P301; WILLIAMS AI, 1969, ARCH DIS CHILD, V44, P511, DOI 10.1136/adc.44.236.511	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46097	10.1371/journal.pone.0046097	http://dx.doi.org/10.1371/journal.pone.0046097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049948	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100135
J	Lee, JH; Kim, EJ; Kim, DK; Lee, JM; Park, SB; Lee, IK; Harris, RA; Lee, MO; Choi, HS				Lee, Ja Hee; Kim, Eun-Jin; Kim, Don-Kyu; Lee, Ji-Min; Park, Seung Bum; Lee, In-Kyu; Harris, Robert A.; Lee, Mi-Ock; Choi, Hueng-Sik			Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERR gamma	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; ESTROGEN-RELATED RECEPTORS; INDUCIBLE FACTOR-1; OXYGEN HOMEOSTASIS; ADIPOSE-TISSUE; KEY REGULATOR; COACTIVATOR; ALPHA; ADAPTATION; METABOLISM	Multiple cellular signaling pathways that control metabolism and survival are activated when cell are incubated under hypoxic conditions. Activation of the hypoxia inducible factor (HIF)-1 promotes expression of genes that increase the capacity to cope with the stress imposed by a reduced oxygen environment. Here we show that the orphan nuclear receptor estrogen related receptor gamma (ERR gamma) plays a critical role in hypoxia-mediated activation of pyruvate dehydrogenase kinase 4 (PDK4) gene expression. ERR gamma mRNA and protein levels were increased by hypoxia or desferrioxamine (DFO) treatment in hepatoma cell lines. Co-expression of HIF-1 alpha and beta increased ERRc promoter activity as well as mRNA expression, while knockdown of endogenous HIF-1 alpha reduced the hypoxia-mediated induction of ERR gamma. In addition, hypoxia also increased the promoter activity and mRNA level of PDK4 in HepG2 cells. Adenovirus mediated-overexpression of ERR gamma specifically increased PDK4 gene expression, while ablation of endogenous ERR gamma significantly decreased hypoxia-mediated induction of PDK4 gene expression. Finally, GSK5182, an inverse agonist of ERR gamma, strongly inhibited the hypoxia-mediated induction of PDK4 protein and promoter activity. Regulation of the transcriptional activity of ERR gamma may provide a therapeutic approach for the regulation of PDK4 gene expression under hypoxia.	[Kim, Eun-Jin; Lee, Mi-Ock] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Ja Hee; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Kwangju, South Korea; [Lee, Ja Hee; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, World Class Univ Program, Res Inst Aging & Metab, Taegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ Hosp, Dept Endocrinol & Metab, Taegu, South Korea; [Harris, Robert A.] Roudebush VA Med Ctr, Indianapolis, IN USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, World Class Univ Program, Indianapolis, IN USA; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju, South Korea	Seoul National University (SNU); Chonnam National University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Lee, MO (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	molee@snu.ac.kr; hsc@chonnam.ac.kr	Lee, In-Kyu/AAR-6374-2021; Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology [20110018305]; NRF [2009-0080757]; SRC/ERC [R11-2007-107-01001-0]; World Class University Program through the National Research Foundation of Korea (NRF) [R32-10064]; Ministry of Education, Science, and Technology	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; NRF; SRC/ERC(European Research Council (ERC)); World Class University Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a National Creative Research Initiatives Grant (20110018305) from the Korean Ministry of Education, Science and Technology. And M.-O Lee was supported by grants from the NRF(2009-0080757), and the SRC/ERC(R11-2007-107-01001-0). I.-K Lee was supported by World Class University Program (R32-10064) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	34	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46324	10.1371/journal.pone.0046324	http://dx.doi.org/10.1371/journal.pone.0046324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050013	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100178
J	Lodola, F; Laforenza, U; Bonetti, E; Lim, D; Dragoni, S; Bottino, C; Ong, HL; Guerra, G; Ganini, C; Massa, M; Manzoni, M; Ambudkar, IS; Genazzani, AA; Rosti, V; Pedrazzoli, P; Tanzi, F; Moccia, F; Porta, C				Lodola, Francesco; Laforenza, Umberto; Bonetti, Elisa; Lim, Dmitry; Dragoni, Silvia; Bottino, Cinzia; Ong, Hwei Ling; Guerra, Germano; Ganini, Carlo; Massa, Margherita; Manzoni, Mariangela; Ambudkar, Indu S.; Genazzani, Armando A.; Rosti, Vittorio; Pedrazzoli, Paolo; Tanzi, Franco; Moccia, Francesco; Porta, Camillo			Store-Operated Ca2+ Entry Is Remodelled and Controls In Vitro Angiogenesis in Endothelial Progenitor Cells Isolated from Tumoral Patients	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CALCIUM-ENTRY; STEM-CELLS; STIM1; PROLIFERATION; CHANNELS; GROWTH; CARCINOMA; RECEPTOR; INFLUX	Background: Endothelial progenitor cells (EPCs) may be recruited from bone marrow to sustain tumor vascularisation and promote the metastatic switch. Understanding the molecular mechanisms driving EPC proliferation and tubulogenesis could outline novel targets for alternative anti-angiogenic treatments. Store-operated Ca2+ entry (SOCE), which is activated by a depletion of the intracellular Ca2+ pool, regulates the growth of human EPCs, where is mediated by the interaction between the endoplasmic reticulum Ca2+-sensor, Stim1, and the plasmalemmal Ca2+ channel, Orai1. As oncogenesis may be associated to the capability of tumor cells to grow independently on Ca2+ influx, it is important to assess whether SOCE regulates EPC-dependent angiogenesis also in tumor patients. Methodology/Principal Findings: The present study employed Ca2+ imaging, recombinant sub-membranal and mitochondrial aequorin, real-time polymerase chain reaction, gene silencing techniques and western blot analysis to investigate the expression and the role of SOCE in EPCs isolated from peripheral blood of patients affected by renal cellular carcinoma (RCC; RCC-EPCs) as compared to control EPCs (N-EPCs). SOCE, activated by either pharmacological (i.e. cyclopiazonic acid) or physiological (i.e. ATP) stimulation, was significantly higher in RCC-EPCs and was selectively sensitive to BTP-2, and to the trivalent cations, La3+ and Gd3+. Furthermore, 2-APB enhanced thapsigargin-evoked SOCE at low concentrations, whereas higher doses caused SOCE inhibition. Conversely, the anti-angiogenic drug, carboxyamidotriazole (CAI), blocked both SOCE and the intracellular Ca2+ release. SOCE was associated to the over-expression of Orai1, Stim1, and transient receptor potential channel 1 (TRPC1) at both mRNA and protein level The intracellular Ca2+ buffer, BAPTA, BTP-2, and CAI inhibited RCC-EPC proliferation and tubulogenesis. The genetic suppression of Stim1, Orai1, and TRPC1 blocked CPA-evoked SOCE in RCC-EPCs. Conclusions: SOCE is remodelled in EPCs from RCC patients and stands out as a novel molecular target to interfere with RCC vascularisation due to its ability to control proliferation and tubulogenesis.	[Lodola, Francesco; Dragoni, Silvia; Tanzi, Franco; Moccia, Francesco] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Laforenza, Umberto; Bottino, Cinzia] Univ Pavia, Sect Human Physiol, Dept Mol Med, I-27100 Pavia, Italy; [Bonetti, Elisa; Rosti, Vittorio] Clin Epidemiol Lab Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Lim, Dmitry; Genazzani, Armando A.] Univ Eastern Piedmont Amedeo Avogadro, Dept Pharmaceut Sci, Novara, Italy; [Ong, Hwei Ling; Ambudkar, Indu S.] Natl Inst Dent & Craniofacial Res, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Guerra, Germano] Univ Molise, Dept Hlth Sci, Campobasso, Italy; [Ganini, Carlo; Manzoni, Mariangela; Pedrazzoli, Paolo; Porta, Camillo] Med Oncol IRCCS Policlin San Matteo, Pavia, Italy; [Massa, Margherita] Fdn IRCCS Policlin San Matteo, Biotechnol Lab, Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Eastern Piedmont Amedeo Avogadro; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Molise; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Moccia, F (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	francesco.moccia@unipv.it	Porta, Camillo/AAB-9482-2020; Moccia, Francesco/AAX-6447-2020; Lim, Dmitry/H-9101-2012; Lodola, Francesco/J-8129-2018; Massa, Margherita/K-4682-2016; Genazzani, Armando/AAI-8280-2020; Rosti, Vittorio/K-1743-2018; Ganini, Carlo/V-6297-2017; Bonetti, Elisa/D-4478-2016; Pedrazzoli, Paolo/AAB-8690-2019	Moccia, Francesco/0000-0003-0010-0098; Lodola, Francesco/0000-0002-3506-5619; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; Ganini, Carlo/0000-0002-5839-3965; Bonetti, Elisa/0000-0002-8406-5252; Pedrazzoli, Paolo/0000-0002-9419-7160; Porta, Camillo/0000-0003-2412-1563; Dragoni, Silvia/0000-0002-9107-6291; Genazzani, Armando/0000-0003-1923-7430; Ong, Hwei Ling/0000-0002-7551-6883; Laforenza, Umberto/0000-0003-2951-5983	Ricerca Corrente, IRCCS Policlinico San Matteo Foundation, Pavia [674]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	Ricerca Corrente, IRCCS Policlinico San Matteo Foundation, Pavia; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from Ricerca Corrente, #674, IRCCS Policlinico San Matteo Foundation, Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Antigny F, 2012, J BIOL CHEM, V287, P5917, DOI 10.1074/jbc.M111.295733; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhatt RS, 2011, BRIT J CANCER, V105, P112, DOI 10.1038/bjc.2011.186; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Bussolati B, 2010, CURR VASC PHARMACOL, V8, P220, DOI 10.2174/157016110790887036; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Carrichon L, 2011, BBA-BIOMEMBRANES, V1808, P78, DOI 10.1016/j.bbamem.2010.08.002; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Ciarcia R, 2010, J CELL PHYSIOL, V224, P443, DOI 10.1002/jcp.22140; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Collado B, 2007, BIOCHIM BIOPHYS ACTA, V744, P224; D'Amato M, 2003, BIOCHEM BIOPH RES CO, V301, P907, DOI 10.1016/S0006-291X(03)00062-7; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Dutcher JP, 2005, CANCER, V104, P2392, DOI 10.1002/cncr.21473; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Faehling M, 2002, FASEB J, V16, P1805, DOI 10.1096/fj.01-0938fje; Feldman B, 2010, CELL CALCIUM, V47, P525, DOI 10.1016/j.ceca.2010.05.002; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Harper MT, 2011, CELL CALCIUM, V50, P351, DOI 10.1016/j.ceca.2011.06.005; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hill PA, 2010, PATHOLOGY, V42, P479, DOI 10.3109/00313025.2010.494284; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang JB, 2004, CANCER RES, V64, P2482, DOI 10.1158/0008-5472.CAN-03-3501; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwata S, 2009, EUR J PHARMACOL, V605, P15, DOI 10.1016/j.ejphar.2008.12.045; Jaffe LF, 2005, ADV CANCER RES, V94, P231, DOI 10.1016/S0065-230X(05)94006-2; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Korkiamaki T, 2002, AM J PATHOL, V160, P1981, DOI 10.1016/S0002-9440(10)61148-0; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Kuang CY, 2010, BIOCHEM BIOPH RES CO, V398, P315, DOI 10.1016/j.bbrc.2010.06.088; Lazzari C, 2011, J NEUROCHEM, V116, P881, DOI 10.1111/j.1471-4159.2010.07015.x; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Moccia F, 2003, J CELL PHYSIOL, V194, P139, DOI 10.1002/jcp.10198; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Moccia F, 2010, CURR DRUG THER, V5, P277, DOI 10.2174/157488510792927483; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Munaron L, 2009, CURR MED CHEM, V16, P4691, DOI 10.2174/092986709789878210; Munaron L, 2008, TECHNOL CANCER RES T, V7, P335, DOI 10.1177/153303460800700408; Namdarian B, 2010, BJU INT, V106, P1081, DOI 10.1111/j.1464-410X.2010.09245.x; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park JH, 2008, CELL PROLIFERAT, V41, P786, DOI 10.1111/j.1365-2184.2008.00552.x; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Patton AM, 2003, CURR PHARM DESIGN, V9, P543, DOI 10.2174/1381612033391559; Piaggio G, 2009, BLOOD, V114, P3127, DOI 10.1182/blood-2008-12-190991; Pla AF, 2008, MOL CANCER RES, V6, P535, DOI 10.1158/1541-7786.MCR-07-0271; Pla AF, 2010, MOL CANCER RES, V8, P1466, DOI 10.1158/1541-7786.MCR-10-0002; Porta C, 2012, CRIT REV ONCOL HEMAT, V82, P323, DOI 10.1016/j.critrevonc.2011.06.001; Porta C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-105; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sanchez-Hernandez Y, 2010, STEM CELLS DEV, V19, P1967, DOI 10.1089/scd.2010.0047; Shang J, 2004, BIOCHEMISTRY-US, V43, P9576, DOI 10.1021/bi049358o; Shi YK, 2010, EXP BIOL MED, V235, P317, DOI 10.1258/ebm.2009.009237; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2002, EXP HEMATOL, V30, P1219, DOI 10.1016/S0301-472X(02)00893-7; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stadler WM, 2005, J CLIN ONCOL, V23, P3726, DOI 10.1200/JCO.2005.44.150; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Takezawa R, 2006, MOL PHARMACOL, V69, P1413, DOI 10.1124/mol.105.021154; Touchberry CD, 2011, BIOCHEM BIOPH RES CO, V416, P45, DOI 10.1016/j.bbrc.2011.10.133; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu YG, 1997, CLIN CANCER RES, V3, P1915; Yamazaki D, 2007, J PHARMACOL SCI, V104, P103, DOI 10.1254/jphs.SC0070080; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590	99	122	124	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42541	10.1371/journal.pone.0042541	http://dx.doi.org/10.1371/journal.pone.0042541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049731	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100003
J	Tigerholm, J; Borjesson, SI; Lundberg, L; Elinder, F; Fransen, E				Tigerholm, Jenny; Borjesson, Sara I.; Lundberg, Linnea; Elinder, Fredrik; Fransen, Erik			Dampening of Hyperexcitability in CA1 Pyramidal Neurons by Polyunsaturated Fatty Acids Acting on Voltage-Gated Ion Channels	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; POTASSIUM CHANNELS; CORTICAL-NEURONS; KETOGENIC DIET; ELECTRICAL SYNAPSES; SODIUM CURRENTS; NA+ CHANNELS; IN-VIVO; EXCITABILITY; GENE	A ketogenic diet is an alternative treatment of epilepsy in infants. The diet, rich in fat and low in carbohydrates, elevates the level of polyunsaturated fatty acids (PUFAs) in plasma. These substances have therefore been suggested to contribute to the anticonvulsive effect of the diet. PUFAs modulate the properties of a range of ion channels, including K and Na channels, and it has been hypothesized that these changes may be part of a mechanistic explanation of the ketogenic diet. Using computational modelling, we here study how experimentally observed PUFA-induced changes of ion channel activity affect neuronal excitability in CA1, in particular responses to synaptic input of high synchronicity. The PUFA effects were studied in two pathological models of cellular hyperexcitability associated with epileptogenesis. We found that experimentally derived PUFA modulation of the A-type K (K-A) channel, but not the delayed-rectifier K channel, restored healthy excitability by selectively reducing the response to inputs of high synchronicity. We also found that PUFA modulation of the transient Na channel was effective in this respect if the channel's steady-state inactivation was selectively affected. Furthermore, PUFA-induced hyperpolarization of the resting membrane potential was an effective approach to prevent hyperexcitability. When the combined effect of PUFA on the K-A channel, the Na channel, and the resting membrane potential, was simulated, a lower concentration of PUFA was needed to restore healthy excitability. We therefore propose that one explanation of the beneficial effect of PUFAs lies in its simultaneous action on a range of ion-channel targets. Furthermore, this work suggests that a pharmacological cocktail acting on the voltage dependence of the Na-channel inactivation, the voltage dependences of K-A channels, and the resting potential can be an effective treatment of epilepsy.	[Tigerholm, Jenny; Lundberg, Linnea; Fransen, Erik] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden; [Tigerholm, Jenny; Fransen, Erik] KTH Royal Inst Technol, Stockholm Brain Inst, Stockholm, Sweden; [Borjesson, Sara I.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden	Royal Institute of Technology; Royal Institute of Technology; Linkoping University	Tigerholm, J (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden.	tige@kth.se	Liin, Sara/I-2941-2012	Liin, Sara/0000-0001-8493-0114; Elinder, Fredrik/0000-0001-9125-5583; Lundberg, Linnea/0000-0001-8508-6402	Swedish Research Council [621-2007-4223, 13043]; USA NIH [MH061492-06A2]; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victorias Freemasons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); USA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victorias Freemasons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Swedish Research Council (grant numbers 621-2007-4223 and 13043, the USA NIH (grant number MH061492-06A2), the Swedish Heart-Lung Foundation, the Swedish Brain Foundation, the County Council of Ostergotland, and King Gustaf V and Queen Victorias Freemasons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1999, J NEUROSCI, V19, P2209; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; CYMBALYUK GS, 1994, BIOL CYBERN, V71, P153, DOI 10.1007/BF00197318; Francis J, 1997, NEUROSCI LETT, V232, P91, DOI 10.1016/S0304-3940(97)00593-4; Fransen E, 2010, HIPPOCAMPUS, V20, P877, DOI 10.1002/hipo.20694; Fraser DD, 2003, NEUROLOGY, V60, P1026, DOI 10.1212/01.WNL.0000049974.74242.C6; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hahn A, 2009, BRAIN DEV-JPN, V31, P515, DOI 10.1016/j.braindev.2009.04.012; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong MP, 2004, BRAIN RES, V1008, P81, DOI 10.1016/j.brainres.2004.02.033; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; Lasztoczi B, 2004, EUR J NEUROSCI, V19, P1361, DOI 10.1111/j.1460-9568.2004.03231.x; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; Loring DW, 2007, NEUROPSYCHOL REV, V17, P413, DOI 10.1007/s11065-007-9043-9; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Migliore M, 2008, HIPPOCAMPUS, V18, P1122, DOI 10.1002/hipo.20480; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Pfeuty B, 2005, NEURAL COMPUT, V17, P633, DOI 10.1162/0899766053019917; Pfeuty B, 2003, J NEUROSCI, V23, P6280; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Sankar Raman, 2004, J Child Neurol, V19 Suppl 1, pS6, DOI 10.1177/08830738040190010201; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; Singh B, 2006, NEUROBIOL DIS, V24, P245, DOI 10.1016/j.nbd.2006.07.001; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Taha AY, 2010, EPILEPSIA, V51, P1348, DOI 10.1111/j.1528-1167.2010.02654.x; Takekawa T, 2007, J COMPUT NEUROSCI, V23, P189, DOI 10.1007/s10827-007-0027-9; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Tigerholm J, 2011, BIOPHYS J, V101, P1871, DOI 10.1016/j.bpj.2011.08.055; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu XP, 2008, EPILEPSY RES, V80, P57, DOI 10.1016/j.eplepsyres.2008.03.013; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	65	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44388	10.1371/journal.pone.0044388	http://dx.doi.org/10.1371/journal.pone.0044388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049748	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100013
J	Vlijm, R; Smitshuijzen, JSJ; Lusser, A; Dekker, C				Vlijm, Rifka; Smitshuijzen, Jeremy S. J.; Lusser, Alexandra; Dekker, Cees			NAP1-Assisted Nucleosome Assembly on DNA Measured in Real Time by Single-Molecule Magnetic Tweezers	PLOS ONE			English	Article							HISTONE (H3-H4)(2) TETRAMER; LINKING NUMBER CHANGE; CORE PARTICLE; REPLICATION INVITRO; CHROMATIN; RESOLUTION; DYNAMICS; OCTAMER; FORCE; ACF	While many proteins are involved in the assembly and (re) positioning of nucleosomes, the dynamics of protein-assisted nucleosome formation are not well understood. We study NAP1 (nucleosome assembly protein 1) assisted nucleosome formation at the single-molecule level using magnetic tweezers. This method allows to apply a well-defined stretching force and supercoiling density to a single DNA molecule, and to study in real time the change in linking number, stiffness and length of the DNA during nucleosome formation. We observe a decrease in end-to-end length when NAP1 and core histones (CH) are added to the dsDNA. We characterize the formation of complete nucleosomes by measuring the change in linking number of DNA, which is induced by the NAP1-assisted nucleosome assembly, and which does not occur for nonnucleosomal bound histones H3 and H4. By rotating the magnets, the supercoils formed upon nucleosome assembly are removed and the number of assembled nucleosomes can be counted. We find that the compaction of DNA at low force is about 56 nm per assembled nucleosome. The number of compaction steps and associated change in linking number indicate that NAP1-assisted nucleosome assembly is a two-step process.	[Vlijm, Rifka; Smitshuijzen, Jeremy S. J.; Dekker, Cees] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Delft, Netherlands; [Lusser, Alexandra] Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria	Delft University of Technology; Medical University of Innsbruck	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Delft, Netherlands.		Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518; Dekker, Cees/0000-0001-6273-071X; Lusser, Alexandra/0000-0002-2226-9081	Foundation for Fundamental Research on Matter (FOM) [103]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Foundation for Fundamental Research on Matter (FOM) [Project 103, DNA in action: Physics of the genome]. Funding for open access charge: Foundation for Fundamental Research on Matter (FOM), www.fom.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bennink ML, 2001, SINGLE MOL, V2, P91, DOI 10.1002/1438-5171(200107)2:2<91::AID-SIMO91>3.0.CO;2-S; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Bowman A, 2010, NUCLEIC ACIDS RES, V38, P695, DOI 10.1093/nar/gkp1003; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; DABAN JR, 1982, J MOL BIOL, V156, P771, DOI 10.1016/0022-2836(82)90141-3; De Lucia F, 1999, J MOL BIOL, V285, P1101, DOI 10.1006/jmbi.1998.2382; Drabik CE, 1997, J MOL BIOL, V267, P794, DOI 10.1006/jmbi.1997.0917; Gemmen GJ, 2005, J MOL BIOL, V351, P89, DOI 10.1016/j.jmb.2005.05.058; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Ito T, 1996, MOL CELL BIOL, V16, P3112; JORCANO JL, 1979, BIOCHEMISTRY-US, V18, P768, DOI 10.1021/bi00572a005; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; Leuba SH, 2003, P NATL ACAD SCI USA, V100, P495, DOI 10.1073/pnas.0136890100; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; RUIZCARRILLO A, 1979, P NATL ACAD SCI USA, V76, P3284, DOI 10.1073/pnas.76.7.3284; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Sivolob A, 2009, FLEXIBILITY NUCLEOSO, P251; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; TRIFONOV EN, 1985, CRC CR REV BIOCH MOL, V19, P89, DOI 10.3109/10409238509082540; Vilfan ID, 2009, HANDBOOK OF SINGLE-MOLECULE BIOPHYSICS, P371, DOI 10.1007/978-0-387-76497-9_13; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	41	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46306	10.1371/journal.pone.0046306	http://dx.doi.org/10.1371/journal.pone.0046306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050009	gold, Green Published			2022-12-25	WOS:000309556100174
J	Zhao, G; Gu, XB; Lu, XL; Pan, JJ; Duan, ZQ; Zhao, KK; Gu, M; Liu, QT; He, L; Chen, J; Ge, SQ; Wang, YH; Chen, SJ; Wang, XQ; Peng, DX; Wan, HQ; Liu, XF				Zhao, Guo; Gu, Xiaobing; Lu, Xinlun; Pan, Jinjin; Duan, Zhiqiang; Zhao, Kunkun; Gu, Min; Liu, Qingtao; He, Liang; Chen, Jian; Ge, Shengqiang; Wang, Yanhong; Chen, Sujuan; Wang, Xiaoquan; Peng, Daxin; Wan, Hongquan; Liu, Xiufan			Novel Reassortant Highly Pathogenic H5N2 Avian Influenza Viruses in Poultry in China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; HEMAGGLUTININ MOLECULE; A VIRUSES; EVOLUTION; EMERGENCE; DUCKS; IDENTIFICATION; VIRULENCE	There has been multiple evidence that domestic poultry may act as a vessel for the generation of novel influenza A viruses. In this study, we have analyzed the evolution and pathogenicity of 4 H5N2 avian influenza viruses isolated from apparently healthy poultry from H5N1 virus endemic areas in China. Phylogenetic analysis revealed that two of these viruses, A/duck/Eastern China/1111/2011 (DK/EC/1111/11) and A/goose/Eastern China/1112/2011 (GS/EC/1112/11) were derived from reassortment events in which clade 2.3.4 highly pathogenic avian influenza (HPAI) H5N1 viruses acquired novel neuraminidase and nonstructural protein genes. Another two isolates, A/chicken/Hebei/1102/2010 (CK/HB/1102/10) and A/duck/Hebei/0908/2009 (DK/HB/0908/09), possess hemagglutinin (HA) gene belong to clade 7 H5 viruses and other genes from endemic H9N2 viruses, or from viruses of various subtypes of the natural gene pool. All of these H5N2 isolates bear characteristic sequences of HPAI virus at the cleavage site of HA, and animal experiments indicated that all of these viruses but DK/HB/0908/09 is highly pathogenic to chickens. In particular, DK/EC/1111/11 and GS/EC/1112/11 are also highly pathogenic to ducks and moderately pathogenic to mice. All of these 4 viruses were able to replicate in domestic ducks and mice without prior adaptation. The emergence of these novel H5N2 viruses adds more evidence for the active evolution of H5 viruses in Asia. The maintenance of the highly pathogenic phenotype of some of these viruses even after reassortment with a new NA subtypes, their ability to replicate and transmit in domestic poultry, and the pathogenicity in the mammalian mouse model, highlight the potential threat posed by these viruses to both veterinary and public health.	[Zhao, Guo; Gu, Xiaobing; Lu, Xinlun; Pan, Jinjin; Duan, Zhiqiang; Zhao, Kunkun; Gu, Min; Liu, Qingtao; He, Liang; Chen, Jian; Ge, Shengqiang; Wang, Yanhong; Chen, Sujuan; Wang, Xiaoquan; Peng, Daxin; Wan, Hongquan; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhao, Guo; Liu, Xiufan] Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Liu, XF (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	xfliu@yzu.edu.cn	Peng, Daxin/AAJ-3476-2021	Wan, Hongquan/0000-0002-6374-0343	Major National Basic Research Development Program (973 Program) [2011CB505003]; National Key Technologies R&D Program of China [2010BAD04B01]; Important National Science & Technology Specific Projects [2008ZX10004-013, 2009ZX10004-214]; Jiangsu Natural Science Foundation for Universities and Colleges [10KJA230055]; Special Fund for Agro-scientific Research in the Public Interest [201003012]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [IRT0978]	Major National Basic Research Development Program (973 Program)(National Basic Research Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); Important National Science & Technology Specific Projects; Jiangsu Natural Science Foundation for Universities and Colleges; Special Fund for Agro-scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Major National Basic Research Development Program (973 Program) (grant number 2011CB505003), the National Key Technologies R&D Program of China (grant number 2010BAD04B01), the Important National Science & Technology Specific Projects (No. 2008ZX10004-013 and 2009ZX10004-214), the Jiangsu Natural Science Foundation for Universities and Colleges (grant number 10KJA230055), the Special Fund for Agro-scientific Research in the Public Interest (201003012), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Cheng MC, 2010, AVIAN DIS, V54, P885, DOI 10.1637/9208-120609-Reg.1; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Eagles D, 2009, REV SCI TECH OIE, V28, P341, DOI 10.20506/rst.28.1.1864; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gu M, 2011, EMERG INFECT DIS, V17, P1060, DOI [10.3201/eid1706.101406, 10.3201/eid/1706.101406]; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guang-Jian Z, 2011, VET MICROBIOL, V155, P409; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Kim HR, 2010, J GEN VIROL, V91, P1978, DOI 10.1099/vir.0.021238-0; Lee JH, 2009, J VIROL, V83, P4205, DOI [10.1128/JVI.02403-08, 10.1128/JVI.02403-09]; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Londt BZ, 2007, AVIAN PATHOL, V36, P347, DOI 10.1080/03079450701589134; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Snoeck CJ, 2011, J GEN VIROL, V92, P1172, DOI 10.1099/vir.0.029728-0; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	41	102	108	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46183	10.1371/journal.pone.0046183	http://dx.doi.org/10.1371/journal.pone.0046183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049973	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100149
J	van Jaarsveld, MTM; Helleman, J; Boersma, AWM; van Kuijk, PF; van IJcken, WF; Despierre, E; Vergote, I; Mathijssen, RHJ; Berns, EMJJ; Verweij, J; Pothof, J; Wiemer, EAC				van Jaarsveld, M. T. M.; Helleman, J.; Boersma, A. W. M.; van Kuijk, P. F.; van IJcken, W. F.; Despierre, E.; Vergote, I.; Mathijssen, R. H. J.; Berns, E. M. J. J.; Verweij, J.; Pothof, J.; Wiemer, E. A. C.			miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells	ONCOGENE			English	Article						cisplatin; drug resistance; KEAP1; miR-141; ovarian cancer	MICRORNA EXPRESSION PROFILES; MIR-200 FAMILY; MESENCHYMAL TRANSITION; PLATINUM RESISTANCE; CONFERS RESISTANCE; CLINICAL-TRIALS; REPRESSORS ZEB1; DOWN-REGULATION; TRANSCRIPTION; ACTIVATION	Epithelial ovarian cancer is the most lethal gynecological malignancy in the Western world. A major impediment for the successful treatment is the development of drug resistance. The molecular processes that contribute to resistance have been extensively studied; however, there is not much known about regulation by microRNAs (miRNAs). We compared miRNA expression profiles of an isogenic cisplatin-sensitive and -resistant ovarian cancer cell line pair (A2780/A2780 DDP) and found 27 miRNAs to be differentially expressed (>= 2-fold). Five of these, including the family members miR-141/200c, showed a correlation with cisplatin sensitivity in the NCI-60 panel. Overexpression of miR-141 resulted in enhanced resistance to cisplatin in ovarian cancer cell lines. We next correlated the expression level of miR-141 in 132 primary ovarian tumors (108 serous and 24 non-serous) with response to platinum-based chemotherapy. Although no differences were observed in the serous tumors, miR-141 levels were higher in non-serous ovarian tumors that did not respond well to therapy (platinum-free interval <6 months). We demonstrate that miR-141 directly targets KEAP1, and that downregulation of KEAP1 induces cisplatin resistance. Conversely, overexpression of KEAP1 significantly enhanced cisplatin sensitivity. Expression of KEAP1 with its 3'-UTR, and a 3'-UTR in which the miR-141 target site has been mutated, revealed that miR-141 regulates KEAP1 upon exposure to cisplatin. Finally, we show that the NF-kappa B pathway, which can be regulated by KEAP1, is activated upon miR-141 overexpression, and that inhibition of this pathway partially reverses miR-141-mediated cisplatin resistance. These findings demonstrate that the miR-141-mediated regulation of KEAP1 has a crucial role in the cellular response to cisplatin.	[van Jaarsveld, M. T. M.; Helleman, J.; Boersma, A. W. M.; van Kuijk, P. F.; Mathijssen, R. H. J.; Berns, E. M. J. J.; Verweij, J.; Wiemer, E. A. C.] Erasmus Univ, Daniel den Hoed Canc Ctr, Med Ctr, Dept Med Oncol, NL-3015 GE Rotterdam, Netherlands; [van IJcken, W. F.] Erasmus MC, Erasmus Ctr Biom, Rotterdam, Netherlands; [Despierre, E.; Vergote, I.] Univ Hosp Leuven, Dept Obstet & Gynecol, European Union, Louvain, Belgium; [Despierre, E.; Vergote, I.] Univ Hosp Leuven, Leuven Canc Inst, Div Gynecol Oncol, European Union, Louvain, Belgium; [Pothof, J.] Erasmus MC, Dept Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Erasmus University Rotterdam; Erasmus MC	Wiemer, EAC (corresponding author), Erasmus Univ, Daniel den Hoed Canc Ctr, Med Ctr, Dept Med Oncol, Room Be422,Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	e.wiemer@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301; Wiemer, Erik/0000-0002-0673-7236	Dutch Cancer Society EMCR [2007-3794]	Dutch Cancer Society EMCR	We thank Dr Kevin Scanlon (Keck Graduate Institute of Applied Life Sciences, Claremont, USA) for the kind gift of the cisplatin-sensitive/resistant A2780 cell line pair. We thank Mariel Brok and Kirsten Ruigrok-Ritstier for technical assistance, Andrea Sacchetti for FACS-sorting KEAP1-transfected cells and Herman Burger for critical comments on the manuscript. This project is supported by a grant from the Dutch Cancer Society EMCR 2007-3794.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; CARMICHAEL J, 1987, CANCER RES, V47, P936; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Eberle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021496; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Friedlander M, 2011, INT J GYNECOL CANCER, V21, P771, DOI 10.1097/IGC.0b013e31821bb8aa; Gallagher MF, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-19; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Ledermann JA, 2011, INT J GYNECOL CANCER, V21, P763, DOI 10.1097/IGC.0b013e31821b2669; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; McLellan LI, 1999, DRUG RESIST UPDATE, V2, P153, DOI 10.1054/drup.1999.0083; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; OZOLS RF, 2005, PRINCIPLES PRACTICE; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; SCHMIDT W, 1993, CANCER RES, V53, P799; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223	50	179	181	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4284	4293		10.1038/onc.2012.433	http://dx.doi.org/10.1038/onc.2012.433			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045278				2022-12-25	WOS:000324168000010
J	Gagan, J; Dey, BK; Layer, R; Yan, Z; Dutta, A				Gagan, Jeffrey; Dey, Bijan K.; Layer, Ryan; Yan, Zhen; Dutta, Anindya			Notch3 and Mef2c Proteins Are Mutually Antagonistic via Mkp1 Protein and miR-1/206 MicroRNAs in Differentiating Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE PROGENITOR CELLS; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR; SATELLITE CELL; MYOGENIC BHLH; ACTIVATION; P38; BINDING; GENE; REGENERATION	The Notch signaling pathway is a well known regulator of skeletal muscle stem cells known as satellite cells. Loss of Notch1 signaling leads to spontaneous myogenic differentiation. Notch1, normally expressed in satellite cells, is targeted for proteasomal degradation by Numb during differentiation. A homolog of Notch1, Notch3, is also expressed in these cells but is not inhibited by Numb. We find that Notch3 is paradoxically up-regulated during the early stages of differentiation by an enhancer that requires both MyoD and activated Notch1. Notch3 itself strongly inhibits the myogenic transcription factor Mef2c, most likely by increasing the p38 phosphatase Mkp1, which inhibits the Mef2c activator p38 MAP kinase. Active Notch3 decreases differentiation. Mef2c, however, induces microRNAs miR-1 and miR-206, which directly down-regulate Notch3 and allow differentiation to proceed. Thus, the myogenic differentiation-induced microRNAs miR-1 and -206 are important for differentiation at least partly because they turn off Notch3. We suggest that the transient expression of Notch3 early in differentiation generates a temporal lag between myoblast activation by MyoD and terminal differentiation into myotubes directed by Mef2c.	[Gagan, Jeffrey; Dey, Bijan K.; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Layer, Ryan] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Dept Comp Sci, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Dept Med & Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Robert M Berne Cardiovasc Res Ctr, 1334 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Yan, Zhen/0000-0002-4826-9813; Dey, Bijan/0000-0001-9386-2475; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 AR053948, R01 AR050429]; Cell and Molecular Biology Training Grant [T32 GM008136]; Heart and Stroke Foundation of Canada; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053948, R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Biology Training Grant; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR053948 (to A. D.) and R01 AR050429 (to Z. Y.).; Supported by Cell and Molecular Biology Training Grant T32 GM008136.; Supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada.	Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gagan J, 2012, CURR OPIN PHARMACOL, V12, P383, DOI 10.1016/j.coph.2012.02.001; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shi H, 2010, FASEB J, V24, P2985, DOI 10.1096/fj.09-150045; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	50	70	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40360	40370		10.1074/jbc.M112.378414	http://dx.doi.org/10.1074/jbc.M112.378414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055528	hybrid, Green Published			2022-12-25	WOS:000311448800027
J	Pakala, SB; Nair, VS; Reddy, SD; Kumar, R				Pakala, Suresh B.; Nair, Vasudha S.; Reddy, Sirigiri DivijendraNatha; Kumar, Rakesh			Signaling-dependent Phosphorylation of Mitotic Centromere-associated Kinesin Regulates Microtubule Depolymerization and Its Centrosomal Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; AURORA-A; MCAK; SUBSTRATE; MITOSIS; GROWTH; ORGANIZATION; EXPRESSION; TUBULIN; PROTEIN	Although p21-activated kinase 1 (PAK1) and microtubule (MT) dynamics regulate numerous fundamental processes including cytoskeleton remodeling, directional motility, and mitotic functions, the significance of PAK1 signaling in regulating the functions of MT-destabilizing protein mitotic centromere-associated kinesin (MCAK) remains unknown. Here we found that MCAK is a cognate substrate of PAK1 wherein PAK1 phosphorylates MCAK on serines 192 and 111 both in vivo and in vitro. Furthermore, we found that PAK1 phosphorylation of MCAK on serines 192 and 111 preferentially regulates its microtubule depolymerization activity and localization to centrosomes, respectively, in the mammalian cells.	[Pakala, Suresh B.; Nair, Vasudha S.; Reddy, Sirigiri DivijendraNatha; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA90970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90970 (to R. K.).	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Aoki S, 2005, FEBS J, V272, P2132, DOI 10.1111/j.1742-4658.2005.04600.x; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; Cau J, 2001, J CELL BIOL, V155, P1029, DOI 10.1083/jcb.200104123; Charvet C, 2002, J BIOL CHEM, V277, P15376, DOI 10.1074/jbc.M111627200; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Katayama H, 2008, CELL CYCLE, V7, P2691, DOI 10.4161/cc.7.17.6460; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Sanhaji M, 2011, ONCOTARGET, V2, P935; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Senger DL, 2002, CANCER RES, V62, P2131; SHU HB, 1995, J CELL BIOL, V130, P1137, DOI 10.1083/jcb.130.5.1137; Tanenbaum Marvin E, 2011, Bioarchitecture, V1, P80; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	40	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40560	40569		10.1074/jbc.M112.399576	http://dx.doi.org/10.1074/jbc.M112.399576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055517	Green Published, hybrid			2022-12-25	WOS:000311448800046
J	Chao, X; Zhang, ZL; Guo, LL; Zhu, JJ; Peng, ML; Vermorken, AJM; Van de Ven, WJM; Chen, C; Cui, YL				Chao, Xu; Zhang, Zhuoli; Guo, Lili; Zhu, Jingjing; Peng, Mingli; Vermorken, Alphonsus J. M.; Van de Ven, Wim J. M.; Chen, Chao; Cui, Yali			A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer Chemotherapy	PLOS ONE			English	Article							GOLD; CYTOTOXICITY; PARTICLES; FIELD	Background: Magnetic nanoparticles (NPs) loaded with antitumor drugs in combination with an external magnetic field (EMF)-guided delivery can improve the efficacy of treatment and may decrease serious side effects. The purpose of this study was 1) to investigate application of PEG modified GMNPs (PGMNPs) as a drug carrier of the chemotherapy compound doxorubicin (DOX) in vitro; 2) to evaluate the therapeutic efficiency of DOX-conjugated PGMNPs (DOX-PGMNPs) using an EMF-guided delivery in vivo. Methods: First, DOX-PGMNPs were synthesized and the cytotoxicity of DOX-PGMNPs was assessed in vitro. Second, upon intravenous administration of DOX-PMGPNs to H22 hepatoma cell tumor-bearing mice, the DOX biodistribution in different organs (tissues) was measured. The antitumor activity was evaluated using different treatment strategies such as DOX-PMGPNs or DOX-PMGPNs with an EMF-guided delivery (DOX-PGMNPs-M). Results: The relative tumor volumes in DOX-PGMNPs-M, DOX-PGMNPs, and DOX groups were 5.46 +/- 1.48, 9.22 +/- 1.51, and 14.8 +/- 1.64, respectively (each p < 0.05), following treatment for 33 days. The life span of tumor-bearing mice treated with DOX-PGMNPs-M, DOX-PGMNPs, and DOX were 74.8 +/- 9.95, 66.1 +/- 13.5 +/- 13.5, and 31.3 +/- 3.31 days, respectively (each p < 0.05). Conclusion: This simple and adaptive nanoparticle design may accommodate chemotherapy for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers in the near future.	[Chao, Xu; Chen, Chao; Cui, Yali] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China; [Guo, Lili; Peng, Mingli; Chen, Chao; Cui, Yali] Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Peoples R China; [Zhang, Zhuoli] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Zhu, Jingjing; Vermorken, Alphonsus J. M.; Van de Ven, Wim J. M.] Katholieke Univ Leuven, Mol Oncol Lab, Dept Human Genet, Louvain, Belgium; [Chao, Xu] Shaanxi Univ Chinese Med, Coll Basic Med Sci, Xianyang, Peoples R China	Northwest University Xi'an; Northwestern University; KU Leuven; Shaanxi University of Chinese Medicine	Cui, YL (corresponding author), NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China.	yali_cui@mail.com	Zhu, Jingjing/R-3277-2017	Zhu, Jingjing/0000-0003-0993-4849; Vermorken, Alphons/0000-0003-2918-298X	National High Technology Research and Development (863) Program of China [2006AA020705]	National High Technology Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development (863) Program of China (2006AA020705). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Chao X, 2011, J DRUG TARGET, V19, P161, DOI 10.3109/10611861003801842; Chao X, 2010, PHARMAZIE, V65, P500, DOI 10.1691/ph.2010.9362; Cho WS, 2010, TOXICOL APPL PHARM, V245, P116, DOI 10.1016/j.taap.2010.02.013; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cui YL, 2005, BIOMED MICRODEVICES, V7, P153, DOI 10.1007/s10544-005-1596-x; Gibson JD, 2007, J AM CHEM SOC, V129, P11653, DOI 10.1021/ja075181k; Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Huang X, 2011, NANOSCALE, V3, P1600, DOI 10.1039/c0nr00835d; Huynh NT, 2010, NANOMEDICINE-UK, V5, P1415, DOI [10.2217/nnm.10.113, 10.2217/NNM.10.113]; Jain KK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-83; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kim J, 2006, ANGEW CHEM INT EDIT, V45, P7754, DOI 10.1002/anie.200602471; Kuruppuarachchi M, 2011, MOL PHARMACEUT, V8, P920, DOI 10.1021/mp200023y; Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li ZF, 2007, FOOD ADDIT CONTAM A, V24, P21, DOI 10.1080/02652030600949592; Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117; Mejias R, 2011, BIOMATERIALS, V32, P2938, DOI 10.1016/j.biomaterials.2011.01.008; Meng YD, 2010, NANOMEDICINE-UK, V5, P1559, DOI [10.2217/nnm.10.91, 10.2217/NNM.10.91]; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Sanson C, 2011, ACS NANO, V5, P1122, DOI 10.1021/nn102762f; Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007; Shukla S, 2003, BIOCONJUGATE CHEM, V14, P158, DOI 10.1021/bc025586o; Singh A, 2011, ACS APPL MATER INTER, V3, P842, DOI 10.1021/am101196v; Yang XQ, 2011, BIOMATERIALS, V32, P4151, DOI 10.1016/j.biomaterials.2011.02.006; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180; Zhao XL, 2008, ANAL CHEM, V80, P9091, DOI 10.1021/ac801581m; Zharov VP, 2005, J PHYS D APPL PHYS, V38, P2571, DOI 10.1088/0022-3727/38/15/007	32	31	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e40388	10.1371/journal.pone.0040388	http://dx.doi.org/10.1371/journal.pone.0040388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056167	gold, Green Published, Green Submitted			2022-12-25	WOS:000309831500003
J	Alen, BO; Nieto, L; Gurriaran-Rodriguez, U; Mosteiro, CS; Alvarez-Perez, JC; Otero-Alen, M; Camina, JP; Gallego, R; Garcia-Caballero, T; Martin-Pastor, M; Casanueva, FF; Jimenez-Barbero, J; Pazos, Y				Alen, Begona O.; Nieto, Lidia; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Otero-Alen, Maria; Camina, Jesus P.; Gallego, Rosalia; Garcia-Caballero, Tomas; Martin-Pastor, Manuel; Casanueva, Felipe F.; Jimenez-Barbero, Jesus; Pazos, Yolanda			The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; GASTRIC-CANCER CELLS; GHRELIN-GENE; PROTEIN; PROLIFERATION; EXPRESSION; RECEPTOR; ANTIGEN; TARGET	The quest for therapeutic applications of obestatin involves, as a first step, the determination of its 3D solution structure and the relationship between this structure and the biological activity of obestatin. On this basis, we have employed a combination of circular dichroism (CD), nuclear magnetic resonance (NMR) spectroscopy, and modeling techniques to determine the solution structure of human obestatin (1). Other analogues, including human non-amidated obestatin (2) and the fragment peptides (6-23)-obestatin (3), (11-23)-obestatin (4), and (16-23)-obestatin (5) have also been scrutinized. These studies have been performed in a micellar environment to mimic the cell membrane (sodium dodecyl sulfate, SDS). Furthermore, structural-activity relationship studies have been performed by assessing the in vitro proliferative capabilities of these peptides in the human retinal pigmented epithelial cell line ARPE-19 (ERK1/2 and Akt phosphorylation, Ki67 expression, and cellular proliferation). Our findings emphasize the importance of both the primary structure (composition and size) and particular segments of the obestatin molecule that posses significant alpha-helical characteristics. Additionally, details of a species-specific role for obestatin have also been hypothesized by comparing human and mouse obestatins(1 and 6, respectively) at both the structural and bioactivity levels.	[Alen, Begona O.; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Camina, Jesus P.; Casanueva, Felipe F.; Pazos, Yolanda] Complejo Hosp Univ Santiago de Compostela CHUS, SERGAS, IDIS, Area Endocrinol Mol & Celular, Santiago De Compostela, Spain; [Alen, Begona O.; Gurriaran-Rodriguez, Uxia; Mosteiro, Carlos S.; Alvarez-Perez, Juan C.; Camina, Jesus P.; Casanueva, Felipe F.; Pazos, Yolanda] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Nieto, Lidia; Jimenez-Barbero, Jesus] CIB CSIC, Ctr Invest Biol, Madrid, Spain; [Martin-Pastor, Manuel] Univ Santiago de Compostela, RIAIDT, Unidad Resonancia Magnet, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidade de Santiago de Compostela	Pazos, Y (corresponding author), Complejo Hosp Univ Santiago de Compostela CHUS, SERGAS, IDIS, Area Endocrinol Mol & Celular, Santiago De Compostela, Spain.	yolanda.pazos.randulfe@sergas.es	Perez, Juan c Alvarez/J-8294-2016; Perez, Juan Carlos Alvarez/AAE-4518-2021; Garcia-Caballero, Tomas/H-7213-2015; JIMENEZ-BARBERO, JESUS/D-4431-2014	Perez, Juan c Alvarez/0000-0001-6396-311X; Perez, Juan Carlos Alvarez/0000-0001-6396-311X; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Otero Alen, Begona/0000-0002-2876-6732; Rosalia, Gallego/0000-0002-6015-4680; Otero-Alen, Maria/0000-0002-0640-5776; Garcia-Caballero, Tomas/0000-0002-7938-1437; Gurriaran, Uxia/0000-0002-5375-0142; Martin-Pastor, Manuel/0000-0001-6024-1656	Ministerio de Economia y Competitividad [SAF2010-20451, CTQ2009-08536]; Xunta de Galicia [INCITE09PXIB 918374PR]; Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain) [PS09/02202, PS09/02075]; Instituto de Salud Carlos III; SERGAS; Xunta de Galicia	Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); SERGAS; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by grants from Ministerio de Economia y Competitividad (SAF2010-20451, CTQ2009-08536), Xunta de Galicia (INCITE09PXIB 918374PR) and Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Spain; PS09/02202, PS09/02075). CIBER is an initiative of Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, Spain). Instituto de Salud Carlos III and SERGAS fund the work of J.P. Camina, and Y. Pazos through a research-staff stabilization contract. Xunta de Galicia funds U. Gurriaran-Rodriguez through a research-staff contract Isabel Barreto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Camina JP, 2007, J CELL PHYSIOL, V211, P1, DOI 10.1002/jcp.20925; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gurriaran-Rodriguez U, 2011, J CELL MOL MED, V15, P1927, DOI 10.1111/j.1582-4934.2010.01192.x; Gurriaran-Rodriguez U, 2011, J ENDOCRINOL, V210, pR1, DOI 10.1530/JOE-11-0233; Keller R., 2004, COMPUTER AIDED RESON, V1; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nagaraj S, 2008, BIOCHEM BIOPH RES CO, V366, P731, DOI 10.1016/j.bbrc.2007.12.036; Pazos Y, 2007, GROWTH FACTORS, V25, P373, DOI 10.1080/08977190801889313; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Samson WK, 2007, AM J PHYSIOL-REG I, V292, pR637, DOI 10.1152/ajpregu.00395.2006; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; SCHWYZER R, 1995, J MOL RECOGNIT, V8, P3, DOI 10.1002/jmr.300080103; Scrima M, 2007, BIOCHEM BIOPH RES CO, V363, P500, DOI 10.1016/j.bbrc.2007.08.200; Seim I, 2011, MOL CELL ENDOCRINOL, V340, P111, DOI 10.1016/j.mce.2011.03.018; Subasinghage AP, 2010, PEPTIDES, V31, P1697, DOI 10.1016/j.peptides.2010.05.015; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhang JV, 2008, MOL ENDOCRINOL, V22, P1464, DOI 10.1210/me.2007-0569; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	30	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45434	10.1371/journal.pone.0045434	http://dx.doi.org/10.1371/journal.pone.0045434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056203	Green Published, Green Submitted, gold			2022-12-25	WOS:000309580800003
J	De-Miguel, FF; Santamaria-Holek, I; Noguez, P; Bustos, C; Hernandez-Lemus, E; Rubi, JM				De-Miguel, Francisco F.; Santamaria-Holek, Ivan; Noguez, Paula; Bustos, Carlos; Hernandez-Lemus, Enrique; Miguel Rubi, J.			Biophysics of Active Vesicle Transport, an Intermediate Step That Couples Excitation and Exocytosis of Serotonin in the Neuronal Soma	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; CHROMAFFIN CELLS; SECRETORY GRANULES; LEECH NEURONS; RELEASE; 5-HYDROXYTRYPTAMINE; TERMINALS; CALCIUM; COMMUNICATION; TRANSMISSION	Transmitter exocytosis from the neuronal soma is evoked by brief trains of high frequency electrical activity and continues for several minutes. Here we studied how active vesicle transport towards the plasma membrane contributes to this slow phenomenon in serotonergic leech Retzius neurons, by combining electron microscopy, the kinetics of exocytosis obtained from FM1-43 dye fluorescence as vesicles fuse with the plasma membrane, and a diffusion equation incorporating the forces of local confinement and molecular motors. Electron micrographs of neurons at rest or after stimulation with 1 Hz trains showed cytoplasmic clusters of dense core vesicles at 1.5+/-0.2 and 3.7+/-0.3 mu m distances from the plasma membrane, to which they were bound through microtubule bundles. By contrast, after 20 Hz stimulation vesicle clusters were apposed to the plasma membrane, suggesting that transport was induced by electrical stimulation. Consistently, 20 Hz stimulation of cultured neurons induced spotted FM1-43 fluorescence increases with one or two slow sigmoidal kinetics, suggesting exocytosis from an equal number of vesicle clusters. These fluorescence increases were prevented by colchicine, which suggested microtubule-dependent vesicle transport. Model fitting to the fluorescence kinetics predicted that 52-951 vesicles/cluster were transported along 0.60-6.18 mu m distances at average 11-95 nms(-1) velocities. The ATP cost per vesicle fused (0.4-72.0), calculated from the ratio of the Delta G(process)/Delta G(ATP), depended on the ratio of the traveling velocity and the number of vesicles in the cluster. Interestingly, the distance-dependence of the ATP cost per vesicle was bistable, with low energy values at 1.4 and 3.3 mu m, similar to the average resting distances of the vesicle clusters, and a high energy barrier at 1.6-2.0 mu m. Our study confirms that active vesicle transport is an intermediate step for somatic serotonin exocytosis by Retzius neurons and provides a quantitative method for analyzing similar phenomena in other cell types.	[De-Miguel, Francisco F.; Noguez, Paula; Bustos, Carlos] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Santamaria-Holek, Ivan] Univ Nacl Autonoma Mexico, UMJ Fac Ciencias, Queretaro, Mexico; [Hernandez-Lemus, Enrique] Inst Nacl Med Genom, Dept Genom Computac, Mexico City, DF, Mexico; [Miguel Rubi, J.] Univ Barcelona, Fac Fis, E-08028 Barcelona, Spain	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; University of Barcelona	De-Miguel, FF (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad Univ, Mexico City 04510, DF, Mexico.	ffernand@ifc.unam.mx	Santamaria-Holek, Ivan/AAQ-9584-2021; de Miguel, Francisco Fernández/AAT-8913-2020; Bustos-Segura, Carlos/AAF-2564-2020	Bustos-Segura, Carlos/0000-0002-8624-3251; Hernandez-Lemus, Enrique/0000-0002-1872-1397; Santamaria-Holek, I./0000-0002-5306-197X	Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN211511, IN 102609]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico [130031]; CONACyT [193987]	Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was founded by grants IN211511 from the Direccion General de Apoyo del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) and grant 130031 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico to FFM, and by DGAPA-UNAM grant IN 102609 to ISH. PN was supported by a CONACyT fellowship 193987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTY RA, 1992, BIOCHEMISTRY-US, V31, P10610, DOI 10.1021/bi00158a025; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, NEURON, V9, P805, DOI 10.1016/0896-6273(92)90235-6; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Bunin MA, 1998, J NEUROSCI, V18, P4854; CHAZAL G, 1987, J COMP NEUROL, V259, P317, DOI 10.1002/cne.902590302; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; COGGESHALL RE, 1972, ANAT RECORD, V172, P489, DOI 10.1002/ar.1091720303; Colgan LA, 2009, J NEUROSCI, V29, P15878, DOI 10.1523/JNEUROSCI.4210-09.2009; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; Fu XW, 2002, J PHYSIOL-LONDON, V539, P503, DOI 10.1113/jphysiol.2001.013071; Fuxe K, 2012, FRONT PHYSL, V3, P175; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Kaushalya SK, 2008, J NEUROSCI RES, V86, P3469, DOI 10.1002/jnr.21794; Kravitz EA, 2000, J COMP PHYSIOL A, V186, P221, DOI 10.1007/s003590050423; Kuffler DP, 1987, J COMP NEUROL, V22, P516; Manneville JB, 2003, J CELL SCI, V116, P3927, DOI 10.1242/jcs.00672; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Moukhles H, 1997, NEUROSCIENCE, V76, P1159, DOI 10.1016/S0306-4522(96)00452-6; Neco P, 2003, EUR J NEUROSCI, V18, P733, DOI 10.1046/j.1460-9568.2003.02801.x; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Park JJ, 2008, MOL ENDOCRINOL, V22, P989, DOI 10.1210/me.2007-0473; Patel JC, 2009, J NEUROSCI, V29, P6568, DOI 10.1523/JNEUROSCI.0181-09.2009; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Rose SD, 2002, ANN NY ACAD SCI, V971, P222, DOI 10.1111/j.1749-6632.2002.tb04466.x; Santamaria-Holek I, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2241190; Santamaria-Holek I, 2007, J PHYS CHEM B, V111, P2293, DOI 10.1021/jp0675375; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Siddall ME, 2007, P R SOC B, V274, P1481, DOI 10.1098/rspb.2007.0248; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Trueta C, 2003, J PHYSIOL-LONDON, V547, P405, DOI 10.1113/jphysiol.2002.030684; Trueta C, 2004, J PHYSL, V547, P309; Trueta C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00175; Velazquez-Ulloa N, 2003, J NEUROBIOL, V54, P604, DOI 10.1002/neu.10184; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Weiger WA, 1997, BIOL REV, V72, P61, DOI 10.1017/S0006323196004975; WILLARD AL, 1981, J NEUROSCI, V1, P936; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	47	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45454	10.1371/journal.pone.0045454	http://dx.doi.org/10.1371/journal.pone.0045454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056204	Green Published, gold, Green Submitted			2022-12-25	WOS:000309454000007
J	Lin, CC; Yen, JC; Wu, YT; Lin, LC; Tsai, TH				Lin, Chia-Chun; Yen, Jiin-Cherng; Wu, Yu-Tse; Lin, Lie-Chwen; Tsai, Tung-Hu			Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats	PLOS ONE			English	Article							MATERNAL TISSUE DISTRIBUTION; BLOOD-BRAIN-BARRIER; NEURAMINIDASE INHIBITORS; LIQUID-CHROMATOGRAPHY; PRODRUG OSELTAMIVIR; RO 64-0802; LC-MS/MS; INFLUENZA; PLASMA; PHOSPHATE	In view of the limited information on the pharmacokinetics of oseltamivir (OSE) during pregnancy, this study aims to evaluate the placental transportation of OSE and its active metabolite oseltamivir carboxylic acid (OCA) in rats. A validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) system coupled to an in vivo transplacental model has been developed to determine OSE and OCA in the placenta, amniotic fluids and fetus of 13-day pregnant Sprague-Dawley rats. Concentrations of OSE and OCA in plasma, amniotic fluids, placenta, and fetus were measured by the validated LC-MS/MS after OSE administration (10 mg/kg, iv). The pharmacokinetic data of both analytes were examined by non-compartmental modeling. The area under the concentration-time curve (AUC) of OCA in maternal plasma was found to be 3.6 times larger than that of OSE. The AUCs of OCA in both amniotic fluid and fetus were significantly decreased, in comparison with that in maternal plasma (reduced by 76.7 and 98.1%, respectively). We found that both OSE and OCA can penetrate the placenta, amniotic fluids and fetus in rats during pregnancy; however, the penetration of OCA was much lower than that of OSE. The mother-to-fetus transfer ratio was defined as AUC(fetus)/AUC(mother). The data demonstrated that the mother-to-fetus transfer ratio of OSE and OCA were 1.64 and 0.019, respectively, suggesting that OSE, but not OCA, penetrated through the placenta. Moreover, OCA might not be easily metabolized in the fetus due to the lack of carboxylase in the fetus.	[Wu, Yu-Tse; Lin, Lie-Chwen; Tsai, Tung-Hu] Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan; [Lin, Chia-Chun; Yen, Jiin-Cherng] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Lin, Lie-Chwen] Natl Res Inst Chinese Med, Taipei, Taiwan; [Tsai, Tung-Hu] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan; [Wu, Yu-Tse; Tsai, Tung-Hu] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; China Medical University Taiwan; Taipei City Hospital	Tsai, TH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan.	thtsai@ym.edu.tw	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547; Wu, Yu-Tse/0000-0002-5731-2107	National Science Council, Taiwan [NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3]; Taipei City Hospital, Taiwan [TCH 99001-62-015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital, Taiwan	Funding for this study was provided in part by research grants from the National Science Council (NSC99-2113-M-010-001-MY3, NSC99-2628-B-010-008-MY3) Taiwan and TCH 99001-62-015 from Taipei City Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TAM OS PHOSPH PRESCR; Bahrami G, 2008, J CHROMATOGR B, V864, P38, DOI 10.1016/j.jchromb.2008.01.048; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Chang Q, 2009, BIOMED CHROMATOGR, V23, P852, DOI 10.1002/bmc.1195; Donner B, 2010, DRUG SAFETY, V33, P631, DOI 10.2165/11536370-000000000-00000; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; He K, 2008, DRUG METAB DISPOS, V36, P2564, DOI 10.1124/dmd.108.022764; Heinig K, 2008, J CHROMATOGR B, V876, P129, DOI 10.1016/j.jchromb.2008.10.037; Hoffmann G, 2009, ANTIMICROB AGENTS CH, V53, P4753, DOI 10.1128/AAC.01541-08; Holodniy M, 2008, ANTIMICROB AGENTS CH, V52, P3013, DOI 10.1128/AAC.00047-08; Jabbaribar F, 2008, CHEM PHARM BULL, V56, P1639, DOI 10.1248/cpb.56.1639; Kanneti R, 2011, BIOMED CHROMATOGR, V25, P727, DOI 10.1002/bmc.1509; Karpf M, 2001, J ORG CHEM, V66, P2044, DOI 10.1021/jo005702l; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Lindegardh N, 2007, J CHROMATOGR B, V859, P74, DOI 10.1016/j.jchromb.2007.09.018; Lindegardh N, 2006, ANTIMICROB AGENTS CH, V50, P3197, DOI 10.1128/AAC.00500-06; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; Novotna M, 2004, REPROD TOXICOL, V18, P785, DOI 10.1016/j.reprotox.2004.04.014; Ose A, 2009, DRUG METAB DISPOS, V37, P315, DOI 10.1124/dmd.108.024018; PADYKULA HA, 1958, J ANAT, V92, P118; PERROTTA CA, 1958, J ANAT, V92, P110; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shi DS, 2006, J PHARMACOL EXP THER, V319, P1477, DOI 10.1124/jpet.106.111807; Shin HC, 2003, COMP BIOCHEM PHYS C, V136, P95, DOI 10.1016/j.cca.2003.08.004; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Wiltshire H, 2000, J CHROMATOGR B, V745, P373, DOI 10.1016/S0378-4347(00)00300-5; Worley KC, 2008, INFECT DIS OBSTET GY, V2008; Zollner P, 2003, LC GC EUR, V16, P163	33	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46062	10.1371/journal.pone.0046062	http://dx.doi.org/10.1371/journal.pone.0046062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056234	gold, Green Published, Green Submitted			2022-12-25	WOS:000309454000014
J	Chan, WFN; Gurnot, C; Montine, TJ; Sonnen, JA; Guthrie, KA; Nelson, JL				Chan, William F. N.; Gurnot, Cecile; Montine, Thomas J.; Sonnen, Joshua A.; Guthrie, Katherine A.; Nelson, J. Lee			Male Microchimerism in the Human Female Brain	PLOS ONE			English	Article							FETAL CELL MICROCHIMERISM; MATERNAL MICROCHIMERISM; ALZHEIMERS-DISEASE; HEALTHY WOMEN; BONE-MARROW; PURKINJE NEURONS; QUANTITATIVE-ANALYSIS; REPRODUCTIVE FACTORS; HEMATOPOIETIC-CELLS; PERIPHERAL-BLOOD	In humans, naturally acquired microchimerism has been observed in many tissues and organs. Fetal microchimerism, however, has not been investigated in the human brain. Microchimerism of fetal as well as maternal origin has recently been reported in the mouse brain. In this study, we quantified male DNA in the human female brain as a marker for microchimerism of fetal origin (i.e. acquisition of male DNA by a woman while bearing a male fetus). Targeting the Y-chromosome-specific DYS14 gene, we performed real-time quantitative PCR in autopsied brain from women without clinical or pathologic evidence of neurologic disease (n = 26), or women who had Alzheimer's disease (n = 33). We report that 63% of the females (37 of 59) tested harbored male microchimerism in the brain. Male microchimerism was present in multiple brain regions. Results also suggested lower prevalence (p = 0.03) and concentration (p = 0.06) of male microchimerism in the brains of women with Alzheimer's disease than the brains of women without neurologic disease. In conclusion, male microchimerism is frequent and widely distributed in the human female brain.	[Chan, William F. N.; Gurnot, Cecile; Guthrie, Katherine A.; Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Montine, Thomas J.; Sonnen, Joshua A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nelson, J. Lee] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chan, WFN (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada.	fchan@ualberta.ca	Sonnen, Joshua/AAT-5788-2021; Sonnen, Joshua Aaron/H-3738-2016	Sonnen, Joshua Aaron/0000-0001-9267-8705	National Institutes of Health [NS 071418, AI-41721]; Canadian Institutes of Health Research [SIB-95173]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NS 071418 and AI-41721 to JLN). WFNC was supported by a Canadian Institutes of Health Research Fellowship Award (SIB-95173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aging NIo, 1997, NEUROBIOL AGING, V18, pS1; Angert RM, 2004, AM J OBSTET GYNECOL, V190, P1087, DOI 10.1016/j.ajog.2003.10.562; ARNEMANN J, 1987, NUCLEIC ACIDS RES, V15, P8713, DOI 10.1093/nar/15.21.8713; Bayes-Genis A, 2005, J HEART LUNG TRANSPL, V24, P2179, DOI 10.1016/j.healun.2005.06.003; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CANTOR KP, 1993, CANCER CAUSE CONTROL, V4, P505, DOI 10.1007/BF00052425; Chan WFN, 2012, ARTHRITIS RHEUM-US, V64, P380, DOI 10.1002/art.33358; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Colucci M, 2006, EUR J NEUROL, V13, P1374, DOI 10.1111/j.1468-1331.2006.01520.x; de Bellefon Laurent Meric, 2010, Chimerism, V1, P56, DOI 10.4161/chim.1.2.14294; DEMOOR G, 1988, ACTA CLIN BELG, V43, P231; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Fujiki Y, 2008, BIOL REPROD, V79, P841, DOI 10.1095/biolreprod.108.068973; Fujiki Y, 2009, BIOL REPROD, V81, P26, DOI 10.1095/biolreprod.108.074468; Gammill HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024101; Gammill HS, 2010, INT J DEV BIOL, V54, P531, DOI 10.1387/ijdb.082767hg; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Gotherstrom C, 2005, FETAL DIAGN THER, V20, P355, DOI 10.1159/000086812; Hatch EE, 2005, INT J CANCER, V114, P797, DOI 10.1002/ijc.20776; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Jonsson AM, 2010, PEDIATR RES, V68, P199, DOI 10.1203/00006450-201011001-00387; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Kaplan J, 2005, J IMMUNOL, V174, P7123, DOI 10.4049/jimmunol.174.11.7123; Khosrotehrani K, 2005, J REPROD IMMUNOL, V66, P1, DOI 10.1016/j.jri.2005.02.001; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Koopmans M, 2008, J REPROD IMMUNOL, V78, P68, DOI 10.1016/j.jri.2008.01.002; Lambe M, 1997, INT J CANCER, V72, P389; Lambert NC, 2005, ANN RHEUM DIS, V64, P845, DOI 10.1136/ard.2004.029314; Lambert NC, 2004, ARTHRITIS RHEUM-US, V50, P906, DOI 10.1002/art.20200; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; Lee TH, 1999, BLOOD, V93, P3127; Lo YMD, 2000, CLIN CHEM, V46, P1301; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Ptok U, 2002, Arch Womens Ment Health, V5, P83, DOI 10.1007/s00737-002-0142-6; Sato T, 2008, OBSTET GYNECOL, V112, P593, DOI 10.1097/AOG.0b013e31818345da; SOBOW TM, 2003, GER J PSYCHIATRY, V6, P49; Stevens AM, 2005, RHEUMATOLOGY, V44, P187, DOI 10.1093/rheumatology/keh453; Stevens AM, 2004, LAB INVEST, V84, P1603, DOI 10.1038/labinvest.3700193; Stevens AM, 2009, PEDIATR DEVEL PATHOL, V12, P337, DOI 10.2350/08-07-0499.1; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	56	64	66	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45592	10.1371/journal.pone.0045592	http://dx.doi.org/10.1371/journal.pone.0045592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049819	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300035
J	Clay, JR; Forger, DB; Paydarfar, D				Clay, John R.; Forger, Daniel B.; Paydarfar, David			Ionic Mechanism Underlying Optimal Stimuli for Neuronal Excitation: Role of Na+ Channel Inactivation	PLOS ONE			English	Article							LACUNOSUM-MOLECULARE INTERNEURONS; HIPPOCAMPAL CA1-REGION; EXCITABILITY; SPIKING; MODELS; INPUTS; AXONS	The ionic mechanism underlying optimal stimulus shapes that induce a neuron to fire an action potential, or spike, is relevant to understanding optimal information transmission and therapeutic stimulation in the nervous system. Here we analyze for the first time the ionic basis for stimulus optimality in the Hodgkin and Huxley model and for eliciting a spike in squid giant axons, the preparation for which the model was devised. The experimentally determined stimulus is a smoothly varying biphasic current waveform having a relatively long and shallow hyperpolarizing phase followed by a depolarizing phase of briefer duration. The hyperpolarizing phase removes a small degree of the resting level of Na+ channel inactivation. This result together with the subsequent depolarizing phase provides a signal that is energetically more efficient for eliciting spikes than rectangular current pulses. Sodium channel inactivation is the only variable that is changed during the stimulus waveform, other than the membrane potential, V. The activation variables for Na+ and K+ channels are unchanged throughout the stimulus. This result demonstrates how an optimal stimulus waveform relates to ionic dynamics and may have implications for energy efficiency of neural excitation in many systems including the mammalian brain.	[Clay, John R.] NINDS, NIH, Bethesda, MD 20892 USA; [Forger, Daniel B.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Forger, Daniel B.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Paydarfar, David] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Paydarfar, David] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Paydarfar, David] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University	Clay, JR (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	jrclay@ninds.nih.gov; forger@umich.edu; david.paydarfar@umassmed.edu	Forger, Daniel/C-5552-2015	Forger, Daniel/0000-0001-7581-4031	National Institute of Neurological Disorders and Stroke, United States National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002608] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, United States National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the National Institute of Neurological Disorders and Stroke, United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian Y, 2011, J NEUROPHYSIOL, V106, P1038, DOI 10.1152/jn.00427.2010; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; CLAY JR, 1983, BIOPHYS J, V42, P151, DOI 10.1016/S0006-3495(83)84381-1; Coffey RJ, 2009, ARTIF ORGANS, V33, P208, DOI 10.1111/j.1525-1594.2008.00620.x; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Forger DB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002089; Forger DB, 2004, J THEOR BIOL, V230, P521, DOI 10.1016/j.jtbi.2004.04.043; FRASER DD, 1991, J NEUROSCI, V11, P2812; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hofmann Lorenz, 2011, Front Neuroeng, V4, P9, DOI 10.3389/fneng.2011.00009; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Moehlis J, 2006, J COMPUT NONLIN DYN, V1, P358, DOI 10.1115/1.2338654; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45983	10.1371/journal.pone.0045983	http://dx.doi.org/10.1371/journal.pone.0045983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049913	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300071
J	Mane-Padros, D; Cruz, J; Cheng, A; Raikhel, AS				Mane-Padros, Daniel; Cruz, Josefa; Cheng, Andrew; Raikhel, Alexander S.			A Critical Role of the Nuclear Receptor HR3 in Regulation of Gonadotrophic Cycles of the Mosquito Aedes aegypti	PLOS ONE			English	Article							COMPETENCE FACTOR BETA-FTZ-F1; STARVATION-INDUCED AUTOPHAGY; ECDYSONE RECEPTOR; FAT-BODY; DROSOPHILA METAMORPHOSIS; VITELLOGENIC RESPONSE; ECDYSTEROID RECEPTOR; DISTINCT ROLES; GENE; 20-HYDROXYECDYSONE	The orphan nuclear receptor HR3 is essential for developmental switches during insect development and metamorphosis regulated by 20-hydroxyecdysone (20E). Reproduction of female mosquitoes of the major vector of Dengue fever, Aedes aegypti, is cyclic because of its dependence on blood feeding. 20E is an important hormone regulating vitellogenic events in this mosquito; however, any role for HR3 in 20E-driven reproductive events has not been known. Using RNA interference (RNAi) approach, we demonstrated that Aedes HR3 plays a critical role in a timely termination of expression of the vitellogenin (Vg) gene encoding the major yolk protein precursor. It is also important for downregulation of the Target-of-Rapamycin pathway and activation of programmed autophagy in the Aedes fat body at the end of vitellogenesis. HR3 is critical in activating betaFTZ-F1, EcRB and USPA, the expressions of which are highly elevated at the end of vitellogenesis. RNAi depletion of HR3 (iHR3) prior to the first gonadotrophic cycle affects a normal progression of the second gonadotrophic cycle. Most of ovaries 24 h post second blood meal from iHR3 females in the second cycle were small with follicles that were only slightly different in length from of those of resting stage. In addition, these iHR3 females laid a significantly reduced number of eggs per mosquito as compared to those of iMal and the wild type. Our results indicate an important role of HR3 in regulation of 20E-regulated developmental switches during reproductive cycles of A. aegypti females.	[Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	araikhel@ucr.edu		Cruz, Josefa/0000-0003-3490-6591	National Institutes of Health [2R01AI036959]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the award 2R01AI036959 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquier N, 2005, CURR BIOL, V15, P19, DOI 10.1016/j.cub.2004.12.037; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Chen L, 2004, J MOL ENDOCRINOL, V33, P743, DOI 10.1677/jme.1.01531; Cruz J, 2009, FEBS J, V276, P1233, DOI 10.1111/j.1742-4658.2008.06860.x; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kokoza VA, 2001, GENE, V274, P47, DOI 10.1016/S0378-1119(01)00602-3; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Li C, 2000, DEV BIOL, V224, P96, DOI 10.1006/dbio.2000.9792; Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Raikhel A. S., 2005, COMPREHENSIVE MOL IN; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4; Raikhel AS, 2004, BIOL DIS VECTORS, P329; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sun GQ, 2005, P NATL ACAD SCI USA, V102, P15506, DOI 10.1073/pnas.0503501102; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Wang SF, 2002, MOL CELL ENDOCRINOL, V196, P29, DOI 10.1016/S0303-7207(02)00225-3; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zhu JS, 2007, MOL CELL ENDOCRINOL, V267, P97, DOI 10.1016/j.mce.2007.01.006; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	46	25	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45019	10.1371/journal.pone.0045019	http://dx.doi.org/10.1371/journal.pone.0045019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049766	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300015
J	Schmidt, J; Opgenoorth, L; Holl, S; Bastrop, R				Schmidt, Joachim; Opgenoorth, Lars; Hoell, Steffen; Bastrop, Ralf			Into the Himalayan Exile: The Phylogeography of the Ground Beetle Ethira clade Supports the Tibetan Origin of Forest-Dwelling Himalayan Species Groups	PLOS ONE			English	Article							GENUS PTEROSTICHUS; COLEOPTERA; PHYLOGENY; EVOLUTION; CARABIDAE; MITOCHONDRIAL; PLATEAU; GROWTH; RISE	The Himalayan mountain arc is one of the hotspots of biodiversity on earth, and species diversity is expected to be especially high among insects in this region. Little is known about the origin of the Himalayan insect fauna. With respect to the fauna of high altitude cloud forests, it has generally been accepted that Himalayan lineages are derived from ancestors that immigrated from Western Asia and from adjacent mountainous regions of East and Southeast Asia (immigration hypothesis). In this study, we sought to test a Tibetan Origin as an alternative hypothesis for groups with a poor dispersal ability through a phylogeographic analysis of the Ethira clade of the genus Pterostichus. We sequenced COI mtDNA and the 18S and 28S rDNA genes in 168 Pterostichini specimens, including 46 species and subspecies of the Ethira clade. In our analysis, we were able to show that the Ethira clade is monophyletic and, thus, represents a Himalayan endemic clade, supporting endemism of two of the basal lineages to the Central Himalaya and documenting large distributional gaps within the phylogeographic structure of the Ethira clade. Furthermore, the molecular data strongly indicate very limited dispersal abilities of species and subspecies of these primary wingless ground beetles. These results are consistent with the hypothesis of a Tibetan Origin, which explains the evolution, diversity and distribution of the Himalayan ground beetle Ethira clade much more parsimoniously than the original immigration hypothesis.	[Schmidt, Joachim] Univ Marburg, Fac Geog, Marburg, Germany; [Opgenoorth, Lars] Univ Marburg, Dept Ecol, Marburg, Germany; [Schmidt, Joachim; Hoell, Steffen; Bastrop, Ralf] Univ Rostock, Inst Biol Sci, Rostock, Germany	Philipps University Marburg; Philipps University Marburg; University of Rostock	Schmidt, J (corresponding author), Univ Marburg, Fac Geog, Marburg, Germany.	schmidt@agonum.de; Opgenoorth@uni-marburg.de	Opgenoorth, Lars/C-9624-2018	Opgenoorth, Lars/0000-0003-0737-047X	German Reserach Council; DFG [MI 271/20]	German Reserach Council; DFG(German Research Foundation (DFG))	German Reserach Council. DFG grant MI 271/20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2004, PHYLOGENY ZOOGEOGRAP; Allegro Gianni, 2010, Bollettino del Museo Civico di Storia Naturale di Verona Botanica Zoologia, V34, P3; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; BARTHLOTT W, 1996, ERDKUNDE, V50, P327; Bousquet Yves, 1999, Fabreries Supplement, V9, P1; Contreras-Diaz HG, 2007, MOL PHYLOGENET EVOL, V42, P687, DOI 10.1016/j.ympev.2006.10.007; DeCelles PG, 2007, EARTH PLANET SC LETT, V253, P389, DOI 10.1016/j.epsl.2006.11.001; Deuve T., 1988, Entomologica Basiliensia, V12, P115; DEUVE T, 1983, Revue Francaise d'Entomologie (Nouvelle Serie), V5, P1; Deuve Thierry, 2007, Bulletin de la Societe Entomologique de France, V112, P53; Dostal A., 1984, Entomologische Zeitschrift, V94, P134; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facchini S., 2000, Koleopterologische Rundschau, V70, P1; Faille A, 2011, ZOOL SCR, V40, P282, DOI 10.1111/j.1463-6409.2010.00467.x; Gomez-Zurita J, 2000, MOL PHYLOGENET EVOL, V14, P304, DOI 10.1006/mpev.1999.0712; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hieke Fritz, 2003, P107; Hodges KV, 2001, TECTONICS, V20, P799, DOI 10.1029/2001TC001281; Holloway J.D., 1974, ECOLOGY BIOGEOGRAPHY, P473; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Klebs R., 1910, SCHRIFTEN PHYSIKALIS, V51, P217; Lobl I., 2003, CATALOGUE PALAEARCTI; Lorenz W, 2005, SYSTEMATIC LIST EXTE; Mai DH., 1995, TERTI RE VEGETATIONS; Mani M. S., 1986, BUTTERFLIES HIMALAYA; Mani MS., 1974, ECOLOGY BIOGEOGRAPHY, P698, DOI DOI 10.1007/978-94-010-2331-3_24; Martens J, 1993, NEUE FORSCHUNGEN HIM, P231; Martens Jochen, 2011, Ornithological Monographs, V70, P64; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Morvan P, 1997, LOENED AZIAD AMPREVA, V1, P1; Morvan P, 1984, CHAETOBROSCUS COLEOP; Mulch A, 2006, NATURE, V439, P670, DOI 10.1038/439670a; Muller-Motzfeld G, 2006, KAFER MITTELEUROPAS, DOI [10.1101/603217, DOI 10.1101/603217]; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Pruser F, 1998, INSECT MOL BIOL, V7, P121, DOI 10.1046/j.1365-2583.1998.72056.x; Ruiz C, 2009, MOL PHYLOGENET EVOL, V50, P44, DOI 10.1016/j.ympev.2008.09.023; Sasakawa K, 2005, ENTOMOL SCI, V8, P389, DOI 10.1111/j.1479-8298.2005.00139.x; Sasakawa K, 2007, ANN ENTOMOL SOC AM, V100, P100, DOI 10.1603/0013-8746(2007)100[100:PAGEOC]2.0.CO;2; Schimmel R., 1996, POLLICHIA-BUCH, V33, P1; Schmidt J, 2007, VEROFFENTLICHUNGEN N, V26, P13; Schmidt J, 2012, BIODIVERSITY NATURAL; Schmidt J, 2000, ENTOMOLOGISCHE ABHAN, V58, P5; Schmidt J, 2011, VERNATE, V30, P169; Schmidt J, 2009, NOTES TAXONOMY DISTR, V2009, P131; Schmidt J, 1999, ADV CARABIDOLOGY, P299; Schmidt J, 2012, VEROFFENTLICHUNGEN N, V25, P197; Schmidt Joachim, 2009, Vernate, V28, P183; Schmidt Joachim, 2009, Zootaxa, V2009, P1; Schmidt Joachim, 2006, P179; Schmidt Joachim, 2003, P85; Schoniger M, 1999, J MOL EVOL, V49, P691, DOI 10.1007/PL00006590; Sciaky R, 2003, B MUS REG SCI NAT TO, V20, P401; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Stork Nigel E., 1997, P41; Straneo S.L., 1985, Entomologica Basiliensia, V10, P67; STRANEO S L, 1984, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V125, P11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Umea University, 2010, 6 TIM MOR INS SPEC T; Wang Y, 2008, EARTH PLANET SC LETT, V270, P73, DOI 10.1016/j.epsl.2008.03.006; Weigold H., 2005, MITTEILUNGEN VEREINS, V3, P1; Weitschat W., 1998, ATLAS PFLANZEN TIERE; Will KW, 2008, ANN CARNEGIE MUS, V77, P93, DOI 10.2992/0097-4463-77.1.93; Xu R., 1982, MONOGRAPH MOUNT XIXI, P356; Xu R., 1981, GEOLOGICAL ECOLOGICA, P139; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211	70	30	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45482	10.1371/journal.pone.0045482	http://dx.doi.org/10.1371/journal.pone.0045482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049805	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300028
J	Bashinskaya, B; Nahed, BV; Walcott, BP; Coumans, JVCE; Onuma, OK				Bashinskaya, Bronislava; Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.; Onuma, Oyere K.			Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States	PLOS ONE			English	Article							HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RISK-FACTORS; US ADULTS; CHOLESTEROL LEVELS; FORMAL EDUCATION; POPULATION; AMERICAN; HEALTH	Background: Increasingly studies have identified socioeconomic factors adversely affecting healthcare outcomes for a multitude of diseases. To date, however, there has not been a study correlating socioeconomic details from nationwide databases on the prevalence of advanced coronary artery disease. We seek to identify whether socioeconomic factors contribute to advanced coronary artery disease prevalence in the United States. Methods and Findings: State specific prevalence data was queried form the United States Nationwide Inpatient Sample for 2009. Patients undergoing percutaneous coronary angioplasty and coronary artery bypass graft were identified as principal procedures. Non-cardiac related procedures, lung lobectomy and hip replacement (partial and total) were identified and used as control groups. Information regarding prevalence was then merged with data from the Behavioral Risk Factor Surveillance System, the largest, on-going telephone health survey system tracking health conditions and risk behaviors in the United States. Pearson's correlation coefficient was calculated for individual socioeconomic variables including employment status, level of education, and household income. Household income and education level were inversely correlated with the prevalence of percutaneous coronary angioplasty (-0.717; -0.787) and coronary artery bypass graft surgery (-0.541; -0.618). This phenomenon was not seen in the non-cardiac procedure control groups. In multiple linear regression analysis, socioeconomic factors were significant predictors of coronary artery bypass graft and percutaneous transluminal coronary angioplasty (p < 0.001 and p=0.005, respectively). Conclusions: Socioeconomic status is related to the prevalence of advanced coronary artery disease as measured by the prevalence of percutaneous coronary angioplasty and coronary artery bypass graft surgery.	[Bashinskaya, Bronislava; Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.; Onuma, Oyere K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.] Harvard Univ, Sch Med, Dept Surg, Div Neurosurg, Boston, MA 02115 USA; [Bashinskaya, Bronislava; Onuma, Oyere K.] Harvard Univ, Sch Med, Dept Med, Div Cardiol, Boston, MA USA; [Bashinskaya, Bronislava] Boston Univ, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	Walcott, BP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	walcott.brian@mgh.harvard.edu	; Nahed, Brian/E-4239-2014	Onuma, Oyere/0000-0003-1186-7104; Nahed, Brian/0000-0001-8537-106X				Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Bashinskaya B, 2011, J GLOB INFECT DIS, V3, P366, DOI 10.4103/0974-777X.91061; CALLAHAN LF, 1988, ARTHRITIS RHEUM-US, V31, P1346, DOI 10.1002/art.1780311102; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eagle Kim A, 2004, Circulation, V110, pe340; Elixhauser A, 1996, MOST FREQUENT DIAGNO, piii; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gillum RF, 2003, J CLIN EPIDEMIOL, V56, P188, DOI 10.1016/S0895-4356(02)00535-8; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; LINN S, 1989, AM J EPIDEMIOL, V129, P281, DOI 10.1093/oxfordjournals.aje.a115133; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Saleh SS, 2005, AM J CARDIOL, V96, P1190, DOI 10.1016/j.amjcard.2005.06.054; Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Unger JB, 2004, J COMMUN HEALTH, V29, P467, DOI 10.1007/s10900-004-3395-3; Walcott BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029193; Walcott BP, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1124; Wamala SP, 1999, DIABETES CARE, V22, P1999, DOI 10.2337/diacare.22.12.1999; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46314	10.1371/journal.pone.0046314	http://dx.doi.org/10.1371/journal.pone.0046314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23050011	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100176
J	Caputo, I; Secondo, A; Lepretti, M; Paolella, G; Auricchio, S; Barone, MV; Esposito, C				Caputo, Ivana; Secondo, Agnese; Lepretti, Marilena; Paolella, Gaetana; Auricchio, Salvatore; Barone, Maria Vittoria; Esposito, Carla			Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca2+ Mobilization in Caco-2 Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; CELIAC-DISEASE; ENDOPLASMIC-RETICULUM; INTESTINAL INFLAMMATION; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; EPITHELIAL-CELLS; CROSS-LINKING; PROTEIN	Background: Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically susceptible individuals after exposure to dietary wheat gliadin. The role of post-translational modifications of gliadin catalyzed by tissue transglutaminase (tTG) seems to play a crucial role in CD. However, it remains to be established how and where tTG is activated in vivo. We have investigated whether gliadin peptides modulate intracellular Ca2+ homeostasis and tTG activity. Methods/Principal Findings: We studied Ca2+ homeostasis in Caco-2 cells by single cell microfluorimetry. Under our conditions, A-gliadin peptides 31-43 and 57-68 rapidly mobilized Ca2+ from intracellular stores. Specifically, peptide 31-43 mobilized Ca2+ from the endoplasmic reticulum (ER) and mitochondria, whereas peptide 57-68 mobilized Ca2+ only from mitochondria. We also found that gliadin peptide-induced Ca2+ mobilization activates the enzymatic function of intracellular tTG as revealed by in situ tTG activity using the tTG substrate pentylamine-biotin. Moreover, we demonstrate that peptide 31-43, but not peptide 57-68, induces an increase of tTG expression. Finally, we monitored the expression of glucose-regulated protein-78 and of CCAAT/enhancer binding protein-homologous protein, which are two biochemical markers of ER-stress, by real-time RT-PCR and western blot. We found that chronic administration of peptide 31-43, but not of peptide 57-68, induces the expression of both genes. Conclusions: By inducing Ca2+ mobilization from the ER, peptide 31-43 could promote an ER-stress pathway that may be relevant in CD pathogenesis. Furthermore, peptides 31-43 and 57-68, by activating intracellular tTG, could alter inflammatory key regulators, and induce deamidation of immunogenic peptides and gliadin-tTG crosslinking in enterocytes and specialized antigen-presenting cells.	[Caputo, Ivana; Lepretti, Marilena; Paolella, Gaetana; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Caputo, Ivana; Auricchio, Salvatore; Barone, Maria Vittoria; Esposito, Carla] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Secondo, Agnese] Univ Naples Federico II, Dept Neurosci, Naples, Italy; [Barone, Maria Vittoria] Univ Naples Federico II, Dept Pediat, Naples, Italy	University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Caputo, I (corresponding author), Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy.	icaputo@unisa.it	Secondo, Agnese/AAA-3407-2022	PAOLELLA, Gaetana/0000-0003-2188-3829; BARONE, Maria Vittoria/0000-0001-6190-4917; Marilena, Lepretti/0000-0003-4441-7214; Secondo, Agnese/0000-0001-5054-4098; Caputo, Ivana/0000-0003-2825-9711	Fondi di Ateneo per la Ricerca di Base (FARB) [ORSA090313]	Fondi di Ateneo per la Ricerca di Base (FARB)	This work was supported by a grant from "Fondi di Ateneo per la Ricerca di Base (FARB)" 2009, ORSA090313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Bailey CDC, 2005, J NEUROCHEM, V92, P83, DOI 10.1111/j.1471-4159.2004.02839.x; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Bodger K, 2006, GUT, V55, P973, DOI 10.1136/gut.2005.086413; Caputo I, 2011, AMINO ACIDS, DOI [10.1007/s00726-011-1120-yOnline First&TRADE, DOI 10.1007/S00726-011-1120-YONLINE]; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orru S, 2003, J BIOL CHEM, V278, P31766, DOI 10.1074/jbc.M305080200; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Schuppan D, 1998, NAT MED, V4, P666, DOI 10.1038/nm0698-666; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Silano M, 2007, PEDIATR RES, V61, P67, DOI 10.1203/01.pdr.0000250173.88049.79; Simula MP, 2010, MOL MED, V16, P199, DOI 10.2119/molmed.2009.00173; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	36	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45209	10.1371/journal.pone.0045209	http://dx.doi.org/10.1371/journal.pone.0045209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049776	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100032
J	He, HCH; Kashat, L; Kak, I; Kunavisarut, T; Gundelach, R; Kim, D; So, AKC; MacMillan, C; Freeman, JL; Ralhan, R; Walfish, PG				He, Helen C. -H.; Kashat, Lawrence; Kak, Ipshita; Kunavisarut, Tada; Gundelach, Raefe; Kim, Dae; So, Anthony K. -C.; MacMillan, Christina; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.			An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYTOLOGICAL SPECIMENS; DIAGNOSTIC-ACCURACY; CANCER; EPCAM; EXPRESSION; CELLS; NEOPLASMS; MUTATION; IMPROVES	Background: Nuclear accumulation of the intracellular domain of epithelial cell adhesion molecule (Ep-ICD) in tumor cells was demonstrated to predict poor prognosis in thyroid carcinoma patients in our earlier study. Here, we investigated the clinical significance of Ep-ICD subcellular localization index (ESLI) in distinguishing aggressive papillary thyroid carcinoma (PTC) from non-aggressive cases. Methods: Using domain specific antibodies against the intracellular (Ep-ICD) and extracellular (EpEx) domains of epithelial cell adhesion molecule, 200 archived tissues from a new cohort of patients with benign thyroid disease as well as malignant aggressive and non aggressive PTC were analyzed by immunohistochemistry (IHC). ESLI was defined as sum of the IHC scores for accumulation of nuclear and cytoplasmic Ep-ICD and loss of membranous EpEx; ESLI = [Ep-ICDnuc + Ep-ICDcyt + loss of membranous EpEx]. Results: For the benign thyroid tissues, non-aggressive PTC and aggressive PTC, the mean ESLI scores were 4.5, 6.7 and 11 respectively. Immunofluorescence double staining confirmed increased nuclear Ep-ICD accumulation and decreased membrane EpEx expression in aggressive PTC. Receiver-operating characteristic (ROC) curve analysis showed an area under the curve (AUC) of 0.841, 70.2% sensitivity and 83.9% specificity for nuclear Ep-ICD for differentiating aggressive PTC from non-aggressive PTC. ESLI distinguished aggressive PTC from non-aggressive cases with improved AUC of 0.924, 88.4% sensitivity and 85.5% specificity. Our study confirms nuclear accumulation of Ep-ICD and loss of membranous EpEx occurs in aggressive PTC underscoring the potential of Ep-ICD and ESLI to serve as diagnostic markers for aggressive PTC. Kaplan Meier survival analysis revealed significantly reduced disease free survival (DFS) for ESLI positive (cutoff >10) PTC (p<0.05), mean DFS = 133 months as compared to 210 months for patients who did not show positive ESLI. Conclusion: ESLI scoring improves the identification of aggressive PTC and thereby may serve as a useful index for defining aggressiveness and poor prognosis among PTC patients.	[He, Helen C. -H.; Kashat, Lawrence; Kak, Ipshita; Kunavisarut, Tada; So, Anthony K. -C.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Dept Otolaryngol, Head & Neck Surg Program, Toronto, ON M5G 1X5, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Sch Med, Toronto, ON, Canada; [MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Kak, Ipshita/AAK-8658-2021		Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research (CIHR); The Temmy Latner/Dynacare Foundation; George Knudson Oakdale Golf Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); The Temmy Latner/Dynacare Foundation; George Knudson Oakdale Golf Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, Canadian Institutes of Health Research (CIHR) for CIHR Chair in Advanced Cancer Diagnostics, The Temmy Latner/Dynacare Foundation, George Knudson Oakdale Golf Fund Raiser, and the Mount Sinai Hospital Department of Medicine Research Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cantara S, 2010, J CLIN ENDOCR METAB, V95, P1365, DOI 10.1210/jc.2009-2103; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Chaves-Perez A, 2012, ONCOGENE; Ciampi R, 2005, ENDOCR PATHOL, V16, P163, DOI 10.1385/EP:16:3:163; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cimino A, 2009, BREAST CANC RES TREA; Cochand-Priollet B, 2011, THYROID, V21, P1067, DOI 10.1089/thy.2011.0014; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Fadda G, 2011, EUR J ENDOCRINOL, V165, P447, DOI 10.1530/EJE-11-0181; Ghossein R, 2009, ARCH PATHOL LAB MED, V133, P683, DOI 10.1043/1543-2165-133.5.683; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Lennard CM, 2001, SURGERY, V129, P552, DOI 10.1067/msy.2001.112592; Lin JD, 2009, THYROID, V19, P1053, DOI 10.1089/thy.2009.0133; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Moses W, 2010, WORLD J SURG, V34, P2589, DOI 10.1007/s00268-010-0720-0; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohori NP, 2010, CANCER CYTOPATHOL, V118, P17, DOI 10.1002/cncy.20063; Patriarca C, 2011, CANC TREAT REV; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Shan YF, 2010, MED ONCOL; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Weismann P, 2009, NEOPLASMA, V56, P230	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42893	10.1371/journal.pone.0042893	http://dx.doi.org/10.1371/journal.pone.0042893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049733	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100005
J	Kriszt, R; Krifaton, C; Szoboszlay, S; Cserhati, M; Kriszt, B; Kukolya, J; Czeh, A; Feher-Toth, S; Torok, L; Szoke, Z; Kovacs, KJ; Barna, T; Ferenczi, S				Kriszt, Rokus; Krifaton, Csilla; Szoboszlay, Sandor; Cserhati, Matyas; Kriszt, Balazs; Kukolya, Jozsef; Czeh, Arpad; Feher-Toth, Szilvia; Toeroek, Livia; Szoke, Zsuzsanna; Kovacs, Krisztina J.; Barna, Terez; Ferenczi, Szilamer			A New Zearalenone Biodegradation Strategy Using Non-Pathogenic Rhodococcus pyridinivorans K408 Strain	PLOS ONE			English	Article							MYCOTOXIN ZEARALENONE; ESTROGENIC ACTIVITY; TRICHOSPORON-MYCOTOXINIVORANS; BIOLOGICAL DETOXIFICATION; AFLATOXIN B-1; SP-NOV.; DEGRADATION; TOXICITY; BETA; BIOTRANSFORMATION	Zearalenone (hereafter referred to as ZEA) is a nonsteroidal estrogenic mycotoxin produced by several Fusarium spp. on cereal grains. ZEA is one of the most hazardous natural endocrine disrupting chemicals (EDC) which induces hyper estrogenic responses in mammals. This can result in reproductive disorders in farm animals as well as in humans. Consequently, detoxification strategies for contaminated crops are crucial for food safety. In this study we have developed a bacterial based detoxification system using a non-pathogen Rhodococcus pyridinivorans K408 strain. Following 5 days treatment of ZEA with R. pyridinivorans K408 strain HPLC analyses showed an 87.21% ZEA-degradation efficiency of the bacterial enzyme systems. In another approach, the strain biotransformation ability has also been confirmed by a bioluminescent version of the yeast estrogen screening system (BLYES), which detected an 81.75% of biodegradability of ZEA, in a good agreement with the chemical analyses. Furthermore, the capacity of R. pyridinivorans to eliminate the estrogenic effects of ZEA was tested by using an immature uterotrophic assay. Prepubertal female rats were treated with vehicle (olive oil), 17 beta-estradiol, ZEA (0.1-1-5-10 mg/kg body weight) and LB broth containing 500 mg/l ZEA that has already been incubated with or without Rhodococcus pyridinivorans K408 strain. Uterine weights were measured and the mRNA level changes relating to apelin, aquaporin 5, complement component 2, and calbindin-3 genes were measured by qRT-PCR. These genes represent the major pathways that are affected by estromimetic compounds. Zearalenone feeding significantly increased the uterus weight in a dose dependent manner and at the same time upregulated complement component 2 and calbindin-3 expression as well as decreased apelin and aquaporin 5 mRNA levels comparable to that seen in 17 beta-estradiol exposed rats. In contrast, LB broth in which ZEA was incubated with Rhodococcus pyridinivorans K408 prior to the feeding did not display any estrogenic effect neither on uterine weight nor on the expression of estrogen-regulated genes. Consequently, the identification of Rhodococcus pyridinivorans K408 strain in ZEA biodegradation proved to be a very efficient biological tool that is able to eliminate the complete estrogenic effects of ZEA. It is also remarkable that this biotransformation pathway of ZEA did not result in any residual estrogenic effects.	[Kriszt, Rokus; Kovacs, Krisztina J.; Ferenczi, Szilamer] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Krifaton, Csilla; Szoboszlay, Sandor; Cserhati, Matyas; Kriszt, Balazs; Kukolya, Jozsef] Szent Istvan Univ, Dept Environm Protect & Safety, Budapest, Hungary; [Czeh, Arpad; Feher-Toth, Szilvia; Toeroek, Livia; Szoke, Zsuzsanna] Soft Flow Hungary R&D Ltd, Pecs, Hungary; [Czeh, Arpad; Feher-Toth, Szilvia] Univ Pecs, Fac Med, Dept Biophys, Pecs, Hungary; [Barna, Terez] Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian University of Agriculture & Life Sciences; University of Pecs; University of Debrecen	Ferenczi, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	ferenczi@koki.hu	barna, terez/R-1357-2018	Kriszt, Balazs/0000-0002-9236-2820; Szoboszlay, Sandor/0000-0002-0479-6726; Szoke, Zsuzsanna/0000-0001-9302-1115	Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office) [NKTHTECH_08-A3/2-2008-0385 (OM-00234/2008)]	Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office)	This study was supported by the Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office) (NKTHTECH_08-A3/2-2008-0385 (OM-00234/2008) MYCOSTOP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS HK, 1984, APPL ENVIRON MICROB, V48, P654, DOI 10.1128/AEM.48.3.654-661.1984; Alberts JF, 2006, INT J FOOD MICROBIOL, V109, P121, DOI 10.1016/j.ijfoodmicro.2006.01.019; Altalhi AD, 2009, J HAZARD MATER, V161, P1166, DOI 10.1016/j.jhazmat.2008.04.068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz NH, 1997, NAHRUNG, V41, P34, DOI 10.1002/food.19970410109; Becci PJ, 1982, J APPL TOXICOL, V2, P201, DOI 10.1002/jat.2550020406; BIEHL ML, 1993, TOXICOL APPL PHARM, V121, P152, DOI 10.1006/taap.1993.1140; Chang HJ, 2008, BIOTECHNOL LETT, V30, P1801, DOI 10.1007/s10529-008-9770-x; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Dong M, 2010, TOXICON, V55, P523, DOI 10.1016/j.toxicon.2009.10.004; ELSHARKAWY S, 1988, XENOBIOTICA, V18, P365, DOI 10.3109/00498258809041672; FARNWORTH ER, 1981, J ENVIRON SCI HEAL B, V16, P239, DOI 10.1080/03601238109372255; FITZPATRICK DW, 1989, COMP BIOCHEM PHYS C, V94, P691, DOI 10.1016/0742-8413(89)90133-3; Haroune N, 2002, APPL ENVIRON MICROB, V68, P6114, DOI 10.1128/AEM.68.12.6114-6120.2002; Heneweer M, 2007, TOXICOL SCI, V99, P303, DOI 10.1093/toxsci/kfm151; Igawa T, 2007, APPL ENVIRON MICROB, V73, P1622, DOI 10.1128/AEM.01077-06; ITO Y, 1994, J VET MED SCI, V56, P1155, DOI 10.1292/jvms.56.1155; Jung IG, 2005, CHEMOSPHERE, V61, P451, DOI 10.1016/j.chemosphere.2005.03.007; Jung IG, 2004, J BIOSCI BIOENG, V97, P429, DOI 10.1016/S1389-1723(04)70232-7; Kakeya H, 2002, BIOSCI BIOTECH BIOCH, V66, P2723, DOI 10.1271/bbb.66.2723; Karlovsky P, 1999, NAT TOXINS, V7, P1, DOI 10.1002/(SICI)1522-7189(199902)7:1<1::AID-NT37>3.0.CO;2-9; KATZENELLENBOGEN BS, 1979, ENDOCRINOLOGY, V105, P33, DOI 10.1210/endo-105-1-33; Krifaton C, 2011, MUTAT RES-GEN TOX EN, V726, P1, DOI 10.1016/j.mrgentox.2011.07.011; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Massart F, 2010, INT J ANDROL, V33, P369, DOI 10.1111/j.1365-2605.2009.01009.x; McKenzie KS, 1997, FOOD CHEM TOXICOL, V35, P807, DOI 10.1016/S0278-6915(97)00052-5; Minervini F, 2005, TOXICOL LETT, V159, P272, DOI 10.1016/j.toxlet.2005.05.017; Mitterbauer R, 2003, APPL ENVIRON MICROB, V69, P805, DOI 10.1128/AEM.69.2.805-811.2003; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Moreau M, 2011, J APPL TOXICOL; Precigou S, 2004, BIOTECHNOL LETT, V26, P1379, DOI 10.1023/B:BILE.0000045636.47527.99; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Sabater-Vilar M, 2007, MYCOPATHOLOGIA, V163, P81, DOI 10.1007/s11046-007-0093-6; Sanseverino J, 2005, APPL ENVIRON MICROB, V71, P4455, DOI 10.1128/AEM.71.8.4455-4460.2005; Sanseverino J, 2009, TOXICOL SCI, V107, P122, DOI 10.1093/toxsci/kfn229; Shier WT, 2001, TOXICON, V39, P1435, DOI 10.1016/S0041-0101(00)00259-2; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1395, DOI 10.1080/15287390903212741; Takahashi-Ando N, 2004, APPL ENVIRON MICROB, V70, P3239, DOI 10.1128/AEM.70.6.3239-3245.2004; Teniola OD, 2005, INT J FOOD MICROBIOL, V105, P111, DOI 10.1016/j.ijfoodmicro.2005.05.004; Vekiru E, 2010, APPL ENVIRON MICROB, V76, P2353, DOI 10.1128/AEM.01438-09; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu F, 2008, J AGR FOOD CHEM, V56, P3900, DOI 10.1021/jf072697e; Yoon JH, 2000, INT J SYST EVOL MICR, V50, P2173, DOI 10.1099/00207713-50-6-2173; Yu YS, 2011, BIODEGRADATION, V22, P613, DOI 10.1007/s10532-010-9435-z; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	47	42	45	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43608	10.1371/journal.pone.0043608	http://dx.doi.org/10.1371/journal.pone.0043608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049739	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100009
J	Kuchenreuther, JM; Britt, RD; Swartz, JR				Kuchenreuther, Jon M.; Britt, R. David; Swartz, James R.			New Insights into [FeFe] Hydrogenase Activation and Maturase Function	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; H-CLUSTER; LYSINE 2,3-AMINOMUTASE; AZOTOBACTER-VINELANDII; PROTEIN; SULFUR; ISCU; HYDG; ADENOSYLMETHIONINE	[FeFe] hydrogenases catalyze H-2 production using the H-cluster, an iron-sulfur cofactor that contains carbon monoxide (CO), cyanide (CN-), and a dithiolate bridging ligand. The HydE, HydF, and HydG maturases assist in assembling the H-cluster and maturing hydrogenases into their catalytically active form. Characterization of these maturases and in vitro hydrogenase activation methods have helped elucidate steps in the H-cluster biosynthetic pathway such as the HydG-catalyzed generation of the CO and CN- ligands from free tyrosine. We have refined our cell-free approach for H-cluster synthesis and hydrogenase maturation by using separately expressed and purified HydE, HydF, and HydG. In this report, we illustrate how substrates and protein constituents influence hydrogenase activation, and for the first time, we show that each maturase can function catalytically during the maturation process. With precise control over the biomolecular components, we also provide evidence for H-cluster synthesis in the absence of either HydE or HydF, and we further show that hydrogenase activation can occur without exogenous tyrosine. Given these findings, we suggest a new reaction sequence for the [FeFe] hydrogenase maturation pathway. In our model, HydG independently synthesizes an iron-based compound with CO and CN- ligands that is a precursor to the H-cluster [2Fe](H) subunit, and which we have termed HydG-co. We further propose that HydF is a transferase that stabilizes HydG-co and also shuttles the complete [2Fe](H) subcluster to the hydrogenase, a translocation process that may be catalyzed by HydE. In summary, this report describes the first example of reconstructing the [FeFe] hydrogenase maturation pathway using purified maturases and subsequently utilizing this in vitro system to better understand the roles of HydE, HydF, and HydG.	[Kuchenreuther, Jon M.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Kuchenreuther, Jon M.; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Davis; Stanford University	Swartz, JR (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu			United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-09ER46632]; United States Department of Energy, Office of Sciences [DE-SC0004334]	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); United States Department of Energy, Office of Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award #DE-FG02-09ER46632 (cell-free studies) and the United States Department of Energy, Office of Sciences under award #DE-SC0004334 (spectroscopic studies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 1996, J BIOL CHEM, V271, P4256; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chen DW, 2001, BIOCHEMISTRY-US, V40, P596, DOI 10.1021/bi002265w; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Flint DH, 1996, J BIOL CHEM, V271, P16068; FREY PA, 1993, FASEB J, V7, P662, DOI 10.1096/fasebj.7.8.8500691; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; MORGAN TV, 1984, P NATL ACAD SCI-BIOL, V81, P1931, DOI 10.1073/pnas.81.7.1931; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Shepard EM, 2011, CURR OPIN CHEM BIOL; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; VanderSpek TM, 1996, EUR J BIOCHEM, V237, P629; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200	35	55	55	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45850	10.1371/journal.pone.0045850	http://dx.doi.org/10.1371/journal.pone.0045850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049878	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100091
J	Stein, GY; Yosef, N; Reichman, H; Horev, J; Laser-Azogui, A; Berens, A; Resau, J; Ruppin, E; Sharan, R; Tsarfaty, I				Stein, Gideon Y.; Yosef, Nir; Reichman, Hadar; Horev, Judith; Laser-Azogui, Adi; Berens, Angelique; Resau, James; Ruppin, Eytan; Sharan, Roded; Tsarfaty, Ilan			Met Kinetic Signature Derived from the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION SIGNATURE; C-MET; TRASTUZUMAB RESISTANCE; COLORECTAL-CANCER; ESTROGEN-RECEPTOR; PROGNOSTIC-FACTOR; IN-VITRO; PROTEIN; NODE	To determine the signaling pathways leading from Met activation to metastasis and poor prognosis, we measured the kinetic gene alterations in breast cancer cell lines in response to HGF/SF. Using a network inference tool we analyzed the putative protein-protein interaction pathways leading from Met to these genes and studied their specificity to Met and prognostic potential. We identified a Met kinetic signature consisting of 131 genes. The signature correlates with Met activation and with response to anti-Met therapy (p<0.005) in in-vitro models. It also identifies breast cancer patients who are at high risk to develop an aggressive disease in six large published breast cancer patient cohorts (p<0.01, N>1000). Moreover, we have identified novel putative Met pathways, which correlate with Met activity and patient prognosis. This signature may facilitate personalized therapy by identifying patients who will respond to anti-Met therapy. Moreover, this novel approach may be applied for other tyrosine kinases and other malignancies.	[Stein, Gideon Y.; Reichman, Hadar; Horev, Judith; Laser-Azogui, Adi; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Stein, Gideon Y.] Beilinson Med Ctr, Dept Internal Med B, Rabin Med Ctr, Petah Tiqwa, Israel; [Yosef, Nir; Ruppin, Eytan; Sharan, Roded] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Berens, Angelique; Resau, James] Van Andel Res Inst, Grand Rapids, MI USA	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Van Andel Institute	Tsarfaty, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940; Tsarfaty, Ilan/0000-0002-5230-7093	Bikura Converging Technologies grants from the Israel Science Foundation; Breast Cancer Research Foundation; Binational Scientific Foundation; Federico Foundation	Bikura Converging Technologies grants from the Israel Science Foundation; Breast Cancer Research Foundation; Binational Scientific Foundation; Federico Foundation	The Breast Cancer Research Foundation, Binational Scientific Foundation, Federico Foundation and the Bikura Converging Technologies grants from the Israel Science Foundation funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstock RT, 2000, CYTOMETRY, V41, P155, DOI 10.1002/1097-0320(20001101)41:3<155::AID-CYTO1>3.0.CO;2-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balliet RM, 2011, CELL CYCLE, V10, P4065, DOI 10.4161/cc.10.23.18254; Basha R, 2011, GYNECOL ONCOL, V122, P163, DOI 10.1016/j.ygyno.2011.03.014; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Braun R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-488; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen HHW, 2007, BREAST CANCER RES TR, V103, P167, DOI 10.1007/s10549-006-9360-3; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Dulak AM, 2011, ONCOGENE; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Fukukawa C, 2010, GENE CHROMOSOME CANC, V49, P861, DOI 10.1002/gcc.20795; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Garcia S, 2007, INT J ONCOL, V31, P49; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gerritsen ME, 2003, BRIT J PHARMACOL, V140, P595, DOI 10.1038/sj.bjp.0705494; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Goormachtigh G, 2011, BIOCHEM BIOPH RES CO, V411, P780, DOI 10.1016/j.bbrc.2011.07.024; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Huhn S, 2011, INT J MOL EPIDEMIOL, V2, P36; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Jansen MP, 2012, BREAST CANC RES TREA; Kamalati T, 1999, J MAMMARY GLAND BIOL, V4, P69, DOI 10.1023/A:1018756620265; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Keyhanian K, 2007, MOL CELL BIOCHEM, V304, P199, DOI 10.1007/s11010-007-9500-z; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mbalaviele G, 1996, CANCER RES, V56, P4063; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Ocal IT, 2003, CANCER-AM CANCER SOC, V97, P1841, DOI 10.1002/cncr.11335; Ou WB, 2011, NEOPLASIA, V13, P12, DOI 10.1593/neo.101156; Pauley R J, 1993, Eur J Cancer Prev, V2 Suppl 3, P67; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; RONG S, 1993, CANCER RES, V53, P5355; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Salgia R, 2009, SEMIN ONCOL, V36, pS52, DOI 10.1053/j.seminoncol.2009.02.008; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Tsarfaty I, 1999, ANAL QUANT CYTOL, V21, P397; TSARFATY I, 1992, SCIENCE, V257, P1258, DOI 10.1126/science.1387731; Tsutamoto T, 2000, J AM COLL CARDIOL, V35, P714, DOI 10.1016/S0735-1097(99)00594-X; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Uluer ET, 2011, ACTA HISTOCHEM; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yamashita SI, 2007, ANTICANCER RES, V27, P2803; Yosef N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001935; Yosef N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.3; Yoshida Y, 2011, ANTICANCER RES, V31, P2535; Zhang YW, 2004, CANCER CELL, V6, P5, DOI 10.1016/j.ccr.2004.07.003	76	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45969	10.1371/journal.pone.0045969	http://dx.doi.org/10.1371/journal.pone.0045969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049908	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100111
J	Shan, TZ; Liu, WY; Kuang, SH				Shan, Tizhong; Liu, Weiyi; Kuang, Shihuan			Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues	FASEB JOURNAL			English	Article						mouse; stromal vascular fraction	COMMITTED PREADIPOCYTES; STEM-CELLS; DISTINCT; IDENTIFICATION; ADIPOGENESIS; COMMITMENT; RESPONSES; RECEPTOR; ROLES; OBESE	Adipose tissues regulate metabolism, reproduction, and life span. The development and growth of adipose tissue are due to increases of both adipocyte cell size and cell number; the latter is mediated by adipocyte progenitors. Various markers have been used to identify either adipocyte progenitors or mature adipocytes. The fatty acid binding protein 4 (FABP4), commonly known as adipocyte protein 2 (aP2), has been extensively used as a marker for differentiated adipocytes. However, whether aP2 is expressed in adipogenic progenitors is controversial. Using Cre/LoxP-based cell lineage tracing in mice, we have identified a population of aP2-expressing progenitors in the stromal vascular fraction (SVF) of both white and brown adipose tissues. The aP2-lineage progenitors reside in the adipose stem cell niche and express adipocyte progenitor markers, including CD34, Sca1, Dlk1, and PDGFR alpha. When isolated and grown in culture, the aP2-expressing SVF cells proliferate and differentiate into adipocytes upon induction. Conversely, ablation of the aP2 lineage greatly reduces the adipogenic potential of SVF cells. When grafted into wild-type mice, the aP2-lineage progenitors give rise to adipose depots in recipient mice. Therefore, the expression of aP2 is not limited to mature adipocytes, but also marks a pool of undifferentiated progenitors associated with the vasculature of adipose tissues. Our finding adds to the repertoire of adipose progenitor markers and points to a new regulator of adipose plasticity.-Shan, T., Liu, W., Kuang, S. Fatty acid-binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB J. 27, 277-287 (2013). www.fasebj.org	[Shan, Tizhong; Liu, Weiyi; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 174B Smith Hall,901 W State St, W Lafayette, IN 47907 USA.	skuang@purdue.edu	liu, weiyi/B-2053-2014; Shan, Tizhong/G-1947-2015; liu, weiyi/G-2730-2012	Kuang, Shihuan/0000-0001-9180-3180	Muscular Dystrophy Association; U.S. National Institutes of Health; U.S. Department of Agriculture; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Pengpeng Bi for comments on the manuscript, and Jun Wu for mouse colony support. The project is partially supported by funding from the Muscular Dystrophy Association, the U.S. National Institutes of Health, and the U.S. Department of Agriculture to S.K. The authors declare no conflict of interests.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Barlow C, 1997, NUCLEIC ACIDS RES, V25, P2543, DOI 10.1093/nar/25.12.2543; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Liu WY, 2012, DEV BIOL, V361, P27, DOI 10.1016/j.ydbio.2011.10.011; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Mussig K, 2012, CLIN ENDOCRINOL, V77, P139, DOI 10.1111/j.1365-2265.2012.04343.x; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Russell AP, 2012, INT J OBESITY, V36, P155, DOI 10.1038/ijo.2011.85; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shan T, 2010, J ANIM SCI, V88, P3909, DOI 10.2527/jas.2010-2880; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchoukalova YD, 2004, AM J PHYSIOL-REG I, V287, pR1132, DOI 10.1152/ajpregu.00337.2004; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	38	125	132	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					277	287		10.1096/fj.12-211516	http://dx.doi.org/10.1096/fj.12-211516			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047894	Green Published			2022-12-25	WOS:000313103200026
J	Robinet, C; Kehlenbeck, H; Kriticos, DJ; Baker, RHA; Battisti, A; Brunel, S; Dupin, M; Eyre, D; Faccoli, M; Ilieva, Z; Kenis, M; Knight, J; Reynaud, P; Yart, A; van der Werf, W				Robinet, Christelle; Kehlenbeck, Hella; Kriticos, Darren J.; Baker, Richard H. A.; Battisti, Andrea; Brunel, Sarah; Dupin, Maxime; Eyre, Dominic; Faccoli, Massimo; Ilieva, Zhenya; Kenis, Marc; Knight, Jon; Reynaud, Philippe; Yart, Annie; van der Werf, Wopke			A Suite of Models to Support the Quantitative Assessment of Spread in Pest Risk Analysis	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; LONG-DISTANCE DISPERSAL; POPULATION EXPANSION; ECONOMIC-IMPACT; PITCH CANKER; INVASION; CLIMATE; EUROPE; TRADE; SIMULATION	Pest Risk Analyses (PRAs) are conducted worldwide to decide whether and how exotic plant pests should be regulated to prevent invasion. There is an increasing demand for science-based risk mapping in PRA. Spread plays a key role in determining the potential distribution of pests, but there is no suitable spread modelling tool available for pest risk analysts. Existing models are species specific, biologically and technically complex, and data hungry. Here we present a set of four simple and generic spread models that can be parameterised with limited data. Simulations with these models generate maps of the potential expansion of an invasive species at continental scale. The models have one to three biological parameters. They differ in whether they treat spatial processes implicitly or explicitly, and in whether they consider pest density or pest presence/absence only. The four models represent four complementary perspectives on the process of invasion and, because they have different initial conditions, they can be considered as alternative scenarios. All models take into account habitat distribution and climate. We present an application of each of the four models to the western corn rootworm, Diabrotica virgifera virgifera, using historic data on its spread in Europe. Further tests as proof of concept were conducted with a broad range of taxa (insects, nematodes, plants, and plant pathogens). Pest risk analysts, the intended model users, found the model outputs to be generally credible and useful. The estimation of parameters from data requires insights into population dynamics theory, and this requires guidance. If used appropriately, these generic spread models provide a transparent and objective tool for evaluating the potential spread of pests in PRAs. Further work is needed to validate models, build familiarity in the user community and create a database of species parameters to help realize their potential in PRA practice.	[van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, Wageningen, Netherlands; [Robinet, Christelle; Dupin, Maxime; Yart, Annie] INRA, UR Zool Forestiere 633, Orleans, France; [Kehlenbeck, Hella] Julius Kuhn Inst, Inst Natl & Int Plant Hlth, Kleinmachnow, Germany; [Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia; [Baker, Richard H. A.; Eyre, Dominic] Food & Environm Res Agcy, York, N Yorkshire, England; [Battisti, Andrea; Faccoli, Massimo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, Italy; [Brunel, Sarah] European & Mediterranean Plant Protect Org, Paris, France; [Ilieva, Zhenya] Inst Plant Protect, Kostinbrod, Bulgaria; [Knight, Jon] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Kenis, Marc] CABI Europe Switzerland, Delemont, Switzerland; [Knight, Jon] HDC, Agr & Hort Dev Board, Kenilworth, Warwick, England; [Reynaud, Philippe] Anses Lab Sante Vegetaux, Montferrier Sur Lez, France	Wageningen University & Research; INRAE; Julius Kuhn-Institut; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Food & Environment Research Agency; University of Padua; Agricultural Academy - Bulgaria; Imperial College London; Agriculture & Horticulture Development Board (AHDB); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	van der Werf, W (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, Wageningen, Netherlands.	Wopke.vanderWerf@wur.nl	Faccoli, Massimo/AAC-8141-2020; Ilieva, Zhenya/AAB-8513-2019; Kriticos, Darren J/A-4170-2008; Battisti, Andrea/F-6243-2015; Van Der Werf, Wopke/A-2557-2009	Ilieva, Zhenya/0000-0002-9937-2749; Kriticos, Darren J/0000-0003-2599-8105; Battisti, Andrea/0000-0002-2497-3064; Van Der Werf, Wopke/0000-0002-5506-4699; FACCOLI, MASSIMO/0000-0002-9355-0516; Kehlenbeck, Hella/0000-0002-5568-4070; Robinet, Christelle/0000-0002-4933-4656	EU [RATIQUE KBBE-2007-212459, ISEFOR KBBE-2009-245268]; Netherlands Agricultural Economics Institute, LEI-DLO	EU(European Commission); Netherlands Agricultural Economics Institute, LEI-DLO	The authors gratefully acknowledge support for this work from the EU project PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques; [32]). WvdW acknowledges financial support from the Netherlands Agricultural Economics Institute, LEI-DLO. Publication costs were shared equally between Wageningen University Library and the EU project ISEFOR KBBE-2009-245268 (FP7 Project, Increasing Sustainability of European Forests). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca F, 1993, 21 YUG ENT C BELGR; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Baufeld P., 2005, BCPC Symposium Proceedings, V81, P149; Baufeld P, 2001, 8 M IWGO DIABR SUBGR; Bianchi FJJA, 2009, BIOL CONTROL, V50, P267, DOI 10.1016/j.biocontrol.2009.04.014; Biosecurity Australia, 2007, IMP RISK AN 2007; Bolker B, 2008, ECOLOGICAL MODELS DA; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Carrasco LR, 2010, ECOL ECON, V69, P1303, DOI 10.1016/j.ecolecon.2010.02.001; Carrasco LR, 2009, ANN APPL BIOL, V155, P1; Carrasco LR, 2009, THESIS, P230; Ciosi M, 2011, EVOL APPL, V4, P54, DOI 10.1111/j.1752-4571.2010.00133.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; De Boer D, 2004, DISTRIBUTION POTENTI; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Desprez-Loustau Marie-Laure, 2009, V3, P15; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; EPPO, 2011, EPPO PEST RISK AN; EPPO, 1994, EPPO REP SERV 94 001; EPPO (European and Mediterranean Plant Protection Organization), 2011, GUID PEST RISK AN DE; FAO, 2007, FRAM PEST RISK AN IS; FAO, 2004, FAO PUBL, V11; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hemerik L, 2004, ENTOMOL EXP APPL, V111, P59, DOI 10.1111/j.0013-8703.2004.00150.x; Higgins SI, 1996, ECOL MODEL, V87, P249, DOI 10.1016/0304-3800(95)00022-4; Hilborn Ray, 1997, V28; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kehlenbeck H., 2012, Bulletin OEPP, V42, P74, DOI [10.1111/epp.2550, 10.1111/j.1365-2338.2012.02550.x]; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Kenis M, 2010, BIORISK, V4, P51; Koch FH, 2009, RISK ANAL, V29, P1227, DOI 10.1111/j.1539-6924.2009.01251.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kot M., 2001, ELEMENTS MATH BIOL; Kriticos D, 2008, CLIMATIC PREDICTION; Kriticos D. J., 2012, Bulletin OEPP, V42, P56, DOI [10.1111/j.1365-2338.2012.02540.x, 10.1111/epp.2540]; Krugener S., 2011, Journal fur Kulturpflanzen, V63, P69; Liebhold Andrew M., 2006, American Entomologist, V52, P48; LUDWIG D, 1985, CAN J FISH AQUAT SCI, V42, P1066, DOI 10.1139/f85-132; MacLeod A., 2005, Plant protection and plant health in Europe: introduction and spread of invasive species, held at Humboldt University, Berlin, Germany, 9-11 June 2005, P167; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; McGill University, 2011, 175 CROPS DAT AR YIE; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Murray J.D., 2002, INTERDISCIPLINARY AP, V17; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Pitt JPW, 2011, ECOL MODEL, V222, P1880, DOI 10.1016/j.ecolmodel.2011.03.023; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Pitt JPW, 2008, THESIS, P228; Purdue University, 2011, W CORN ROOTW; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roques Alain, 2010, New Zealand Journal of Forestry Science, V40, pS77; Roques Alain, 2009, V3, P63; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Shigesada N, 1997, BIOL INVASIONS THEOR; Sivcev I, 2000, 7 M IWGO DIABR SUBGR; Soetaert K., 2009, PRACTICAL GUIDE ECOL; Sutherst R. W., 2007, CLIMEX VERSION 3 USE, P131; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Turchin Peter, 1998; USDA-APHIS, 2000, GUID PATHW IN PEST R; Waage JK, 2005, NEW AGENDA BIOSECURI, P190; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Williamson M., 1996, BIOL INVASIONS; Zseller IH, 2000, 7 M IWGO DIABR SUBGR; Zseller IH, 2001, 8 M IWGO DIABR SUBGR	79	54	57	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43366	10.1371/journal.pone.0043366	http://dx.doi.org/10.1371/journal.pone.0043366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056174	Green Submitted, Green Published, gold			2022-12-25	WOS:000309889400003
J	Ciccarelli, A; Calza, A; Panzanelli, P; Concas, A; Giustetto, M; Sassoe-Pognetto, M				Ciccarelli, Alessandro; Calza, Arianna; Panzanelli, Patrizia; Concas, Alessandra; Giustetto, Maurizio; Sassoe-Pognetto, Marco			Organization of GABAergic Synaptic Circuits in the Rat Ventral Tegmental Area	PLOS ONE			English	Article							GABA(A) RECEPTORS; DOPAMINE NEURONS; IN-VIVO; GLUTAMATERGIC NEURONS; SUBSTANTIA-NIGRA; NUCLEUS; REWARD; BRAIN; ACTIVATION; AFFERENTS	The ventral tegmental area (VTA) is widely implicated in drug addiction and other psychiatric disorders. This brain region is densely populated by dopaminergic (DA) neurons and also contains a sparse population of gamma-aminobutyric acid (GABA)ergic cells that regulate the activity of the principal neurons. Therefore, an in-depth knowledge of the organization of VTA GABAergic circuits and of the plasticity induced by drug consumption is essential for understanding the mechanisms by which drugs induce stable changes in brain reward circuits. Using immunohistochemistry, we provide a detailed description of the localization of major GABA(A) and GABA(B) receptor subunits in the rat VTA. We show that DA and GABAergic cells express both GABA(A) and GABA(B) receptors. However VTA neurons differ considerably in the expression of GABAA receptor subunits, as the alpha 1 subunit is associated predominantly with non-DA cells, whereas the alpha 3 subunit is present at low levels in both types of VTA neurons. Using an unbiased stereological method, we then demonstrate that alpha 1-positive elements represent only a fraction of non-DA neurons and that the ratio of DA and non-DA cells is quite variable throughout the rostro-caudal extent of the VTA. Interestingly, DA and non-DA cells receive a similar density of perisomatic synapses, whereas axo-dendritic synapses are significantly more abundant in non-DA cells, indicating that local interneurons receive prominent GABAergic inhibition. These findings reveal a differential expression of GABA receptor subtypes in the two major categories of VTA neurons and provide an anatomical basis for interpreting the plasticity of inhibitory circuits induced by drug exposure.	[Ciccarelli, Alessandro; Panzanelli, Patrizia; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Ciccarelli, Alessandro; Panzanelli, Patrizia; Giustetto, Maurizio; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Calza, Arianna; Concas, Alessandra] Univ Cagliari, Dept Expt Biol, Cagliari, Italy; [Calza, Arianna; Concas, Alessandra] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Cagliari, Italy	University of Turin; University of Cagliari; University of Cagliari	Sassoe-Pognetto, M (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	marco.sassoe@unito.it	Sassoe-Pognetto, Marco/AAE-3536-2022; giustetto, maurizio/D-6606-2011; Panzanelli, Patrizia/AAE-7773-2022	giustetto, maurizio/0000-0003-1323-4060; Sassoe-Pognetto, Marco/0000-0001-8906-0613; Ciccarelli, Alessandro/0000-0002-7612-8161; Panzanelli, Patrizia/0000-0002-5127-2757	Italian Telethon Foundation [GGP09196, GGP11095]; Fondazione SanPaolo [2007]; Italian MIUR [2005059123, 2008KN7J7J]; Fondazione CRT; Regione Piemonte (Ricerca Sanitaria Finalizzata) [POS FESR 07/13 BANP]	Italian Telethon Foundation(Fondazione Telethon); Fondazione SanPaolo(Compagnia di San Paolo); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione CRT(Fondazione CRT); Regione Piemonte (Ricerca Sanitaria Finalizzata)(Regione Piemonte)	This study was supported by the Italian Telethon Foundation (GGP09196 and GGP11095 to M.G.), Regione Piemonte (Ricerca Sanitaria Finalizzata 2006 to M.S-P.; POS FESR 07/13 BANP to M.G.), Fondazione SanPaolo (grant 2007 to M.S-P.) and Italian MIUR (Prin 2005059123 and Prin 2008KN7J7J to A.C. and M. S-P.). Alessandro Ciccarelli received financial support from Fondazione CRT (Progetto Lagrange 2005 and Progetto Alfieri 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes E, 2003, J PHARMACOL EXP THER, V307, P450, DOI 10.1124/jpet.103.054965; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bonci A, 1997, J NEUROSCI, V17, P796; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; Chouinard G, 2004, J CLIN PSYCHIAT, V65, P7; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Colussi-Mas J, 2007, EUR J NEUROSCI, V26, P1011, DOI 10.1111/j.1460-9568.2007.05738.x; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Doherty M, 2007, BRAIN RES, V1150, P62, DOI 10.1016/j.brainres.2007.02.081; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Geisler S, 2008, NEUROPSYCHOPHARMACOL, V33, P2688, DOI 10.1038/sj.npp.1301650; GERMAN DC, 1993, J COMP NEUROL, V331, P297, DOI 10.1002/cne.903310302; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; Griffiths RR, 2005, J CLIN PSYCHIAT, V66, P31; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Laviolette SR, 2004, EUR J NEUROSCI, V20, P2179, DOI 10.1111/j.1460-9568.2004.03665.x; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; Okada M, 2000, J NEUROSCI, V20, P2202; Olson VG, 2007, SYNAPSE, V61, P87, DOI 10.1002/syn.20345; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rodrigues RWP, 2004, INT J NEUROSCI, V114, P197, DOI 10.1080/00207450490249338; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwarzer C, 2001, J COMP NEUROL, V433, P526, DOI 10.1002/cne.1158; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102	61	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46250	10.1371/journal.pone.0046250	http://dx.doi.org/10.1371/journal.pone.0046250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056271	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500032
J	Vukoti, K; Kimura, T; Macke, L; Gawrisch, K; Yeliseev, A				Vukoti, Krishna; Kimura, Tomohiro; Macke, Laura; Gawrisch, Klaus; Yeliseev, Alexei			Stabilization of Functional Recombinant Cannabinoid Receptor CB2 in Detergent Micelles and Lipid Bilayers	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; ADENOSINE A(2A) RECEPTOR; ESCHERICHIA-COLI; LIGAND STABILIZATION; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DRUG DISCOVERY; EXPRESSION; PURIFICATION; ACTIVATION	Elucidation of the molecular mechanisms of activation of G protein-coupled receptors (GPCRs) is among the most challenging tasks for modern membrane biology. For studies by high resolution analytical methods, these integral membrane receptors have to be expressed in large quantities, solubilized from cell membranes and purified in detergent micelles, which may result in a severe destabilization and a loss of function. Here, we report insights into differential effects of detergents, lipids and cannabinoid ligands on stability of the recombinant cannabinoid receptor CB2, and provide guidelines for preparation and handling of the fully functional receptor suitable for a wide array of downstream applications. While we previously described the expression in Escherichia coli, purification and liposome-reconstitution of multi-milligram quantities of CB2, here we report an efficient stabilization of the recombinant receptor in micelles - crucial for functional and structural characterization. The effects of detergents, lipids and specific ligands on structural stability of CB2 were assessed by studying activation of G proteins by the purified receptor reconstituted into liposomes. Functional structure of the ligand binding pocket of the receptor was confirmed by binding of H-2-labeled ligand measured by solid-state NMR. We demonstrate that a concerted action of an anionic cholesterol derivative, cholesteryl hemisuccinate (CHS) and high affinity cannabinoid ligands CP-55,940 or SR-144,528 are required for efficient stabilization of the functional fold of CB2 in dodecyl maltoside (DDM)/CHAPS detergent solutions. Similar to CHS, the negatively charged phospholipids with the serine headgroup (PS) exerted significant stabilizing effects in micelles while uncharged phospholipids were not effective. The purified CB2 reconstituted into lipid bilayers retained functionality for up to several weeks enabling high resolution structural studies of this GPCR at physiologically relevant conditions.	[Vukoti, Krishna; Kimura, Tomohiro; Macke, Laura; Gawrisch, Klaus; Yeliseev, Alexei] NIAAA, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Yeliseev, A (corresponding author), NIAAA, NIH, Bethesda, MD USA.	yeliseeva@mail.nih.gov	Yeliseev, Alexei A/B-3143-2009; Kimura, Tomohiro/AEJ-1621-2022	Kimura, Tomohiro/0000-0002-4192-7852	intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the intramural research program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), to KG. KG participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Attrill H, 2009, PROTEIN EXPRES PURIF, V64, P32, DOI 10.1016/j.pep.2008.10.001; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Feng W, 2002, PROTEIN EXPRES PURIF, V26, P496, DOI 10.1016/S1046-5928(02)00569-7; Filppula S, 2004, J PEPT RES, V64, P225, DOI 10.1111/j.1399-3011.2004.00188.x; Gawrisch K, 2008, CHEM PHYS LIPIDS, V153, P64, DOI 10.1016/j.chemphyslip.2008.02.016; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Grisshammer R, 1999, BIOCHEM SOC T, V27, P899, DOI 10.1042/bst0270899; Grisshammer R, 2009, METHOD ENZYMOL, V463, P631, DOI 10.1016/S0076-6879(09)63036-6; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kimura T, 2012, J BIOL CHEM, V287, P4076, DOI 10.1074/jbc.M111.268425; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kubota M, 2009, J BIOCHEM, V146, P875, DOI 10.1093/jb/mvp132; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lin SS, 1996, BIOCHEMISTRY-US, V35, P14445, DOI 10.1021/bi961619+; LINDER ME, 1990, J BIOL CHEM, V265, P8243; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Lorch M, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P361; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Magnin T, 2009, PROTEIN EXPRES PURIF, V64, P1, DOI 10.1016/j.pep.2008.09.007; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Mumby SM, 1994, HETEROTRIMERIC G, V237, P254; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; O'Malley MA, 2011, BIOPHYS J, V100, pL11, DOI 10.1016/j.bpj.2010.12.3698; Ott D, 2005, PROTEIN ENG DES SEL, V18, P153, DOI 10.1093/protein/gzi012; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Pertwee RG, 2002, PHARMACOL THERAPEUT, V95, P165, DOI 10.1016/S0163-7258(02)00255-3; Ratnala VRP, 2006, BIOTECHNOL LETT, V28, P767, DOI 10.1007/s10529-006-9005-y; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Sanchez C, 2001, CANCER RES, V61, P5784; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Sykora J, 2009, BBA-BIOMEMBRANES, V1788, P324, DOI 10.1016/j.bbamem.2008.11.008; THOMAS BF, 1990, J PHARMACOL EXP THER, V255, P624; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Yeliseev A, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P219; Yeliseev A, 2007, PROTEIN EXPRES PURIF, V53, P153, DOI 10.1016/j.pep.2006.12.003; Zhang RD, 2007, PROTEIN EXPRES PURIF, V55, P225, DOI 10.1016/j.pep.2007.03.018	48	37	37	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46290	10.1371/journal.pone.0046290	http://dx.doi.org/10.1371/journal.pone.0046290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056277	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000030
J	Smith, ZJ; Chu, KQ; Wachsmann-Hogiu, S				Smith, Zachary J.; Chu, Kaiqin; Wachsmann-Hogiu, Sebastian			Nanometer-Scale Sizing Accuracy of Particle Suspensions on an Unmodified Cell Phone Using Elastic Light Scattering	PLOS ONE			English	Article							SIZE DISTRIBUTION; MICROSCOPY; CYTOMETRY	We report on the construction of a Fourier plane imaging system attached to a cell phone. By illuminating particle suspensions with a collimated beam from an inexpensive diode laser, angularly resolved scattering patterns are imaged by the phone's camera. Analyzing these patterns with Mie theory results in predictions of size distributions of the particles in suspension. Despite using consumer grade electronics, we extracted size distributions of sphere suspensions with better than 20 nm accuracy in determining the mean size. We also show results from milk, yeast, and blood cells. Performing these measurements on a portable device presents opportunities for field-testing of food quality, process monitoring, and medical diagnosis.	[Smith, Zachary J.; Chu, Kaiqin; Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Smith, ZJ (corresponding author), Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA.	zsmith@ucdavis.edu; swachsmann@ucdavis.edu	Smith, Zachary/S-2211-2019; Smith, Zachary/K-6888-2016	Smith, Zachary/0000-0002-7946-7863; 	Center for Biophotonics Science and Technology;  [PHY0120999]	Center for Biophotonics Science and Technology; 	This work was supported by the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center managed by the University of California Davis, under Cooperative Agreement No. PHY0120999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322, DOI 10.1093/ajcp/80.3.322; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; GREEN R, 1989, BLOOD CELLS, V15, P481; Hammer M, 1998, APPL OPTICS, V37, P7410, DOI 10.1364/AO.37.007410; KIM YR, 1983, CYTOMETRY, V3, P419, DOI 10.1002/cyto.990030606; LATIMER P, 1968, J COLLOID INTERF SCI, V27, P475, DOI 10.1016/0021-9797(68)90184-7; LIN SHC, 1971, BIOCHEMISTRY-US, V10, P4788, DOI 10.1021/bi00801a029; Michalski MC, 2002, LAIT, V82, P193, DOI 10.1051/lait:2002004; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Paquin P, 1999, INT DAIRY J, V9, P329, DOI 10.1016/S0958-6946(99)00083-7; Pasternack RM, 2011, CYTOM PART A, V79A, P137, DOI 10.1002/cyto.a.21011; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Smith ZJ, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3124797; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; Wax A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2102767; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; Wilson JD, 2007, THESIS U ROCHESTER; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a	21	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46030	10.1371/journal.pone.0046030	http://dx.doi.org/10.1371/journal.pone.0046030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056228	Green Submitted, Green Published, gold			2022-12-25	WOS:000309452600021
J	de Jager, CPC; Wever, PC; Gemen, EFA; Kusters, R; van Gageldonk-Lafeber, AB; van der Poll, T; Laheij, RJF				de Jager, Cornelis P. C.; Wever, Peter C.; Gemen, Eugenie F. A.; Kusters, Ron; van Gageldonk-Lafeber, Arianne B.; van der Poll, Tom; Laheij, Robert J. F.			The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							SEPTIC SHOCK; PREOPERATIVE NEUTROPHIL; PROGNOSTIC ACCURACY; BIOMARKERS; LYMPHOPENIA; BACTEREMIA; APOPTOSIS; SEVERITY; MARKERS; SEPSIS	Study Objective: The neutrophil-lymphocyte count ratio (NLCR) has been identified as a predictor of bacteremia in medical emergencies. The aim of this study was to investigate the value of the NLCR in patients with community-acquired pneumonia (CAP). Methods and Results: Consecutive adult patients were prospectively studied. Pneumonia severity (CURB-65 score), clinical characteristics, complications and outcomes were related to the NLCR and compared with C-reactive protein (CRP), neutrophil count, white blood cell (WBC) count. The study cohort consisted of 395 patients diagnosed with CAP. The mean age of the patients was 63.4 +/- 16.0 years. 87.6% (346/395) of the patients required hospital admission, 7.8% (31/395) patients were admitted to the Intensive Care Unit (ICU) and 5.8% (23/395) patients of the study cohort died. The NLCR was increased in all patients, predicted adverse medical outcome and consistently increased as the CURB-65 score advanced. NLCR levels (mean +/- SD) were significantly higher in non-survivors (23.3 +/- 16.8) than in survivors (13.0 +/- 11.4). The receiver-operating characteristic (ROC) curve for NLCR predicting mortality showed an area under the curve (AUC) of 0.701. This was better than the AUC for the neutrophil count, WBC count, lymphocyte count and CRP level (0.681, 0.672, 0.630 and 0.565, respectively). Conclusion: Admission NLCR at the emergency department predicts severity and outcome of CAP with a higher prognostic accuracy as compared with traditional infection markers.	[de Jager, Cornelis P. C.; Laheij, Robert J. F.] Jeroen Bosch Ziekenhuis, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands; [Wever, Peter C.] Jeroen Bosch Ziekenhuis, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Gemen, Eugenie F. A.; Kusters, Ron] Jeroen Bosch Ziekenhuis, Dept Clin Chem & Hematol, sHertogenbosch, Netherlands; [van Gageldonk-Lafeber, Arianne B.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1012 WX Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands; [Laheij, Robert J. F.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	de Jager, CPC (corresponding author), Jeroen Bosch Ziekenhuis, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands.	p.de.jager@jbz.nl						Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Adams Nicholas G, 2005, Emerg Med Australas, V17, P371, DOI 10.1111/j.1742-6723.2005.00759.x; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Blasi F, 2012, EUR J INTERN MED, V23, P429, DOI 10.1016/j.ejim.2012.05.002; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Chalupa P, 2011, INFECTION, V39, P411, DOI 10.1007/s15010-011-0126-4; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; de Wit NCJ, 2009, CLIN CHEM LAB MED, V47, P1407, DOI 10.1515/CCLM.2009.307; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Fantin B, 1996, CLIN INFECT DIS, V22, P1096, DOI 10.1093/clinids/22.6.1096; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P322, DOI 10.1111/j.1469-0691.2007.01915.x; Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043; GOODMAN DA, 1995, AM SURGEON, V61, P257; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Heyland DK, 2011, CRIT CARE MED, V39, P1792, DOI 10.1097/CCM.0b013e31821201a5; Huehnergarth KV, 2005, AM J CARDIOL, V95, P1492, DOI 10.1016/j.amjcard.2005.02.022; Jilma B, 1999, AM J RESP CRIT CARE, V159, P857, DOI 10.1164/ajrccm.159.3.9805087; Joshi VD, 2003, FEBS LETT, V555, P180, DOI 10.1016/S0014-5793(03)01271-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez R, 2011, EUR RESPIR J, V37, P393, DOI 10.1183/09031936.00040710; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; WILLIAMS RC, 1983, AM J MED, V75, P807, DOI 10.1016/0002-9343(83)90412-6; Wyllie DH, 2005, J CLIN PATHOL, V58, P352, DOI 10.1136/jcp.2004.022293; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	44	182	186	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46561	10.1371/journal.pone.0046561	http://dx.doi.org/10.1371/journal.pone.0046561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049706	gold, Green Published			2022-12-25	WOS:000309388500033
J	Huse, K; Bakkebo, M; Walchli, S; Oksvold, MP; Hilden, VI; Forfang, L; Bredahl, ML; Liestol, K; Alizadeh, AA; Smeland, EB; Myklebust, JH				Huse, Kanutte; Bakkebo, Maren; Walchli, Sebastien; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Liestol, Knut; Alizadeh, Ash A.; Smeland, Erlend B.; Myklebust, June H.			Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; RECEPTOR-TYPE-II; UP-REGULATION; EXPRESSION; APOPTOSIS; CANCER; PATHWAY; PROLIFERATION; MICRORNA-155; NETWORKS	Bone morphogenetic protein (BMP) expression and signaling are altered in a variety of cancers, but the functional impact of these alterations is uncertain. In this study we investigated the impact of expression of multiple BMPs and their signaling pathway components in human B-cell lymphoma. BMP messages, in particular BMP7, were detected in normal and malignant B cells. Addition of exogenous BMPs inhibited DNA synthesis in most lymphoma cell lines examined, but some cell lines were resistant. Tumor specimens from three out of five lymphoma patients were also resistant to BMPs, as determined by no activation of the BMP effectors Smad1/5/8. We have previously shown that BMP-7 potently induced apoptosis in normal B cells, which was in contrast to no or little inhibitory effect of this BMP in the lymphoma cells tested. BMP-resistance mechanisms were investigated by comparing sensitive and resistant cell lines. While BMP receptors are downregulated in many cancers, we documented similar receptor levels in resistant and sensitive lymphoma cells. We found a positive correlation between activation of Smad1/5/8 and inhibition of DNA synthesis. Gene expression analysis of two independent data sets showed that the levels of inhibitory Smads varied across different B-cell lymphoma. Furthermore, stable overexpression of Smad7 in two different BMP-sensitive cell lines with low endogenous levels of SMAD7, rendered them completely resistant to BMPs. This work highlights the role of Smads in determining the sensitivity to BMPs and shows that upregulation of Smad7 in cancer cells is sufficient to escape the negative effects of BMPs.	[Huse, Kanutte; Bakkebo, Maren; Walchli, Sebastien; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Smeland, Erlend B.; Myklebust, June H.] Oslo Univ Hosp, Immunol Sect, Oslo, Norway; [Huse, Kanutte; Bakkebo, Maren; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Liestol, Knut; Smeland, Erlend B.; Myklebust, June H.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of Oslo; University of Oslo; University of Oslo; Stanford University	Huse, K (corresponding author), Oslo Univ Hosp, Immunol Sect, Oslo, Norway.	kanutte.huse@rr-research.no	Alizadeh, Ash A/C-5594-2009; Myklebust, June Helen/ABH-6494-2020; Smeland, Erlend/AAO-3214-2020	Alizadeh, Ash A/0000-0002-5153-5625; Myklebust, June Helen/0000-0003-0394-9986; Walchli, Sebastien/0000-0001-5869-1746; Huse, Kanutte/0000-0001-9128-670X	The Norwegian Cancer Society; The Research Council of Norway; South-Eastern Norway Regional Health Authority	The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); The Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	KH and JHM were supported by fellowships from The Norwegian Cancer Society, and this work has been supported by The Research Council of Norway and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Choi YS, 1997, IMMUNOL RES, V16, P161, DOI 10.1007/BF02786360; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daibata M, 2007, CLIN CANCER RES, V13, P3528, DOI 10.1158/1078-0432.CCR-06-2766; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Grcevic D, 2010, LEUKEMIA RES, V34, P742, DOI 10.1016/j.leukres.2009.10.016; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Ide H, 1997, CANCER RES, V57, P5022; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Kim IY, 2006, CANCER LETT, V241, P118, DOI 10.1016/j.canlet.2005.10.009; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; Kim IY, 2003, CLIN CANCER RES, V9, P6046; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kim YH, 2004, ANN ONCOL, V15, P574, DOI 10.1093/annonc/mdh131; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kleeff J, 1999, BIOCHEM BIOPH RES CO, V255, P268, DOI 10.1006/bbrc.1999.0171; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Levy L, 2002, CYTOKINE GROWTH F R, V17, P41; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Torlakovic E, 2005, J PATHOL, V206, P312, DOI 10.1002/path.1777; Tsalavos S, 2011, J IMMUNOL, V186, P6860, DOI 10.4049/jimmunol.1001833; VARAS A, 2009, INMUNOLOGIA, V28, P125; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	55	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46117	10.1371/journal.pone.0046117	http://dx.doi.org/10.1371/journal.pone.0046117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049692	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388500019
J	Garrido, I; Garcia-Sanchez, M; Casimiro, I; Casero, PJ; Garcia-Romera, I; Ocampo, JA; Espinosa, F				Garrido, Inmaculada; Garcia-Sanchez, Mercedes; Casimiro, Ilda; Joaquin Casero, Pedro; Garcia-Romera, Inmaculada; Antonio Ocampo, Juan; Espinosa, Francisco			Oxidative Stress Induced in Sunflower Seedling Roots by Aqueous Dry Olive-Mill Residues	PLOS ONE			English	Article							PROTEIN OXIDATION; PROLINE ACCUMULATION; SUPEROXIDE DISMUTASE; ANTIOXIDANT CAPACITY; LIPID-PEROXIDATION; GROWTH-INHIBITION; WASTE-WATER; OXYGEN; CUCUMBER; PLANTS	The contamination of soils with dry olive-mill residue can represent a serious problem as being an environmental stressor in plants. It has been demonstrated that inoculation of aqueous extract of olive oil-mill residue (ADOR) with saprobe fungi removes some phenolic compounds. In this paper we studied the effect of ADOR uninoculated or inoculated with saprobe fungi in sunflower seedling roots. The germination and root growth, O2 center dot(-) generation, superoxide dismutase (SOD) and extracellular peroxidases (EC-POXs) activities, and the content of some metabolites involved in the tolerance of stress were tested. The roots germinated in ADOR uninoculated show a decrease in meristem size, resulting in a reduction of the root length and fresh weight, and in the number of layers forming the cortex, but did not alter the dry weight, protein and soluble amino acid content. ADOR caused the decreases in O2 center dot(-) generation and EC-POX's activities and protein oxidation, but enhanced SOD activity, lipid peroxidation and proline content. Fluorescence imaging showed that ADOR induced O2 center dot(-) and H2O2 accumulation in the roots. The increase in SOD and the decrease in EC-POX's activities might be involved in the enhancement of H2O2 content and lipid peroxidation. Control roots treated with ADOR for 10 min show an oxidative burst. Roots germinated in ADOR inoculated with saprobe fungi partially recovered normal levels of ROS, morphological characteristics and antioxidant activities. These results suggested that treatment with ADOR caused a phytotoxic effect during germination inducing an oxidative stress. The inoculation of ADOR with saprobe fungi limited the stress.	[Garrido, Inmaculada; Espinosa, Francisco] Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain; [Garcia-Sanchez, Mercedes; Garcia-Romera, Inmaculada; Antonio Ocampo, Juan] CSIC, Dept Microorganismos Rizosfer Promotores Crecimie, Estac Expt Zaidin, Granada, Spain; [Casimiro, Ilda; Joaquin Casero, Pedro] Univ Extremadura, Dept Anat Biol Celular & Zool, Badajoz, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad de Extremadura	Garrido, I (corresponding author), Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain.	igarridoc@unex.es	García Sánchez, Mercedes/AAA-2411-2022; Romera, Inmaculada García/L-1204-2014; Espinosa, Francisco/I-8205-2018; Casimiro, Ilda/R-3506-2019; Mercedes, Garcia Sanchez/AAA-9813-2021; Ocampo, Juan Antonio/K-7565-2014	García Sánchez, Mercedes/0000-0001-5967-4091; Romera, Inmaculada García/0000-0001-6351-1885; Espinosa, Francisco/0000-0002-6467-0359; GARRIDO CARBALLO, INMACULADA/0000-0002-2367-0985	regional government of Extremadura [GR10084]	regional government of Extremadura	This research was supported by the regional government of Extremadura (GR10084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda E, 2006, INT BIODETER BIODEGR, V58, P176, DOI 10.1016/j.ibiod.2006.06.006; Aranda E, 2007, CHEMOSPHERE, V66, P67, DOI 10.1016/j.chemosphere.2006.05.021; Aranda E, 2004, APPL MICROBIOL BIOT, V64, P132, DOI 10.1007/s00253-003-1368-6; Arbona V, 2008, PHYSIOL PLANTARUM, V132, P452, DOI 10.1111/j.1399-3054.2007.01029.x; AUH CK, 1995, PLANT PHYSIOL, V107, P1241, DOI 10.1104/pp.107.4.1241; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Blum U, 2005, J CHEM ECOL, V31, P1907, DOI 10.1007/s10886-005-5934-5; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Burgos NR, 2004, J CHEM ECOL, V30, P671, DOI 10.1023/B:JOEC.0000018637.94002.ba; Christensen JH, 1998, PLANT PHYSIOL, V118, P125, DOI 10.1104/pp.118.1.125; D'Annibale A, 2004, CHEMOSPHERE, V54, P887, DOI 10.1016/j.chemosphere.2003.10.010; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Denisov E.T., 2005, OXIDATION ANTIOXIDAN, DOI 10.1021/ja059854f; Diaz R, 2010, APPL MICROBIOL BIOT, V88, P133, DOI 10.1007/s00253-010-2723-z; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doblinski PMF, 2003, BRAZ ARCH BIOL TECHN, V46, P193, DOI 10.1590/S1516-89132003000200009; Fabro G, 2004, MOL PLANT MICROBE IN, V17, P343, DOI 10.1094/MPMI.2004.17.4.343; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Garrido I, 1998, PROTOPLASMA, V205, P141, DOI 10.1007/BF01279304; Hajdari A, 2010, ACTA HORTIC, V860, P75; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hernandez-Mata G, 2010, J PLANT GROWTH REGUL, V29, P441, DOI 10.1007/s00344-010-9156-x; Hossain Z, 2006, FUNCT PLANT BIOL, V33, P91, DOI 10.1071/FP05149; Hossain Z, 2009, J PLANT PHYSIOL, V166, P1391, DOI 10.1016/j.jplph.2009.02.012; Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Zanardo DIL, 2009, ENVIRON EXP BOT, V66, P25, DOI 10.1016/j.envexpbot.2008.12.014; Ma BH, 2007, PLANT GROWTH REGUL, V52, P91, DOI 10.1007/s10725-007-9183-1; Martin J, 2002, SOIL BIOL BIOCHEM, V34, P1769, DOI 10.1016/S0038-0717(02)00164-5; Mata Georgina Hernández, 2006, Braz. J. Plant Physiol., V18, P351, DOI 10.1590/S1677-04202006000200012; Matthaus B, 2002, J AGR FOOD CHEM, V50, P3444, DOI 10.1021/jf011440s; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mehta SK, 1999, NEW PHYTOL, V143, P253, DOI 10.1046/j.1469-8137.1999.00447.x; Mika Angela, 2004, Phytochemistry Reviews, V3, P173, DOI 10.1023/B:PHYT.0000047806.21626.49; MISRA HP, 1972, J BIOL CHEM, V247, P188; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; NGO TT, 1980, ANAL BIOCHEM, V105, P389, DOI 10.1016/0003-2697(80)90475-3; Paredes C, 2001, BIODEGRADATION, V12, P225, DOI 10.1023/A:1017374421565; Politycka B, 1996, ACTA PHYSIOL PLANT, V18, P365; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rios JJ, 2008, SCI HORTIC-AMSTERDAM, V116, P248, DOI 10.1016/j.scienta.2008.01.008; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Ruiz JM, 2003, INT J PHYTOREMEDIAT, V5, P203, DOI 10.1080/713779220; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sampedro I, 2004, APPL SOIL ECOL, V26, P149, DOI 10.1016/j.apsoil.2003.10.011; Schinkel H, 1998, J EXP BOT, V49, P931, DOI 10.1093/jexbot/49.323.931; Sgherri C, 2007, J PLANT PHYSIOL, V164, P1152, DOI 10.1016/j.jplph.2006.05.020; Sgobba A, 2011, 10 INT C REACT OX NI, P134; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tripathi BN, 2004, PLANTA, V219, P397, DOI 10.1007/s00425-004-1237-2; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Wang FJ, 2009, ARCH ENVIRON CON TOX, V56, P723, DOI 10.1007/s00244-008-9226-2; Yang SL, 2009, J PLANT PHYSIOL, V166, P1694, DOI 10.1016/j.jplph.2009.04.006; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Zeng Bin, 2008, Acta Agronomica Sinica, V34, P823, DOI 10.3724/SP.J.1006.2008.00823	75	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46137	10.1371/journal.pone.0046137	http://dx.doi.org/10.1371/journal.pone.0046137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049960	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300089
J	Hussain, RS; McGarvey, ST; Shahab, T; Fruzzetti, LM				Hussain, Rashid S.; McGarvey, Stephen T.; Shahab, Tabassam; Fruzzetti, Lina M.			Fatigue and Fear with Shifting Polio Eradication Strategies in India: A Study of Social Resistance to Vaccination	PLOS ONE			English	Article							HIGH-RISK DISTRICTS; PARALYTIC POLIO; ENDGAME	Shifting polio eradication strategies may have generated fear and "resistance" to the eradication program in Aligarh, India during the summer of 2009. Participant observation and formal interviews with 107 people from May to August 2009 indicated that the intensified frequency of vaccination was correlated with patients' doubt in the efficacy of the vaccine. This doubt was exacerbated in a few cases as families were uninformed of the use of monovalent mOPV1, while P3 cases continued to occur. Many families had also come to believe that their children had been adversely affected by OPV after being told the vaccine carried no risk. Though polio is now largely eradicated in India, with only a single case in 2011, greater transparency about changes with vaccination policy may need to be considered to build trust with the public in future eradication programs.	[Hussain, Rashid S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA; [Shahab, Tabassam] Jawaharlal Nehru Med Coll, Dept Paediat, Aligarh, Uttar Pradesh, India; [Fruzzetti, Lina M.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA	Brown University; Brown University; Aligarh Muslim University; Brown University	Hussain, RS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Rashid_Hussain@brown.edu	McGarvey, Stephen T/I-1788-2014	McGarvey, Stephen T/0000-0003-1233-6970	Watson Institute for International Studies' Brown International Scholars Program	Watson Institute for International Studies' Brown International Scholars Program	This project was made possible by funding from the Watson Institute for International Studies' Brown International Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligarh Muslim University, 2004, POL ER PROGR COLL EF; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; [Anonymous], 1996, MMWR, V6, P1; [Anonymous], 2003, TIMES INDIA; Ansari MA, 2007, J R SOC PROMO HEALTH, V127, P276, DOI 10.1177/1466424007083705; Bodenheimer T, 2008, UNDERSTANDING HLTH P; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; C Chaturvedi G., 2008, VITAL DROP COMMUNICA; Chaturvedi G, 2006, BUILDING COMMUNICATI; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Das J, 2003, SOC SCI MED, V57, P97, DOI 10.1016/S0277-9536(02)00302-7; Dasgupta R, 2008, INDIAN PEDIATR, V45, P357; Friedman AL, 2007, HEALTH EDUC BEHAV, V34, P471, DOI 10.1177/1090198106292022; Global Polio Eradication Initiative, 2010, GPEI PROGR WORK 2010; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Harris KJ, 1997, HUM ORGAN, V56, P375, DOI 10.17730/humo.56.3.w525025611458003; John TJ, 2000, NEW ENGL J MED, V343, P806, DOI 10.1056/NEJM200009143431111; John TJ, 2002, B WORLD HEALTH ORGAN, V80, P917; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kishore J, 2003, NATL MED J INDIA, V16, P131; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P987; Mittal SK, 2007, INDIAN J PEDIATR, V74, P153, DOI 10.1007/s12098-007-0009-y; Mukherji S, 2005, Med J Armed Forces India, V61, P364, DOI 10.1016/S0377-1237(05)80069-3; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367; Paul Y, 2005, BIOETHICS, V19, P393, DOI 10.1111/j.1467-8519.2005.00451.x; Paul Yash, 2005, Indian J Med Ethics, V2, P115; Roberts L, 2007, SCIENCE, V316, P362, DOI 10.1126/science.316.5823.362; Sathyamala C, 2005, INT J HEALTH SERV, V35, P361, DOI 10.2190/K882-9792-3QYX-JKTD; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; The World Health Organization and the Government of India, 2011, NAT POL SURV PROJ	37	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46274	10.1371/journal.pone.0046274	http://dx.doi.org/10.1371/journal.pone.0046274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23050003	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300102
J	Jenkins, R; Cooper, R				Jenkins, Rowena; Cooper, Rose			Improving Antibiotic Activity against Wound Pathogens with Manuka Honey In Vitro	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERIAL-RESISTANCE; COMBINATIONS; INFECTIONS; INHIBITION; DRUGS; ACID	Following the discovery of synergistic action between oxacillin and manuka honey against methicillin-resistant Staphylococcus aureus, this study was undertaken to search for further synergistic combinations of antibiotics and honey that might have potential in treating wounds. Fifteen antibiotics were tested with and without sublethal concentrations of manuka honey against each of MRSA and Pseudomonas aeruginosa using disc diffusion, broth dilution, E strip, chequerboard titration and growth curves. Five novel antibiotic and manuka honey combinations were found that improved antibacterial effectiveness in vitro and these offer a new avenue of future topical treatments for wound infections caused by these two important pathogens.	[Jenkins, Rowena; Cooper, Rose] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Ctr Biomed Sci, Cardiff, S Glam, Wales	Cardiff Metropolitan University; Cardiff University	Jenkins, R (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Ctr Biomed Sci, Cardiff, S Glam, Wales.	rojenkins@cardiffmet.ac.uk		Jenkins, Rowena/0000-0001-6664-6099	Waterloo Foundation [1117535]; Sir Halley Stewart trust [208491]	Waterloo Foundation; Sir Halley Stewart trust	Funding was provided by the Waterloo Foundation (Charity number 1117535) (http://www.waterloofoundation.org.uk/) and the Sir Halley Stewart trust (Charity number 208491) (http://www.sirhalleystewart.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jabri AA, 2005, SAUDI MED J, V26, P767; Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cooper RA, 2010, EUR J CLIN MICROBIOL, V29, P1237, DOI 10.1007/s10096-010-0992-1; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Gibbons S, 2008, PLANTA MED, V74, P594, DOI 10.1055/s-2008-1074518; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Henriques AF, 2010, EUR J CLIN MICROBIOL, V29, P45, DOI 10.1007/s10096-009-0817-2; Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; Jayaraman P, 2010, INT J BIOL SCI, V6, P556; Jenkins R, 2011, INT J ANTIMICROB AG, V37, P373, DOI 10.1016/j.ijantimicag.2010.11.036; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Karayil S, 1998, J Postgrad Med, V44, P93; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Lee JW, 2007, J MICROBIOL, V45, P350; Mendoza N, 2010, EXPERT OPIN EMERG DR, V15, P509, DOI 10.1517/14728214.2010.497486; Mukherjee S, 2011, INDIAN J EXP BIOL, V49, P547; Natarajan S, 2001, J DERMATOL TREAT, V12, P33, DOI 10.1080/095466301750163563; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Rahal JJ, 2006, CLIN INFECT DIS, V43, pS95, DOI 10.1086/504486; SUZUKI T, 1963, J BIOCHEM-TOKYO, V54, P25, DOI 10.1093/oxfordjournals.jbchem.a127742; Tiwari RP, 2005, INDIAN J MED RES, V122, P80; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016	30	55	56	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45600	10.1371/journal.pone.0045600	http://dx.doi.org/10.1371/journal.pone.0045600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049822	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300038
J	Akdogan, Y; Reichenwallner, J; Hinderberger, D				Akdogan, Yasar; Reichenwallner, Joerg; Hinderberger, Dariush			Evidence for Water-Tuned Structural Differences in Proteins: An Approach Emphasizing Variations in Local Hydrophilicity	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; FATTY-ACIDS; CONFORMATIONAL-CHANGES; MEMBRANE-PROTEINS; LIGAND-BINDING; HYDROPHOBICITY; SEQUENCE; CRYSTAL; NMR; CALMODULIN	We present experimental evidence for the significant effect that water can have on the functional structure of proteins in solution. Human (HSA) and Bovine Serum Albumin (BSA) have an amino acid sequence identity of 75.52% and are chosen as model proteins. We employ EPR-based nanoscale distance measurements using double electron-electron resonance (DEER) spectroscopy and both albumins loaded with long chain fatty acids (FAs) in solution to globally (yet indirectly) characterize the tertiary protein structures from the bound ligands' points of view. The complete primary structures and crystal structures of HSA and as of recently also BSA are available. We complement the picture as we have recently determined the DEER-derived solution structure of HSA and here present the corresponding BSA solution structure. The characteristic asymmetric FA distribution in the crystal structure of HSA can surprisingly be observed by DEER in BSA in solution. This indicates that the BSA conformational ensemble in solution seems to be narrow and close to the crystal structure of HSA. In contrast, for HSA in solution a much more symmetric FA distribution was found. Thus, conformational adaptability and flexibility dominate in the HSA solution structure while BSA seems to lack these properties. We further show that differences in amino acid hydropathies of specific structural regions in both proteins can be used to correlate the observed difference in the global (tertiary) solution structures with the differences on the primary structure level.	[Akdogan, Yasar; Reichenwallner, Joerg; Hinderberger, Dariush] Max Planck Inst Polymer Res, Mainz, Germany; [Reichenwallner, Joerg] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany	Max Planck Society; Johannes Gutenberg University of Mainz	Hinderberger, D (corresponding author), Max Planck Inst Polymer Res, Mainz, Germany.	dariush.hinderberger@mpip-mainz.mpg.de	Hinderberger, Dariush/B-7865-2008	Reichenwallner, Jorg/0000-0002-6862-1802; Akdogan, Yasar/0000-0002-2465-8873	Max Planck Society; Max Planck Graduate Center; University of Mainz (MPGC)	Max Planck Society(Max Planck Society); Max Planck Graduate Center(Max Planck Society); University of Mainz (MPGC)	This work was funded by the Max Planck Society (www.mpg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christian Bauer for technical support, Prof. Hans W. Spiess for continuing support, and Prof. Wolfgang E. Trommer for helpful discussions and comments. D.H. acknowledges support by the Max Planck Graduate Center with the University of Mainz (MPGC).	Akdogan Y, 2011, J PHYS CHEM B, V115, P15422, DOI 10.1021/jp209646f; Akdogan Y, 2011, BIOMACROMOLECULES, V12, P1072, DOI 10.1021/bm1014156; ATKINS P, 2001, PHYS CHEM; Ben-Naim A, 2008, PHYS CHEM CHEM PHYS, V10, P2451, DOI 10.1039/b716116f; Ben-Naim A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2205860; Ben-Naim A, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976442; BENNAIM A, 1994, CURR OPIN STRUC BIOL, V4, P264, DOI 10.1016/S0959-440X(94)90318-2; Berg J.M., 2011, BIOCHEMIE; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; Bird GH, 2008, ACS NANO, V2, P1857, DOI 10.1021/nn800327g; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Hanelt I, 2010, J BIOL CHEM, V285, P28210, DOI 10.1074/jbc.M110.139311; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; Heller J, 2010, J PHYS CHEM B, V114, P7429, DOI 10.1021/jp910335t; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Inouye H, 2000, J MOL BIOL, V300, P1283, DOI 10.1006/jmbi.2000.3926; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Junk MJN, 2011, BIOPHYS J, V100, P2293, DOI 10.1016/j.bpj.2011.03.050; Junk MJN, 2011, J MAGN RESON, V210, P210, DOI 10.1016/j.jmr.2011.03.003; Junk MJN, 2010, ANGEW CHEM INT EDIT, V49, P8755, DOI 10.1002/anie.201003495; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kim M, 2008, BIOCHEMISTRY-US, V47, P670, DOI 10.1021/bi7016415; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Naderi-Manesh H, 2001, PROTEINS, V42, P452, DOI 10.1002/1097-0134(20010301)42:4<452::AID-PROT40>3.0.CO;2-Q; Nelson D, 2009, BIOCHEMIE; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Patel AJ, 2012, J PHYS CHEM B, V116, P2498, DOI 10.1021/jp2107523; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TANFORD C, 1956, J PHYS CHEM-US, V60, P225, DOI 10.1021/j150536a020; Trivedi VD, 1997, BIOCHEM MOL BIOL INT, V43, P1; WATKINS S, 1993, P NATL ACAD SCI USA, V90, P2409, DOI 10.1073/pnas.90.6.2409	56	59	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45681	10.1371/journal.pone.0045681	http://dx.doi.org/10.1371/journal.pone.0045681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049837	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100067
J	Fox, KCR; Zakarauskas, P; Dixon, M; Ellamil, M; Thompson, E; Christoff, K				Fox, Kieran C. R.; Zakarauskas, Pierre; Dixon, Matt; Ellamil, Melissa; Thompson, Evan; Christoff, Kalina			Meditation Experience Predicts Introspective Accuracy	PLOS ONE			English	Article							EVOKED-POTENTIALS; CEREBRAL-CORTEX; BRAIN DYNAMICS; REPRESENTATION; PRACTITIONERS; ORGANIZATION; AWARENESS; ACUITY; MOTOR	The accuracy of subjective reports, especially those involving introspection of one's own internal processes, remains unclear, and research has demonstrated large individual differences in introspective accuracy. It has been hypothesized that introspective accuracy may be heightened in persons who engage in meditation practices, due to the highly introspective nature of such practices. We undertook a preliminary exploration of this hypothesis, examining introspective accuracy in a cross-section of meditation practitioners (1-15,000 hrs experience). Introspective accuracy was assessed by comparing subjective reports of tactile sensitivity for each of 20 body regions during a 'body-scanning' meditation with averaged, objective measures of tactile sensitivity (mean size of body representation area in primary somatosensory cortex; two-point discrimination threshold) as reported in prior research. Expert meditators showed significantly better introspective accuracy than novices; overall meditation experience also significantly predicted individual introspective accuracy. These results suggest that long-term meditators provide more accurate introspective reports than novices.	[Fox, Kieran C. R.; Dixon, Matt; Ellamil, Melissa; Christoff, Kalina] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Zakarauskas, Pierre; Christoff, Kalina] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Thompson, Evan] Univ Toronto, Dept Philosophy, Toronto, ON M5S 1A1, Canada	University of British Columbia; University of British Columbia; University of Toronto	Fox, KCR (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	kfox@psych.ubc.ca		Thompson, Evan/0000-0003-0084-8477; Dixon, Matthew/0000-0001-8033-8113	Hampton Research Endowment Fund [F08-05696]; UBC	Hampton Research Endowment Fund; UBC	This research was supported in part by Hampton Research Endowment Fund grant F08-05696 to Kalina Christoff and a UBC First-Year Fellowship to Kieran Fox. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analayo B., 2003, SATIPATTHANA DIRECT; CELESIA GG, 1979, ARCH NEUROL-CHICAGO, V36, P399, DOI 10.1001/archneur.1979.00500430029003; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corallo G, 2008, PSYCHOL SCI, V19, P1110, DOI 10.1111/j.1467-9280.2008.02211.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; FREDRICK WC, 1980, J EDUC RES, V73, P183, DOI 10.1080/00220671.1980.10885233; Goenka S.N., 2000, DISCOURSE SUMMARIES; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Jack AI, 2002, TRENDS COGN SCI, V6, P333, DOI 10.1016/S1364-6613(02)01941-1; James W, 1890, PRINCIPLES PSYCHOL, V1; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kabat-Zinn J., 1994, MINDFULNESS MEDITATI; Kerr CE, 2008, EXP BRAIN RES, V188, P317, DOI 10.1007/s00221-008-1409-6; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; KNIBESTOL M, 1980, J PHYSIOL-LONDON, V300, P251, DOI 10.1113/jphysiol.1980.sp013160; Kozhevnikov M, 2009, PSYCHOL SCI, V20, P645, DOI 10.1111/j.1467-9280.2009.02345.x; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lutz A, 2003, J CONSCIOUSNESS STUD, V10, P31; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Michael GA, 2011, CONSCIOUS COGN, V20, P603, DOI 10.1016/j.concog.2010.11.013; Nielsen L, 2006, EMOTION, V6, P392, DOI 10.1037/1528-3542.6.3.392; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pantev C, 2001, ANN NY ACAD SCI, V930, P300, DOI 10.1111/j.1749-6632.2001.tb05740.x; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Weber EH., 1978, EH WEBER SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195; WOOLSEY CN, 1979, J NEUROSURG, V51, P476, DOI 10.3171/jns.1979.51.4.0476	47	103	103	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45370	10.1371/journal.pone.0045370	http://dx.doi.org/10.1371/journal.pone.0045370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049790	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100041
J	Gienapp, P; Bregnballe, T				Gienapp, Phillip; Bregnballe, Thomas			Fitness Consequences of Timing of Migration and Breeding in Cormorants	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; TIT PARUS-MAJOR; GREAT TIT; REPRODUCTIVE SUCCESS; CLIMATE-CHANGE; CLUTCH-SIZE; TROPHIC INTERACTIONS; CAUSAL RELATIONSHIP; NATURAL-SELECTION; SEASONAL DECLINE	In most bird species timing of breeding affects reproductive success whereby early breeding is favoured. In migratory species migration time, especially arrival at the breeding grounds, and breeding time are expected to be correlated. Consequently, migration time should also have fitness consequences. However, in contrast to breeding time, evidence for fitness consequences of migration time is much more limited. Climate change has been shown to negatively affect the synchrony between trophic levels thereby leading to directional selection on timing but again direct evidence in avian migration time is scarce. We here analysed fitness consequences of migration and breeding time in great cormorants and tested whether climate change has led to increased selection on timing using a long-term data set from a breeding colony on the island of Vorso (Denmark). Reproductive success, measured as number of fledglings, correlated with breeding time and arrival time at the colony and declined during the season. This seasonal decline became steeper during the study period for both migration and breeding time and was positively correlated to winter/spring climate, i.e. selection was stronger after warmer winters/springs. However, the increasing selection pressure on timing seems to be unrelated to climate change as the climatic variables that were related to selection strength did not increase during the study period. There is indirect evidence that phenology or abundances of preferred prey species have changed which could have altered selection on timing of migration and breeding.	[Gienapp, Phillip] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Bregnballe, Thomas] Aarhus Univ, Dept Biosci, Ronde, Denmark	University of Helsinki; Aarhus University	Gienapp, P (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	p.gienapp@nioo.knaw.nl	Bregnballe, Thomas/L-1890-2013; Gienapp, Phillip/A-2261-2014	Bregnballe, Thomas/0000-0003-2867-478X; Gienapp, Phillip/0000-0002-9368-8769	Ministry of Environment and Aarhus University; Academy of Finland	Ministry of Environment and Aarhus University; Academy of Finland(Academy of Finland)	The long-term study was financed by grants from the Ministry of Environment and Aarhus University. PG was supported by a grant from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERG R, 1985, J FISH BIOL, V26, P537, DOI 10.1111/j.1095-8649.1985.tb04294.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bregnballe T, 1997, BIRD STUDY, V44, P257, DOI 10.1080/00063659709461062; Bregnballe T, 1996, REPROD PERFORMANCE G; Bregnballe T, 2011, 7 INT C CORM, P8; Bregnballe Thomas, 1996, Dansk Ornitologisk Forenings Tidsskrift, V90, P15; Bregnballe T, 2006, ARDEA, V94, P619; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Brown CR, 1998, EVOLUTION, V52, P1461, DOI 10.1111/j.1558-5646.1998.tb02027.x; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Carscadden J, 1997, CAN J FISH AQUAT SCI, V54, P781, DOI 10.1139/cjfas-54-4-781; CRISTOL DA, 1995, BEHAV ECOL, V6, P87, DOI 10.1093/beheco/6.1.87; DIRKSEN S, 1995, ARDEA, V83, P167; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Frederiksen M, 2002, WILDLIFE BIOL, V8, P241, DOI 10.2981/wlb.2002.021; Frederiksen M, 2001, P ROY SOC B-BIOL SCI, V268, P1519, DOI 10.1098/rspb.2001.1701; Frederiksen M, 2011, MAR ECOL PROG SER, V432, P137, DOI 10.3354/meps09177; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Gienapp P, 2006, EVOLUTION, V60, P2381; Harkonen T.J., 1986, GUIDE OTOLITHS BONY, P256; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Kalmbach E, 2001, WATERBIRDS, V24, P345, DOI 10.2307/1522064; Kato A, 2001, ECOL RES, V16, P745, DOI 10.1046/j.1440-1703.2001.00441.x; KLOMP H, 1970, ARDEA, V58, P1; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Moller AP, 2009, BEHAV ECOL, V20, P433, DOI 10.1093/beheco/arn142; Nehls George, 1997, Vogelwelt, V118, P33; Nur N, 1999, BIRD STUDY, V46, P92; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLATTEEUW M, 1995, ARDEA, V83, P223; PLATTEEUW M, 1995, ARDEA, V83, P235; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Saino N, 2010, P ROYAL S B IN PRESS; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Sheldon BC, 2003, EVOLUTION, V57, P406; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Suter W, 1997, ARDEA, V85, P9; van Rijn S., 2003, VOGELWELT, V124, P15; VANNOORDWIJK AJ, 1981, OECOLOGIA, V49, P158, DOI 10.1007/BF00349183; Verboven N, 2001, ARDEA, V89, P387; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	66	42	42	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46165	10.1371/journal.pone.0046165	http://dx.doi.org/10.1371/journal.pone.0046165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049966	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000309556100145
J	MacManes, MD; Lacey, EA				MacManes, Matthew D.; Lacey, Eileen A.			The Social Brain: Transcriptome Assembly and Characterization of the Hippocampus from a Social Subterranean Rodent, the Colonial Tuco-Tuco (Ctenomys sociabilis)	PLOS ONE			English	Article							GENE-EXPRESSION; SONG SPARROW; ALIGNMENT; BEHAVIOR; RECEPTOR; MICROSATELLITES; VOCALIZATIONS; CALCINEURIN; DIVERSITY; EVOLUTION	Elucidating the genetic mechanisms that underlie complex adaptive phenotypes is a central problem in evolutionary biology. For behavioral biologists, the ability to link variation in gene expression to the occurrence of specific behavioral traits has long been a largely unobtainable goal. Social interactions with conspecifics represent a fundamental component of the behavior of most animal species. Although several studies of mammals have attempted to uncover the genetic bases for social relationships using a candidate gene approach, none have attempted more comprehensive, transcriptome-based analyses using high throughout sequencing. As a first step toward improved understanding of the genetic underpinnings of mammalian sociality, we generated a reference transcriptome for the colonial tuco-tuco (Ctenomys sociabilis), a social species of subterranean rodent that is endemic to southwestern Argentina. Specifically, we analyzed over 500 million Illumina sequencing reads derived from the hippocampi of 10 colonial tuco-tucos housed in captivity under a variety of social conditions. The resulting reference transcriptome provides a critical tool for future studies aimed at exploring relationships between social environment and gene expression in this non-model species of social mammal.	[MacManes, Matthew D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Lacey, Eileen A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Lacey, Eileen A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	MacManes, MD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	macmanes@gmail.com	MacManes, Matthew/B-8303-2011	MacManes, Matthew/0000-0002-2368-6960	Museum of Vertebrate Zoology Directors Fund; National Institutes of Health NRSA Post-Doctoral fellowship; Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093227] Funding Source: NIH RePORTER	Museum of Vertebrate Zoology Directors Fund; National Institutes of Health NRSA Post-Doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Museum of Vertebrate Zoology Directors Fund. During all phases of the research, MDM was supported by a National Institutes of Health NRSA Post-Doctoral fellowship. Computational resources were supported by the Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight, which is supported by National Science Foundation grant number OCI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Beery AK, 2008, J COMP NEUROL, V507, P1847, DOI 10.1002/cne.21638; Bell AM, 2011, SCIENCE, V332, P1161, DOI 10.1126/science.1203295; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan YL, 2005, BIOL LETT-UK, V1, P423, DOI 10.1098/rsbl.2005.0354; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Drnevich JM, 2004, P ROY SOC B-BIOL SCI, V271, P2267, DOI 10.1098/rspb.2004.2880; Durbin R, 2009, BIOINFORMATICS; Ebensperger LA, 2008, BEHAV PROCESS, V79, P85, DOI 10.1016/j.beproc.2008.05.006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Fjerdingstad EJ, 2006, AM NAT, V167, P390, DOI 10.1086/499545; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Heckel G, 2008, PROG BRAIN RES, V170, P321, DOI 10.1016/S0079-6123(08)00426-3; Johnston M, 1998, CURR BIOL, V8, pR171, DOI 10.1016/S0960-9822(98)70103-4; Lacey EA, 1997, J MAMMAL, V78, P556, DOI 10.2307/1382907; Lacey EA, 2004, BEHAV ECOL, V15, P988, DOI 10.1093/beheco/arh104; Lacey EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P449, DOI 10.1007/s00265-004-0805-6; Lacey EA, 2003, J MAMMAL, V84, P1198, DOI 10.1644/BLe-014; Lacey EA, 1999, MOL ECOL, V8, P1754, DOI 10.1046/j.1365-294x.1999.00723-1.x; Lacey EA, 2001, HEREDITY, V86, P628, DOI 10.1046/j.1365-2540.2001.00881.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JI, 2004, MOL CELLS, V17, P390; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Miller Jim Wayne, 2010, GENOMICS, P1; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Suzuki G, 2009, HUM MOL GENET, V18, P1652, DOI 10.1093/hmg/ddp086; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wacker DW, 2010, J COMP NEUROL, V518, P3819, DOI 10.1002/cne.22426; WESTNEAT DF, 1993, BEHAV ECOL, V4, P49, DOI 10.1093/beheco/4.1.49; Whittington CM, 2009, J PROTEOMICS, V72, P155, DOI 10.1016/j.jprot.2008.12.004; Woodruff JA, 2010, J EXP ZOOL PART A, V313A, P498, DOI 10.1002/jez.621; Young LJ, 2007, TRENDS GENET, V23, P209, DOI 10.1016/j.tig.2007.02.010	59	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45524	10.1371/journal.pone.0045524	http://dx.doi.org/10.1371/journal.pone.0045524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049809	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100053
J	Remelli, W; Guerrieri, N; Klodmann, J; Papenbrock, J; Pagani, S; Forlani, F				Remelli, William; Guerrieri, Nicoletta; Klodmann, Jennifer; Papenbrock, Jutta; Pagani, Silvia; Forlani, Fabio			Involvement of the Azotobacter vinelandii Rhodanese-Like Protein RhdA in the Glutathione Regeneration Pathway	PLOS ONE			English	Article							OXIDATIVE STRESS; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; ESCHERICHIA-COLI; THIYL RADICALS; THIOREDOXIN; CYSTEINE; SULFUR; IDENTIFICATION; METABOLISM; ANTIOXIDANT	The phenotypic features of the Azotobacter vinelandii RhdA mutant MV474 (in which the rhdA gene was deleted) indicated that defects in antioxidant systems in this organism were related to the expression of the tandem-domain rhodanese RhdA. In this work, further insights on the effects of the oxidative imbalance generated by the absence of RhdA (e.g. increased levels of lipid hydroperoxides) are provided. Starting from the evidence that glutathione was depleted in MV474, and using both in silico and in vitro approaches, here we studied the interaction of wild-type RhdA and Cys(230) Ala site-directed RhdA mutant with glutathione species. We found that RhdA was able to bind in vitro reduced glutathione (GSH) and that RhdA-Cys(230) residue was mandatory for the complex formation. RhdA catalyzed glutathione-disulfide formation in the presence of a system generating the glutathione thiyl radical (GS(.), an oxidized form of GSH), thereby facilitating GSH regeneration. This reaction was negligible when the Cys230 Ala RhdA mutant was used. The efficiency of RhdA as catalyst in GS(.)-scavenging activity is discussed on the basis of the measured parameters of both interaction with glutathione species and kinetic studies.	[Remelli, William; Guerrieri, Nicoletta; Pagani, Silvia; Forlani, Fabio] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy; [Klodmann, Jennifer] Leibniz Univ Hannover, Inst Pflanzengenet, Hannover, Germany; [Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, Hannover, Germany	University of Milan; Leibniz University Hannover; Leibniz University Hannover	Forlani, F (corresponding author), Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy.	fabio.forlani@unimi.it	Forlani, Fabio/Y-4265-2019; Guerrieri, Nicoletta/B-1241-2012; Braun, Hans-Peter/E-7149-2011; Klodmann, Jennifer/B-2131-2013	Forlani, Fabio/0000-0001-9405-973X; Guerrieri, Nicoletta/0000-0003-3536-4886; Braun, Hans-Peter/0000-0002-4459-9727; Remelli, William/0000-0003-4992-0855; Senkler, Jennifer/0000-0002-1377-3841	Vigoni project [0815171]; Fondo interno ricerca scientifica e tecnologica	Vigoni project; Fondo interno ricerca scientifica e tecnologica	Mobility of researchers between Italy and Germany was sponsored by Vigoni project number 0815171 (2009-2010; and Ateneo Italo-Tedesco, Deutscher Akademischer Austausch Dienst) to FF and JP. SP was partially funded by "Fondo interno ricerca scientifica e tecnologica" (2007; Universita degli Studi di Milano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bordo D, 2000, J MOL BIOL, V298, P691, DOI 10.1006/jmbi.2000.3651; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Bordo' D, 2001, BIOL CHEM, V382, P1245, DOI 10.1515/BC.2001.155; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADSHAW TP, 1995, FREE RADICAL BIO MED, V18, P279, DOI 10.1016/0891-5849(94)E0136-7; Cartini F, 2011, AMINO ACIDS, V41, P141, DOI 10.1007/s00726-010-0529-z; Cereda A, 2007, FEBS LETT, V581, P1625, DOI 10.1016/j.febslet.2007.03.028; Cereda A, 2009, BIOCHEM J, V418, P135, DOI 10.1042/BJ20081218; Colnaghi R, 1996, EUR J BIOCHEM, V236, P240, DOI 10.1111/j.1432-1033.1996.00240.x; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Florczyk MA, 2001, INFECT IMMUN, V69, P5777, DOI 10.1128/IAI.69.9.5777-5785.2001; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Griffiths G, 2000, J EXP BOT, V51, P1363, DOI 10.1093/jexbot/51.349.1363; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Krivobok S, 2003, J BACTERIOL, V185, P3828, DOI 10.1128/JB.185.13.3828-3841.2003; KWAK HS, 1995, P NATL ACAD SCI USA, V92, P4582, DOI 10.1073/pnas.92.10.4582; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; NEWTON JW, 1953, J BIOL CHEM, V204, P445; Noguera V, 2005, J MOL BIOL, V353, P629, DOI 10.1016/j.jmb.2005.08.035; PAGANI S, 1984, EUR J BIOCHEM, V142, P361, DOI 10.1111/j.1432-1033.1984.tb08295.x; Pagani S, 2000, FEBS LETT, V472, P307, DOI 10.1016/S0014-5793(00)01477-0; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QUINTILIANI M, 1977, INT J RADIAT BIOL, V32, P195, DOI 10.1080/09553007714550891; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Remelli W, 2010, BIOL CHEM, V391, P777, DOI 10.1515/BC.2010.073; Riemenschneider A, 2005, PLANT PHYSIOL BIOCH, V43, P473, DOI 10.1016/j.plaphy.2005.04.001; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; SCHREIBER J, 1989, J BIOL CHEM, V264, P7936; SEVILLA MD, 1990, INT J RADIAT BIOL, V57, P65, DOI 10.1080/09553009014550351; Sipe HJ, 1997, DRUG METAB DISPOS, V25, P468; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Ward Paul, 1995, P1; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Zhao R, 1997, J CHEM SOC PERK T 2, P569, DOI 10.1039/a605727f	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45193	10.1371/journal.pone.0045193	http://dx.doi.org/10.1371/journal.pone.0045193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049775	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100031
J	Brambillasca, S; Altkrueger, A; Colombo, SF; Friederich, A; Eickelmann, P; Mark, M; Borgese, N; Solimena, M				Brambillasca, Silvia; Altkrueger, Anke; Colombo, Sara Francesca; Friederich, Anne; Eickelmann, Peter; Mark, Michael; Borgese, Nica; Solimena, Michele			CDK5 Regulatory Subunit-associated Protein 1-Like 1 (CDKAL1) Is a Tail-anchored Protein in the Endoplasmic Reticulum (ER) of Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEMBRANE-PROTEINS; GENE-EXPRESSION; SECRETION; INSERTION; ICA512; IDENTIFICATION; BIOSYNTHESIS; EXOCYTOSIS; PSORIASIS	Genome-wide association studies have led to the identification of numerous susceptibility genes for type 2 diabetes. Among them is Cdkal1, which is associated with reduced beta-cell function and insulin release. Recently, CDKAL1has been shown to be a methylthiotransferase that modifies tRNA(Lys) to enhance translational fidelity of transcripts, including the one encoding proinsulin. Here, we report that out of several CDKAL1 isoforms deposited in public databases, only isoform 1, which migrates as a 61-kDa protein by SDS-PAGE, is expressed in human islets and pancreatic insulinoma INS-1 and MIN6 cells. We show that CDKAL1 is a novel member of the tail-anchored protein family and exploits the TCR40/Get3-assisted pathway for insertion of its C-terminal transmembrane domain into the endoplasmic reticulum. Using endo-beta-N-acetylglucosaminidase H and peptide: N-glycosidase F sensitivity assays on CDKAL1 constructs carrying an N-glycosylation site within the luminal domain, we further established that CDKAL1 is an endoplasmic reticulum-resident protein. Moreover, we observed that silencingCDKAL1in INS-1 cells reduces the expression of secretory granule proteins prochromogranin A and proICA512/ICA512-TMF, in addition to proinsulin and insulin. This correlated with reduced glucose-stimulated insulin secretion. Taken together, our findings provide new insight into the role of CDKAL1 in insulin-producing cells and help to understand its involvement in the pathogenesis of diabetes.	[Brambillasca, Silvia; Altkrueger, Anke; Friederich, Anne; Solimena, Michele] Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-01307 Dresden, Germany; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, Biometra Dept, I-20129 Milan, Italy; [Eickelmann, Peter; Mark, Michael] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, D-88397 Biberach, Germany; [Borgese, Nica] Univ Catanzaro Magna Graecia, Dept Hlth Sci, I-88100 Catanzaro, Italy; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Boehringer Ingelheim; Magna Graecia University of Catanzaro; Max Planck Society	Solimena, M (corresponding author), Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, Fetscherstr 74, D-01307 Dresden, Germany.	michele.solimena@tu-dresden.de	Borgese, Nica/GWZ-8895-2022; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011	Borgese, Nica/0000-0002-7537-3974; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961	German Ministry for Education and Research; Boehringer Ingelheim; Italian Association for Cancer Research [IG9040]; Dresden University of Technology Medical School	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim(Boehringer Ingelheim); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Dresden University of Technology Medical School	This work was supported in part by funds from the German Ministry for Education and Research to the German Centre for Diabetes Research, a research grant from Boehringer Ingelheim (to M. S.), and by Italian Association for Cancer Research Grant IG9040 (to the N. B. laboratory).; Recipient of a MedDrive grant from the Dresden University of Technology Medical School.	Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; BAILYES EM, 1991, ENZYME, V45, P301, DOI 10.1159/000468903; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Li YH, 2009, J INVEST DERMATOL, V129, P629, DOI 10.1038/jid.2008.297; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Quaranta M, 2009, GENES IMMUN, V10, P654, DOI 10.1038/gene.2009.51; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Steiner DF, 1996, DIABETES METAB, V22, P94; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	44	26	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41808	41819		10.1074/jbc.M112.376558	http://dx.doi.org/10.1074/jbc.M112.376558			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23048041	hybrid, Green Published			2022-12-25	WOS:000312103000022
J	Zhao, HY; Avenarius, MR; Gillespie, PG				Zhao, Hongyu; Avenarius, Matthew R.; Gillespie, Peter G.			Improved Biolistic Transfection of Hair Cells	PLOS ONE			English	Article							IN-VIVO; GENE-TRANSFER; MYOSIN VIIA; HARMONIN; COCHLEA; TRANSDUCTION; CADHERIN-23; COMPLEXES; DELIVERY; STEREOCILIA	Transient transfection of hair cells has proven challenging. Here we describe modifications to the Bio-Rad Helios Gene Gun that, along with an optimized protocol, improve transfection of bullfrog, chick, and mouse hair cells. The increased penetrating power afforded by our method allowed us to transfect mouse hair cells from the basal side, through the basilar membrane; this configuration protects hair bundles from damage during the procedure. We characterized the efficiency of transfection of mouse hair cells with fluorescently-tagged actin fusion protein using both the optimized procedure and a published procedure; while the efficiency of the two methods was similar, the morphology of transfected hair cells was improved with the new procedure. In addition, using the improved method, we were able to transfect hair cells in the bullfrog sacculus and chick cochlea for the first time. We used fluorescent-protein fusions of harmonin b (USH1C) and PMCA2 (ATP2B2; plasma-membrane Ca2+-ATPase isoform 2) to examine protein distribution in hair cells. While PMCA2-EGFP localization was similar to endogenous PMCA2 detected with antibodies, high levels of harmonin-EGFP were found at stereocilia tapers in bullfrog and chick, but not mouse; by contrast, harmonin-EGFP was concentrated in stereocilia tips in mouse hair cells.	[Zhao, Hongyu] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Zhao, HY (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Avenarius, Matthew/0000-0001-9516-5163; Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health (NIH) [R01 DC002368, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by National Institutes of Health (NIH) (www.nih.gov) grants R01 DC002368 and P30 DC005983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Bedrosian JC, 2006, MOL THER, V14, P328, DOI 10.1016/j.ymthe.2006.04.003; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Belyantseva Inna A., 2009, V493, P103, DOI 10.1007/978-1-59745-523-7_7; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Dalluge R, 2002, BBA-GENE STRUCT EXPR, V1576, P45, DOI 10.1016/S0167-4781(02)00291-9; Dazert S, 2001, HEARING RES, V151, P30, DOI 10.1016/S0378-5955(00)00189-1; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; Driver EC, 2010, CURR PROTOC NEUROSCI, P1; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Finsinger D, 2000, GENE THER, V7, P1183, DOI 10.1038/sj.gt.3301227; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Holt JR, 2002, AUDIOL NEURO-OTOL, V7, P157, DOI 10.1159/000058302; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Ishimoto S, 2002, HEARING RES, V173, P187, DOI 10.1016/S0378-5955(02)00579-8; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Klimaschewski L, 2002, J NEUROSCI METH, V113, P63, DOI 10.1016/S0165-0270(01)00473-3; Liu YH, 2005, MOL THER, V12, P725, DOI 10.1016/j.ymthe.2005.03.021; Luebke AE, 2001, HUM GENE THER, V12, P773, DOI 10.1089/104303401750148702; Ma BC, 2007, J CONTROL RELEASE, V123, P184, DOI 10.1016/j.jconrel.2007.08.022; O'Brien JA, 2001, J NEUROSCI METH, V112, P57, DOI 10.1016/S0165-0270(01)00457-5; Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745; Raju PA, 2006, VACCINE, V24, P4644, DOI 10.1016/j.vaccine.2005.08.067; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; THOMAS JL, 2001, J INSECT SCI, V1, P9; Wang H, 2012, GENE THER, V19, P255, DOI 10.1038/gt.2011.91; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zuidam NJ, 1999, INT J PHARM, V183, P43, DOI 10.1016/S0378-5173(99)00041-1	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46765	10.1371/journal.pone.0046765	http://dx.doi.org/10.1371/journal.pone.0046765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049715	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388500042
J	Kim, S; Chang, KA; Kim, JA; Park, HG; Ra, JC; Kim, HS; Suh, YH				Kim, Saeromi; Chang, Keun-A; Kim, Jeong A.; Park, Hyeong-Geun; Ra, Jeong Chan; Kim, Hye-Sun; Suh, Yoo-Hun			The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer's Disease Mice	PLOS ONE			English	Article							STROMAL CELLS; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTORS; TRANSGENIC MODEL; AMYLOID-PROTEIN; NERVOUS-SYSTEM; GROWTH-FACTOR; MOUSE MODEL; IN-VITRO; TRANSPLANTATION	Alzheimer's disease (AD) is characterized by the accumulation of amyloid plaques and neurofibrillary tangles accompanied by cognitive dysfunction. The aim of the present study was to elucidate preventive and therapeutic potential of stem cells for AD. Among stem cells, autologous human adipose-derived stem cells (hASCs) elicit no immune rejection responses, tumorigenesis, or ethical problems. We found that intravenously transplanted hASCs passed through the BBB and migrated into the brain. The learning, memory and pathology in an AD mouse model (Tg2576) mice greatly improved for at least 4 months after intravenous injection of hASC. The number of amyloid plaques and A beta levels decreased significantly in the brains of hASC-injected Tg mice compared to those of Tg-sham mice. Here, we first report that intravenously or intracerebrally transplanted hASCs significantly rescues memory deficit and neuropathology, in the brains of Tg mice by upregulating IL-10 and VEGF and be a possible use for the prevention and treatment of AD.	[Kim, Saeromi; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, MRC,Dept Pharmacol, Seoul, South Korea; [Park, Hyeong-Geun; Ra, Jeong Chan] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu, South Korea; [Chang, Keun-A] Gachon Univ Med & Sci, Dept Pharmacol, Inchon, South Korea	Seoul National University (SNU); Korea Brain Research Institute (KBRI); Gachon University	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, MRC,Dept Pharmacol, Seoul, South Korea.	yhsuh@snu.ac.kr	Suh, Yoo-Hun/J-2761-2012		Conversing Research Center Program through the National Research Foundation of Korea (NRF) [2011K000678]; Mid-career Researcher Program through NRF grant; MEST [20110027566]; Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea [2011K000270]	Conversing Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Mid-career Researcher Program through NRF grant(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea	This research was supported by the Conversing Research Center Program through the National Research Foundation of Korea (NRF) (2011K000678), Mid-career Researcher Program through NRF grant funded by the MEST (20110027566), and a grant (2011K000270) from Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022; Enzmann GU, 2006, J NEUROTRAUM, V23, P479, DOI 10.1089/neu.2006.23.479; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Huang TT, 2007, J SPINAL CORD MED, V30, pS35, DOI 10.1080/10790268.2007.11753967; Ikegaya Y, 2001, J CELL SCI, V114, P4083; Jeynes B, 2011, J NEUROSCI RES, V89, P22, DOI 10.1002/jnr.22527; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Ra JC, 2011, SAFETY INTRAVENOUS I; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	41	97	105	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45757	10.1371/journal.pone.0045757	http://dx.doi.org/10.1371/journal.pone.0045757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049854	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517300051
J	McNulty, SN; Abubucker, S; Simon, GM; Mitreva, M; McNulty, NP; Fischer, K; Curtis, KC; Brattig, NW; Weil, GJ; Fischer, PU				McNulty, Samantha N.; Abubucker, Sahar; Simon, Gabriel M.; Mitreva, Makedonka; McNulty, Nathan P.; Fischer, Kerstin; Curtis, Kurt C.; Brattig, Norbert W.; Weil, Gary J.; Fischer, Peter U.			Transcriptomic and Proteomic Analyses of a Wolbachia-Free Filarial Parasite Provide Evidence of Trans-Kingdom Horizontal Gene Transfer	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; PROTEIN IDENTIFICATIONS; INTRACELLULAR BACTERIA; ABC TRANSPORTERS; GENOME; ENDOSYMBIONTS; PHYLOGENY; STRATEGY; SPECTRA; TOOLS	Most filarial parasites in the subfamilies Onchocercinae and Dirofilariinae depend on Wolbachia endobacteria to successfully carry out their life cycle. Recently published data indicate that the few Wolbachia-free species in these subfamilies were infected in the distant past and have subsequently shed their endosymbionts. We used an integrated transcriptomic and proteomic analysis of Onchocerca flexuosa to explore the molecular mechanisms that allow worms of this species to survive without a bacterial partner. Roche/454 sequencing of the adult transcriptome produced 16,814 isogroup and 47,252 singleton sequences that are estimated to represent approximately 41% of the complete gene set. Sequences similar to 97 Wolbachia genes were identified from the transcriptome, some of which appear on the same transcripts as sequences similar to nematode genes. Computationally predicted peptides, including those with similarity to Wolbachia proteins, were classified at the domain and pathway levels in order to assess the metabolic capabilities of O. flexuosa and compare against the Wolbachia-dependent model filaria, Brugia malayi. Transcript data further facilitated a shotgun proteomic analysis of O. flexuosa adult worm lysate, resulting in the identification of 1,803 proteins. Three of the peptides detected by mass spectroscopy map to two ABC transport-related proteins from Wolbachia. Antibodies raised to one of the Wolbachia-like peptides labeled a single 38 kDa band on Western blots of O. flexuosa lysate and stained specific worm tissues by immunohistology. Future studies will be required to determine the exact functions of Wolbachia-like peptides and proteins in O. flexuosa and to assess their roles in worm biology.	[McNulty, Samantha N.; Fischer, Kerstin; Curtis, Kurt C.; Weil, Gary J.; Fischer, Peter U.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Abubucker, Sahar; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Simon, Gabriel M.; McNulty, Nathan P.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brattig, Norbert W.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Bernhard Nocht Institut fur Tropenmedizin	McNulty, SN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.	smcnulty@wustl.edu		Fischer, Peter/0000-0003-4558-3417; Mitreva, Makedonka/0000-0001-9572-3436	Barnes-Jewish Hospital Foundation; National Institutes of Health Grant [T32-AI007172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI081803] Funding Source: NIH RePORTER	Barnes-Jewish Hospital Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Barnes-Jewish Hospital Foundation and by National Institutes of Health Grant T32-AI007172 to SNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R.C., 1976, CIH Keys Nematode Parasites Vert, VNo. 3, P59; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P541; [Anonymous], 2000, NEMATODE PARASITES V; Ardelli BF, 2007, T ROY SOC TROP MED H, V101, P1223, DOI 10.1016/j.trstmh.2005.03.019; Ardelli BF, 2004, ANN TROP MED PARASIT, V98, P371, DOI 10.1179/000349804225003415; ASH LR, 1970, J PARASITOL, V56, P969, DOI 10.2307/3277515; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bourguinat C, 2008, MOL BIOCHEM PARASIT, V158, P101, DOI 10.1016/j.molbiopara.2007.11.017; Buggiotti L, 2008, PROTEOMICS, V8, P2150, DOI 10.1002/pmic.200701006; Carpentier SC, 2008, MASS SPECTROM REV, V27, P354, DOI 10.1002/mas.20170; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Chan CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004524; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Dafa'alla TH, 2000, MOL BIOCHEM PARASIT, V106, P37, DOI 10.1016/S0166-6851(99)00198-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Fischer K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001174; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2003, MED MICROBIOL IMMUN, V192, P211, DOI 10.1007/s00430-002-0174-6; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jiang DJ, 2008, INT J PARASITOL, V38, P503, DOI 10.1016/j.ijpara.2007.09.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; PLENGEBONIG A, 1995, PARASITOL RES, V81, P66, DOI 10.1007/BF00932419; Ramani AK, 2011, GENOME RES; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Tompkins JB, 2011, PARASITOL RES, V109, P1311, DOI 10.1007/s00436-011-2378-4; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wasmuth James, 2009, V533, P221, DOI 10.1007/978-1-60327-136-3_10; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	49	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45777	10.1371/journal.pone.0045777	http://dx.doi.org/10.1371/journal.pone.0045777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049857	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000309517300052
J	Bifulco, K; Longanesi-Cattani, I; Franco, P; Pavone, V; Mugione, P; Di Carluccio, G; Masucci, MT; Arra, C; Pirozzi, G; Stoppelli, MP; Carriero, MV				Bifulco, Katia; Longanesi-Cattani, Immacolata; Franco, Paola; Pavone, Vincenzo; Mugione, Pietro; Di Carluccio, Gioconda; Masucci, Maria Teresa; Arra, Claudio; Pirozzi, Giuseppe; Stoppelli, Maria Patrizia; Carriero, Maria Vincenza			Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FORMYL PEPTIDE RECEPTOR; VITRONECTIN RECEPTOR; CRYSTAL-STRUCTURE; DEFICIENT MICE; BREAST-CANCER; UPAR; ADHESION; BINDING; LIGAND	The receptor for urokinase-type plasminogen activator (uPAR) plays an important role in controlling cell migration. uPAR binds urokinase and vitronectin extracellular ligands, and signals in complex with transmembrane receptors such as Formylpeptide Receptors (FPR)s and integrins. Previous work from this laboratory has shown that synthetic peptides, corresponding to the uPAR(88-92) chemotactic sequence, when carrying the S90P or S90E substitutions, up-or down-regulate cell migration, respectively. To gain mechanistic insights into these opposite cell responses, the functional consequences of S90P and S90E mutations in full-length uPAR were evaluated. First, (HEK)-293 embryonic kidney cells expressing uPAR S90P exhibit enhanced FPR activation, increased random and directional cell migration, long-lasting Akt phosphorylation, and increased adhesion to vitronectin, as well as uPAR/vitronectin receptor association. In contrast, the S90E substitution prevents agonist-triggered FPR activation and internalization, decreases binding and adhesion to vitronectin, and inhibits uPAR/vitronectin receptor association. Also, 293/uPAR(S90P) cells appear quite elongated and their cytoskeleton well organized, whereas 293/uPARS(90E) cells assume a large flattened morphology, with random orientation of actin filaments. Interestingly, when HT1080 cells co-express wild type uPAR with uPAR S90E, the latter behaves as a dominant-negative, impairing uPAR-mediated signaling and reducing cell wound repair as well as lung metastasis in nude mice. In contrast, signaling, wound repair and in vivo lung metastasis of HT1080 cells bearing wild type uPAR are enhanced when they co-express uPAR(S90P). In conclusion, our findings indicate that Ser(90) is a critical residue for uPAR signaling and that the S90P and S90E exert opposite effects on uPAR activities. These findings may be accommodated in a molecular model, in which uPAR(S90E) and uPAR(S90P) are forced into inactive and active forms, respectively, suggesting important implications for the development of novel drugs targeting uPAR function.	[Bifulco, Katia; Longanesi-Cattani, Immacolata; Mugione, Pietro; Di Carluccio, Gioconda; Masucci, Maria Teresa; Arra, Claudio; Pirozzi, Giuseppe; Carriero, Maria Vincenza] Natl Canc Inst Naples, Dept Expt Oncol, Naples, Italy; [Franco, Paola; Stoppelli, Maria Patrizia] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Pavone, Vincenzo] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	IRCCS Fondazione Pascale; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Carriero, MV (corresponding author), Natl Canc Inst Naples, Dept Expt Oncol, Naples, Italy.	mariolinacarriero@yahoo.it	Franco, Paola/O-5897-2015; Pavone, Vincenzo/D-1688-2011; Carriero, Maria Vincenza/K-1240-2018	Franco, Paola/0000-0002-3289-7284; Pavone, Vincenzo/0000-0001-6432-0802; Carriero, Maria Vincenza/0000-0002-9768-2997; Arra, Claudio/0000-0003-3162-2091; MASUCCI, Maria Teresa/0000-0001-5213-6557; Di Carluccio, Gioconda/0000-0002-3571-9889	AIRC (Associazione Italiana per la Ricerca sul Cancro) [10251]; ESF (European Science Foundation) [M.L.SHC-CT-2003-503237]; MERIT (MEdical Research in ITaly) [RBNE08YFN3]	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); ESF (European Science Foundation)(European Science Foundation (ESF)); MERIT (MEdical Research in ITaly)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) 2010, project 10251, ESF (European Science Foundation), Eurocore Project contact M.L.SHC-CT-2003-503237 and MERIT (MEdical Research in ITaly) n. RBNE08YFN3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bifulco K, 2010, J THROMB HAEMOST, V8, P2789, DOI 10.1111/j.1538-7836.2010.04075.x; Bifulco K, 2008, FEBS LETT, V582, P1141, DOI 10.1016/j.febslet.2008.03.001; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Carriero MV, 1999, CANCER RES, V59, P5307; Carriero MV, 1997, CLIN CANCER RES, V3, P1299; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gargiulo L, 2005, J BIOL CHEM, V280, P25225, DOI 10.1074/jbc.M412605200; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Hellriegel C, 2011, FASEB J, V25, P2883, DOI 10.1096/fj.11-181537; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2011, CELL MOL LIFE SCI, V68, P2453, DOI 10.1007/s00018-010-0564-7; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Selleri C, 2006, CANCER RES, V66, P10885, DOI 10.1158/0008-5472.CAN-06-1311; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Silvestri I, 2002, INT J CANCER, V102, P562, DOI 10.1002/ijc.10744; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yuan C, 2007, CELL MOL LIFE SCI, V64, P1033, DOI 10.1007/s00018-007-6498-z	50	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44806	10.1371/journal.pone.0044806	http://dx.doi.org/10.1371/journal.pone.0044806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049759	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100022
J	Di Nunzio, F; Danckaert, A; Fricke, T; Perez, P; Fernandez, J; Perret, E; Roux, P; Shorte, S; Charneau, P; Diaz-Griffero, F; Arhel, NJ				Di Nunzio, Francesca; Danckaert, Anne; Fricke, Thomas; Perez, Patricio; Fernandez, Juliette; Perret, Emmanuelle; Roux, Pascal; Shorte, Spencer; Charneau, Pierre; Diaz-Griffero, Felipe; Arhel, Nathalie J.			Human Nucleoporins Promote HIV-1 Docking at the Nuclear Pore, Nuclear Import and Integration	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MESSENGER-RNA EXPORT; CENTRAL DNA FLAP; NUCLEOCYTOPLASMIC TRANSPORT; IN-VIVO; PREINTEGRATION COMPLEX; REVERSE TRANSCRIPTION; NONDIVIDING CELLS; GENE-EXPRESSION; PROTEIN EXPORT	The nuclear pore complex (NPC) mediates nucleo-cytoplasmic transport of macromolecules and is an obligatory point of passage and functional bottleneck in the replication of some viruses. The Human Immunodeficiency Virus (HIV) has evolved the required mechanisms for active nuclear import of its genome through the NPC. However the mechanisms by which the NPC allows or even assists HIV translocation are still unknown. We investigated the involvement of four key nucleoporins in HIV-1 docking, translocation, and integration: Nup358/RanBP2, Nup214/CAN, Nup98 and Nup153. Although all induce defects in infectivity when depleted, only Nup153 actually showed any evidence of participating in HIV-1 translocation through the nuclear pore. We show that Nup358/RanBP2 mediates docking of HIV-1 cores on NPC cytoplasmic filaments by interacting with the cores and that the C-terminus of Nup358/RanBP2 comprising a cyclophilin-homology domain contributes to binding. We also show that Nup214/CAN and Nup98 play no role in HIV-1 nuclear import per se: Nup214/CAN plays an indirect role in infectivity read-outs through its effect on mRNA export, while the reduction of expression of Nup98 shows a slight reduction in proviral integration. Our work shows the involvement of nucleoporins in diverse and functionally separable steps of HIV infection and nuclear import.	[Di Nunzio, Francesca; Fernandez, Juliette; Charneau, Pierre; Arhel, Nathalie J.] Inst Pasteur, Mol Virol & Vaccinol Unit, CNRS, URA 3015,Dept Virol, Paris, France; [Danckaert, Anne; Perret, Emmanuelle; Roux, Pascal; Shorte, Spencer] Inst Pasteur, Imagopole, Paris, France; [Fricke, Thomas; Perez, Patricio; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yeshiva University; Albert Einstein College of Medicine	Arhel, NJ (corresponding author), Hop St Louis, INSERM, UMR S 941, Paris, France.	nathalie.arhel@inserm.fr	Fricke, Thomas/B-6885-2013; CHARNEAU, Pierre/M-1565-2017; fernandez, juliette/D-4600-2016; Di Nunzio, Francesca/A-6153-2014	CHARNEAU, Pierre/0000-0003-1184-5773; fernandez, juliette/0000-0003-2969-8150; Di Nunzio, Francesca/0000-0003-2879-3164; Shorte, Spencer/0000-0002-2125-8663; Arhel, Nathalie/0000-0001-5309-1725	CNRS (Centre National de Recherche Scientifique); ANRS (Agence Nationale de Recherche sur le SIDA); FRM (Fondation pour la Recherche Medicale); Sidaction; Pasteur Institute; European Union; National Institutes of Health [R01 AI087390, 4R00MH086162-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086162] Funding Source: NIH RePORTER	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANRS (Agence Nationale de Recherche sur le SIDA)(ANRSFrench National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); Sidaction; Pasteur Institute; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the CNRS (Centre National de Recherche Scientifique), the ANRS (Agence Nationale de Recherche sur le SIDA), the FRM (Fondation pour la Recherche Medicale), the Sidaction, the Pasteur Institute and the European Union. ML, PP and FDG were supported by an National Institutes of Health R01 AI087390 grant and a pathway to independence award 4R00MH086162-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2000, J CELL SCI, V113, P1651; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Arhel NJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-38; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; BORMAN AM, 1995, J VIROL, V69, P2058, DOI 10.1128/JVI.69.4.2058-2067.1995; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Galat A, 2010, CELL MOL LIFE SCI, V67, P3467, DOI 10.1007/s00018-010-0437-0; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Greber UF, 2003, TRAFFIC, V4, P136, DOI 10.1034/j.1600-0854.2003.00114.x; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liang Y, 2011, CURR OPIN CELL BIOL, V23, P65, DOI 10.1016/j.ceb.2010.09.008; Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marechal V, 1998, J VIROL, V72, P2208; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rode K, 2011, J VIROL, V85, P4271, DOI 10.1128/JVI.02067-10; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	80	112	113	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46037	10.1371/journal.pone.0046037	http://dx.doi.org/10.1371/journal.pone.0046037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049930	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100124
J	Frynta, D; Baudysova, J; Hradcova, P; Faltusova, K; Kratochvil, L				Frynta, Daniel; Baudysova, Jana; Hradcova, Petra; Faltusova, Katerina; Kratochvil, Lukas			Allometry of Sexual Size Dimorphism in Domestic Dog	PLOS ONE			English	Article							RENSCHS RULE; BODY-SIZE; EVOLUTION; SELECTION; HAPLOTYPE; ORIGIN; CHROMOSOME; CANIDAE; PATTERN	Background: The tendency for male-larger sexual size dimorphism (SSD) to scale with body size - a pattern termed Rensch's rule - has been empirically supported in many animal lineages. Nevertheless, its theoretical elucidation is a subject of debate. Here, we exploited the extreme morphological variability of domestic dog (Canis familiaris) to gain insights into evolutionary causes of this rule. Methodology/Principal Findings: We studied SSD and its allometry among 74 breeds ranging in height from less than 19 cm in Chihuahua to about 84 cm in Irish wolfhound. In total, the dataset included 6,221 individuals. We demonstrate that most dog breeds are male-larger, and SSD in large breeds is comparable to SSD of their wolf ancestor. Among breeds, SSD becomes smaller with decreasing body size. The smallest breeds are nearly monomorphic. Conclusions/Significance: SSD among dog breeds follows the pattern consistent with Rensch's rule. The variability of body size and corresponding changes in SSD among breeds of a domestic animal shaped by artificial selection can help to better understand processes leading to emergence of Rensch's rule.	[Kratochvil, Lukas] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic; [Frynta, Daniel; Baudysova, Jana; Hradcova, Petra; Faltusova, Katerina] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	Charles University Prague; Charles University Prague	Kratochvil, L (corresponding author), Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic.	lukas.kratochvil@natur.cuni.cz	Kratochvil, Lukas/M-2134-2019; Faltusova, Katerina/AAI-2315-2021; Frynta, Daniel/L-7350-2016; Kratochvíl, Lukáš/A-1997-2008; Faltusova, Katerina/M-5303-2017	Faltusova, Katerina/0000-0003-4260-8797; Frynta, Daniel/0000-0002-1375-7972; Kratochvíl, Lukáš/0000-0002-3515-729X; Faltusova, Katerina/0000-0003-4260-8797	Grant Agency of the Czech Academy of Sciences [IAA6111410]; Czech Science Foundation [206-05-H012, 206/09/0895]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The project was supported by the Grant Agency of the Czech Academy of Sciences (project No. IAA6111410). The personal costs of K.F. were provided by the Czech Science Foundation (project No. 206-05-H012). L.K. was supported by the Czech Science Foundation (project No. 206/09/0895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Andersson Malte, 1994; Bannasch DL, 2005, MAMM GENOME, V16, P273, DOI 10.1007/s00335-004-2435-8; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; Cox Robert M., 2007, P38; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin G., 1871, P423; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Federation Cynologique Internationale, 2008, NOM STAND; Geffen E, 1996, AM NAT, V147, P140, DOI 10.1086/285844; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Gundry RL, 2007, J FORENSIC SCI, V52, P562, DOI 10.1111/j.1556-4029.2007.00425.x; Herre W, 1980, NOVA ACTA LEOPOLDINA, V241, P1; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Kratochvil Lukas, 2007, P154; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1309, DOI 10.1016/S0093-691X(03)00146-8; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindenfors Patrik, 2007, P16; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Macdonald D.W., 2004, CANIDS FOXES WOLVES; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Moehlman Patricia D., 1997, P76; MOREY DF, 1994, AM SCI, V82, P336; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Polak J, 2010, EVOL ECOL, V24, P1255, DOI 10.1007/s10682-010-9354-9; Polak J, 2009, BIOL J LINN SOC, V98, P872, DOI 10.1111/j.1095-8312.2009.01294.x; Remes V, 2010, J EVOLUTION BIOL, V23, P2754, DOI 10.1111/j.1420-9101.2010.02126.x; Rensch B., 1950, Bonner Zoologische Beitraege, V1, P58; Rensch B., 1959, EVOLUTION SPECIES LE; Ricankova V, 2004, ZOOL SCRI, V33, P311; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shearin AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000310; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Sol D, 2008, BIOL J LINN SOC, V93, P657, DOI 10.1111/j.1095-8312.2008.00957.x; Starostova Z, 2010, J EVOLUTION BIOL, V23, P670, DOI 10.1111/j.1420-9101.2010.01933.x; StatSoft Inc, STATISTICA VERS 6 0; Stephens PR, 2009, EVOLUTION, V63, P910, DOI 10.1111/j.1558-5646.2008.00597.x; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; Szekely Tamas, 2007, P27; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Walker SPW, 2009, P ROY SOC B-BIOL SCI, V276, P3335, DOI 10.1098/rspb.2009.0767; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Webb TJ, 2007, PLOS ONE, V2007, P1	65	28	29	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46125	10.1371/journal.pone.0046125	http://dx.doi.org/10.1371/journal.pone.0046125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049956	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100140
J	van Alphen, LB; Burt, SA; Veenendaal, AKJ; Bleumink-Pluym, NMC; van Putten, JPM				van Alphen, Lieke B.; Burt, Sara A.; Veenendaal, Andreas K. J.; Bleumink-Pluym, Nancy M. C.; van Putten, Jos P. M.			The Natural Antimicrobial Carvacrol Inhibits Campylobacter jejuni Motility and Infection of Epithelial Cells	PLOS ONE			English	Article							PATHOGEN BACILLUS-CEREUS; PLANT OIL AROMATICS; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; MAMMALIAN-CELLS; INVASION; PROTEIN; ADHERENCE; MEMBRANES; IDENTIFICATION	Background: Natural compounds with anti-microbial properties are attractive reagents to reduce the use of conventional antibiotics. Carvacrol, the main constituent of oregano oil, inhibits the growth of a variety of bacterial foodborne pathogens. As concentrations of carvacrol may vary in vivo or when used in animal feed, we here investigated the effect of subinhibitory concentrations of the compound on major virulence traits of the principal bacterial foodborne pathogen Campylobacter jejuni. Methods/Principal Findings: Motility assays revealed that subinhibitory concentrations of carvacrol inhibited the motility of C. jejuni without affecting bacterial growth. Immunoblotting and electron microscopy showed that carvacrol-treated C. jejuni still expressed flagella. The loss of motility was not caused by reduced intracellular ATP levels. In vitro infection assays demonstrated that subinhibitory concentrations of carvacrol also abolished C. jejuni invasion of human epithelial cells. Bacterial uptake of invasive Escherichia coli was not blocked by carvacrol. Exposure of C. jejuni to carvacrol prior to infection also inhibited cellular infection, indicating that the inhibition of invasion was likely caused by an effect on the bacteria rather than inhibition of epithelial cell function. Conclusions/Significance: Bacterial motility and invasion of eukaryotic cells are considered key steps in C. jejuni infection. Our results indicate that subinhibitory concentrations of carvacrol effectively block these virulence traits by interfering with flagella function without disturbing intracellular ATP levels. These results broaden the spectrum of anti-microbial activity of carvacrol and support the potential of the compound for use in novel infection prevention strategies.	[van Alphen, Lieke B.; Veenendaal, Andreas K. J.; Bleumink-Pluym, Nancy M. C.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Burt, Sara A.] Univ Utrecht, Fac Vet Med, Inst Risk Assessment Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	van Putten, JPM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	j.vanputten@uu.nl		van Putten, Jos/0000-0002-4126-8172	Utrecht University, the Netherlands; European Union [PERG02-GA-2007-224937]	Utrecht University, the Netherlands(Netherlands Government); European Union(European Commission)	This research received financial support from Utrecht University, the Netherlands and the European Union to A.K.J.V. (Grant: PERG02-GA-2007-224937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Burt SA, 2007, APPL ENVIRON MICROB, V73, P4484, DOI 10.1128/AEM.00340-07; BUTZLER JP, 1991, INT J FOOD MICROBIOL, V12, P1, DOI 10.1016/0168-1605(91)90043-O; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Di Pasqua R, 2006, J AGR FOOD CHEM, V54, P2745, DOI 10.1021/jf052722l; Di Pasqua R, 2007, J AGR FOOD CHEM, V55, P4863, DOI 10.1021/jf0636465; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; ENDTZ HP, 1993, RES MICROBIOL, V144, P703, DOI 10.1016/0923-2508(93)90034-Y; Fabian D, 2006, TOXICOL IN VITRO, V20, P1435, DOI 10.1016/j.tiv.2006.06.012; Fernando U, 2007, INT J FOOD MICROBIOL, V118, P194, DOI 10.1016/j.ijfoodmicro.2007.07.038; Friedman M, 2002, J FOOD PROTECT, V65, P1545, DOI 10.4315/0362-028X-65.10.1545; Gascon J, 2006, DIGESTION, V73, P102, DOI 10.1159/000089785; Gill AO, 2006, INT J FOOD MICROBIOL, V111, P170, DOI 10.1016/j.ijfoodmicro.2006.04.046; Gill AO, 2006, INT J FOOD MICROBIOL, V108, P1, DOI 10.1016/j.ijfoodmicro.2005.10.009; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Griggs DJ, 2009, ANTIMICROB AGENTS CH, V53, P3357, DOI 10.1128/AAC.01655-08; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hagmuller W, 2006, BERL MUNCH TIERARZTL, V119, P50; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Manzanilla EG, 2006, J ANIM SCI, V84, P2743, DOI 10.2527/jas.2005-509; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Oussalah M, 2006, J FOOD PROTECT, V69, P1046, DOI 10.4315/0362-028X-69.5.1046; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; Ravishankar S, 2008, J FOOD PROTECT, V71, P1145, DOI 10.4315/0362-028X-71.6.1145; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Till D, 2008, J WATER HEALTH, V6, P443, DOI 10.2166/wh.2008.071; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Ultee A, 2001, INT J FOOD MICROBIOL, V64, P373, DOI 10.1016/S0168-1605(00)00480-3; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Wosten MMSM, 2010, MOL MICROBIOL, V75, P1577, DOI 10.1111/j.1365-2958.2010.07079.x; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x	50	50	50	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45343	10.1371/journal.pone.0045343	http://dx.doi.org/10.1371/journal.pone.0045343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049787	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100039
J	Zhu, J; Shao, CY; Yang, W; Zhang, XM; Wu, ZY; Zhou, L; Wang, XX; Li, YH; Xia, J; Luo, JH; Shen, Y				Zhu, Jia; Shao, Chong-Yu; Yang, Wei; Zhang, Xiao-Min; Wu, Zhen-Yong; Zhou, Liang; Wang, Xin-Xin; Li, Yun-Hong; Xia, Jun; Luo, Jian-Hong; Shen, Ying			Chronic Zinc Exposure Decreases the Surface Expression of NR2A-Containing NMDA Receptors in Cultured Hippocampal Neurons	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HISTOCHEMICALLY-REACTIVE ZINC; ALZHEIMERS-DISEASED BRAINS; PROTEIN-TYROSINE KINASES; AIRWAY EPITHELIAL-CELLS; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; MOLECULAR-ORGANIZATION; EXCITATORY SYNAPSES	Background: Zinc distributes widely in the central nervous system, especially in the hippocampus, amygdala and cortex. The dynamic balance of zinc is critical for neuronal functions. Zinc modulates the activity of N-methyl-D-aspartate receptors (NMDARs) through the direct inhibition and various intracellular signaling pathways. Abnormal NMDAR activities have been implicated in the aetiology of many brain diseases. Sustained zinc accumulation in the extracellular fluid is known to link to pathological conditions. However, the mechanism linking this chronic zinc exposure and NMDAR dysfunction is poorly understood. Methodology/Principal Findings: We reported that chronic zinc exposure reduced the numbers of NR1 and NR2A clusters in cultured hippocampal pyramidal neurons. Whole-cell and synaptic NR2A-mediated currents also decreased. By contrast, zinc did not affect NR2B, suggesting that chronic zinc exposure specifically influences NR2A-containg NMDARs. Surface biotinylation indicated that zinc exposure attenuated the membrane expression of NR1 and NR2A, which might arise from to the dissociation of the NR2A-PSD-95-Src complex. Conclusions: Chronic zinc exposure perturbs the interaction of NR2A to PSD-95 and causes the disorder of NMDARs in hippocampal neurons, suggesting a novel action of zinc distinct from its acute effects on NMDAR activity.	[Zhu, Jia; Shao, Chong-Yu; Yang, Wei; Zhang, Xiao-Min; Wu, Zhen-Yong; Zhou, Liang; Wang, Xin-Xin; Luo, Jian-Hong; Shen, Ying] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Zhejiang Prov K, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Jun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Li, Yun-Hong] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Hong Kong University of Science & Technology; Ningxia Medical University	Shen, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Zhejiang Prov K, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	Luo, jian/HGE-7331-2022; Yang, Wei/GWV-4107-2022; shen, ying/HHS-5635-2022; Yang, Wei/HIA-0360-2022; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Zhang, Xiaomin/0000-0002-1179-979X	National Basic Research Program (973) of Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [30600168, 31070945, 30960108, 31060140]; National Foundation of Natural Science [30731160616, N_HKUST605/07]; Research Grants Council of Hong Kong, China [30731160616, N_HKUST605/07]; New Century Talent Award of Ministry of Education of China [NCET-07-0751]; Zhejiang Provincial Foundation of Natural Science of China [R206018]	National Basic Research Program (973) of Ministry of Science and Technology of China(National Basic Research Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong, China(Hong Kong Research Grants Council); New Century Talent Award of Ministry of Education of China; Zhejiang Provincial Foundation of Natural Science of China	This work was supported by grants from National Basic Research Program (973) of Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), National Foundation of Natural Science of China (30600168, 31070945, 30960108 and 31060140), joint grant from the National Foundation of Natural Science and the Research Grants Council of Hong Kong, China (30731160616 and N_HKUST605/07), New Century Talent Award of Ministry of Education of China (NCET-07-0751), and Zhejiang Provincial Foundation of Natural Science of China (R206018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras MA, 2009, EUR J NEUROSCI, V30, P2250, DOI 10.1111/j.1460-9568.2009.07026.x; Bellinger FP, 2002, SYNAPSE, V43, P95, DOI 10.1002/syn.10020; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carriedo SG, 1998, J NEUROSCI, V18, P7727; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ji YF, 2011, BIOCHEM BIOPH RES CO, V405, P691, DOI 10.1016/j.bbrc.2011.01.105; Jiang XN, 2008, ANN NEUROL, V63, P632, DOI 10.1002/ana.21365; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klimaviciusa L, 2008, NEUROTOXICOLOGY, V29, P101, DOI 10.1016/j.neuro.2007.09.006; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Liao GY, 2000, J NEUROCHEM, V75, P282, DOI 10.1046/j.1471-4159.2000.0750282.x; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Lu YM, 2000, SYNAPSE, V38, P187, DOI 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nam HT, 2010, J BIOCHEM, V148, P573, DOI 10.1093/jb/mvq089; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Niethammer M, 1996, J NEUROSCI, V16, P2157; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PELLEGRINIGIAMPIETRO DE, 1994, J NEUROCHEM, V62, P1067; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Porter NM, 1997, J NEUROSCI, V17, P5629; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Rowley M, 2001, J MED CHEM, V44, P477, DOI 10.1021/jm0002432; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samet JM, 1999, AM J RESP CELL MOL, V21, P357, DOI 10.1165/ajrcmb.21.3.3656; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen Y, 1999, EUR J NEUROSCI, V11, P4233, DOI 10.1046/j.1460-9568.1999.00851.x; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Suvarna N, 2005, J BIOL CHEM, V280, P31450, DOI 10.1074/jbc.M504120200; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Tal TL, 2006, TOXICOL APPL PHARM, V214, P16, DOI 10.1016/j.taap.2005.11.011; Traynelis SF, 1998, J NEUROSCI, V18, P6163; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang WW, 2010, BRAIN RES, V1328, P162, DOI 10.1016/j.brainres.2010.02.055; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	81	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46012	10.1371/journal.pone.0046012	http://dx.doi.org/10.1371/journal.pone.0046012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049922	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100119
J	Shakarian, P; Wickiser, JK				Shakarian, Paulo; Wickiser, J. Kenneth			Similar Pathogen Targets in Arabidopsis thaliana and Homo sapiens Protein Networks	PLOS ONE			English	Article							TRANSMISSION; CENTRALITY; VIRULENCE	We study the behavior of pathogens on host protein networks for humans and Arabidopsis - noting striking similarities. Specifically, we preform k-shell decomposition analysis on these networks - which groups the proteins into various "shells" based on network structure. We observe that shells with a higher average degree are more highly targeted (with a power-law relationship) and that highly targeted nodes lie in shells closer to the inner-core of the network. Additionally, we also note that the inner core of the network is significantly under-targeted. We show that these core proteins may have a role in intra-cellular communication and hypothesize that they are less attacked to ensure survival of the host. This may explain why certain high-degree proteins are not significantly attacked.	[Shakarian, Paulo] United States Mil Acad, Paulo Shakarian Dept Elect Engn & Comp Sci, West Point, NY USA; [Wickiser, J. Kenneth] United States Mil Acad, J Kenneth Wickiser Dept Life Sci, West Point, NY USA	United States Department of Defense; United States Army; United States Department of Defense; United States Army	Shakarian, P (corresponding author), United States Mil Acad, Paulo Shakarian Dept Elect Engn & Comp Sci, West Point, NY USA.	paulo@shakarian.net	Shakarian, Paulo/GPK-6176-2022	Shakarian, Paulo/0000-0002-3159-4660	ARO [611102B74F]	ARO	P.S. and J.K.W. are supported by ARO grant 611102B74F, the opinions in this paper are those of the authors and do not necessarily reflect the opinions of the funders, the U. S. Military Academy, or the U. S. Army. http://www.arl.army.mil/www/default.cfm?page = 29 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenos C, 2011, J EVOLUTIONARY BIOL, V24; Best A, 2009, AM NAT, V173, P779, DOI 10.1086/598494; Brandes U, 2005, LECT NOTES COMPUT SC, V3404, P533; Brandes U, 2001, J MATH SOCIOL, P25; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Jensen K, 2006, PLOS BIOL, V4; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kover PX, 1998, AM NAT, V152, P165, DOI 10.1086/286159; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Reshef D., 2011, SCIENCE, V334; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Smith J, 2007, AM NAT, V170, P542, DOI 10.1086/521236; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6	17	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45154	10.1371/journal.pone.0045154	http://dx.doi.org/10.1371/journal.pone.0045154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23049774	Green Published, gold			2022-12-25	WOS:000309392800029
J	Chintala, H; Liu, HB; Parmar, R; Kamalska, M; Kim, YJ; Lovett, D; Grant, MB; Chaqour, B				Chintala, Hembindu; Liu, Haibo; Parmar, Rahul; Kamalska, Monika; Kim, Yoon Ji; Lovett, David; Grant, Maria B.; Chaqour, Brahim			Connective Tissue Growth Factor Regulates Retinal Neovascularization through p53 Protein-dependent Transactivation of the Matrix Metalloproteinase (MMP)-2 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; VASCULAR ENDOTHELIAL-CELLS; ANGIOGENESIS IN-VIVO; MATRIX-METALLOPROTEINASE-2 MMP-2; EXTRACELLULAR-MATRIX; FACTOR CYR61; ISCHEMIA; MICE; CCN; PREMATURITY	Pathological angiogenesis in the retina is driven by dysregulation of hypoxia-driven stimuli that coordinate physiological vessel growth. How the various components of the neovascularization signaling network are integrated to yield pathological changes has not been defined. Connective tissue growth factor (CTGF/CCN2) is an inducible matricellular protein that plays a major role in fibroproliferative disorders. Here, we show that CTGF/CCN2 was dynamically expressed in the developing murine retinal vasculature and was abnormally increased and localized within neovascular tufts in the mouse eye with oxygen-induced retinopathy. Consistent with its propitious vascular localization, ectopic expression of the CTGF/CCN2 gene further accelerated neovascularization, whereas lentivirus-mediated loss-of-function or -expression of CTGF/CCN2 harnessed ischemia-induced neovessel outgrowth in oxygen-induced retinopathy mice. The neovascular effects of CTGF/CCN2 were mediated, at least in part, through increased expression and activity of matrix metalloproteinase (MMP)-2, which drives vascular remodeling through degradation of matrix and non matrix proteins, migration and invasion of endothelial cells, and formation of new vascular patterns. In cultured cells, CTGF/CCN2 activated the MMP-2 promoter through increased expression and tethering of the p53 transcription factor to a highly conserved p53-binding sequence within the MMP-2 promoter. Concordantly, the neovascular effects of CTGF/CCN2 were suppressed by p53 inhibition that culminated in reduced enrichment of the MMP-2 promoter with p53 and decreased MMP-2 gene expression. Our data identified new gene targets and downstream effectors of CTGF/CCN2 and provided the rational basis for targeting the p53 pathway to curtail the effects of CTGF/CCN2 on neovessel formation associated with ischemic retinopathy.	[Chintala, Hembindu; Liu, Haibo; Parmar, Rahul; Kamalska, Monika; Kim, Yoon Ji; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Lovett, David] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Grant, Maria B.] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Grant, Maria B.] Univ Florida, Dept Therapeut, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	National Institutes of Health [EY022091-01, EY019387-01A1]; NEI [DK39776]; NATIONAL EYE INSTITUTE [R01EY022091, R21EY019387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039776, R56DK039776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022091-01 and EY019387-01A1 (to B. C.) and DK39776 (to D. L.) from NEI.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Apte RS, 2010, ADV EXP MED BIOL, V664, P15, DOI 10.1007/978-1-4419-1399-9_2; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Barnett JM, 2007, INVEST OPHTH VIS SCI, V48, P907, DOI 10.1167/iovs.06-0082; Bergers G, 2000, CURR OPIN GENET DEV, V10, P120, DOI 10.1016/S0959-437X(99)00043-X; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2010, J CELL COMMUN SIGNAL, V4, P63, DOI 10.1007/s12079-009-0080-4; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Di Giovanni S, 2012, CELL TISSUE RES, V349, P87, DOI 10.1007/s00441-011-1292-5; Doherty HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012909; Fleck BW, 2008, EARLY HUM DEV, V84, P83, DOI 10.1016/j.earlhumdev.2007.11.008; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hinton DR, 2004, DIABETES CARE, V27, P758, DOI 10.2337/diacare.27.3.758; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kalka C, 2000, HERZ, V25, P611, DOI 10.1007/PL00001974; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kociok N, 2006, INVEST OPHTH VIS SCI, V47, P5057, DOI 10.1167/iovs.06-0407; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; Kowluru RA, 2009, FREE RADICAL BIO MED, V46, P1677, DOI 10.1016/j.freeradbiomed.2009.03.024; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kuiper EJ, 2008, J HISTOCHEM CYTOCHEM, V56, P785, DOI 10.1369/jhc.2008.950980; Kuiper EJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1139, DOI 10.1369/jhc.7A7258.2007; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lee JG, 2005, P NATL ACAD SCI USA, V102, P16345, DOI 10.1073/pnas.0508085102; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; McVicar CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011870; Mohammad G, 2010, LAB INVEST, V90, P1365, DOI 10.1038/labinvest.2010.89; Pi LY, 2011, INVEST OPHTH VIS SCI, V52, P8701, DOI 10.1167/iovs.11-7870; Quinn GE, 2010, CHINESE MED J-PEKING, V123, P2929, DOI 10.3760/cma.j.issn.0366-6999.2010.20.033; Sakimoto S, 2012, DEVELOPMENT, V139, P1327, DOI 10.1242/dev.072330; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Twigg SM, 2001, ENDOCRINOLOGY, V142, P1760, DOI 10.1210/endo.142.5.8141; Vinores SA, 2007, J NEUROIMMUNOL, V182, P73, DOI 10.1016/j.jneuroim.2006.09.015; Watson MG, 2012, J R SOC INTERFACE, V9, P2351, DOI 10.1098/rsif.2012.0067; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Wunderlich K, 2000, GRAEF ARCH CLIN EXP, V238, P910, DOI 10.1007/s004170000199; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	69	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40570	40585		10.1074/jbc.M112.386565	http://dx.doi.org/10.1074/jbc.M112.386565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048035	Green Published, hybrid			2022-12-25	WOS:000311448800047
J	Rengel, D; Arribat, S; Maury, P; Martin-Magniette, ML; Hourlier, T; Laporte, M; Vares, D; Carrere, S; Grieu, P; Balzergue, S; Gouzy, J; Vincourt, P; Langlade, NB				Rengel, David; Arribat, Sandrine; Maury, Pierre; Martin-Magniette, Marie-Laure; Hourlier, Thibaut; Laporte, Marion; Vares, Didier; Carrere, Sebastien; Grieu, Philippe; Balzergue, Sandrine; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.			A Gene-Phenotype Network Based on Genetic Variability for Drought Responses Reveals Key Physiological Processes in Controlled and Natural Environments	PLOS ONE			English	Article							OSMOTIC ADJUSTMENT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; STRESS TOLERANCE; JASMONIC ACID; WATER-DEFICIT; ABIOTIC STRESS; DIFFERENTIAL EXPRESSION; PROLINE ACCUMULATION; ABA RESPONSES	Identifying the connections between molecular and physiological processes underlying the diversity of drought stress responses in plants is key for basic and applied science. Drought stress response involves a large number of molecular pathways and subsequent physiological processes. Therefore, it constitutes an archetypical systems biology model. We first inferred a gene-phenotype network exploiting differences in drought responses of eight sunflower (Helianthus annuus) genotypes to two drought stress scenarios. Large transcriptomic data were obtained with the sunflower Affymetrix microarray, comprising 32423 probesets, and were associated to nine morpho-physiological traits (integrated transpired water, leaf transpiration rate, osmotic potential, relative water content, leaf mass per area, carbon isotope discrimination, plant height, number of leaves and collar diameter) using sPLS regression. Overall, we could associate the expression patterns of 1263 probesets to six phenotypic traits and identify if correlations were due to treatment, genotype and/or their interaction. We also identified genes whose expression is affected at moderate and/or intense drought stress together with genes whose expression variation could explain phenotypic and drought tolerance variability among our genetic material. We then used the network model to study phenotypic changes in less tractable agronomical conditions, i.e. sunflower hybrids subjected to different watering regimes in field trials. Mapping this new dataset in the gene-phenotype network allowed us to identify genes whose expression was robustly affected by water deprivation in both controlled and field conditions. The enrichment in genes correlated to relative water content and osmotic potential provides evidence of the importance of these traits in agronomical conditions.	[Rengel, David; Hourlier, Thibaut; Vares, Didier; Carrere, Sebastien; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Rengel, David; Hourlier, Thibaut; Vares, Didier; Carrere, Sebastien; Gouzy, Jerome; Vincourt, Patrick; Langlade, Nicolas B.] CNRS, LIPM, UMR2594, Castanet Tolosan, France; [Arribat, Sandrine; Martin-Magniette, Marie-Laure; Balzergue, Sandrine] Univ Evry Val dEssonne, INRA, URGV, UMR1165,ERL CNRS 8196,CP 5708, Evry, France; [Maury, Pierre; Laporte, Marion; Grieu, Philippe] Univ Toulouse, INPT ENSAT, AGIR UMR1248, Castanet Tolosan, France; [Maury, Pierre; Laporte, Marion; Grieu, Philippe] INRA, AGIR UMR1248, F-31326 Castanet Tolosan, France; [Martin-Magniette, Marie-Laure] AgroParisTech, INRA, UMR518, Paris, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Langlade, NB (corresponding author), INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France.	Nicolas.Langlade@toulouse.inra.fr	Langlade, Nicolas/C-6191-2008; Gouzy, Jerome/AAH-4977-2020; Martin-Magniette, Marie-Laure/AAP-1644-2020	Langlade, Nicolas/0000-0002-5651-1446; Gouzy, Jerome/0000-0001-5695-4557; Martin-Magniette, Marie-Laure/0000-0003-4000-9600; Maury, Pierre/0000-0002-1271-2334; Carrere, Sebastien/0000-0002-2348-0778; Hourlier, Thibaut/0000-0003-4894-7773	ANR [ANR-07-GPLA-022]; National Institute for Agronomic Research (INRA); Laboratoire d'Excellence (LABEX) entitled TULIP [ANR-10-LABX-41]	ANR(French National Research Agency (ANR)); National Institute for Agronomic Research (INRA); Laboratoire d'Excellence (LABEX) entitled TULIP	This work was supported by funds from the ANR project entitled SUNYFUEL (ANR-07-GPLA-022), from a grant from the National Institute for Agronomic Research (INRA, "package 2007") and is part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; BOYER JS, 1968, PLANT PHYSIOL, V43, P1056, DOI 10.1104/pp.43.7.1056; Bray EA, 2002, ANN BOT-LONDON, V89, P803, DOI 10.1093/aob/mcf104; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Casadebaig P, 2008, EUR J AGRON, V28, P646, DOI 10.1016/j.eja.2008.02.001; Casadebaig P, 2011, AGR FOREST METEOROL, V151, P163, DOI 10.1016/j.agrformet.2010.09.012; Cechin I, 2006, PHOTOSYNTHETICA, V44, P143, DOI 10.1007/s11099-005-0171-2; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; CHIMENTI CA, 1993, EUPHYTICA, V71, P201, DOI 10.1007/BF00040409; CHIMENTI CA, 1994, PLANT SOIL, V166, P101, DOI 10.1007/BF02185486; Conn SJ, 2011, PLANT CELL, V23, P240, DOI 10.1105/tpc.109.072769; CONROY JP, 1988, PLANT PHYSIOL, V86, P1108, DOI 10.1104/pp.86.4.1108; Coque M., 2008, P 17 INT SUNFL C COR, P725; COSGROVE DJ, 1993, PLANT PHYSIOL, V102, P1, DOI 10.1104/pp.102.1.1; Cubillos FA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-117; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Cuin TA, 2008, PLANT SIGNAL BEHAV, V3, P207, DOI 10.4161/psb.3.3.4966; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geisler M., 2009, Genes for plant abiotic stress, P55, DOI 10.1002/9780813809380.ch3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Gimeno J, 2009, PLANT MOL BIOL, V70, P403, DOI 10.1007/s11103-009-9481-2; Golldack D, 2011, PLANT CELL REP, P1; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gouzy J, 2009, BIOINFORMATICS, V25, P670, DOI 10.1093/bioinformatics/btp024; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Isokpehi RD, 2011, BIOINFORMATICS BIOL, P5; JONES MM, 1980, AUST J PLANT PHYSIOL, V7, P181, DOI 10.1071/PP9800181; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Jury WA, 2005, P NATL ACAD SCI USA, V102, P15715, DOI 10.1073/pnas.0506467102; Kane NC, 2009, EVOLUTION, V63, P2061, DOI 10.1111/j.1558-5646.2009.00703.x; Kerstiens G, 1996, J EXP BOT, V47, P1813, DOI 10.1093/jxb/47.12.1813; Kiani SP, 2007, THEOR APPL GENET, V114, P193, DOI 10.1007/s00122-006-0419-7; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liu F, 2010, CELL RES, V20, P539, DOI 10.1038/cr.2010.36; Lorenz WW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-264; Manavella PA, 2008, PLANT J, V56, P376, DOI 10.1111/j.1365-313X.2008.03604.x; Manavella PA, 2006, PLANT J, V48, P125, DOI 10.1111/j.1365-313X.2006.02865.x; Maury P, 2000, PLANT SOIL, V223, P155, DOI 10.1023/A:1004849509673; MCCREE KJ, 1984, PLANT PHYSIOL, V76, P898, DOI 10.1104/pp.76.4.898; MERRIEN A, 1981, AGRONOMIE, V1, P917, DOI 10.1051/agro:19811013; Missihoun TD, 2011, PLANTA, V233, P369, DOI 10.1007/s00425-010-1297-4; MOJAYAD F, 1994, CROP SCI, V34, P103, DOI 10.2135/cropsci1994.0011183X003400010018x; Morizet J., 1990, TOURNESOL EAU, P7; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nolot Jean-Marie, 2003, Cahiers Agricultures, V12, P387; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pose D, 2009, PLANT J, V59, P63, DOI 10.1111/j.1365-313X.2009.03849.x; Przybyla D, 2008, PLANT J, V54, P236, DOI 10.1111/j.1365-313X.2008.03409.x; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; SADRAS VO, 1993, FIELD CROP RES, V31, P27, DOI 10.1016/0378-4290(93)90048-R; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Schafleitner R, 2007, PLANT PHYSIOL BIOCH, V45, P673, DOI 10.1016/j.plaphy.2007.06.003; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seiler GJ, 2004, EXPLORATION WILD HEL; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sinclair TR, 2005, AGRON J, V97, P1148, DOI 10.2134/agronj2004.0286; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Tardieu F, 2011, CURRENT OPINION PLAN; Tsay YF, 2011, ANNU REV PLANT BIOL, V62, P207, DOI 10.1146/annurev-arplant-042110-103837; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Vear F, 2008, EUPHYTICA, V164, P561, DOI 10.1007/s10681-008-9759-5; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wong CE, 2006, PLANT PHYSIOL, V140, P1437, DOI 10.1104/pp.105.070508; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang YY, 2007, J INTEGR PLANT BIOL, V49, P87, DOI 10.1111/j.1744-7909.2006.00417.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	107	40	42	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45249	10.1371/journal.pone.0045249	http://dx.doi.org/10.1371/journal.pone.0045249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056196	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500015
J	Falciani, C; Lozzi, L; Pollini, S; Luca, V; Carnicelli, V; Brunetti, J; Lelli, B; Bindi, S; Scali, S; Di Giulio, A; Rossolini, GM; Mangoni, ML; Bracci, L; Pini, A				Falciani, Chiara; Lozzi, Luisa; Pollini, Simona; Luca, Vincenzo; Carnicelli, Veronica; Brunetti, Jlenia; Lelli, Barbara; Bindi, Stefano; Scali, Silvia; Di Giulio, Antonio; Rossolini, Gian Maria; Mangoni, Maria Luisa; Bracci, Luisa; Pini, Alessandro			Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BRANCHED NEUROTENSIN PEPTIDES; HOST-DEFENSE PEPTIDES; IN-VIVO; STRATEGIES; LIPOSOMES; LL-37; LIPOPOLYSACCHARIDE; PROTEINASES; PROTEOLYSIS	The branched M33 antimicrobial peptide was previously shown to be very active against Gram-negative bacterial pathogens, including multidrug-resistant strains. In an attempt to produce back-up molecules, we synthesized an M33 peptide isomer consisting of D-aminoacids (M33-D). This isomeric version showed 4 to 16-fold higher activity against Gram-positive pathogens, including Staphylococcus aureus and Staphylococcus epidermidis, than the original peptide, while retaining strong activity against Gram-negative bacteria. The antimicrobial activity of both peptides was influenced by their differential sensitivity to bacterial proteases. The better activity shown by M33-D against S. aureus compared to M33-L was confirmed in biofilm eradication experiments where M33-L showed 12% activity with respect to M33-D, and in vivo models where Balb-c mice infected with S. aureus showed 100% and 0% survival when treated with M33-D and M33-L, respectively. M33-D appears to be an interesting candidate for the development of novel broad-spectrum antimicrobials active against bacterial pathogens of clinical importance.	[Falciani, Chiara; Lozzi, Luisa; Pollini, Simona; Lelli, Barbara; Bindi, Stefano; Scali, Silvia; Rossolini, Gian Maria; Bracci, Luisa; Pini, Alessandro] Univ Siena, Dipartimento Biotecnol Med, I-53100 Siena, Italy; [Carnicelli, Veronica; Di Giulio, Antonio] Univ Aquila, Dipartimento Sci & Tecnol Biomed, I-67100 Laquila, Italy; [Luca, Vincenzo; Mangoni, Maria Luisa] Univ Rome, Dipartimento Sci Biochim A Fanelli, Rome, Italy; [Brunetti, Jlenia] SetLance Srl, Siena, Italy; [Bindi, Stefano; Rossolini, Gian Maria; Bracci, Luisa; Pini, Alessandro] Azienda Osped Univ Senese, Policlin Le Scotte, Siena, Italy	University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of L'Aquila; Sapienza University Rome; University of Siena; University Hospital of Siena	Pini, A (corresponding author), Univ Siena, Dipartimento Biotecnol Med, Via Laterina 8, I-53100 Siena, Italy.	alessandro.pini@unisi.it	Brunetti, Luisa/E-6464-2019; Lozzi, Luisa/Q-8542-2018; Bracci, Luisa/V-9913-2018; Pini, Alessandro/R-1359-2018; Falciani, Chiara/R-1330-2018; LUCA, Vincenzo/AAV-7385-2020; Pollini, Simona/D-1709-2017	Brunetti, Luisa/0000-0001-8144-7186; Lozzi, Luisa/0000-0002-1603-8770; Bracci, Luisa/0000-0002-0738-5746; Pini, Alessandro/0000-0002-3832-8349; Falciani, Chiara/0000-0002-1027-8482; LUCA, Vincenzo/0000-0002-7834-0334; Mangoni, Maria Luisa/0000-0002-5991-5868; ROSSOLINI, Gian Maria/0000-0002-9386-0434; CARNICELLI, Veronica/0000-0003-3375-4637; DI GIULIO, Antonio/0000-0001-8777-0160	Italian Foundation for Cystic Fibrosis [24/2011]; Tuscan Regional Administration; PROGETTO PRIN [2008KCLR7M_004]	Italian Foundation for Cystic Fibrosis(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Tuscan Regional Administration; PROGETTO PRIN(Ministry of Education, Universities and Research (MIUR))	This research was financed by the Italian Foundation for Cystic Fibrosis (project FFC#24/2011 adopted by FFC delegations from Legnago, Varese, Reggio Emilia and Assistgroup), the Tuscan Regional Administration (Project SPAC: POR CReO FESR 2007-2013) and PROGETTO PRIN (2008KCLR7M_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TM, 2007, AM J HEALTH-SYST PH, V64, P819, DOI 10.2146/ajhp060473; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Coccia C, 2011, EUR BIOPHYS J BIOPHY, V40, P577, DOI 10.1007/s00249-011-0681-8; de Kreij A, 2000, J BIOL CHEM, V275, P31115, DOI 10.1074/jbc.M003889200; Epand RM, 2003, METHOD ENZYMOL, V372, P124; Falciani C, 2010, CURR CANCER DRUG TAR, V10, P695, DOI 10.2174/156800910793605875; Falciani C, 2007, MOL CANCER THER, V6, P2441, DOI 10.1158/1535-7163.MCT-07-0164; Falciani C, 2007, CHEM BIOL DRUG DES, V69, P216, DOI 10.1111/j.1747-0285.2007.00487.x; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hornef Mathias W., 2005, V86, P72, DOI 10.1159/000086652; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; Lai YP, 2007, MOL MICROBIOL, V63, P497, DOI 10.1111/j.1365-2958.2006.05540.x; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Michalopoulos A, 2008, CRIT CARE CLIN, V24, P377, DOI 10.1016/j.ccc.2007.12.003; MORIHARA K, 1964, J BACTERIOL, V88, P745, DOI 10.1128/JB.88.3.745-757.1964; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pini A, 2006, BIOCHEM J, V395, P157, DOI 10.1042/BJ20051747; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Pini A, 2008, CURR PROTEIN PEPT SC, V9, P468, DOI 10.2174/138920308785915227; Pini A, 2007, J PEPT SCI, V13, P393, DOI 10.1002/psc.858; Pini A, 2012, AMINO ACIDS, V43, P467, DOI 10.1007/s00726-011-1103-z; Pini A, 2010, FASEB J, V24, P1015, DOI 10.1096/fj.09-145474; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TEUFEL P, 1993, J BACTERIOL, V175, P4218, DOI 10.1128/JB.175.13.4218-4224.1993; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x	40	49	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46259	10.1371/journal.pone.0046259	http://dx.doi.org/10.1371/journal.pone.0046259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056272	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309452600031
J	Roessner, ED; Vitacolonna, M; Hohenberger, P				Roessner, Eric Dominic; Vitacolonna, Mario; Hohenberger, Peter			Confocal Laser Scanning Microscopy Evaluation of an Acellular Dermis Tissue Transplant (Epiflex (R))	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL RECONSTRUCTION; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; CLINICAL-EXPERIENCE; BASEMENT-MEMBRANE; IMMUNE-RESPONSE; ALPHA-GAL; SKIN; SCAFFOLDS	The structure of a biological scaffold is a major determinant of its biological characteristics and its interaction with cells. An acellular dermis tissue transplant must undergo a series of processing steps, to remove cells and genetic material and provide the sterility required for surgical use. During manufacturing and sterilization the structure and composition of tissue transplants may change. The composition of the human cell-free dermis transplant Epiflex (R) was investigated with specific attention paid to its structure, matrix composition, cellular content and biomechanics. We demonstrated that after processing, the structure of Epiflex remains almost unchanged with an intact collagen network and extracellular matrix (ECM) protein composition providing natural cell interactions. Although the ready to use transplant does contain some cellular and DNA debris, the processing procedure results in a total destruction of cells and active DNA which is a requirement for an immunologically inert and biologically safe substrate. Its biomechanical parameters do not change significantly during the processing.	[Roessner, Eric Dominic; Vitacolonna, Mario; Hohenberger, Peter] Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Mannheim, Germany	Ruprecht Karls University Heidelberg	Roessner, ED (corresponding author), Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Mannheim, Germany.	eric.roessner@googlemail.com		Smith, Mark D/0000-0003-0452-5982; Roessner, Eric Dominic/0000-0003-1173-1098				Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296; Arnold GA, 2009, VET SURG, V38, P834, DOI 10.1111/j.1532-950X.2009.00577.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Balbir-Gurman A, 2002, ANN RHEUM DIS, V61, P237, DOI 10.1136/ard.61.3.237; Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120; Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519; Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9; Butler CE, 2004, PLAST RECONSTR SURG, V114, P464, DOI 10.1097/01.PRS.0000132670.81794.7E; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; Dellgren G, 1999, SCAND CARDIOVASC J, V33, P259; Edelman David S, 2002, JSLS, V6, P203; Edwards C, 1995, CLIN DERMATOL, V13, P375, DOI 10.1016/0738-081X(95)00078-T; ELSNER P, 1990, BRIT J DERMATOL, V122, P607, DOI 10.1111/j.1365-2133.1990.tb07282.x; Erdag G, 2004, CELL TRANSPLANT, V13, P701, DOI 10.3727/000000004783983594; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gock H, 2004, TRANSPLANTATION, V77, P751, DOI 10.1097/01.TP.0000116420.17173.E4; Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379; Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Karpelowsky JS, 2010, PEDIATR SURG INT, V26, P315, DOI 10.1007/s00383-009-2501-0; Kim YG, 2008, PROTEOMICS, V8, P2596, DOI 10.1002/pmic.200700972; Kolker AR, 2005, ANN PLAS SURG, V55, P36, DOI 10.1097/01.sap.0000168248.83197.d4; Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Mertsching H, 2009, TRANSPLANTATION, V88, P203, DOI 10.1097/TP.0b013e3181ac15e1; Minuth WW, 2003, ZUKUNFTSTECHNOLOGIE; Miyagawa S, 2012, CURR OPIN ORGAN TRAN, V17, P174, DOI 10.1097/MOT.0b013e3283508189; Pearsall AW, 2003, ARTHROSCOPY, V19, P1091, DOI 10.1016/j.arthro.2003.10.015; PIERARD GE, 1977, ARCH DERMATOL RES, V260, P231, DOI 10.1007/BF00561418; Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688; Roessner E, 2010, CELL TISSUE IN PRESS; Roessner ED, 2009, J BIOMATER APPL; Rossner E, 2010, CELL TISSUE BANK; ROZENGURT E, 1995, CANCER SURV, V24, P81; Schwarzbauer J, 1999, CURR BIOL, V9, pR242, DOI 10.1016/S0960-9822(99)80153-5; Sheppard D, 2000, MATRIX BIOL, V19, P203, DOI 10.1016/S0945-053X(00)00065-2; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025; Wang JH, 2000, J BIOMED MATER RES, V51, P761, DOI 10.1002/1097-4636(20000915)51:4<761::AID-JBM26>3.3.CO;2-U; Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160; Xu H, 2012, J SHOULDER ELB SURG, V21, P580, DOI 10.1016/j.jse.2011.03.014; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071; Zervolea I, 2000, BIOCHEM BIOPH RES CO, V276, P785, DOI 10.1006/bbrc.2000.3544; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170; Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p	63	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45991	10.1371/journal.pone.0045991	http://dx.doi.org/10.1371/journal.pone.0045991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056225	gold, Green Submitted, Green Published			2022-12-25	WOS:000309452600019
J	Jiang, HM; An, LL; Lin, SM; Feng, G; Qiu, YQ				Jiang, Hongmei; An, Lingling; Lin, Simon M.; Feng, Gang; Qiu, Yuqing			A Statistical Framework for Accurate Taxonomic Assignment of Metagenomic Sequencing Reads	PLOS ONE			English	Article							GENERATION; BLAST	The advent of next-generation sequencing technologies has greatly promoted the field of metagenomics which studies genetic material recovered directly from an environment. Characterization of genomic composition of a metagenomic sample is essential for understanding the structure of the microbial community. Multiple genomes contained in a metagenomic sample can be identified and quantitated through homology searches of sequence reads with known sequences catalogued in reference databases. Traditionally, reads with multiple genomic hits are assigned to non-specific or high ranks of the taxonomy tree, thereby impacting on accurate estimates of relative abundance of multiple genomes present in a sample. Instead of assigning reads one by one to the taxonomy tree as many existing methods do, we propose a statistical framework to model the identified candidate genomes to which sequence reads have hits. After obtaining the estimated proportion of reads generated by each genome, sequence reads are assigned to the candidate genomes and the taxonomy tree based on the estimated probability by taking into account both sequence alignment scores and estimated genome abundance. The proposed method is comprehensively tested on both simulated datasets and two real datasets. It assigns reads to the low taxonomic ranks very accurately. Our statistical approach of taxonomic assignment of metagenomic reads, TAMER, is implemented in R and available at http://faculty.wcas.northwestern.edu/similar to hji403/MetaR.htm.	[Jiang, Hongmei; Qiu, Yuqing] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [An, Lingling] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ USA; [An, Lingling] Univ Arizona, Interdisciplinary Program Stat, Tucson, AZ USA; [Lin, Simon M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Lin, Simon M.] Univ Wisconsin, Inst Clin & Translat Res, Madison, WI USA; [Feng, Gang] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA	Northwestern University; University of Arizona; University of Arizona; University of Wisconsin System; University of Wisconsin Madison; Northwestern University	Jiang, HM (corresponding author), Northwestern Univ, Dept Stat, Evanston, IL 60208 USA.	hongmei@northwestern.edu	Jiang, Hongmei/AAU-2911-2021	An, Lingling/0000-0001-8273-0776	National Science Foundation [DMS 1043080, DMS 1222592]; National Institutes of Health [1UL1RR025011, UL1RR025741]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation (DMS 1043080 to HJ, LA, and SL, and DMS 1222592 to LA and HJ) and partially by National Institutes of Health (1UL1RR025011 to SL and UL1RR025741 to GF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belda-Ferre P, 2011, ISME J; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Clemente JC, 2010, BIOCOMPUT-PAC SYM, P3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Efron B., 1982, JACKKNIFE BOOTSTRAP; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/jour-nal.pone.0037919; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Richter DC, 2008, PLOS ONE, V3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sharma VK, 2012, PLOS ONE, V7; Team RDC, 2010, R LANG ENV STAT COMP; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	33	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46450	10.1371/journal.pone.0046450	http://dx.doi.org/10.1371/journal.pone.0046450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049702	Green Published, gold			2022-12-25	WOS:000309388500029
J	de Oliveira, EAG; Romeiro, NC; Ribeiro, ED; Santa-Catarina, C; Oliveira, AEA; Silveira, V; de Souza, GA; Venancio, TM; Cruz, MAL				Gamosa de Oliveira, Eduardo Alves; Romeiro, Nelilma Correia; Ribeiro, Elane da Silva; Santa-Catarina, Claudete; Amancio Oliveira, Antonia Elenir; Silveira, Vanildo; de Souza Filho, Goncalo Apolinario; Venancio, Thiago Motta; Lopes Cruz, Marco Antonio			Structural and Functional Characterization of the Protein Kinase Mps1 in Arabidopsis thaliana	PLOS ONE			English	Article							POLE BODY DUPLICATION; CYCLIN-DEPENDENT KINASES; PLANT-CELL CYCLE; SPINDLE-ASSEMBLY CHECKPOINT; LATERAL ROOT INITIATION; MITOTIC CHECKPOINT; PHOSPHORYLATION SITES; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; KINETOCHORE LOCALIZATION	In eukaryotes, protein kinases catalyze the transfer of a gamma-phosphate from ATP (or GTP) to specific amino acids in protein targets. In plants, protein kinases have been shown to participate in signaling cascades driving responses to environmental stimuli and developmental processes. Plant meristems are undifferentiated tissues that provide the major source of cells that will form organs throughout development. However, non-dividing specialized cells can also dedifferentiate and re-initiate cell division if exposed to appropriate conditions. Mps1 (Monopolar spindle) is a dual-specificity protein kinase that plays a critical role in monitoring the accuracy of chromosome segregation in the mitotic checkpoint mechanism. Although Mps1 functions have been clearly demonstrated in animals and fungi, its role in plants is so far unclear. Here, using structural and biochemical analyses here we show that Mps1 has highly similar homologs in many plant genomes across distinct lineages (e. g. AtMps1 in Arabidopsis thaliana). Several structural features (i.e. catalytic site, DFG motif and threonine triad) are clearly conserved in plant Mps1 kinases. Structural and sequence analysis also suggest that AtMps1 interact with other cell cycle proteins, such as Mad2 and MAPK1. By using a very specific Mps1 inhibitor (SP600125) we show that compromised AtMps1 activity hampers the development of A. thaliana seedlings in a dose-dependent manner, especially in secondary roots. Moreover, concomitant administration of the auxin IAA neutralizes the AtMps1 inhibition phenotype, allowing secondary root development. These observations let us to hypothesize that AtMps1 might be a downstream regulator of IAA signaling in the formation of secondary roots. Our results indicate that Mps1 might be a universal component of the Spindle Assembly Checkpoint machinery across very distant lineages of eukaryotes.	[Ribeiro, Elane da Silva; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Gamosa de Oliveira, Eduardo Alves; Lopes Cruz, Marco Antonio] Univ Fed Rio de Janeiro, Lab Biotecnol Vegetal, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil; [Gamosa de Oliveira, Eduardo Alves; Romeiro, Nelilma Correia] Univ Fed Rio de Janeiro, Lab Integrado Computacao Cient, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil; [Silveira, Vanildo; de Souza Filho, Goncalo Apolinario] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Rio De Janeiro, Brazil; [Santa-Catarina, Claudete] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Venancio, TM (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil.	thiago.venancio@gmail.com; marco.cruz@macae.ufrj.br	Venancio, Thiago M/B-5003-2011; Romeiro, Nelilma/H-8719-2013; Oliveira, Antonia Elenir Amancio/AAS-3885-2021; Santa-Catarina, Claudete/L-5531-2014; Ribeiro, Elane da Silva/Q-8192-2017; Silveira, Vanildo/E-8887-2011; de Souza Filho, Goncalo/S-7251-2017	Venancio, Thiago M/0000-0002-2215-8082; Oliveira, Antonia Elenir Amancio/0000-0002-2618-8916; Santa-Catarina, Claudete/0000-0002-1669-660X; Ribeiro, Elane da Silva/0000-0001-9315-3038; Silveira, Vanildo/0000-0001-5697-6932; Cruz, Marco Antonio Lopes/0000-0002-3013-657X; de Souza Filho, Goncalo/0000-0003-1028-4425	Universidade Estadual do Norte Fluminense Darcy Ribeiro; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Universidade Estadual do Norte Fluminense Darcy Ribeiro; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge Universidade Estadual do Norte Fluminense Darcy Ribeiro and the following Brazilian funding agencies for supporting our research: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2007, ANNU REV MICROBIOL, V61, P453, DOI 10.1146/annurev.micro.61.080706.093309; Aravind L, 2009, BIRTH DEFECTS RES C, V87, P143, DOI 10.1002/bdrc.20153; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Caillaud MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006757; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; de Jager SM, 2005, SEMIN CELL DEV BIOL, V16, P385, DOI 10.1016/j.semcdb.2005.02.004; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Denes D, 2011, ANN BOT-LONDON, V107, P1193, DOI 10.1093/aob/mcr038; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fischer MS, 2004, J ZOOL SYST EVOL RES, V42, P1; Fisk HA, 2004, CURR BIOL, V14, pR1058, DOI 10.1016/j.cub.2004.11.047; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Leyser O, 2010, PLANT PHYSIOL, V154, P501, DOI 10.1104/pp.110.161323; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Mironov V, 1999, PLANT CELL, V11, P509; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Pike AN, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-9; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Poss KD, 2002, DEVELOPMENT, V129, P5141; Robert Stephanie, 2009, Arabidopsis Book, V7, pe0109, DOI 10.1199/tab.0109; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sasabe M, 2011, P NATL ACAD SCI USA, V108, P17844, DOI 10.1073/pnas.1110174108; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suijkerbuijk SJE, 2008, BBA-REV CANCER, V1786, P24, DOI 10.1016/j.bbcan.2008.04.001; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Umeda M, 2005, PLANT CELL PHYSIOL, V46, P1437, DOI 10.1093/pcp/pci170; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang Huachun, 2007, Arabidopsis Book, V5, pe0106, DOI 10.1199/tab.0106; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	101	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45707	10.1371/journal.pone.0045707	http://dx.doi.org/10.1371/journal.pone.0045707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049844	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300045
J	Hoque, ME; Ghuman, S				Hoque, Muhammad Ehsanul; Ghuman, Shanaz			Knowledge, Practices, and Attitudes of Emergency Contraception among Female University Students in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							LEVONORGESTREL; GHANA	Objective: The purpose of this study is to investigate the knowledge, practices, and attitudes among female university students in South Africa regarding emergency contraceptives (EC). Methods: A cross-sectional study was conducted among 582 female university students who were selected using multi-stage sampling techniques. Multivariate logistic regression analysis was used to find significant predictors for EC awareness. Results: The average age of the female students was 20.9 years (SD = 3.0) and 57.2% were presently sexually active. Overall, 49.8% of the participants reported having heard about EC prior to the study. Regarding sexual activities among the female students, 53.2% reported to have sex, and 21.2% of the sexually experienced students used EC prior to the study. Regarding the effectiveness of EC, 29.5% students said it could be used up to 72 hours after unprotected sexual intercourse, and 8% said it could be used just before sex. About two-thirds (61.8%) would recommend the use of EC and 63.2% would use it if they needed. The multivariate analysis indicated that students who were older (>20 years), presently sexually active, and living with their parents were more likely to be aware of EC (p<0.05). Conclusion: The students' knowledge and utilization of EC were low. Health education and promotion should be targeted towards these students, and the EC services should be offered on campus.	[Hoque, Muhammad Ehsanul] Univ Limpopo, Sch Hlth Care Sci, Dept Publ Hlth, Pretoria, South Africa; [Ghuman, Shanaz] Mangosuthu Univ Technol, Dept Environm Hlth, Durban, South Africa	University of Limpopo; Mangosuthu University of Technology	Hoque, ME (corresponding author), Univ Limpopo, Sch Hlth Care Sci, Dept Publ Hlth, Medunsa Campus, Pretoria, South Africa.	muhammad.ehsanul@gmail.com			Academic Board & Research & Ethics Committee of Mangosuthu University of Technology	Academic Board & Research & Ethics Committee of Mangosuthu University of Technology	The authors wish to acknowledge the Academic Board & Research & Ethics Committee of Mangosuthu University of Technology for supporting the study. Also acknowledge Mrs. Chetty for editing the manuscript.	Abasiattai A M, 2007, Niger J Clin Pract, V10, P30; Addo VN, 2009, INT J GYNECOL OBSTET, V105, P206, DOI 10.1016/j.ijgo.2009.01.008; Adhikari Ramesh, 2009, BMC Womens Health, V9, P27, DOI 10.1186/1472-6874-9-27; Akani Ci, 2008, Ghana Med J, V42, P68; Baiden F, 2002, CONTRACEPTION, V66, P23, DOI 10.1016/S0010-7824(02)00315-3; CHENG L, 2004, COCHRANE DB SYST REV, V3; Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007; Department of Health Republic of South Africa, 2001, S AFR DEM HLTH SURV; Ebuehi O M, 2006, East Afr Med J, V83, P90; Ellertson C, 2003, OBSTET GYNECOL, V101, P1168, DOI 10.1016/S0029-7844(03)00352-1; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Grimes DA, 2002, ANN INTERN MED, V137, P180, DOI 10.7326/0003-4819-137-3-200208060-00010; Hariparsad N, 2001, EUR J CONTRACEP REPR, V6, P21; Hoque ME, 2011, GENDER BEHAV, V9, P3710; International Consortium for Emergency Contraception, 2004, EM CONTR PILLS; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Kistnasamy EJ, 2009, S AFR FAM PRACT, V51, P423, DOI 10.1080/20786204.2009.10873896; Kongnyuy EJ, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-7; Makiwane M, 2010, DEV SO AFR, V27, P193, DOI 10.1080/03768351003740498; Morroni Chelsea, 2006, BMC Pregnancy Childbirth, V6, P26, DOI 10.1186/1471-2393-6-26; Morroni C, 2006, SAMJ S AFR MED J, V96, P620; Mqhayi Mmabatho Margaret, 2004, Afr J Reprod Health, V8, P137, DOI 10.2307/3583187; Myer Landon, 2007, BMC Womens Health, V7, P14, DOI 10.1186/1472-6874-7-14; Nworah JAO, 2010, INT J MED SCI, V2, P001; Roberts Candice, 2004, J Obstet Gynaecol, V24, P441, DOI 10.1080/01443610410001685619; Rodrigues I, 2001, AM J OBSTET GYNECOL, V184, P531, DOI 10.1067/mob.2001.111102; Tamire W., 2007, Ethiopian Journal of Health Development, V21, P111; Tapia-Curiel Amparo, 2008, Rev Med Inst Mex Seguro Soc, V46, P33; Vahratian A, 2008, J WOMENS HEALTH, V17, P103, DOI 10.1089/jwh.2007.0391	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46346	10.1371/journal.pone.0046346	http://dx.doi.org/10.1371/journal.pone.0046346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050018	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300108
J	Prasad, R; Katiyar, SK				Prasad, Ram; Katiyar, Santosh K.			Bioactive Phytochemical Proanthocyanidins Inhibit Growth of Head and Neck Squamous Cell Carcinoma Cells by Targeting Multiple Signaling Molecules	PLOS ONE			English	Article							DEPENDENT KINASES; INDUCE APOPTOSIS; FACTOR RECEPTOR; CYCLE CONTROL; BCL-2 FAMILY; IN-VIVO; CANCER; THERAPY; PROTEIN; CASPASE-3	Despite advances in surgical and medical therapies, approximate 50% survival rate of head and neck squamous cell carcinoma (HNSCC) has had marginal improvement in the last 30 years. Therefore, alternative strategies are required for the management of HNSCC. Here, we report the chemotherapeutic effect of proanthocyanidins on HNSCC cells using in vitro and in vivo models. Treatment of human HNSCC cell lines from different sub-sites, such as oral cavity (SCC1), larynx (SCC5), tongue (OSC19) and pharynx (FaDu), with grape seed proanthocyanidins (GSPs) reduced their cell viability and induced cell death in a dose-and time-dependent manner. GSPs induced inhibition of cell viability was associated with: (i) G1-phase arrest, (ii) inhibition of expressions of cyclins (cyclin D1 and Cyclin D2) and cyclin-dependent kinases (Cdk), (iii) increased expression of the Cdk inhibitory proteins (Cip1/p21, Kip1/p27), enhanced binding of Cdk inhibitors to Cdks, and downregulation of E2F transcription factor. GSPs significantly (P<0.05-0.001) increased apoptosis of SCC1 and OSC19 cells with induction of Bax, reduced expression of Bcl-2, and activation of caspase-3. GSPs also reduced the expression of epidermal growth factor receptor (EGFR), and treatment of SCC1 cells with erlotinib, an EGFR-targeting small molecule tyrosine kinase inhibitor, significantly (P<0.05-0.001) reduced cell viability and increased cell death. Dietary administration of GSPs (0.5%, w/w) in supplementation with AIN76A control diet inhibited the growth of SCC1 tumor xenografts in athymic nude mice, which was associated with: (i) inhibition of cell proliferation, (ii) induction of apoptosis of tumor xenograft cells, (iii) decreased expression of cyclins and Cdks, (iv) decreased expression of EGFR, and (v) increased expression of Cip1/p21 and Kip1/p27 proteins and their increased binding to Cdks in tumor xenograft samples. Together, these results suggest that GSPs may be a promising candidate for head and neck squamous cell carcinoma therapy.	[Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Prasad, Ram; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Katiyar, SK (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.	skatiyar@uab.edu			Veterans Administration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; Arbes SJ, 1999, CANCER CAUSE CONTROL, V10, P513, DOI 10.1023/A:1008911300100; Bock JM, 2007, MOL CARCINOGEN, V46, P857, DOI 10.1002/mc.20318; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; DAY GL, 1992, CANCER, V70, P14, DOI 10.1002/1097-0142(19920701)70:1<14::AID-CNCR2820700103>3.0.CO;2-S; Epstein JB, 2001, HEAD NECK-J SCI SPEC, V23, P389, DOI 10.1002/hed.1049; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Friedlander P, 2002, HEAD NECK-J SCI SPEC, V24, P111, DOI 10.1002/hed.10015.abs; Gellrich NC, 2002, J ORAL MAXIL SURG, V60, P772, DOI 10.1053/joms.2002.33244; GRANA X, 1995, ONCOGENE, V11, P211; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; He YK, 1998, JNCI-J NATL CANCER I, V90, P1080, DOI 10.1093/jnci/90.14.1080; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Leon X, 2001, Expert Rev Anticancer Ther, V1, P125, DOI 10.1586/14737140.1.1.125; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Masuda M, 2011, J ONCOL, V2011, DOI 10.1155/2011/540148; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Perlmutter MA, 2002, ARCH OTOLARYNGOL, V128, P887, DOI 10.1001/archotol.128.8.887; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; Raina K, 2007, CANCER RES, V67, P5976, DOI 10.1158/0008-5472.CAN-07-0295; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; RICARDO-DA-SILVA JM, 1991, PHYTOCHEMISTRY, V30, P1259, DOI 10.1016/S0031-9422(00)95213-0; Roy AM, 2005, NEOPLASIA, V7, P24, DOI 10.1593/neo.04412; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sweeny L, 2012, LARYNGOSCOPE, V122, P1539, DOI 10.1002/lary.23266; Ye X, 1999, MOL CELL BIOCHEM, V196, P99, DOI 10.1023/A:1006926414683	45	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46404	10.1371/journal.pone.0046404	http://dx.doi.org/10.1371/journal.pone.0046404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050025	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300115
J	Strand, AE; Williams, LM; Oleksiak, MF; Sotka, EE				Strand, Allan E.; Williams, Larissa M.; Oleksiak, Marjorie F.; Sotka, Erik E.			Can Diversifying Selection Be Distinguished from History in Geographic Clines? A Population Genomic Study of Killifish (Fundulus heteroclitus)	PLOS ONE			English	Article							BIOCHEMICAL GENETICS; LDH-B; PHYLOGEOGRAPHY; POLYMORPHISMS; ADAPTATIONS; FREQUENCIES; DIVERGENCE; EXPRESSION; PROMISE; MODEL	A common geographical pattern of genetic variation is the one-dimensional cline. Clines may be maintained by diversifying selection across a geographical gradient but can also reflect historical processes such as allopatry followed by secondary contact. To identify loci that may be undergoing diversifying selection, we examined the distribution of geographical variation patterns across the range of the killifish (Fundulus heteroclitus) in 310 loci, including microsatellites, allozymes, and single nucleotide polymorphisms. We employed two approaches to detect loci under strong diversifying selection. First, we developed an automated method to identify clinal variation on a per-locus basis and examined the distribution of clines to detect those that exhibited signifcantly steeper slopes. Second, we employed a classic F-ST-outlier method as a complementary approach. We also assessed performance of these techniques using simulations. Overall, latitudinal clines were detected in nearly half of all loci genotyped (i.e., all eight microsatellite loci, 12 of 16 allozyme loci and 44% of the 285 SNPs). With the exception of few outlier loci (notably mtDNA and malate dehydrogenase), the positions and slopes of Fundulus clines were statistically indistinguishable. The high frequency of latitudinal clines across the genome indicates that secondary contact plays a central role in the historical demography of this species. Our simulation results indicate that accurately detecting diversifying selection using genome scans is extremely difficult in species with a strong signal of secondary contact; neutral evolution under this history produces clines as steep as those expected under selection. Based on these results, we propose that demographic history can explain all clinal patterns observed in F. heteroclitus without invoking natural selection to either establish or maintain the pattern we observe today.	[Strand, Allan E.; Sotka, Erik E.] Coll Charleston, Dept Biol, Grice Marine Lab, Charleston, SC 29424 USA; [Williams, Larissa M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Oleksiak, Marjorie F.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	College of Charleston; Woods Hole Oceanographic Institution; University of Miami	Strand, AE (corresponding author), Coll Charleston, Dept Biol, Grice Marine Lab, Charleston, SC 29424 USA.			Williams, Larissa/0000-0001-8972-9735	National Science Foundation [DEB-0919064, IOS-1052262]; Direct For Biological Sciences [1158241] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DEB-0919064 and IOS-1052262; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe TA, 2005, CAN J ZOOL, V83, P13; Adams SM, 2006, MOL ECOL, V15, P1109, DOI 10.1111/j.1365-294X.2006.02859.x; ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; ATZ JW, 1986, AM ZOOL, V26, P111; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES EVOLUTI; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; CASHON RE, 1981, BIOCHEM GENET, V19, P715, DOI 10.1007/BF00484004; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Endler J.A., 1977, Monographs in Population Biology, pi; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Flight PA, 2011, MOL ECOL, V20, P4503, DOI 10.1111/j.1365-294X.2011.05290.x; Gardner JPA, 1997, ADV MAR BIOL, V31, P1, DOI 10.1016/S0065-2881(08)60221-7; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; GONZALEZVILLASENOR LI, 1990, EVOLUTION, V44, P27, DOI 10.1111/j.1558-5646.1990.tb04277.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Haney RA, 2009, J HERED, V100, P284, DOI 10.1093/jhered/esn107; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kircheis Frederick W., 1998, North American Journal of Fisheries Management, V18, P175, DOI 10.1577/1548-8675(1998)018&lt;0175:SCAEVO&gt;2.0.CO;2; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; MITTON JB, 1975, GENETICS, V79, P97; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Powell Mark A., 1992, Molecular Marine Biology and Biotechnology, V1, P391; Powers DA, 1998, J EXP ZOOL, V282, P71; POWERS DA, 1978, BIOCHEM GENET, V16, P593, DOI 10.1007/BF00484222; ROPSON IJ, 1990, EVOLUTION, V44, P16, DOI 10.1111/j.1558-5646.1990.tb04276.x; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Schulte PM, 2001, COMP BIOCHEM PHYS B, V128, P597, DOI 10.1016/S1096-4959(00)00357-2; Schulte PM, 1997, GENETICS, V145, P759; SLATKIN M, 1973, GENETICS, V75, P733; Smith MW, 1998, MOL MAR BIOL BIOTECH, V7, P79; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Vasemagi A, 2006, GENETICS, V173, P2411, DOI 10.1534/genetics.106.059881; Whitehead A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-11; Williams LM, 2011, MOL BIOL EVOL, V28, P1817, DOI 10.1093/molbev/msr004; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Woodruff D S, 1978, Science, V199, P1329, DOI 10.1126/science.199.4335.1329	55	26	27	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45138	10.1371/journal.pone.0045138	http://dx.doi.org/10.1371/journal.pone.0045138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049770	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300016
J	Guzzo, C; Hopman, WM; Mat, NFC; Wobeser, W; Gee, K				Guzzo, Christina; Hopman, Wilma M.; Mat, Nor Fazila Che; Wobeser, Wendy; Gee, Katrina			IL-27-Induced Gene Expression Is Downregulated in HIV-Infected Subjects	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; I CYTOKINE RECEPTOR; CD4(+) T-CELLS; HUMAN MONOCYTES; UP-REGULATION; IL-27; INTERLEUKIN-27; MACROPHAGES; INTERFERON	Objective: To characterize the effect of HIV infection on IL-27-induced gene expression. Design: During HIV infection, cytokine expression and function become deregulated. IL-27 is an important modulator of inflammatory responses. Interestingly, IL-27 can inhibit HIV replication in T cells and monocytes, implicating IL-27 as a potential adjunct to anti-viral treatment. Our previous work demonstrated that circulating HIV may suppress IL-27 expression, therefore, this study, in continuation of our previous work, aimed to understand how HIV affects expression levels of the IL-27 receptor and downstream functions of IL-27. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from whole blood of HIV negative and HIV positive (viremic) individuals to assess IL-27-induced gene expression by flow cytometry and ELISA. PBMC were also processed for monocyte enrichment to assess IL-27 receptor expression by flow cytometry and real-time PCR. Results: Expression of the IL-27 receptor subunit, gp130, was upregulated in response to IL-27 in HIV negative individuals, however, in HIV positive individuals, this IL-27 response was diminished. Furthermore, we observed downregulation of IL-27-induced IL-6, TNF-alpha, and IL-10 expression in HIV positive subjects. Conclusion: In HIV infection, IL-27-induced gene expression was impaired, indicating HIV-mediated dysregulation of IL-27 functions occurs during HIV infection. This study provides evidence for new viral pathogenic mechanisms contributing to the widespread impairment of immune responses observed in HIV pathogenesis.	[Guzzo, Christina; Mat, Nor Fazila Che; Wobeser, Wendy; Gee, Katrina] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Hopman, Wilma M.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Wobeser, Wendy] Queens Univ, Dept Med, Div Infect Dis, Kingston, ON K7L 3N6, Canada; [Mat, Nor Fazila Che] Univ Sains Malaysia, Sch Hlth Sci, Kelantan, Malaysia	Queens University - Canada; Queens University - Canada; Queens University - Canada; Universiti Sains Malaysia	Gee, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	kgee@queensu.ca	MAT, NOR FAZILA CHE/M-3349-2015; Gee, Katrina/H-3093-2016	MAT, NOR FAZILA CHE/0000-0002-1698-3633; Gee, Katrina/0000-0002-7535-2882; Guzzo, Christina/0000-0002-3042-0976	Queen's University; National Sciences and Engineering Council of Canada (NSERC) [342168-07]; Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR) Vanier Scholarship	Queen's University; National Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR) Vanier Scholarship(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from Queen's University (www.queensu.ca,grant number: N/A) and the National Sciences and Engineering Council of Canada (NSERC) (www.nserc-crsng.gc.ca/index_eng.as, grant number: 342168-07). CG has been supported by a studentship from the Ontario HIV Treatment Network (OHTN; www.ohtn.on.ca) and the Canadian Institutes of Health Research (CIHR) Vanier Scholarship (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhetheel A, 2008, AIDS, V22, P1137, DOI 10.1097/QAD.0b013e3283013d42; Baqui AAMA, 2000, IMMUNOPHARM IMMUNOT, V22, P401, DOI 10.3109/08923970009026002; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; BIRX DL, 1990, BLOOD, V76, P2303; Canque B, 1996, BLOOD, V87, P2011; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; de Arquer GR, 2007, J LEUKOCYTE BIOL, V82, P72, DOI 10.1189/jlb.1106698; Demyanets S, 2012, VASC PHARMACOL, V56, P34, DOI 10.1016/j.vph.2011.12.004; Feng XM, 2008, BIOCHEMBIOPHYSRESCOM; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jones ML, 2003, AIDS RES HUM RETROV, V19, P283, DOI 10.1089/088922203764969483; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; McQuaid A, 2003, CLIN EXP IMMUNOL, V134, P321, DOI 10.1046/j.1365-2249.2003.02271.x; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; SADEGHI HM, 1995, J INFECT DIS, V172, P547, DOI 10.1093/infdis/172.2.547; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Tjernlund A, 2003, AIDS, V17, P1303, DOI 10.1097/00002030-200306130-00004; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wong CK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3067	30	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45706	10.1371/journal.pone.0045706	http://dx.doi.org/10.1371/journal.pone.0045706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049843	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100072
J	Lekas, M; Lekas, P; Mei, SHJ; Deng, YP; Dumont, DJ; Stewart, DJ				Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Dumont, Daniel J.; Stewart, Duncan J.			Tie2-Dependent Neovascularization of the Ischemic Hindlimb Is Mediated by Angiopoietin-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; NITRIC-OXIDE; INTRAMUSCULAR INJECTION; TYROSINE KINASE; CELL SURVIVAL; TIE2 RECEPTOR; GENE-TRANSFER; IN-VIVO; ANGIOGENESIS	The angiopoietins (ANGPT) are ligands for the endothelial cell (EC) receptor tyrosine kinase, Tie2. Angpt-1 is a Tie2 agonist that promotes vascular maturation and stabilization, whereas Angpt-2 is a partial agonist/antagonist involved in the initiation of postnatal angiogenesis. Therefore, we hypothesized that overexpression of Angpt-2 would be more effective than Angpt-1 for enhancing the perfusion recovery in the ischemic hindlimb. Perfusion recovery was markedly impaired in Tie2-deficient animals at day 35 in a model of chronic hindlimb ischemia. Injections of Angpt-2 or VEGFA plasmid at 7 days post femoral artery resection enhanced recovery and improved arteriogenesis as assessed by angiographic scores, whereas Angpt-1 or null plasmid had no effect. In addition, Angpt-2 together with VEGF resulted in greater improvement in perfusion and collateral vessel formation than VEGF alone. Similarly, conditional overexpression of Angpt-2 in mice improved ischemic limb blood flow recovery, while Angpt-1 overexpression was ineffective. These data from Tie2 heterozygote deficient mice demonstrate, for the first time, the importance of the Tie2 pathway in spontaneous neovascularization in response to chronic hindlimb ischemia. Moreover, they show that overexpression of the partial agonist, Angpt-2, but not Angpt-1, enhanced ischemic hind limb perfusion recovery and collateralization, suggesting that a coordinated sequence antagonist and agonist activity is required for effective therapeutic revascularization.	[Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Stewart, Duncan J.] Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Res Labs, Toronto, ON M5S 1A1, Canada; [Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Stewart, Duncan J.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Dumont, Daniel J.; Stewart, Duncan J.] Univ Toronto, Fac Med, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 1A1, Canada; [Dumont, Daniel J.] Sunnybrook Res Inst, Toronto, ON, Canada; [Mei, Shirley H. J.; Stewart, Duncan J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Mei, Shirley H. J.; Stewart, Duncan J.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Stewart, DJ (corresponding author), Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Res Labs, Toronto, ON M5S 1A1, Canada.	djstewart@ohri.ca		Mei, Shirley/0000-0003-4727-1177	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Physician Services Incorporated Foundation (PSI); Heart & Stroke Richard Lewar TACTICS Research Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Physician Services Incorporated Foundation (PSI); Heart & Stroke Richard Lewar TACTICS Research Fellowship	Financial support for this research work is provided by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC) and Physician Services Incorporated Foundation(PSI) funding grant. ML held a Heart & Stroke Richard Lewar TACTICS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, CIRC RES, V104, P1333, DOI 10.1161/CIRCRESAHA.109.196154; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Comerota AJ, 2002, J VASC SURG, V35, P930, DOI 10.1067/mva.2002.123677; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Goede V, 1998, LAB INVEST, V78, P1385; Hackett SF, 2000, J CELL PHYSIOL, V184, P275, DOI 10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z; Haninec AL, 2006, BIOCHEM BIOPH RES CO, V345, P1299, DOI 10.1016/j.bbrc.2006.04.149; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tanaka S, 1999, J CLIN INVEST, V103, P341, DOI 10.1172/JCI4891; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Yamauchi A, 2003, J GENE MED, V5, P994, DOI 10.1002/jgm.439; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	40	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43568	10.1371/journal.pone.0043568	http://dx.doi.org/10.1371/journal.pone.0043568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049737	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100008
J	Nacif-Pimenta, R; de Mattos, ACA; Orfano, AD; Barbosa, L; Pimenta, PFP; Coelho, PMZ				Nacif-Pimenta, Rafael; Alves de Mattos, Ana Carolina; Orfano, Alessandra da Silva; Barbosa, Luciene; Paolucci Pimenta, Paulo Filemon; Zech Coelho, Paulo Marcos			Schistosoma mansoni in Susceptible and Resistant Snail Strains Biomphalaria tenagophila: In Vivo Tissue Response and In Vitro Hemocyte Interactions	PLOS ONE			English	Article							DOMINANT CHARACTER; GLABRATA; COMPATIBILITY; SPOROCYSTS; PLASMA; PARTICIPATION; INFECTION; HEMOLYMPH; PROTEINS	Schistosomiasis is a parasitic disease that is highly prevalent, especially in developing countries. Biomphalaria tenagophila is an important invertebrate host of Schistosoma mansoni in Brazil, with some strains (e. g. Cabo Frio) being highly susceptible to the parasite, whereas others (e.g. Taim) are completely resistant to infection. Therefore, B. tenagophila is an important research model for studying immune defense mechanisms against S. mansoni. The internal defense system (IDS) of the snail comprises hemocytes and hemolymph factors acting together to recognize self from non-self molecular patterns to eliminate the threat of infection. We performed experiments to understand the cellular defenses related to the resistance and/or susceptibility of B. tenagophila to S. mansoni. During the early stages of infection, fibrous host cells of both snail strains were arranged as a thin layer surrounding the sporocysts. However, at later stages of infection, the cellular reactions in resistant snails were increasingly more intense, with thicker layers surrounding the parasites, in contrast to susceptible strains. All parasites were damaged or destroyed inside resistant snails after 10 h of infection. By contrast, parasites inside susceptible snails appeared to be morphologically healthy. We also performed experiments using isolated hemocytes from the two strains interacting with sporocysts. Hemocyte attachment started as early as 1 h after initial infection in both strains, but the killing of sporocysts was exclusive to hemocytes from the resistant strain and was time course dependent. The resistant strain was able to kill all sporocysts. In conclusion, our study revealed important aspects of the initial process of infection related to immune defense responses of strains of B. tenagophila that were resistant to S. mansoni compared with strains that were susceptible. Such information is relevant for the survival or death of the parasites and so is important in the development of control measures against this parasite.	[Alves de Mattos, Ana Carolina; Zech Coelho, Paulo Marcos] Ctr Pesquisas Rene Rachou Fiocruz, Lab Esquistossomose, Belo Horizonte, MG, Brazil; [Nacif-Pimenta, Rafael; Orfano, Alessandra da Silva; Paolucci Pimenta, Paulo Filemon] Ctr Pesquisas Rene Rachou Fiocruz, Lab Entomol Med, Belo Horizonte, MG, Brazil; [Barbosa, Luciene] Univ Fed Sergipe, Lab Entomol & Parasitol Trop, Aracaju, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Sergipe	Coelho, PMZ (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Lab Esquistossomose, Belo Horizonte, MG, Brazil.	coelhopm@cpqrr.fiocruz.br	Pimenta, Paulo/AAH-1502-2020; Coelho, Paulo Marcos Zech/ABE-6169-2021	Coelho, Paulo Marcos Zech/0000-0002-2443-8897	Fundacao Oswaldo Cruz	Fundacao Oswaldo Cruz	This work was supported by Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Azevedo CM, 2006, MEM I OSWALDO CRUZ, V101, P199, DOI 10.1590/S0074-02762006000900031; Barbosa L, 2006, MEM I OSWALDO CRUZ, V101, P639, DOI 10.1590/S0074-02762006000600010; Barbosa L, 2006, PARASITE IMMUNOL, V28, P209, DOI 10.1111/j.1365-3024.2006.00827.x; BASCH PF, 1976, EXP PARASITOL, V39, P150, DOI 10.1016/0014-4894(76)90022-9; BAYNE CJ, 1980, EXP PARASITOL, V50, P409, DOI 10.1016/0014-4894(80)90043-0; Bezerra F. S. D. M., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P197, DOI 10.1590/S0036-46651997000400003; Bezerra FSD, 2003, MEM I OSWALDO CRUZ, V98, P73, DOI 10.1590/S0074-02762003000100010; BOSWELL CA, 1986, IMMUNOLOGY, V57, P261; Chaia G, 1968, REV BRAS MALAR DOENC, V8, P355; CHENG TC, 1968, PAC SCI, V22, P141; Coelho JR, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000100022; Coelho PMZ, 2004, MEM I OSWALDO CRUZ, V99, P109, DOI 10.1590/S0074-02762004000900020; Cousin C, 1995, J PARASITOL, V81, P905, DOI 10.2307/3284038; COUSTAU C, 1994, J INVERTEBR PATHOL, V63, P82, DOI 10.1006/jipa.1994.1013; Fester T, 2008, J MICROSC-OXFORD, V231, P342, DOI 10.1111/j.1365-2818.2008.01999.x; GRANATH WO, 1984, EXP PARASITOL, V58, P188, DOI 10.1016/0014-4894(84)90034-1; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; JOKY A, 1983, DEV COMP IMMUNOL, V7, P669, DOI 10.1016/0145-305X(83)90090-3; KRUPA PL, 1977, J INVERTEBR PATHOL, V30, P35, DOI 10.1016/0022-2011(77)90034-9; Lemos Queli Teixeira, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P343, DOI 10.1590/S0037-86821999000400002; Lie KJ, 1979, IMMUNE RESPONSES PAR, P211; LoVerde P.T., 1984, Progress in Clinical and Biological Research, V157, P17; Martins-Souza RL, 2006, MEM I OSWALDO CRUZ, V101, P185, DOI 10.1590/S0074-02762006000900029; Martins-Souza RL, 2011, MEM I OSWALDO CRUZ, V106, P884, DOI 10.1590/S0074-02762011000700015; Mattos ACA, 2006, MEM I OSWALDO CRUZ, V101, P283, DOI 10.1590/S0074-02762006000900044; Meuleman EA, 1987, DEV COMP IMMUNOL, P116; Negrao-Correa D, 2007, ISJ-INVERT SURVIV J, V4, P101; Pan C, 1965, AM J TROP MED HYG, V14, P6; PARAENSE W. L., 1970, ESQUISTOSSOMOSE MANS, P13; PARAENSE WL, 1978, J PARASITOL, V64, P822, DOI 10.2307/3279509; Pellegrino J, 1968, Adv Parasitology, V6, P233, DOI 10.1016/S0065-308X(08)60475-3; Pereira CAJ, 2008, PARASITE IMMUNOL, V30, P610, DOI 10.1111/j.1365-3024.2008.01062.x; Richards C.S., 1976, Symposia Br Soc Parasit, V14, P45; RICHARDS CS, 1987, J PARASITOL, V73, P1146, DOI 10.2307/3282295; RICHARDS EH, 1991, J COMP PHYSIOL B, V161, P43, DOI 10.1007/BF00258745; Rosa FM, 2005, MEM I OSWALDO CRUZ, V100, P19, DOI 10.1590/S0074-02762005000100004; Rosa FM, 2004, MEM I OSWALDO CRUZ, V99, P85, DOI 10.1590/S0074-02762004000100015; SANTOS M. B. L., 1979, Revista do Instituto de Medicina Tropical de Sao Paulo, V21, P281; Silva LM, 2008, TOXICON, V51, P693, DOI 10.1016/j.toxicon.2007.12.009; Souza CP, 1993, THESIS ICB UFMG BELO; Souza SD, 2006, MEM I OSWALDO CRUZ, V101, P213, DOI 10.1590/S0074-02762006000900033; SPRAY FJ, 1988, COMP BIOCHEM PHYS B, V91, P619, DOI 10.1016/0305-0491(88)90182-4; Sullivan JT, 1990, T AM MICROSC SOC, V111, P1; Teodoro TM, 2010, MOL PHYLOGENET EVOL, V57, P144, DOI 10.1016/j.ympev.2010.05.019; VANDERKNAAP WPW, 1990, PARASITOL TODAY, V6, P175, DOI 10.1016/0169-4758(90)90349-9; YOSHINO TP, 1976, J MORPHOL, V150, P485; ZELCK UE, 1995, DEV COMP IMMUNOL, V19, P181, DOI 10.1016/0145-305X(95)00012-I	48	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45637	10.1371/journal.pone.0045637	http://dx.doi.org/10.1371/journal.pone.0045637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049828	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100062
J	Paulitschke, V; Gruber, S; Hofstatter, E; Haudek-Prinz, V; Klepeisz, P; Schicher, N; Jonak, C; Petzelbauer, P; Pehamberger, H; Gerner, C; Kunstfeld, R				Paulitschke, Verena; Gruber, Silke; Hofstaetter, Elisabeth; Haudek-Prinz, Verena; Klepeisz, Philipp; Schicher, Nikolaus; Jonak, Constanze; Petzelbauer, Peter; Pehamberger, Hubert; Gerner, Christopher; Kunstfeld, Rainer			Proteome Analysis Identified the PPAR gamma Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; IN-VITRO; MOLECULAR CHAPERONE; SIGNALING PATHWAYS; CANCER; EXPRESSION; GROWTH; AGONISTS; METASTASIS; APOPTOSIS	Peroxisome proliferator-activated receptors (PPARs) have been originally thought to be restricted to lipid metabolism or glucose homeostasis. Recently, evidence is growing that PPAR gamma ligands have inhibitory effects on tumor growth. To shed light on the potential therapeutic effects on melanoma we tested a panel of PPAR agonists on their ability to block tumor proliferation in vitro. Whereas ciglitazone, troglitazone and WY14643 showed moderate effects on proliferation, 15d-PGJ2 displayed profound anti-tumor activity on four different melanoma cell lines tested. Additionally, 15d-PGJ2 inhibited proliferation of tumor-associated fibroblasts and tube formation of endothelial cells. 15d-PGJ2 induced the tumor suppressor gene p21, a G(2)/M arrest and inhibited tumor cell migration. Shot gun proteome analysis in addition to 2D-gel electrophoresis and immunoprecipitation of A375 melanoma cells suggested that 15d-PGJ2 might exert its effects via modification and/or downregulation of Hsp-90 (heat shock protein 90) and several chaperones. Applying the recently established CPL/MUW database with a panel of defined classification signatures, we demonstrated a regulation of proteins involved in metastasis, transport or protein synthesis including paxillin, angio-associated migratory cell protein or matrix metalloproteinase-2 as confirmed by zymography. Our data revealed for the first time a profound effect of the single compound 15d-PGJ2 on melanoma cells in addition to the tumor-associated microenvironment suggesting synergistic therapeutic efficiency.	[Paulitschke, Verena; Gruber, Silke; Hofstaetter, Elisabeth; Schicher, Nikolaus; Jonak, Constanze; Petzelbauer, Peter; Pehamberger, Hubert; Kunstfeld, Rainer] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Haudek-Prinz, Verena; Klepeisz, Philipp; Gerner, Christopher] Med Univ Vienna, Dept Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Kunstfeld, R (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	rainer.kunstfeld@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022	Gerner, Christopher/0000-0003-4964-0642; Petzelbauer, Peter/0000-0001-7080-5259	Austrian Federal Reserve Bank [12215, 11425]; Interdisziplinarer Krebsforschungsfond; Hans und Blanca Moser Stipendium; Burgermeisterfond der Stadt Wien	Austrian Federal Reserve Bank; Interdisziplinarer Krebsforschungsfond; Hans und Blanca Moser Stipendium; Burgermeisterfond der Stadt Wien	This study was supported by the following grants of the Austrian Federal Reserve Bank: Project No. 12215 (VP) and No. 11425 (RK), the "Interdisziplinarer Krebsforschungsfond" (VP), "Hans und Blanca Moser Stipendium" (VP) and "Burgermeisterfond der Stadt Wien", (VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bundscherer A, 2009, ANTI-CANCER AGENT ME, V9, P816, DOI 10.2174/187152009789056912; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Ferruzzi P, 2005, J CLIN ENDOCR METAB, V90, P1332, DOI 10.1210/jc.2004-0978; Fievet C, 2009, CURR ATHEROSCLER REP, V11, P281, DOI 10.1007/s11883-009-0043-5; Funovics P, 2006, PROSTAG OTH LIPID M, V79, P230, DOI 10.1016/j.prostaglandins.2006.02.002; Galli A, 2004, GUT, V53, P1688, DOI 10.1136/gut.2003.031997; Gerner C, 2010, ELECTROPHORESIS, V31, P1822, DOI 10.1002/elps.200900753; Ortiz AG, 2010, CLIN TRANSL ONCOL, V12, P166, DOI 10.1007/s12094-010-0486-8; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Griss J, 2010, PROTEOMICS; Groger M, 2007, J INVEST DERMATOL, V127, P2893, DOI 10.1038/sj.jid.5701031; Grommes C, 2006, MOL PHARMACOL, V70, P1524, DOI 10.1124/mol.106.022194; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARPER JW, 1993, CELL, V75, P805; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoeller C, 2005, J INVEST DERMATOL, V124, P1300, DOI 10.1111/j.0022-202X.2005.23720.x; Hoeller C, 2005, J INVEST DERMATOL, V124, P1293, DOI 10.1111/j.0022-202X.2005.23685.x; Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982; Hofmeister V, 2008, CANCER IMMUNOL IMMUN, V57, P1, DOI 10.1007/s00262-007-0365-5; Kihara S, 1998, ATHEROSCLEROSIS, V136, P163, DOI 10.1016/S0021-9150(97)00207-4; Kubota T, 1998, CANCER RES, V58, P3344; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Li Y, 2006, MED ONCOL, V23, P393, DOI 10.1385/MO:23:3:393; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Mossner R, 2002, J INVEST DERMATOL, V119, P576, DOI 10.1046/j.1523-1747.2002.01861.x; MUELLER BM, 1991, CANCER RES, V51, P2193; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Paulitschke V, 2009, J INVEST DERMATOL; Paulitschke V, 2010, MOL MODULAR TUMOR TH; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Placha W, 2003, MELANOMA RES, V13, P447, DOI 10.1097/00008390-200310000-00003; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Prakash J, 2009, NEOPLASIA, V11, P1348, DOI 10.1593/neo.91188; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Schadendorf D, 2009, J INVEST DERMATOL, V129, P1061, DOI 10.1038/jid.2009.56; Schicher N, 2009, CLIN CANCER RES, V15, P3495, DOI 10.1158/1078-0432.CCR-08-2407; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Shen D, 2007, POSTGRAD MED J, V83, P414, DOI 10.1136/pmj.2006.052761; Shields JD, 2004, BRIT J CANCER, V90, P693, DOI 10.1038/sj.bjc.6601571; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Smith AG, 2009, INT J BIOCHEM CELL B, V41, P844, DOI 10.1016/j.biocel.2008.08.037; Torra IP, 2001, CURR OPIN LIPIDOL, V12, P245, DOI 10.1097/00041433-200106000-00002; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tsuzuki T, 2008, CARCINOGENESIS; Vandoros GP, 2006, J CANCER RES CLIN, V132, P76, DOI 10.1007/s00432-005-0042-z; Wimmer H, 2009, ELECTROPHORESIS, V30, P2076, DOI 10.1002/elps.200900072; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	57	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46103	10.1371/journal.pone.0046103	http://dx.doi.org/10.1371/journal.pone.0046103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049949	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100136
J	Vanoverberghe, K; Lehen'kyi, V; Thebault, S; Raphael, M; Vanden Abeele, F; Slomianny, C; Mariot, P; Prevarskaya, N				Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia			Cytoskeleton Reorganization as an Alternative Mechanism of Store-Operated Calcium Entry Control in Neuroendocrine-Differentiated Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; PLASMA-MEMBRANE; CA2+ INFLUX; IN-VITRO; INTRACELLULAR CA2+; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; TRP CHANNELS; LNCAP CELLS	Neuroendocrine differentiation (NED) is a hallmark of advanced androgen-independent prostate cancer, for which no successful therapy exists. NED tumour cells escape apoptotic cell death by alterations of Ca2+ homeostasis where the store-operated Ca2+ entry (SOCE) is known to be a key event. We have previously shown that the downregulation of Orai1 protein representing the major molecular component of endogenous SOCE in human prostate cancer cells, and constituting the principal source of Ca2+ influx used by the cell to trigger apoptosis, contributes to the establishment of an apoptosis-resistant phenotype (Cell Death Dis. 2010 Sep 16;1:e75.). Here, we report for the first time that the decrease of SOCE during NED may be caused by alternative NED-induced mechanism involving cytoskeleton reorganisation. NED induced by androgen deprivation resulted in a decrease of SOCE due to cortical F-actin over-polymerization which inhibits thapsigargin-induced SOCE. The disruption of F-actin polymerization by Cytochalasin D in NED cells restored SOCE, while the induction of F-actin polymerization by jasplakinolide or calyculin A diminished SOCE without changing the expression of key SOCE players: Orai1, STIM1, and TRPC1. Our data suggest that targeting cytoskeleton-induced pathways of malignant cells together with SOCE-involved channels may prove a useful strategy in the treatment of advanced prostate cancer.	[Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia] INSERM, Equipe Labellisee Ligue Natl Canc, U1003, Villeneuve Dascq, France; [Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia] USTL, Lab Excellence Ion Channels Sci & Therapeut, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Prevarskaya, N (corresponding author), INSERM, Equipe Labellisee Ligue Natl Canc, U1003, Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Slomianny, Christian/L-8285-2018; Thébault, Stéphanie/AAD-8350-2019; Vanden Abeele, Fabien/O-6012-2017; LEHEN'KYI, V'yacheslav/AAJ-6008-2020	LEHEN'KYI, V'yacheslav/0000-0003-0806-8766; Mariot, Pascal/0000-0001-7226-9162; Vanden Abeele, Fabien/0000-0001-7111-7220; Prevarskaya, natacha/0000-0003-0316-197X; Thebault, Stephanie/0000-0003-3233-282X	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer (ARC); Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer (ARC), the Ligue Nationale contre le Cancer and the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; AMBUDKAR IS, 2004, SCI STKE, pPE32; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P263; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P70; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P98; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bonkhoff H, 2001, ANN ONCOL, V12, pS141, DOI 10.1093/annonc/12.suppl_2.S141; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COHEN RJ, 1991, BRIT J UROL, V68, P258, DOI 10.1111/j.1464-410X.1991.tb15318.x; Di Sant'Agnese PA, 1998, UROLOGY, V51, P121, DOI 10.1016/S0090-4295(98)00064-8; diSantAgnese PA, 1996, CANCER, V78, P357, DOI 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; Donald CD, 2001, CELL MOL BIOL, V47, P1033; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fixemer T, 2002, PROSTATE, V53, P118, DOI 10.1002/pros.10133; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Grimaldi M, 1999, J BIOL CHEM, V274, P33557, DOI 10.1074/jbc.274.47.33557; HIRANO K, 1992, J MUSCLE RES CELL M, V13, P341, DOI 10.1007/BF01766462; Holda JR, 1997, FEBS LETT, V403, P191, DOI 10.1016/S0014-5793(97)00051-3; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HSIEH TC, 1995, EXP CELL RES, V218, P137, DOI 10.1006/excr.1995.1140; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; KREIENBUHL P, 1992, BLOOD, V80, P2911; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Montell C, 2004, NAT CELL BIOL, V6, P690, DOI 10.1038/ncb0804-690; Montell C, 2004, NOVART FDN SYMP, V258, P263; Montell C, 2004, NOVART FDN SYMP, V258, P12; Montell C, 2004, NOVART FDN SYMP, V258, P98; Montell Craig, 2004, Novartis Found Symp, V258, P3; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Peng JB, 2003, J PHYSIOL-LONDON, V551, P729, DOI 10.1113/jphysiol.2003.043349; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Putney James W Jr, 2004, Novartis Found Symp, V258, P123; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P155; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P133; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P263; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Rumpold H, 2002, PROSTATE, V53, P101, DOI 10.1002/pros.10129; Sanada M, 2004, NEUROREPORT, V15, P197, DOI 10.1097/00001756-200401190-00038; SHINOKI N, 1995, J CELL BIOCHEM, V59, P368, DOI 10.1002/jcb.240590308; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; TARLE M, 1994, PROSTATE, V24, P143, DOI 10.1002/pros.2990240308; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Vanden Abeele F, 2004, J BIOL CHEM; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Xing NZ, 2001, PROSTATE, V48, P7, DOI 10.1002/pros.1076; Xue Y, 1997, AM J PATHOL, V151, P1759; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8	70	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45615	10.1371/journal.pone.0045615	http://dx.doi.org/10.1371/journal.pone.0045615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049826	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100060
J	Yakala, GK; van der Heijden, R; Molema, G; Schipper, M; Wielinga, PY; Kleemann, R; Kooistra, T; Heeringa, P				Yakala, Gopala K.; van der Heijden, Roel; Molema, Grietje; Schipper, Martin; Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake; Heeringa, Peter			Beneficial Effects of an Alternating High- Fat Dietary Regimen on Systemic Insulin Resistance, Hepatic and Renal Inflammation and Renal Function	PLOS ONE			English	Article							DIABETES-MELLITUS; WEIGHT-GAIN; OBESITY; MICE; EXPRESSION; PREVENTION; DISEASE; RATS	Background: An Alternating high-cholesterol dietary regimen has proven to be beneficial when compared to daily high-cholesterol feeding. In the current study we explored whether the same strategy is applicable to a high-fat dietary regimen. Objective: To investigate whether an alternating high-fat dietary regimen can effectively diminish insulin resistance, hepatic and renal inflammation and renal dysfunction as compared to a continuous high-fat diet. Design: Four groups of male ApoE*3Leiden mice (n = 15) were exposed to different diet regimens for 20 weeks as follows: Group 1: low-fat diet (10 kcal% fat); Group 2: intermediate-fat diet (25 kcal% fat); Group 3: high-fat diet (45 kcal% fat) and Group 4: alternating-fat diet (10 kcal% fat for 4 days and 45 kcal% fat for 3 days in a week). Results: Compared to high fat diet feeding, the alternating and intermediate-fat diet groups had reduced body weight gain and did not develop insulin resistance or albuminuria. In addition, in the alternating and intermediate-fat diet groups, parameters of tissue inflammation were markedly reduced compared to high fat diet fed mice. Conclusion: Both alternating and intermediate-fat feeding were beneficial in terms of reducing body weight gain, insulin resistance, hepatic and renal inflammation and renal dysfunction. Thus beneficial effects of alternating feeding regimens on cardiometabolic risk factors are not only applicable for cholesterol containing diets but can be extended to diets high in fat content.	[Yakala, Gopala K.; van der Heijden, Roel; Molema, Grietje; Schipper, Martin; Heeringa, Peter] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake] TNO Metab Hlth Res, Leiden, Netherlands; [Yakala, Gopala K.; van der Heijden, Roel; Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake; Heeringa, Peter] Top Inst Food & Nutr, Wageningen, Netherlands	University of Groningen; Netherlands Organization Applied Science Research; Top Institute Food & Nutrition	Yakala, GK (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	g.k.yakala@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Molema, Grietje/0000-0002-4147-6676				Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hattori M, 1999, KIDNEY INT, V56, pS47, DOI 10.1046/j.1523-1755.1999.07112.x; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kodama N, 1999, KIDNEY INT, V56, pS174, DOI 10.1016/S0085-2538(15)46633-5; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Wielinga PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018432; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45866	10.1371/journal.pone.0045866	http://dx.doi.org/10.1371/journal.pone.0045866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049881	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100094
J	Yano, J; Kolls, JK; Happel, KI; Wormley, F; Wozniak, KL; Fidel, PL				Yano, Junko; Kolls, Jay K.; Happel, Kyle I.; Wormley, Floyd; Wozniak, Karen L.; Fidel, Paul L., Jr.			The Acute Neutrophil Response Mediated by S100 Alarmins during Vaginal Candida Infections Is Independent of the Th17-Pathway	PLOS ONE			English	Article							TH17 CELLS; T-CELLS; IMMUNITY; IL-17; EXPRESSION; INNATE; RESISTANCE; IL-22; IMMUNOPATHOGENESIS; INTERLEUKIN-1	Vulvovaginal candidiasis (VVC) caused by Candida albicans affects a significant number of women during their reproductive ages. Clinical observations revealed that a robust vaginal polymorphonuclear neutrophil (PMN) migration occurs in susceptible women, promoting pathological inflammation without affecting fungal burden. Evidence to date in the mouse model suggests that a similar acute PMN migration into the vagina is mediated by chemotactic S100A8 and S100A9 alarmins produced by vaginal epithelial cells in response to Candida. Based on the putative role for the Th17 response in mucosal candidiasis as well as S100 alarmin induction, this study aimed to determine whether the Th17 pathway plays a role in the S100 alarmin-mediated acute inflammation during VVC using the experimental mouse model. For this, IL-23p19(-/-), IL-17RA(-/-) and IL-22(-/-) mice were intravaginally inoculated with Candida, and vaginal lavage fluids were evaluated for fungal burden, PMN infiltration, the presence of S100 alarmins and inflammatory cytokines and chemokines. Compared to wild-type mice, the cytokine-deficient mice showed comparative levels of vaginal fungal burden and PMN infiltration following inoculation. Likewise, inoculated mice of all strains with substantial PMN infiltration exhibited elevated levels of vaginal S100 alarmins in both vaginal epithelia and secretions in the vaginal lumen. Finally, cytokine analyses of vaginal lavage fluid from inoculated mice revealed equivalent expression profiles irrespective of the Th17 cytokine status or PMN response. These data suggest that the vaginal S100 alarmin response to Candida does not require the cells or cytokines of the Th17 lineage, and therefore, the immunopathogenic inflammatory response during VVC occurs independently of the Th17-pathway.	[Yano, Junko; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Happel, Kyle I.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Crit Care Med, New Orleans, LA USA; [Wormley, Floyd; Wozniak, Karen L.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas at San Antonio (UTSA)	Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	pfidel@lsuhsc.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Wozniak, Karen/0000-0003-1798-2146	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health [R01 AI32556]; Louisiana Vaccine Center; Louisiana Board of Regents; South Louisiana Institute for Infectious Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032556] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health; Louisiana Vaccine Center; Louisiana Board of Regents; South Louisiana Institute for Infectious Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant R01 AI32556 (PLF Jr.) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH) http://www.niaid.nih.gov, and in part by Louisiana Vaccine Center http://www.louisianavc.org and South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana Board of Regents http://regents.state.la.us. This content is solely the responsibility of the authors and does not reflect the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barousse MM, 2004, SEX TRANSM INFECT, V80, P48, DOI 10.1136/sti.2002.003855; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dongari-Bagtzoglou A, 2005, J DENT RES, V84, P966, DOI 10.1177/154405910508401101; ELLER MS, 1995, J CELL SCI, V108, P2741; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 2003, MED MYCOL, V41, P97, DOI 10.1080/714043904; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; FIDEL PL, 1993, INFECT IMMUN, V61, P1990, DOI 10.1128/IAI.61.5.1990-1995.1993; Fidel PL, 2001, AM J REPROD IMMUNOL, V45, P200, DOI 10.1111/j.8755-8920.2001.450402.x; Fidel PL, 1999, HDB ANIMAL MODELS IN, P741; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; LeBlanc DM, 2006, INFECT IMMUN, V74, P3213, DOI 10.1128/IAI.01824-05; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.010; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; Sorenson BS, 2012, MUCOSAL IMMUNOL, V5, P66, DOI 10.1038/mi.2011.48; Taylor BN, 2000, MED MYCOL, V38, P419, DOI 10.1080/714030969; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	32	74	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46311	10.1371/journal.pone.0046311	http://dx.doi.org/10.1371/journal.pone.0046311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050010	gold, Green Published			2022-12-25	WOS:000309556100175
J	Rochelle, T; Daubon, T; Van Troys, M; Harnois, T; Waterschoot, D; Ampe, C; Roy, L; Bourmeyster, N; Constantin, B				Rochelle, Tristan; Daubon, Thomas; Van Troys, Marleen; Harnois, Thomas; Waterschoot, Davy; Ampe, Christophe; Roy, Lydia; Bourmeyster, Nicolas; Constantin, Bruno			p210(bcr-abl) induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1	FASEB JOURNAL			English	Article						isoform selectivity; cell migration; GTPases; actin-binding proteins; signalplex; leukemia	TUMOR-CELL INVASION; ACTIN-DEPOLYMERIZING FACTOR; BCR-ABL ONCOGENE; CHEMOTACTIC RESPONSE; RHO-GTPASES; LIM-KINASE; MIGRATION; COFILIN; BCR/ABL; PHOSPHORYLATION	We previously demonstrated that the BcrAbl oncogene, p210(bcr-abl), through its unique GEF domain, specifically activates RhoA and induces spontaneous amoeboid motility. We intend to study the pathways downstream RhoA controlling amoeboid motility. Mouse prolymphoblastic cells (Ba/F3 cell line) expressing different forms of Bcr-Abl were embedded in 3-dimensional (3D) Matrigel to study motility and explore the effects of inhibiting Rho pathway (inhibitors and siRNAs). The phosphorylation levels of cofilin-1 and destrin were analyzed by 2-dimensional electrophoresis. Composition of Bcr-Abl signalplex in different conditions was determined by coimmunoprecipitation. Ba/F3p190 and Ba/F3 expressing a mutant form of p210(bcr-abl) (unable to activate RhoA) cells presented a spontaneous motility, but not an amoeboid type. p210(bcr-abl)-induced amoeboid motility in a 3D matrix requires isoform-specific RhoA/ROCK-1/destrin signaling. Next to the conventional Rho/ROCK/MLC/myosin pathway, this pathway is a crucial determinant for amoeboid motility, specific for the destrin isoform (and not its coexpressed homologue cofilin-1). Also, the presence of destrin (and not cofilin-1) in the p210(bcr-abl) complex is dependent on ROCK1, and this signalplex is required for amoeboid motility. This underscores isoform-specific function within the ADF/cofilin family and provides new insight into Bcr-Abl signaling to amoeboid motility and possible impact on understanding chronic myeloid leukemia progression.-Rochelle, T., Daubon, T., Van Troys, M., Harnois, T., Waterschoot, D., Ampe, C., Roy, L., Bourmeyster, N., Constantin, B. p210(bcr-abl) induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1. FASEB J. 27, 123-134 (2013). www.fasebj.org	[Rochelle, Tristan; Daubon, Thomas; Roy, Lydia; Bourmeyster, Nicolas; Constantin, Bruno] Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; [Harnois, Thomas; Bourmeyster, Nicolas] Univ Poitiers, Plateforme Prote ProteomeUP, F-86022 Poitiers, France; [Van Troys, Marleen; Waterschoot, Davy; Ampe, Christophe] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium; [Van Troys, Marleen; Waterschoot, Davy; Ampe, Christophe] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; [Harnois, Thomas; Roy, Lydia; Bourmeyster, Nicolas] Ctr Hosp Univ Poitiers, Poitiers, France; [Roy, Lydia] INSERM, CIC 802, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Poitiers; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers	Bourmeyster, N (corresponding author), Univ Poitiers, CNRS, UMR 6187, Inst Physiol & Biol Cellulaires, Batiment B36,1 Rue Georges Bonnet, F-86022 Poitiers, France.	n.bourmeyster@chu-poitiers.fr	Constantin, Bruno/AAH-6463-2021	Bourmeyster, Nicolas/0000-0002-9563-5142; DAUBON, Thomas/0000-0002-0319-7617; Van Troys, Marleen/0000-0003-4283-8103; Constantin, Bruno/0000-0003-1668-581X	Ligue Nationale Contre le Cancer (Vienne, Charente-Maritime, Deux-Sevres, Loir-et-Cher); Sport et Collection; Association Pictave pour l'Etude des Maladies du SAng (APEMSA)	Ligue Nationale Contre le Cancer (Vienne, Charente-Maritime, Deux-Sevres, Loir-et-Cher); Sport et Collection; Association Pictave pour l'Etude des Maladies du SAng (APEMSA)	The authors thank Nathalie Piccirilli for efficient technical help with cell cultures and Anne Cantereau for the microscopy platform ImageUP. This work was realized using grants from the Ligue Nationale Contre le Cancer (Vienne, Charente-Maritime, Deux-Sevres, Loir-et-Cher), Sport et Collection, and Association Pictave pour l'Etude des Maladies du SAng (APEMSA). The authors declare no conflicts of interest.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Chang YC, 2009, ONCOGENE, V28, P4105, DOI 10.1038/onc.2009.260; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Daubon T, 2008, ONCOGENE, V27, P2673, DOI 10.1038/sj.onc.1210933; Estornes Y, 2007, INT J CANCER, V121, P2162, DOI 10.1002/ijc.22911; Fierro FA, 2008, J MOL BIOL, V377, P1082, DOI 10.1016/j.jmb.2008.01.085; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Geay JF, 2005, CANCER RES, V65, P2676, DOI 10.1158/0008-5472.CAN-04-2152; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gorlich A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026789; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Harnois T, 2003, ONCOGENE, V22, P6445, DOI 10.1038/sj.onc.1206626; Hirayama A, 2007, J LEUKOCYTE BIOL, V81, P720, DOI 10.1189/jlb.0506314; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Kuure S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001176; Kuzelova Katerina, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P261, DOI 10.2174/187152908786786241; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lee CF, 2010, PROTEOMICS, V10, P3321, DOI 10.1002/pmic.201000176; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Okada K, 1996, EXP CELL RES, V227, P116, DOI 10.1006/excr.1996.0256; Peled A, 2002, STEM CELLS, V20, P259, DOI 10.1634/stemcells.20-3-259; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; Salgia R, 1999, BLOOD, V94, P4233; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shi JJ, 2011, PEDIATR CARDIOL, V32, P297, DOI 10.1007/s00246-011-9920-0; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Torka R, 2006, EXP CELL RES, V312, P3857, DOI 10.1016/j.yexcr.2006.08.025; Unwin RD, 2005, J BIOL CHEM, V280, P6316, DOI 10.1074/jbc.M410598200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wertheim JA, 2003, BLOOD, V102, P2220, DOI 10.1182/blood-2003-01-0062; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152	58	12	12	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					123	134		10.1096/fj.12-205112	http://dx.doi.org/10.1096/fj.12-205112			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047898				2022-12-25	WOS:000313103200013
J	Schaap, IAT; Eghiaian, F; des Georges, A; Veigel, C				Schaap, Iwan A. T.; Eghiaian, Frederic; des Georges, Amedee; Veigel, Claudia			Effect of Envelope Proteins on the Mechanical Properties of Influenza Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; A VIRUS; ELECTRON-MICROSCOPY; CELL-MEMBRANES; ELASTIC PROPERTIES; VIRAL CAPSIDS; LOW PH; HEMAGGLUTININ; NEURAMINIDASE; PARTICLES	The envelope of the influenza virus undergoes extensive structural change during the viral life cycle. However, it is unknown how lipid and protein components of the viral envelope contribute to its mechanical properties. Using atomic force microscopy, here we show that the lipid envelope of spherical influenza virions is similar to 10 times softer (similar to 0.05 nanonewton nm(-1)) than a viral protein-capsid coat and sustains deformations of one-third of the virion's diameter. Compared with phosphatidylcholine liposomes, it is twice as stiff, due to membrane-attached protein components. We found that virus indentation resulted in a biphasic force-indentation response. We propose that the first phase, including a stepwise reduction in stiffness at similar to 10-nm indentation and similar to 100 piconewtons of force, is due to mobilization of membrane proteins by the indenting atomic force microscope tip, consistent with the glycoprotein ectodomains protruding similar to 13 nm from the bilayer surface. This phase was obliterated for bromelain-treated virions with the ectodomains removed. Following pH 5 treatment, virions were as soft as pure liposomes, consistent with reinforcing proteins detaching from the lipid bilayer. We propose that the soft, pH-dependent mechanical properties of the envelope are critical for the pH-regulated life cycle and support the persistence of the virus inside and outside the host.	[Schaap, Iwan A. T.; Eghiaian, Frederic; Veigel, Claudia] Natl Inst Med Res, London NW7 1AA, England; [des Georges, Amedee] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC National Institute for Medical Research; MRC Laboratory Molecular Biology	Veigel, C (corresponding author), Univ Munich, Dept Cellular Physiol, Schillerstr 44, D-80336 Munich, Germany.	claudia.veigel@med.uni-muenchen.de	Schaap, Iwan A. T./L-3177-2013; Georges, Amédée des/C-3588-2014	Schaap, Iwan A. T./0000-0001-6665-5104; Georges, Amédée des/0000-0002-9704-3781	Medical Research Council; Royal Society; Deutsche Forschungsgemeinschaft [SFB 863]; Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany; Marie Curie intra-European fellowship	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany; Marie Curie intra-European fellowship(European Commission)	This work was supported by the Medical Research Council, the Royal Society, Deutsche Forschungsgemeinschaft Grant SFB 863, and the Centre of Nanosciences, Ludwig-Maximilians Universitat Munchen, Germany.; Supported by a Marie Curie intra-European fellowship.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; Burleigh LM, 2005, J VIROL, V79, P1262, DOI 10.1128/JVI.79.2.1262-1270.2005; Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Delorme N, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030901; Dimova R, 2000, BIOPHYS J, V79, P340, DOI 10.1016/S0006-3495(00)76296-5; Dublineau A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028043; Giocondi MC, 2010, J GEN VIROL, V91, P329, DOI 10.1099/vir.0.015156-0; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Knipe DM, 2007, FIELDS VIROLOGY; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kol N, 2006, BIOPHYS J, V91, P767, DOI 10.1529/biophysj.105.079657; Laney DE, 1997, BIOPHYS J, V72, P806, DOI 10.1016/S0006-3495(97)78714-9; Li S, 2011, BIOPHYS J, V100, P637, DOI 10.1016/j.bpj.2010.12.3701; Lipowski R., 2004, STRUCTURE DYNAMICS M; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Mui B, 2003, METHOD ENZYMOL, V367, P3; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Shvartsman DE, 2003, J CELL BIOL, V163, P879, DOI 10.1083/jcb.200308142; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009	54	48	49	0	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41078	41088		10.1074/jbc.M112.412726	http://dx.doi.org/10.1074/jbc.M112.412726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048030	Green Published, hybrid			2022-12-25	WOS:000311887600025
J	Felisberto-Rodrigues, C; Blangy, S; Goulet, A; Vestergaard, G; Cambillau, C; Garrett, RA; Ortiz-Lombardia, M				Felisberto-Rodrigues, Catarina; Blangy, Stephanie; Goulet, Adeline; Vestergaard, Gisle; Cambillau, Christian; Garrett, Roger A.; Ortiz-Lombardia, Miguel			Crystal Structure of ATV(ORF273), a New Fold for a Thermo- and Acido-Stable Protein from the Acidianus Two-Tailed Virus	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; SECONDARY-STRUCTURE; ARCHAEAL VIRUS; FILAMENTOUS VIRUS; FEATURES; REFINEMENT; SOFTWARE; GEOMETRY; PROGRAM; SYSTEM	Acidianus two-tailed virus (ATV) infects crenarchaea of the genus Acidianus living in terrestrial thermal springs at extremely high temperatures and low pH. ATV is a member of the Bicaudaviridae virus family and undergoes extra-cellular development of two tails, a process that is unique in the viral world. To understand this intriguing phenomenon, we have undertaken structural studies of ATV virion proteins and here we present the crystal structure of one of these proteins, ATV(ORF273). ATV(ORF273) forms tetramers in solution and a molecular envelope is provided for the tetramer, computed from small-angle X-ray scattering (SAXS) data. The crystal structure has properties typical of hyperthermostable proteins, including a relatively high number of salt bridges. However, the protein also exhibits flexible loops and surface pockets. Remarkably, ATV(ORF273) displays a new alpha+beta protein fold, consistent with the absence of homologues of this protein in public sequence databases.	[Felisberto-Rodrigues, Catarina; Blangy, Stephanie; Goulet, Adeline; Cambillau, Christian; Ortiz-Lombardia, Miguel] Aix Marseille Univ, CNRS, AFMB, UMR 7257, Marseille, France; [Vestergaard, Gisle; Garrett, Roger A.] Univ Copenhagen, Archaea Ctr, Dept Biol, Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen	Ortiz-Lombardia, M (corresponding author), Aix Marseille Univ, CNRS, AFMB, UMR 7257, Campus Luminy, Marseille, France.	miguel.ortiz-lombardia@afmb.univ-mrs.fr	Garrett, Roger A/M-2450-2014	Garrett, Roger A/0000-0001-8452-9099; Vestergaard, Gisle/0000-0003-2541-4974; Goulet, Adeline/0000-0002-5971-9488	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/44380/2008]; Ville de Marseille; Danish Natural Science Research Council	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ville de Marseille(Region Provence-Alpes-Cote d'Azur); Danish Natural Science Research Council(Danish Natural Science Research Council)	C.F.-R. was funded by a doctoral fellowship from the Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/), Portugal (SFRH/BD/44380/2008). The Ville de Marseille (http://www.marseille.fr) provided a financial installation aid to M.O.-L. The Archaea Centre, Copenhagen was supported by a grant from the Danish Natural Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blanc E., 2011, BUSTER VERSION 2 11; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goulet A, 2010, J VIROL, V84, P5025, DOI 10.1128/JVI.01664-09; Goulet A, 2010, ACTA CRYSTALLOGR D, V66, P304, DOI 10.1107/S0907444909051798; Goulet A, 2009, P NATL ACAD SCI USA, V106, P21155, DOI 10.1073/pnas.0909893106; Goulet A, 2009, PROTEINS, V76, P1020, DOI 10.1002/prot.22448; Goulet A, 2009, PROTEIN SCI, V18, P1316, DOI 10.1002/pro.122; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hendlich M, 2003, J MOL BIOL, V326, P607, DOI 10.1016/S0022-2836(02)01408-0; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mochizuki T, 2012, P NATL ACAD SCI USA, V109, P13386, DOI 10.1073/pnas.1203668109; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; Prangishvili D, 2012, ARCH VIROL, V157, P791, DOI 10.1007/s00705-012-1229-7; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Scheele U, 2011, J VIROL, V85, P4812, DOI 10.1128/JVI.00072-11; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiang XY, 2005, J VIROL, V79, P8677, DOI 10.1128/JVI.79.14.8677-8686.2005; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	57	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45847	10.1371/journal.pone.0045847	http://dx.doi.org/10.1371/journal.pone.0045847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056221	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500021
J	Takarada, T; Nakamichi, N; Kitajima, S; Fukumori, R; Nakazato, R; Le, NQ; Kim, YH; Fujikawa, K; Kou, M; Yoneda, Y				Takarada, Takeshi; Nakamichi, Noritaka; Kitajima, Seiya; Fukumori, Ryo; Nakazato, Ryota; Nguyen Quynh Le; Kim, Yeong-Hun; Fujikawa, Koichi; Kou, Miki; Yoneda, Yukio			Promoted Neuronal Differentiation after Activation of Alpha4/Beta2 Nicotinic Acetylcholine Receptors in Undifferentiated Neural Progenitors	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; INTRACELLULAR CALCIUM LEVELS; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SUBVENTRICULAR ZONE; PARKINSONS-DISEASE; CEREBRAL-CORTEX; DENTATE GYRUS; ADULT	Background: Neural progenitor is a generic term used for undifferentiated cell populations of neural stem, neuronal progenitor and glial progenitor cells with abilities for proliferation and differentiation. We have shown functional expression of ionotropic N-methyl-D-aspartate (NMDA) and gamma-aminobutyrate type-A receptors endowed to positively and negatively regulate subsequent neuronal differentiation in undifferentiated neural progenitors, respectively. In this study, we attempted to evaluate the possible functional expression of nicotinic acetylcholine receptor (nAChR) by undifferentiated neural progenitors prepared from neocortex of embryonic rodent brains. Methodology/Principal Findings: Reverse transcription polymerase chain reaction analysis revealed mRNA expression of particular nAChR subunits in undifferentiated rat and mouse progenitors prepared before and after the culture with epidermal growth factor under floating conditions. Sustained exposure to nicotine significantly inhibited the formation of neurospheres composed of clustered proliferating cells and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide reduction activity at a concentration range of 1 mu M to 1 mM without affecting cell survival. In these rodent progenitors previously exposed to nicotine, marked promotion was invariably seen for subsequent differentiation into cells immunoreactive for a neuronal marker protein following the culture of dispersed cells under adherent conditions. Both effects of nicotine were significantly prevented by the heteromeric alpha 4 beta 2 nAChR subtype antagonists dihydro-beta-erythroidine and 4-(5-ethoxy-3-pyridinyl)-N-methyl-(3E)-3-buten-1-amine, but not by the homomeric alpha 7 nAChR subtype antagonist methyllycaconitine, in murine progenitors. Sustained exposure to nicotine preferentially increased the expression of Math1 among different basic helix-loop-helix proneural genes examined. In undifferentiated progenitors from embryonic mice defective of NMDA receptor subunit-1, nicotine was still effective in significantly inhibiting the proliferation. Conclusions/Significance: Functional alpha 4 beta 2 nAChR subtype would be constitutively expressed to play a role in the mechanism underlying the determination of proliferation and subsequent differentiation fate into a neuronal lineage in association with preferential promotion of Math1 expression in undifferentiated neural progenitors of developing rodent neocortex independently of NMDA receptor activation.	[Takarada, Takeshi; Nakamichi, Noritaka; Kitajima, Seiya; Fukumori, Ryo; Nakazato, Ryota; Nguyen Quynh Le; Kim, Yeong-Hun; Fujikawa, Koichi; Kou, Miki; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020; Nakamichi, Noritaka/D-8403-2015; Nakamichi, Noritaka/AAB-7388-2020	Yoneda, Yukio/0000-0002-4624-177X; Nakamichi, Noritaka/0000-0002-0283-3546; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 21659018]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research to T. T. (No. 22500330) and Y.Y. (No. 21659018) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; Atluri P, 2001, DEV BIOL, V240, P143, DOI 10.1006/dbio.2001.0453; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Cavanagh JFR, 1997, CEREB CORTEX, V7, P293, DOI 10.1093/cercor/7.4.293; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joo JY, 2007, J CELL SCI, V120, P1358, DOI 10.1242/jcs.002154; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kitayama T, 2004, J NEUROSCI RES, V76, P599, DOI 10.1002/jnr.20095; Kitayama T, 2003, J NEUROCHEM, V84, P767, DOI 10.1046/j.1471-4159.2003.01567.x; Lacomme M, 2012, MOL CELL BIOL, V32, P2596, DOI 10.1128/MCB.06745-11; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; Liu L, 1998, BRAIN RES, V809, P238, DOI 10.1016/S0006-8993(98)00862-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MORENS DM, 1995, NEUROLOGY, V45, P1041, DOI 10.1212/WNL.45.6.1041; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamichi N, 2009, J PHARMACOL SCI, V110, P133, DOI 10.1254/jphs.08R03CR; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Rathouz MM, 1996, MOL NEUROBIOL, V12, P117, DOI 10.1007/BF02740649; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; SEGUELA P, 1993, J NEUROSCI, V13, P596; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Weiland S, 2000, BEHAV BRAIN RES, V113, P43, DOI 10.1016/S0166-4328(00)00199-6; Yoneyama M, 2008, J NEUROSCI RES, V86, P2392, DOI 10.1002/jnr.21696; Yoneyama M, 2007, J NEUROCHEM, V100, P1667, DOI 10.1111/j.1471-4159.2006.04322.x; Young A, 2011, NEUROSCIENCE, V192, P793, DOI 10.1016/j.neuroscience.2011.04.039	43	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46177	10.1371/journal.pone.0046177	http://dx.doi.org/10.1371/journal.pone.0046177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056257	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800013
J	Jaine, FRA; Couturier, LIE; Weeks, SJ; Townsend, KA; Bennett, MB; Fiora, K; Richardson, AJ				Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Weeks, Scarla J.; Townsend, Kathy A.; Bennett, Michael B.; Fiora, Kym; Richardson, Anthony J.			When Giants Turn Up: Sighting Trends, Environmental Influences and Habitat Use of the Manta Ray Manta alfredi at a Coral Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; SPATIAL DYNAMICS; NINGALOO REEF; WHALE SHARKS; CATCH RATES; ZOOPLANKTON; CIRCULATION; CURRENTS; SEA	Manta rays Manta alfredi are present all year round at Lady Elliot Island (LEI) in the southern Great Barrier Reef, Australia, with peaks in abundance during autumn and winter. Drivers influencing these fluctuations in abundance of M. alfredi at the site remain uncertain. Based on daily count, behavioural, weather and oceanographic data collected over a three-year period, this study examined the link between the relative number of sightings of manta rays at LEI, the biophysical environment, and the habitat use of individuals around the LEI reef using generalised additive models. The response variable in each of the three generalised additive models was number of sightings (per trip at sea) of cruising, cleaning or foraging M. alfredi. We used a set of eleven temporal, meteorological, biological, oceanographic and lunar predictor variables. Results for cruising, cleaning and foraging M. alfredi explained 27.5%, 32.8% and 36.3% of the deviance observed in the respective models and highlighted five predictors (year, day of year, wind speed, chlorophyll-a concentration and fraction of moon illuminated) as common influences to the three models. There were more manta rays at LEI in autumn and winter, slower wind speeds, higher productivity, and around the new and full moon. The winter peak in sightings of foraging M. alfredi was found to precede peaks in cleaning and cruising activity around the LEI reef, which suggests that enhanced food availability may be a principal driver for this seasonal aggregation. A spatial analysis of behavioural observations highlighted several sites around the LEI reef as 'multi-purpose' areas where cleaning and foraging activities commonly occur, while the southern end of the reef is primarily a foraging area. The use of extensive citizen science datasets, such as those collected by dive operators in this study, is encouraged as they can provide valuable insights into a species' ecology.	[Jaine, Fabrice R. A.; Weeks, Scarla J.] Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia; [Jaine, Fabrice R. A.; Couturier, Lydie I. E.; Richardson, Anthony J.] CSIRO Marine & Atmospher Res, Ecosci Precinct, Climate Adaptat Flagship, Dutton Pk, Australia; [Couturier, Lydie I. E.; Bennett, Michael B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Townsend, Kathy A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Townsend, Kathy A.] Univ Queensland, Moreton Bay Res Stn, Dunwich, Australia; [Fiora, Kym] Lady Elliot Isl Eco Resort, Watersports, Torquay, Australia; [Richardson, Anthony J.] Univ Queensland, Sch Math & Phys, Ctr Applicat Nat Resource Math, St Lucia, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Queensland; University of Queensland	Jaine, FRA (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Biophys Oceanog Grp, St Lucia, Qld, Australia.	f.jaine@uq.edu.au	Richardson, Anthony J/B-3649-2010; Bennett, Michael/A-7218-2012; Couturier, Lydie I. E./J-9695-2014; Bennett, Michael/L-4483-2019; Jaine, Fabrice/D-1622-2016; Townsend, Kathy Ann/K-9486-2016; Weeks, Scarla J/E-8632-2013; Couturier, Lydie/I-9793-2019	Richardson, Anthony J/0000-0002-9289-7366; Couturier, Lydie I. E./0000-0002-3885-3397; Bennett, Michael/0000-0001-8051-0040; Jaine, Fabrice/0000-0002-9304-5034; Townsend, Kathy Ann/0000-0002-2581-2158; Weeks, Scarla J/0000-0002-0579-7069; Couturier, Lydie/0000-0002-3885-3397	Australian Research Council [LP110100712]; University of Queensland; Earthwatch Institute Australia; Brother Pty Ltd; Lady Elliot Island Eco Resort	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); Earthwatch Institute Australia; Brother Pty Ltd; Lady Elliot Island Eco Resort	This work was funded by the Australian Research Council (Linkage Grant LP110100712) and supported by the University of Queensland, Earthwatch Institute Australia, Brother Pty Ltd and Lady Elliot Island Eco Resort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; ANDREWS JC, 1989, DEEP-SEA RES, V36, P957, DOI 10.1016/0198-0149(89)90037-X; ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; [Anonymous], 1967, TREATISE LIMNOL; ATKINSON LP, 1978, B MAR SCI, V28, P667; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bhattacharjee Y, 2005, SCIENCE, V308, P1402, DOI 10.1126/science.308.5727.1402; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Burrage DM, 1996, REMOTE SENS ENVIRON, V56, P21, DOI 10.1016/0034-4257(95)00226-X; Carleton JH, 2001, MAR BIOL, V139, P705; Choukroun S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005761; Clark T.B., 2010, THESIS U HAWAII MANO; Cotton PA, 2005, FISH OCEANOGR, V14, P151, DOI 10.1111/j.1365-2419.2005.00331.x; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Delaney DG, 2008, BIOL INVASIONS, V10, P117, DOI 10.1007/s10530-007-9114-0; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; FLAGG CN, 1994, DEEP-SEA RES PT II, V41, P411, DOI 10.1016/0967-0645(94)90030-2; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; GRIFFIN DA, 1987, AUST J MAR FRESH RES, V38, P461; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; GYURIS E, 1994, CORAL REEFS, V13, P137, DOI 10.1007/BF00301189; HAMNER WM, 1981, LIMNOL OCEANOGR, V26, P1084, DOI 10.4319/lo.1981.26.6.1084; HAMNER WM, 1977, AUST J MAR FRESH RES, V28, P333; Hastie GD, 2005, ICES J MAR SCI, V62, P760, DOI 10.1016/j.icesjms.2005.02.004; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Homma K, 1999, PROCEEDINGS OF THE 5TH INDO-PACIFIC FISH CONFERENCE, P209; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jaine FRA, J FISH BIOL IN PRESS; KLEYPAS JA, 1994, INT J REMOTE SENS, V15, P2051, DOI 10.1080/01431169408954227; Klimley AP, 2001, MAR BIOL, V138, P1; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Luiz OJ, 2009, ICHTHYOL RES, V56, P96, DOI 10.1007/s10228-008-0060-3; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2010, AFR J MAR SCI, V32, P573, DOI 10.2989/1814232X.2010.538152; Marshall A.D., 2009, THESIS U QUEENSLAND; Marshall AD, 2009, ZOOTAXA, P1; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; O'Dor RK, 2002, B MAR SCI, V71, P601; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; OREILLY JE, 2000, 2000206892 NASA GO 3, V11; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Pillans RD, 2006, THESIS U QUEENSLAND; PLOURDE S, 1993, MAR ECOL PROG SER, V102, P217, DOI 10.3354/meps102217; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; PRESSLEY PH, 1980, ENVIRON BIOL FISH, V5, P153; RECHER H F, 1972, Emu, V72, P85; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Samoilys MA, 1997, MAR ECOL PROG SER, V160, P149, DOI 10.3354/meps160149; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V382, P77, DOI 10.1016/j.jembe.2009.10.015; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Walsh WA, 2001, FISH RES, V53, P115, DOI 10.1016/S0165-7836(00)00306-4; Weeks SJ, 2010, CORAL REEFS, P1; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson SG, 2001, ENVIRON BIOL FISH, V61, P1, DOI 10.1023/A:1011069914753; WOLANSKI E, 1994, MARINE SCI SERIES; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	87	73	76	2	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46170	10.1371/journal.pone.0046170	http://dx.doi.org/10.1371/journal.pone.0046170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056255	Green Submitted, Green Published, gold			2022-12-25	WOS:000309454000022
J	Wang, JH; Chen, XT; Wen, ZS; Zheng, M; Deng, JM; Wang, MZ; Lin, HX; Chen, K; Li, J; Yun, JP; Luo, RZ; Song, LB				Wang, Jian-Hua; Chen, Xiu-Ting; Wen, Zhe-Sheng; Zheng, Min; Deng, Jian-Ming; Wang, Ming-Zhi; Lin, Huan-Xin; Chen, Kun; Li, Jun; Yun, Jing-Ping; Luo, Rong-Zhen; Song, Li-Bing			High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis	PLOS ONE			English	Article							CANCER; GOLGI; MTOR	Background: Whether the expression of Golgi phosphoprotein 3 (GOLPH3) correlates with esophageal cancer tumorigenesis is currently unclear. The aim of this study was to examine GOLPH3 expression in patients with esophageal squamous cell cancer (ESCC) and explore its clinical significance. Methods: Differences in the expression of GOLPH3 at the mRNA and protein level were examined via quantitative reverse transcriptase PCR and western blotting, respectively. GOLPH3 expression levels in ESCC tissue were determined through immunohistochemistry, and were compared in accordance with specific clinicopathological features of the patients and tissue specimens. Factors associated with patient survival were also analyzed. Results: A notably higher level of GOLPH3 expression was found in ESCC cell lines and tissues at both mRNA and protein levels. High expression of GOLPH3 in ESCC patients was positively associated with clinical stage, TNM classification, histological differentiation and vital status (all P < 0.0001). Expression of GOLPH3 was found to be an independent prognostic factor in ESCC patients. ESCC patients expressing high levels of GOLPH3 exhibited a substantially lower 5-year overall survival than GOLPH3-negative patients. Furthermore, a significant correlation between high GOLPH3 expression and shorter overall survival time was found in different subgroups of ESCC patients stratified by the clinical stage, T classification, and lymph node metastasis. Conclusions: Experiments demonstrated potential involvement of GOLPH3 in the development, differentiation, and tumorigenesis of ESCC, and concludes the possibility of its use as a diagnostic and prognostic marker in patients with ESCC.	[Wang, Jian-Hua; Deng, Jian-Ming; Wang, Ming-Zhi] Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China; [Chen, Xiu-Ting; Wen, Zhe-Sheng; Zheng, Min; Song, Li-Bing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Zhe-Sheng] Sun Yat Sen Univ, Ctr Canc, Dept Chest, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Min] Sun Yat Sen Univ, Ctr Canc, Dept Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huan-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Yun, Jing-Ping; Luo, Rong-Zhen] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Kun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Inst Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, JH (corresponding author), Second Peoples Hosp Guangdong Prov, Dept Chest, Guangzhou, Guangdong, Peoples R China.	wangjh296@163.com	Song, LB/AAL-1968-2020		Guangdong Provincial Medical Research Foundation [A2009143]; National Natural Science Foundation of China [81171948]; Natural Science Foundation of China [30900569]	Guangdong Provincial Medical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Provincial Medical Research Foundation (No. A2009143), supported in part by the National Natural Science Foundation of China (grant 81171948) to Min Zheng, and supported in part by the Natural Science Foundation of China (No. 30900569) to Li-Bing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Ganesh B, 2009, CANCER EPIDEMIOL, V33, P431, DOI 10.1016/j.canep.2009.09.002; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Planchamp C, 2007, MOL PHARMACOL, V71, P1089, DOI 10.1124/mol.106.030759; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Tong L, 2012, DIS ESOPHAGUS, V25, P72, DOI 10.1111/j.1442-2050.2011.01211.x; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	17	53	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45622	10.1371/journal.pone.0045622	http://dx.doi.org/10.1371/journal.pone.0045622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056210	Green Published, Green Submitted, gold			2022-12-25	WOS:000309452600011
J	Lildballe, DL; Mutti, E; Birn, H; Nexo, E				Lildballe, Dorte L.; Mutti, Elena; Birn, Henrik; Nexo, Ebba			Maximal Load of the Vitamin B12 Transport System: A Study on Mice Treated for Four Weeks with High-Dose Vitamin B12 or Cobinamide	PLOS ONE			English	Article							COBALAMIN ANALOGS; INTRINSIC-FACTOR; HUMAN-PLASMA; HAPTOCORRIN; BINDING; INSULIN; B12	Several studies suggest that the vitamin B12 (B12) transport system can be used for the cellular delivery of B12-conjugated drugs, also in long-term treatment Whether this strategy will affect the endogenous metabolism of B12 is not known. To study the effect of treatment with excess B12 or an inert derivative, we established a mouse model using implanted osmotic minipumps to deliver saline, cobinamide (Cbi) (4.25 nmol/h), or B12 (1.75 nmol/h) for 27 days (n = 7 in each group). B12 content and markers of B12 metabolism were analysed in plasma, urine, kidney, liver, and salivary glands. Both Cbi and B12 treatment saturated the transcobalamin protein in mouse plasma. Cbi decreased the content of B12 in tissues to 33-50% of the level in control animals but did not influence any of the markers examined. B12 treatment increased the tissue B12 level up to 350%. In addition, the transcript levels for methylenetetrahydrofolate reductase in kidneys and for transcobalamin and transcobalamin receptor in the salivary glands were reduced. Our study confirms the feasibility of delivering drugs through the B12 transport system but emphasises that B12 status should be monitored because there is a risk of decreasing the transport of endogenous B12. This risk may lead to B12 deficiency during prolonged treatment.	[Lildballe, Dorte L.; Mutti, Elena; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Lildballe, Dorte L.] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Lildballe, DL (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	dolild@rm.dk	Mutti, Elena/M-8056-2016; Birn, Henrik/C-3931-2009	Mutti, Elena/0000-0001-5621-4786; Birn, Henrik/0000-0003-3715-7266; Nexo, Ebba/0000-0001-9406-9081	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Briggs C, 2000, CLIN LAB HAEMATOL, V22, P345, DOI 10.1046/j.1365-2257.2000.00330.x; Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Heimann M, 2009, LAB ANIM-UK, V43, P255, DOI 10.1258/la.2008.007073; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Nielsen MJ, 2012, NAT REV GASTROENTERO; Petrus AK, 2009, CHEMMEDCHEM, V4, P421, DOI 10.1002/cmdc.200800346; Roche, 2012, VIT B12 AN US EL COB; ROSENTHAL WS, 1967, BLOOD-J HEMATOL, V30, P198, DOI 10.1182/blood.V30.2.198.198; RUSSELLJONES GJ, 1995, BIOCONJUGATE CHEM, V6, P34, DOI 10.1021/bc00031a600; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Tamura J, 1999, CLIN EXP IMMUNOL, V116, P28; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wang XY, 2007, BIOORGAN MED CHEM, V15, P1780, DOI 10.1016/j.bmc.2006.11.036; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	23	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46657	10.1371/journal.pone.0046657	http://dx.doi.org/10.1371/journal.pone.0046657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049711	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388500038
J	Shi, JJ; Petrie, HT				Shi, Jianjun; Petrie, Howard T.			Activation Kinetics and Off-Target Effects of Thymus-Initiated Cre Transgenes	PLOS ONE			English	Article							T-CELL DEVELOPMENT; IMMATURE THYMOCYTES; EXPRESSION; RECOMBINASE; RECEPTOR; MICE; CD4; MICROENVIRONMENTS; TOXICITY; PROTEIN	The bacteriophage enzyme Cre is a site-specific recombinase widely used to delete loxP-flanked DNA sequences in lineage-specific fashion. Several mouse lines that direct Cre expression to lymphoid progenitors in the thymus have been established, but a side-by-side comparison of when they first become active, and/or their relative efficiency at various developmental stages, has been lacking. In this study, we evaluated these in four common Cre transgenic strains with thymus-initiated promoters (Lck, Cd2, or Cd4). We found that while all of them eventually labeled nearly all thymocytes, their kinetics were dramatically different, and other than Cd4[Cre], did not faithfully recapitulate the expression pattern of the corresponding endogenous gene. Perhaps even more importantly, while thymuses from some strains compared favorably to thymuses from control (Cre-negative) mice, we found that Cre expression could also result in off-target effects, including moderate to severe decreases in thymic cellularity. These effects occurred in the absence of loxP-flanked DNA target genes, and were dose and copy number dependent. Loss of cellularity was attributable to a specific decrease in CD4(+)8(+) immature cells, and corresponds to an increased rate of programmed cell death. In addition to a comprehensive analysis of activation kinetics in thymus-initiated Cre transgenes, our data show that Cre is toxic to CD4(+)8(+) cells in a dose-dependent fashion, and emphasize that the choice of thymus-initiated Cre strain is critically important for minimizing off-target effects of Cre.	[Shi, Jianjun; Petrie, Howard T.] Scripps Res Inst, Jupiter, FL USA	Scripps Research Institute	Shi, JJ (corresponding author), Scripps Res Inst, Jupiter, FL USA.	hpetrie@scripps.edu	shi, Jianjun/A-3351-2011	shi, Jianjun/0000-0002-5856-1025	Public Health Service [R01AG034876]; The Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE ON AGING [R01AG034876] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); The Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Public Health Service grant R01AG034876. JS is supported by a fellowship from The Frenchman's Creek Women for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Jeannotte L, 2011, GENESIS, V49, P152, DOI 10.1002/dvg.20720; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; REYNOLDS PJ, 1990, MOL CELL BIOL, V10, P4266, DOI 10.1128/MCB.10.8.4266; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V36, P269; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Shi JJ, 2011, BLOOD, V118, P2511, DOI 10.1182/blood-2011-04-346726; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yuan JS, 2011, BLOOD, V117, P1184, DOI 10.1182/blood-2010-07-296616	25	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46590	10.1371/journal.pone.0046590	http://dx.doi.org/10.1371/journal.pone.0046590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049709	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388500036
J	Hurtado, MD; Acosta, A; Riveros, PP; Baum, BJ; Ukhanov, K; Brown, AR; Dotson, CD; Herzog, H; Zolotukhin, S				Hurtado, Maria D.; Acosta, Andres; Riveros, Paola P.; Baum, Bruce J.; Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.; Herzog, Herbert; Zolotukhin, Sergei			Distribution of Y-Receptors in Murine Lingual Epithelia	PLOS ONE			English	Article							NEUROPEPTIDE YY1 RECEPTOR; PANCREATIC-POLYPEPTIDE; PROTEIN EXPRESSION; MICE LACKING; PEPTIDE YY; RAT-BRAIN; CELLS; PROLIFERATION; INTERNALIZATION; MIGRATION	Peptide hormones and their cognate receptors belonging to neuropeptide Y (NPY) family mediate diverse biological functions in a number of tissues. Recently, we discovered the presence of the gut satiation peptide YY (PYY) in saliva of mice and humans and defined its role in the regulation of food intake and body weight maintenance. Here we report the systematic analysis of expression patterns of all NPY receptors (Rs), Y1R, Y2R, Y4R, and Y5R in lingual epithelia in mice. Using four independent assays, immunohistochemistry, in situ hybridization, immunocytochemistry and RT PCR, we show that the morphologically different layers of the keratinized stratified epithelium of the dorsal layer of the tongue express Y receptors in a very distinctive yet overlapping pattern. In particular, the monolayer of basal progenitor cells expresses both Y1 and Y2 receptors. Y1Rs are present in the parabasal prickle cell layer and the granular layer, while differentiated keratinocytes display abundant Y5Rs. Y4Rs are expressed substantially in the neuronal fibers innervating the lamina propria and mechanoreceptors. Basal epithelial cells positive for Y2Rs respond robustly to PYY3-36 by increasing intracellular Ca2+ suggesting their possible functional interaction with salivary PYY. In taste buds of the circumvallate papillae, some taste receptor cells (TRCs) express YRs localized primarily at the apical domain, indicative of their potential role in taste perception. Some of the YR-positive TRCs are co-localized with neuronal cell adhesion molecule (NCAM), suggesting that these TRCs may have synaptic contacts with nerve terminals. In summary, we show that all YRs are abundantly expressed in multiple lingual cell types, including epithelial progenitors, keratinocytes, neuronal dendrites and TRCs. These results suggest that these receptors may be involved in the mediation of a wide variety of functions, including proliferation, differentiation, motility, taste perception and satiation.	[Hurtado, Maria D.; Zolotukhin, Sergei] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA; [Acosta, Andres] Univ Florida, Dept Med, Gainesville, FL USA; [Riveros, Paola P.; Baum, Bruce J.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.] Univ Florida, Dept Neurosci, Ctr Smell & Taste, Gainesville, FL 32610 USA; [Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.] Univ Florida, Dept Psychiat, Ctr Smell & Taste, Gainesville, FL 32610 USA; [Herzog, Herbert] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Garvan Institute of Medical Research	Zolotukhin, S (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32611 USA.	szlt@ufl.edu	Riveros, Paola/AAL-4161-2021; Brown, Alicia/C-6478-2008	Brown, Alicia/0000-0001-6602-7917; , Herbert/0000-0002-1713-1029; Hurtado, Maria Daniela/0000-0002-2322-7334	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK62302-01]; Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062302] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Intramural Research of the National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 1R01DK62302-01 (National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases) to SZ; the Division of Intramural Research of the National Institute of Dental and Craniofacial Research in part supported this research (BB). HH is funded by an NHMRC of Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; Dawidson I, 1996, LIFE SCI, V60, P269, DOI 10.1016/S0024-3205(96)00627-3; Dumont Y, 2002, NEUROPEPTIDE RECEPTO; Fabry M, 2000, EUR J BIOCHEM, V267, P5631, DOI 10.1046/j.1432-1327.2000.01631.x; Fetissov SO, 2004, J COMP NEUROL, V470, P256, DOI 10.1002/cne.11047; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; Ghersi G, 2001, PEPTIDES, V22, P453, DOI 10.1016/S0196-9781(01)00340-0; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Mahomed F, 2010, J ORAL PATHOL MED, V39, P121, DOI 10.1111/j.1600-0714.2009.00834.x; Mannon PJ, 2000, BIOCHEM J, V350, P655, DOI 10.1042/0264-6021:3500655; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Ralevic V, 1998, PHARMACOL REV, V50, P413; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Stanic D, 2008, P NATL ACAD SCI USA, V105, P3610, DOI 10.1073/pnas.0712303105; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Stanic D, 2011, J COMP NEUROL, V519, P1219, DOI 10.1002/cne.22608; Tipoe GL, 1996, ORAL ONCOL, V32B, P24, DOI 10.1016/0964-1955(95)00049-6; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Yoshida R, 2010, INT REV CEL MOL BIO, V279, P101, DOI 10.1016/S1937-6448(10)79004-3; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	34	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46358	10.1371/journal.pone.0046358	http://dx.doi.org/10.1371/journal.pone.0046358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050020	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300110
J	Mahfouz, H; Ragnini-Wilson, A; Venditti, R; De Matteis, MA; Wilson, C				Mahfouz, Hichem; Ragnini-Wilson, Antonella; Venditti, Rossella; De Matteis, Maria Antonietta; Wilson, Cathal			Mutational Analysis of the Yeast TRAPP Subunit Trs20p Identifies Roles in Endocytic Recycling and Sporulation	PLOS ONE			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-TRANSPORT; CRYSTAL-STRUCTURE; GOLGI-APPARATUS; MEMBRANE; COMPLEX; ER; RETRIEVAL; ENCODES	Trs20p is a subunit of the evolutionarily conserved TRAPP (TRAnsport Protein Particle) complex that mediates various aspects of membrane trafficking. Three TRAPP complexes have been identified in yeast with roles in ER-to-Golgi trafficking, post-Golgi and endosomal-to-Golgi transport and in autophagy. The role of Trs20p, which is essential for viability and a component of all three complexes, and how it might function within each TRAPP complex, has not been clarified to date. To begin to address the role of Trs20p we generated different mutants by random mutagenesis but, surprisingly, no defects were observed in diverse anterograde transport pathways or general secretion in Trs20 temperature-sensitive mutants. Instead, mutation of Trs20 led to defects in endocytic recycling and a block in sporulation/meiosis. The phenotypes of different mutants appear to be separable suggesting that the mutations affect the function of Trs20 in different TRAPP complexes.	[Venditti, Rossella; De Matteis, Maria Antonietta; Wilson, Cathal] Telethon Inst Genet & Med, Naples, Italy; [Ragnini-Wilson, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Mahfouz, Hichem; Ragnini-Wilson, Antonella] Consorzio Mario Negri Sud, Chieti, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Rome Tor Vergata; Consorzio Mario Negri Sud	Wilson, C (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	wilson@tigem.it	De Matteis, Maria Antonietta/AHE-5161-2022; Ragnini, Antonella/A-8089-2014; Venditti, Rossella/AAT-4281-2020	De Matteis, Maria Antonietta/0000-0003-0053-3061; Ragnini, Antonella/0000-0001-7963-7554; Venditti, Rossella/0000-0002-1884-6501; Wilson, Cathal/0000-0002-0637-8608	Telethon [GGP07075, GGP08183, GGP06166]; AIRC [IG 8623]	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Telethon grants GGP07075 to CW, GGP08183 to ARW, GGP06166 to MADM and the AIRC grant IG 8623 to MADM (http://www.telethon.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Belgareh-Touze N, 2003, TRAFFIC, V4, P607, DOI 10.1034/j.1600-0854.2003.00116.x; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; KAYTOR MD, 1995, YEAST, V11, P1147, DOI 10.1002/yea.320111205; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Montpetit B, 2009, TRAFFIC, V10, P713, DOI 10.1111/j.1600-0854.2009.00895.x; Morishita M, 2007, TRAFFIC, V8, P1231, DOI 10.1111/j.1600-0854.2007.00606.x; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Wagner W, 2002, EMBO J, V21, P6397, DOI 10.1093/emboj/cdf650; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Zhang CJ, 2002, YEAST, V19, P1075, DOI 10.1002/yea.903; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	59	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e41408	10.1371/journal.pone.0041408	http://dx.doi.org/10.1371/journal.pone.0041408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049729	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300004
J	Ostapenko, D; Burton, JL; Solomon, MJ				Ostapenko, Denis; Burton, Janet L.; Solomon, Mark J.			Identification of Anaphase Promoting Complex Substrates in S-cerevisiae	PLOS ONE			English	Article							SPINDLE CHECKPOINT; PSEUDOSUBSTRATE INHIBITION; DEPENDENT DEGRADATION; MEDIATED PROTEOLYSIS; MITOTIC SPINDLE; KEN BOX; YEAST; APC; UBIQUITIN; KINASE	The Anaphase-Promoting Complex/Cyclosome (APC/C) is an essential ubiquitin ligase that targets numerous proteins for proteasome-mediated degradation in mitosis and G1. To gain further insight into cellular pathways controlled by APC/C-Cdh1, we developed two complementary approaches to identify additional APC/C-Cdh1 substrates in budding yeast. First, we analyzed the stabilities of proteins that were expressed at the same time in the cell cycle as known APC/C substrates. Second, we screened for proteins capable of interacting with the Cdh1 substrate-binding protein in a yeast two-hybrid system. Here we characterize five potential APC/C substrates identified using these approaches: the transcription factors Tos4 and Pdr3; the mRNA processing factor Fir1; the spindle checkpoint protein kinase Mps1; and a protein of unknown function, Ybr138C. Analysis of the degradation motifs within these proteins revealed that the carboxyl-terminal KEN box and D-boxes of Tos4 are important for its interaction with Cdh1, whereas the N-terminal domain of Ybr138C is required for its instability. Functionally, we found that a stabilized form of Mps1 delayed cell division upon mild spindle disruption, and that elevated levels of Ybr138C reduced cell fitness. Interestingly, both Tos4 and Pdr3 have been implicated in the DNA damage response, whereas Mps1 regulates the spindle assembly checkpoint. Thus, the APC/C-Cdh1-mediated degradation of these proteins may help to coordinate re-entry into the cell cycle following environmental stresses.	[Ostapenko, Denis; Burton, Janet L.; Solomon, Mark J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Solomon, MJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	Mark.Solomon@yale.edu			National Institutes of Health [GM76200, GM88272]; American Heart Association Founders Affiliate [12GRNT12060663]; March of Dimes Foundation [1-FY05-114]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076200, R01GM088272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Founders Affiliate(American Heart Association); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM76200 and GM88272 from the National Institutes of Health, grant 12GRNT12060663 from the American Heart Association Founders Affiliate, and grant 1-FY05-114 from the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hershkovits G, 2006, P NATL ACAD SCI USA, V103, P9808, DOI 10.1073/pnas.0602014103; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; James P, 1996, GENETICS, V144, P1425; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Klitzing Cv, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOUMAL.PONE.0028998; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Mangus DA, 2004, MOL CELL BIOL, V24, P4196, DOI 10.1128/MCB.24.10.4196-4206.2004; Moore DD, 1995, GLOB MOB SURV; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Ostapenko D, 2011, MOL BIOL CELL, V22, P2175, DOI 10.1091/mbc.E11-01-0031; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfleger CM, 2000, GENE DEV, V14, P655; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838	54	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45895	10.1371/journal.pone.0045895	http://dx.doi.org/10.1371/journal.pone.0045895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049888	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300062
J	Ersoz, ES; Wright, MH; Pangilinan, JL; Sheehan, MJ; Tobias, C; Casler, MD; Buckler, ES; Costich, DE				Ersoz, Elhan S.; Wright, Mark H.; Pangilinan, Jasmyn L.; Sheehan, Moira J.; Tobias, Christian; Casler, Michael D.; Buckler, Edward S.; Costich, Denise E.			SNP Discovery with EST and NextGen Sequencing in Switchgrass (Panicum virgatum L.)	PLOS ONE			English	Article							IDENTIFICATION; DIVERSITY	Although yield trials for switchgrass (Panicum virgatum L.), a potentially high value biofuel feedstock crop, are currently underway throughout North America, the genetic tools for crop improvement in this species are still in the early stages of development. Identification of high-density molecular markers, such as single nucleotide polymorphisms (SNPs), that are amenable to high-throughput genotyping approaches, is the first step in a quantitative genetics study of this model biofuel crop species. We generated and sequenced expressed sequence tag (EST) libraries from thirteen diverse switchgrass cultivars representing both upland and lowland ecotypes, as well as tetraploid and octoploid genomes. We followed this with reduced genomic library preparation and massively parallel sequencing of the same samples using the Illumina Genome Analyzer technology platform. EST libraries were used to generate unigene clusters and establish a gene-space reference sequence, thus providing a framework for assembly of the short sequence reads. SNPs were identified utilizing these scaffolds. We used a custom software program for alignment and SNP detection and identified over 149,000 SNPs across the 13 short-read sequencing libraries (SRSLs). Approximately 25,000 additional SNPs were identified from the entire EST collection available for the species. This sequencing effort generated data that are suitable for marker development and for estimation of population genetic parameters, such as nucleotide diversity and linkage disequilibrium. Based on these data, we assessed the feasibility of genome wide association mapping and genomic selection applications in switchgrass. Overall, the SNP markers discovered in this study will help facilitate quantitative genetics experiments and greatly enhance breeding efforts that target improvement of key biofuel traits and development of new switchgrass cultivars.	[Ersoz, Elhan S.; Sheehan, Moira J.; Buckler, Edward S.; Costich, Denise E.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Pangilinan, Jasmyn L.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Tobias, Christian] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Casler, Michael D.] ARS, USDA, US Dairy Forage Res Ctr, Madison, WI USA; [Buckler, Edward S.; Costich, Denise E.] ARS, USDA, Robert Holley Ctr, Ithaca, NY USA	Cornell University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ersoz, ES (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	elhan.ersoz@syngenta.com; dc58@cornell.edu	Tobias, Christian/B-6602-2009; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Tobias, Christian/0000-0002-7881-750X; Buckler, Edward/0000-0002-3100-371X; Wright, Mark/0000-0001-8036-1161	United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses'' [DE-A102-07ER64454]	United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses''	This study was funded by United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program grant DE-A102-07ER64454 named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOEN DOE MISS FOC; [Anonymous], PLANT FEEDST GEN BIO; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barnes RF, 2003, FORAGES, V1; BARNETT FL, 1967, CROP SCI, V7, P301, DOI 10.2135/cropsci1967.0011183X000700040005x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Brunken JN, 1975, NATURE, V4, P379; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Christian D. G, 1998, ENERGY PLANT SPECIES; Costich DE, 2010, PLANT GENOME-US, V3, P130, DOI 10.3835/plantgenome2010.04.0010; Cushman JH, 1987, OAK RIDGE NATL LAB H; Gasler MD, 2006, SWITCHGRASS GENE POO; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gunter LE, 1996, CROP SCI, V36, P1017, DOI 10.2135/cropsci1996.0011183X003600040034x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hultquist SJ, 1996, CROP SCI, V36, P1049, DOI 10.2135/cropsci1996.0011183X003600040039x; Jackson BG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S14; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MCMILLAN C, 1959, AM J BOT, V46, P590, DOI 10.2307/2439303; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nielson EL, 1944, J AGRIC RES, V69, P0327; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Riley RD, 1982, CROP SCEINCE, V22, P1022; Samson RA, 1992, SWITCHGRASS POTENTIA; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2005, THEOR APPL GENET, V111, P956, DOI 10.1007/s00122-005-0030-3; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; WHEELER WC, 1994, J HERED, V85, P417, DOI 10.1093/oxfordjournals.jhered.a111492; Zalapa JE, 2011, THEOR APPL GENET, V122, P805, DOI 10.1007/s00122-010-1488-1	37	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44112	10.1371/journal.pone.0044112	http://dx.doi.org/10.1371/journal.pone.0044112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049744	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100011
J	Heffernan, C; Sumer, H; Guillemin, GJ; Manuelpillai, U; Verma, PJ				Heffernan, Corey; Sumer, Huseyin; Guillemin, Gilles J.; Manuelpillai, Ursula; Verma, Paul J.			Design and Screening of a Glial Cell-Specific, Cell Penetrating Peptide for Therapeutic Applications in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; ANTENNAPEDIA HOMEODOMAIN; RECOMBINANT PROTEINS; IMPROVES DELIVERY; FUSION PROTEIN; TAT PROTEIN; SPINAL-CORD; 3RD HELIX	Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system (CNS) characterized by demyelination through glial cell loss. Current and proposed therapeutic strategies to arrest demyelination and/or promote further remyelination include: (i) modulation of the host immune system; and/or (ii) transplantation of myelinating/stem or progenitor cells to the circulation or sites of injury. However, significant drawbacks are inherent with both approaches. Cell penetrating peptides (CPP) are short amino acid sequences with an intrinsic ability to translocate across plasma membranes, and theoretically represent an attractive vector for delivery of therapeutic peptides or nanoparticles to glia to promote cell survival or remyelination. The CPPs described to date are commonly non-selective in the cell types they transduce, limiting their therapeutic application in vivo. Here, we describe a theoretical framework for design of a novel CPP sequence that selectively transduces human glial cells (excluding non-glial cell types), and conduct preliminary screens of purified, recombinant CPPs with immature and matured human oligodendrocytes and astrocytes, and two non-glial cell types. A candidate peptide, termed TD2.2, consistently transduced glial cells, was significantly more effective at transducing immature oligodendrocytes than matured progeny, and was virtually incapable of transducing two non-glial cell types: (i) human neural cells and (ii) human dermal fibroblasts. Time-lapse confocal microscopy confirms trafficking of TD2.2 (fused to EGFP) to mature oligodendrocytes 3-6 hours after protein application in vitro. We propose selectivity of TD2.2 for glial cells represents a new therapeutic strategy for the treatment of glial-related disease, such as MS.	[Heffernan, Corey; Sumer, Huseyin; Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Reprogramming & Stem Cell Lab, Clayton, Vic, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Placental Stem Cell Lab, Clayton, Vic, Australia; [Guillemin, Gilles J.] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia; [Verma, Paul J.] S Australian Res & Dev Ind, Turretfield Res Ctr, Rosedale, SA, Australia	Monash University; Monash University; University of New South Wales Sydney	Verma, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Reprogramming & Stem Cell Lab, Clayton, Vic, Australia.	Paul.Verma@monash.edu	Verma, Paul/AAQ-4657-2021; Guillemin, Gilles J/C-3878-2015	Guillemin, Gilles J/0000-0001-8105-4470; Sumer, Huseyin/0000-0001-9413-5579	Victorian Government's Operational Infrastructure Support Program; Australian Stem Cell Centre iPS Program Grant; Harold Mitchell Foundation; Australian National Health & Medical Research Council (NHMRC); NHMRC Grant [606473]	Victorian Government's Operational Infrastructure Support Program; Australian Stem Cell Centre iPS Program Grant; Harold Mitchell Foundation; Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Grant(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by the Victorian Government's Operational Infrastructure Support Program, and funded by Australian Stem Cell Centre iPS Program Grant and Harold Mitchell Foundation. Personal postgraduate funding for CH and research support for GJG was provided by Australian National Health & Medical Research Council (NH&MRC). UM supported by NH&MRC Grant #606473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas Y, 2005, BIOCONJUGATE CHEM, V16, P1503, DOI 10.1021/bc050217o; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Benn SC, 2005, J NEUROCHEM, V95, P1118, DOI 10.1111/j.1471-4159.2005.03459.x; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; BOWIE JU, 1989, J BIOL CHEM, V264, P7596; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Chian RJ, 2009, BRAIN RES, V1287, P1, DOI 10.1016/j.brainres.2009.06.066; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Goyal A, 2000, BIOCHEM J, V345, P247, DOI 10.1042/0264-6021:3450247; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Heffernan C, 2012, STEM CELLS IN PRESS; Heffernan C, 2010, REPROD FERT DEVELOP, V22, P1022, DOI 10.1071/RD09265; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Johansson HJ, 2011, METHODS MOL BIOL, V683, P233, DOI 10.1007/978-1-60761-919-2_17; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Larsen KE, 2006, BRAIN RES, V1120, P1, DOI 10.1016/j.brainres.2006.08.079; Lim C. K., 2007, INT C SER, V1304, P213, DOI [10.1016/j.ics.2007.07.011, DOI 10.1016/J.ICS.2007.07.011]; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; McCandless EE, 2009, J IMMUNOL, V183, P613, DOI 10.4049/jimmunol.0802258; MCLAURIN J, 1995, J NEUROBIOL, V26, P283, DOI 10.1002/neu.480260212; Milward E, 2008, J NEUROIMMUNOL, V193, P140, DOI 10.1016/j.jneuroim.2007.11.001; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Rambukkana A, 2003, P NATL ACAD SCI USA, V100, P16071, DOI 10.1073/pnas.2232366100; Ravichandran V, 2006, PROTEOMICS, V6, P5628, DOI 10.1002/pmic.200600261; Ren ZH, 2011, J NEUROSCI, V31, P8329, DOI 10.1523/JNEUROSCI.1028-11.2011; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Sawant R, 2010, MOL BIOSYST, V6, P628, DOI 10.1039/b916297f; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	44	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45501	10.1371/journal.pone.0045501	http://dx.doi.org/10.1371/journal.pone.0045501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049807	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100052
J	Jangpatarapongsa, K; Xia, H; Fang, Q; Hu, KM; Yuan, YY; Peng, MY; Gao, Q; Sattabongkot, J; Cui, LW; Li, BQ; Udomsangpetch, R				Jangpatarapongsa, Kulachart; Xia, Hui; Fang, Qiang; Hu, Kaiming; Yuan, Yuanying; Peng, Meiyu; Gao, Qi; Sattabongkot, Jetsumon; Cui, Liwang; Li, Baiqing; Udomsangpetch, Rachanee			Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China	PLOS ONE			English	Article							REGULATORY T-CELLS; ASEXUAL BLOOD STAGES; IN-VITRO GROWTH; FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; DENDRITIC CELLS; B-CELLS; GAMMA; ANTIGENS; LYMPHOCYTES	Background: P. vivax infection is characterised by relapsing fever, indicating reinfection by previously hidden parasites in the host. Relapsed infection can lead to the activation of the memory T cell pool, which may lead to protective immunity. This study aims to characterise immune responses in acute P. vivax-infected patients living in an area of central China characterised by only P. vivax infection. Methodology/Principal Findings: We conducted a cross-sectional immune-phenotypic analysis of adults using the following inclusion criteria: acute P. vivax infection (N = 37), a history of P. vivax infection (N = 17), and no known history of P. vivax infection (N = 21). We also conducted a 2-week longitudinal analysis following acute P. vivax infection, in which PBMC proliferation was measured in response to P. vivax and P. falciparum blood stage lysates. Using flow cytometry, we showed elevated memory T cells in the blood during acute P. vivax infection. The levels of gamma delta T cells were two-fold higher than those measured in naive controls. This result suggested that in the two populations, memory and gamma delta T cells promptly responded to P. vivax parasites. Interestingly, P. falciparum antigens stimulated T cells obtained from P. vivax-infected patients during a day 14-convalescence, whereas lymphocytes from the naive control group responded to a lower degree of convalescence. Conclusions/Significance: Cell-mediated immunity during the convalescent period of the P. vivax-infected hosts was comprised of T cells that were specifically able to recognise P. falciparum antigens. Although the magnitude of the response was only half that measured after stimulation with P. vivax antigens, the matter of cross-antigenic stimulation is of great interest.	[Xia, Hui; Fang, Qiang; Li, Baiqing] Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China; [Jangpatarapongsa, Kulachart] Mahidol Univ, Ctr Innovat Dev & Technol Transfer, Fac Med Technol, Bangkok 10700, Thailand; [Jangpatarapongsa, Kulachart] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand; [Xia, Hui; Fang, Qiang; Hu, Kaiming; Yuan, Yuanying] Bengbu Med Coll, Dept Parasitol, Bengbu, Anhui, Peoples R China; [Peng, Meiyu; Li, Baiqing] Bengbu Med Coll, Dept Immunol, Bengbu, Anhui, Peoples R China; [Gao, Qi] Jiangsu Inst Parasit Dis, Wuxi, Peoples R China; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Ctr, Bangkok, Thailand; [Cui, Liwang] Penn State Univ, Dept Entomol, State Coll, PA USA; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Ctr Neglected Infect Dis, Bangkok 10700, Thailand	Bengbu Medical College; Mahidol University; Mahidol University; Bengbu Medical College; Bengbu Medical College; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Mahidol University; Mahidol University	Li, BQ (corresponding author), Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China.	bb_bqli@yahoo.com; rachanee.udo@mahidol.ac.th	Prachumsri, Jetsumon/AAZ-7732-2021	Jangpatarapongsa, Kulachart/0000-0002-4181-3425; Sattabongkot, Jetsumon/0000-0002-3938-4588	Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Fogarty International Center, NIH [D43TW006571]; Commission on Higher Education; Thailand Research Fund [BRG498009]; Key Program of Natural Science Foundation of the Anhui Higher Education Institutions [KJ2012A200]; Anhui Provincial Education Department [2004sys008]; FOGARTY INTERNATIONAL CENTER [D43TW006571] Funding Source: NIH RePORTER	Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Commission on Higher Education; Thailand Research Fund(Thailand Research Fund (TRF)); Key Program of Natural Science Foundation of the Anhui Higher Education Institutions; Anhui Provincial Education Department; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; a grant [D43TW006571] funded by the Fogarty International Center, NIH; the Commission on Higher Education to KJ [CHE-RES-PD]; the Thailand Research Fund to RU [BRG498009]; The Key Program of Natural Science Foundation of the Anhui Higher Education Institutions (no. KJ2012A200) to HX; and the key research programme [2004sys008] for Key Lab of Provincial University from Anhui Provincial Education Department to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIDI EA, 1995, ACTA TROP, V59, P173, DOI 10.1016/0001-706X(95)00076-Q; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; BEHR C, 1992, INT IMMUNOL, V4, P361, DOI 10.1093/intimm/4.3.361; Bergmann ES, 1997, CELL IMMUNOL, V180, P143, DOI 10.1006/cimm.1997.1186; BORDESSOULE D, 1990, J CLIN PATHOL, V43, P461, DOI 10.1136/jcp.43.6.461; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; Daniel Ribeiro C, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P633, DOI 10.1590/S0074-02761988000500076; DIGGS CL, 1965, EXP PARASITOL, V16, P217, DOI 10.1016/0014-4894(65)90046-9; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Farouk SE, 2004, EUR J IMMUNOL, V34, P2248, DOI 10.1002/eji.200424861; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; GOODIER M, 1992, INT IMMUNOL, V4, P33, DOI 10.1093/intimm/4.1.33; Hviid L, 2000, INFECT IMMUN, V68, P6087, DOI 10.1128/IAI.68.10.6087-6089.2000; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 1998, Expert Rev Mol Med, V1998, P1, DOI 10.1017/S1462399498000179; Iriemenam NC, 2009, AFR HEALTH SCI, V9, P66; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Jangpatarapongsa K, 2006, MICROBES INFECT, V8, P680, DOI 10.1016/j.micinf.2005.09.003; Kassa D, 2006, CLIN VACCINE IMMUNOL, V13, P376, DOI 10.1128/CVI.13.3.376-379.2006; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; KROTOSKI WA, 1980, BMJ-BRIT MED J, V280, P153, DOI 10.1136/bmj.280.6208.153-a; LANDEWE RBM, 1995, CLIN EXP IMMUNOL, V102, P144; Lee HK, 2001, ANN TROP MED PARASIT, V95, P31, DOI 10.1080/00034980020035898; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lin JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018716; Mavoungou E, 2003, EUR CYTOKINE NETW, V14, P134; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Palmer DR, 2002, EUR J IMMUNOL, V32, P652, DOI 10.1002/1521-4141(200203)32:3<652::AID-IMMU652>3.0.CO;2-9; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; Qingjun L, 1998, Bull World Health Organ, V76 Suppl 1, P21; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salwati E, 2011, J INFECT DIS, V203, P1192, DOI 10.1093/infdis/jiq166; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; SCHULTZ KR, 1995, BLOOD, V86, P4344, DOI 10.1182/blood.V86.11.4344.bloodjournal86114344; Seixas EMG, 1999, J IMMUNOL, V162, P2837; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Srisurapanon S., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P310; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Troye-Blomberg M, 1999, SCAND J IMMUNOL, V50, P642, DOI 10.1046/j.1365-3083.1999.00647.x; Tsuji M, 2010, EXP PARASITOL, V126, P421, DOI 10.1016/j.exppara.2009.11.009; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206	59	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45971	10.1371/journal.pone.0045971	http://dx.doi.org/10.1371/journal.pone.0045971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049909	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100112
J	La Fleur, L; Johansson, AC; Roberg, K				La Fleur, Linnea; Johansson, Ann-Charlotte; Roberg, Karin			A CD44(high)/EGFR(low) Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment	PLOS ONE			English	Article							STEM-CELLS; SQUAMOUS CARCINOMA; PANCREATIC-CANCER; INITIATING CELLS; DRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; IDENTIFICATION; GROWTH; EMT	Mortality in head and neck squamous cell carcinoma (HNSCC) is high due to emergence of therapy resistance which results in local and regional recurrences that may have their origin in resistant cancer stem cells (CSCs) or cells with an epithelial-mesenchymal transition (EMT) phenotype. In the present study, we investigate the possibility of using the cell surface expression of CD44 and epidermal growth factor receptor (EGFR), both of which have been used as stem cell markers, to identify subpopulations within HNSCC cell lines that differ with respect to phenotype and treatment sensitivity. Three subpopulations, consisting of CD44(high)/EGFR(low), CD44(high)/EGFR(high) and CD44(low) cells, respectively, were collected by fluorescence-activated cell sorting. The CD44(high)/EGFR(low) population showed a spindle-shaped EMT-like morphology, while the CD44(low) population was dominated by cobblestone-shaped cells. The CD44(high)/EGFR(low) population was enriched with cells in G0/G1 and showed a relatively low proliferation rate and a high plating efficiency. Using a real time PCR array, 27 genes, of which 14 were related to an EMT phenotype and two with stemness, were found to be differentially expressed in CD44(high)/EGFR(low) cells in comparison to CD44(low) cells. Moreover, CD44(high)/EGFR(low) cells showed a low sensitivity to radiation, cisplatin, cetuximab and gefitinib, and a high sensitivity to dasatinib relative to its CD44(high)/EGFR(high) and CD44(low) counterparts. In conclusion, our results show that the combination of CD44 (high) and EGFR (low) cell surface expression can be used to identify a treatment resistant subpopulation with an EMT phenotype in HNSCC cell lines.	[La Fleur, Linnea; Johansson, Ann-Charlotte; Roberg, Karin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden; [Roberg, Karin] Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden	Linkoping University; City Council Ostergotland	Roberg, K (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden.	karin.roberg@liu.se		Johansson, Ann-Charlotte/0000-0002-5191-8204	Swedish Laryng Foundation; Foundation of Signhild Engkvist; Foundation of Ake Wiberg; Swedish Cancer Society [2008/552, 2010/545]; County Council of Ostergotland; Linkoping University Hospital	Swedish Laryng Foundation; Foundation of Signhild Engkvist; Foundation of Ake Wiberg; Swedish Cancer Society(Swedish Cancer Society); County Council of Ostergotland; Linkoping University Hospital	This study was supported by the Swedish Laryng Foundation, the Foundation of Signhild Engkvist, the Foundation of Ake Wiberg, the Swedish Cancer Society (2008/552, 2010/545), the County Council of Ostergotland and the Research Funds of Linkoping University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; [Anonymous], J NATL CANC I, V98, P1777; Ansell A, 2009, ORAL ONCOL, V45, P866, DOI 10.1016/j.oraloncology.2009.02.008; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costello RT, 2000, CANCER RES, V60, P4403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnebo L, 2008, ONCOL REP, V20, P453, DOI 10.3892/or_00000028; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Heppner G, 1986, Prog Clin Biol Res, V212, P45; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Holz C, 2011, RADIOTHER ONCOL, V101, P158, DOI 10.1016/j.radonc.2011.05.042; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jedlinski A, 2012, J ORAL PATHOL MED; Jerhammar F, 2010, CANCER BIOL THER, V10, P1244, DOI 10.4161/cbt.10.12.13432; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Le Roy H, 2010, STEM CELLS DEV, V19, P209, DOI 10.1089/scd.2009.0150; Leutenegger CM, 1999, VET IMMUNOL IMMUNOP, V71, P291, DOI 10.1016/S0165-2427(99)00100-2; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Roberg K, 2008, DIFFERENTIATION, V76, P868, DOI 10.1111/j.1432-0436.2008.00267.x; Shibata SI, 2009, INT J ONCOL, V34, P1433, DOI 10.3892/ijo_00000272; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skvortsova I, 2010, RADIOTHER ONCOL, V96, P108, DOI 10.1016/j.radonc.2010.04.017; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Wang XH, 2006, ORAL ONCOL, V42, P740, DOI 10.1016/j.oraloncology.2005.11.018	42	43	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44071	10.1371/journal.pone.0044071	http://dx.doi.org/10.1371/journal.pone.0044071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049743	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100010
J	Tsai, YL; Wang, HTT; Chang, HFG; Tsai, CF; Lin, CK; Teng, PH; Su, C; Jeng, CC; Lee, PY				Tsai, Yun-Long; Wang, Hwa-Tang Thomas; Chang, Hsiao-Fen Grace; Tsai, Chuan-Fu; Lin, Ching-Ko; Teng, Ping-Hua; Su, Chen; Jeng, Chien-Chung; Lee, Pei-Yu			Development of TaqMan Probe-Based Insulated Isothermal PCR (iiPCR) for Sensitive and Specific On-Site Pathogen Detection	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; NUCLEIC-ACID AMPLIFICATION; TIME QUANTITATIVE PCR; DNA; POLYMERASE; CONVECTION; DIAGNOSIS; BACTERIA; MINUTES; PRODUCT	Insulated isothermal PCR (iiPCR), established on the basis of Ralyeigh-Benard convection, is a rapid and low-cost platform for nucleic acid amplification. However, the method used for signal detection, namely gel electrophoresis, has limited the application of iiPCR. In this study, TaqMan probe-based iiPCR system was developed to obviate the need of post-amplification processing. This system includes an optical detection module, which was designed and integrated into the iiPCR device to detect fluorescent signals generated by the probe. TaqMan probe-iiPCR assays targeting white spot syndrome virus (WSSV) and infectious myonecrosis virus were developed for preliminary evaluation of this system. Significant elevation of fluorescent signals was detected consistently among positive iiPCR reactions in both assays, correlating with amplicon detection by gel electrophoresis analysis. After condition optimization, a threshold value of S/N (fluorescent intensity(after)/fluorescent intensity(before)) for positive reactions was defined for WSSV TaqMan probe-iiPCR on the basis of 20 blank reactions. WSSV TaqMan probe-iiPCR generated positive S/Ns from as low as 10 1 copies of standard DNA and lightly infected Litopenaeus vannamei. Compared with an OIE-certified nested PCR, WSSV TaqMan probe-iiPCR showed a sensitivity of 100% and a specificity of 96.67% in 120 WSSV-free or lightly infected shrimp samples. Generating positive signals specifically and sensitively, TaqMan probe-iiPCR system has a potential as a low-cost and rapid on-site diagnostics method.	[Lee, Pei-Yu] Cent Taiwan Univ Sci & Technol, Inst Med Biotechnol, Taichung, Taiwan; [Tsai, Yun-Long; Wang, Hwa-Tang Thomas; Chang, Hsiao-Fen Grace; Tsai, Chuan-Fu; Lin, Ching-Ko; Teng, Ping-Hua; Su, Chen] GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan; [Jeng, Chien-Chung] Natl Chung Hsing Univ, Inst Nanosci, Taichung 40227, Taiwan; [Jeng, Chien-Chung] Natl Chung Hsing Univ, Dept Phys, Taichung 40227, Taiwan	Central Taiwan University Science & Technology; National Chung Hsing University; National Chung Hsing University	Lee, PY (corresponding author), Cent Taiwan Univ Sci & Technol, Inst Med Biotechnol, Taichung, Taiwan.	pylee@ctust.edu.tw			Taiwan National Science Council (NSC) grant [NSC 99-2112-M-005-006-MY3]; NSC-Central Taiwan Science Park grant [NSC-CTSP 302403501]	Taiwan National Science Council (NSC) grant; NSC-Central Taiwan Science Park grant	This study was supported by the Taiwan National Science Council (NSC) grant NSC 99-2112-M-005-006-MY3 to CCJ, and NSC-Central Taiwan Science Park grant NSC-CTSP 302403501 to GeneReach Biotechnology Corporation (http://web1.nsc.gov.tw/mp.aspx?mp=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209; Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453; Chou WP, 2011, BIOTECHNIQUES, V50, P52, DOI 10.2144/000113589; Dwivedi HP, 2011, CRIT REV MICROBIOL, V37, P40, DOI 10.3109/1040841X.2010.506430; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hameed ASS, 2003, DIS AQUAT ORGAN, V57, P157, DOI 10.3354/dao057157; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Krishnan M, 2002, SCIENCE, V298, P793, DOI 10.1126/science.298.5594.793; Krishnan N, 2004, ANAL CHEM, V76, P6254, DOI 10.1021/ac049323u; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Musthaq SS, 2006, J INVERTEBR PATHOL, V93, P75, DOI 10.1016/j.jip.2006.06.006; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang X, 2006, HIGH THROUGHPUT PRIM; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389	25	68	78	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45278	10.1371/journal.pone.0045278	http://dx.doi.org/10.1371/journal.pone.0045278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049781	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100035
J	Yan, H; Tian, L; Yan, J; Sun, W; Liu, Q; Zhang, YB; Li, XM; Zang, YF; Zhang, D				Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Yan-Bo; Li, Xin-Ming; Zang, Yu-Feng; Zhang, Dai			Functional and Anatomical Connectivity Abnormalities in Cognitive Division of Anterior Cingulate Cortex in Schizophrenia	PLOS ONE			English	Article							EARLY-ONSET SCHIZOPHRENIA; DIFFUSION-TENSOR MRI; IN-VIVO MORPHOMETRY; RESTING-STATE FMRI; HUMAN BRAIN; 1ST-EPISODE SCHIZOPHRENIA; 1ST-DEGREE RELATIVES; CEREBRAL ASYMMETRY; BASAL GANGLIA; DEFAULT MODE	Introduction: Current pathophysiological theories of schizophrenia highlight the role of altered brain functional and anatomical connectivity. The cognitive division of anterior cingulate cortex (ACC-cd) is a commonly reported abnormal brain region in schizophrenia for its importance in cognitive control process. The aim of this study was to investigate the functional and anatomical connectivity of ACC-cd and its cognitive and clinical manifestation significance in schizophrenia by using the resting-state functional magnetic resonance imaging (fMRI) and the diffusion tensor imaging (DTI). Methods: Thirty-three medicated schizophrenics and 30 well-matched health controls were recruited. Region-of-interest (ROI)-based resting-state functional connectivity analysis and Tract-Based Spatial Statistics (TBSS) were performed on 30 patients and 30 controls, and 24 patients and 29 controls, respectively. The Pearson correlation was performed between the imaging measures and the Stroop performance and scores of the Positive and Negative Syndrome Scale (PANSS), respectively. Results: Patients with schizophrenia showed significantly abnormal in the functional connectivity and its hemispheric asymmetry of the ACC-cd with multiple brain areas, e. g., decreased positive connectivity with the bilateral putamen and caudate, increased negative connectivity with the left posterior cingulated cortex (PCC), increased asymmetry of connectivity strength with the contralateral inferior frontal gyrus (IFG). The FA of the right anterior cingulum was significantly decreased in patients group (p = 0.014). The abnormal functional and structural connectivity of ACC-cd were correlated with Stroop performance and the severity of the symptoms in patients. Conclusions: Our results suggested that the abnormal connectivity of the ACC-cd might play a role in the cognitive impairment and clinical symptoms in schizophrenia.	[Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Yan-Bo; Li, Xin-Ming] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK S7N 0W0, Canada; [Zhang, Yan-Bo; Li, Xin-Ming] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada; [Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Zang, Yu-Feng] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Dai] Tsinghua Univ, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China	Peking University; University of Saskatchewan; University of Manitoba; Hangzhou Normal University; Hangzhou Normal University; Beijing Normal University; Tsinghua University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Yan, Hao/U-1330-2017	ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Hao/0000-0003-0376-9037	International Science & Technology Cooperation Program of China [2010DFB30820]; National Basic Research Program of China [2011CB707805]; National Natural Science Foundation of China [81000580, 81071088]; Specialized Research Fund for the Doctoral Program of Higher Education [20100001120120]	International Science & Technology Cooperation Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the International Science & Technology Cooperation Program of China (2010DFB30820 to D.Z.), the National Basic Research Program of China (2011CB707805 to J.Y.), the National Natural Science Foundation of China (81000580 to H.Y., 81071088 to D.Z.), and Specialized Research Fund for the Doctoral Program of Higher Education (20100001120120 to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rick, 2007, Neuropsychiatr Dis Treat, V3, P87, DOI 10.2147/nedt.2007.3.1.87; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Artiges E, 2000, SCHIZOPHRENIA BULL, V26, P709, DOI 10.1093/oxfordjournals.schbul.a033488; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; BUCHSBAUM MS, 1990, SCHIZOPHRENIA BULL, V16, P377, DOI 10.1093/schbul/16.3.377; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; FORNITO A, 2008, SCHIZOPHR B; Fox M, 2009, J NEUROPHYSIOL; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hadjulis M, 2004, BIOL PSYCHIAT, V55, P148, DOI 10.1016/S0006-3223(02)01905-4; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Huster RJ, 2007, NEUROIMAGE, V34, P888, DOI 10.1016/j.neuroimage.2006.10.023; Kawasaki Y, 2008, BIOL PSYCHIAT, V63, P793, DOI 10.1016/j.biopsych.2007.08.008; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Lang DJ, 2006, SCHIZOPHR RES, V87, P89, DOI 10.1016/j.schres.2006.05.002; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P280, DOI 10.1016/j.pnpbp.2007.08.019; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sallet PC, 2003, PSYCHIAT RES-NEUROIM, V123, P65, DOI 10.1016/S0925-4927(03)00020-9; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun ZG, 2003, NEUROREPORT, V14, P1833, DOI 10.1097/00001756-200310060-00015; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Tian L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028794; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Wang F, 2009, J PSYCHIATR NEUROSCI, V34, P181; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yucel M, 2002, BIOL PSYCHIAT, V52, P15, DOI 10.1016/S0006-3223(02)01312-4; Yucel M, 2003, BRIT J PSYCHIAT, V182, P518, DOI 10.1192/bjp.182.6.518; Zetzsche T, 2007, SCHIZOPHR RES, V96, P34, DOI 10.1016/j.schres.2007.07.027; Zhou Y, 2007, SCHIZOPHR RES; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zou LQ, 2008, ACAD RADIOL, V15, P285, DOI 10.1016/j.acra.2007.09.026	70	66	67	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45659	10.1371/journal.pone.0045659	http://dx.doi.org/10.1371/journal.pone.0045659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049832	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100065
J	You, G; Yan, W; Zhang, W; Wang, YZ; Bao, ZS; Li, SW; Li, SW; Li, GL; Song, YJ; Kang, CS; Jiang, T				You, Gan; Yan, Wei; Zhang, Wei; Wang, Yongzhi; Bao, Zhaoshi; Li, Shouwei; Li, Shaowu; Li, Guilin; Song, Yijun; Kang, Chunsheng; Jiang, Tao			Significance of miR-196b in Tumor-Related Epilepsy of Patients with Gliomas	PLOS ONE			English	Article							EXPRESSION LEVELS; IMMUNE-RESPONSE; MICRORNAS; SEIZURES; GLIOBLASTOMA; CANCER; INFLAMMATION; SURVIVAL; DISEASE; MIRNAS	Objectives: Seizure is a common presenting symptom of primary brain tumors. There are no published studies regarding the roles of MicroRNA (miRNA) in tumor-related epilepsy. The authors set out to correlate miR-196b expression in low-grade glioma patients with pre-operative seizures and post-operative seizure control. Methods: Twenty-three patients with WHO grade II astrocytomas and 83 similar patients for independent validation were included. Follow-up visits regarding seizure prognosis were scheduled at 6 months. MiRNA profiling was used to identify differentially expressed miRNAs. The most important miRNA was determined by quantitative reverse-transcriptase polymerase chain reaction (q-PCR) in the validation cohort. Gene ontology (GO) analysis and whole genome mRNA profiling was performed to investigate the underlying biological processes. Results: Array results showed that 30 miRNAs were overexpressed and 10 miRNAs were underexpressed (with more than 2 fold change) in patients with pre-operative seizures. MiR-196b was validated in the independent validation cohort. Patients with good seizure prognosis exhibited low levels of miR-196b expression compared with those who had poor seizure prognosis in the group without pre-operative seizures. Biological processes that relate to transcription and cell cycles were over-represented in the miR-196b-associated gene expression signature. MiR-196b-associated gene expression profiling was characterized by enrichment of genes usually involved in cell proliferation. Conclusions: We have provided the first evidence that expression of miR-196b was associated with the occurrence of pre-operative seizures in low-grade gliomas, and may predict seizure prognosis in patients without pre-operative seizures. Targeted treatments that decrease endogenous levels of miR-196b might represent novel therapeutic strategies.	[You, Gan; Yan, Wei; Zhang, Wei; Wang, Yongzhi; Bao, Zhaoshi; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Song, Yijun; Kang, Chunsheng] Tianjin Med Univ, Gen Hosp, Lab Neurooncol, Dept Neurosurg,Tianjin Neurol Inst, Tianjin, Peoples R China; [Li, Shouwei; Jiang, Tao] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Shaowu] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Li, Guilin] Beijing Neurosurg Inst, Dept Neuropathol, Beijing, Peoples R China	Capital Medical University; Tianjin Medical University; Capital Medical University; Capital Medical University; Beijing Neurosurgical Institute	Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	taojiang1964@yahoo.com.cn	jiang, tao/GWC-7108-2022; Kang, Chunsheng/AAM-5979-2021; Jiang, Tao/N-8142-2014	Kang, Chunsheng/0000-0002-3255-3369; Li, Shouwei/0000-0003-3320-2517	National High Technology Research and Development Program of China [2012AA02A508]; International Cooperation Program [2012DFA30470]; National Basic Research Program of China [2010CB529406]; National Natural Science Foundation of China [81201993]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); International Cooperation Program; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Research and Development Program of China (No. 2012AA02A508), the International Cooperation Program (No. 2012DFA30470), the National Basic Research Program of China (No. 2010CB529406), and the National Natural Science Foundation of China (No. 81201993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Baraniskin A, 2012, NEURO-ONCOLOGY, V14, P29, DOI 10.1093/neuonc/nor169; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Danfors T, 2009, EUR J NEUROL, V16, P823, DOI 10.1111/j.1468-1331.2009.02599.x; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lee JW, 2010, ARCH NEUROL-CHICAGO, V67, P336, DOI 10.1001/archneurol.2010.2; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Ma RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038096; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Schaller B, 2003, EPILEPSIA, V44, P1223, DOI 10.1046/j.1528-1157.2003.05203.x; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Weller M, 2011, NEUROLOGY, V77, P1156, DOI 10.1212/WNL.0b013e31822f02e1; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169	32	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46218	10.1371/journal.pone.0046218	http://dx.doi.org/10.1371/journal.pone.0046218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049982	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100156
J	Bourget, G				Bourget, Gulhan			Handling Missing Data in Transmission Disequilibrium Test in Nuclear Families with One Affected Offspring	PLOS ONE			English	Article							ASSOCIATION; LINKAGE	The Transmission Disequilibrium Test (TDT) compares frequencies of transmission of two alleles from heterozygote parents to an affected offspring. This test requires all genotypes to be known from all members of the nuclear families. However, obtaining all genotypes in a study might not be possible for some families, in which case, a data set results in missing genotypes. There are many techniques of handling missing genotypes in parents but only a few in offspring. The robust TDT (rTDT) is one of the methods that handles missing genotypes for all members of nuclear families [with one affected offspring]. Even though all family members can be imputed, the rTDT is a conservative test with low power. We propose a new method, Mendelian Inheritance TDT (MITDT-ONE), that controls type I error and has high power. The MITDT-ONE uses Mendelian Inheritance properties, and takes population frequencies of the disease allele and marker allele into account in the rTDT method. One of the advantages of using the MITDT-ONE is that the MITDT-ONE can identify additional significant genes that are not found by the rTDT. We demonstrate the performances of both tests along with Sib-TDT (S-TDT) in Monte Carlo simulation studies. Moreover, we apply our method to the type 1 diabetes data from the Warren families in the United Kingdom to identify significant genes that are related to type 1 diabetes.	Calif State Univ Fullerton, Dept Math, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Bourget, G (corresponding author), Calif State Univ Fullerton, Dept Math, Fullerton, CA 92634 USA.	galpargu@fullerton.edu			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Allen AS, 2003, AM J HUM GENET, V72, P671, DOI 10.1086/368276; Alpargu G, 2011, COMPUT STAT DATA AN, V55, P1236, DOI 10.1016/j.csda.2010.09.004; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Cervino ACL, 2000, AM J HUM GENET, V67, P120, DOI 10.1086/302992; Chen YH, 2004, GENET EPIDEMIOL, V27, P131, DOI 10.1002/gepi.20004; Clayton D, 1999, AM J HUM GENET, V65; Ewens WJ, 1997, CURRENT PROTOCOL S15; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Knapp M, 1999, AM J HUM GENET, V64; Knapp M, 1999, AM J HUM GENET, V64; Little R.J.A., 2002, STAT ANAL MISSING DA; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McGinnis RE, 1998, ANN HUM GENET, V62, P159, DOI 10.1046/j.1469-1809.1998.6220159.x; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Sebastiani P, 2004, GENETICS, V168, P2329, DOI 10.1534/genetics.103.025841; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46100	10.1371/journal.pone.0046100	http://dx.doi.org/10.1371/journal.pone.0046100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056239	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500026
J	Kulangara, C; Luedin, S; Dietz, O; Rusch, S; Frank, G; Mueller, D; Moser, M; Kajava, AV; Corradin, G; Beck, HP; Felger, I				Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Frank, Geraldine; Mueller, Dania; Moser, Mirjam; Kajava, Andrey V.; Corradin, Giampietro; Beck, Hans-Peter; Felger, Ingrid			Cell Biological Characterization of the Malaria Vaccine Candidate Trophozoite Exported Protein 1	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; MAURERS CLEFTS; HOST-CELL; MEMBRANE; CYTOADHERENCE; SEQUENCE; ANTIGEN; IDENTIFICATION	In a genome-wide screen for alpha-helical coiled coil motifs aiming at structurally defined vaccine candidates we identified PFF0165c. This protein is exported in the trophozoite stage and was named accordingly Trophozoite exported protein 1 (Tex1). In an extensive preclinical evaluation of its coiled coil peptides Tex1 was identified as promising novel malaria vaccine candidate providing the rational for a comprehensive cell biological characterization of Tex1. Antibodies generated against an intrinsically unstructured N-terminal region of Tex1 and against a coiled coil domain were used to investigate cytological localization, solubility and expression profile. Co-localization experiments revealed that Tex1 is exported across the parasitophorous vacuole membrane and located to Maurer's clefts. Change in location is accompanied by a change in solubility: from a soluble state within the parasite to a membrane-associated state after export to Maurer's clefts. No classical export motifs such as PEXEL, signal sequence/anchor or transmembrane domain was identified for Tex1.	[Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Mueller, Dania; Moser, Mirjam; Beck, Hans-Peter; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Frank, Geraldine; Corradin, Giampietro] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Kulangara, Caroline; Luedin, Samuel; Dietz, Olivier; Rusch, Sebastian; Mueller, Dania; Moser, Mirjam; Beck, Hans-Peter; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Kajava, Andrey V.] Univ Montpellier 1 & 2, Ctr Natl Rech Sci, Ctr Rech Biochim Macromol, Montpellier, France	University of Basel; Swiss Tropical & Public Health Institute; University of Lausanne; University of Basel; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Felger, I (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Felger, Ingrid/0000-0003-1255-2606; Beck, Hans-Peter/0000-0001-8326-4834; Ludin, Samuel/0000-0002-2803-2536	Swiss National Science Foundation [310030-112244]; Novartis Stiftung fur Medizinisch-Biologische Forschung; EMVI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung fur Medizinisch-Biologische Forschung; EMVI	The project was supported by the Swiss National Science Foundation (http://www.snf.ch/) grant number 310030-112244, by the Novartis Stiftung fur Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/) and EMVI (http://www.emvi.org). This study was funded by the Novartis Stiftung fur Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agak GW, 2008, VACCINE, V26, P1963, DOI 10.1016/j.vaccine.2008.02.020; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; BARNES DA, 1994, MOL BIOCHEM PARASIT, V66, P21, DOI 10.1016/0166-6851(94)90032-9; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Bourke PF, 1996, MOL BIOCHEM PARASIT, V82, P25, DOI 10.1016/0166-6851(96)02715-6; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caly DL, 2010, J MOL BIOL, V403, P405, DOI 10.1016/j.jmb.2010.08.051; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; CULVENOR JG, 1987, EXP PARASITOL, V63, P58, DOI 10.1016/0014-4894(87)90078-6; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Dixon MWA, 2008, TRAFFIC, V9, P1316, DOI 10.1111/j.1600-0854.2008.00768.x; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Helg A, 2003, J IMMUNOL METHODS, V276, P19, DOI 10.1016/S0022-1759(03)00075-9; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; JENSEN JB, 1978, AM J TROP MED HYG, V27, P743, DOI 10.4269/ajtmh.1978.27.743; KNAPP B, 1989, MOL BIOCHEM PARASIT, V37, P47, DOI 10.1016/0166-6851(89)90101-1; Kulangara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005419; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Okitsu SL, 2007, PEPTIDES, V28, P2051, DOI 10.1016/j.peptides.2007.08.007; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46112	10.1371/journal.pone.0046112	http://dx.doi.org/10.1371/journal.pone.0046112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056243	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000309831500027
J	Chen, SH; Li, YN; Stojanovic, A; Zhang, J; Wang, YB; Wang, QM; Seiler, T				Chen, Shihao; Li, Yini; Stojanovic, Aleksander; Zhang, Jia; Wang, Yibo; Wang, Qinmei; Seiler, Theo			Evaluation of the Efficacy of Excimer Laser Ablation of Cross-Linked Porcine Cornea	PLOS ONE			English	Article							PELLUCID MARGINAL DEGENERATION; TOPOGRAPHY-GUIDED PRK; ULTRAVIOLET-A LIGHT; PHOTOREFRACTIVE KERATECTOMY; BULLOUS KERATOPATHY; IN-VIVO; LINKING; COLLAGEN; RIBOFLAVIN; KERATOCONUS	Background: Combination of riboflavin/UVA cross-linking (CXL) and excimer laser ablation is a promising therapy for treating corneal ectasia. The cornea is strengthened by cross-linking, while the irregular astigmatism is reduced by laser ablation. This study aims to compare the efficacy of excimer laser ablation on porcine corneas with and without cross-linking. Methods and Findings: The porcine cornea was de-epithelialized and treated with 0.1% riboflavin solution for 30 minutes. A half of the cornea was exposed to UVA-radiation for another 30 minutes while the controlled half of the cornea was protected from the UVA using a metal shield. Photo therapeutic keratectomy (PTK) was then performed on the central cornea. Corneal thickness of 5 paired locations on the horizontal line, +/- 0.5, +/- 1.0, +/- 1.5, +/- 2.0, and +/- 2.5 mm from the central spot, were measured using optical coherence tomography prior to and after PTK. The ablation depth was then determined by the corneal thickness. There was a 9% difference (P<0.001) in the overall ablation depth between the CXL-half corneas (15 +/- 22 mu m) and the control-half corneas (174 +/- 26 mu m). The ablation depths of all 5 correspondent locations on the CXL-half were significantly smaller (P<0.001). Conclusion: The efficacy of the laser ablation seems to be lower in cross-linked cornea. Current ablation algorithms may need to be modified for cross-linked corneas.	[Chen, Shihao; Li, Yini; Zhang, Jia; Wang, Yibo; Wang, Qinmei] Wenzhou Med Coll, Affiliated Eye Hosp, Wenzhou, Zhejiang, Peoples R China; [Stojanovic, Aleksander] Univ Hosp N Norway, Eye Dept, Tromso, Norway; [Seiler, Theo] Inst Refract & Ophthalm Surg, Zurich, Switzerland; [Stojanovic, Aleksander] Synslaser Kirurgi AS, Tromso, Norway	Wenzhou Medical University; UiT The Arctic University of Tromso; University Hospital of North Norway	Wang, QM (corresponding author), Wenzhou Med Coll, Affiliated Eye Hosp, Wenzhou, Zhejiang, Peoples R China.	wqm2@mail.eye.ac.cn						Bohnke M, 1998, J REFRACT SURG, V14, P140; Ehlers N, 2009, J REFRACT SURG, V25, pS803, DOI 10.3928/1081597X-20090813-08; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; Fagerholm P, 2003, ACTA OPHTHALMOL SCAN, V81, P19, DOI 10.1034/j.1600-0420.2003.00015.x; Ferrari TM, 2009, EUR J OPHTHALMOL, V19, P295, DOI 10.1177/112067210901900221; Gartry D S, 1991, Refract Corneal Surg, V7, P420; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Huebscher HJ, 1996, INVEST OPHTH VIS SCI, V37, P42; Kampik D, 2010, INVEST OPHTH VIS SCI, V51, P3929, DOI 10.1167/iovs.09-4524; Kanellopoulos AJ, 2007, CORNEA, V26, P891, DOI 10.1097/ICO.0b013e318074e424; Kanellopoulos AJ, 2009, J REFRACT SURG, V25, pS812, DOI 10.3928/1081597X-20090813-10; Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; Krueger RR, 2010, J REFRACT SURG, V26, pS827, DOI 10.3928/1081597X-20100921-11; KRUEGER RR, 1985, ARCH OPHTHALMOL-CHIC, V103, P1741; Kymionis GD, 2009, OPHTHALMOLOGY, V116, P2336, DOI 10.1016/j.ophtha.2009.09.018; Mazzotta C, 2011, CORNEA, V30, P225, DOI 10.1097/ICO.0b013e3181e16de5; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Sauer A, 2010, INVEST OPHTH VIS SCI, V51, P3950, DOI 10.1167/iovs.09-4013; Schnitzler E, 2000, KLIN MONATSBL AUGENH, V217, P190, DOI 10.1055/s-2000-10344; Seiler T., 1996, Investigative Ophthalmology and Visual Science, V37, pS1017; SEILER T, 1991, OPHTHALMOLOGY, V98, P1156; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; Sondergaard AP, 2010, CURR EYE RES, V35, P116, DOI 10.3109/02713680903431847; Spadea L, 2010, J REFRACT SURG, V26, P375, DOI 10.3928/1081597X-20100114-03; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Stojanovic A, 2010, J REFRACT SURG, V26, P145, DOI 10.3928/1081597X-20100121-10; Vinciguerra P, 2009, OPHTHALMOLOGY, V116, P369, DOI 10.1016/j.ophtha.2008.09.048; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, OPHTHALMIC RES, V41, P114, DOI 10.1159/000187630	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46232	10.1371/journal.pone.0046232	http://dx.doi.org/10.1371/journal.pone.0046232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056269	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000026
J	Minde, DP; Maurice, MM; Rudiger, SGD				Minde, David P.; Maurice, Madelon M.; Rudiger, Stefan G. D.			Determining Biophysical Protein Stability in Lysates by a Fast Proteolysis Assay, FASTpp	PLOS ONE			English	Article							P53 CORE DOMAIN; GREEN FLUORESCENT PROTEIN; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; SCANNING CALORIMETRY; ESCHERICHIA-COLI; PYRUVATE-KINASE; BINDING PROTEIN; IN-VITRO; THERMOLYSIN	The biophysical stability is an important parameter for protein activity both in vivo and in vitro. Here we propose a method to analyse thermal melting of protein domains in lysates: Fast parallel proteolysis (FASTpp). Combining unfolding by a temperature gradient in a thermal cycler with simultaneous proteolytic cleavage of the unfolded state, we probed stability of single domains in lysates. We validated FASTpp on proteins from 10 kDa to 240 kDa and monitored stabilisation and coupled folding and binding upon interaction with small-molecule ligands. Within a total reaction time of approximately 1 min, we probed subtle stability differences of point mutations with high sensitivity and in agreement with data obtained by intrinsic protein fluorescence. We anticipate a wide range of applications of FASTpp in biomedicine and protein engineering as it requires only standard laboratory equipment.	[Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Minde, David P.; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; s.g.d.rudiger@uu.nl	Minde, David Paul/D-3847-2012; Rüdiger, Stefan GD/G-4906-2012	Minde, David Paul/0000-0002-2985-622X; Rüdiger, Stefan GD/0000-0002-1807-2972; minde, david/0000-0003-2471-0421; Maurice, Madelon/0000-0001-6885-5361	European Union [MEXT-CT-2005-025651]; VIDI by the Netherlands Organization for Scientific Research (NWO) [700.55.421]; Utrecht University; European Research Council (ERC-StG) [242958]	European Union(European Commission); VIDI by the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council (ERC-StG)(European Research Council (ERC))	SGDR was supported by a Marie-Curie Excellence Grant of the European Union (MEXT-CT-2005-025651), a VIDI career development grant (700.55.421) by the Netherlands Organization for Scientific Research (NWO) and a High Potential Grant of Utrecht University. MMM was supported by the European Research Council (ERC-StG no. 242958) and a High Potential Grant of Utrecht University. URLs of funders: NWO: http://www.nwo.nl/; EU: http://europa.eu/index_en.htm; Utrecht University: http://www.uu.nl/; ERC: http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Bark SJ, 2001, J AM CHEM SOC, V123, P1774, DOI 10.1021/ja002909n; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; DEMEL RA, 1989, J BIOL CHEM, V264, P3988; DESMAZEA.MJ, 1971, EUR J BIOCHEM, V19, P51, DOI 10.1111/j.1432-1033.1971.tb01286.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Ignatova Zoya, 2009, V490, P165, DOI 10.1007/978-1-59745-367-7_7; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Kudryashova EV, 1998, BBA-PROTEIN STRUCT M, V1386, P199, DOI 10.1016/S0167-4838(98)00055-7; KUNUGI S, 1982, EUR J BIOCHEM, V124, P157, DOI 10.1111/j.1432-1033.1982.tb05919.x; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Reckel S, 2012, CHEMBIOCHEM, V13, P534, DOI 10.1002/cbic.201100721; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsvetkov P, 2012, MOL BIOSYST, V8, P368, DOI 10.1039/c1mb05283g; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Veltman OR, 1998, BIOCHEMISTRY-US, V37, P5312, DOI 10.1021/bi9725879; Wang QH, 2011, BIOCHEMISTRY-US, V50, P9225, DOI 10.1021/bi201287e; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Williams R, 2006, BIOCHEMISTRY-US, V45, P5421, DOI 10.1021/bi0524262; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011	46	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46147	10.1371/journal.pone.0046147	http://dx.doi.org/10.1371/journal.pone.0046147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056252	gold, Green Published, Green Submitted			2022-12-25	WOS:000309454000020
J	Morris, LX; Spradling, AC				Morris, Lucy X.; Spradling, Allan C.			Steroid Signaling within Drosophila Ovarian Epithelial Cells Sex-Specifically Modulates Early Germ Cell Development and Meiotic Entry	PLOS ONE			English	Article							STEM-CELLS; NICHE FORMATION; OOGENESIS; ECDYSONE; MECHANISMS; PROTEIN; GROWTH; GENE; DIFFERENTIATION; REQUIREMENTS	Drosophila adult females but not males contain high levels of the steroid hormone ecdysone, however, the roles played by steroid signaling during Drosophila gametogenesis remain poorly understood. Drosophila germ cells in both sexes initially follow a similar pathway. After germline stem cells are established, their daughters form interconnected cysts surrounded by somatic escort (female) or cyst (male) cells and enter meiosis. Subsequently, female cysts acquire a new covering of somatic cells to form follicles. Knocking down expression of the heterodimeric ecdysteroid receptor (EcR/Usp) or the E75 early response gene in escort cells disrupts 16-cell cyst production, meiotic entry and follicle formation. Escort cells lose their squamous morphology and unsheath germ cells. By contrast, disrupting ecdysone signaling in males does not perturb cyst development or ensheathment. Thus, sex-specific steroid signaling is essential for female germ cell development at the time male and female pathways diverge. Our results suggest that steroid signaling plays an important sex-specific role in early germ cell development in Drosophila, a strategy that may be conserved in mammals.	[Morris, Lucy X.; Spradling, Allan C.] Carnegie Inst, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst, Dept Embryol, Howard Hughes Med Inst, 115 W Univ Pkwy, Baltimore, MD USA.	spradling@ciwemb.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; BOWNES M, 1983, J EMBRYOL EXP MORPH, V78, P249; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DING D, 1993, P NATL ACAD SCI USA, V90, P2512, DOI 10.1073/pnas.90.6.2512; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; LIN HF, 1994, DEVELOPMENT, V120, P947; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; ORO AE, 1992, DEVELOPMENT, V115, P449; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; SHEA MJ, 1990, GENE DEV, V4, P1128, DOI 10.1101/gad.4.7.1128; Sim H, 2008, TRENDS ENDOCRIN MET, V19, P213, DOI 10.1016/j.tem.2008.04.002; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Terashima J, 2005, J ENDOCRINOL, V187, P69, DOI 10.1677/joe.1.06220; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083	40	62	64	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46109	10.1371/journal.pone.0046109	http://dx.doi.org/10.1371/journal.pone.0046109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056242	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600022
J	Stubendorff, K; Aarsland, D; Minthon, L; Londos, E				Stubendorff, Kajsa; Aarsland, Dag; Minthon, Lennart; Londos, Elisabet			The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORTHOSTATIC HYPOTENSION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NONMOTOR SYMPTOMS; ORGANIC DEMENTIA; BLOOD-PRESSURE; PROGRESSION; DIAGNOSIS; PREDICTORS	Introduction: Autonomic dysfunction is a well-known feature in neurodegenerative dementias, especially common in alpha-synucleinopathies like dementia with Lewy bodies and Parkinson's disease with dementia. The most common symptoms are orthostatic hypotension, incontinence and constipation, but its relevance in clinical practice is poorly understood. There are no earlier studies addressing the influence of autonomic dysfunction on clinical course and survival. The aim of this study was to investigate the frequency of the three most common features of autonomic dysfunction and analyze how it affects survival. Methods: Thirty patients with dementia with Lewy bodies and Parkinson's disease with dementia were included in this prospective, longitudinal follow-up study. Presence of incontinence and constipation was recorded at baseline. Blood pressure was measured at baseline, after 3 months and after 6 months according to standardized procedures, with 5 measurements during 10 minutes after rising. Orthostatic hypotension was defined using consensus definitions and persistent orthostatic hypotension was defined as 5 or more measurements with orthostatic hypotension. Difference in survival was analyzed 36 months after baseline. Results: There was a high frequency of persistent orthostatic blood pressure (50%), constipation (30%) and incontinence (30%). Patients with persistent orthostatic hypotension had a significantly shorter survival compared to those with no or non-persistent orthostatic hypotension (Log rank x(2) = 4.47, p = 0.034). Patients with constipation and/or urinary incontinence, in addition to persistent orthostatic hypotension, had a poorer prognosis compared to those with isolated persistent orthostatic hypotension or no orthostatic hypotension (Log rank x(2) = 6.370, p = 0.041). Discussion: According to our findings, the identification of autonomic dysfunction seems to be of great importance in clinical practice, not only to avoid falls and other complications, but also as a possible predictor of survival.	[Stubendorff, Kajsa; Minthon, Lennart; Londos, Elisabet] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Aarsland, Dag] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Ward & Soc, Stockholm, Sweden	Lund University; Stavanger University Hospital; Karolinska Institutet	Stubendorff, K (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden.	Kajsa.Stubendorff@med.lu.se		Aarsland, Dag/0000-0001-6314-216X	Swedish Research Council [523-2010-520]; Swedish Parkinson Foundation; H. Lundbeck A/S; Novartis; GE Healthcare; Merck-Serono	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; H. Lundbeck A/S; Novartis(Novartis); GE Healthcare(General ElectricGE Healthcare); Merck-Serono(Merck & Company)	Swedish Research Council (nr 523-2010-520) and the Swedish Parkinson Foundation gave financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: D.A. has received honoraria and research support from H. Lundbeck A/S, Novartis, GE Healthcare and Merck-Serono. E.L. has received honoraria from H. Lundbeck A/S and Novartis for lectures. K.S. and L.M. have no conflicts of interest to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, and the authors have declared that no other competing interests exist.	Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Andersson M, 2008, INT J GERIATR PSYCH, V23, P192, DOI 10.1002/gps.1861; Arbogast SD, 2009, AM J MED, V122, P574, DOI 10.1016/j.amjmed.2008.10.040; Ballard C, 2001, INT J GERIATR PSYCH, V16, P499, DOI 10.1002/gps.381; Bostrom F, 2007, ALZ DIS ASSOC DIS, V21, P150, DOI 10.1097/WAD.0b013e318065c4a9; Bostrom F, 2009, DEMENT GERIATR COGN, V28, P314, DOI 10.1159/000249145; Campbell S, 2001, DRUG AGING, V18, P397, DOI 10.2165/00002512-200118060-00002; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Findley L, 2002, MOVEMENT DISORD, V17, P60; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gray WK, 2009, MOVEMENT DISORD, V24, P2432, DOI 10.1002/mds.22834; Hanyu H, 2009, EUR J NEUROL, V16, P212, DOI 10.1111/j.1468-1331.2008.02388.x; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Helmes E, 2003, DEMENT GERIATR COGN, V15, P67, DOI 10.1159/000067969; Horimoto Y, 2003, J NEUROL, V250, P530, DOI 10.1007/s00415-003-1029-9; Jellinger KA, 2007, NEURODEGENER DIS, V4, P428, DOI 10.1159/000107703; Kenny RAM, 2002, ANN NY ACAD SCI, V977, P183, DOI 10.1111/j.1749-6632.2002.tb04816.x; Kovari E, 2009, BRAIN RES BULL, V80, P203, DOI 10.1016/j.brainresbull.2009.06.018; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Lopez OL, 2000, NEUROLOGY, V54, P1774, DOI 10.1212/WNL.54.9.1774; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Magierski R, 2010, NEUROL NEUROCHIR POL, V44, P139; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Passant U, 1996, CLIN AUTON RES, V6, P29, DOI 10.1007/BF02291403; Passant U, 1997, INT J GERIATR PSYCH, V12, P395, DOI 10.1002/(SICI)1099-1166(199703)12:3<395::AID-GPS527>3.3.CO;2-R; Poewe W, 2009, MOVEMENT DISORD, V24, pS671, DOI 10.1002/mds.22600; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Steenland K, 2010, NEUROEPIDEMIOLOGY, V35, P28, DOI 10.1159/000306055; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Tada M, 2007, ARCH NEUROL-CHICAGO, V64, P256, DOI 10.1001/archneur.64.2.256; Thaisetthawatkul P, 2004, NEUROLOGY, V62, P1804, DOI 10.1212/01.WNL.0000125192.69777.6D; Wenning GK, 1999, J NEUROL NEUROSUR PS, V67, P620, DOI 10.1136/jnnp.67.5.620; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	39	74	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45451	10.1371/journal.pone.0045451	http://dx.doi.org/10.1371/journal.pone.0045451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049679	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500006
J	Garcia-Quispes, WA; Pastor, S; Galofre, P; Biarnes, J; Castell, J; Velazquez, A; Marcos, R				Andres Garcia-Quispes, Wilser; Pastor, Susana; Galofre, Pere; Biarnes, Josefina; Castell, Joan; Velazquez, Antonia; Marcos, Ricard			Possible Role of the WDR3 Gene on Genome Stability in Thyroid Cancer Patients	PLOS ONE			English	Article							REPEAT PROTEINS; LYMPHOCYTES; INDIVIDUALS; ASSOCIATION; FREQUENCY; HAPLOTYPE; REGIONS; ASSAY; RISK; SNPS	The role of the WDR3 gene on genomic instability has been evaluated in a group of 115 differentiated thyroid cancer (DTC) patients. Genomic instability has been measured according to the response of peripheral blood lymphocytes to ionizing radiation (0.5 Gy). The response has been measured with the micronucleus (MN) test evaluating the frequency of binucleated cells with MN (BNMN), both before and after the irradiation. No differences between genotypes, for the BNMN frequencies previous the irradiation, were observed. Nevertheless significant decreases in DNA damage after irradiation were observed in individuals carrying the variant alleles for each of the three genotyped SNPs: rs3754127 [-8.85 (-15.01 to -2.70), P<0.01]; rs3765501 [-8.98 (-15.61 to -2.36), P<0.01]; rs4658973 [-8.70 (-14.94 to -2.46), P<0.01]. These values correspond to those obtained assuming a dominant model. This study shows for the first time that WDR3 can modulate genome stability.	[Andres Garcia-Quispes, Wilser; Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, Bellaterra, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, Madrid, Spain; [Galofre, Pere; Castell, Joan] Hosp Univ Vall dHebron, Nucl Med Serv, Barcelona, Spain; [Biarnes, Josefina] Hosp Josep Trueta, Unitat Endocrinol, Girona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Marcos, R (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, Bellaterra, Spain.	ricard.marcos@uab.es	Marcos, Ricard/G-9671-2015; Pastor, Susana/H-7545-2015	Marcos, Ricard/0000-0001-7891-357X; Pastor, Susana/0000-0003-2454-5163; Garcia Quispes, Wilser Andres/0000-0001-6628-2985	Spanish Ministry of Education and Science [SAF2007-6338]; Generalitat de Catalunya (CIRIT) [2009SGR-725]; Universitat Autonoma de Barcelona (PIF)	Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya (CIRIT)(Generalitat de Catalunya); Universitat Autonoma de Barcelona (PIF)	Spanish Ministry of Education and Science (SAF2007-6338) and the Generalitat de Catalunya (CIRIT; 2009SGR-725). W. A. Garcia-Quispes was supported by a predoctoral fellowship from the Universitat Autonoma de Barcelona (PIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdi A, 2010, THYROID, V20, P803, DOI 10.1089/thy.2010.0072; [Anonymous], 2010, R LANG ENV STAT COMP; Baeyens A, 2010, INT J RADIAT BIOL, V86, P584, DOI 10.3109/09553001003734576; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Claudio JO, 1999, GENOMICS, V59, P85, DOI 10.1006/geno.1999.5858; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Guo YJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-140; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Jeggo P, 2010, RADIAT RES, V174, P825, DOI 10.1667/RR1844.1; Jin F, 2004, BIOCHEM GENET, V42, P419, DOI 10.1023/B:BIGI.0000043954.64202.61; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Scott D, 1998, BRIT J CANCER, V77, P614, DOI 10.1038/bjc.1998.98; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Surralles J, 1997, MUTAT RES-GEN TOX EN, V392, P165, DOI 10.1016/S0165-1218(97)00054-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhang J, 1999, CANCER GENET CYTOGEN, V111, P119, DOI 10.1016/S0165-4608(98)00196-4	24	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44288	10.1371/journal.pone.0044288	http://dx.doi.org/10.1371/journal.pone.0044288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049746	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300009
J	Marhefka, JN; Abbud-Antaki, RA				Marhefka, Joie N.; Abbud-Antaki, Rula A.			Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets	PLOS ONE			English	Article							CATHEPSIN-L; CELL-TRANSFORMATION; GENE-EXPRESSION; PI3K PATHWAY; IN-VITRO; INHIBITION; PROLIFERATION; RNAI; GROWTH; MIGRATION	Genomic studies have revealed that breast cancer consists of a complex biological process with patient-specific genetic variations, revealing the need for individualized cancer diagnostic testing and selection of patient-specific optimal therapies. One of the bottlenecks in translation of genomic breakthroughs to the clinic is the lack of functional genomic assays that have high clinical translatability. Anchorage-independent three-dimensional (3D) growth assays are considered to be the gold-standard for chemosensitivity testing, and leads identified with these assays have high probability of clinical success. The Cancer BioChip System (CBCS) allows for the simultaneous, quantitative, and real time evaluation of multitudes of anchorage-independent breast cancer cell growth inhibitors. We employed a Test Cancer BioChip that contains silencing RNAs (siRNAs) targeting cancer-related genes to identify 3D-specific effectors of breast cancer cell growth. We compared the effect of these siRNAs on colony growth of the hormone receptor positive (MCF7) and Human Epidermal Growth Factor Receptor 2/c-Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2/c-erb-b2) positive (SK-BR-3) cells on the Test Cancer BioChip. Our results confirmed cell-specific inhibition of MCF7 and SK-BR-3 colony formation by estrogen receptor a (ESR1) and (ERBB2) siRNA, respectively. Both cell lines were also suppressed by Phosphoinositide-3-kinase Catalytic, alpha Polypeptide (PIK3CA) siRNA. Interestingly, we have observed responses to siRNA that are unique to this 3D setting. For example, beta-actin (ACTB) siRNA suppressed colony growth in both cell types while Cathepsin L2 (CTSL2) siRNA caused opposite effects. These results further validate the importance of the CBCS as a tool for the identification of clinically relevant breast cancer targets.	[Marhefka, Joie N.; Abbud-Antaki, Rula A.] Falcon Genom Inc, Pittsburgh, PA USA		Abbud-Antaki, RA (corresponding author), Falcon Genom Inc, Pittsburgh, PA USA.	rabbud@falcongenomics.com		ABBUD-ANTAKI, RULA/0000-0002-0211-3645	National Cancer Institute [1 R43 CA141962-01A2]; NATIONAL CANCER INSTITUTE [R43CA141962] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported through a Phase 1 SBIR grant from the National Cancer Institute: 1 R43 CA141962-01A2, PI: Dr. Rula A. Abbud-Antaki.	Abbud-Antaki RA, 2012, HORM CANC; Bauer JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2595; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; BERWALD Y, 1963, NATURE, V200, P1182, DOI 10.1038/2001182a0; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blumenthal RD, 2005, METH MOLEC MED, V110, P3; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Clarke M, 1998, LANCET, V351, P1451; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Faltus T, 2004, NEOPLASIA, V6, P786, DOI 10.1593/neo.04313; Fedorov Y, 2005, NAT METHODS, V2, P241, DOI 10.1038/nmeth0405-241; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Fu HJ, 2006, CANCER BIOL THER, V5, P842, DOI 10.4161/cbt.5.7.2840; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Iorns E, 2009, BIOCHEM J, V417, P361, DOI 10.1042/BJ20081682; Isaacs C, 2011, BREAST CANCER RES TR, V125, P137, DOI 10.1007/s10549-010-1226-z; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; KOPEMAIER P, 1992, CHEM-BIOL INTERACT, V82, P295; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Lee AV, 2011, ONCOLOGY-NY, V25, P535; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mukohara T, 2011, CHEMOTHER RES PRACT; Mukohara T, 2009, CANCER LETT, V282, P14, DOI 10.1016/j.canlet.2009.02.056; Munster PN, 2009, BRIT J CANCER, V101, P1044, DOI 10.1038/sj.bjc.6605293; Navab R, 2001, J BIOL CHEM, V276, P13644, DOI 10.1074/jbc.M100019200; Nencioni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009024; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Ocana A, 2008, CLIN CANCER RES, V14, P961, DOI 10.1158/1078-0432.CCR-07-1630; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shin IJ, 2011, ONCOL REP, V25, P1313, DOI 10.3892/or.2011.1214; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sparano JA, 2009, CLIN CANCER RES, V15, P7693, DOI 10.1158/1078-0432.CCR-09-1450; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391; Warnberg F, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1395; Xing RY, 1998, CANCER RES, V58, P904; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zang XP, 2008, ANTICANCER RES, V28, P2733; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng X, 2009, AM J PHYSIOL-CELL PH, V296, pC65, DOI 10.1152/ajpcell.00082.2008	56	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46086	10.1371/journal.pone.0046086	http://dx.doi.org/10.1371/journal.pone.0046086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049944	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300082
J	Mole, TB; Kennedy, N; Ndoya, N; Emond, A				Mole, Thomas B.; Kennedy, Neil; Ndoya, Noel; Emond, Alan			ThermoSpots to Detect Hypothermia in Children with Severe Acute Malnutrition	PLOS ONE			English	Article							NEONATAL HYPOTHERMIA; TEMPERATURE	Introduction: Hypothermia is a risk factor for increased mortality in children with severe acute malnutrition (SAM). Yet frequent temperature measurement remains unfeasible in under-resourced units in developing countries. ThermoSpot is a continuous temperature monitoring sticker designed originally for neonates. When applied to skin, its liquid crystals are designed to turn black with hypothermia and remain green with normothermia. Aims: To (i) estimate the diagnostic accuracy of ThermoSpots for detecting WHO-defined hypothermia (core temperature, <35.5 degrees C or peripheral temperature, <35.0 degrees C) in children with SAM and (ii) determine their acceptability amongst mothers. Methods: Children with SAM in a malnutrition unit in Malawi were enrolled during March-July 2010. The sensitivity and specificity of ThermoSpots were calculated by comparing the device colour against 'gold standard' rectal temperatures taken on admission and follow up peripheral temperatures taken until discharge. Guardians completed a questionnaire to assess acceptability. Results: Hypothermia was uncommon amongst the 162 children enrolled. ThermoSpot successfully detected the one rectal temperature and two peripheral temperatures recorded that met the WHO definition of hypothermia. Overall, 3/846 (0.35%) temperature measurements were in the WHO-defined hypothermia range. Interpreting the brown transition colour (between black and green) as hypothermia improved sensitivities. For milder hypothermia definitions, sensitivities declined (<35.4 degrees C, 50.0%; <35.9 degrees C, 39.2%). Specificity was consistently above 94%. From questionnaires, 40/43 (93%) mothers reported they were 90-100% happy with the device overall. Free-text answers revealed themes of "Skin Rashes'', "User-satisfaction'' and "Empowerment". Conclusion: Although hypothermia was uncommon in this study, ThermoSpots successfully detected these episodes in malnourished children and were acceptable to mothers. Research in settings where hypothermia is common is needed to determine performance with certainty. Instructing users to act when the device's transition colour appears could improve accuracy. If reliable, ThermoSpots may offer simple, acceptable and continuous temperature measurement for high-burden areas and reduce the workload of over-stretched staff.	[Mole, Thomas B.; Emond, Alan] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Kennedy, Neil] Univ Malawi, Dept Pediat & Child Hlth, Blantyre, Malawi; [Ndoya, Noel] Univ Malawi, Kamuzu Coll Nursing, Blantyre, Malawi	University of Bristol; University of Malawi; University of Malawi	Mole, TB (corresponding author), Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	t.b.mole@doctors.org.uk	Mole, Tom/P-7588-2015	Mole, Tom/0000-0001-8732-8188; Kennedy, Neil/0000-0002-6262-2679				Ashworth A, 2001, J PEDIATR GASTR NUTR, V32, P516, DOI 10.1097/00005176-200105000-00003; BROOKE OG, 1972, BMJ-BRIT MED J, V1, P331, DOI 10.1136/bmj.1.5796.331; Green DA, 2006, ARCH DIS CHILD-FETAL, V91, pF96, DOI 10.1136/adc.2005.078410; Kambarami R, 2002, ANN TROP PAEDIATR, V22, P219, DOI 10.1179/027249302125001516; Kennedy N, 2000, LANCET, V355, P1364, DOI 10.1016/S0140-6736(05)72592-7; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Mallet ML, 2002, QJM-INT J MED, V95, P775, DOI 10.1093/qjmed/95.12.775; Manary MJ, 2008, BRIT MED J, V13, p[337, a2180]; Morley D, 2002, TROP DOCT, V32, P22, DOI 10.1177/004947550203200111; Pejaver Ranjan Kumar, 2004, Indian Journal of Pediatrics, V71, P795, DOI 10.1007/BF02730715; Talbert A, 2009, J TROP PEDIATRICS, V55, P413, DOI 10.1093/tropej/fmp038; Teaching Aids at Low Cost (TALC), 2012, J ZEAL THERMOSPOT NO; Wariki WM, 2010, INTERVENTIONS PREVEN; World Health Organisation, 2011, PREV TREAT HYP SEV M; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45823	10.1371/journal.pone.0045823	http://dx.doi.org/10.1371/journal.pone.0045823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049871	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300057
J	Terasawa, M; Uruno, T; Mori, S; Kukimoto-Niino, M; Nishikimi, A; Sanematsu, F; Tanaka, Y; Yokoyama, S; Fukui, Y				Terasawa, Masao; Uruno, Takehito; Mori, Sayako; Kukimoto-Niino, Mutsuko; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Yokoyama, Shigeyuki; Fukui, Yoshinori			Dimerization of DOCK2 Is Essential for DOCK2-Mediated Rac Activation and Lymphocyte Migration	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CELL-MIGRATION; CDC42 ACTIVATOR; PROTEIN DOCK2; RHO-GTPASES; DOMAIN; OLIGOMERIZATION; RESPONSES; ZIZIMIN1; MOTILITY	The migratory properties of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain the Dbl homology domain typically found in guanine nucleotide exchange factors (GEFs), DOCK2 mediates the GTP-GDP exchange reaction for Rac via its DOCK homology region (DHR)-2 (also known as CZH2 or Docker) domain. DOCK2 DHR-2 domain is composed of three lobes, and Rac binding site and catalytic center are generated entirely from lobes B and C. On the other hand, lobe A has been implicated in dimer formation, yet its physiological significance remains unknown. Here, we report that lobe A-mediated DOCK2 dimerization is crucial for Rac activation and lymphocyte migration. We found that unlike wild-type DOCK2, DOCK2 mutant lacking lobe A failed to restore motility and polarity when expressed in thymoma cells and primary T cells lacking endogenous expression of DOCK2. Similar results were obtained with the DOCK2 point mutant having a defect in dimerization. Deletion of lobe A from the DHR-2 domain did not affect Rac GEF activity in vitro. However, fluorescence resonance energy transfer analyses revealed that lobe A is required for DOCK2 to activate Rac effectively during cell migration. Our results thus indicate that DOCK2 dimerization is functionally important under the physiological condition where only limited amounts of DOCK2 and Rac are localized to the plasma membrane.	[Terasawa, Masao; Uruno, Takehito; Mori, Sayako; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan; [Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 812, Japan; [Terasawa, Masao; Uruno, Takehito; Kukimoto-Niino, Mutsuko; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Yokoyama, Shigeyuki; Fukui, Yoshinori] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Kukimoto-Niino, Mutsuko; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); RIKEN; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan.	fukui@bioreg.kyushu-u.ac.jp	Uruno, Takehito/AAF-7998-2019; Kukimoto-Niino, Mutsuko/C-6704-2017; Nishikimi, Akihiko/I-4692-2018; Yokoyama, Shigeyuki/N-6911-2015	Uruno, Takehito/0000-0002-2812-9645; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Nishikimi, Akihiko/0000-0001-9497-7557; Yokoyama, Shigeyuki/0000-0003-3133-7338; Fukui, Yoshinori/0000-0003-2335-8745	CREST program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [22247017]; Strategic Japanese-Swiss Cooperative Program of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24590586] Funding Source: KAKEN	CREST program of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Japanese-Swiss Cooperative Program of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST program (YF and SY) (http://www.immunesystem.jst.go.jp/en/researcher/index.html) and Strategic Japanese-Swiss Cooperative Program (YF) (http://www.jst.go.jp/inter/english/project/country/switzerland.html) of Japan Science and Technology Agency; Targeted Proteins Research Project (http://www.tanpaku.org/e_research/mp.php) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (YF; 22247017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	27	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46277	10.1371/journal.pone.0046277	http://dx.doi.org/10.1371/journal.pone.0046277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050005	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300104
J	Garfield, AS; Chan, WS; Dennis, RJ; Ito, D; Heisler, LK; Rochford, JJ				Garfield, Alastair S.; Chan, Wai S.; Dennis, Rowena J.; Ito, Daisuke; Heisler, Lora K.; Rochford, Justin J.			Neuroanatomical Characterisation of the Expression of the Lipodystrophy and Motor-Neuropathy Gene Bscl2 in Adult Mouse Brain	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS; ADIPOSE-TISSUE; CATECHOLAMINE NEURONS; SEIPIN; LEPTIN; MUTATIONS; GAMMA; HETEROGENEITY; METABOLISM; DISEASE	The endoplasmic reticulum localised protein seipin, encoded by the gene Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), serves a critical but poorly defined function in the physiology of both adipose and neural tissue. In humans, BSCL2 loss-of-function mutations cause a severe form of lipodystrophy, whilst a distinct set of gain-of-toxic-function mutations are associated with a heterogeneous group of neuropathies. However, despite the importance of seipin dysfunction to the pathophysiology of these conditions, little is known about its physiological role in adipocytes or neurons. BSCL2 mRNA has previously been identified in human and mouse brain, yet no definitive assessment of its expression has been undertaken. Here we comprehensively characterised the neuroanatomical distribution of mouse Bscl2 using complementary in situ hybridisation histochemistry and immunohistochemistry techniques. Whilst Bscl2 was broadly expressed throughout the rostral-caudal extent of the mouse brain, it exhibited a discrete neuroanatomical profile. Bscl2 was most abundantly expressed in the hypothalamus and in particular regions associated with the regulation of energy balance including, the paraventricular, ventromedial, arcuate and dorsomedial nuclei. Bscl2 expression was also identified within the brainstem dorsal vagal complex, which together with the paraventricular nucleus of the hypothalamus represented the site of highest expression. Further neurochemical profiling of these two nuclei revealed Bscl2/seipin expression within energy balance related neuronal populations. Specifically, seipin was detected in oxytocin neurons of the paraventricular nucleus of the hypothalamus and in catecholamine neurons of the dorsal vagal complex. These data raise the possibility that in addition to its role in adipose tissue development, seipin may also be involved in the central regulation of energy balance.	[Garfield, Alastair S.; Chan, Wai S.; Heisler, Lora K.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Dennis, Rowena J.; Rochford, Justin J.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Ito, Daisuke] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo, Japan	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Keio University	Heisler, LK (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	lkh30@cam.ac.uk	Ito, Daisuke/GXF-1648-2022; Ito, Daisuke/M-3608-2013	Ito, Daisuke/0000-0002-4740-1675; Rochford, Justin/0000-0002-5020-4939; Garfield, Alastair/0000-0002-9628-6140	Medical Research Council [GO800203]; Wellcome Trust [WT081713, WT09801]; National Institute for Health Research Comprehensive Biomedical Research Centre [CG50826]; Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD); Medical Research Council [G0800203, G0600717B] Funding Source: researchfish; MRC [G0800203] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (GO800203 to JJR), the Wellcome Trust (WT081713 and WT09801 to LKH), the National Institute for Health Research Comprehensive Biomedical Research Centre (CG50826 to RJD), and by the Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; Atasoy D, 2012, NATURE; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cartwright BR, 2012, J LIPID RES, V53, P1042, DOI 10.1194/jlr.R023754; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cui RJ, 2011, J NEUROSCI, V31, P3484, DOI 10.1523/JNEUROSCI.3187-10.2011; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; PETROV T, 1993, BRAIN RES, V609, P81, DOI 10.1016/0006-8993(93)90858-K; Potes CS, 2010, AM J PHYSIOL-REG I, V299, pR623, DOI 10.1152/ajpregu.00791.2009; Rochford JJ, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001547; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; SILVER JR, 1966, ANN HUM GENET, V30, P69, DOI 10.1111/j.1469-1809.1966.tb00007.x; Simha V, 2003, J CLIN ENDOCR METAB, V88, P5433, DOI 10.1210/jc.2003-030835; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Wang LX, 2000, REGUL PEPTIDES, V92, P79, DOI 10.1016/S0167-0115(00)00153-1; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304	40	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45790	10.1371/journal.pone.0045790	http://dx.doi.org/10.1371/journal.pone.0045790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049863	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100081
J	Hill, DJ; Whittles, C; Virji, M				Hill, Darryl J.; Whittles, Cheryl; Virji, Mumtaz			A Novel Group of Moraxella catarrhalis UspA Proteins Mediates Cellular Adhesion via CEACAMs and Vitronectin	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN CEA; OUTER-MEMBRANE PROTEIN; HAEMOPHILUS-INFLUENZAE; NEISSERIA-MENINGITIDIS; EPITHELIAL-CELLS; N-DOMAIN; IFN-GAMMA; SURFACE; EXPRESSION; PATHOGEN	Moraxella catarrhalis (Mx) is a common cause of otitis media and exacerbation of chronic obstructive pulmonary disease, an increasing worldwide problem. Surface proteins UspA1 and UspA2 of Mx bind to a number of human receptors and may function in pathogenesis. Genetic recombination events in the pathogen can generate hybrid proteins termed UspA2H. However, whether certain key functions (e.g. UspA1-specific CEACAM binding) can be exchanged between these adhesin families remains unknown. In this study, we have shown that Mx can incorporate the UspA1 CEACAM1-binding region not only into rare UspA1 proteins devoid of CEACAM-binding ability, but also into UspA2 which normally lack this capacity. Further, a screen of Mx isolates revealed the presence of novel UspA2 Variant proteins (UspA2V) in similar to 14% of the CEACAM-binding population. We demonstrate that the expression of UspA2/2V with the CEACAM-binding domain enable Mx to bind both to cell surface CEACAMs and to integrins, the latter via vitronectin. Such properties of UspA2/2V have not been reported to date. The studies demonstrate that the UspA family is much more heterogeneous than previously believed and illustrate the in vivo potential for exchange of functional regions between UspA proteins which could convey novel adhesive functions whilst enhancing immune evasion.	[Hill, Darryl J.; Whittles, Cheryl; Virji, Mumtaz] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol	Hill, DJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	Darryl.J.Hill@bristol.ac.uk; m.virji@bristol.ac.uk			Wellcome Trust [077461]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was supported by a grant from the Wellcome Trust (Ref: 077461). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1997, INFECT IMMUN, V65, P4367, DOI 10.1128/IAI.65.11.4367-4377.1997; Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bootsma HJ, 2000, J INFECT DIS, V181, P1376, DOI 10.1086/315374; Brooks MJ, 2008, INFECT IMMUN, V76, P5330, DOI 10.1128/IAI.00573-08; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Brozyna S, 2009, COPD, V6, P4, DOI 10.1080/15412550902724164; Casutt-Meyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015159; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Cripps AW, 2005, VACCINE, V23, P2304, DOI 10.1016/j.vaccine.2005.01.023; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; DANSKYULLMANN C, 1995, CYTOKINE, V7, P118, DOI 10.1006/cyto.1995.1016; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; de Vries SPW, 2009, MICROBIOL MOL BIOL R, V73, P389, DOI 10.1128/MMBR.00007-09; Di Stefano A, 2004, EUR RESPIR J, V24, P78, DOI 10.1183/09031936.04.00080303; Diavatopoulos DA, 2006, J EVOLUTION BIOL, V19, P1931, DOI 10.1111/j.1420-9101.2006.01154.x; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Fahlgren A, 2003, SCAND J IMMUNOL, V58, P628, DOI 10.1111/j.1365-3083.2003.01342.x; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Heiniger N, 2005, INFECT IMMUN, V73, P8247, DOI 10.1128/IAI.73.12.8247-8255.2005; HELMINEN ME, 1994, J INFECT DIS, V170, P867, DOI 10.1093/infdis/170.4.867; Hendley JO, 2005, APMIS, V113, P213, DOI 10.1111/j.1600-0463.2005.apm1130310.x; Hill DJ, 2005, MOL MICROBIOL, V55, P1515, DOI 10.1111/j.1365-2958.2005.04487.x; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; IZUMI M, 1989, BIOCHIM BIOPHYS ACTA, V990, P101, DOI 10.1016/S0304-4165(89)80019-4; KLINGMAN KL, 1994, INFECT IMMUN, V62, P1150, DOI 10.1128/IAI.62.4.1150-1155.1994; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Lafontaine ER, 2001, J BACTERIOL, V183, P1540, DOI 10.1128/JB.183.5.1540-1551.2001; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Manolov T, 2008, J IMMUNOL METHODS, V333, P180, DOI 10.1016/j.jim.2007.12.012; McMichael JC, 1998, INFECT IMMUN, V66, P4374; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Meier PS, 2005, VACCINE, V23, P2000, DOI 10.1016/j.vaccine.2004.09.036; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nordstrom T, 2005, J IMMUNOL, V175, P3628, DOI 10.4049/jimmunol.175.6.3628; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Parameswaran GI, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-178; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Spaniol V, 2009, J INFECT DIS, V200, P1593, DOI 10.1086/644640; Tan TT, 2006, J INFECT DIS, V194, P493, DOI 10.1086/505581; Tan TT, 2005, J INFECT DIS, V192, P1029, DOI 10.1086/432759; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	54	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45452	10.1371/journal.pone.0045452	http://dx.doi.org/10.1371/journal.pone.0045452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049802	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100050
J	Garcia, MN; Farias, MSD; Fazzi, L; Grasso, D; Rabinovich, RD; Avila, MM				Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Fazzi, Lucia; Grasso, Daniel; Daniel Rabinovich, Roberto; Mercedes Avila, Maria			Presence of IgG Anti-gp160/120 Antibodies Confers Higher HIV Capture Capacity to Erythrocytes from HIV-Positive Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RED-BLOOD-CELLS; IMMUNE-COMPLEXES; T-CELLS; COMPLEMENT; RECEPTOR; ANTIGEN; BINDING; INFECTION; PLASMA	Background: HIV binding has been demonstrated in erythrocytes from HIV-positive and HIV-negative individuals. However, the presence of immunoglobulins G anti-HIV (IgG anti-HIV) in erythrocytes from HIV-positive individuals is still to be elucidated. Moreover, the capacity of erythrocytes from HIV-positive individuals to capture an additional amount of HIV has not been studied. Indeed, it is unknown if HIV binding to erythrocytes in HIV-positive persons could have consequences on the cell-free infectious virus available. Methodology/Principal Findings: IgGs anti-HIV associated to erythrocytes were found in 77.3% (58/75) of the HIV-positive individuals studied and the IgGs anti-gp160 and anti-p24 were the most frequently found. We found a positive association between detectable plasma viral load (pVL) and presence of IgGs anti-HIV associated to erythrocyte (p < 0.005), though the anti-p24/160 were present with or without detectable pVL. The HIV capture capacity was higher in erythrocytes from HIV-positive than HIV-negative individuals (p < 0.0001). Furthermore, among the HIV-positive individuals the higher viral capture capacity was associated with the presence of anti-gp160/gp120 on erythrocytes. Moreover, the viral capture by erythrocytes was independent of pVL (rho = 0.022, p = 0.8817). Additionally, reduction of cell-free infectious virus and available viral load was observed in the presence of erythrocytes from HIV-positive individuals. Conclusions/Significance: Results suggest that in HIV-positive individuals, erythrocytes are capable of capturing high amounts of HIV by the presence of IgGs anti-gp160/120 on their membranes and this may produce a reduction in the available free virus. Finally, the current measurement of pVL would underestimate the real viral quantity due to the HIV binding through specific antibodies to erythrocytes.	[Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Fazzi, Lucia; Daniel Rabinovich, Roberto; Mercedes Avila, Maria] Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina; [Grasso, Daniel] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Garcia, MN (corresponding author), Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina.	mnoegarcia@gmail.com		GRASSO, DANIEL/0000-0002-8932-716X; Garcia, Maria Noe/0000-0002-2167-1298	Argentina's National Agency for Promotion of Science and Technology [PICT 2067]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT)	This work was supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 2067 to MMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2011, VIROLOGY, V412, P441, DOI 10.1016/j.virol.2011.01.037; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Bonsch C, 2008, J VIROL, V82, P11784, DOI 10.1128/JVI.01399-08; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Farias MSD, 2009, J VIROL METHODS, V158, P6, DOI 10.1016/j.jviromet.2009.01.010; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; MONTEFIORI DC, 1994, J INFECT DIS, V170, P429, DOI 10.1093/infdis/170.2.429; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Garcia MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014544; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHIFFERLI JA, 1988, J IMMUNOL, V140, P899; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; Zhou JT, 1996, VIROLOGY, V226, P13, DOI 10.1006/viro.1996.0623	20	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45808	10.1371/journal.pone.0045808	http://dx.doi.org/10.1371/journal.pone.0045808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049866	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100083
J	Penalosa-Ruiz, G; Aranda, C; Ongay-Larios, L; Colon, M; Quezada, H; Gonzalez, A				Penalosa-Ruiz, Georgina; Aranda, Cristina; Ongay-Larios, Laura; Colon, Maritrini; Quezada, Hector; Gonzalez, Alicia			Paralogous ALT1 and ALT2 Retention and Diversification Have Generated Catalytically Active and Inactive Aminotransferases in Saccharomyces cerevisiae	PLOS ONE			English	Article							OMEGA-AMIDASE PATHWAY; ALANINE AMINOTRANSFERASE; METABOLIC-FLUX; GENE; GLUTAMINE; DEHYDROGENASE; PURIFICATION; DUPLICATION; EXPRESSION; MODEL	Background: Gene duplication and the subsequent divergence of paralogous pairs play a central role in the evolution of novel gene functions. S. cerevisiae possesses two paralogous genes (ALT1/ALT2) which presumably encode alanine aminotransferases. It has been previously shown that Alt1 encodes an alanine aminotransferase, involved in alanine metabolism; however the physiological role of Alt2 is not known. Here we investigate whether ALT2 encodes an active alanine aminotransferase. Principal Findings: Our results show that although ALT1 and ALT2 encode 65% identical proteins, only Alt1 displays alanine aminotransferase activity; in contrast ALT2 encodes a catalytically inert protein. ALT1 and ALT2 expression is modulated by Nrg1 and by the intracellular alanine pool. ALT1 is alanine-induced showing a regulatory profile of a gene encoding an enzyme involved in amino acid catabolism, in agreement with the fact that Alt1 is the sole pathway for alanine catabolism present in S. cerevisiae. Conversely, ALT2 expression is alanine-repressed, indicating a role in alanine biosynthesis, although the encoded-protein has no alanine aminotransferase enzymatic activity. In the ancestral-like yeast L. kluyveri, the alanine aminotransferase activity was higher in the presence of alanine than in the presence of ammonium, suggesting that as for ALT1, LkALT1 expression could be alanine-induced. ALT2 retention poses the questions of whether the encoded protein plays a particular function, and if this function was present in the ancestral gene. It could be hypotesized that ALT2 diverged after duplication, through neo-functionalization or that ALT2 function was present in the ancestral gene, with a yet undiscovered function. Conclusions: ALT1 and ALT2 divergence has resulted in delegation of alanine aminotransferase activity to Alt1. These genes display opposed regulatory profiles: ALT1 is alanine-induced, while ALT2 is alanine repressed. Both genes are negatively regulated by the Nrg1 repressor. Presented results indicate that alanine could act as ALT2 Nrg1-co-repressor.	[Penalosa-Ruiz, Georgina; Aranda, Cristina; Colon, Maritrini; Gonzalez, Alicia] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Div Ciencia Basica, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Ongay-Larios, Laura] Univ Nacl Autonoma Mexico, Unidad Biol Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Quezada, Hector] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gonzalez, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Div Ciencia Basica, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	amanjarr@ifc.unam.mx	Quezada, Hector/AAJ-8486-2021	Quezada, Hector/0000-0003-2663-4696; Colon-Gonzalez, Maritrini/0000-0001-6821-1726; Penalosa Ruiz, Georgina/0000-0002-7148-6613; Gonzalez, Alicia/0000-0002-1276-5719	Direccion General de Asuntos del Personal Academico, UNAM [IN2042093]; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PIFUTP08-1654]; Consejo Nacional de Ciencia y Tecnologia [152448]; International Centre for Genetic Engineering and Biotechnology [CRP/MEX10-03]	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); International Centre for Genetic Engineering and Biotechnology	This study was funded by Direccion General de Asuntos del Personal Academico, UNAM, grant IN2042093 (http://dgapa.unam.mx); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico, grant PIFUTP08-1654 (http://www.icyt.df.gob.mx), Consejo Nacional de Ciencia y Tecnologia grant 152448, and grant NoCRP/MEX10-03 from the International Centre for Genetic Engineering and Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CALDERON J, 1985, J BACTERIOL, V161, P807; CHICO E, 1978, A VAN LEEUW J MICROB, V44, P193, DOI 10.1007/BF00643222; Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099; COOPER AJL, 1977, CRC CR REV BIOCH MOL, V4, P281, DOI 10.3109/10409237709102560; de Sousa CAF, 2003, ENVIRON EXP BOT, V50, P1, DOI 10.1016/S0098-8472(02)00108-9; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; DEROSA G, 1975, J BIOL CHEM, V250, P7961; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; DURAN S, 1995, MICROBIOL-UK, V141, P2883, DOI 10.1099/13500872-141-11-2883; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Feng ZY, 2002, J BACTERIOL, V184, P5001, DOI 10.1128/JB.184.18.5001-5010.2002; Garcia-Campusano F, 2009, CAN J MICROBIOL, V55, P368, DOI [10.1139/W08-150, 10.1139/w08-150]; GATEHOUSE PW, 1967, J BIOL CHEM, V242, P2319; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kursteiner O, 2003, PLANT PHYSIOL, V132, P968, DOI 10.1104/pp.102.016907; Liu L, 2008, PROTEIN EXPRES PURIF, V60, P225, DOI 10.1016/j.pep.2008.04.006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MCCOWEN SM, 1974, J BACTERIOL, V118, P590, DOI 10.1128/JB.118.2.590-597.1974; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; QIU HF, 1991, MOL CELL BIOL, V11, P2169, DOI 10.1128/MCB.11.4.2169; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; Ricoult C, 2005, PHYSIOL PLANTARUM, V123, P30, DOI 10.1111/j.1399-3054.2005.00449.x; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Sato T, 2002, J EXP BOT, V53, P1847, DOI 10.1093/jxb/erf036; Scott EM, 2010, GENE DEV, V24, P1903, DOI 10.1101/gad.1935910; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; SOBERON M, 1987, J GEN MICROBIOL, V133, P9; SOBERON M, 1989, J GEN MICROBIOL, V135, P2693; STRUHL K, 1981, J MOL BIOL, V152, P535, DOI 10.1016/0022-2836(81)90267-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMEMURA I, 1994, BIOSCI BIOTECH BIOCH, V58, P283, DOI 10.1271/bbb.58.283; Vyas VK, 2005, EUKARYOT CELL, V4, P1882, DOI 10.1128/EC.4.11.1882-1891.2005; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WANG MD, 1987, J BACTERIOL, V169, P5610, DOI 10.1128/jb.169.12.5610-5614.1987; Wang NC, 2006, APPL MICROBIOL BIOT, V73, P339, DOI 10.1007/s00253-006-0475-6; WEINSTOCK KG, 1993, YEAST, V9, P351, DOI 10.1002/yea.320090405; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yen KY, 2003, YEAST, V20, P1255, DOI 10.1002/yea.1037; Zhou H, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-5	52	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45702	10.1371/journal.pone.0045702	http://dx.doi.org/10.1371/journal.pone.0045702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049841	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100070
J	Suhr, F; Brenig, J; Muller, R; Behrens, H; Bloch, W; Grau, M				Suhr, Frank; Brenig, Julian; Mueller, Rebecca; Behrens, Hilke; Bloch, Wilhelm; Grau, Marijke			Moderate Exercise Promotes Human RBC-NOS Activity, NO Production and Deformability through Akt Kinase Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; PRIMARY PULMONARY-HYPERTENSION; ERYTHROCYTE NA+/H+ EXCHANGE; INDUCED ATP RELEASE; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; CYCLIC-GMP; MECHANISMS; PHOSPHORYLATION	Background: Nitric oxide (NO) produced by nitric oxide synthase (NOS) in human red blood cells (RBCs) was shown to depend on shear stress and to exhibit important biological functions, such as inhibition of platelet activation. In the present study we hypothesized that exercise-induced shear stress stimulates RBC-NOS activation pathways, NO signaling, and deformability of human RBCs. Methods/Findings: Fifteen male subjects conducted an exercise test with venous blood sampling before and after running on a treadmill for 1 hour. Immunohistochemical staining as well as western blot analysis were used to determine phosphorylation and thus activation of Akt kinase and RBC-NOS as well as accumulation of cyclic guanylyl monophosphate (cGMP) induced by the intervention. The data revealed that activation of NO upstream located enzyme Akt kinase was significantly increased after the test. Phosphorylation of RBC-NOSSer(1177) was also significantly increased after exercise, indicating activation of RBC-NOS through Akt kinase. Total detectable RBC-NOS content and phosphorylation of RBC-NOSThr(495) were not affected by the intervention. NO production by RBCs, determined by DAF fluorometry, and RBC deformability, measured via laser-assisted-optical-rotational red cell analyzer, were also significantly increased after the exercise test. The content of the NO downstream signaling molecule cGMP increased after the test. Pharmacological inhibition of phosphatidylinositol 3 (PI3)-kinase/Akt kinase pathway led to a decrease in RBC-NOS activation, NO production and RBC deformability. Conclusion/Significance: This human in vivo study first-time provides strong evidence that exercise-induced shear stress stimuli activate RBC-NOS via the PI3-kinase/Akt kinase pathway. Actively RBC-NOS-produced NO in human RBCs is critical to maintain RBC deformability. Our data gain insights into human RBC-NOS regulation by exercise and, therefore, will stimulate new therapeutic exercise-based approaches for patients with microvascular disorders.	[Suhr, Frank; Brenig, Julian; Mueller, Rebecca; Behrens, Hilke; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Cologne, Germany; [Suhr, Frank; Bloch, Wilhelm] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Cologne, Germany.	m.grau@dshs-koeln.de	Suhr, Frank/AAU-5080-2021; Grau, Marijke/AAM-7025-2020	Suhr, Frank/0000-0002-9013-3944; Grau, Dr. Marijke/0000-0003-1980-9195	German Research Center of Elite Sport (momentum)	German Research Center of Elite Sport (momentum)	The research described in this article was supported by The German Research Center of Elite Sport (momentum). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423, DOI 10.1152/ajpheart.1996.270.2.H423; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; BOGLE RG, 1991, BIOCHEM BIOPH RES CO, V180, P926, DOI 10.1016/S0006-291X(05)81154-4; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; BUSSE R, 1988, AM J PHYSIOL, V254, pH828, DOI 10.1152/ajpheart.1988.254.5.H828; Chmiel B, 2003, TRANSPLANT P, V35, P2163, DOI 10.1016/S0041-1345(03)00760-7; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FORSTERMANN U, 1993, EUR HEART J, V14, P10; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hofmann F, 2000, J CELL SCI, V113, P1671; Huang QB, 1997, AM J PHYSIOL-HEART C, V273, pH2442, DOI 10.1152/ajpheart.1997.273.5.H2442; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kabanova S, 2009, INT J MED SCI, V6, P156; Kaneko FT, 1998, AM J RESP CRIT CARE, V158, P917, DOI 10.1164/ajrccm.158.3.9802066; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; Ludolph B, 2007, VASC HEALTH RISK MAN, V3, P1069; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mihov D, 2009, AM J PHYSIOL-CELL PH, V297, pC378, DOI 10.1152/ajpcell.00543.2008; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; de Oliveira S, 2008, CLIN HEMORHEOL MICRO, V39, P363, DOI 10.3233/CH-2008-1101; PETROV V, 1994, EUR J BIOCHEM, V221, P195, DOI 10.1111/j.1432-1033.1994.tb18729.x; Petrov V, 1996, AM J PHYSIOL-CELL PH, V271, pC1556, DOI 10.1152/ajpcell.1996.271.5.C1556; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Senturk UK, 2001, J APPL PHYSIOL, V91, P1999, DOI 10.1152/jappl.2001.91.5.1999; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2001, EXP BIOL MED, V226, P434, DOI 10.1177/153537020122600507; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Suhr F, 2009, NITRIC OXIDE-BIOL CH, V20, P95, DOI 10.1016/j.niox.2008.10.004; SZYGULA Z, 1990, SPORTS MED, V10, P181, DOI 10.2165/00007256-199010030-00004; Ulker P, 2009, BIORHEOLOGY, V46, P121, DOI 10.3233/BIR-2009-0532; Ulker P, 2011, NITRIC OXIDE-BIOL CH, V24, P184, DOI 10.1016/j.niox.2011.03.003; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Yalcin O, 2000, J APPL PHYSIOL, V88, P2074, DOI 10.1152/jappl.2000.88.6.2074; Zhang QJ, 2009, J PHYSIOL-LONDON, V587, P3911, DOI 10.1113/jphysiol.2009.172916	54	76	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45982	10.1371/journal.pone.0045982	http://dx.doi.org/10.1371/journal.pone.0045982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049912	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100113
J	Topping, CJ; Dalkvist, T; Grimm, V				Topping, Christopher J.; Dalkvist, Trine; Grimm, Volker			Post-Hoc Pattern-Oriented Testing and Tuning of an Existing Large Model: Lessons from the Field Vole	PLOS ONE			English	Article							MICROTUS-AGRESTIS; SMALL MAMMALS; PERIODIC FLUCTUATIONS; INFORMATION CRITERION; SOCIAL-ORGANIZATION; POPULATION-DENSITY; ECOLOGICAL MODELS; SMALL RODENTS; LIFE-HISTORY; DYNAMICS	Pattern-oriented modeling (POM) is a general strategy for modeling complex systems. In POM, multiple patterns observed at different scales and hierarchical levels are used to optimize model structure, to test and select sub-models of key processes, and for calibration. So far, POM has been used for developing new models and for models of low to moderate complexity. It remains unclear, though, whether the basic idea of POM to utilize multiple patterns, could also be used to test and possibly develop existing and established models of high complexity. Here, we use POM to test, calibrate, and further develop an existing agent-based model of the field vole (Microtus agrestis), which was developed and tested within the ALMaSS framework. This framework is complex because it includes a high-resolution representation of the landscape and its dynamics, of the individual's behavior, and of the interaction between landscape and individual behavior. Results of fitting to the range of patterns chosen were generally very good, but the procedure required to achieve this was long and complicated. To obtain good correspondence between model and the real world it was often necessary to model the real world environment closely. We therefore conclude that post-hoc POM is a useful and viable way to test a highly complex simulation model, but also warn against the dangers of over-fitting to real world patterns that lack details in their explanatory driving factors. To overcome some of these obstacles we suggest the adoption of open-science and open-source approaches to ecological simulation modeling.	[Topping, Christopher J.; Dalkvist, Trine] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Dalkvist, Trine] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modeling, Leipzig, Germany	Aarhus University; Roskilde University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Topping, CJ (corresponding author), Aarhus Univ, Dept Biosci, Ronde, Denmark.	cjt@dmu.dk	Topping, Christopher J/A-9167-2009	Topping, Christopher J/0000-0003-0874-7603	Danish National Research Council	Danish National Research Council(Danmarks Grundforskningsfond)	TD received financial support from the Danish National Research Council. There were no other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRELL J, 1995, BEHAV ECOL, V6, P182, DOI 10.1093/beheco/6.2.182; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Borowski Z, 2003, ACTA THERIOL, V48, P325, DOI 10.1007/BF03194172; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Christensen J.T., 1978, Natura Jutlandica, V20, P163; CLARKE JR, 1977, OIKOS, V29, P457, DOI 10.2307/3543587; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; Dalkvist T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022834; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; Dyczkowski J, 1998, MAMMAL REV, V28, P165, DOI 10.1046/j.1365-2907.1998.00032.x; Elton C., 1942, VOLES MICE LEMMINGS; Elton CS, 1924, BR J EXP BIOL, V2, P119; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 1996, SCI TOTAL ENVIRON, V183, P151, DOI 10.1016/0048-9697(95)04966-5; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm Volker, 2002, Natural Resource Modeling, V15, P23; HAKKARAINEN H, 1992, ANN ZOOL FENN, V29, P279; Hammershoj Mette, 1998, Flora og Fauna, V104, P1; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Hansson L, 1999, OIKOS, V86, P159, DOI 10.2307/3546581; HANSSON L, 1968, OIKOS, V19, P53, DOI 10.2307/3564730; HANSSON L, 1975, OIKOS, V26, P398, DOI 10.2307/3543513; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Hendrichsen Ditte K., 2009, BMC Ecology, V9, P10, DOI 10.1186/1472-6785-9-10; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; Huitu O, 2003, ECOLOGY, V84, P2108, DOI 10.1890/02-0040; Huitu O, 2008, OECOLOGIA, V155, P53, DOI 10.1007/s00442-007-0885-x; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Jensen T.S., 2003, FLORA FAUNA, V109, P9; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; Jepsen JU, 2005, ECOL MODEL, V181, P445, DOI 10.1016/j.ecolmodel.2003.11.019; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Kleijnen J.P.C., 2008, DESIGN ANAL SIMULATI; KOSKELA E, 1995, BEHAV ECOL, V6, P311, DOI 10.1093/beheco/6.3.311; Lambin X, 2000, J ANIM ECOL, V69, P106, DOI 10.1046/j.1365-2656.2000.00380.x; Latombe G, 2011, ECOL MODEL, V222, P1557, DOI 10.1016/j.ecolmodel.2011.02.020; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lopes JS, 2010, INFECT GENET EVOL, V10, P826, DOI 10.1016/j.meegid.2009.10.010; Loughran MFE, 2006, ACTA THERIOL, V51, P233, DOI 10.1007/BF03192675; MARCSTROM V, 1990, J ANIM ECOL, V59, P753, DOI 10.2307/4893; MYLLYMAKI A, 1977, OIKOS, V29, P468, DOI 10.2307/3543588; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Piou C, 2009, ECOL MODEL, V220, P1957, DOI 10.1016/j.ecolmodel.2009.05.003; Railsback S.F., 2011, AGENT BASED INDIVIDU; Railsback SF, 2001, ECOL MODEL, V139, P47, DOI 10.1016/S0304-3800(01)00228-9; Ruger N, 2008, ECOSYSTEMS, V11, P868, DOI 10.1007/s10021-008-9166-8; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; SANDELL M, 1991, OECOLOGIA, V86, P153, DOI 10.1007/BF00317525; SANDELL M, 1990, OECOLOGIA, V83, P145, DOI 10.1007/BF00317745; Scheller RM, 2010, FRONT ECOL ENVIRON, V8, P253, DOI 10.1890/080141; Schmidt NM, 2005, BASIC APPL ECOL, V6, P57, DOI 10.1016/j.baae.2004.09.009; Schmidt NM, 2003, DJF RAPPORT MARKBRUG, V91, P157; Sitch S, 2000, THESIS LUND U LUND; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Tattersall FH, 2000, BIOL CONSERV, V96, P123, DOI 10.1016/S0006-3207(99)00098-1; Topping C, 2003, ANN ZOOL FENN, V40, P255; Topping C, 2005, VEGETATION GROWTH SI; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2011, ECOL ENG, V37, P2009, DOI 10.1016/j.ecoleng.2011.08.010; Topping CJ, 2010, ECOL MODEL, V221, P729, DOI 10.1016/j.ecolmodel.2009.11.004; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Tyre AJ, 2001, ECOL APPL, V11, P1722, DOI 10.2307/3061091; Wheeler P, 2005, ACTA THERIOL, V50, P483, DOI 10.1007/BF03192641; Wheeler P, 2008, AGR ECOSYST ENVIRON, V123, P49, DOI 10.1016/j.agee.2007.04.003; Wiegand T, 2004, BIODIVERS CONSERV, V13, P53, DOI 10.1023/B:BIOC.0000004313.86836.ab; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	76	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45872	10.1371/journal.pone.0045872	http://dx.doi.org/10.1371/journal.pone.0045872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049882	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100095
J	Jeppsson, F; Eketjall, S; Janson, J; Karlstrom, S; Gustavsson, S; Olsson, LL; Radesater, AC; Ploeger, B; Cebers, G; Kolmodin, K; Swahn, BM; von Berg, S; Bueters, T; Falting, J				Jeppsson, Fredrik; Eketjall, Susanna; Janson, Juliette; Karlstrom, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesater, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Falting, Johanna			Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE INHIBITORS; BETA-SECRETASE; IN-VIVO; CEREBROSPINAL-FLUID; LEAD GENERATION; A-BETA; BRAIN; MODEL; REDUCTION	beta-Site amyloid precursor protein cleaving enzyme1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid beta peptide (A beta species. Because cerebral deposition of A beta species might be critical for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease. Here, we report the discovery and comprehensive preclinical characterization of AZD3839, a potent and selective inhibitor of human BACE1. AZD3839 was identified using fragment-based screening and structure-based design. In a concentration-dependent manner, AZD3839 inhibited BACE1 activity in a biochemical fluorescence resonance energy transfer (FRET) assay, A beta and sAPP beta release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons. Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, respectively. AZD3839 exhibited dose-and time-dependent lowering of plasma, brain, and cerebrospinal fluid A beta levels in mouse, guinea pig, and non-human primate. Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects. These results suggest that AZD3839 effectively reduces the levels of A beta in brain, CSF, and plasma in several preclinical species. It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias. Based on the overall pharmacological profile and its drug like properties, AZD3839 has been progressed into Phase 1 clinical trials in man.	[Jeppsson, Fredrik; Eketjall, Susanna; Janson, Juliette; Karlstrom, Sofia; Gustavsson, Susanne; Radesater, Ann-Cathrine; Ploeger, Bart; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Falting, Johanna] Innovat Med AstraZeneca, CNS & Pain, S-15185 Sodertalje, Sweden; [Jeppsson, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17165 Solna, Sweden; [Eketjall, Susanna] AstraZeneca Translat Sci Ctr, Sci Life Lab, S-17165 Solna, Sweden; [Olsson, Lise-Lotte] AstraZeneca, Discovery Sci, S-43153 Molndal, Sweden; [Cebers, Gvido] AstraZeneca Neurosci, Cambridge, MA 02139 USA	AstraZeneca; Karolinska Institutet; AstraZeneca; AstraZeneca; AstraZeneca	Falting, J (corresponding author), AstraZeneca R&D, Innovat Med, CNS & Pain, Sodertalje, Sweden.	Johanna.Falting@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca.	Albert J., 2007, [No title captured], Patent No. [WO 2007058601A1, 2007058601, WO 2007058601 A1 20070524]; Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Arnold J., 2007, PCT International Application, Patent No. [WO2007149033, 2007149033]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Borgegard T., 2012, ALZHEIMERS DIS RES J, V3, P29; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bricogne G., 2010, AUTOBUSTER; Chang WP, 2011, FASEB J, V25, P775, DOI 10.1096/fj.10-167213; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cumming JN, 2012, BIOORG MED CHEM LETT, V22, P2444, DOI 10.1016/j.bmcl.2012.02.013; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Das R, 2011, B MATH BIOL, V73, P230, DOI 10.1007/s11538-010-9540-5; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DELANO WL, 2002, PYMOL MOL GRAPHIS SY; Di L, 2011, DRUG METAB DISPOS, V39, P1270, DOI 10.1124/dmd.111.038778; Edwards PD, 2007, J MED CHEM, V50, P5912, DOI 10.1021/jm070829p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evin G, 2010, INT J BIOCHEM CELL B, V42, P1923, DOI 10.1016/j.biocel.2010.08.017; Friden M, 2009, DRUG METAB DISPOS, V37, P1226, DOI 10.1124/dmd.108.026377; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Geschwindner S, 2007, J MED CHEM, V50, P5903, DOI 10.1021/jm070825k; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holenz J., 2010, PCT International Application, Patent No. [WO 010056196, 010056196]; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ito K, 2011, J PHARM SCI-US, V100, P3939, DOI 10.1002/jps.22487; Janson J., 2012, PAGE POPULATION PKPD, P21; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Lanz TA, 2010, J PHARMACOL EXP THER, V334, P269, DOI 10.1124/jpet.110.167379; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Lu YS, 2012, J PHARMACOL EXP THER, V342, P366, DOI 10.1124/jpet.112.192625; Lu YS, 2011, J PHARMACOL EXP THER, V339, P922, DOI 10.1124/jpet.111.186791; Malamas MS, 2010, BIOORG MED CHEM LETT, V20, P6597, DOI 10.1016/j.bmcl.2010.09.029; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Post TM, 2008, J PHARMACOKINET PHAR, V35, P185, DOI 10.1007/s10928-007-9081-1; Probst G, 2012, EXPERT OPIN THER PAT, V22, P511, DOI 10.1517/13543776.2012.681302; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2006, J MED CHEM, V49, P6147, DOI 10.1021/jm060884i; Stachel SJ, 2009, DRUG DEVELOP RES, V70, P101, DOI 10.1002/ddr.20289; Stanton MG, 2007, J MED CHEM, V50, P3431, DOI 10.1021/jm070272d; Swahn BM, 2012, J MED CHEM, V55, P9346, DOI 10.1021/jm3009025; Swahn BM, 2012, BIOORG MED CHEM LETT, V22, P1854, DOI 10.1016/j.bmcl.2012.01.079; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Tai LM, 2012, J PHARMACOKINET PHAR, V39, P227, DOI 10.1007/s10928-012-9246-4; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Visser S. A. G., 2012, ANN M POP APPR GROUP, P21; Xu YC, 2012, ACTA CRYSTALLOGR D, V68, P13, DOI 10.1107/S0907444911047251; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhong ZY, 2007, ARCH GEN PSYCHIAT, V64, P718, DOI 10.1001/archpsyc.64.6.718	69	93	105	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41245	41257		10.1074/jbc.M112.409110	http://dx.doi.org/10.1074/jbc.M112.409110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048024	hybrid, Green Published			2022-12-25	WOS:000311887600039
J	Thompson, ED; Mayer, GD; Glover, CN; Capo, T; Walsh, PJ; Hogstrand, C				Thompson, E. David; Mayer, Gregory D.; Glover, Chris N.; Capo, Tom; Walsh, Patrick J.; Hogstrand, Christer			Zinc Hyperaccumulation in Squirrelfish (Holocentrus adscenscionis) and Its Role in Embryo Viability	PLOS ONE			English	Article							WATER RAINBOW-TROUT; FEMALE SQUIRRELFISH; GENE-EXPRESSION; VITELLOGENIN; BINDING; PHYSIOLOGY; PROTEIN; METALLOTHIONEIN; ZEBRAFISH; OOCYTES	Female squirrelfish (Fam. Holocentridae) can accumulate and temporarily sequester copious amounts of zinc (Zn) in their livers. There, it is initially compartmentalized before a subsequent, estrogen-triggered redistribution to the ovaries. Here we show that cellular uptake of Zn is also influenced by estrogen signaling, and that estrogen increases concentrations of the plasma Zn-binding protein vitellogenin (VTG). However, estrogen-mediated increases in VTG are not sufficient to accommodate the magnitude of hepato-ovarian Zn transfer in female squirrelfish (Holocentrus adscensionis). These findings suggest that holocentrids have acquired the ability to use hormonal cues to drive hepatic uptake and storage of Zn, signal for its physiological redistribution, and influence the capacity for systemic transport of Zn beyond the mediation of increased plasma VTG concentrations. Such specific adaptations suggest an advantage for the oocyte, which is corroborated in further studies where we determined that oocyte Zn concentrations are positively correlated with egg viability in captivespawned squirrelfish. The novel nature of these findings underlies the importance of Zn in squirrelfish reproductive biology.	[Thompson, E. David] No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA; [Mayer, Gregory D.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Glover, Chris N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Capo, Tom; Walsh, Patrick J.; Hogstrand, Christer] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Walsh, Patrick J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Hogstrand, Christer] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	Northern Kentucky University; Texas Tech University System; Texas Tech University; University of Canterbury; University of Miami; University of Ottawa; University of London; King's College London	Thompson, ED (corresponding author), No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA.	thompsone1@nku.edu	Mayer, Gregory D/A-8459-2017; Mayer, Gregory D/K-4496-2012; Mayer, Gregory/N-1401-2019; Hogstrand, Christer/C-9041-2013	Mayer, Gregory D/0000-0002-2652-9856; Mayer, Gregory D/0000-0002-2652-9856; Mayer, Gregory/0000-0002-2652-9856; Glover, Chris/0000-0001-9170-5759; Hogstrand, Christer/0000-0001-7545-6975	National Science Foundation (NSF) [IBN-9631441]; University of London; Natural Sciences and Engineering Council of Canada; Canada Research Chairs Program	National Science Foundation (NSF)(National Science Foundation (NSF)); University of London; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This study was in part funded by National Science Foundation (NSF) grant IBN-9631441 to CH and travel grants from the University of London Central Research Fund to CH and CNG. PJW is supported by a Discovery Grant from the Natural Sciences and Engineering Council of Canada and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCHISON GJ, 1987, ENVIRON BIOL FISH, V18, P11, DOI 10.1007/BF00002324; BENTLEY PJ, 1991, COMP BIOCHEM PHYS C, V100, P491, DOI 10.1016/0742-8413(91)90028-R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSELBERG D, 1994, J NEUROPHYSIOL, V71, P1491, DOI 10.1152/jn.1994.71.4.1491; Carrillo M., 2000, Cahiers Options Mediterraneennes, V47, P61; CRAIK JCA, 1988, AQUACULTURE, V73, P309, DOI 10.1016/0044-8486(88)90064-6; Davies SJ, 2010, ESSENTIAL REV EXPT B; DYKE B, 1987, BIOCHEMISTRY-US, V26, P3228, DOI 10.1021/bi00385a044; EID AE, 1994, AQUACULTURE, V119, P259, DOI 10.1016/0044-8486(94)90180-5; ElTanani MKK, 1997, J STEROID BIOCHEM, V60, P269, DOI 10.1016/S0960-0760(96)00226-9; Falchuk KH, 2001, BIOMETALS, V14, P385, DOI 10.1023/A:1012994427351; Feeney GP, 2005, BBA-GENE STRUCT EXPR, V1732, P88, DOI 10.1016/j.bbaexp.2005.12.002; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; GHOSH P, 1995, MAR ENVIRON RES, V39, P165, DOI 10.1016/0141-1136(94)00035-N; Glover CN, 2003, PHYSIOL BIOCHEM ZOOL, V76, P321, DOI 10.1086/375428; Glover CN, 2002, J EXP BIOL, V205, P151; HOGSTRAND C, 1990, TOXICOL APPL PHARM, V103, P56, DOI 10.1016/0041-008X(90)90262-S; Hogstrand C, 1996, MAR BIOL, V125, P23, DOI 10.1007/BF00350757; Hogstrand C, 1996, J EXP BIOL, V199, P2543; Hogstrand C, 1996, AM J PHYSIOL-REG I, V270, pR1141; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Huddleston JR, 2006, APPL ENVIRON MICROB, V72, P7036, DOI 10.1128/AEM.00774-06; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; MONTORZI M, 1994, BIOCHEM BIOPH RES CO, V200, P1407, DOI 10.1006/bbrc.1994.1607; MUNKITTRICK KR, 1989, ECOTOX ENVIRON SAFE, V18, P15, DOI 10.1016/0147-6513(89)90088-2; NAGLER JJ, 1990, BIOCHEM CELL BIOL, V68, P330, DOI 10.1139/o90-045; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; PATERSON PG, 1991, J NUTR, V121, P338, DOI 10.1093/jn/121.3.338; Qiu A, 2007, AQUAT TOXICOL, V84, P142, DOI 10.1016/j.aquatox.2007.02.020; Riggio M, 2003, COMP BIOCHEM PHYS C, V135, P191, DOI 10.1016/S1532-0456(03)00107-8; Shinozaki-Mendes RA, 2007, SCI MAR, V71, P715, DOI 10.3989/scimar.2007.71n4715; SILVERSAND C, 1989, J CHROMATOGR, V478, P387, DOI 10.1016/S0021-9673(01)84408-3; SILVERSAND C, 1993, J EXP ZOOL, V267, P587, DOI 10.1002/jez.1402670606; Thompson ED, 2003, COMP BIOCHEM PHYS A, V134, P819, DOI 10.1016/S1095-6433(03)00015-1; Thompson ED, 2002, J EXP BIOL, V205, P3367; Thompson ED, 2001, AM J PHYSIOL-REG I, V280, pR527, DOI 10.1152/ajpregu.2001.280.2.R527; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; WEITZEL G, 1954, H-S Z PHYSIOL CHEM, V296, P19, DOI 10.1515/bchm2.1954.296.1.19; WOLFFE AP, 1985, EUR J BIOCHEM, V146, P489, DOI 10.1111/j.1432-1033.1985.tb08678.x; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	43	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46127	10.1371/journal.pone.0046127	http://dx.doi.org/10.1371/journal.pone.0046127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056248	gold, Green Published, Green Submitted			2022-12-25	WOS:000309580800012
J	d'Onofrio, A; Manfredi, P; Poletti, P				d'Onofrio, Alberto; Manfredi, Piero; Poletti, Piero			The Interplay of Public Intervention and Private Choices in Determining the Outcome of Vaccination Programmes	PLOS ONE			English	Article							BEHAVIOR; GAME; INFORMATION; OSCILLATORITY; TRANSMISSION; AWARENESS; DYNAMICS; DISEASES; SPREAD; IMPACT	After a long period of stagnation, traditionally explained by the voluntary nature of the programme, a considerable increase in routine measles vaccine uptake has been recently observed in Italy after a set of public interventions aiming to promote MMR immunization, whilst retaining its voluntary aspect. To account for this take-off in coverage we propose a simple SIR transmission model with vaccination choice, where, unlike similar works, vaccinating behaviour spreads not only through the diffusion of "private'' information spontaneously circulating among parents of children to be vaccinated, which we call imitation, but also through public information communicated by the public health authorities. We show that public intervention has a stabilising role which is able to reduce the strength of imitation-induced oscillations, to allow disease elimination, and to even make the disease-free equilibrium where everyone is vaccinated globally attractive. The available Italian data are used to evaluate the main behavioural parameters, showing that the proposed model seems to provide a much more plausible behavioural explanation of the observed take-off of uptake of vaccine against measles than models based on pure imitation alone.	[Manfredi, Piero] Univ Pisa, Dept Stat & Appl Math, Pisa, Italy; [d'Onofrio, Alberto] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Poletti, Piero] Fdn Bruno Kessler, Trento, Italy; [Poletti, Piero] Bocconi Univ, DONDENA Ctr Res Social Dynam, Milan, Italy	University of Pisa; IRCCS European Institute of Oncology (IEO); Fondazione Bruno Kessler; Bocconi University	Manfredi, P (corresponding author), Univ Pisa, Dept Stat & Appl Math, Pisa, Italy.	manfredi@ec.unipi.it	d'Onofrio, Alberto/R-4683-2016	d'Onofrio, Alberto/0000-0002-2190-272X; Poletti, Piero/0000-0001-5453-5199				BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bhattacharyya S, 2010, J THEOR BIOL, V267, P276, DOI 10.1016/j.jtbi.2010.09.005; Chen FH, 2009, MATH BIOSCI, V217, P125, DOI 10.1016/j.mbs.2008.11.005; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; d'Onofrio A, 2010, J THEOR BIOL, V264, P237, DOI 10.1016/j.jtbi.2010.02.007; D'Onofrio A, 2008, MATH MED BIOL, V25, P337, DOI 10.1093/imammb/dqn019; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Efimov DV, 2009, SIAM J CONTROL OPTIM, V48, P618, DOI 10.1137/070706963; Efimov DV, 2008, MATH BIOSCI, V216, P187, DOI 10.1016/j.mbs.2008.10.003; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferro A, 2008, Ann Ig, V20, P3; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036118; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Geoffard PY, 1997, AM ECON REV, V87, P222; Hatzopoulos V, 2011, MATH BIOSCI, V231, P197, DOI 10.1016/j.mbs.2011.03.006; ICONA Working group, 2008, 0929 ICONA WORK GROU; ICONA Working group, 1998, 9833 ICONA WORK GROU; ICONA Working group, 2003, 0337 ICONA WORK GROU; Istituto Superiore di Sanita, 2003, 032 I SUP SAN; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Manfredi P, 2009, VACCINE, V28, P98, DOI 10.1016/j.vaccine.2009.09.109; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Reluga TC, 2011, MATH BIOSCI, V230, P67, DOI 10.1016/j.mbs.2011.01.003; Reluga Timothy C., 2009, Journal of Biological Dynamics, V3, P515, DOI 10.1080/17513750802638399; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Shim E, 2009, MATH BIOSCI ENG, V6, P839, DOI 10.3934/mbe.2009.6.839; South Staffordshire NHS, 2010, DIR ENH SERV CHILDH; UK Department of Health, 2011, GREEN BOOK IMM; Vardavas Raffaele, 2010, BMC Res Notes, V3, P92, DOI 10.1186/1756-0500-3-92	38	45	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45653	10.1371/journal.pone.0045653	http://dx.doi.org/10.1371/journal.pone.0045653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049682	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388500009
J	Ringelhan, M; Schmid, RM; Geisler, F				Ringelhan, Marc; Schmid, Roland M.; Geisler, Fabian			The NF-kappa B Subunit RelA/p65 Is Dispensable for Successful Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							TNF-INDUCED APOPTOSIS; IKK-BETA; INTERLEUKIN-6-DEFICIENT MICE; MOUSE HEPATOCYTES; C-JUN; ACTIVATION; PROLIFERATION; INHIBITION; DELETION; GROWTH	Background: The transcription factor NF-kappa B consisting of the subunits RelA/p65 and p50 is known to be quickly activated after partial hepatectomy (PH), the functional relevance of which is still a matter of debate. Current concepts suggest that activation of NF-kappa B is especially critical in non-parenchymal cells to produce cytokines (TNF, IL-6) to adequately prime hepatocytes to proliferate after PH, while NF-kappa B within hepatocytes mainly bears cytoprotective functions. Methods: To study the role of the NF-kappa B pathway in different liver cell compartments, we generated conditional knockout mice in which the transactivating NF-kappa B subunit RelA/p65 can be inactivated specifically in hepatocytes (Rela(F/F)AlbCre) or both in hepatocytes plus non-parenchymal cells including Kupffer cells (Rela(F/F)MxCre). 2/3 and 80% PH were performed in controls (Rela(F/F)) and conditional knockout mice (Rela(F/F)AlbCre and Rela(F/F)MxCre) and analyzed for regeneration. Results: Hepatocyte-specific deletion of RelA/p65 in Rela(F/F)AlbCre mice resulted in an accelerated cell cycle progression without altering liver mass regeneration after 2/3 PH. Surprisingly, hepatocyte apoptosis or liver damage were not enhanced in Rela(F/F)AlbCre mice, even when performing 80% PH. The additional inactivation of RelA/p65 in non-parenchymal cells in Rela(F/F)MxCre mice reversed the small proliferative advantage observed after hepatocyte-specific deletion of RelA/p65 so that Rela(F/F)MxCre mice displayed normal cell cycle progression, DNA-synthesis and liver mass regeneration. Conclusion: The NF-kappa B subunit RelA/p65 fulfills opposite functions in different liver cell compartments in liver regeneration after PH. However, the effects observed after conditional deletion of RelA/p65 are small and do not alter liver mass regeneration after PH. We therefore do not consider RelA/p65-containing canonical NF-kappa B signalling to be essential for successful liver regeneration after PH.	[Ringelhan, Marc; Schmid, Roland M.; Geisler, Fabian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany	Technical University of Munich	Geisler, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany.	fabian.geisler@lrz.tum.de		Ringelhan, Marc/0000-0003-3131-5657	Else Kroner-Fresenius-Stiftung (EKFS) [P10/07]	Else Kroner-Fresenius-Stiftung (EKFS)	This work has been supported by a grant from the Else Kroner-Fresenius-Stiftung (EKFS, grant P10/07 to F.G. and R.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Beraza N, 2007, GASTROENTEROLOGY, V132, P2504, DOI 10.1053/j.gastro.2007.03.045; Bettermann K, CANC CELL, V17, P481; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Boyce S, 2008, LAB ANIMAL, V37, P529, DOI 10.1038/laban1108-529; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Chakraborty JB, 2010, J HEPATOL, V52, P285, DOI 10.1016/j.jhep.2009.10.030; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Doerr RJ, 1990, CLIN ANAT, V3, P279; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fujita J, 2001, SURGERY, V129, P48, DOI 10.1067/msy.2001.109120; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayashi H, 2005, LIVER INT, V25, P162, DOI 10.1111/j.1478-3231.2005.01029.x; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Koch KS, 2009, BIOCHEM BIOPH RES CO, V380, P349, DOI 10.1016/j.bbrc.2009.01.085; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Malato Y, 2009, J HEPATOL, V50, pS310, DOI 10.1016/S0168-8278(09)60853-9; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Paulsen J E, 1990, In Vivo, V4, P235; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang L, 2005, AM J PHYSIOL-GASTR L, V289, pG530, DOI 10.1152/ajpgi.00526.2004; YOKOYAMA HO, 1953, CANCER RES, V13, P80	51	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46469	10.1371/journal.pone.0046469	http://dx.doi.org/10.1371/journal.pone.0046469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049704	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500031
J	Gelman, BB; Chen, TS; Lisinicchia, JG; Soukup, VM; Carmical, JR; Starkey, JM; Masliah, E; Commins, DL; Brandt, D; Grant, I; Singer, EJ; Levine, AJ; Miller, J; Winkler, JM; Fox, HS; Luxon, BA; Morgello, S				Gelman, Benjamin B.; Chen, Tiansheng; Lisinicchia, Joshua G.; Soukup, Vicki M.; Carmical, J. Russ; Starkey, Jonathan M.; Masliah, Eliezer; Commins, Deborah L.; Brandt, Dianne; Grant, Igor; Singer, Elyse J.; Levine, Andrew J.; Miller, Jeremy; Winkler, Jessica M.; Fox, Howard S.; Luxon, Bruce A.; Morgello, Susan		Natl NeuroAIDS Tissue Consortium	The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; WHITE-MATTER; ENDOTHELIAL-CELLS; EXPRESSION ANALYSIS; INTERFERON-GAMMA; INFECTED BRAIN; RNA INTEGRITY; AIDS DEMENTIA; GROWTH-FACTOR	Background: The National NeuroAIDS Tissue Consortium (NNTC) performed a brain gene expression array to elucidate pathophysiologies of Human Immunodeficiency Virus type 1 (HIV-1)-associated neurocognitive disorders. Methods: Twenty-four human subjects in four groups were examined A) Uninfected controls; B) HIV-1 infected subjects with no substantial neurocognitive impairment (NCI); C) Infected with substantial NCI without HIV encephalitis (HIVE); D) Infected with substantial NCI and HIVE. RNA from neocortex, white matter, and neostriatum was processed with the Affymetrix (R) array platform. Results: With HIVE the HIV-1 RNA load in brain tissue was three log(10) units higher than other groups and over 1,900 gene probes were regulated. Interferon response genes (IFRGs), antigen presentation, complement components and CD163 antigen were strongly upregulated. In frontal neocortex downregulated neuronal pathways strongly dominated in HIVE, including GABA receptors, glutamate signaling, synaptic potentiation, axon guidance, clathrin-mediated endocytosis and 14-3-3 protein. Expression was completely different in neuropsychologically impaired subjects without HIVE. They had low brain HIV-1 loads, weak brain immune responses, lacked neuronally expressed changes in neocortex and exhibited upregulation of endothelial cell type transcripts. HIV-1-infected subjects with normal neuropsychological test results had upregulation of neuronal transcripts involved in synaptic transmission of neostriatal circuits. Interpretation: Two patterns of brain gene expression suggest that more than one pathophysiological process occurs in HIV-1-associated neurocognitive impairment. Expression in HIVE suggests that lowering brain HIV-1 replication might improve NCI, whereas NCI without HIVE may not respond in kind; array results suggest that modulation of transvascular signaling is a potentially promising approach. Striking brain regional differences highlighted the likely importance of circuit level disturbances in HIV/AIDS. In subjects without impairment regulation of genes that drive neostriatal synaptic plasticity reflects adaptation. The array provides an infusion of public resources including brain samples, clinicopathological data and correlative gene expression data for further exploration (http://www.nntc.org/gene-array-project).	[Gelman, Benjamin B.; Chen, Tiansheng; Lisinicchia, Joshua G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Soukup, Vicki M.] Univ Texas Med Branch, Dept Neurol, Galveston, TX USA; [Carmical, J. Russ; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Starkey, Jonathan M.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Commins, Deborah L.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Brandt, Dianne] EMMES Corp, Bethesda, MD USA; [Grant, Igor] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Singer, Elyse J.; Levine, Andrew J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Miller, Jeremy] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Winkler, Jessica M.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Morgello, Susan] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of Southern California; Emmes Corporation; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Nebraska System; University of Nebraska Medical Center; Icahn School of Medicine at Mount Sinai	Gelman, BB (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	bgelman@utmb.edu	Luxon, Bruce A/C-9140-2012; Levine, Andrew/ABD-7628-2021	Starkey, Jonathan/0000-0002-9083-6455; Fox, Howard/0000-0003-2032-374X	US National Institutes of Health [U01MH083507, U01MH083501, U01MH083500, U01MH083506, U01MH083545]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545, U01MH083507, U01MH083506, U24MH100929, U01MH083501, U01MH083500] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support was provided through the following cooperative agreements from the US National Institutes of Health U01MH083507; U01MH083501; U01MH083500; U01MH083506; U01MH083545. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the five cooperative agreements was with the EMMES Corporation. The EMMES Corporation in cooperation with the United States National Institutes of Health maintains the integrity of databases pertaining to this study, including patient confidentiality and compliance with regulations pertaining to health record information.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ACHIM CL, 1994, J NEUROPATH EXP NEUR, V53, P284, DOI 10.1097/00005072-199405000-00010; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; An SF, 1997, J NEUROPATH EXP NEUR, V56, P1262, DOI 10.1097/00005072-199711000-00011; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Baldeweg T, 1997, INT J PSYCHOPHYSIOL, V26, P431, DOI 10.1016/S0167-8760(97)00780-0; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Banks WA, 2006, PHYSIOL BEHAV, V89, P472, DOI 10.1016/j.physbeh.2006.07.004; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; BROOIMANS RA, 1989, J IMMUNOL, V142, P2024; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Buesa C, 2004, J NEUROPATH EXP NEUR, V63, P1003, DOI 10.1093/jnen/63.10.1003; Burdo TH, 2008, J INFECT DIS, V198, P715, DOI 10.1086/590504; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; de Chaldee M, 2003, GENOME RES, V13, P1646, DOI 10.1101/gr.1173403; de Larranaga GF, 2003, THROMB RES, V110, P93, DOI 10.1016/S0049-3848(03)00291-3; Deutch AY, 2007, PARKINSONISM RELAT D, V13, pS251, DOI 10.1016/S1353-8020(08)70012-9; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ervin JF, 2007, J NEUROPATH EXP NEUR, V66, P1093, DOI 10.1097/nen.0b013e31815c196a; Everall I, 2005, J NEUROIMMUNOL, V170, P158, DOI 10.1016/j.jneuroim.2005.09.009; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Fox HS, 2008, J NEUROVIROL, V14, P286, DOI 10.1080/13550280802132824; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Gelman BB, 2004, J NEUROIMMUNOL, V157, P111, DOI 10.1016/j.jneuroim.2004.08.044; Gelman BB, 2005, JAIDS-J ACQ IMM DEF, V39, P422, DOI 10.1097/01.qai.0000164250.41475.f2; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; Gelman Benjamin B, 2007, Handb Clin Neurol, V85, P301, DOI 10.1016/S0072-9752(07)85018-4; Gelman BB, 2010, J NEUROIMMUNE PHARM, V5, P92, DOI 10.1007/s11481-009-9168-0; GLASS JD, 1993, NEUROLOGY, V43, P2230, DOI 10.1212/WNL.43.11.2230; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gray F, 2003, J NEUROPATH EXP NEUR, V62, P429, DOI 10.1093/jnen/62.5.429; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Ke Y, 2004, PSYCHIAT RES-NEUROIM, V130, P283, DOI 10.1016/j.pscychresns.2003.12.001; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MASLIAH E, 1995, J NEUROPATH EXP NEUR, V54, P350, DOI 10.1097/00005072-199505000-00008; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McCarthy MJ, 1998, FEBS LETT, V423, P334, DOI 10.1016/S0014-5793(98)00122-7; Melendez MM, 2008, CLIN INFECT DIS, V46, P775, DOI 10.1086/527563; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Morgello S, 2002, ARCH PATHOL LAB MED, V126, P182; Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; Oide T, 2006, NEUROPATH APPL NEURO, V32, P170, DOI 10.1111/j.1365-2990.2006.00710.x; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Paul RH, 2007, J NEUROPSYCH CLIN N, V19, P283, DOI 10.1176/appi.neuropsych.19.3.283; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; POWER C, 1993, ANN NEUROL, V34, P339, DOI 10.1002/ana.410340307; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; Roberts ES, 2006, J NEUROSCI, V26, P4577, DOI 10.1523/JNEUROSCI.4504-05.2006; Roberts ES, 2004, J NEUROIMMUNOL, V157, P81, DOI 10.1016/j.jneuroim.2004.08.030; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Ross AC, 2008, JAIDS-J ACQ IMM DEF, V49, P499, DOI 10.1097/QAI.0b013e318189a794; Sas AR, 2007, AIDS, V21, P2151, DOI 10.1097/QAD.0b013e3282f08c2f; SCHMIDBAUER M, 1992, NEUROPATH APPL NEURO, V18, P489, DOI 10.1111/j.1365-2990.1992.tb00816.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tar K, 2004, J CELL BIOCHEM, V92, P534, DOI 10.1002/jcb.20036; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Vastag M, 1998, IMMUNOBIOLOGY, V199, P5, DOI 10.1016/S0171-2985(98)80059-4; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626; WILEY CA, 1994, ANN NEUROL, V36, P673, DOI 10.1002/ana.410360422; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Xing HQ, 2003, J NEUROVIROL, V9, P508, DOI 10.1080/13550280390218904; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	95	111	117	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46178	10.1371/journal.pone.0046178	http://dx.doi.org/10.1371/journal.pone.0046178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049970	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300094
J	Hu, WG; Yin, JF; Chau, D; Negrych, LM; Cherwonogrodzky, JW				Hu, Wei-Gang; Yin, Junfei; Chau, Damon; Negrych, Laurel M.; Cherwonogrodzky, John W.			Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody	PLOS ONE			English	Article							RESHAPING HUMAN-ANTIBODIES; EQUINE ENCEPHALITIS-VIRUS; HYPERVARIABLE REGIONS; COMBINING SITE; TOXIN; IMMUNOGENICITY; EXPRESSION; MECHANISM; THERAPY; RIBOSOMES	Ricin is regarded as a high terrorist risk for the public due to its high toxicity and ease of production. Currently, there is no therapeutic or vaccine available against ricin. D9, a murine monoclonal antibody developed previously in our laboratory, can strongly neutralize ricin and is therefore a good candidate for humanization. Humanization of D9 variable regions was achieved by a complementarity-determining region grafting approach. The humanized D9 (hD9) variable regions were further grafted onto human heavy and light chain constant regions to assemble the complete antibody gene. A foot-and-mouth-disease virus-derived 2A self-processing sequence was introduced between heavy and light chain DNA sequences to cleave the recombinant protein into a functional full-length antibody molecule from a single open reading frame driven by a single promoter in an adenoviral vector. After expression in mammalian cells and purification, the hD9 was demonstrated to have equimolar expression of the full-length antibody heavy and light chains. More importantly, the hD9 exhibited high affinity to ricin with K-D of 1.63 nM, comparable to its parental murine D9 (2.55 nM). In a mouse model, intraperitoneal (i.p.) administration of hD9, at a low dose of 5 mu g per mouse, 4 hours after the i.p. challenge with 5xLD50 ricin was found to rescue 100% of the mice. In addition, administered 6 hours post-challenge, hD9 could still rescue 50% of the mice. The hD9 has the potential to be used for prophylactic or therapeutic purposes against ricin poisoning.	[Hu, Wei-Gang; Yin, Junfei; Chau, Damon; Negrych, Laurel M.; Cherwonogrodzky, John W.] Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada		Hu, WG (corresponding author), Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada.	wei-gang.hu@drdc-rddc.gc.ca			Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada [08-0112TA]	Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada	This study was supported by the Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada (Project 08-0112TA). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views or policies of the CRTI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Binder P, 2003, COMP IMMUNOL MICROB, V26, P401, DOI 10.1016/S0147-9571(03)00023-7; BRUGGEMANN M, 1989, J EXP MED, V170, P2153, DOI 10.1084/jem.170.6.2153; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Hu WG, 2008, HUM VACCINES, V4, P74, DOI 10.4161/hv.4.1.4778; Hu WG, 2007, VACCINE, V25, P3210, DOI 10.1016/j.vaccine.2007.01.034; Hu WG, 2010, VACCINE, V28, P5558, DOI 10.1016/j.vaccine.2010.06.038; Hu WG, 2010, APPL BIOCHEM BIOTECH, V160, P1206, DOI 10.1007/s12010-009-8657-1; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; Kabat EA, 1984, FUNDAMENTAL IMMUNOLO, P595; KANTHA S S, 1991, Keio Journal of Medicine, V40, P35; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Mirick GR, 2004, Q J NUCL MED MOL IM, V48, P251; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; Nakanishi T, 2008, PROTEIN SCI, V17, P261, DOI 10.1110/ps.073156708; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; NICOLSON GL, 1975, CANCER RES, V35, P144; Nussenzweig MC, 2004, NAT MED, V10, P1304, DOI 10.1038/nm1204-1304; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TAKAHASHI H, 1994, J MOL BIOL, V243, P494, DOI 10.1006/jmbi.1994.1675; Tamura M, 2000, J IMMUNOL, V164, P1432, DOI 10.4049/jimmunol.164.3.1432; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Tsurushita N, 2005, METHODS, V36, P69, DOI 10.1016/j.ymeth.2005.01.007; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Wang YG, 2007, BIOTECHNOL LETT, V29, P1811, DOI 10.1007/s10529-007-9478-3; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wu Feng, 2010, World J Biol Chem, V1, P188, DOI 10.4331/wjbc.v1.i5.188; YOULE RJ, 1987, J BIOL CHEM, V262, P4676; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	50	25	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45595	10.1371/journal.pone.0045595	http://dx.doi.org/10.1371/journal.pone.0045595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049820	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300036
J	Manikkam, M; Tracey, R; Guerrero-Bosagna, C; Skinner, MK				Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.			Dioxin (TCDD) Induces Epigenetic Transgenerational Inheritance of Adult Onset Disease and Sperm Epimutations	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; POLYCYSTIC-OVARY-SYNDROME; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; IN-UTERO; LACTATIONAL EXPOSURE; FEMALE RATS; 2,4,5-TRICHLOROPHENOXYACETIC ACID; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL-FACTORS; PERINATAL EXPOSURE	Environmental compounds can promote epigenetic transgenerational inheritance of adult-onset disease in subsequent generations following ancestral exposure during fetal gonadal sex determination. The current study examined the ability of dioxin (2,3,7,8-tetrachlorodibenzo[p]dioxin, TCDD) to promote epigenetic transgenerational inheritance of disease and DNA methylation epimutations in sperm. Gestating F0 generation females were exposed to dioxin during fetal day 8 to 14 and adult-onset disease was evaluated in F1 and F3 generation rats. The incidences of total disease and multiple disease increased in F1 and F3 generations. Prostate disease, ovarian primordial follicle loss and polycystic ovary disease were increased in F1 generation dioxin lineage. Kidney disease in males, pubertal abnormalities in females, ovarian primordial follicle loss and polycystic ovary disease were increased in F3 generation dioxin lineage animals. Analysis of the F3 generation sperm epigenome identified 50 differentially DNA methylated regions (DMR) in gene promoters. These DMR provide potential epigenetic biomarkers for transgenerational disease and ancestral environmental exposures. Observations demonstrate dioxin exposure of a gestating female promotes epigenetic transgenerational inheritance of adult onset disease and sperm epimutations.	[Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	USA Department of Defense (DOD); NIH, NIEHS	USA Department of Defense (DOD); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support of the USA Department of Defense (DOD) and NIH, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; COURTNEY KD, 1971, TOXICOL APPL PHARM, V20, P396, DOI 10.1016/0041-008X(71)90282-1; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Davis BJ, 2000, CANCER RES, V60, P5414; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P858, DOI 10.1289/ehp.7820; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P22, DOI 10.1289/ehp.6573; Flaws JA, 1997, TOXICOL APPL PHARM, V147, P351, DOI 10.1006/taap.1997.8295; Gao X, 2000, TOXICOLOGY, V147, P15, DOI 10.1016/S0300-483X(00)00161-X; Gao X, 1999, TOXICOL APPL PHARM, V157, P107, DOI 10.1006/taap.1999.8649; Gehrs BC, 1997, TOXICOLOGY, V122, P229, DOI 10.1016/S0300-483X(97)00099-1; Gray LE, 1997, TOXICOL APPL PHARM, V146, P11, DOI 10.1006/taap.1997.8223; GRAY LE, 1995, TOXICOL APPL PHARM, V133, P285, DOI 10.1006/taap.1995.1153; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2012, REPROD TOXI IN PRESS; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guo YL, 2000, LANCET, V356, P1240, DOI 10.1016/S0140-6736(00)02792-6; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Heimler I, 1998, REPROD TOXICOL, V12, P69, DOI 10.1016/S0890-6238(97)00101-9; Huang L, 2011, J TOXICOL SCI, V36, P713, DOI 10.2131/jts.36.713; IOM, 2010, VET AG OR UPD 2010; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kakeyama M, 2008, J ENDOCRINOL, V197, P351, DOI 10.1677/JOE-08-0062; KOCIBA RJ, 1976, TOXICOL APPL PHARM, V35, P553, DOI 10.1016/0041-008X(76)90078-8; LI XL, 1995, TOXICOL APPL PHARM, V133, P321, DOI 10.1006/taap.1995.1157; Lu CF, 2009, ARCH ENVIRON CON TOX, V57, P767, DOI 10.1007/s00244-009-9323-x; Manikkam M, 2012, PLASTICS DERIV UNPUB; Manikkam M, 2012, REPROD TOXICOL UNPUB; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; MATTISON DR, 1980, TOXICOL APPL PHARM, V53, P249, DOI 10.1016/0041-008X(80)90424-X; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Moran FM, 2001, REPROD TOXICOL, V15, P377, DOI 10.1016/S0890-6238(01)00138-1; Mustafa A, 2011, BIRTH DEFECTS RES B, V92, P82, DOI 10.1002/bdrb.20285; Ni HG, 2010, ENVIRON TOXICOL CHEM, V29, P1237, DOI 10.1002/etc.160; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Nishimura N, 2008, TOXICOL APPL PHARM, V231, P374, DOI 10.1016/j.taap.2008.05.012; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Roby KF, 2000, BIOL REPROD, V62, P284; Roby KF, 2001, ENDOCRINOLOGY, V142, P2328, DOI 10.1210/en.142.6.2328; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Salisbury TB, 2002, BIOL REPROD, V66, P1621, DOI 10.1095/biolreprod66.6.1621; SILBERGELD EK, 1987, AM J IND MED, V11, P131, DOI 10.1002/ajim.4700110203; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Son DS, 1999, REPROD TOXICOL, V13, P521, DOI 10.1016/S0890-6238(99)00048-9; Spaulding SW, 2011, CURR OPIN ENDOCRINOL, V18, P315, DOI 10.1097/MED.0b013e32834a8764; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Tracey R, 2012, REPROD TOXICOL UNPUB; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; UMBREIT TH, 1987, ARCH ENVIRON CON TOX, V16, P461, DOI 10.1007/BF01055268; van Leeuwen FXR, 2000, CHEMOSPHERE, V40, P1095, DOI 10.1016/S0045-6535(99)00358-6; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Warner M, 2004, ENVIRON HEALTH PERSP, V112, P1289, DOI 10.1289/ehp.7004; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Wolff MS, 2005, ENVIRON HEALTH PERSP, V113, pA17, DOI 10.1289/ehp.113-a17; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; York Geoffrey, 2008, GLOBE MAIL	73	170	178	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46249	10.1371/journal.pone.0046249	http://dx.doi.org/10.1371/journal.pone.0046249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049995	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300100
J	Martin, S; Fernandez-Rojo, MA; Stanley, AC; Bastiani, M; Okano, S; Nixon, SJ; Thomas, G; Stow, JL; Parton, RG				Martin, Sally; Fernandez-Rojo, Manuel A.; Stanley, Amanda C.; Bastiani, Michele; Okano, Satomi; Nixon, Susan J.; Thomas, Gethin; Stow, Jennifer L.; Parton, Robert G.			Caveolin-1 Deficiency Leads to Increased Susceptibility to Cell Death and Fibrosis in White Adipose Tissue: Characterization of a Lipodystrophic Model	PLOS ONE			English	Article							INTERLEUKIN-6 STIMULATES LIPOLYSIS; TRANSCRIPT-RELEASE FACTOR; LIVER-REGENERATION; INSULIN-RESISTANCE; LIPID TRAFFICKING; DROPLET PROTEINS; POLYMERASE-I; TNF-ALPHA; ADIPOCYTES; PERILIPIN	Caveolin-1 (CAV1) is an important regulator of adipose tissue homeostasis. In the present study we examined the impact of CAV1 deficiency on the properties of mouse adipose tissue both in vivo and in explant cultures during conditions of metabolic stress. In CAV1(-/-) mice fasting caused loss of adipose tissue mass despite a lack of hormone-sensitive lipase (HSL) phosphorylation. In addition, fasting resulted in increased macrophage infiltration, enhanced deposition of collagen, and a reduction in the level of the lipid droplet protein perilipin A (PLIN1a). Explant cultures of CAV1(-/-) adipose tissue also showed a loss of PLIN1a during culture, enhanced secretion of IL-6, increased release of lactate dehydrogenase, and demonstrated increased susceptibility to cell death upon collagenase treatment. Attenuated PKA-mediated signaling to HSL, loss of PLIN1a and increased secretion of IL-6 were also observed in adipose tissue explants of CAV1(+/+) mice with diet-induced obesity. Together these results suggest that while alterations in adipocyte lipid droplet biology support adipose tissue metabolism in the absence of PKA-mediated pro-lipolytic signaling in CAV1(-/-) mice, the tissue is intrinsically unstable resulting in increased susceptibility to cell death, which we suggest underlies the development of fibrosis and inflammation during periods of metabolic stress.	[Martin, Sally; Fernandez-Rojo, Manuel A.; Stanley, Amanda C.; Bastiani, Michele; Okano, Satomi; Nixon, Susan J.; Stow, Jennifer L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Thomas, Gethin] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Martin, S (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	s.martin@uq.edu.au; R.Parton@imb.uq.edu.au	Okano, Satomi/AAX-9546-2021; Thomas, Gethin P/A-3624-2011; Martin, Sally/A-7150-2010; Fernandez-Rojo, Manuel Alejandro/P-2981-2014; Stow, Jennifer L/I-4723-2013; Parton, Robert G/C-5673-2009; Bastiani, Michele/J-1823-2014; Nixon, Susan/D-4588-2017	Okano, Satomi/0000-0003-4913-9612; Martin, Sally/0000-0001-9294-5404; Fernandez-Rojo, Manuel Alejandro/0000-0002-2240-1951; Stow, Jennifer L/0000-0002-5409-9101; Parton, Robert G/0000-0002-7494-5248; Bastiani, Michele/0000-0001-6752-4157; Thomas, Gethin/0000-0001-9081-3686; Nixon, Susan/0000-0003-0346-9683	National Health and Medical Research Council of Australia [511005, 569452, 455865]; Diabetes Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia	This work was supported by grants from the National Health and Medical Research Council of Australia (to RGP, grant numbers 511005 and 569452, and RGP and SM, grant number 455865) (www.nhmrc.gov.au) and Diabetes Australia (SM) (www.diabetesaustralia.com.au). MAF was an MEC/Fulbright Postdoctoral Fellow (Ministry of Education and Science, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2011, DIABETES, V60, P757, DOI 10.2337/db10-0744; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Bezaire V, 2009, FEBS LETT, V583, P3045, DOI 10.1016/j.febslet.2009.08.019; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FAN JY, 1983, J CELL SCI, V61, P219; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fernandez-Rojo MA, 2011, HEPATOLOGY; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Mattsson CL, 2010, AM J PHYSIOL-ENDOC M, V299, pE374, DOI 10.1152/ajpendo.00071.2010; Mattsson CL, 2011, BIOCHIM BIOPHYS ACTA, V1803, P983; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Thompson BR, 2010, MOL CELL ENDOCRINOL, V318, P24, DOI 10.1016/j.mce.2009.08.015; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; VERNON RG, 1992, P NUTR SOC, V51, P397, DOI 10.1079/PNS19920053; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	53	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46242	10.1371/journal.pone.0046242	http://dx.doi.org/10.1371/journal.pone.0046242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049990	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300099
J	Shou, WH; Wang, DZ; Zhang, KY; Wang, BL; Wang, ZM; Shi, JX; Huang, W				Shou, Weihua; Wang, Dazhi; Zhang, Kaiyue; Wang, Beilan; Wang, Zhimin; Shi, Jinxiu; Huang, Wei			Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population	PLOS ONE			English	Article							MDR1 P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; HUMAN PLACENTA; ASSOCIATION; POLYMORPHISMS; HAPLOTYPES; GENOME; PHARMACOKINETICS; GENOTYPE; PROTEIN	In order to comprehensively screen genetic variants leading to differential expression of the important human ABCB1 gene in the primary drug-metabolizing organ, ABCB1 mRNA expression levels were measured in 73 normal liver tissue samples from Chinese subjects. A set of Tag SNPs. were genotyped. In addition, imputation was performed within a 500 kb region around the ABCB1 gene using the reference panels of 1,000 Genome project and HapMap III. Bayesian regression was used to assess the strength of associations by compute Bayes Factors for imputed SNPs. Through imputation and linkage disequilibrium analysis, the imputed loci rs28373093, rs1002205, rs1029421, rs2285647, and rs10235835, may represent independent and strong association signals. rs28373093, a polymorphism 1.5 kb upstream from the ABCB1 transcription start site, has the strongest association. 2677 G>A/T and 3435C>T confer a clear gene-dosage effect on ABCB1 mRNA expression. The systematic characterization of gene-wide common quantitative trait loci associated with ABCB1 mRNA expression in normal liver tissues would provide the candidate markers to ABCB1-relevant clinical phenotypes in Chinese population.	[Shou, Weihua; Wang, Dazhi; Zhang, Kaiyue; Wang, Beilan; Wang, Zhimin; Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Shou, Weihua; Huang, Wei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shi, JX (corresponding author), Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	shijx@chgc.sh.cn; weihuangsh@gmail.com			Chinese High-Tech Program [2009AA022709]; Ministry of Health [201202008]; Chinese National Natural Science Fund for Distinguished Young Scholars [30625019]; Chinese National Natural Science Fund for Youth [30900828]	Chinese High-Tech Program; Ministry of Health; Chinese National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National Natural Science Fund for Youth	This work was supported by grants from the Chinese High-Tech Program (2009AA022709), Special Fund for Public Benefit Research from Ministry of Health (201202008), Chinese National Natural Science Fund for Distinguished Young Scholars (30625019) and Chinese National Natural Science Fund for Youth (30900828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bercovich D, 2006, ATHEROSCLEROSIS, V185, P97, DOI 10.1016/j.atherosclerosis.2005.05.025; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; De Luca V, 2003, PHARMACOGENOMICS J, V3, P297, DOI 10.1038/sj.tpj.6500196; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Haenisch S, 2007, PHARMACOGENOMICS J, V7, P56, DOI 10.1038/sj.tpj.6500403; Hitzl M, 2004, PHARMACOGENETICS, V14, P309, DOI 10.1097/00008571-200405000-00006; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jamroziak Krzysztof, 2004, Hematology, V9, P91, DOI 10.1080/10245330310001638974; Koyama T, 2006, BIOL PHARM BULL, V29, P1449, DOI 10.1248/bpb.29.1449; Kwan P, 2009, PHARMACOGENOMICS, V10, P723, DOI [10.2217/pgs.09.32, 10.2217/PGS.09.32]; Leith CP, 1999, BLOOD, V94, P1086; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67; Loeuillet C, 2007, PHARMACOGENET GENOM, V17, P951, DOI 10.1097/FPC.0b013e3282eff934; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Potocnik U, 2008, CANCER GENET CYTOGEN, V183, P28, DOI 10.1016/j.cancergencyto.2008.01.023; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Roy JN, 2006, PHARMACOGENET GENOM, V16, P659, DOI 10.1097/01.fpc.0000220571.20961.dd; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siegsmund M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019412.87412.BC; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Tanigawara Y, 2000, THER DRUG MONIT, V22, P137, DOI 10.1097/00007691-200002000-00029; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Uwal Y, 2004, J HUM GENET, V49, P40; Verstuyft C, 2003, EUR J CLIN PHARMACOL, V58, P809, DOI 10.1007/s00228-003-0567-5; Wang BS, 2006, MOL PHARMACOL, V70, P267, DOI 10.1124/mol.105.019810; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zheng HX, 2005, J CLIN PHARMACOL, V45, P404, DOI 10.1177/0091270005274507	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46295	10.1371/journal.pone.0046295	http://dx.doi.org/10.1371/journal.pone.0046295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050008	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517300106
J	Viswanathan, K; Bot, I; Liu, LY; Dai, EB; Turner, PC; Togonu-Bickersteth, B; Richardson, J; Davids, JA; Williams, JM; Bartee, MY; Chen, H; van Berkel, TJC; Biessen, EAL; Moyer, RW; Lucas, AR				Viswanathan, Kasinath; Bot, Ilze; Liu, Liying; Dai, Erbin; Turner, Peter C.; Togonu-Bickersteth, Babajide; Richardson, Jakob; Davids, Jennifer A.; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; van Berkel, Theo J. C.; Biessen, Erik A. L.; Moyer, Richard W.; Lucas, Alexandra R.			Viral Cross-Class Serpin Inhibits Vascular Inflammation and T Lymphocyte Fratricide; A Study in Rodent Models In Vivo and Human Cell Lines In Vitro	PLOS ONE			English	Article							MYXOMA-VIRUS SERP2; GRANZYME-B; INTERLEUKIN-1-BETA-CONVERTING ENZYME; APOPTOSIS; FAS; ATHEROSCLEROSIS; ACTIVATION; MECHANISMS; EXPRESSION; CRMA	Poxviruses express highly active inhibitors, including serine proteinase inhibitors (serpins), designed to target host immune defense pathways. Recent work has demonstrated clinical efficacy for a secreted, myxomaviral serpin, Serp-1, which targets the thrombotic and thrombolytic proteases, suggesting that other viral serpins may have therapeutic application. Serp-2 and CrmA are intracellular cross-class poxviral serpins, with entirely distinct functions from the Serp-1 protein. Serp-2 and CrmA block the serine protease granzyme B (GzmB) and cysteine proteases, caspases 1 and 8, in apoptotic pathways, but have not been examined for extracellular anti-inflammatory activity. We examined the ability of these cross-class serpins to inhibit plaque growth after arterial damage or transplant and to reduce leukocyte apoptosis. We observed that purified Serp-2, but not CrmA, given as a systemic infusion after angioplasty, transplant, or cuff-compression injury markedly reduced plaque growth in mouse and rat models in vivo. Plaque growth was inhibited both locally at sites of surgical trauma, angioplasty or transplant, and systemically at non-injured sites in ApoE-deficient hyperlipidemic mice. With analysis in vitro of human cells in culture, Serp-2 selectively inhibited T cell caspase activity and blocked cytotoxic T cell (CTL) mediated killing of T lymphocytes (termed fratricide). Conversely, both Serp-2 and CrmA inhibited monocyte apoptosis. Serp-2 inhibitory activity was significantly compromised either in vitro with GzmB antibody or in vivo in ApoE/GzmB double knockout mice. Conclusions The viral cross-class serpin, Serp-2, that targets both apoptotic and inflammatory pathways, reduces vascular inflammation in a GzmB-dependent fashion in vivo, and inhibits human T cell apoptosis in vitro. These findings indicate that therapies targeting Granzyme B and/or T cell apoptosis may be used to inhibit T lymphocyte apoptosis and inflammation in response to arterial injury.	[Viswanathan, Kasinath; Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Richardson, Jakob; Lucas, Alexandra R.] Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5C1, Canada; [Bot, Ilze; van Berkel, Theo J. C.; Biessen, Erik A. L.] Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Bot, Ilze; van Berkel, Theo J. C.; Biessen, Erik A. L.] Univ Maastracht, Maastracht, Netherlands; [Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Div Rheumatol, Gainesville, FL USA; [Turner, Peter C.; Davids, Jennifer A.; Bartee, Mee Y.; Moyer, Richard W.; Lucas, Alexandra R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Western University (University of Western Ontario); Leiden University; Leiden University - Excl LUMC; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lucas, AR (corresponding author), Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5C1, Canada.	alexandra.lucas@medicine.ufl	Van Berkel, Theo/ABD-7677-2021	Bot, Ilze/0000-0002-1242-1959; Biessen, Erik/0000-0002-6454-8548; Turner, Peter/0000-0002-7706-4593	Canadian Institutes of Health research (CIHR); Heart and Stroke foundation of Ontario (HSFO); National Institutes of Health (NIH) ARRA [1RC1HL100202-01]; American Heart Association (AHA) [0855421 E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); National Institutes of Health (NIH) ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by research grants from the Canadian Institutes of Health research (CIHR), the Heart and Stroke foundation of Ontario (HSFO), the National Institutes of Health (NIH) ARRA grant 1RC1HL100202-01, and the American Heart Association (AHA) grant 0855421 E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Akyurek LM, 1998, J CLIN INVEST, V101, P2889, DOI 10.1172/JCI1177; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Alcouffe J, 2004, FASEB J, V18, P122, DOI 10.1096/fj.02-0808fje; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bot I, 2003, CIRC RES, V93, P464, DOI 10.1161/01.RES.0000090993.01633.D4; Callard RE, 2003, TRENDS IMMUNOL, V24, P370, DOI 10.1016/S1471-4906(03)00164-9; Choy JC, 2005, AM J TRANSPLANT, V5, P494, DOI 10.1111/j.1600-6143.2004.00710.x; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FOX WM, 1993, HUM PATHOL, V24, P477, DOI 10.1016/0046-8177(93)90159-E; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; Gramling MW, 2010, THROMB RES, V125, P377, DOI 10.1016/j.thromres.2009.11.034; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Liu ZX, 2001, J IMMUNOL, V166, P3035, DOI 10.4049/jimmunol.166.5.3035; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Messud-Petit F, 1998, J VIROL, V72, P7830, DOI 10.1128/JVI.72.10.7830-7839.1998; Nathaniel R, 2004, J GEN VIROL, V85, P1267, DOI 10.1099/vir.0.79905-0; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schneider DF, 2007, J BURN CARE RES, V28, P365, DOI 10.1097/BCR.0B013E318053D40B; Seto T, 2010, J HEART LUNG TRANSPL, V29, P352, DOI 10.1016/j.healun.2009.09.008; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Solovyan VT, 2002, J BIOL CHEM, V277, P21458, DOI 10.1074/jbc.M110621200; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Turner PC, 1999, J VIROL, V73, P6394, DOI 10.1128/JVI.73.8.6394-6404.1999; Turner PC, 2001, ASM NEWS, V67, P201; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Yang J, 2004, ARTERIOSCL THROM VAS, V24, P1466, DOI 10.1161/01.ATV.0000134402.94963.2f; Zadelaar ASM, 2005, ATHEROSCLEROSIS, V183, P244, DOI 10.1016/j.atherosclerosis.2005.03.044	48	25	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44694	10.1371/journal.pone.0044694	http://dx.doi.org/10.1371/journal.pone.0044694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049756	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300011
J	Szolajska, E; Burmeister, WP; Zochowska, M; Nerlo, B; Andreev, I; Schoehn, G; Andrieu, JP; Fender, P; Naskalska, A; Zubieta, C; Cusack, S; Chroboczek, J				Szolajska, Ewa; Burmeister, Wim P.; Zochowska, Monika; Nerlo, Barbara; Andreev, Igor; Schoehn, Guy; Andrieu, Jean-Pierre; Fender, Pascal; Naskalska, Antonina; Zubieta, Chloe; Cusack, Stephen; Chroboczek, Jadwiga			The Structural Basis for the Integrity of Adenovirus Ad3 Dodecahedron	PLOS ONE			English	Article							PROTEIN TRANSDUCTION; CRYSTAL-STRUCTURE; VIRUS; INTEGRATION; ANTIGENS; DELIVERY; SEQUENCE; REVEALS; DOMAINS; TYPE-3	During the viral life cycle adenoviruses produce excess capsid proteins. Human adenovirus serotype 3 (Ad3) synthesizes predominantly an excess of free pentons, the complexes of pentameric penton base and trimeric fiber proteins, which are responsible for virus penetration. In infected cells Ad3 pentons spontaneously assemble into dodecahedral virus-like nano-particles containing twelve pentons. They also form in insect cells during expression in the baculovirus system. Similarly, in the absence of fiber protein dodecahedric particles built of 12 penton base pentamers can be produced. Both kinds of dodecahedra show remarkable efficiency of intracellular penetration and can be engineered to deliver several millions of foreign cargo molecules to a single target cell. For this reason, they are of great interest as a delivery vector. In order to successfully manipulate this potential vector for drug and/or gene delivery, an understanding of the molecular basis of vector assembly and integrity is critical. Crystallographic data in conjunction with site-directed mutagenesis and biochemical analysis provide a model for the molecular determinants of dodecamer particle assembly and the requirements for stability. The 3.8 angstrom crystal structure of Ad3 penton base dodecamer (Dd) shows that the dodecahedric structure is stabilized by strand-swapping between neighboring penton base molecules. Such N-terminal strand-swapping does not occur for Dd of Ad2, a serotype which does not form Dd under physiological conditions. This unique stabilization of the Ad3 dodecamer is controlled by residues 59-61 located at the site of strand switching, the residues involved in putative salt bridges between pentamers and by the disordered N-terminus (residues 1-47), as confirmed by site directed mutagenesis and biochemical analysis of mutant and wild type protein. We also provide evidence that the distal N-terminal residues are externally exposed and available for attaching cargo.	[Szolajska, Ewa; Zochowska, Monika; Nerlo, Barbara; Naskalska, Antonina; Chroboczek, Jadwiga] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Burmeister, Wim P.; Schoehn, Guy; Fender, Pascal; Cusack, Stephen] UJF Grenoble 1, Unit Virus Host Cell Interact, EMBL, Ctr Natl Rech Sci,CNRS UMI 3265, Grenoble, France; [Andreev, Igor] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Schoehn, Guy; Andrieu, Jean-Pierre] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel IBS, Grenoble, France; [Zubieta, Chloe] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Zubieta, Chloe; Cusack, Stephen] EMBL, Grenoble Outstn, Grenoble, France; [Chroboczek, Jadwiga] UJF Grenoble 1, Tech Ingn Med & Complexite Informat Math & Applic, UMR CNRS 5525, La Tronche, France; [Schoehn, Guy; Andrieu, Jean-Pierre] UJF Grenoble 1, IBS, Grenoble, France; [Schoehn, Guy; Andrieu, Jean-Pierre] CNRS, IBS UMR 5075, Grenoble, France	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Szolajska, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	ewasz@ibb.waw.pl; wpb@embl.fr; jadwiga.chroboczek@imag.fr	Andreev, Igor/G-6194-2016; Chroboczek, Jadwiga/M-6554-2014	Andreev, Igor/0000-0002-3706-8514; Cusack, Stephen/0000-0002-9324-0796; Zubieta, Chloe/0000-0003-4558-9333; Burmeister, Wim/0000-0003-0876-6118; Naskalska, Antonina/0000-0002-5868-1000; Fender, Pascal/0000-0002-6698-3367; Szolajska, Ewa/0000-0002-7400-4333; Schoehn, Guy/0000-0002-1459-3201; Zochowska, Monika/0000-0002-3824-4962	Polish Ministry of Education and Computer Sciences (MNII) [2PO4B02329]; National Science Centre [N N302 505738]; MAE-French Atomic Energy Commission (CEA); NATO CLG grant	Polish Ministry of Education and Computer Sciences (MNII); National Science Centre(National Science Centre, Poland); MAE-French Atomic Energy Commission (CEA); NATO CLG grant(NATO (North Atlantic Treaty Organisation))	This work was in part supported by Polish Ministry of Education and Computer Sciences (MNII) grant 2PO4B02329, National Science Centre N N302 505738, MAE-French Atomic Energy Commission (CEA) and NATO CLG grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2012, J VIROL, V86, P5380, DOI 10.1128/JVI.07127-11; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Garcel A, 2006, J GENE MED, V8, P524, DOI 10.1002/jgm.862; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gout E, 2010, J CELL BIOCHEM, V111, P699, DOI 10.1002/jcb.22756; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naskalska A, 2009, VACCINE, V27, P7385, DOI 10.1016/j.vaccine.2009.09.021; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NORRBY E, 1969, VIROLOGY, V37, P565, DOI 10.1016/0042-6822(69)90274-8; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sirena D, 2005, VIROLOGY, V343, P283, DOI 10.1016/j.virol.2005.08.024; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Villegas-Mendez A, 2010, MOL THER, V18, P1046, DOI 10.1038/mt.2010.16; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, J VIROL, V85, P6390, DOI 10.1128/JVI.00514-11; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zochowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005569; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	38	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46075	10.1371/journal.pone.0046075	http://dx.doi.org/10.1371/journal.pone.0046075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049939	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100131
J	Toth, K; Sipos, F; Kalmar, A; Patai, AV; Wichmann, B; Stoehr, R; Golcher, H; Schellerer, V; Tulassay, Z; Molnar, B				Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Patai, Arpad V.; Wichmann, Barnabas; Stoehr, Robert; Golcher, Henriette; Schellerer, Vera; Tulassay, Zsolt; Molnar, Bela			Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers	PLOS ONE			English	Article							COLORECTAL-CANCER; CARCINOEMBRYONIC ANTIGEN; DNA METHYLATION; BLOOD; SERUM; SURVEILLANCE; BIOMARKER; MARKERS; STAGE; COLONOSCOPY	Background: Methylated Septin 9 (SEPT9) is a sensitive biomarker for colorectal cancer (CRC) from peripheral blood. However, its relationship to cancer localization, guaiac-based fecal occult blood test (gFOBT) and carcinoembryonic antigen (CEA) have not been described. Methodology/Principal Findings: Plasma samples were collected for SEPT9 analysis from patients with no evidence of disease (NED) (n = 92) before colonoscopy and CRC (n = 92) before surgical treatment. DNA was isolated and bisulfite-converted using Epi proColon kit 2.0. Qualitative determination was performed using Epi proColon 2.0 RT-PCR assay. Samples for gFOBT and CEA analysis were collected from NED (n = 17 and 27, respectively) and CRC (n = 22 and 27, respectively). SEPT9 test was positive in 15.2% (14/92) of NED and 95.6% (88/92) of CRC, including 100% (67/67) from stage II to stage IV CRC and 84% (21/25) of stage I CRC when a sample was called positive if 1 out of 3 PCR replicates was positive. In a second analysis (2 out of 3 PCR replicates) specificity improved to 99% (91/92) of NEDs, at a sensitivity of 79.3% (73/92) of SEPT9 positives in CRC. gFOBT was positive in 29.4% (5/17) of NED and 68.2% (15/22) of CRC and elevated CEA levels were detected in 14.8% (4/27) of NED and 51.8% (14/27) of CRC. Both SEPT9 (84.8%) and CEA (85.2%) showed higher specificity than gFOBT (70.6%). SEPT9 was positive in 96.4% (54/56) of left-sided colon cancer (LSCC) cases and 94.4% (34/36) of rightsided colon cancer (RSCC) cases. gFOBT was positive in 83.3% (10/12) of cases with LSCC and 50% (5/10) of cases with RSCC, elevated CEA was detected 60% (9/15) of LSCC and 41.7% (5/12) of RSCC. Conclusions/Significance: The high degree of sensitivity and specificity of SEPT9 in plasma makes it a better method to detect CRC than gFOBT and CEA, even for the more difficult to detect RSCC.	[Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Wichmann, Barnabas; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Stoehr, Robert] Univ Klinikum Erlangen, Inst Pathol, Erlangen, Germany; [Golcher, Henriette; Schellerer, Vera] Univ Klinikum Erlangen, Dept Surg, Erlangen, Germany	Semmelweis University; Hungarian Academy of Sciences; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Toth, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	drtothkinga@yahoo.com	Sipos, Ferenc/GYV-6182-2022		Epigenomics AG (Berlin, Germany)	Epigenomics AG (Berlin, Germany)	This study was supported by Epigenomics AG (Berlin, Germany). The sponsor has partially supplied the reagents for the study, performed technical training and support. Data collection, decision to publish and preparation of the manuscript were performed by the authors.; This study was supported by Epigenomics AG (Berlin, Germany). The sponsor has partially supplied the reagents for the study, performed technical training and support. The authors declare that they are not employed and not consultants at the funder. The authors have no share in patents, products in development or marketed products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bauer KM, 2012, MOL CARCINOGEN, V51, P411, DOI 10.1002/mc.20804; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Benedix F, 2011, EJSO-EUR J SURG ONC, V37, P134, DOI 10.1016/j.ejso.2010.12.004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Chen JS, 2010, CLIN CHEM LAB MED, V48, P719, DOI 10.1515/CCLM.2010.123; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Ghazi S, 2012, J GASTROENTEROL, V47, P619, DOI 10.1007/s00535-011-0520-9; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hara M, 2010, J SURG ONCOL, V102, P154, DOI 10.1002/jso.21599; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Komuro K, 2005, J SURG RES, V124, P216, DOI 10.1016/j.jss.2004.10.009; LEON SA, 1977, CANCER RES, V37, P646; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Payne SR, 2010, EPIGENOMICS-UK, V2, P575, DOI [10.2217/epi.10.35, 10.2217/EPI.10.35]; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tanaka J, 2007, J SURG ONCOL, V96, P611, DOI 10.1002/jso.20877; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119	39	131	142	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46000	10.1371/journal.pone.0046000	http://dx.doi.org/10.1371/journal.pone.0046000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049919	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100117
J	Vanderschuren, H; Moreno, I; Anjanappa, RB; Zainuddin, IM; Gruissem, W				Vanderschuren, Herve; Moreno, Isabel; Anjanappa, Ravi B.; Zainuddin, Ima M.; Gruissem, Wilhelm			Exploiting the Combination of Natural and Genetically Engineered Resistance to Cassava Mosaic and Cassava Brown Streak Viruses Impacting Cassava Production in Africa	PLOS ONE			English	Article							NICOTIANA-BENTHAMIANA; EAST-AFRICA; DNA-A; DISEASE; RNA; TRANSFORMATION; SUPPRESSION; GEMINIVIRUSES; EPIDEMIOLOGY; IMPROVEMENT	Cassava brown streak disease (CBSD) and cassava mosaic disease (CMD) are currently two major viral diseases that severely reduce cassava production in large areas of Sub-Saharan Africa. Natural resistance has so far only been reported for CMD in cassava. CBSD is caused by two virus species, Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV). A sequence of the CBSV coat protein (CP) highly conserved between the two virus species was used to demonstrate that a CBSV-CP hairpin construct sufficed to generate immunity against both viral species in the cassava model cultivar (cv. 60444). Most of the transgenic lines showed high levels of resistance under increasing viral loads using a stringent top-grafting method of inoculation. No viral replication was observed in the resistant transgenic lines and they remained free of typical CBSD root symptoms 7 month post-infection. To generate transgenic cassava lines combining resistance to both CBSD and CMD the hairpin construct was transferred to a CMD-resistant farmer-preferred Nigerian landrace TME 7 (Oko-Iyawo). An adapted protocol allowed the efficient Agrobacterium-based transformation of TME 7 and the regeneration of transgenic lines with high levels of CBSV-CP hairpin-derived small RNAs. All transgenic TME 7 lines were immune to both CBSV and UCBSV infections. Further evaluation of the transgenic TME 7 lines revealed that CBSD resistance was maintained when plants were co-inoculated with East African cassava mosaic virus (EACMV), a geminivirus causing CMD. The innovative combination of natural and engineered virus resistance in farmer-preferred landraces will be particularly important to reducing the increasing impact of cassava viral diseases in Africa.	[Vanderschuren, Herve; Moreno, Isabel; Anjanappa, Ravi B.; Zainuddin, Ima M.; Gruissem, Wilhelm] ETH, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vanderschuren, H (corresponding author), ETH, Dept Biol, Zurich, Switzerland.	hvanderschuren@ethz.ch	Vanderschuren, Hervé/AAF-5118-2021; Gruissem, Wilhelm/H-1752-2013	Gruissem, Wilhelm/0000-0002-1872-2998; Zainuddin, Ima Mulyama/0000-0002-2923-8691; Vanderschuren, Herve/0000-0003-2102-9737	Bill & Melinda Gates Foundation (BioCassava Plus Program); ETH Zurich; North-South Centre (ETH Zurich); Swiss Federal Commission for Scholarships for Foreign Students (FCS)	Bill & Melinda Gates Foundation (BioCassava Plus Program); ETH Zurich(ETH Zurich); North-South Centre (ETH Zurich)(ETH Zurich); Swiss Federal Commission for Scholarships for Foreign Students (FCS)	This work was partially funded by the Bill & Melinda Gates Foundation (BioCassava Plus Program) and ETH Zurich. RBA received a PhD fellowship from the North-South Centre (ETH Zurich) and IMZ received a scholarship from the Swiss Federal Commission for Scholarships for Foreign Students (FCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Bucher E, 2006, J GEN VIROL, V87, P3697, DOI 10.1099/vir.0.82276-0; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Di Nicola-Negri E, 2010, PLANT CELL REP, V29, P1435, DOI 10.1007/s00299-010-0933-6; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Fregene M, 2000, THEOR APPL GENET, V100, P678, DOI 10.1007/s001220051339; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Legg JP, 2006, ADV VIRUS RES, V67, P355, DOI 10.1016/S0065-3527(06)67010-3; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Legg JP, 2000, VIRUS RES, V71, P135, DOI 10.1016/S0168-1702(00)00194-5; Leibman D, 2011, MOL PLANT MICROBE IN, V24, P1220, DOI 10.1094/MPMI-05-11-0128; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; Lokko Y, 2005, AFR J BIOTECHNOL, V4, P873; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; Niklaus Michael, 2011, GM Crops, V2, P193, DOI 10.4161/gmcr.2.3.18866; Ogwok E, 2010, J VIROL METHODS, V169, P296, DOI 10.1016/j.jviromet.2010.07.030; Okogbenin E, 2007, CROP SCI, V47, P1895, DOI 10.2135/cropsci2006.10.0688; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Raji A, 2008, J INTEGR PLANT BIOL, V50, P311, DOI 10.1111/j.1744-7909.2007.00606.x; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zainuddin I, 2012, PLANT METHO IN PRESS; Zainuddin IM, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-24; Zhou XP, 1997, J GEN VIROL, V78, P2101, DOI 10.1099/0022-1317-78-8-2101	50	53	55	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45277	10.1371/journal.pone.0045277	http://dx.doi.org/10.1371/journal.pone.0045277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049780	Green Published, gold			2022-12-25	WOS:000309556100034
J	Otten, JJT; de Jager, SCA; Kavelaars, A; Seijkens, T; Bot, I; Wijnands, E; Beckers, L; Westra, MM; Bot, M; Busch, M; Bermudez, B; van Berkel, TJC; Heijnen, CJ; Biessen, EAL				Otten, Jeroen J. T.; de Jager, Saskia C. A.; Kavelaars, Annemieke; Seijkens, Tom; Bot, Ilze; Wijnands, Erwin; Beckers, Linda; Westra, Marijke M.; Bot, Martine; Busch, Matthias; Bermudez, Beatriz; van Berkel, Theo J. C.; Heijnen, Cobi J.; Biessen, Erik A. L.			Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice	FASEB JOURNAL			English	Article						mouse model of atherosclerosis; chemotaxis; leukocytes	ACCELERATED ATHEROSCLEROSIS; CHEMOKINE RECEPTORS; INDUCED APOPTOSIS; BONE-MARROW; GRK2; CELLS; CCR5; EXPRESSION; GENE; PHOSPHORYLATION	Leukocyte chemotaxis is deemed instrumental in initiation and progression of atherosclerosis. It is mediated by G-protein-coupled receptors (e. g., CCR2 and CCR5), the activity of which is controlled by G-protein-coupled receptor kinases (GRKs). In this study, we analyzed the effect of hematopoietic deficiency of a potent regulator kinase of chemotaxis (GRK2) on atherogenesis. LDL receptor-deficient (LDLr-/-) mice with heterozygous hematopoietic GRK2 deficiency, generated by bone marrow transplantation (n = 15), displayed a dramatic attenuation of plaque development, with 79% reduction in necrotic core and increased macrophage content. Circulating monocytes decreased and granulocytes increased in GRK2(+/-) chimeras, which could be attributed to diminished granulocyte colony-forming units in bone marrow. Collectively, these data pointed to myeloid cells as major mediators of the impaired atherogenic response in GRK2(+/-) chimeras. LDLr-/- mice with macrophage/granulocyte-specific GRK2 deficiency (LysM-Cre GRK2(flox/flox); n = 8) failed to mimic the aforementioned phenotype, acquitting these cells as major responsible subsets for GRK2 deficiency-associated atheroprotection. To conclude, even partial hematopoietic GRK2 deficiency prevents atherosclerotic lesion progression beyond the fatty streak stage, identifying hematopoietic GRK2 as a potential target for intervention in atherosclerosis.-Otten, J. J. T., de Jager, S. C. A., Kavelaars, A., Seijkens, T., Bot, I., Wijnands, E., Beckers, L., Westra, M. M., Bot, M., Busch, M., Bermudez, B., van Berkel, T. J. C., Heijnen, C. J., Biessen, E. A. L. Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice. FASEB J. 27, 265-276 (2013). www.fasebj.org	[Otten, Jeroen J. T.; Seijkens, Tom; Wijnands, Erwin; Beckers, Linda; Busch, Matthias; Bermudez, Beatriz; Biessen, Erik A. L.] Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht, NL-6229 HX Maastricht, Netherlands; [de Jager, Saskia C. A.; Bot, Ilze; Westra, Marijke M.; Bot, Martine; van Berkel, Theo J. C.; Biessen, Erik A. L.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Kavelaars, Annemieke] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA; [Bermudez, Beatriz] CSIC, Inst Grasa & Derivados, Lab Cellular & Mol Nutr, E-41012 Seville, Spain	Maastricht University; Leiden University; Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Biessen, EAL (corresponding author), Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	erik.biessen@mumc.nl	Busch, Matthias/ABF-4740-2021; Van Berkel, Theo/ABD-7677-2021	de Jager, Saskia/0000-0002-5233-0066; Biessen, Erik/0000-0002-6454-8548; Bot, Ilze/0000-0002-1242-1959; Seijkens, Tom/0000-0001-6370-1267; Busch, Matthias/0000-0001-7324-2471	Netherlands Heart Foundation [2003T201]; U.S. National Institutes of Health [R01-NS003939, NS074999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073939, R01NS074999] Funding Source: NIH RePORTER	Netherlands Heart Foundation(Netherlands Heart Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. M. Gijbels for her help in plaque morphology scoring. E. B. is the recipient of an Established Investigator Fellowship (grant 2003T201) of The Netherlands Heart Foundation. This work was supported in part by the U.S. National Institutes of Health (grants R01-NS003939 and NS074999 to A.K.).	Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Burke-Gaffney A, 2002, VASC PHARMACOL, V38, P283, DOI 10.1016/S1537-1891(02)00253-7; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; DERIJKE YB, 1994, BIOCHEM J, V304, P69, DOI 10.1042/bj3040069; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P352; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hall SE, 2009, MOL PHARMACOL, V75, P1325, DOI 10.1124/mol.108.053470; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Herijgers N, 1997, ARTERIOSCL THROM VAS, V17, P1995, DOI 10.1161/01.ATV.17.10.1995; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kavelaars A, 2011, BRAIN BEHAV IMMUN, V25, P1055, DOI 10.1016/j.bbi.2011.03.019; LEVINE JD, 1988, P NATL ACAD SCI USA, V85, P4553, DOI 10.1073/pnas.85.12.4553; Liehn Elisa A., 2006, Archives of Physiology and Biochemistry, V112, P229, DOI 10.1080/13813450601093583; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lombardi MS, 1999, FASEB J, V13, P715, DOI 10.1096/fasebj.13.6.715; Lukacs NW, 1996, J LEUKOCYTE BIOL, V59, P13, DOI 10.1002/jlb.59.1.13; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; MULLER S, 1995, BIOCHEM SOC T, V23, P141; Nijboer CH, 2010, BRAIN BEHAV IMMUN, V24, P420, DOI 10.1016/j.bbi.2009.11.009; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Parvataneni S, 2011, INT J CLIN EXP MED, V4, P320; Patial S, 2011, J CELL PHYSIOL, V226, P627, DOI 10.1002/jcp.22384; Penela P, 2008, EMBO J, V27, P1206, DOI 10.1038/emboj.2008.55; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Wu JH, 2012, ARTERIOSCL THROM VAS, V32, P308, DOI 10.1161/ATVBAHA.111.239608	61	15	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2013	27	1					265	276		10.1096/fj.12-205351	http://dx.doi.org/10.1096/fj.12-205351			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047899	Green Published			2022-12-25	WOS:000313103200025
J	Hargreaves, VV; Putnam, CD; Kolodner, RD				Hargreaves, Victoria V.; Putnam, Christopher D.; Kolodner, Richard D.			Engineered Disulfide-forming Amino Acid Substitutions Interfere with a Conformational Change in the Mismatch Recognition Complex Msh2-Msh6 Required for Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; DNA MISMATCH; COLORECTAL-CANCER; MISPAIR-BINDING; ATP HYDROLYSIS; TRANSLOCATION MECHANISM; BIOCHEMICAL-ANALYSIS; CRYSTAL-STRUCTURES; PROTEIN MUTS	ATP binding causes the mispair-bound Msh2-Msh6 mismatch recognition complex to slide along the DNA away from the mismatch, and ATP is required for the mispair-dependent interaction between Msh2-Msh6 and Mlh1-Pms1. It has been inferred from these observations that ATP induces conformational changes in Msh2-Msh6; however, the nature of these conformational changes and their requirement in mismatch repair are poorly understood. Here we show that ATP induces a conformational change within the C-terminal region of Msh6 that protects the trypsin cleavage site after Msh6 residue Arg(1124). An engineered disulfide bond within this region prevented the ATP-driven conformational change and resulted in an Msh2-Msh6 complex that bound mispaired bases but could not form sliding clamps or bind Mlh1-Pms1. The engineered disulfide bond also reduced mismatch repair efficiency in vivo, indicating that this ATP-driven conformational change plays a role in mismatch repair.	[Kolodner, Richard D.] Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020	Putnam, Christopher/0000-0002-6145-1265	National Institutes of Health [GM50006, CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA092584.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Biswas I, 2001, J MOL BIOL, V305, P805, DOI 10.1006/jmbi.2000.4367; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, CELL, V126, P239, DOI 10.1016/j.cell.2006.07.003; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Winkler I, 2011, J BIOL CHEM, V286, P17326, DOI 10.1074/jbc.M110.187641	60	11	11	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41232	41244		10.1074/jbc.M112.402495	http://dx.doi.org/10.1074/jbc.M112.402495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23045530	hybrid, Green Published			2022-12-25	WOS:000311887600038
J	Wu, KC; McDonald, PR; Liu, JJ; Chaguturu, R; Klaassen, CD				Wu, Kai Connie; McDonald, Peter R.; Liu, Jie Jerry; Chaguturu, Rathnam; Klaassen, Curtis D.			Implementation of a High-Throughput Screen for Identifying Small Molecules to Activate the Keap1-Nrf2-ARE Pathway	PLOS ONE			English	Article							CYTOPROTECTIVE ENZYMES; NRF2; MICE; KEAP1; CANCER; GENE; CARCINOGENS; MECHANISMS; GENERATION; INDUCTION	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that induces a battery of cytoprotective genes involved in antioxidant defense through binding to Antioxidant Response Elements (ARE) located in the promoter regions of these genes. To identify Nrf2 activators for the treatment of oxidative/electrophilic stress-induced diseases, the present study developed a high-throughput assay to evaluate Nrf2 activation using AREc32 cells that contain a luciferase gene under the control of ARE promoters. Of the 47,000 compounds screened, 238 (top 0.5% hits) of the chemicals increased the luminescent signal more than 14.4-fold and were re-tested at eleven concentrations in a range of 0.01-30 mu M. Of these 238 compounds, 231 (96%) increased the luminescence signal in a concentration-dependent manner. Chemical structure relationship analysis of these 231 compounds indicated enrichment of four chemical scaffolds (diaryl amides and diaryl ureas, oxazoles and thiazoles, pyranones and thiapyranones, and pyridinones and pyridazinones). In addition, 30 of these 231 compounds were highly effective and/or potent in activating Nrf2, with a greater than 80-fold increase in luminescence, or an EC50 lower than 1.6 mu M. These top 30 compounds were also screened in Hepa1c1c7 cells for an increase in Nqo1 mRNA, the prototypical Nrf2-target gene. Of these 30 compounds, 17 increased Nqo1 mRNA in a concentration-dependent manner. In conclusion, the present study documents the development, implementation, and validation of a high-throughput screen to identify activators of the Keap1-Nrf2-ARE pathway. Results from this screening identified Nrf2 activators, and provide novel insights into chemical scaffolds that might prevent oxidative/electrophilic stress-induced toxicity and carcinogenesis.	[Liu, Jie Jerry; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Wu, Kai Connie] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [McDonald, Peter R.] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66045 USA; [Chaguturu, Rathnam] SRI Int, Ctr Adv Drug Res, Harrisonburg, VA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; SRI International	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	cklaasse@kumc.edu	Wu, Kai/I-2202-2013		United States National Institutes of Health [DK081461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study was funded by United States National Institutes of Health grant DK081461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell PJ, 2005, MOL CELL ENDOCRINOL, V243, P27, DOI 10.1016/j.mce.2005.08.002; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610; JEFFREY AM, 1985, PHARMACOL THERAPEUT, V28, P237, DOI 10.1016/0163-7258(85)90013-0; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kumar V, 2011, J MED CHEM, V54, P4147, DOI 10.1021/jm2002348; Lee CY, 2010, EUR J MED CHEM, V45, P2957, DOI 10.1016/j.ejmech.2010.03.023; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Natsch A, 2008, TOXICOL SCI, V102, P110, DOI 10.1093/toxsci/kfm259; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Ramos-Gomez M, 2003, CARCINOGENESIS, V24, P461, DOI 10.1093/carcin/24.3.461; Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Tanaka A, 2010, BIOORGAN MED CHEM, V18, P3133, DOI 10.1016/j.bmc.2010.03.034; Tanaka Y, 2009, TOXICOL SCI, V108, P247, DOI 10.1093/toxsci/kfp020; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Wu KC, 2012, TOXICOL APPL PHARM; Wu KC, 2012, FREE RADIC RES; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	28	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44686	10.1371/journal.pone.0044686	http://dx.doi.org/10.1371/journal.pone.0044686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056183	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500006
J	Baker, ME; Chandsawangbhuwana, C				Baker, Michael E.; Chandsawangbhuwana, Charlie			3D Models of MBP, a Biologically Active Metabolite of Bisphenol A, in Human Estrogen Receptor alpha and Estrogen Receptor beta	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; SCORING FUNCTION; AFFINITY PREDICTION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; HUMAN EXPOSURE; ESTRADIOL; SPECIFICITY	Bisphenol A [BPA] is a widely dispersed environmental chemical that is of much concern because the BPA monomer is a weak transcriptional activator of human estrogen receptor alpha [ER alpha] and ER beta in cell culture. A BPA metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl) pent-1-ene [MBP], has transcriptional activity at nM concentrations, which is 1000-fold lower than the concentration for estrogenic activity of BPA, suggesting that MBP may be an environmental estrogen. To investigate the structural basis for the activity of MBP at nM concentrations and the lower activity of BPA for human ER alpha and ER beta, we constructed 3D models of human ER alpha and ER beta with MBP and BPA for comparison with estradiol in these ERs. These 3D models suggest that MBP, but not BPA, has key contacts with amino acids in human ERa and ERb that are important in binding of estradiol by these receptors. Metabolism of BPA to MBP increases the spacing between two phenolic rings, resulting in contacts between MBP and ER alpha and ER beta that mimic those of estradiol with these ERs. Mutagenesis of residues on these ERs that contact the phenolic hydroxyls will provide a test for our 3D models. Other environmental chemicals containing two appropriately spaced phenolic rings and an aliphatic spacer instead of an estrogenic B and C ring also may bind to ERa or ERb and interfere with normal estrogen physiology. This analysis also may be useful in designing novel chemicals for regulating the actions of human ER alpha and ER beta.	[Baker, Michael E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chandsawangbhuwana, Charlie] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Baker, ME (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbaker@ucsd.edu	Baker, Michael/ABB-8508-2020	Baker, Michael/0000-0003-4387-3269				Baker ME, 2005, INTEGR COMP BIOL, V45, P172, DOI 10.1093/icb/45.1.172; Baker ME, 2011, BIOCHEM PHARMACOL, V82, P1, DOI 10.1016/j.bcp.2011.03.008; Baker ME, 2009, BIOCHEM BIOPH RES CO, V386, P516, DOI 10.1016/j.bbrc.2009.06.079; Baker ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006038; Billon-Gales A, 2011, P NATL ACAD SCI USA, V108, P13311, DOI 10.1073/pnas.1105632108; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Celik L, 2007, BIOCHEMISTRY-US, V46, P1743, DOI 10.1021/bi061656t; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Eiler S, 2001, PROTEIN EXPRES PURIF, V22, P165, DOI 10.1006/prep.2001.1409; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Hall JM, 2002, J BIOL CHEM, V277, P44455, DOI 10.1074/jbc.M200849200; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jeyakunnar M, 2011, J BIOL CHEM, V286, P12971, DOI 10.1074/jbc.M110.205112; Katzenellenbogen JA, 2011, J MED CHEM, V54, P5271, DOI 10.1021/jm200801h; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lappano R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016631; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Minutolo F, 2011, MED RES REV, V31, P364, DOI 10.1002/med.20186; Mocklinghoff S, 2010, CHEMBIOCHEM, V11, P2251, DOI 10.1002/cbic.201000532; MORRIS GM, 2009, J COMPUT CHEM; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Okuda K, 2010, TOXICOL LETT, V197, P7, DOI 10.1016/j.toxlet.2010.04.017; Richter CA, 2007, ENVIRON HEALTH PERSP, V115, P902, DOI 10.1289/ehp.9804; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Seo JW, 2006, J MED CHEM, V49, P2496, DOI 10.1021/jm0512037; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047	55	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46078	10.1371/journal.pone.0046078	http://dx.doi.org/10.1371/journal.pone.0046078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056236	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800007
J	Liu, MX; Qi, L; Zeng, Y; Yang, Y; Bi, Y; Shi, XD; Zhu, H; Zhou, ZM; Sha, JH				Liu, Mingxi; Qi, Lin; Zeng, Yan; Yang, Yang; Bi, Ye; Shi, Xiaodan; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao			Transient Scrotal Hyperthermia Induces Lipid Droplet Accumulation and Reveals a Different ADFP Expression Pattern between the Testes and Liver in Mice	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; ADULT MALE-MICE; PROTEOMIC ANALYSIS; SERTOLI-CELLS; LONG-CHAIN; RAT TESTES; SPERMATOGENESIS; PROTEIN; MEN; TESTOSTERONE	Background: In most mammals, the testes provide a stable environment for spermatogenesis, which depends on a lower temperature than the core body temperature. It has been reported that mild testicular heating safely and reversibly suppresses spermatogenesis, and is under consideration for its potential application as a male contraceptive. Previously, we focused on the molecular mechanism of germ cell apoptosis and anti-apoptotic factors induced by heat treatment in humans and mice. However, the recovery process remains under investigation. Results: In this study, we found that lipid droplets in mouse testes are dramatically increased after a brief period of scrotal hyperthermia, and gradually dissipate following temperature normalization. Analysis of the human testis proteome revealed nine proteins associated with lipid droplets. Two of them, ADFP (also known as ADRP and PLIN2) and TIP47 (also known as PLIN3) may participate in acute lipid droplet formation in mammalian testes. We show that Adfp expression is upregulated after scrotal heat treatment in mice. Surprisingly, we find Adfp lacking its 5'-UTR is observed in Adfp(Delta 1/Delta 1) mouse testes, but is not detectable in liver. Conclusions: These results reveal testis Adfp transcriptional regulation is tissue-specific, and is associated with lipid droplet accumulation induced by heat. The results also indicate that the testes could retain functional proteins through testes-specific transcriptional regulation.	[Liu, Mingxi; Qi, Lin; Zeng, Yan; Yang, Yang; Bi, Ye; Shi, Xiaodan; Zhu, Hui; Zhou, Zuomin; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZM (corresponding author), Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zhouzm@njmu.edu.cn	Bi, Ye/A-6272-2017	Liu, Mingxi/0000-0001-6499-7899	China National 973 Program Project [2011CB944304]	China National 973 Program Project(National Basic Research Program of China)	This work was supported by China National 973 Program Project (2011CB944304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU I, 1982, CELL TISSUE RES, V222, P143; Aktas C, 2009, J MOL HISTOL, V40, P31, DOI 10.1007/s10735-009-9210-9; BARTH AD, 1994, CAN VET J, V35, P93; Bensoussan K, 1998, J ANDROL, V19, P266; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bonde JP, 2010, ASIAN J ANDROL, V12, P152, DOI 10.1038/aja.2009.83; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; CHOWDHURY AK, 1964, AM J ANAT, V115, P509, DOI 10.1002/aja.1001150307; Cui YG, 2008, J PROTEOME RES, V7, P3984, DOI 10.1021/pr800259t; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Furland NE, 2007, BIOL REPROD, V77, P181, DOI 10.1095/biolreprod.106.056556; Furland NE, 2011, LIPIDS, V46, P443, DOI 10.1007/s11745-011-3527-3; Furland NE, 2003, LIPIDS, V38, P73, DOI 10.1007/s11745-003-1033-9; Grinspon RP, 2010, HORM RES PAEDIAT, V73, P81, DOI 10.1159/000277140; HAND JW, 1979, INT J RADIAT BIOL, V35, P521, DOI 10.1080/09553007914550631; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Ivell R, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-15; KANDEEL FR, 1988, FERTIL STERIL, V49, P1; KERR JB, 1975, J REPROD FERTIL, V43, P1; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2006, J CLIN ENDOCR METAB, V91, P539, DOI 10.1210/jc.2005-1808; LYNCH R, 1986, FERTIL STERIL, V46, P476; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; MIEUSSET R, 1995, INT J ANDROL, V18, P169, DOI 10.1111/j.1365-2605.1995.tb00408.x; MIEUSSET R, 1994, INT J ANDROL, V17, P186, DOI 10.1111/j.1365-2605.1994.tb01241.x; MIEUSSET R, 1992, J REPROD FERTIL, V94, P337, DOI 10.1530/jrf.0.0940337; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Nistal M, 2005, FERTIL STERIL, V83, P1489, DOI 10.1016/j.fertnstert.2004.12.032; PANIAGUA R, 1987, J REPROD FERTIL, V80, P335; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; Rockett JC, 2001, BIOL REPROD, V65, P229, DOI 10.1095/biolreprod65.1.229; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Xiong WP, 2009, REPRODUCTION, V137, P469, DOI 10.1530/REP-08-0343; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhu H, 2010, PROTEOMICS, V10, P3480, DOI 10.1002/pmic.201000281; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733	42	17	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e45694	10.1371/journal.pone.0045694	http://dx.doi.org/10.1371/journal.pone.0045694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056214	Green Submitted, Green Published, gold			2022-12-25	WOS:000309580800004
J	Fenimore, PW; Muhammad, MA; Fischer, WM; Foley, BT; Bakken, RR; Thurmond, JR; Yusim, K; Yoon, H; Parker, M; Hart, MK; Dye, JM; Korber, B; Kuiken, C				Fenimore, Paul W.; Muhammad, Majidat A.; Fischer, William M.; Foley, Brian T.; Bakken, Russell R.; Thurmond, James R.; Yusim, Karina; Yoon, Hyejin; Parker, Michael; Hart, Mary Kate; Dye, John M.; Korber, Bette; Kuiken, Carla			Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMORRHAGIC-FEVER; EBOLA; RESPONSES; INFECTION; IMMUNITY; BREADTH	We report the rational design and in vivo testing of mosaic proteins for a polyvalent pan-filoviral vaccine using a computational strategy designed for the Human Immunodeficiency Virus type 1 (HIV-1) but also appropriate for Hepatitis C virus (HCV) and potentially other diverse viruses. Mosaics are sets of artificial recombinant proteins that are based on natural proteins. The recombinants are computationally selected using a genetic algorithm to optimize the coverage of potential cytotoxic T lymphocyte (CTL) epitopes. Because evolutionary history differs markedly between HIV-1 and filoviruses, we devised an adapted computational technique that is effective for sparsely sampled taxa; our first significant result is that the mosaic technique is effective in creating high-quality mosaic filovirus proteins. The resulting coverage of potential epitopes across filovirus species is superior to coverage by any natural variants, including current vaccine strains with demonstrated cross-reactivity. The mosaic cocktails are also robust: mosaics substantially outperformed natural strains when computationally tested against poorly sampled species and more variable genes. Furthermore, in a computational comparison of cross-reactive potential a design constructed prior to the Bundibugyo outbreak performed nearly as well against all species as an updated design that included Bundibugyo. These points suggest that the mosaic designs would be more resilient than natural-variant vaccines against future Ebola outbreaks dominated by novel viral variants. We demonstrate in vivo immunogenicity and protection against a heterologous challenge in a mouse model. This design work delineates the likely requirements and limitations on broadly-protective filoviral CTL vaccines.	[Fenimore, Paul W.; Fischer, William M.; Foley, Brian T.; Yusim, Karina; Yoon, Hyejin; Korber, Bette; Kuiken, Carla] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Muhammad, Majidat A.; Bakken, Russell R.; Parker, Michael; Dye, John M.] USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD USA; [Thurmond, James R.] Indiana Univ, Bloomington, IN USA; [Hart, Mary Kate] DynPort Vaccine Co, Frederick, MD USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Indiana University System; Indiana University Bloomington	Fenimore, PW (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM USA.	paulf@lanl.gov	Foley, Brian T/N-4527-2018; Fischer, Will/AAD-2807-2019	Foley, Brian T/0000-0002-1086-0296; Fischer, Will/0000-0003-4579-4062; Korber, Bette/0000-0002-2026-5757; Thurmond, Jim/0000-0002-5142-2583; Dye, John/0000-0002-0883-5016	Defense Threat Reduction Agency [CBM.VAXPLAT.05.10.RD.005]; USAMRIID [TA2F06062]; Los Alamos National Laboratory [20050155DR]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); USAMRIID; Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	Funding was provided by the Defense Threat Reduction Agency, project #CBM.VAXPLAT.05.10.RD.005 and by USAMRIID subcontract TA2F06062 and Los Alamos National Laboratory Directed Research funds 20050155DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bruno WJ, 1996, MOL BIOL EVOL, V13, P1368, DOI 10.1093/oxfordjournals.molbev.a025583; Cohen J, 2004, INFECT DIS, V2004, P2106; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hart MK, 2005, United State Patent Application, Patent No. 20100034843; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; MIRANDA MEG, 1991, LANCET, V337, P425, DOI 10.1016/0140-6736(91)91199-5; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Ndhlovu ZM, 2011, J IMMUNOL, V186, P6914, DOI 10.4049/jimmunol.1004231; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Santra S, 2012, VIROLOGY, V428, P121, DOI 10.1016/j.virol.2012.03.012; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Siegert R, 1987, DEUT MED WOCHENSCHR, V103, P1176; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yusim K, 2010, J GEN VIROL, V91, P1194, DOI 10.1099/vir.0.017491-0	34	20	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e44769	10.1371/journal.pone.0044769	http://dx.doi.org/10.1371/journal.pone.0044769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056184	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000004
J	Kralik, JD; Xu, ER; Knight, EJ; Khan, SA; Levine, WJ				Kralik, Jerald D.; Xu, Eric R.; Knight, Emily J.; Khan, Sara A.; Levine, William J.			When Less Is More: Evolutionary Origins of the Affect Heuristic	PLOS ONE			English	Article							SOMATIC MARKER HYPOTHESIS; PREFERENCE REVERSALS; RETROSPECTIVE EVALUATIONS; SEPARATE EVALUATIONS; PREFRONTAL CORTEX; QUANTITY; PERFORMANCE; INTEGRATION; RESPONSES; JOINT	The human mind is built for approximations. When considering the value of a large aggregate of different items, for example, we typically do not summate the many individual values. Instead, we appear to form an immediate impression of the likeability of the option based on the average quality of the full collection, which is easier to evaluate and remember. While useful in many situations, this affect heuristic can lead to apparently irrational decision-making. For example, studies have shown that people are willing to pay more for a small set of high-quality goods than for the same set of high-quality goods with lower-quality items added [e.g. 1]. We explored whether this kind of choice behavior could be seen in other primates. In two experiments, one in the laboratory and one in the field, using two different sets of food items, we found that rhesus monkeys preferred a highly-valued food item alone to the identical item paired with a food of positive but lower value. This finding provides experimental evidence that, under certain conditions, macaque monkeys follow an affect heuristic that can cause them to prefer less food. Conservation of this affect heuristic could account for similar 'irrational' biases in humans, and may reflect a more general complexity reduction strategy in which averages, prototypes, or stereotypes represent a set or group.	[Kralik, Jerald D.; Xu, Eric R.; Knight, Emily J.; Khan, Sara A.; Levine, William J.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Kralik, JD (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	Jerald.D.Kralik@Dartmouth.edu		Knight, Emily/0000-0002-6971-1148	National Institute of Mental Health (NIMH) [NIMH 1 K22 MH071756-01]; National Center for Research Resources (NCRR) [CM-5 P40 RR003640-20]; NATIONAL INSTITUTE OF MENTAL HEALTH [K22MH071756] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant NIMH 1 K22 MH071756-01 from the National Institute of Mental Health (NIMH), a component of the National Institutes of Health (NIH): http://www.nimh.nih.gov/index.shtml. Grant CM-5 P40 RR003640-20 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH): http://www.ncats.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2011, P ROY SOC B-BIOL SCI, V278, P849, DOI 10.1098/rspb.2010.1602; Anderson JR, 2000, J EXP PSYCHOL ANIM B, V26, P87, DOI 10.1037/0097-7403.26.1.87; Baumgartner H, 1997, J MARKETING RES, V34, P219, DOI 10.2307/3151860; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Beran MJ, 2009, LEARN MOTIV, V40, P186, DOI 10.1016/j.lmot.2008.11.002; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Neys W, 2011, CONT TOP COGN NEUROS, P125; Do AM, 2008, PSYCHON B REV, V15, P96, DOI 10.3758/PBR.15.1.96; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FREDRICKSON BL, 1993, J PERS SOC PSYCHOL, V65, P45, DOI 10.1037/0022-3514.65.1.45; Genty E, 2011, BEHAV PROCESS, V86, P133, DOI 10.1016/j.beproc.2010.10.006; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Goel V, 2003, NEUROIMAGE, V20, P2314, DOI 10.1016/j.neuroimage.2003.07.027; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Hassin R. R., 2010, SELF CONTROL SOC MIN; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Hsee CK, 2010, PERSPECT PSYCHOL SCI, V5, P343, DOI 10.1177/1745691610374586; Hsee CK, 1998, J BEHAV DECIS MAKING, V11, P107, DOI 10.1002/(SICI)1099-0771(199806)11:2<107::AID-BDM292>3.3.CO;2-P; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; Hsee CK, 2004, J PERS SOC PSYCHOL, V86, P680, DOI 10.1037/0022-3514.86.5.680; Hsee CK, 1996, ORGAN BEHAV HUM DEC, V67, P247, DOI 10.1006/obhd.1996.0077; Janson CH, 1986, FRUGIVORES SEED DISP; Janson CH, 2007, ANIM COGN, V10, P357, DOI 10.1007/s10071-007-0080-9; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kahneman D, 2011, THINKING FAST SLOW; Kahneman D., 2005, CAMBRIDGE HDB THINKI, P267, DOI DOI 10.1111/COGS.12119; Khan SA, 2011, PSYCHOL SCI, V22, P1001, DOI 10.1177/0956797611415543; Kralik JD, 2002, J COMP PSYCHOL, V116, P39, DOI 10.1037//0735-7036.116.1.39; Kralik JD, 2011, J COMP PSYCHOL; Kralik JD, 2011, BEHAV PROCESSES; Kurtz JL, 2007, J EXP SOC PSYCHOL, V43, P979, DOI 10.1016/j.jesp.2006.10.020; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Lakshminaryanan V, 2008, PHILOS T R SOC B, V363, P3837, DOI 10.1098/rstb.2008.0149; LEIGHTON M, 1993, INT J PRIMATOL, V14, P257, DOI 10.1007/BF02192635; List JA, 2002, AM ECON REV, V92, P1636, DOI 10.1257/000282802762024692; Mazur JE, 2005, LEARNING BEHAV; MELLERS BA, 1992, ORGAN BEHAV HUM DEC, V51, P313, DOI 10.1016/0749-5978(92)90016-Z; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; Normand E, 2009, ANIM COGN, V12, P797, DOI 10.1007/s10071-009-0239-7; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Reisberg D, 2010, COGNITION EXPLORING; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; Russell SP, 2010, ARTIFICIAL INTELLIGE; Schreiber CA, 2000, J EXP PSYCHOL GEN, V129, P27, DOI 10.1037//0096-3445.129.1.27; Shifferman EM, 2009, ANIM COGN, V12, P547, DOI 10.1007/s10071-009-0215-2; Silberberg A, 1998, J EXP PSYCHOL ANIM B, V24, P215, DOI 10.1037/0097-7403.24.2.215; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Stanovich K.E., 2012, OXFORD HDB THINKING; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Vogel ER, 2007, ANIM BEHAV, V74, P71, DOI 10.1016/j.anbehav.2007.02.003; Williams BA, 2002, ANIM LEARN BEHAV, V30, P1, DOI 10.3758/BF03192905; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Xu ER, 2011, Q J EXP PSYCHOL, V64, P2301, DOI 10.1080/17470218.2011.591936; Xueqing Sun, 2011, Journal of Control Theory and Applications, V9, P440, DOI 10.1007/s11768-011-1047-6; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zentall TR, 2007, J EXP ANAL BEHAV, V88, P131, DOI 10.1901/jeab.2007.27-06	75	40	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46240	10.1371/journal.pone.0046240	http://dx.doi.org/10.1371/journal.pone.0046240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	23056270	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000027
J	Covell, DG				Covell, David G.			Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CANCER-CELL LINES; OXIDATIVE STRESS; CONNECTIVITY MAP; DRUG DEVELOPMENT; SMALL MOLECULES; NORMAL-TISSUES; TUMOR; CAMPTOTHECIN; MECHANISM	Studies into the genetic origins of tumor cell chemoactivity pose significant challenges to bioinformatic mining efforts. Connections between measures of gene expression and chemoactivity have the potential to identify clinical biomarkers of compound response, cellular pathways important to efficacy and potential toxicities; all vital to anticancer drug development. An investigation has been conducted that jointly explores tumor-cell constitutive NCI60 gene expression profiles and small-molecule NCI60 growth inhibition chemoactivity profiles, viewed from novel applications of self-organizing maps (SOMs) and pathway-centric analyses of gene expressions, to identify subsets of over- and under-expressed pathway genes that discriminate chemo-sensitive and chemo-insensitive tumor cell types. Linear Discriminant Analysis (LDA) is used to quantify the accuracy of discriminating genes to predict tumor cell chemoactivity. LDA results find 15% higher prediction accuracies, using similar to 30% fewer genes, for pathway-derived discriminating genes when compared to genes derived using conventional gene expression-chemoactivity correlations. The proposed pathway-centric data mining procedure was used to derive discriminating genes for ten well-known compounds. Discriminating genes were further evaluated using gene set enrichment analysis (GSEA) to reveal a cellular genetic landscape, comprised of small numbers of key over and under expressed on- and off-target pathway genes, as important for a compound's tumor cell chemoactivity. Literature-based validations are provided as support for chemo-important pathways derived from this procedure. Qualitatively similar results are found when using gene expression measurements derived from different microarray platforms. The data used in this analysis is available at http://pubchem.ncbi.nlm.nih.gov/ and http://www.ncbi.nlm.nih.gov/projects/geo (GPL96, GSE32474).	NIH, Dev Therapeut Program, Frederick Natl Lab, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Covell, DG (corresponding author), NIH, Dev Therapeut Program, Frederick Natl Lab, Frederick, MD USA.	covelld@mail.nih.gov						Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen B, 2010, J MOL GRAPH MODEL, V28, P420, DOI 10.1016/j.jmgm.2009.10.001; Cheng TJ, 2011, J CHEM INF MODEL, V51, P2440, DOI 10.1021/ci200192v; Cheng TJ, 2010, BIOINFORMATICS, V26, P2881, DOI 10.1093/bioinformatics/btq550; Covell DG, 2005, PROTEINS, V59, P403, DOI 10.1002/prot.20392; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Deng N, 2012, GUT; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Francia G, 2010, NAT BIOTECHNOL, V28, P561, DOI 10.1038/nbt0610-561; Glover CJ, 2007, BIOCHEM PHARMACOL, V73, P331, DOI 10.1016/j.bcp.2006.10.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Haarer BK, 2004, MOL BIOL CELL, V15, P4522, DOI 10.1091/mbc.E04-06-0445; Holmes E, 2000, CHEM RES TOXICOL, V13, P471, DOI 10.1021/tx990210t; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang R, 2005, PHARMACOGENOMICS J, V5, P381, DOI 10.1038/sj.tpj.6500331; Huang RL, 2006, MOL CANCER THER, V5, P2417, DOI 10.1158/1535-7163.MCT-06-0239; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Iyer S, 1998, CANCER RES, V58, P4510; JAKOBSSON B, 1989, ANTICANCER RES, V9, P285; Jettte L, 2008, ANTICANCER RES, V28, P2175; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Knockaert M, 2002, ONCOGENE, V21, P6413, DOI 10.1038/sj.onc.1205908; Kohonen T., 1997, SPRINGER SERIES INFO; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Tourneau C, 2010, J CLIN ONCOL, V28, P1401, DOI 10.1200/JCO.2009.25.9606; Lee AC, 2008, J CHEM INF MODEL, V48, P1379, DOI 10.1021/ci800097k; Lee S, 2002, MOL CELLS, V14, P348; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lin HL, 2003, BRIT J CANCER, V88, P973, DOI 10.1038/sj.bjc.6600788; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maeshima K, 2010, NAT STRUCT MOL BIOL, V17, P1065, DOI 10.1038/nsmb.1878; Malumbres M, 2000, BIOL CHEM, V381, P827, DOI 10.1515/BC.2000.105; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morandi E, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-66; Nakatsu N, 2005, MOL CANCER THER, V4, P399; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Newell DR, 2005, EUR J CANCER, V41, P676, DOI 10.1016/j.ejca.2004.12.024; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Petrangolini G, 2006, J PHARMACOL EXP THER, V318, P939, DOI 10.1124/jpet.106.103481; Rabow AA, 2002, J MED CHEM, V45, P818, DOI 10.1021/jm010385b; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rossi F, 2010, MOL CANCER RES, V8, P1271, DOI 10.1158/1541-7786.MCR-10-0065; Saito A, 2004, STROKE, V35, P1443, DOI 10.1161/01.STR.0000128416.28778.7a; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; SENDEROFF RI, 1990, INVEST OPHTH VIS SCI, V31, P2572; Sharma V, 2004, CHEM BIOL, V11, P1689, DOI 10.1016/j.chembiol.2004.10.006; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Sleno L, 2008, CURR OPIN CHEM BIOL, V12, P46, DOI 10.1016/j.cbpa.2008.01.022; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Strobl JS, 1998, BREAST CANCER RES TR, V51, P83, DOI 10.1023/A:1006046604062; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teicher BA, 2010, ANTICANCER DRUG DEV; Wang YL, 2010, NUCLEIC ACIDS RES, V38, pD255, DOI 10.1093/nar/gkp965; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WARNER E, 1995, INT J GYNECOL CANCER, V5, P161, DOI 10.1046/j.1525-1438.1995.05030161.x; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Won HJ, 2010, ANTI-CANCER DRUG, V21, P270, DOI 10.1097/CAD.0b013e328334562c; Wu YY, 2007, APOPTOSIS, V12, P593, DOI 10.1007/s10495-006-0007-y; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Zhang W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002429; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	78	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44631	10.1371/journal.pone.0044631	http://dx.doi.org/10.1371/journal.pone.0044631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056181	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600006
J	Maymo, JL; Perez-Perez, A; Maskin, B; Duenas, JL; Calvo, JC; Margalet, VS; Varone, CL				Lorena Maymo, Julieta; Perez-Perez, Antonio; Maskin, Bernardo; Luis Duenas, Jose; Carlos Calvo, Juan; Sanchez Margalet, Victor; Laura Varone, Cecilia			The Alternative Epac/cAMP Pathway and the MAPK Pathway Mediate hCG Induction of Leptin in Placental Cells	PLOS ONE			English	Article							PROTEIN-KINASE-A; HUMAN CHORIONIC-GONADOTROPIN; CYCLIC-AMP; B-RAF; HUMAN TROPHOBLAST; SIGNALING PATHWAYS; CROSS-TALK; GENE-EXPRESSION; CAMP; ACTIVATION	Pleiotropic effects of leptin have been identified in reproduction and pregnancy, particularly in the placenta, where it works as an autocrine hormone. In this work, we demonstrated that human chorionic gonadotropin (hCG) added to JEG-3 cell line or to placental explants induces endogenous leptin expression. We also found that hCG increased cAMP intracellular levels in BeWo cells in a dose-dependent manner, stimulated cAMP response element (CRE) activity and the cotransfection with an expression plasmid of a dominant negative mutant of CREB caused a significant inhibition of hCG stimulation of leptin promoter activity. These results demonstrate that hCG indeed activates cAMP/PKA pathway, and that this pathway is involved in leptin expression. Nevertheless, we found leptin induction by hCG is dependent on cAMP levels. Treatment with (Bu)(2)cAMP in combination with low and non stimulatory hCG concentrations led to an increase in leptin expression, whereas stimulatory concentrations showed the opposite effect. We found that specific PKA inhibition by H89 caused a significant increase of hCG leptin induction, suggesting that probably high cAMP levels might inhibit hCG effect. It was found that hCG enhancement of leptin mRNA expression involved the MAPK pathway. In this work, we demonstrated that hCG leptin induction through the MAPK signaling pathway is inhibited by PKA. We observed that ERK1/2 phosphorylation increased when hCG treatment was combined with H89. In view of these results, the involvement of the alternative cAMP/Epac signaling pathway was studied. We observed that a cAMP analogue that specifically activates Epac (CPT-OMe) stimulated leptin expression by hCG. In addition, the overexpression of Epac and Rap1 proteins increased leptin promoter activity and enhanced hCG. In conclusion, we provide evidence suggesting that hCG induction of leptin gene expression in placenta is mediated not only by activation of the MAPK signaling pathway but also by the alternative cAMP/Epac signaling pathway.	[Lorena Maymo, Julieta; Carlos Calvo, Juan; Laura Varone, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Perez-Perez, Antonio; Sanchez Margalet, Victor] Univ Seville, Fac Med, Hosp Univ Virgen Macarena, Dept Bioquim Med & Biol Mol, Seville, Spain; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Luis Duenas, Jose] Hosp Univ Virgen Macarena, Serv Ginecol & Obstet, Seville, Spain; [Carlos Calvo, Juan] IBYME, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Varone, CL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	cvarone@qb.fcen.uba.ar	Maymo, Julieta/AAU-3777-2020; Dueñas-Díez, José-Luis/E-6320-2010; Sánchez-Margalet, Victor/AAB-9986-2021; Pérez -Perez, Antonio/GRF-5099-2022	Maymo, Julieta/0000-0003-1308-9887; Dueñas-Díez, José-Luis/0000-0001-7596-6289; Sánchez-Margalet, Victor/0000-0001-8638-8680; Pérez -Perez, Antonio/0000-0002-5660-735X; Varone, Cecilia/0000-0001-5930-4082	Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET) [PIP 2010-247]; Instituto de Salud Carlos III [CM07/00025]; Universidad de Buenos Aires (UBACYT); ANPCyT [PICT 2008-0425]; Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain [PS09/00119]	Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Buenos Aires (UBACYT)(University of Buenos Aires); ANPCyT(ANPCyT); Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	JLM is supported by a Consejo Nacional de Investigaciones Cientificas Y Tecnicas (CONICET) fellowship. APP is a research fellow supported by the Instituto de Salud Carlos III (CM07/00025). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT (PICT 2008-0425), the CONICET (PIP 2010-247), the Fundacion Florencio Fiorini, Buenos Aires, Argentina and the Instituto de Salud Carlos III (PS09/00119), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Bi S, 1997, J BIOL CHEM, V272, P30583, DOI 10.1074/jbc.272.48.30583; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; Cameo Paula, 2004, Reprod Biol Endocrinol, V2, P50, DOI 10.1186/1477-7827-2-50; Cameron MR, 1996, BIOL REPROD, V55, P111, DOI 10.1095/biolreprod55.1.111; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Cauzac M, 2003, PLACENTA, V24, P378, DOI 10.1053/plac.2002.0915; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CLEGG CH, 1992, BIOCHEMISTRY-US, V31, P3720, DOI 10.1021/bi00129a023; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Coya R, 2001, BIOL REPROD, V65, P814, DOI 10.1095/biolreprod65.3.814; Coya R, 2006, GYNECOL ENDOCRINOL, V22, P620, DOI 10.1080/09513590601012587; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEMERS LM, 1973, BIOCHIM BIOPHYS ACTA, V313, P202; Domali E, 2002, J Matern Fetal Neonatal Med, V12, P222, DOI 10.1080/713605673; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FAURE M, 1994, J BIOL CHEM, V269, P7851; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gambino YP, 2012, PLACENTA, V33, pS63, DOI 10.1016/j.placenta.2011.12.001; Gambino YP, 2010, BIOL REPROD, V83, P42, DOI 10.1095/biolreprod.110.083535; Ge YC, 2011, REPRODUCTION, V142, P369, DOI 10.1530/REP-11-0053; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Henson MC, 2000, BIOL REPROD, V63, P1219, DOI 10.1095/biolreprod63.5.1219; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Henson MC, 2002, SEMIN REPROD MED, V20, P113, DOI 10.1055/s-2002-32502; Henson MC, 2005, BIOL REPROD; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacNicol MC, 1999, J BIOL CHEM, V274, P13193, DOI 10.1074/jbc.274.19.13193; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; Menon KMJ, 2004, BIOL REPROD, V70, P861, DOI 10.1095/biolreprod.103.024471; MENON KMJ, 1973, J CLIN ENDOCR METAB, V36, P1104, DOI 10.1210/jcem-36-6-1104; Monjo M, 2005, AM J PHYSIOL-ENDOC M, V289, pE145, DOI 10.1152/ajpendo.00563.2004; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258, DOI 10.1074/jbc.271.3.1258; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Perez-Perez A, 2010, BIOCHEM BIOPH RES CO, V396, P956, DOI 10.1016/j.bbrc.2010.05.031; Perez-Perez A, 2009, BIOL REPROD, V81, P826, DOI 10.1095/biolreprod.109.076513; Pidoux G, 2007, J CELL PHYSIOL, V212, P26, DOI 10.1002/jcp.20995; Popovic Vera, 2002, Hormones (Athens), V1, P204; Randeva HS JA, 2001, FETAL MATERN MED REV, V12, P198; Rao CV, 2001, SEMIN REPROD MED, V19, P7, DOI 10.1055/s-2001-13906; REBUTBONNETON C, 1992, MOL CELL ENDOCRINOL, V85, P65, DOI 10.1016/0303-7207(92)90125-P; Reitman ML, 2001, BIOCHEM SOC T, V29, P68, DOI 10.1042/BST0290068; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Salvador LM, 2002, ENDOCRINOLOGY, V143, P2986, DOI 10.1210/en.143.8.2986; Schubring C, 1998, HORM RES, V50, P276, DOI 10.1159/000023290; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Seminara SB, 2006, ENDOCRINOLOGY, V147, P2122, DOI 10.1210/en.2005-1550; Senaris R, 1997, ENDOCRINOLOGY, V138, P4501, DOI 10.1210/en.138.10.4501; Serrano MA, 2007, PLACENTA, V28, P107, DOI 10.1016/j.placenta.2006.03.009; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Srisuparp S, 2003, BIOL REPROD, V68, P457, DOI 10.1095/biolreprod.102.007625; Standley PR, 2002, AM J HYPERTENS, V15, P565, DOI 10.1016/S0895-7061(02)02272-0; Staples KJ, 2001, J IMMUNOL, V167, P2074, DOI 10.4049/jimmunol.167.4.2074; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; STRAUSS JF, 1992, PLACENTA, V13, P389, DOI 10.1016/0143-4004(92)90047-W; Syme MR, 2004, CLIN PHARMACOKINET, V43, P487, DOI 10.2165/00003088-200443080-00001; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Terasaki T, 2001, BIOL PHARM BULL, V24, P111, DOI 10.1248/bpb.24.111; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WANG H, 1991, J BIOL CHEM, V266, P780; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yoshie M, 2010, HUM REPROD, V25, P2229, DOI 10.1093/humrep/deq190; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905; Zygmunt M, 1998, PLACENTA, V19, P587, DOI 10.1016/S0143-4004(98)90019-4	94	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46216	10.1371/journal.pone.0046216	http://dx.doi.org/10.1371/journal.pone.0046216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056265	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600026
J	ter Haar, WM; Meester-Smoor, MA; van Wely, KHM; Schot, CCMM; Janssen, MJFW; Geverts, B; Bonten, J; Grosveld, GC; Houtsmuller, AB; Zwarthoff, EC				ter Haar, W. Martijn; Meester-Smoor, Magda A.; van Wely, Karel H. M.; Schot, Claudia C. M. M.; Janssen, Marjolein J. F. W.; Geverts, Bart; Bonten, Jacqueline; Grosveld, Gerard C.; Houtsmuller, Adriaan B.; Zwarthoff, Ellen C.			The Leukemia-Associated Fusion Protein MN1-TEL Blocks TEL-Specific Recognition Sequences	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; POLYMERASE-II TRANSCRIPTION; POLYCOMB GROUP PROTEIN; DNA-BINDING; CHROMATIN; GENE; OVEREXPRESSION; EXPRESSION; REPRESSOR; GROWTH	The leukemia-associated fusion protein MN1-TEL combines the transcription-activating domains of MN1 with the DNA-binding domain of the transcriptional repressor TEL. Quantitative photobleaching experiments revealed that similar to 20% of GFP-tagged MN1 and TEL is transiently immobilised, likely due to indirect or direct DNA binding, since transcription inhibition abolished immobilisation. Interestingly, similar to 50% of the MN1-TEL fusion protein was immobile with much longer binding times than unfused MN1 and TEL. MN1-TEL immobilisation was not observed when the TEL DNA-binding domain was disrupted, suggesting that MN1-TEL stably occupies TEL recognition sequences, preventing binding of factors required for proper transcription regulation, which may contribute to leukemogenesis.	[ter Haar, W. Martijn; Meester-Smoor, Magda A.; van Wely, Karel H. M.; Schot, Claudia C. M. M.; Janssen, Marjolein J. F. W.; Geverts, Bart; Houtsmuller, Adriaan B.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Bonten, Jacqueline; Grosveld, Gerard C.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Erasmus University Rotterdam; Erasmus MC; St Jude Children's Research Hospital	Zwarthoff, EC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl		van Wely, Karel Hermanus Martinus/0000-0001-8431-8072	Dutch Cancer Society [2003-2869]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Dutch Cancer Society (grant 2003-2869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett O, 2006, BIOCHEM SOC SYMP, V73, P67, DOI 10.1042/bss0730067; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; BUIJS A, 1995, ONCOGENE, V10, P1511; Buijs A, 2000, MOL CELL BIOL, V20, P9281, DOI 10.1128/MCB.20.24.9281-9293.2000; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carella C, 2006, LEUKEMIA, V20, P1582, DOI 10.1038/sj.leu.2404298; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Hu Y, 2009, J CELL BIOL, V185, P87, DOI 10.1083/jcb.200809196; JANSSEN JWG, 1995, BRIT J HAEMATOL, V90, P222, DOI 10.1111/j.1365-2141.1995.tb03407.x; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kawamata N, 2012, ONCOGENE, V31, P966, DOI 10.1038/onc.2011.291; Lopez RG, 2003, J BIOL CHEM, V278, P41316, DOI 10.1074/jbc.M306435200; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; van Wely K, 2007, ONCOGENE, V26, P5733, DOI 10.1038/sj.onc.1210382; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Wu Y, 2006, MOL CELL BIOL, V26, P6633, DOI 10.1128/MCB.01534-05; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46085	10.1371/journal.pone.0046085	http://dx.doi.org/10.1371/journal.pone.0046085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049943	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300081
J	Wiggs, JL; Hewitt, AW; Fan, BJ; Wang, DY; Sena, DRF; O'Brien, C; Realini, A; Craig, JE; Dimasi, DP; Mackey, DA; Haines, JL; Pasquale, LR				Wiggs, Janey L.; Hewitt, Alex W.; Fan, Bao Jian; Wang, Dan Yi; Sena, Dayse R. Figueiredo; O'Brien, Colm; Realini, Anthony; Craig, Jamie E.; Dimasi, David P.; Mackey, David A.; Haines, Jonathan L.; Pasquale, Louis R.			The p53 Codon 72 PRO/PRO Genotype May Be Associated with Initial Central Visual Field Defects in Caucasians with Primary Open Angle Glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; RETINAL GANGLION-CELL; GENOME-WIDE SCAN; RISK-FACTORS; INTRAOCULAR-PRESSURE; GENE-EXPRESSION; POLYMORPHISM; POPULATION; VARIANTS; RESPONSES	Background: Loss of vision in glaucoma is due to apoptotic retinal ganglion cell loss. While p53 modulates apoptosis, gene association studies between p53 variants and glaucoma have been inconsistent. In this study we evaluate the association between a p53 variant functionally known to influence apoptosis (codon 72 Pro/Arg) and the subset of primary open angle glaucoma (POAG) patients with early loss of central visual field. Methods: Genotypes for the p53 codon 72 polymorphism (Pro/Arg) were obtained for 264 POAG patients and 400 controls from the U. S. and in replication studies for 308 POAG patients and 178 controls from Australia (GIST). The glaucoma patients were divided into two groups according to location of initial visual field defect (either paracentral or peripheral). All cases and controls were Caucasian with European ancestry. Results: The p53-PRO/PRO genotype was more frequent in the U. S. POAG patients with early visual field defects in the paracentral regions compared with those in the peripheral regions or control group (p = 2.7x10(-5)). We replicated this finding in the GIST cohort (p = 7.3x10(-3), and in the pooled sample (p = 6.6x10(-7)) and in a meta-analysis of both the US and GIST datasets (1.3x10(-6), OR 2.17 (1.58-2.98 for the PRO allele). Conclusions: These results suggest that the p53 codon 72 PRO/PRO genotype is potentially associated with early paracentral visual field defects in primary open-angle glaucoma patients.	[Wiggs, Janey L.; Fan, Bao Jian; Wang, Dan Yi; Sena, Dayse R. Figueiredo; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Hewitt, Alex W.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [O'Brien, Colm] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Realini, Anthony] W Virginia Univ, Dept Ophthalmol, Sch Med, Morgantown, WV 26506 USA; [Craig, Jamie E.; Dimasi, David P.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University College Dublin; West Virginia University; Flinders Medical Centre; Flinders University South Australia; Lions Eye Institute; University of Western Australia; Vanderbilt University	Wiggs, JL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA.	janey_wiggs@meei.harvard.edu	Haines, Jonathan/C-3374-2012; Hewitt, Alex W/D-1936-2013; Sena, Dayse F/H-5232-2013; Mackey, David A/H-5340-2014	Haines, Jonathan/0000-0002-4351-4728; Hewitt, Alex W/0000-0002-5123-5999; Sena, Dayse F/0000-0002-9426-0166; Mackey, David A/0000-0001-7914-4709; Fan, Baojian/0000-0002-6851-2737; Craig, Jamie/0000-0001-9955-9696	National Institutes of Health/National Eye Institute [R01EY015872, R01EY015473, P30EY014104]; Research to Prevent Blindness; Harvard Glaucoma Center of Excellence; Massachusetts Lions Eye Research Fund; National Health & Medical Research Council [229960]; Ophthalmic Research Institute of Australia; Glaucoma Australia; NATIONAL EYE INSTITUTE [R21EY022766, P30EY014104, R01EY015872, R01EY015473] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; Massachusetts Lions Eye Research Fund; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Glaucoma Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health/National Eye Institute grants: R01EY015872 (Wiggs), R01EY015473 (Pasquale), P30EY014104 (Wiggs), Research to Prevent Blindness (Wiggs, Pasquale, Realini), the Harvard Glaucoma Center of Excellence (Wiggs, Pasquale), The Massachusetts Lions Eye Research Fund (Wiggs, Pasquale), National Health & Medical Research Council Project grant 229960, the Ophthalmic Research Institute of Australia, and Glaucoma Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya M, 2002, MOL VIS, V8, P367; Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Blanco-Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI 10.1167/iovs.11-7489; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Cheng JW, 2009, OPHTHALMOLOGY, V116, P1243, DOI 10.1016/j.ophtha.2009.01.036; Daugherty CL, 2009, MOL VIS, V15, P1939; Den Reijer PM, 2008, MECH AGEING DEV, V129, P175, DOI 10.1016/j.mad.2007.12.006; Deva NC, 2008, CLIN EXP OPHTHALMOL, V36, P217, DOI 10.1111/j.1442-9071.2008.01716.x; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; Dimasi DP, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032458; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974; Golubnitschaja-Labudova O, 2000, CURR EYE RES, V21, P867, DOI 10.1076/ceyr.21.5.867.5534; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Guo Y, 2012, INVEST OPHTH VIS SCI, V12, P9818; Guo Y, 2010, INVEST OPHTH VIS SCI, V51, P3003, DOI 10.1167/iovs.09-4663; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kim NR, 2011, J GLAUCOMA; Lemmela S, 2007, INVEST OPHTH VIS SCI, V48, P4136, DOI 10.1167/iovs.06-1092; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Li Y, 2002, MOL VIS, V8, P341; Lin HJ, 2002, BRIT J OPHTHALMOL, V86, P767, DOI 10.1136/bjo.86.7.767; Mabuchi F, 2009, MOL VIS, V15, P1045; Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Osborne NN, 2010, NEUROCHEM RES, V35, P2027, DOI 10.1007/s11064-010-0273-5; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Ressiniotis T, 2004, J MED GENET, V41, P296, DOI 10.1136/jmg.2003.016089; Saglar E, 2009, MOL VIS, V15, P1270; Sansone P, 2007, BRIT J CANCER, V96, P1302, DOI 10.1038/sj.bjc.6603723; Silva RE, 2009, GENET MOL RES, V8, P268, DOI 10.4238/vol8-1gmr578; Stein JD, 2011, OPHTHALMOLOGY, V118, P1031, DOI 10.1016/j.ophtha.2010.10.024; Toffoli G, 2009, CLIN CANCER RES, V15, P3550, DOI 10.1158/1078-0432.CCR-08-2249; Umihira J, 2002, CURR EYE RES, V24, P147, DOI 10.1076/ceyr.24.2.147.8160; Viana RJS, 2010, CNS NEUROL DISORD-DR, V9, P679; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109	42	43	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45613	10.1371/journal.pone.0045613	http://dx.doi.org/10.1371/journal.pone.0045613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049825	Green Published, gold			2022-12-25	WOS:000309517300039
J	Yau, KH; Mak, JCW; Leung, SWS; Yang, D; Vanhoutte, PM				Yau, Kwok-hei; Mak, Judith Choi-wo; Leung, Susan Wai-sum; Yang, Dan; Vanhoutte, Paul M.			A Synthetic Chloride Channel Relaxes Airway Smooth Muscle of the Rat	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; PIG TRACHEAL MYOCYTES; CYSTIC-FIBROSIS; ION CHANNELS; CL-SECRETION; CA2+ STORES; CURRENTS; CANINE; CELLS; CONTRACTION	Synthetic ion channels may have potential therapeutic applications, provided they possess appropriate biological activities. The present study was designed to examine the ability of small molecule-based synthetic Cl- channels to modulate airway smooth muscle responsiveness. Changes in isometric tension were measured in rat tracheal rings. Relaxations to the synthetic chloride channel SCC-1 were obtained during sustained contractions to KCl. The anion dependency of the effect of SCC-1 was evaluated by ion substitution experiments. The sensitivity to conventional Cl- transport inhibitors was also tested. SCC-1 caused concentration- dependent relaxations during sustained contractions to potassium chloride. This relaxing effect was dependent on the presence of extracellular Cl- and HCO3-. It was insensitive to conventional Cl- channels/transport inhibitors that blocked the cystic fibrosis transmembrane conductance regulator and calcium-activated Cl- channels. SCC-1 did not inhibit contractions induced by carbachol, endothelin-1, 5-hydroxytryptamine or the calcium ionophore A23187. SCC-1 relaxes airway smooth muscle during contractions evoked by depolarizing solutions. The Cl- conductance conferred by this synthetic compound is distinct from the endogenous transport systems for chloride anions.	[Mak, Judith Choi-wo; Leung, Susan Wai-sum; Vanhoutte, Paul M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yau, Kwok-hei; Yang, Dan] Univ Hong Kong, Fac Sci, Dept Chem, Morningside Lab Chem Biol, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-wo] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Vanhoutte, PM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	vanhoutte.hku@hku.hk	YANG, Dan/HHD-2733-2022; /D-3151-2009	Mak, Judith/0000-0002-8234-1313; /0000-0002-1726-9335	University of Hong Kong; Hong Kong Research Grants Council Collaborative Research Fund [HKU2/06C, HKU8/CRF/10]	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council)	This study was supported by grants from the University of Hong Kong and the Hong Kong Research Grants Council Collaborative Research Fund (HKU2/06C and HKU8/CRF/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins JL, 2010, CHEM COMMUN, V46, P8166, DOI 10.1039/c0cc03138k; Barnes PJ, 1998, AM J RESP CRIT CARE, V158, pS123, DOI 10.1164/ajrccm.158.supplement_2.13tac800; BARNES PJ, 1985, BRIT J CLIN PHARMACO, V20, pS289, DOI 10.1111/j.1365-2125.1985.tb02815.x; Barnes PJ, 1998, PHARMACOL REV, V50, P515; BOURREAU JP, 1991, AM J PHYSIOL, V261, pC497, DOI 10.1152/ajpcell.1991.261.3.C497; BOURREAU JP, 1993, AM J PHYSIOL, V265, pC28, DOI 10.1152/ajpcell.1993.265.1.C28; Broughman JR, 2004, AM J PHYSIOL-CELL PH, V286, pC1312, DOI 10.1152/ajpcell.00426.2002; Broughman JR, 2001, AM J PHYSIOL-CELL PH, V280, pC451, DOI 10.1152/ajpcell.2001.280.3.C451; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; COBURN RF, 1977, J PHARMACOL EXP THER, V201, P276; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; FARLEY JM, 1977, J PHARMACOL EXP THER, V201, P199; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Fyles TM, 2007, CHEM SOC REV, V36, P335, DOI 10.1039/b603256g; Gallos G, 2008, AM J PHYSIOL-LUNG C, V295, pL1040, DOI 10.1152/ajplung.90330.2008; Gleason NR, 2009, J APPL PHYSIOL, V106, P1257, DOI 10.1152/japplphysiol.91314.2008; Gokel GW, 2007, CHEM SOC REV, V36, P378, DOI 10.1039/b605910b; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HOPPE M, 1992, J ALLERGY CLIN IMMUN, V89, P688, DOI 10.1016/0091-6749(92)90375-C; Ishiguro H, 2009, J GEN PHYSIOL, V133, P315, DOI 10.1085/jgp.200810122; ITO Y, 1989, BRIT J PHARMACOL, V98, P1249, DOI 10.1111/j.1476-5381.1989.tb12671.x; ITO Y, 1995, BRIT J PHARMACOL, V116, P2738, DOI 10.1111/j.1476-5381.1995.tb17235.x; Janssen LJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1757, DOI 10.1152/ajpcell.1997.272.6.C1757; JANSSEN LJ, 1993, AM J PHYSIOL, V265, pC877, DOI 10.1152/ajpcell.1993.265.4.C877; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; JANSSEN LJ, 1993, J PHYSIOL-LONDON, V465, P661, DOI 10.1113/jphysiol.1993.sp019699; JANSSEN LJ, 1992, J PHYSIOL-LONDON, V453, P197, DOI 10.1113/jphysiol.1992.sp019224; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; KAMEI K, 1995, BRIT J PHARMACOL, V115, P1493, DOI 10.1111/j.1476-5381.1995.tb16642.x; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; KOTLIKOFF MI, 1988, AM J PHYSIOL, V254, pC793, DOI 10.1152/ajpcell.1988.254.6.C793; Leevy WM, 2002, J AM CHEM SOC, V124, P9022, DOI 10.1021/ja017052o; Li X, 2007, J AM CHEM SOC, V129, P7264, DOI 10.1021/ja071961h; Li X, 2009, J AM CHEM SOC, V131, P13676, DOI 10.1021/ja902352g; MARTHAN R, 1989, J APPL PHYSIOL, V66, P1706, DOI 10.1152/jappl.1989.66.4.1706; Matile S., 2011, CHEM SOC REV; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; Sisson AL, 2006, CHEM SOC REV, V35, P1269, DOI 10.1039/b512423a; SOUHRADA M, 1993, J APPL PHYSIOL, V74, P1948, DOI 10.1152/jappl.1993.74.4.1948; Teixeira MCL, 2000, EUR J PHARMACOL, V394, P117, DOI 10.1016/S0014-2999(00)00089-3; Wallace DP, 2000, BBA-BIOMEMBRANES, V1464, P69, DOI 10.1016/S0005-2736(99)00248-5; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Yim PD, 2011, FASEB J	46	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45340	10.1371/journal.pone.0045340	http://dx.doi.org/10.1371/journal.pone.0045340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049786	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300021
J	Bender, HS; Murchison, EP; Pickett, HA; Deakin, JE; Strong, MA; Conlan, C; McMillan, DA; Neumann, AA; Greider, CW; Hannon, GJ; Reddel, RR; Graves, JAM				Bender, Hannah S.; Murchison, Elizabeth P.; Pickett, Hilda A.; Deakin, Janine E.; Strong, Margaret A.; Conlan, Carly; McMillan, Daniel A.; Neumann, Axel A.; Greider, Carol W.; Hannon, Gregory J.; Reddel, Roger R.; Graves, Jennifer A. Marshall			Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length	PLOS ONE			English	Article							FACIAL-TUMOR DISEASE; GENE; TRANSMISSION; DIVERSITY; DEFECTS; BIOLOGY; ROLES; CELLS	Telomeres, specialised structures that protect chromosome ends, play a critical role in preserving chromosome integrity. Telomere dynamics in the Tasmanian devil (Sarcophilus harrisii) are of particular interest in light of the emergence of devil facial tumour disease (DFTD), a transmissible malignancy that causes rapid mortality and threatens the species with extinction. We used fluorescent in situ hybridisation to investigate telomere length in DFTD cells, in healthy Tasmanian devils and in four closely related marsupial species. Here we report that animals in the Order Dasyuromorphia have chromosomes characterised by striking telomere length dimorphism between homologues. Findings in sex chromosomes suggest that telomere length dimorphism may be regulated by events in the parental germlines. Long telomeres on the Y chromosome imply that telomere lengthening occurs during spermatogenesis, whereas telomere diminution occurs during oogenesis. Although found in several somatic cell tissue types, telomere length dimorphism was not found in DFTD cancer cells, which are characterised by uniformly short telomeres. This is, to our knowledge, the first report of naturally occurring telomere length dimorphism in any species and suggests a novel strategy of telomere length control. Comparative studies in five distantly related marsupials and a monotreme indicate that telomere dimorphism evolved at least 50 million years ago.	[Bender, Hannah S.; Deakin, Janine E.; Conlan, Carly; McMillan, Daniel A.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Murchison, Elizabeth P.; Hannon, Gregory J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Pickett, Hilda A.; Neumann, Axel A.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Pickett, Hilda A.; Neumann, Axel A.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Strong, Margaret A.; Greider, Carol W.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Australian National University; Cold Spring Harbor Laboratory; Children's Medical Research Institute - Australia; University of Sydney; Johns Hopkins University	Bender, HS (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	hb78@cornell.edu	Hannon, Gregory/AAB-3568-2019; Reddel, Roger R/A-6635-2014; Deakin, Janine/A-1941-2008	Reddel, Roger R/0000-0002-6302-6107; Deakin, Janine/0000-0002-1259-3531; Strong, Margaret/0000-0002-0055-6573; Greider, Carol/0000-0002-5494-8126; Graves, Jennifer/0000-0001-6480-7856; Murchison, Elizabeth Proby/0000-0001-7462-8907; Bender, Hannah/0000-0001-9458-4964	Australian Research Council [LP0562190]; American Australian Association; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); American Australian Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Australian Research Council (LP0562190, HSB, JAMG) the American Australian Association (EPM) and in part by grants from the National Institutes of Health (GJH) and generous gifts from Kathryn Davis and Dr. David Middleton (The devils' angels grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Amber Alsop (Walter and Eliza Hall Institute), Anne-Maree Pearse and Kate Swift (Tasmanian Department of Primary Industries, Parks, Water and Environment) for laboratory assistance and Elizabeth Blackburn and Denis O'Meally for helpful discussion. For their assistance collecting or providing tissue samples we acknowledge Drs Colette Harmsen, Jemma Bergfeld and Alan Marcus, as well as the staff and veterinarians at Taronga Zoo in Sydney and the National Zoo and Aquarium in Canberra. HSB was supported by the Australian Research Council and EPM by the American Australian Association. Thanks also to Kathryn Davis and Dr David Middleton (The devils' angels grant) for their generous contributions to this project.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Britt-Compton B, 2009, FEBS LETT, V583, P3076, DOI 10.1016/j.febslet.2009.08.029; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Deakin JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002483; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Griner L, 1979, JNCI-J NATL CANCER I, V62; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Henson JD, 2005, CLIN CANCER RES, V11, P217; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; Metcalfe CJ, 2004, CHROMOSOME RES, V12, P405, DOI 10.1023/B:CHRO.0000034133.77878.88; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Oakwood M, 2001, P ROY SOC B-BIOL SCI, V268, P407, DOI 10.1098/rspb.2000.1369; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017473; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Pickett HA, 2012, CELL CYCLE, V11, P1309, DOI 10.4161/cc.19632; Pyecroft SB, 2007, ECOHEALTH, V4, P346, DOI 10.1007/s10393-007-0126-0; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	52	20	21	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46195	10.1371/journal.pone.0046195	http://dx.doi.org/10.1371/journal.pone.0046195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049977	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000309556100152
J	Bundy, MGR; Thompson, OA; Sieger, MT; Shpak, ED				Bundy, Mark G. R.; Thompson, Olivia A.; Sieger, Matthew T.; Shpak, Elena D.			Patterns of Cell Division, Cell Differentiation and Cell Elongation in Epidermis and Cortex of Arabidopsis pedicels in the Wild Type and in erecta	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; FUNCTIONAL-ANALYSIS; FLOWER DEVELOPMENT; FRUIT-DEVELOPMENT; DEVELOPING LEAVES; GROWTH; PROLIFERATION; GIBBERELLIN; SHOOT; SIZE	Plant organ shape and size are established during growth by a predictable, controlled sequence of cell proliferation, differentiation, and elongation. To understand the regulation and coordination of these processes, we studied the temporal behavior of epidermal and cortex cells in Arabidopsis pedicels and used computational modeling to analyze cell behavior in tissues. Pedicels offer multiple advantages for such a study, as their growth is determinate, mostly one dimensional, and epidermis differentiation is uniform along the proximodistal axis. Three developmental stages were distinguished during pedicel growth: a proliferative stage, a stomata differentiation stage, and a cell elongation stage. Throughout the first two stages pedicel growth is exponential, while during the final stage growth becomes linear and depends on flower fertilization. During the first stage, the average cell cycle duration in the cortex and during symmetric divisions of epidermal cells was constant and cells divided at a fairly specific size. We also examined the mutant of ERECTA, a gene with strong influence on pedicel growth. We demonstrate that during the first two stages of pedicel development ERECTA is important for the rate of cell growth along the proximodistal axis and for cell cycle duration in epidermis and cortex. The second function of ERECTA is to prolong the proliferative phase and inhibit premature cell differentiation in the epidermis. Comparison of epidermis development in the wild type and erecta suggests that differentiation is a synchronized event in which the stomata differentiation and the transition of pavement cells from proliferation to expansion are intimately connected.	[Bundy, Mark G. R.; Thompson, Olivia A.; Sieger, Matthew T.; Shpak, Elena D.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Shpak, ED (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	eshpak@utk.edu	Sieger, Matthew/B-4261-2011	Sieger, Matthew/0000-0001-7387-3660; Shpak, Elena/0000-0002-5702-7517	National Science Foundation [IOS-0843340]; Division Of Integrative Organismal Systems [0843340] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation [IOS-0843340 to E.S]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Asl LK, 2011, PLANT PHYSIOL, V156, P2172, DOI 10.1104/pp.111.181180; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Beemster GTS, 2002, PLANT PHYSIOL, V129, P854, DOI 10.1104/pp.002923; Das P, 2011, CURR OPIN GENET DEV, V21, P606, DOI 10.1016/j.gde.2011.07.002; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Delgado D, 2011, ANN BOT-LONDON, V107, P1247, DOI 10.1093/aob/mcr060; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Douglas SJ, 2005, DEV BIOL, V284, P451, DOI 10.1016/j.ydbio.2005.06.011; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Jurado S, 2010, PLANT CELL, V22, P3891, DOI 10.1105/tpc.110.078972; Karve R, 2011, RNA, V17, P1907, DOI 10.1261/rna.2825811; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Mundermann L, 2005, PLANT PHYSIOL, V139, P960, DOI 10.1104/pp.105.060483; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Ragni L, 2011, PLANT CELL, V23, P1322, DOI 10.1105/tpc.111.084020; RAYLE DL, 1970, P NATL ACAD SCI USA, V65, P184, DOI 10.1073/pnas.65.1.184; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Tisne S, 2011, ANN BOT-LONDON, V108, P159, DOI 10.1093/aob/mcr091; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; Vivian-Smith A, 2001, DEVELOPMENT, V128, P2321; Wang H, 2000, ADV IND CON; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Yokoyama R, 1998, PLANT J, V15, P301, DOI 10.1046/j.1365-313X.1998.00203.x	49	17	17	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46262	10.1371/journal.pone.0046262	http://dx.doi.org/10.1371/journal.pone.0046262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050000	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100171
J	Lai, YZ; Cheng, K; Kisaalita, W				Lai, Yinzhi; Cheng, Ke; Kisaalita, William			Three Dimensional Neuronal Cell Cultures More Accurately Model Voltage Gated Calcium Channel Functionality in Freshly Dissected Nerve Tissue	PLOS ONE			English	Article							3-D COLLAGEN HYDROGELS; LIPID RAFTS; SIGNALING MICRODOMAINS; POLYMER SCAFFOLDS; CA2+ CHANNELS; LIVING CELLS; ION CHANNELS; PROTEIN; LOCALIZATION; ORGANIZATION	It has been demonstrated that neuronal cells cultured on traditional flat surfaces may exhibit exaggerated voltage gated calcium channel (VGCC) functionality. To gain a better understanding of this phenomenon, primary neuronal cells harvested from mice superior cervical ganglion (SCG) were cultured on two dimensional (2D) flat surfaces and in three dimensional (3D) synthetic poly-L-lactic acid (PLLA) and polystyrene (PS) polymer scaffolds. These 2D- and 3D-cultured cells were compared to cells in freshly dissected SCG tissues, with respect to intracellular calcium increase in response to high K+ depolarization. The calcium increases were identical for 3D-cultured and freshly dissected, but significantly higher for 2D-cultured cells. This finding established the physiological relevance of 3D-cultured cells. To shed light on the mechanism behind the exaggerated 2D- cultured cells' functionality, transcriptase expression and related membrane protein distributions (caveolin-1) were obtained. Our results support the view that exaggerated VGCC functionality from 2D cultured SCG cells is possibly due to differences in membrane architecture, characterized by uniquely organized caveolar lipid rafts. The practical implication of use of 3D-cultured cells in preclinical drug discovery studies is that such platforms would be more effective in eliminating false positive hits and as such improve the overall yield from screening campaigns.	[Lai, Yinzhi; Cheng, Ke; Kisaalita, William] Univ Georgia, Coll Engn, Cellular Bioengn Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kisaalita, W (corresponding author), Univ Georgia, Coll Engn, Cellular Bioengn Lab, Athens, GA 30602 USA.	williamk@engr.uga.edu	Lai, Yinzhi/G-8892-2012	Lai, Yinzhi/0000-0003-0131-2172	National Science Foundation [0304340]; UGA Engineering Grants	National Science Foundation(National Science Foundation (NSF)); UGA Engineering Grants	This work was partly supported by National Science Foundation (0304340) and UGA Engineering Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Belletti S, 2002, J NEUROSCI RES, V70, P703, DOI 10.1002/jnr.10419; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Calder PC, 2007, J NUTR, V137, P545, DOI 10.1093/jn/137.3.545; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cosford NDP, 2002, CNS NEUROL DISORD-DR, V1, P81, DOI 10.2174/1568007023339463; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Denyer J, 1998, DRUG DISCOV TODAY, V3, P323, DOI 10.1016/S1359-6446(98)01199-4; Desai A, 2006, BIOSENS BIOELECTRON, V21, P1483, DOI 10.1016/j.bios.2005.07.005; Dolphin AC, 1999, ADV SEC MESS PHOSPH, V33, P153; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9; Godfraind T., 2004, MIL DRUG TH; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; JESSUP JM, 1993, J CELL BIOCHEM, V51, P290, DOI 10.1002/jcb.240510308; Joshi DC, 2011, NEUROCHEM INT, V59, P913, DOI 10.1016/j.neuint.2011.06.023; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kisaalita WS, 2009, 3 D CELL BASED BIOSE; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Lagrutta A.A., 2006, VOLTAGE GATED ION CH, P444; Lai YZ, 2012, JALA-J LAB AUTOM, V17, P284, DOI 10.1177/2211068212442503; Leitinger B, 2002, J CELL SCI, V115, P963; LEWIS ML, 1993, J CELL BIOCHEM, V51, P265, DOI 10.1002/jcb.240510305; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; Mao C, 2004, BIOSENS BIOELECTRON, V19, P1075, DOI 10.1016/j.bios.2003.10.008; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; MEIER K, 1988, ENDOCRINOLOGY, V122, P2764, DOI 10.1210/endo-122-6-2764; MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R; O'Connell KMS, 2004, TRENDS CARDIOVAS MED, V14, P37, DOI 10.1016/j.tcm.2003.10.002; O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871, DOI 10.1016/S0956-5663(99)00055-X; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Saino T, 2004, J ELECTRON MICROSC, V53, P49, DOI 10.1093/jmicro/53.1.49; Shitaka Y, 1996, J NEUROSCI, V16, P6476; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Taverna E, 2004, J BIOL CHEM, V279, P5127, DOI 10.1074/jbc.M308798200; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Wang LN, 2010, J BIOMED MATER RES B, V94B, P238, DOI 10.1002/jbm.b.31646; Wang SSS, 2001, J CELL BIOCHEM, V83, P574, DOI 10.1002/jcb.1252; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5; Wu ZZ, 2006, BIOSENS BIOELECTRON, V22, P685, DOI 10.1016/j.bios.2006.02.003; Wu ZZ, 2006, COLLOID SURFACE B, V52, P14, DOI 10.1016/j.colsurfb.2006.06.001; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	68	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45074	10.1371/journal.pone.0045074	http://dx.doi.org/10.1371/journal.pone.0045074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049767	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100026
J	Choi, JC; Wu, W; Muchir, A; Iwata, S; Homma, S; Worman, HJ				Choi, Jason C.; Wu, Wei; Muchir, Antoine; Iwata, Shinichi; Homma, Shunichi; Worman, Howard J.			Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PHOSPHATASE-1; HEART-FAILURE; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; INSULIN-RESISTANCE; PREMATURE DEATH; HYPERTROPHY; STRESS; METABOLISM	Mutations in the lamin A/C gene (LMNA) cause a diverse spectrum of diseases, the most common of which is dilated cardiomyopathy often with skeletal muscular dystrophy. Lamin A and C are fundamental components of the nuclear lamina, a dynamic meshwork of intermediate filaments lining the nuclear envelope inner membrane. Prevailing evidence suggests that the nuclear envelope functions as a signaling node and that abnormality in the nuclear lamina leads to dysregulated signaling pathways that underlie disease pathogenesis. We previously showed that activated ERK1/2 in hearts of a mouse model of LMNA cardiomyopathy (Lmna(H222P/H222P) mice) contributes to disease, but the complete molecular pathogenesis remains poorly understood. Here we uncover a pathogenic role of dual specificity phosphatase 4 (Dusp4), which is transcriptionally induced by ERK1/2. Dusp4 is highly expressed in the hearts of LmnaH222P/H222P mice, and transgenic mice with cardiac-selective overexpression of Dusp4 display heart dysfunction similar to LMNA cardiomyopathy. In both primary tissue and cell culture models, overexpression of Dusp4 positively regulates AKT-mTOR signaling, resulting in impaired autophagy. These findings identify a pathogenic role of Dusp4 in LMNA cardiomyopathy.	[Choi, Jason C.; Wu, Wei; Muchir, Antoine; Iwata, Shinichi; Homma, Shunichi; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Choi, Jason C.; Wu, Wei; Muchir, Antoine; Worman, Howard J.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Worman, HJ (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, 630W 168th St,P&S 10-508, New York, NY 10032 USA.	hjw14@columbia.edu		Muchir, Antoine/0000-0002-4780-9275	National Institutes of Health [R01AR048997, F32-HL094037]; Muscular Dystrophy Association [MDA172222]; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL094037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR048997. This work was also supported by Muscular Dystrophy Association Grant MDA172222 ( to H. J. W.). The authors have reported a direct financial conflict of interest: H. J. W. and A. M. are inventors on a pending patent application (PCT/US09/42614) on methods for treating and/or preventing cardiomyopathies by ERK and JNK inhibition filed by the trustees of Columbia University. H. J. W. and J. C. C. are inventors on a provisional patent application on the use of rapamycin and rapamycin analogs for the treatment of dilated cardiomyopathies filed by the trustees of Columbia University.; Supported by a Ruth L. Kirschstein National Research Service Award Individual Fellowship through NHLBI, National Institutes of Health Grant F32-HL094037.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Baba HA, 2003, CARDIOVASC RES, V59, P390, DOI 10.1016/S0008-6363(03)00393-6; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brooks WW, 2010, GENOMICS, V95, P84, DOI 10.1016/j.ygeno.2009.12.002; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Communal C, 2002, J CARD FAIL, V8, P86, DOI 10.1054/jcaf.2002.32755; Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Haq S, 2001, CIRCULATION, V103, P670; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Karoor V, 2004, J MOL CELL CARDIOL, V36, P305, DOI 10.1016/j.yjmcc.2003.11.006; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; LIN F, 1993, J BIOL CHEM, V268, P16321; Luckey SW, 2009, J MOL CELL CARDIOL, V46, P739, DOI 10.1016/j.yjmcc.2009.02.010; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; OPIE LH, 1968, AM HEART J, V76, P685, DOI 10.1016/0002-8703(68)90168-3; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Semple D, 2011, J AM SOC NEPHROL, V22, P207, DOI 10.1681/ASN.2009090900; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Zebedin E, 2007, AM J PHYSIOL-HEART C, V292, pH439, DOI 10.1152/ajpheart.00119.2006	47	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40513	40524		10.1074/jbc.M112.404541	http://dx.doi.org/10.1074/jbc.M112.404541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048029	Green Published, hybrid			2022-12-25	WOS:000311448800042
J	Deuschle, U; Schuler, J; Schulz, A; Schluter, T; Kinzel, O; Abel, U; Kremoser, C				Deuschle, Ulrich; Schueler, Julia; Schulz, Andreas; Schlueter, Thomas; Kinzel, Olaf; Abel, Ulrich; Kremoser, Claus			FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; SMALL HETERODIMER PARTNER; ORPHAN NUCLEAR RECEPTOR; HUMAN COLON-CARCINOMA; BILE-ACID RECEPTOR; HEPATOCELLULAR-CARCINOMA; ACTIVATED RECEPTOR; REGULATORY CASCADE; CELL CARCINOMA; EXPRESSION	The farnesoid X receptor (FXR) is expressed predominantly in tissues exposed to high levels of bile acids and controls bile acid and lipid homeostasis. FXR-/- mice develop hepatocellular carcinoma (HCC) and show an increased prevalence for intestinal malignancies, suggesting a role of FXR as a tumor suppressor in enterohepatic tissues. The N-myc downstream-regulated gene 2 (NDRG2) has been recognized as a tumor suppressor gene, which is downregulated in human hepatocellular carcinoma, colorectal carcinoma and many other malignancies. We show reduced NDRG2 mRNA in livers of FXR-/- mice compared to wild type mice and both, FXR and NDRG2 mRNAs, are reduced in human HCC compared to normal liver. Gene reporter assays and Chromatin Immunoprecipitation data support that FXR directly controls NDRG2 transcription via IR1-type element(s) identified in the first introns of the human, mouse and rat NDRG2 genes. NDRG2 mRNA was induced by non-steroidal FXR agonists in livers of mice and the magnitude of induction of NDRG2 mRNA in three different human hepatoma cell lines was increased when ectopically expressing human FXR. Growth and metastasis of SK-Hep-1 cells was strongly reduced by non-steroidal FXR agonists in an orthotopic liver xenograft tumor model. Ectopic expression of FXR in SK-Hep1 cells reduced tumor growth and metastasis potential of corresponding cells and increased the anti-tumor efficacy of FXR agonists, which may be partly mediated via increased NDRG2 expression. FXR agonists may show a potential in the prevention and/or treatment of human hepatocellular carcinoma, a devastating malignancy with increasing prevalence and limited therapeutic options.	[Deuschle, Ulrich; Schulz, Andreas; Schlueter, Thomas; Kinzel, Olaf; Kremoser, Claus] Phenex Pharmaceut AG, Dept Res, Heidelberg, Germany; [Schueler, Julia] Oncotest GmbH, Dept Vivo Tumor Biol, Freiburg, Germany; [Abel, Ulrich] Merz Pharmaceut GmbH, Dept Med Chem, Frankfurt, Germany	Oncotest GmbH; Merz Pharmaceuticals GmbH	Deuschle, U (corresponding author), Phenex Pharmaceut AG, Dept Res, Heidelberg, Germany.	ulrich.deuschle@phenex-pharma.com		Schlueter, Thomas/0000-0001-5829-9381	German Federal Ministry of Education and Research [031547000]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors acknowledge the support by grant KMU-Innovative-2 #031547000 from the German Federal Ministry of Education and Research to Phenex Pharmaceuticals AG (http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel U, 2010, BIOORG MED CHEM LETT, V20, P4911, DOI 10.1016/j.bmcl.2010.06.084; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Chu D, 2011, MOL CANCER THER, V10, P47, DOI 10.1158/1535-7163.MCT-10-0614; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Higashiyama H, 2008, ACTA HISTOCHEM, V110, P86, DOI 10.1016/j.acthis.2007.08.001; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kremoser C., 2011, WO Pat., Patent No. [WO2011020615A1, 2011020615]; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Lax S, 2012, INT J CANCER, V130, P2232, DOI 10.1002/ijc.26293; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma JJ, 2008, BIOL PHARM BULL, V31, P1316, DOI 10.1248/bpb.31.1316; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Piepoli A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-11; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Shi H, 2010, CANCER SCI, V101, P1292, DOI 10.1111/j.1349-7006.2010.01529.x; SHOUVAL D, 1988, VIRCHOWS ARCH A, V412, P595, DOI 10.1007/BF00844296; Smith DLH, 2010, CARCINOGENESIS, V31, P1100, DOI 10.1093/carcin/bgq050; Song SP, 2011, MED ONCOL, V2; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tepel M, 2008, INT J CANCER, V123, P2080, DOI 10.1002/ijc.23705; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang SW, 2009, J HEPATOL, V51, P380, DOI 10.1016/j.jhep.2009.03.025; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zheng J, 2010, ASIAN PAC J CANCER P, V11, P1817; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	51	63	70	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43044	10.1371/journal.pone.0043044	http://dx.doi.org/10.1371/journal.pone.0043044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056173	Green Published, Green Submitted, gold			2022-12-25	WOS:000309889400002
J	Lombardo, E; van Roomen, CPAA; van Puijvelde, GH; Ottenhoff, R; van Eijk, M; Aten, J; Kuiper, J; Overkleeft, HS; Groen, AK; Verhoeven, AJ; Aerts, JMFG; Bietrix, F				Lombardo, Elisa; van Roomen, Cindy P. A. A.; van Puijvelde, Gijs H.; Ottenhoff, Roelof; van Eijk, Marco; Aten, Jan; Kuiper, Johan; Overkleeft, Herman S.; Groen, Albert K.; Verhoeven, Arthur J.; Aerts, Johannes M. F. G.; Bietrix, Florence			Correction of Liver Steatosis by a Hydrophobic Iminosugar Modulating Glycosphingolipids Metabolism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; IMPROVES GLYCEMIC CONTROL; INSULIN SENSITIVITY; NONALCOHOLIC STEATOHEPATITIS; ANIMAL-MODELS; OBESE MICE; INFLAMMATORY RESPONSE; HEPATIC STEATOSIS; GANGLIOSIDE GM3; DISEASE	The iminosugar N-(5'-adamantane-1'-yl-methoxy)-pentyl-1-deoxynoijirimycin (AMP-DNM), an inhibitor of glycosphingolipid (GSL) biosynthesis is known to ameliorate diabetes, insulin sensitivity and to prevent liver steatosis in ob/ob mice. Thus far the effect of GSL synthesis inhibition on pre-existing NASH has not yet been assessed. To investigate it, LDLR(-/-) mice were kept on a western-type diet for 12 weeks to induce NASH. Next, the diet was continued for 6 weeks in presence or not of AMP-DNM in the diet. AMP-DNM treated mice showed less liver steatosis, inflammation and fibrosis. Induction of fatty acid beta-oxydation was observed, as well as a reduction of plasma lipids. Our study demonstrates that AMP-DNM treatment is able to significantly correct pre-existing NASH, suggesting that inhibiting GSL synthesis may represent a novel strategy for the treatment of this pathology.	[Lombardo, Elisa; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; van Eijk, Marco; Verhoeven, Arthur J.; Aerts, Johannes M. F. G.; Bietrix, Florence] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Puijvelde, Gijs H.; Kuiper, Johan] Leiden Univ, Div Biopharmaceut, LACDR, Leiden, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Groen, Albert K.] Univ Med Ctr Groningen, Dept Pediat, NL-9713 AV Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen	Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.aerts@amc.uva.nl	van Puijvelde, Gijs/AAM-9889-2020; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Overkleeft, Herman/0000-0001-6976-7005	Netherlands Heart Foundation [2007B030]; Dutch Diabetes foundation [2009.80.016]	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes foundation	Elisa Lombardo is supported by the Netherlands Heart Foundation, grant 2007B030. Marco van Eijk is supported by the Dutch Diabetes foundation, grant 2009.80.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gastaldelli A, 2010, ALIMENT PHARM THER, V32, P769, DOI 10.1111/j.1365-2036.2010.04405.x; Jennemann R, 2010, HEPATOLOGY, V51, P1799, DOI 10.1002/hep.23545; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Langeveld M, 2012, METABOLISM, V61, P99, DOI 10.1016/j.metabol.2011.05.013; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Levels JHM, 2003, CRIT CARE MED, V31, P1647, DOI 10.1097/01.CCM.0000063260.07222.76; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rull A, 2009, CYTOKINE, V48, P273, DOI 10.1016/j.cyto.2009.08.006; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Solga SF, 2006, BIOMARKERS, V11, P174, DOI 10.1080/13547500500421070; Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970	42	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e38520	10.1371/journal.pone.0038520	http://dx.doi.org/10.1371/journal.pone.0038520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056165	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500001
J	Wong, A; Shafiee, MJ; Azimifar, Z				Wong, Alexander; Shafiee, Mohammad Javad; Azimifar, Zohreh			Statistical Conditional Sampling for Variable-Resolution Video Compression	PLOS ONE			English	Article								In this study, we investigate a variable-resolution approach to video compression based on Conditional Random Field and statistical conditional sampling in order to further improve compression rate while maintaining high-quality video. In the proposed approach, representative key-frames within a video shot are identified and stored at full resolution. The remaining frames within the video shot are stored and compressed at a reduced resolution. At the decompression stage, a region-based dictionary is constructed from the key-frames and used to restore the reduced resolution frames to the original resolution via statistical conditional sampling. The sampling approach is based on the conditional probability of the CRF modeling by use of the constructed dictionary. Experimental results show that the proposed variable-resolution approach via statistical conditional sampling has potential for improving compression rates when compared to compressing the video at full resolution, while achieving higher video quality when compared to compressing the video at reduced resolution.	[Wong, Alexander] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Shafiee, Mohammad Javad; Azimifar, Zohreh] Shiraz Univ, Sch Elect & Comp Engn, Shiraz, Iran	University of Waterloo; Shiraz University	Wong, A (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	a28wong@uwaterloo.ca	MohammadShafiee, MohammadReza/J-2988-2013; Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezdek J, 1984, COMPUTERS GEOSCIENCE; Bjontegaard G, 2000, H 26L TEST MODEL LON; Chou LC, 2007, 14TH INTERNATIONAL CONFERENCE ON IMAGE ANALYSIS AND PROCESSING, PROCEEDINGS, P399, DOI 10.1109/ICIAP.2007.4362811; Cook GW, 2006, IEEE T IMAGE PROCESS, V15, P2170, DOI 10.1109/TIP.2006.875185; Deforges Olivier, 2008, Proceedings 3rd International Design and Test Workshop (IDT 2008), P187, DOI 10.1109/IDT.2008.4802494; Deforges O, 2000, 2000 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, PROCEEDINGS VOLS I-III, P107, DOI 10.1109/ICME.2000.869556; Deforges O, 2007, IEEE T CIRC SYST VID, V17, P974, DOI 10.1109/TCSVT.2007.897112; Int Telecommun Union-Telecommun, 1999, NARR BAND VIS TEL SY; Int Telecommun Union-Telecommun, 1994, GEN COD MOV PICT ASS; Kong D, 2006, INT C PATT RECOG, P619; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li J., 2009, 2009 IEEE 36th International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2009.5227467; Sahabi H., 1995, Proceedings of the 8th International Conference on VLSI Design (Cat. No.95TH802), P214, DOI 10.1109/ICVD.1995.512111; Sullivan GJ, 1998, IEEE SIGNAL PROC MAG, V15, P74, DOI 10.1109/79.733497; Video Trace Library, 2012, TRAC YUV VID SEQ; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wei L, 2009, P SOC PHOTO-OPT INS, V7495; Wiegand T, 1999, IEEE T CIRC SYST VID, V9, P70, DOI 10.1109/76.744276; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Wiegand T, 1996, IEEE T CIRC SYST VID, V6, P182, DOI 10.1109/76.488825; Wiegand T., 2001, MULTIFRAME MOTION CO; Xiong RQ, 2008, IEEE T CIRC SYST VID, V18, P145, DOI 10.1109/TCSVT.2007.913765	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45002	10.1371/journal.pone.0045002	http://dx.doi.org/10.1371/journal.pone.0045002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056188	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500009
J	Khemlani, SS; Lotstein, M; Johnson-Laird, P				Khemlani, Sangeet S.; Lotstein, Max; Johnson-Laird, Phil			The Probabilities of Unique Events	PLOS ONE			English	Article							JUDGMENT; MODEL	Many theorists argue that the probabilities of unique events, even real possibilities such as President Obama's re-election, are meaningless. As a consequence, psychologists have seldom investigated them. We propose a new theory (implemented in a computer program) in which such estimates depend on an intuitive non-numerical system capable only of simple procedures, and a deliberative system that maps intuitions into numbers. The theory predicts that estimates of the probabilities of conjunctions should often tend to split the difference between the probabilities of the two conjuncts. We report two experiments showing that individuals commit such violations of the probability calculus, and corroborating other predictions of the theory, e. g., individuals err in the same way even when they make non-numerical verbal estimates, such as that an event is highly improbable.	[Khemlani, Sangeet S.] USN, Res Lab, Navy Ctr Appl Res Artificial Intelligence, Washington, DC 20375 USA; [Lotstein, Max; Johnson-Laird, Phil] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Princeton University	Khemlani, SS (corresponding author), USN, Res Lab, Navy Ctr Appl Res Artificial Intelligence, Washington, DC 20375 USA.	skhemlani@gmail.com			National Science Foundation Graduate Research Fellowship; National Science Foundation [SES 0844851]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This research was supported by a National Science Foundation Graduate Research Fellowship, as well as National Science Foundation Grant No. SES 0844851 to study deductive and probabilistic reasoning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, SUBJECTIVE PROBABILI; [Anonymous], 1993, THEORY PROBABILITY C; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Carey S., 2009, ORIGIN CONCEPTS; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; De Finetti B., 1970, ACTA PSYCHOL, V34, P129, DOI 10.1016/0001-6918(70)90012-0; Dehaene S., 1997, NUMBER SENSE; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fantino E, 1997, PSYCHON B REV, V4, P96, DOI 10.3758/BF03210779; Gigerenzer G, 2005, RISK ANAL, V25, P623, DOI 10.1111/j.1539-6924.2005.00608.x; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Girotto V, 2004, PSYCHOLOGIA, V47, P207, DOI 10.2117/psysoc.2004.207; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Hopcroft J. E., 1979, FORMAL LANGUAGES THE; Johnson-Laird, 1983, MENTAL MODELS; Johnson-Laird Philip Nicholas, 2006, WE REASON; Johnson-Laird PN, 1999, PSYCHOL REV, V106, P62, DOI 10.1037/0033-295X.106.1.62; Kahneman D., 2011, THINKING FAST SLOW; Khemlani S, 2012, IMMEDIATE INFE UNPUB; Khemlani S, 2013, ARGUM COMPUT, V4, P4, DOI 10.1080/19462166.2012.674060; Khemlani S, 2009, MEM COGNITION, V37, P615, DOI 10.3758/MC.37.5.615; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pascal B., 1966, PENSEES; Pothos EM, 2012, BEHAV BRAIN IN PRESS; Ramsey F. P., 1990, FP RAMSEY PHILOS PAP; Savage L. J., 1972, FDN STAT; Stanovich K. E., 1999, WHO IS RATIONAL STUD; Turing AM, 1939, P LOND MATH SOC, V45, P161; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; Verschueren N, 2005, THINK REASONING, V11, P239, DOI 10.1080/13546780442000178; von Mises Richard, 1961, PROBABILITY STAT TRU, VSecond; Wolfe CR, 2010, J BEHAV DECIS MAKING, V23, P203, DOI 10.1002/bdm.650; WYER RS, 1976, ORGAN BEHAV HUM PERF, V15, P1, DOI 10.1016/0030-5073(76)90026-X; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45975	10.1371/journal.pone.0045975	http://dx.doi.org/10.1371/journal.pone.0045975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056224	gold, Green Submitted, Green Published			2022-12-25	WOS:000309452600018
J	Spaak, E; Zeitler, M; Gielen, S				Spaak, Eelke; Zeitler, Magteld; Gielen, Stan			Hippocampal Theta Modulation of Neocortical Spike Times and Gamma Rhythm: A Biophysical Model Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; NEURONAL OSCILLATIONS; SYNAPTIC INHIBITION; PHASE PRECESSION; GAP-JUNCTIONS; CELLS; NETWORK; SYNCHRONIZATION; ACTIVATION; SYNAPSES	The hippocampal theta and neocortical gamma rhythms are two prominent examples of oscillatory neuronal activity. The hippocampus has often been hypothesized to influence neocortical networks by its theta rhythm, and, recently, evidence for such a direct influence has been found. We examined a possible mechanism for this influence by means of a biophysical model study using conductance-based model neurons. We found, in agreement with previous studies, that networks of fast-spiking GABA -ergic interneurons, coupled with shunting inhibition, synchronize their spike activity at a gamma frequency and are able to impose this rhythm on a network of pyramidal cells to which they are coupled. When our model was supplied with hippocampal theta-modulated input fibres, the theta rhythm biased the spike timings of both the fast-spiking and pyramidal cells. Furthermore, both the amplitude and frequency of local field potential gamma oscillations were influenced by the phase of the theta rhythm. We show that the fast-spiking cells, not pyramidal cells, are essential for this latter phenomenon, thus highlighting their crucial role in the interplay between hippocampus and neocortex.	[Spaak, Eelke] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Zeitler, Magteld; Gielen, Stan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Spaak, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	eelke.spaak@donders.ru.nl	Spaak, Eelke/Y-3826-2019; Zeitler, Magteld/K-2039-2016; Spaak, Eelke/W-9804-2018; Gielen, Stan CAM/D-3380-2009	Spaak, Eelke/0000-0002-2018-3364; Zeitler, Magteld/0000-0001-6241-9921; Spaak, Eelke/0000-0002-2018-3364; 	Netherlands Organization for Scientific Research [635.100.019]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO Grant No. 635.100.019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Baranauskas G, 2012, J NEUROPHYSIOL, V107, P984, DOI 10.1152/jn.00470.2011; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Gabbott P, 2002, BRAIN RES, V946, P314, DOI 10.1016/S0006-8993(02)02487-3; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jensen O, 2012, TRENDS COGNITIVE SCI; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kleppe IC, 1999, BIOPHYS J, V77, P1418, DOI 10.1016/S0006-3495(99)76990-0; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Pettersen KH, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P92; ROSENE DL, 1977, SCIENCE, V198, P315, DOI 10.1126/science.410102; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2005, P NATL ACAD SCI USA, V102, P18638, DOI 10.1073/pnas.0509291102; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Wang XJ, 1996, J NEUROSCI, V16, P6402	65	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45688	10.1371/journal.pone.0045688	http://dx.doi.org/10.1371/journal.pone.0045688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056213	Green Submitted, Green Published, gold			2022-12-25	WOS:000309452600015
J	Dean, PJA; Seiss, E; Sterr, A				Dean, Philip John Ainsley; Seiss, Ellen; Sterr, Annette			Motor Planning in Chronic Upper-Limb Hemiparesis: Evidence from Movement-Related Potentials	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTSTROKE HEMIPARESIS; HAND MOVEMENTS; CORTICAL POTENTIALS; BRAIN ACTIVATION; CHRONIC STROKE; INTERHEMISPHERIC INTERACTIONS; IPSILATERAL ACTIVATION; UNAFFECTED HEMISPHERE; PREMOTOR CORTEX	Background: Chronic hemiplegia is a common long-term consequence of stroke, and subsequent motor recovery is often incomplete. Neurophysiological studies have focused on motor execution deficits in relatively high functioning patients. Much less is known about the influence exerted by processes related to motor preparation, particularly in patients with poor motor recovery. Methodology/Principal Findings: The current study investigates motor preparation using a modified response-priming experiment in a large sample of patients (n = 50) with moderate-to-severe chronic hemiparesis. The behavioural results revealed that hemiparetic patients had an increased response-priming effect compared to controls, but that their response times were markedly slower for both hands. Patients also demonstrated significantly enhanced midline late contingent negative variation (CNV) during paretic hand preparation, despite the absence of overall group differences when compared to controls. Furthermore, increased amplitude of the midline CNV correlated with a greater response-priming effect. We propose that these changes might reflect greater anticipated effort to respond in patients, and consequently that advance cueing of motor responses may be of benefit in these individuals. We further observed significantly reduced CNV amplitudes over the lesioned hemisphere in hemiparetic patients compared to controls during non-paretic hand preparation, preparation of both hands and no hand preparation. Two potential explanations for these CNV reductions are discussed: alterations in anticipatory attention or state changes in motor processing, for example an imbalance in interhemispheric inhibition. Conclusions/Significance: Overall, this study provides evidence that movement preparation could play a crucial role in hemiparetic motor deficits, and that advance motor cueing may be of benefit in future therapeutic interventions. In addition, it demonstrates the importance of monitoring both the non-paretic and paretic hand after stroke and during therapeutic intervention.	[Dean, Philip John Ainsley; Seiss, Ellen; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	University of Surrey	Sterr, A (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England.	a.sterr@surrey.ac.uk	Seiss, Ellen/Y-6216-2019	Sterr, Annette/0000-0003-4490-985X; Dean, Philip/0000-0002-2362-513X	Medical Research Council, UK [61501]; MRC [G0200128] Funding Source: UKRI; Medical Research Council [G0200128] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council, UK. [Grant ID: 61501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AW, 2000, CLIN REHABIL, V14, P79, DOI 10.1191/026921500673950113; Battaglia F, 2006, CLIN NEUROPHYSIOL, V117, P1009, DOI 10.1016/j.clinph.2006.01.008; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Caramia MD, 2000, CLIN NEUROPHYSIOL, V111, P1990, DOI 10.1016/S1388-2457(00)00430-2; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Cramer SC, 1999, J NEUROPHYSIOL, V81, P383, DOI 10.1152/jn.1999.81.1.383; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Fang Y, 2007, J NEUROL SCI, V256, P21, DOI 10.1016/j.jns.2007.01.078; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Green JB, 1999, STROKE, V30, P2659, DOI 10.1161/01.STR.30.12.2659; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Hummel FC, 2009, NEUROLOGY, V72, P1766, DOI 10.1212/WNL.0b013e3181a609c5; Jankelowitz SK, 2005, EXP BRAIN RES, V161, P104, DOI 10.1007/s00221-004-2051-6; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Leuthold H, 2001, COGNITIVE BRAIN RES, V12, P207, DOI 10.1016/S0926-6410(01)00052-0; Leuthold H, 2009, PSYCHOPHYSIOLOGY, V46, P539, DOI 10.1111/j.1469-8986.2009.00799.x; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2656, DOI 10.1016/j.clinph.2007.08.027; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2050, DOI 10.1016/j.clinph.2007.06.010; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Luke C, 2004, CLIN REHABIL, V18, P888, DOI 10.1191/0269215504cr793oa; Mathews S, 2006, CLIN NEUROPHYSIOL, V117, P2675, DOI 10.1016/j.clinph.2006.08.001; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nelles G, 2011, J NEUROL, V258, P2168, DOI 10.1007/s00415-011-6085-y; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; Platz T, 2000, BRAIN, V123, P2475, DOI 10.1093/brain/123.12.2475; Rehme AK, 2011, NEUROIMAGE; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; ROSENBAUM DA, 1982, ACTA PSYCHOL, V51, P223, DOI 10.1016/0001-6918(82)90036-1; Schaechter JD, 2008, CEREB CORTEX, V18, P638, DOI 10.1093/cercor/bhm096; Serrien DJ, 2004, EXP NEUROL, V190, P425, DOI 10.1016/j.expneurol.2004.08.004; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Slobounov S, 2004, CLIN NEUROPHYSIOL, V115, P2391, DOI 10.1016/j.clinph.2004.05.021; Sterr A, 2006, BIOL PSYCHOL, V72, P154, DOI 10.1016/j.biopsycho.2005.09.002; Sterr A, 2004, BEHAV NEUROL, V15, P55, DOI 10.1155/2004/703746; Sterr A, 2002, BRAIN INJURY, V16, P1093, DOI 10.1080/02699050210155267; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Sterr A, 2008, EUR J NEUROSCI, V27, P254, DOI 10.1111/j.1460-9568.2007.05975.x; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Sterr A, 2006, NEUROREHABILITATION, V21, P97; Takeuchi N, 2007, STROKE, V38, P1551, DOI 10.1161/STROKEAHA.106.470187; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Verleger R, 2003, CLIN NEUROPHYSIOL, V114, P1468, DOI 10.1016/S1388-2457(03)00125-1; Verleger R, 2011, BRAIN COGN; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward N, 2009, BRAIN REORGANISATION, V2009; Ward NS, 2006, ARCH PHYS MED REHAB, V87, pS30, DOI 10.1016/j.apmr.2006.08.334; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Wiese H, 2005, STROKE, V36, P1474, DOI 10.1161/01.STR.0000170639.26891.30	62	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44558	10.1371/journal.pone.0044558	http://dx.doi.org/10.1371/journal.pone.0044558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049676	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309388500003
J	Hyacinth, HI; Adekeye, OA; Ibeh, JN; Osoba, T				Hyacinth, Hyacinth I.; Adekeye, Oluwatoyosi A.; Ibeh, Joy N.; Osoba, Tolulope			Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; WOMEN; ATTITUDES; KNOWLEDGE	Cervical cancer is a leading cause of cancer death in women in developing countries. A key factor linked to the relatively high levels of cervical cancer in these populations is the lack of awareness and access to preventive methods. This study aimed to determine the level of awareness of cervical cancer and Papanicolaou test (Pap smear test) and factors associated with the utilization of Pap test among female civil servants in Jos. Data was obtained from female workers (n = 388) aged 18-65 years in a Nigerian Federal establishment. Participants were randomly approached and instructed to complete validated questionnaires. Data was analyzed using Chi-square, t-tests and logistic regression analysis to determine if there was an association between variables and identify any predictors of awareness and utilization of the Pap test. Cervical cancer and Pap smear test awareness was 50.9% and 38.6% respectively, with the media as the major source of information. Pap smear test utilization rate was 10.2%, with routine antenatal care (ANC) as the major reason for getting screened. Personal barriers to screening include the lack of awareness, and belief that cervical cancer is not preventable. Opportunistic screening, mass media campaigns and ANC education were suggested as ways of improving awareness and utilization of cervical cancer screening services.	[Hyacinth, Hyacinth I.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Adekeye, Oluwatoyosi A.] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Ibeh, Joy N.] Univ Coll Ibadan Hosp, Dept Pediat, Ibadan, Nigeria; [Hyacinth, Hyacinth I.; Osoba, Tolulope] Univ Liverpool, Dept Publ Hlth, Fac Med, Liverpool L69 3BX, Merseyside, England	Morehouse School of Medicine; Morehouse School of Medicine; University of Liverpool	Hyacinth, HI (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	hhyacinth@msm.edu	Hyacinth, Hyacinth/U-5722-2017	Hyacinth, Hyacinth/0000-0002-1991-7463				Adewole IF, 2005, GYNECOL ONCOL, V99, pS209, DOI 10.1016/j.ygyno.2005.07.086; Al Sairafi M, 2009, MED PRIN PRACT, V18, P35, DOI 10.1159/000163044; Ayinde O A, 2004, Afr J Reprod Health, V8, P68, DOI 10.2307/3583394; Bastos J, 2010, INT J CANCER, V126, P2700, DOI 10.1002/ijc.24963; Bosch FX, 2006, INT J GYNECOL OBSTET, V94, pS8, DOI 10.1016/S0020-7292(07)60004-6; Bosch FX, 1997, BIOMED PHARMACOTHER, V51, P268, DOI 10.1016/S0753-3322(97)83542-1; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Cyril CD, 2009, T R SOC TROP MED HYG, V103, P852, DOI [10.1016/j.trstmh.2009.03.020, DOI 10.1016/J.TRSTMH.2009.03.020]; Ezem BU, 2007, ANN AFR MED, V6, P94, DOI 10.4103/1596-3519.55727; Federal Ministry of Health of Nigeria, 2003, NAT HLTH POL STAT RE; Gharoro EP, 2006, INT J GYNECOL CANCER, V16, P1063, DOI 10.1111/j.1525-1438.2006.00579.x; Hyacinth IH, 2006, THESIS U JOS; Levi F, 2000, EUR J CANCER, V36, P2266, DOI 10.1016/S0959-8049(00)00346-4; Maaita M, 2002, J Obstet Gynaecol, V22, P421, DOI 10.1080/01443610220141416; Monga AK, 2000, GYNAECOLOGY 10 TEACH; Najem GR, 1996, AM J PREV MED, V12, P482, DOI 10.1016/S0749-3797(18)30272-1; National Cancer Institute, 2008, AP B SEL PLANN FRAM, P217; National Cancer Institute, 2005, SEER INC US MORT RAT; National Health Service, 2009, NHS CERV SCREEN PROG; Nwobodo E I, 2005, Niger Postgrad Med J, V12, P255; Obafunwa JO, 1991, TROP J OBSTET GYNAEC, V9, P16; Obiechina N J A, 2009, Niger J Med, V18, P384; Ogun GO, 2006, UN INT CANC CONTR UI, P8; Olaleye F, 2011, LAGOS NIG HLTH J; Onajole AT, 2004, NIG MED PRACTITIONER, V45, P52; Oyebode A, 2004, THESIS W AFRICAN COL; Programme on cancer control of the department of reproductive health and research, 2002, CERV CANC SCREEN DEV, P1; Ramirez AG, 2000, AM J HEALTH PROMOT, V14, P292, DOI 10.4278/0890-1171-14.5.292; Roy B, 2008, J CANCER EDUC, V23, P253, DOI 10.1080/08858190802189105; Sait KH, 2009, SAUDI MED J, V30, P1208; Schiavo, 2013, HLTH COMMUNICATION T; Schorge JO, 2008, WILLIAMS GYNECOLOGY; WHO, 2006, COMPR CERV CANC CONT; World Health Organization, 2004, GLOB BURD DIS REP CA	34	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46583	10.1371/journal.pone.0046583	http://dx.doi.org/10.1371/journal.pone.0046583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049708	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388500035
J	Flydal, MI; Chatfield, CH; Zheng, HX; Gunderson, FF; Aubi, O; Cianciotto, NP; Martinez, A				Flydal, Marte I.; Chatfield, Christa H.; Zheng, Huaixin; Gunderson, Felizza F.; Aubi, Oscar; Cianciotto, Nicholas P.; Martinez, Aurora			Phenylalanine Hydroxylase from Legionella pneumophila Is a Thermostable Enzyme with a Major Functional Role in Pyomelanin Synthesis	PLOS ONE			English	Article							AMINO-ACID HYDROXYLASES; II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; LEGIONNAIRES-DISEASE; VIBRIO-CHOLERAE; INTRACELLULAR MULTIPLICATION; CHROMOBACTERIUM-VIOLACEUM; CAENORHABDITIS-ELEGANS; THERMOPHILIC PROTEINS; AROMATIC CLUSTERS	Background: Legionella pneumophila is a pathogenic bacterium that can cause Legionnaires' disease and other non-pneumonic infections in humans. This bacterium produces a pyomelanin pigment, a potential virulence factor with ferric reductase activity. In this work, we have investigated the role of phenylalanine hydroxylase from L. pneumophila (lpPAH), the product of the phhA gene, in the synthesis of the pyomelanin pigment and the growth of the bacterium in defined compositions. Methodology/Principal Findings: Comparative studies of wild-type and phhA mutant corroborate that lpPAH provides the excess tyrosine for pigment synthesis. phhA and letA (gacA) appear transcriptionally linked when bacteria were grown in buffered yeast extract medium at 37 degrees C. phhA is expressed in L. pneumophila growing in macrophages. We also cloned and characterized lpPAH, which showed many characteristics of other PAHs studied so far, including Fe(II) requirement for activity. However, it also showed many particular properties such as dimerization, a high conformational thermal stability, with a midpoint denaturation temperature (T-m) = 79 +/- 0.5 degrees C, a high specific activity at 37 degrees C (10.2 +/- 0.3 mu mol L-Tyr/mg/min) and low affinity for the substrate (K-m (L-Phe) = 735 +/- 50 mu M. Conclusions/Significance: lpPAH has a major functional role in the synthesis of pyomelanin and promotes growth in low-tyrosine media. The high thermal stability of lpPAH might reflect the adaptation of the enzyme to withstand relatively high survival temperatures.	[Chatfield, Christa H.; Zheng, Huaixin; Gunderson, Felizza F.; Cianciotto, Nicholas P.] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Flydal, Marte I.; Aubi, Oscar; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway	Northwestern University; University of Bergen	Cianciotto, NP (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	n-cianciotto@northwestern.edu; aurora.martinez@biomed.uib.no	Martinez, Aurora/M-3088-2019	Martinez, Aurora/0000-0003-1643-6506; Flydal, Marte/0000-0002-4070-8367	Research Council of Norway [185181]; Meltzer Fond; Western Norway Health Authorities [911618]; NIH [AI089712, AI034937, T32 AI0007476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034937, R21AI089712, T32AI007476] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Meltzer Fond; Western Norway Health Authorities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by The Research Council of Norway (grant 185181 to AM), the Meltzer Fond (to MIF) and the Western Norway Health Authorities (grant 911618 to AM), and by NIH grants AI089712 and AI034937 awarded to NPC FFG was partly supported by NIH training grant T32 AI0007476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2006; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; BAINE WB, 1979, ANN INTERN MED, V90, P619, DOI 10.7326/0003-4819-90-4-619; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; BYRD TF, 1989, J CLIN INVEST, V83, P1457, DOI 10.1172/JCI114038; Calvo AC, 2008, FASEB J, V22, P3046, DOI 10.1096/fj.08-108522; Campocasso A, 2012, INT J SYST IN PRESS; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; Chatfield CH, 2012, MICROBIOL-SGM, V158, P721, DOI 10.1099/mic.0.055533-0; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; DOSKELAND AP, 1984, J BIOL CHEM, V259, P1242; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Ekstrom F, 2003, ACTA CRYSTALLOGR D, V59, P1310, DOI 10.1107/S090744490301014X; Erlandsen H, 2002, J MOL BIOL, V320, P645, DOI 10.1016/S0022-2836(02)00496-5; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Fitzpatrick PF, 2000, ADV ENZYMOL RAMB, V74, P235; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Flydal MI, 2010, AMINO ACIDS, V39, P1463, DOI 10.1007/s00726-010-0611-6; Gal-Mor O, 2003, MICROB PATHOGENESIS, V34, P187, DOI 10.1016/S0882-4010(03)00027-5; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Herrera MC, 2007, J MOL BIOL, V366, P1374, DOI 10.1016/j.jmb.2006.12.008; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Konishi T, 2006, J BIOSCI BIOENG, V101, P478, DOI 10.1263/jbb.101.478; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Kusnetsov JM, 1996, J APPL BACTERIOL, V81, P341; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; LINDSTEDT S, 1977, BIOCHEMISTRY-US, V16, P3369, DOI 10.1021/bi00634a013; Loaiza A, 2008, INORG CHEM, V47, P4877, DOI 10.1021/ic800181q; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Olafsdottir S, 1999, J BIOL CHEM, V274, P6280, DOI 10.1074/jbc.274.10.6280; Olsson E, 2011, CHEM-EUR J, V17, P3746, DOI 10.1002/chem.201002910; ONISHI A, 1991, J BIOL CHEM, V266, P18454; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pearce MM, 2012, INT J SYST IN PRESS; Pey AL, 2009, J BIOL INORG CHEM, V14, P521, DOI 10.1007/s00775-009-0467-y; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Shuman HA, 1996, CURR TOP MICROBIOL, V209, P99; Siltberg-Liberles J, 2008, GENE, V427, P86, DOI 10.1016/j.gene.2008.09.005; Steinert M, 2001, FEMS MICROBIOL LETT, V203, P41, DOI 10.1111/j.1574-6968.2001.tb10818.x; Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Trebbi B, 2005, J PHYS CHEM B, V109, P18184, DOI 10.1021/jp052333u; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Wang RB, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-109; WIATER LA, 1994, MOL MICROBIOL, V11, P641; WINTERMEYER E, 1994, INFECT IMMUN, V62, P1109, DOI 10.1128/IAI.62.3.1109-1117.1994; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366; Zoidakis J, 2005, J INORG BIOCHEM, V99, P771, DOI 10.1016/j.jinorgbio.2004.12.017; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	80	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46209	10.1371/journal.pone.0046209	http://dx.doi.org/10.1371/journal.pone.0046209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049981	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300097
J	Hu, JL; Ji, M; Niu, C; Aini, A; Zhou, QN; Zhang, L; Jiang, T; Yan, Y; Hou, YM				Hu, Jialu; Ji, Meng; Niu, Conway; Aini, Asiyeguli; Zhou, Qina; Zhang, Ling; Jiang, Tao; Yan, Yan; Hou, Yuemei			Effects of Renal Sympathetic Denervation on Post-Myocardial Infarction Cardiac Remodeling in Rats	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; NERVE ACTIVITY; CLINICAL-IMPLICATIONS; SYSTEM; MECHANISM; DISEASE; TRIAL	Objective: To investigate the therapeutic effects of renal denervation (RD) on post-myocardial infarction (MI) cardiac remodeling in rats, the most optimal time for intervention and the sustainability of these effects. Methods: One hundred SPF male Wistar rats were randomly assigned to N group (Normal, n = 10), MI group(MI, n = 20), RD group (RD, n = 10), RD3+MI (MI three days after RD, n = 20), MI1+RD (RD one day after MI, n = 20), MI7+RD (RD seven days after MI, n = 20). MI was produced through thoracotomic ligation of the anterior descending artery. RD was performed through laparotomic stripping of the renal arteriovenous adventitial sympathetic nerve. Left ventricular function, hemodynamics, plasma BNP, urine volume, urine sodium excretion and other indicators were measured four weeks after MI. Results: (1) The left ventricular function of the MI group significantly declined (EF<40%), plasma BNP was elevated, urine output was significantly reduced, and 24-hour urine sodium excretion was significantly reduced. (2) Denervation can be achieved by surgically stripping the arteriovenous adventitia, approximately 3 mm from the abdominal aorta. (3) In rats with RD3+MI, MI1+RD and MI7+RD, compared with MI rats respectively, the LVEF was significantly improved (75 +/- 8.4%, 69 +/- 3.8%, 73 +/- 5.5%), hemodynamic indicators were significantly improved, plasma BNP was significantly decreased, and the urine output was significantly increased (21.3 +/- 5 ml, 23.8 +/- 5.4 ml, 25.2 +/- 8.7 ml). However, the urinary sodium excretion also increased but without significant difference. Conclusions: RD has preventive and therapeutic effects on post-MI cardiac remodeling. These effects can be sustained for at least four weeks, but there were no significant differences between denervation procedures performed at different times in the course of illness. Cardiac function, hemodynamics, urine volume and urine sodium excretion in normal rats were not affected by RD.	[Hu, Jialu; Yan, Yan] Fudan Univ, Dept Cardiol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ji, Meng; Aini, Asiyeguli; Zhou, Qina; Zhang, Ling; Jiang, Tao] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Xinjiang, Peoples R China; [Niu, Conway] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Hou, Yuemei] Cent Hosp Fengxian Dist, Dept Cardiol, Shanghai, Peoples R China	Fudan University; Xinjiang Medical University; Fudan University	Yan, Y (corresponding author), Fudan Univ, Dept Cardiol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	jackyan000@hotmail.com; houyuemei@sina.com	Zhou, Qina/L-1907-2017	Niu, Conway/0000-0002-0078-5173	National Science Foundation of China [30960132]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grant from National Science Foundation of China (30960132, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso S, 2009, INT J CARDIOL, V131, P240, DOI 10.1016/j.ijcard.2007.10.029; DIBONA GF, 1991, AM J PHYSIOL, V260, pR298, DOI 10.1152/ajpregu.1991.260.2.R298; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; Esler M, 2011, EXP PHYSIOL, V96, P1, DOI 10.1113/expphysiol.2011.052332; Goliasch G, 2010, WIEN KLIN WOCHENSCHR, V122, P723, DOI 10.1007/s00508-010-1486-y; Hjalmarson A, 1999, LANCET, V353, P2001; Kasama S, 2007, J NUCL MED, V48, P1993, DOI 10.2967/jnumed.107.045427; Krum H, 2011, LANCET, V378, P713, DOI 10.1016/S0140-6736(11)61038-6; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lechat P, 1999, LANCET, V353, P9; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Nozawa T, 2002, HEART VESSELS, V16, P51, DOI 10.1007/s380-002-8317-8; Nozawa Takashi, 2007, Nihon Rinsho, V65 Suppl 4, P257; OH BH, 1993, CIRCULATION, V87, P598, DOI 10.1161/01.CIR.87.2.598; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184; PETTERSSON A, 1989, ACTA PHYSIOL SCAND, V135, P487, DOI 10.1111/j.1748-1716.1989.tb08607.x; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Ramchandra R, 2009, P NATL ACAD SCI USA, V106, P924, DOI 10.1073/pnas.0811929106; RAYA TE, 1989, CIRC RES, V64, P330, DOI 10.1161/01.RES.64.2.330; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Souza DRB, 2004, BRAZ J MED BIOL RES, V37, P285, DOI 10.1590/S0100-879X2004000200017; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsutamoto T, 2008, CIRC J, V72, P740, DOI 10.1253/circj.72.740; VILLARREAL D, 1994, AM J PHYSIOL, V266, pR1599, DOI 10.1152/ajpregu.1994.266.5.R1599	27	30	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45986	10.1371/journal.pone.0045986	http://dx.doi.org/10.1371/journal.pone.0045986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049914	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517300072
J	Lee, GQ; Swenson, LC; Poon, AFY; Martin, JN; Hatano, H; Deeks, SG; Harrigan, R				Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Martin, Jeffrey N.; Hatano, Hiroyu; Deeks, Steven G.; Harrigan, Richard			Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 "Deep" Sequencing	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DRUG-RESISTANCE; INTEGRASE INHIBITORS; GENOTYPIC RESISTANCE; MUTATIONS; EVOLUTION; STRAINS; RNA; FAILURE; ESCAPE	The evolution of drug resistance mutations in plasma samples is relatively well-characterized. However, the viral population and diversity in other body compartments such as peripheral blood mononuclear cells (PBMC) remains poorly understood. Previous studies have mostly focused on protease and reverse transcriptase drug resistance mutations (DRMs). In this study, we used 454 "deep" sequencing technology to observe and quantify longitudinally the prevalence of resistance mutations associated with the integrase inhibitor, raltegravir, in plasma versus PBMC samples from a San Francisco-based cohort. Four heavily treatment-experienced subjects were monitored in this study over a median of 1.2 years since the initiation of raltegravir-containing regimens. We observed a consistent discordance in the prevalence of DRMs, but not resistance pathway(s), in the plasma versus PBMC viral populations. In the final paired samples that were tested while the subjects were on a raltegravir-containing regimen, DRM prevalence reached 100% in plasma but remained 1% in PBMC on day 177 post-therapy in Subject 3180 (Q148H/G140S), 100% in plasma and 36% in PBMC on day 224 in Subject 3242 (N155H), 78% in plasma and 11-12% in PBMC on day 338 in Subject 3501 (Q148H/G140S), and 100% in plasma and 0% in PBMC on day 197 in Subject 3508 (Y143R). Furthermore, absolute sequence homology comparison between the two compartments revealed that 21% - 99% of PBMC sequences had no match in plasma, whereas 14% - 100% of plasma sequences had no match in PBMC. Overall, our observations suggested that plasma and PBMC hosted drastically different HIV-1 populations even after a prolonged exposure to raltegravir selection pressure.	[Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Harrigan, Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Harrigan, Richard] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Martin, Jeffrey N.; Hatano, Hiroyu; Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94143 USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Francisco	Harrigan, R (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Lee, Guinevere Q./D-4436-2017; Poon, Art/W-9811-2019; Swenson, Luke/E-8549-2014	Lee, Guinevere Q./0000-0002-9412-886X; Poon, Art/0000-0003-3779-154X; Swenson, Luke/0000-0001-5381-7709	National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI087145, K24AI069994]; University of California, San Francisco (UCSF) Center for AIDS Research (CFAR) [P30 AI27763]; UCSF Clinical & Translational Science Institute (CTSI) [UL1 RR024131]; CFAR Network of Integrated Systems [R24 AI067039]; Canadian Institutes of Health Research (CIHR) [201009HOP-235256]; ViiV/Pfizer; Quest; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI027763, R01AI087145, K24AI069994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California, San Francisco (UCSF) Center for AIDS Research (CFAR)(University of California System); UCSF Clinical & Translational Science Institute (CTSI); CFAR Network of Integrated Systems; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); ViiV/Pfizer; Quest; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This SCOPE cohort was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) (RO1 AI087145, K24AI069994), the University of California, San Francisco (UCSF) Center for AIDS Research (CFAR) (P30 AI27763), the UCSF Clinical & Translational Science Institute (CTSI) (UL1 RR024131), and CFAR Network of Integrated Systems (R24 AI067039). AFYP is supported by a Canadian Institutes of Health Research (CIHR) Operating Grant (201009HOP-235256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PRH has received consulting fees from ViiV/Pfizer and Quest; holds stock options in Merck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors: No competing interests exist.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Baatz F, 2011, ANTIVIR RES, V92, P488, DOI 10.1016/j.antiviral.2011.10.003; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Charpentier C, 2008, HIV MED, V9, P765, DOI 10.1111/j.1468-1293.2008.00628.x; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; da Silva D, 2010, J ANTIMICROB CHEMOTH, V65, P1262, DOI 10.1093/jac/dkq099; Dalmau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032714; Devereux HL, 2000, AIDS RES HUM RETROV, V16, P1025, DOI 10.1089/08892220050075273; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Harrigan PR, 2002, 14 INT AIDS C BARC S; Hatano H, 2010, JAIDS-J ACQ IMM DEF, V54, P389, DOI 10.1097/QAI.0b013e3181c42ea4; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Mukherjee R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0b013e32834b34de; Nakahara K, 2009, ANTIVIR RES, V81, P141, DOI 10.1016/j.antiviral.2008.10.007; Paolucci S, 2001, J MED VIROL, V65, P207, DOI 10.1002/jmv.2022; Rozera G, 2009, AIDS, V23, P2541, DOI 10.1097/QAD.0b013e32832fd2e1; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Sarmati L, 2003, J CLIN MICROBIOL, V41, P1760, DOI 10.1128/JCM.41.4.1760-1762.2003; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sichtig N, 2009, J ANTIMICROB CHEMOTH, V64, P25, DOI 10.1093/jac/dkp153; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Turriziani O, 2007, JAIDS-J ACQ IMM DEF, V44, P518, DOI 10.1097/QAI.0b013e3180315515; Wang YM, 2007, CURR HIV RES, V5, P235; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544	31	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46181	10.1371/journal.pone.0046181	http://dx.doi.org/10.1371/journal.pone.0046181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049972	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300095
J	Blangy, A; Touaitahuata, H; Cres, G; Pawlak, G				Blangy, Anne; Touaitahuata, Heiani; Cres, Gaelle; Pawlak, Geraldine			Cofilin Activation during Podosome Belt Formation in Osteoclasts	PLOS ONE			English	Article							ACTIN DYNAMICS; REGULATES COFILIN; PHOSPHATASE SLINGSHOT; CULTURED OSTEOCLASTS; LIM-KINASE; PATHWAY; CORTACTIN; ORGANIZATION; INVADOPODIA; ADF/COFILIN	Podosomes are dynamic actin-based structures found constitutively in cells of monocytic origin such as macrophages, dendritic cells and osteoclasts. They have been involved in osteoclast cell adhesion, motility and matrix degradation, and all these functions rely on the ability of podosomes to form supra-molecular structures called podosome belts or sealing zones on mineralized substrates. Podosomes contain two distinct domains, an actin-rich core enriched in actin polymerization regulators, surrounded by a ring of signaling and plaque molecules. The organization of podosome arrays into belts is linked to actin dynamics. Cofilin is an actin-severing protein that is known to regulate cytoskeleton architecture and cell migration. Cofilin is present in lamellipodia and invadopodia where it regulates actin polymerization. In this report, we show that cofilin is a novel component of the podosome belt, the mature osteoclast adhesion structure. Time-course analysis demonstrated that cofilin is activated during primary osteoclast differentiation, at the time of podosome belt assembly. Immunofluorescence studies reveal a localization of active cofilin in the podosome core structure, whereas phosphorylated, inactive cofilin is concentrated in the podosome cloud. Pharmacological studies unraveled the role of a specific cofilin phosphatase to achieve cofilin activation during osteoclast differentiation. We ruled out the implication of PP1/PP2A and PTEN in this process, and rather provided evidence for the involvement of SSH1. In summary, our data involve cofilin as a regulator of podosome organization that is activated during osteoclast differentiation by a RANKL-mediated signaling pathway targeting the SSH1 phosphatase.	[Blangy, Anne; Touaitahuata, Heiani; Cres, Gaelle; Pawlak, Geraldine] Univ Montpellier, CNRS UMR 5237, Ctr Rech Biochim Macromol, F-34059 Montpellier, France; [Pawlak, Geraldine] Univ Grenoble 1, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Blangy, A (corresponding author), Univ Montpellier, CNRS UMR 5237, Ctr Rech Biochim Macromol, F-34059 Montpellier, France.	anne.blangy@crbm.cnrs.fr		BLANGY, Anne/0000-0001-7043-0784	Fondation pour la Recherche Medicale (FRM) [DVO20081013473]; Institut National du Cancer [INCa-4361]; Agence Nationale de la Recherche (ANR) [ANR-2011-BLAN-006]; Grants-in-Aid for Scientific Research [24592816] Funding Source: KAKEN	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Fondation pour la Recherche Medicale (FRM grant # DVO20081013473 to AB), the Institut National du Cancer (grant # INCa-4361 to AB) and the Agence Nationale de la Recherche (ANR grant # ANR-2011-BLAN-006 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brazier H, 2009, INT J BIOCHEM CELL B, V41, P1391, DOI 10.1016/j.biocel.2008.12.007; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Crimaldi L, 2009, EXP CELL RES, V315, P2581, DOI 10.1016/j.yexcr.2009.06.012; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vitolo MI, 2013, ONCOGENE, V32, P2200, DOI 10.1038/onc.2012.234; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	46	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45909	10.1371/journal.pone.0045909	http://dx.doi.org/10.1371/journal.pone.0045909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049890	Green Published, gold			2022-12-25	WOS:000309556100098
J	De Deyn, GB; Quirk, H; Oakley, S; Ostle, NJ; Bardgett, RD				De Deyn, Gerlinde B.; Quirk, Helen; Oakley, Simon; Ostle, Nick J.; Bardgett, Richard D.			Increased Plant Carbon Translocation Linked to Overyielding in Grassland Species Mixtures	PLOS ONE			English	Article							PRODUCTIVITY RELATIONSHIPS; NITROGEN FORMS; DIVERSITY; BIODIVERSITY; RICHNESS; COMPLEMENTARITY; COMMUNITIES; MECHANISMS; FERTILITY; SELECTION	Plant species richness and productivity often show a positive relationship, but the underlying mechanisms are not fully understood, especially at the plant species level. We examined how growing plants in species mixture influences intraspecific rates of short-term carbon(C-) translocation, and determined whether such short-term responses are reflected in biomass yields. We grew monocultures and mixtures of six common C3 grassland plant species in outdoor mesocosms, applied a C-13-CO2 pulse in situ to trace assimilated C through plants, into the soil, and back to the atmosphere, and quantified species-specific biomass. Pulse derived C-13 enrichment was highest in the legumes Lotus corniculatus and Trifolium repens, and relocation (i.e. transport from the leaves to other plant parts) of the recently assimilated C-13 was most rapid in T. repens grown in 6-species mixtures. The grass Anthoxanthum odoratum also showed high levels of C-13 enrichment in 6-species mixtures, while C-13 enrichment was low in Lolium perenne, Plantago lanceolata and Achillea millefolium. Rates of C loss through respiration were highest in monocultures of T. repens and relatively low in species mixtures, while the proportion of C-13 in the respired CO2 was similar in monocultures and mixtures. The grass A. odoratum and legume T. repens were most promoted in 6-species mixtures, and together with L. corniculatus, caused the net biomass increase in 6-species mixtures. These plant species also had highest rates of C-13- label translocation, and for A. odoratum and T. repens this effect was greatest in plant individuals grown in species mixtures. Our study reveals that short-term plant C translocation can be accelerated in plant individuals of legume and C3 grass species when grown in mixtures, and that this is strongly positively related to overyielding. These results demonstrate a mechanistic coupling between changes in intraspecific plant carbon physiology and increased community level productivity in grassland systems.	[De Deyn, Gerlinde B.; Quirk, Helen; Bardgett, Richard D.] Univ Lancaster, Lancaster Environm Ctr, Soil & Ecosyst Ecol Lab, Lancaster, England; [De Deyn, Gerlinde B.] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands; [Oakley, Simon; Ostle, Nick J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Plant Soil Interact Grp, Lancaster, England	Lancaster University; Wageningen University & Research; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH)	De Deyn, GB (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Soil & Ecosyst Ecol Lab, Lancaster, England.	gerlindede@gmail.com	Oakley, Simon/K-1857-2013; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/AFI-8702-2022; Ostle, Nicholas J/E-4847-2014; Ostle, Nick J/K-6891-2012; De Deyn, Gerlinde/F-7080-2017	Oakley, Simon/0000-0002-5757-7420; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; Ostle, Nicholas J/0000-0003-3263-3702; De Deyn, Gerlinde/0000-0003-4823-6912	BBSRC Agri-Food Committee; EU; Biotechnology and Biological Sciences Research Council [BB/I008969/1, BB/D003946/1] Funding Source: researchfish; Natural Environment Research Council [lsmsf010003, CEH010021] Funding Source: researchfish; BBSRC [BB/I008969/1, BB/D003946/1] Funding Source: UKRI; NERC [lsmsf010003] Funding Source: UKRI	BBSRC Agri-Food Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funds from the BBSRC Agri-Food Committee, awarded to RDB and NJO. GBDD acknowledges the EU for support by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSE F, 1983, J ECOL, V71, P379, DOI 10.2307/2259721; BOUTTON T W, 1991, P155; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; De Deyn GB, 2011, BIOGEOSCIENCES, V8, P1131, DOI 10.5194/bg-8-1131-2011; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; de Wit CT, 1965, J AGR SCI, V13, P212; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; HARRIS D, 1985, NEW PHYTOL, V101, P427, DOI 10.1111/j.1469-8137.1985.tb02849.x; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Hartwig Ueli A., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P92, DOI 10.1078/1433-8319-00054; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Ostle N, 2007, SOIL BIOL BIOCHEM, V39, P768, DOI 10.1016/j.soilbio.2006.09.025; Ostle N, 2003, SOIL BIOL BIOCHEM, V35, P877, DOI 10.1016/S0038-0717(03)00117-2; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; RODWELL JS, 1992, BRIT PLANT COMMUNITI; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROSS DJ, 1992, SOIL BIOL BIOCHEM, V24, P343, DOI 10.1016/0038-0717(92)90194-3; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Ward SE, 2009, FUNCT ECOL, V23, P454, DOI 10.1111/j.1365-2435.2008.01521.x; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	37	16	17	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45926	10.1371/journal.pone.0045926	http://dx.doi.org/10.1371/journal.pone.0045926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049893	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309556100100
J	Garcia, JC; Crawford, AJ; Mendoza, AM; Ospina, O; Cardenas, H; Castro, F				Garcia, Juan C.; Crawford, Andrew J.; Maria Mendoza, Angela; Ospina, Oscar; Cardenas, Heiber; Castro, Fernando			Comparative Phylogeography of Direct-Developing Frogs (Anura: Craugastoridae: Pristimantis) in the Southern Andes of Colombia	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; SPECIES RICHNESS; MOUNTAIN PASSES; COSTA-RICAN; POPULATION; DNA; DIVERSITY; ORIGIN; MITOCHONDRIAL; AMPLIFICATION	The Andes of South America hosts perhaps the highest amphibian species diversity in the world, and a sizable component of that diversity is comprised of direct-developing frogs of the genus Pristimantis (Anura: Craugastoridae). In order to better understand the initial stages of species formation in these frogs, this study quantified local-scale spatial genetic structuring in three species of Pristimantis. DNA sequences of two mitochondrial gene fragments (16S and COI) were obtained from P. brevifrons, P. palmeri and P. jubatus at different locations in the Cordillera Occidental. We found high levels of genetic diversity in the three species, with highly structured populations (as measured by F-ST) in P. brevifrons and P. palmeri while P. jubatus showed panmixia. Large effective population sizes, inferred from the high levels of genetic diversity, were found in the three species and two highly divergent lineages were detected within P. jubatus and P. palmeri. Estimated divergence times among populations within P. brevifrons and P. palmeri coincide with the Pleistocene, perhaps due to similar responses to climatic cycling or recent geological history. Such insights have important implications for linking alpha and beta diversity, suggesting regional scale patterns may be associated with local scale processes in promoting differentiation among populations in the Andes.	[Garcia, Juan C.; Maria Mendoza, Angela; Ospina, Oscar; Cardenas, Heiber; Castro, Fernando] Univ Valle, Dept Biol, Cali, Colombia; [Crawford, Andrew J.] Smithsonian Trop Res Inst, Panama City, Panama; [Crawford, Andrew J.] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad del Valle; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad de los Andes (Colombia)	Garcia, JC (corresponding author), Massey Univ, Inst Nat Resources, Palmerston North, New Zealand.	j.c.garciaramirez@massey.ac.nz	Crawford, Andrew J./G-6365-2012; Ospina, Oscar E/S-2918-2016; Garcia-R, Juan C./X-3399-2019; Mendoza-Henao, Angela M./D-6346-2013	Crawford, Andrew J./0000-0003-3153-6898; Ospina, Oscar E/0000-0001-5986-4207; Garcia-R, Juan C./0000-0002-6665-9671; Mendoza-Henao, Angela M./0000-0002-6752-9238; CASTRO HERRERA, FERNANDO/0000-0002-7626-0103	Universidad del Valle [CI-746]	Universidad del Valle	This research was supported by Universidad del Valle (Convocatoria Interna CI-746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amphibia Web, 2012, INF AMPH BIOL CONS; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beavis AS, 2011, BIOL J LINN SOC, V104, P805, DOI 10.1111/j.1095-8312.2011.01753.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bermingham E, 1998, MOL ECOL, V7, P367, DOI 10.1046/j.1365-294x.1998.00424.x; Bernal MH, 2008, ZOOTAXA, P1, DOI 10.11646/zootaxa.1826.1.1; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Boulenger G. A., 1912, Annals & Magazine of Natural History, V10; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Cadena C. D., 2011, P ROYAL SOC B, V279, P194, DOI DOI 10.1098/RSPB.2011.0720; Cadena CD, 2007, EVOLUTION, V61, P1120, DOI 10.1111/j.1558-5646.2007.00095.x; Cadena CD, 2011, P ROYAL SOC B; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Crawford AJ, 2010, P NATL ACAD SCI; Crawford AJ, 2007, MOL ECOL, V16, P4789, DOI 10.1111/j.1365-294X.2007.03524.x; Dawson MN, 2012, MOL ECOL, V21, P987, DOI 10.1111/j.1365-294X.2011.05417.x; de Porta J, 2003, REV ACAD COLOMB CIEN, VXXVII, P191; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Elmer KR, 2007, HEREDITY, V99, P506, DOI 10.1038/sj.hdy.6801025; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Garcia JC, 2006, ZOOTAXA, P39, DOI 10.11646/zootaxa.1171.1.4; Garcia-Paris M, 2000, P NATL ACAD SCI USA, V97, P1640, DOI 10.1073/pnas.97.4.1640; Garcia JC, 2005, CALDASIA, V27, P299; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Graham A, 2009, ANN MO BOT GARD, V96, P371, DOI 10.3417/2007146; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hubbell Stephen P., 2001, V32, pi; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kessing B., 2004, SPECIAL PUBLICATION; Kessler Michael, 2008, P35; KIMURA M, 1969, GENETICS, V61, P893; KLIMAN RM, 1993, GENETICS, V133, P375; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYNCH J D, 1981, Occasional Papers of the Museum of Zoology University of Michigan, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 1999, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P143; Lynch John D., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P117; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OVASKA K, 1992, COPEIA, P569; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Streicher JW, 2009, MOL PHYLOGENET EVOL, V53, P620, DOI 10.1016/j.ympev.2009.07.011; TAJIMA F, 1989, GENETICS, V123, P585; Van der Hammen T, 2000, REV ACAD COLOMB CIEN, V24, P231; Velasquez-E BE, 2008, HERPETOTROPICOS, V4, P65; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vences M, 2012, DNA BARCODES METHODS, P79, DOI DOI 10.1007/978-1-61779-591-6; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	73	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46077	10.1371/journal.pone.0046077	http://dx.doi.org/10.1371/journal.pone.0046077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049941	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100133
J	Long, AR; O'Brien, CC; Alder, NN				Long, Ashley R.; O'Brien, Catherine C.; Alder, Nathan N.			The Cell-Free Integration of a Polytopic Mitochondrial Membrane Protein into Liposomes Occurs Cotranslationally and in a Lipid-Dependent Manner	PLOS ONE			English	Article							NASCENT POLYPEPTIDE-CHAINS; FREE EXPRESSION SYSTEMS; RIBOSOMAL EXIT TUNNEL; ADP/ATP CARRIER; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FREE TRANSLATION; NUCLEOTIDE-BINDING; LACTOSE PERMEASE	The ADP/ATP Carrier (AAC) is the most abundant transporter of the mitochondrial inner membrane. The central role that this transporter plays in cellular energy production highlights the importance of understanding its structure, function, and the basis of its pathologies. As a means of preparing proteoliposomes for the study of membrane proteins, several groups have explored the use of cell-free translation systems to facilitate membrane protein integration directly into preformed unilamellar vesicles without the use of surfactants. Using AAC as a model, we report for the first time the detergent-free reconstitution of a mitochondrial inner membrane protein into liposomes using a wheat germ-based in vitro translation system. Using a host of independent approaches, we demonstrate the efficient integration of AAC into vesicles with an inner membrane-mimetic lipid composition and, more importantly, that the integrated AAC is functionally active in transport. By adding liposomes at different stages of the translation reaction, we show that this direct integration is obligatorily cotranslational, and by synthesizing stable ribosome-bound nascent chain intermediates, we show that the nascent AAC polypeptide interacts with lipid vesicles while ribosome-bound. Finally, we show that the presence of the phospholipid cardiolipin in the liposomes specifically enhances AAC translation rate as well as the efficiency of vesicle association and integration. In light of these results, the possible mechanisms of liposome-assisted membrane protein integration during cell-free translation are discussed with respect to the mode of integration and the role of specific lipids.	[Long, Ashley R.; O'Brien, Catherine C.; Alder, Nathan N.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Connecticut	Alder, NN (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA.	nathan.alder@uconn.edu		Alder, Nathan/0000-0003-4474-7803	Scientist Development Grant from the American Heart Association [09SDG2380019]	Scientist Development Grant from the American Heart Association(American Heart Association)	This work was funded by a Scientist Development Grant from the American Heart Association to NA (Grant #: 09SDG2380019) (http://www.heart.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Alder NN, 2011, STRUCTURE BIOL MEMBR, P315; Babot M, 2012, J BIOL CHEM, V287, P10368, DOI 10.1074/jbc.M111.320697; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berrier C, 2011, BBA-BIOMEMBRANES, V1808, P41, DOI 10.1016/j.bbamem.2010.09.018; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Cappuccio JA, 2009, METHODS MOL BIOL HIG; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Hovijitra NT, 2009, BIOTECHNOL BIOENG, V104, P40, DOI 10.1002/bit.22385; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Jha S, 2011, BIOTECHNOL J, V6, P623, DOI 10.1002/biot.201000327; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kawashima Y, 2008, J BIOL CHEM, V283, P24489, DOI 10.1074/jbc.M801812200; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kuruma Y, 2010, METHODS MOL BIOL, V607, P161, DOI 10.1007/978-1-60327-331-2_14; Liguori L, 2010, PROTEIN EXPRES PURIF, V69, P106, DOI 10.1016/j.pep.2009.07.004; Lionaki E, 2008, J BIOL CHEM, V283, P15747, DOI 10.1074/jbc.M800350200; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Nozawa A, 2007, PLANT CELL PHYSIOL, V48, P1815, DOI 10.1093/pcp/pcm150; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rajesh S, 2011, NEW BIOTECHNOL, V28, P250, DOI 10.1016/j.nbt.2010.07.011; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ridder ANJA, 2001, EMBO REP, V2, P403; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schwarz D, 2008, PROTEOMICS, V8, P3933, DOI 10.1002/pmic.200800171; Schwarz D, 2007, METHODS, V41, P355, DOI 10.1016/j.ymeth.2006.07.001; Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; STANLOTTER H, 1986, EUR J BIOCHEM, V154, P321, DOI 10.1111/j.1432-1033.1986.tb09400.x; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	85	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46332	10.1371/journal.pone.0046332	http://dx.doi.org/10.1371/journal.pone.0046332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050015	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100179
J	Krausz, C; Giachini, C; Lo Giacco, D; Daguin, F; Chianese, C; Ars, E; Ruiz-Castane, E; Forti, G; Rossi, E				Krausz, Csilla; Giachini, Claudia; Lo Giacco, Deborah; Daguin, Fabrice; Chianese, Chiara; Ars, Elisabet; Ruiz-Castane, Eduard; Forti, Gianni; Rossi, Elena			High Resolution X Chromosome-Specific Array-CGH Detects New CNVs in Infertile Males	PLOS ONE			English	Article							COPY NUMBER; Y-CHROMOSOME; POLYMORPHISMS; AZOOSPERMIA; GENES; MEN; OLIGOZOOSPERMIA; COHORT; GENOME	Context: The role of CNVs in male infertility is poorly defined, and only those linked to the Y chromosome have been the object of extensive research. Although it has been predicted that the X chromosome is also enriched in spermatogenesis genes, no clinically relevant gene mutations have been identified so far. Objectives: In order to advance our understanding of the role of X-linked genetic factors in male infertility, we applied high resolution X chromosome specific array-CGH in 199 men with different sperm count followed by the analysis of selected, patient-specific deletions in large groups of cases and normozoospermic controls. Results: We identified 73 CNVs, among which 55 are novel, providing the largest collection of X-linked CNVs in relation to spermatogenesis. We found 12 patient-specific deletions with potential clinical implication. Cancer Testis Antigen gene family members were the most frequently affected genes, and represent new genetic targets in relationship with altered spermatogenesis. One of the most relevant findings of our study is the significantly higher global burden of deletions in patients compared to controls due to an excessive rate of deletions/person (0.57 versus 0.21, respectively; p = 8.785x10(-6)) and to a higher mean sequence loss/person (11.79 Kb and 8.13 Kb, respectively; p = 3.435x10(-4)). Conclusions: By the analysis of the X chromosome at the highest resolution available to date, in a large group of subjects with known sperm count we observed a deletion burden in relation to spermatogenic impairment and the lack of highly recurrent deletions on the X chromosome. We identified a number of potentially important patient-specific CNVs and candidate spermatogenesis genes, which represent novel targets for future investigations.	[Krausz, Csilla; Giachini, Claudia; Daguin, Fabrice; Chianese, Chiara] Univ Florence, Dept Clin Physiopathol, Mol Genet Lab, Unit Sexual Med & Androl, Florence, Italy; [Krausz, Csilla; Lo Giacco, Deborah; Ruiz-Castane, Eduard] Fundacio Puigvert, Androl Serv, Barcelona, Spain; [Lo Giacco, Deborah; Ars, Elisabet] Univ Autonoma Barcelona, Fundacio Puigvert, Mol Biol Lab, E-08193 Barcelona, Spain; [Forti, Gianni] Univ Florence, Dept Clin Physiopathol, Endocrinol Unit, Florence, Italy; [Rossi, Elena] Univ Pavia, I-27100 Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Florence; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert; University of Florence; University of Pavia	Krausz, C (corresponding author), Univ Florence, Dept Clin Physiopathol, Mol Genet Lab, Unit Sexual Med & Androl, Florence, Italy.	c.krausz@dfc.unifi.it	Ars, Elisabet/AAM-8454-2021; Rossi, Elena/O-1664-2016	Ars, Elisabet/0000-0002-4118-4358; Rossi, Elena/0000-0001-9152-435X; Krausz, Csilla Gabriella/0000-0001-6748-8918	Tuscan Regional Health Research Program; Italian Ministry of University; Italian Telethon [GGP08204]; Spanish Ministry of Health [FIS-08/1138, FIS-11/02254]	Tuscan Regional Health Research Program; Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Italian Telethon(Fondazione Telethon); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Tuscan Regional Health Research Program ("Progetto Salute 2009") to GF, the Italian Ministry of University (grant PRIN 2010-2012 to CK), the Italian Telethon (Grant GGP08204 to CK) and the Spanish Ministry of Health (grant FIS-08/1138, grant FIS-11/02254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; DELCASTILLO EB, 1947, J CLIN ENDOCRINOL, V7, P493; Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001; Jensen TK, 2009, AM J EPIDEMIOL, V170, P559, DOI 10.1093/aje/kwp168; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Krausz C, 2011, J ENDOCRINOL INVEST, V34, P376, DOI [10.1007/BF03347463, 10.3275/7612]; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Maduro MR, 2003, MOL HUM REPROD, V9, P61, DOI 10.1093/molehr/gag013; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Salonia A, 2009, EUR UROL, V56, P1025, DOI 10.1016/j.eururo.2009.03.001; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Stouffs K, HUM REPROD, V27, P921; Stouffs K, 2009, HUM REPROD UPDATE, V15, P623, DOI 10.1093/humupd/dmp023; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; Tyler-Smith C, 2009, NEW ENGL J MED, V360, P925, DOI 10.1056/NEJMe0900301; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927	26	52	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e44887	10.1371/journal.pone.0044887	http://dx.doi.org/10.1371/journal.pone.0044887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056185	gold, Green Published, Green Submitted			2022-12-25	WOS:000309889400005
J	Wimmerova, M; Kozmon, S; Necasova, I; Mishra, SK; Komarek, J; Koca, J				Wimmerova, Michaela; Kozmon, Stanislav; Necasova, Ivona; Mishra, Sushil Kumar; Komarek, Jan; Koca, Jaroslav			Stacking Interactions between Carbohydrate and Protein Quantified by Combination of Theoretical and Experimental Methods	PLOS ONE			English	Article							SMALL MOLECULAR-INTERACTIONS; DENSITY-FUNCTIONAL THEORY; SEPARATE TOTAL ENERGIES; INTERACTIONS AB-INITIO; DOT-PI-INTERACTIONS; O HYDROGEN-BONDS; AROMATIC INTERACTIONS; RALSTONIA-SOLANACEARUM; STRUCTURAL BASIS; EXCHANGE-ENERGY	Carbohydrate - receptor interactions are an integral part of biological events. They play an important role in many cellular processes, such as cell-cell adhesion, cell differentiation and in-cell signaling. Carbohydrates can interact with a receptor by using several types of intermolecular interactions. One of the most important is the interaction of a carbohydrate's apolar part with aromatic amino acid residues, known as dispersion interaction or CH/pi interaction. In the study presented here, we attempted for the first time to quantify how the CH/pi interaction contributes to a more general carbohydrate - protein interaction. We used a combined experimental approach, creating single and double point mutants with high level computational methods, and applied both to Ralstonia solanacearum (RSL) lectin complexes with alpha-L-Me-fucoside. Experimentally measured binding affinities were compared with computed carbohydrate-aromatic amino acid residue interaction energies. Experimental binding affinities for the RSL wild type, phenylalanine and alanine mutants were -8.5, -7.1 and -4.1 kcal.mol(-1), respectively. These affinities agree with the computed dispersion interaction energy between carbohydrate and aromatic amino acid residues for RSL wild type and phenylalanine, with values -8.8, -7.9 kcal.mol(-1), excluding the alanine mutant where the interaction energy was -0.9 kcal.mol(-1). Molecular dynamics simulations show that discrepancy can be caused by creation of a new hydrogen bond between the alpha-L-Me-fucoside and RSL. Observed results suggest that in this and similar cases the carbohydrate-receptor interaction can be driven mainly by a dispersion interaction.	[Wimmerova, Michaela; Kozmon, Stanislav; Koca, Jaroslav] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Wimmerova, Michaela; Kozmon, Stanislav; Necasova, Ivona; Mishra, Sushil Kumar; Komarek, Jan; Koca, Jaroslav] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Wimmerova, M (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic.	michaw@chemi.muni.cz; jkoca@chemi.muni.cz	Kozmon, Stanislav/D-8525-2012; Koca, Jaroslav/E-4460-2012; Wimmerova, Michaela/A-4114-2010; Kozmon, Stanislav/AAQ-6945-2020; Komarek, Jan/N-5564-2019; Mishra, Sushil K./O-4779-2014; Mishra, Sushil K./AAV-9553-2021; Nečasová, Ivona/ABB-7674-2020	Kozmon, Stanislav/0000-0002-0946-3453; Koca, Jaroslav/0000-0002-2780-4901; Wimmerova, Michaela/0000-0002-7108-4198; Kozmon, Stanislav/0000-0002-0946-3453; Komarek, Jan/0000-0003-4496-1658; Mishra, Sushil K./0000-0002-3080-9754; Mishra, Sushil K./0000-0002-3080-9754; 	European Union under the Seventh Framework Programme by CEITEC from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; SYLICA [286154]; SoMoPro [2SGA2747, 229603]; Czech Science Foundation [GD301/09/H004,303/09/1168]; South Moravian region	European Union under the Seventh Framework Programme by CEITEC from European Regional Development Fund; SYLICA; SoMoPro; Czech Science Foundation(Grant Agency of the Czech Republic); South Moravian region	The research leading to these results obtained financial contribution from the European Union under the Seventh Framework Programme by CEITEC (CZ.1.05/1.1.00/02.0068) project from European Regional Development Fund, SYLICA (Contract No. 286154 under "Capacities" specific programme) and SoMoPro (No. 2SGA2747, under the FP/2007-2013 grant agreement No. 229603) programme, and the Czech Science Foundation (GD301/09/H004,303/09/1168). The research is also co-funded by the South Moravian region. The authors would like to thank the Czech National Supercomputing Centre, METACENTRUM, for providing computational resources. Access to the MetaCentrum computing facilities is provided under the research intent MSM6383917201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Ahlrichs R, 2009, TURBOMOLE V6 0; Arda A, 2011, CHEM-EUR J, V17, P4821, DOI 10.1002/chem.201002872; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bernardi A, 2004, CHEM-EUR J, V10, P4395, DOI 10.1002/chem.200400084; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Boys SF, 2002, MOL PHYS, V100, P65, DOI 10.1080/00268970110088901; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Campbell B, 2001, SMITHSONIAN, V32, P18; Case D.A., 2022, AMBER 2020; Cerny J, 2007, PHYS CHEM CHEM PHYS, V9, P5291, DOI 10.1039/b704781a; Cobb BA, 2005, EUR J IMMUNOL, V35, P352, DOI 10.1002/eji.200425889; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Dreitlein WB, 2001, CLIN THER, V23, P327, DOI 10.1016/S0149-2918(01)80042-4; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Grabowski SJ, 2011, J PHYS CHEM A, V115, P4765, DOI 10.1021/jp2005327; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hattig C, 2000, J CHEM PHYS, V113, P5154, DOI 10.1063/1.1290013; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Hosono M, 2005, BBA-GEN SUBJECTS, V1725, P160, DOI 10.1016/j.bbagen.2005.07.009; Jimenez-Barbero J, 2006, ACS SYM SER, V930, P60; Jimenez-Barbero J, 2006, ADV CARBOHYD CHEM BI, V60, P303, DOI 10.1016/S0065-2318(06)60007-3; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Kozmon S, 2011, CHEM-EUR J, V17, P5680, DOI 10.1002/chem.201002876; Kumar RM, 2010, J PHYS CHEM A, V114, P4313, DOI 10.1021/jp907547f; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Lucas R, 2011, J AM CHEM SOC, V133, P1909, DOI 10.1021/ja108962j; Manikandan K, 2004, PROTEINS, V56, P768, DOI 10.1002/prot.20152; Maresca M, 2008, PHYS CHEM CHEM PHYS, V10, P2792, DOI 10.1039/b802594k; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Patrick WM, 2010, FEBS J, V277, P4549, DOI 10.1111/j.1742-4658.2010.07869.x; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; Pitonak M, 2008, CHEMPHYSCHEM, V9, P1636, DOI 10.1002/cphc.200800286; Raju RK, 2008, PHYS CHEM CHEM PHYS, V10, P6500, DOI 10.1039/b809164a; Ramirez-Gualito K., 2010, J NAT PRODUCTS, V73, P1623; Ramirez-Gualito K, 2009, J AM CHEM SOC, V131, P18129, DOI 10.1021/ja903950t; Riley KE, 2007, J PHYS CHEM A, V111, P8257, DOI 10.1021/jp073358r; Scheiner S, 2001, J BIOL CHEM, V276, P9832, DOI 10.1074/jbc.M010770200; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharma R, 2008, PHYS CHEM CHEM PHYS, V10, P2767, DOI 10.1039/b719764k; Spiwok V, 2004, CARBOHYD RES, V339, P2275, DOI 10.1016/j.carres.2004.06.016; Su Z, 2009, CHEM PHYS LETT, V471, P17, DOI 10.1016/j.cplett.2009.02.043; Sujatha MS, 2007, J MOL STRUC-THEOCHEM, V814, P11, DOI 10.1016/j.theochem.2007.02.032; Takahashi O, 2010, CHEM REV, V110, P6049, DOI 10.1021/cr100072x; Terraneo G, 2007, J AM CHEM SOC, V129, P2890, DOI 10.1021/ja066633g; Tsuzuki S, 2009, J PHYS CHEM B, V113, P5617, DOI 10.1021/jp8093726; Vacas T, 2010, J AM CHEM SOC, V132, P12074, DOI 10.1021/ja1046439; Watanabe Y, 2009, J CHROMATOGR A, V1216, P8563, DOI 10.1016/j.chroma.2009.10.046; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Weigend F, 1997, THEOR CHEM ACC, V97, P331, DOI 10.1007/s002140050269; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weiss MS, 2001, TRENDS BIOCHEM SCI, V26, P521, DOI 10.1016/S0968-0004(01)01935-1; Woods RJ, 2008, J COMPUT CHEM, V29, P622	62	48	48	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46032	10.1371/journal.pone.0046032	http://dx.doi.org/10.1371/journal.pone.0046032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056230	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500025
J	van Heerwaarden, J; Del Vecchyo, DO; Alvarez-Buylla, ER; Bellon, MR				van Heerwaarden, Joost; Ortega Del Vecchyo, Diego; Alvarez-Buylla, Elena R.; Bellon, Mauricio R.			New Genes in Traditional Seed Systems: Diffusion, Detectability and Persistence of Transgenes in a Maize Metapopulation	PLOS ONE			English	Article							POPULATION-GENETICS; MEXICO; LANDRACES; OAXACA; FLOW; DOMESTICATION; INTROGRESSION; CONSERVATION; MANAGEMENT; DIVERSITY	Gene flow of transgenes into non-target populations is an important biosafety concern. The case of genetically modified GM) maize in Mexico has been of particular interest because of the country's status as center of origin and landrace diversity. In contrast to maize in the U. S. and Europe, Mexican landraces form part of an evolving metapopulation in which new genes are subject to evolutionary processes of drift, gene flow and selection. Although these processes are affected by seed management and particularly seed flow, there has been little study into the population genetics of transgenes under traditional seed management. Here, we combine recently compiled data on seed management practices with a spatially explicit population genetic model to evaluate the importance of seed flow as a determinant of the long-term fate of transgenes in traditional seed systems. Seed flow between farmers leads to a much wider diffusion of transgenes than expected by pollen movement alone, but a predominance of seed replacement over seed mixing lowers the probability of detection due to a relative lack of homogenization in spatial frequencies. We find that in spite of the spatial complexities of the modeled system, persistence probabilities under positive selection are estimated quite well by existing theory. Our results have important implications concerning the feasibility of long term transgene monitoring and control in traditional seed systems.	[van Heerwaarden, Joost] Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands; [van Heerwaarden, Joost; Ortega Del Vecchyo, Diego; Alvarez-Buylla, Elena R.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Alvarez-Buylla, Elena R.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [Ortega Del Vecchyo, Diego] Univ Calif Los Angeles, Interdept PhD Program Bioinformat, Los Angeles, CA USA; [Bellon, Mauricio R.] Biovers Int, Rome, Italy	Wageningen University & Research; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Los Angeles; Alliance; Bioversity International	van Heerwaarden, J (corresponding author), Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands.	joost.vanheerwaarden@wur.nl	Vecchyo, Diego Ortega-Del/AAB-8246-2019; van Heerwaarden, Joost/A-1424-2014; Bellon, Mauricio/L-9546-2019	Vecchyo, Diego Ortega-Del/0000-0003-4054-3766; van Heerwaarden, Joost/0000-0002-4959-3914; Bellon, Mauricio/0000-0003-0642-3402; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	Rockefeller Foundation [FS013, FS185]; UC MEXUS-CONACYT [CN08-187]; CONACYT [124909];  [SEMARNAT-CONACYT0538/A-1]	Rockefeller Foundation; UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	Funding was provided by the Rockefeller Foundation (grants FS013 & FS185), UC MEXUS-CONACYT CN08-187, SEMARNAT-CONACYT0538/A-1 (ucmexus.ucr.edu), CONACYT 124909 "Red Complejidad, Ciencia y Sociedad,'' and a UC MEXUS-CONACYT doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badstue LB, 2007, WORLD DEV, V35, P1579, DOI 10.1016/j.worlddev.2006.05.023; Bellon MR, 2011, P NATL ACAD SCI USA, V108, P13432, DOI 10.1073/pnas.1103373108; BELLON MR, 1991, HUM ECOL, V19, P389, DOI 10.1007/BF00888984; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; Bucchini L, 2002, ENVIRON HEALTH PERSP, V110, P5, DOI 10.1289/ehp.021105; Chambers KJ, 2010, PROF GEOGR, V62, P305, DOI 10.1080/00330124.2010.483624; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Dyer GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029067; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; ELLSTRAND NC, 1990, BIOSCIENCE, V40, P438, DOI 10.2307/1311390; FAO, 2004, STAT AGR COMM MARK; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; KIMURA M, 1962, GENETICS, V47, P713; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma BL, 2004, CROP SCI, V44, P1273, DOI 10.2135/cropsci2004.1273; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; MELLON M, 2004, GONE SEED TRANSGENIC; Mercer KL, 2008, AGR ECOSYST ENVIRON, V123, P109, DOI 10.1016/j.agee.2007.05.007; Messeguer J, 2006, PLANT BIOTECHNOL J, V4, P633, DOI 10.1111/j.1467-7652.2006.00207.x; Ortiz-Garcia S, 2005, P NATL ACAD SCI USA, V102, P12338, DOI 10.1073/pnas.0503356102; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; R Development Core Team, 2009, R LANG ENV STAT COMP; Schoen DJ, 2008, BIOSCIENCE, V58, P71, DOI 10.1641/B580112; Serratos-Hernandez Jose-Antonio, 2004, Environmental Biosafety Research, V3, P149, DOI 10.1051/ebr:2004013; Serratos-Hernandez JA, 2007, FRONT ECOL ENVIRON, V5, P247, DOI 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.CO;2; Smale M, 1999, EC WORKING PAPERS; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; Stewart CN, 2008, NAT BIOTECHNOL, V26, P1222, DOI 10.1038/nbt1108-1222; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; van Heerwaarden J, 2009, THEOR APPL GENET, V119, P875, DOI 10.1007/s00122-009-1096-0; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; [No title captured]	37	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46123	10.1371/journal.pone.0046123	http://dx.doi.org/10.1371/journal.pone.0046123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056246	gold, Green Published			2022-12-25	WOS:000309454000018
J	Bell, TG; Makondo, E; Martinson, NA; Kramvis, A				Bell, Trevor G.; Makondo, Euphodia; Martinson, Neil A.; Kramvis, Anna			Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt - That Is the Question	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK-FACTORS; POSITIVE PATIENTS; HIV; COINFECTION; PREVALENCE; HBV; EPIDEMIOLOGY; TRANSFUSION; GENOTYPES	Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) share transmission routes and are endemic in sub-Saharan Africa. The objective of the present study was to use the Taormina definition of occult HBV infection, together with stringent amplification conditions, to determine the prevalence and characteristics of HBV infection in antiretroviral treatment (ART)-naive HIV+ve adults in a rural cohort in South Africa. The presence of HBV serological markers was determined by enzyme linked immunoassay (ELISA) tests. HBV DNA-positivity was determined by polymerase chain reaction (PCR) of at least two of three different regions of the HBV genome. HBV viral loads were determined by real-time PCR. Liver fibrosis was determined using the aspartate aminotransferase-to-platelet ratio index. Of the 298 participants, 231 (77.5%) showed at least one HBV marker, with 53.7% HBV DNA(-ve) (resolved) and 23.8% HBV DNA(+ve) (current) [8.7% HBsAg(+ve) : 15.1% HBsAg(-ve)]. Only the total number of sexual partners distinguished HBV DNA(+ve) and HBV DNA(-ve) participants, implicating sexual transmission of HBV and/or HIV. It is plausible that sexual transmission of HBV and/or HIV may result in a new HBV infection, superinfection and re-activation as a consequence of immunesuppression. Three HBsAg(-ve) HBV DNA(+ve) participants had HBV viral loads <200 IU/ml and were therefore true occult HBV infections. The majority of HBsAg(-ve) HBV DNA(+ve) participants did not differ from HBsAg(+ve) HBV DNA(+ve) (overt) participants in terms of HBV viral loads, ALT levels or frequency of liver fibrosis. Close to a quarter of HIV+ve participants were HBV DNA(+ve), of which the majority were HBsAg(-ve) and were only detected using nucleic acid testing. Detection of HBsAg(-ve) HBV DNA(+ve) subjects is advisable considering they were clinically indistinguishable from HBsAg(+ve) HBV DNA(+ve) individuals and should not be overlooked, especially if lamivudine is included in the ART.	[Bell, Trevor G.; Makondo, Euphodia; Kramvis, Anna] Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltmore, MD USA	University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Kramvis, A (corresponding author), Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	Bell, Trevor Graham/B-7388-2016	Bell, Trevor Graham/0000-0003-2630-7513; Kramvis, Anna/0000-0001-6006-3765	South African Medical Research Council; National Research Foundation (NRF) [65530]; National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF	This study was supported by grants received from the South African Medical Research Council and the National Research Foundation (NRF; GUN#65530) awarded to AK. TGB received bursaries from the National Bioinformatics Network, Poliomyelitis Research Foundation (PRF) and NRF. EM received a Belgium Technical Cooperation Fellowship and bursaries from the NRF and PRF. The funders had no role in study design, data collection and analysis, decision to publish.	Avettand-Fenoel V, 2006, J CLIN MICROBIOL, V44, P2250, DOI 10.1128/JCM.00234-06; Barth RE, 2011, J MED VIROL, V83, P929, DOI 10.1002/jmv.22026; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Chu CM, 2012, CLIN INFECT DIS, V54, P88, DOI 10.1093/cid/cir755; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Chung Raymond T, 2006, Top HIV Med, V14, P78; Firnhaber C, 2012, INT J INFECT DIS, V16, pE268, DOI 10.1016/j.ijid.2011.12.007; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074; Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hollinger FB, 2008, TRANSFUSION, V48, P1001, DOI 10.1111/j.1537-2995.2008.01701.x; Iser DM, 2011, AIDS, V25, P197, DOI 10.1097/QAD.0b013e3283410ccb; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lebensztejn DM, 2005, HEPATOLOGY, V41, P1434, DOI 10.1002/hep.20736; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lindh M, 1997, J INFECT DIS, V175, P1285, DOI 10.1086/516458; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P344, DOI 10.1097/QAI.0b013e31802f12d3; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Makondo E, 2012, PLOSONE IN PRESS, DOI [10.1371/journal.pone.0046345, DOI 10.1371/JOURNAL.PONE.0046345]; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Mayaphi SH, 2012, SAMJ S AFR MED J, V102, P157, DOI 10.7196/SAMJ.4944; MELEGARI M, 1994, VIROLOGY, V199, P292, DOI 10.1006/viro.1994.1127; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; National Department of Health SA, 2004, NAT ANT TREATM GUID; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Shisana O, 2009, S AFRICAN NATL HIV P; Soriano V, 2006, AIDS, V20, P451, DOI 10.1097/01.aids.0000200538.25103.3a; Stuart JWTC, 2009, J MED VIROL, V81, P441, DOI 10.1002/jmv.21422; Sun HY, 2010, J VIRAL HEPATITIS, V17, P578, DOI 10.1111/j.1365-2893.2009.01212.x; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thomas DL, 2006, HEPATOLOGY, V43, pS221, DOI 10.1002/hep.21033; Togashi H, 2008, J HEPATOL, V49, P17, DOI 10.1016/j.jhep.2008.03.019; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; VENTO S, 1989, LANCET, V1, P332; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8	50	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45750	10.1371/journal.pone.0045750	http://dx.doi.org/10.1371/journal.pone.0045750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049685	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500012
J	Stanski, A; Hellwich, O				Stanski, Adam; Hellwich, Olaf			A Projection and Density Estimation Method for Knowledge Discovery	PLOS ONE			English	Article								A key ingredient to modern data analysis is probability density estimation. However, it is well known that the curse of dimensionality prevents a proper estimation of densities in high dimensions. The problem is typically circumvented by using a fixed set of assumptions about the data, e.g., by assuming partial independence of features, data on a manifold or a customized kernel. These fixed assumptions limit the applicability of a method. In this paper we propose a framework that uses a flexible set of assumptions instead. It allows to tailor a model to various problems by means of 1d-decompositions. The approach achieves a fast runtime and is not limited by the curse of dimensionality as all estimations are performed in 1d-space. The wide range of applications is demonstrated at two very different real world examples. The first is a data mining software that allows the fully automatic discovery of patterns. The software is publicly available for evaluation. As a second example an image segmentation method is realized. It achieves state of the art performance on a benchmark dataset although it uses only a fraction of the training data and very simple features.	[Stanski, Adam; Hellwich, Olaf] Tech Univ Berlin, Comp Vis & Remote Sensing Grp, Berlin, Germany	Technical University of Berlin	Stanski, A (corresponding author), Tech Univ Berlin, Comp Vis & Remote Sensing Grp, Franklinstr, Berlin, Germany.	stanski@mailbox.tu-berlin.de						Bellman R., 1961, ADAPTIVE CONTROL PRO; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Maire M, 2008, PROC CVPR IEEE, P611; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Miller EG, 2003, PROC CVPR IEEE, P114; Pantofaru C, 2005, TECH REP; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Ren XF, 2008, LECT NOTES COMPUT SC, V5304, P533; Shi J, 2004, GRAPH BASED IMAGE SE; Silverman B.W., 1986, DENSITY ESTIMATION S; Vincent P, 2003, MANIFOLD PARZEN WIND	12	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44495	10.1371/journal.pone.0044495	http://dx.doi.org/10.1371/journal.pone.0044495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049675	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388500002
J	Zollner, AM; Abilez, OJ; Bol, M; Kuhl, E				Zoellner, Alexander M.; Abilez, Oscar J.; Boel, Markus; Kuhl, Ellen			Stretching Skeletal Muscle: Chronic Muscle Lengthening through Sarcomerogenesis	PLOS ONE			English	Article							SARCOMERE-LENGTH; CARDIAC GROWTH; FINITE GROWTH; GROWING SKIN; ADAPTATION; DISTRACTION; EXPANSION; STRESS; NUMBER; MODEL	Skeletal muscle responds to passive overstretch through sarcomerogenesis, the creation and serial deposition of new sarcomere units. Sarcomerogenesis is critical to muscle function: It gradually re-positions the muscle back into its optimal operating regime. Animal models of immobilization, limb lengthening, and tendon transfer have provided significant insight into muscle adaptation in vivo. Yet, to date, there is no mathematical model that allows us to predict how skeletal muscle adapts to mechanical stretch in silico. Here we propose a novel mechanistic model for chronic longitudinal muscle growth in response to passive mechanical stretch. We characterize growth through a single scalar-valued internal variable, the serial sarcomere number. Sarcomerogenesis, the evolution of this variable, is driven by the elastic mechanical stretch. To analyze realistic three-dimensional muscle geometries, we embed our model into a nonlinear finite element framework. In a chronic limb lengthening study with a muscle stretch of 1.14, the model predicts an acute sarcomere lengthening from 3.09 mu m to 3.51 mu m, and a chronic gradual return to the initial sarcomere length within two weeks. Compared to the experiment, the acute model error was 0.00% by design of the model; the chronic model error was 2.13%, which lies within the rage of the experimental standard deviation. Our model explains, from a mechanistic point of view, why gradual multi-step muscle lengthening is less invasive than single-step lengthening. It also explains regional variations in sarcomere length, shorter close to and longer away from the muscle-tendon interface. Once calibrated with a richer data set, our model may help surgeons to prevent muscle overstretch and make informed decisions about optimal stretch increments, stretch timing, and stretch amplitudes. We anticipate our study to open new avenues in orthopedic and reconstructive surgery and enhance treatment for patients with ill proportioned limbs, tendon lengthening, tendon transfer, tendon tear, and chronically retracted muscles.	[Zoellner, Alexander M.; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Kuhl, Ellen] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kuhl, Ellen] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Abilez, Oscar J.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Boel, Markus] TU Braunschweig, Dept Mech Engn, Braunschweig, Germany	Stanford University; Stanford University; Stanford University; Stanford University; Braunschweig University of Technology	Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Böl, Markus/P-8333-2019; Abilez, Oscar J./B-5014-2012; Kuhl, Ellen/G-4444-2011	Abilez, Oscar J./0000-0002-9991-400X; Kuhl, Ellen/0000-0002-6283-935X; Bol, Markus/0000-0003-1185-6309	National Science Foundation CAREER award [CMMI 0952021]; National Institutes of Health Grant [U54 GM072970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER award CMMI 0952021 and National Institutes of Health Grant U54 GM072970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Arnold AS, 2006, GAIT POSTURE, V23, P273, DOI 10.1016/j.gaitpost.2005.03.003; Arnold EM, 2011, PHILOS T R SOC B, V366, P1530, DOI 10.1098/rstb.2010.0345; BARNETT JG, 1980, AM J PHYSIOL, V239, pC39, DOI 10.1152/ajpcell.1980.239.1.C39; Bol M, 2012, INT J MULTISCALE COM, V10, P171, DOI 10.1615/IntJMultCompEng.2011002352; Bol M, 2011, COMPUT MECH, V47, P591, DOI 10.1007/s00466-010-0567-0; Bol M, 2009, COMPUT MECH, V43, P535, DOI 10.1007/s00466-008-0328-5; Bottinelli R, 2006, ADV MUSCLE RES, V2; Burkholder TJ, 2007, FRONT BIOSCI-LANDMRK, V12, P174, DOI 10.2741/2057; Burkholder TJ, 1998, J EXP BIOL, V201, P309; Caiozzo VJ, 2002, CLIN ORTHOP RELAT R, pS133, DOI 10.1097/blo.0000031971.69509.b3; Calvo B, 2010, J BIOMECH, V43, P318, DOI 10.1016/j.jbiomech.2009.08.032; Ehler E, 2008, SARCOMERE SKELETAL M; Epstein M, 2000, INT J PLASTICITY, V16, P951, DOI 10.1016/S0749-6419(99)00081-9; Garikipati K, 2009, APPL MECH REV, V62, DOI 10.1115/1.3090829; Gerber C, 2009, J SHOULDER ELB SURG, V18, P163, DOI 10.1016/j.jse.2008.09.003; Goktepe S, 2010, J MECH PHYS SOLIDS, V58, P1661, DOI 10.1016/j.jmps.2010.07.003; Goktepe S, 2010, J THEOR BIOL, V265, P433, DOI 10.1016/j.jtbi.2010.04.023; GOLDSPINK G, 1968, J CELL SCI, V3, P539; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Hayatsu K, 2001, J ORTHOPAED RES, V19, P897, DOI 10.1016/S0736-0266(01)00002-X; HERRING SW, 1984, MUSCLE NERVE, V7, P161, DOI 10.1002/mus.880070213; Himpel G, 2005, CMES-COMP MODEL ENG, V8, P119; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; Kerckhoffs RCP, 2012, MECH RES COMMUN, V42, P40, DOI 10.1016/j.mechrescom.2011.11.004; Klepach D, 2012, MECH RES COMMUN, V42, P134, DOI 10.1016/j.mechrescom.2012.03.005; Kober C, 2012, INT J MULTISCALE COM, V10, P131, DOI 10.1615/IntJMultCompEng.2011002392; Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x; LEE EH, 1969, J APPL MECH, V36, P1, DOI 10.1115/1.3564580; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Lubarda VA, 2002, INT J SOLIDS STRUCT, V39, P4627, DOI 10.1016/S0020-7683(02)00352-9; MATANO T, 1994, J ORTHOPAED RES, V12, P193, DOI 10.1002/jor.1100120207; Menzel A, 2005, BIOMECH MODEL MECHAN, V3, P147, DOI 10.1007/s10237-004-0047-6; Menzel A, 2012, MECH RES COMMUN, V42, P1, DOI 10.1016/j.mechrescom.2012.02.007; O'Sullivan K, 2012, BRIT J SPORT MED, V46, P838, DOI 10.1136/bjsports-2011-090835; Rausch MK, 2011, BIOMECH MODEL MECHAN, V10, P799, DOI 10.1007/s10237-010-0275-x; RODRIGUEZ EK, 1993, AM J PHYSIOL, V264, pH1048, DOI 10.1152/ajpheart.1993.264.4.H1048; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Schmid H, 2012, COMPUT METHOD BIOMEC, V15, P547, DOI 10.1080/10255842.2010.548325; SPECTOR SA, 1982, EXP NEUROL, V76, P94, DOI 10.1016/0014-4886(82)90104-2; Taber LA, 1995, APPL MECH REV, V48, P487, DOI [10.1115/1.3005109, DOI 10.1115/1.3005109]; Taylor RL., 2017, FEAP FINITE ELEMENT; Tepole AB, 2012, INT J NONLIN MECH, V47, P938, DOI 10.1016/j.ijnonlinmec.2011.07.006; Tepole AB, 2011, J MECH PHYS SOLIDS, V59, P2177, DOI 10.1016/j.jmps.2011.05.004; Tsamis A, 2012, J MECH BEHAV BIOMED, V8, P165, DOI 10.1016/j.jmbbm.2011.12.006; WILLIAMS PE, 1978, J ANAT, V127, P459; Zollner A, 2012, BIOMECH MODEL MECHAN, V11, P855, DOI 10.1007/s10237-011-0357-4; Zollner AM, 2012, J THEOR BIOL, V297, P166, DOI 10.1016/j.jtbi.2011.12.022; Zumstein MA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-50	49	67	70	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45661	10.1371/journal.pone.0045661	http://dx.doi.org/10.1371/journal.pone.0045661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049683	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500010
J	Bouzas-Mosquera, A; Broullon, FJ; Alvarez-Garcia, N; Peteiro, J; Mosquera, VX; Castro-Beiras, A				Bouzas-Mosquera, Alberto; Broullon, Francisco J.; Alvarez-Garcia, Nemesio; Peteiro, Jesus; Mosquera, Victor X.; Castro-Beiras, Alfonso			Association of Left Ventricular Mass with All-Cause Mortality, Myocardial Infarction and Stroke	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ECHOCARDIOGRAPHIC-ASSESSMENT; PROGNOSTIC-SIGNIFICANCE; ESSENTIAL-HYPERTENSION; ELDERLY COHORT; HEART-DISEASE; SUDDEN-DEATH; HYPERTROPHY; RECOMMENDATIONS; SURVIVAL	Background: Our aim was to assess the association of left ventricular mass with mortality and nonfatal cardiovascular events. Methodology/Principal Findings: Left ventricular mass was measured by echocardiography in 40138 adult patients (mean age 61.1+/-16.4 years, 52.5% male). The primary endpoint was all-cause mortality. Secondary endpoints included nonfatal myocardial infarction and nonfatal stroke. During a mean follow-up period of 5.6+/-3.9 years, 9181 patients died, 901 patients had a nonfatal myocardial infarction, and 2139 patients had a nonfatal stroke. Cumulative 10-year mortality was 26.8%, 31.9%, 37.4% and 46.4% in patients with normal, mildly, moderately and severely increased left ventricular mass, respectively (p < 0.001). Ten-year rates of nonfatal myocardial infarction and stroke ranged from 3.2% and 6.7% in patients with normal left ventricular mass to 5.3% and 12.7% in those with severe increase in left ventricular mass, respectively. After multivariate adjustment, left ventricular mass remained an independent predictor of all-cause mortality (hazard ratio [HR] per 100 g increase 1.21, 95% confidence interval [CI] 1.14-1-27, p < 0.001 in women, and HR 1.09, 95% CI 1.04-1-13, p < 0.001 in men), myocardial infarction (HR 1.60, 95% CI 1.31-1.94, p < 0.001 in women and HR 1.15, 95% CI 1.02-1.29, p = 0.019 in men) and stroke (HR 1.26, 95% CI 1.13-1.40, p < 0.001 in women and HR 1.19, 95% CI 1.09-1.30, p < 0.001 in men). Conclusions/Significance: Left ventricular mass has a graded and independent association with all-cause mortality, myocardial infarction and stroke.	[Bouzas-Mosquera, Alberto; Alvarez-Garcia, Nemesio; Peteiro, Jesus; Castro-Beiras, Alfonso] Hosp Univ A Coruna, Dept Cardiol, La Coruna, Spain; [Bouzas-Mosquera, Alberto; Peteiro, Jesus; Castro-Beiras, Alfonso] Inst Salud Carlos III, Spanish Cooperat Cardiovasc Dis Res Network RECAV, Madrid, Spain; [Broullon, Francisco J.] Hosp Univ A Coruna, Dept Informat Technol, La Coruna, Spain; [Mosquera, Victor X.] Hosp Univ A Coruna, Dept Cardiac Surg, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III; Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Bouzas-Mosquera, A (corresponding author), Hosp Univ A Coruna, Dept Cardiol, La Coruna, Spain.	alberto.bouzas.mosquera@sergas.es	Molanes, Francisco Javier Broullon/AAD-7490-2020; Bouzas-Mosquera, Alberto/S-3919-2018	Bouzas-Mosquera, Alberto/0000-0002-2741-732X				Alfakih K, 2004, EUR J RADIOL, V52, P103, DOI 10.1016/j.ejrad.2003.09.015; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; BOLOGNESE L, 1994, AM J CARDIOL, V73, P1, DOI 10.1016/0002-9149(94)90717-X; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; East MA, 2003, J AM COLL CARDIOL, V41, P949, DOI 10.1016/S0735-1097(02)03006-1; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; HOUGHTON JL, 1990, J AM COLL CARDIOL, V15, P43, DOI 10.1016/0735-1097(90)90173-M; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LIAO YL, 1995, JAMA-J AM MED ASSOC, V273, P1592, DOI 10.1001/jama.273.20.1592; LIAO YL, 1995, CIRCULATION, V92, P805, DOI 10.1161/01.CIR.92.4.805; PARFREY PS, 1990, NEPHRON, V55, P114, DOI 10.1159/000185937; Rodriguez CJ, 2006, HYPERTENSION, V48, P87, DOI 10.1161/01.HYP.0000223330.03088.58; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Swamy Rajiv S, 2010, Curr Cardiol Rep, V12, P277, DOI 10.1007/s11886-010-0104-y; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; Wolk R, 2000, EUROPACE, V2, P216, DOI 10.1053/eupc.2000.0110; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45570	10.1371/journal.pone.0045570	http://dx.doi.org/10.1371/journal.pone.0045570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049815	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300033
J	Iranzo, J; Floria, LM; Moreno, Y; Sanchez, A				Iranzo, Jaime; Floria, Luis M.; Moreno, Yamir; Sanchez, Angel			Empathy Emerges Spontaneously in the Ultimatum Game: Small Groups and Networks	PLOS ONE			English	Article							EVOLUTION; BEHAVIOR; ALTRUISM	The Ultimatum game, in which one subject proposes how to share a pot and the other has veto power on the proposal, in which case both lose everything, is a paradigmatic scenario to probe the degree of cooperation and altruism in human subjects. It has been shown that if individuals are empathic, i.e., they play the game having in mind how their opponent will react by offering an amount that they themselves would accept, then non-rational large offers well above the smallest possible ones are evolutionarily selected. We here show that empathy itself may be selected and need not be exogenously imposed provided that interactions take place only with a fraction of the total population, and that the role of proposer or responder is randomly changed from round to round. These empathic agents, that displace agents with independent (uncorrelated) offers and proposals, behave far from what is expected rationally, offering and accepting sizable fractions of the amount to be shared. Specific values for the typical offer depend on the details of the interacion network and on the existence of hubs, but they are almost always significantly larger than zero, indicating that the mechanism at work here is quite general and could explain the emergence of empathy in very many different contexts.	[Iranzo, Jaime] CSIC, INTA, Ctr Astrobiol, Torrejon De Ardoz, Spain; [Iranzo, Jaime; Floria, Luis M.; Moreno, Yamir; Sanchez, Angel] Univ Zaragoza, Inst Biocomp & Fs Sistemas Complejos, Zaragoza, Spain; [Floria, Luis M.] Univ Zaragoza, Dept Fs Mat Condensada, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fs Teor, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos III Madrid, GISC, Leganes, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Zaragoza; University of Zaragoza; University of Zaragoza; Universidad Carlos III de Madrid	Iranzo, J (corresponding author), CSIC, INTA, Ctr Astrobiol, Torrejon De Ardoz, Spain.	iranzosj@cab.inta-csic.es	Iranzo, Jaime/H-5197-2011; Sánchez, Angel/A-9229-2008; Floria, Luis Mario/L-7261-2014; Moreno, Yamir/A-1076-2009	Iranzo, Jaime/0000-0002-4538-7726; Sánchez, Angel/0000-0003-1874-2881; Floria, Luis Mario/0000-0002-1406-8810; Moreno, Yamir/0000-0002-0895-1893	Comunidad de Madrid (Spain); grant MODELICOCM (Comunidad de Madrid, Spain); MICINN, Spain [FIS2011-27569]; MICINN [FIS2011-25167]; Comunidad de Arag'on; MICINN (Ministerio de Ciencia e Innovaci'on) [FIS2011-25167, FIS2008-01240, FIS2009-13364-C02-01]; FET-Open project DYNANETS [233847]; European Commission; Comunidad de Arag'on (Spain) [FMI22/10]; MOSAICO; PRODIEVO; Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain); MODELICO-CM (Comunidad de Madrid, Spain)	Comunidad de Madrid (Spain)(Comunidad de Madrid); grant MODELICOCM (Comunidad de Madrid, Spain); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Arag'on(Comunidad de Madrid); MICINN (Ministerio de Ciencia e Innovaci'on)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FET-Open project DYNANETS; European Commission(European CommissionEuropean Commission Joint Research Centre); Comunidad de Arag'on (Spain)(Comunidad de Madrid); MOSAICO; PRODIEVO; Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain); MODELICO-CM (Comunidad de Madrid, Spain)(Comunidad de Madrid)	JI was supported by a research contract of the Comunidad de Madrid (Spain), grant MODELICOCM (Comunidad de Madrid, Spain) and project FIS2011-27569 (MICINN, Spain). LMF is grateful to FIS2011-25167 from MICINN and to Comunidad de Arag'on. YM was partially supported by Spanish MICINN (Ministerio de Ciencia e Innovaci'on) projects FIS2008-01240, FIS2009-13364-C02-01, and FIS2011-25167, by the FET-Open project DYNANETS (grant no. 233847) funded by the European Commission, and by Comunidad de Arag'on (Spain) through the project FMI22/10. AS acknowledges grants MOSAICO, PRODIEVO and Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain) and MODELICO-CM (Comunidad de Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C, 2003, BEHAV GAME THEORY; Cartwright J, 2000, EVOLUTION HUMAN BEHA; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; Eguiluz VM, 2009, ADV COMPLEX SYST, V12, P221, DOI 10.1142/S0219525909002179; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P., 2003, GENETIC CULTURAL EVO; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Henrich J., 2005, FDN HUMAN SOCIALITY; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; Kagel JH, 1995, HDB EXPT EC; Killingback T, 2001, P ROY SOC B-BIOL SCI, V268, P1797, DOI 10.1098/rspb.2001.1697; Kuperman MN, 2008, EUR PHYS J B, V62, P233, DOI 10.1140/epjb/e2008-00133-x; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2002, B MATH BIOL, V64, P1101, DOI 10.1006/bulm.2002.0321; Page KM, 2001, J THEOR BIOL, V209, P173, DOI 10.1006/jtbi.2000.2251; Page KM, 2000, SPATIAL ULTIMATUM GA, P1116; Sanchez A, 2005, J THEOR BIOL, V235, P233, DOI 10.1016/j.jtbi.2005.01.006; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Seymour RM, 2000, J MATH SOCIOL, V24, P193, DOI 10.1080/0022250X.2000.9990236; Sigmund K., 2010, CALCULUS SELFISHNESS; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wilson E.O., 1975, P1	35	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43781	10.1371/journal.pone.0043781	http://dx.doi.org/10.1371/journal.pone.0043781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049740	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517300007
J	Shibistova, O; Yohannes, Y; Boy, J; Richter, A; Wild, B; Watzka, M; Guggenberger, G				Shibistova, Olga; Yohannes, Yonas; Boy, Jens; Richter, Andreas; Wild, Birgit; Watzka, Margarethe; Guggenberger, Georg			Rate of Belowground Carbon Allocation Differs with Successional Habit of Two Afromontane Trees	PLOS ONE			English	Article							HIGH TEMPORAL RESOLUTION; ISOTOPE COMPOSITION; GAS-EXCHANGE; PHYSIOLOGICAL ECOLOGY; ORGANIC-COMPOUNDS; SOIL RESPIRATION; FAGUS-SYLVATICA; WATER RELATIONS; EUROPEAN BEECH; FOREST	Background: Anthropogenic disturbance of old-growth tropical forests increases the abundance of early successional tree species at the cost of late successional ones. Quantifying differences in terms of carbon allocation and the proportion of recently fixed carbon in soil CO2 efflux is crucial for addressing the carbon footprint of creeping degradation. Methodology: We compared the carbon allocation pattern of the late successional gymnosperm Podocarpus falcatus (Thunb.) Mirb. and the early successional (gap filling) angiosperm Croton macrostachyus Hochst. es Del. in an Ethiopian Afromontane forest by whole tree (CO2)-C-13 pulse labeling. Over a one-year period we monitored the temporal resolution of the label in the foliage, the phloem sap, the arbuscular mycorrhiza, and in soil-derived CO2. Further, we quantified the overall losses of assimilated C-13 with soil CO2 efflux. Principal Findings: C-13 in leaves of C. macrostachyus declined more rapidly with a larger size of a fast pool (64% vs. 50% of the assimilated carbon), having a shorter mean residence time (14 h vs. 55 h) as in leaves of P. falcatus. Phloem sap velocity was about 4 times higher for C. macrostachyus. Likewise, the label appeared earlier in the arbuscular mycorrhiza of C. macrostachyus and in the soil CO2 efflux as in case of P. falcatus (24 h vs. 72 h). Within one year soil CO2 efflux amounted to a loss of 32% of assimilated carbon for the gap filling tree and to 15% for the late successional one. Conclusions: Our results showed clear differences in carbon allocation patterns between tree species, although we caution that this experiment was unreplicated. A shift in tree species composition of tropical montane forests (e. g., by degradation) accelerates carbon allocation belowground and increases respiratory carbon losses by the autotrophic community. If ongoing disturbance keeps early successional species in dominance, the larger allocation to fast cycling compartments may deplete soil organic carbon in the long run.	[Shibistova, Olga; Yohannes, Yonas; Boy, Jens; Guggenberger, Georg] Leibniz Univ Hannover, Inst Soil Sci, Hannover, Germany; [Shibistova, Olga] Russian Acad Sci, Siberian Branch, VN Sukachev Inst Forest, Krasnoyarsk, Russia; [Yohannes, Yonas] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Richter, Andreas; Wild, Birgit; Watzka, Margarethe] Univ Vienna, Dept Chem Ecol & Ecosyst Res, Vienna, Austria	Leibniz University Hannover; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; Ethiopian Institute of Agricultural Research (EIAR); University of Vienna	Shibistova, O (corresponding author), Leibniz Univ Hannover, Inst Soil Sci, Hannover, Germany.	olgas@ksc.krasn.ru	Richter, Andreas/D-8483-2012; Watzka, Margarete/C-3843-2014; Guggenberger, Georg/C-8423-2013; Boy, Jens/B-2926-2018; Wild, Birgit/E-6476-2012; Shibistova, Olga/AAP-1594-2020	Richter, Andreas/0000-0003-3282-4808; Watzka, Margarete/0000-0003-0334-1823; Guggenberger, Georg/0000-0002-6962-8264; Boy, Jens/0000-0002-2751-957X; Wild, Birgit/0000-0002-9611-0815; 	German Research Foundation [DFG Gu 406/19-1]	German Research Foundation(German Research Foundation (DFG))	Financial support was given by the German Research Foundation (to G. G., DFG Gu 406/19-1). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2004, THESIS U BAYREUTH; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Andrews JA, 1999, SOIL SCI SOC AM J, V63, P1429, DOI 10.2136/sssaj1999.6351429x; [Anonymous], 2013, MEASUREMENTS TERREST; Ashagrie Y, 2007, SOIL TILL RES, V94, P101, DOI 10.1016/j.still.2006.07.005; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Barthel M, 2011, NEW PHYTOL, V192, P925, DOI 10.1111/j.1469-8137.2011.03848.x; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Bekele T., 1999, FOREST GENETIC RESOU, P39; Bombelli A, 2009, BIOGEOSCIENCES, V6, P2193, DOI 10.5194/bg-6-2193-2009; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; BRUGGEMANN N, 2011, BIOGEOSCIENCES, V8, P3457, DOI DOI 10.5194/bg-8-3457-2011; Canadell JG, 2009, BIOGEOSCIENCES, V6, P463, DOI 10.5194/bg-6-463-2009; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Cernusak Lucas A., 2011, Smithsonian Contributions to Botany, P189; Chambers JQ, 2001, NATURE, V410, P429, DOI 10.1038/35068624; Ciais P, 2011, PHILOS T R SOC A, V369, P2038, DOI 10.1098/rsta.2010.0328; Ciais P, 2009, BIOGEOSCIENCES, V6, P1935, DOI 10.5194/bg-6-1935-2009; Coomes David A., 2011, Smithsonian Contributions to Botany, P119; Dannoura M, 2011, NEW PHYTOL, V190, P181, DOI 10.1111/j.1469-8137.2010.03599.x; DOUDS DD, 1988, PLANT PHYSIOL, V86, P491, DOI 10.1104/pp.86.2.491; Ehleringer J.R., 1991, CARBON ISOTOPE TECHN, P187; Eissenstat DM., 2002, PLANT ROOTS HIDDEN H, V3, P221, DOI DOI 10.1201/9780203909423; Epron D, 2011, BIOGEOSCIENCES, V8, P1153, DOI 10.5194/bg-8-1153-2011; Epron D, 2012, TREE PHYSIOL, V32, P776, DOI 10.1093/treephys/tps057; *FAO ISRIC, 1998, WORLD REF BAS SOIL R; Fetene M, 2004, TREES-STRUCT FUNCT, V18, P428, DOI 10.1007/s00468-004-0321-3; Friies I., 1992, FORESTS FOREST TREES; Fritzsche F, 2007, CATENA, V70, P209, DOI 10.1016/j.catena.2006.09.005; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; GAMALEI Y, 1991, TREES-STRUCT FUNCT, V5, P50, DOI 10.1007/BF00225335; Gessler A, 2004, PLANT BIOLOGY, V6, P721, DOI 10.1055/s-2004-830350; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gindaba J, 2004, BIOL FERT SOILS, V40, P393, DOI 10.1007/s00374-004-0767-x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; HORWATH WR, 1994, TREE PHYSIOL, V14, P1163, DOI 10.1093/treephys/14.10.1163; Hughes JK, 2008, TRENDS PLANT SCI, V13, P583, DOI 10.1016/j.tplants.2008.08.010; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Keitel C, 2003, PLANT CELL ENVIRON, V26, P1157, DOI 10.1046/j.1365-3040.2003.01040.x; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Kuptz D, 2011, NEW PHYTOL, V191, P160, DOI 10.1111/j.1469-8137.2011.03676.x; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Langley JA, 2005, PLANT SOIL, V277, P335, DOI 10.1007/s11104-005-7932-3; LARCHER W, 1969, PHOTOSYNTHETICA, V3, P167; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Leuschner Christoph, 2006, Ecotropica (Bonn), V12, P151; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Lusk CH, 2003, NEW PHYTOL, V160, P329, DOI 10.1046/j.1469-8137.2003.00879.x; Lusk Christopher H., 2011, Smithsonian Contributions to Botany, P157; Luttge U, 2003, TREES-STRUCT FUNCT, V17, P40, DOI 10.1007/s00468-002-0201-7; MORDACQ L, 1986, PLANT CELL ENVIRON, V9, P735, DOI 10.1111/j.1365-3040.1986.tb02106.x; Negash L, 1995, INDIGENOUS TREES ETH; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Plain C, 2009, TREE PHYSIOL, V29, P1433, DOI 10.1093/treephys/tpp072; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pretzsch H, 2008, ANN BOT-LONDON, V101, P1065, DOI 10.1093/aob/mcm246; Pumpanen JS, 2009, TREES-STRUCT FUNCT, V23, P611, DOI 10.1007/s00468-008-0306-8; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Seyoum Y, 2012, TREES-STRUCT FUNCT, V26, P1495, DOI 10.1007/s00468-012-0723-6; Simard SW, 1997, PLANT SOIL, V191, P41, DOI 10.1023/A:1004205727882; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Strobl S, 2011, TREES-STRUCT FUNCT, V25, P769, DOI 10.1007/s00468-011-0554-x; SVEJCAR TJ, 1990, AGRON J, V82, P18, DOI 10.2134/agronj1990.00021962008200010004x; Tamrat B., 1993, ACTA PHYTOGEOGRAPHIC, V79, P1; Teketay D, 1997, ACTA OECOL, V18, P557, DOI 10.1016/S1146-609X(97)80041-0; Tesfaye G, 2002, FLORA, V197, P461, DOI 10.1078/0367-2530-1210063; Tesfaye G, 2010, FLORA, V205, P135, DOI 10.1016/j.flora.2008.12.006; Tohjima Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011734; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Valentine AJ, 2007, MYCORRHIZA, V17, P137, DOI 10.1007/s00572-006-0093-2; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Wild B, 2010, J EXP BOT, V61, P1375, DOI 10.1093/jxb/erq006; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wubet T, 2009, MYCOL PROG, V8, P317, DOI 10.1007/s11557-009-0602-8; Yohannes Y, 2011, FOREST ECOL MANAG, V261, P1090, DOI 10.1016/j.foreco.2010.12.032	87	10	10	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45540	10.1371/journal.pone.0045540	http://dx.doi.org/10.1371/journal.pone.0045540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049813	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300031
J	Aguilera, MA; Navarrete, SA				Aguilera, Moises A.; Navarrete, Sergio A.			Interspecific Competition for Shelters in Territorial and Gregarious Intertidal Grazers: Consequences for Individual Behaviour	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; HERBIVORE ASSEMBLAGES; HUMAN EXCLUSION; LIMPET; PATTERNS; PATELLA; COEXISTENCE; HABITAT; AGGREGATION; VARIABILITY	Experiments have shown that interspecific interactions within consumer guilds can alter patterns of distribution, abundance and size of species. Plastic behavioural responses can be modulated by agonistic interactions. In many cases, consumers compete for space and shelters, and these interactions change the manner in which they exploit food. This study investigates the consequences of competition in the spatial and temporal organization of behaviour of intertidal grazers, which share algal resources and the use of rock crevices while resting, but exhibit different body sizes, spatial behaviour and foraging modes. We evaluate interaction strength between small gregarious Siphonaria lessoni and the larger territorial keyhole limpet Fissurella crassa and between S. lessoni and the medium-size gregarious chiton Chiton granosus. Using field manipulations and artificial arenas in the laboratory, we tested whether the use of crevices, micro-spatial distribution and activity are modified by the density of conspecifics and the presence of heterospecifics. Our results show that small-scale spatial segregation observed in the field between S. lessoni and C. granosus result from species-specific differences in habitat use. In turn, we found evidence that spatial segregation between F. crassa and S. lessoni results from highly asymmetric interference competition in the use of shelters. The presence of F. crassa reduced the use of crevices and growth rates of S. lessoni. Effects on growth rates are assumed to result from exposure to harsh environmental conditions rather than food limitation. Thus, neither gregarious behaviour nor differences in activity were sufficient to prevent competition with the larger grazer. Our study illustrates the importance of competition for shelters, which results in behavioural changes of the smaller-sized species, and how these plastic responses can translate into differences in growth rates. Use of shelters can thus be modulated by environmental conditions in a species-specific as well as an interactive manner within consumers' guilds.	[Aguilera, Moises A.] Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Coquimbo, Chile; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat, Santiago, Chile; [Navarrete, Sergio A.] Estn Costera Invest Marinas, Las Cruces, Chile	Universidad Catolica del Norte; Pontificia Universidad Catolica de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Navarrete, Sergio/D-4645-2013	Aguilera, Moisés/0000-0002-3517-6255; 	Centro de Estudios Avanzados en Zonas Aridas (CEAZA); Fondap Fondecyt [15001-0001]; Fondecyt [1070335]; ICM of Ministerio de Economia, Fomento y Turismo, Chile	Centro de Estudios Avanzados en Zonas Aridas (CEAZA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAZA); Fondap Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM of Ministerio de Economia, Fomento y Turismo, Chile	Funding was provided by Centro de Estudios Avanzados en Zonas Aridas (CEAZA), Fondap Fondecyt grant 15001-0001, Fondecyt grant 1070335 and funds from ICM of Ministerio de Economia, Fomento y Turismo, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Basset A, 2007, OIKOS, V116, P1363, DOI 10.1111/j.2007.0030-1299.15702.x; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; Boaventura D, 2003, J ANIM ECOL, V72, P435, DOI 10.1046/j.1365-2656.2003.00713.x; BRANCH GM, 1976, J ANIM ECOL, V45, P507, DOI 10.2307/3888; BRANCH GM, 1975, J ANIM ECOL, V44, P575, DOI 10.2307/3612; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Chapman MG, 2000, J EXP MAR BIOL ECOL, V250, P77, DOI 10.1016/S0022-0981(00)00180-5; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Coleman RA, 2010, J EXP MAR BIOL ECOL, V386, P113, DOI 10.1016/j.jembe.2010.02.011; COX TF, 1981, BIOMETRICS, V37, P367, DOI 10.2307/2530424; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Davies MS, 1998, ADV MAR BIOL, V34, P1, DOI 10.1016/S0065-2881(08)60210-2; DeLong JP, 2012, PLOS ONE, V7, P406, DOI 10.1371/journal.pone.0030081; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Finke R, 2007, MARINE ECOLOGY PROGR, V343, P57; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; FLETCHER WJ, 1987, ECOLOGY, V68, P387, DOI 10.2307/1939270; FOCARDI S, 1990, J ANIM ECOL, V59, P347, DOI 10.2307/5177; GODOY C, 1989, OIKOS, V54, P101, DOI 10.2307/3565902; Harper KD, 2001, J ZOOL, V253, P293, DOI 10.1017/S0952836901000279; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; IWASAKI K, 1992, ECOL RES, V7, P305, DOI 10.1007/BF02347099; Keough MJ, 1997, J EXP MAR BIOL ECOL, V215, P19, DOI 10.1016/S0022-0981(97)00027-0; LEVINGS SC, 1984, OECOLOGIA, V64, P152, DOI 10.1007/BF00376863; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; MARSHALL PA, 1994, J EXP MAR BIOL ECOL, V177, P121, DOI 10.1016/0022-0981(94)90147-3; Martins GM, 2010, BIOL CONSERV, V143, P203, DOI 10.1016/j.biocon.2009.10.004; Menge B, 1981, ECOL MONOGR, V21, P421; Moreira J, 2007, J EXP MAR BIOL ECOL, V347, P134, DOI 10.1016/j.jembe.2007.04.001; Munoz JLP, 2008, J THERM BIOL, V33, P149, DOI 10.1016/j.jtherbio.2007.10.002; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Nakano S, 1999, J ANIM ECOL, V68, P1079, DOI 10.1046/j.1365-2656.1999.00355.x; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; OLIVA D, 1986, MAR ECOL-P S Z N I, V7, P201, DOI 10.1111/j.1439-0485.1986.tb00158.x; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B, 1986, MONOGRAFIAS BIOLOGIC, P147; Santini G, 2005, ETHOL ECOL EVOL, V17, P65; Schmitt RJ, 1996, ECOLOGY, V77, P408, DOI 10.2307/2265618; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SEBENS KP, 1982, AM NAT, V120, P189, DOI 10.1086/283982; Stafford R, 2012, MARINE ECOL IN PRESS; STIMSON J, 1973, ECOLOGY, V54, P1020, DOI 10.2307/1935568; Underwood AJ, 2004, J EXP MAR BIOL ECOL, V300, P161, DOI 10.1016/j.jembe.2003.12.006; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1984, OECOLOGIA, V64, P211, DOI 10.1007/BF00376873; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; WILLIAMS GA, 1995, MAR ECOL PROG SER, V124, P89, DOI 10.3354/meps124089; Wilson TL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00247.1	62	21	22	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46205	10.1371/journal.pone.0046205	http://dx.doi.org/10.1371/journal.pone.0046205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049980	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100155
J	Altieri, P; Spallarossa, P; Barisione, C; Garibaldi, S; Garuti, A; Fabbi, P; Ghigliotti, G; Brunelli, C				Altieri, Paola; Spallarossa, Paolo; Barisione, Chiara; Garibaldi, Silvano; Garuti, Anna; Fabbi, Patrizia; Ghigliotti, Giorgio; Brunelli, Claudio			Inhibition of Doxorubicin-Induced Senescence by PPAR delta Activation Agonists in Cardiac Muscle Cells: Cooperation between PPAR delta and Bcl6	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; THERAPEUTIC TARGETS; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; PREMATURE SENESCENCE; H9C2 CARDIOMYOBLASTS; RECEPTOR-BETA/DELTA; DOWN-REGULATION; INFLAMMATION; EXPRESSION	Senescence and apoptosis are two distinct cellular programs that are activated in response to a variety of stresses. Low or high doses of the same stressor, i.e., the anticancer drug doxorubicin, may either induce apoptosis or senescence, respectively, in cardiac muscle cells. We have demonstrated that PPAR delta, a ligand-activated transcriptional factor that controls lipid metabolism, insulin sensitivity and inflammation, is also involved in the doxorubicin-induced senescence program. This occurs through its interference with the transcriptional repressor protein B cell lymphoma-6 (Bcl6). Low doses of doxorubicin increase the expression of PPAR delta that sequesters Bcl6, thus preventing it from exerting its anti-senescent effects. We also found that L-165041, a specific PPAR delta activator, is highly effective in protecting cardiomyocytes from doxorubicin-induced senescence through a Bcl6 related mechanism. In fact, L-165041 increases Bcl6 expression via p38, JNK and Akt activation, and at the same time it induces the release of Bcl6 from PPAR delta, thereby enabling Bcl6 to bind to its target genes. L-165041 also prevented apoptosis induced by higher doses of doxorubicin. However, while experiments performed with siRNA analysis techniques very clearly showed the weight of Bcl6 in the cellular senescence program, no role was found for Bcl6 in the anti-apoptotic effects of L-165041, thus confirming that senescence and apoptosis are two very distinct stress response cellular programs. This study increases our understanding of the molecular mechanism of anthracycline cardiotoxicity and suggests a potential role for PPAR delta agonists as cardioprotective agents.	[Altieri, Paola; Barisione, Chiara; Garibaldi, Silvano; Fabbi, Patrizia; Brunelli, Claudio] Univ Genoa, Res Ctr Cardiovasc Biol, Genoa, Italy; [Spallarossa, Paolo; Ghigliotti, Giorgio; Brunelli, Claudio] Univ Genoa, Div Cardiol, IRCCS Univ Hosp San Martino, Genoa, Italy; [Garuti, Anna] Univ Genoa, Dept Internal Med, Lab Cellular Therapies, I-16126 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Altieri, P (corresponding author), Univ Genoa, Res Ctr Cardiovasc Biol, Genoa, Italy.	Paola.Altieri@unige.it	Spallarossa, Paolo/AAC-8981-2019	Ghigliotti, Giorgio/0000-0001-8484-542X	University of Genova (cofinanziamento di Ateneo)	University of Genova (cofinanziamento di Ateneo)	This work was supported by grants from the University of Genova (cofinanziamento di Ateneo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Auner HW, 2001, CANCER RES, V61, P2335; Barnabe N, 2002, FREE RADICAL BIO MED, V33, P266, DOI 10.1016/S0891-5849(02)00873-0; Baron BW, 2002, P NATL ACAD SCI USA, V99, P2860, DOI 10.1073/pnas.042702599; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bishop-Bailey D, 2009, PHARMACOL THERAPEUT, V124, P141, DOI 10.1016/j.pharmthera.2009.06.011; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Dent AL, 2002, CRIT REV ONCOL HEMAT, V41, P1, DOI 10.1016/S1040-8428(01)00164-0; Di Paola R, 2010, J LEUKOCYTE BIOL, V88, P291, DOI 10.1189/jlb.0110053; Dimri GP, 1995, P NATL ACAD SCI USA, V92, P363; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; Gerland LM, 2003, EXP GERONTOL, V38, P887, DOI 10.1016/S0531-5565(03)00132-3; Glauser DA, 2009, J RECEPT SIG TRANSD, V29, P293, DOI 10.3109/10799890903241824; Gong J, 2007, LIFE SCI, V80, P1143, DOI 10.1016/j.lfs.2006.12.012; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He TR, 2011, HYPERTENSION, V58, P287, DOI 10.1161/HYPERTENSIONAHA.111.172189; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Karpe F, 2009, CURR OPIN LIPIDOL, V20, P333, DOI 10.1097/MOL.0b013e32832dd4b1; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kim HJ, 2011, BIOCHEM BIOPH RES CO, V406, P564, DOI 10.1016/j.bbrc.2011.02.091; Kim JY, 2011, VASCUL PHARM; Kojima S, 2001, DEVELOPMENT, V128, P57; Konorev EA, 2008, FREE RADICAL BIO MED, V45, P1723, DOI 10.1016/j.freeradbiomed.2008.09.006; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumagai T, 1999, ONCOGENE, V18, P467, DOI 10.1038/sj.onc.1202306; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Liang YJ, 2010, EUR J PHARMACOL, V643, P84, DOI 10.1016/j.ejphar.2010.06.031; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Plutzky J, 2003, SCIENCE, V302, P406, DOI 10.1126/science.1091172; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Spallarossa P, 2010, J PHARMACOL EXP THER, V332, P87, DOI 10.1124/jpet.109.159525; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; van Bilsen M, 2010, EXPERT OPIN THER TAR, V14, P1029, DOI 10.1517/14728222.2010.512917; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Zingarelli B, 2010, AM J PATHOL, V177, P1834, DOI 10.2353/ajpath.2010.091010	62	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46126	10.1371/journal.pone.0046126	http://dx.doi.org/10.1371/journal.pone.0046126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049957	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100141
J	Jones, CM; Toe, HK; Sanou, A; Namountougou, M; Hughes, A; Diabate, A; Dabire, R; Simard, F; Ranson, H				Jones, Christopher M.; Toe, Hyacinthe K.; Sanou, Antoine; Namountougou, Moussa; Hughes, Angela; Diabate, Abdoulaye; Dabire, Roch; Simard, Frederic; Ranson, Hilary			Additional Selection for Insecticide Resistance in Urban Malaria Vectors: DDT Resistance in Anopheles arabiensis from Bobo-Dioulasso, Burkina Faso	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; SUB-SAHARAN AFRICA; DAR-ES-SALAAM; GAMBIAE COMPLEX; MOLECULAR-BASIS; KDR MUTATIONS; DENGUE VECTOR; AEDES-AEGYPTI; IDENTIFICATION; WEST	In the city of Bobo-Dioulasso in Burkina Faso, Anopheles arabiensis has superseded Anopheles gambiae s.s. as the major malaria vector and the larvae are found in highly polluted habitats normally considered unsuitable for Anopheles mosquitoes. Here we show that An. gambiae s.l. adults emerging from a highly polluted site in the city centre (Dioulassoba) have a high prevalence of DDT resistance (percentage mortality after exposure to diagnostic dose = 65.8% in the dry season and 70.4% in the rainy season, respectively). An investigation into the mechanisms responsible found an unexpectedly high frequency of the 1014S kdr mutation (allele frequency = 0.4), which is found at very low frequencies in An. arabiensis in the surrounding rural areas, and an increase in transcript levels of several detoxification genes, notably from the glutathione transferase and cytochrome P450 gene families. A number of ABC transporter genes were also expressed at elevated levels in the DDT resistant An. arabiensis. Unplanned urbanisation provides numerous breeding grounds for mosquitoes. The finding that Anopheles mosquitoes adapted to these urban breeding sites have a high prevalence of insecticide resistance has important implications for our understanding of the selective forces responsible for the rapid spread of insecticide resistant populations of malaria vectors in Africa.	[Jones, Christopher M.; Toe, Hyacinthe K.; Hughes, Angela; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Toe, Hyacinthe K.; Namountougou, Moussa; Diabate, Abdoulaye; Dabire, Roch; Simard, Frederic] Inst Rech Sci Sante Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Toe, Hyacinthe K.; Sanou, Antoine] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Simard, Frederic] Inst Rech Dev, Montpellier, France	Liverpool School of Tropical Medicine; University of Liverpool; Institut de Recherche pour le Developpement (IRD)	Jones, CM (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	jonescm@liverpool.ac.uk	Jones, Christopher/U-1832-2017; Dabire, Roch Kounbobr/ABF-3525-2020; Frederic, SIMARD/AFV-5001-2022; Jones, Christopher M/S-5838-2019; SIMARD, Frederic/J-9489-2016	Jones, Christopher/0000-0002-6504-6224; Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Ranson, Hilary/0000-0003-2332-8247; Sanou, Antoine/0000-0002-3598-8800; DIABATE, Abdoulaye/0000-0002-9666-9395	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization)	This investigation received partial financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR). No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 1998, WHOCDCMAL98; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; CHINERY WA, 1984, J TROP MED HYG, V87, P75; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Dongus S, 2009, GEOSPATIAL HEALTH, V3, P189, DOI 10.4081/gh.2009.220; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Fournet F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-78; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; GRANT DF, 1991, INSECT BIOCHEM, V21, P421, DOI 10.1016/0020-1790(91)90009-4; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kerah-Hinzoumbe C., 2009, BMC INFECT DIS, V9, P71, DOI DOI 10.1186/1471-2334-9-71; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; TANG AH, 1994, J BIOL CHEM, V269, P27876; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066	65	79	84	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45995	10.1371/journal.pone.0045995	http://dx.doi.org/10.1371/journal.pone.0045995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049917	gold, Green Accepted, Green Published			2022-12-25	WOS:000309556100116
J	Larghi, P; Porta, C; Riboldi, E; Totaro, MG; Carraro, L; Orabona, C; Sica, A				Larghi, Paola; Porta, Chiara; Riboldi, Elena; Totaro, Maria Grazia; Carraro, Lorenzo; Orabona, Ciriana; Sica, Antonio			The p50 Subunit of NF-kappa B Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity	PLOS ONE			English	Article							T-CELL; IN-VIVO; PERIPHERAL TOLERANCE; ANTIGEN PRESENTATION; STEADY-STATE; EXPRESSION; MATURATION; IMMUNOTHERAPY; MACROPHAGES; RECEPTORS	Dendritic cells play a central role in keeping the balance between immunity and immune tolerance. A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses. Here we show that lipopolysaccharide-driven DC maturation is paralleled by increased nuclear levels of p50 NF-kappa B, an event associated with DC apoptosis. Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-beta, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells. In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth. We propose that nuclear accumulation of the p50 NF-kappa B subunit in DC, as occurring during lipopolysaccharide-driven maturation, is a homeostatic mechanism tuning the balance between uncontrolled activation of adaptive immunity and immune tolerance.	[Larghi, Paola; Totaro, Maria Grazia; Sica, Antonio] Humanitas Clin & Res Ctr, Milan, Italy; [Porta, Chiara; Riboldi, Elena; Carraro, Lorenzo; Sica, Antonio] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy; [Orabona, Ciriana] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Perugia	Sica, A (corresponding author), Humanitas Clin & Res Ctr, Milan, Italy.	antonio.sica@humanitasresearch.it	Orabona, Ciriana/L-8725-2015; Sica, Antonio/AAB-9546-2020; Larghi, Paola/K-6061-2016	Orabona, Ciriana/0000-0003-3113-0572; Larghi, Paola/0000-0001-7074-1590; PORTA, Chiara/0000-0002-7183-5561	Associazione Italiana Ricerca sul Cancro (AIRC), Italy; Fondazione Cariplo, Italy; Ministero Universita Ricerca (MIUR) e Salute, Italy; Regione Piemonte, Italy	Associazione Italiana Ricerca sul Cancro (AIRC), Italy(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo, Italy(Fondazione Cariplo); Ministero Universita Ricerca (MIUR) e Salute, Italy(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte, Italy(Regione Piemonte)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC), Italy; Fondazione Cariplo, Italy; Ministero Universita Ricerca (MIUR) e Salute, Italy; and Regione Piemonte, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Artis D, 2005, J IMMUNOL, V174, P7154, DOI 10.4049/jimmunol.174.11.7154; Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Dai J, 2007, EUR J IMMUNOL, V37, P706, DOI 10.1002/eji.200636643; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Gao K, 2006, CANCER RES, V66, P8382, DOI 10.1158/0008-5472.CAN-05-4402; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; GHOSH P, 1994, CANCER RES, V54, P2969; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim JH, 2005, GENE THER, V12, P1517, DOI 10.1038/sj.gt.3302584; KONO S, 1994, ENDOCRINOLOGY, V135, P1529, DOI 10.1210/en.135.4.1529; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Lu LN, 1997, J IMMUNOL, V158, P5676; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Radhakrishnan S, 2007, J IMMUNOL, V178, P1426, DOI 10.4049/jimmunol.178.3.1426; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Riboldi E, 2003, BRIT J PHARMACOL, V140, P377, DOI 10.1038/sj.bjp.0705428; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zanoni I, 2011, AUTOIMMUNITY, V44, P23, DOI 10.3109/08916931003782148; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Ziegler-Heitbrock HWL, 1997, IMMUNOBIOLOGY, V198, P73; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	60	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45279	10.1371/journal.pone.0045279	http://dx.doi.org/10.1371/journal.pone.0045279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049782	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100036
J	Leukel, C; Lundbye-Jensen, J; Christensen, MS; Gollhofer, A; Nielsen, JB; Taube, W				Leukel, Christian; Lundbye-Jensen, Jesper; Christensen, Mark Schram; Gollhofer, Albert; Nielsen, Jens Bo; Taube, Wolfgang			Subconscious Visual Cues during Movement Execution Allow Correct Online Choice Reactions	PLOS ONE			English	Article							MOTOR CONTROL; STIMULATION; INHIBITION; PERCEPTION; STIMULUS; CORTEX; MONKEY	Part of the sensory information is processed by our central nervous system without conscious perception. Subconscious processing has been shown to be capable of triggering motor reactions. In the present study, we asked the question whether visual information, which is not consciously perceived, could influence decision-making in a choice reaction task. Ten healthy subjects (28 +/- 5 years) executed two different experimental protocols. In the Motor reaction protocol, a visual target cue was shown on a computer screen. Depending on the displayed cue, subjects had to either complete a reaching movement (go-condition) or had to abort the movement (stop-condition). The cue was presented with different display durations (20-160 ms). In the second Verbalization protocol, subjects verbalized what they experienced on the screen. Again, the cue was presented with different display durations. This second protocol tested for conscious perception of the visual cue. The results of this study show that subjects achieved significantly more correct responses in the Motor reaction protocol than in the Verbalization protocol. This difference was only observed at the very short display durations of the visual cue. Since correct responses in the Verbalization protocol required conscious perception of the visual information, our findings imply that the subjects performed correct motor responses to visual cues, which they were not conscious about. It is therefore concluded that humans may reach decisions based on subconscious visual information in a choice reaction task.	[Leukel, Christian; Gollhofer, Albert] Univ Freiburg, Dept Sport Sci, D-79106 Freiburg, Germany; [Leukel, Christian; Taube, Wolfgang] Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland; [Lundbye-Jensen, Jesper; Christensen, Mark Schram; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Lundbye-Jensen, Jesper; Christensen, Mark Schram; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Christensen, Mark Schram] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark	University of Freiburg; University of Fribourg; University of Copenhagen; University of Copenhagen; University of Copenhagen	Leukel, C (corresponding author), Univ Freiburg, Dept Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	christian.leukel@sport.uni-freiburg.de	Albert, Gollhofer/V-3291-2019; Nielsen, Jens Bo/C-7632-2015; Taube, Wolfgang/E-4018-2012; Gollhofer, Albert/ABF-5766-2020; Lundbye-Jensen, Jesper/ABH-4025-2020	Nielsen, Jens Bo/0000-0001-5568-2916; Taube, Wolfgang/0000-0002-8802-2065; Lundbye-Jensen, Jesper/0000-0003-3144-861X	German Research Foundation (DFG); Albert-Ludwigs University Freiburg (funding program Open Access Publishing)	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs University Freiburg (funding program Open Access Publishing)	The German Research Foundation (DFG) and the Albert-Ludwigs University Freiburg (funding program Open Access Publishing) funded the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Christensen MS, 2008, P NATL ACAD SCI USA, V105, P1353, DOI 10.1073/pnas.0705858105; Day BL, 2001, BRAIN, V124, P1832, DOI 10.1093/brain/124.9.1832; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Eimer M, 2003, BIOL PSYCHOL, V64, P7, DOI 10.1016/S0301-0511(03)00100-5; Eimer M, 2002, NEUROPSYCHOLOGIA, V40, P2438, DOI 10.1016/S0028-3932(02)00079-9; Eimer M, 2002, PSYCHON B REV, V9, P514, DOI 10.3758/BF03196307; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hesse C, 2011, SEEING PERCEIVING, V24, P151, DOI 10.1163/187847511X570105; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Neumann O, 1994, ATTENTIION PERFORMAN; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schenk T, 2011, VISION RES, V51, P812, DOI 10.1016/j.visres.2011.02.003; Schmidt Filipp, 2011, Adv Cogn Psychol, V7, P120, DOI 10.2478/v10053-008-0092-2; Taylor JL, 1996, EXP BRAIN RES, V110, P62	25	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44496	10.1371/journal.pone.0044496	http://dx.doi.org/10.1371/journal.pone.0044496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049749	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100014
J	Saroussi, S; Schushan, M; Ben-Tal, N; Junge, W; Nelson, N				Saroussi, Shai; Schushan, Maya; Ben-Tal, Nir; Junge, Wolfgang; Nelson, Nathan			Structure and Flexibility of the C-Ring in the Electromotor of Rotary FoF1-ATPase of Pea Chloroplasts	PLOS ONE			English	Article							ELASTIC POWER TRANSMISSION; NORMAL-MODE ANALYSIS; COLI ATP SYNTHASE; CRYSTAL-STRUCTURE; ROTOR RING; VISCOELASTIC DYNAMICS; NA+-ATPASE; F-ATPASE; MECHANISM; PROTEIN	A ring of 8-15 identical c-subunits is essential for ion-translocation by the rotary electromotor of the ubiquitous FOF1-ATPase. Here we present the crystal structure at 3.4 angstrom resolution of the c-ring from chloroplasts of a higher plant (Pisum sativum), determined using a native preparation. The crystal structure was found to resemble that of an (ancestral) cyanobacterium. Using elastic network modeling to investigate the ring's eigen-modes, we found five dominant modes of motion that fell into three classes. They revealed the following deformations of the ring: (I) ellipsoidal, (II) opposite twisting of the luminal circular surface of the ring against the stromal surface, and (III) kinking of the hairpin-shaped monomers in the middle, resulting in bending/stretching of the ring. Extension of the elastic network analysis to rings of different cn-symmetry revealed the same classes of dominant modes as in P. sativum (c(14)). We suggest the following functional roles for these classes: The first and third classes of modes affect the interaction of the c-ring with its counterparts in F-O, namely subunits a and bb'. These modes are likely to be involved in ion-translocation and torque generation. The second class of deformation, along with deformations of subunits gamma and epsilon might serve to elastically buffer the torque transmission between F-O and F-1.	[Saroussi, Shai; Schushan, Maya; Ben-Tal, Nir; Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel; [Junge, Wolfgang] Univ Osnabruck, Div Biophys, Osnabruck, Germany	Tel Aviv University; University Osnabruck	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel.	nelson@post.tau.ac.il	Junge, Wolfgang/F-6289-2012; Saroussi, Shai/Y-2163-2019	Saroussi, Shai/0000-0003-0422-6165; Ben-Tal, Nir/0000-0001-6901-832X; Nelson, Nathan/0000-0003-3588-7265	Israel Science Foundation (ISF) [204-10, 1331/11]; United States-Israel Agricultural Research and Development Fund (BARD) Research grant [IS-4229-09]; Eshkol Foundation; Israeli Ministry of Science; Edmond J. Safra Bioinformatics program at Tel-Aviv University	Israel Science Foundation (ISF)(Israel Science Foundation); United States-Israel Agricultural Research and Development Fund (BARD) Research grant; Eshkol Foundation; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Edmond J. Safra Bioinformatics program at Tel-Aviv University	This work was supported by the Israel Science Foundation Grant 204-10 (ISF) and by the United States-Israel Agricultural Research and Development Fund (BARD) Research grant No. IS-4229-09. S.S. was supported by the Eshkol Foundation, the Israeli Ministry of Science. M.S. was supported by the Edmond J. Safra Bioinformatics program at Tel-Aviv University. N.B.-T. acknowledges the support of grant 1331/11 from the Israel Science Foundation. Eshkol Foundation, the Israeli Ministry of Science URL: http://www.most.gov.il/nr/exeres/8F309A05-C3FC-498D-AF16-DB2456D8AC4A.htm, Edmond J. Safra Bioinformatics program URL: http://safrabio.cs.tau.ac.il/, Israel Science Foundation grant 1331/11 URL: http://www.isf.org.il/english/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Echeverria C, 2011, PHYS CHEM CHEM PHYS, V13, P10527, DOI 10.1039/c1cp00003a; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Franklin MJ, 2004, BIOPHYS J, V87, P3594, DOI 10.1529/biophysj.104.044248; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haliloglu T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000164; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kessel A, 2002, CURR TOP MEMBR, V52, P205; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Krebstakies T, 2008, BIOCHEMISTRY-US, V47, P6907, DOI 10.1021/bi800173a; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lezon TR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000496; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; SCHOENKNECHT G, 1986, FEBS LETT, V203, P289, DOI 10.1016/0014-5793(86)80760-8; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Yeheskel A, 2010, BIOPHYS J, V98, P2179, DOI 10.1016/j.bpj.2010.01.049	63	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43045	10.1371/journal.pone.0043045	http://dx.doi.org/10.1371/journal.pone.0043045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049735	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100007
J	Spiering, R; van der Zee, R; Wagenaar, J; Kapetis, D; Zolezzi, F; van Eden, W; Broere, F				Spiering, Rachel; van der Zee, Ruurd; Wagenaar, Josee; Kapetis, Dimos; Zolezzi, Francesca; van Eden, Willem; Broere, Femke			Tolerogenic Dendritic Cells That Inhibit Autoimmune Arthritis Can Be Induced by a Combination of Carvacrol and Thermal Stress	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; EXTRACELLULAR METALLOTHIONEIN; IMMUNOMODULATORY ACTIVITIES; INTERLEUKIN-10 PRODUCTION; RHEUMATOID-ARTHRITIS; BONE-MARROW; IN-VITRO; INDUCTION; ALPHA	Tolerogenic dendritic cells (DCs) can induce regulatory T cells and dampen pathogenic T cell responses. Therefore, they are possible therapeutic targets in autoimmune diseases. In this study we investigated whether mouse tolerogenic DCs are induced by the phytonutrient carvacrol, a molecule with known anti-inflammatory properties, in combination with a physiological stress. We show that treatment of DCs with carvacrol and thermal stress led to the mRNA expression of both pro- and anti-inflammatory mediators. Interestingly, treated DCs with this mixed gene expression profile had a reduced ability to activate pro-inflammatory T cells. Furthermore, these DCs increased the proportion of FoxP3(+) regulatory T cells. In vivo, prophylactic injection of carvacrol-thermal stress treated DCs pulsed with the disease inducing antigen was able to suppress disease in a mouse model of arthritis. These findings suggest that treatment of mouse bone marrow derived DCs with carvacrol and thermal stress induce a functionally tolerogenic DC that can suppress autoimmune arthritis. Herewith carvacrol seems to offer novel opportunities for the development of a dietary based intervention in chronic inflammatory diseases.	[Spiering, Rachel; van der Zee, Ruurd; Wagenaar, Josee; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kapetis, Dimos; Zolezzi, Francesca] Univ Milano Bicocca, Genopolis, Dept Biotechnol & Biosci, Milan, Italy	Utrecht University; University of Milano-Bicocca	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	van der Zee, Ruurd/O-5256-2015	van der Zee, Ruurd/0000-0002-4331-2755; Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics [IGE07004]; European Union FP7 TOLERAGE [HEALTH-F4-2008-20215]; Dutch Arthritis Association	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics; European Union FP7 TOLERAGE; Dutch Arthritis Association	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics: IGE07004 (http://www.agentschapnl.nl/en) European Union FP7 TOLERAGE: HEALTH-F4-2008-20215 (http://www.tolerage.eu/) Dutch Arthritis Association (http://www.reumafonds.nl/informatie-voor-doelgroepen/professionals/research-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bles N, 2010, BLOOD, V116, P3219, DOI 10.1182/blood-2010-01-265611; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; deSchoolmeester ML, 2003, J IMMUNOL, V170, P4693, DOI 10.4049/jimmunol.170.9.4693; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Healy Louise J, 2008, Open Rheumatol J, V2, P71, DOI 10.2174/1874312900802010071; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Huh S, 2007, J MICROBIOL BIOTECHN, V17, P348; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Landa P, 2009, ARCH PHARM RES, V32, P75, DOI 10.1007/s12272-009-1120-6; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; LYNES MA, 1993, TOXICOLOGY, V85, P161, DOI 10.1016/0300-483X(93)90040-Y; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Ostberg JR, 2006, CANCER IMMUNOL IMMUN, V55, P292, DOI 10.1007/s00262-005-0689-y; Reus IS, 2003, J BIOCHEM MOL TOXIC, V17, P161, DOI 10.1002/jbt.10074; Salazar L, 2008, ANN RHEUM DIS, V67, P1235, DOI 10.1136/ard.2007.072199; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stoop JN, 2011, ANN RHEUM DIS, V70, P1526, DOI 10.1136/ard.2011.151654; Stoop JN, 2010, ARTHRITIS RHEUM-US, V62, P3656, DOI 10.1002/art.27756; Thomson AW, 2008, ANN RHEUM DIS, V67, P90, DOI 10.1136/ard.2008.099176; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Wieten L, 2010, CELL STRESS CHAPERON, V15, P25, DOI 10.1007/s12192-009-0119-8; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Yamane S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-5; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; YOUN J, 1995, J TOXICOL ENV HEALTH, V45, P397, DOI 10.1080/15287399509532004; Youn J, 1999, TOXICOL SCI, V52, P199, DOI 10.1093/toxsci/52.2.199; Youn J, 2002, CLIN EXP IMMUNOL, V129, P232, DOI 10.1046/j.1365-2249.2002.01922.x	41	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46336	10.1371/journal.pone.0046336	http://dx.doi.org/10.1371/journal.pone.0046336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050016	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100180
J	Sukharnikov, LO; Alahuhta, M; Brunecky, R; Upadhyay, A; Himmel, ME; Lunin, VV; Zhulin, IB				Sukharnikov, Leonid O.; Alahuhta, Markus; Brunecky, Roman; Upadhyay, Amit; Himmel, Michael E.; Lunin, Vladimir V.; Zhulin, Igor B.			Sequence, Structure, and Evolution of Cellulases in Glycoside Hydrolase Family 48	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN; ALIGNMENT; GENE; CELLOBIOHYDROLASE; EXPRESSION; CONVERSION; DISCOVERY; INSIGHTS	Currently, the cost of cellulase enzymes remains a key economic impediment to commercialization of biofuels (1). Enzymes from glycoside hydrolase family 48 (GH48) are a critical component of numerous natural lignocellulose-degrading systems. Although computational mining of large genomic data sets is a promising new approach for identifying novel cellulolytic activities, current computational methods are unable to distinguish between cellulases and enzymes with different substrate specificities that belong to the same protein family. We show that by using a robust computational approach supported by experimental studies, cellulases and non-cellulases can be effectively identified within a given protein family. Phylogenetic analysis of GH48 showed non-monophyletic distribution, an indication of horizontal gene transfer. Enzymatic function of GH48 proteins coded by horizontally transferred genes was verified experimentally, which confirmed that these proteins are cellulases. Computational and structural studies of GH48 enzymes identified structural elements that define cellulases and can be used to computationally distinguish them from noncellulases. We propose that the structural element that can be used for in silico discrimination between cellulases and noncellulases belonging to GH48 is an omega-loop located on the surface of the molecule and characterized by highly conserved rare amino acids. These markers were used to screen metagenomics data for "true" cellulases.	[Sukharnikov, Leonid O.; Alahuhta, Markus; Brunecky, Roman; Upadhyay, Amit; Himmel, Michael E.; Lunin, Vladimir V.; Zhulin, Igor B.] Univ Tennessee, Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Sukharnikov, Leonid O.; Upadhyay, Amit; Zhulin, Igor B.] Univ Tennessee, Oak Ridge Natl Lab, Joint Inst Computat Sci, Oak Ridge, TN 37831 USA; [Alahuhta, Markus; Brunecky, Roman; Himmel, Michael E.; Lunin, Vladimir V.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Lunin, VV (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.	vladimir.lunin@nrel.gov; joulineib@ornl.gov	Alahuhta, Markus/E-9344-2012; Zhulin, Igor/T-3509-2019; Zhulin, Igor B/A-2308-2012; Upadhyay, Amit/R-5056-2019	Alahuhta, Markus/0000-0001-9375-778X; Zhulin, Igor/0000-0002-6708-5323; Zhulin, Igor B/0000-0002-6708-5323; Upadhyay, Amit/0000-0002-0952-4164; Brunecky, Roman/0000-0002-8352-4234	Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center	Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of Science, Office of Biological and Environmental Research, through the BioEnergy Science Center, a Department of Energy Bioenergy Research Center.	Aden A, 2009, CELLULOSE, V16, P535, DOI 10.1007/s10570-009-9327-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Brulc JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025329; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huws SA, 2010, FEMS MICROBIOL ECOL, V73, P396, DOI 10.1111/j.1574-6941.2010.00892.x; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Izquierdo JA, 2010, APPL ENVIRON MICROB, V76, P3545, DOI 10.1128/AEM.02689-09; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu CC, 1998, GENE, V211, P39, DOI 10.1016/S0378-1119(98)00081-X; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olson DG, 2010, P NATL ACAD SCI USA, V107, P17727, DOI 10.1073/pnas.1003584107; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Ramirez-Ramirez N, 2008, INT J MOL SCI, V9, P247, DOI 10.3390/ijms9030247; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; SHEN H, 1995, BIOCHEM J, V311, P67, DOI 10.1042/bj3110067; Sluiter A, 2006, NRELTP51042618; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Sukharnikov LO, 2011, TRENDS BIOTECHNOL, V29, P473, DOI 10.1016/j.tibtech.2011.04.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430	50	27	30	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41068	41077		10.1074/jbc.M112.405720	http://dx.doi.org/10.1074/jbc.M112.405720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055526	Green Published, hybrid			2022-12-25	WOS:000311887600024
J	Coffey, K; Blackburn, TJ; Cook, S; Golding, BT; Griffin, RJ; Hardcastle, IR; Hewitt, L; Huberman, K; McNeill, HV; Newell, DR; Roche, C; Ryan-Munden, CA; Watson, A; Robson, CN				Coffey, Kelly; Blackburn, Timothy J.; Cook, Susan; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Hewitt, Lorraine; Huberman, Kety; McNeill, Hesta V.; Newell, David R.; Roche, Celine; Ryan-Munden, Claudia A.; Watson, Anna; Robson, Craig N.			Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; DNA-DAMAGE RESPONSE; ANDROGEN RECEPTOR; IN-VITRO; ACETYLATION; COACTIVATOR; PROTEIN; APOPTOSIS; ACTIVATION; EXPRESSION	Tip60 (KAT5) is a histone acetyltransferase (HAT enzyme) involved in multiple cellular processes including transcriptional regulation, DNA damage repair and cell signalling. In prostate cancer, aggressive cases over-express Tip60 which functions as an androgen receptor co-activator via direct acetylation of lysine residues within the KLKK motif of the receptor hinge region. The purpose of this study was to identify and characterise a Tip60 acetylase inhibitor. High-throughput screening revealed an isothiazole that inhibited both Tip60 and p300 HAT activity. This substance (initially identified as 4-methyl-5-bromoisothiazole) and other isothiazoles were synthesised and assayed against Tip60. Although an authentic sample of 4-methyl-5-bromoisothiazole was inactive against Tip60, in an in vitro HAT assay, 1,2-bis(isothiazol-5-yl)disulfane (NU9056) was identified as a relatively potent inhibitor (IC50 2 mu M). Cellular activity was confirmed by analysis of acetylation of histone and non-histone proteins in a prostate cancer cell line model. NU9056 treatment inhibited cellular proliferation in a panel of prostate cancer cell lines (50% growth inhibition, 8-27 mu M) and induced apoptosis via activation of caspase 3 and caspase 9 in a concentration-and time-dependent manner. Also, decreased androgen receptor, prostate specific antigen, p53 and p21 protein levels were demonstrated in response to treatment with NU9056. Furthermore, pre-treatment with NU9056 inhibited both ATM phosphorylation and Tip60 stabilization in response to ionising radiation. Based on the activity of NU9056 and the specificity of the compound towards Tip60 relative to other HAT enzymes, these chemical biology studies have identified Tip60 as a potential therapeutic target for the treatment of prostate cancer.	[Coffey, Kelly; Cook, Susan; Hewitt, Lorraine; McNeill, Hesta V.; Ryan-Munden, Claudia A.; Robson, Craig N.] Newcastle Univ, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blackburn, Timothy J.; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Newell, David R.; Roche, Celine; Watson, Anna] Newcastle Univ, Drug Discovery & Imaging Grp, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Huberman, Kety] OSI Pharmaceut Inc, Farmingdale, NY USA; [Blackburn, Timothy J.; Golding, Bernard T.; Griffin, Roger J.; Hardcastle, Ian R.; Roche, Celine; Watson, Anna] Newcastle Univ, Res & Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Astellas Pharmaceuticals; OSI Pharmaceuticals; Newcastle University - UK	Robson, CN (corresponding author), Newcastle Univ, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.n.robson@ncl.ac.uk	Hardcastle, Ian/AAY-3748-2020; Coffey, Kelly/AAZ-4433-2020	Hardcastle, Ian/0000-0001-7495-3769; Coffey, Kelly/0000-0003-0502-2914; Pendlebury, Anna/0000-0002-4033-8458	Cancer Research UK (CRUK) [C240/A7409, C29821/A10348]; Medical Research Council (MRC) PROMPT [G0100100/64424]; OSI Pharmaceuticals; MRC [G0900871] Funding Source: UKRI; Cancer Research UK [15751] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Medical Research Council (MRC) PROMPT; OSI Pharmaceuticals(Astellas Pharmaceuticals); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by Cancer Research UK (CRUK) (C240/A7409; C29821/A10348) (www.cancerresearchuk.org) and Medical Research Council (MRC) PROMPT (G0100100/64424) (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge OSI Pharmaceuticals for sponsorship of this research collaboration, Dr Jacqueline Stockley and Dr Stuart Williamson for providing expertise in flow cytometry; Miss Lynsey Rogerson, Miss Grace Tan, Mr Christopher J. Keilty and Dr Fadhel Shaheen for technical assistance. The use of the EPSRC mass spectrometry service at the University of Wales (Swansea) is gratefully acknowledged.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Biel M, 2004, ANGEW CHEM INT EDIT, V43, P3974, DOI 10.1002/anie.200453879; Blum KA, 2009, BRIT J HAEMATOL, V147, P507, DOI 10.1111/j.1365-2141.2009.07881.x; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Culig Z, 2006, J CELL BIOCHEM, V99, P373, DOI 10.1002/jcb.20898; Dekker FJ, 2009, BIOORGAN MED CHEM, V17, P460, DOI 10.1016/j.bmc.2008.12.008; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gorsuch S, 2009, BIOORGAN MED CHEM, V17, P467, DOI 10.1016/j.bmc.2008.11.079; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lin XH, 2001, CANCER RES, V61, P8611; Mai A, 2008, J MED CHEM, V51, P2279, DOI 10.1021/jm701595q; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Park KC, 2005, BIOCHEM BIOPH RES CO, V331, P1469, DOI 10.1016/j.bbrc.2005.04.030; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rigas AC, 2007, ONCOGENE, V26, P7611, DOI 10.1038/sj.onc.1210586; Sbardella G, 2008, BIOORG MED CHEM LETT, V18, P2788, DOI 10.1016/j.bmcl.2008.04.017; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shiota M, PROSTATE, V70, P540; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	39	87	93	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45539	10.1371/journal.pone.0045539	http://dx.doi.org/10.1371/journal.pone.0045539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056207	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500020
J	Zou, YZ; Weis, WI; Kobilka, BK				Zou, Yaozhong; Weis, William I.; Kobilka, Brian K.			N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; ANTAGONIST; COMPLEX; GPCR	A highly crystallizable T4 lysozyme (T4L) was fused to the N-terminus of the beta(2) adrenergic receptor (beta(2)AR), a G-protein coupled receptor (GPCR) for catecholamines. We demonstrate that the N-terminal fused T4L is sufficiently rigid relative to the receptor to facilitate crystallogenesis without thermostabilizing mutations or the use of a stabilizing antibody, G protein, or protein fused to the 3rd intracellular loop. This approach adds to the protein engineering strategies that enable crystallographic studies of GPCRs alone or in complex with a signaling partner.	[Zou, Yaozhong; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, GM083118, GM56169]; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, R01GM056169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge support from National Institutes of Health Grants NS028471 and GM083118 ( B. K. K.), GM56169 ( W. I. W.), and the Mathers Foundation ( B. K. K. and W. I. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	18	66	68	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46039	10.1371/journal.pone.0046039	http://dx.doi.org/10.1371/journal.pone.0046039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056231	Green Submitted, gold, Green Published			2022-12-25	WOS:000309580800006
J	Boone, DR; Sell, SL; Micci, MA; Crookshanks, JM; Parsley, M; Uchida, T; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Sell, Stacy L.; Micci, Maria-Adelaide; Crookshanks, Jeanna M.; Parsley, Margaret; Uchida, Tatsuo; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Traumatic Brain Injury-Induced Dysregulation of the Circadian Clock	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS; ALZHEIMERS-DISEASE; RAT HIPPOCAMPUS; GENE-EXPRESSION; HEAD TRAUMA; RHYTHMS; MEMORY; NEURONS; OSCILLATION	Circadian rhythm disturbances are frequently reported in patients recovering from traumatic brain injury (TBI). Since circadian clock output is mediated by some of the same molecular signaling cascades that regulate memory formation (cAMP/MAPK/CREB), cognitive problems reported by TBI survivors may be related to injury-induced dysregulation of the circadian clock. In laboratory animals, aberrant circadian rhythms in the hippocampus have been linked to cognitive and memory dysfunction. Here, we addressed the hypothesis that circadian rhythm disruption after TBI is mediated by changes in expression of clock genes in the suprachiasmatic nuclei (SCN) and hippocampus. After fluid-percussion TBI or sham surgery, male Sprague-Dawley rats were euthanized at 4 h intervals, over a 48 h period for tissue collection. Expression of circadian clock genes was measured using quantitative real-time PCR in the SCN and hippocampus obtained by laser capture and manual microdissection respectively. Immunofluorescence and Western blot analysis were used to correlate TBI-induced changes in circadian gene expression with changes in protein expression. In separate groups of rats, locomotor activity was monitored for 48 h. TBI altered circadian gene expression patterns in both the SCN and the hippocampus. Dysregulated expression of key circadian clock genes, such as Bmal1 and Cry1, was detected, suggesting perturbation of transcriptional-translational feedback loops that are central to circadian timing. In fact, disruption of circadian locomotor activity rhythms in injured animals occurred concurrently. These results provide an explanation for how TBI causes disruption of circadian rhythms as well as a rationale for the consideration of drugs with chronobiotic properties as part of a treatment strategy for TBI.	[Boone, Deborah R.; Sell, Stacy L.; Micci, Maria-Adelaide; Crookshanks, Jeanna M.; Parsley, Margaret; Uchida, Tatsuo; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Moody Foundation/Mission Connect; Department of Anesthesiology	Moody Foundation/Mission Connect; Department of Anesthesiology	This study was supported in part by the Moody Foundation/Mission Connect and in part by the Department of Anesthesiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Alamili M, 2010, DAN MED BULL, V57; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Benca R, 2009, BRAIN RES REV, V62, P57, DOI 10.1016/j.brainresrev.2009.09.005; Boyce P, 2010, AUST FAM PHYSICIAN, V39, P307; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Cheeseman JF, 2012, P NATL ACAD SCI USA, V109, P7061, DOI 10.1073/pnas.1201734109; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen Z, 2007, CELL CYCLE, V6, P2906, DOI 10.4161/cc.6.23.5041; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Dawson D, 1996, PHARMACOL THERAPEUT, V69, P15, DOI 10.1016/0163-7258(95)02020-9; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Eckel-Mahan KL, 2009, EMBO REP, V10, P584, DOI 10.1038/embor.2009.123; Gamsby JJ, 2009, J BIOL RHYTHM, V24, P193, DOI 10.1177/0748730409334748; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Gerstner JR, 2012, FRONTIERS MOL NEUROS, V5, P1; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gouin JP, 2010, J AFFECT DISORDERS, V126, P161, DOI 10.1016/j.jad.2010.04.002; Halberg Franz, 2003, J Circadian Rhythms, V1, P2, DOI 10.1186/1740-3391-1-2; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; LeSauter J, 1999, J NEUROSCI, V19, P5574; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Paparrigopoulos T, 2006, BRAIN INJURY, V20, P873, DOI 10.1080/02699050600832114; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rawashdeh O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00027; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; SAS Institute Inc, 2004, SAS STAT US GUID VER; Sassone-Corsi P, 2010, MOL ENDOCRINOL, V24, P2081, DOI 10.1210/me.2010-0359; Schaaf MJM, 2000, MOL BRAIN RES, V75, P342, DOI 10.1016/S0169-328X(99)00314-9; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Uz T, 2005, NEUROSCIENCE, V134, P1309, DOI 10.1016/j.neuroscience.2005.05.003; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	68	56	59	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46204	10.1371/journal.pone.0046204	http://dx.doi.org/10.1371/journal.pone.0046204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056261	Green Published, gold			2022-12-25	WOS:000309454000025
J	Hayes, CD; Dey, D; Palavicini, JP; Wang, HJ; Araki, W; Lakshmana, MK				Hayes, Crystal D.; Dey, Debleena; Palavicini, Juan Pablo; Wang, Hongjie; Araki, Wataru; Lakshmana, Madepalli K.			Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice	PLOS ONE			English	Article							PRECURSOR PROTEIN; 2-CHLORODEOXYADENOSINE; TOXICITY; DISEASE; PIN1; PHARMACOKINETICS; MULTICENTER; LYMPHOMAS; LEUKEMIA; THERAPY	Background: The clinical uses of 2-chloro-2'-deoxyadenosine (2-CDA) or cladribine which was initially prescribed to patients with hematological and lymphoid cancers is now extended to treat patients with multiple sclerosis (MS). Previous data has shown that 2-CDA has high affinity to the brain and readily passes through the blood brain barrier reaching CSF concentrations 25% of that found in plasma. However, whether long-term administration of 2-CDA can lead to any adverse effects in patients or animal models is not yet clearly known. Methodology: Here we show that exposure of 2-CDA to CHO cells stably expressing wild-type APP751 increased generation and secretion of amyloid beta peptide (A beta) in to the conditioned medium. Interestingly, increased A beta levels were noticed even at non-toxic concentrations of 2-CDA. Remarkably, chronic treatment of APdE9 mice, a model of Alzheimer's disease with 2-CDA for 60 days increased amyloid plaque burden by more than 1-fold. Increased A beta generation appears to result from increased turnover of APP as revealed by cycloheximide-chase experiments. Additionally, surface labeling of APP with biotin and immunoprecipitation of surface labeled proteins with anti-biotin antibody also indicated increased APP at the cell surface in 2-CDA treated cells compared to controls. Increased turnover of APP by 2-CDA in turn might be a consequence of decreased protein levels of PIN 1, which is known to regulate cis-trans isomerization and phosphorylation of APP. Most importantly, like many other oncology drugs, 2-CDA administration led to significant delay in acquiring a reward-based learning task in a T maze paradigm. Conclusions: Taken together, these data provide compelling evidence for the first time that chronic 2-CDA administration can increase amyloidogenic processing of APP leading to robustly increased plaque burden which may be responsible for the observed deficits in learning skills. Thus chronic treatment of mice with 2-CDA can have deleterious effects in vivo.	[Hayes, Crystal D.; Dey, Debleena; Palavicini, Juan Pablo; Wang, Hongjie; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA; [Araki, Wataru] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Kodaira, Tokyo 1870031, Japan	Torrey Pines Institute for Molecular Studies, Florida; National Center for Neurology & Psychiatry - Japan	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA.	mlakshmana@tpims.org	Araki, Wataru/G-7913-2014	Araki, Wataru/0000-0001-8467-6937	Alzheimer's and Aging Institute; TPIMS, Florida	Alzheimer's and Aging Institute; TPIMS, Florida	The authors are grateful to the seed money obtained in the form of a small institutional grant from Alzheimer's and Aging Institute, TPIMS, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Asher Arash, 2011, Am J Phys Med Rehabil, V90, pS16, DOI 10.1097/PHM.0b013e31820be463; BEUTLER E, 1992, LANCET, V340, P952, DOI 10.1016/0140-6736(92)92826-2; Blum KA, 2006, CANCER, V107, P2817, DOI 10.1002/cncr.22344; CARSON DA, 1983, BLOOD, V62, P737; CARSON DA, 1977, P NATL ACAD SCI USA, V74, P5677, DOI 10.1073/pnas.74.12.5677; CHESON BD, 1994, J CLIN ONCOL, V12, P2216, DOI 10.1200/JCO.1994.12.10.2216; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Davis Jr JC, 1988, ARTHRITIS RHEUM, V41, P335; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Developmental Therapeutics Program NCI/NIH, DEV THER PROGR; Djaldetti R, 1996, J SUBMICR CYTOL PATH, V28, P319; Duddy M, 2011, J NEUROL, V258, P728, DOI 10.1007/s00415-011-6009-x; Gasperini C, 2011, EXPERT OPIN EMERG DR, V16, P697, DOI 10.1517/14728214.2011.642861; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gold R, 2011, CNS DRUGS, V25, P37, DOI 10.2165/11539820-000000000-00000; Hartman WR, 2004, MOL PHARMACOL, V65, P227, DOI 10.1124/mol.65.1.227; Hartung HP, 2010, J NEUROL, V257, P163, DOI 10.1007/s00415-009-5359-0; Hentosh P, 2010, EXPERT OPIN DRUG MET, V6, P75, DOI 10.1517/17425250903393745; KAWASAKI H, 1993, BLOOD, V81, P597; Khachanova N V, 2011, Zh Nevrol Psikhiatr Im S S Korsakova, V111, P99; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Liliemark J, 1997, CLIN PHARMACOKINET, V32, P120, DOI 10.2165/00003088-199732020-00003; Lindemalm S, 2004, CANCER LETT, V210, P171, DOI 10.1016/j.canlet.2004.03.007; Lotfi K, 2003, LEUKEMIA LYMPHOMA, V44, P1705, DOI 10.1080/1042819031000099698; Lu PJ, 1999, NATURE, V399, P784; Myers Jamie S, 2012, Oncol Nurs Forum, V39, pE31, DOI 10.1188/12.ONF.E31-E40; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Ogura M, 2004, INT J HEMATOL, V80, P267, DOI 10.1532/IJH97.04077; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Rice GPA, 2000, NEUROLOGY, V54, P1145, DOI 10.1212/WNL.54.5.1145; Robak T, 2000, BRIT J HAEMATOL, V108, P357; Roe CM, 2005, NEUROLOGY, V64, P895, DOI 10.1212/01.WNL.0000152889.94785.51; Romine JS, 1999, P ASSOC AM PHYSICIAN, V111, P35, DOI 10.1046/j.1525-1381.1999.09115.x; Rummel MJ, 1999, ANN ONCOL, V10, P115, DOI 10.1023/A:1008325212484; Salvat C, 2009, ANN C EUR COMM TREAT; SAVEN A, 1994, ANN INTERN MED, V120, P784, DOI 10.7326/0003-4819-120-9-199405010-00010; SAVEN A, 1993, J CLIN ONCOL, V11, P671, DOI 10.1200/JCO.1993.11.4.671; Schirmer M, 1997, SCAND J RHEUMATOL, V26, P376, DOI 10.3109/03009749709065702; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; Sipe Jack C, 2005, Expert Rev Neurother, V5, P721, DOI 10.1586/14737175.5.6.721; SIPE JC, 1994, LANCET, V344, P9, DOI 10.1016/S0140-6736(94)91046-4; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Tack GJ, 2011, WORLD J GASTROENTERO, V17, P506, DOI 10.3748/wjg.v17.i4.506; VAHDAT L, 1994, BLOOD, V84, P3429; Zachariae R, 2011, NAT REV UROL, V8, P182, DOI 10.1038/nrurol.2011.29	49	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e45841	10.1371/journal.pone.0045841	http://dx.doi.org/10.1371/journal.pone.0045841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056220	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000012
J	Joshi, AD; Loilome, W; Siu, IM; Tyler, B; Gallia, GL; Riggins, GJ				Joshi, Avadhut D.; Loilome, Watcharin; Siu, I-Mei; Tyler, Betty; Gallia, Gary L.; Riggins, Gregory J.			Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy	PLOS ONE			English	Article							PHASE-II TRIAL; EGFR; GROWTH; GEFITINIB; ERLOTINIB; CELLS; SENSITIVITY; PROTEIN; GLIOMAS	Glioblastoma multiforme (GBM) is the most common intracranial cancer but despite recent advances in therapy the overall survival remains about 20 months. Whole genome exon sequencing studies implicate mutations in the receptor tyrosine kinase pathways (RTK) for driving tumor growth in over 80% of GBMs. In spite of various RTKs being mutated or altered in the majority of GBMs, clinical studies have not been able to demonstrate efficacy of molecular targeted therapies using tyrosine kinase inhibitors in GBMs. Activation of multiple downstream signaling pathways has been implicated as a possible means by which inhibition of a single RTK has been ineffective in GBM. In this study, we sought a combination of approved drugs that would inhibit in vitro and in vivo growth of GBM oncospheres. A combination consisting of gefitinib and sunitinib acted synergistically in inhibiting growth of GBM oncospheres in vitro. Sunitinib was the only RTK inhibitor that could induce apoptosis in GBM cells. However, the in vivo efficacy testing of the gefitinib and sunitinib combination in an EGFR amplified/PTEN wild type GBM xenograft model revealed that gefitinib alone could significantly improve survival in animals whereas sunitinib did not show any survival benefit. Subsequent testing of the same drug combination in a different syngeneic glioma model that lacked EGFR amplification but was more susceptible to sunitinib in vitro demonstrated no survival benefit when treated with gefitinib or sunitinib or the gefitinib and sunitinib combination. Although a modest survival benefit was obtained in one of two animal models with EGFR amplification due to gefitinib alone, the addition of sunitinib, to test our best in vitro combination therapy, did not translate to any additional in vivo benefit. Improved targeted therapies, with drug properties favorable to intracranial tumors, are likely required to form effective drug combinations for GBM.	[Joshi, Avadhut D.; Loilome, Watcharin; Siu, I-Mei; Tyler, Betty; Gallia, Gary L.; Riggins, Gregory J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA	Johns Hopkins University	Riggins, GJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	griggin1@jhmi.edu	Loilome, Watcharin/AAW-6203-2021		National Institutes of Health (NIH) [R01 NS052507]; Virginia; D.K. Ludwig Fund for Cancer Research; Children's Cancer Foundation; Irving J. Sherman M. D. Neurosurgery Research Professorship; Matt Trainham ABTA; Faculty of Medicine at Khon Kaen University, Thailand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia; D.K. Ludwig Fund for Cancer Research; Children's Cancer Foundation; Irving J. Sherman M. D. Neurosurgery Research Professorship; Matt Trainham ABTA; Faculty of Medicine at Khon Kaen University, Thailand; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health (NIH) Grant R01 NS052507, the Virginia and D.K. Ludwig Fund for Cancer Research, and the Children's Cancer Foundation. GJR is supported by the Irving J. Sherman M. D. Neurosurgery Research Professorship. AJ was supported by Matt Trainham ABTA basic research fellowship (http://www.abta.org/). WL was supported by the Faculty of Medicine at Khon Kaen University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielen A, 2011, MOL CANCER THER, V10, P1407, DOI 10.1158/1535-7163.MCT-11-0205; Cappuzzo F, 2005, J NATL CANCER I, V97, P868, DOI 10.1093/jnci/dji169; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; de Vries NA, 2012, INVEST NEW DRUG, V30, P443, DOI 10.1007/s10637-010-9569-1; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Neyns B, 2011, J NEURO-ONCOL, V103, P491, DOI 10.1007/s11060-010-0402-7; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sathornsumetee S, 2009, EXPERT OPIN INV DRUG, V18, P277, DOI [10.1517/13543780802692603, 10.1517/13543780802692603 ]; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Trembath DG, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-30; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773	25	36	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e44372	10.1371/journal.pone.0044372	http://dx.doi.org/10.1371/journal.pone.0044372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056179	Green Submitted, gold, Green Published			2022-12-25	WOS:000309452600003
J	O'Dell, WB; Baker, DC; McLain, SE				O'Dell, William B.; Baker, David C.; McLain, Sylvia E.			Structural Evidence for Inter-Residue Hydrogen Bonding Observed for Cellobiose in Aqueous Solution	PLOS ONE			English	Article							SYNCHROTRON X-RAY; CONFORMATIONAL-ANALYSIS; GLYCOSIDIC LINKAGES; CRYSTAL-STRUCTURE; D-GLUCOSE; CELLULOSE; HYDRATION; WATER; NMR; H-1-NMR	The structure of the disaccharide cellulose subunit cellobiose (4-O-beta-D-glucopyranosyl-D-glucose) in solution has been determined via neutron diffraction with isotopic substitution (NDIS), computer modeling and nuclear magnetic resonance (NMR) spectroscopic studies. This study shows direct evidence for an intramolecular hydrogen bond between the reducing ring HO3 hydroxyl group and the non-reducing ring oxygen (O5') that has been previously predicted by computation and NMR analysis. Moreover, this work shows that hydrogen bonding to the non-reducing ring O5' oxygen is shared between water and the HO3 hydroxyl group with an average of 50% occupancy by each hydrogen-bond donor. The glycosidic torsion angles phi(H) and psi(H) from the neutron diffraction-based model show a fairly tight distribution of angles around approximately 22 degrees and -40 degrees, respectively, in solution, consistent with the NMR measurements. Similarly, the hydroxymethyl torsional angles for both reducing and non-reducing rings are broadly consistent with the NMR measurements in this study, as well as with those from previous measurements for cellobiose in solution.	[O'Dell, William B.; Baker, David C.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [McLain, Sylvia E.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Tennessee System; University of Tennessee Knoxville; University of Oxford	Baker, DC (corresponding author), Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA.	dcbaker@utk.edu; sylvia.mclain@bioch.ox.ac.uk	O'Dell, William B/R-2753-2017	O'Dell, William B/0000-0002-8063-5190; McLain, Sylvia/0000-0002-3347-7759	LDRD (Laboratory Directed Research and Development) - SEED from Oak Ridge National Laboratory; University of Tennessee; Engineering and Physical Sciences Research Council [EP/J002615/1] Funding Source: researchfish; EPSRC [EP/J002615/1] Funding Source: UKRI	LDRD (Laboratory Directed Research and Development) - SEED from Oak Ridge National Laboratory; University of Tennessee; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an LDRD (Laboratory Directed Research and Development) - SEED money grant from Oak Ridge National Laboratory, operated by UT-Batelle for the United States Department of Energy. SEM received additional support from the Engineering and Physical Sciences Research Council, United Kingdom. WBO recieved a travel grant from the Chancellor's Honors Program, University of Tennessee, in support of this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283; Barnett CB, 2008, J PHYS CHEM B, V112, P15450, DOI 10.1021/jp8067409; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bernet B, 2000, HELV CHIM ACTA, V83, P2055, DOI 10.1002/1522-2675(20000906)83:9&lt;2055::AID-HLCA2055&gt;3.0.CO;2-C; Bowron DT, 2006, J AM CHEM SOC, V128, P5119, DOI 10.1021/ja0583057; Cheetham NWH, 2003, CARBOHYD RES, V338, P955, DOI 10.1016/S0008-6215(03)00069-7; Christensen NJ, 2010, CARBOHYD RES, V345, P474, DOI 10.1016/j.carres.2009.12.009; CHU SSC, 1968, ACTA CRYSTALL B-STRU, VB 24, P830, DOI 10.1107/S0567740868003250; Cloran F, 1999, J AM CHEM SOC, V121, P9843, DOI 10.1021/ja984384t; De Spirito M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041801; Deetlefs M, 2005, J PHYS CHEM B, V109, P1593, DOI 10.1021/jp047742p; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; Flugge LA, 1999, J AM CHEM SOC, V121, P7228, DOI 10.1021/ja990561u; Foglia F, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3488998; French AD, 2006, CAN J CHEM, V84, P603, DOI 10.1139/V06-050; French AD, 2012, CARBOHYD RES, V350, P68, DOI 10.1016/j.carres.2011.12.023; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Hargreaves R, 2011, J AM CHEM SOC, V133, P16524, DOI 10.1021/ja205804k; HARVEY JM, 1978, J SOLUTION CHEM, V7, P571, DOI 10.1007/BF00646035; Headen TF, 2010, J AM CHEM SOC, V132, P5735, DOI 10.1021/ja909084e; Hulme EC, 2006, BIOPHYS J, V91, P2371, DOI 10.1529/biophysj.106.089185; Imberti S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/40/404212; *IUPAC IUB JOINT C, 1983, PURE APPL CHEM, V55, P1269; Kamm B, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 1, P3; KROON J, 1994, J MOL STRUCT, V322, P27, DOI 10.1016/0022-2860(94)87018-7; LEEFLANG BR, 1992, CARBOHYD RES, V230, P41, DOI 10.1016/S0008-6215(00)90512-3; Malardier-Jugroot C, 2010, PHYS CHEM CHEM PHYS, V12, P382, DOI 10.1039/b915346b; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Mancinelli R, 2007, PHYS CHEM CHEM PHYS, V9, P2959, DOI 10.1039/b701855j; Mason PE, 2005, J PHYS CHEM B, V109, P13104, DOI 10.1021/jp040622x; Mason PE, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2393237; McLain SE, 2004, ANGEW CHEM INT EDIT, V43, P1952, DOI 10.1002/anie.200353289; McLain SE, 2008, ANGEW CHEM INT EDIT, V47, P9059, DOI 10.1002/anie.200802679; McLain SE, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2784555; Meyer KH, 1928, BER DTSCH CHEM GES, V61, P593, DOI 10.1002/cber.19280610402; Meyer KH, 1936, HELV CHIM ACTA, V20, P232; Missori M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238001; NISHIDA Y, 1984, TETRAHEDRON LETT, V25, P1575, DOI 10.1016/S0040-4039(01)90014-0; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Olsson U, 2008, J PHYS CHEM B, V112, P4447, DOI 10.1021/jp710977k; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Pagnotta SE, 2010, J PHYS CHEM B, V114, P4904, DOI 10.1021/jp911940h; PARFONDRY A, 1977, CARBOHYD RES, V59, P299, DOI 10.1016/S0008-6215(00)83172-9; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Pincu M, 2011, J PHYS CHEM A, V115, P9498, DOI 10.1021/jp112109p; POPPE L, 1994, NAT STRUCT BIOL, V1, P215, DOI 10.1038/nsb0494-215; REES DA, 1968, CARBOHYD RES, V7, P334, DOI 10.1016/S0008-6215(00)81206-9; Rockwell GD, 1998, J AM CHEM SOC, V120, P10953, DOI 10.1021/ja981958l; Roslund MU, 2008, CARBOHYD RES, V343, P101, DOI 10.1016/j.carres.2007.10.008; Sears V.F., 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; SHALLENBERGER RS, 1982, ADV SUGAR CHEM PRINC; Shen TY, 2009, J AM CHEM SOC, V131, P14786, DOI 10.1021/ja9034158; Soper A.K., 1989, ATLAS ANAL TIME OF F; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Soper AK, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104204; Sponsler O. L., 1926, COLLOID S MONOGRAPH, V4, P174; Stenutz R, 2002, J ORG CHEM, V67, P949, DOI 10.1021/jo010985i; Sugiyama H, 2000, J MOL STRUCT, V556, P173, DOI 10.1016/S0022-2860(00)00630-X; Sugiyama M, 2000, TMRSJ, V25, P743; Towey JJ, 2011, J PHYS CHEM B, V115, P7799, DOI 10.1021/jp203140b; Umemura M, 2005, J MOL STRUC-THEOCHEM, V730, P1, DOI 10.1016/j.theochem.2005.05.034; Venturi G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3176413; WILLKER W, 1995, MAGN RESON CHEM, V33, P632, DOI 10.1002/mrc.1260330804; Zhang WH, 2009, CARBOHYD RES, V344, P1582, DOI 10.1016/j.carres.2009.06.007; Zhou H, 2007, J ORG CHEM, V72, P7071; Zugenmaier P., 2008, CRYSTALLINE CELLULOS, DOI 10.1007/978-3-540-73934-0	67	32	32	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45311	10.1371/journal.pone.0045311	http://dx.doi.org/10.1371/journal.pone.0045311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056199	gold, Green Submitted, Green Published			2022-12-25	WOS:000309452600010
J	Kreuzer, PM; Landgrebe, M; Schecklmann, M; Staudinger, S; Langguth, B				Kreuzer, Peter M.; Landgrebe, Michael; Schecklmann, Martin; Staudinger, Susanne; Langguth, Berthold		TRI Database Study Grp	Trauma-Associated Tinnitus: Audiological, Demographic and Clinical Characteristics	PLOS ONE			English	Article							OPERATION IRAQI FREEDOM; BRAIN-INJURY; DEPRESSION; ANXIETY; SEVERITY; SENSITIVITY; DYSFUNCTION; INVENTORY; ANNOYANCE; ATTENTION	Background: Tinnitus can result from different etiologies. Frequently, patients report the development of tinnitus after traumatic injuries. However, to which extent this specific etiologic factor plays a role for the phenomenology of tinnitus is still incompletely understood. Additionally, it remains a matter of debate whether the etiology of tinnitus constitutes a relevant criterion for defining tinnitus subtypes. Objective: By investigating a worldwide sample of tinnitus patients derived from the Tinnitus Research Initiative (TRI) Database, we aimed to identify differences in demographic, clinical and audiological characteristics between tinnitus patients with and without preceding trauma. Materials: A total of 1,604 patients were investigated. Assessment included demographic data, tinnitus related clinical data, audiological data, the Tinnitus Handicap Inventory, the Tinnitus Questionnaire, the Beck Depression Inventory, various numeric tinnitus rating scales, and the World Health Organisation Quality of Life Scale (WHOQoL). Results: Our data clearly indicate differences between tinnitus patients with and without trauma at tinnitus onset. Patients suffering from trauma-associated tinnitus suffer from a higher mental burden than tinnitus patients presenting with phantom perceptions based on other or unknown etiologic factors. This is especially the case for patients with whiplash and head trauma. Patients with posttraumatic noise-related tinnitus experience more frequently hyperacousis, were younger, had longer tinnitus duration, and were more frequently of male gender. Conclusions: Trauma before tinnitus onset seems to represent a relevant criterion for subtypization of tinnitus. Patients with posttraumatic tinnitus may require specific diagnostic and therapeutic management. A more systematic and - at best standardized assessment for hearing related sequelae of trauma is needed for a better understanding of the underlying pathophysiology and for developing more tailored treatment approaches as well.	[Kreuzer, Peter M.; Landgrebe, Michael; Schecklmann, Martin; Staudinger, Susanne; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Landgrebe, Michael] Sozialstiftung Bamberg, Dept Psychiat Psychosomat Med & Psychotherapy, Bamberg, Germany	University of Regensburg	Kreuzer, PM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany.	peter.kreuzer@medbo.de	Langguth, Berthold/AAP-2638-2021; Kleinjung, Tobias/AAJ-3141-2020; Coelho, Claudia/J-6250-2016	Kleinjung, Tobias/0000-0003-3867-234X; Coelho, Claudia/0000-0002-2441-0739; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative/TRI	Tinnitus Research Initiative/TRI	The study was supported by the Tinnitus Research Initiative/TRI (www.tinnitusresearch.org). All authors confirm no conflicts of interest in regard to the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchic L, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00018; Andersson G, 2009, J AM ACAD AUDIOL, V20, P315, DOI 10.3766/jaaa.20.5.5; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Boniver Raymond, 2002, Int Tinnitus J, V8, P129; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Geckle L, 2004, SOLDIER PERCEPTIONS; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leske M C, 1981, ASHA, V23, P229; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lewis J E, 2002, J Am Acad Audiol, V13, P339; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malouff JM, 2011, CURR PSYCHIAT REP, V13, P31, DOI 10.1007/s11920-010-0163-1; Mao J. C., 2011, J NEUROTRAUMA; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nicolas-Puel Cecile, 2006, Int Tinnitus J, V12, P64; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Organization WH, 1996, WHOQOL BREF INTR ADM; Potier M, 2009, EAR HEARING, V30, P291, DOI 10.1097/AUD.0b013e31819769fc; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shida S, 1990, Nihon Jibiinkoka Gakkai Kaiho, V93, P1823; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; STEER RA, 1986, J CLIN PSYCHOL, V42, P475, DOI 10.1002/1097-4679(198605)42:3<475::AID-JCLP2270420311>3.0.CO;2-D; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner Oliver, 2007, Ann Gen Psychiatry, V6, P26, DOI 10.1186/1744-859X-6-26; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yankaskas K, 2012, HEAR RES	55	28	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45599	10.1371/journal.pone.0045599	http://dx.doi.org/10.1371/journal.pone.0045599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049821	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300037
J	Leoncini, E; Prata, C; Malaguti, M; Marotti, I; Segura-Carretero, A; Catizone, P; Dinelli, G; Hrelia, S				Leoncini, Emanuela; Prata, Cecilia; Malaguti, Marco; Marotti, Ilaria; Segura-Carretero, Antonio; Catizone, Pietro; Dinelli, Giovanni; Hrelia, Silvana			Phytochemical Profile and Nutraceutical Value of Old and Modern Common Wheat Cultivars	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TRITICUM-AESTIVUM L.; PHASE-II ENZYMES; ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; HEALTH-BENEFITS; NEURODEGENERATIVE DISEASES; CEREAL-GRAINS; WHOLE GRAINS	Among health-promoting phytochemicals in whole grains, phenolic compounds have gained attention as they have strong antioxidant properties and can protect against many degenerative diseases. Aim of this study was to profile grain phenolic extracts of one modern and five old common wheat (Triticum aestivum L.) varieties and to evaluate their potential antiproliferative or cytoprotective effect in different cell culture systems. Wheat extracts were characterized in terms of antioxidant activity and phenolic composition (HPLC/ESI-TOF-MS profile, polyphenol and flavonoid contents). Results showed that antioxidant activity (FRAP and DPPH) is mostly influenced by flavonoid (both bound and free) content and by the ratio flavonoids/polyphenols. Using a leukemic cell line, HL60, and primary cultures of neonatal rat cardiomyocytes, the potential antiproliferative or cytoprotective effects of different wheat genotypes were evaluated in terms of intracellular reactive oxygen species levels and cell viability. All tested wheat phenolic extracts exerted dose-dependent cytoprotective and antiproliferative effects on cardiomyocytes and HL60 cells, respectively. Due to the peculiar phenolic pattern of each wheat variety, a significant genotype effect was highlighted. On the whole, the most relevant scavenging effect was found for the old variety Verna. No significant differences in terms of anti-proliferative activities among wheat genotypes was observed. Results reported in this study evidenced a correspondence between the in vitro antioxidant activity and potential healthy properties of different extracts. This suggests that an increased intake of wheat grain derived products could represent an effective strategy to achieve both chemoprevention and protection against oxidative stress related diseases.	[Leoncini, Emanuela; Prata, Cecilia; Malaguti, Marco; Hrelia, Silvana] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy; [Marotti, Ilaria; Catizone, Pietro; Dinelli, Giovanni] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Segura-Carretero, Antonio] Univ Granada, Dept Analyt Chem, E-18071 Granada, Spain	University of Bologna; University of Bologna; University of Granada	Hrelia, S (corresponding author), Univ Bologna, Dept Biochem, I-40126 Bologna, Italy.	silvana.hrelia@unibo.it	Carretero, Antonio Segura/B-6867-2014; Hrelia, Silvana/P-2864-2015; Malaguti, Marco/K-5994-2015	Carretero, Antonio Segura/0000-0002-5564-5338; Hrelia, Silvana/0000-0001-7857-4512; Malaguti, Marco/0000-0003-0349-7772; Dinelli, Giovanni/0000-0003-1740-3511	Italian Ministry of Economic Development, Emilia Romagna region, Italy [CUP J31J09000430002]; Italian Ministry of Agriculture [CUP 31J09000370001]; Fondazione del Monte di Bologna e Ravenna (Italy)	Italian Ministry of Economic Development, Emilia Romagna region, Italy; Italian Ministry of Agriculture; Fondazione del Monte di Bologna e Ravenna (Italy)(Fondazione del Monte di Bologna e Ravenna)	This work was supported by grants from the Italian Ministry of Economic Development (Project "Made in Italy-over 50"), Emilia Romagna region, Italy (Project "BioPane", CUP J31J09000430002) and the Italian Ministry of Agriculture (Project "Pane della salute" MiPAF-OIGA, CUP 31J09000370001) and by Fondazione del Monte di Bologna e Ravenna (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adom KK, 2003, J AGR FOOD CHEM, V51, P7825, DOI 10.1021/jf030404l; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Angeloni C, 2008, AM J PHYSIOL-HEART C, V294, pH1233, DOI 10.1152/ajpheart.01091.2007; Angeloni C, 2007, BIOCHIMIE, V89, P73, DOI 10.1016/j.biochi.2006.09.006; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bilodeau M, 2002, J MULTIVARIATE ANAL, V82, P457, DOI 10.1006/jmva.2001.2027; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bonfili L, 2009, BIOCHIMIE, V91, P1131, DOI 10.1016/j.biochi.2009.06.001; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; Chen LJ, 2003, CHEM RES TOXICOL, V16, P1155, DOI 10.1021/tx0340605; Chlopicka J, 2012, LWT-FOOD SCI TECHNOL, V46, P548, DOI 10.1016/j.lwt.2011.11.009; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Di Silvestro R, 2012, J SCI FOOD AGR, V92, P2800, DOI 10.1002/jsfa.5590; Dinelli G, 2007, ELECTROPHORESIS, V28, P4212, DOI 10.1002/elps.200700301; Dinelli G, 2011, J CHROMATOGR A, V1218, P7670, DOI 10.1016/j.chroma.2011.05.065; Dinelli G, 2009, J CHROMATOGR A, V1216, P7229, DOI 10.1016/j.chroma.2009.08.041; Diplock AT, 1999, BRIT J NUTR, V81, pS1, DOI 10.1017/S0007114599000471; Dykes L, 2007, CEREAL FOOD WORLD, V52, P105, DOI 10.1094/CFW-52-3-0105; Eilat-Adar S, 2010, NUTR METAB CARDIOVAS, V20, P459, DOI 10.1016/j.numecd.2010.01.011; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Felice F, 2012, EUR J PHARM BIOPHARM, V80, P176, DOI 10.1016/j.ejpb.2011.09.002; FENG Y, 1988, CEREAL CHEM, V65, P452; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; Halliwell B., 2007, FREE RADICAL BIOL ME; Harris KA, 2010, CURR ATHEROSCLER REP, V12, P368, DOI 10.1007/s11883-010-0136-1; Heimler D, 2010, J AGR FOOD CHEM, V58, P7329, DOI 10.1021/jf1010534; Jambu M, 1991, STAT MODELING DECISI; Jonnalagadda SS, 2011, J NUTR, V141, p1011S, DOI 10.3945/jn.110.132944; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kutala VK, 2007, ANTIOXID REDOX SIGN, V9, P1193, DOI 10.1089/ars.2007.1636; Lacikova L, 2009, MOLECULES, V14, P3259, DOI 10.3390/molecules14093259; LAM TBT, 1990, PHYTOCHEMISTRY, V29, P429, DOI 10.1016/0031-9422(90)85091-S; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z; Matus-Cadiz MA, 2008, J AGR FOOD CHEM, V56, P1644, DOI 10.1021/jf072970c; MCCALLUM JA, 1990, CEREAL CHEM, V67, P282; Middleton E, 2000, PHARMACOL REV, V52, P673; Okarter N, 2010, CRIT REV FOOD SCI, V50, P193, DOI 10.1080/10408390802248734; Olenichenko NA, 2006, RUSS J PLANT PHYSL+, V53, P495, DOI 10.1134/S1021443706040108; Pauwels EKJ, 2010, MED PRIN PRACT, V20, P103, DOI 10.1159/000321197; Prata C, 2010, LEUKEMIA RES, V34, P1630, DOI 10.1016/j.leukres.2010.02.032; Price RK, 2012, BR J NUTR, P1; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Serpen A, 2008, J AGR FOOD CHEM, V56, P7285, DOI 10.1021/jf8010855; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; Yu LL, 2002, J AGR FOOD CHEM, V50, P1619, DOI 10.1021/jf010964p	58	56	58	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45997	10.1371/journal.pone.0045997	http://dx.doi.org/10.1371/journal.pone.0045997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049918	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300073
J	Veracx, A; Rivet, R; McCoy, KD; Brouqui, P; Raoult, D				Veracx, Aurelie; Rivet, Romain; McCoy, Karen D.; Brouqui, Philippe; Raoult, Didier			Evidence That Head and Body Lice on Homeless Persons Have the Same Genotype	PLOS ONE			English	Article							BARTONELLA-QUINTANA; POPULATION-GENETICS; MITOCHONDRIAL-DNA; PHTHIRAPTERA; PEDICULIDAE; HUMANS; ORIGIN	Human head lice and body lice are morphologically and biologically similar but have distinct ecologies. They were shown to have almost the same basic genetic content (one gene is absent in head lice), but differentially express certain genes, presumably responsible for the vector competence. They are now believed to be ecotypes of the same species (Pediculus humanus) and based on mitochondrial studies, body lice have been included with head lice in one of three clades of human head lice (Clade A). Here, we tested whether head and body lice collected from the same host belong to the same population by examining highly polymorphic intergenic spacers. This study was performed on lice collected from five homeless persons living in the same shelter in which Clade A lice are prevalent. Lice were individually genotyped at four spacer loci. The genetic identity and diversity of lice from head and body populations were compared for each homeless person. Population genetic structure was tested between lice from the two body regions and between the lice from different host individuals. We found two pairs of head and body lice on the same homeless person with identical multi locus genotypes. No difference in genetic diversity was found between head and body louse populations and no evidence of significant structure between the louse populations was found, even after controlling for a possible effect of the host individual. More surprisingly, no structure was obvious between lice of different homeless persons. We believe that the head and body lice collected from our five subjects belong to the same population and are shared between people living in the same shelter. These findings confirm that head and body lice are two ecotypes of the same species and show the importance of implementing measures to prevent lice transmission between homeless people in shelters.	[Veracx, Aurelie; Rivet, Romain; Brouqui, Philippe; Raoult, Didier] Univ Aix Marseille, URMITE UMR 6236, CNRS IRD, Fac Med, Marseille, France; [McCoy, Karen D.] Ctr IRD, MIVEGEC UMR 5290, CNRS IRD UM1 UM2, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Raoult, D (corresponding author), Univ Aix Marseille, URMITE UMR 6236, CNRS IRD, Fac Med, Marseille, France.	Didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Brouqui, Philippe/P-5771-2016; McCoy, Karen D/F-7061-2012	RAOULT, Didier/0000-0002-0633-5974; McCoy, Karen D/0000-0002-8972-3808; RIVET, Romain/0000-0002-7290-6069				Amevigbe MDD, 2000, MED VET ENTOMOL, V14, P419, DOI 10.1046/j.1365-2915.2000.00260.x; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Angelakis E, 2011, FEMS IMMUNOL MED MIC, V62, P244, DOI 10.1111/j.1574-695X.2011.00804.x; Badiaga S, 2009, EUR J PUBLIC HLTH, V19; Badiaga S, 2008, EMERG INFECT DIS, V14, P1353, DOI 10.3201/eid1409.080204; Badiaga S, 2008, J ANTIMICROB CHEMOTH, V62, P404, DOI 10.1093/jac/dkn161; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Brouqui P, 2005, MEDICINE BALTIMORE, V84; Busvine J., 1985, CUTANEOUS INFESTATIO, P163; Busvine J. R., 1944, PROC ROY ENT SOC LONDON SER A, V19, P22; BUSVINE JR, 1978, SYST ENTOMOL, V3, P1, DOI 10.1111/j.1365-3113.1978.tb00383.x; BUXTON PA, 1946, LOUSE ACCOUNT LICE W; Cutler SJ, 2009, CLIN MICROBIOL INFEC, V15; de Meeus T, 2007, INFECT GENET EVOL, V7, P308, DOI 10.1016/j.meegid.2006.07.003; Durden Lance A., 2002, P45, DOI 10.1016/B978-012510451-7/50006-2; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Leo NP, 2002, J MED ENTOMOL, V39, P662, DOI 10.1603/0022-2585-39.4.662; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; McMeniman CJ, 2006, HEREDITY, V96, P63, DOI 10.1038/sj.hdy.6800760; Nuttall G. H. F., 1920, Parasitology Cambridge, V12, DOI 10.1017/S0031182000014098; Olds BP, 2012, INSECT MOL BIOL, V21, P257, DOI 10.1111/j.1365-2583.2012.01132.x; Raoult D, 1999, CLIN INFECT DIS, V29; Raoult D, 2008, J INFECT DIS, P197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Sasaki-Fukatsu K, 2006, APPL ENV MICROBIOL, V72; Schaefer CW, 1978, T R SOC TROP MED HYG, V72; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Veracx A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037804; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yong Z, 2003, C R BIOL, V326	40	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45903	10.1371/journal.pone.0045903	http://dx.doi.org/10.1371/journal.pone.0045903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049889	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300063
J	Bernard, JA; Seidler, RD				Bernard, Jessica A.; Seidler, Rachael D.			Hand Dominance and Age Have Interactive Effects on Motor Cortical Representations	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERHEMISPHERIC-TRANSFER TIME; HUMAN CORPUS-CALLOSUM; INTRACORTICAL INHIBITION; HEMISPHERIC-ASYMMETRY; EVOKED POTENTIALS; OLDER-ADULTS; HANDEDNESS; MUSCLE; PREFERENCE	Older adults exhibit more bilateral motor cortical activity during unimanual task performance than young adults. Interestingly, a similar pattern is seen in young adults with reduced hand dominance. However, older adults report stronger hand dominance than young adults, making it unclear how handedness is manifested in the aging motor cortex. Here, we investigated age differences in the relationships between handedness, motor cortical organization, and interhemispheric communication speed. We hypothesized that relationships between these variables would differ for young and older adults, consistent with our recent proposal of an age-related shift in interhemispheric interactions. We mapped motor cortical representations of the right and left first dorsal interosseous muscles using transcranial magnetic stimulation (TMS) in young and older adults recruited to represent a broad range of the handedness spectrum. We also measured interhemispheric communication speed and bimanual coordination. We observed that more strongly handed older adults exhibited more ipsilateral motor activity in response to TMS; this effect was not present in young adults. Furthermore, we found opposing relationships between interhemispheric communication speed and bimanual performance in the two age groups. Thus, handedness manifests itself differently in the motor cortices of young and older adults and has interactive effects with age.	[Bernard, Jessica A.; Seidler, Rachael D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Seidler, Rachael D.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bernard, JA (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jessbern@umich.edu		Seidler, Rachael/0000-0003-2452-9024	National Institute on Aging [T32 AG000114]; UM Claude D. Pepper Older American Independence Center; NATIONAL INSTITUTE ON AGING [T32AG000114] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UM Claude D. Pepper Older American Independence Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.B. is supported by National Institute on Aging T32 AG000114 (R. Miller, PI). This research was also supported by the UM Claude D. Pepper Older American Independence Center (human subjects' core). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; BIEGON A, 1994, NEUROBIOL AGING, V15, P393, DOI 10.1016/0197-4580(94)90070-1; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; Dittmar M, 2002, HUM BIOL, V74, P569, DOI 10.1353/hub.2002.0040; Fling BW, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00038; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; Fling BW, HUMAN BRAIN IN PRESS; Fling BW, NEUROBIOL A IN PRESS; Fling BW, CEREB CORTE IN PRESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Hopkins WD, 2007, CEREB CORTEX, V17, P1757, DOI 10.1093/cercor/bhl086; Jeeves MA, 1996, NEUROPSYCHOLOGIA, V34, P627, DOI 10.1016/0028-3932(95)00157-3; Jung P, 2006, MUSCLE NERVE, V34, P431, DOI 10.1002/mus.20604; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Koerte I, 2010, DEV MED CHILD NEUROL, V52, P1106, DOI 10.1111/j.1469-8749.2010.03766.x; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Luders E, 2010, NEUROIMAGE, V52, P43, DOI 10.1016/j.neuroimage.2010.04.016; Manson SC, 2006, EXP BRAIN RES, V174, P728, DOI 10.1007/s00221-006-0517-4; Marzi CA, 1999, BRAIN RES BULL, V50, P421, DOI 10.1016/S0361-9230(99)00174-4; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Poffenberger AT., 1912, ARCH PSYCHOL, V23, P1; PORAC C, 1993, CAN J EXP PSYCHOL, V47, P697, DOI 10.1037/h0078873; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 1999, PSYCHOL SCI, V10, P494, DOI 10.1111/1467-9280.00195; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Saron CD, 2002, IS CL CO NE, P171; Schulte T, 2004, NEUROPSYCHOLOGIA, V42, P257, DOI 10.1016/S0028-3932(03)00155-6; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinohara M, 2003, J APPL PHYSIOL, V94, P966, DOI 10.1152/japplphysiol.00836.2002; Siebner HR, 2002, J NEUROSCI, V22, P2816, DOI 10.1523/JNEUROSCI.22-07-02816.2002; Soteropoulos DS, 2011, J NEUROSCI, V31, P11208, DOI 10.1523/JNEUROSCI.0257-11.2011; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; STEINGRUBER HJ, 1971, Z EXP ANGEW PSYCHOL, V18, P337; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Talelli P, 2008, EXP BRAIN RES, V186, P59, DOI 10.1007/s00221-007-1205-8; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; TRIGGS WJ, 1994, BRAIN RES, V636, P270, DOI 10.1016/0006-8993(94)91026-X; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zaidel E, 2002, IS CL CO NE, P319; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	61	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45443	10.1371/journal.pone.0045443	http://dx.doi.org/10.1371/journal.pone.0045443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049800	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100048
J	Dalkmann, P; Broszat, M; Siebe, C; Willaschek, E; Sakinc, T; Huebner, J; Amelung, W; Grohmann, E; Siemens, J				Dalkmann, Philipp; Broszat, Melanie; Siebe, Christina; Willaschek, Elisha; Sakinc, Tuerkan; Huebner, Johannes; Amelung, Wulf; Grohmann, Elisabeth; Siemens, Jan			Accumulation of Pharmaceuticals, Enterococcus, and Resistance Genes in Soils Irrigated with Wastewater for Zero to 100 Years in Central Mexico	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; POTENTIAL ENDOCRINE; ACIDIC PHARMACEUTICALS; DISRUPTING COMPOUNDS; ORGANIC-MATTER; MANURE; SORPTION; FATE; MASS; CARBAMAZEPINE	Irrigation with wastewater releases pharmaceuticals, pathogenic bacteria, and resistance genes, but little is known about the accumulation of these contaminants in the environment when wastewater is applied for decades. We sampled a chronosequence of soils that were variously irrigated with wastewater from zero up to 100 years in the Mezquital Valley, Mexico, and investigated the accumulation of ciprofloxacin, enrofloxacin, sulfamethoxazole, trimethoprim, clarithromycin, carbamazepine, bezafibrate, naproxen, diclofenac, as well as the occurrence of Enterococcus spp., and sul and qnr resistance genes. Total concentrations of ciprofloxacin, sulfamethoxazole, and carbamazepine increased with irrigation duration reaching 95% of their upper limit of 1.4 mu g/kg (ciprofloxacin), 4.3 mu g/kg (sulfamethoxazole), and 5.4 mu g/kg (carbamazepine) in soils irrigated for 19-28 years. Accumulation was soil-type-specific, with largest accumulation rates in Leptosols and no time-trend in Vertisols. Acidic pharmaceuticals (diclofenac, naproxen, bezafibrate) were not retained and thus did not accumulate in soils. We did not detect qnrA genes, but qnrS and qnrB genes were found in two of the irrigated soils. Relative concentrations of sul1 genes in irrigated soils were two orders of magnitude larger (3.15x10(-3)+/- 0.22x10(-3) copies/16S rDNA) than in non-irrigated soils (4.35x10(-5)+/- 1.00x10(-5) copies/16S rDNA), while those of sul2 exceeded the ones in nonirrigated soils still by a factor of 22 (6.61x10(-4)+/- 0.59x10(-4) versus 2.99x10(-5)+/- 0.26x10(-5) copies/16S rDNA). Absolute numbers of sul genes continued to increase with prolonging irrigation together with Enterococcus spp. 23S rDNA and total 16S rDNA contents. Increasing total concentrations of antibiotics in soil are not accompanied by increasing relative abundances of resistance genes. Nevertheless, wastewater irrigation enlarges the absolute concentration of resistance genes in soils due to a long-term increase in total microbial biomass.	[Dalkmann, Philipp; Willaschek, Elisha; Amelung, Wulf; Siemens, Jan] Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & Soi, Bonn, Germany; [Broszat, Melanie; Sakinc, Tuerkan; Huebner, Johannes; Grohmann, Elisabeth] Univ Hosp Freiburg, Dept Infect Dis, Freiburg, Germany; [Broszat, Melanie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Siebe, Christina] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City 04510, DF, Mexico	University of Bonn; University of Freiburg; University of Freiburg; Universidad Nacional Autonoma de Mexico	Dalkmann, P (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & Soi, Bonn, Germany.	philipp.dalkmann@uni-bonn.de	Amelung, Wulf/H-2136-2013	Amelung, Wulf/0000-0002-4920-4667; Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646; Siebe, Christina/0000-0002-2636-6778	German Research Foundation (DFG) [FI1106/5-1, GR1792/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants ( FI1106/5-1 and GR1792/4-1) from the German Research Foundation (DFG;http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ansari MI, 2008, J APPL MICROBIOL, V104, P1774, DOI 10.1111/j.1365-2672.2008.03736.x; Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Barron L, 2009, ANALYST, V134, P663, DOI 10.1039/b817822d; Binh CTT, 2008, FEMS MICROBIOL ECOL, V66, P25, DOI 10.1111/j.1574-6941.2008.00526.x; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Carballa M, 2007, WATER RES, V41, P2139, DOI 10.1016/j.watres.2007.02.012; Chavez A, 2011, ENVIRON POLLUT, V159, P1354, DOI 10.1016/j.envpol.2011.01.008; Chefetz B, 2008, CHEMOSPHERE, V73, P1335, DOI 10.1016/j.chemosphere.2008.06.070; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Conkle JL, 2010, CHEMOSPHERE, V80, P1353, DOI 10.1016/j.chemosphere.2010.06.012; Cummings DE, 2011, ENVIRON SCI TECHNOL, V45, P447, DOI 10.1021/es1029206; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Dashti AA, 2006, INT J ANTIMICROB AG, V27, P73, DOI 10.1016/j.ijantimicag.2005.09.007; Duran-Alvarez JC, 2012, CHEMOSPHERE, V88, P84, DOI 10.1016/j.chemosphere.2012.02.067; Duran-Alvarez JC, 2009, TALANTA, V78, P1159, DOI 10.1016/j.talanta.2009.01.035; FAO, 2007, STAT FOOD AGR 2007 2, P119; Figueroa-Diva RA, 2010, CHEMOSPHERE, V79, P786, DOI 10.1016/j.chemosphere.2010.03.017; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Friedel JK, 2000, BIOL FERT SOILS, V31, P414, DOI 10.1007/s003749900188; Gibson R, 2007, J CHROMATOGR A, V1169, P31, DOI 10.1016/j.chroma.2007.08.056; Gibson R, 2010, CHEMOSPHERE, V81, P1437, DOI 10.1016/j.chemosphere.2010.09.006; Gobel A, 2005, J CHROMATOGR A, V1085, P179, DOI 10.1016/j.chroma.2005.05.051; Golet EM, 2002, ANAL CHEM, V74, P5455, DOI 10.1021/ac025762m; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heuer H, 2008, SOIL BIOL BIOCHEM, V40, P1892, DOI 10.1016/j.soilbio.2008.03.014; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Heuer H, 2011, APPL ENVIRON MICROB, V77, P2527, DOI 10.1128/AEM.02577-10; Igbinosa EO, 2011, INT J ENVIRON HEAL R, V21, P402, DOI 10.1080/09603123.2011.572278; IMS, 2008, IMS CHEM COUNTR PROF; IUSS, 2006, WORK GROUP WRB WORLD; Jimenez B, 2004, WATER SCI TECHNOL, V50, P269; JimenezCisneros B, 1995, WATER SCI TECHNOL, V32, P173, DOI 10.1016/0273-1223(96)00152-7; Juarez-Figueroa LA, 2003, SALUD PUBLICA MEXICO, V45, P389; Kinney CA, 2006, ENVIRON TOXICOL CHEM, V25, P317, DOI 10.1897/05-187R.1; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kuhn I, 2003, INT J FOOD MICROBIOL, V88, P133, DOI 10.1016/S0168-1605(03)00176-4; Liu F, 2010, ENVIRON CHEM, V7, P370, DOI 10.1071/EN09160; Lobe I, 2005, SOIL BIOL BIOCHEM, V37, P1898, DOI 10.1016/j.soilbio.2005.02.030; da Costa PM, 2006, WATER RES, V40, P1735, DOI 10.1016/j.watres.2006.02.025; Mazari-Hiriart M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002305; Miao XS, 2005, ENVIRON SCI TECHNOL, V39, P7469, DOI 10.1021/es050261e; Monteiro SC, 2010, REV ENVIRON CONTAM T, V202, P53, DOI 10.1007/978-1-4419-1157-5_2; Munir M, 2011, J ENVIRON QUAL, V40, P248, DOI 10.2134/jeq2010.0209; Nordmann P, 2005, J ANTIMICROB CHEMOTH, V56, P463, DOI 10.1093/jac/dki245; Oyamada Y, 2006, J MED MICROBIOL, V55, P1395, DOI 10.1099/jmm.0.46636-0; Preger AC, 2010, EUR J SOIL SCI, V61, P551, DOI 10.1111/j.1365-2389.2010.01248.x; Raschid-Sally L., 2008, INT WATER MANAGEMENT; Rosendahl I, 2012, J ENVIRON QUAL, V41, P1275, DOI 10.2134/jeq2011.0459; Rysz M, 2004, WATER RES, V38, P3705, DOI 10.1016/j.watres.2004.06.015; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Siebe C, 1998, SOIL USE MANAGE, V14, P119, DOI 10.1111/j.1475-2743.1998.tb00628.x; Siebe C, 1994, AKKUMULATION MOBILIT; Siebe Christina, 1995, International Journal of Environmental Health Research, V5, P161, DOI 10.1080/09603129509356845; Siemens J, 2008, WATER RES, V42, P2124, DOI 10.1016/j.watres.2007.11.019; Siemens J, 2010, J ENVIRON QUAL, V39, P1201, DOI 10.2134/jeq2009.0105; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamtam F, 2011, SCI TOTAL ENVIRON, V409, P540, DOI 10.1016/j.scitotenv.2010.10.033; Ternes TA, 2007, CHEMOSPHERE, V66, P894, DOI 10.1016/j.chemosphere.2006.06.035; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; UN/WWAP, 2006, 2 UNWWAP UNESCO; Vasudevan D, 2009, GEODERMA, V151, P68, DOI 10.1016/j.geoderma.2009.03.007; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1; Wang AH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-68; Wang CJ, 2010, J HAZARD MATER, V183, P309, DOI 10.1016/j.jhazmat.2010.07.025; Werner G, 2008, Euro Surveill, V13; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Wu CX, 2008, CHEMOSPHERE, V73, P511, DOI 10.1016/j.chemosphere.2008.06.026	76	120	125	5	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45397	10.1371/journal.pone.0045397	http://dx.doi.org/10.1371/journal.pone.0045397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049795	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100044
J	Fedarovich, A; Djordjevic, KA; Swanson, SM; Peterson, YK; Nicholas, RA; Davies, C				Fedarovich, Alena; Djordjevic, Kevin A.; Swanson, Shauna M.; Peterson, Yuri K.; Nicholas, Robert A.; Davies, Christopher			High-Throughput Screening for Novel Inhibitors of Neisseria gonorrhoeae Penicillin-Binding Protein 2	PLOS ONE			English	Article							MIMETIC BETA-LACTAMS; MOSAIC-LIKE STRUCTURE; ANTIBIOTIC-RESISTANCE; DECREASED SUSCEPTIBILITY; SPECTRUM CEPHALOSPORINS; REDUCED SUSCEPTIBILITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LEVEL RESISTANCE; TRANSITION-STATE	The increasing prevalence of N. gonorrhoeae strains exhibiting decreased susceptibility to third-generation cephalosporins and the recent isolation of two distinct strains with high-level resistance to cefixime or ceftriaxone heralds the possible demise of beta-lactam antibiotics as effective treatments for gonorrhea. To identify new compounds that inhibit penicillin-binding proteins (PBPs), which are proven targets for b-lactam antibiotics, we developed a high-throughput assay that uses fluorescence polarization (FP) to distinguish the fluorescent penicillin, Bocillin-FL, in free or PBP-bound form. This assay was used to screen a 50,000 compound library for potential inhibitors of N. gonorrhoeae PBP 2, and 32 compounds were identified that exhibited >50% inhibition of Bocillin-FL binding to PBP 2. These included a cephalosporin that provided validation of the assay. After elimination of compounds that failed to exhibit concentration-dependent inhibition, the antimicrobial activity of the remaining 24 was tested. Of these, 7 showed antimicrobial activity against susceptible and penicillin-or cephalosporin-resistant strains of N. gonorrhoeae. In molecular docking simulations using the crystal structure of PBP 2, two of these inhibitors docked into the active site of the enzyme and each mediate interactions with the active site serine nucleophile. This study demonstrates the validity of a FP-based assay to find novel inhibitors of PBPs and paves the way for more comprehensive high-throughput screening against highly resistant strains of N. gonorrhoeae. It also provides a set of lead compounds for optimization of anti-gonococcal agents.	[Fedarovich, Alena; Djordjevic, Kevin A.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Swanson, Shauna M.; Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Peterson, Yuri K.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill	Fedarovich, A (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	fedorove@musc.edu; davies@musc.edu			National Institutes of Health [GM66861, AI36901]; MUSC Hollings Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Hollings Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants GM66861 to C.D. and AI36901 to R.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Charles D. Smith for technical advice. The MUSC Drug Discovery Shared Resource is supported by the MUSC Hollings Cancer Center.	Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], EURO SURVEILL; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; BAUER AW, 1959, ARCH INTERN MED, V104, P208, DOI 10.1001/archinte.1959.00270080034004; BRANNIGAN JA, 1990, MOL MICROBIOL, V4, P913, DOI 10.1111/j.1365-2958.1990.tb00664.x; DANIELSSON D, 1986, INFECT IMMUN, V52, P529, DOI 10.1128/IAI.52.2.529-533.1986; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; DOWSON CG, 1989, MOL MICROBIOL, V3, P35, DOI 10.1111/j.1365-2958.1989.tb00101.x; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golparian D, 2010, SEX TRANSM INFECT, V86, P454, DOI 10.1136/sti.2010.045377; Inglis SR, 2009, J MED CHEM, V52, P6097, DOI 10.1021/jm9009718; Ito M, 2005, ANTIMICROB AGENTS CH, V49, P137, DOI 10.1128/AAC.49.1.137-143.2005; Josephine HR, 2006, BIOCHEMISTRY-US, V45, P15873, DOI 10.1021/bi061804f; Josephine HR, 2004, J AM CHEM SOC, V126, P8122, DOI 10.1021/ja048850s; Kumar I, 2007, ACS CHEM BIOL, V2, P620, DOI 10.1021/cb7001347; Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Miguet L, 2009, J MED CHEM, V52, P5926, DOI 10.1021/jm900625q; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; Nicholas RA, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P397, DOI 10.1007/978-1-4614-1400-1_11; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ochiai S, 2007, J ANTIMICROB CHEMOTH, V60, P54, DOI 10.1093/jac/dkm166; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Olesky M, 2002, ANTIMICROB AGENTS CH, V46, P2811, DOI 10.1128/AAC.46.9.2811-2820.2002; Pechenov A, 2003, BIOCHEMISTRY-US, V42, P579, DOI 10.1021/bi026726k; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shafer WM, 2010, NEISSERIA: MOLECULAR MECHANISMS OF PATHOGENESIS, P245; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Tapsall J, 2009, J MED MICROBIOL, V58, P683, DOI 10.1099/jmm.0.007641-0; Tomberg J, 2010, BIOCHEMISTRY-US, V49, P8062, DOI 10.1021/bi101167x; Turk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019418; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zervosen A, 2004, ANTIMICROB AGENTS CH, V48, P961, DOI 10.1128/AAC.48.3.961-969.2004; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	48	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44918	10.1371/journal.pone.0044918	http://dx.doi.org/10.1371/journal.pone.0044918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049763	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100024
J	Gropp, M; Shilo, V; Vainer, G; Gov, M; Gil, Y; Khaner, H; Matzrafi, L; Idelson, M; Kopolovic, J; Zak, NB; Reubinoff, BE				Gropp, Michal; Shilo, Vitali; Vainer, Gilad; Gov, Miri; Gil, Yaniv; Khaner, Hanita; Matzrafi, Limor; Idelson, Maria; Kopolovic, Juri; Zak, Naomi B.; Reubinoff, Benjamin E.			Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN BLASTOCYSTS; LINES; TUMORIGENICITY	Teratoma tumor formation is an essential criterion in determining the pluripotency of human pluripotent stem cells. However, currently there is no consistent protocol for assessment of teratoma forming ability. Here we present detailed characterization of a teratoma assay that is based on subcutaneous co-transplantation of defined numbers of undifferentiated human embryonic stem cells (hESCs) with mitotically inactivated feeder cells and Matrigel into immunodeficient mice. The assay was highly reproducible and 100% efficient when 100,000 hESCs were transplanted. It was sensitive, promoting teratoma formation after transplantation of 100 hESCs, though larger numbers of animals and longer follow-up were required. The assay could detect residual teratoma forming cells within differentiated hESC populations however its sensitivity was decreased in the presence of differentiated cells. Our data lay the foundation, for standardization of a teratoma assay for pluripotency analysis. The assay can also be used for bio-safety analysis of pluripotent stem cellderived differentiated progeny.	[Gropp, Michal; Gil, Yaniv; Khaner, Hanita; Idelson, Maria; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Gropp, Michal; Gil, Yaniv; Khaner, Hanita; Idelson, Maria; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Dept Gynecol, Jerusalem, Israel; [Shilo, Vitali; Gov, Miri; Matzrafi, Limor; Zak, Naomi B.] CellCure NeuroSci Ltd, Jerusalem, Israel; [Vainer, Gilad; Kopolovic, Juri] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Reubinoff, BE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	benjaminr@ekmd.hugi.ac.il	Vainer, Gilad W./ABH-8314-2020	Vainer, Gilad W./0000-0002-8828-8138; Reubinoff, Benjamin/0000-0003-0353-1299	Cell Cure Neurosciences Ltd.; Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor	Cell Cure Neurosciences Ltd.; Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor	This work was supported by Cell Cure Neurosciences Ltd., and by a grant to the company from the Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Cohen M. A., 2007, CURR PROTOC CELL BIO; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Goldring CE, CELL STEM CELL, V8, P618; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MAYOR S, 2010, BRIT MED J, V341, pE5724; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516	29	79	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45532	10.1371/journal.pone.0045532	http://dx.doi.org/10.1371/journal.pone.0045532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049812	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100055
J	Pagonas, N; Vautz, W; Seifert, L; Slodzinski, R; Jankowski, J; Zidek, W; Westhoff, TH				Pagonas, Nikolaos; Vautz, Wolfgang; Seifert, Luzia; Slodzinski, Rafael; Jankowski, Joachim; Zidek, Walter; Westhoff, Timm H.			Volatile Organic Compounds in Uremia	PLOS ONE			English	Article							BREATH AMMONIA; HEMODIALYSIS; CREATININE	Background: Although "uremic fetor'' has long been felt to be diagnostic of renal failure, the compounds exhaled in uremia remain largely unknown so far. The present work investigates whether breath analysis by ion mobility spectrometry can be used for the identification of volatile organic compounds retained in uremia. Methods: Breath analysis was performed in 28 adults with an eGFR >= 60 ml/min per 1.73 m(2), 26 adults with chronic renal failure corresponding to an eGFR of 10-59 ml/min per 1.73 m(2), and 28 adults with end-stage renal disease (ESRD) before and after a hemodialysis session. Breath analysis was performed by ion mobility spectrometry after gas-chromatographic preseparation. Identification of the compounds of interest was performed by thermal desorption gas chromatography/mass spectrometry. Results: Breath analyses revealed significant differences in the spectra of patients with and without renal failure. Thirteen compounds were chosen for further evaluation. Some compounds including hydroxyacetone, 3-hydroxy-2-butanone and ammonia accumulated with decreasing renal function and were eliminated by dialysis. The concentrations of these compounds allowed a significant differentiation between healthy, chronic renal failure with an eGFR of 10-59 ml/min, and ESRD (p<0.05 each). Other compounds including 4-heptanal, 4-heptanone, and 2-heptanone preferentially or exclusively occurred in patients undergoing hemodialysis. Conclusion: Impairment of renal function induces a characteristic fingerprint of volatile compounds in the breath. The technique of ion mobility spectrometry can be used for the identification of lipophilic uremic retention molecules.	[Pagonas, Nikolaos; Jankowski, Joachim; Zidek, Walter; Westhoff, Timm H.] Charite Campus Benjamin Franklin, Deparment Nephrol, Berlin, Germany; [Vautz, Wolfgang; Seifert, Luzia; Slodzinski, Rafael] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Westhoff, TH (corresponding author), Charite Campus Benjamin Franklin, Deparment Nephrol, Berlin, Germany.	timm.westhoff@charite.de	Pagonas, Nikolaos/V-2241-2019	Westhoff, Timm H./0000-0001-5797-834X	European Union [217967]; German Bundesministerium fur Bildung und Forschung; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	European Union(European Commission); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	European Union (Project 217967: Second Generation Locator for Urban Search and Rescue Operations), the German Bundesministerium fur Bildung und Forschung and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ION MOBILITY SPECTRO; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P89, DOI 10.1007/s12127-008-0013-6; Bunkowski A, 2010, INT J ION MOBIL SPEC, V13, P169, DOI 10.1007/s12127-010-0045-6; Hariharan CB, 2011, INT J ION MOBIL SPEC, V14, P31, DOI 10.1007/s12127-011-0059-8; Hippokrates Oeuvres Completes d'Hippocrate, 1979, HIPPOKRATES OEUVRES, V5, P11; Hippokrates Oeuvres Completes d'Hippocrate, 1979, HIPPOKRATES OEUVRES, V4, P17; Ishida H, 2008, BIO-MED MATER ENG, V18, P99, DOI 10.3233/BME-2008-0513; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Loyek C, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-158; Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Qin T, CANC EPIDEMIOL BIOMA, V19, P2247; SIMENHOFF ML, 1977, NEW ENGL J MED, V297, P132, DOI 10.1056/NEJM197707212970303; Song G, LUNG CANC, V67, P227; Vautz W, 2010, INT J ION MOBIL SPEC, V13, P41, DOI 10.1007/s12127-010-0039-4; Vautz W, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/036004; Wahl HG, 2004, NEPHROL DIAL TRANSPL, V19, P2576, DOI 10.1093/ndt/gfh425	20	39	39	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46258	10.1371/journal.pone.0046258	http://dx.doi.org/10.1371/journal.pone.0046258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049998	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100169
J	Schoormans, D; Radonic, T; de Witte, P; Groenink, M; Azim, D; Lutter, R; Mulder, BJM; Sprangers, MAG; Zwinderman, AH				Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Azim, Donija; Lutter, Rene; Mulder, Barbara J. M.; Sprangers, Mirjam A. G.; Zwinderman, Aeilko H.			Mental Quality of Life Is Related to a Cytokine Genetic Pathway	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; CHRONIC HEART-FAILURE; CHRONIC HEPATITIS-C; SF-36 HEALTH SURVEY; MARFAN-SYNDROME; CANCER SURVIVORS; POLYMORPHISMS; FATIGUE; PATIENT; ASSOCIATION	Background: Quality of life (QoL) in patients with chronic disease is impaired and cannot be solely explained by disease severity. We explored whether genetic variability and activity contributes to QoL in patients with Marfan syndrome (MFS), a genetic connective tissue disorder. Methodology/Principal Findings: In 121 MFS patients, patient characteristics (i.e. demographics and MFS-related symptoms) were assessed. Patients completed the SF-36 to measure QoL. In addition, transcriptome wide gene expression and 484 Single Nucleotide Polymorphysms (SNPs) in cytokine genes were available. QoL was first analyzed and associated with patient characteristics. Patients' physical QoL was impaired and weakly related with age and scoliosis, whereas mental quality of life (MCS) was normal. To explain a largely lacking correlation between disease severity and QoL, we related genome wide gene expression to QoL. Patients with lower MCS scores had high expression levels of CXCL9 and CXCL11 cytokine-related genes (p = 0.001; p = 0.002); similarly, patients with low vitality scores had high expression levels of CXCL9, CXCL11 and IFNA6 cytokine-related genes (p = 0.02; p = 0.02; p = 0.04), independent of patient characteristics. Subsequently, we associated cytokine related SNPs to mental QoL (MCS and vitality). SNP-cluster in the IL4R gene showed a weak association with MCS and vitality (strongest association p = 0.0017). Although overall mental QoL was normal, >10% of patients had low scores for MCS and vitality. Post-hoc analysis of systemic inflammatory mediators showed that patients with lowest MCS and vitality scores had high levels of CCL11 cytokine (p = 0.03; p = 0.04). Conclusions/Significance: Variation in the cytokine genetic pathway and its activation is related to mental QoL. These findings might allow us to identify and, ultimately, treat patients susceptible to poor QoL.	[Radonic, Teodora; Azim, Donija; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Azim, Donija; Sprangers, Mirjam A. G.; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Zwinderman, AH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.h.zwinderman@amc.uva.nl	Radonic, Teodora/HGU-0171-2022	Radonic, Teodora/0000-0002-6015-5202	The Netherlands Heart Foundation [2008B115]; Fighting Aneurysmal Disease (FAD) project; Interuniversity Cardiology Institute of The Netherlands [03607]	The Netherlands Heart Foundation(Netherlands Heart Foundation); Fighting Aneurysmal Disease (FAD) project; Interuniversity Cardiology Institute of The Netherlands	This study is funded by The Netherlands Heart Foundation (grant 2008B115) [www.hartstichting.nl], the Fighting Aneurysmal Disease (FAD) project [www.fighting-aneurysm.org], and The Interuniversity Cardiology Institute of The Netherlands (grant 03607) [www.icin.nl]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bluthe RM, 2002, NEUROPSYCHOPHARMACOL, V26, P86, DOI 10.1016/S0893-133X(01)00305-0; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Falasca K, 2009, CLIN INVEST MED, V32, pE212; Foran JRH, 2005, AM J MED GENET A, V134A, P58, DOI 10.1002/ajmg.a.30525; Fusar-Poli P, 2008, PSYCHOSOMATICS, V49, P243, DOI 10.1176/appi.psy.49.3.243; Groenink M, 1999, HEART, V82, P499, DOI 10.1136/hrt.82.4.499; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P1044, DOI 10.1016/j.pnpbp.2007.03.004; Kullowatz A, 2007, RESP MED, V101, P638, DOI 10.1016/j.rmed.2006.06.002; Lalchandani S, 2003, EUR J OBSTET GYN R B, V110, P125, DOI 10.1016/S0301-2115(03)00151-9; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Macedo JA, 2007, J NEUROIMMUNOL, V188, P159, DOI 10.1016/j.jneuroim.2007.06.002; Majer M, 2008, BRAIN BEHAV IMMUN, V22, P870, DOI 10.1016/j.bbi.2007.12.009; Malik UR, 2001, CANCER, V92, P1664, DOI 10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9; Mommersteeg PMC, 2010, BRAIN BEHAV IMMUN, V24, P615, DOI 10.1016/j.bbi.2010.01.004; Montinaro V, 2010, CLIN NEPHROL, V73, P36, DOI 10.2379/CNX06364; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Nes RB, 2006, PSYCHOL MED, V36, P1033, DOI 10.1017/S0033291706007409; Panju AH, 2009, SUPPORT CARE CANCER, V17, P539, DOI 10.1007/s00520-008-0512-3; Pelle AJ, 2009, QUAL LIFE RES, V18, P689, DOI 10.1007/s11136-009-9485-z; Pryce H, 2010, INT J AUDIOL, V49, P473, DOI 10.3109/14992021003627892; Radonic T, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-3; Rand-Hendriksen S, 2010, GENET MED, V12, P517, DOI 10.1097/GIM.0b013e3181ea4c1c; Rausch SM, 2010, CANCER-AM CANCER SOC, V116, P4103, DOI 10.1002/cncr.25255; Reinertsen KV, 2011, BRAIN BEHAV IMMUN, V25, P1376, DOI 10.1016/j.bbi.2011.04.001; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Solovieva S, 2004, PAIN, V109, P8, DOI 10.1016/j.pain.2003.10.020; Sprangers MAG, 2002, ACTA ONCOL, V41, P229, DOI 10.1080/02841860260088764; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1429, DOI 10.1007/s11136-010-9652-2; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Sprangers MAG, 2009, TWIN RES HUM GENET, V12, P301, DOI 10.1375/twin.12.3.301; Svedberg P, 2005, J GERONTOL B-PSYCHOL, V60, pS331, DOI 10.1093/geronb/60.6.S331; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dijk N, 2008, CLIN AUTON RES, V18, P187, DOI 10.1007/s10286-008-0475-y; Verbraecken J, 2001, CLIN GENET, V60, P360, DOI 10.1034/j.1399-0004.2001.600507.x; Wald A, 2011, BEST PRACT RES CL GA, V25, P19, DOI 10.1016/j.bpg.2010.12.004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59	45	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45126	10.1371/journal.pone.0045126	http://dx.doi.org/10.1371/journal.pone.0045126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049769	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100028
J	Zhu, ZL; Zhao, CX; Hou, YK				Zhu, Zhengli; Zhao, Chunxia; Hou, Yingkun			Research on Similarity Measurement for Texture Image Retrieval	PLOS ONE			English	Article							CLASSIFICATION	A complete texture image retrieval system includes two techniques: texture feature extraction and similarity measurement. Specifically, similarity measurement is a key problem for texture image retrieval study. In this paper, we present an effective similarity measurement formula. The MIT vision texture database, the Brodatz texture database, and the Outex texture database were used to verify the retrieval performance of the proposed similarity measurement method. Dual-tree complex wavelet transform and nonsubsampled contourlet transform were used to extract texture features. Experimental results show that the proposed similarity measurement method achieves better retrieval performance than some existing similarity measurement methods.	[Zhu, Zhengli; Zhao, Chunxia; Hou, Yingkun] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Peoples R China; [Zhu, Zhengli] Nanjing Forestry Univ, Coll Informat Sci & Technol, Nanjing, Peoples R China; [Hou, Yingkun] Taishan Univ, Sch Informat Sci & Technol, Tai An 271021, Shandong, Peoples R China	Nanjing University of Science & Technology; Nanjing Forestry University; Taishan University	Zhu, ZL (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Peoples R China.	haitian2001@163.com		Hou, Yingkun/0000-0003-2153-9040	National Science Foundation of China [90820306, 61072148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under Grants 90820306 and 61072148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodatz P., 1996, TEXTURES PHOTOGRAPHI; da Cunha AL, 2006, IEEE T IMAGE PROCESS, V15, P3089, DOI 10.1109/TIP.2006.877507; de Rivaz P., 1999, Proceedings 1999 International Conference on Image Processing (Cat. 99CH36348), P109, DOI 10.1109/ICIP.1999.821576; de Ves E, 2007, LECT NOTES COMPUT SC, V4673, P895; Do MN, 2002, IEEE T IMAGE PROCESS, V11, P146, DOI 10.1109/83.982822; Kingsbury, 2015, 9 EUR SIGN PROC C EU, DOI DOI 10.5281/ZENODO.36900; Kokare M, 2005, IEEE T SYST MAN CY B, V35, P1168, DOI 10.1109/TSMCB.2005.850176; Kokare M, 2003, TENCON IEEE REGION, P571, DOI 10.1109/TENCON.2003.1273228; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; Manjunath BS, 1996, IEEE T PATTERN ANAL, V18, P837, DOI 10.1109/34.531803; MIT Vision and Modeling Group, VIS TEXT; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Shutao L, 2004, JOINT IAPR INT WORKS, V3138, P1126; UNSER M, 1995, IEEE T IMAGE PROCESS, V4, P1549, DOI 10.1109/83.469936; Van de Wouwer G, 1999, IEEE T IMAGE PROCESS, V8, P592, DOI 10.1109/83.753747; Zhou JP, 2005, IEEE INT C IMAGE PRO, V1, P469	17	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45302	10.1371/journal.pone.0045302	http://dx.doi.org/10.1371/journal.pone.0045302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049785	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100038
J	Wemhoner, K; Silbernagel, N; Marzian, S; Netter, MF; Rinne, S; Stansfeld, PJ; Decher, N				Wemhoener, Konstantin; Silbernagel, Nicole; Marzian, Stefanie; Netter, Michael F.; Rinne, Susanne; Stansfeld, Phillip J.; Decher, Niels			A Leucine Zipper Motif Essential for Gating of Hyperpolarization-activated Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; PACEMAKER CHANNELS; S4-S5 LINKER; K+ CHANNELS; C-TERMINUS; VOLTAGE; PROTEIN; DOMAIN; STOICHIOMETRY; TRAFFICKING	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are pacemakers in cardiac myocytes and neurons. Although their membrane topology closely resembles that of voltage-gated K+ channels, the mechanism of their unique gating behavior in response to hyperpolarization is still poorly understood. We have identified a highly conserved leucine zipper motif in the S5 segment of HCN family members. In order to study the role of this motif for channel function, the leucine residues of the zipper were individually mutated to alanine, arginine, or glutamine residues. Leucine zipper mutants traffic to the plasma membrane, but the channels lose their sensitivity to open upon hyperpolarization. Thus, our data indicate that the leucine zipper is an important molecular determinant for hyperpolarization-activated channel gating. Residues of the leucine zipper interact with the adjacent S6 segment of the channel. This interaction is essential for voltage-dependent gating of the channel. The lower part of the leucine zipper, at the intracellular mouth of the channel, is important for stabilizing the closed state. Mutations at these sites increase current amplitudes or result in channels with deficient closing and increased min-Po. Our data are further supported by homology models of the open and closed state of the HCN2 channel pore. Thus, we conclude that the leucine zipper of HCN channels is a major determinant for hyperpolarization-activated channel gating.	[Wemhoener, Konstantin; Silbernagel, Nicole; Marzian, Stefanie; Netter, Michael F.; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol, Vegetat Physiol Grp, D-35037 Marburg, Germany; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England	Philipps University Marburg; University of Oxford	Decher, N (corresponding author), Univ Marburg, Inst Physiol, Vegetat Physiol Grp, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020; Decher, Niels/AAF-5002-2020	Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; 	Deutsche Forschungsgemeinschaft [DE1482-2/1, DE1482-3/2]; BBSRC [BB/H000267/1, BB/I019855/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BEP17032, BB/I019855/1, BB/H000267/1, BBS/B/16011, B19456] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grants DE1482-2/1 and DE1482-3/2 (to N. D.).	Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	26	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40150	40160		10.1074/jbc.M112.378513	http://dx.doi.org/10.1074/jbc.M112.378513			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048023	Green Published, hybrid			2022-12-25	WOS:000311448800006
J	Kim, SH; Min, KS; Kim, NH; Yoon, JT				Kim, Sang Hwan; Min, Kwan Sik; Kim, Nam Hyung; Yoon, Jong Taek			Differential Expression of Programmed Cell Death on the Follicular Development in Normal and Miniature Pig Ovary	PLOS ONE			English	Article							APOPTOSIS; PROTEIN; FRAGMENTATION; AUTOPHAGY; OOCYTE	Follicles are important in oocyte maturation. Successful estrous cycle requires remodeling of follicular cells, and proper execution of programmed cell death is crucial for normal follicular development. The objectives of the present study were to understand programmed cell death during follicle development, to analyze the differential follicle development patterns, and to assess the patterns of apoptosis and autophagy expression during follicle development in normal and miniature pigs. Through the analysis of differential patterns of programmed cell death during follicular development in porcine, MAP1LC3A, B and other autophagy-associated genes (ATG5, mTOR, Beclin-1) were found to increase in normal pigs, while it decreased in miniature pigs. However, for the apoptosis-associated genes, progression of genes during follicular development increased in miniature pigs, while it decreased in normal pigs. Thus, results show that normal and miniature pigs showed distinct patterns of follicular remodeling manifesting that programmed cell death largely depends on the types of pathway during follicular development (Type II or autophagy for normal pigs and Type I or apoptosis for miniature pigs).	[Yoon, Jong Taek] Hankyong Natl Univ, Dept Anim Life Sci, Ansung, Gyeonggi Do, South Korea; [Kim, Sang Hwan] Hankyong Natl Univ, Inst Genet Engn, Ansung, Gyeonggi Do, South Korea; [Min, Kwan Sik] Hankyong Natl Univ, Grad Sch Bio & Informat Technol, Ansung, Gyeonggi Do, South Korea; [Kim, Nam Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea	Hankyong National University; Hankyong National University; Hankyong National University; Chungbuk National University	Yoon, JT (corresponding author), Hankyong Natl Univ, Dept Anim Life Sci, Ansung, Gyeonggi Do, South Korea.	jtyoon@hknu.ac.kr		Kim, SangHwan/0000-0003-0996-6912	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008029]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008029), Rural Development Administration, Republic of Korea (http://atis.rda.go.kr). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Billig H, 1996, HUM REPROD UPDATE, V2, P103, DOI 10.1093/humupd/2.2.103; Byskov AG., 1979, OVARIAN FOLLICULAR D, P41; Choi JY, 2010, FERTIL STERIL, V93, P2532, DOI 10.1016/j.fertnstert.2009.11.021; CLARK JR, 1982, THERIOGENOLOGY, V18, P697, DOI 10.1016/0093-691X(82)90035-8; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; DAILEY RA, 1976, J ANIM SCI, V43, P175, DOI 10.2527/jas1976.431175x; Day BN, 1968, REPRODUCTION FARM AN, P279; Dor FJMF, 2004, TRANSPLANTATION, V78, P15, DOI 10.1097/01.TP.0000130487.68051.EB; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Focchi G R, 1996, Sao Paulo Med J, V114, P1173; Gilbert SF, 2000, DEV BIOL, P212; GUTHRIE HD, 1995, J ANIM SCI, V73, P2834; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOWARD PK, 1982, ANAT REC, V203, P55, DOI 10.1002/ar.1092030106; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; Hwang SO, 2008, AUTOPHAGY, V4, P70, DOI 10.4161/auto.5065; Hwang SO, 2008, BIOTECHNOL BIOENG, V99, P678, DOI 10.1002/bit.21589; Kim SH, 2009, REPROD DEV BIOL, V33, P156; KING BF, 1993, J ANIM SCI, V71, P975, DOI 10.2527/1993.714975x; Manabe N, 1998, APOPTOSIS ITS ROLES, P97; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Othman EQG, 2009, J CLIN LAB ANAL, V23, P249, DOI 10.1002/jcla.20309; SAWYER HR, 1995, J REPROD FERTIL, P97; SHAW HJ, 1985, J REPROD FERTIL, V75, P17, DOI 10.1530/jrf.0.0750017; Smitz JEJ, 2002, REPRODUCTION, V123, P185, DOI 10.1530/rep.0.1230185; Thomas FH, 2003, HUM REPROD UPDATE, V9, P541, DOI 10.1093/humupd/dmg042; TILLY JL, 1992, SERONO SYM, V94, P157; Wartenberg H, 2001, ANAT EMBRYOL, V204, P421, DOI 10.1007/s00429-001-0216-7	36	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46194	10.1371/journal.pone.0046194	http://dx.doi.org/10.1371/journal.pone.0046194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056260	gold, Green Submitted, Green Published			2022-12-25	WOS:000309831500030
J	Yamanaka, K; Dorjsuren, D; Eoff, RL; Egli, M; Maloney, DJ; Jadhav, A; Simeonov, A; Lloyd, RS				Yamanaka, Kinrin; Dorjsuren, Dorjbal; Eoff, Robert L.; Egli, Martin; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton; Lloyd, R. Stephen			A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase kappa	PLOS ONE			English	Article							CROSS-LINKS; ERROR-FREE; REPLICATION; BYPASS; ADDUCTS; REPAIR; IOTA; MECHANISM; ACROLEIN	Human DNA polymerase kappa (pol kappa) is a translesion synthesis (TLS) polymerase that catalyzes TLS past various minor groove lesions including N-2-dG linked acrolein-and polycyclic aromatic hydrocarbon-derived adducts, as well as N-2-dG DNA-DNA interstrand cross-links introduced by the chemotherapeutic agent mitomycin C. It also processes ultraviolet light-induced DNA lesions. Since pol kappa TLS activity can reduce the cellular toxicity of chemotherapeutic agents and since gliomas overexpress pol kappa, small molecule library screens targeting pol kappa were conducted to initiate the first step in the development of new adjunct cancer therapeutics. A high-throughput, fluorescence-based DNA strand displacement assay was utilized to screen similar to 16,000 bioactive compounds, and the 60 top hits were validated by primer extension assays using non-damaged DNAs. Candesartan cilexetil, manoalide, and MK-886 were selected as proof-of-principle compounds and further characterized for their specificity toward pol kappa by primer extension assays using DNAs containing a site-specific acrolein-derived, ring-opened reduced form of gamma-HOPdG. Furthermore, candesartan cilexetil could enhance ultraviolet light-induced cytotoxicity in xeroderma pigmentosum variant cells, suggesting its inhibitory effect against intracellular pol kappa. In summary, this investigation represents the first high-throughput screening designed to identify inhibitors of pol kappa, with the characterization of biochemical and biologically relevant endpoints as a consequence of pol kappa inhibition. These approaches lay the foundation for the future discovery of compounds that can be applied to combination chemotherapy.	[Yamanaka, Kinrin; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; [Yamanaka, Kinrin] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Dorjsuren, Dorjbal; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Ctr Mol Toxicol, Nashville, TN 37212 USA; [Egli, Martin] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Arkansas System; University of Arkansas Medical Sciences; Vanderbilt University; Vanderbilt University	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X; Jadhav, Ajit/0000-0001-7955-1451	National Institute of Environmental Health Sciences [ES05355]; National Cancer Institute [CA106858]; National Institute of Mental Health [R03 MH 094179]; National Institute of General Medical Sciences [R00 GM 084460]; NATIONAL CANCER INSTITUTE [P01CA160032, R01CA106858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338, R00GM084460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094179] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Environmental Health Sciences [ES05355 to R. S. L.], National Cancer Institute [CA106858 to R. S. L.], National Institute of Mental Health [R03 MH 094179 to R. S. L.], and National Institute of General Medical Sciences [R00 GM 084460 to R. L. E.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Cleaver JE, 1999, CANCER RES, V59, P1102; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; Ebada SS, 2010, MAR DRUGS, V8, P313, DOI 10.3390/md8020313; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Folmer F, 2010, BIOCHEM PHARMACOL, V80, P1793, DOI 10.1016/j.bcp.2010.08.024; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Ishida T, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/650514; Kimura T, 2009, BIOORGAN MED CHEM, V17, P1811, DOI 10.1016/j.bmc.2009.01.064; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lehoczky P, 2007, FEMS MICROBIOL REV, V31, P109, DOI 10.1111/j.1574-6976.2006.00046.x; Mamelak AN, 2005, ONCOLOGY-NY, V19, P1803; Maruo S, 2011, BIOORGAN MED CHEM, V19, P5803, DOI 10.1016/j.bmc.2011.08.023; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; Mizushina Y, 2011, INT J MOL SCI, V12, P1115, DOI 10.3390/ijms12021115; Mizushina Y, 2010, BIOCHEM PHARMACOL, V80, P1125, DOI 10.1016/j.bcp.2010.06.031; Mizushina Y, 2009, MAR DRUGS, V7, P624, DOI 10.3390/md7040624; Mizushina Y, 2009, MOLECULES, V14, P102, DOI 10.3390/molecules14010102; Nakao Y, 2007, J NAT PROD, V70, P689, DOI 10.1021/np060600x; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Smirnov SV, 1998, BRIT J PHARMACOL, V124, P572, DOI 10.1038/sj.bjp.0701855; Wang HB, 2010, NEURO-ONCOLOGY, V12, P679, DOI 10.1093/neuonc/nop074; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Yamanaka K, 2012, DNA REPAIR CANC BENC; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, MUTAT RES-FUND MOL M, V510, P23, DOI 10.1016/S0027-5107(02)00249-X; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	40	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45032	10.1371/journal.pone.0045032	http://dx.doi.org/10.1371/journal.pone.0045032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056190	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500011
J	Chen, R; Jiang, LY; Qiao, GX				Chen, Rui; Jiang, Li-Yun; Qiao, Ge-Xia			The Effectiveness of Three Regions in Mitochondrial Genome for Aphid DNA Barcoding: A Case in Lachininae	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; EVOLUTION; HEMIPTERA; SEQUENCES; INSECTA; NUMBER	Background: The mitochondrial gene COI has been widely used by taxonomists as a standard DNA barcode sequence for the identification of many animal species. However, the COI region is of limited use for identifying certain species and is not efficiently amplified by PCR in all animal taxa. To evaluate the utility of COI as a DNA barcode and to identify other barcode genes, we chose the aphid subfamily Lachninae (Hemiptera: Aphididae) as the focus of our study. We compared the results obtained using COI with two other mitochondrial genes, COII and Cytb. In addition, we propose a new method to improve the efficiency of species identification using DNA barcoding. Methodology/Principal Findings: Three mitochondrial genes (COI, COII and Cytb) were sequenced and were used in the identification of over 80 species of Lachninae. The COI and COII genes demonstrated a greater PCR amplification efficiency than Cytb. Species identification using COII sequences had a higher frequency of success (96.9% in "best match'' and 90.8% in "best close match'') and yielded lower intra-and higher interspecific genetic divergence values than the other two markers. The use of "tag barcodes'' is a new approach that involves attaching a species-specific tag to the standard DNA barcode. With this method, the "barcoding overlap'' can be nearly eliminated. As a result, we were able to increase the identification success rate from 83.9% to 95.2% by using COI and the "best close match'' technique. Conclusions/Significance: A COII-based identification system should be more effective in identifying lachnine species than COI or Cytb. However, the Cytb gene is an effective marker for the study of aphid population genetics due to its high sequence diversity. Furthermore, the use of "tag barcodes'' can improve the accuracy of DNA barcoding identification by reducing or removing the overlap between intra-and inter-specific genetic divergence values.	[Chen, Rui; Jiang, Li-Yun; Qiao, Ge-Xia] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Chen, Rui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, LY (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	jiangliyun@gmail.com; qiaogx@ioz.ac.cn			National Natural Sciences Foundation of China [30830017]; National Science Funds for Distinguished Young Scientists [31025024]; National Science Fund for Fostering Talents in Basic Research [J0930004]; Ministry of Science and Technology of the People's Republic of China (MOST) [2011FY120200]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Funds for Distinguished Young Scientists; National Science Fund for Fostering Talents in Basic Research; Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	This work was funded by the National Natural Sciences Foundation of China (No. 30830017), National Science Funds for Distinguished Young Scientists (No. 31025024), National Science Fund for Fostering Talents in Basic Research (No. J0930004), and the Ministry of Science and Technology of the People's Republic of China (MOST Grant No. 2011FY120200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heie O.E., 1987, World Crop Pests, V2A, P367; Heie O.E., 1980, Fauna Entomologica Scandinavica, V9, P1; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lopez P, 2002, MOL BIOL EVOL, V19, P1; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NEI M, 2000, MOL EVOLUTION PHYLOG; Philippe H, 2001, TRENDS BIOCHEM SCI, V26, P414, DOI 10.1016/S0968-0004(01)01877-1; Remaudiere G., 1997, Catalogue des Aphididae du monde: Homoptera Aphidoidea.; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; STERN DL, 1994, P ROY SOC B-BIOL SCI, V256, P203, DOI 10.1098/rspb.1994.0071; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zhang GX, 1983, EC INSECT FAUNA CH 1, V25, P1; Zhang He-Cai, 2006, Acta Entomologica Sinica, V49, P521	36	40	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46190	10.1371/journal.pone.0046190	http://dx.doi.org/10.1371/journal.pone.0046190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056258	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000024
J	Bendtsen, KMB; Krych, L; Sorensen, DB; Pang, WY; Nielsen, DS; Josefsen, K; Hansen, LH; Sorensen, SJ; Hansen, AK				Bendtsen, Katja Maria Bangsgaard; Krych, Lukasz; Sorensen, Dorte Bratbo; Pang, Wanyong; Nielsen, Dennis Sandris; Josefsen, Knud; Hansen, Lars H.; Sorensen, Soren J.; Hansen, Axel Kornerup			Gut Microbiota Composition Is Correlated to Grid Floor Induced Stress and Behavior in the BALB/c Mouse	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; INTESTINAL MICROBIOTA; GASTROINTESTINAL-TRACT; LIGHT/DARK BOX; OPEN-FIELD; ANXIETY; MICE; GENISTEIN; BACTERIUM; CYTOKINES	Stress has profound influence on the gastro-intestinal tract, the immune system and the behavior of the animal. In this study, the correlation between gut microbiota composition determined by Denaturing Grade Gel Electrophoresis (DGGE) and tag-encoded 16S rRNA gene amplicon pyrosequencing (454/FLX) and behavior in the Tripletest (Elevated Plus Maze, Light/Dark Box, and Open Field combined), the Tail Suspension Test, and Burrowing in 28 female BALB/c mice exposed to two weeks of grid floor induced stress was investigated. Cytokine and glucose levels were measured at baseline, during and after exposure to grid floor. Stressing the mice clearly changed the cecal microbiota as determined by both DGGE and pyrosequencing. Odoribacter, Alistipes and an unclassified genus from the Coriobacteriaceae family increased significantly in the grid floor housed mice. Compared to baseline, the mice exposed to grid floor housing changed the amount of time spent in the Elevated Plus Maze, in the Light/Dark Box, and burrowing behavior. The grid floor housed mice had significantly longer immobility duration in the Tail Suspension Test and increased their number of immobility episodes from baseline. Significant correlations were found between GM composition and IL-1 alpha, IFN-gamma, closed arm entries of Elevated Plus Maze, total time in Elevated Plus Maze, time spent in Light/Dark Box, and time spent in the inner zone of the Open Field as well as total time in the Open Field. Significant correlations were found to the levels of Firmicutes, e. g. various species of Ruminococccaceae and Lachnospiraceae. No significant difference was found for the evaluated cytokines, except an overall decrease in levels from baseline to end. A significant lower level of blood glucose was found in the grid floor housed mice, whereas the HbA1c level was significantly higher. It is concluded that grid floor housing changes the GM composition, which seems to influence certain anxiety-related parameters.	[Bendtsen, Katja Maria Bangsgaard; Sorensen, Dorte Bratbo; Pang, Wanyong; Hansen, Axel Kornerup] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Krych, Lukasz; Nielsen, Dennis Sandris] Univ Copenhagen, Dept Food Sci, Fac Hlth & Med Sci, Copenhagen, Denmark; [Josefsen, Knud] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Hansen, Lars H.; Sorensen, Soren J.] Univ Copenhagen, Fac Sci, Dept Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Bendtsen, KMB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark.	kab@life.ku.dk	Nielsen, Dennis/A-9769-2015; Sørensen, Søren Johannes/N-2120-2019; Krych, Luaksz/F-4446-2015; Sørensen, Søren J/J-5015-2014	Nielsen, Dennis/0000-0001-8121-1114; Sørensen, Søren Johannes/0000-0001-6227-9906; Krych, Luaksz/0000-0003-3224-1346; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Sorensen, Dorte Bratbo/0000-0002-6144-1710	Villum Foundation; Center for Applied Laboratory Animal Research	Villum Foundation(Villum Fonden); Center for Applied Laboratory Animal Research	Wanyong Pang was financed by a grant from the Villum Foundation. This research was supported by the Center for Applied Laboratory Animal Research (www.calar.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V302, pG168, DOI 10.1152/ajpgi.00190.2011; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2009, PYNAST FLEXIBLE TOOL; Caso JR, 2008, CURR MOL MED, V8, P299, DOI 10.2174/156652408784533751; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Chang YC, 1995, J NAT PROD, V58, P1901, DOI 10.1021/np50126a016; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Deacon RMJ, 2009, BEHAV BRAIN RES, V200, P128, DOI 10.1016/j.bbr.2009.01.007; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fraser LM, 2010, PSYCHOPHARMACOLOGY, V211, P99, DOI 10.1007/s00213-010-1873-0; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Haas BJ, 2011, CHIMERIC 16S RRNA SE; Hansen AK, 2002, COUNC EUR CONV ETS A; Hansen CHF, 2012, PLOS ONE IN PRESS; Hansen CHF, 2012, DIABETOLOGI IN PRESS; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Husum H, 2002, NEUROPHARMACOLOGY, V42, P798, DOI 10.1016/S0028-3908(02)00038-2; Jayagopal V, 2002, DIABETES CARE, V25, P1709, DOI 10.2337/diacare.25.10.1709; Krohn TC, 2003, ANIM WELFARE, V12, P53; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Matthies A, 2008, APPL ENVIRON MICROB, V74, P4847, DOI 10.1128/AEM.00555-08; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagai F, 2010, INT J SYST EVOL MICR, V60, P1296, DOI 10.1099/ijs.0.014571-0; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neufeld KA, 2009, J PSYCHIATR NEUROSCI, V34, P230; Neufeld Karen-Anne M, 2011, Commun Integr Biol, V4, P492, DOI 10.4161/cib.4.4.15702; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Pang W, 2011, LAB ANIM IN PRESS; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pruett SB, 2001, INT IMMUNOPHARMACOL, V1, P507, DOI 10.1016/S1567-5769(00)00030-8; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 2008, BEHAV BRAIN RES, V193, P277, DOI 10.1016/j.bbr.2008.06.007; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Sim YB, 2010, ARCH PHARM RES, V33, P1679, DOI 10.1007/s12272-010-1018-3; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Sorensen DB, 2005, SCAND J LAB ANIM SCI, V32, P117; Stub C, 2002, SCAND J LAB ANIM SCI, V29, P149; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weiss IC, 1999, BEHAV PHARMACOL, V10, P139, DOI 10.1097/00008877-199903000-00003; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wolin MJ, 2008, INT J SYST EVOL MICR, V58, P742, DOI 10.1099/ijs.0.65850-0; Wolin MJ, 2003, APPL ENVIRON MICROB, V69, P6321, DOI 10.1128/AEM.69.10.6321-6326.2003; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	67	169	174	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46231	10.1371/journal.pone.0046231	http://dx.doi.org/10.1371/journal.pone.0046231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056268	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600029
J	Bloom, CI; Graham, CM; Berry, MPR; Wilkinson, KA; Oni, T; Rozakeas, F; Xu, ZH; Rossello-Urgell, J; Chaussabel, D; Banchereau, J; Pascual, V; Lipman, M; Wilkinson, RJ; O'Garra, A				Bloom, Chloe I.; Graham, Christine M.; Berry, Matthew P. R.; Wilkinson, Katalin A.; Oni, Tolu; Rozakeas, Fotini; Xu, Zhaohui; Rossello-Urgell, Jose; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia; Lipman, Marc; Wilkinson, Robert J.; O'Garra, Anne			Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; TREATMENT RESPONSE; TUBERCULOSIS; BIOMARKERS; RESISTANCE; DRUGS; EMERGENCE; SIGNATURE; CULTURE	Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.	[Bloom, Chloe I.; Graham, Christine M.; Berry, Matthew P. R.; Rozakeas, Fotini; O'Garra, Anne] MRC Natl Inst Med Res, Div Immunoregulat, London, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England; [Berry, Matthew P. R.] Imperial Coll Healthcare NHS Trust, Dept Resp Med, London, England; [Wilkinson, Katalin A.; Oni, Tolu; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Oni, Tolu; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Wright Fleming Inst, London, England; [Xu, Zhaohui; Rossello-Urgell, Jose; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia] INSERM, Baylor Inst Immunol Research ANRS Ctr Human Vacci, Dallas, TX USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Lipman, Marc] Royal Free Hosp NHS Trust, Dept Thorac Med, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Imperial College London; University of Cape Town; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Benaroya Research Institute; University of London; University College London	Bloom, CI (corresponding author), MRC Natl Inst Med Res, Div Immunoregulat, London, England.	cbloom@nimr.mrc.ac.uk	Pascual, Virginia/ABD-3099-2020; Bloom, Chloe/ABC-1693-2020; Wilkinson, Katalin/AAF-6805-2020; Chaussabel, Damien/AAX-1909-2020; Wilkinson, Katalin/AAQ-7713-2021	Bloom, Chloe/0000-0003-1285-7602; Wilkinson, Katalin/0000-0002-9796-2040; Oni, Tolu/0000-0003-4499-1910; Chaussabel, Damien/0000-0002-6131-7242; Lipman, Marc/0000-0001-7501-4448; O'Garra, Anne/0000-0001-9845-6134; Wilkinson, Robert/0000-0002-2753-1800; Xu, Zhaohui/0000-0003-0645-1737; Graham, Christine/0000-0001-9329-6231	Medical Research Council [U117565642]; Institute Merieux; European Union; Wellcome Trust [088316, 084323]; MRC [MC_EX_G0802346, MC_U117565642, MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117565642, MC_EX_G0802346, MC_U117588499] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute Merieux; European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding were the Medical Research Council (U117565642), Institute Merieux, European Union and Wellcome Trust (088316 and 084323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A U. S. patent has been assigned for the findings in this manuscript. Title: Early Detection of Tuberculosis Treatment Response. Serial No.: 61/610,121. Filing Date: March 13, 2012.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; [Center for Communicable Disease Control and Prevention CCDC], 2007, REP TUB US 2007 C; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P2329, DOI 10.1128/AAC.00185-07; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; JINDANI A, 1980, AM REV RESPIR DIS, V121, P939; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P2229, DOI 10.1128/JCM.35.9.2229-2234.1997; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; World Health Organization, 2010, GLOB TUB CONTR; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	27	143	149	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46191	10.1371/journal.pone.0046191	http://dx.doi.org/10.1371/journal.pone.0046191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056259	Green Published, Green Submitted, gold			2022-12-25	WOS:000309452600025
J	Kang, DZ; Wang, JJ; Zhang, WY; Song, YL; Li, XL; Zou, Y; Zhu, MT; Zhu, Z; Chen, FY; Yang, CJ				Kang, Dezhi; Wang, Jiangjie; Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Mingtao; Zhu, Zhi; Chen, Fuyong; Yang, Chaoyong James			Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity	PLOS ONE			English	Article							NUCLEIC-ACID APTAMERS; CANCER-CELLS; MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; BRAIN-TUMORS; LIVE CELLS; SELEX; STRATEGIES; SURVIVAL; THERAPY	Background: Glioblastoma is the most common and most lethal form of brain tumor in human. Unfortunately, there is still no effective therapy to this fatal disease and the median survival is generally less than one year from the time of diagnosis. Discovery of ligands that can bind specifically to this type of tumor cells will be of great significance to develop early molecular imaging, targeted delivery and guided surgery methods to battle this type of brain tumor. Methodology/Principal Findings: We discovered two target-specific aptamers named GBM128 and GBM131 against cultured human glioblastoma cell line U118-MG after 30 rounds selection by a method called cell-based Systematic Evolution of Ligands by EXponential enrichment (cell-SELEX). These two aptamers have high affinity and specificity against target glioblastoma cells. They neither recognize normal astraglial cells, nor do they recognize other normal and cancer cell lines tested. Clinical tissues were also tested and the results showed that these two aptamers can bind to different clinical glioma tissues but not normal brain tissues. More importantly, binding affinity and selectivity of these two aptamers were retained in complicated biological environment. Conclusion/Significance: The selected aptamers could be used to identify specific glioblastoma biomarkers. Methods of molecular imaging, targeted drug delivery, ligand guided surgery can be further developed based on these ligands for early detection, targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma.	[Kang, Dezhi; Wang, Jiangjie; Zhu, Mingtao; Chen, Fuyong] Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Zhi; Yang, Chaoyong James] Xiamen Univ, Coll Chem & Chem Engn, Dept Biol Chem, Xiamen, Fujian, Peoples R China; [Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Zhi; Yang, Chaoyong James] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Analyt Sci, State Key Lab Phys Chem Solid Surfaces,Key Lab Ch, Xiamen, Fujian, Peoples R China	Fujian Medical University; Xiamen University; Xiamen University	Kang, DZ (corresponding author), Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.	kdz99988@sina.com; cyyang@xmu.edu.cn	Yang, Chaoyong/Q-5734-2019; Song, Yanling/ABB-7055-2021; Zhu, Zhi/D-3721-2011; yang, chaoyong/F-9741-2010; Song, Yanling/AAT-7783-2020	Yang, Chaoyong/0000-0002-2374-5342; Zhu, Zhi/0000-0002-3287-4920; yang, chaoyong/0000-0002-2374-5342; 	National Basic Research Program of China [2010CB732402]; National Instrumentation Program [2011YQ03012412]; Natural Science Foundation of Fujian Province for Distinguished Young Scholars [2010 J06004]; Key Laboratory for Chemical Biology of Fujian Province	National Basic Research Program of China(National Basic Research Program of China); National Instrumentation Program; Natural Science Foundation of Fujian Province for Distinguished Young Scholars; Key Laboratory for Chemical Biology of Fujian Province	This work was supported by the National Basic Research Program of China (2010CB732402), National Instrumentation Program (2011YQ03012412), the Natural Science Foundation of Fujian Province for Distinguished Young Scholars (2010 J06004), and the Key Laboratory for Chemical Biology of Fujian Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrac AT, 2011, ACS CHEM NEUROSCI, V2, P175, DOI 10.1021/cn100114k; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Guo KT, 2006, STEM CELLS, V24, P2220, DOI 10.1634/stemcells.2006-0015; Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Jiang YX, 2003, ANAL CHEM, V75, P2112, DOI 10.1021/ac026182s; LAPERRIERE NJ, 1994, CA-CANCER J CLIN, V44, P96, DOI 10.3322/canjclin.44.2.96; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Ng HK, 1998, PATHOLOGY, V30, P196, DOI 10.1080/00313029800169236; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Pu Y, 2010, ANAL BIOANAL CHEM, V397, P3225, DOI 10.1007/s00216-010-3715-7; Rupcich N, 2006, J AM CHEM SOC, V128, P780, DOI 10.1021/ja053336n; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; SOULE HD, 1990, CANCER RES, V50, P6075; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Thiel WH, 2011, NUCLEIC ACID THER, V21, P253, DOI 10.1089/nat.2011.0288; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	33	41	48	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e42731	10.1371/journal.pone.0042731	http://dx.doi.org/10.1371/journal.pone.0042731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056171	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600001
J	Marchese, S; Silva, E				Marchese, Stephanie; Silva, Elisabete			Disruption of 3D MCF-12A Breast Cell Cultures by Estrogens - An In Vitro Model for ER-Mediated Changes Indicative of Hormonal Carcinogenesis	PLOS ONE			English	Article							MAMMARY EPITHELIAL ACINI; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; LUMEN FORMATION; CANCER CELLS; BISPHENOL-A; PROLIFERATION; ACTIVATION; APOPTOSIS; MORPHOGENESIS	Introduction: Estrogens regulate the proliferation of normal and neoplastic breast epithelium. Although the intracellular mechanisms of estrogens in the breast are largely understood, little is known about how they induce changes in the structure of the mammary epithelium, which are characteristic of breast cancer. In vitro three dimensional (3D) cultures of immortalised breast epithelial cells recapitulate features of the breast epithelium in vivo, including formation of growth arrested acini with hollow lumen and basement membrane. This model can also reproduce features of malignant transformation and breast cancer, such as increased cellular proliferation and filling of the lumen. However, a system where a connection between estrogen receptor (ER) activation and disruption of acini formation can be studied to elucidate the role of estrogens is still missing. Methods/Principal Findings: We describe an in vitro 3D model for breast glandular structure development, using breast epithelial MCF-12A cells cultured in a reconstituted basement membrane matrix. These cells are estrogen receptor (ER) a, ERb and G-protein coupled estrogen receptor 1 (GPER) competent, allowing the investigation of the effects of estrogens on mammary gland formation and disruption. Under normal conditions, MCF-12A cells formed organised acini, with deposition of basement membrane and hollow lumen. However, treatment with 17 beta-estradiol, and the exogenous estrogens bisphenol A and propylparaben resulted in deformed acini and filling of the acinar lumen. When these chemicals were combined with ER and GPER inhibitors (ICI 182,780 and G-15, respectively), the deformed acini recovered normal features, such as a spheroid shape, proliferative arrest and luminal clearing, suggesting a role for the ER and GPER in the estrogenic disruption of acinar formation. Conclusion: This new model offers the opportunity to better understand the role of the ER and GPER in the morphogenesis of breast glandular structure as well as the events implicated in breast cancer initiation and progression.	[Marchese, Stephanie; Silva, Elisabete] UCL Sch Pharm, London, England; [Silva, Elisabete] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	University of London; University College London; Brunel University	Silva, E (corresponding author), UCL Sch Pharm, London, England.	elisabete.silva@brunel.ac.uk			School of Pharmacy Studentship	School of Pharmacy Studentship	Stephanie Marchese was funded by a School of Pharmacy Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Altucci L, 1996, ONCOGENE, V12, P2315; Bedard PL, 2008, BREAST CANCER RES TR, V108, P307, DOI 10.1007/s10549-007-9606-8; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Cheskis BJ, 2004, J CELL BIOCHEM, V93, P20, DOI 10.1002/jcb.20180; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI 10.1177/0192623309354108; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gompel A, 2004, MATURITAS, V49, P16, DOI 10.1016/j.maturitas.2004.06.009; Gompel A, 2000, STEROIDS, V65, P593, DOI 10.1016/S0039-128X(00)00172-0; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Harris J, 1999, DIS BREAST; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Kabil A, 2008, CARCINOGENESIS, V29, P1862, DOI 10.1093/carcin/bgn138; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; LaPensee EW, 2010, CANCER LETT, V290, P167, DOI 10.1016/j.canlet.2009.09.005; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu YE, 2007, ONCOGENE, V26, P2115, DOI 10.1038/sj.onc.1210000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; PAINE TM, 1992, INT J CANCER, V50, P463, DOI 10.1002/ijc.2910500323; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Robbins AS, 2007, J CLIN ONCOL, V25, P3437, DOI 10.1200/JCO.2007.11.4132; Russo J, 2002, ENVIRON MOL MUTAGEN, V39, P254, DOI 10.1002/em.10052; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Russo J, 2006, FASEB J, V20, P1622, DOI 10.1096/fj.05-5399com; Silva E, 2007, ENVIRON HEALTH PERSP, V115, P91, DOI 10.1289/ehp.9363; Silva E, 2010, TOXICOL APPL PHARM, V245, P159, DOI 10.1016/j.taap.2010.02.015; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; SOULE HD, 1990, CANCER RES, V50, P6075; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Yanochko GM, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1392	47	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45767	10.1371/journal.pone.0045767	http://dx.doi.org/10.1371/journal.pone.0045767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056216	Green Published, Green Submitted, gold			2022-12-25	WOS:000309452600016
J	Pitpitan, EV; Kalichman, SC; Cain, D; Eaton, LA; Carey, KB; Carey, MP; Harel, O; Simbayi, LC; Mehlomakhulu, V; Mwaba, K				Pitpitan, Eileen V.; Kalichman, Seth C.; Cain, Demetria; Eaton, Lisa A.; Carey, Kate B.; Carey, Michael P.; Harel, Ofer; Simbayi, Leickness C.; Mehlomakhulu, Vuyelwa; Mwaba, Kelvin			Condom Negotiation, HIV Testing, and HIV Risks among Women from Alcohol Serving Venues in Cape Town, South Africa	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; SEXUAL-BEHAVIOR; AIDS-PREVENTION; AMERICAN WOMEN; KNOWLEDGE; PLACES; INFECTION; ATTITUDES; PATRONS	Background: Women in South Africa are at particularly high-risk for HIV infection and are dependent on their male partners' use of condoms for sexual risk reduction. However, many women are afraid to discuss condoms with male partners, placing them at higher risk of HIV infection. Purpose: To examine the association between fear of condom negotiation with HIV testing and transmission risk behaviors, including alcohol use and sexual risks among South African women. Method: Women (N = 1333) residing in a primarily Xhosa-speaking African township in Cape Town and attending informal alcohol-serving venues (shebeens) completed anonymous surveys. Logistic regression was used to test the hypothesis that fear of condom negotiation would be associated with increased risk for HIV. Results: Compared to women who did not fear condom negotiation, those who did were significantly less likely to have been tested for HIV, were more likely to have experienced relationship abuse, and to report more alcohol use and more unprotected sex. Conclusions: For women in South Africa, fear of condom negotiation is related to higher risk of HIV. HIV prevention efforts, including targeted HIV counseling and testing, must directly address gender issues.	[Pitpitan, Eileen V.; Kalichman, Seth C.; Cain, Demetria; Eaton, Lisa A.; Harel, Ofer] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Carey, Kate B.; Carey, Michael P.] Brown Univ, Dept Behav & Social Sci, Providence, RI 02912 USA; [Carey, Michael P.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Carey, Michael P.] Miriam Hosp, Ctr Behav Med, Providence, RI 02906 USA; [Simbayi, Leickness C.; Mehlomakhulu, Vuyelwa] Human Sci Res Council, Cape Town, South Africa; [Mwaba, Kelvin] Univ Western Cape, Cape Town, South Africa; [Carey, Michael P.] Miriam Hosp, Ctr Prevent Med, Providence, RI USA	University of Connecticut; Brown University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Human Sciences Research Council-South Africa; University of the Western Cape; Lifespan Health Rhode Island; Miriam Hospital	Pitpitan, EV (corresponding author), Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA.	epitpitan@ucsd.edu	Carey, Kate/GLU-7707-2022; Harel, Ofer/L-8906-2019	Harel, Ofer/0000-0002-1054-3055	National Institute on Alcohol Abuse and Alcoholism [R01-AA017399]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017399] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by National Institute on Alcohol Abuse and Alcoholism Grants R01-AA017399 (http://www.niaaa.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cline RJ Welch, 1992, HEALTH COMMUN, V4, P39, DOI DOI 10.1207/S15327027HC0401_4; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; KONDELULE JK, 1989, AIDS, V3, P513, DOI 10.1097/00002030-198908000-00005; LINDAN C, 1991, AIDS, V5, P993, DOI 10.1097/00002030-199108000-00011; Michael-Johnson P, 1989, AIDS COMMUNICATION M; Mittal M, FEAR VIOLEN IN PRESS; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; Pitpitan EV, 2012, SOC SCI MED, V75, P1417, DOI 10.1016/j.socscimed.2012.06.020; Pitpitan EV, 2012, ANN BEHAV MED, V43, P362, DOI 10.1007/s12160-012-9346-9; Raiford JL, 2009, AM J PUBLIC HEALTH, V99, P1067, DOI 10.2105/AJPH.2007.131482; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, GLOB REP UNAIDS REP; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015; Weir SS, 2002, SEX TRANSM INFECT, V78, pI106, DOI 10.1136/sti.78.suppl_1.i106; WILSON D, 1988, CENT AFR J MED, V34, P95	21	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45631	10.1371/journal.pone.0045631	http://dx.doi.org/10.1371/journal.pone.0045631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056211	gold, Green Published			2022-12-25	WOS:000309452600012
J	Chen, W; Xia, YP; Zhao, XL; Wang, H; Chen, WJ; Yu, MH; Li, YM; Ye, HY; Zhang, Y				Chen, Wei; Xia, Yanping; Zhao, Xuelan; Wang, Hao; Chen, Wenjie; Yu, Maohua; Li, Yiming; Ye, Hongying; Zhang, Yu			The Critical Role of Astragalus Polysaccharides for the Improvement of PPRA alpha-Mediated Lipotoxicity in Diabetic Cardiomyopathy	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; ACTIVATED RECEPTOR-ALPHA; CARDIAC-HYPERTROPHY; CONTRACTILE DYSFUNCTION; HEART; MICE; 1,2-DIACYLGLYCEROL; DISORDER; GLUCOSE; DB/DB	Background: Obesity-related diabetes mellitus leads to increased myocardial uptake and oxidation of fatty acids, resulting in a form of cardiac dysfunction referred to as lipotoxic cardiomyopathy. We have shown previously that Astragalus polysaccharides (APS) administration was sufficient to improve the systemic metabolic disorder and cardiac dysfunction in diabetic models. Methodology/Principal Findings: To investigate the precise role of APS therapy in the pathogenesis of myocardial lipotoxity in diabetes, db/db diabetic mice and myosin heavy chain (MHC)- peroxisome proliferator-activated receptor (PPAR) alpha mice were characterized and administrated with or without APS with C57 wide- type mice as normal control. APS treatment strikingly improved the myocyte triacylglyceride accumulation and cardiac dysfunction in both db/db mice and MHC-PPAR alpha mice, with the normalization of energy metabolic derangements in both db/db diabetic hearts and MHC-PPAR alpha hearts. Consistently, the activation of PPAR alpha target genes involved in myocardial fatty acid uptake and oxidation in both db/db diabetic hearts and MHC-PPAR alpha hearts was reciprocally repressed by APS administration, while PPAR alpha-mediated suppression of genes involved in glucose utilization of both diabetic hearts and MHC-PPAR alpha hearts was reversed by treatment with APS. Conclusions: We conclude that APS therapy could prevent the development of diabetic cardiomyopathy through a mechanism mainly dependent on the cardiac PPAR alpha-mediated regulatory pathways.	[Chen, Wei; Xia, Yanping; Zhao, Xuelan; Chen, Wenjie; Yu, Maohua; Zhang, Yu] Fudan Univ, Hushan Hosp, Dept Geriatr, Sch Med, Shanghai 200433, Peoples R China; [Wang, Hao] Fudan Univ, Core Ctr Anim Facil, Sch Med, Shanghai 200433, Peoples R China; [Li, Yiming; Ye, Hongying] Fudan Univ, Huashan Hosp, Dept Endocrinol, Sch Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, Y (corresponding author), Fudan Univ, Hushan Hosp, Dept Geriatr, Sch Med, Shanghai 200433, Peoples R China.	dryehongying@hotmail.com; billycai56@yahoo.com.cn			Chinese State Natural Science Funds Commission [81001568]; Shanghai Health Bureau Science Funds for Chinese Medicine [2010QJ033A]	Chinese State Natural Science Funds Commission; Shanghai Health Bureau Science Funds for Chinese Medicine	This work was supported by Chinese State Natural Science Funds Commission (Grant No: 81001568), and Shanghai Health Bureau Science Funds for Chinese Medicine (Grant No: 2010QJ033A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Chen W, 2008, EXP CLIN ENDOCR DIAB, V116, P468, DOI 10.1055/s-2008-1058081; Chen W, 2010, J DIABETES COMPLICAT, V24, P199, DOI 10.1016/j.jdiacomp.2008.12.003; Chen W, 2010, ACTA DIABETOL, V47, pS35, DOI 10.1007/s00592-009-0116-5; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; GAMBLE J, 1994, BBA-MOL BASIS DIS, V1225, P191, DOI 10.1016/0925-4439(94)90078-7; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Saburi Y, 2003, CARDIOVASC RES, V57, P92, DOI 10.1016/S0008-6363(02)00608-9; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; Takahashi R, 2003, CARDIOVASC RES, V58, P565, DOI 10.1016/S0008-6363(03)00291-8; Thrainsdottir IS, 2004, J CARDIOVASC PHARM, V44, P101, DOI 10.1097/00005344-200407000-00014; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200	28	20	29	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45541	10.1371/journal.pone.0045541	http://dx.doi.org/10.1371/journal.pone.0045541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049681	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388500008
J	Wong, DM; Li, JY; Chen, QH; Han, Q; Mutunga, JM; Wysinski, A; Anderson, TD; Ding, HZ; Carpenetti, TL; Verma, A; Islam, R; Paulson, SL; Lam, PCH; Totrov, M; Bloomquist, JR; Carlier, PR				Wong, Dawn M.; Li, Jianyong; Chen, Qiao-Hong; Han, Qian; Mutunga, James M.; Wysinski, Ania; Anderson, Troy D.; Ding, Haizhen; Carpenetti, Tiffany L.; Verma, Astha; Islam, Rafique; Paulson, Sally L.; Lam, Polo C. -H.; Totrov, Maxim; Bloomquist, Jeffrey R.; Carlier, Paul R.			Select Small Core Structure Carbamates Exhibit High Contact Toxicity to "Carbamate-Resistant" Strain Malaria Mosquitoes, Anopheles gambiae (Akron)	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; CONFERS INSECTICIDE RESISTANCE; ANHYDRIDE HYDROLASE ACTIVITY; HUMAN ACETYLCHOLINESTERASE; HUMAN BUTYRYLCHOLINESTERASE; CULEX-QUINQUEFASCIATUS; EXPRESSION; DIPTERA; METABOLISM; INHIBITION	Acetylcholinesterase (AChE) is a proven target for control of the malaria mosquito (Anopheles gambiae). Unfortunately, a single amino acid mutation (G119S) in An. gambiae AChE-1 (AgAChE) confers resistance to the AChE inhibitors currently approved by the World Health Organization for indoor residual spraying. In this report, we describe several carbamate inhibitors that potently inhibit G119S AgAChE and that are contact-toxic to carbamate-resistant An. gambiae. PCR-RFLP analysis was used to confirm that carbamate-susceptible G3 and carbamate-resistant Akron strains of An. gambiae carry wild-type (WT) and G119S AChE, respectively. G119S AgAChE was expressed and purified for the first time, and was shown to have only 3% of the turnover number (k(cat)) of the WT enzyme. Twelve carbamates were then assayed for inhibition of these enzymes. High resistance ratios (>2,500-fold) were observed for carbamates bearing a benzene ring core, consistent with the carbamate-resistant phenotype of the G119S enzyme. Interestingly, resistance ratios for two oxime methylcarbamates, and for five pyrazol-4-yl methylcarbamates were found to be much lower (4- to 65-fold). The toxicities of these carbamates to live G3 and Akron strain An. gambiae were determined. As expected from the enzyme resistance ratios, carbamates bearing a benzene ring core showed low toxicity to Akron strain An. gambiae (LC50>5,000 mu g/mL). However, one oxime methylcarbamate (aldicarb) and five pyrazol-4-yl methylcarbamates (4a-e) showed good to excellent toxicity to the Akron strain (LC50 = 32-650 mu g/mL). These results suggest that appropriately functionalized "small-core" carbamates could function as a resistance-breaking anticholinesterase insecticides against the malaria mosquito.	[Wong, Dawn M.; Chen, Qiao-Hong; Verma, Astha; Carlier, Paul R.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA; [Li, Jianyong; Han, Qian; Ding, Haizhen] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Mutunga, James M.; Wysinski, Ania; Anderson, Troy D.; Carpenetti, Tiffany L.; Paulson, Sally L.; Bloomquist, Jeffrey R.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Islam, Rafique; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Lam, Polo C. -H.; Totrov, Maxim] Molsoft LLC, San Diego, CA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida	Wong, DM (corresponding author), Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA.	pcarlier@vt.edu	Han, Qian/J-8696-2014; Chen, QH/GXH-3158-2022; Han, Qian/AAS-2134-2020	Han, Qian/0000-0001-6245-5252; Anderson, Troy/0000-0002-9403-2833; totrov, maxim/0000-0001-8594-274X; Mutunga, James/0000-0002-7321-3176; Carlier, Paul/0000-0002-6683-285X; Wong, Dawn/0000-0003-0153-2589	National Institutes of Health [1R01AI082581]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [GCGH-1497]; Innovative Vector Control Consortium; Virginia Tech College of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Innovative Vector Control Consortium; Virginia Tech College of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health (1R01AI082581), the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH-1497), the Innovative Vector Control Consortium, and the Virginia Tech College of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R A, 2012, ICM SOFTWARE MANUAL; Akogbeto M, 2010, MALARIA J, V9, P1475; Alout H, 2008, CHEM-BIOL INTERACT, V175, P138, DOI 10.1016/j.cbi.2008.03.018; Alout H, 2008, COMP BIOCHEM PHYS B, V150, P271, DOI 10.1016/j.cbpb.2008.03.008; Alout H, 2007, INSECT BIOCHEM MOLEC, V37, P41, DOI 10.1016/j.ibmb.2006.10.001; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; Altman RA, 2008, J ORG CHEM, V73, P284, DOI 10.1021/jo702024p; Andraos J, 1996, J CHEM EDUC, V73, P150, DOI 10.1021/ed073p150; [Anonymous], 2006, PESTICIDES THEIR APP; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Benedict MQ, 2003, J HERED, V94, P227, DOI 10.1093/jhered/esg056; Bourguet D, 1996, J NEUROCHEM, V67, P2115, DOI 10.1046/j.1471-4159.1996.67052115.x; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; BULL DL, 1967, J AGR FOOD CHEM, V15, P610, DOI 10.1021/jf60152a019; Canales M, 1998, ENZYME MICROB TECH, V23, P58, DOI 10.1016/S0141-0229(98)00012-X; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Drummond A., 2011, GENEIOUS V5 5; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enserink M, 2008, SCIENCE, V321, P1620, DOI 10.1126/science.321.5896.1620b; Geyer BC, 2005, CHEM-BIOL INTERACT, V157, P331, DOI 10.1016/j.cbi.2005.10.097; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Harel M, 1996, J AM CHEM SOC, V118, P2340, DOI 10.1021/ja952232h; Hartsel JA, 2012, BIOORG MED CHEM LETT, V22, P4593, DOI 10.1016/j.bmcl.2012.05.103; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Jiang HB, 2009, INSECT BIOCHEM MOLEC, V39, P646, DOI 10.1016/j.ibmb.2009.07.002; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kim MM, 2008, TETRAHEDRON LETT, V49, P4026, DOI 10.1016/j.tetlet.2008.04.082; KUHR RJ, 1977, PESTIC BIOCHEM PHYS, V7, P301, DOI 10.1016/0048-3575(77)90033-5; Lockridge O, 1997, BIOCHEMISTRY-US, V36, P786, DOI 10.1021/bi961412g; Manulis S, 1981, PESTIC BIOCHEM PHYS, V15, P261; Millard CB, 1995, BIOCHEMISTRY-US, V34, P15925, DOI 10.1021/bi00049a007; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Nauen R, 2006, PUBLIC HLTH BAYER EN, V18, P8; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; O'Brien R.D., 1967, INSECTICIDES ACTION; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851; Paul R., 2012, Patent No. [8,129,428, 8129428]; Poyot T, 2006, BBA-PROTEINS PROTEOM, V1764, P1470, DOI 10.1016/j.bbapap.2006.07.008; Radic Z, 2006, TOXICOLOGY ORGANOPHO, P161; RAFFA K F, 1985, Journal of Agricultural Entomology, V2, P27; REGUPATHY A, 1982, INDIAN J AGR SCI, V52, P130; REINER E, 1967, BIOCHEM J, V105, P171, DOI 10.1042/bj1050171; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Scott MP, 2007, P NATL ACAD SCI USA, V104, P11865, DOI 10.1073/pnas.0704795104; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Thompson CM, 2004, PESTICIDE TOXICOLOGY, P89; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; VELAN B, 1994, J BIOL CHEM, V269, P22719; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, WORLD MAL REP 2011	61	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46712	10.1371/journal.pone.0046712	http://dx.doi.org/10.1371/journal.pone.0046712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049714	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388500041
J	Kraehenmann, R; Vollenweider, FX; Seifritz, E; Kometer, M				Kraehenmann, Rainer; Vollenweider, Franz X.; Seifritz, Erich; Kometer, Michael			Crowding Deficits in the Visual Periphery of Schizophrenia Patients	PLOS ONE			English	Article							TO-NOISE RATIO; PERCEPTUAL ORGANIZATION; EYE-MOVEMENTS; CONTRAST SENSITIVITY; OBJECT-RECOGNITION; SPATIAL-RESOLUTION; BACKWARD-MASKING; ATTENTION; INFORMATION; SEARCH	Accumulating evidence suggests that basic visual information processing is impaired in schizophrenia. However, deficits in peripheral vision remain largely unexplored. Here we hypothesized that sensory processing of information in the visual periphery would be impaired in schizophrenia patients and, as a result, crowding - the breakdown in target recognition that occurs in cluttered visual environments - would be stronger. Therefore, we assessed visual crowding in the peripheral vision of schizophrenia patients and healthy controls. Subjects were asked to identify a target letter that was surrounded by distracter letters of similar appearance. Targets and distracters were displayed at 8 degrees and 10 degrees of visual angle from the fixation point (eccentricity), and target-distracter spacing was 2 degrees, 3 degrees, 4 degrees, 5 degrees, 6 degrees, 7 degrees or 8 degrees of visual angle. Eccentricity and target-distracter spacing were randomly varied. Accuracy was defined as the proportion of correctly identified targets. Critical spacing was defined as the spacing at which target identification accuracy began to deteriorate, and was assessed at viewing eccentricities of 8 degrees and 10 degrees. Schizophrenia patients were less accurate and showed a larger critical spacing than healthy individuals. These results indicate that crowding is stronger and sensory processing of information in the visual periphery is impaired in schizophrenia. This is in line with previous reports of preferential magnocellular dysfunction in schizophrenia. Thus, deficits in peripheral vision may account for perceptual alterations and contribute to cognitive dysfunction in schizophrenia.	[Kraehenmann, Rainer; Vollenweider, Franz X.; Kometer, Michael] Univ Zurich, Clin Affect Disorders & Gen Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Psychiat Univ Hosp, Zurich, Switzerland	University of Zurich	Kometer, M (corresponding author), Univ Zurich, Clin Affect Disorders & Gen Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Psychiat Univ Hosp, Zurich, Switzerland.	michael.kometer@bli.uzh.ch	Krähenmann, Rainer/E-9363-2010		Foundation for Medical Research of the University of Zurich	Foundation for Medical Research of the University of Zurich	The study was funded in part by a restricted grant of the Foundation for Medical Research of the University of Zurich (RK). The Foundation for Medical Research of the University of Zurich had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson EJ, 2012, CURR BIOL, V22, P1199, DOI 10.1016/j.cub.2012.04.063; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ARMAN AC, 2006, J VISION, V6, P804; Bach DR, 2011, SCHIZOPHRENIA BULL, V37, P426, DOI 10.1093/schbul/sbp092; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Behrendt RP, 2004, BEHAV BRAIN SCI, V27, P771, DOI 10.1017/S0140525X04000184; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Butler PD, 2008, SCHIZOPHR RES, V103, P283, DOI 10.1016/j.schres.2008.03.007; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Butler PD, 2010, SCHIZOPHR RES, V118, P20, DOI 10.1016/j.schres.2010.01.005; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Campanella S, 2006, NEUROPHYSIOL CLIN, V36, P71, DOI 10.1016/j.neucli.2006.04.005; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; CEGALIS JA, 1981, J NERV MENT DIS, V169, P751, DOI 10.1097/00005053-198112000-00002; Chakravarthi R, 2011, J VISION, V11, DOI 10.1167/11.8.10; CHAPMAN J, 1966, BRIT J PSYCHIAT, V112, P225, DOI 10.1192/bjp.112.484.225; Chen Y, 2008, COGN AFFECT BEHAV NE, V8, P293, DOI 10.3758/CABN.8.3.293; Chen Y, 2008, SCHIZOPHRENIA BULL, V34, P367, DOI 10.1093/schbul/sbm071; Chkonia E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014268; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; Elahipanah A, 2011, NEUROPSYCHOLOGIA, V49, P3370, DOI 10.1016/j.neuropsychologia.2011.08.011; Elahipanah A, 2010, NEUROPSYCHOLOGY, V24, P192, DOI 10.1037/a0017523; ELKINS IJ, 1992, J ABNORM PSYCHOL, V101, P53, DOI 10.1037/0021-843X.101.1.53; Ethridge L, 2011, SCHIZOPHR RES, V133, P106, DOI 10.1016/j.schres.2011.07.016; Fang F, 2008, J VISION, V8, P9; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Foxe JJ, 2005, CEREB CORTEX, V15, P1914, DOI 10.1093/cercor/bhi069; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P37, DOI 10.1016/j.ijpsycho.2003.12.004; Granholm E, 1996, J ABNORM PSYCHOL, V105, P17; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P939; Green MF, 2009, SCHIZOPHRENIA BULL, V35, P163, DOI 10.1093/schbul/sbn156; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Gross J, 2009, CURR BIOL, V19, pR847, DOI 10.1016/j.cub.2009.07.023; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Keri S, 2007, VISUAL NEUROSCI, V24, P183, DOI 10.1017/S0952523807070253; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; Knebel JF, 2011, PSYCHIAT RES-NEUROIM, V193, P168, DOI 10.1016/j.pscychresns.2011.02.006; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Kroken RA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-24; Kurylo DD, 2007, SCHIZOPHR RES, V95, P205, DOI 10.1016/j.schres.2007.07.001; Kyllingsbaek S, 2007, PERCEPT PSYCHOPHYS, V69, P1040, DOI 10.3758/BF03193942; LEPINE JP, 1989, PSYCHIAT TODAY ACCOM; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; LIEB K, 1994, SCHIZOPHR RES, V14, P47, DOI 10.1016/0920-9964(94)90008-6; LIVINGSTONE MS, 1988, J NEUROSCI, V8, P4334; MAHER BA, 1974, J INDIV PSYCHOL, V30, P98; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; Matsuda Y, 2011, PERCEPT MOTOR SKILL, V112, P369, DOI 10.2466/15.19.22.27.PMS.112.2.369-381; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Merz J, 1975, Psychiatr Neurol Med Psychol (Leipz), V27, P423; MILLER MB, 1990, J ABNORM PSYCHOL, V99, P313, DOI 10.1037/0021-843X.99.3.313; Morrison AP, 2002, BRIT J CLIN PSYCHOL, V41, P259, DOI 10.1348/014466502760379127; Motter BC, 2008, VISION RES, V48, P2382, DOI 10.1016/j.visres.2008.07.020; Must A, 2004, NEUROSCI LETT, V357, P131, DOI 10.1016/j.neulet.2003.12.046; NEALE JM, 1971, J ABNORM PSYCHOL, V77, P196, DOI 10.1037/h0030751; Neri P, 2006, J NEUROPHYSIOL, V96, P142, DOI 10.1152/jn.01261.2005; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P160, DOI 10.1093/schbul/10.2.160; Olevitch BA, 1996, INT J NEUROSCI, V88, P249, DOI 10.3109/00207459609000618; Omtzigt D, 2002, NEUROPSYCHOLOGIA, V40, P1881, DOI 10.1016/S0028-3932(02)00069-6; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Rassovsky Y, 2011, PSYCHOL MED, V41, P487, DOI 10.1017/S0033291710001054; Reddy L, 2007, J VISION, V7, DOI 10.1167/7.2.3; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Revheim N, 2006, SCHIZOPHR RES, V87, P238, DOI 10.1016/j.schres.2006.06.022; RICHARDSON AJ, 1994, INT J PSYCHOPHYSIOL, V18, P227, DOI 10.1016/0167-8760(94)90009-4; RICHARDSON AJ, 1994, INT J PSYCHOPHYSIOL, V18, P251, DOI 10.1016/0167-8760(94)90011-6; Robertshaw E, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/475017; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Saarela TP, 2009, J VISION, V9, DOI 10.1167/9.2.5; Saj A, 2011, CORTEX, P1; Saunders JA, 2012, NEUROBIOL DIS, V46, P93, DOI 10.1016/j.nbd.2011.12.049; Schade U, 2011, VISION RES, V51, P1, DOI 10.1016/j.visres.2010.09.010; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; SERENO AB, 1995, BIOL PSYCHIAT, V37, P394, DOI 10.1016/0006-3223(94)00127-O; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin YW, 2008, SCHIZOPHRENIA BULL, V34, P538, DOI 10.1093/schbul/sbm118; Silverstein SM, 2000, SCHIZOPHR RES, V43, P11, DOI 10.1016/S0920-9964(99)00180-2; Silverstein SM, 1996, J ABNORM PSYCHOL, V105, P410, DOI 10.1037/0021-843X.105.3.410; Slaghuis WL, 2003, NEUROPSYCHOLOGIA, V41, P968, DOI 10.1016/S0028-3932(02)00321-4; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Tjan BS, 2006, J NEUROPHYSIOL, V96, P1556, DOI 10.1152/jn.01367.2005; To MPS, 2011, VISION RES, V51, P1686, DOI 10.1016/j.visres.2011.05.010; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREVARTHEN CB, 1968, PSYCHOL FORSCH, V31, P299, DOI 10.1007/BF00422717; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van Assche M, 2011, SCHIZOPHRENIA BULL, V37, P394, DOI 10.1093/schbul/sbp084; Verghese P, 2004, VISION RES, V44, P1217, DOI 10.1016/j.visres.2003.12.006; Vlaskamp BNS, 2006, VISION RES, V46, P417, DOI 10.1016/j.visres.2005.04.006; Wertheim AH, 2006, EXP BRAIN RES, V170, P387, DOI 10.1007/s00221-005-0221-9; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Williams LE, 2010, NEUROPSYCHOLOGIA, V48, P3128, DOI 10.1016/j.neuropsychologia.2010.06.028; Winterer G, 2002, BIOL PSYCHIAT, V51, p151S; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Yeterian EH, 2010, J COMP NEUROL, V518, P3725, DOI 10.1002/cne.22420; Yoon JH, 2006, PSYCHIAT RES-NEUROIM, V148, P205, DOI 10.1016/j.pscychresns.2006.06.002; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035	127	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45884	10.1371/journal.pone.0045884	http://dx.doi.org/10.1371/journal.pone.0045884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049884	Green Published, gold, Green Accepted			2022-12-25	WOS:000309517300060
J	Maxwell, E; Tan, Y; Tan, YX; Hu, H; Benson, G; Aizikov, K; Conley, S; Staples, GO; Slysz, GW; Smith, RD; Zaia, J				Maxwell, Evan; Tan, Yan; Tan, Yuxiang; Hu, Han; Benson, Gary; Aizikov, Konstantin; Conley, Shannon; Staples, Gregory O.; Slysz, Gordon W.; Smith, Richard D.; Zaia, Joseph			GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHROMATOGRAPHY/MASS SPECTROMETRY; NONREDUCING END; OLIGOSACCHARIDES; PROTEOME; HEPARIN; IDENTIFICATIONS; DATABASES; SPECTRA; CHIP	Glycosylation modifies the physicochemical properties and protein binding functions of glycoconjugates. These modifications are biosynthesized in the endoplasmic reticulum and Golgi apparatus by a series of enzymatic transformations that are under complex control. As a result, mature glycans on a given site are heterogeneous mixtures of glycoforms. This gives rise to a spectrum of adhesive properties that strongly influences interactions with binding partners and resultant biological effects. In order to understand the roles glycosylation plays in normal and disease processes, efficient structural analysis tools are necessary. In the field of glycomics, liquid chromatography/mass spectrometry (LC/MS) is used to profile the glycans present in a given sample. This technology enables comparison of glycan compositions and abundances among different biological samples, i.e. normal versus disease, normal versus mutant, etc. Manual analysis of the glycan profiling LC/MS data is extremely time-consuming and efficient software tools are needed to eliminate this bottleneck. In this work, we have developed a tool to computationally model LC/MS data to enable efficient profiling of glycans. Using LC/MS data deconvoluted by Decon2LS/DeconTools, we built a list of unique neutral masses corresponding to candidate glycan compositions summarized over their various charge states, adducts and range of elution times. Our work aims to provide confident identification of true compounds in complex data sets that are not amenable to manual interpretation. This capability is an essential part of glycomics work flows. We demonstrate this tool, GlycReSoft, using an LC/MS dataset on tissue derived heparan sulfate oligosaccharides. The software, code and a test data set are publically archived under an open source license.	[Maxwell, Evan; Tan, Yan; Tan, Yuxiang; Hu, Han; Benson, Gary; Zaia, Joseph] Boston Univ, Ctr Biomed Mass Spectrometry, Bioinformat Program, Boston, MA 02215 USA; [Maxwell, Evan] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Slysz, Gordon W.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Slysz, Gordon W.; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Tan, Yan] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Zaia, J (corresponding author), Boston Univ, Ctr Biomed Mass Spectrometry, Bioinformat Program, Boston, MA 02215 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019; Tan, Yuxiang/AFQ-4637-2022; Smith, Richard D/J-3664-2012	Zaia, Joseph/0000-0001-9497-8701; Tan, Yuxiang/0000-0002-1704-1293; Smith, Richard D/0000-0002-2381-2349; Slysz, Gordon/0000-0001-6668-6576	NIH [P41RR10888, P41GM104603, R01HL098950]; NSF (National Science Foundation); NIH National Center for Research Resources [RR018522]; W.R. Wiley Environmental Molecular Science Laboratory; US Department of Energy's Office of Biological and Environmental Research; National Institute of Allergy and Infectious Diseases (NIH/DHHS) [Y1-AI-4894-01]; US Department of Energy [DE-AC05-76RL0 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (National Science Foundation)(National Science Foundation (NSF)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); W.R. Wiley Environmental Molecular Science Laboratory; US Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases (NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants P41RR10888, P41GM104603, and R01HL098950 and by an NSF (National Science Foundation) Integrative Graduate Education and Research Traineeship. This research utilized the Decon2LS and DeconTools software developed by the Pacific Northwest National Laboratory, supported by the NIH National Center for Research Resources (Grant RR018522), the W.R. Wiley Environmental Molecular Science Laboratory (a national scientific user facility sponsored by the US Department of Energy's Office of Biological and Environmental Research and located at PNNL), and the National Institute of Allergy and Infectious Diseases (NIH/DHHS through interagency agreement Y1-AI-4894-01). PNNL is operated by Battelle Memorial Institute for the US Department of Energy under contract DE-AC05-76RL0 1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cargile BJ, 2004, J PROTEOME RES, V3, P1082, DOI 10.1021/pr049946o; Ceroni A, 2008, J PROTEOME RES; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Dreyfuss JM, 2011, ANAL BIOANAL CHEM, V399, P727, DOI 10.1007/s00216-010-4235-1; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Henriksen J, 2004, J MASS SPECTROM, V39, P1305, DOI 10.1002/jms.723; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Slysz G.W., 2010, P 58 ASMS C MASS SPE; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Staples GO, 2010, ANAL CHEM, V82, P516, DOI 10.1021/ac901706f; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Yu LR, 2004, MOL CELL PROTEOMICS, V3, P896, DOI 10.1074/mcp.M400034-MCP200; Zaia J, 2009, MASS SPECTROM REV, V28, P254, DOI 10.1002/mas.20200	27	106	107	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45474	10.1371/journal.pone.0045474	http://dx.doi.org/10.1371/journal.pone.0045474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049804	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517300027
J	Sela, I; Karni, A				Sela, Itamar; Karni, Avi			Differences in Learning Volitional (Manual) and Non-Volitional (Posture) Aspects of a Complex Motor Skill in Young Adult Dyslexic and Skilled Readers	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; SUPPORT-SURFACE; CHILDREN; DEFICITS; BALANCE; ACQUISITION; PERFORMANCE; AUTOMATIZATION; CEREBELLUM; MOVEMENT	The 'Cerebellar Deficit Theory' of developmental dyslexia proposes that a subtle developmental cerebellar dysfunction leads to deficits in attaining 'automatic' procedures and therefore manifests as subtle motor impairments (e. g., balance control, motor skill learning) in addition to the reading and phonological difficulties. A more recent version of the theory suggests a core deficit in motor skill acquisition. This study was undertaken to compare the time-course and the nature of practice-related changes in volitional (manual) and non-volitional (posture) motor performance in dyslexic and typical readers while learning a new movement sequence. Seventeen dyslexic and 26 skilled young adult readers underwent a three-session training program in which they practiced a novel sequence of manual movements while standing in a quiet stance position. Both groups exhibited robust and well-retained gains in speed, with no loss of accuracy, on the volitional, manual, aspects of the task, with a time-course characteristic of procedural learning. However, the dyslexic readers exhibited a pervasive slowness in the initiation of volitional performance. In addition, while typical readers showed clear and well-retained task-related adaptation of the balance and posture control system, the dyslexic readers had significantly larger sway and variance of sway throughout the three sessions and were less efficient in adapting the posture control system to support the acquisition of the novel movement sequence. These results support the notion of a non-language-related deficit in developmental dyslexia, one related to the recruitment of motor systems for effective task performance rather than to a general motor learning disability.	[Sela, Itamar; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel; [Karni, Avi] Univ Haifa, Fac Nat Sci, Segol Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Karni, Avi] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Sela, I (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel.	isela01@campus.haifa.ac.il			Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This research was funded by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Adi-Japha E, 2011, RES DEV DISABIL, V32, P1011, DOI 10.1016/j.ridd.2011.01.048; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Bishop DVM, 2002, CORTEX, V38, P491, DOI 10.1016/S0010-9452(08)70018-2; Bock O, 2001, ACTA PHYSL PHARM BUL, V26, P761; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 2006, FLUENCY READING SYNC; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chong RKY, 1999, J GERONTOL A-BIOL, V54, pM129, DOI 10.1093/gerona/54.3.M129; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2002, NEUROPSYCHOLOGY MEMO; Elion O, 2008, 2008 VIRTUAL REHABILITATION, P50, DOI 10.1109/ICVR.2008.4625121; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; FAWCETT AJ, 1992, PERCEPT MOTOR SKILL, V75, P507, DOI 10.2466/pms.1992.75.2.507; Fawcett AJ., 2008, SAGE HDB DYSLEXIA, P11; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Galgon AK, 2010, GAIT POSTURE, V31, P265, DOI 10.1016/j.gaitpost.2009.11.002; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Ivry RB, 2001, TRENDS NEUROSCI, V24, P513, DOI 10.1016/S0166-2236(00)01897-X; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kelly Steve W, 2002, Dyslexia, V8, P43, DOI 10.1002/dys.208; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Lacquaniti F, 1992, Curr Opin Neurobiol, V2, P807, DOI 10.1016/0959-4388(92)90138-B; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Maquet P, 2003, LEARN MEMORY, V10, P237, DOI 10.1101/lm.64303; Massion J, 1996, CLIN DISORDERS BALAN, P10; MATAL, 2007, DIAGN BATT ASS LEARN; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Menghini D, 2008, ANN NY ACAD SCI, V1145, P212, DOI 10.1196/annals.1416.010; Nicolson RI, 2010, DYSLEXIA, V16, P194, DOI 10.1002/dys.408; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2008, SAGE HDB DYSLEXIA, P11; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Raven J.C., 1960, GUIDE STANDARD PROGR; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Rosenblum S, 2003, PERCEPT MOTOR SKILL, V96, P933, DOI 10.2466/PMS.96.3.933-954; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Savage R., 2004, READING WRITING INTE, V17, P301, DOI [DOI 10.1023/B:READ.0000017688.67137.80, 10.1023/B:READ.0000017688.67137.80]; Shany M., 2006, TEL AVIV; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Sosnik R, 2007, EXP BRAIN RES, V176, P311, DOI 10.1007/s00221-006-0617-1; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stelmach GE, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P391; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; The Center of Psychometric Tests, 1994, OR SIL COMPR TEST; Vernazza-Martin S, 2006, EXP BRAIN RES, V173, P62, DOI 10.1007/s00221-006-0364-3; VERWEY WB, 1993, ACTA PSYCHOL, V84, P179, DOI 10.1016/0001-6918(93)90026-N; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Waber DP, 2003, J EXP CHILD PSYCHOL, V84, P338, DOI 10.1016/S0022-0965(03)00030-4; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Wechsler D., 1997, WECHSLER ADULT INTEL; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; Wimmer H., 1998, SCI STUD READ, V2, P321, DOI [10.1207/s1532799xssr0204_2, DOI 10.1207/S1532799XSSR0204_2]; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wulf G, 2010, Q J EXPT PSYCHOL A, V54, P1143; Zeffiro T, 2001, TRENDS NEUROSCI, V24, P512, DOI 10.1016/S0166-2236(00)01898-1	83	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43488	10.1371/journal.pone.0043488	http://dx.doi.org/10.1371/journal.pone.0043488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049736	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517300005
J	Ancelet, LR; Aldwell, FE; Rich, FJ; Kirman, JR				Ancelet, Lindsay R.; Aldwell, Frank E.; Rich, Fenella J.; Kirman, Joanna R.			Oral Vaccination with Lipid-Formulated BCG Induces a Long-lived, Multifunctional CD4(+) T Cell Memory Immune Response	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLE CALMETTE-GUERIN; DELAYED-TYPE HYPERSENSITIVITY; TUBERCULOSIS INFECTION; INTERFERON-GAMMA; PROTECTIVE IMMUNITY; AEROSOL CHALLENGE; LEISHMANIA-MAJOR; MICE; LUNG	Oral delivery of BCG in a lipid formulation (Liporale (TM)-BCG) targets delivery of viable bacilli to the mesenteric lymph nodes and confers protection against an aerosol Mycobacterium tuberculosis challenge. The magnitude, quality and duration of the effector and memory immune response induced by Liporale (TM)-BCG vaccination is unknown. Therefore, we compared the effector and memory CD4(+) T cell response in the spleen and lungs of mice vaccinated with Liporale (TM)-BCG to the response induced by subcutaneous BCG vaccination. Liporale (TM)-BCG vaccination induced a long-lived CD4(+) T cell response, evident by the detection of effector CD4(+) T cells in the lungs and a significant increase in the number of Ag85B tetramer-specific CD4(+) T cells in the spleen up to 30 weeks post vaccination. Moreover, following polyclonal stimulation, Liporale (TM)-BCG vaccination, but not s.c. BCG vaccination, induced a significant increase in both the percentage of CD4(+) T cells in the lungs capable of producing IFN gamma and the number of multifunctional CD4(+) T cells in the lungs at 30 weeks post vaccination. These results demonstrate that orally delivered Liporale (TM)-BCG vaccine induces a long-lived multifunctional immune response, and could therefore represent a practical and effective means of delivering novel BCG-based TB vaccines.	[Kirman, Joanna R.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Ancelet, Lindsay R.; Rich, Fenella J.] Malaghan Inst Med Res, Infect Dis Grp, Wellington, New Zealand; [Aldwell, Frank E.] Univ Otago, Immune Solut Ltd, Ctr Innovat, Dunedin, New Zealand	University of Otago; Malaghan Institute; Victoria University Wellington; University of Otago	Kirman, JR (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	jo.kirman@otago.ac.nz		Kirman, Joanna/0000-0002-4802-7048	Wellington Medical Research Foundation Malaghan Haematology Fellowship; University of Otago; Otago Innovations Ltd	Wellington Medical Research Foundation Malaghan Haematology Fellowship; University of Otago; Otago Innovations Ltd	Financial support was recieved through the Wellington Medical Research Foundation Malaghan Haematology Fellowship (JRK), the University of Otago (LRA), and Otago Innovations Ltd (FEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Ainslie MP, 2002, THORAX, V57, P1054, DOI 10.1136/thorax.57.12.1054; Aldwell FE, 2006, VACCINE, V24, P2071, DOI 10.1016/j.vaccine.2005.11.017; Aldwell FE, 2005, IMMUNOL CELL BIOL, V83, P549, DOI 10.1111/j.1440-1711.2005.01369.x; Aldwell FE, 2005, INFECT IMMUN, V73, P1903, DOI 10.1128/IAI.73.3.1903-1905.2005; Ancelet Lindsay, 2012, Biomol Concepts, V3, P13, DOI 10.1515/bmc.2011.051; Bekker LG, 2001, J IMMUNOL, V166, P6728, DOI 10.4049/jimmunol.166.11.6728; Bingaman AW, 2005, EUR J IMMUNOL, V35, P3173, DOI 10.1002/eji.200526004; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Clark S, 2008, INFECT IMMUN, V76, P3771, DOI 10.1128/IAI.00052-08; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Connor LM, 2010, EUR J IMMUNOL, V40, P2482, DOI 10.1002/eji.200940279; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cosgrove CA, 2006, INFECT IMMUN, V74, P2449, DOI 10.1128/IAI.74.4.2449-2452.2006; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Dorer DE, 2007, CELL MICROBIOL, V9, P544, DOI 10.1111/j.1462-5822.2006.00810.x; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; GHEORGHIU M, 1994, INT J IMMUNOPHARMACO, V16, P435, DOI 10.1016/0192-0561(94)90033-7; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Haile M, 2004, VACCINE, V22, P1498, DOI 10.1016/j.vaccine.2003.10.016; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; ORME IM, 1988, INFECT IMMUN, V56, P3310, DOI 10.1128/IAI.56.12.3310-3312.1988; Ozeki Y, 2011, VACCINE, V29, P6881, DOI 10.1016/j.vaccine.2011.07.051; Partnership WST, 2010, GLOB PLAN STOP TB 20; Ramsey DSL, 2009, TUBERCULOSIS, V89, P163, DOI 10.1016/j.tube.2008.11.002; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vipond J, 2008, MICROBES INFECT, V10, P1577, DOI 10.1016/j.micinf.2008.09.004; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45888	10.1371/journal.pone.0045888	http://dx.doi.org/10.1371/journal.pone.0045888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049885	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100096
J	Chen, YT; Tsai, MS; Yang, TL; Ku, AT; Huang, KH; Huang, CY; Chou, FJ; Fan, HH; Hong, JB; Yen, ST; Wang, WL; Lin, CC; Hsu, YC; Su, KY; Su, IC; Jang, CW; Behringer, RR; Favaro, R; Nicolis, SK; Chien, CL; Lin, SW; Yu, IS				Chen, You-Tzung; Tsai, Ming-Shian; Yang, Tsung-Lin; Ku, Amy Tsu; Huang, Ke-Han; Huang, Cheng-Yen; Chou, Fu-Ju; Fan, Hsiang-Hsuan; Hong, Jin-Bon; Yen, Shuo-Ting; Wang, Wei-Le; Lin, Chang-Ching; Hsu, Yu-Chen; Su, Kang-Yi; Su, I-Chang; Jang, Chuan-Wei; Behringer, Richard R.; Favaro, Rebecca; Nicolis, Silvia K.; Chien, Chung-Liang; Lin, Shu-Wha; Yu, I-Shing			R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GPI-ANCHORED PROTEINS; TARGETING VECTORS; ROSA26 LOCUS; EXPRESSION; RECOMBINASE; TRANSPORT; LINE; GFP; ACTIVATION	Green fluorescent protein (GFP) and its derivatives are the most widely used molecular reporters for live cell imagining. The development of organelle-specific fusion fluorescent proteins improves the labeling resolution to a higher level. Here we generate a R26 dual fluorescent protein reporter mouse, activated by Cre-mediated DNA recombination, labeling target cells with a chromatin-specific enhanced green fluorescence protein (EGFP) and a plasma membrane-anchored monomeric cherry fluorescent protein (mCherry). This dual labeling allows the visualization of mitotic events, cell shapes and intracellular vesicle behaviors. We expect this reporter mouse to have a wide application in developmental biology studies, transplantation experiments as well as cancer/stem cell lineage tracing.	[Tsai, Ming-Shian; Hsu, Yu-Chen; Lin, Shu-Wha] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei 10764, Taiwan; [Chen, You-Tzung; Ku, Amy Tsu; Huang, Ke-Han; Chou, Fu-Ju; Fan, Hsiang-Hsuan; Hong, Jin-Bon; Yen, Shuo-Ting; Wang, Wei-Le; Lin, Chang-Ching] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei 10764, Taiwan; [Chen, You-Tzung; Su, I-Chang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan; [Huang, Cheng-Yen] Natl Taiwan Univ, Core Lab 1, Branch Off Med Res & Dev, Coll Med, Taipei 10764, Taiwan; [Hsu, Yu-Chen; Su, Kang-Yi] Natl Taiwan Univ, Div Genom Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Su, Kang-Yi] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Jang, Chuan-Wei; Behringer, Richard R.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jang, Chuan-Wei; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Jang, Chuan-Wei; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Favaro, Rebecca; Nicolis, Silvia K.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Chien, Chung-Liang] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei 10764, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Transgen Mouse Model Core Facil, Natl Res Program Genom Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Milano-Bicocca; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, SW (corresponding author), Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei 10764, Taiwan.	mtshuwha@ntu.edu.tw; oxfo@tpts6.seed.net.tw	SU, KANG-YI/GNM-5753-2022; Favaro, Rebecca/HHZ-8978-2022	SU, KANG-YI/0000-0002-6538-9526; Favaro, Rebecca/0000-0002-6195-5711; CHEN, YOU-TZUNG/0000-0001-6510-3420; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; Lin, Chang-Ching/0000-0001-6659-5543; Yen, Shuo-Ting/0000-0003-4277-1965; LIN, SHU-WHA/0000-0001-6748-5581; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; Hong, Jin-Bon/0000-0001-9467-6463; YANG, TSUNG-LIN/0000-0001-6521-8631	National Taiwan University (NTU), NTU Hospital; National Science Council (NSC) in Taiwan [NTU CESRP-10R71602C6, NSC 100-2320-B-002-093-, NSC 100-2321-B-002-049-, NTUH 100-S1499, NSC 99-2627-B-002-005-]; National Institutes of Health [HD30284]; Ben F. Love Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030284] Funding Source: NIH RePORTER	National Taiwan University (NTU), NTU Hospital; National Science Council (NSC) in Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben F. Love Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from National Taiwan University (NTU), NTU Hospital, and National Science Council (NSC) in Taiwan to Y.T.C. (NTU CESRP-10R71602C6, NSC 100-2320-B-002-093-, and NSC 100-2321-B-002-049-), to T.L.Y. (NTUH 100-S1499), and to S.W.L. (NSC 99-2627-B-002-005-), the National Institutes of Health HD30284 and the Ben F. Love Endowment to R.R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Drogat B, 2010, BLOOD, V116, P2141, DOI 10.1182/blood-2010-01-264143; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Kondoh G, 1999, FEBS LETT, V458, P299, DOI 10.1016/S0014-5793(99)01172-2; Lakhan SE, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-93; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Meilhac SM, 2009, DEV BIOL, V331, P210, DOI 10.1016/j.ydbio.2009.04.036; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nowotschin S, 2009, GENESIS, V47, P330, DOI 10.1002/dvg.20500; Nowotschin S, 2009, TRENDS BIOTECHNOL, V27, P266, DOI 10.1016/j.tibtech.2009.02.006; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shioi G, 2011, GENESIS, V49, P570, DOI 10.1002/dvg.20758; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stewart MD, 2010, METHOD ENZYMOL, V477, P145, DOI 10.1016/S0076-6879(10)77009-9; Stewart MD, 2009, GENESIS, V47, P708, DOI 10.1002/dvg.20565; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; WILLIAMS AF, 1982, SCIENCE, V216, P696, DOI 10.1126/science.6177036; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	51	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46171	10.1371/journal.pone.0046171	http://dx.doi.org/10.1371/journal.pone.0046171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049968	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100146
J	Jain, S; Yoon, SY; Zhu, L; Brodbeck, J; Dai, J; Walker, D; Huang, YD				Jain, Sachi; Yoon, Seo Yeon; Zhu, Lei; Brodbeck, Jens; Dai, Jessica; Walker, David; Huang, Yadong			Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTORS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN E4; DEPENDENT IMPAIRMENT; MOUSE MODELS; CLASS-I; ACTIN; DENSITY	The ability to distinguish between similar experiences is a critical feature of episodic memory and is primarily regulated by the dentate gyrus (DG) region of the hippocampus. However, the molecular mechanisms underlying such pattern separation tasks are poorly understood. We report a novel role for the small GTPase ADP ribosylation factor 4 (Arf4) in controlling pattern separation by regulating dendritic spine development. Arf4(+/-) mice at 4-5 months of age display severe impairments in a pattern separation task, as well as significant dendritic spine loss and smaller miniature excitatory postsynaptic currents (mEPSCs) in granule cells of the DG. Arf4 knockdown also decreases spine density in primary neurons, whereas Arf4 overexpression promotes spine development. A constitutively active form of Arf4, Arf4-Q71L, promotes spine density to an even greater extent than wildtype Arf4, whereas the inactive Arf4-T31N mutant does not increase spine density relative to controls. Arf4's effects on spine development are regulated by ASAP1, a GTPase-activating protein that modulates Arf4 GTPase activity. ASAP1 overexpression decreases spine density, and this effect is partially rescued by concomitant overexpression of wildtype Arf4 or Arf4-Q71L. In addition, Arf4 overexpression rescues spine loss in primary neurons from an Alzheimer's disease-related apolipoprotein (apo) E4 mouse model. Our findings suggest that Arf4 is a critical modulator of DG-mediated pattern separation by regulating dendritic spine development.	[Jain, Sachi; Yoon, Seo Yeon; Zhu, Lei; Brodbeck, Jens; Dai, Jessica; Walker, David; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Walker, David; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Jain, Sachi; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	yhuang@gladstone.ucsf.edu	Zhu, Lei/J-7210-2013; Brodbeck, Jens/AAB-9275-2020	Zhu, Lei/0000-0002-0898-8602; 	National Institute of Health [P01 AG022074, P30 NS065780, C06RR18928]; National Science Foundation; J. David Gladstone Institutes; Hellman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J. David Gladstone Institutes(University of California System); Hellman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute of Health (P01 AG022074, P30 NS065780, and C06RR18928), the National Science Foundation, the J. David Gladstone Institutes, and gifts from the S.D. Bechtel, Jr. Foundation and the Hellman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen YG, 1996, J BIOL CHEM, V271, P5297, DOI 10.1074/jbc.271.10.5297; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kaneko M, 2012, J NEUROSCI, V32, P4790, DOI 10.1523/JNEUROSCI.4462-11.2012; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Moore CD, 2007, J CELL SCI, V120, P2683, DOI 10.1242/jcs.006346; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Palmer A, 2011, BIOCHEM SOC T, V39, P902, DOI 10.1042/BST0390902; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Salmon David P, 2012, Curr Top Behav Neurosci, V10, P187, DOI 10.1007/7854_2011_171; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki I, 2001, MOL BRAIN RES, V88, P124, DOI 10.1016/S0169-328X(01)00036-5; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Vigers AJ, 2012, NEUROSCIENCE, V212, P1, DOI 10.1016/j.neuroscience.2012.03.031; Wilson IA, 2004, J NEUROSCI, V24, P3870, DOI 10.1523/JNEUROSCI.5205-03.2004; Woo IS, 2009, CANCER LETT, V276, P53, DOI 10.1016/j.canlet.2008.10.031; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	69	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46340	10.1371/journal.pone.0046340	http://dx.doi.org/10.1371/journal.pone.0046340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050017	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100181
J	Liskova, P; Gwilliam, R; Filipec, M; Jirsova, K; Merjava, SR; Deloukas, P; Webb, TR; Bhattacharya, SS; Ebenezer, ND; Morris, AG; Hardcastle, AJ				Liskova, Petra; Gwilliam, Rhian; Filipec, Martin; Jirsova, Katerina; Merjava, Stanislava Reinstein; Deloukas, Panos; Webb, Tom R.; Bhattacharya, Shomi S.; Ebenezer, Neil D.; Morris, Alex G.; Hardcastle, Alison J.			High Prevalence of Posterior Polymorphous Corneal Dystrophy in the Czech Republic; Linkage Disequilibrium Mapping and Dating an Ancestral Mutation	PLOS ONE			English	Article							VSX1 GENE; LOCUS; RECOMBINATION; CHROMOSOME-20; ENDOTHELIUM; KERATOCONUS; POPULATION; EXPRESSION; REPRESSION; MAPS	Posterior polymorphous corneal dystrophy (PPCD) is a rare autosomal dominant genetically heterogeneous disorder. Nineteen Czech PPCD pedigrees with 113 affected family members were identified, and 17 of these kindreds were genotyped for markers on chromosome 20p12.1-20q12. Comparison of haplotypes in 81 affected members, 20 unaffected first degree relatives and 13 spouses, as well as 55 unrelated controls, supported the hypothesis of a shared ancestor in 12 families originating from one geographic location. In 38 affected individuals from nine of these pedigrees, a common haplotype was observed between D20S48 and D20S107 spanning approximately 23 Mb, demonstrating segregation of disease with the PPCD1 locus. This haplotype was not detected in 110 ethnically matched control chromosomes. Within the common founder haplotype, a core mini-haplotype was detected for D20S605, D20S182 and M189K2 in all 67 affected members from families 1-12, however alleles representing the core mini-haplotype were also detected in population matched controls. The most likely location of the responsible gene within the disease interval, and estimated mutational age, were inferred by linkage disequilibrium mapping (DMLE+2.3). The appearance of a disease-causing mutation was dated between 64-133 generations. The inferred ancestral locus carrying a PPCD1 disease-causing variant within the disease interval spans 60 Kb on 20p11.23, which contains a single known protein coding gene, ZNF133. However, direct sequence analysis of coding and untranslated exons did not reveal a potential pathogenic mutation. Microdeletion or duplication was also excluded by comparative genomic hybridization using a dense chromosome 20 specific array. Geographical origin, haplotype and statistical analysis suggest that in 14 unrelated families an as yet undiscovered mutation on 20p11.23 was inherited from a common ancestor. Prevalence of PPCD in the Czech Republic appears to be the highest worldwide and our data suggests that at least one other novel locus for PPCD also exists.	[Liskova, Petra; Jirsova, Katerina; Merjava, Stanislava Reinstein] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Dis, Lab Biol & Pathol Eye, Prague, Czech Republic; [Liskova, Petra; Jirsova, Katerina; Merjava, Stanislava Reinstein] Gen Univ Hosp, Prague, Czech Republic; [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Liskova, Petra; Webb, Tom R.; Bhattacharya, Shomi S.; Ebenezer, Neil D.; Hardcastle, Alison J.] UCL Inst Ophthalmol, London, England; [Gwilliam, Rhian; Deloukas, Panos] Wellcome Trust Res Labs, Sanger Inst, Hinxton, England; [Filipec, Martin] European Eye Clin Lexum, Prague, Czech Republic; [Morris, Alex G.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England	Charles University Prague; General University Hospital Prague; Charles University Prague; University of London; University College London; Wellcome Trust Sanger Institute; Imperial College London	Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Dis, Lab Biol & Pathol Eye, Prague, Czech Republic.	petra.liskova@lf1.cuni.cz	Reinstein Merjava, Stanislava/H-3573-2017; Bhattacharya, Shom/N-2926-2016; Webb, Tom/C-6237-2011; Webb, Tom/GMW-5311-2022; Deloukas, Panos/B-2922-2013; Liskova, Petra/C-9680-2011; Jirsova, Katerina/B-8301-2012	Reinstein Merjava, Stanislava/0000-0001-7478-0706; Bhattacharya, Shom/0000-0002-1601-6344; Deloukas, Panos/0000-0001-9251-070X; Liskova, Petra/0000-0001-7834-8486; Jirsova, Katerina/0000-0002-4625-6701; Hardcastle, Alison/0000-0002-0038-6770; Webb, Tom/0000-0001-5998-8226	GACR [P301/12/P591]; UNCE [204011]; Charles University in Prague [PRVOUK-P24/LF1/3]	GACR(Grant Agency of the Czech Republic); UNCE; Charles University in Prague	This work was supported by research grant GACR P301/12/P591. Institutional support was provided by UNCE 204011 and PRVOUK-P24/LF1/3 programs of the Charles University in Prague. AJH is a Faculty member of the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DEFELICE GP, 1985, GRAEF ARCH CLIN EXP, V223, P265, DOI 10.1007/BF02153657; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; HENRIQUEZ AS, 1984, SURV OPHTHALMOL, V29, P139, DOI 10.1016/0039-6257(84)90171-1; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hosseini SM, 2008, MOL VIS, V14, P71; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; LAGANOWSKI HC, 1991, CORNEA, V10, P224, DOI 10.1097/00003226-199105000-00008; Lai IN, 2010, MOL VIS, V16, P2829; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2007, MOL VIS, V13, P1887; Liskova P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; POLACK FM, 1980, AM J OPHTHALMOL, V89, P575, DOI 10.1016/0002-9394(80)90070-7; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Sherwin JC, 2008, OPHTHALMIC GENET, V29, P149, DOI 10.1080/13816810802334341; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Valleix S, 2006, INVEST OPHTH VIS SCI, V47, P48, DOI 10.1167/iovs.05-0479; Vincent AL, 2009, MOL VIS, V15, P2544; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2	32	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45495	10.1371/journal.pone.0045495	http://dx.doi.org/10.1371/journal.pone.0045495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049806	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100051
J	Liu, B; Barbosa-Sampaio, H; Jones, PM; Persaud, SJ; Muller, DS				Liu, Bo; Barbosa-Sampaio, Helena; Jones, Peter M.; Persaud, Shanta J.; Muller, Dany S.			The CaMK4/CREB/IRS-2 Cascade Stimulates Proliferation and Inhibits Apoptosis of beta-Cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; CAM KINASE-IV; IRS-2 EXPRESSION; BINDING-PROTEIN; UP-REGULATION; IN-VIVO; GLUCOSE; SECRETION; RESISTANCE; SURVIVAL	Progressive reduction in beta-cell mass is responsible for the development of type 2 diabetes mellitus, and alteration in insulin receptor substrate 2 (IRS-2) abundance plays a critical role in this process. IRS-2 expression is stimulated by the transcription factor cAMP response element-binding protein (CREB) and we recently demonstrated that Ca2+/calmodulin dependent kinase 4 (CaMK4) is upstream of CREB activation in beta-cells. This study investigated whether CaMK4 is also a potential target to increase beta-cell mass through CREB-mediated IRS-2 expression, by quantifying mouse MIN6 beta-cell proliferation and apoptosis following IRS-2 knockdown, CaMKs inhibition and alterations in CaMK4 and CREB expression. Expression of constitutively active CaMK4 (Delta CaMK4) and CREB (CREBDIEDLM) significantly stimulated beta-cell proliferation and survival. In contrast, expression of their corresponding dominant negative forms (Delta(K75E)CaMK4 and CREBM1) and silencing of IRS-2 increased apoptosis and reduced beta-cell division. Moreover, CREBDIEDLM and CREBM1 expression completely abolished the effects of Delta(K75E)CaMK4 and of Delta CaMK4, respectively. Our results indicate that CaMK4 regulates beta-cell proliferation and apoptosis in a CREB-dependent manner and that CaMK4-induced IRS-2 expression is important in these processes.	[Liu, Bo; Barbosa-Sampaio, Helena; Jones, Peter M.; Persaud, Shanta J.; Muller, Dany S.] Kings Coll London, Diabet Res Grp, Sch Med, Div Diabet & Nutr Sci, London WC2R 2LS, England	University of London; King's College London	Persaud, SJ (corresponding author), Kings Coll London, Diabet Res Grp, Sch Med, Div Diabet & Nutr Sci, London WC2R 2LS, England.	shanta.persaud@kcl.ac.uk	Persaud, Shanta/AAH-3200-2021; Barbosa-Sampaio, Helena Cristina/L-2160-2019; Sampaio, Helena C. L. Barbosa/B-7083-2015	Barbosa-Sampaio, Helena Cristina/0000-0002-5244-889X; Sampaio, Helena C. L. Barbosa/0000-0002-5244-889X; Persaud, Shanta/0000-0002-4933-5958; Liu, Bo/0000-0002-8697-234X; Jones, Peter/0000-0003-1201-2335	Diabetes UK [06/0003387, 08/0003706]; Society for Endocrinology Early Career Grant	Diabetes UK(Diabetes UK); Society for Endocrinology Early Career Grant	This work was supported by Diabetes UK grants 06/0003387 and 08/0003706 and by a Society for Endocrinology Early Career Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacker-Francoys I, 2005, EXP CLIN ENDOCR DIAB, V113, P423, DOI 10.1055/s-2005-865803; Ban N, 2000, DIABETES, V49, P1142, DOI 10.2337/diabetes.49.7.1142; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; BONNERWEIR S, 1994, RECENT PROG HORM RES, V49, P91; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Krebs J, 1998, BBA-MOL CELL RES, V1448, P183, DOI 10.1016/S0167-4889(98)00142-6; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Polonsky KS, 2000, INT J OBESITY, V24, pS29, DOI 10.1038/sj.ijo.0801273; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yu X, 2004, DIABETES, V53, P1475, DOI 10.2337/diabetes.53.6.1475	43	36	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45711	10.1371/journal.pone.0045711	http://dx.doi.org/10.1371/journal.pone.0045711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049845	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100073
J	Machida, RJ; Knowlton, N				Machida, Ryuji J.; Knowlton, Nancy			PCR Primers for Metazoan Nuclear 18S and 28S Ribosomal DNA Sequences	PLOS ONE			English	Article							RNA GENES; BIODIVERSITY; DIVERSITY		[Machida, Ryuji J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Academia Sinica - Taiwan; Smithsonian Institution; Smithsonian National Museum of Natural History	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gate.sinica.edu.tw			Alfred P. Sloan Foundation; Sant Chair of Marine Science discretionary funds	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sant Chair of Marine Science discretionary funds	Financial support was provided by the Alfred P. Sloan Foundation and the Sant Chair of Marine Science discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Committee on Metagenomics National Research Council, 2007, CHALL FUNCT APPL NEW, P170; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; McIntyre AD, 2010, LIFE WORLDS OCEANS D; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PHILIPPE H, 1994, J EVOLUTION BIOL, V7, P247, DOI 10.1046/j.1420-9101.1994.7020247.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	29	62	68	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46180	10.1371/journal.pone.0046180	http://dx.doi.org/10.1371/journal.pone.0046180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049971	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100148
J	Ribeiro, JMC; Assumpcao, TCF; Ma, DY; Alvarenga, PH; Pham, VM; Andersen, JF; Francischetti, IMB; Macaluso, KR				Ribeiro, Jose M. C.; Assumpcao, Teresa C. F.; Ma, Dongying; Alvarenga, Patricia H.; Pham, Van M.; Andersen, John F.; Francischetti, Ivo M. B.; Macaluso, Kevin R.			An Insight into the Sialotranscriptome of the Cat Flea, Ctenocephalides felis	PLOS ONE			English	Article							SALIVARY ADENOSINE-DEAMINASE; APYRASE ACTIVITY; ORAL SECRETION; BLACK FLY; DATABASE; IDENTIFICATION; SIALOME; PROTEIN; SIPHONAPTERA; PREDICTION	Background: Saliva of hematophagous arthropods contains a diverse mixture of compounds that counteracts host hemostasis. Immunomodulatory and antiinflammatory components are also found in these organisms' saliva. Blood feeding evolved at least ten times within arthropods, providing a scenario of convergent evolution for the solution of the salivary potion. Perhaps because of immune pressure from hosts, the salivary proteins of related organisms have considerable divergence, and new protein families are often found within different genera of the same family or even among subgenera. Fleas radiated with their vertebrate hosts, including within the mammal expansion initiated 65 million years ago. Currently, only one flea species-the rat flea Xenopsylla cheopis-has been investigated by means of salivary transcriptome analysis to reveal salivary constituents, or sialome. We present the analysis of the sialome of cat flea Ctenocephaides felis. Methodology and Critical Findings: A salivary gland cDNA library from adult fleas was randomly sequenced, assembled, and annotated. Sialomes of cat and rat fleas have in common the enzyme families of phosphatases (inactive), CD-39-type apyrase, adenosine deaminases, and esterases. Antigen-5 members are also common to both sialomes, as are defensins. FS-I/Cys7 and the 8-Cys families of peptides are also shared by both fleas and are unique to these organisms. The Gly-His-rich peptide similar to holotricin was found only in the cat flea, as were the abundantly expressed Cys-less peptide and a novel short peptide family. Conclusions/Significance: Fleas, in contrast to bloodsucking Nematocera (mosquitoes, sand flies, and black flies), appear to concentrate a good portion of their sialome in small polypeptides, none of which have a known function but could act as inhibitors of hemostasis or inflammation. They are also unique in expansion of a phosphatase family that appears to be deficient of enzyme activity and has an unknown function.	[Ribeiro, Jose M. C.; Assumpcao, Teresa C. F.; Ma, Dongying; Pham, Van M.; Andersen, John F.; Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, Rockville, MD USA; [Alvarenga, Patricia H.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil; [Alvarenga, Patricia H.] INCT EM, Rio De Janeiro, Brazil; [Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Ribeiro, JMC (corresponding author), NIAID, Vector Biol Sect, Lab Malaria & Vector Res, Rockville, MD USA.	jribeiro@niaid.nih.gov	Ribeiro, Jose/J-7011-2015; ma, dongying/D-8623-2012; Alvarenga, Patricia Hessab/I-2272-2012	Ribeiro, Jose/0000-0002-9107-0818; Hessab Alvarenga, Patricia/0000-0002-2236-6308	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health; NIAID grant [AI077784]; Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784, ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health; NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health, by NIAID grant (AI077784 KRM) to Dr. Macaluso, and by Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ) to Dr. Alvarenga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-102; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENJAMINI E, 1963, EXP PARASITOL, V13, P143, DOI 10.1016/0014-4894(63)90064-X; Charlab R, 2000, EXP PARASITOL, V95, P45, DOI 10.1006/expr.2000.4503; Cheeseman MT, 1998, INSECT BIOCHEM MOLEC, V28, P1025, DOI 10.1016/S0965-1748(98)00093-9; Cheeseman MT, 2001, INSECT BIOCHEM MOLEC, V31, P157, DOI 10.1016/S0965-1748(00)00113-2; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frank GR, 1998, ADV VET DERMATOLOGY, V3, P201; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; GREENE WK, 1993, PARASITE IMMUNOL, V15, P69, DOI 10.1111/j.1365-3024.1993.tb00586.x; Grimaldi David, 2005, pi; Huang Diying, 2012, Nature, V483, P201, DOI 10.1038/nature10839; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kato H, 2007, J EXP BIOL, V210, P733, DOI 10.1242/jeb.001289; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane RP., 1993, MED INSECTS ARACHNID, P723; Lawrence W, 2002, J VECTOR ECOL, V27, P39; Lee SE, 1997, PARASITE IMMUNOL, V19, P13, DOI 10.1046/j.1365-3024.1997.d01-140.x; LEE SY, 1994, J BIOCHEM-TOKYO, V115, P82, DOI 10.1093/oxfordjournals.jbchem.a124309; Liu CB, 2010, FREE RADICAL BIO MED, V48, P1173, DOI 10.1016/j.freeradbiomed.2010.01.036; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; McDermott MJ, 2000, MOL IMMUNOL, V37, P361, DOI 10.1016/S0161-5890(00)00061-4; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RIBEIRO JMC, 1990, COMP BIOCHEM PHYS B, V95, P215, DOI 10.1016/0305-0491(90)90067-4; Ribeiro JMC, 2000, INSECT BIOCHEM MOLEC, V30, P279, DOI 10.1016/S0965-1748(99)00123-X; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2010, AM J TROP MED HYG, V82, P1060, DOI 10.4269/ajtmh.2010.09-0769; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRUDEAU WL, 1993, CLIN EXP ALLERGY, V23, P377, DOI 10.1111/j.1365-2222.1993.tb00342.x; Volfova V, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000294; WADE SE, 1988, J MED ENTOMOL, V25, P186, DOI 10.1093/jmedent/25.3.186; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; YOUNG JD, 1963, EXP PARASITOL, V13, P155, DOI 10.1016/0014-4894(63)90065-1	46	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44612	10.1371/journal.pone.0044612	http://dx.doi.org/10.1371/journal.pone.0044612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049752	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100017
J	Sun, J; Li, H; Yuan, QP				Sun, Jie; Li, Hao; Yuan, Qipeng			Metabolic Regulation of Trisporic Acid on Blakeslea trispora Revealed by a GC-MS-Based Metabolomic Approach	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; BETA-CAROTENE; MICROBIOLOGICAL PRODUCTION; SACCHAROMYCES-CEREVISIAE; MICROBIAL METABOLOMICS; HORMONE SYNTHESIS; GENES; BIOSYNTHESIS; CAROTENOGENESIS; IMPROVEMENT	The zygomycete Blakeslea trispora is used commercially as natural source of a (a) over cap -carotene. Trisporic acid (TA) is secreted from the mycelium of B. trispora during mating between heterothallic strains and is considered as a mediator of the regulation of mating processes and an enhancer of carotene biosynthesis. Gas chromatography-mass spectrometry and multivariate analysis were employed to investigate TA-associated intracellular biochemical changes in B. trispora. By principal component analysis, the differential metabolites discriminating the control groups from the TA-treated groups were found, which were also confirmed by the subsequent hierarchical cluster analysis. The results indicate that TA is a global regulator and its main effects at the metabolic level are reflected on the content changes in several fatty acids, carbohydrates, and amino acids. The carbon metabolism and fatty acids synthesis are sensitive to TA addition. Glycerol, glutamine, and (a) over bar -aminobutyrate might play important roles in the regulation of TA. Complemented by two-dimensional electrophoresis, the results indicate that the actions of TA at the metabolic level involve multiple metabolic processes, such as glycolysis and the bypass of the classical tricarboxylic acid cycle. These results reveal that the metabolomics strategy is a powerful tool to gain insight into the mechanism of a microorganism's cellular response to signal inducers at the metabolic level.	[Sun, Jie; Li, Hao; Yuan, Qipeng] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Coll Life Sci & Technol, Beijing, Peoples R China	Beijing University of Chemical Technology	Yuan, QP (corresponding author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Coll Life Sci & Technol, Beijing, Peoples R China.	yuanqp@mail.buct.edu.cn			Natural Science Foundation of China [20976009, 21176018]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (20976009 and 21176018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Beecher CWW, 2003, METABOLIC PROFILING: ITS ROLE IN BIOMARKER DISCOVERY AND GENE FUNCTION ANALYSIS, P311; Bhosale P, 2004, APPL MICROBIOL BIOT, V63, P351, DOI 10.1007/s00253-003-1441-1; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Burmester A, 2007, FUNGAL GENET BIOL, V44, P1096, DOI 10.1016/j.fgb.2007.07.008; CIEGLER A, 1959, APPL MICROBIOL, V7, P98, DOI 10.1128/AEM.7.2.98-101.1959; Hajjaj H, 1998, FEMS MICROBIOL LETT, V164, P195, DOI 10.1016/S0378-1097(98)00191-8; HESSELTINE CW, 1957, MYCOLOGIA, V49, P449, DOI 10.2307/3756153; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Kumar S, 1997, MYCOL RES, V101, P403, DOI 10.1017/S0953756296002742; Kuzina V, 2008, CURR GENET, V54, P143, DOI 10.1007/s00294-008-0206-x; Li Q, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-44; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Nieto MJ, 2004, APPL MICROBIOL BIOT, V66, P153, DOI 10.1007/s00253-004-1669-4; Mantzouridou F, 2008, J AGR FOOD CHEM, V56, P2668, DOI 10.1021/jf703667d; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Mendoza H, 1999, J APPL PHYCOL, V11, P15, DOI 10.1023/A:1008014332067; NIEUWENHUIS M, 1975, ARCH MICROBIOL, V102, P167, DOI 10.1007/BF00428363; RAO S, 1977, EXPERIENTIA, V33, P31, DOI 10.1007/BF01936735; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Schachtschabel D, 2008, CHEMBIOCHEM, V9, P3004, DOI 10.1002/cbic.200800477; Schimek C, 2003, MYCOL RES, V107, P736, DOI 10.1017/S0953756203007949; Schmidt AD, 2005, APPL MICROBIOL BIOT, V67, P549, DOI 10.1007/s00253-005-1941-2; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Stephanopoulos G, 2004, NAT BIOTECHNOL, V22, P1261, DOI 10.1038/nbt1016; Strelkov S, 2004, BIOL CHEM, V385, P853, DOI 10.1515/BC.2004.111; SUTTER RP, 1973, J BACTERIOL, V114, P1074, DOI 10.1128/JB.114.3.1074-1082.1973; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; VANDENEN.H, 1972, ARCH MIKROBIOL, V86, P175; VANDENENDE H, 1968, J BACTERIOL, V96, P1298, DOI 10.1128/JB.96.4.1298-1303.1968; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	35	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46110	10.1371/journal.pone.0046110	http://dx.doi.org/10.1371/journal.pone.0046110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049952	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100137
J	Larrea, SCV; Haikarainen, T; Narwal, M; Schlesinger, M; Venkannagari, H; Flawia, MM; Villamil, SHF; Lehtio, L				Vilchez Larrea, Salome C.; Haikarainen, Teemu; Narwal, Mohit; Schlesinger, Mariana; Venkannagari, Harikanth; Flawia, Mirtha M.; Fernandez Villamil, Silvia H.; Lehtio, Lari			Inhibition of poly(ADP-ribose) Polymerase Interferes with Trypanosoma cruzi Infection and Proliferation of the Parasite	PLOS ONE			English	Article							NF-KAPPA-B; POTENT INHIBITORS; STRUCTURAL BASIS; PARP INHIBITOR; CHAGAS-DISEASE; DERIVATIVES; DISCOVERY; EXPRESSION; ALIGNMENT; ABT-888	Poly(ADP-ribosylation) is a post-translational covalent modification of proteins catalyzed by a family of enzymes termed poly(ADP-ribose) polymerases (PARPs). In the human genome, 17 different genes have been identified that encode members of the PARP superfamily. Poly (ADP-ribose) metabolism plays a role in a wide range of biological processes. In Trypanosoma cruzi, PARP enzyme appears to play a role in DNA repair mechanisms and may also be involved in controlling the different phases of cell growth. Here we describe the identification of potent inhibitors for T. cruzi PARP with a fluorescence-based activity assay. The inhibitors were also tested on T. cruzi epimastigotes, showing that they reduced ADPribose polymer formation in vivo. Notably, the identified inhibitors are able to reduce the growth rate of T. cruzi epimastigotes. The best inhibitor, Olaparib, is effective at nanomolar concentrations, making it an efficient chemical tool for chacterization of ADP-ribose metabolism in T. cruzi. PARP inhibition also decreases drastically the amount of amastigotes but interestingly has no effect on the amount of trypomastigotes in the cell culture. Knocking down human PARP-1 decreases both the amount of amastigotes and trypomastigotes in cell culture, indicating that the effect would be mainly due to inhibition of human PARP-1. The result suggests that the inhibition of PARP could be a potential way to interfere with T. cruzi infection.	[Vilchez Larrea, Salome C.; Schlesinger, Mariana; Flawia, Mirtha M.; Fernandez Villamil, Silvia H.] Univ Buenos Aires, Natl Inst Genet Engn & Mol Biol INGEBI CONICET, Buenos Aires, DF, Argentina; [Haikarainen, Teemu; Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Haikarainen, Teemu; Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari] Univ Oulu, Dept Biochem, Oulu, Finland; [Narwal, Mohit; Venkannagari, Harikanth] Abo Akad Univ, Dept Biosci, Turku, Finland	University of Buenos Aires; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Abo Akademi University	Villamil, SHF (corresponding author), Univ Buenos Aires, Natl Inst Genet Engn & Mol Biol INGEBI CONICET, Buenos Aires, DF, Argentina.	s.villamil@ingebi.conicet.gov.ar; lari.lehtio@oulu.fi	Venkannagari, Harikanth/AAX-6211-2021	Lehtio, Lari/0000-0001-7250-832X; Vilchez Larrea, Salome/0000-0001-8302-1509	Academy of Finland [128322]; Biocenter Oulu; Sigrid Juselius Foundation; European Molecular Biology Organization	Academy of Finland(Academy of Finland); Biocenter Oulu; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The work was funded by Academy of Finland [grant no. 128322] (www.aka.fi), Biocenter Oulu (www.biocenter.oulu.fi), Sigrid Juselius Foundation (www.sigridjuselius.fi), and the European Molecular Biology Organization (www.embo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Daunes S, 2001, J MED CHEM, V44, P2976, DOI 10.1021/jm000502n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eltze T, 2008, MOL PHARMACOL, V74, P1587, DOI 10.1124/mol.108.048751; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Guhl F, 2007, MEM I OSWALDO CRUZ, V102, P29, DOI 10.1590/S0074-02762007005000099; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Huang H, 1999, INFECT IMMUN, V67, P5434, DOI 10.1128/IAI.67.10.5434-5440.1999; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jagtap PG, 2004, BIOORG MED CHEM LETT, V14, P81, DOI 10.1016/j.bmcl.2003.10.007; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Loup G, 2011, CURR OPIN INFECT DIS, V24, P428, DOI 10.1097/QCO.0b013e32834a667f; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Nakajima H, 2005, J PHARMACOL EXP THER, V312, P472, DOI 10.1124/jpet.104.075465; Narwal M, 2012, J BIOMOL SCREEN, V17, P593, DOI 10.1177/1087057112436558; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Pinto AMT, 2011, CELL MICROBIOL, V13, P1518, DOI 10.1111/j.1462-5822.2011.01636.x; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soeiro Maria de Nazare C, 2011, Open Med Chem J, V5, P21, DOI 10.2174/1874104501105010021; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Larrea SCV, 2011, INT J PARASITOL, V41, P405, DOI 10.1016/j.ijpara.2010.11.008; Villamil SHF, 2008, INT J PARASITOL, V38, P277, DOI 10.1016/j.ijpara.2007.08.003; WILLIAMS GT, 1984, J CELL BIOL, V99, P79, DOI 10.1083/jcb.99.1.79	38	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46063	10.1371/journal.pone.0046063	http://dx.doi.org/10.1371/journal.pone.0046063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049934	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100127
J	Watanabe, K; Ishima, Y; Akaike, T; Sawa, T; Kuroda, T; Ogawa, W; Watanabe, H; Suenaga, A; Kai, T; Otagiri, M; Maruyama, T				Watanabe, Kaori; Ishima, Yu; Akaike, Takaaki; Sawa, Tomohiro; Kuroda, Teruo; Ogawa, Wakano; Watanabe, Hiroshi; Suenaga, Ayaka; Kai, Toshiya; Otagiri, Masaki; Maruyama, Toru			S-nitrosated alpha-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis	FASEB JOURNAL			English	Article						nitric oxide; acute-phase protein; post-translational modification	NITRIC-OXIDE; ALPHA(1)-ACID GLYCOPROTEIN; ANTIBACTERIAL; NITROSYLATION; EXPRESSION; IDENTIFICATION; CHROMATOGRAPHY; CELLS	Treating infections with exogenous NO, which shows broad-spectrum antimicrobial activity, appears to be effective. Similar to NO biosynthesis, biosynthesis of alpha-1-acid glycoprotein variant A (AGPa), with a reduced cysteine (Cys149), increases markedly during inflammation and infection. We hypothesized that AGPa is an S-nitrosation target in acute-phase proteins. This study aimed to determine whether S-nitrosated AGPa (SNO-AGPa) may be the first compound of this novel antibacterial class against multidrug-resistant bacteria. AGPa was incubated with RAW264.7 cells activated by lipopolysaccharide and interferon-gamma. The antimicrobial effects of SNO-AGPa were determined by measuring the turbidity of the bacterial suspensions in vitro and survival in a murine sepsis model in vivo, respectively. Results indicated that endogenous NO generated by activated RAW264.7 cells caused S-nitrosation of AGPa at Cys149. SNO-AGPa strongly inhibited growth of gram-positive, gram-negative, and multidrug-resistant bacteria and was an extremely potent bacteriostatic compound (IC50: 10(-9) to 10(-6) M). The antibacterial mechanism of SNO-AGPa involves S-transnitrosation from SNO-AGPa to bacterial cells. Treatment with SNO-AGPa, but not with AGPa, markedly reduced bacterial counts in blood and liver in a mouse sepsis model. The sialyl residues of AGPa seem to suppress the antibacterial activity, since SNO-asialo AGPa was more potent than SNO-AGPa.-Watanabe, K., Ishima, Y., Akaike, T., Sawa, T., Kuroda, T., Ogawa, W., Watanabe, H., Suenaga, A., Kai, T., Otagiri, M., Maruyama, T. S-nitrosated alpha-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis. FASEB J. 27, 391-398 (2013). www.fasebj.org	[Watanabe, Kaori; Ishima, Yu; Watanabe, Hiroshi; Suenaga, Ayaka; Kai, Toshiya; Otagiri, Masaki; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Akaike, Takaaki; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Microbiol, Kumamoto 8620973, Japan; [Ishima, Yu; Watanabe, Hiroshi; Maruyama, Toru] Kumamoto Univ, Sch Pharm, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Sawa, Tomohiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Kuroda, Teruo; Ogawa, Wakano] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Microbiol, Okayama 7008530, Japan; [Kai, Toshiya] Tohoku Nipro Pharmaceut Corp, Fukushima, Japan; [Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Otagiri, Masaki] Sojo Univ, Drug Delivery Syst DDS Res Inst, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); Okayama University; Sojo University; Sojo University	Maruyama, T (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	tomaru@gpo.kumamoto-u.ac.jp	Ogawa, Wakano/AAI-2887-2020; OGAWA, Wakano/B-1997-2011; KURODA, Teruo/B-2028-2011		Japan Society for the Promotion of Science (JSPS) [KAKENHI 18390051, 22790162]; Uehara Memorial Fund; Kumayaku Alumni Research Fund; Grants-in-Aid for Scientific Research [23651239, 24659076] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Fund; Kumayaku Alumni Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Ms. Judith B. Gandy for editing the manuscript. Thanks are also due to members of the Gene Technology Center in Kumamoto University for their important contributions to the experiments. The authors also thank the members of the Chemo-Sero-Therapeutic Research Institute (Kumamoto, Japan) for donation of lyophilized AGP. This research was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS; KAKENHI 18390051 and 22790162). This work was also supported in part by grants from the Uehara Memorial Fund and the Kumayaku Alumni Research Fund.	Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cordero EM, 2008, TUBERCULOSIS, V88, P203, DOI 10.1016/j.tube.2007.10.004; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Ewing JF, 1997, J PHARMACOL EXP THER, V283, P947; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Foley E, 2003, GENE DEV, V17, P115, DOI 10.1101/gad.1018503; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; HERVE F, 1992, J CHROMATOGR-BIOMED, V577, P43, DOI 10.1016/0378-4347(92)80597-J; Hochepied T, 2000, J BIOL CHEM, V275, P14903, DOI 10.1074/jbc.275.20.14903; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; INCZE K, 1974, APPL MICROBIOL, V27, P202, DOI 10.1128/AEM.27.1.202-205.1974; Ishima Y, 2007, J PHARMACOL EXP THER, V320, P969, DOI 10.1124/jpet.106.114959; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; LAMBRE CR, 1988, CLIN EXP IMMUNOL, V73, P230; Levy S.B, 2002, ANTIBIOTIC PARADOX, V2nd; Matsumoto K, 2010, DRUG METAB PHARMACOK, V25, P101, DOI 10.2133/dmpk.25.101; Miyamoto Y, 2000, BBA-PROTEIN STRUCT M, V1477, P90, DOI 10.1016/S0167-4838(99)00264-2; Miyamoto Y, 2000, BIOCHEM BIOPH RES CO, V267, P918, DOI 10.1006/bbrc.1999.2046; Mnaimneh S, 1997, J IMMUNOL, V158, P308; Muchitsch EM, 1998, FUNDAM CLIN PHARM, V12, P173, DOI 10.1111/j.1472-8206.1998.tb00938.x; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nishi K, 2011, J BIOL CHEM, V286, P14427, DOI 10.1074/jbc.M110.208926; Nishi K, 2010, DRUG METAB PHARMACOK, V25, P200, DOI 10.2133/dmpk.25.200; Piagnerelli M, 2003, CRIT CARE MED, V31, P2156, DOI 10.1097/01.CCM.0000079608.00875.14; PRIMOZIC S, 1985, J PHARM SCI, V74, P473, DOI 10.1002/jps.2600740421; Sakarya S, 2010, J APPL MICROBIOL, V108, P1313, DOI 10.1111/j.1365-2672.2009.04525.x; Miranda MS, 2006, INT J EXP PATHOL, V87, P485, DOI 10.1111/j.1365-2613.2006.00504.x; WARREN L, 1959, J BIOL CHEM, V234, P1971; WHO, 2008, PHARMAFORUM 0121; YATVIN MB, 1980, SCIENCE, V210, P1253, DOI 10.1126/science.7434025	37	10	10	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					391	398		10.1096/fj.12-217794	http://dx.doi.org/10.1096/fj.12-217794			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047897				2022-12-25	WOS:000313103200037
J	Nihei, Y; Ito, D; Suzuki, N				Nihei, Yoshihiro; Ito, Daisuke; Suzuki, Norihiro			Roles of Ataxin-2 in Pathological Cascades Mediated by TAR DNA-binding Protein 43 (TDP-43) and Fused in Sarcoma (FUS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; INCLUSION-BODY FORMATION; STRESS GRANULES; PROCESSING BODIES; NUCLEAR IMPORT; P-BODIES; MUTATIONS; ALS; EXPANSIONS	The RNA-binding proteins TDP-43 and Fused in Sarcoma (FUS) play central roles in neurodegeneration associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Both proteins are components of messenger ribonucleoprotein (mRNP) granules and show cytoplasmic mislocalization in affected tissues. Recently, ataxin-2 was identified as a potent modifier of TDP-43 toxicity in an RNA-dependent manner. This study investigated to clarify how ataxin-2 modifies the TDP-43 and FUS pathological pathway. The expression of cytoplasmic TDP-43, the 35-kDa C-terminal fragment (TDP-p35f), and mutant FUS recruited ataxin-2 to mRNP granules, whereas increased ataxin-2 inhibited the mRNP granule formation of the 35-kDa C-terminal fragment and mutant FUS. A subcellular compartment analysis showed that the overexpressed ataxin-2 increased the cytoplasmic concentrations of both proteins, whereas it decreased their nuclear distributions. These data indicate that increased ataxin-2 impairs the assembly of TDP-43 and FUS into mRNP granules, leading to an aberrant distribution of RNA-binding proteins. Consequently, these sequences may exacerbate the impairment of the RNA-quality control system mediated by amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated RNA-binding proteins, which forms the core of the degenerative cascade.	[Nihei, Yoshihiro; Ito, Daisuke; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Ito, D (corresponding author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	d-ito@jk9.so-net.ne.jp	Ito, Daisuke/GXF-1648-2022; Suzuki, Norihiro/J-5125-2013; Ito, Daisuke/M-3608-2013	Suzuki, Norihiro/0000-0002-0399-6590; Ito, Daisuke/0000-0002-4740-1675	Eisai Co. Ltd; Ministry of Education, Culture, Sports, Science and Technology of Japan [23591254]; ALS Foundation; Japan ALS Association	Eisai Co. Ltd(Eisai Co Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ALS Foundation; Japan ALS Association	This work was supported by Eisai Co. Ltd, by Ministry of Education, Culture, Sports, Science and Technology of Japan Grant 23591254, by the ALS Foundation, and by the Japan ALS Association.	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Corrado L, 2011, HUM GENET, V130, P575, DOI 10.1007/s00439-011-1000-2; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Hart MP, 2012, J NEUROSCI, V32, P9133, DOI 10.1523/JNEUROSCI.0996-12.2012; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee T, 2011, NEUROLOGY, V76, P2062, DOI 10.1212/WNL.0b013e31821f4447; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Orr HT, 2004, NATURE, V431, P747, DOI 10.1038/431747a; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942	37	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41310	41323		10.1074/jbc.M112.398099	http://dx.doi.org/10.1074/jbc.M112.398099			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23048034	hybrid, Green Published			2022-12-25	WOS:000311887600045
J	Hui, W; Chen, C; Hsieh, FS				Hui Wang; Chen Chen; Hsieh Fushing			Extracting Multiscale Pattern Information of fMRI Based Functional Brain Connectivity with Application on Classification of Autism Spectrum Disorders	PLOS ONE			English	Article							COGNITIVE CONTROL; CHILDREN; SCHIZOPHRENIA; DIAGNOSIS; NETWORKS; STATE; TASK; MRI	We employed a multi-scale clustering methodology known as "data cloud geometry" to extract functional connectivity patterns derived from functional magnetic resonance imaging (fMRI) protocol. The method was applied to correlation matrices of 106 regions of interest (ROIs) in 29 individuals with autism spectrum disorders (ASD), and 29 individuals with typical development (TD) while they completed a cognitive control task. Connectivity clustering geometry was examined at both "fine" and "coarse" scales. At the coarse scale, the connectivity clustering geometry produced 10 valid clusters with a coherent relationship to neural anatomy. A supervised learning algorithm employed fine scale information about clustering motif configurations and prevalence, and coarse scale information about intra-and inter-regional connectivity; the algorithm correctly classified ASD and TD participants with sensitivity of 82.8% and specificity of 82.8%. Most of the predictive power of the logistic regression model resided at the level of the fine-scale clustering geometry, suggesting that cellular versus systems level disturbances are more prominent in individuals with ASD. This article provides validation for this multi-scale geometric approach to extracting brain functional connectivity pattern information and for its use in classification of ASD.	[Hui Wang; Chen Chen; Hsieh Fushing] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis	Hsieh, FS (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	fushing@wald.ucdavis.edu			National Science Foundation (NSF) [DMS-1007219]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was partly supported by National Science Foundation (NSF) grant: DMS-1007219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Lee PS, 2007, NEUROIMAGE, V38, P184, DOI 10.1016/j.neuroimage.2007.07.013; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rosano C, 2005, NEUROIMAGE, V28, P881, DOI 10.1016/j.neuroimage.2005.05.059; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Snitz BE, 2005, AM J PSYCHIAT, V162, P2322, DOI 10.1176/appi.ajp.162.12.2322; Solomon M, 2008, INT J DEV NEUROSCI, V26, P239, DOI 10.1016/j.ijdevneu.2007.11.001; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Stevenson JL, 2010, J NEUROSCI, V30, P16763, DOI 10.1523/JNEUROSCI.4946-10.2010; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Williams DL, 2006, CHILD NEUROPSYCHOL, V12, P279, DOI 10.1080/09297040600681190; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	34	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45502	10.1371/journal.pone.0045502	http://dx.doi.org/10.1371/journal.pone.0045502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056205	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500019
J	Kadiallah, A; Franklin, DW; Burdet, E				Kadiallah, Abdelhamid; Franklin, David W.; Burdet, Etienne			Generalization in Adaptation to Stable and Unstable Dynamics	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; SIGNAL-DEPENDENT NOISE; IMPEDANCE CONTROL; MOTOR ADAPTATION; ADAPTIVE-CONTROL; INTERNAL-MODELS; ARM MOVEMENTS; SHORT-TERM; MUSCLE; STABILITY	Humans skillfully manipulate objects and tools despite the inherent instability. In order to succeed at these tasks, the sensorimotor control system must build an internal representation of both the force and mechanical impedance. As it is not practical to either learn or store motor commands for every possible future action, the sensorimotor control system generalizes a control strategy for a range of movements based on learning performed over a set of movements. Here, we introduce a computational model for this learning and generalization, which specifies how to learn feedforward muscle activity in a function of the state space. Specifically, by incorporating co-activation as a function of error into the feedback command, we are able to derive an algorithm from a gradient descent minimization of motion error and effort, subject to maintaining a stability margin. This algorithm can be used to learn to coordinate any of a variety of motor primitives such as force fields, muscle synergies, physical models or artificial neural networks. This model for human learning and generalization is able to adapt to both stable and unstable dynamics, and provides a controller for generating efficient adaptive motor behavior in robots. Simulation results exhibit predictions consistent with all experiments on learning of novel dynamics requiring adaptation of force and impedance, and enable us to re-examine some of the previous interpretations of experiments on generalization.	[Kadiallah, Abdelhamid; Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Franklin, David W.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England	Imperial College London; University of Cambridge	Burdet, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	eburdet@imperial.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Burdet, Etienne/0000-0002-2123-0185	EU-FP7 VIACTORS grant; Wellcome Trust; Algerian government	EU-FP7 VIACTORS grant; Wellcome Trust(Wellcome TrustEuropean Commission); Algerian government	There are no current external funding sources for this study. However, EB was supported in part by the EU-FP7 VIACTORS grant, DWF by the Wellcome Trust and HK by a scholarship from the Algerian government. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien Z., 1998, ITERATIVE LEARNING C; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E, 1998, IEEE CONTR SYST MAG, V18, P39, DOI 10.1109/37.664654; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Burdet E, 1996, THESIS ETH ZURICH SW; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; CRAGO PE, 1976, J NEUROPHYSIOL, V39, P925, DOI 10.1152/jn.1976.39.5.925; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Dimitriou M, 2012, J NEUROPHYSIOL, V107, P890, DOI 10.1152/jn.00787.2011; Dimitriou M, 2010, CURR BIOL, V20, P1763, DOI 10.1016/j.cub.2010.08.049; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; Donchin O, 2003, J NEUROSCI, V23, P9032; Duda R.O., 2006, PATTERN CLASSIFICATI; Emken JL, 2007, J NEUROPHYSIOL, V97, P3997, DOI 10.1152/jn.01095.2006; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Gowrishankar G, 2010, P INT C ROB AUT ICRA; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; Guigon E, 2007, J NEUROPHYSIOL, V97, P331, DOI 10.1152/jn.00290.2006; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kadiallah A, 2011, J NEUROPHYSIOL, V106, P2737, DOI 10.1152/jn.00079.2011; Kamper DG, 2000, MUSCLE NERVE, V23, P954, DOI 10.1002/(SICI)1097-4598(200006)23:6<954::AID-MUS17>3.0.CO;2-0; Kargo WJ, 2008, J NEUROSCI, V28, P2409, DOI 10.1523/JNEUROSCI.3229-07.2008; KATAYAMA M, 1993, BIOL CYBERN, V69, P353, DOI 10.1007/BF01185407; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KIRSCH RF, 1994, IEEE T BIO-MED ENG, V41, P758, DOI 10.1109/10.310091; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; LACQUANITI F, 1987, BRAIN RES, V406, P373, DOI 10.1016/0006-8993(87)90810-9; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; LOEB GE, 1990, COLD SH Q B, V55, P791; Mcqueen J., 1967, P 5 BERK S MATH STAT, V1, P281; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; MUSSAIVALDI FA, 1992, BIOL CYBERN, V67, P491, DOI 10.1007/BF00198756; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Rancourt D, 2001, J MOTOR BEHAV, V33, P193, DOI 10.1080/00222890109603150; Sanner RM, 1999, BIOL CYBERN, V80, P369, DOI 10.1007/s004220050532; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shemmell J, 2009, J NEUROSCI, V29, P13255, DOI 10.1523/JNEUROSCI.0892-09.2009; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Stroeve S, 1999, BIOL CYBERN, V81, P495, DOI 10.1007/s004220050578; Tee KP, 2010, BIOL CYBERN, V102, P31, DOI 10.1007/s00422-009-0348-z; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tong C, 2003, J NEUROPHYSIOL, V90, P578, DOI 10.1152/jn.01087.2002; Trainin E, 2007, J NEUROPHYSIOL, V97, P3736, DOI 10.1152/jn.01064.2006; Wagner MJ, 2008, J NEUROSCI, V28, P10663, DOI 10.1523/JNEUROSCI.5479-07.2008; WON J, 1995, EXP BRAIN RES, V107, P125; Yang CG, 2011, IEEE T ROBOT, V27, P918, DOI 10.1109/TRO.2011.2158251; [No title captured]; [No title captured]	70	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45075	10.1371/journal.pone.0045075	http://dx.doi.org/10.1371/journal.pone.0045075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056191	Green Published, gold			2022-12-25	WOS:000309831500013
J	Kim, TH; Kim, JS; Kim, ZH; Huang, RB; Wang, RS				Kim, Tae Hwan; Kim, Ju Sung; Kim, Zoo Haye; Huang, Ren Bin; Wang, Ren Sheng			Khz (Fusion of Ganoderma lucidum and Polyporus umbellatus Mycelia) Induces Apoptosis by Increasing Intracellular Calcium Levels and Activating JNK and NADPH Oxidase-Dependent Generation of Reactive Oxygen Species	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HUMAN LEUKEMIA-CELLS; N-TERMINAL KINASE; OXIDATIVE STRESS; CANCER CELLS; ANGIOTENSIN-II; MAP KINASE; IN-VITRO; MECHANISMS; ANTITUMOR	Khz is a compound derived from the fusion of Ganoderma lucidum and Polyporus umbellatus mycelia that inhibits the growth of cancer cells. The results of the present study show that Khz induced apoptosis preferentially in transformed cells and had only minimal effects on non-transformed cells. Furthermore, Khz induced apoptosis by increasing the intracellular Ca2+ concentration ([Ca2+](i)) and activating JNK to generate reactive oxygen species (ROS) via NADPH oxidase and the mitochondria. Khz-induced apoptosis was caspase-dependent and occurred via a mitochondrial pathway. ROS generation by NADPH oxidase was critical for Khz-induced apoptosis, and although mitochondrial ROS production was also required, it appeared to occur secondary to ROS generation by NADPH oxidase. Activation of NADPH oxidase was demonstrated by the translocation of regulatory subunits p47(phox) and p67(phox) to the cell membrane and was necessary for ROS generation by Khz. Khz triggered a rapid and sustained increase in [Ca2+](i), which activated JNK. JNK plays a key role in the activation of NADPH oxidase because inhibition of its expression or activity abrogated membrane translocation of the p47(phox) and p67(phox) subunits and ROS generation. In summary, these data indicate that Khz preferentially induces apoptosis in cancer cells, and the signaling mechanisms involve an increase in [Ca2+](i), JNK activation, and ROS generation via NADPH oxidase and mitochondria.	[Kim, Tae Hwan; Wang, Ren Sheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Peoples R China; [Kim, Ju Sung] Harbin Med Univ, Harbin, Peoples R China; [Kim, Zoo Haye] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Huang, Ren Bin] Guangxi Med Univ, Grad Sch Pharmacol, Nanning, Peoples R China	Guangxi Medical University; Harbin Medical University; Nagoya University; Guangxi Medical University	Wang, RS (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Peoples R China.	wrsgx@yahoo.com.cn						ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gao YH, 2005, IMMUNOL INVEST, V34, P171, DOI 10.1081/IMM-200055813; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Hiraoka W, 1998, J CLIN INVEST, V102, P1961, DOI 10.1172/JCI3437; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Jiang JH, 2010, INT J ONCOL, V37, P1529, DOI 10.3892/ijo_00000806; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim JE, 2008, EXP MOL MED, V40, P709, DOI 10.3858/emm.2008.40.6.709; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Kuppusamy P, 2002, CANCER RES, V62, P307; Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mesner P W Jr, 1997, Adv Pharmacol, V41, P461, DOI 10.1016/S1054-3589(08)61069-8; Miyajima A, 1997, BRIT J CANCER, V76, P206, DOI 10.1038/bjc.1997.363; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Palombo JD, 2002, CANCER LETT, V177, P163, DOI 10.1016/S0304-3835(01)00796-0; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Saeki K, 2002, BIOCHEM J, V368, P705, DOI 10.1042/BJ20020101; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Wang G, 2006, HYPERTENSION, V48, P482, DOI 10.1161/01.HYP.0000236647.55200.07; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512	38	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46208	10.1371/journal.pone.0046208	http://dx.doi.org/10.1371/journal.pone.0046208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056263	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500031
J	Kumar, S; ten Siethoff, L; Persson, M; Lard, M; Kronnie, GT; Linke, H; Mansson, A				Kumar, Saroj; ten Siethoff, Lasse; Persson, Malin; Lard, Mercy; Kronnie, Geertruy Te; Linke, Heiner; Mansson, Alf			Antibodies Covalently Immobilized on Actin Filaments for Fast Myosin Driven Analyte Transport	PLOS ONE			English	Article							BIOMOLECULAR MOTOR-DRIVEN; IN-VITRO; F-ACTIN; SLIDING MOVEMENT; STRUCTURAL DYNAMICS; SELECTIVE DETECTION; ACTOMYOSIN FUNCTION; MOLECULAR SHUTTLES; CARGO; PROTEINS	Biosensors would benefit from further miniaturization, increased detection rate and independence from external pumps and other bulky equipment. Whereas transportation systems built around molecular motors and cytoskeletal filaments hold significant promise in the latter regard, recent proof-of-principle devices based on the microtubule-kinesin motor system have not matched the speed of existing methods. An attractive solution to overcome this limitation would be the use of myosin driven propulsion of actin filaments which offers motility one order of magnitude faster than the kinesin-microtubule system. Here, we realized a necessary requirement for the use of the actomyosin system in biosensing devices, namely covalent attachment of antibodies to actin filaments using heterobifunctional cross-linkers. We also demonstrated consistent and rapid myosin II driven transport where velocity and the fraction of motile actin filaments was negligibly affected by the presence of antibody-antigen complexes at rather high density (>20 mu m(-1)). The results, however, also demonstrated that it was challenging to consistently achieve high density of functional antibodies along the actin filament, and optimization of the covalent coupling procedure to increase labeling density should be a major focus for future work. Despite the remaining challenges, the reported advances are important steps towards considerably faster nanoseparation than shown for previous molecular motor based devices, and enhanced miniaturization because of high bending flexibility of actin filaments.	[Kumar, Saroj; ten Siethoff, Lasse; Persson, Malin; Mansson, Alf] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Lard, Mercy; Linke, Heiner] Lund Univ, Nanometer Struct Consortium, Lund, Sweden; [Lard, Mercy; Linke, Heiner] Lund Univ, Div Solid State Phys, Lund, Sweden; [Kronnie, Geertruy Te] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	Linnaeus University; Lund University; Lund University; University of Padua	Mansson, A (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	alf.mansson@lnu.se	Lard, Mercy/R-2035-2019; Kumar, Saroj/AAV-2592-2021; Persson, Malin/K-6133-2017; Kronnie, Geertruy te/L-1014-2016; Kumar, Saroj/O-6574-2017; Mansson, Alf/ABC-6271-2021; Lard, Mercy/AAV-6577-2021; Linke, Heiner/A-5825-2010; Lard, Mercy/C-4193-2011	Lard, Mercy/0000-0001-9243-4735; Kumar, Saroj/0000-0002-1886-9674; Persson, Malin/0000-0003-2819-3046; Kumar, Saroj/0000-0002-1886-9674; Mansson, Alf/0000-0002-5889-7792; Linke, Heiner/0000-0003-4451-4006; Lard, Mercy/0000-0001-9243-4735; te Kronnie, Geertruy/0000-0001-7143-4795; ten Siethoff, Lasse/0000-0001-6878-3142; /0000-0001-5636-1006	The European commission (FP7) under the contract MONAD [NMP4-SL-2009-228971]; The Carl Trygger Foundation; The Swedish Research Council [621-2007-6137, 621-2010-5146]; Faculty of Natural Sciences and Engineering at Linnaeus University	The European commission (FP7) under the contract MONAD; The Carl Trygger Foundation; The Swedish Research Council(Swedish Research Council); Faculty of Natural Sciences and Engineering at Linnaeus University	This work was funded by The European commission (FP7) under the contract MONAD (NMP4-SL-2009-228971), The Carl Trygger Foundation, The Swedish Research Council (Projects # 621-2007-6137 and 621-2010-5146), nmC@LU, and the Faculty of Natural Sciences and Engineering at Linnaeus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albet-Torres N, 2011, LANGMUIR, V27, P7108, DOI 10.1021/la201081w; Ashikari N, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BL03; Bachand GD, 2006, SMALL, V2, P381, DOI 10.1002/smll.200500262; Balaz M, 2005, ANAL BIOCHEM, V338, P224, DOI 10.1016/j.ab.2004.12.012; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Brunner C, 2007, LAB CHIP, V7, P1263, DOI 10.1039/b707301a; Bunk R, 2005, NANOTECHNOLOGY, V16, P710, DOI 10.1088/0957-4484/16/6/014; Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824; Byun KE, 2007, LANGMUIR, V23, P9535, DOI 10.1021/la7019318; Carroll-Portillo A, 2009, BIOTECHNOL BIOENG, V104, P1182, DOI 10.1002/bit.22501; Carroll-Portillo A, 2009, SMALL, V5, P1835, DOI 10.1002/smll.200900491; DABROWSKA R, 1983, J MUSCLE RES CELL M, V4, P83, DOI 10.1007/BF00711959; Fischer T, 2009, NAT NANOTECHNOL, V4, P162, DOI [10.1038/nnano.2008.393, 10.1038/NNANO.2008.393]; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Grotzky A, 2011, BIOMACROMOLECULES, V12, P134, DOI 10.1021/bm101074s; Grove TJ, 2005, IEEE T ADV PACKAGING, V28, P556, DOI 10.1109/TADVP.2005.858341; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hiyama S, 2009, NANO LETT, V9, P2407, DOI 10.1021/nl901013k; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; Iyer G, 2011, BIOCONJUGATE CHEM, V22, P1006, DOI 10.1021/bc100593m; Jokerst JV, 2010, ANAL CHEM, V82, P1571, DOI 10.1021/ac901743u; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; Kozlov IA, 2004, BIOPOLYMERS, V73, P621, DOI 10.1002/bip.20009; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kron S. J., 1991, METHOD ENZYMOL, P399; Kumar S, 2012, MICR WORKSH MSW 2012; Kumar S, 2011, 2 INT C BIOS TECHN A; Lee KB, 2004, NANO LETT, V4, P1869, DOI 10.1021/nl049002y; Lin CT, 2008, NANO LETT, V8, P1041, DOI 10.1021/nl072742x; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Malcos JL, 2011, APPL MICROBIOL BIOT, V90, P1, DOI 10.1007/s00253-011-3140-7; Mansson A, 2005, IEEE T ADV PACKAGING, V28, P547, DOI 10.1109/TADVP.2005.858309; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; Marston SB, 1996, J MUSCLE RES CELL M, V17, P497, DOI 10.1007/BF00123365; Mulvaney SP, 2009, BIOSENS BIOELECTRON, V24, P1109, DOI 10.1016/j.bios.2008.06.010; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8; Nicolau DV, 1999, BIOPHYS J, V77, P1126, DOI 10.1016/S0006-3495(99)76963-8; Nitta T, 2008, NANO LETT, V8, P2305, DOI 10.1021/nl8010885; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Persson M, 2010, LANGMUIR, V26, P9927, DOI 10.1021/la100395a; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; Raab M, 2008, BIOTECHNOL BIOENG, V99, P764, DOI 10.1002/bit.21645; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Soto CM, 2008, ANAL CHEM, V80, P5433, DOI 10.1021/ac800541x; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sundberg M, 2007, J COLLOID INTERF SCI, V313, P454, DOI 10.1016/j.jcis.2007.04.067; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Sundberg M, 2006, LANGMUIR, V22, P7286, DOI 10.1021/la060854i; Suzuki H, 1997, BIOPHYS J, V72, P1997, DOI 10.1016/S0006-3495(97)78844-1; Taira S, 2006, BIOTECHNOL BIOENG, V95, P533, DOI 10.1002/bit.21055; Takatsuki H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245101; Takatsuki H, 2010, SMALL, V6, P452, DOI 10.1002/smll.200901369; Turner D, 1996, ANAL BIOCHEM, V242, P20, DOI 10.1006/abio.1996.0422; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vikhorev PG, 2008, LANGMUIR, V24, P13509, DOI 10.1021/la8016112; Vikhorev PG, 2008, BIOPHYS J, V95, P5809, DOI 10.1529/biophysj.108.140335; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Zhang CY, 2005, NAT MATER, V4, P826, DOI 10.1038/nmat1508; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	70	15	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46298	10.1371/journal.pone.0046298	http://dx.doi.org/10.1371/journal.pone.0046298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056279	gold, Green Published, Green Submitted			2022-12-25	WOS:000309454000032
J	Pratx, G; Chen, K; Sun, C; Martin, L; Carpenter, CM; Olcott, PD; Xing, L				Pratx, Guillem; Chen, Kai; Sun, Conroy; Martin, Lynn; Carpenter, Colin M.; Olcott, Peter D.; Xing, Lei			Radioluminescence Microscopy: Measuring the Heterogeneous Uptake of Radiotracers in Single Living Cells	PLOS ONE			English	Article							GLUCOSE-UPTAKE ACTIVITY; CANCER; PROBE; PET	Radiotracers play an important role in interrogating molecular processes both in vitro and in vivo. However, current methods are limited to measuring average radiotracer uptake in large cell populations and, as a result, lack the ability to quantify cell-to-cell variations. Here we apply a new technique, termed radioluminescence microscopy, to visualize radiotracer uptake in single living cells, in a standard fluorescence microscopy environment. In this technique, live cells are cultured sparsely on a thin scintillator plate and incubated with a radiotracer. Light produced following beta decay is measured using a highly sensitive microscope. Radioluminescence microscopy revealed strong heterogeneity in the uptake of [F-18]fluorodeoxyglucose (FDG) in single cells, which was found consistent with fluorescence imaging of a glucose analog. We also verified that dynamic uptake of FDG in single cells followed the standard two-tissue compartmental model. Last, we transfected cells with a fusion PET/fluorescence reporter gene and found that uptake of FHBG (a PET radiotracer for transgene expression) coincided with expression of the fluorescent protein. Together, these results indicate that radioluminescence microscopy can visualize radiotracer uptake with single-cell resolution, which may find a use in the precise characterization of radiotracers.	[Pratx, Guillem; Chen, Kai; Sun, Conroy; Martin, Lynn; Carpenter, Colin M.; Xing, Lei] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Olcott, Peter D.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Pratx, G (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	pratx@stanford.edu	Sun, Conroy/S-3222-2019; Pratx, Guillem/AAK-8006-2020; Sun, Conroy/B-5611-2013	Sun, Conroy/0000-0001-5193-6907; Sun, Conroy/0000-0001-5193-6907; Xing, Lei/0000-0003-2536-5359; Pratx, Guillem/0000-0002-0247-6470	Department of Defense [W81XWH-11-1-0070]; National Institutes of Health, ICMIC [P50CA114747]; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health, ICMIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by the Department of Defense under grant W81XWH-11-1-0070 and by the National Institutes of Health, ICMIC P50CA114747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carson RE, 2005, POSITRON EMISSION TO, P127, DOI [10.1007/1-84628-007-9_6, DOI 10.1007/1-84628-007-9_6]; CHARPAK G, 1989, P NATL ACAD SCI USA, V86, P1741, DOI 10.1073/pnas.86.6.1741; Chen LY, 2008, J NUCL MED, V49, P1141, DOI 10.2967/jnumed.107.040568; Dobrucki LW, 2010, NAT REV CARDIOL, V7, P38, DOI 10.1038/nrcardio.2009.201; ENSLEY JF, 1987, CYTOMETRY, V8, P488, DOI 10.1002/cyto.990080509; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; Kanno S, 2007, J RADIOANAL NUCL CH, V272, P565, DOI 10.1007/s10967-007-0625-z; Leidholdt EM, 2006, ESSENTIAL PHYS MED I; Mettivier G, 2003, PHYS MED BIOL, V48, pN173, DOI 10.1088/0031-9155/48/12/403; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; OBRIEN RT, 1959, NATURE, V183, P1461, DOI 10.1038/1831461a0; Ott R, 2000, PHYS MED BIOL, V45, P2011, DOI 10.1088/0031-9155/45/7/322; PALTSYN AA, 1990, B EXP BIOL MED+, V110, P1731, DOI 10.1007/BF00842611; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Phelps ME, 2000, J NUCL MED, V41, P661; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Tseng JC, 2012, MOL IMAGING IN PRESS; Yaghoubi S, 2001, J NUCL MED, V42, P1225; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yoshioka K, 1996, BIOSCI BIOTECH BIOCH, V60, P1899, DOI 10.1271/bbb.60.1899	28	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46285	10.1371/journal.pone.0046285	http://dx.doi.org/10.1371/journal.pone.0046285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056276	Green Submitted, Green Published, gold			2022-12-25	WOS:000309454000029
J	Liu, MQ; Bjornlund, L; Ronn, R; Christensen, S; Ekelund, F				Liu, Manqiang; Bjornlund, Lisa; Ronn, Regin; Christensen, Soren; Ekelund, Flemming			Disturbance Promotes Non-Indigenous Bacterial Invasion in Soil Microcosms: Analysis of the Roles of Resource Availability and Community Structure	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; RELATIVE IMPORTANCE; PROPAGULE PRESSURE; SPECIES-DIVERSITY; PLANT-COMMUNITIES; NAKED AMEBAS; INVASIBILITY; PSEUDOMONAS; BIODIVERSITY; COMPETITION	Background: Invasion-biology is largely based on non-experimental observation of larger organisms. Here, we apply an experimental approach to the subject. By using microbial-based microcosm-experiments, invasion-biology can be placed on firmer experimental, and hence, less anecdotal ground. A better understanding of the mechanisms that govern invasion-success of bacteria in soil communities will provide knowledge on the factors that hinder successful establishment of bacteria artificially inoculated into soil, e. g. for remediation purposes. Further, it will yield valuable information on general principles of invasion biology in other domains of life. Methodology/Principal Findings: Here, we studied invasion and establishment success of GFP-tagged Pseudomonas fluorescens DSM 50090 in laboratory microcosms during a 42-day period. We used soil heating to create a disturbance gradient, and hypothesized that increased disturbance would facilitate invasion; our experiments confirmed this hypothesis. We suggest that the key factors associated with the heating disturbance that explain the enhanced invasion success are increased carbon substrate availability and reduced diversity, and thus, competition-and predation-release. In a second experiment we therefore separated the effects of increased carbon availability and decreased diversity. Here, we demonstrated that the effect of the indigenous soil community on bacterial invasion was stronger than that of resource availability. In particular, introduced bacteria established better in a long term perspective at lower diversity and predation pressure. Conclusion: We propose increased use of microbial systems, for experimental study of invasion scenarios. They offer a simple and cost-efficient way to study and understand biological invasion. Consequently such systems can help us to better predict the mechanisms controlling changes in stability of communities and ecosystems. This is becoming increasingly relevant since anthropogenic disturbance causes increasing global change, which promotes invasion. Moreover, a thorough understanding of factors controlling invasion and establishment of artificially amended microorganisms will mean a major step forward for soil-remediation microbiology.	[Liu, Manqiang; Bjornlund, Lisa; Ronn, Regin; Christensen, Soren; Ekelund, Flemming] Univ Copenhagen, Terr Ecol Sect, Dept Biol, Copenhagen K, Denmark; [Liu, Manqiang] Nanjing Agr Univ, Soil Ecol Lab, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	University of Copenhagen; Nanjing Agricultural University	Ekelund, F (corresponding author), Univ Copenhagen, Terr Ecol Sect, Dept Biol, Copenhagen K, Denmark.	fekelund@bio.ku.dk	Christensen, Soren/J-6246-2014; Rønn, Regin/K-4460-2014; Ekelund, Flemming/M-1731-2014; Liu, Manqiang/G-6566-2012	Christensen, Soren/0000-0002-7067-5586; Rønn, Regin/0000-0002-7486-1191; Ekelund, Flemming/0000-0002-2144-7659; Liu, Manqiang/0000-0001-6654-7795	National Foundation of Sciences in China [30900210]; Chinese-Danish Government Exchange Scholarship; PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions); Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF) [2104-08-0012]; Danish Environmental Agency [MST: 667-00081]	National Foundation of Sciences in China; Chinese-Danish Government Exchange Scholarship; PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions); Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF); Danish Environmental Agency	ML was fully sponsored by the National Foundation of Sciences in China (No. 30900210), the Chinese-Danish Government Exchange Scholarship, and the PADA (Priority Academic Program Development of Jiangsu Higher Education Institutions). FE received funding from The Danish Strategic Research Council (Det Strategiske Forskningsrad, DSF, 2104-08-0012; MIRESOWA). FE and RR received funding from the Danish Environmental Agency (MST: 667-00081, GENEPEASE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2008, PLANT SOIL, V304, P103, DOI 10.1007/s11104-007-9525-9; [Anonymous], 1988, NEW KEY FRESHWATER S; Chantigny MH, 2010, SOIL SCI SOC AM J, V74, P517, DOI 10.2136/sssaj2008.0347; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; EKELUND F, 1994, FEMS MICROBIOL REV, V15, P321, DOI 10.1111/j.1574-6976.1994.tb00144.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Fleming GM, 2009, ECOL APPL, V19, P2210, DOI 10.1890/07-1959.1; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Griffiths BS, 2004, MICROB ECOL, V47, P104, DOI 10.1007/s00248-002-2043-7; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; Kneitel JM, 2006, COMMUNITY ECOL, V7, P245, DOI 10.1556/ComEc.7.2006.2.11; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Otfinowski R, 2010, BIOL INVASIONS, V12, P1349, DOI 10.1007/s10530-009-9551-z; Pedersen AL, 2009, MICROB ECOL, V57, P501, DOI 10.1007/s00248-008-9455-y; Romanuk TN, 2005, BIOL INVASIONS, V7, P711, DOI 10.1007/s10530-004-0997-8; RONN R, 1995, PEDOBIOLOGIA, V39, P10; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Schooler SS, 2010, BIOL INVASIONS, V12, P3289, DOI 10.1007/s10530-010-9722-y; Thirup L, 2000, SOIL BIOL BIOCHEM, V32, P1615, DOI 10.1016/S0038-0717(00)00075-4; van Elsas JD, 2007, ISME J, V1, P204, DOI 10.1038/ismej.2007.21; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; Wolters V, 2000, BIOSCIENCE, V50, P1089, DOI 10.1641/0006-3568(2000)050[1089:EOGCOA]2.0.CO;2	31	29	32	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e45306	10.1371/journal.pone.0045306	http://dx.doi.org/10.1371/journal.pone.0045306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056198	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600009
J	Todd, RG; Helikar, T				Todd, Robert G.; Helikar, Tomas			Ergodic Sets as Cell Phenotype of Budding Yeast Cell Cycle	PLOS ONE			English	Article							TRANSCRIPTION; NETWORKS; MODEL; GENE; CLN3; MORPHOGENESIS; CHECKPOINT; INHIBITOR; PROMOTERS; GROWTH	It has been suggested that irreducible sets of states in Probabilistic Boolean Networks correspond to cellular phenotype. In this study, we identify such sets of states for each phase of the budding yeast cell cycle. We find that these "ergodic sets" underly the cyclin activity levels during each phase of the cell cycle. Our results compare to the observations made in several laboratory experiments as well as the results of differential equation models. Dynamical studies of this model: (i) indicate that under stochastic external signals the continuous oscillating waves of cyclin activity and the opposing waves of CKIs emerge from the logic of a Boolean-based regulatory network without the need for specific biochemical/kinetic parameters; (ii) suggest that the yeast cell cycle network is robust to the varying behavior of cell size (e.g., cell division under nitrogen deprived conditions); (iii) suggest the irreversibility of the Start signal is a function of logic of the G1 regulon, and changing the structure of the regulatory network can render start reversible.	[Todd, Robert G.; Helikar, Tomas] Univ Nebraska, Dept Math, Omaha, NE 68182 USA	University of Nebraska System	Todd, RG (corresponding author), Univ Nebraska, Dept Math, Omaha, NE 68182 USA.	rtodd@unomaha.edu	Todd, Robert/GWM-4486-2022	Helikar, Tomas/0000-0003-3653-1906				Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; Alberghina L, 2009, J BIOTECHNOL, V144, P224, DOI 10.1016/j.jbiotec.2009.07.009; Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Barberis M, 2007, PLOS COMPUTATIONS BI, V3; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bruna M, 2005, SIGNAL PROCESSING, V85; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen RH, 2007, J BIOMED SCI, V14, P475, DOI 10.1007/s11373-007-9157-3; Ching WK, 2007, BIOINFORMATICS, V23, P1511, DOI 10.1093/bioinformatics/btm142; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Ferrell JE, 2011, MOL CELL, V43, P497, DOI 10.1016/j.molcel.2011.08.002; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Ge H, 2008, MATH BIOSCI, V211, P132, DOI 10.1016/j.mbs.2007.10.003; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; HASHIMOTO R. F., 2009, P IEEE INT WORKSHOP, P1, DOI DOI 10.1109/GENSIPS.2009.5174356; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; Hognas G., 1977, Journal of the Australian Mathematical Society, Series A (Pure Mathematics), V23, P481; Hood-DeGrenier JK, 2007, CURR GENET, V51, P1, DOI 10.1007/s00294-006-0102-1; Hunt T, 2011, PHILOS T R SOC B, V366, P3494, DOI 10.1098/rstb.2011.0274; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73; Kim S, 2002, J BIOL SYST, V10, P337, DOI 10.1142/S0218339002000676; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; MAHER M, 1995, MOL CELL BIOL, V15, P3129; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhang SQ, 2007, INT J DATA MINING BI, V1; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009	50	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45780	10.1371/journal.pone.0045780	http://dx.doi.org/10.1371/journal.pone.0045780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049686	Green Published, gold			2022-12-25	WOS:000309388500013
J	Biswas, D; Pandya, V; Singh, AK; Mondal, AK; Kumaran, S				Biswas, Dipanwita; Pandya, Vaibhav; Singh, Appu Kumar; Mondal, Alok K.; Kumaran, S.			Co-Factor Binding Confers Substrate Specificity to Xylose Reductase from Debaryomyces hansenii	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; CONFORMATIONAL-CHANGES; ACTIVE-SITE; ALLOSTERIC REGULATION; CATALYTIC MECHANISM; ENZYME DYNAMICS; XYLITOL; NADPH; YEAST; INSIGHTS	Binding of substrates into the active site, often through complementarity of shapes and charges, is central to the specificity of an enzyme. In many cases, substrate binding induces conformational changes in the active site, promoting specific interactions between them. In contrast, non-substrates either fail to bind or do not induce the requisite conformational changes upon binding and thus no catalysis occurs. In principle, both lock and key and induced-fit binding can provide specific interactions between the substrate and the enzyme. In this study, we present an interesting case where cofactor binding pre-tunes the active site geometry to recognize only the cognate substrates. We illustrate this principle by studying the substrate binding and kinetic properties of Xylose Reductase from Debaryomyces hansenii (DhXR), an AKR family enzyme which catalyzes the reduction of carbonyl substrates using NADPH as co-factor. DhXR reduces D-xylose with increased specificity and shows no activity towards "non-substrate" sugars like L-rhamnose. Interestingly, apo-DhXR binds to D-xylose and L-rhamnose with similar affinity (K-d similar to 5.0-10.0 mM). Crystal structure of apo-DhXR-rhamnose complex shows that L-rhamnose is bound to the active site cavity. L-rhamnose does not bind to holo-DhXR complex and thus, it cannot competitively inhibit D-xylose binding and catalysis even at 4-5 fold molar excess. Comparison of K-d values with K-m values reveals that increased specificity for D-xylose is achieved at the cost of moderately reduced affinity. The present work reveals a latent regulatory role for cofactor binding which was previously unknown and suggests that cofactor induced conformational changes may increase the complimentarity between D-xylose and active site similar to specificity achieved through induced-fit mechanism.	[Biswas, Dipanwita; Pandya, Vaibhav; Singh, Appu Kumar; Mondal, Alok K.; Kumaran, S.] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumaran, S (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	skumaran@imtech.res.in		Pandya, Vaibhav/0000-0002-8500-9009	Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI; CSIR, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported in part by a grant from Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI project. Fellowships for DB, VP, and AKS were funded by CSIR, India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG JM, 2007, BIOCHEMISTRY; Breuer U, 2006, YEAST, V23, P415, DOI 10.1002/yea.1374; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieulaine S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001066; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fischer JD, 2010, BIOINFORMATICS, V26, P2496, DOI 10.1093/bioinformatics/btq442; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; GURGEL PV, 1995, BIORESOURCE TECHNOL, V52, P219, DOI 10.1016/0960-8524(95)00025-A; Hamill MJ, 2011, BIOCHEMISTRY-US, V50, P10159, DOI 10.1021/bi201340t; HEPPEL LA, 1951, J BIOL CHEM, V188, P665; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kaur H, 2011, BIOCHIMIE, V93, P175, DOI 10.1016/j.biochi.2010.09.008; Kavanagh KL, 2002, BIOCHEMISTRY-US, V41, P8785, DOI 10.1021/bi025786n; Khurana S, 1998, P NATL ACAD SCI USA, V95, P6768, DOI 10.1073/pnas.95.12.6768; Klimacek M, 2007, BIOCATAL BIOTRANSFOR, V25, P194, DOI 10.1080/10242420701379775; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kratzer R, 2006, BIOCHEM J, V393, P51, DOI 10.1042/BJ20050831; Kratzer R, 2006, IUBMB LIFE, V58, P499, DOI 10.1080/15216540600818143; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; Lindner AB, 1999, J MOL BIOL, V285, P421, DOI 10.1006/jmbi.1998.2309; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mayr P, 2002, BIOCHEM J, V366, P889, DOI 10.1042/BJ20020080; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Neuhauser W, 1998, BIOCHEMISTRY-US, V37, P1116, DOI 10.1021/bi9717800; NIGAM P, 1995, PROCESS BIOCHEM, V30, P117, DOI 10.1016/0032-9592(95)95709-R; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan R, 2010, J BIOL CHEM, V285, P22948, DOI 10.1074/jbc.M110.103549; Pandya V, 2011, ANAL BIOCHEM, V418, P134, DOI 10.1016/j.ab.2011.06.029; PARAJO JC, 1995, BIOPROCESS ENG, V13, P125, DOI 10.1007/BF00369695; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sanli G, 2003, CELL BIOCHEM BIOPHYS, V38, P79, DOI 10.1385/CBB:38:1:79; Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; SCHNEIDER H, 1989, CRIT REV BIOTECHNOL, V9, P1, DOI 10.1080/07388550490465817; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; ZEREZ CR, 1987, J BACTERIOL, V169, P184, DOI 10.1128/jb.169.1.184-188.1987	51	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45525	10.1371/journal.pone.0045525	http://dx.doi.org/10.1371/journal.pone.0045525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049810	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300030
J	Cendra, MD; Juarez, A; Torrents, E				del Mar Cendra, Maria; Juarez, Antonio; Torrents, Eduard			Biofilm Modifies Expression of Ribonucleotide Reductase Genes in Escherichia coli	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; STRESS; K-12; ACTIVATION; CLONING; OPERON; STRAIN; GROWTH; ENZYME; LEVEL	Ribonucleotide reductase (RNR) is an essential enzyme for all living organisms since is the responsible for the last step in the synthesis of the four deoxyribonucleotides (dNTPs) necessary for DNA replication and repair. In this work, we have investigated the expression of the three-RNR classes (Ia, Ib and III) during Escherichia coli biofilm formation. We show the temporal and spatial importance of class Ib and III RNRs during this process in two different E. coli wild-type strains, the commensal MG1655 and the enteropathogenic and virulent E2348/69, the prototype for the enteropathogenic E. coli (EPEC). We have established that class Ib RNR, so far considered cryptic, play and important role during biofilm formation. The implication of this RNR class under the specific growth conditions of biofilm formation is discussed.	[del Mar Cendra, Maria; Juarez, Antonio; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Juarez, Antonio] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.	etorrents@ibecbarcelona.eu	Torrents, Eduard/C-7184-2008; Cendra, M/A-6821-2019; del Mar Cendra, Maria/AAX-8114-2020	Torrents, Eduard/0000-0002-3010-1609; Cendra, M/0000-0002-2100-2406; del Mar Cendra, Maria/0000-0002-2100-2406; Juarez, Antonio/0000-0002-5027-8778	ERA-NET Pathogenomics [BIO2008-04362-E]; Spanish Ministerio de Ciencia e Innovacion [PI081062, BFU2011-24066]; Consolider-Intermods from the Spanish MICINN [CDS2008-00013]	ERA-NET Pathogenomics; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Intermods from the Spanish MICINN	This work was supported by grants from the "ERA-NET Pathogenomics-BIO2008-04362-E" and from the Spanish Ministerio de Ciencia e Innovacion (PI081062) and (BFU2011-24066) to ET and Consolider-Intermods (CDS2008-00013) from the Spanish MICINN to ET and AJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Torrents E, 2000, CURR MICROBIOL, V41, P346, DOI 10.1007/s002840010147; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weiss-Muszkat M, 2010, APPL ENVIRON MICROB, V76, P1545, DOI 10.1128/AEM.01395-09	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46350	10.1371/journal.pone.0046350	http://dx.doi.org/10.1371/journal.pone.0046350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050019	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300109
J	Vanderkelen, L; Ons, E; Van Herreweghe, JM; Callewaert, L; Goddeeris, BM; Michiels, CW				Vanderkelen, Lise; Ons, Ellen; Van Herreweghe, Joris M.; Callewaert, Lien; Goddeeris, Bruno M.; Michiels, Chris W.			Role of Lysozyme Inhibitors in the Virulence of Avian Pathogenic Escherichia coli	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; CHROMOSOMAL GENES; CHICKEN; AUTOTRANSPORTER; IDENTIFICATION; EXPRESSION; RESISTANCE; SURVIVAL; SEQUENCE; ADHESIN	Lysozymes are key effectors of the animal innate immunity system that kill bacteria by hydrolyzing peptidoglycan, their major cell wall constituent. Recently, specific inhibitors of the three major lysozyme families occuring in the animal kingdom (c-, g- and i-type) have been discovered in Gram-negative bacteria, and it has been proposed that these may help bacteria to evade lysozyme mediated lysis during interaction with an animal host. Escherichia coli produces two inhibitors that are specific for c-type lysozyme (Ivy, Inhibitor of vertebrate lysozyme; MliC, membrane bound lysozyme inhibitor of c-type lysozyme), and one specific for g-type lysozyme (PliG, periplasmic lysozyme inhibitor of g-type lysozyme). Here, we investigated the role of these lysozyme inhibitors in virulence of Avian Pathogenic E. coli (APEC) using a serum resistance test and a subcutaneous chicken infection model. Knock-out of mliC caused a strong reduction in serum resistance and in in vivo virulence that could be fully restored by genetic complementation, whereas ivy and pliG could be knocked out without effect on serum resistance and virulence. This is the first in vivo evidence for the involvement of lysozyme inhibitors in bacterial virulence. Remarkably, the virulence of a ivy mliC double knock-out strain was restored to almost wild-type level, and this strain also had a substantial residual periplasmic lysozyme inhibitory activity that was higher than that of the single knock-out strains. This suggests the existence of an additional periplasmic lysozyme inhibitor in this strain, and indicates a regulatory interaction in the expression of the different inhibitors.	[Vanderkelen, Lise; Van Herreweghe, Joris M.; Callewaert, Lien; Michiels, Chris W.] Katholieke Univ Leuven, Food Microbiol Lab, Louvain, Belgium; [Vanderkelen, Lise; Van Herreweghe, Joris M.; Callewaert, Lien; Michiels, Chris W.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium; [Ons, Ellen; Goddeeris, Bruno M.] Katholieke Univ Leuven, Lab Vaccine Design, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Michiels, CW (corresponding author), Katholieke Univ Leuven, Food Microbiol Lab, Louvain, Belgium.	Chris.Michiels@biw.kuleuven.be	Goddeeris, Bruno Maria/L-2440-2015; Michiels, Chris/I-6847-2013	Goddeeris, Bruno Maria/0000-0003-3729-7592; Michiels, Chris/0000-0002-7710-6802	Research Foundation Flanders (FWO-Vlaanderen) [G.0363.08]; Flemish Institute for the Promotion of Scientific Technological Research (IWT); KU Leuven Research Fund [METH/07/03]	Research Foundation Flanders (FWO-Vlaanderen)(FWO); Flemish Institute for the Promotion of Scientific Technological Research (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven Research Fund(KU Leuven)	This work was financially supported by the Research Foundation Flanders (FWO-Vlaanderen research project G.0363.08, postdoc fellowship to L. C. and PhD fellowship to J.V.H.) (www.fwo.be), the Flemish Institute for the Promotion of Scientific Technological Research (IWT; www.iwt.be) (doctoral fellowship to L. V.) and by the KU Leuven Research Fund (research project METH/07/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; Deckers D, 2008, APPL ENVIRON MICROB, V74, P4434, DOI 10.1128/AEM.00589-08; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dho-Moulin M, 1999, VET RES, V30, P299; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; IKE K, 1992, J VET MED SCI, V54, P1091, DOI 10.1292/jvms.54.1091; Kyomuhendo P, 2007, CELL MOL LIFE SCI, V64, P2841, DOI 10.1007/s00018-007-7372-8; Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Myers FA, 2006, NUCLEIC ACIDS RES, V34, P4025, DOI 10.1093/nar/gkl543; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Nile CJ, 2004, CELL MOL LIFE SCI, V61, P2760, DOI 10.1007/s00018-004-4345-z; Painbeni E, 1997, P NATL ACAD SCI USA, V94, P6712, DOI 10.1073/pnas.94.13.6712; REED L. J., 1938, AMER JOUR HYG, V27, P493; STONE BJ, 1995, MOL MICROBIOL, V17, P701, DOI 10.1111/j.1365-2958.1995.mmi_17040701.x; TAYLOR PW, 1983, MICROBIOL REV, V47, P46, DOI 10.1128/MMBR.47.1.46-83.1983; Van Herreweghe JM, 2010, CELL MOL LIFE SCI, V67, P1177, DOI 10.1007/s00018-009-0241-x; van Houdt R, 2006, FEMS MICROBIOL LETT, V262, P201, DOI 10.1111/j.1574-6968.2006.00391.x; Vandemaele F, 2005, AVIAN PATHOL, V34, P264, DOI 10.1080/03079450500112682; Vandemaele F, 2003, VET RES, V34, P153, DOI 10.1051/vetres:2002062; VANDENBOSCH JF, 1993, INFECT IMMUN, V61, P800, DOI 10.1128/IAI.61.3.800-806.1993; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Vanderkelen L, 2011, APPL ENVIRON MICROB, V77, P4697, DOI 10.1128/AEM.00427-11; Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	32	16	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45954	10.1371/journal.pone.0045954	http://dx.doi.org/10.1371/journal.pone.0045954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049900	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300066
J	Yadav, DK; Pospisil, P				Yadav, Deepak Kumar; Pospisil, Pavel			Evidence on the Formation of Singlet Oxygen in the Donor Side Photoinhibition of Photosystem II: EPR Spin-Trapping Study	PLOS ONE			English	Article							MOLECULAR-OXYGEN; MANGANESE COMPLEX; QUALITY-CONTROL; CHARGE RECOMBINATION; ACID HYDROPEROXIDE; ELECTRON-TRANSPORT; IN-VIVO; PROTEIN; LIGHT; LIPIDS	When photosystem II (PSII) is exposed to excess light, singlet oxygen (O-1(2)) formed by the interaction of molecular oxygen with triplet chlorophyll. Triplet chlorophyll is formed by the charge recombination of triplet radical pair (3)[P680(center dot+)Pheo(center dot 2)] in the acceptor-side photoinhibition of PSII. Here, we provide evidence on the formation of O-1(2) in the donor side photoinhibition of PSII. Light- induced O-1(2) production in Tris-treated PSII membranes was studied by electron paramagnetic resonance (EPR) spin-trapping spectroscopy, as monitored by TEMPONE EPR signal. Light-induced formation of carbon-centered radicals (R-center dot) was observed by POBN-R adduct EPR signal. Increased oxidation of organic molecules at high pH enhanced the formation of TEMPONE and POBN-R adduct EPR signals in Tris-treated PSII membranes. Interestingly, the scavenging of R-center dot by propyl gallate significantly suppressed O-1(2). Based on our results, it is concluded that O-1(2) formation correlates with R-center dot formation on the donor side of PSII due to oxidation of organic molecules (lipids and proteins) by long-lived P680(center dot+)/TyrZ(center dot). It is proposed here that the Russell mechanism for the recombination of two peroxyl radicals formed by the interaction of R-center dot with molecular oxygen is a plausible mechanism for O-1(2) formation in the donor side photoinhibition of PSII.	[Yadav, Deepak Kumar; Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Pospisil, P (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic.	pospip@prfnw.upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019	POSPÍŠIL, Pavel/0000-0001-9126-2011; Yadav, Deepak Kumar/0000-0002-4555-3851	Centre of the Region Hana for Biotechnological and Agricultural Research [ED0007/01/01]; Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic [CZ.1.07/2.3.00/20.0057]	Centre of the Region Hana for Biotechnological and Agricultural Research; Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic	This work was supported by the grants no. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research and no. CZ.1.07/2.3.00/20.0057 Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2010, P NATL ACAD SCI USA, V107, P3924, DOI 10.1073/pnas.0913460107; Anderson JM, 2002, PHILOS T R SOC B, V357, P1421, DOI 10.1098/rstb.2002.1138; Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; Angelin M, 2006, EUR J ORG CHEM, V2006, P4323, DOI 10.1002/ejoc.200600288; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Brudvig GW, 2008, PHILOS T R SOC B, V363, P1211, DOI 10.1098/rstb.2007.2217; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Chow WS, 2005, ADV PHOTO RESPIRAT, V22, P627; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dean RT, 1997, BIOCHEM J, V324, P1; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fischer BB, 2007, FEBS LETT, V581, P5555, DOI 10.1016/j.febslet.2007.11.003; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; HOWARD JA, 1968, J AM CHEM SOC, V90, P1056, DOI 10.1021/ja01006a037; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P4118, DOI 10.1021/bi047922p; Ivanov B, 2003, ANTIOXID REDOX SIGN, V5, P43, DOI 10.1089/152308603321223531; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kern J, 2011, J PHOTOCH PHOTOBIO B, V104, P19, DOI 10.1016/j.jphotobiol.2011.02.025; Khorobrykh SA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P683, DOI 10.1023/A:1016154506817; Khorobrykh SA, 2011, BIOCHEMISTRY-US, V50, P10658, DOI 10.1021/bi200945v; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MENDENHALL GD, 1991, J AM CHEM SOC, V113, P8976, DOI 10.1021/ja00023a073; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; NIU QJ, 1992, J AM CHEM SOC, V114, P165, DOI 10.1021/ja00027a024; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NORTH JA, 1992, J BIOL CHEM, V267, P5743; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2006, BIOCHEM J, V397, P321, DOI 10.1042/BJ20060068; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Rinalducci S, 2004, BBA-BIOENERGETICS, V1608, P63, DOI 10.1016/j.bbabio.2003.10.009; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; Santabarbara S, 2002, PHOTOCHEM PHOTOBIOL, V75, P613, DOI 10.1562/0031-8655(2002)075<0613:PIVAIV>2.0.CO;2; Santabarbara S, 2001, FEBS LETT, V491, P109, DOI 10.1016/S0014-5793(01)02174-3; Sinha RK, 2012, PLANT CELL ENVIRON, V35, P806, DOI 10.1111/j.1365-3040.2011.02454.x; Stolze K, 2005, BIOCHEM PHARMACOL, V69, P297, DOI 10.1016/j.bcp.2004.09.021; Sun SN, 2007, BIOCHEMISTRY-US, V46, P6668, DOI 10.1021/bi700178u; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; TELFER A, 1994, J BIOL CHEM, V269, P13244; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANMIEGHEM F, 1995, BIOCHEMISTRY-US, V34, P4798, DOI 10.1021/bi00014a038; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vass I, 2007, COMPR SER PHOTOCH, V8, P393; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Yadav DK, 2010, BBA-BIOENERGETICS, V1797, P1807, DOI 10.1016/j.bbabio.2010.07.003; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yanykin DV, 2010, BBA-BIOENERGETICS, V1797, P516, DOI 10.1016/j.bbabio.2010.01.014; Zein S, 2008, PHILOS T R SOC B, V363, P1167, DOI 10.1098/rstb.2007.2212; Zolla L, 2002, BIOCHEMISTRY-US, V41, P14391, DOI 10.1021/bi0265776	73	31	31	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45883	10.1371/journal.pone.0045883	http://dx.doi.org/10.1371/journal.pone.0045883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049883	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300059
J	Bhardwaj, R; O'Shea, RP				Bhardwaj, Rishi; O'Shea, Robert P.			Temporal Analysis of Image-Rivalry Suppression	PLOS ONE			English	Article							BINOCULAR-RIVALRY; VISUAL CONSCIOUSNESS; SPATIAL-FREQUENCY; LUMINANCE; FUSION; MOTION; COLOR; DEPTH; TIME	During binocular rivalry, perception alternates between two different images presented one to each eye. At any moment, one image is visible, dominant, while the other is invisible, suppressed. Alternations in perception during rivalry could involve competition between eyes, eye-rivalry, or between images, image-rivalry, or both. We measured response criteria, sensitivities, and thresholds to brief contrast increments to one of the rival stimuli in conventional rivalry displays and in a display in which the rival stimuli swapped between the eyes every 333 ms-swap rivalry-that necessarily involves image rivalry. We compared the sensitivity and threshold measures in dominance and suppression to assess the strength of suppression. We found that response criteria are essentially the same during dominance and suppression for the two sorts of rivalry. Critically, we found that swap-rivalry suppression is weak after a swap and strengthens throughout the swap interval. We propose that image rivalry is responsible for weak initial suppression immediately after a swap and that eye rivalry is responsible for the stronger suppression that comes later.	[Bhardwaj, Rishi; O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Bhardwaj, Rishi] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Bhardwaj, Rishi] Nethradhama Sch Optometry, Bangalore, Karnataka, India; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia	University of Otago; Durham University; Southern Cross University	Bhardwaj, R (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	dr.rishi.bhardwaj@gmail.com	O'Shea, Robert P./C-5723-2008; Bhardwaj, Rishi/AAQ-4074-2020	O'Shea, Robert P./0000-0003-3132-7199; Bhardwaj, Rishi/0000-0003-0932-6931				Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Baker DH, 2010, CURR BIOL, V20, pR644, DOI 10.1016/j.cub.2010.06.010; Bartels A, 2010, J VISION, V10, DOI 10.1167/10.12.3; Bhardwaj R, 2008, J VISION, V8, DOI 10.1167/8.11.2; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; Blake R, 2008, SCHOLARPEDIA, V3, P1578, DOI DOI 10.4249/SCH0LARPEDIA.1578; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caetta F, 2007, J VISION, V7, DOI 10.1167/7.7.4; CAMPBELL FW, 1972, J PHYSIOL-LONDON, V225, pP19; Crick F, 1996, NATURE, V379, P485, DOI 10.1038/379485a0; FOX R, 1968, J EXP PSYCHOL, V78, P388, DOI 10.1037/h0026440; FOX R, 1966, PERCEPT PSYCHOPHYS, V1, P331, DOI 10.3758/BF03215798; Green DM, 1966, SIGNAL DETECTION THE; Khoe W, 2008, J VISION, V8, DOI 10.1167/8.3.18; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Macmillan N. A., 1991, DETECTION THEORY USE; Naber M, 2010, VISION RES, V50, P818, DOI 10.1016/j.visres.2010.02.004; Necker L.A, 1832, LONDON EDINBURGH PHI, V1, P329, DOI 10.1080/14786443208647909; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; O'Shea RP, 2009, VISION RES, V49, P671, DOI 10.1016/j.visres.2009.01.020; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; OOI TL, 1994, VISION RES, V34, P2997, DOI 10.1016/0042-6989(94)90272-0; OSHEA RP, 1984, PERCEPT PSYCHOPHYS, V36, P266, DOI 10.3758/BF03206368; OSHEA RP, 1981, PERCEPTION, V10, P283, DOI 10.1068/p100283; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; SHIMOJO S, 1990, VISION RES, V30, P69, DOI 10.1016/0042-6989(90)90128-8; SMITH EL, 1982, SCIENCE, V218, P802, DOI 10.1126/science.7134975; Stuit SM, 2009, J VISION, V9, DOI 10.1167/9.11.17; Suzuki S, 2002, NEURON, V36, P143, DOI 10.1016/S0896-6273(02)00934-0; TANNER TA, 1970, J MATH PSYCHOL, V7, P259, DOI 10.1016/0022-2496(70)90048-9; WALES R, 1970, PERCEPT PSYCHOPHYS, V8, P90, DOI 10.3758/BF03210180; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; WOLFE JM, 1986, PSYCHOL REV, V93, P269, DOI 10.1037/0033-295X.93.3.269	45	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45407	10.1371/journal.pone.0045407	http://dx.doi.org/10.1371/journal.pone.0045407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049797	Green Published, Green Accepted, gold			2022-12-25	WOS:000309556100045
J	Donat, U; Weibel, S; Hess, M; Stritzker, J; Hartl, B; Sturm, JB; Chen, NG; Gentschev, I; Szalay, AA				Donat, Ulrike; Weibel, Stephanie; Hess, Michael; Stritzker, Jochen; Haertl, Barbara; Sturm, Julia B.; Chen, Nanhai G.; Gentschev, Ivaylo; Szalay, Aladar A.			Preferential Colonization of Metastases by Oncolytic Vaccinia Virus Strain GLV-1h68 in a Human PC-3 Prostate Cancer Model in Nude Mice	PLOS ONE			English	Article							BREAST-TUMORS; CARCINOMA; THERAPY; ANGIOGENESIS; SUPPRESSION; XENOGRAFTS; REGRESSION; INFECTION; SURVIVAL; CELLS	Recently, we showed that the oncolytic vaccinia virus GLV-1h68 has a significant therapeutic potential in treating lymph node metastases of human PC-3 prostate carcinoma in tumor xenografts. In this study, underlying mechanisms of the virus-mediated metastases reduction were analyzed. Immunohistochemistry demonstrated that virus-treatment resulted in a drastically decrease of blood and lymph vessels, representing essential routes for PC-3 cell migration, in both tumors and metastases. Thus, GLV-1h68 drastically reduced essential routes for the metastatic spread of PC-3 cells. Furthermore, analysis of viral distribution in GLV-1h68-injected tumor-bearing mice by plaque assays, revealed significantly higher virus titers in metastases compared to solid tumors. To elucidate conditions potentially mediating the preferential viral colonization and eradication of metastases, microenvironmental components of uninfected tumors and metastases were compared by microscopic studies. These analyses revealed that PC-3 lymph node metastases showed increased vascular permeability, higher proliferation status of tumor cells as determined by BrdU-and Ki-67 assays and lesser necrosis of PC-3 cells than solid tumors. Moreover, an increased number of immune cells (MHCII+/CD68(+) macrophages, MHCII+/CD19(+) B lymphocytes) combined with an up-regulated expression of pro-inflammatory cytokines was observed in metastases in comparison to primary PC-3 tumors. We propose that these microenvironmental components mediated the metastatic tropism of GLV-1h68. Therefore, vaccinia virus-based oncolytic virotherapy might offer a novel treatment of metastatic prostate carcinomas in humans.	[Donat, Ulrike; Weibel, Stephanie; Hess, Michael; Stritzker, Jochen; Haertl, Barbara; Sturm, Julia B.; Gentschev, Ivaylo; Szalay, Aladar A.] Univ Wurzburg, Inst Biochem, D-8700 Wurzburg, Germany; [Stritzker, Jochen; Chen, Nanhai G.; Gentschev, Ivaylo; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, Rebecca & John Moores Comprehens Canc Ctr, San Diego, CA 92103 USA; [Haertl, Barbara; Szalay, Aladar A.] Genelux GmbH, Bernried, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolph Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany	University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Inst Biochem, Rontgenring 11, D-8700 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021		University of Wurzburg	University of Wurzburg	Drs. Jochen Stritzker, Nanhai G. Chen, Ivaylo Gentschev and Aladar A. Szalay are employees of Genelux Corporation and have financial interests in Genelux Corporation. Dr. Barbara Hartl is an employee of Genelux GmbH. Genelux Corporation also provided a Service Grant to the University of Wurzburg. Dr. Ulrike Donat and Dr. Stephanie Weibel are recipients of a postdoctoral fellowship. Dr. Julia Sturm and Mr. Michael Hess are recipients of a graduate fellowship from the University of Wurzburg. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript. There are no patents or products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	APPLE JS, 1985, RADIOLOGY, V154, P601, DOI 10.1148/radiology.154.3.2578678; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chen ZT, 2005, CANCER RES, V65, P9004, DOI 10.1158/0008-5472.CAN-05-0885; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ivanov VN, 2011, J CELL BIOCHEM, V112, P463, DOI 10.1002/jcb.22934; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; LEWENHAUPT A, 1990, BRIT J UROL, V66, P182, DOI 10.1111/j.1464-410X.1990.tb14900.x; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Parato KA, 2011, MOL THER; Roger W, 1973, GRAYS ANATOMY, P588; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Skvortsova I, 2008, PROTEOMICS, V8, P4521, DOI 10.1002/pmic.200800113; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Worschech A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-301; WYNDER EL, 1971, CANCER, V28, P344, DOI 10.1002/1097-0142(197108)28:2<344::AID-CNCR2820280214>3.0.CO;2-#; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	31	21	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45942	10.1371/journal.pone.0045942	http://dx.doi.org/10.1371/journal.pone.0045942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049897	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100104
J	Higuchi, A; Inoue, H; Kawakita, T; Ogishima, T; Tsubota, K				Higuchi, Akihiro; Inoue, Hiroyoshi; Kawakita, Tetsuya; Ogishima, Tadashi; Tsubota, Kazuo			Selenium Compound Protects Corneal Epithelium against Oxidative Stress	PLOS ONE			English	Article							DRY EYE MODEL; SELENOPROTEIN-P; OCULAR SURFACE; LACTOFERRIN; DAMAGE; IDENTIFICATION; INFLAMMATION; ANDROGEN; AGENTS	The ocular surface is strongly affected by oxidative stress, and anti-oxidative systems are maintained in corneal epithelial cells and tear fluid. Dry eye is recognized as an oxidative stress-induced disease. Selenium compound eye drops are expected to be a candidate for the treatment of dry eye. We estimated the efficacy of several selenium compounds in the treatment of dry eye using a dry eye rat model. All of the studied selenium compounds were uptaken into corneal epithelial cells in vitro. However, when the selenium compounds were administered as eye drops in the dry eye rat model, most of the selenium compounds did not show effectiveness except for Se-lactoferrin. Se-lactoferrin is a lactoferrin that we prepared that binds selenium instead of iron. Se-lactoferrin eye drops suppressed the up-regulated expression of heme oxygenase-1, cyclooxygenase-2, matrix metallopeptidase-9, and interleukin-6 and also suppressed 8-OHdG production in the cornea induced by surgical removal of the lacrimal glands. Compared with Se-lactoferrin, apolactoferrin eye drops weakly improved dry eye in high dose. The effect of Se-lactoferrin eye drops on dry eye is possibly due to the effect of selenium and also the effect of apolactoferrin. Se-lactoferrin is a candidate for the treatment of dry eye via regulation of oxidative stress in the corneal epithelium.	[Higuchi, Akihiro] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Higuchi, Akihiro; Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Inoue, Hiroyoshi] Keio Univ, Sch Med, Dept Chem, Tokyo, Kanagawa, Japan; [Ogishima, Tadashi] Kyushu Univ, Fac Sci, Dept Chem, Fukuoka 812, Japan	Keio University; Keio University; Keio University; Kyushu University	Higuchi, A (corresponding author), Keio Univ, Sch Med, Ctr Integrated Med Res, Shinanomachi Res Pk 6N9, Tokyo, Japan.	ahiguchi@z6.keio.jp		Kawakita, Tetsuya/0000-0002-8665-7518	Kowa Company, Ltd.	Kowa Company, Ltd.	This work was supported by grants from Kowa Company, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; BAYFIELD RF, 1985, ANAL BIOCHEM, V144, P569, DOI 10.1016/0003-2697(85)90155-1; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Dogru M, 2007, OPHTHALMOLOGY, V114, P2366, DOI 10.1016/j.ophtha.2007.06.027; Fujihara T, 1998, J OCUL PHARMACOL TH, V14, P99, DOI 10.1089/jop.1998.14.99; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Fujihara T, 2000, CORNEA, V19, P207, DOI 10.1097/00003226-200003000-00015; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Higuchi A, 2011, MOL VIS, V17, P2400; Higuchi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009911; Inoue H, 2005, PCT/JP2005/024286, Patent No. 2005024286; Inoue H, 2005, JP4634809, Patent No. 4634809; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; Modis L, 1998, GRAEF ARCH CLIN EXP, V236, P86, DOI 10.1007/s004170050047; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Offord EA, 1999, INVEST OPHTH VIS SCI, V40, P1091; Rocha EM, 2000, BRIT J OPHTHALMOL, V84, P76, DOI 10.1136/bjo.84.1.76; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Sharif NA, 1998, INVEST OPHTH VIS SCI, V39, P2562; Shimmura S, 1998, INVEST OPHTH VIS SCI, V39, P1346; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Suzuki T, 2001, CURR EYE RES, V22, P28, DOI 10.1076/ceyr.22.1.28.6980; Tsubota K, 2000, INT OPHTHALMOL CLIN, V40, P113, DOI 10.1097/00004397-200010000-00009; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; ZUCLICH JA, 1976, INVEST OPHTH VISUAL, V15, P760	31	42	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45612	10.1371/journal.pone.0045612	http://dx.doi.org/10.1371/journal.pone.0045612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049824	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100059
J	Koumanov, F; Pereira, VJ; Whitley, PR; Holman, GD				Koumanov, Francoise; Pereira, Vinit J.; Whitley, Paul R.; Holman, Geoffrey D.			GLUT4 Traffic through an ESCRT-III-Dependent Sorting Compartment in Adipocytes	PLOS ONE			English	Article							SENSITIVE GLUCOSE-TRANSPORTER; HEAVY-CHAIN ISOFORM; RAT ADIPOSE-CELLS; STRUCTURAL BASIS; INSULIN; PROTEIN; UBIQUITIN; INTERACTS; MEMBRANE; AMSH	In insulin target tissues, GLUT4 is known to traffic through multiple compartments that may involve ubiquitin- and/or SUMO-dependent targeting. During these trafficking steps, GLUT4 is sorted into a storage reservoir compartment that is acutely released by insulin signalling processes that are downstream of PI 3-kinase associated changes in inositol phospholipids. As ESCRT components have recently been found to influence cellular sorting processes that are related to changes in both ubiquitination and inositol phospholipids, we have examined whether GLUT4 traffic is routed through ESCRT dependent sorting steps. Introduction of the dominant negative inhibitory constructs of the ESCRT-III components CHMP3 (CHMP3(1-179)) and Vps4 (GFP-Vps4(E235Q)) into rat adipocytes leads to the accumulation of GLUT4 in large, coalesced and extended vesicles structures that co-localise with the inhibitory constructs over large parts of the extended structure. A new swollen hybrid and extensively ubiquitinated compartment is produced in which GLUT4 co-localises more extensively with the endosomal markers including EEA1 and transferrin receptors but also with the TGN marker syntaxin6. These perturbations are associated with failure of insulin action on GLUT4 traffic to the cell surface and suggest impairment in an ESCRT-dependent sorting step used for GLUT4 traffic to its specialised reservoir compartment.	[Koumanov, Francoise; Pereira, Vinit J.; Whitley, Paul R.; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Koumanov, F (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	f.koumanov@bath.ac.uk	Koumanov, Francoise/AAV-7654-2020	Koumanov, Francoise/0000-0002-9029-3390; Holman, Geoffrey/0000-0001-7045-1358	Wellcome Trust [081168/Z/06/Z]; Diabetes UK [08/0003788]; MRC [MR/J003417/1, G9225018, G0300415] Funding Source: UKRI; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [MR/J003417/1, G9225018, G0300415] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Wellcome Trust (081168/Z/06/Z) and Diabetes UK (08/0003788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Malide D, 2000, J CELL SCI, V113, P4203; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; SATOH S, 1993, J BIOL CHEM, V268, P17820; Sbrissa D, 2012, AM J PHYSL CELL PHYS; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	62	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44141	10.1371/journal.pone.0044141	http://dx.doi.org/10.1371/journal.pone.0044141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049745	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100012
J	Kunte, DP; DelaCruz, M; Wali, RK; Menon, A; Du, HY; Stypula, Y; Patel, A; Backman, V; Roy, HK				Kunte, Dhananjay P.; DelaCruz, Mart; Wali, Ramesh K.; Menon, Ashwaty; Du, Hongyan; Stypula, Yolanda; Patel, Amir; Backman, Vadim; Roy, Hemant K.			Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening	PLOS ONE			English	Article							CPG ISLAND METHYLATION; COLORECTAL-CANCER; PLASMA MICRORNAS; EARLY EVENT; GENE; EXPRESSION; BIOMARKERS; HYPERMETHYLATION; SIGNATURES; NEOPLASIA	Colorectal cancer (CRC) screening tests often have a trade-off between efficacy and patient acceptability/cost. Fecal tests (occult blood, methylation) engender excellent patient compliance but lack requisite performance underscoring the need for better population screening tests. We assessed the utility of microRNAs (miRNAs) as markers of field carcinogenesis and their potential role for CRC screening using the azoxymethane (AOM)-treated rat model. We found that 63 miRNAs were upregulated and miR-122, miR-296-5p and miR-503# were downregulated in the uninvolved colonic mucosa of AOM rats. We monitored the expression of selected miRNAs in colonic biopsies of AOM rats at 16 weeks and correlated it with tumor development. We noted that the tumor bearing rats had significantly greater miRNA modulation compared to those without tumors. The miRNAs showed good diagnostic performance with an area under the receiver operator curve (AUROC) of >0.7. We also noted that the miRNA induction in the colonic mucosa was mirrorred in the mucus layer fecal colonocytes isolated from AOM rat stool and the degree of miRNA induction was greater in the tumor bearing rats compared to those without tumors. Lastly, we also noted significant miRNA modulation in the Pirc rats- the genetic model of colon carcinogenesis, both in the uninvolved colonic mucosa and the fecal colonocytes. We thus demonstrate that miRNAs are excellent markers of field carcinogenesis and could accurately predict future neoplasia. Based on our results, we propose an accurate, inexpensive, non-invasive miRNA test for CRC risk stratification based on rectal brushings or from abraded fecal colonocytes.	[Kunte, Dhananjay P.; DelaCruz, Mart; Wali, Ramesh K.; Menon, Ashwaty; Du, Hongyan; Patel, Amir; Roy, Hemant K.] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Stypula, Yolanda; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	NorthShore University Health System; Northwestern University	Roy, HK (corresponding author), NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA.	h-roy@northwestern.edu	Roy, Hemant/AAC-9096-2020; Backman, Vadim/B-6689-2009		National Institutes of Health [U01CA111257, R01CA156186, R42CA130508, R21CA141112, R21CA140936, R01CA128641]; NATIONAL CANCER INSTITUTE [R01CA156186, R21CA141112, R01CA128641, U01CA111257, R21CA140936, R42CA130508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health U01CA111257, R01CA156186, R42CA130508, R21CA141112, R21CA140936, R01CA128641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Grady WM, 2010, GUT, V59, P706, DOI 10.1136/gut.2009.200022; Heavey PM, 2004, NUTR CANCER, V48, P124, DOI 10.1207/s15327914nc4802_2; Hesson LB, 2005, ONCOGENE, V24, P3987, DOI 10.1038/sj.onc.1208566; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Keku TO, 2008, CANCER EPIDEM BIOMAR, V17, P306, DOI 10.1158/1055-9965.EPI-07-0066; Koga Y, 2010, CANCER PREV RES, V3, P1435, DOI 10.1158/1940-6207.CAPR-10-0036; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, GUT, V58, P1318, DOI 10.1136/gut.2009.176875; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; White V, 2009, CANCER EPIDEM BIOMAR, V18, P2006, DOI 10.1158/1055-9965.EPI-08-1145; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	32	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45591	10.1371/journal.pone.0045591	http://dx.doi.org/10.1371/journal.pone.0045591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049818	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100057
J	Park, HY; Noh, EH; Chung, HM; Kang, MJ; Kim, EY; Park, SP				Park, Hyo Young; Noh, Eun Hyung; Chung, Hyung-Min; Kang, Man-Jong; Kim, Eun Young; Park, Se Pill			Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MAGNETIC FORCE; SOMATIC-CELLS; GENE DELIVERY; IN-VITRO; FIBROBLASTS; INDUCTION; DIFFERENTIATION; EXPRESSION	The generation of induced pluripotent stem (iPS) cells is a powerful tool in regenerative medicine, and advances in nanotechnology clearly have great potential to enhance stem cell research. Here, we introduce a liposomal magnetofection (LMF) method for iPS cell generation. Efficient conditions for generating virus-free iPS cells from mouse embryonic fibroblast (MEF) cells were determined through the use of different concentrations of CombiMag nanoparticle-DNA(pCX-OKS-2A and pCX-cMyc)-lipoplexes and either one or two cycles of the LMF procedure. The cells were prepared in a short reprogramming time period (<= 8 days, 0.032-0.040%). Among the seven LMF-iPS cell lines examined, two were confirmed to be integration-free, and an integration-free LMF-iPS cell line was produced under the least toxic conditions (single LMF cycle with a half-dose of plasmid). This cell line also displayed in vitro/in vivo pluripotency, including teratoma formation and chimeric mouse production. In addition, the safety of CombiMag-DNA lipoplexes for the transfection of MEF cells was confirmed through lactate dehydrogenase activity assay and transmission electron microscopy. These results demonstrated that the LMF method is simple, effective, and safe. LMF may represent a superior technique for the generation of virus-free or integration-free iPS cell lines that could lead to enhanced stem cell therapy in the future.	[Park, Hyo Young; Noh, Eun Hyung; Kim, Eun Young; Park, Se Pill] Mirae Biotech, Miraebio Res Inst, Seoul, South Korea; [Park, Hyo Young; Noh, Eun Hyung; Kim, Eun Young; Park, Se Pill] Jeju Natl Univ, Stem Cell Res Ctr, Cheju, South Korea; [Chung, Hyung-Min] Pochon CHA Univ, CHA Stem Cell Inst, Seoul, South Korea; [Chung, Hyung-Min] Pochon CHA Univ, CHA Biotech, Seoul, South Korea; [Kang, Man-Jong] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Anim Sci & Technol, Kwangju, South Korea; [Park, Se Pill] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Cheju, South Korea	Jeju National University; Pochon Cha University; Pochon Cha University; Chonnam National University; Jeju National University	Kim, EY (corresponding author), Mirae Biotech, Miraebio Res Inst, Seoul, South Korea.	jlokey@daum.net; sppark@jejunu.ac.kr			Bio-industry Technology Development Program [308008-5]; Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program [PJ009075]; Cooperative Research Program for Agriculture Science & Technology Development [PJ009103]; Rural Development Administration, Republic of Korea	Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program; Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by grants from the Bio-industry Technology Development Program (308008-5); the Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program (PJ009075); and the Cooperative Research Program for Agriculture Science & Technology Development (PJ009103), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	30	3	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45812	10.1371/journal.pone.0045812	http://dx.doi.org/10.1371/journal.pone.0045812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049868	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100084
J	Kushawaha, PK; Gupta, R; Tripathi, CDP; Khare, P; Jaiswal, AK; Sundar, S; Dube, A				Kushawaha, Pramod K.; Gupta, Reema; Tripathi, Chandra Dev Pati; Khare, Prashant; Jaiswal, Anil Kumar; Sundar, Shyam; Dube, Anuradha			Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; INTERFERON-GAMMA PRODUCTION; INTEGRAL MEMBRANE-PROTEINS; NITRIC-OXIDE SYNTHASE; CELLULAR-RESPONSES; REACTIVE NITROGEN; INFECTED PATIENTS; DNA VACCINATION; IFN-GAMMA; T-CELLS	Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 million people at risk. Due to the non availability of an ideal drug, development of a safe, effective, and affordable vaccine could be a solution for control and prevention of this disease. In this study, a potential Th1 stimulatory protein-Triose phosphate isomerase (TPI), a glycolytic enzyme, identified through proteomics from a fraction of Leishmania donovani soluble antigen ranging from 89.9-97.1 kDa, was assessed for its potential as a suitable vaccine candidate. The protein-L. donovani TPI (LdTPI) was cloned, expressed and purified which exhibited the homology of 99% with L. infantum TPI. The rLdTPI was further evaluated for its immunogenicity by lymphoproliferative response (LTT), nitric oxide (NO) production and estimation of cytokines in cured Leishmania patients/hamster. It elicited strong LTT response in cured patients as well as NO production in cured hamsters and stimulated remarkable Th1-type cellular responses including IFN-(a) over bar and IL-12 with extremely lower level of IL-10 in Leishmania-infected cured/exposed patients PBMCs in vitro. Vaccination with LdTPI-DNA construct protected naive golden hamsters from virulent L. donovani challenge unambiguously (similar to 90%). The vaccinated hamsters demonstrated a surge in IFN-a, TNF-a and IL-12 levels but extreme down-regulation of IL-10 and IL-4 along with profound delayed type hypersensitivity and increased levels of Leishmania-specific IgG2 antibody. Thus, the results are suggestive of the protein having the potential of a strong candidate vaccine.	[Kushawaha, Pramod K.; Gupta, Reema; Tripathi, Chandra Dev Pati; Khare, Prashant; Jaiswal, Anil Kumar; Dube, Anuradha] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India; [Sundar, Shyam] Benaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	anuradha_dube@hotmail.com	Jaiswal, Anil Kumar/I-1369-2019; TRIPATHI, CHANDRA DEV/S-5617-2019; Khare, Prashant/O-8447-2017	Jaiswal, Anil Kumar/0000-0002-8169-0335; Khare, Prashant/0000-0001-5792-3082; Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi [BT/PR11782/MED/29/113/2009]; CSIR-CDRI's Supra-institutional network project [SIP-0026, 8321]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI's Supra-institutional network project	This work was supported by the Department of Biotechnology, New Delhi (BT/PR11782/MED/29/113/2009) and CSIR-CDRI's Supra-institutional network project (SIP-0026, 8321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Ali N, 1997, J PARASITOL, V83, P70, DOI 10.2307/3284319; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Chakravarty J, 2011, VACCINE, V29, P3531, DOI 10.1016/j.vaccine.2011.02.096; Coler RN, 2007, INFECT IMMUN; Das A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00099; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Evans KJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/892817; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2005, VACCINE, V23, P1189, DOI 10.1016/j.vaccine.2004.06.054; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Hailu A, 2001, J INFECT DIS, V184, P112, DOI 10.1086/320994; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Kubar J, 2005, LANCET INFECT DIS, V5, P107, DOI 10.1016/S1473-3099(05)70085-2; Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; LIEW FY, 1990, IMMUNOLOGY, V71, P556; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; Liu LM, 2005, STEROIDS, V70, P604, DOI 10.1016/j.steroids.2005.02.020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maecker B., 2001, Current Molecular Medicine (Hilversum), V1, P609, DOI 10.2174/1566524013363447; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Modabber F, 1995, ANN TROP MED PARASIT, V89, P83, DOI 10.1080/00034983.1995.11813017; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; MURRAY HW, 1983, ANN INTERN MED, V98, P1016, DOI 10.7326/0003-4819-98-6-1016; Nylen S, 2009, FUTURE MICROBIOL, V4, P241, DOI 10.2217/17460913.4.2.241; Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Sinha PK, 2005, INDIAN J MED RES, V121, P407; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wang YW, 2011, INFECT IMMUN, V79, P1124, DOI 10.1128/IAI.00658-10; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu Yinchang, 2002, Southeast Asian J Trop Med Public Health, V33, P207	70	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45766	10.1371/journal.pone.0045766	http://dx.doi.org/10.1371/journal.pone.0045766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23049855	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700069
J	Chittka, A; Nitarska, J; Grazini, U; Richardson, WD				Chittka, Alexandra; Nitarska, Justyna; Grazini, Ursula; Richardson, William D.			Transcription Factor Positive Regulatory Domain 4 (PRDM4) Recruits Protein Arginine Methyltransferase 5 (PRMT5) to Mediate Histone Arginine Methylation and Control Neural Stem Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; GENE-EXPRESSION; NEUROGENESIS; CYCLE; FATE; REPRESSION; CHROMATIN; BLIMP1; SPECIFICATION; PROGRESSION	During development of the cerebral cortex, neural stem cells (NSCs) undergo a temporal switch from proliferative (symmetric) to neuron-generating (asymmetric) divisions. We investigated the role of Schwann cell factor 1 (SC1/PRDM4), a member of the PRDM family of transcription factors, in this critical transition. We discovered that SC1 recruits the chromatin modifier PRMT5, an arginine methyltransferase that catalyzes symmetric dimethylation of histone H4 arginine 3 (H4R3me2s) and that this modification is preferentially associated with undifferentiated cortical NSCs. Overexpressing SC1 in embryonic NSCs led to an increase in the number of Nestin-expressing precursors; mutational analysis of SC1 showed that this was dependent on recruitment of PRMT5. We found that SC1 protein levels are down-regulated at the onset of neurogenesis and that experimental knockdown of SC1 in primary NSCs triggers precocious neuronal differentiation. We propose that SC1 and PRMT5 are components of an epigenetic regulatory complex that maintains the "stem-like" cellular state of the NSC by preserving their proliferative capacity and modulating their cell cycle progression. Our findings provide evidence that histone arginine methylation regulates NSC differentiation.	[Chittka, Alexandra; Grazini, Ursula; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Chittka, Alexandra; Grazini, Ursula; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England; [Nitarska, Justyna] UCL, Med Res Council, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London	Chittka, A (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	a.chittka@ucl.ac.uk	Chittka, Alexandra/AAR-9370-2021; Richardson FMedSci FRS, William D/C-1762-2008	Chittka, Alexandra/0000-0002-3495-270X; Nitarska, Justyna/0000-0001-6992-6686; Richardson FMedSci FRS, William D/0000-0001-7261-2485	Wellcome Trust [WT076656MA]; United Kingdom Medical Research Council; BBSRC [BB/J006602/1] Funding Source: UKRI; MRC [G0800575] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J006602/1] Funding Source: researchfish; Medical Research Council [G0800575] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Career Re-entry Fellowship WT076656MA (to A. C.) and by funds from the United Kingdom Medical Research Council (to W. D. R.).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikoff EK, 2009, CURR OPIN GENET DEV, V19, P379, DOI 10.1016/j.gde.2009.05.005; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Cimato TR, 2002, J NEUROSCI RES, V67, P435, DOI 10.1002/jnr.10123; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Derunes C, 2005, BIOCHEM BIOPH RES CO, V333, P925, DOI 10.1016/j.bbrc.2005.05.190; Dirks PB, 2010, MOL ONCOL, V4, P420, DOI 10.1016/j.molonc.2010.08.001; Eom GH, 2009, BIOCHEM BIOPH RES CO, V388, P131, DOI 10.1016/j.bbrc.2009.07.134; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi K, 2006, CELL CYCLE, V5, P615, DOI 10.4161/cc.5.6.2572; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Huang JH, 2011, J BIOL CHEM, V286, P44424, DOI 10.1074/jbc.M111.277046; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; Kendall SE, 2003, DEV BRAIN RES, V144, P151, DOI 10.1016/S0165-3806(03)00166-4; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Robertson EJ, 2007, DEVELOPMENT, V134, P4335, DOI 10.1242/dev.012047; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	50	59	60	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42995	43006		10.1074/jbc.M112.392746	http://dx.doi.org/10.1074/jbc.M112.392746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23048031	hybrid, Green Published			2022-12-25	WOS:000312501600056
J	Tachibanaki, S; Yonetsu, SI; Fukaya, S; Koshitani, Y; Kawamura, S				Tachibanaki, Shuji; Yonetsu, Shin-Ichi; Fukaya, Satoshi; Koshitani, Yuki; Kawamura, Satoru			Low Activation and Fast Inactivation of Transducin in Carp Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; VISUAL PIGMENT; RODS; PHOTOTRANSDUCTION; PHOSPHORYLATION; PHOTORECEPTORS; PHOTORESPONSES; AMPLIFICATION; METABOLISM; EXPRESSION	Cone photoreceptors show lower light sensitivity and briefer light responses than rod photoreceptors. The light detection signal in these cells is amplified through a phototransduction cascade. The first step of amplification in the cascade is the activation of a GTP-binding protein, transducin (Tr), by light-activated visual pigment (R*). We quantified transducin activation by measuring the binding of GTP gamma S in purified carp rod and cone membrane preparations with the use of a rapid quench apparatus and found that transducin activation by an R* molecule is similar to 5 times less efficient in cones than in rods. Transducin activation terminated in less than 1 s in cones, more quickly than in rods. The rate of GTP hydrolysis in Tr*, and thus the rate of Tr* inactivation, was similar to 25 times higher in cones than in rods. This faster inactivation of Tr* ensures briefer light responses in cones. The expression level of RGS9 was found to be similar to 20 times higher in cones than in rods, which explains higher GTP hydrolytic activity and, thus, faster Tr* inactivation in cones than in rods. Although carp rods and cones express rod-or cone-versions of visual pigment and transducin, these molecules themselves do not seem to induce the differences significantly in the transducin activation and Tr* inactivation in rods and cones. Instead, the differences seem to be brought about in a rod or cone cell-type specific manner.	[Tachibanaki, Shuji; Yonetsu, Shin-Ichi; Fukaya, Satoshi; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Koshitani, Yuki; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [20370060, 23227002, 222770150, 24570085]; Human Frontier Science Program grant; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program grant(Human Frontier Science Program); Naito Foundation(Naito Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science Grants 20370060 and 23227002 (to S. K.) and 222770150 and 24570085 (to S. T.), by a Human Frontier Science Program grant (to S. K.), and by the Naito Foundation (to S. T.).	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Alves ID, 2005, BIOPHYS J, V88, P198, DOI 10.1529/biophj.104.046722; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; DETURCO EBR, 1991, J NEUROSCI, V11, P3667; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Golobokova EY, 2006, VISION RES, V46, P2287, DOI 10.1016/j.visres.2005.12.017; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Shimauchi-Matsukawa Y, 2008, MOL VIS, V14, P358; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Vogalis F, 2011, J PHYSIOL-LONDON, V589, P2321, DOI 10.1113/jphysiol.2010.204156; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	24	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41186	41194		10.1074/jbc.M112.403717	http://dx.doi.org/10.1074/jbc.M112.403717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23045532	hybrid, Green Published			2022-12-25	WOS:000311887600034
J	Chan, EYL; McQuibban, GA				Chan, Eliana Y. L.; McQuibban, G. Angus			Phosphatidylserine Decarboxylase 1 (Psd1) Promotes Mitochondrial Fusion by Regulating the Biophysical Properties of the Mitochondrial Membrane and Alternative Topogenesis of Mitochondrial Genome Maintenance Protein 1 (Mgm1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLETHANOLAMINE; CARDIOLIPIN; MORPHOLOGY; PROTEASE; LIPIDS; YEAST; COMPETENT; CURVATURE; PATHWAYS	Non-bilayer-forming lipids such as cardiolipin, phosphatidic acid, and phosphatidylethanolamine (PE) are proposed to generate negative membrane curvature, promoting membrane fusion. However, the mechanism by which lipids regulate mitochondrial fusion remains poorly understood. Here, we show that mitochondrial-localized Psd1, the key yeast enzyme that synthesizes PE, is required for proper mitochondrial morphology and fusion. Yeast cells lacking Psd1 exhibit fragmented and aggregated mitochondria with impaired mitochondrial fusion during mating. More importantly, we demonstrate that a reduction in PE reduces the rate of lipid mixing during fusion of liposomes with lipid compositions reflecting the mitochondrial membrane. This suggests that the mitochondrial fusion defect in the Delta psd1 strain could be due to the altered biophysical properties of the mitochondrial membrane, resulting in reduced fusion kinetics. The Delta psd1 strain also has impaired mitochondrial activity such as oxidative phosphorylation and reduced mitochondrial ATP levels which are due to a reduction in mitochondrial PE. The loss of Psd1 also impairs the biogenesis of s-Mgm1, a protein essential for mitochondrial fusion, further exacerbating the mitochondrial fusion defect of the Delta psd1 strain. Increasing s-Mgm1 levels in Delta psd1 cells markedly reduced mitochondrial aggregation. Our results demonstrate that mitochondrial PE regulates mitochondrial fusion by regulating the biophysical properties of the mitochondrial membrane and by enhancing the biogenesis of s-Mgm1. While several proteins are required to orchestrate the intricate process of membrane fusion, we propose that specific phospholipids of the mitochondrial membrane promote fusion by enhancing lipid mixing kinetics and by regulating the action of profusion proteins.	[Chan, Eliana Y. L.; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	McQuibban, GA (corresponding author), 1 Kings Coll Circle,Med Sci Bldg,Rm 5342, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca			Canadian Institutes of Health Research; University of Toronto open fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto open fellowship(University of Toronto)	This work was supported by an operating grant from the Canadian Institutes of Health Research.; Supported in part by a University of Toronto open fellowship.	Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Epand RM, 1996, BIOPHYS J, V71, P1806, DOI 10.1016/S0006-3495(96)79381-5; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fritz S, 2003, MOL BIOL CELL, V14, P2303, DOI 10.1091/mbc.E02-12-0831; Gregg C., 2009, JOVE-J VIS EXP, pe1417; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; RAMSEY RB, 1976, BIOCHEM J, V158, P501, DOI 10.1042/bj1580501; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yang QL, 1997, BIOPHYS J, V73, P277, DOI 10.1016/S0006-3495(97)78068-8; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	33	63	64	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40131	40139		10.1074/jbc.M112.399428	http://dx.doi.org/10.1074/jbc.M112.399428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23045528	hybrid, Green Published			2022-12-25	WOS:000311448800004
J	Fiori, MC; Figueroa, V; Zoghbi, ME; Saez, JC; Reuss, L; Altenberg, GA				Fiori, Mariana C.; Figueroa, Vania; Zoghbi, Maria E.; Saez, Juan C.; Reuss, Luis; Altenberg, Guillermo A.			Permeation of Calcium through Purified Connexin 26 Hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; C-MEDIATED PHOSPHORYLATION; INOSITOL 1,4,5-TRISPHOSPHATE; ATP RELEASE; INNER-EAR; CA2+; PERMEABILITY; MECHANISM; DEAFNESS; MUTANT	Gap junction channels communicate the cytoplasms of two cells and are formed by head to head association of two hemichannels, one from each of the cells. Gap junction channels and hemichannels are permeable to ions and hydrophilic molecules of up to M-r 1,000, including second messengers and metabolites. Intercellular Ca2+ signaling can occur by movement of a number of second messengers, including Ca2+, through gap junction channels, or by a paracrine pathway that involves activation of purinergic receptors in neighboring cells following ATP release through hemichannels. Understanding Ca2+ permeation through Cx26 hemichannels is important to assess the role of gap junction channels and hemichannels in health and disease. In this context, it is possible that increased Ca2+ influx through hemichannels under ischemic conditions contributes to cell damage. Previous studies suggest Ca2+ permeation through hemichannels, based on indirect arguments. Here, we demonstrate for the first time hemichannel permeability to Ca2+ by measuring Ca2+ transport through purified Cx26 hemichannels reconstituted in liposomes. We trapped the low affinity Ca2+-sensitive fluorescent probe Fluo-5N into the liposomes and followed the increases in intraliposomal [Ca2+] in response to an imposed [Ca2+] gradient. We show that Ca2+ does move through Cx26 hemichannels and that the permeability of the hemichannels to Ca2+ is high, similar to that for Na+. We suggest that hemichannels can be a significant pathway for Ca2+ influx into cells under conditions such as ischemia.	[Fiori, Mariana C.; Zoghbi, Maria E.; Reuss, Luis; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Fiori, Mariana C.; Zoghbi, Maria E.; Reuss, Luis; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Figueroa, Vania; Saez, Juan C.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Figueroa, Vania; Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Inst Nucleo Milenio, Valparaiso, Chile	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center; Pontificia Universidad Catolica de Chile	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673; Altenberg, Guillermo/0000-0002-8932-740X; Figueroa Ipinza, Vania A./0000-0002-2953-9507	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Center of Membrane Protein Research; Programa MECE 2 Educacion Superior [UVA 0603]; Consejo Nacional de Investigacion Cientifica y Tecnologica [21090112, ACT71]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Membrane Protein Research; Programa MECE 2 Educacion Superior; Consejo Nacional de Investigacion Cientifica y Tecnologica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by a grant from the Center of Membrane Protein Research, and Programa MECE 2 Educacion Superior, Projecto UVA 0603, and Consejo Nacional de Investigacion Cientifica y Tecnologica grants 21090112 and ACT71.	Ambrosi C, 2010, BIOPHYS J, V98, P1809, DOI 10.1016/j.bpj.2010.01.019; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Ayad WA, 2006, J BIOL CHEM, V281, P16727, DOI 10.1074/jbc.M600136200; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Bao XY, 2004, AM J PHYSIOL-CELL PH, V286, pC647, DOI 10.1152/ajpcell.00295.2003; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; CHRIST GJ, 1992, AM J PHYSIOL, V263, pC373, DOI 10.1152/ajpcell.1992.263.2.C373; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Harris AL, 2001, METH MOL B, V154, P357; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Isakson BE, 2007, CIRC RES, V100, P246, DOI 10.1161/01.RES.0000257744.23795.93; Kanaporis G, 2008, J GEN PHYSIOL, V131, P293, DOI 10.1085/jgp.200709934; Leybaert L, 1998, GLIA, V24, P398, DOI 10.1002/(SICI)1098-1136(199812)24:4<398::AID-GLIA5>3.0.CO;2-R; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Martinez AD, 2009, ANTIOXID REDOX SIGN, V11, P309, DOI 10.1089/ars.2008.2138; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Orellana JA, 2012, REV NEUROSCIENCE, V23, P163, DOI 10.1515/revneuro-2011-0065; Orellana JA, 2012, ADV EXP MED BIOL, V740, P777, DOI 10.1007/978-94-007-2888-2_34; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Sanchez HA, 2009, AM J PHYSIOL-CELL PH, V297, pC665, DOI 10.1152/ajpcell.00200.2009; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Sun JJ, 2005, AM J PHYSIOL-CELL PH, V288, pC613, DOI 10.1152/ajpcell.00341.2004; Tao L, 2004, J BIOL CHEM, V279, P38544, DOI 10.1074/jbc.M405654200; Venance L, 1997, J NEUROSCI, V17, P1981; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	41	65	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40826	40834		10.1074/jbc.M112.383281	http://dx.doi.org/10.1074/jbc.M112.383281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048025	Green Published, hybrid			2022-12-25	WOS:000311448800070
J	Jirouskova, M; Zbodakova, O; Gregor, M; Chalupsky, K; Sarnova, L; Hajduch, M; Ehrmann, J; Jirkovska, M; Sedlacek, R				Jirouskova, Marketa; Zbodakova, Olga; Gregor, Martin; Chalupsky, Karel; Sarnova, Lenka; Hajduch, Marian; Ehrmann, Jiri; Jirkovska, Marie; Sedlacek, Radislav			Hepatoprotective Effect of MMP-19 Deficiency in a Mouse Model of Chronic Liver Fibrosis	PLOS ONE			English	Article							HUMAN MATRIX-METALLOPROTEINASE; HEPATIC STELLATE CELLS; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; TUMOR INVASION; TGF-BETA; RAT; SURFACE; INJURY; PROLIFERATION	Liver fibrosis is characterized by the deposition and increased turnover of extracellular matrix. This process is controlled by matrix metalloproteinases (MMPs), whose expression and activity dynamically change during injury progression. MMP-19, one of the most widely expressed MMPs, is highly expressed in liver; however, its contribution to liver pathology is unknown. The aim of this study was to elucidate the role of MMP-19 during the development and resolution of fibrosis by comparing the response of MMP-19-deficient (MMP19KO) and wild-type mice upon chronic liver CCl4-intoxication. We show that loss of MMP-19 was beneficial during liver injury, as plasma ALT and AST levels, deposition of fibrillar collagen, and phosphorylation of SMAD3, a TGF-beta 1 signaling molecule, were all significantly lower in MMP19KO mice. The ameliorated course of the disease in MMP19KO mice likely results from a slower rate of basement membrane destruction and ECM remodeling as the knockout mice maintained significantly higher levels of type IV collagen and lower expression and activation of MMP-2 after 4 weeks of CCl4-intoxication. Hastened liver regeneration in MMP19KO mice was associated with slightly higher IGF-1 mRNA expression, slightly increased phosphorylation of Akt kinase, decreased TGF-beta 1 mRNA levels and significantly reduced SMAD3 phosphorylation. In addition, primary hepatocytes isolated from MMP19KO mice showed impaired responsiveness towards TGF-beta 1 stimulation, resulting in lower expression of Snail1 and vimentin mRNA. Thus, MMP-19-deficiency improves the development of hepatic fibrosis through the diminished replacement of physiological extracellular matrix with fibrotic deposits in the beginning of the injury, leading to subsequent changes in TGF-beta and IGF-1 signaling pathways.	[Jirouskova, Marketa; Zbodakova, Olga; Gregor, Martin; Chalupsky, Karel; Sarnova, Lenka; Sedlacek, Radislav] ASCR, Inst Mol Genet, Prague, Czech Republic; [Hajduch, Marian; Ehrmann, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Hajduch, Marian; Ehrmann, Jiri] Univ Hosp Olomouc, Olomouc, Czech Republic; [Ehrmann, Jiri] Palacky Univ, Fac Med & Dent, Dept Clin & Mol Pathol, CR-77147 Olomouc, Czech Republic; [Jirkovska, Marie] Charles Univ Prague, Fac Med 1, Inst Histol & Embryol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; Charles University Prague	Sedlacek, R (corresponding author), ASCR, Inst Mol Genet, Prague, Czech Republic.	radislav.sedlacek@img.cas.cz	Gregor, Martin/G-4411-2014; Hajduch, Marian/J-4015-2014; Ehrmann, Jiri/C-9074-2009; Jirkovská, Marie/P-2219-2017; Chalupsky, Karel/K-7647-2014; Sedlacek, Radislav/G-4408-2014	Gregor, Martin/0000-0001-6841-9527; Hajduch, Marian/0000-0002-4834-908X; Ehrmann, Jiri/0000-0002-8419-3414; Jirkovská, Marie/0000-0003-3902-4758; 	GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic) [IAA500520812]; GACR (Grantova Agentura Ceske Pepubliky) [P303/10/2044]; Academy of Sciences of the Czech Republic [RVO 68378050]; Ministry of School and Education, Czech Republic [CZ.1.05/1.1.00/02.0109, CZ.1.05/2.1.00/01.0030]	GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic); GACR (Grantova Agentura Ceske Pepubliky); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of School and Education, Czech Republic	Financial support was given to RS by GAAV (The Grant Agency of the Academy of Sciences of the Czech Republic) (IAA500520812; http://www.gaav.cz), GACR (Grantova Agentura Ceske Pepubliky) (P303/10/2044; http://www.gacr.cz/), Academy of Sciences of the Czech Republic (RVO 68378050; http://www.cas.cz/), and by Ministry of School and Education, Czech Republic (Operational Program Research and Development for Innovations) to RS (CZ.1.05/1.1.00/02.0109) and MH (CZ.1.05/2.1.00/01.0030; http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Beck IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002343; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chan KC, 2011, INT J CANCER, V129, P1826, DOI 10.1002/ijc.25855; Cossins J, 1996, BIOCHEM BIOPH RES CO, V228, P494, DOI 10.1006/bbrc.1996.1688; Gentilini A, 1998, J CELL PHYSIOL, V174, P240; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Gueders MM, 2010, AM J RESP CELL MOL, V43, P286, DOI 10.1165/rcmb.2008-0426OC; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kahraman A, 2009, HEPATOL RES, V39, P805, DOI 10.1111/j.1872-034X.2009.00541.x; Kakinuma M, 2005, J CHROMATOGR B, V824, P161, DOI 10.1016/j.jchromb.2005.07.019; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Kolb C, 1997, IMMUNOL LETT, V57, P83, DOI 10.1016/S0165-2478(97)00057-6; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; MILANI S, 1994, AM J PATHOL, V144, P528; Moldeus P, 1978, Methods Enzymol, V52, P60; Mueller MS, 2000, GENE, V256, P101, DOI 10.1016/S0378-1119(00)00369-3; Onozuka I, 2011, BIOCHEM BIOPH RES CO, V406, P134, DOI 10.1016/j.bbrc.2011.02.012; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; Radbill BD, 2002, DIGEST DIS SCI, V56, P406; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505; Sedlacek R, 1998, IMMUNOBIOLOGY, V198, P408, DOI 10.1016/S0171-2985(98)80049-1; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stracke JO, 2000, FEBS LETT, V478, P52, DOI 10.1016/S0014-5793(00)01819-6; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; TAKAHARA T, 1995, HEPATOLOGY, V21, P787; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Ueno H, 2000, HUM GENE THER, V11, P33, DOI 10.1089/10430340050016139; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yu G, 2012, AM J RESP CRIT CARE; Yu Q, 2000, GENE DEV, V14, P163; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang M, 2009, OSTEOARTHR CARTILAGE, V17, P100, DOI 10.1016/j.joca.2008.05.007; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447	52	24	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e46271	10.1371/journal.pone.0046271	http://dx.doi.org/10.1371/journal.pone.0046271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056273	gold, Green Submitted, Green Published			2022-12-25	WOS:000309889400011
J	Alves, CS; Konstantopoulos, K				Alves, Christina S.; Konstantopoulos, Konstantinos			PDGF Suppresses the Sulfation of CD44v and Potentiates CD44v-Mediated Binding of Colon Carcinoma Cells to Fibrin under Flow	PLOS ONE			English	Article							TUMOR-CELLS; VARIANT ISOFORMS; SELECTIN LIGANDS; VASCULAR INTERACTIONS; CANCER METASTASIS; PLATELETS; ADHESION; ANGIOGENESIS; INVOLVEMENT; MOLECULE	Fibrin(ogen) mediates sustained tumor cell adhesion and survival in the pulmonary vasculature, thereby facilitating the metastatic dissemination of tumor cells. CD44 is the major functional fibrin receptor on colon carcinoma cells. Growth factors, such as platelet-derived growth factor (PDGF), induce post-translational protein modifications, which modulate ligand binding activity. In view of the roles of PDGF, fibrin(ogen) and CD44 in cancer metastasis, we aimed to delineate the effect of PDGF on CD44-fibrin recognition. By immunoprecipitating CD44 from PDGF-treated and untreated LS174T colon carcinoma cells, which express primarily CD44v, we demonstrate that PDGF enhances the adhesion of CD44v-coated beads to immobilized fibrin. Enzymatic inhibition studies coupled with flow-based adhesion assays and autoradiography reveal that PDGF augments the binding of CD44v to fibrin by significantly attenuating the extent of CD44 sulfation primarily on chondroitin and dermatan sulfate chains. Surface plasmon resonance assays confirm that PDGF enhances the affinity of CD44v-fibrin binding by markedly reducing its dissociation rate while modestly increasing the association rate. PDGF mildly reduces the affinity of CD44v-hyaluronan binding without affecting selectin-CD44v recognition. The latter is attributed to the fact that CD44v binds to selectins via sialofucosylated O-linked residues independent of heparan, dermatan and chondroitin sulfates. Interestingly, PDGF moderately reduces the sulfation of CD44s and CD44s-fibrin recognition. Collectively, these data offer a novel perspective into the mechanism by which PGDF regulates CD44-dependent binding of metastatic colon carcinoma cells to fibrin(ogen).	[Alves, Christina S.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Oncol, Baltimore, MD 21205 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	konstant@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		United States National Institutues of Health/National Cancer Institute [R01 CA101135, U54 CA143868]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA101135, U54CA143868] Funding Source: NIH RePORTER	United States National Institutues of Health/National Cancer Institute; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the United States National Institutues of Health/National Cancer Institute R01 CA101135 and U54 CA143868 (K.K.), and a predoctoral fellowship from the American Heart Association (C.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2008, AM J PHYSIOL-CELL PH, V294, pC907, DOI 10.1152/ajpcell.00463.2007; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Greenfield B, 1999, J BIOL CHEM, V274, P2511, DOI 10.1074/jbc.274.4.2511; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nieswandt B, 1999, CANCER RES, V59, P1295; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raman PS, 2011, J CELL SCI, V124, P1903, DOI 10.1242/jcs.079814; Takahashi K, 1996, J BIOL CHEM, V271, P9490, DOI 10.1074/jbc.271.16.9490; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	26	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e41472	10.1371/journal.pone.0041472	http://dx.doi.org/10.1371/journal.pone.0041472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056168	gold, Green Submitted, Green Published			2022-12-25	WOS:000309831500004
J	Robciuc, MR; Skrobuk, P; Anisimov, A; Olkkonen, VM; Alitalo, K; Eckel, RH; Koistinen, HA; Jauhiainen, M; Ehnholm, C				Robciuc, Marius R.; Skrobuk, Paulina; Anisimov, Andrey; Olkkonen, Vesa M.; Alitalo, Kari; Eckel, Robert H.; Koistinen, Heikki A.; Jauhiainen, Matti; Ehnholm, Christian			Angiopoietin-Like 4 Mediates PPAR Delta Effect on Lipoprotein Lipase-Dependent Fatty Acid Uptake but Not on Beta-Oxidation in Myotubes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; TISSUE-SPECIFIC REGULATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; GLUCOSE; METABOLISM; EXPRESSION; PROTEIN-4; MICE; HYPERLIPIDEMIA	Peroxisome proliferator-activated receptor (PPAR) delta is an important regulator of fatty acid (FA) metabolism. Angiopoietin-like 4 (Angptl4), a multifunctional protein, is one of the major targets of PPAR delta in skeletal muscle cells. Here we investigated the regulation of Angptl4 and its role in mediating PPAR delta functions using human, rat and mouse myotubes. Expression of Angptl4 was upregulated during myotubes differentiation and by oleic acid, insulin and PPAR delta agonist GW501516. Treatment with GW501516 or Angptl4 overexpression inhibited both lipoprotein lipase (LPL) activity and LPL-dependent uptake of FAs whereas uptake of BSA-bound FAs was not affected by either treatment. Activation of retinoic X receptor (RXR), PPAR delta functional partner, using bexarotene upregulated Angptl4 expression and inhibited LPL activity in a PPAR delta dependent fashion. Silencing of Angptl4 blocked the effect of GW501516 and bexarotene on LPL activity. Treatment with GW501516 but not Angptl4 overexpression significantly increased palmitate oxidation. Furthermore, Angptl4 overexpression did not affect the capacity of GW501516 to increase palmitate oxidation. Basal and insulin stimulated glucose uptake, glycogen synthesis and glucose oxidation were not significantly modulated by Angptl4 overexpression. Our findings suggest that FAs-PPARdelta/RXR-Angptl4 axis controls the LPL-dependent uptake of FAs in myotubes, whereas the effect of PPAR delta activation on beta-oxidation is independent of Angptl4.	[Robciuc, Marius R.; Jauhiainen, Matti; Ehnholm, Christian] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Skrobuk, Paulina; Olkkonen, Vesa M.; Koistinen, Heikki A.] Minerva Fdn, Unit Metab, Helsinki, Finland; [Skrobuk, Paulina; Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Div Cardiol, Dept Med, Helsinki, Finland; [Skrobuk, Paulina; Koistinen, Heikki A.] Univ Helsinki, Fac Med, Inst Clin Med, Helsinki, Finland; [Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Mol Canc Biol Lab, Inst Mol Med Finland, Res Programs Unit, Helsinki, Finland; [Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Eckel, Robert H.] Univ Colorado, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Colorado System; University of Colorado Anschutz Medical Campus	Robciuc, MR (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	marius.robciuc@helsinki.fi	Alitalo, Kari K/J-5013-2014; Koistinen, Heikki/J-7313-2016	Alitalo, Kari K/0000-0002-7331-0902; Koistinen, Heikki/0000-0001-7870-070X; Olkkonen, Vesa/0000-0001-5553-7997	National Institute for Health and Welfare; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Sigrid Juselius Foundation; Novo Nordisk Fonden; Finnish Academy of Science [127093]; Finska Lakaresallskapet; Paulo Foundation; Oskar Oflunds Stiftelse; United States National Institutes of Health [DK26356]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026356] Funding Source: NIH RePORTER	National Institute for Health and Welfare; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Finnish Academy of Science(Academy of Finland); Finska Lakaresallskapet; Paulo Foundation; Oskar Oflunds Stiftelse; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute for Health and Welfare (M.J.), Finnish Foundation for Cardiovascular Research and Magnus Ehrnrooth Foundation (M. R. R., M.J., C. E.), Sigrid Juselius Foundation, Novo Nordisk Fonden and Finnish Academy of Science grant no 127093 (H. A. K), Finska Lakaresallskapet (C. E., M. R. R., P. S.), Paulo Foundation, Oskar Oflunds Stiftelse (M. R. R.) and United States National Institutes of Health Grant DK26356 (RHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Assaf C, 2006, BRIT J DERMATOL, V155, P261, DOI 10.1111/j.1365-2133.2006.07329.x; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; FARESE RV, 1991, METABOLISM, V40, P214, DOI 10.1016/0026-0495(91)90178-Y; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Gray NE, 2012, J BIOL CHEM; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Herschey MDVE, 2010, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2010.92, DOI 10.1038/NPROT.2010.92]; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Klopper JP, 2008, CLIN CANCER RES, V14, P589, DOI 10.1158/1078-0432.CCR-07-0269; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Poirier P, 2000, BIOCHEM BIOPH RES CO, V270, P997, DOI 10.1006/bbrc.2000.2528; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Rune A, 2009, ACTA PHYSIOL, V197, P207, DOI 10.1111/j.1748-1716.2009.02010.x; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Somwar R, 1998, CLIN THER, V20, P125, DOI 10.1016/S0149-2918(98)80040-4; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yamada T, 2006, BIOCHEM BIOPH RES CO, V347, P1138, DOI 10.1016/j.bbrc.2006.07.032; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Young SG, 2011, J LIPID RES	42	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46212	10.1371/journal.pone.0046212	http://dx.doi.org/10.1371/journal.pone.0046212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056264	Green Published, gold, Green Submitted			2022-12-25	WOS:000309580800015
J	Schutz, C; Sort, J; Bacsik, Z; Oliynyk, V; Pellicer, E; Fall, A; Wagberg, L; Berglund, L; Bergstrom, L; Salazar-Alvarez, G				Schutz, Christina; Sort, Jordi; Bacsik, Zoltan; Oliynyk, Vitaliy; Pellicer, Eva; Fall, Andreas; Wagberg, Lars; Berglund, Lars; Bergstrom, Lennart; Salazar-Alvarez, German			Hard and Transparent Films Formed by Nanocellulose-TiO2 Nanoparticle Hybrids	PLOS ONE			English	Article							REFRACTIVE-INDEX; INORGANIC NANOCOMPOSITES; MECHANICAL-PROPERTIES; CELLULOSE; TITANIA; COMPOSITES; OXIDATION; NANOPAPER; POLYMERS; AEROGELS	The formation of hybrids of nanofibrillated cellulose and titania nanoparticles in aqueous media has been studied. Their transparency and mechanical behavior have been assessed by spectrophotometry and nanoindentation. The results show that limiting the titania nanoparticle concentration below 16 vol% yields homogeneous hybrids with a very high Young's modulus and hardness, of up to 44 GPa and 3.4 GPa, respectively, and an optical transmittance above 80%. Electron microscopy shows that higher nanoparticle contents result in agglomeration and an inhomogeneous hybrid nanostructure with a concomitant reduction of hardness and optical transmittance. Infrared spectroscopy suggests that the nanostructure of the hybrids is controlled by electrostatic adsorption of the titania nanoparticles on the negatively charged nanocellulose surfaces.	[Schutz, Christina; Bacsik, Zoltan; Oliynyk, Vitaliy; Bergstrom, Lennart; Salazar-Alvarez, German] Stockholm Univ, S-10691 Stockholm, Sweden; [Schutz, Christina; Wagberg, Lars; Berglund, Lars; Salazar-Alvarez, German] KTH, Wallenberg Wood Sci Ctr, Stockholm, Sweden; [Sort, Jordi] Univ Autonoma Barcelona, ICREA, Bellaterra, Spain; [Sort, Jordi; Pellicer, Eva] Univ Autonoma Barcelona, Dept Fs, Bellaterra, Spain; [Fall, Andreas; Wagberg, Lars; Berglund, Lars] KTH, Royal Inst Technol, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona; Royal Institute of Technology	Salazar-Alvarez, G (corresponding author), Stockholm Univ, S-10691 Stockholm, Sweden.	german@mmk.su.se	Bergström, Lennart/ABH-1143-2021; Salazar-Alvarez, German/A-4802-2009; Bergström, Lennart/F-2938-2011; Berglund, Lars A/A-6971-2010; Schütz, Christina/AAA-8846-2019; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Oliynyk, Viktor V./C-8555-2014; Sort, Jordi/GPP-6695-2022; Pellicer, Eva/G-2917-2014; Schütz, Christina/N-9628-2015; Sort, Jordi/F-6582-2014	Bergström, Lennart/0000-0002-5702-0681; Salazar-Alvarez, German/0000-0002-0671-435X; Bergström, Lennart/0000-0002-5702-0681; Berglund, Lars A/0000-0001-5818-2378; Schütz, Christina/0000-0003-0238-1639; Oliynyk, Viktor V./0000-0002-2959-6253; Pellicer, Eva/0000-0002-8901-0998; Schütz, Christina/0000-0003-0238-1639; Sort, Jordi/0000-0003-1213-3639	Wallenberg Wood Science Center (WWSC); Spanish MICINN [MAT2011-27380-C02-01]; ICREA Funding Source: Custom	Wallenberg Wood Science Center (WWSC); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	This work was supported by Wallenberg Wood Science Center (WWSC) and Spanish MICINN grant MAT2011-27380-C02-01. The Knut and Alice Wallenberg Foundation is acknowledged for the electron microscopy facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Alonso B, 2010, ANGEW CHEM INT EDIT, V49, P8201, DOI 10.1002/anie.201002104; Banerjee S, 2002, NANO LETT, V2, P195, DOI 10.1021/nl015651n; Bartl MH, 2005, ACCOUNTS CHEM RES, V38, P263, DOI 10.1021/ar040177o; Beecher JF, 2007, NAT NANOTECHNOL, V2, P466, DOI 10.1038/nnano.2007.239; Caruso RA, 2001, CHEM MATER, V13, P400, DOI 10.1021/cm001175a; CERAM Research Ltd, TIT DIOX; Cervin NT, 2011, ABSTR PAP AM CHEM S, P241; Chen B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125406; Chen WC, 1999, J MAT CHEM, V9; Coakley KM, 2003, APPL PHYS LETT, V83, P3380, DOI 10.1063/1.1616197; Davis SA, 2001, CHEM MATER, V13, P3218, DOI 10.1021/cm011068w; Diez I, 2011, MACROMOL BIOSCI, V11, P1185, DOI 10.1002/mabi.201100099; Drew C, 2003, NANO LETT, V3, P143, DOI 10.1021/nl025850m; Feng W, 2000, B CHEM SOC JPN, V73, P2627, DOI 10.1246/bcsj.73.2627; Fischer-Cripps A.C., 2004, NANOINDENTATION; Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103; Gaillard Y, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145305; Gebauer D, 2011, NANOSCALE, V3, P3563, DOI 10.1039/c1nr10681c; Gonzalez RJ, 1997, PHYS REV B, V55, P7014, DOI 10.1103/PhysRevB.55.7014; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Johnson RK, 2010, THESIS VIRGINIA TECH; Kedem S, 2005, LANGMUIR, V21, P5600, DOI 10.1021/la0502443; Kettunen M, 2011, ADV FUNCT MATER, V21, P510, DOI 10.1002/adfm.201001431; Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b; KRUG H, 1994, NEW J CHEM, V18, P1125; Kwak SY, 2001, ENVIRON SCI TECHNOL, V35, P2388, DOI 10.1021/es0017099; Lahiji RR, 2010, LANGMUIR, V26, P4480, DOI 10.1021/la903111j; Larena A, 2002, APPL SURF SCI, V187, P339, DOI 10.1016/S0169-4332(01)01044-3; Lee LH, 2001, CHEM MATER, V13, P1137, DOI 10.1021/cm000937z; Li GQ, 1999, CEMENT CONCRETE RES, V29, P1455, DOI 10.1016/S0008-8846(99)00119-2; Li J, 2006, POLYMER, V47, P7361, DOI 10.1016/j.polymer.2006.08.059; Li XW, 2003, APPL SURF SCI, V217, P16, DOI 10.1016/S0169-4332(03)00565-8; Liu AD, 2011, BIOMACROMOLECULES, V12, P633, DOI 10.1021/bm101296z; Mammeri F, 2005, J MATER CHEM, V15, P3787, DOI 10.1039/b507309j; Ng CB, 2001, ADV COMPOS LETT, V10, P101; Nogi M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146056; Nussbaumer RJ, 2003, MACROMOL MATER ENG, V288, P44, DOI 10.1002/mame.200290032; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]; Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002; Roy BK, 2011, J AM CERAM SOC; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Schmidt H, 2000, J SOL-GEL SCI TECHN, V19, P39, DOI 10.1023/A:1008706003996; Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907; Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c; Socrates G., 2004, INFRARED RAMAN CHARA; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sun ZC, 2006, CHEMPHYSCHEM, V7, P370, DOI 10.1002/cphc.200500340; Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230; WANG A, 1994, SOL ENERGY, V52, P459, DOI 10.1016/0038-092X(94)90653-X; Wojcieszak Damian, 2010, Proceedings of the 2010 International Students and Young Scientists Workshop "Photonics And Microsystems", P86, DOI 10.1109/STYSW.2010.5714178; Yoshida M, 1997, J MATER SCI, V32, P4047, DOI 10.1023/A:1018645722633; Zhang M, 2004, LANGMUIR, V20, P1420, DOI 10.1021/la030183d; ZHANG MH, 1991, ACI MATER J, V88, P240; Zimmermann T, 2005, ADV ENG MATER, V7, P1156, DOI 10.1002/adem.200500157; Zywitzki O, 2004, SURF COAT TECH, V180, P538, DOI 10.1016/j.surfcoat.2003.10.115	64	63	67	1	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45828	10.1371/journal.pone.0045828	http://dx.doi.org/10.1371/journal.pone.0045828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049689	Green Published, gold			2022-12-25	WOS:000309388500016
J	Sisodia, S; Singh, BN				Sisodia, Seema; Singh, Bashisth N.			Experimental Evidence for Nutrition Regulated Stress Resistance in Drosophila ananassae	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; STARVATION RESISTANCE; PHENOTYPIC PLASTICITY; TRADE-OFFS; RESOURCE-ALLOCATION; CERATITIS-CAPITATA; GENE-EXPRESSION; METABOLIC-RATE; DIET QUALITY; AMINO-ACIDS	Background: The amount and quality of nutrients consumed by organisms have a strong impact on stress resistance, life-history traits and reproduction. The balance between energy acquisition and expenditure is crucial to the survival and reproductive success of animals. The ability of organisms to adjust their development, physiology or behavior in response to environmental conditions, called phenotypic plasticity, is a defining property of life. One of the most familiar and important examples of phenotypic plasticity is the response of stress tolerance and reproduction to changes in developmental nutrition. Larval nutrition may affect a range of different life-history traits as well as responses to environmental stress in adult. Principal Findings: Here we investigate the effect of larval nutrition on desiccation, starvation, chill-coma recovery, heat resistance as well as egg to adult viability, egg production and ovariole number in Drosophila ananassae. We raised larvae on either protein rich diet or carbohydrate rich diet. We found that flies consuming protein rich diet have higher desiccation and heat shock resistance whereas flies developed on carbohydrate rich diet have higher starvation and cold resistance. Egg production was higher in females developed on protein rich diet and we also found trade-off between egg production and Egg to adult viability of the flies. Viability was higher in carbohydrate rich diet. However, sex specific viability was found in different nutritional regimes. Higher Egg production might be due to higher ovariole number in females of protein rich diet. Conclusion: Thus, Drosophila ananassae adapts different stress tolerance and life-history strategies according to the quality of the available diet, which are correlated with phenotypic adjustment at anatomical and physiological levels.	[Sisodia, Seema; Singh, Bashisth N.] Banaras Hindu Univ, Dept Zool, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, BN (corresponding author), Banaras Hindu Univ, Dept Zool, Varanasi 221005, Uttar Pradesh, India.	bnsingh@bhu.ac.in			Department of Science and Technology, New Delhi [SR/WOS-A/LS-190/2010]	Department of Science and Technology, New Delhi(Department of Science & Technology (India))	Department of Science and Technology, New Delhi: Grant Number SR/WOS-A/LS-190/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TS, 1991, INVERTEBR REPROD DEV, V20, P49, DOI 10.1080/07924259.1991.9672177; Allard CM, 2005, ENVIRON ENTOMOL, V34, P6, DOI 10.1603/0046-225X-34.1.6; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Ashby PD, 1998, AM ZOOL, V38, P561; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; Bauerfeind SS, 2005, J INSECT PHYSIOL, V51, P545, DOI 10.1016/j.jinsphys.2005.02.002; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; Chang CL, 2004, ANN ENTOMOL SOC AM, V97, P529, DOI 10.1603/0013-8746(2004)097[0529:EOAAOL]2.0.CO;2; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CLARKE A, 1987, MAR ECOL PROG SER, V38, P89, DOI 10.3354/meps038089; Cruz-Neto AP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P877, DOI 10.1086/425187; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Harshman LG, 1998, EVOLUTION, V52, P1679, DOI [10.2307/2411340, 10.1111/j.1558-5646.1998.tb02247.x]; Helland S, 2003, MAR BIOL, V142, P1141, DOI 10.1007/s00227-003-1045-4; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kennington WJ, 2001, HEREDITY, V87, P363, DOI 10.1046/j.1365-2540.2001.00925.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Kristensen TN, 2011, BIOL LETTERS, V7, P269, DOI 10.1098/rsbl.2010.0872; Kyneb A, 2004, J APPL ENTOMOL, V128, P658, DOI 10.1111/j.1439-0418.2004.00905.x; Lalouette L, 2007, FEBS J, V274, P1759, DOI 10.1111/j.1742-4658.2007.05723.x; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; LEROI AM, 1994, AM NAT, V144, P661, DOI 10.1086/285699; Lobe SL, 2006, J ANAT, V208, P795, DOI 10.1111/j.1469-7580.2006.00565.x; Markow TA, 1999, FUNCT ECOL, V13, P78, DOI 10.1046/j.1365-2435.1999.00285.x; Markow TA, 2001, P ROY SOC B-BIOL SCI, V268, P1527, DOI 10.1098/rspb.2001.1673; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Matzkin LM, 2007, FLY, V1, P268, DOI 10.4161/fly.5293; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Naya DE, 2007, J INSECT PHYSIOL, V53, P132, DOI 10.1016/j.jinsphys.2006.11.004; Nestel D, 2008, ENTOMOL EXP APPL, V126, P53, DOI 10.1111/j.1570-7458.2007.00639.x; Parkash R, 2008, FLY, V2, P111, DOI 10.4161/fly.6351; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Pompermayer P, 2001, ENTOMOL EXP APPL, V99, P79, DOI 10.1023/A:1018979013928; POUGH FH, 1989, PHYSIOL ZOOL, V62, P199, DOI 10.1086/physzool.62.2.30156169; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Reichling TD, 2000, J NUTR, V130, P2326, DOI 10.1093/jn/130.9.2326; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Roff DA, 2003, J EVOLUTION BIOL, V16, P55, DOI 10.1046/j.1420-9101.2003.00480.x; Ryne C, 2004, J INSECT PHYSIOL, V50, P429, DOI 10.1016/j.jinsphys.2004.02.010; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; SIBLY RM, 1991, FUNCT ECOL, V5, P184, DOI 10.2307/2389256; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Singh BN, 2010, INDIAN J EXP BIOL, V48, P333; Singh BN, 2000, CURR SCI INDIA, V78, P391; Singh P, 2008, GENET RES, V90, P409, DOI 10.1017/S0016672308009737; Sisodia S, 2010, J EVOLUTION BIOL, V23, P1979, DOI 10.1111/j.1420-9101.2010.02061.x; Sisodia S, 2010, J THERM BIOL, V35, P117, DOI 10.1016/j.jtherbio.2010.01.001; Smith DC, 1998, HYDROBIOLOGIA, V378, P187, DOI 10.1023/A:1003210210032; Smith EM, 2007, J NUTR, V137, P2006, DOI 10.1093/jn/137.9.2006; Sorensen JG, 2007, EXP GERONTOL, V42, P1123, DOI 10.1016/j.exger.2007.09.001; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Taylor EN, 2005, OECOLOGIA, V144, P206, DOI 10.1007/s00442-005-0056-x; WANG L, 1995, BIOCHEM GENET, V33, P149, DOI 10.1007/BF00554727; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Wenzel U, 2006, GENES NUTR, V1, P85, DOI 10.1007/BF02829950; White T. C. R., 1993, INADEQUATE ENV NITRO; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Zera AJ, 1998, AM NAT, V152, P7, DOI 10.1086/286146	76	51	55	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46131	10.1371/journal.pone.0046131	http://dx.doi.org/10.1371/journal.pone.0046131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049693	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500020
J	Tullin, S; Sams, A; Brandt, J; Dahl, K; Gong, W; Jeppesen, CB; Krogh, TN; Olsen, GS; Liu, Y; Pedersen, AA; Petersen, JM; Rolin, B; Wahlund, PO; Kalthoff, C				Tullin, Soren; Sams, Anette; Brandt, Jakob; Dahl, Kirsten; Gong, Wei; Jeppesen, Claus Bekker; Krogh, Thomas Nylandsted; Olsen, Grith Skytte; Liu, Yun; Pedersen, Anette Amstrup; Petersen, Jorn Meidahl; Rolin, Bidda; Wahlund, Per-Olof; Kalthoff, Christoph			Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-SPECIFIC PROTEIN; FATTY-ACID OXIDATION; GLOBULAR DOMAIN; DEFICIENT MICE; OBESITY; EXPRESSION; ATHEROSCLEROSIS; ADIPOCYTES; DISEASE	Aims/Hypothesis: Several studies have shown that adiponectin can lower blood glucose in diabetic mice. The aim of this study was to establish an effective adiponectin production process and to evaluate the anti-diabetic potential of the different adiponectin forms in diabetic mice and sand rats. Methods: Human high molecular weight, mouse low molecular weight and mouse plus human globular adiponectin forms were expressed and purified from mammalian cells or yeast. The purified protein was administered at 10-30 mg/kg i.p. b.i.d. to diabetic db/db mice for 2 weeks. Furthermore, high molecular weight human and globular mouse adiponectin batches were administered at 5-15 mg/kg i.p. b.i.d. to diabetic sand rats for 12 days. Results: Surprisingly, none of our batches had any effect on blood glucose, HbA1c, plasma lipids or body weight in diabetic db/db mice or sand rats. In vitro biological, biochemical and biophysical data suggest that the protein was correctly folded and biologically active. Conclusions/Interpretation: Recombinant adiponectin is ineffective at lowering blood glucose in diabetic db/db mice or sand rats.	[Tullin, Soren; Sams, Anette; Brandt, Jakob; Dahl, Kirsten; Jeppesen, Claus Bekker; Krogh, Thomas Nylandsted; Olsen, Grith Skytte; Pedersen, Anette Amstrup; Petersen, Jorn Meidahl; Rolin, Bidda; Wahlund, Per-Olof; Kalthoff, Christoph] Novo Nordisk AS, Malov, Denmark; [Gong, Wei; Liu, Yun] Novo Nordisk RD Ctr China, Beijing, Peoples R China	Novo Nordisk; Novo Nordisk	Tullin, S (corresponding author), Novo Nordisk AS, Novo Nordisk Pk, Malov, Denmark.	stu@novonordisk.com	Sams, Anette/R-1764-2016	Sams, Anette/0000-0002-9203-4333; Jeppesen, Claus Bekker/0000-0003-2878-4348; /0000-0001-5063-1554				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Egel-Mitani M, 2000, ENZYME MICROB TECH, V26, P671, DOI 10.1016/S0141-0229(00)00158-7; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Harizi H, 2007, J NEUROIMMUNOL, V189, P59, DOI 10.1016/j.jneuroim.2007.06.019; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kamio N, 2009, FEMS IMMUNOL MED MIC, V56, P241, DOI 10.1111/j.1574-695X.2009.00573.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Liu DG, 2007, BIOCHEM BIOPH RES CO, V363, P769, DOI 10.1016/j.bbrc.2007.09.025; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Sulpice T, 2009, ENDOCRINOLOGY, V150, P4493, DOI 10.1210/en.2008-1768; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44270	10.1371/journal.pone.0044270	http://dx.doi.org/10.1371/journal.pone.0044270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049674	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388500001
J	Galanzha, EI; Shashkov, E; Sarimollaoglu, M; Beenken, KE; Basnakian, AG; Shirtliff, ME; Kim, JW; Smeltzer, MS; Zharov, VP				Galanzha, Ekaterina I.; Shashkov, Evgeny; Sarimollaoglu, Mustafa; Beenken, Karen E.; Basnakian, Alexei G.; Shirtliff, Mark E.; Kim, Jin-Woo; Smeltzer, Mark S.; Zharov, Vladimir P.			In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PHOTODYNAMIC THERAPY; STREAM INFECTION; OXIDATIVE STRESS; CELLS; NANODIAGNOSTICS; NANOTECHNOLOGY; BACTEREMIA; CHALLENGES	Bacterial infections are a primary cause of morbidity and mortality worldwide. Bacteremia is a particular concern owing to the possibility of septic shock and the development of metastatic infections. Treatment of bacteremia is increasingly compromised by the emergence of antibiotic resistant strains, creating an urgent need for alternative therapy. Here, we introduce a method for in vivo photoacoustic (PA) detection and photothermal (PT) eradication of Staphylococcus aureus in tissue and blood. We show that this method could be applicable for label-free diagnosis and treatment of in the bloodstream using intrinsic near-infrared absorption of endogenous carotenoids with nonlinear PA and PT contrast enhancement. To improve sensitivity and specificity for detection of circulating bacteria cells (CBCs), two-color gold and multilayer magnetic nanoparticles with giant amplifications of PA and PT contrasts were functionalized with an antibody cocktail for molecular targeting of S. aureus surface-associated markers such as protein A and lipoprotein. With a murine model, the utility of this approach was demonstrated for ultrasensitive detection of CBCs with threshold sensitivity as low as 0.5 CBCs/mL, in vivo magnetic enrichment of CBCs, PT eradication of CBCs, and real-time monitoring of therapeutic efficacy by CBC counting. Our PA-PT nano-theranostic platform, which integrates in vivo multiplex targeting, magnetic enrichment, signal amplification, multicolor recognition, and feedback control, could be used as a biological tool to gain insights on dissemination pathways of CBCs, infection progression by bacteria re-seeding, and sepsis development and treatment, and could potentially be feasible in humans, especially using bypass schematic.	[Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Galanzha, Ekaterina I.; Shashkov, Evgeny; Sarimollaoglu, Mustafa; Zharov, Vladimir P.] Univ Arkansas Med Sci, Phillips Class Laser & Nanomed Labs, Little Rock, AR 72205 USA; [Galanzha, Ekaterina I.; Zharov, Vladimir P.] Univ Arkansas Med Sci, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA; [Basnakian, Alexei G.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Shirtliff, Mark E.] Univ Maryland Baltimore, Sch Dent, Dept Mol Pathogenesis, Baltimore, MD USA; [Kim, Jin-Woo] Univ Arkansas, Inst Nanosci & Engn, Bio Nano Technol Lab, Fayetteville, AR 72701 USA; [Kim, Jin-Woo] Univ Arkansas, Dept Biol & Agr Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University System of Maryland; University of Maryland Baltimore; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Smeltzer, MS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shirtliff, Mark E/H-2563-2017; Zharov, Vladimir/J-9728-2013; Shashkov, Evgeny V/H-7858-2018; Kim, Jin-Woo/H-5148-2011; Smeltzer, Mark/M-2009-2018	Shirtliff, Mark E/0000-0002-8913-3445; Shashkov, Evgeny V/0000-0003-0920-6366; Kim, Jin-Woo/0000-0002-7119-8208; Smeltzer, Mark/0000-0002-0878-0692; Zharov, Vladimir/0000-0003-4773-0548; Sarimollaoglu, Mustafa/0000-0003-0246-9702	National Institutes of Health [R01CA131164, R01 EB009230, R56-AI093126, R21CA139373]; National Science Foundation [DBI-0852737]; Department of Defense [W88XWH-10-2-0130, W81XWH-10-BCRP-CA, W81XWH-11-1-0129]; Arkansas Biosciences Institute; NATIONAL CANCER INSTITUTE [R01CA131164, R21CA139373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093126, R01AI069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009230] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0852737] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Arkansas Biosciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the National Institutes of Health grants: R01CA131164, R01 EB009230, R56-AI093126, and R21CA139373, the National Science Foundation, grant number DBI-0852737, and Department of Defense grants: W88XWH-10-2-0130, W81XWH-10-BCRP-CA, and W81XWH-11-1-0129, and Arkansas Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2561; Allaker RP, 2008, T ROY SOC TROP MED H, V102, P1, DOI 10.1016/j.trstmh.2007.07.003; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Blevins JS, 2003, INFECT IMMUN, V71, P516, DOI 10.1128/IAI.71.1.516-523.2003; Boucher HW, 2010, CLIN INFECT DIS, V50, pS4, DOI 10.1086/647937; Brady RA, 2007, APPL ENVIRON MICROB, V73, P6612, DOI 10.1128/AEM.00855-07; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; CALHOUN JH, 1991, ORTHOP CLIN N AM, V22, P467; Chen YS, 2011, NANO LETT, V11, P348, DOI 10.1021/nl1042006; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; Embleton ML, 2004, MICROB DRUG RESIST, V10, P92, DOI 10.1089/1076629041310000; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Galanzha EI, 2012, METHODS IN PRESS; Galanzha EI, 2009, J BIOPHOTONICS, V2, P725, DOI 10.1002/jbio.200910078; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Galanzha EI, 2009, CANCER RES, V69, P7926, DOI 10.1158/0008-5472.CAN-08-4900; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Grinhoic M, 2008, J PHOTOCH PHOTOBIO B, V90, P57, DOI 10.1016/j.jphotobiol.2007.11.002; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Huang XH, 2011, ALEX J MED, V47, P1, DOI 10.1016/j.ajme.2011.01.001; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Kennedy LC, 2011, SMALL, V7, P169, DOI 10.1002/smll.201000134; Kim JW, 2007, LASER SURG MED, V39, P622, DOI 10.1002/lsm.20534; Kim JW, 2010, CHEM COMMUN, V46, P7142, DOI 10.1039/c0cc00218f; Kim JW, 2009, NAT NANOTECHNOL, V4, P688, DOI 10.1038/nnano.2009.231; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; Lapotko D, 1999, CYTOMETRY, V37, P320, DOI 10.1002/(SICI)1097-0320(19991201)37:4<320::AID-CYTO10>3.0.CO;2-U; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Ma XP, 2009, MED HYPOTHESES, V73, P18, DOI 10.1016/j.mehy.2009.01.033; Manthe RL, 2010, MOL PHARMACEUT, V7, P1880, DOI 10.1021/mp1001944; Menyaev YA, 2006, P SOC PHOTO-OPT INS, V6087, P30; Napirei M, 2006, HEPATOLOGY, V43, P297, DOI 10.1002/hep.21034; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/NCHEM.1012, 10.1038/nchem.1012]; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pissuwan D, 2010, TRENDS BIOTECHNOL, V28, P207, DOI 10.1016/j.tibtech.2009.12.004; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Sarkar A, 2011, TOXICOLOGY, V290, P208, DOI 10.1016/j.tox.2011.09.086; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; TSCHEPE J, 1994, P SOC PHOTO-OPT INS, V2084, P133, DOI 10.1117/12.167326; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; WILSON M, 1993, J APPL BACTERIOL, V75, P299, DOI 10.1111/j.1365-2672.1993.tb02780.x; Wyllie DH, 2005, BMJ-BRIT MED J, V331, P992, DOI 10.1136/bmj.38558.453310.8F; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zharov Vladimir P., 1999, Proceedings of the SPIE - The International Society for Optical Engineering, V3829, P141, DOI 10.1117/12.353119; Zharov VP, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793746; Zharov VP, 2011, NAT PHOTONICS, V5, P110, DOI [10.1038/nphoton.2010.280, 10.1038/NPHOTON.2010.280]; Zharov VP, 2006, BIOPHYS J, V90, P619, DOI 10.1529/biophysj.105.061895; Zharov VP, 2003, APPL PHYS LETT, V83, P4897, DOI 10.1063/1.1632546; Zharov VP, 2001, CRIT REV BIOMED ENG, V29, P111; ZHAROV VP, 1993, P SOC PHOTO-OPT INS, V1892, P38, DOI 10.1117/12.147504; ZHAROV VP, 2000, P SOC PHOTO-OPT INS, V1, P331	59	65	74	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45557	10.1371/journal.pone.0045557	http://dx.doi.org/10.1371/journal.pone.0045557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049814	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300032
J	Poppinga, S; Hartmeyer, SRH; Seidel, R; Masselter, T; Hartmeyer, I; Speck, T				Poppinga, Simon; Hartmeyer, Siegfried Richard Heinrich; Seidel, Robin; Masselter, Tom; Hartmeyer, Irmgard; Speck, Thomas			Catapulting Tentacles in a Sticky Carnivorous Plant	PLOS ONE			English	Article							DROSERA TENTACLES; ACTION POTENTIALS; VENUS FLYTRAP; TRAP	Among trapping mechanisms in carnivorous plants, those termed 'active' have especially fascinated scientists since Charles Darwin's early works because trap movements are involved. Fast snap-trapping and suction of prey are two of the most spectacular examples for how these plants actively catch animals, mainly arthropods, for a substantial nutrient supply. We show that Drosera glanduligera, a sundew from southern Australia, features a sophisticated catapult mechanism: Prey animals walking near the edge of the sundew trigger a touch-sensitive snap-tentacle, which swiftly catapults them onto adjacent sticky glue-tentacles; the insects are then slowly drawn within the concave trap leaf by sticky tentacles. This is the first detailed documentation and analysis of such catapult-flypaper traps in action and highlights a unique and surprisingly complex mechanical adaptation to carnivory.	[Poppinga, Simon; Seidel, Robin; Masselter, Tom; Speck, Thomas] Univ Freiburg, Plant Biomech Grp, D-79106 Freiburg, Germany	University of Freiburg	Poppinga, S (corresponding author), Univ Freiburg, Plant Biomech Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	simon.poppinga@biologie.uni-freiburg.de	Poppinga, Simon/B-7260-2012; Speck, Thomas/N-9208-2013	Poppinga, Simon/0000-0001-5341-9188; Masselter, Tom/0000-0001-5465-8252	German Federal Ministry of Education and Research within BIONA; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Federal Ministry of Education and Research within BIONA; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the German Federal Ministry of Education and Research within the funding directive BIONA. http://www.bmbf.de/en/index.php. http://www.bionische-innovationen.de/#home.html. The article processing charge was (partly) funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Darwin C., 1875, INSECTIVOROUS PLANTS; Davion R, 1995, FLYTRAP NEWS, V8, P17; Davion R, 1999, FLYTRAP NEWS, V13, P10; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Hartmeyer I, 2010, CARNIVOROUS PLANT NE, V39, P101; Krol E, 2012, ANN BOT-LONDON, V109, P47, DOI 10.1093/aob/mcr249; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Lowrie A., 1989, CARNIVOROUS PLANTS A, V2; Pereira CG, 2012, P NATL ACAD SCI USA, V109, P1154, DOI 10.1073/pnas.1114199109; Poppinga S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041928; Seine R., 1993, Beitrage zur Biologie der Pflanzen, V67, P345; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; VERBEEK NAM, 1993, AUST J ECOL, V18, P203, DOI 10.1111/j.1442-9993.1993.tb00444.x; WATSON AP, 1982, AUST J ECOL, V7, P13, DOI 10.1111/j.1442-9993.1982.tb01296.x; WILLIAMS SE, 1976, P AM PHILOS SOC, V120, P187; WILLIAMS SE, 1972, PLANTA, V103, P193, DOI 10.1007/BF00386844; WILLIAMS SE, 1972, PLANTA, V103, P222, DOI 10.1007/BF00386845	20	35	35	3	268	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45735	10.1371/journal.pone.0045735	http://dx.doi.org/10.1371/journal.pone.0045735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049849	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517300047
J	Voedisch, S; Rochlitzer, S; Veres, TZ; Spies, E; Braun, A				Voedisch, Sabrina; Rochlitzer, Sabine; Veres, Tibor Z.; Spies, Emma; Braun, Armin			Neuropeptides Control the Dynamic Behavior of Airway Mucosal Dendritic Cells	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; T-CELLS; IN-VIVO; ASTHMA; INFLAMMATION; MURINE; RECEPTOR; LUNG; ACTIVATION; EXPRESSION	The airway mucosal epithelium is permanently exposed to airborne particles. A network of immune cells patrols at this interface to the environment. The interplay of immune cells is orchestrated by different mediators. In the current study we investigated the impact of neuronal signals on key functions of dendritic cells (DC). Using two-photon microscopic time-lapse analysis of living lung sections from CD11c-EYFP transgenic mice we studied the influence of neuropeptides on airway DC motility. Additionally, using a confocal microscopic approach, the phagocytotic capacity of CD11c(+) cells after neuropeptide stimulation was determined. Electrical field stimulation (EFS) leads to an unspecific release of neuropeptides from nerves. After EFS and treatment with the neuropeptides vasoactive intestinal peptide (VIP) or calcitonin gene-related peptide (CGRP), airway DC in living lung slices showed an altered motility. Furthermore, the EFS-mediated effect could partially be blocked by pre-treatment with the receptor antagonist CGRP(8-37). Additionally, the phagocytotic capacity of bone marrow-derived and whole lung CD11c(+) cells could be inhibited by neuropeptides CGRP, VIP, and Substance P. We then cross-linked these data with the in vivo situation by analyzing DC motility in two different OVA asthma models. Both in the acute and prolonged OVA asthma model altered neuropeptide amounts and DC motility in the airways could be measured. In summary, our data suggest that neuropeptides modulate key features motility and phagocytosis of mouse airway DC. Therefore altered neuropeptide levels in airways during allergic inflammation have impact on regulation of airway immune mechanisms and therefore might contribute to the pathophysiology of asthma.	[Voedisch, Sabrina; Rochlitzer, Sabine; Veres, Tibor Z.; Spies, Emma; Braun, Armin] German Ctr Lung Res, Dept Airway Immunol, Fraunhofer Inst Toxicol & Expt Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Voedisch, Sabrina; Spies, Emma; Braun, Armin] Hannover Med Sch MHH, Dept Immunol, Hannover, Germany; [Veres, Tibor Z.] Univ Turku, MediCity Res Lab, Turku, Finland	Fraunhofer Gesellschaft; Hannover Medical School; University of Turku	Braun, A (corresponding author), German Ctr Lung Res, Dept Airway Immunol, Fraunhofer Inst Toxicol & Expt Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.	armin.braun@item.fraunhofer.de	Braun, Armin/B-8750-2009	Braun, Armin/0000-0002-1142-1463	Deutsche Forschungsgemeinschaft [SFB587/B4]; Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine)	This work was supported by Deutsche Forschungsgemeinschaft (SFB587/B4), Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; Barnes PJ, 2001, RESP PHYSIOL, V125, P145, DOI 10.1016/S0034-5687(00)00210-3; BARNES PJ, 1986, LANCET, V1, P242; BOOMSMA JD, 1992, CHEST, V101, pS389, DOI 10.1378/chest.101.6_Supplement.389S; CARDELL LO, 1994, EUR RESPIR J, V7, P2169, DOI 10.1183/09031936.94.07122169; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Fischer A, 1996, J CLIN INVEST, V98, P2284, DOI 10.1172/JCI119039; Fukai N, 2003, ENDOCRINOLOGY, V144, P447, DOI 10.1210/en.2002-220463; Fukai Nozomi, 2004, Nihon Rinsho, V62 Suppl 9, P189; Groneberg DA, 2004, ALLERGY, V59, P1139, DOI 10.1111/j.1398-9995.2004.00665.x; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kraneveld AD, 2001, INT IMMUNOPHARMACOL, V1, P1629, DOI 10.1016/S1567-5769(01)00099-6; Kuipers H, 2004, CURR OPIN IMMUNOL, V16, P702, DOI 10.1016/j.coi.2004.09.010; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 2001, RESP RES, V2, P133, DOI 10.1186/rr49; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marriott I, 2001, J NEUROIMMUNOL, V114, P131, DOI 10.1016/S0165-5728(00)00466-5; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Path G, 2002, AM J RESP CRIT CARE, V166, P818, DOI 10.1164/rccm.200202-134OC; Rochlitzer S, 2011, CLIN EXP ALLERGY; Rose CE, 2010, CELL MOL IMMUNOL, V7, P361, DOI 10.1038/cmi.2010.31; Shah S, 1998, BRIT J PHARMACOL, V125, P510, DOI 10.1038/sj.bjp.0702068; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Spina D, 2002, CURR OPIN PHARMACOL, V2, P283, DOI 10.1016/S1471-4892(02)00160-1; Springer J, 2003, PULM PHARMACOL THER, V16, P121, DOI 10.1016/S1094-5539(03)00049-X; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Van Rijt LS, 2005, CLIN EXP ALLERGY, V35, P1125, DOI 10.1111/j.1365-2222.2005.02321.x; Veres TZ, 2009, PHARMACOL THERAPEUT, V122, P203, DOI 10.1016/j.pharmthera.2009.02.007; Veres TZ, 2009, AM J PATHOL, V174, P808, DOI 10.2353/ajpath.2009.080800; Veres TZ, 2011, AM J PATHOL, V179, P603, DOI 10.1016/j.ajpath.2011.04.039; Wells JW, 2005, SCAND J IMMUNOL, V61, P251, DOI 10.1111/j.1365-3083.2005.01556.x	36	28	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45951	10.1371/journal.pone.0045951	http://dx.doi.org/10.1371/journal.pone.0045951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049899	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517300065
J	Bukovinszky, T; Verschoor, AM; Helmsing, NR; Bezemer, TM; Bakker, ES; Vos, M; Domis, LND				Bukovinszky, Tibor; Verschoor, Antonie M.; Helmsing, Nico R.; Bezemer, T. Martijn; Bakker, Elisabeth S.; Vos, Matthijs; Domis, Lisette N. de Senerpont			The Good, the Bad and the Plenty: Interactive Effects of Food Quality and Quantity on the Growth of Different Daphnia Species	PLOS ONE			English	Article							LIFE-HISTORY; FRESH-WATER; AQUATIC HERBIVORES; BODY-SIZE; STOICHIOMETRY; ZOOPLANKTON; LIMITATION; PERFORMANCE; DIETS; CLADOCERANS	Effects of food quality and quantity on consumers are neither independent nor interchangeable. Although consumer growth and reproduction show strong variation in relation to both food quality and quantity, the effects of food quality or food quantity have usually been studied in isolation. In two experiments, we studied the growth and reproduction in three filter-feeding freshwater zooplankton species, i.e. Daphnia galeata x hyalina, D. pulicaria and D. magna, on their algal food (Scenedesmus obliquus), varying in carbon to phosphorus (C:P) ratios and quantities (concentrations). In the first experiment, we found a strong positive effect of the phosphorus content of food on growth of Daphnia, both in their early and late juvenile development. Variation in the relationship between the P-content of animals and their growth rate reflected interspecific differences in nutrient requirements. Although growth rates typically decreased as development neared maturation, this did not affect these species-specific couplings between growth rate and Daphnia P-content. In the second experiment, we examined the effects of food quality on Daphnia growth at different levels of food quantity. With the same decrease in P-content of food, species with higher estimated P-content at zero growth showed a larger increase in threshold food concentrations (i.e. food concentration sufficient to meet metabolic requirements but not growth). These results suggest that physiological processes such as maintenance and growth may in combination explain effects of food quality and quantity on consumers. Our study shows that differences in response to variation in food quality and quantity exist between species. As a consequence, species-specific effects of food quality on consumer growth will also determine how species deal with varying food levels, which has implications for resource-consumer interactions.	[Bukovinszky, Tibor; Verschoor, Antonie M.; Helmsing, Nico R.; Bakker, Elisabeth S.; Domis, Lisette N. de Senerpont] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Bukovinszky, Tibor; Bezemer, T. Martijn] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Verschoor, Antonie M.] Ingrepro Bv, Borculo, Netherlands; [Verschoor, Antonie M.] Ctr Excellence Sustainable Water Technol, Wetsus, Leeuwarden, Netherlands; [Vos, Matthijs] Univ Potsdam, Dept Ecol & Ecosyst Modeling, Potsdam, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Potsdam	Bukovinszky, T (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	tibor.bukovinszki@wur.nl	Bakker, Elisabeth S/B-7185-2008; Bezemer, Martijn/A-4068-2009; Domis, Lisette N. de Senerpont/C-2902-2008; Vos, Matthijs/B-3802-2009; KNAW, NIOO-KNAW/A-4320-2012	Bakker, Elisabeth S/0000-0002-5900-9136; Bezemer, Martijn/0000-0002-2878-3479; Domis, Lisette N. de Senerpont/0000-0001-7509-9541; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research [817.01.007]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	LdSD was supported by the Netherlands Organization for Scientific Research (grant 817.01.007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2004, LIMNOL OCEANOGR, V49, P656, DOI 10.4319/lo.2004.49.3.0656; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Boersma M, 2002, ECOLOGY, V83, P2552, DOI 10.1890/0012-9658(2002)083[2552:LATEIF]2.0.CO;2; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; Dudycha JL, 2005, EVOLUTION, V59, P565; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; HALL DJ, 1976, ANNU REV ECOL SYST, V7, P177, DOI 10.1146/annurev.es.07.110176.001141; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; Hood JM, 2010, AM NAT, V176, P651, DOI 10.1086/656489; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Jensen TC, 2004, FRESHWATER BIOL, V49, P1138, DOI 10.1111/j.1365-2427.2004.01255.x; Jeyasingh PD, 2009, ECOL LETT, V12, P1229, DOI 10.1111/j.1461-0248.2009.01368.x; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KOOIJMAN SALM, 1995, J THEOR BIOL, V177, P139; Kreutzer C, 1999, ECOLOGY, V80, P2348, DOI 10.2307/176915; Kyle M, 2006, FRESHWATER BIOL, V51, P2087, DOI 10.1111/j.1365-2427.2006.01639.x; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lana RP, 2005, LIVEST PROD SCI, V98, P219, DOI 10.1016/j.livprodsci.2005.03.008; MCKEE MJ, 1987, FRESHWATER BIOL, V18, P341, DOI 10.1111/j.1365-2427.1987.tb01318.x; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167; Plath K, 2001, ECOLOGY, V82, P1260, DOI 10.1890/0012-9658(2001)082[1260:MLOZSC]2.0.CO;2; ROTHHAUPT KO, 1990, FRESHWATER BIOL, V23, P561, DOI 10.1111/j.1365-2427.1990.tb00295.x; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Seidendorf B, 2010, OECOLOGIA, V162, P349, DOI 10.1007/s00442-009-1452-4; Shimizu Y, 2008, OECOLOGIA, V155, P21, DOI 10.1007/s00442-007-0896-7; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1994, LIMNOL OCEANOGR, V39, P1228, DOI 10.4319/lo.1994.39.5.1228; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Sterner RW, 2001, LIMNOL OCEANOGR, V46, P410, DOI 10.4319/lo.2001.46.2.0410; Urabe J, 2001, FUNCT ECOL, V15, P165, DOI 10.1046/j.1365-2435.2001.00511.x; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; van de Waal DB, 2010, FRONT ECOL ENVIRON, V8, P145, DOI 10.1890/080178; Van Donk E, 2008, LIMNOLOGICA, V38, P189, DOI 10.1016/j.limno.2008.05.005; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x; Vijverberg J, 2006, FRESHWATER BIOL, V51, P756, DOI 10.1111/j.1365-2427.2006.01528.x; Weider LJ, 2008, OECOLOGIA, V158, P47, DOI 10.1007/s00442-008-1126-7	45	19	19	0	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42966	10.1371/journal.pone.0042966	http://dx.doi.org/10.1371/journal.pone.0042966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049734	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100006
J	Dalet, A; Bonsacquet, J; Gaboyard-Niay, S; Calin-Jageman, I; Chidavaenzi, RL; Venteo, S; Desmadryl, G; Goldberg, JM; Lysakowski, A; Chabbert, C				Dalet, Antoine; Bonsacquet, Jeremie; Gaboyard-Niay, Sophie; Calin-Jageman, Irina; Chidavaenzi, Robstein L.; Venteo, Stephanie; Desmadryl, Gilles; Goldberg, Jay M.; Lysakowski, Anna; Chabbert, Christian			Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; AMINO-ACID TRANSPORTERS; COMPARATIVE MORPHOLOGY; SYNAPTIC-TRANSMISSION; EXTRACELLULAR-MATRIX; CRISTAE AMPULLARES; AFFERENT SYNAPSES; RAT UTRICLE; RECEPTOR; ACTIVATION	Glutamate is the neurotransmitter released from hair cells. Its clearance from the synaptic cleft can shape neurotransmission and prevent excitotoxicity. This may be particularly important in the inner ear and in other sensory organs where there is a continually high rate of neurotransmitter release. In the case of most cochlear and type II vestibular hair cells, clearance involves the diffusion of glutamate to supporting cells, where it is taken up by EAAT1 (GLAST), a glutamate transporter. A similar mechanism cannot work in vestibular type I hair cells as the presence of calyx endings separates supporting cells from hair-cell synapses. Because of this arrangement, it has been conjectured that a glutamate transporter must be present in the type I hair cell, the calyx ending, or both. Using whole-cell patch-clamp recordings, we demonstrate that a glutamate-activated anion current, attributable to a high-affinity glutamate transporter and blocked by DL-TBOA, is expressed in type I, but not in type II hair cells. Molecular investigations reveal that EAAT4 and EAAT5, two glutamate transporters that could underlie the anion current, are expressed in both type I and type II hair cells and in calyx endings. EAAT4 has been thought to be expressed almost exclusively in the cerebellum and EAAT5 in the retina. Our results show that these two transporters have a wider distribution in mice. This is the first demonstration of the presence of transporters in hair cells and provides one of the few examples of EAATs in presynaptic elements.	[Dalet, Antoine; Bonsacquet, Jeremie; Gaboyard-Niay, Sophie; Venteo, Stephanie; Desmadryl, Gilles; Chabbert, Christian] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Calin-Jageman, Irina] Dominican Univ, Dept Biol, River Forest, IL USA; [Chidavaenzi, Robstein L.; Lysakowski, Anna] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Goldberg, Jay M.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Dalet, A (corresponding author), INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	antoine.dalet@gmail.com; christian.chabbert@inserm.fr	Lysakowski, Anna/F-9534-2010	Lysakowski, Anna/0000-0001-6259-0294; Gaboyard-Niay, Sophie/0000-0001-8256-8692; Calin-Jageman, Irina/0000-0002-2529-4223	Centre National da'Etudes Spatiales; French Ministry of Research and New Technologies; National Institute on Deafness and Other Communication Disorders [DC2058]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC002058, R01DC002058] Funding Source: NIH RePORTER	Centre National da'Etudes Spatiales; French Ministry of Research and New Technologies; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Centre National da'Etudes Spatiales, the French Ministry of Research and New Technologies (grants to AD and JB) and the National Institute on Deafness and Other Communication Disorders (DC2058 to JMG and AL) (http://www.nidcd.nih.gov/Pages/default.aspx, http://www.cnes.fr/web/CNES-fr/6919-cnes-tout-sur-l-espace.php, http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Bonsacquet J, 2006, J PHYSIOL-LONDON, V576, P63, DOI 10.1113/jphysiol.2006.116467; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chabbert C, 2003, J PHYSIOL-LONDON, V553, P113, DOI 10.1113/jphysiol.2003.043034; Chen JWY, 2000, J NEUROPHYSIOL, V84, P139, DOI 10.1152/jn.2000.84.1.139; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Desai SS, 2005, J NEUROPHYSIOL, V93, P267, DOI 10.1152/jn.00747.2003; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Gaboyard S, 2005, NEUROSCIENCE, V133, P253, DOI 10.1016/j.neuroscience.2005.02.011; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Gincel D, 2007, EXP NEUROL, V203, P205, DOI 10.1016/j.expneurol.2006.08.016; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Holt JC, 2007, J NEUROPHYSIOL, V98, P1083, DOI 10.1152/jn.00332.2007; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ishiyama G, 2002, BRAIN RES, V935, P16, DOI 10.1016/S0006-8993(02)02419-8; Lysakowski A, 1997, J COMP NEUROL, V389, P419, DOI 10.1002/(SICI)1096-9861(19971222)389:3<419::AID-CNE5>3.0.CO;2-3; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Matsubara A, 1999, BRAIN RES, V819, P58, DOI 10.1016/S0006-8993(98)01345-6; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rennie KJ, 2006, J NEUROPHYSIOL, V95, P26, DOI 10.1152/jn.00641.2005; RENNIE KJ, 1994, J NEUROPHYSIOL, V71, P317, DOI 10.1152/jn.1994.71.1.317; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Takumi Y, 1997, NEUROSCIENCE, V79, P1137, DOI 10.1016/S0306-4522(97)00025-0; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WERSALL J, 1956, Acta Otolaryngol Suppl, V126, P1; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	46	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46261	10.1371/journal.pone.0046261	http://dx.doi.org/10.1371/journal.pone.0046261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049999	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100170
J	Jiang, J; Jia, ZF; Cao, DH; Jin, MS; Kong, F; Suo, J; Cao, XY				Jiang, Jing; Jia, Zhifang; Cao, Donghui; Jin, Mei-Shan; Kong, Fei; Suo, Jian; Cao, Xueyuan			Polymorphisms of the DNA Methyltransferase 1 Associated with Reduced Risks of Helicobacter pylori Infection and Increased Risks of Gastric Atrophy	PLOS ONE			English	Article							T-CELLS; CANCER RISK; CPG ISLANDS; DNMT1 POLYMORPHISMS; SATELLITE REGIONS; MESSENGER-RNA; IFN-GAMMA; METHYLATION; EXPRESSION; GENE	Introduction: DNA methyltransferase-1(DNMT1) is an important enzyme in determining genomic methylation patterns in mammalian cells. We investigated the associations between SNPs in the DNMT1 gene and risks of developing H. pylori seropositivity, gastric atrophy and gastric cancer in the Chinese population. Methods: The study consisted of 447 patients with gastric cancer; 111 patients with gastric atrophy; and 961 healthy controls. Five SNPs, rs10420321, rs16999593, rs8101866, rs8111085 and rs2288349 of the DNMT1 gene were genotyped. Anti-H.pylori IgG was detected by ELISA. Gastric atrophy was screened by the level of serum pepsinogen Iand II and then confirmed by endoscopy and histopatholgical examinations. Results: The age- and sex-adjusted OR of H. pylori seropositivity was 0.67 (95%CI: 0.51-0.87) for rs8111085 TC/CC genotypes, significantly lower than the TT genotype in healthy controls. The adjusted OR of H. pylori seropositivity was 0.68 (95%CI: 0.52-0.89) for rs10420321 AG/GG genotypes. In addition, patients carrying rs2228349 AA genotype have a significantly increased risk for H. pylori seropositivity (OR = 1.67; 95%CI: 1.02-2.75). Further haplotype analyses also showed that the ATTTG and ATCTA are significantly associated with increased risks in H. pylori infection compared to the GTCCG haplotype (OR = 1.38, 95%CI: 1.08-1.77; OR = 1.40, 95%CI: 1.09-1.80). The adjusted ORs of gastric atrophy were 1.66 (95%CI: 1.06-2.61) for rs10420321 GG genotype, and 1.67 (95%CI 1.06-2.63, P = 0.03) for rs8111085 CC genotype, but no association was found between SNPs in the DNMT1 gene and risk of developing gastric cancer. Conclusions: Individuals with rs10420321 GG and rs8111085 CC genotype of the DNMT1 gene were associated with reduced risks for H. pylori infection. On the other hand, higher risks of gastric atrophy were found in the carriers with these two genotypes compared to other genotypes. Our results suggested that SNPs of DNMT1 could be used as genotypic markers for predicting genetic susceptibilities to H. pylori infection and risks in gastric atrophy.	[Suo, Jian; Cao, Xueyuan] Jilin Univ, Dept Gastr & Colorectal Surg, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing; Jia, Zhifang; Cao, Donghui; Kong, Fei] Jilin Univ, Div Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Jin, Mei-Shan] Jilin Univ, Div Pathol, Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Cao, XY (corresponding author), Jilin Univ, Dept Gastr & Colorectal Surg, Hosp 1, Changchun 130023, Peoples R China.	ccmzc32jdyycao@yahoo.com.cn			National Natural Science Foundation of China [30940060, 81072369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by National Natural Science Foundation of China (30940060 and 81072369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; [Anonymous], 2011, YB HLTH PEOPL REP CH; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bodger K, 1998, BRIT MED BULL, V54, P139; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Cao Q, 2007, J DIGEST DIS, V8, P15, DOI 10.1111/j.1443-9573.2007.00271.x; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chun JY, 2009, BMB REP, V42, P834, DOI 10.5483/BMBRep.2009.42.12.834; D'Elios MM, 2003, MICROBES INFECT, V5, P723, DOI 10.1016/S1286-4579(03)00114-X; De La Vega Francisco M, 2007, Methods Mol Biol, V376, P177; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Gao XA, 2010, CLIN BREAST CANCER, V10, P373, DOI 10.3816/CBC.2010.n.049; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Hamiliton SA, 2000, WHO CLASSIFICATION T; Harlid S, 2011, INT J CANCER, V129, P1689, DOI 10.1002/ijc.25786; Hishida A, 2010, WORLD J GASTRO ONCOL, V2, P369, DOI 10.4251/wjgo.v2.i10.369; Kabir S, 2009, HELICOBACTER, V14, P159, DOI 10.1111/j.1523-5378.2009.00677.x; Kanai Y, 2003, CANCER LETT, V192, P75, DOI 10.1016/S0304-3835(02)00689-4; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1183; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1177; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Leng SG, 2008, CARCINOGENESIS, V29, P1380, DOI 10.1093/carcin/bgn121; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Lochhead P, 2007, BEST PRACT RES CL GA, V21, P281, DOI 10.1016/j.bpg.2007.02.002; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Nakajima T, 2009, INT J CANCER, V124, P905, DOI 10.1002/ijc.24018; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Park BL, 2004, J HUM GENET, V49, P642, DOI 10.1007/s10038-004-0192-x; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Snaith Ailsa, 2008, Expert Rev Gastroenterol Hepatol, V2, P577, DOI 10.1586/17474124.2.4.577; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Ye CZ, 2010, BREAST CANCER RES TR, V121, P765, DOI 10.1007/s10549-009-0569-9; Zeng D, 2006, BIOSTATISTICS, V7, P486, DOI 10.1093/biostatistics/kxj021	42	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46058	10.1371/journal.pone.0046058	http://dx.doi.org/10.1371/journal.pone.0046058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049933	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100126
J	Stokholm, J; Schjorring, S; Pedersen, L; Bischoff, AL; Folsgaard, N; Carson, CG; Chawes, B; Bonnelykke, K; Molgaard, A; Krogfelt, KA; Bisgaard, H				Stokholm, Jakob; Schjorring, Susanne; Pedersen, Louise; Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo; Bonnelykke, Klaus; Molgaard, Anne; Krogfelt, Karen A.; Bisgaard, Hans			Living with Cat and Dog Increases Vaginal Colonization with E. coli in Pregnant Women	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ONSET NEONATAL SEPSIS; PATTERNS; PRETERM; BURDEN; ASTHMA; RISK	Background: Furred pets in the household are known reservoirs for pathogenic bacteria, but it is not known if transmission of bacteria between pet and owner leads to significantly increased rate of infections. We studied whether cats and dogs living in the household of pregnant women affect the commensal vaginal flora, and furthermore the need for oral antibiotics and rate of urinary tract infections during pregnancy. Methods: The novel unselected Copenhagen Prospective Study on Asthma in Childhood (COPSAC(2010)) pregnancy cohort of 709 women participated in this analysis. Detailed information on pet exposure, oral antibiotic prescriptions filled at pharmacy and urinary tract infection during pregnancy was obtained and verified prospectively during clinic visits. Vaginal cultures were obtained at pregnancy week 36. Results: Women, who had cat or dog in the home during pregnancy, had a different vaginal flora, in particular with increased Escherichia coli (E. coli) colonization; odds ratio after adjustment for lifestyle confounders and antibiotics 2.20, 95% CI, [1.27-3.80], p = 0.005.43% of women living with cat and/or dog in the home used oral antibiotics compared to 33% of women with no cat or dog; adjusted odds ratio 1.51, 95% CI, [1.08-2.12], p = 0.016. Women living with cat had increased frequency of self-reported urinary tract infection; adjusted odds ratio 1.57, 95% CI, [1.02-2.43], p = 0.042. Conclusions: The increased vaginal E. coli colonization in women living with cat or dog suggests a clinically important transmission of pathogenic bacteria from pet to owner substantiated by increased rate of antibiotic use and urinary tract infections which, which is of particular concern during pregnancy.	[Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo; Bonnelykke, Klaus; Molgaard, Anne; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark; [Stokholm, Jakob; Pedersen, Louise] Univ Copenhagen, Naestved Hosp, Naestved, Denmark; [Schjorring, Susanne; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark.	bisgaard@copsac.com	Krogfelt, Karen Angeliki A/O-8145-2016; Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016; Krogfelt, Karen Angeliki/P-2430-2018	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Bisgaard, Hans/0000-0003-4131-7592; Schjorring, Susanne/0000-0001-5575-7252; Chawes, Bo/0000-0001-6846-6243; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Lundbeck Foundation; Strategic Research Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre	Lundbeck Foundation(Lundbeckfonden); Strategic Research Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre	COPSAC is funded by private and public research funds all listed on www.copsac.com. The Lundbeck Foundation; The Strategic Research Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided core support for COPSAC. No pharmaceutical companies were involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson B, 2011, OBSTET GYNECOL, V117, P844, DOI 10.1097/AOG.0b013e318209dd57; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Carey JC, 2005, AM J OBSTET GYNECOL, V192, P1341, DOI 10.1016/j.ajog.2004.12.069; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; CUNNINGHAM FG, 1994, BAILLIERE CLIN OB GY, V8, P353, DOI 10.1016/S0950-3552(05)80325-6; Damborg P, 2009, EPIDEMIOL INFECT, V137, P1457, DOI 10.1017/S095026880900226X; Forbes RL, 2011, THORAX; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Johnson JR, 2009, J CLIN MICROBIOL, V47, P3721, DOI 10.1128/JCM.01581-09; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Macejko AM, 2007, UROL CLIN N AM, V34, P35, DOI 10.1016/j.ucl.2006.10.010; NADISAUSKIENE R, 1995, GYNECOL OBSTET INVES, V40, P179, DOI 10.1159/000292331; Schieve AH, AM J PUBLIC HLTH, V84, P405; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2	23	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46226	10.1371/journal.pone.0046226	http://dx.doi.org/10.1371/journal.pone.0046226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049986	gold, Green Published, Green Submitted			2022-12-25	WOS:000309556100159
J	Su, HN; Chen, ZH; Song, XY; Chen, XL; Shi, M; Zhou, BC; Zhao, X; Zhang, YZ				Su, Hai-Nan; Chen, Zhi-Hua; Song, Xiao-Yan; Chen, Xiu-Lan; Shi, Mei; Zhou, Bai-Cheng; Zhao, Xian; Zhang, Yu-Zhong			Antimicrobial Peptide Trichokonin VI-Induced Alterations in the Morphological and Nanomechanical Properties of Bacillus subtilis	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BACTERIAL VIABILITY; PEPTAIBOLS; CELLS; ANTIBIOTICS; ELASTICITY; CHITOSANS; STAIN	Antimicrobial peptides are promising alternative antimicrobial agents compared to conventional antibiotics. Understanding the mode of action is important for their further application. We examined the interaction between trichokonin VI, a peptaibol isolated from Trichoderma pseudokoningii, and Bacillus subtilis, a representative Gram-positive bacterium. Trichokonin VI was effective against B. subtilis with a minimal inhibitory concentration of 25 mu M. Trichokonin VI exhibited a concentration-and time-dependent effect against B. subtilis, which was studied using atomic force microscopy. The cell wall of B. subtilis collapsed and the roughness increased upon treatment with trichokonin VI. Nanoindentation experiments revealed a progressive decrease in the stiffness of the cells. Furthermore, the membrane permeabilization effect of trichokonin VI on B. subtilis was monitored, and the results suggest that the leakage of intracellular materials is a possible mechanism of action for trichokonin VI, which led to alterations in the morphological and nanomechanical properties of B. subtilis.	[Song, Xiao-Yan] Shandong Univ, State Key Lab Crystal Mat, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; Shandong Univ, State Key Lab Microbial Technol, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Song, XY (corresponding author), Shandong Univ, State Key Lab Crystal Mat, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China.	xysong@sdu.edu.cn; zhangyz@sdu.edu.cn			Hi-Tech Research and Development Program of China [2011AA090704]; National Natural Science Foundation of China [30870047, 81071804]; Specialized Research Fund for the Doctoral Program of Higher Education [BA2009YY009]; Program of Shandong for Taishan Scholars; Natural Science Foundation of Shandong Province [JQ200910, 2008BS02019]; Independent Innovation Foundation of Shandong University [2009TS079, 2011DX002]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shandong for Taishan Scholars; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	The work was supported by Hi-Tech Research and Development Program of China (2011AA090704), National Natural Science Foundation of China (30870047, 81071804), Specialized Research Fund for the Doctoral Program of Higher Education (BA2009YY009), Program of Shandong for Taishan Scholars, Natural Science Foundation of Shandong Province (JQ200910, 2008BS02019) and Independent Innovation Foundation of Shandong University (2009TS079, 2011DX002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; da Silva A, 2005, WORLD J MICROB BIOT, V21, P1103, DOI 10.1007/s11274-005-0077-y; Degenkolb T, 2007, CHEM BIODIVERS, V4, P1052, DOI 10.1002/cbdv.200790096; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Dong XW, 2010, SPECTROSC SPECT ANAL, V30, P458, DOI 10.3964/j.issn.1000-0593(2010)02-0458-04; Duclohier H, 2004, EUR BIOPHYS J BIOPHY, V33, P169, DOI 10.1007/s00249-003-0383-y; Duclohier H, 2010, CURR PHARM DESIGN, V16, P3212, DOI 10.2174/138161210793292500; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Eaton P, 2008, ULTRAMICROSCOPY, V108, P1128, DOI 10.1016/j.ultramic.2008.04.015; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Fernandes JC, 2009, ULTRAMICROSCOPY, V109, P854, DOI 10.1016/j.ultramic.2009.03.015; Formosa C, 2012, NANOMED-NANOTECHNOL, V8, P12, DOI 10.1016/j.nano.2011.09.009; Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hocquellet A, 2010, PEPTIDES, V31, P58, DOI 10.1016/j.peptides.2009.10.006; Kubicek CP, 2007, CHEM BIODIVERS, V4, P1068, DOI 10.1002/cbdv.200790097; Langsrud S, 1996, J APPL BACTERIOL, V81, P411; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Liu SB, 2010, NANOSCALE, V2, P2744, DOI 10.1039/c0nr00441c; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Rossetto G, 2007, NANOMED-NANOTECHNOL, V3, P198, DOI 10.1016/j.nano.2007.06.002; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Scheuring S, 2010, MOL MICROBIOL, V75, P1327, DOI 10.1111/j.1365-2958.2010.07064.x; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-26; Silva ON, 2012, BIOPOLYMERS, V98, P322, DOI 10.1002/bip.22071; Song XY, 2006, FEMS MICROBIOL LETT, V260, P119, DOI 10.1111/j.1574-6968.2006.00316.x; Soon RL, 2009, ANTIMICROB AGENTS CH, V53, P4979, DOI 10.1128/AAC.00497-09; Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g; Whitmore L, 2004, EUR BIOPHYS J BIOPHY, V33, P233, DOI 10.1007/s00249-003-0348-1; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yu PL, 2010, INT J ANTIMICROB AG, V35, P288, DOI 10.1016/j.ijantimicag.2009.10.017; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	38	36	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45818	10.1371/journal.pone.0045818	http://dx.doi.org/10.1371/journal.pone.0045818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049870	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100085
J	Belogurov, AA; Stepanov, AV; Smirnov, IV; Melamed, D; Bacon, A; Mamedov, AE; Boitsov, VM; Sashchenko, LP; Ponomarenko, NA; Sharanova, SN; Boyko, AN; Dubina, MV; Friboulet, A; Genkin, DD; Gabibov, AG				Belogurov, Alexey A., Jr.; Stepanov, Alexey V.; Smirnov, Ivan V.; Melamed, Dobroslav; Bacon, Andrew; Mamedov, Azad E.; Boitsov, Vitali M.; Sashchenko, Lidia P.; Ponomarenko, Natalia A.; Sharanova, Svetlana N.; Boyko, Alexey N.; Dubina, Michael V.; Friboulet, Alain; Genkin, Dmitry D.; Gabibov, Alexander G.			Liposome-encapsulated peptides protect against experimental allergic encephalitis	FASEB JOURNAL			English	Article						multiple sclerosis; myelin basic protein; small unilamellar vesicles; brain-derived neurotrophic factor; remyelination	MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; SUPPRESSION; ANTIGEN; AUTOANTIBODIES; IMMUNOTHERAPY; DEGRADATION; SPECIFICITY	Multiple sclerosis (MS) is a severe inflammatory and neurodegenerative disease with an autoimmune background. Despite the variety of therapeutics available against MS, the development of novel approaches to its treatment is of high importance in modern pharmaceutics. In this study, experimental autoimmune encephalomyelitis (EAE) in Dark Agouti rats has been treated with immunodominant peptides of the myelin basic protein (MBP) encapsulated in mannosylated small unilamellar vesicles. The results show that liposome-encapsulated MBP46-62 is the most effective in reducing maximal disease score during the first attack, while MBP124-139 and MBP147-170 can completely prevent the development of the exacerbation stage. Both mannosylation of liposomes and encapsulation of peptides are critical for the therapeutic effect, since neither naked peptides nor nonmannosylated liposomes, loaded or empty, have proved effective. The liposome-mediated synergistic effect of the mixture of 3 MBP peptides significantly suppresses the progression of protracted EAE, with the median cumulative disease score being reduced from 22 to 14 points, compared to the placebo group; prevents the production of circulating autoantibodies; down-regulates the synthesis of Th1 cytokines; and induces the production of brain-derived neurotrophic factor in the central nervous system. Thus, the proposed formulation ameliorates EAE, providing for a less severe first attack and rapid recovery from exacerbation, and offers a promising therapeutic modality in MS treatment.-Belogurov, A. A., Jr., Stepanov, A. V., Smirnov, I. V., Melamed, D., Bacon, A., Mamedov, A. E., Boitsov, V. M., Sashchenko, L. P., Ponomarenko, N. A., Sharanova, S. N., Boyko, A. N., Dubina, M. V., Friboulet, A., Genkin, D. D., Gabibov, A. G. Liposome-encapsulated peptides protect against experimental allergic encephalitis. FASEB J. 27, 222-231 (2013). www.fasebj.org	[Belogurov, Alexey A., Jr.; Stepanov, Alexey V.; Smirnov, Ivan V.; Mamedov, Azad E.; Ponomarenko, Natalia A.; Gabibov, Alexander G.] RAS, MM Shemyakin & YA Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Belogurov, Alexey A., Jr.; Sashchenko, Lidia P.; Gabibov, Alexander G.] RAS, Inst Gene Biol, Moscow 117997, Russia; [Smirnov, Ivan V.; Gabibov, Alexander G.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Melamed, Dobroslav] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel; [Bacon, Andrew; Genkin, Dmitry D.] Xenet Biosci, London, England; [Boitsov, Vitali M.; Dubina, Michael V.] St Petersburg Acad Univ, RAS, Nanotechnol Res & Educ Ctr, St Petersburg, Russia; [Sharanova, Svetlana N.; Boyko, Alexey N.] NI Pirogov Natl Res Med Univ, City Hosp 11, Dept Neurol & Neurosurg, Moscow Multiple Sclerosis Ctr, Moscow, Russia; [Friboulet, Alain] Univ Technol Compiegne, CNRS, UMR 6022, Compiegne, France	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Pirogov Russian National Research Medical University; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS)	Gabibov, AG (corresponding author), RAS, MM Shemyakin & YA Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.	gabibov@mx.ibch.ru	Smirnov, Ivan V/B-2491-2014; Belogurov, Alexey/L-5859-2017; Stepanov, Alexey/AAN-8721-2020; Dubina, Michael/E-1888-2014; Smirnov, Ivan/N-5635-2017; Boitsov, Vitali/E-1863-2014; Mamedov, Azad E/O-6863-2017; Boyko, Alexey N/Z-2106-2018	Smirnov, Ivan V/0000-0002-0384-6568; Belogurov, Alexey/0000-0002-2033-9621; Stepanov, Alexey/0000-0003-1616-4408; Dubina, Michael/0000-0002-6606-3309; Smirnov, Ivan/0000-0002-0384-6568; Boitsov, Vitali/0000-0002-4857-2046; Boyko, Alexei/0000-0003-3306-9541; Bacon, Andrew/0000-0002-9099-9158; Ponomarenko, Natalia/0000-0003-3129-3515; Mamedov, Azad/0000-0001-9343-4550	Ministry of Industry and Trade of the Russian Federation [11411.0810200. 13. B20, 3.1]; Russian Foundation for Basic Research [10-04-00673-a]; Presidium of the Russian Academy of Sciences [2046.2012.4, 24];  [CRP/RUS09-01]	Ministry of Industry and Trade of the Russian Federation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); 	This work was performed within the framework of innovative projects launched by the Ministry of Industry and Trade of the Russian Federation (state contract 11411.0810200. 13. B20, code Copolymer 3.1) and supported by the Skolkovo program, Russian Foundation for Basic Research (project 10-04-00673-a); CRP/RUS09-01, The Role of B Cell Response in Multiple Sclerosis; Scientific Schools 2046.2012.4, Chemical Basis of Biocatalysis, Federal Special Purpose; and programs Detection of Viral Antigens as Possible Triggers of Autoimmune Neurodegeneration and Nanotechnologies and Nanomaterials (no. 24) of the Presidium of the Russian Academy of Sciences.	Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Aharoni R, 1998, J NEUROIMMUNOL, V91, P135, DOI 10.1016/S0165-5728(98)00166-0; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; AVRILIONIS K, 1991, J NEUROIMMUNOL, V35, P201, DOI 10.1016/0165-5728(91)90174-6; Belogurov AA, 2009, AUTOIMMUNITY, V42, P362, DOI 10.1080/08916930902832090; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Bielekova B, 2004, J IMMUNOL, V172, P3893, DOI 10.4049/jimmunol.172.6.3893; Cavaletti G, 2009, MOL PHARMACEUT, V6, P1363, DOI 10.1021/mp8001478; Croxford JL, 1998, J IMMUNOL, V160, P5181; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Espuelas S, 2003, BIOORG MED CHEM LETT, V13, P2557, DOI 10.1016/S0960-894X(03)00472-4; Gabibov AG, 2011, FASEB J, V25, P4211, DOI 10.1096/fj.11-190769; Garren H., 2009, RESULTS PROBLEMS CEL, P259; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Hikada Masaki, 2010, Nat Immunol, V11, P1065, DOI 10.1038/ni1210-1065; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Katsara M, 2008, J NEUROIMMUNOL, V200, P77, DOI 10.1016/j.jneuroim.2008.06.013; Katsara M, 2009, J MED CHEM, V52, P214, DOI 10.1021/jm801250v; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Luca ME, 2005, J NEUROIMMUNOL, V160, P178, DOI 10.1016/j.jneuroim.2004.11.014; Miyakoshi A, 2003, J IMMUNOL, V170, P6371, DOI 10.4049/jimmunol.170.12.6371; Oliver AR, 2003, J IMMUNOL, V171, P462, DOI 10.4049/jimmunol.171.1.462; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schweingruber N, 2011, J IMMUNOL, V187, P4310, DOI 10.4049/jimmunol.1101604; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; StLouis J, 1997, J NEUROIMMUNOL, V73, P90, DOI 10.1016/S0165-5728(96)00174-9; van Bergen J, 1999, IMMUNOL REV, V172, P87; Wiendl H, 2002, BIODRUGS, V16, P183, DOI 10.2165/00063030-200216030-00003	32	37	40	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					222	231		10.1096/fj.12-213975	http://dx.doi.org/10.1096/fj.12-213975			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23047895	Green Published			2022-12-25	WOS:000313103200021
J	Maddukuri, L; Ketkar, A; Eddy, S; Zafar, MK; Griffin, WC; Eoff, RL				Maddukuri, Leena; Ketkar, Amit; Eddy, Sarah; Zafar, Maroof K.; Griffin, Wezley C.; Eoff, Robert L.			Enhancement of Human DNA Polymerase eta Activity and Fidelity Is Dependent Upon a Bipartite Interaction with the Werner Syndrome Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK PROGRESSION; THYMINE-THYMINE DIMER; CONFORMATIONAL-CHANGES; TRANSLESION SYNTHESIS; KINETIC-ANALYSIS; DAMAGE RESPONSE; BINDING; MECHANISM; HELICASE; PCNA	We have investigated the interaction between human DNA polymerase eta (hpol eta) and the Werner syndrome protein (WRN). Functional assays revealed that the WRN exonuclease and RecQ C-terminal (RQC) domains are necessary for full stimulation of hpol eta-catalyzed formation of correct base pairs. We find that WRN does not stimulate hpol eta-catalyzed formation of mispairs. Moreover, the exonuclease activity of WRN prevents stable mispair formation by hpol eta. These results are consistent with a proofreading activity for WRN during single-nucleotide additions. ATP hydrolysis by WRN appears to attenuate stimulation of hpol eta. Pre-steady-state kinetic results show that k(pol) is increased 4-fold by WRN. Finally, pulldown assays reveal a bipartite physical interaction between hpol eta and WRN that is mediated by the exonuclease and RQC domains. Taken together, these results are consistent with alteration of the rate-limiting step in polymerase catalysis by direct protein-protein interactions between WRN and hpol eta. In summary, WRN improves the efficiency and fidelity of hpol eta to promote more effective replication of DNA.	[Maddukuri, Leena; Ketkar, Amit; Eddy, Sarah; Zafar, Maroof K.; Griffin, Wezley C.; Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Eoff, RL (corresponding author), Biomed Res Ctr 1, Rm B421E,4301 W Markham St, Little Rock, AR 72205 USA.	RLEOFF@UAMS.EDU	Ketkar, Amit/H-8022-2019	ketkar, amit/0000-0002-6536-7415	National Institutes of Health [R00 GM084460]; National Center for Research Resources [UL1RR029884]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM084460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 GM084460 (to R. L. E.) and Award Number UL1RR029884 from the National Center for Research Resources (to C. Lowery).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Eoff RL, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/830473; Eoff RL, 2009, J BIOL CHEM, V284, P21090, DOI 10.1074/jbc.M109.009506; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fygenson DK, 1997, J BIOL CHEM, V272, P27931, DOI 10.1074/jbc.272.44.27931; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Kamath-Loeb AS, 2012, J BIOL CHEM, V287, P12480, DOI 10.1074/jbc.M111.332577; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Murfuni I, 2013, ONCOGENE, V32, P610, DOI 10.1038/onc.2012.80; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Phillips LG, 2010, DNA REPAIR, V9, P1064, DOI 10.1016/j.dnarep.2010.07.006; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; Rucker R, 2010, PROTEINS, V78, P671, DOI 10.1002/prot.22596; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Ummat A, 2012, J MOL BIOL, V415, P627, DOI 10.1016/j.jmb.2011.11.038; van der Kemp PA, 2009, NUCLEIC ACIDS RES, V37, P2549, DOI 10.1093/nar/gkp105; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Xing GX, 2009, MOL MICROBIOL, V71, P678, DOI 10.1111/j.1365-2958.2008.06553.x; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuasa MS, 2006, GENES CELLS, V11, P731, DOI 10.1111/j.1365-2443.2006.00974.x	60	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42312	42323		10.1074/jbc.M112.410332	http://dx.doi.org/10.1074/jbc.M112.410332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23045531	hybrid, Green Published			2022-12-25	WOS:000312103000066
J	Neumayer, G; Helfricht, A; Shim, SY; Le, HT; Lundin, C; Belzil, C; Chansard, M; Yu, YP; Lees-Miller, SP; Gruss, OJ; van Attikum, H; Helleday, T; Nguyen, MD				Neumayer, Gernot; Helfricht, Angela; Shim, Su Yeon; Hoa Thi Le; Lundin, Cecilia; Belzil, Camille; Chansard, Mathieu; Yu, Yaping; Lees-Miller, Susan P.; Gruss, Oliver J.; van Attikum, Haico; Helleday, Thomas; Minh Dang Nguyen			Targeting Protein for Xenopus Kinesin-like Protein 2 (TPX2) Regulates gamma-Histone 2AX (gamma-H2AX) Levels upon Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; DOUBLE-STRAND BREAKS; DEPHOSPHORYLATES GAMMA-H2AX; CELL-CYCLE; THERAPEUTIC TARGET; CYTOPLASMIC DYNEIN; CATALYTIC SUBUNIT; IMPORTIN-ALPHA; KEY REGULATOR; CNS NEURONS	The microtubule-associated protein targeting protein for Xenopus kinesin-like protein 2 (TPX2) plays a key role in spindle assembly and is required for mitosis in human cells. In interphase, TPX2 is actively imported into the nucleus to prevent its premature activity in microtubule organization. To date, no function has been assigned to nuclear TPX2. We now report that TPX2 plays a role in the cellular response to DNA double strand breaks induced by ionizing radiation. Loss of TPX2 leads to inordinately strong and transient accumulation of ionizing radiation-dependent Ser-139-phosphorylated Histone 2AX (gamma-H2AX) at G(0) and G(1) phases of the cell cycle. This is accompanied by the formation of increased numbers of high intensity gamma-H2AX ionizing radiation-induced foci. Conversely, cells overexpressing TPX2 have reduced levels of gamma-H2AX after ionizing radiation. Consistent with a role for TPX2 in the DNA damage response, we found that the protein accumulates at DNA double strand breaks and associates with the mediator of DNA damage checkpoint 1 (MDC1) and the ataxia telangiectasia mutated (ATM) kinase, both key regulators of gamma-H2AX amplification. Pharmacologic inhibition or depletion of ATM or MDC1, but not of DNA-dependent protein kinase (DNA-PK), antagonizes the gamma-H2AX phenotype caused by TPX2 depletion. Importantly, the regulation of gamma-H2AX signals by TPX2 is not associated with apoptosis or the mitotic functions of TPX2. In sum, our study identifies a novel and the first nuclear function for TPX2 in the cellular responses to DNA damage.	[Neumayer, Gernot; Shim, Su Yeon; Hoa Thi Le; Belzil, Camille; Chansard, Mathieu; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Neumayer, Gernot; Shim, Su Yeon; Hoa Thi Le; Belzil, Camille; Chansard, Mathieu; Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Neumayer, Gernot; Shim, Su Yeon; Yu, Yaping; Lees-Miller, Susan P.; Minh Dang Nguyen] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Lundin, Cecilia; Helleday, Thomas] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, S-17121 Stockholm, Sweden; [Helfricht, Angela; van Attikum, Haico] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2333 ZC Leiden, Netherlands; [Gruss, Oliver J.] Univ Heidelberg ZMBH Alliance, ZMBH, Zentrum Mol Biol, Deutsch Krebsforschungszentrum DKFZ, D-69120 Heidelberg, Germany	University of Calgary; University of Calgary; University of Calgary; Karolinska Institutet; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca	Helleday, Thomas/D-5224-2013; van Attikum, Haico/A-4596-2010	Helleday, Thomas/0000-0002-7384-092X; Lees-Miller, Susan/0000-0001-5809-2516; Van Attikum, Haico/0000-0001-8590-0240	Canadian Institute of Health Research (CIHR); Alberta Innovates - Health Solutions (AI-HS) cancer grant; Medical Research Council; Austrian Academy of Sciences; University of Calgary; Alberta Cancer Foundation; Netherlands Organisation for Scientific Research (VIDI grant); Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant); Leiden University Medical Center; Leids Universiteits Fonds/Gratama stichting	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions (AI-HS) cancer grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Academy of Sciences; University of Calgary; Alberta Cancer Foundation; Netherlands Organisation for Scientific Research (VIDI grant); Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant); Leiden University Medical Center; Leids Universiteits Fonds/Gratama stichting	This work was supported in part by a Canadian Institute of Health Research (CIHR) operating grant, an Alberta Innovates - Health Solutions (AI-HS) cancer grant (to M. D. N.), and the Medical Research Council (to T. H.).; Recipient of a DOC-fellowship from the Austrian Academy of Sciences, an Achievers in Medical Sciences award from the University of Calgary, and a scholarship from the Alberta Cancer Foundation.; Recipient of grants from the Netherlands Organisation for Scientific Research (VIDI grant), Human Frontier Science Program Organization (HFSPO) (HFSP Career Development Award grant), the Leiden University Medical Center, and the Leids Universiteits Fonds/Gratama stichting.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Arbour N, 2008, J NEUROSCI, V28, P6068, DOI 10.1523/JNEUROSCI.4940-07.2008; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Cha H, 2010, CANCER RES, V70, P4112, DOI 10.1158/0008-5472.CAN-09-4244; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Durocher D, 2000, COLD SPRING HARB SYM, V65, P423, DOI 10.1101/sqb.2000.65.423; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gietz R D, 2002, Methods Mol Biol, V185, P471; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Heidebrecht HJ, 1997, BLOOD, V90, P226; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kagawa S, 2001, CLIN CANCER RES, V7, P1474; Kahana JA, 2001, SCIENCE, V291, P1718, DOI 10.1126/science.1059765; Karsenti E, 2005, MOL CELL, V19, P431, DOI 10.1016/j.molcel.2005.08.002; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li B, 2010, BRAIN RES, V1352, P200, DOI 10.1016/j.brainres.2010.06.060; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Macurek L, 2010, ONCOGENE, V29, P2281, DOI 10.1038/onc.2009.501; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Pramparo T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001331; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sii-Felice K, 2008, CELL CYCLE, V7, P1911, DOI 10.4161/cc.7.13.6235; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	84	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42206	42222		10.1074/jbc.M112.385674	http://dx.doi.org/10.1074/jbc.M112.385674			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23045526	Green Published, hybrid			2022-12-25	WOS:000312103000057
J	Aikawa, Y; Hirakawa, H; Lee, S				Aikawa, Yoshikatsu; Hirakawa, Hideki; Lee, Sangho			Spatiotemporal Regulation of the Ubiquitinated Cargo-binding Activity of Rabex-5 in the Endocytic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR RABEX-5; STRUCTURAL BASIS; MEMBRANE-FUSION; RAB5; PROTEINS; DOMAINS; VPS9; TRAFFICKING; RECOGNITION; ACTIVATION	Ubiquitin (Ub)-dependent endocytosis of membrane proteins requires precise molecular recognition of ubiquitinated cargo by Ub-binding proteins (UBPs). Many UBPs are often themselves monoubiquitinated, a mechanism referred to as coupled monoubiquitination, which prevents them from binding in trans to the ubiquitinated cargo. However, the spatiotemporal regulatory mechanism underlying the interaction of UBPs with the ubiquitinated cargo, via their Ub-binding domains (UBDs) remains unclear. Previously, we reported the interaction of Rabex-5, a UBP and guanine nucleotide exchange factor (GEF) for Rab5, with ubiquitinated neural cell adhesion molecule L1, via its motif interacting with Ub (MIU) domain. This interaction is critical for the internalization and sorting of the ubiquitinated L1 into endosomal/lysosomal compartments. The present study demonstrated that the interaction of Rabex-5 with Rab5 depends specifically on interaction of the MIU domain with the ubiquitinated L1 to drive its internalization. Notably, impaired GEF mutants and the Rabex-5(E213A) mutant increased the flexibility of the hinge region in the HB-VPS9 tandem domain, which significantly affected their interactions with the ubiquitinated L1. In addition, GEF mutants increased the catalytic efficiency, which resulted in a reduced interaction with the ubiquitinated L1. Furthermore, the coupled monoubiquitination status of Rabex-5 was found to be significantly associated with interaction of Rabex-5 and the ubiquitinated L1. Collectively, our study reveals a novel mechanism, wherein the GEF activity of Rabex-5 acts as an intramolecular switch orchestrating ubiquitinated cargo-binding activity and coupled monoubiquitination to permit the spatiotemporal dynamic exchange of the ubiquitinated cargos.	[Aikawa, Yoshikatsu] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, Kyoto 6100394, Japan; [Hirakawa, Hideki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Doshisha University; Kazusa DNA Research Institute; Sungkyunkwan University (SKKU)	Aikawa, Y (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Lab Neural Membrane Biol, 1-3 Miyakodani, Kyoto 6100394, Japan.	yaikawa@mail.doshisha.ac.jp	Lee, Sangho/P-4204-2018	Lee, Sangho/0000-0003-3886-4579	Japan Society for the Promotion of Science [20790085]; Uehara Memorial Foundation; Doshisha University; Ministry of Education, Science, and Technology [2011-0023402]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Doshisha University; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a Grant-in-aid for Young Scientists (B) (20790085) from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, an individual research allowance from Doshisha University (to Y. A.), and a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2011-0023402) (to S. L.).	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Ali BR, 2005, BIOCHEM SOC T, V33, P652, DOI 10.1042/BST0330652; Archer FR, 1999, EUR J NEUROSCI, V11, P3565, DOI 10.1046/j.1460-9568.1999.00773.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Donaldson KM, 2003, CURR BIOL, V13, P258, DOI 10.1016/S0960-9822(03)00043-5; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Keren-Kaplan T, 2012, EMBO J, V31, P378, DOI 10.1038/emboj.2011.397; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; LI GP, 1994, J BIOL CHEM, V269, P14631; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2006, TRENDS BIOCHEM SCI, V31, P541, DOI 10.1016/j.tibs.2006.07.009; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	42	3	3	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40586	40597		10.1074/jbc.M112.411793	http://dx.doi.org/10.1074/jbc.M112.411793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048039	Green Published, hybrid			2022-12-25	WOS:000311448800048
J	Xue, HY; Slavov, D; Wischmeyer, PE				Xue, Hongyu; Slavov, Dobromir; Wischmeyer, Paul E.			Glutamine-mediated Dual Regulation of Heat Shock Transcription Factor-1 Activation and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; SENSING RESPONSE PATHWAY; AMINO-ACID REGULATION; BINDING-PROTEIN-BETA; C/EBP-BETA; STRESS; HEAT-SHOCK-PROTEIN-70; PHOSPHORYLATION; MECHANISMS; RATS	Heat shock transcription factor-1 (HSF1) is the master regulator for cytoprotective heat shock protein (Hsp) expression. It is widely thought that HSF1 expression is non-inducible, and thus the key control point of Hsp expression is regulation of the transactivation activity of HSF1. How HSF1 expression is regulated remains unknown. Herein we demonstrate that glutamine (Gln), a preferred fuel substrate for the gut, enhanced Hsp expression both in rat colonic epithelium in vivo and in cultured non-transformed young adult mouse colonic epithelial cells. This was associated with up-regulation of the transactivation activity of HSF1 via increased HSF1 trimerization, nuclear localization, DNA binding, and relative abundance of activating phosphorylation at Ser-230 of HSF1. More intriguingly, Gln enhanced HSF1 protein and mRNA expression and Hsf1 gene promoter activity. Within the -281/-200 region of the Hsf1 promoter, deletion of the putative CCAAT enhancer-binding protein (C/EBP) binding site abolished the HSF1 response to Gln. C/EBP beta was further shown to bind to this 82-bp sequence both in vitro and in vivo. Gln availability strikingly altered the ratio of C/EBP beta inhibitory and active isoforms, i.e. liver-enriched inhibitory protein and liver-enriched activating protein. Liver-enriched inhibitory protein and liver-enriched activating protein were further shown to be an independent repressor and activator, respectively, for Hsf1 gene transcription, and the relative abundance of these two C/EBP beta isoforms was demonstrated to determine Hsf1 transcription. We show for the first time that Gln not only enhances the transactivation of HSF1 but also induces Hsf1 expression by activating its transcription in a C/EBP beta-dependent manner.	[Xue, Hongyu; Wischmeyer, Paul E.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA; [Slavov, Dobromir] Univ Colorado Denver, Dept Cardiol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Xue, HY (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Anschutz Med Campus,RC2,P15,Box 8602,12700 E 19th, Aurora, CO 80045 USA.	Hongyu.Xue@ucdenver.edu	Xue, Hongyu/E-4201-2013		National Institutes of Health [RO1 GM078312]; Department of Anesthesiology, University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology, University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM078312 (to P. E. W.). This work was also supported by a start-up grant from the Department of Anesthesiology, University of Colorado (to H. X.).	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Banine F, 1998, BBA-GENE STRUCT EXPR, V1398, P1, DOI 10.1016/S0167-4781(98)00042-6; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; BELLON G, 1995, BBA-MOL CELL RES, V1268, P311, DOI 10.1016/0167-4889(95)00093-8; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Ding XZ, 1996, MOL CELL BIOCHEM, V158, P189; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; GUERRINI L, 1993, MOL CELL BIOL, V13, P3202, DOI 10.1128/MCB.13.6.3202; Hegazi RA, 2011, CRIT CARE, V15, DOI 10.1186/cc10430; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Jeppesen Palle Bekker, 2002, Curr Gastroenterol Rep, V4, P338, DOI 10.1007/s11894-002-0085-0; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Metzler B, 2003, AM J PATHOL, V162, P1669, DOI 10.1016/S0002-9440(10)64301-5; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Ren HY, 2001, GASTROENTEROLOGY, V121, P631, DOI 10.1053/gast.2001.27028; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Ropeleski MJ, 2005, GASTROENTEROLOGY, V129, P170, DOI 10.1053/j.gastro.2005.05.017; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Singleton KD, 2007, AM J PHYSIOL-REG I, V292, pR1839, DOI 10.1152/ajpregu.00755.2006; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonna LA, 2010, CELL STRESS CHAPERON, V15, P55, DOI 10.1007/s12192-009-0121-1; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STRAUS DS, 1994, J NUTR, V124, P1041, DOI 10.1093/jn/124.7.1041; Sundar SV, 2005, BIOCHEM BIOPH RES CO, V332, P688, DOI 10.1016/j.bbrc.2005.05.008; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wheelhouse NM, 1999, J ENDOCRINOL, V163, P353, DOI 10.1677/joe.0.1630353; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wischmeyer P, 2011, CURR OPIN ANESTHESIO, V24, P381, DOI 10.1097/ACO.0b013e32834872b6; Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403, DOI 10.1152/jappl.2001.90.6.2403; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yang JQ, 2008, ITESS: 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES, PT 1, P1, DOI 10.1109/CVPR.2008.4587647; Zhou JD, 2008, CHINESE MED J-PEKING, V121, P1269, DOI 10.1097/00029330-200807020-00004; Ziegler TR, 2005, INTENS CARE MED, V31, P1079, DOI 10.1007/s00134-005-2690-5; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	59	33	34	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40400	40413		10.1074/jbc.M112.410712	http://dx.doi.org/10.1074/jbc.M112.410712			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23055521	Green Published, hybrid			2022-12-25	WOS:000311448800031
J	Dineen, RA; Bradshaw, CM; Constantinescu, CS; Auer, DP				Dineen, Robert A.; Bradshaw, Christopher M.; Constantinescu, Cris S.; Auer, Dorothee P.			Extra-Hippocampal Subcortical Limbic Involvement Predicts Episodic Recall Performance in Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL IMPAIRMENT; FORNIX TRANSECTION; DIFFUSION MRI; MEMORY; ATROPHY; INTACT; RECOLLECTION	Background: Episodic memory impairment is a common but poorly-understood phenomenon in multiple sclerosis (MS). We aim to establish the relative contributions of reduced integrity of components of the extended hippocampal-diencephalic system to memory performance in MS patients using quantitative neuroimaging. Methodology/Principal Findings: 34 patients with relapsing-remitting MS and 24 healthy age-matched controls underwent 3 T MRI including diffusion tensor imaging and 3-D T1-weighted volume acquisition. Manual fornix regions-of-interest were used to derive fornix fractional anisotropy (FA). Normalized hippocampal, mammillary body and thalamic volumes were derived by manual segmentation. MS subjects underwent visual recall, verbal recall, verbal recognition and verbal fluency assessment. Significant differences between MS patients and controls were found for fornix FA (0.38 vs. 0.46, means adjusted for age and fornix volume, P<.0005) and mammillary body volumes (age-adjusted means 0.114 ml vs. 0.126 ml, P<.023). Multivariate regression analysis identified fornix FA and mammillary bodies as predictor of visual recall (R-2=.31, P=.003, P=.006), and thalamic volume as predictive of verbal recall (R-2=.37, P<.0005). No limbic measures predicted verbal recognition or verbal fluency. Conclusions/Significance: These findings indicate that structural and ultrastructural alterations in subcortical limbic components beyond the hippocampus predict performance of episodic recall in MS patients with mild memory dysfunction.	[Dineen, Robert A.; Auer, Dorothee P.] Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Bradshaw, Christopher M.] Univ Nottingham, Dept Psychopharmacol, Nottingham NG7 2RD, England; [Constantinescu, Cris S.] Univ Nottingham, Div Clin Neurol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Dineen, RA (corresponding author), Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England.	rob.dineen@nottingham.ac.uk	Sanders, Kate L/D-1507-2019; Milton, David A/A-9794-2011; Dineen, Robert/S-7192-2019	Sanders, Kate L/0000-0002-9581-268X; Auer, Dorothee P./0000-0002-4745-3635; Constantinescu, Cris/0000-0003-2066-7585; Dineen, Robert/0000-0002-9523-2546	Nottingham University Hospitals Charity	Nottingham University Hospitals Charity	The study was part funded by Nottingham University Hospitals Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Aggleton JP, 2001, PHILOS T R SOC B, V356, P1467, DOI 10.1098/rstb.2001.0946; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Benton A.L., 1974, REVISED VISUAL RETEN; Benton AL, 1983, MULTILINGUAL APHASIA; Bozoki AC, 2011, HUMAN BRAIN MAPPING; Buckley MJ, 2008, BEHAV NEUROSCI, V122, P44, DOI 10.1037/0735-7044.122.1.44; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Charles DP, 2004, J NEUROSCI, V24, P2037, DOI 10.1523/JNEUROSCI.3796-03.2004; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Easton A, 2009, HIPPOCAMPUS, V19, P837, DOI 10.1002/hipo.20567; Goncalves CV, 2009, SAO PAULO MED J, V127, P359, DOI 10.1590/S1516-31802009000600008; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Nelson HE, 1991, NATL ADULT READING 2; Pagani E, 2005, AM J NEURORADIOL, V26, P341; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RAO SM, 1985, ARCH NEUROL-CHICAGO, V42, P678, DOI 10.1001/archneur.1985.04060070068018; Rashid W, 2004, MULT SCLER J, V10, P9, DOI 10.1191/1352458504ms985oa; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433; Rudebeck SR, 2009, J NEUROSCI, V29, P14987, DOI 10.1523/JNEUROSCI.4707-09.2009; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; TSOLAKI M, 1994, DEMENTIA, V5, P48, DOI 10.1159/000106694; Turner B, 2001, NEURORADIOLOGY, V43, P608, DOI 10.1007/s002340000457; Vann SD, 2008, NEUROPSYCHOLOGY, V22, P658, DOI 10.1037/a0012542; YOUNGJOHN JR, 1993, CLIN NEUROPSYCHOL, V7, P155, DOI 10.1080/13854049308401517; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44942	10.1371/journal.pone.0044942	http://dx.doi.org/10.1371/journal.pone.0044942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056187	gold, Green Submitted, Green Published			2022-12-25	WOS:000309831500008
J	Mooney, C; Haslam, NJ; Pollastri, G; Shields, DC				Mooney, Catherine; Haslam, Niall J.; Pollastri, Gianluca; Shields, Denis C.			Towards the Improved Discovery and Design of Functional Peptides: Common Features of Diverse Classes Permit Generalized Prediction of Bioactivity	PLOS ONE			English	Article							DATABASE	The conventional wisdom is that certain classes of bioactive peptides have specific structural features that endow their particular functions. Accordingly, predictions of bioactivity have focused on particular subgroups, such as antimicrobial peptides. We hypothesized that bioactive peptides may share more general features, and assessed this by contrasting the predictive power of existing antimicrobial predictors as well as a novel general predictor, PeptideRanker, across different classes of peptides. We observed that existing antimicrobial predictors had reasonable predictive power to identify peptides of certain other classes i.e. toxin and venom peptides. We trained two general predictors of peptide bioactivity, one focused on short peptides (4-20 amino acids) and one focused on long peptides (>20 amino acids). These general predictors had performance that was typically as good as, or better than, that of specific predictors. We noted some striking differences in the features of short peptide and long peptide predictions, in particular, high scoring short peptides favour phenylalanine. This is consistent with the hypothesis that short and long peptides have different functional constraints, perhaps reflecting the difficulty for typical short peptides in supporting independent tertiary structure. We conclude that there are general shared features of bioactive peptides across different functional classes, indicating that computational prediction may accelerate the discovery of novel bioactive peptides and aid in the improved design of existing peptides, across many functional classes. An implementation of the predictive method, PeptideRanker, may be used to identify among a set of peptides those that may be more likely to be bioactive.	[Mooney, Catherine; Haslam, Niall J.; Pollastri, Gianluca; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 4, Ireland; [Mooney, Catherine; Haslam, Niall J.; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland; [Mooney, Catherine; Haslam, Niall J.; Shields, Denis C.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Pollastri, Gianluca] Natl Univ Ireland Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin	Shields, DC (corresponding author), Natl Univ Ireland Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 4, Ireland.	denis.shields@ucd.ie		Pollastri, Gianluca/0000-0002-5825-4949; Mooney, Catherine/0000-0002-7696-1364; Haslam, Niall/0000-0001-7007-5137; Shields, Denis/0000-0003-4015-2474	Science Foundation Ireland [08/IN.1/B1864, 10/RFP/GEN2749]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The work was funded through a Science Foundation Ireland principal investigator grant (grant 08/IN.1/B1864) to DCS and a Science Foundation Ireland research frontiers grant (grant 10/RFP/GEN2749) to GP. (http://www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Demidova-Rice TN, 2011, WOUND REPAIR REGEN, V19, P59, DOI 10.1111/j.1524-475X.2010.00642.x; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1, 10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A]; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; FitzGerald RJ, 2000, BRIT J NUTR, V84, pS33; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Kaminski S, 2007, J APPL GENET, V48, P189, DOI 10.1007/BF03195213; Lata S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-263; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Liu F, 2008, J PROTEOME RES, V7, P4119, DOI 10.1021/pr800037n; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mooney C, 2011, BIOINFORMATICS, V27, P2812, DOI 10.1093/bioinformatics/btr494; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; R Core Team, 2022, R LANG ENV STAT COMP; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025	29	223	231	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e45012	10.1371/journal.pone.0045012	http://dx.doi.org/10.1371/journal.pone.0045012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056189	Green Published, Green Submitted, gold			2022-12-25	WOS:000309831500010
J	Sunyer, R; Jin, AJ; Nossal, R; Sackett, DL				Sunyer, Raimon; Jin, Albert J.; Nossal, Ralph; Sackett, Dan L.			Fabrication of Hydrogels with Steep Stiffness Gradients for Studying Cell Mechanical Response	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SUBSTRATE STIFFNESS; RIGIDITY; MOVEMENT; TIPS	Many fundamental cell processes, such as angiogenesis, neurogenesis and cancer metastasis, are thought to be modulated by extracellular matrix stiffness. Thus, the availability of matrix substrates having well-defined stiffness profiles can be of great importance in biophysical studies of cell-substrate interaction. Here, we present a method to fabricate biocompatible hydrogels with a well defined and linear stiffness gradient. This method, involving the photopolymerization of films by progressively uncovering an acrylamide/bis-acrylamide solution initially covered with an opaque mask, can be easily implemented with common lab equipment. It produces linear stiffness gradients of at least 115 kPa/mm, extending from similar to 1 kPa to 240 kPa (in units of Young's modulus). Hydrogels with less steep gradients and narrower stiffness ranges can easily be produced. The hydrogels can be covalently functionalized with uniform coatings of proteins that promote cell adhesion. Cell spreading on these hydrogels linearly correlates with hydrogel stiffness, indicating that this technique effectively modifies the mechanical environment of living cells. This technique provides a simple approach that produces steeper gradients, wider rigidity ranges, and more accurate profiles than current methods.	[Sunyer, Raimon; Nossal, Ralph; Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Jin, Albert J.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Sunyer, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	raimon.sunyer@nih.gov	Sunyer, Raimon/G-8605-2013	Sunyer, Raimon/0000-0003-0777-3973; Jin, Albert/0000-0003-3826-1081	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health; Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government); Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000015] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government); Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funds from the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. R Sunyer was supported by a postdoctoral fellowship from the Agency of Research and Universities (Ministry of Economy and Knowledge, Catalan Government) and the Cofund program (Marie Curie Actions, Seventh Framework Programme of the European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Aratyn-Schaus Yvonne, 2010, J Vis Exp, DOI 10.3791/2173; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Johnson PM, 2005, POLYMER, V46, P3300, DOI 10.1016/j.polymer.2005.02.085; Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0; Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Ramachandra M, 1996, MOL BIOL CELL, V7, P1485, DOI 10.1091/mbc.7.10.1485; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; ROSS RA, 1983, J NATL CANCER I, V71, P741; Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011; Tse J. R., 2009, CURR PROT CELL BIO; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	30	146	147	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2012	7	10							e46107	10.1371/journal.pone.0046107	http://dx.doi.org/10.1371/journal.pone.0046107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	017HM	23056241	Green Submitted, Green Published, gold			2022-12-25	WOS:000309580800010
J	Maddalo, D; Neeb, A; Jehle, K; Schmitz, K; Muhle-Goll, C; Shatkina, L; Walther, TV; Bruchmann, A; Gopal, SM; Wenzel, W; Ulrich, AS; Cato, ACB				Maddalo, Danilo; Neeb, Antje; Jehle, Katja; Schmitz, Katja; Muhle-Goll, Claudia; Shatkina, Liubov; Walther, Tamara Vanessa; Bruchmann, Anja; Gopal, Srinivasa M.; Wenzel, Wolfgang; Ulrich, Anne S.; Cato, Andrew C. B.			A Peptidic Unconjugated GRP78/BiP Ligand Modulates the Unfolded Protein Response and Induces Prostate Cancer Cell Death	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHAPERONE ACTIVITY; ANDROGEN RECEPTOR; SURFACE GRP78; UP-REGULATION; ACTIVATION; BAG-1; EXPRESSION; ANTIBODIES; PREDICTOR	The molecular chaperone GRP78/BiP is a key regulator of protein folding in the endoplasmic reticulum, and it plays a pivotal role in cancer cell survival and chemoresistance. Inhibition of its function has therefore been an important strategy for inhibiting tumor cell growth in cancer therapy. Previous efforts to achieve this goal have used peptides that bind to GRP78/BiP conjugated to pro-drugs or cell-death-inducing sequences. Here, we describe a peptide that induces prostate tumor cell death without the need of any conjugating sequences. This peptide is a sequence derived from the cochaperone Bag-1. We have shown that this sequence interacts with and inhibits the refolding activity of GRP78/BiP. Furthermore, we have demonstrated that it modulates the unfolded protein response in ER stress resulting in PARP and caspase-4 cleavage. Prostate cancer cells stably expressing this peptide showed reduced growth and increased apoptosis in in vivo xenograft tumor models. Amino acid substitutions that destroyed binding of the Bag-1 peptide to GRP78/BiP or downregulation of the expression of GRP78 compromised the inhibitory effect of this peptide. This sequence therefore represents a candidate lead peptide for anti-tumor therapy.	[Maddalo, Danilo; Neeb, Antje; Jehle, Katja; Shatkina, Liubov; Walther, Tamara Vanessa; Bruchmann, Anja; Cato, Andrew C. B.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Schmitz, Katja] Karlsruhe Inst Technol, Inst Organ Chem, Eggenstein Leopoldshafen, Germany; [Muhle-Goll, Claudia; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces 2, Eggenstein Leopoldshafen, Germany; [Gopal, Srinivasa M.; Wenzel, Wolfgang] Karlsruhe Inst Technol, Inst Nanotechnol, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Cato, ACB (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	andrew.cato@kit.edu	Wenzel, Wolfgang/B-3207-2009; Ulrich, Anne S/H-5519-2013; Muhle-Goll, Claudia/AAM-6070-2021; Schmitz, Katja/B-9342-2008; Cato, Andrew C. B./H-2071-2013	Wenzel, Wolfgang/0000-0001-9487-4689; Ulrich, Anne S/0000-0001-5571-9483; Cato, Andrew C. B./0000-0001-8508-3834; Maddalo, Danilo/0000-0002-3228-1703; Schmitz, Katja/0000-0001-9023-318X; Neeb, Antje/0000-0002-6516-2938	Association for International Cancer Research, United Kingdom; German Science Foundation; European Union 6th framework program PRIMA; Karlsruhe Institute of Technology; Marie Curie research fellowship CANCURE in the European Union 6th framework program	Association for International Cancer Research, United Kingdom; German Science Foundation(German Research Foundation (DFG)); European Union 6th framework program PRIMA; Karlsruhe Institute of Technology(Helmholtz Association); Marie Curie research fellowship CANCURE in the European Union 6th framework program	This work was supported by grants from the Association for International Cancer Research, United Kingdom; the German Science Foundation, the European Union 6th framework program PRIMA, and start-up funds from the Karlsruhe Institute of Technology. Danilo Maddalo was a recipient of a Marie Curie research fellowship CANCURE in the European Union 6th framework program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawashdeh FY, 2010, EUR J GASTROEN HEPAT, V22, P1099, DOI 10.1097/MEG.0b013e3283378405; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bifulco G, 2012, GYNECOL ONCOL, V125, P220, DOI 10.1016/j.ygyno.2011.11.045; Bonomo J, 2010, BIOPHYS CHEM, V149, P58, DOI 10.1016/j.bpc.2010.04.001; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gray MD, 2005, MOL PHARMACOL, V68, P1699, DOI 10.1124/mol.105.014753; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holtrup F, 2011, BRIT J PHARMACOL, V162, P1045, DOI 10.1111/j.1476-5381.2010.01125.x; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hung WJ, 2003, MOL CELL BIOL, V23, P3477, DOI 10.1128/MCB.23.10.3477-3486.2003; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee E, 2011, INT J CANCER, V128, P726, DOI 10.1002/ijc.25370; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin S, 2010, PIGM CELL MELANOMA R, V23, P675, DOI 10.1111/j.1755-148X.2010.00731.x; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Park HR, 2007, TOXICOLOGY, V229, P253, DOI 10.1016/j.tox.2006.11.049; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scriven P, 2009, BRIT J CANCER, V101, P1692, DOI 10.1038/sj.bjc.6605365; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Underhill MF, 2005, BIOTECHNOL BIOENG, V89, P805, DOI 10.1002/bit.20403; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walther TV, 2012, JOVE-J VIS EXP, DOI 10.3791/3540; Wang HQ, 2007, ENDOCRINOLOGY, V148, P3258, DOI 10.1210/en.2006-1564; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Yang L, 2007, J CELL BIOCHEM, V102, P786, DOI 10.1002/jcb.21328; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	63	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45690	10.1371/journal.pone.0045690	http://dx.doi.org/10.1371/journal.pone.0045690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049684	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388500011
J	Weissteiner, S; Huetteroth, W; Kollmann, M; Weissbecker, B; Romani, R; Schachtner, J; Schutz, S				Weissteiner, Sonja; Huetteroth, Wolf; Kollmann, Martin; Weissbecker, Bernhard; Romani, Roberto; Schachtner, Joachim; Schuetz, Stefan			Cockchafer Larvae Smell Host Root Scents in Soil	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; ANTENNAL-LOBE; PLANT VOLATILES; BACKGROUND ODOR; SELECTION; LOCATION; INSECTS; BEETLE; BRAIN; ORGANIZATION	In many insect species olfaction is a key sensory modality. However, examination of the chemical ecology of insects has focussed up to now on insects living above ground. Evidence for behavioral responses to chemical cues in the soil other than CO2 is scarce and the role played by olfaction in the process of finding host roots below ground is not yet understood. The question of whether soil-dwelling beetle larvae can smell their host plant roots has been under debate, but proof is as yet lacking that olfactory perception of volatile compounds released by damaged host plants, as is known for insects living above ground, occurs. Here we show that soil-dwelling larvae of Melolontha hippocastani are well equipped for olfactory perception and respond electrophysiologically and behaviorally to volatiles released by damaged host-plant roots. An olfactory apparatus consisting of pore plates at the antennae and about 70 glomeruli as primary olfactory processing units indicates a highly developed olfactory system. Damage induced host plant volatiles released by oak roots such as eucalyptol and anisol are detected by larval antennae down to 5 ppbv in soil air and elicit directed movement of the larvae in natural soil towards the odor source. Our results demonstrate that plant-root volatiles are likely to be perceived by the larval olfactory system and to guide soil-dwelling white grubs through the dark below ground to their host plants. Thus, to find below-ground host plants cockchafer larvae employ mechanisms that are similar to those employed by the adult beetles flying above ground, despite strikingly different physicochemical conditions in the soil.	[Weissteiner, Sonja; Weissbecker, Bernhard; Schuetz, Stefan] Univ Gottingen, Gottingen, Germany; [Huetteroth, Wolf; Kollmann, Martin; Schachtner, Joachim] Univ Marburg, Marburg, Germany; [Romani, Roberto] Univ Perugia, Dipartimento Sci Agr & Ambientali, I-06100 Perugia, Italy	University of Gottingen; Philipps University Marburg; University of Perugia	Schutz, S (corresponding author), Univ Gottingen, Gottingen, Germany.	stefan.schuetz@forst.uni-goettingen.de	Schachtner, Joachim/D-5522-2009; Huetteroth, Wolf/I-6661-2015; Schachtner, Joachim/AAG-1101-2020; Romani, Roberto/F-4157-2014; Huetteroth, Wolf/L-5252-2019; Romani, Roberto/O-4004-2019	Schachtner, Joachim/0000-0001-7268-0699; Romani, Roberto/0000-0002-2059-4702; Huetteroth, Wolf/0000-0003-3421-9935; Romani, Roberto/0000-0002-2059-4702	Cusanuswerk Scholarship; Deutsche Forschungsgemeinschaft (DFG) [SPP 1392]	Cusanuswerk Scholarship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	SW is grateful for the financial support to the Cusanuswerk Scholarship. Support by the Deutsche Forschungsgemeinschaft (DFG) SPP 1392 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bernklau EJ, 2009, J ECON ENTOMOL, V102, P558, DOI 10.1603/029.102.0213; Bezemer TM, 2004, J CHEM ECOL, V30, P53, DOI 10.1023/B:JOEC.0000013182.50662.2a; BOURGOIN T, 1994, INT J INSECT MORPHOL, V23, P159, DOI 10.1016/0020-7322(94)90008-6; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Dreyer D, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.003.2010; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; Farbert P, 1997, ENVIRON ENTOMOL, V26, P1105, DOI 10.1093/ee/26.5.1105; Gosset V, 2009, J EXP BOT, V60, P1231, DOI 10.1093/jxb/erp015; Hasler T, 1986, THESIS ETH ZURICH; HIBBARD BE, 1994, J CHEM ECOL, V20, P3335, DOI 10.1007/BF02033730; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hiltpold I, 2008, J CHEM ECOL, V34, P628, DOI 10.1007/s10886-008-9467-6; Hu JH, 2011, ARTHROPOD STRUCT DEV, V40, P420, DOI 10.1016/j.asd.2011.03.003; Immler Thomas, 2008, Forstschutz Aktuell, V45, P17; Johnson SN, 2006, PHYSIOL ENTOMOL, V31, P1, DOI 10.1111/j.1365-3032.2005.00487.x; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kent K.S., 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V315, P1, DOI 10.1098/rstb.1987.0001; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Lewis C. T, 1970, Tissue Cell, V2, P375, DOI 10.1016/S0040-8166(70)80038-6; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Niinemets U, 2002, NEW PHYTOL, V153, P243, DOI 10.1046/j.0028-646X.2001.00323.x; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; NORDENHEM H, 1994, J APPL ENTOMOL, V117, P457, DOI 10.1111/j.1439-0418.1994.tb00762.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; Reinecke A, 2008, BASIC APPL ECOL, V9, P568, DOI 10.1016/j.baae.2007.10.002; Robert CAM, 2012, NEW PHYTOL, V194, P1061, DOI 10.1111/j.1469-8137.2012.04127.x; Ruther J, 2000, PHYSIOL ENTOMOL, V25, P172, DOI 10.1046/j.1365-3032.2000.00183.x; Satomura T, 2006, ECOL RES, V21, P741, DOI 10.1007/s11284-006-0182-x; Schachtner J, 2004, J EXP BIOL, V207, P2389, DOI 10.1242/jeb.01036; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Schutz S, 1999, BIOSENS BIOELECTRON, V14, P221, DOI 10.1016/S0956-5663(98)00092-X; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Schutz S, 2003, NOVA ACTA LEOPOLDINA, V328, P215; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Staudacher EM, 2005, ADV INSECT PHYSIOL, V32, P49, DOI 10.1016/S0065-2806(05)32002-9; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Thomas RS, 2008, SOIL BIOL BIOCHEM, V40, P207, DOI 10.1016/j.soilbio.2007.08.002; Utz S, 2008, DEV NEUROBIOL, V68, P123, DOI 10.1002/dneu.20579; Vrkocova P, 2000, BIOCHEM SYST ECOL, V28, P933, DOI 10.1016/S0305-1978(00)00042-9; Weissbecker B, 2004, J CHROMATOGR A, V1056, P209, DOI 10.1016/j.chroma.2004.06.120; Weissteiner S., 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P51	48	44	46	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45827	10.1371/journal.pone.0045827	http://dx.doi.org/10.1371/journal.pone.0045827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049688	Green Published, gold			2022-12-25	WOS:000309388500015
J	Nabavi, N; Pustylnik, S; Harrison, RE				Nabavi, Noushin; Pustylnik, Sofia; Harrison, Rene E.			Rab GTPase Mediated Procollagen Trafficking in Ascorbic Acid Stimulated Osteoblasts	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; POLYMERASE CHAIN-REACTION; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; PLASMA-MEMBRANE; BREFELDIN-A; COLLAGEN BIOSYNTHESIS; NUCLEOTIDE EXCHANGE; SECRETORY PROTEINS; GOLGI-APPARATUS	Despite advances in investigating functional aspects of osteoblast (OB) differentiation, especially studies on how bone proteins are deposited and mineralized, there has been little research on the intracellular trafficking of bone proteins during OB differentiation. Collagen synthesis and secretion is the major function of OBs and is markedly up-regulated upon ascorbic acid (AA) stimulation, significantly more so than in fibroblast cells. Understanding the mechanism by which collagen is mobilized in specialized OB cells is important for both basic cell biology and diseases involving defects in bone protein secretion and deposition. Protein trafficking along the exocytic and endocytic pathways is aided by many molecules, with Rab GTPases being master regulators of vesicle targeting. In this study, we used microarray analysis to identify the Rab GTPases that are up-regulated during a 5-day AA differentiation of OBs, namely Rab1, Rab3d, and Rab27b. Further, we investigated the role of identified Rabs in regulating the trafficking of collagen from the site of synthesis in the ER to the Golgi and ultimately to the plasma membrane utilizing Rab dominant negative (DN) expression. We also observed that experimental halting of biosynthetic trafficking by these mutant Rabs initiated proteasome-mediated degradation of procollagen and ceased global protein translation. Acute expression of Rab1 and Rab3d DN constructs partially alleviated this negative feedback mechanism and resulted in impaired ER to Golgi trafficking of procollagen. Similar expression of Rab27b DN constructs resulted in dispersed collagen vesicles which may represent failed secretory vesicles sequestered in the cytosol. A significant and strong reduction in extracellular collagen levels was also observed implicating the functional importance of Rab1, Rab3d and Rab27b in these major collagen-producing cells.	[Nabavi, Noushin; Harrison, Rene E.] Univ Tronto Scarborought, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nabavi, Noushin; Pustylnik, Sofia; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Tronto Scarborought, Dept Cell & Syst Biol, Toronto, ON, Canada.	harrison@utsc.utoronto.ca		Nabavi, Noushin/0000-0002-5471-6229	Natural Science and Engineering Research Council (NSERC) [RGPIN 298538-09]; Ontario Early Researcher Award; Canadian Institutes of Health Research New Investigator Award; General Motors Women in Sciences and Mathematics; NSERC-CGS scholarship	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); General Motors Women in Sciences and Mathematics; NSERC-CGS scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council (NSERC) grant (RGPIN 298538-09) to REH who is also the recipient of an Ontario Early Researcher Award and a Canadian Institutes of Health Research New Investigator Award. NN is a recipient of a General Motors Women in Sciences and Mathematics and NSERC-CGS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2003, SYNTHESE, V134, P1; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; BERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P4746, DOI 10.1073/pnas.77.8.4746; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Billiard J, 2003, J CELL BIOCHEM, V89, P389, DOI 10.1002/jcb.10514; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Brinckmann J., 2005, COLLAGEN PRIMER STRU; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Carinci F, 2005, ARCH ORAL BIOL, V50, P481, DOI 10.1016/j.archoralbio.2004.11.006; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Christiansen HE, AM J HUMAN GENETICS, V86, P389; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Figueiredo AC, 2008, J BIOL CHEM, V283, P23209, DOI 10.1074/jbc.M804134200; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; KIRK TZ, 1987, J BIOL CHEM, V262, P5540; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kresh J, 2011, PFLUGERS ARCH EUROPE, P1; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; LEBLOND CP, 1989, ANAT REC, V224, P123, DOI 10.1002/ar.1092240204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS BL, 1984, NUCLEIC ACIDS RES, V12, P2569, DOI 10.1093/nar/12.5.2569; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; MURAD S, 1981, P NATL ACAD SCI-BIOL, V78, P2879, DOI 10.1073/pnas.78.5.2879; Muslin AJ, 2001, CIRC RES, V89, P1087, DOI 10.1161/res.89.12.1087; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Ripley CR, 1997, EXP CELL RES, V236, P147, DOI 10.1006/excr.1997.3707; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Tabellini G, 2009, LOCALIZATION SMALL M; Tamaki H, 2002, J HISTOCHEM CYTOCHEM, V50, P1611, DOI 10.1177/002215540205001205; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Toomre D, 1999, J CELL SCI, V112, P21; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Tzaphlidou M, 2005, MICRON, V36, P593, DOI 10.1016/j.micron.2005.05.009; Valentijn JA, 2007, AM J PHYSIOL-GASTR L, V293, pG165, DOI 10.1152/ajpgi.00520.2006; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xing W, 2011, PHYSL GENOMICS; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	71	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46265	10.1371/journal.pone.0046265	http://dx.doi.org/10.1371/journal.pone.0046265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050002	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517300101
J	Chen, Y; Dong, YM; Sandiford, S; Dimopoulos, G				Chen, Yang; Dong, Yuemei; Sandiford, Simone; Dimopoulos, George			Transcriptional Mediators Kto and Skd Are Involved in the Regulation of the IMD Pathway and Anti-Plasmodium Defense in Anopheles gambiae	PLOS ONE			English	Article							C-ELEGANS; MALARIA PARASITE; INNATE IMMUNITY; NEURAL CREST; COMPLEX; GENE; EXPRESSION; SUBUNITS; COACTIVATOR; INFECTION	The malarial parasite Plasmodium must complete a complex lifecycle in its Anopheles mosquito host, the main vector for Plasmodium. The mosquito resists infection with the human malarial parasite P. falciparum by engaging the NF-kappa B immune signaling pathway, IMD. Here we show that the conserved transcriptional mediators Kto and Skd are involved in the regulation of the mosquito IMD pathway. RNAi-mediated depletion of Kto and Skd in the Anopheles gambiae cell line L5-3 resulted in a decrease in the transcript abundance of Cec1, which is controlled by the IMD pathway. Silencing the two genes also resulted in an increased susceptibility of the mosquito to bacterial and Plasmodium falciparum infection, but not to infection with the rodent malaria parasite P. berghei. We also showed that Kto and Skd are not transcriptional co-activators of Rel2 or other key factors of the IMD pathway; however, they participate in the regulation of the IMD pathway, which is crucial for the mosquito's defense against P. falciparum.	[Chen, Yang; Dong, Yuemei; Sandiford, Simone; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	gdimopou@jhsph.edu	Chen, Yang/F-3130-2013	Dong, Yuemei/0000-0002-7902-2899; Dimopoulos, George/0000-0001-6755-8111	NIH/NIAD [R01AI061576]	NIH/NIAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01AI061576 from the NIH/NIAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen Y, 2008, INSECT SCI, V15, P45, DOI 10.1111/j.1744-7917.2008.00186.x; Chen Y, 2009, INSECT SCI, V16, P443, DOI 10.1111/j.1744-7917.2009.01296.x; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Lim J, 2007, DEV BIOL, V308, P322, DOI 10.1016/j.ydbio.2007.05.029; Lin H, 2007, INSECT SCI, V14, P185, DOI 10.1111/j.1744-7917.2007.00142.x; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meister S, 2004, INT J PARASITOL, V34, P1473, DOI 10.1016/j.ijpara.2004.10.004; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Treisman JE, 2001, DEVELOPMENT, V128, P603; Wang JC, 2004, J BIOL CHEM, V279, P29270, DOI 10.1074/jbc.M401242200; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776; Zhang H, 2000, GENE DEV, V14, P2161, DOI 10.1101/gad.814700; Zheng XL, 2002, INSECT MOL BIOL, V11, P517, DOI 10.1046/j.1365-2583.2002.00360.x	38	8	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45580	10.1371/journal.pone.0045580	http://dx.doi.org/10.1371/journal.pone.0045580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049816	gold, Green Submitted, Green Published			2022-12-25	WOS:000309556100056
J	Hoegl, T; Heinrich, H; Barth, W; Losel, F; Moll, GH; Kratz, O				Hoegl, Thomas; Heinrich, Hartmut; Barth, Wolfgang; Loesel, Friedrich; Moll, Gunther H.; Kratz, Oliver			Time Course Analysis of Motor Excitability in a Response Inhibition Task According to the Level of Hyperactivity and Impulsivity in Children with ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRANSCRANIAL MAGNETIC STIMULATION; STOP-SIGNAL PARADIGM; INTRACORTICAL INHIBITION; TOURETTE-SYNDROME; VOLITIONAL INHIBITION; CORTEX; DEFICIT; METHYLPHENIDATE; MECHANISMS	Short interval intracortical inhibition (SICI) of motor cortex, measured by transcranial magnetic stimulation (TMS) in a passive (resting) condition, has been suggested as a neurophysiological marker of hyperactivity in attention-deficit/hyperactivity disorder (ADHD). The aim of this study was to determine motor excitability in a go/nogo task at stages of response preparation, activation and suppression in children with ADHD, depending on the level of hyperactivity and impulsivity. Motor evoked potentials were recorded in 29 typically developing children and 43 children with ADHD (subdivided in two groups with higher and lower levels of hyperactivity/impulsivity; H/I-high and H/I-low). In the H/I-high group, SICI was markedly reduced in the resting condition and during response preparation. Though these children were able to increase SICI when inhibiting a response, SICI was still reduced compared to typically developing children. Interestingly, SICI at rest and during response activation were comparable, which may be associated with their hypermotoric behaviour. In the H/I-low group, response activation was accompanied by a pronounced decrease of SICI, indicating reduced motor control in the context of a fast motor response. In summary, different excitability patterns were obtained for the three groups allowing a better understanding of dysfunctional response activation and inhibition processes within the motor cortex in children with ADHD.	[Hoegl, Thomas; Heinrich, Hartmut; Barth, Wolfgang; Moll, Gunther H.; Kratz, Oliver] Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, D-91054 Erlangen, Germany; [Heinrich, Hartmut] Heckscher Klinikum Munchen, Munich, Germany; [Loesel, Friedrich] Univ Erlangen Nurnberg, Inst Psychol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hoegl, T (corresponding author), Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, D-91054 Erlangen, Germany.	thomas.hoegl@uk-erlangen.de		Heinrich, Hartmut/0000-0002-8156-489X				Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Banaschewski T, 2004, J NEURAL TRANSM, V111, P841, DOI 10.1007/s00702-003-0040-8; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; BARKER AT, 1985, LANCET, V1, P1106; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Boroojerdi B, 2002, J CLIN NEUROPHYSIOL, V19, P255, DOI 10.1097/00004691-200208000-00002; Boylan LS, 2000, CLIN NEUROPHYSIOL, V111, P504, DOI 10.1016/S1388-2457(99)00280-1; Buchmann J, 2006, NEUROSCI LETT, V405, P14, DOI 10.1016/j.neulet.2006.06.026; Buchmann J, 2007, BIOL PSYCHIAT, V62, P963, DOI 10.1016/j.biopsych.2007.05.010; Burle B, 2002, PSYCHOPHYSIOLOGY, V39, P207, DOI 10.1017/S0048577201392119; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Di Lazzaro V, 2006, J PHYSIOL-LONDON, V575, P721, DOI 10.1113/jphysiol.2006.114694; Dopfner M, 2000, DISYPS KJ DIAGNOSTIK; Fujiyama H, 2011, PSYCHOPHYSIOLOGY; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Gilbert DL, 2005, BIOL PSYCHIAT, V57, P1597, DOI 10.1016/j.biopsych.2005.02.022; Gilbert DL, 2004, MOVEMENT DISORD, V19, P416, DOI 10.1002/mds.20044; Gilbert DL, 2006, BRAIN, V129, P2038, DOI 10.1093/brain/awl147; Groom MJ, 2010, BIOL PSYCHIAT, V67, P624, DOI 10.1016/j.biopsych.2009.09.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Heise KF, 2010, BRAIN, V133, P580, DOI 10.1093/brain/awp299; Hoegl T, 2011, INT J PSYCHOPHYSIOL, V81, P99, DOI 10.1016/j.ijpsycho.2011.05.004; Hoshiyama M, 1997, ELECTROMYOGR MOTOR C, V105, P255, DOI 10.1016/S0924-980X(97)00019-2; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kratz O, 2011, J ECT, V27, P48, DOI 10.1097/YCT.0b013e3181d2ef85; Kratz O, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-12; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Moll GH, 2000, NEUROSCI LETT, V284, P121, DOI 10.1016/S0304-3940(00)00980-0; Moll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Scheres A, 2001, CHILD NEUROPSYCHOL, V7, P172, DOI 10.1076/chin.7.3.172.8746; Shanahan MA, 2008, DEV NEUROPSYCHOL, V33, P137, DOI 10.1080/87565640701884238; Sohn YH, 2002, J NEUROPHYSIOL, V88, P333, DOI 10.1152/jn.2002.88.1.333; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Sonuga-Barke EJS, 2010, BIOL PSYCHIAT, V67, P599, DOI 10.1016/j.biopsych.2010.01.017; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; van den Wildenberg WPM, 2010, J COGNITIVE NEUROSCI, V22, P225, DOI 10.1162/jocn.2009.21248; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2011, CEREB CORTEX, V21, P1639, DOI 10.1093/cercor/bhq235; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7	57	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46066	10.1371/journal.pone.0046066	http://dx.doi.org/10.1371/journal.pone.0046066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049936	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100129
J	Kuo, WH; Chang, YY; Lai, LC; Tsai, MH; Hsiao, CK; Chang, KJ; Chuang, EY				Kuo, Wen-Hung; Chang, Yao-Yin; Lai, Liang-Chuan; Tsai, Mong-Hsun; Hsiao, Chuhsing Kate; Chang, King-Jen; Chuang, Eric Y.			Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas	PLOS ONE			English	Article							BASAL-LIKE SUBTYPE; TGF-BETA; PORTRAITS; PHENOTYPE; TUMORS; MYC	Background: Triple-negative breast cancer is a subtype of breast cancer with aggressive tumor behavior and distinct disease etiology. Due to the lack of an effective targeted medicine, treatment options for triple-negative breast cancer are few and recurrence rates are high. Although various multi-gene prognostic markers have been proposed for the prediction of breast cancer outcome, most of them were proven clinically useful only for estrogen receptor-positive breast cancers. Reliable identification of triple-negative patients with a favorable prognosis is not yet possible. Methodology/Principal Findings: Clinicopathological information and microarray data from 157 invasive breast carcinomas were collected at National Taiwan University Hospital from 1995 to 2008. Gene expression data of 51 triple-negative and 106 luminal breast cancers were generated by oligonucleotide microarrays. Hierarchical clustering analysis revealed that the majority (94%) of triple-negative breast cancers were tightly clustered together carrying strong basal-like characteristics. A 45-gene prognostic signature giving 98% predictive accuracy in distant recurrence of our triple-negative patients was determined using the receiver operating characteristic analysis and leave-one-out cross validation. External validation of the prognostic signature in an independent microarray dataset of 59 early-stage triple-negative patients also obtained statistical significance (hazard ratio 2.29, 95% confidence interval (CI) 1.04-5.06, Cox P = 0.04), outperforming five other published breast cancer prognostic signatures. The 45-gene signature identified in this study revealed that TGF-beta signaling of immune/inflammatory regulation may play an important role in distant metastatic invasion of triple-negative breast cancer. Conclusions/Significance: Gene expression data and recurrence information of triple-negative breast cancer were collected and analyzed in this study. A novel set of 45-gene signature was found to be statistically predictive in disease recurrence of triple-negative breast cancer. The 45-gene signature, if further validated, may be a clinically useful tool in risk assessment of distant recurrence for early-stage triple-negative patients.	[Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Chang, Yao-Yin; Chuang, Eric Y.] Natl Taiwan Univ, Dept Elect Engn, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chang, Yao-Yin; Chuang, Eric Y.] NTU Ctr Genom Med, Bioinformat & Biostat Core, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Dept Surg, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chang, KJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan.	kingjen@ntu.edu.tw; chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; KUO, WEN-HUNG/0000-0002-9881-4605; hsiao, chuhsing kate/0000-0003-4905-8484; TSAI, MONG-HSUN/0000-0001-8777-5818; Chang, King jen/0000-0001-9811-3422	National Science Council of Taiwan [NSC97-2314-B-002-154-MY3]; Department of Health, Taiwan [DOH101-TD-C-111-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This study was supported by the National Science Council of Taiwan (NSC97-2314-B-002-154-MY3) and the Department of Health, Taiwan (DOH101-TD-C-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1832; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; SMOLA MG, 1991, CANCER, V68, P1026, DOI 10.1002/1097-0142(19910901)68:5<1026::AID-CNCR2820680520>3.0.CO;2-H; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	34	60	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45831	10.1371/journal.pone.0045831	http://dx.doi.org/10.1371/journal.pone.0045831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049873	Green Submitted, Green Published, gold			2022-12-25	WOS:000309556100087
J	Namekar, M; Kumar, M; O'Connell, M; Nerurkar, VR				Namekar, Madhuri; Kumar, Mukesh; O'Connell, Maile; Nerurkar, Vivek R.			Effect of Serum Heat-Inactivation and Dilution on Detection of Anti-WNV Antibodies in Mice by West Nile Virus E-protein Microsphere Immunoassay	PLOS ONE			English	Article							ST-LOUIS-ENCEPHALITIS; PERSISTENCE; ASSAY; INTERFERENCE; INFECTIONS; VALIDATION; PROTECTION; VACCINE	Immunopathogenesis studies employing West Nile virus (WNV) mice model are important for the development of antivirals and vaccines against WNV. Since antibodies produced in mice early during WNV infection are essential for clearing virus from the periphery, it is important to detect early and persistent anti-WNV antibodies. ELISA and plaque reduction neutralization tests are traditionally used for detection of anti-WNV antibodies and WNV-neutralizing antibodies, respectively. Although these assays are sensitive and specific, they are expensive and time consuming. Microsphere immunoassays (MIA) are sensitive, specific, allow for high throughput, are cost effective, require less time to perform than other methods, and require low serum volumes. Several assay parameters such as serum heat-inactivation (HI) and dilution can alter WNV MIA sensitivity. We examined the effect of these parameters on WNV E-protein MIA (WNV E-MIA) for the enhanced detection of anti-WNV IgM and IgG antibodies. WNV E-MIA was conducted using serial dilutions of HI and non-HI (NHI) serum collected at various time points from mice inoculated with WNV. HI significantly enhanced detection of IgM and IgG antibodies as compared to NHI serum. WNV IgM and IgG antibodies in HI sera were detected earlier at day 3 and IgM antibodies persisted up to day 24 after infection. HI serum at 1: 20 dilution was found to be optimal for detection of both IgM and IgG antibodies as compared to higher-serum dilutions. Further, addition of exogenous complement to the HI serum decreased the WNV E-MIA sensitivity. These results suggest that serum-HI and optimal dilution enhance WNV E-MIA sensitivity by eliminating the complement interference, thereby detecting low-titer anti-WNV antibodies during early and late phases of infection. This improved MIA can also be readily employed for detection of low-titer antibodies for detection of other infectious agents and host proteins.	[Namekar, Madhuri; Kumar, Mukesh; O'Connell, Maile; Nerurkar, Vivek R.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Nerurkar, VR (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Namekar, Madhuri/AAU-9421-2021; Nerurkar, Vivek R/F-5533-2011; Kumar, Mukesh/N-8814-2015; Kumar, Mukesh/AAI-1046-2019	Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences [P20GM103516]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [U01AI078213]; Department of Defense, and Institutional Funds [W8IXWH0720073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense, and Institutional Funds(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants (P20GM103516) from the Centers of Biomedical Research Excellence, National Institute of General Medical Sciences and (U01AI078213) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and (W8IXWH0720073) from the Department of Defense, and Institutional Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Balasuriya UBR, 2006, J VET DIAGN INVEST, V18, P392, DOI 10.1177/104063870601800413; Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93; Bellisario R, 2001, EARLY HUM DEV, V64, P21, DOI 10.1016/S0378-3782(01)00167-0; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P879; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862; Go YY, 2008, CLIN VACCINE IMMUNOL, V15, P76, DOI 10.1128/CVI.00388-07; Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005; Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07; Jones LP, 2002, CLIN DIAGN LAB IMMUN, V9, P633, DOI 10.1128/CDLI.9.3.633-638.2002; Karakus R, 2005, J IMMUNOASS IMMUNOCH, V26, P109, DOI 10.1081/IAS-200051994; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lowe D, 2007, INT J IMMUNOGENET, V34, P288; Martins TB, 2008, AM J CLIN PATHOL, V129, P34, DOI 10.1309/65VKWVNAQ38PHMGQ; MCHUGH TM, 1988, J CLIN MICROBIOL, V26, P1957, DOI 10.1128/JCM.26.10.1957-1961.1988; Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Perkins J, 2007, CLIN VACCINE IMMUNOL, V14, P1472, DOI 10.1128/CVI.00227-07; Prince HE, 2008, J CLIN VIROL, V43, P102, DOI 10.1016/j.jcv.2008.03.025; Roe K, 2012, J GEN VIROL; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; SCHETTERS T, 1988, J IMMUNOL METHODS, V109, P193, DOI 10.1016/0022-1759(88)90242-6; Schnaidt M, 2011, TRANSPLANTATION, V92, P510, DOI 10.1097/TP.0b013e31822872dd; Schwenk JM, 2011, METHODS MOL BIOL, V723, P29, DOI 10.1007/978-1-61779-043-0_3; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Stewart BS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-6; Tate Jill, 2004, Clin Biochem Rev, V25, P105; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Verma S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-66; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; WEBER TH, 1990, SCAND J CLIN LAB INV, V50, P77, DOI 10.3109/00365519009085803; Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004; Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003	39	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45851	10.1371/journal.pone.0045851	http://dx.doi.org/10.1371/journal.pone.0045851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049879	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100092
J	Zhu, GP; Petersen, MJ; Bu, WJ				Zhu, Gengping; Petersen, Matthew J.; Bu, Wenjun			Selecting Biological Meaningful Environmental Dimensions of Low Discrepancy among Ranges to Predict Potential Distribution of Bean Plataspid Invasion	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; NICHE CONSERVATISM; CLIMATIC NICHE; SHIFTS; UNCERTAINTY; GEOGRAPHY; ACCURACY; GARP	Background: The Bean plataspid (Megacopta cribraria) (Hemiptera: Pentatomidae), native to Asia, is becoming an invasive species in North America; its potential spread to soybean producing areas in the US is of great concern. Ecological niche modelling (ENM) has been used increasingly in predicting invasive species' potential distribution; however, poor niche model transferability was sometimes reported, leading to the artifactual conclusion of niche differentiation during species' invasion. Methodology/Principals: We aim to improve the geographical transferability of ENM via environmental variable selection to predict the potential distribution of Bean plataspid invasion. Sixteen environmental dimensions between native and introduced Bean plataspid populations were compared, and classified into two datasets with different degrees of discrepancy by the interquartile range (IQR) overlap in boxplot. Niche models based on these two datasets were compared in native model prediction and invading model projection. Classical niche model approaches (i.e., model calibrated on native range and transferred outside) were used to anticipate the potential distribution of Bean plataspid invasion. Conclusions/Significance: Niche models based on the two datasets showed little difference in native model predictions; however, when projecting onto the introduced area, models based on the environmental datasets showing low discrepancy among ranges recovered good model transferability in predicting the newly established population of Bean plataspid in the US. Recommendations were made for selecting biological meaningful environmental dimensions of low discrepancy among ranges to improve niche model transferability among these geographically separated areas. Outside of its native range, areas with invasion potential include the southeastern US in North America, southwestern Europe, southeastern South America, southern Africa, and the eastern coastal Australia.	[Zhu, Gengping] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Zhu, Gengping; Bu, Wenjun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Petersen, Matthew J.] Cornell Univ, Dept Entomol, Geneva, NY USA	Nankai University; Nankai University; Cornell University	Zhu, GP (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/CAF-4192-2022; Zhu, Gengping/E-4730-2013	Zhu, Gengping/0000-0001-6823-5840; 	China Postdoctoral Science Foundation [2012M510744]; National Education Project in Basic Science for Special Subjects [J0930005]; National Natural Science Foundation of China [31071959]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Education Project in Basic Science for Special Subjects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the China Postdoctoral Science Foundation (2012M510744), the National Education Project in Basic Science for Special Subjects (Insect Systematics, no. J0930005) and National Natural Science Foundation of China (no. 31071959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GAZETTEER CHINA; APHIS, 2004, NAPIS PESTTRACKER PU; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Brito JC, 2008, BIOL J LINN SOC, V95, P790, DOI 10.1111/j.1095-8312.2008.01071.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Chen Q, 2009, J HENAN AGR SCI, V4, P88; Eger J.E. Jr., 2010, Insecta Mundi, V0121, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Fent M, 2011, NORTH-WEST J ZOOL, V7, P72; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Jenkins Tracie M., 2011, Insects, V2, P264, DOI 10.3390/insects2030264; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kikuchi A, 2010, JPN J APPL ENTOMOL Z, V54, P37, DOI 10.1303/jjaez.2010.37; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Li YH, 2001, PLANT PROT TECHNOL E, V21, P11; Liu XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018429; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Montandon A. L., 1896, Annales de la Societe Entomologique de Belgique, Vxl, P86; Montandon A L, 1897, ANN SOC ENTOMOLOGIQU, V1896, P436; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rabitsch W, 2008, ZOOTAXA, P1; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Suiter DR, 2010, MEGACOPTA CRIBRARIA; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAYUTIVUTIKUL J, 1990, Japanese Journal of Entomology, V58, P533; Upton G., 1996, UNDERSTANDING STAT, P55; USDA, 2010, INV INS BEAN PLAT PO; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; YANG WE-I, 1934, BULL FAN MEM INST BIOL [ZOOL], V5, P137; Zhang S.M., 1985, EC INSECT FAUNA CHIN; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	69	11	14	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46247	10.1371/journal.pone.0046247	http://dx.doi.org/10.1371/journal.pone.0046247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049993	Green Submitted, gold, Green Published			2022-12-25	WOS:000309556100165
J	Derbal-Wolfrom, L; Pencreach, E; Saandi, T; Aprahamian, M; Martin, E; Greferath, R; Tufa, E; Choquet, P; Lehn, JM; Nicolau, C; Duluc, I; Freund, JN				Derbal-Wolfrom, L.; Pencreach, E.; Saandi, T.; Aprahamian, M.; Martin, E.; Greferath, R.; Tufa, E.; Choquet, P.; Lehn, J-M; Nicolau, C.; Duluc, I.; Freund, J-N			Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2	ONCOGENE			English	Article						hypoxia; ITPP; colon cancer; xenograft; MAP kinase; homeobox gene	EXPRESSION; INHIBITOR	Preventing tumor neovascularisation is one of the strategies recently developed to limit the dissemination of cancer cells and apparition of metastases. Although these approaches could improve the existing treatments, a number of unexpected negative effects have been reported, mainly linked to the hypoxic condition and the subsequent induction of the pro-oncogenic hypoxia inducible factor(s) resulting from cancer cells' oxygen starvation. Here, we checked in vivo on colon cancer cells an alternative approach. It is based on treatment with myo-inositol trispyrophosphate (ITPP), a molecule that leads to increased oxygenation of tumors. We provide evidence that ITPP increases the survival of mice in a model of carcinomatosis of human colon cancer cells implanted into the peritoneal cavity. ITPP also reduced the growth of subcutaneous colon cancer cells xenografted in nu/nu mice. In the subcutaneous tumors, ITPP stimulated the expression of the homeobox gene Cdx2 that is crucial for intestinal differentiation and that also has an anti-tumoral function. On this basis, human colon cancer cells were cultured in vitro in hypoxic conditions. Hypoxia was shown to decrease the level of Cdx2 protein, mRNA and the activity of the Cdx2 promoter. This decline was unrelated to the activation of HIF1 alpha and HIF2 alpha by hypoxia. However, it resulted from the activation of a phosphatidylinositol 3-kinases-like mitogen-activated protein kinase pathway, as assessed by the fact that LY294002 and U0126 restored high Cdx2 expression in hypoxia. Corroborating these results, U0126 recapitulated the increase of Cdx2 triggered by ITPP in subcutaneous colon tumor xenografts. The present study provides evidence that a chemical compound that increases oxygen pressure can antagonize the hypoxic setting and reduce the growth of human colon tumors implanted in nu/nu mice.	[Derbal-Wolfrom, L.; Saandi, T.; Aprahamian, M.; Martin, E.; Duluc, I.; Freund, J-N] INSERM, U682, Strasbourg, France; [Pencreach, E.] CHU Hautepierre, Lab Biochim & Biol Mol, EA Physiopathol & Med Translat 4438, F-67098 Strasbourg, France; [Greferath, R.; Tufa, E.; Nicolau, C.] NormOxys Inc, Boston, MA USA; [Choquet, P.] CHU Hautepierre, Serv Biophys & Med Nucl, Fre3240, CNRS, F-67098 Strasbourg, France; [Greferath, R.; Tufa, E.; Lehn, J-M] CNRS, UMR 7006, ISIS, Strasbourg, France; [Nicolau, C.] Tufts Univ, Friedman Sch Nutr Sci, Boston, MA 02111 USA; [Derbal-Wolfrom, L.; Pencreach, E.; Saandi, T.; Aprahamian, M.; Martin, E.; Choquet, P.; Lehn, J-M; Duluc, I.; Freund, J-N] Univ Strasbourg, Fac Med, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Centre National de la Recherche Scientifique (CNRS); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tufts University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Freund, JN (corresponding author), Univ Strasbourg, INSERM, U682, 3 Ave Moliere, F-67200 Strasbourg, France.	jean-noel.freund@inserm.fr	Duluc, Isabelle/O-1972-2017; DULUC, Isabelle/AAA-7062-2022; Freund, Jean-Noel/R-4383-2016; CHOQUET, Philippe/H-5868-2019; Pencreach, Erwan/R-3750-2016	Duluc, Isabelle/0000-0001-8396-6385; DULUC, Isabelle/0000-0001-8396-6385; Freund, Jean-Noel/0000-0002-0971-3774; CHOQUET, Philippe/0000-0003-0514-0726; 	INSERM (France); NormOxys Inc (USA); Ligue contre la Cancer du Haut-Rhin (France); AICR (UK); Departement of Mayotte (France)	INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); NormOxys Inc (USA); Ligue contre la Cancer du Haut-Rhin (France); AICR (UK); Departement of Mayotte (France)	This work was supported by the INSERM (France), NormOxys Inc (USA) and the Ligue contre la Cancer du Haut-Rhin (France). Ms Saandi was supported by the AICR (UK) and the Departement of Mayotte (France).	Aprahamian M, 2011, CHEMBIOCHEM, V12, P777, DOI 10.1002/cbic.201000619; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Benahmed F, 2007, AM J PATHOL, V170, P733, DOI 10.2353/ajpath.2007.060696; Biolo A, 2009, P NATL ACAD SCI USA, V106, P1926, DOI 10.1073/pnas.0812381106; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Gross I, 2008, ONCOGENE, V27, P107, DOI 10.1038/sj.onc.1210601; Gross I, 2005, ONCOGENE, V24, P7955, DOI 10.1038/sj.onc.1208945; Hinkel I, 2012, GASTROENTEROLOGY, V142, P875, DOI 10.1053/j.gastro.2011.12.037; Kieda C, 2006, P NATL ACAD SCI USA, V103, P15576, DOI 10.1073/pnas.0607109103; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; PEARSON JW, 1989, CANCER RES, V49, P3562; Pencreach E, 2009, CLIN CANCER RES, V15, P1297, DOI 10.1158/1078-0432.CCR-08-0889; Renouf B, 2012, NUCLEIC ACIDS RES, V40, P3456, DOI 10.1093/nar/gkr1242; Sihn G, 2007, FEBS LETT, V581, P962, DOI 10.1016/j.febslet.2007.01.079; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Turck N, 2005, EXP CELL RES, V303, P494, DOI 10.1016/j.yexcr.2004.10.025; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006	19	22	23	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4313	4318		10.1038/onc.2012.445	http://dx.doi.org/10.1038/onc.2012.445			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045284				2022-12-25	WOS:000324168000013
J	Gusenbauer, S; Vlaicu, P; Ullrich, A				Gusenbauer, S.; Vlaicu, P.; Ullrich, A.			HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors	ONCOGENE			English	Article						HGF; EGFR; resistance; gefitinib; kinase-independent	EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; FACTOR RECEPTOR; ACQUIRED-RESISTANCE; MET AMPLIFICATION; GEFITINIB RESISTANCE; T790M MUTATIONS; C-MET; EXPRESSION; ACTIVATION	The epidermal growth factor receptor (EGFR) is overexpressed and activated in many human cancers and predicts poor patient prognosis. Targeting the kinase domain with specific EGFR tyrosine kinase inhibitors (TKIs) like gefitinib and erlotinib has been used in anticancer treatments. However, patient response rates in different human cancers were initially low. Only a subgroup of non-small-cell lung cancer (NSCLC) patients harboring EGFR-activating mutations responds to EGFR TKI treatment, but most of these responders relapse and acquire resistance. Recent clinical studies have demonstrated that MET proto-oncogene overexpression correlates with resistance to EGFR TKI treatment. Similarly to MET overexpression, the tumor microenvironment-derived ligand hepatocyte growth factor (HGF) was shown to activate Met and thereby induce short-term resistance to EGFR TKI treatment in gefitinib-sensitive NSCLC cell lines in vitro. However, only little is known about the HGF/Met-induced EGFR TKI resistance mechanism in other human cancer types. Therefore, in order to develop possible new anticancer strategies for diverse human cancers, we screened 12 carcinoma cell lines originating from the breast, kidney, liver and tongue for HGF-induced EGFR tyrosine kinase (TK)-inhibition. In addition, in order to advance our understanding of a TK-inactive EGFR, we used EGFR co-immunoprecipitation, followed by mass spectrometry to identify novel HGF-induced EGFR binding partners, which are potentially involved in tyrosine kinase-independent EGFR signaling mechanisms. Here we show for the first time that HGF-induced EGFR TK-inhibition is a very common mechanism in human cancers, and that the kinase-inactive EGFR directly interacts with and stabilizes several cancer-relevant proteins, including the receptor tyrosine kinases Axl and EphA2, and the CUB domain-containing protein-1. This study has strong implications for the development of new anticancer strategies.	[Gusenbauer, S.; Vlaicu, P.; Ullrich, A.] Max Planck Inst Biochem, Dept Mol Biol, D-85152 Martinsried, Germany	Max Planck Society	Ullrich, A (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-85152 Martinsried, Germany.	ullrich@biochem.mpg.de						Arteaga CL, 2002, ONCOLOGIST, V7, P31; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blagosklonny MV, 2003, CANCER BIOL THER, V2, P137, DOI 10.4161/cbt.2.2.286; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Castillo L, 2004, ANN ONCOL, V15, P1007, DOI 10.1093/annonc/mdh257; Chen HJ, 2009, PATHOL ONCOL RES, V15, P651, DOI 10.1007/s12253-009-9167-8; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dickler MN, 2009, BREAST CANCER RES TR, V115, P115, DOI 10.1007/s10549-008-0055-9; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Gordon AN, 2005, INT J GYNECOL CANCER, V15, P785, DOI 10.1111/j.1525-1438.2005.00137.x; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Laimer K, 2007, ORAL ONCOL, V43, P193, DOI 10.1016/j.oraloncology.2006.02.009; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Liu LB, 2008, J MED CHEM, V51, P3688, DOI 10.1021/jm800401t; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pai R, 2003, FASEB J, V17, P1640, DOI 10.1096/fj.02-1011com; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peghini PL, 2002, CLIN CANCER RES, V8, P2273; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Reznik TE, 2008, MOL CANCER RES, V6, P139, DOI 10.1158/1541-7786.MCR-07-0236; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Spix JK, 2007, EXP CELL RES, V313, P3319, DOI 10.1016/j.yexcr.2007.06.006; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Timpson P, 2007, CANCER RES, V67, P9304, DOI 10.1158/0008-5472.CAN-07-0798; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Twombly R, 2005, J NATL CANCER I, V97, P249, DOI 10.1093/jnci/97.4.249; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Xu L, 2010, ONCOGENE, V29, P2616, DOI 10.1038/onc.2010.16; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yoshida T, 2010, BIOCHEM PHARMACOL, V80, P613, DOI 10.1016/j.bcp.2010.05.014; Zhuang GL, 2010, CANCER RES, V70, P299, DOI 10.1158/0008-5472.CAN-09-1845; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	53	80	86	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3846	3856		10.1038/onc.2012.396	http://dx.doi.org/10.1038/onc.2012.396			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	23045285				2022-12-25	WOS:000323210200007
J	Kowalski-Chauvel, A; Najib, S; Tikhonova, IG; Huc, L; Lopez, F; Martinez, LO; Cohen-Jonathan-Moyal, E; Ferrand, A; Seva, C				Kowalski-Chauvel, Aline; Najib, Souad; Tikhonova, Irina G.; Huc, Laurence; Lopez, Frederic; Martinez, Laurent O.; Cohen-Jonathan-Moyal, Elizabeth; Ferrand, Audrey; Seva, Catherine			Identification of the F-1-ATPase at the Cell Surface of Colonic Epithelial Cells ROLE IN MEDIATING CELL PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-EXTENDED GASTRIN; ATP SYNTHASE; BIOLOGICAL-ACTIVITY; ENDOTHELIAL-CELLS; STIMULATES PROLIFERATION; COLORECTAL-CARCINOMA; ONCOGENIC RAS; GROWTH-FACTOR; TUMOR-CELLS; FERRIC IONS	F-1 domain of F1Fo-ATPase was initially believed to be strictly expressed in the mitochondrial membrane. Interestingly, recent reports have shown that the F-1 complex can serve as a cell surface receptor for apparently unrelated ligands. Here we show for the first time the presence of the F-1-ATPase at the cell surface of normal or cancerous colonic epithelial cells. Using surface plasmon resonance technology and mass spectrometry, we identified a peptide hormone product of the gastrin gene (glycine-extended gastrin (G-gly)) as a new ligand for the F-1-ATPase. By molecular modeling, we identified the motif in the peptide sequence (E(E/D)XY), that directly interacts with the F-1-ATPase and the amino acids in the F-1-ATPase that bind this motif. Replacement of the Glu-9 residue by an alanine in the E(E/D)XY motif resulted in a strong decrease of G-gly binding to the F-1-ATPase and the loss of its biological activity. In addition we demonstrated that F-1-ATPase mediates the growth effects of the peptide. Indeed, blocking F-1-ATPase activity decreases G-glyinduced cell growth. The mechanism likely involves ADP production by the membrane F-1-ATPase, which is induced by G-gly. These results suggest an important contribution of cell surface F-1-ATPase in the pro-proliferative action of this gastrointestinal peptide.	[Kowalski-Chauvel, Aline; Najib, Souad; Lopez, Frederic; Cohen-Jonathan-Moyal, Elizabeth; Ferrand, Audrey; Seva, Catherine] Univ Toulouse 3, Canc Res Ctr Toulouse, INSERM UMR 1037, F-31052 Toulouse, France; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland; [Huc, Laurence] Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,TOXALIM Res Ctr Food Toxicol, F-31300 Toulouse, France; [Martinez, Laurent O.] Inst Malad Metab & Cardiovasc I2MC, INSERM UMR 1048, F-31432 Toulouse, France; [Cohen-Jonathan-Moyal, Elizabeth] Inst Claudius Regaud, F-31052 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Queens University Belfast; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud	Seva, C (corresponding author), Inst Claudius Regaud, INSERM UMR CRCT 1037, 20-24 Rue Pont St Pierre, F-31052 Toulouse, France.	cathy.seva@inserm.fr	Huc, Laurence/J-1888-2014; FERRAND, Audrey/I-5623-2016; Martinez, Laurent O/B-8343-2015; Moyal, Elizabeth/A-9802-2015; SEVA, Catherine/O-9166-2014; Martinez, Laurent O./ABD-6880-2020; Kowalski-Chauvel, Aline/O-9212-2014	Huc, Laurence/0000-0002-0336-7559; FERRAND, Audrey/0000-0002-1057-8151; Martinez, Laurent O/0000-0002-0985-3152; Moyal, Elizabeth/0000-0002-6593-9276; SEVA, Catherine/0000-0002-4265-7372; Martinez, Laurent O./0000-0002-0985-3152; Najib, Souad/0000-0001-5509-1411	INSERM; French Association for Cancer Research [ARC-SFI-201112-03828]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Association for Cancer Research	This work was supported by INSERM, the French Association for Cancer Research (ARC-SFI-201112-03828).	Alard JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014654; Aly A, 2001, INT J CANCER, V94, P307, DOI 10.1002/ijc.1483; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bertrand C, 2010, INT J CANCER, V126, P2847, DOI 10.1002/ijc.25001; Biason JV, 2011, J MOL BIOL, V406, P443, DOI 10.1016/j.jmb.2010.12.025; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Chakladar A, 2005, BIOCHEM BIOPH RES CO, V336, P190, DOI 10.1016/j.bbrc.2005.08.061; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chang HJ, 2007, CANCER SCI, V98, P1184, DOI 10.1111/j.1349-7006.2007.00527.x; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; CICCOTOSTO GD, 1995, GASTROENTEROLOGY, V109, P1142, DOI 10.1016/0016-5085(95)90572-3; Clarke PA, 2006, CANCER RES, V66, P3504, DOI 10.1158/0008-5472.CAN-05-0280; Dardousis K, 2007, MOL THER, V15, P94, DOI 10.1038/sj.mt.6300003; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Ferrand A, 2006, WORLD J GASTROENTERO, V12, P1859, DOI 10.3748/wjg.v12.i12.1859; Ferrand A, 2006, CANCER LETT, V238, P15, DOI 10.1016/j.canlet.2005.06.025; Ferrand A, 2010, AM J PHYSIOL-GASTR L, V299, pG220, DOI 10.1152/ajpgi.00046.2010; FINLEY GG, 1993, CANCER RES, V53, P2919; He H, 2005, AM J PHYSIOL-GASTR L, V289, pG478, DOI 10.1152/ajpgi.00034.2005; Hollande F, 1997, GASTROENTEROLOGY, V113, P1576, DOI 10.1053/gast.1997.v113.pm9352860; Houli N, 2006, REGUL PEPTIDES, V134, P9, DOI 10.1016/j.regpep.2005.10.001; Iwase K, 1997, GASTROENTEROLOGY, V113, P782, DOI 10.1016/S0016-5085(97)70172-0; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Koh TJ, 1999, J CLIN INVEST, V103, P1119, DOI 10.1172/JCI4910; Koh TJ, 2004, CANCER RES, V64, P196, DOI 10.1158/0008-5472.CAN-03-2112; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Mowery YM, 2008, CANCER BIOL THER, V7, P1836, DOI 10.4161/cbt.7.11.7155; Nakata H, 1998, GASTROENTEROLOGY, V115, P1144, DOI 10.1016/S0016-5085(98)70085-X; NEMETH J, 1993, GUT, V34, P90, DOI 10.1136/gut.34.1.90; Ogunwobi OA, 2006, REGUL PEPTIDES, V134, P1, DOI 10.1016/j.regpep.2005.08.002; Ogunwobi OO, 2008, MOL CELL ENDOCRINOL, V296, P94, DOI 10.1016/j.mce.2008.08.004; Pannequin J, 2004, J ENDOCRINOL, V181, P315, DOI 10.1677/joe.0.1810315; Pannequin J, 2004, J BIOL CHEM, V279, P2453, DOI 10.1074/jbc.M309806200; Pannequin J, 2002, J BIOL CHEM, V277, P48602, DOI 10.1074/jbc.M208440200; Radojkovic C, 2009, ARTERIOSCL THROM VAS, V29, P1125, DOI 10.1161/ATVBAHA.109.187997; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; SOLEIMANI M, 1994, J BIOL CHEM, V269, P27973; Stepan VM, 1999, AM J PHYSIOL-REG I, V277, pR572, DOI 10.1152/ajpregu.1999.277.2.R572; Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321; VANSOLINGE WW, 1993, GASTROENTEROLOGY, V104, P1099, DOI 10.1016/0016-5085(93)90279-L; Wang JB, 2008, CANCER BIOL THER, V7, P1829, DOI 10.4161/cbt.7.11.6861; Watson SA, 1996, CANCER RES, V56, P880	46	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41458	41468		10.1074/jbc.M112.382465	http://dx.doi.org/10.1074/jbc.M112.382465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23055519	hybrid, Green Published			2022-12-25	WOS:000311887600057
J	Johar, K; Priya, A; Wong-Riley, MTT				Johar, Kaid; Priya, Anusha; Wong-Riley, Margaret T. T.			Regulation of Na+/K+-ATPase by Nuclear Respiratory Factor 1 IMPLICATION IN THE TIGHT COUPLING OF NEURONAL ACTIVITY, ENERGY GENERATION, AND ENERGY CONSUMPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; GENE-EXPRESSION; NEUROCHEMICAL ORGANIZATION; TRANSCRIPTIONAL REGULATION; NA,K-ATPASE ALPHA-1; BETA-SUBUNITS; FACTOR-I; RAT; METABOLISM; ISOFORM	Energy generation and energy consumption are tightly coupled to neuronal activity at the cellular level. Na+/K+-ATPase, a major energy-consuming enzyme, is well expressed in neurons rich in cytochrome c oxidase, an important enzyme of the energy-generating machinery, and glutamatergic receptors that are mediators of neuronal activity. The present study sought to test our hypothesis that the coupling extends to the molecular level, whereby Na+/K+-ATPase subunits are regulated by the same transcription factor, nuclear respiratory factor 1 (NRF-1), found recently by our laboratory to regulate all cytochrome c oxidase subunit genes and some NMDA and AMPA receptor subunit genes. By means of multiple approaches, including in silico analysis, electrophoretic mobility shift and supershift assays, in vivo chromatin immunoprecipitation, promoter mutational analysis, and real-time quantitative PCR, NRF-1 was found to functionally bind to the promoters of Atp1a1 and Atp1b1 genes but not of the Atp1a3 gene in neurons. The transcripts of Atp1a1 and Atp1b1 subunit genes were up-regulated by KCl and down-regulated by tetrodotoxin. Atp1b1 is positively regulated by NRF-1, and silencing of NRF-1 with small interference RNA blocked the up-regulation of Atp1b1 induced by KCl, whereas overexpression of NRF-1 rescued these transcripts from being suppressed by tetrodotoxin. On the other hand, Atp1a1 is negatively regulated by NRF-1. The binding sites of NRF-1 on Atp1a1 and Atp1b1 are conserved among mice, rats, and humans. Thus, NRF-1 regulates key Na+/K+-ATPase subunits and plays an important role in mediating the tight coupling between energy consumption, energy generation, and neuronal activity at the molecular level.	[Johar, Kaid; Priya, Anusha; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Johar, Kaid/AAC-9182-2021; Wong-Riley, Margaret/AGM-6202-2022; Johar, Kaid/F-5034-2013	Johar, Kaid/0000-0002-1703-6611	National Institutes of Health [R01EY018441, T32-EY14537]; NATIONAL EYE INSTITUTE [R01EY018441, T32EY014537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY018441 and Grant T32-EY14537.	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ASTRUP J, 1981, STROKE, V12, P726, DOI 10.1161/01.STR.12.6.726; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhar SS, 2011, BBA-MOL CELL RES, V1813, P403, DOI 10.1016/j.bbamcr.2010.12.013; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; Dhar SS, 2009, J NEUROCHEM, V108, P1595, DOI 10.1111/j.1471-4159.2009.05929.x; Dhar SS, 2009, J NEUROSCI, V29, P483, DOI 10.1523/JNEUROSCI.3704-08.2009; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GICK GG, 1993, J MEMBRANE BIOL, V131, P229, DOI 10.1007/BF02260111; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Habiba A, 2000, BRAIN RES, V875, P1, DOI 10.1016/S0006-8993(00)02541-5; HEVNER RF, 1992, NEUROSCI LETT, V138, P188, DOI 10.1016/0304-3940(92)90502-X; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; KANO I, 1989, FEBS LETT, V250, P91, DOI 10.1016/0014-5793(89)80691-X; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Liang HL, 2006, NEUROREPORT, V17, P401, DOI 10.1097/01.wnr.0000204980.98876.11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; SHULL MM, 1990, GENOMICS, V6, P451, DOI 10.1016/0888-7543(90)90475-A; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; SUZUKIYAGAWA Y, 1992, MOL CELL BIOL, V12, P4046, DOI 10.1128/MCB.12.9.4046; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wong-Riley M, 1998, NEUROSCIENCE, V83, P1025, DOI 10.1016/S0306-4522(97)00432-6; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Wong-Riley MTT, 2012, ADV EXP MED BIOL, V748, P283, DOI 10.1007/978-1-4614-3573-0_12; Wong-Riley MTT, 1998, VISION RES, V38, P1455, DOI 10.1016/S0042-6989(98)00001-7; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yu HY, 1996, BBA-GENE STRUCT EXPR, V1309, P239, DOI 10.1016/S0167-4781(96)00130-3; Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x	56	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40381	40390		10.1074/jbc.M112.414573	http://dx.doi.org/10.1074/jbc.M112.414573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048038	Green Published, hybrid			2022-12-25	WOS:000311448800029
J	Li, JJ; Zhou, F; Zhan, DG; Gao, QQ; Cui, N; Li, JW; Iakhiaeva, E; Zwieb, C; Lin, BY; Wong, JM				Li, Jingjing; Zhou, Fan; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Iakhiaeva, Elena; Zwieb, Christian; Lin, Biaoyang; Wong, Jiemin			A Novel Histone H4 Arginine 3 Methylation-sensitive Histone H4 Binding Activity and Transcriptional Regulatory Function for Signal Recognition Particle Subunits SRP68 and SRP72	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; DNA METHYLATION; GENE-EXPRESSION; PROTEIN; RNA; IDENTIFICATION; COMPLEX; H3R2; MUTAGENESIS; BIOGENESIS	Arginine methylation broadly occurs in the tails of core histones. However, the mechanisms by which histone arginine methylation regulates transcription remain poorly understood. In this study we attempted to identify nuclear proteins that specifically recognize methylated arginine 3 in the histone H4 (H4R3) tail using an unbiased proteomic approach. No major nuclear protein was observed to specifically bind to methylated H4R3 peptides. However, H4R3 methylation markedly inhibited the binding of two proteins to H4 tail peptide. These proteins were identified as the SRP68 and SRP72 heterodimers (SRP68/72), the components of the signal recognition particle (SRP). Only SRP68/72, but not the SRP complex, bound the H4 tail peptide. SRP68 and SRP72 bound the H4 tail in vitro and associated with chromatin in vivo. The chromatin association of SRP68 and SRP72 was regulated by PRMT5 and PRMT1. Both SRP68 and SRP72 activated transcription when tethered to a reporter via a heterologous DNA binding domain. Analysis of the genome-wide occupancy of SRP68 identified target genes regulated by SRP68. Taken together, these results demonstrate a role of H4R3 methylation in blocking the binding of effectors to chromatin and reveal a novel role for the SRP68/SRP72 heterodimer in the binding of chromatin and transcriptional regulation.	[Li, Jingjing; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Li, Jingjing; Zhan, Deguo; Gao, Qinqin; Cui, Nan; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Zhou, Fan; Lin, Biaoyang] Zhejiang Univ, Zhejiang California Int Nanosyst Inst ZCNI, Syst Biol Div, Hangzhou 310029, Zhejiang, Peoples R China; [Iakhiaeva, Elena; Zwieb, Christian] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	East China Normal University; East China Normal University; Zhejiang University; University of Texas System; University of Texas Health San Antonio	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	Lin, Biaoyang/AAA-1258-2020	Lin, Biaoyang/0000-0002-2189-0407; Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2010CB944903, 2009CB918402, 2009CB825601]; National Natural Science Foundation of China [90919025, 30871381]; Science Technology Commission of Shanghai Municipality [09DJ1400400, 11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2010CB944903, 2009CB918402, and 2009CB825601, National Natural Science Foundation of China Grants 90919025 and 30871381, and Science Technology Commission of Shanghai Municipality Grants 09DJ1400400 and 11DZ2260300.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Iakhiaeva E, 2006, PROTEIN SCI, V15, P1290, DOI 10.1110/ps.051861406; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Leung E, 2010, BIOCHEM SOC T, V38, P1093, DOI 10.1042/BST0381093; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Liu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030375; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Politz JC, 2002, J CELL BIOL, V159, P411, DOI 10.1083/jcb.200208037; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wu JC, 2012, P NATL ACAD SCI USA, V109, P5675, DOI 10.1073/pnas.1114905109; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034692; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Yin J, 2007, RNA BIOL, V4, P154, DOI 10.4161/rna.4.3.5428; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	46	14	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40641	40651		10.1074/jbc.M112.414284	http://dx.doi.org/10.1074/jbc.M112.414284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048028	hybrid, Green Published			2022-12-25	WOS:000311448800053
J	Wildenhain, S; Ingenhag, D; Ruckert, C; Degistirici, O; Dugas, M; Meisel, R; Hauer, J; Borkhardt, A				Wildenhain, Sarah; Ingenhag, Deborah; Ruckert, Christian; Degistirici, Oezer; Dugas, Martin; Meisel, Roland; Hauer, Julia; Borkhardt, Arndt			Homeobox Protein HB9 Binds to the Prostaglandin E Receptor 2 Promoter and Inhibits Intracellular cAMP Mobilization in Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANT LEUKEMIA; EXPRESSION; GENES; ETV6; EP2; DIFFERENTIATION; HLXB9; AML; T(7/12)(Q36,P13); T(7-12)(Q36-P13)	The transcription factor HB9, encoded by the homeobox gene B9 (HLXB9), is involved in the development of pancreatic betaand motor neuronal cells. In addition, HLXB9 is recurrently rearranged in young children with acute myeloid leukemia characterized by a chromosomal translocation t(7;12)-HLXB9/TEL and concomitant high expression of the unrearranged, wildtype HLXB9 allele. However, target genes of HB9 in hematopoietic cells are not known to date. In this study, we used ChIP-on-chip analysis together with expression profiling and identified PTGER2 (prostaglandin E receptor 2) as a target gene of HB9 in a hematopoietic cell line. The functional HB9 homeodomain as well as the HB9 binding domain within the PTGER2 promoter are essential for binding of HB9 to the PTGER2 promoter region and down-regulation of PTGER2 expression. Functionally, HB9 conducted down-regulation of PTGER2 results in a reduced content of intracellular cAMP mobilization and furthermore the decreased PTGER2 gene expression is valid in bone marrow cells from translocation t(7;12) positive patients. Among the primary and secondary target genes of HB9 in the myeloid cell line HL60, 78% of significantly regulated genes are down-regulated, indicating an overall repressive function of HB9. Differentially regulated genes were preferentially confined to pathways involved in cell-adhesion and cell-cell interactions, similar to the gene expression footprint of HLXB9-expressing cells from t(7;12) positive patients.	[Wildenhain, Sarah; Ingenhag, Deborah; Degistirici, Oezer; Meisel, Roland; Hauer, Julia; Borkhardt, Arndt] Univ Dusseldorf, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ruckert, Christian; Dugas, Martin] Univ Munster, Inst Med Informat, D-48149 Munster, Germany	Heinrich Heine University Dusseldorf; University of Munster	Hauer, J (corresponding author), Univ Dusseldorf, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Moorenstr 5, D-40225 Dusseldorf, Germany.	Julia.Hauer@med.uni-duesseldorf.de	Dugas, Martin/F-5454-2011; Degistirici, Özer/ABC-3439-2021; Ruckert, Christian/A-8732-2013	Ruckert, Christian/0000-0001-9915-1287	Forschungskommission of the Heinrich Heine University of Dusseldorf	Forschungskommission of the Heinrich Heine University of Dusseldorf	This work was partially funded by the Forschungskommission of the Heinrich Heine University of Dusseldorf.	Beverloo HB, 2001, CANCER RES, V61, P5374; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; DALTON WT, 1988, BLOOD, V71, P242; DEGUCHI Y, 1991, BLOOD, V78, P323; Denizot Y, 2005, INT J CANCER, V115, P499, DOI 10.1002/ijc.20877; DHOOGHE MC, 1993, LEUKEMIA, V7, P1777; Fedyk ER, 1996, MOL IMMUNOL, V33, P33, DOI 10.1016/0161-5890(95)00130-1; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Hammerich-Hille S, 2010, J BIOL CHEM, V285, P3608, DOI 10.1074/jbc.M109.066431; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hauer J, 2008, PEDIATR BLOOD CANCER, V50, P921, DOI 10.1002/pbc.21376; Hollington P, 2004, ANTICANCER RES, V24, P955; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kobayashi Y, 2005, J BIOL CHEM, V280, P24035, DOI 10.1074/jbc.M500926200; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kornblau SM, 2010, BLOOD, V116, P4251, DOI 10.1182/blood-2010-01-262071; Malissein E, 2006, LEUKEMIA RES, V30, P1309, DOI 10.1016/j.leukres.2005.12.017; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Mielke C, 2000, GENE, V254, P1, DOI 10.1016/S0378-1119(00)00294-8; Nagel S, 2005, GENE CHROMOSOME CANC, V42, P170, DOI 10.1002/gcc.20113; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; SANTORO MG, 1977, CANCER RES, V37, P3774; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Slater RM, 2001, LEUKEMIA, V15, P915, DOI 10.1038/sj.leu.2402121; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tosi S, 2000, GENE CHROMOSOME CANC, V29, P325, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1039>3.0.CO;2-9; Tosi S, 2003, GENE CHROMOSOME CANC, V38, P191, DOI 10.1002/gcc.10258; von Bergh ARM, 2006, GENE CHROMOSOME CANC, V45, P731, DOI 10.1002/gcc.20335; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Wildenhain S, 2010, LEUKEMIA, V24, P1657, DOI 10.1038/leu.2010.146; Wilkens L, 2011, VIRCHOWS ARCH, V458, P697, DOI 10.1007/s00428-011-1070-5; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732	41	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40703	40712		10.1074/jbc.M111.308965	http://dx.doi.org/10.1074/jbc.M111.308965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23048027	Green Published, hybrid			2022-12-25	WOS:000311448800059
J	Wenners, AS; Mehta, K; Loibl, S; Park, H; Mueller, B; Arnold, N; Hamann, S; Weimer, J; Ataseven, B; Darb-Esfahani, S; Schem, C; Mundhenke, C; Khandan, F; Thomssen, C; Jonat, W; Holzhausen, HJ; von Minckwitz, G; Denkert, C; Bauer, M				Wenners, Antonia Sophie; Mehta, Keyur; Loibl, Sibylle; Park, Hyerim; Mueller, Berit; Arnold, Norbert; Hamann, Sigrid; Weimer, Joerg; Ataseven, Beyhan; Darb-Esfahani, Silvia; Schem, Christian; Mundhenke, Christoph; Khandan, Fariba; Thomssen, Christoph; Jonat, Walter; Holzhausen, Hans-Juergen; von Minckwitz, Gunther; Denkert, Carsten; Bauer, Maret			Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; III RANDOMIZED GEPARTRIO; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC THERAPY; GASTRIC-CANCER; DOCETAXEL; CYCLOPHOSPHAMIDE; DOXORUBICIN; CARCINOMA; PROGNOSIS	In our previous work we showed that NGAL, a protein involved in the regulation of proliferation and differentiation, is overexpressed in human breast cancer (BC) and predicts poor prognosis. In neoadjuvant chemotherapy (NACT) pathological complete response (pCR) is a predictor for outcome. The aim of this study was to evaluate NGAL as a predictor of response to NACT and to validate NGAL as a prognostic factor for clinical outcome in patients with primary BC. Immunohistochemistry was performed on tissue microarrays from 652 core biopsies from BC patients, who underwent NACT in the GeparTrio trial. NGAL expression and intensity was evaluated separately. NGAL was detected in 42.2% of the breast carcinomas in the cytoplasm. NGAL expression correlated with negative hormone receptor (HR) status, but not with other baseline parameters. NGAL expression did not correlate with pCR in the full population, however, NGAL expression and staining intensity were significantly associated with higher pCR rates in patients with positive HR status. In addition, strong NGAL expression correlated with higher pCR rates in node negative patients, patients with histological grade 1 or 2 tumors and a tumor size,40 mm. In univariate survival analysis, positive NGAL expression and strong staining intensity correlated with decreased disease-free survival (DFS) in the entire cohort and different subgroups, including HR positive patients. Similar correlations were found for intense staining and decreased overall survival (OS). In multivariate analysis, NGAL expression remained an independent prognostic factor for DFS. The results show that in low-risk subgroups, NGAL was found to be a predictive marker for pCR after NACT. Furthermore, NGAL could be validated as an independent prognostic factor for decreased DFS in primary human BC.	[Wenners, Antonia Sophie; Park, Hyerim; Arnold, Norbert; Hamann, Sigrid; Weimer, Joerg; Schem, Christian; Mundhenke, Christoph; Jonat, Walter; Bauer, Maret] Univ Med Ctr Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany; [Mehta, Keyur; Loibl, Sibylle; von Minckwitz, Gunther] GBG Forsch GmbH, German Breast Grp, Neu Isenburg, Germany; [Ataseven, Beyhan] Rot Kreuz Klinikum Muenchen, Dept Obstet & Gynaecol, Munich, Germany; [Khandan, Fariba] St Markus Hosp, Frankfurt, Germany; [Mueller, Berit; Darb-Esfahani, Silvia; Denkert, Carsten] Charite, Inst Pathol, Translat Tumorpathol Unit, Berlin, Germany; [Thomssen, Christoph] Univ Halle Wittenberg, Dept Gynecol, Halle, Germany; [Holzhausen, Hans-Juergen] Univ Halle Wittenberg, Dept Pathol, Halle, Germany	University of Kiel; Schleswig Holstein University Hospital; German Breast Group; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Wenners, AS (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Gynecol & Obstet, Kiel, Germany.	antonia.wenners@uk-sh.de	Thomssen, Christoph/ABC-3102-2021; Weimer, Jörg Paul/E-3472-2010; Denkert, Carsten/AHE-2675-2022; Arnold, Norbert/E-3012-2010; Mundhenke, Christoph/D-2593-2010	Weimer, Jörg Paul/0000-0002-4528-8509; Arnold, Norbert/0000-0003-4523-8808; Mundhenke, Christoph/0000-0002-6989-6250; Denkert, Carsten/0000-0002-2249-0982	Werner and Klara Kreitz Stiftung; Sanofi-Aventis; Roche; Novartis	Werner and Klara Kreitz Stiftung; Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Novartis(Novartis)	MB and JW were funded by the Werner and Klara Kreitz Stiftung. CT was funded by Sanofi-Aventis and Roche. WJ was funded by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barresi V, 2011, HUM PATHOL, V42, P1720, DOI 10.1016/j.humpath.2010.05.031; Barresi V, 2010, ONCOL REP, V24, P305, DOI 10.3892/or_00000860; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bonadonna G, 2005, BRIT MED J, V330, P217, DOI 10.1136/bmj.38314.622095.8F; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez-Sanchez M, 2006, MED ONCOL, V23, P171, DOI 10.1385/MO:23:2:171; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Flower DR, 1996, BIOCHEM J, V318, P1; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Gwira JA, 2005, J BIOL CHEM, V280, P7875, DOI 10.1074/jbc.M413192200; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huober J, 2010, BREAST CANCER RES TR, V124, P133, DOI 10.1007/s10549-010-1103-9; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Lee HJ, 2006, INT J CANCER, V118, P2490, DOI 10.1002/ijc.21657; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; Maur M, 2006, ANN ONCOL, V17, pV158, DOI 10.1093/annonc/mdj973; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Portera CCSS, 2007, NEOADJUVANT CHEMOTHE; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Stoesz SP, 1995, ONCOGENE, V11, P2233; Sun Y, 2011, CLIN CANCER RES, V17, P4331, DOI 10.1158/1078-0432.CCR-11-0226; Tewari M, 2008, SURG ONCOL, V17, P301, DOI 10.1016/j.suronc.2008.03.003; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tiezzi DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-36; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P552, DOI 10.1093/jnci/djn089; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P542, DOI 10.1093/jnci/djn085; von Minckwitz G, 2011, J CLIN ONCOL, V29, P2150, DOI 10.1200/JCO.2010.31.9079; Wang HJ, 2010, ANAT REC, V293, P1855, DOI 10.1002/ar.21230; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Zhang HH, 2007, J CLIN PATHOL, V60, P555, DOI 10.1136/jcp.2006.039297	43	42	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e45826	10.1371/journal.pone.0045826	http://dx.doi.org/10.1371/journal.pone.0045826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056218	gold, Green Published, Green Submitted			2022-12-25	WOS:000309889400008
J	Yang, L; Qiu, FM; Lu, XX; Huang, DS; Ma, GP; Guo, Y; Hu, M; Zhou, YM; Pan, MG; Tan, YG; Zhong, HB; Ji, WD; Wei, QY; Ran, PX; Zhong, NS; Zhou, YF; Lu, JC				Yang, Lei; Qiu, Fuman; Lu, Xiaoxiao; Huang, Dongsheng; Ma, Guanpei; Guo, Yuan; Hu, Min; Zhou, Yumin; Pan, Mingan; Tan, Yigang; Zhong, Haibo; Ji, Weidong; Wei, Qingyi; Ran, Pixin; Zhong, Nanshan; Zhou, Yifeng; Lu, Jiachun			Functional Polymorphisms of CHRNA3 Predict Risks of Chronic Obstructive Pulmonary Disease and Lung Cancer in Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR SUBUNIT GENES; SUSCEPTIBILITY LOCUS; FUNCTION DECLINE; EPITHELIAL-CELL; TOBACCO; NICOTINE; VARIANTS; PROLIFERATION; PREVALENCE	Recently, several genome-wide association studies (GWAS) have identified many susceptible single nucleotide polymorphisms (SNPs) for chronic obstructive pulmonary disease (COPD) and lung cancer which are two closely related diseases. Among those SNPs, some of them are shared by both the diseases, reflecting there is possible genetic similarity between the diseases. Here we tested the hypothesis that whether those shared SNPs are common predictor for risks or prognosis of COPD and lung cancer. Two SNPs (rs6495309 and rs1051730) located in nicotinic acetylcholine receptor alpha 3 (CHRNA3) gene were genotyped in 1511 patients with COPD, 1559 lung cancer cases and 1677 controls in southern and eastern Chinese populations. We found that the rs6495309CC and rs6495309CT/CC variant genotypes were associated with increased risks of COPD (OR = 1.32, 95% C. I. = 1.14-1.54) and lung cancer (OR = 1.57; 95% CI = 1.31-1.87), respectively. The rs6495309CC genotype contributed to more rapid decline of annual Forced expiratory volume in one second (FEV1) in both COPD cases and controls (P<0.05), and it was associated with advanced stages of COPD (P = 0.033); the rs6495309CT/CC genotypes conferred a poor survival for lung cancer (HR = 1.41, 95% CI = 1.13-1.75). The luciferase assays further showed that nicotine and other tobacco chemicals had diverse effects on the luciferase activity of the rs6495309C or T alleles. However, none of these effects were found for another SNP, rs1051730G>A. The data show a statistical association and suggest biological plausibility that the rs6495309T>C polymorphism contributed to increased risks and poor prognosis of both COPD and lung cancer.	[Yang, Lei; Qiu, Fuman; Lu, Xiaoxiao; Huang, Dongsheng; Ma, Guanpei; Ji, Weidong; Lu, Jiachun] Guangzhou Med Univ, Sch Publ Hlth, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhou, Yumin; Ran, Pixin; Zhong, Nanshan] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Huang, Dongsheng; Tan, Yigang] Guangzhou Chest Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Guo, Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Pan, Mingan] Sun Yat Sen Univ, Dept Resp Med, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zhong, Haibo] Guangzhou Red Cross Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Hu, Min; Zhou, Yifeng] Soochow Univ, Lab Canc Mol Genet, Coll Med, Suzhou, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Sun Yat Sen University; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center	Lu, JC (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	jcLu@gzhmc.edu.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University grant [IRT0961]; Guangdong natural science foundation team [10351012003000000];  [81170043];  [81001278];  [30872142]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong natural science foundation team; ; ; 	This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366 (JCL), and partly by 81170043 (PXR), 81001278 (Y. Zhou), 30872142 (WDJ); Guangdong Provincial High Level Experts Grants 2010-79 (JCL); Changjiang Scholars and Innovative Research Team in University grant IRT0961 and Guangdong natural science foundation team grant 10351012003000000 (NSZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan G, 2006, INT J ONCOL, V29, P745; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Caramori G, 2011, THORAX, V66, P521, DOI 10.1136/thx.2010.156448; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; Ding D, 2010, ADDICT BEHAV, V35, P989, DOI 10.1016/j.addbeh.2010.06.016; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; Hansel NN, 2009, EUR RESPIR J, V34, P103, DOI 10.1183/09031936.00120408; He JQ, 2009, THORAX, V64, P698, DOI 10.1136/thx.2008.111278; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Liu B, 2010, CARCINOGENESIS, V31, P1405, DOI 10.1093/carcin/bgq126; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154; Tanaka S, 2011, INT J CLIN ONCOL; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Uh Hae-Won, 2007, BMC Proc, V1 Suppl 1, pS114; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Yang L, 2011, CARCINOGENESIS; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zheng HC, 2011, J ONCOL, V2011, DOI 10.1155/2011/635379; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6387	45	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46071	10.1371/journal.pone.0046071	http://dx.doi.org/10.1371/journal.pone.0046071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056235	Green Published, gold, Green Submitted			2022-12-25	WOS:000309454000015
J	Goswami, ND; Hecker, EJ; Vickery, C; Ahearn, MA; Cox, GM; Holland, DP; Naggie, S; Piedrahita, C; Mosher, A; Torres, Y; Norton, BL; Suchindran, S; Park, PH; Turner, D; Stout, JE				Goswami, Neela D.; Hecker, Emily J.; Vickery, Carter; Ahearn, Marshall A.; Cox, Gary M.; Holland, David P.; Naggie, Susanna; Piedrahita, Carla; Mosher, Ann; Torres, Yvonne; Norton, Brianna L.; Suchindran, Sujit; Park, Paul H.; Turner, Debbie; Stout, Jason E.			Geographic Information System-based Screening for TB, HIV, and Syphilis (GIS-THIS): A Cross-Sectional Study	PLOS ONE			English	Article							TUBERCULOSIS TRANSMISSION; SPATIAL-DISTRIBUTION; RISK-FACTORS; CARE; PATTERNS; COSTS; RECOMMENDATIONS; INFECTION; THERAPY; ADULTS	Objective: To determine the feasibility and case detection rate of a geographic information systems (GIS)-based integrated community screening strategy for tuberculosis, syphilis, and human immunodeficiency virus (HIV). Design: Prospective cross-sectional study of all participants presenting to geographic hot spot screenings in Wake County, North Carolina. Methods: The residences of tuberculosis, HIV, and syphilis cases incident between 1/1/05-12/31/07 were mapped. Areas with high densities of all 3 diseases were designated "hot spots." Combined screening for tuberculosis, HIV, and syphilis were conducted at the hot spots; participants with positive tests were referred to the health department. Results and Conclusions: Participants (N = 247) reported high-risk characteristics: 67% previously incarcerated, 40% had lived in a homeless shelter, and 29% had a history of crack cocaine use. However, 34% reported never having been tested for HIV, and 41% did not recall prior tuberculin skin testing. Screening identified 3% (8/240) of participants with HIV infection, 1% (3/239) with untreated syphilis, and 15% (36/234) with latent tuberculosis infection. Of the eight persons with HIV, one was newly diagnosed and co-infected with latent tuberculosis; he was treated for latent TB and linked to an HIV provider. Two other HIV-positive persons had fallen out of care, and as a result of the study were linked back into HIV clinics. Of 27 persons with latent tuberculosis offered therapy, nine initiated and three completed treatment. GIS-based screening can effectively penetrate populations with high disease burden and poor healthcare access. Linkage to care remains challenging and will require creative interventions to impact morbidity.	[Goswami, Neela D.; Hecker, Emily J.; Ahearn, Marshall A.; Cox, Gary M.; Holland, David P.; Naggie, Susanna; Mosher, Ann; Norton, Brianna L.; Suchindran, Sujit; Park, Paul H.; Stout, Jason E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Piedrahita, Carla; Torres, Yvonne; Turner, Debbie] Wake Cty Human Serv, Raleigh, NC USA; [Vickery, Carter] Wake Cty Community Serv, Raleigh, NC USA	Duke University	Goswami, ND (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	neela.goswami@duke.edu; jason.stout@duke.edu		Stout, Jason/0000-0002-6698-8176; Park, Paul/0000-0001-7332-8320	National Institutes of Health T32 AIDS Training Grant [5T32-AI007392-22]; Duke Center for AIDS Research (CFAR), an National Institutes of Health [P30A164518]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, T32AI007392] Funding Source: NIH RePORTER	National Institutes of Health T32 AIDS Training Grant; Duke Center for AIDS Research (CFAR), an National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health T32 AIDS Training Grant to N.D.G. (5T32-AI007392-22) and a developmental grant to J.E.S. from the Duke Center for AIDS Research (CFAR), an National Institutes of Health funded program (P30A164518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2010, REP TUB US 2009; Centers for Disease Control and Prevention, 2009, PROGR COLL SERV INT; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; Geanuracos CG, 2007, AM J PUBLIC HEALTH, V97, P1974, DOI 10.2105/AJPH.2005.076851; Gesink DC, 2011, AM J EPIDEMIOL, V174, P81, DOI 10.1093/aje/kwr035; Goswami ND, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-305; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Heimer R, 2008, AIDS, V22, P123, DOI 10.1097/QAD.0b013e3282f244ef; Hixson BA, 2011, J URBAN HEALTH, V88, P129, DOI 10.1007/s11524-010-9510-0; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Kistemann T, 2002, SOC SCI MED, V55, P7, DOI 10.1016/S0277-9536(01)00216-7; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Law DCG, 2004, SEX TRANSM INFECT, V80, P294, DOI 10.1136/sti.2003.006700; Law DCG, 2006, ANN EPIDEMIOL, V16, P797, DOI 10.1016/j.annepidem.2006.05.003; Magnus M, 2009, AIDS, V23, P1277, DOI 10.1097/QAD.0b013e32832b51da; Mehta SD, 2008, PUBLIC HEALTH REP, V123, P608, DOI 10.1177/003335490812300511; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Moonan PK, 2006, AM J RESP CRIT CARE, V174, P599, DOI 10.1164/rccm.200512-1977OC; Mugavero MJ, 2007, CLIN INFECT DIS, V45, P127, DOI 10.1086/518587; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schleihauf E, 2009, SEX TRANSM INFECT, V85, P45, DOI 10.1136/sti.2008.030197; Shi LY, 2005, J GEN INTERN MED, V20, P148, DOI 10.1111/j.1525-1497.2005.40136.x; Sullivan AB, 2011, ANN EPIDEMIOL, V21, P245, DOI 10.1016/j.annepidem.2010.11.015; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Uphold CR, 2005, AIDS PATIENT CARE ST, V19, P473, DOI 10.1089/apc.2005.19.473; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955	36	36	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46029	10.1371/journal.pone.0046029	http://dx.doi.org/10.1371/journal.pone.0046029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NG	23056227	Green Published, gold, Green Submitted			2022-12-25	WOS:000309452600020
J	Pignatelli, J; Jones, MC; LaLonde, DP; Turner, CE				Pignatelli, Jeanine; Jones, Matthew C.; LaLonde, David P.; Turner, Christopher E.			Beta2-Adaptin Binds Actopaxin and Regulates Cell Spreading, Migration and Matrix Degradation	PLOS ONE			English	Article							CLATHRIN-DEPENDENT ENDOCYTOSIS; FOCAL ADHESION PROTEIN; METALLOPROTEINASE MT1-MMP; MEDIATED ENDOCYTOSIS; ACTIN POLYMERIZATION; RECYCLING PATHWAYS; MEMBRANE; SRC; INVASION; INVADOPODIA	Cell adhesion to the extracellular matrix is a key event in cell migration and invasion and endocytic trafficking of adhesion receptors and signaling proteins plays a major role in regulating these processes. Beta2-adaptin is a subunit of the AP-2 complex and is involved in clathrin-mediated endocytosis. Herein, beta 2-adaptin is shown to bind to the focal adhesion protein actopaxin and localize to focal adhesions during cells spreading in an actopaxin dependent manner. Furthermore, beta 2-adaptin is enriched in adhesions at the leading edge of migrating cells and depletion of beta 2-adaptin by RNAi increases cell spreading and inhibits directional cell migration via a loss of cellular polarity. Knockdown of beta 2-adaptin in both U2OS osteosarcoma cells and MCF10A normal breast epithelial cells promotes the formation of matrix degrading invadopodia, adhesion structures linked to invasive migration in cancer cells. These data therefore suggest that actopaxin-dependent recruitment of the AP-2 complex, via an interaction with beta 2-adaptin, to focal adhesions mediates cell polarity and migration and that beta 2-adaptin may control the balance between the formation of normal cell adhesions and invasive adhesion structures.	[Pignatelli, Jeanine; Jones, Matthew C.; Turner, Christopher E.] SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA; [LaLonde, David P.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University	Turner, CE (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA.	turnerce@upstate.edu		Jones, Matthew/0000-0003-4723-3277	National Institutes of Health [RO1HL070244]; National Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1HL070244 to C. E. Turner and a National Cancer Center predoctoral fellowship to J. Pignatelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Batchelder EM, 2010, MOL BIOL CELL, V21, P3070, DOI 10.1091/mbc.E09-12-1044; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Boyd ND, 2002, BIOCHEMISTRY-US, V41, P7232, DOI 10.1021/bi011501f; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; De Deyne PG, 1998, J CELL SCI, V111, P2729; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Huttenlocher A, 2001, CSH PERSPECT BIOL, V3; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Olski TM, 2001, J CELL SCI, V114, P525; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	63	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e46228	10.1371/journal.pone.0046228	http://dx.doi.org/10.1371/journal.pone.0046228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056266	Green Submitted, Green Published, gold			2022-12-25	WOS:000309452600027
J	Bergougnoux, V; Zalabak, D; Jandova, M; Novak, O; Wiese-Klinkenberg, A; Fellner, M				Bergougnoux, Veronique; Zalabak, David; Jandova, Michaela; Novak, Ondrej; Wiese-Klinkenberg, Anika; Fellner, Martin			Effect of Blue Light on Endogenous Isopentenyladenine and Endoreduplication during Photomorphogenesis and De-Etiolation of Tomato (Solanum lycopersicum L.) Seedlings	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; ARABIDOPSIS-THALIANA; HYPOCOTYL GROWTH; CYTOKININ BIOSYNTHESIS; SIGNALING PATHWAYS; MASS-SPECTROMETRY; MERISTEM ACTIVITY; CELL-DIVISION; PLANT-GROWTH; MUTANT	Light is one of the most important factor influencing plant growth and development all through their life cycle. One of the well-known light-regulated processes is de-etiolation, i.e. the switch from skotomorphogenesis to photomorphogenesis. The hormones cytokinins (CKs) play an important role during the establishment of photomorphogenesis as exogenous CKs induced photomorphogenesis of dark-grown seedlings. Most of the studies are conducted on the plant model Arabidopsis, but no or few information are available for important crop species, such as tomato (Solanum lycopersicum L.). In our study, we analyzed for the first time the endogenous CKs content in tomato hypocotyls during skotomorphogenesis, photomorphogenesis and de-etiolation. For this purpose, two tomato genotypes were used: cv. Rutgers (wild-type; WT) and its corresponding mutant (7B-1) affected in its responses to blue light (BL). Using physiological and molecular approaches, we identified that the skotomorphogenesis is characterized by an endoreduplication-mediated cell expansion, which is inhibited upon BL exposure as seen by the accumulation of trancripts encoding CycD3, key regulators of the cell cycle. Our study showed for the first time that iP (isopentenyladenine) is the CK accumulated in the tomato hypocotyl upon BL exposure, suggesting its specific role in photomorphogenesis. This result was supported by physiological experiments and gene expression data. We propose a common model to explain the role and the relationship between CKs, namely iP, and endoreduplication during de-etiolation and photomorphogenesis.	[Bergougnoux, Veronique; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Bergougnoux, Veronique; Novak, Ondrej; Fellner, Martin] Inst Expt Bot AS CR, Vvi, Olomouc, Czech Republic; [Bergougnoux, Veronique; Zalabak, David] Palacky Univ, Fac Sci, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Jandova, Michaela] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic; [Wiese-Klinkenberg, Anika] Forschungszentrum Julich, IBG Plant Sci 2, Inst Bio & Geosci, D-52425 Julich, Germany	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; Helmholtz Association; Research Center Julich	Bergougnoux, V (corresponding author), Palacky Univ, Fac Sci, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 11, CR-77147 Olomouc, Czech Republic.	v.bergougnoux@yahoo.fr; martin.fellner@upol.cz	Bergougnoux, Veronique/GZK-3304-2022; Wiese-Klinkenberg, Anika/C-8196-2009; Fellner, Martin/B-2068-2010; NOVAK, Ondrej/F-7031-2014	NOVAK, Ondrej/0000-0003-3452-0154; Zalabak, David/0000-0002-4825-8321; Bergougnoux, Veronique/0000-0003-0681-311X	Ministry of Education, Youth and Sports of the Czech Republic [MSM6198959215]; Czech Science Foundation [P501/10/0785]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by a grant of the Ministry of Education, Youth and Sports of the Czech Republic (MSM6198959215) and a grant of the Czech Science Foundation (P501/10/0785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergougnoux V, 2009, J EXP BOT, V60, P1219, DOI 10.1093/jxb/ern366; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; ChinAtkins AN, 1996, PLANTA, V198, P549, DOI 10.1007/BF00262641; Choi J, 2007, J PLANT BIOL, V50, P98, DOI 10.1007/BF03030617; CHORY J, 1994, PLANT PHYSIOL, V104, P339, DOI 10.1104/pp.104.2.339; Chory J, 1991, Symp Soc Exp Biol, V45, P21; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; COSGROVE DJ, 1981, PLANT PHYSIOL, V67, P584, DOI 10.1104/pp.67.3.584; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Gendreau E, 1998, PLANT J, V13, P221, DOI 10.1046/j.1365-313X.1998.00030.x; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Jacqmard A, 1999, PLANTA, V207, P496, DOI 10.1007/s004250050509; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kvarnheden A, 2000, J EXP BOT, V51, P1789, DOI 10.1093/jexbot/51.352.1789; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lochmanova G, 2008, J EXP BOT, V59, P3705, DOI 10.1093/jxb/ern220; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Nisler J, 2010, PHYTOCHEMISTRY, V71, P823, DOI 10.1016/j.phytochem.2010.01.018; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; Perrot-Rechenmann C, 2010, BIOLOGY, DOI [10.1101/cshperspect.a001446., DOI 10.1101/CSHPERSPECT.A001446]; Poire R, 2010, J EXP BOT, V61, P1751, DOI 10.1093/jxb/erq049; Reid BR, 1995, PLANT HORMONES PHYSL, P4848; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sawhney VK, 1997, ADAS, P183; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sheoran IS, 2006, PHYSIOL PLANTARUM, V127, P681, DOI 10.1111/j.1399-3054.2006.00697.x; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Symons GM, 2003, J PLANT GROWTH REGUL, V22, P3, DOI 10.1007/s00344-003-0017-8; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002	50	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45255	10.1371/journal.pone.0045255	http://dx.doi.org/10.1371/journal.pone.0045255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049779	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100033
J	He, D; Miao, M; Sitarz, EE; Muiznieks, LD; Reichheld, S; Stahl, RJ; Keeley, FW; Parkinson, J				He, David; Miao, Ming; Sitarz, Eva E.; Muiznieks, Lisa D.; Reichheld, Sean; Stahl, Richard J.; Keeley, Fred W.; Parkinson, John			Polymorphisms in the Human Tropoelastin Gene Modify In Vitro Self-Assembly and Mechanical Properties of Elastin-Like Polypeptides	PLOS ONE			English	Article							SEQUENCE; PROTEIN; ASSOCIATION; DISSECTION; DOMAIN; COACERVATION; DETERMINANTS; AGGREGATION; MORPHOLOGY; ANEURYSMS	Elastin is a major structural component of elastic fibres that provide properties of stretch and recoil to tissues such as arteries, lung and skin. Remarkably, after initial deposition of elastin there is normally no subsequent turnover of this protein over the course of a lifetime. Consequently, elastic fibres must be extremely durable, able to withstand, for example in the human thoracic aorta, billions of cycles of stretch and recoil without mechanical failure. Major defects in the elastin gene (ELN) are associated with a number of disorders including Supravalvular aortic stenosis (SVAS), Williams-Beuren syndrome (WBS) and autosomal dominant cutis laxa (ADCL). Given the low turnover of elastin and the requirement for the long term durability of elastic fibres, we examined the possibility for more subtle polymorphisms in the human elastin gene to impact the assembly and long-term durability of the elastic matrix. Surveys of genetic variation resources identified 118 mutations in human ELN, 17 being non-synonymous. Introduction of two of these variants, G422S and K463R, in elastin-like polypeptides as well as full-length tropoelastin, resulted in changes in both their assembly and mechanical properties. Most notably G422S, which occurs in up to 40% of European populations, was found to enhance some elastomeric properties. These studies reveal that even apparently minor polymorphisms in human ELN can impact the assembly and mechanical properties of the elastic matrix, effects that over the course of a lifetime could result in altered susceptibility to cardiovascular disease.	[He, David; Miao, Ming; Sitarz, Eva E.; Muiznieks, Lisa D.; Reichheld, Sean; Stahl, Richard J.; Keeley, Fred W.; Parkinson, John] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [He, David; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Keeley, Fred W.; Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Parkinson, J (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jparkin@sickkids.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189	Heart and Stroke Foundation of Ontario [T 6748, T 6725]; New Investigators Award from Canadian Institutes of Health Research and an Early Researchers; Ontario Ministry of Research and Innovation award from the Ontario Ministry of Research and Innovation; Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); New Investigators Award from Canadian Institutes of Health Research and an Early Researchers(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation award from the Ontario Ministry of Research and Innovation; Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre	This work was supported by grants from the Heart and Stroke Foundation of Ontario (JP and FWK: # T 6748; FWK # T 6725). JP is additionally supported by a New Investigators Award from Canadian Institutes of Health Research and an Early Researchers award from the Ontario Ministry of Research and Innovation. DH is supported by the Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa H, 2006, HUM MOL GENET, V15, P1722, DOI 10.1093/hmg/ddl096; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Callewaert B, 2011, HUM MUTAT, V32, P445, DOI 10.1002/humu.21462; Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Cirulis JT, 2010, BIOCHEMISTRY-US, V49, P5726, DOI 10.1021/bi100468v; Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230; DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874; Deng LH, 2009, AM J HYPERTENS, V22, P656, DOI 10.1038/ajh.2009.53; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOSLINE JM, 1978, BIOPOLYMERS, V17, P697, DOI 10.1002/bip.1978.360170312; Hanon O, 2001, HYPERTENSION, V38, P1185, DOI 10.1161/hy1101.096802; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Huntley D, 2006, BIOINFORMATICS, V22, P495, DOI 10.1093/bioinformatics/btk006; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; LEFEVRE M, 1980, BIOCHIM BIOPHYS ACTA, V630, P519, DOI 10.1016/0304-4165(80)90006-9; LeMaire SA, 2011, NAT GENET ADV; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/O09-161, 10.1139/o09-161]; Onda H, 2001, AM J HUM GENET, V69, P804, DOI 10.1086/323614; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Ruigrok YM, 2004, STROKE, V35, P2064, DOI 10.1161/01.STR.0000139380.50649.5c; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Song HY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002406; Sung HW, 2003, BIOMATERIALS, V24, P1335, DOI 10.1016/S0142-9612(02)00509-4; Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093; Urban Z, 2002, AM J HUM GENET, V71, P30, DOI 10.1086/341035; Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wang XW, 2005, SURGERY, V138, P352, DOI 10.1016/j.surg.2005.06.006; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003	49	19	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46130	10.1371/journal.pone.0046130	http://dx.doi.org/10.1371/journal.pone.0046130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049958	Green Published, Green Submitted, gold			2022-12-25	WOS:000309556100142
J	Katsumata, R; Ishigaki, S; Katsuno, M; Kawai, K; Sone, J; Huang, Z; Adachi, H; Tanaka, F; Urano, F; Sobue, G				Katsumata, Ryu; Ishigaki, Shinsuke; Katsuno, Masahisa; Kawai, Kaori; Sone, Jun; Huang, Zhe; Adachi, Hiroaki; Tanaka, Fumiaki; Urano, Fumihiko; Sobue, Gen			c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHRONIC MYELOID-LEUKEMIA; BULBAR MUSCULAR-ATROPHY; TYROSINE KINASE; CELL-DEATH; IMATINIB MESYLATE; BLAST CRISIS; PHENOTYPIC-EXPRESSION; TRANSGENIC MICE; DNA-DAMAGE	Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study revealed the apoptosis-related gene c-Abl to be upregulated in sporadic ALS motor neurons. Methodology/Findings: We investigated the possibility that c-Abl activation is involved in the progression of ALS and that c-Abl inhibition is potentially a therapeutic strategy for ALS. Using a mouse motor neuron cell line, we found that mutation of Cu/Zn-superoxide dismutase-1 (SOD1), which is one of the causative genes of familial ALS, induced the upregulation of c-Abl and decreased cell viability, and that the c-Abl inhibitor dasatinib inhibited cytotoxicity. Activation of c-Abl with a concomitant increase in activated caspase-3 was observed in the lumbar spine of G93A-SOD1 transgenic mice (G93A mice), a widely used model of ALS. The survival of G93A mice was improved by oral administration of dasatinib, which also decreased c-Abl phosphorylation, inactivated caspase-3, and improved the innervation status of neuromuscular junctions. In addition, c-Abl expression in postmortem spinal cord tissues from sporadic ALS patients was increased by 3-fold compared with non-ALS patients. Conclusions/Significance: The present results suggest that c-Abl is a potential therapeutic target for ALS and that the c-Abl inhibitor dasatinib has neuroprotective properties in vitro and in vivo.	[Katsumata, Ryu; Ishigaki, Shinsuke; Katsuno, Masahisa; Kawai, Kaori; Sone, Jun; Huang, Zhe; Adachi, Hiroaki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Ishigaki, Shinsuke; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Ishigaki, Shinsuke; Sobue, Gen] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	Nagoya University; University of Massachusetts System; University of Massachusetts Worcester; Japan Science & Technology Agency (JST); University of Massachusetts System; University of Massachusetts Worcester	Sobue, G (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Tsurumai Cho, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	ISHIGAKI, Shinsuke/I-7305-2014; Sone, Jun/M-5027-2014; Urano, Fumihiko/AAF-4492-2020; Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014	Sone, Jun/0000-0002-9057-7609; Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; Ishigaki, Shinsuke/0000-0002-9555-0659	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology"; Ministry of Health, Labor and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Center-of-Excellence (COE) grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [http://w3serv.nagoya-u.ac.jp/coemed/en/index.html]; a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" [http://www.tmd.ac.jp/mri/shingakujutu/index-e.html], and Grant-in-Aids from Ministry of Education, Culture, Sports, Science, and Technology of Japan [http://www.jsps.go.jp/english/e-grants/index.html]; grants from the Ministry of Health, Labor and Welfare of Japan [http://www.mhlw.go.jp/english/policy/other/research-projects/index.html]; and Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) [http://www.sss.jst.go.jp/english/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Agrawal M, 2010, CURR ONCOL REP, V12, P302, DOI 10.1007/s11912-010-0116-1; Aichberger KJ, 2007, EUR J CLIN INVEST, V37, P808, DOI 10.1111/j.1365-2362.2007.01859.x; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Braconi C, 2008, CURR CANCER DRUG TAR, V8, P359, DOI 10.2174/156800908785133169; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bujassoum S, 2004, LEUKEMIA LYMPHOMA, V45, P401, DOI 10.1080/10428190310001593184; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chen TC, 2007, CELL MICROBIOL, V9, P2676, DOI 10.1111/j.1462-5822.2007.00988.x; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Emery A, 1982, HUMAN MOTOR NEURON D, P139; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; Gonfloni S, 2010, ONCOGENE, V29, P6193, DOI 10.1038/onc.2010.410; Gu JJ, 2009, IMMUNOL REV, V228, P170, DOI 10.1111/j.1600-065X.2008.00751.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ishigaki S, 2002, J NEUROCHEM, V82, P576, DOI 10.1046/j.1471-4159.2002.00998.x; Isobe Y, 2009, INTERN MED J, V39, P408, DOI 10.1111/j.1445-5994.2009.01947.x; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Jiang YM, 2007, J NEUROPATH EXP NEUR, V66, P617, DOI 10.1097/nen.0b013e318093ece3; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lu W, 2007, BIOCHEM BIOPH RES CO, V352, P431, DOI 10.1016/j.bbrc.2006.11.028; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Matsuda M, 2005, INT J HEMATOL, V81, P307, DOI 10.1532/IJH97.04188; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Nowell PC, 1960, SCIENCE, V132, P1488; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Rajappa S, 2004, HEMATOL ONCOL, V22, P179, DOI 10.1002/hon.737; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Simpson E, 2006, CLIN LAB HAEMATOL, V28, P215, DOI 10.1111/j.1365-2257.2006.00782.x; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; TYLER HR, 1991, HDB CLIN NEUROL, P169; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang JYJ, 2001, BIOCHEM SOC T, V29, P666, DOI 10.1042/0300-5127:0290666; WANG JYJ, 1984, CELL, V36, P349; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	58	24	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46185	10.1371/journal.pone.0046185	http://dx.doi.org/10.1371/journal.pone.0046185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049975	Green Published, gold, Green Submitted			2022-12-25	WOS:000309556100150
J	Sun, P; Mantri, N; Lou, HQ; Hu, Y; Sun, D; Zhu, YQ; Dong, TT; Lu, HF				Sun, Peng; Mantri, Nitin; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei			Effects of Elevated CO2 and Temperature on Yield and Fruit Quality of Strawberry (Fragaria x ananassa Duch.) at Two Levels of Nitrogen Application	PLOS ONE			English	Article							CARBON-DIOXIDE; ANTIOXIDANT ACTIVITY; LEAF SENESCENCE; ARABIDOPSIS-THALIANA; PHENOLIC METABOLISM; HARVEST INDEX; SEED-SET; GROWTH; STRESS; WHEAT	We investigated if elevated CO2 could alleviate the negative effect of high temperature on fruit yield of strawberry (Fragaria x ananassa Duch. cv. Toyonoka) at different levels of nitrogen and also tested the combined effects of CO2, temperature and nitrogen on fruit quality of plants cultivated in controlled growth chambers. Results show that elevated CO2 and high temperature caused a further 12% and 35% decrease in fruit yield at low and high nitrogen, respectively. The fewer inflorescences and smaller umbel size during flower induction caused the reduction of fruit yield at elevated CO2 and high temperature. Interestingly, nitrogen application has no beneficial effect on fruit yield, and this may be because of decreased sucrose export to the shoot apical meristem at floral transition. Moreover, elevated CO2 increased the levels of dry matter-content, fructose, glucose, total sugar and sweetness index per dry matter, but decreased fruit nitrogen content, total antioxidant capacity and all antioxidant compounds per dry matter in strawberry fruit. The reduction of fruit nitrogen content and antioxidant activity was mainly caused by the dilution effect of accumulated non-structural carbohydrates sourced from the increased net photosynthetic rate at elevated CO2. Thus, the quality of strawberry fruit would increase because of the increased sweetness and the similar amount of fruit nitrogen content, antioxidant activity per fresh matter at elevated CO2. Overall, we found that elevated CO2 improved the production of strawberry (including yield and quality) at low temperature, but decreased it at high temperature. The dramatic fluctuation in strawberry yield between low and high temperature at elevated CO2 implies that more attention should be paid to the process of flower induction under climate change, especially in fruits that require winter chilling for reproductive growth.	[Sun, Peng; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Mantri, Nitin] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Royal Melbourne Institute of Technology (RMIT)	Sun, P (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Lan, Ruiting/0000-0001-9834-5258; Mantri, Nitin/0000-0002-7621-035X	Project of Scientific and Technological Research Plan of Jinhua [2010-3-078, 2010-3-079]	Project of Scientific and Technological Research Plan of Jinhua	This research was funded by the Project of Scientific and Technological Research Plan of Jinhua (2010-3-078, 2010-3-079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AHMED FE, 1993, PLANT CELL ENVIRON, V16, P835, DOI 10.1111/j.1365-3040.1993.tb00505.x; American Society for Testing Materials, 2002, STAND TEST METH TOT; AVIGDORIAVIDOV H, 1977, ANN BOT-LONDON, V41, P927, DOI 10.1093/oxfordjournals.aob.a085389; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G., 1981, PHYSL FLOWERING, VI; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; CASANO LM, 1994, PLANT PHYSIOL, V106, P1033, DOI 10.1104/pp.106.3.1033; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P195; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P183; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; Deng X, 1998, ANN BOT-LONDON, V81, P67, DOI 10.1006/anbo.1997.0535; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Franzaring J, 2011, ENVIRON EXP BOT, V72, P284, DOI 10.1016/j.envexpbot.2011.04.003; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Goncalves B, 2009, J AGR FOOD CHEM, V57, P265, DOI 10.1021/jf8020199; Grindal G, 1998, J PLANT GROWTH REGUL, V17, P161, DOI 10.1007/PL00007030; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P4107, DOI 10.1021/jf980181c; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2011, J EXP BOT, V62, P1523, DOI 10.1093/jxb/erq401; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Konsin M, 2001, J HORTIC SCI BIOTECH, V76, P77, DOI 10.1080/14620316.2001.11511330; Kovacik J, 2007, PLANT SOIL, V297, P255, DOI 10.1007/s11104-007-9346-x; Kumakura H, 1995, JARQ-JPN AGR RES Q, V29, P241; Ledesma NA, 2008, SCI HORTIC-AMSTERDAM, V116, P186, DOI 10.1016/j.scienta.2007.12.010; Levine LH, 2009, ADV SPACE RES, V44, P887, DOI 10.1016/j.asr.2009.06.017; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Lieten F, 1997, ACTA HORTIC, P583, DOI 10.17660/ActaHortic.1997.439.97; Lin YL, 2011, PLANT GROWTH REGUL, V64, P263, DOI 10.1007/s10725-011-9567-0; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; McConnaughay KDM, 1996, GLOB CHANGE BIOL, V2, P25, DOI 10.1111/j.1365-2486.1996.tb00046.x; MORISHITA M, 1993, J JPN SOC HORTIC SCI, V61, P857, DOI 10.2503/jjshs.61.857; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NITSCH J. P., 1952, QUART REV BIOL, V27, P33, DOI 10.1086/398643; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Prasad PVV, 2003, GLOBAL CHANGE BIOL, V9, P1775, DOI [10.1046/j.1365-2486.2003.00708.x, 10.1046/j.1529-8817.2003.00708.x]; Prasad PVV, 2002, GLOBAL CHANGE BIOL, V8, P710, DOI 10.1046/j.1365-2486.2002.00508.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reddy KR, 2000, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, P161, DOI 10.1079/9780851994390.0161; SAINI HS, 1982, ANN BOT-LONDON, V49, P835, DOI 10.1093/oxfordjournals.aob.a086310; Santos BM, 2009, INT J FRUIT SCI, V9, P126, DOI 10.1080/15538360902991337; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Su WR, 2001, PLANT PHYSIOL BIOCH, V39, P45, DOI 10.1016/S0981-9428(00)01218-3; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki K, 2001, J AM SOC HORTIC SCI, V126, P571, DOI 10.21273/JASHS.126.5.571; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR DR, 1994, PLANT GROWTH REGUL, V15, P235, DOI 10.1007/BF00029896; vanTienderen PH, 1996, AM J BOT, V83, P169, DOI 10.2307/2445934; Wang SY, 2004, J SCI FOOD AGR, V84, P1464, DOI 10.1002/jsfa.1824; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Wheeler TR, 1996, J AGR SCI, V127, P37, DOI 10.1017/S0021859600077352; Xiao G., 2009, ACTA ECOL SIN, V29, P205, DOI [10.1016/j.chnaes.2009.08.002, DOI 10.1016/J.CHNAES.2009.08.002]; Xiong W, 2007, CLIMATIC CHANGE, V81, P205, DOI 10.1007/s10584-006-9123-5; Yamasaki A, 2000, J JPN SOC HORTIC SCI, V69, P40, DOI 10.2503/jjshs.69.40; Yoshida H, 2011, FIELD CROP RES, V124, P433, DOI 10.1016/j.fcr.2011.07.016; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028; Zhu CW, 2009, FUNCT PLANT BIOL, V36, P291, DOI 10.1071/FP08269	71	61	62	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41000	10.1371/journal.pone.0041000	http://dx.doi.org/10.1371/journal.pone.0041000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	23049947	Green Published, Green Submitted, gold			2022-12-25	WOS:000306751300020
J	Jiang, JJ; Huang, LZ; Yu, WZ; Wu, X; Zhou, P; Li, XX				Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin			Overexpression of HTRA1 Leads to Down-Regulation of Fibronectin and Functional Changes in RF/6A Cells and HUVECs	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; SERINE-PROTEASE HTRA1; RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; GENE POLYMORPHISMS; JAPANESE PATIENTS; CHINESE PATIENTS; A1 HTRA1; EXPRESSION	Multiple genetic studies have suggested that high-temperature requirement serine protease (HTRA1) is associated with polypoidal choroidal vasculopathy (PCV). To date, no functional studies have investigated the biological effect of HTRA1 on vascular endothelial cells, essential vascular components involved in polypoidal vascular abnormalities and arteriosclerosis-like changes. In vitro studies were performed to investigate the effect of HTRA1 on the regulation of fibronectin, laminin, vascular endothelial growth factor (VEGF), platelet derived growth factor receptor (PDGFR) and matrix metalloparoteinases 2 (MMP-2) and the role of HTRA1 in choroid-retina endothelial (RF/6A) and human umbilical vein endothelial (HUVEC) cells. Lentivirus-mediated overexpression of HTRA1 was used to explore effects of the protease on RF/6A and HUVEC cells in vitro. HTRA1 overexpression inhibited the proliferation, cell cycle, migration and tube formation of RF/6A and HUVEC cells, effects that might contribute to the early stage of PCV pathological lesions. Fibronectin mRNA and protein levels were significantly down-regulated following the upregulation of HTRA1, whereas the expressions of laminin, VEGF and MMP-2 were unaffected by alterations in HTRA1 expression. The decreased biological function of vascular endothelial cells and the degradation of extracellular matrix proteins, such as fibronectin, may be involved in a contributory role for HTRA1 in PCV pathogenesis.	[Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Jiang, Jingjing] China Japan Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhou, Peng] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Peking University; China-Japan Friendship Hospital; Fudan University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	National Basic Research Program of China (973 Program) [2011CB510200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Program (2011CB510200)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Canfield AE, 2007, BIOCHEM SOC T, V35, P669, DOI 10.1042/BST0350669; Chan CC, 2007, T AM OPHTHAL SOC, V105, P97; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; DeAngelis MM, 2008, OPHTHALMOLOGY, V115, P1209, DOI 10.1016/j.ophtha.2007.10.032; Gotoh N, 2010, JPN J OPHTHALMOL, V54, P609, DOI 10.1007/s10384-010-0865-2; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, MOL VIS, V15, P1057; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lafaut BA, 2000, GRAEF ARCH CLIN EXP, V238, P752, DOI 10.1007/s004170000180; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Libby P, 2006, Handb Exp Pharmacol, P285; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Ng TK, 2011, INVEST OPHTH VIS SCI, V52, P3706, DOI 10.1167/iovs.10-6773; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Park DH, 2012, JPN J OPHTHALMOL, V56, P60, DOI 10.1007/s10384-011-0089-0; Patel N, 2003, J PHARMACOL EXP THER, V306, P838, DOI 10.1124/jpet.103.052167; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tong Y, 2010, MOL VIS, V16, P1958; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; VLODAVSKY I, 1981, NATURE, V289, P304, DOI 10.1038/289304a0; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	48	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46115	10.1371/journal.pone.0046115	http://dx.doi.org/10.1371/journal.pone.0046115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056244	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500028
J	Jiang, JY; Qiu, H; Zhao, GM; Zhou, Y; Zhang, ZJ; Zhang, H; Jiang, QW; Sun, Q; Wu, HY; Yang, LM; Ruan, XN; Xu, WH				Jiang, Junyi; Qiu, Hua; Zhao, Genming; Zhou, Yi; Zhang, Zhijie; Zhang, Hong; Jiang, Qingwu; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan; Xu, Wang-Hong			Dietary Fiber Intake Is Associated with HbA1c Level among Prevalent Patients with Type 2 Diabetes in Pudong New Area of Shanghai, China	PLOS ONE			English	Article							LOW-GLYCEMIC-INDEX; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; WOMENS HEALTH; CEREAL FIBER; MELLITUS; OUTPATIENTS; LOAD; CARBOHYDRATE; HEMOGLOBIN	Background: Dietary factors play an important role in glycemic control in diabetic patients. However, little is known about their effects among Chinese diabetic patients, whose diets are typically abundant in fiber and high in glycemic index (GI) values. Methodology/Principal Findings: 934 patients with type 2 diabetes and 918 healthy volunteers from Pudong New Area, Shanghai, China, were interviewed during the period of Oct-Dec, 2006 to elicit demographic characteristics and lifestyle factors. Dietary habits were assessed using a validated food frequency questionnaire. Anthropometric measurements, biospecimen collection and biochemical assays were conducted at the interview according to a standard protocol. In this population, diabetic patients consumed lower levels of energy and macronutrients but had higher levels of fasting plasma glucose (FPG), glycolated hemoglobin A1c (HbA1c), triglyceride and body mass index than healthy adults. While the average consumption levels of the nutrients among diabetic patients did not vary along duration of the disease, the average levels of FPG and HbA1c increased with increasing duration. Regardless of diabetes duration, HbA1c level was observed lower in patients having a higher fiber or lower GI intake. Compared with those with the lowest tertile intake of fiber, the adjusted odds ratios (ORs) for poor glycemic control reduced from 0.75 (95% CI: 0.54-1.06) to 0.51 (95% CI: 0.34-0.75) with increasing tertile intake (P for trend,0.001). Conclusions: Dietary fiber may play an important role in reducing HbA1c level. Increasing fiber intake may be an effective approach to improve glycemic control among Chinese diabetic patients.	[Qiu, Hua; Zhou, Yi; Zhang, Hong; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan] Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jiang, Junyi; Zhao, Genming; Zhang, Zhijie; Jiang, Qingwu; Xu, Wang-Hong] Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China	Shanghai Center for Disease Control & Prevention; Fudan University	Ruan, XN (corresponding author), Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China.	ruan_118@hotmail.com; wanghong.xu@fudan.edu.cn	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	Shanghai Municipal Health Bureau [08GWZX0201]; Pudong Health Bureau of Shanghai [PWRd2010-03]	Shanghai Municipal Health Bureau; Pudong Health Bureau of Shanghai	This research was funded by Shanghai Municipal Health Bureau (08GWZX0201) and Academic Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRd2010-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Esposito K, 2010, METAB SYNDR RELAT D, V8, P255, DOI 10.1089/met.2009.0096; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franz MJ, 2003, DIABETES CARE, V26, P2466, DOI 10.2337/diacare.26.8.2466; Haimoto H, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-21; He MA, 2010, CIRCULATION, V121, P2162, DOI 10.1161/CIRCULATIONAHA.109.907360; Hessler DM, 2010, PATIENT ED COUNS; Hinata M, 2007, DIABETES RES CLIN PR, V77, P327, DOI 10.1016/j.diabres.2006.10.008; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S, DOI 10.1093/ajcn/76.1.266S; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Kim MS, 2008, NUTR RES PRACT, V2, P62; Larsen RN, 2011, DIABETOLOGIA, V54, P731, DOI 10.1007/s00125-010-2027-y; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pearce KL, 2011, BRIT J NUTR, V105, P584, DOI 10.1017/S0007114510003983; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Roush George, 2011, Conn Med, V75, P325; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yin Wen-ya, 2005, Zhonghua Yufang Yixue Zazhi, V39, P342; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Ziai SA, 2005, J ETHNOPHARMACOL, V102, P202, DOI 10.1016/j.jep.2005.06.042	30	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46552	10.1371/journal.pone.0046552	http://dx.doi.org/10.1371/journal.pone.0046552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23056244	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800008
J	Abdgawad, M; Pettersson, A; Gunnarsson, L; Bengtsson, AA; Geborek, P; Nilsson, L; Segelmark, M; Hellmark, T				Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Bengtsson, Anders A.; Geborek, Pierre; Nilsson, Lars; Segelmark, Marten; Hellmark, Thomas			Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY-BOWEL-DISEASE; GRANULOCYTE-MACROPHAGE; FACTOR-RECEPTOR; WEGENERS-GRANULOMATOSIS; CIRCULATING NEUTROPHILS; LUPUS-ERYTHEMATOSUS; ENDOTHELIAL-CELLS; TARGET-CELLS; PU.1 SPI-1	Background: ANCA-Associated Systemic Vasculitis (AASV) is characterized by leukocytoclasis, accumulation of unscavenged apoptotic and necrotic neutrophils in perivascular tissues. Dysregulation of neutrophil cell death may contribute directly to the pathogenesis of AASV. Methods: Neutrophils from Healthy Blood Donors (HBD), patients with AASV most in complete remission, Polycythemia Vera (PV), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) and renal transplant recipients (TP) were incubated in vitro, and the rate of spontaneous apoptosis was measured by FACS. Plasma levels of cytokines and sFAS were measured with cytometric bead array and ELISA. Expression of pro/anti-apoptotic factors, transcription factors C/EBP-alpha, C/EBP-beta and PU.1 and inhibitors of survival/JAK2-pathway were measured by real-time-PCR. Results: AASV, PV and RA neutrophils had a significantly lower rate of apoptosis compared to HBD neutrophils (AASV 50 +/- 14% vs. HBD 64 +/- 11%, p < 0.0001). In RA but not in AASV and PV, low apoptosis rate correlated with increased plasma levels of GM-CSF and high mRNA levels of anti-apoptotic factors Bcl-2A1 and Mcl-1. AASV patients had normal levels of G-CSF, GM-CSF and IL-3. Both C/EBP-alpha, C/EBP-beta were significantly higher in neutrophils from AASV patients than HBD. Levels of sFAS were significantly higher in AASV compared to HBD. Conclusion: Neutrophil apoptosis rates in vitro are decreased in AASV, RA and PV but mechanisms seem to differ. Increased mRNA levels of granulopoiesis-associated transcription factors and increased levels of sFAS in plasma were observed in AASV. Additional studies are required to define the mechanisms behind the decreased apoptosis rates, and possible connections with accumulation of dying neutrophils in regions of vascular lesions in AASV patients.	[Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Segelmark, Marten; Hellmark, Thomas] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden; [Bengtsson, Anders A.; Geborek, Pierre] Lund Univ, Dept Rheumatol, S-22101 Lund, Sweden; [Nilsson, Lars] Lund Univ, Dept Haematol, S-22101 Lund, Sweden; [Segelmark, Marten] Linkoping Univ, Dept Hlth & Med, Linkoping, Sweden	Lund University; Lund University; Lund University; Linkoping University	Abdgawad, M (corresponding author), Lund Univ, Dept Nephrol, S-22101 Lund, Sweden.	Mohamed.Abdgawad@med.lu.se	Hellmark, Thomas/U-6289-2017	Hellmark, Thomas/0000-0002-2952-1155; Segelmark, Marten/0000-0002-1221-0772; Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [71X-15152]; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation	This study was supported by Swedish Research Council (grant 71X-15152) and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIETTA M, 1993, STEM CELLS, V11, P83; AGLIETTA M, 1993, BLOOD, V82, P2054; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bijl M, 1998, J AUTOIMMUN, V11, P457, DOI 10.1006/jaut.1998.0233; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Christensson M, 2002, J CLIN IMMUNOL, V22, P220, DOI 10.1023/A:1016040925295; Christensson M, 2000, CLIN NEPHROL, V54, P435; Chuang PI, 1998, BIOCHEM BIOPH RES CO, V249, P361, DOI 10.1006/bbrc.1998.9155; DAI CH, 1992, BLOOD, V80, P891; Dale DC, 1998, AM J HEMATOL, V57, P7, DOI 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Durant S, 2004, J LEUKOCYTE BIOL, V75, P87, DOI 10.1189/jlb.0203079; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; Fujimori K, 2008, GRAEF ARCH CLIN EXP, V246, P285, DOI 10.1007/s00417-007-0659-5; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Harper Lorraine, 2006, Expert Rev Clin Immunol, V2, P237, DOI 10.1586/1744666X.2.2.237; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; HENSHAW TJ, 1994, ARTHRITIS RHEUM, V37, P104, DOI 10.1002/art.1780370116; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kallenberg CGM, 2002, KIDNEY INT, V61, P758, DOI 10.1046/j.1523-1755.2002.00179.x; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; LUQMANI RA, 1994, Q J MED, V87, P671; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; MOUNTZ JD, 1994, ARTHRITIS RHEUM, V37, P1415, DOI 10.1002/art.1780371002; NAKABAYASHI I, 1993, CLIN NEPHROL, V40, P265; Ohlsson S, 2003, CLIN EXP IMMUNOL, V131, P528, DOI 10.1046/j.1365-2249.2003.02083.x; Patry YC, 2001, J AM SOC NEPHROL, V12, P1764, DOI 10.1681/ASN.V1281764; Pederzoli M, 2005, J IMMUNOL, V174, P6381, DOI 10.4049/jimmunol.174.10.6381; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P315, DOI 10.1097/00000478-199104000-00001; Tsujimoto H, 2001, CLIN EXP IMMUNOL, V126, P355, DOI 10.1046/j.1365-2249.2001.01675.x; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Weinmann P, 2007, CLIN EXP RHEUMATOL, V25, P885; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yang JJ, 2000, CLIN EXP IMMUNOL, V121, P165, DOI 10.1046/j.1365-2249.2000.01228.x	51	228	229	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32439	10.1371/journal.pone.0032439	http://dx.doi.org/10.1371/journal.pone.0032439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	22403660	Green Submitted, Green Published, gold			2022-12-25	WOS:000303017700057
J	Jones, DT; Vemuri, P; Murphy, MC; Gunter, JL; Senjem, ML; Machulda, MM; Przybelski, SA; Gregg, BE; Kantarci, K; Knopman, DS; Boeve, BF; Petersen, RC; Jack, CR				Jones, David T.; Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Machulda, Mary M.; Przybelski, Scott A.; Gregg, Brian E.; Kantarci, Kejal; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.; Jack, Clifford R., Jr.			Non-Stationarity in the "Resting Brain's" Modular Architecture	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; AGE-RELATED-CHANGES; SMALL-WORLD; MRI; ORGANIZATION; FMRI; RECONFIGURATION; DYNAMICS; ADULTS	Task-free functional magnetic resonance imaging (TF-fMRI) has great potential for advancing the understanding and treatment of neurologic illness. However, as with all measures of neural activity, variability is a hallmark of intrinsic connectivity networks (ICNs) identified by TF-fMRI. This variability has hampered efforts to define a robust metric of connectivity suitable as a biomarker for neurologic illness. We hypothesized that some of this variability rather than representing noise in the measurement process, is related to a fundamental feature of connectivity within ICNs, which is their non-stationary nature. To test this hypothesis, we used a large (n = 892) population-based sample of older subjects to construct a well characterized atlas of 68 functional regions, which were categorized based on independent component analysis network of origin, anatomical locations, and a functional meta-analysis. These regions were then used to construct dynamic graphical representations of brain connectivity within a sliding time window for each subject. This allowed us to demonstrate the non-stationary nature of the brain's modular organization and assign each region to a "meta-modular" group. Using this grouping, we then compared dwell time in strong sub-network configurations of the default mode network (DMN) between 28 subjects with Alzheimer's dementia and 56 cognitively normal elderly subjects matched 1: 2 on age, gender, and education. We found that differences in connectivity we and others have previously observed in Alzheimer's disease can be explained by differences in dwell time in DMN sub-network configurations, rather than steady state connectivity magnitude. DMN dwell time in specific modular configurations may also underlie the TF-fMRI findings that have been described in mild cognitive impairment and cognitively normal subjects who are at risk for Alzheimer's dementia.	[Jones, David T.; Knopman, David S.; Boeve, Bradley F.; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Vemuri, Prashanthi; Murphy, Matthew C.; Gunter, Jeffrey L.; Senjem, Matthew L.; Gregg, Brian E.; Kantarci, Kejal; Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Machulda, Mary M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Przybelski, Scott A.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jones, DT (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	jack.clifford@mayo.edu	Senjem, Matthew L/GRF-6799-2022; Jack, Clifford R/F-2508-2010; Vemuri, Prashanthi/K-7030-2012; Harris, Adrian/ABA-3343-2020; Buffa, Francesca M./D-2574-2013	Senjem, Matthew L/0000-0001-9308-9275; Jack, Clifford R/0000-0001-7916-622X; Lechertier, Tanguy/0000-0002-0202-8424; Kantarci, Kejal/0000-0002-8001-2081; Bicknell, Roy/0000-0002-0941-8919; Harris, Adrian/0000-0003-1376-8409; Jones, J Louise/0000-0003-3880-3274; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Buffa, Francesca M./0000-0003-0409-406X; Mitter, Richard/0000-0002-1279-3760; Jones, David/0000-0002-4807-9833	National Institute on Aging [R01AG11378, P50 AG16574, U01 AG06786, K99AG37573]; Mayo Foundation; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [U01AG006786, P50AG016574, K99AG037573, R01AG011378, R01AG041851] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The National Institute on Aging (R01AG11378, P50 AG16574, U01 AG06786, K99AG37573), the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation, and Alzheimer's Association New Investigator grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; GLOOR P, 1994, ELECTROEN CLIN NEURO, V90, P253, DOI 10.1016/0013-4694(94)90143-0; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2011, ARCH NEUROL-CHICAGO, V68, P1107, DOI 10.1001/archneurol.2011.202; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	47	280	286	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e39731	10.1371/journal.pone.0039731	http://dx.doi.org/10.1371/journal.pone.0039731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22761880	gold, Green Submitted, Green Published			2022-12-25	WOS:000305826400031
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-25	WOS:000312386600039
